PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bazzocchi, A; Diano, D; Battista, G				Bazzocchi, Alberto; Diano, Danila; Battista, Giuseppe			How fat is fat?	LANCET			English	Editorial Material									[Bazzocchi, Alberto; Diano, Danila; Battista, Giuseppe] Univ Bologna, Imaging Div, Clin Dept Radiol & Histocytopathol Sci, StOrsola Malpighi Hosp, I-40138 Bologna, Italy; [Bazzocchi, Alberto] Rizzoli Orthopaed Inst, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Istituto Ortopedico Rizzoli	Bazzocchi, A (corresponding author), Univ Bologna, Imaging Div, Clin Dept Radiol & Histocytopathol Sci, StOrsola Malpighi Hosp, Via Massarenti 9, I-40138 Bologna, Italy.	abazzo@inwind.it	Bazzocchi, Alberto/O-8048-2016; Battista, Giuseppe/AAC-3362-2021	Bazzocchi, Alberto/0000-0002-2659-4535; Battista, Giuseppe/0000-0003-3639-3494					0	8	8	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 14	2012	380	9837					E1	E1		10.1016/S0140-6736(11)61925-9	http://dx.doi.org/10.1016/S0140-6736(11)61925-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	973KN	22484135				2022-12-24	WOS:000306359100001
J	Speirs, V				Speirs, Valerie			PERSPECTIVE Not just for women	NATURE			English	Editorial Material									Univ Leeds, Leeds Inst Mol Med, Leeds LS2 9JT, W Yorkshire, England	University of Leeds	Speirs, V (corresponding author), Univ Leeds, Leeds Inst Mol Med, Leeds LS2 9JT, W Yorkshire, England.	v.speirs@leeds.ac.uk	Speirs, Valerie/ABE-7377-2021	Speirs, Valerie/0000-0002-0602-4666				Curtis C, 2012, NATURE          0418, DOI [10.1038/nature10983, DOI 10.1038/NATURE10983]; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Johansson I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3116; Lehmann U, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-109; Shaaban AM, 2012, BREAST CANCER RES TR, V133, P949, DOI 10.1007/s10549-011-1856-9; White J, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2930	6	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S66	S66		10.1038/485S66a	http://dx.doi.org/10.1038/485S66a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648505				2022-12-24	WOS:000304608000009
J	Mandrup-Poulsen, T				Mandrup-Poulsen, Thomas			Testing failures	NATURE			English	Editorial Material							ANTAGONIST		[Mandrup-Poulsen, Thomas] Univ Copenhagens, Inst Biomed Sci, Copenhagen, Denmark; [Mandrup-Poulsen, Thomas] Karolinska Inst, Stockholm, Sweden	Karolinska Institutet	Mandrup-Poulsen, T (corresponding author), Univ Copenhagens, Inst Biomed Sci, Copenhagen, Denmark.	tmpo@sund.ku.dk		Mandrup-Poulsen, Thomas/0000-0002-3215-9273				Keymeulen B, 2005, NEW ENGL J MED, V352, P2598, DOI 10.1056/NEJMoa043980; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Larsen CM, 2009, DIABETES CARE, V32, P1663, DOI 10.2337/dc09-0533; Pescovitz MD, 2009, NEW ENGL J MED, V361, P2143, DOI 10.1056/NEJMoa0904452; Sherry N, 2011, LANCET, V378, P487, DOI 10.1016/S0140-6736(11)60931-8	5	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					S17	S17		10.1038/485S17a	http://dx.doi.org/10.1038/485S17a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968AT	22616101	Bronze			2022-12-24	WOS:000305950100008
J	Goldfine, AB				Goldfine, Allison B.			Statins: Is It Really Time to Reassess Benefits and Risks?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METAANALYSIS; THERAPY		[Goldfine, Allison B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Goldfine, Allison B.] Joslin Diabet Ctr, Sect Clin Behav & Outcomes Res, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.	Goldfine, AB (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.			Goldfine, Allison/0000-0002-0345-1048				Kearney PM, 2008, LANCET, V371, P117, DOI 10.1016/S0140-6736(08)60104-X; Preiss D, 2011, JAMA-J AM MED ASSOC, V305, P2556, DOI 10.1001/jama.2011.860; Rajpathak SN, 2009, DIABETES CARE, V32, P1924, DOI 10.2337/dc09-0738; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6	5	65	66	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1752	1755		10.1056/NEJMp1203020	http://dx.doi.org/10.1056/NEJMp1203020			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NB	22533536				2022-12-24	WOS:000303817000002
J	Eisenstein, M				Eisenstein, Michael			DRUG DEVELOPMENT Holding out for reinforcements	NATURE			English	Editorial Material							MALARIA											Adjalley SH, 2011, P NATL ACAD SCI USA, V108, pE1214, DOI 10.1073/pnas.1112037108; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225	6	13	14	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S16	S18		10.1038/484S16a	http://dx.doi.org/10.1038/484S16a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22534526				2022-12-24	WOS:000303200400001
J	O'Grady, M; O'Hare, G				O'Grady, Michael; O'Hare, Gregory			How Smart Is Your City?	SCIENCE			English	Editorial Material									[O'Grady, Michael; O'Hare, Gregory] Univ Coll Dublin, Dublin 4, Ireland	University College Dublin	O'Grady, M (corresponding author), Univ Coll Dublin, Dublin 4, Ireland.	michael.j.ogrady@ucd.ie	O'Hare, Gregory M.P./AAA-7756-2022	O'Hare, Gregory M.P./0000-0002-5124-1686; O'Grady, Michael/0000-0002-3024-3666				Broring A, 2011, SENSORS-BASEL, V11, P7568, DOI 10.3390/s110807568; Cook DJ, 2012, SCIENCE, V335, P1579, DOI 10.1126/science.1217640; De Jong K. A., 2008, COMPUT INTELL MAG IE, V3, P12; Gershenfeld N, 2010, SCIENCE, V327, P1086, DOI 10.1126/science.1174082; Hildebrandt Mireille, 2008, REGULATING TECHNOLOG, p[175, 187]; Kabassi Katerina, 2010, Telematics and Informatics, V27, P51, DOI 10.1016/j.tele.2009.05.003; KASPER JD, 1994, J APPL GERONTOL, V13, P371, DOI 10.1177/073346489401300403; Landau R, 2010, QUAL HEALTH RES, V20, P409, DOI 10.1177/1049732309359171; Reggente M, 2010, CHEM ENGINEER TRANS, V23, P273, DOI 10.3303/CET1023046; Sheth A, 2008, IEEE INTERNET COMPUT, V12, P78, DOI 10.1109/MIC.2008.87; Streitz N., 2011, LECT NOTES COMPUT 3, P425; Vullers R. J. M., 2010, IEEE SOLID STATE CIR, V2, P29, DOI [10.1109/MSSC.2010.936667, DOI 10.1109/MSSC.2010.936667]	12	66	66	5	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1581	1582		10.1126/science.1217637	http://dx.doi.org/10.1126/science.1217637			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915YD	22461597	Green Submitted			2022-12-24	WOS:000302062600029
J	Rogulja, D; Young, MW				Rogulja, Dragana; Young, Michael W.			Control of Sleep by Cyclin A and Its Regulator	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; CIRCADIAN CLOCK; BEHAVIOR; CIRCUIT; REST	How and why the brain reversibly switches from a waking to a sleep state remain among the most intriguing questions in biology. We show that cyclin A (CycA) and regulator of cyclin A1, essential cell cycle factors, function in postmitotic neurons to promote sleep in Drosophila melanogaster. Reducing the abundance of CycA in neurons delayed the wake-sleep transition, caused multiple arousals from sleep, and reduced the homeostatic response to sleep deprivation. CycA is expressed in similar to 40 to 50 neurons in the adult brain, most of which are intermingled with circadian clock neurons, suggesting functional interactions among neurons controlling sleep and circadian behavior.	[Rogulja, Dragana; Young, Michael W.] Rockefeller Univ, Genet Lab, New York, NY 10065 USA	Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, 1230 York Ave, New York, NY 10065 USA.	young@mail.rockefeller.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020		NIH [NS053087, GM054339]; Jane Coffin Childs Memorial Fund for Medical Research; Merck fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054339, R37GM054339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053087] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; Merck fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Allada, B. Dickson, J. Hall, C. Lehner, A. Sehgal, F. Sprenger, and NIG-Fly Stock Center for reagents; N. Stavropoulos for custom MatLab software; and C. Bargmann, M. Crickmore, C. Desplan, A. Keene, S. Shaham, L. Vosshall, and members of the Young lab for helpful discussions and comments on the manuscript. This work was supported by NIH grants NS053087 and GM054339 (to M.W.Y.). D.R. was supported by a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research and by a Merck fellowship.	Boothroyd CE, 2008, ANN NY ACAD SCI, V1129, P350, DOI 10.1196/annals.1417.006; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dong XZ, 1997, GENE DEV, V11, P94, DOI 10.1101/gad.11.1.94; Foltenyi K, 2007, NAT NEUROSCI, V10, P1160, DOI 10.1038/nn1957; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Helfrich-Forster C, 2005, GENES BRAIN BEHAV, V4, P65, DOI 10.1111/j.1601-183X.2004.00092.X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Lear BC, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000154; Nitz DA, 2002, CURR BIOL, V12, P1934, DOI 10.1016/S0960-9822(02)01300-3; Odajima J, 2011, DEV CELL, V21, P655, DOI 10.1016/j.devcel.2011.08.009; Ou CY, 2010, CELL, V141, P846, DOI 10.1016/j.cell.2010.04.011; Parisky KM, 2008, NEURON, V60, P672, DOI 10.1016/j.neuron.2008.10.042; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Rothenfluh A, 2000, GENETICS, V156, P665; Sehgal A, 2011, CELL, V146, P194, DOI 10.1016/j.cell.2011.07.004; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Zielke N, 2006, EMBO REP, V7, P1266, DOI 10.1038/sj.embor.7400851	20	55	55	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1617	1621		10.1126/science.1212476	http://dx.doi.org/10.1126/science.1212476			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461610	Green Accepted			2022-12-24	WOS:000302062600043
J	Jonker, JW; Suh, JM; Atkins, AR; Ahmadian, M; Li, PP; Whyte, J; He, MX; Juguilon, H; Yin, YQ; Phillips, CT; Yu, RT; Olefsky, JM; Henry, RR; Downes, M; Evans, RM				Jonker, Johan W.; Suh, Jae Myoung; Atkins, Annette R.; Ahmadian, Maryam; Li, Pingping; Whyte, Jamie; He, Mingxiao; Juguilon, Henry; Yin, Yun-Qiang; Phillips, Colin T.; Yu, Ruth T.; Olefsky, Jerrold M.; Henry, Robert R.; Downes, Michael; Evans, Ronald M.			A PPAR gamma-FGF1 axis is required for adaptive adipose remodelling and metabolic homeostasis	NATURE			English	Article							CAUSES INSULIN-RESISTANCE; PPAR-GAMMA; FAT NECROSIS; OBESITY; TISSUE; FIBROBLAST-GROWTH-FACTOR-1; ADIPOCYTES; BIOLOGY; FAMILY; MUSCLE	Although feast and famine cycles illustrate that remodelling of adipose tissue in response to fluctuations in nutrient availability is essential for maintaining metabolic homeostasis, the underlying mechanisms remain poorly understood(1,2). Here we identify fibroblast growth factor 1 (FGF1) as a critical transducer in this process in mice, and link its regulation to the nuclear receptor PPAR gamma (peroxisome proliferator activated receptor gamma), which is the adipocyte master regulator and the target of the thiazolidinedione class of insulin sensitizing drugs(3-5). FGF1 is the prototype of the 22-member FGF family of proteins and has been implicated in a range of physiological processes, including development, wound healing and cardiovascular changes(6). Surprisingly, FGF1 knockout mice display no significant phenotype under standard laboratory conditions(7-9). We show that FGF1 is highly induced in adipose tissue in response to a high-fat diet and that mice lacking FGF1 develop an aggressive diabetic phenotype coupled to aberrant adipose expansion when challenged with a high-fat diet. Further analysis of adipose depots in FGF1-deficient mice revealed multiple histopathologies in the vasculature network, an accentuated inflammatory response, aberrant adipocyte size distribution and ectopic expression of pancreatic lipases. On withdrawal of the high-fat diet, this inflamed adipose tissue fails to properly resolve, resulting in extensive fat necrosis. In terms of mechanisms, we show that adipose induction of FGF1 in the fed state is regulated by PPAR gamma acting through an evolutionarily conserved promoter proximal PPAR response element within the FGF1 gene. The discovery of a phenotype for the FGF1 knockout mouse establishes the PPAR gamma-FGF1 axis as critical for maintaining metabolic homeostasis and insulin sensitization.	[Jonker, Johan W.; Suh, Jae Myoung; Atkins, Annette R.; Ahmadian, Maryam; Whyte, Jamie; He, Mingxiao; Juguilon, Henry; Yin, Yun-Qiang; Phillips, Colin T.; Yu, Ruth T.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Li, Pingping; Olefsky, Jerrold M.; Henry, Robert R.] Univ Calif San Diego, Div Endocrinol & Metab, Dept Med, La Jolla, CA 92093 USA; [Henry, Robert R.] Vet Affairs San Diego Healthcare Syst, Sect Diabetes Metab, San Diego, CA 92161 USA; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	downes@salk.edu; evans@salk.edu	Evans, Ronald/AAF-4001-2019; Suh, Jae Myoung/B-3268-2015; Li, Pingping/F-1109-2019; Jonker, Johan W./ABE-6853-2020	Evans, Ronald/0000-0002-9986-5965; Suh, Jae Myoung/0000-0001-8097-4662; Li, Pingping/0000-0003-0679-270X; Jonker, Johan W./0000-0002-3919-5437; Yu, Ruth/0000-0002-9527-9627; Phillips, Colin/0000-0002-6543-0234; Atkins, Annette/0000-0003-2558-7058	National Institutes of Health [DK062434, DK057978, DK090962, DK063491, HL105278]; Helmsley Charitable Trust; Howard Hughes Medical Institute; Human Frontier Science Program (HFSP); Netherlands Organization for Scientific Research (NWO); EU [IRG-277169]; NIDDK; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD012303] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, U19DK062434, R01DK033651, R37DK033651, R37DK057978, R24DK090962] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); EU(European Commission); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. Alvarez, S. Kaufman, N. H. Uhlenhaut, M. Hassan and E. Williams for technical assistance, and L. Ong and S. Ganley for administrative assistance. R. M. E. is an Investigator of the Howard Hughes Medical Institute at the Salk Institute and March of Dimes Chair in Molecular and Developmental Biology. This work was supported by National Institutes of Health grants (DK062434, DK057978, DK090962, DK063491 and HL105278), the Helmsley Charitable Trust, and the Howard Hughes Medical Institute. J. W. J. is supported by the Human Frontier Science Program (HFSP), the Netherlands Organization for Scientific Research (NWO) and an EU Marie Curie Reintegration grant (IRG-277169). M. A. is supported by an F32 Ruth L. Kirschstein National Research Service Award (NIDDK).	Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Barish GD, 2006, J CLIN INVEST, V116, P590, DOI 10.1172/JCI27955; Barish GD, 2010, GENE DEV, V24, P2760, DOI 10.1101/gad.1998010; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Chua Felix, 2006, Proc Am Thorac Soc, V3, P424, DOI 10.1513/pats.200603-078AW; Fang S, 2011, P NATL ACAD SCI USA, V108, P3412, DOI 10.1073/pnas.1017707108; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Hutley L, 2004, DIABETES, V53, P3097, DOI 10.2337/diabetes.53.12.3097; Hutley LJ, 2011, MOL CELL ENDOCRINOL, V339, P165, DOI 10.1016/j.mce.2011.04.012; Itoh N, 2008, DEV DYNAM, V237, P18, DOI 10.1002/dvdy.21388; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kharitonenkov A, 2009, CURR OPIN PHARMACOL, V9, P805, DOI 10.1016/j.coph.2009.07.001; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; Lee J, 2010, CURR OPIN CLIN NUTR, V13, P371, DOI 10.1097/MCO.0b013e32833aabef; LEE PC, 1979, SURG GYNECOL OBSTET, V148, P39; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Miller DL, 2000, MOL CELL BIOL, V20, P2260, DOI 10.1128/MCB.20.6.2260-2268.2000; Moore DD, 2007, SCIENCE, V316, P1436, DOI 10.1126/science.1144837; MYERS RL, 1993, ONCOGENE, V8, P341; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; SCHMITZMOORMANN P, 1978, PATHOL RES PRACT, V163, P93, DOI 10.1016/S0344-0338(78)80078-8; Springer ML, 2000, MOL THER, V1, P82, DOI 10.1006/mthe.1999.0006; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tacer KF, 2010, MOL ENDOCRINOL, V24, P2050, DOI 10.1210/me.2010-0142; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829	31	192	228	3	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					391	U143		10.1038/nature10998	http://dx.doi.org/10.1038/nature10998			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22522926	Green Accepted			2022-12-24	WOS:000304099100047
J	O'Connell, M; Goulden, V				O'Connell, Michael; Goulden, Victoria			"Half-Half" Blisters	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[O'Connell, Michael; Goulden, Victoria] Leeds Gen Infirm, Leeds, W Yorkshire, England	Leeds General Infirmary; University of Leeds	O'Connell, M (corresponding author), Leeds Gen Infirm, Leeds, W Yorkshire, England.								0	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					E31	E31		10.1056/NEJMicm1013242	http://dx.doi.org/10.1056/NEJMicm1013242			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591309				2022-12-24	WOS:000304083000001
J	Patten, IS; Rana, S; Shahul, S; Rowe, GC; Jang, C; Liu, L; Hacker, MR; Rhee, JS; Mitchell, J; Mahmood, F; Hess, P; Farrell, C; Koulisis, N; Khankin, EV; Burke, SD; Tudorache, I; Bauersachs, J; del Monte, F; Hilfiker-Kleiner, D; Karumanchi, SA; Arany, Z				Patten, Ian S.; Rana, Sarosh; Shahul, Sajid; Rowe, Glenn C.; Jang, Cholsoon; Liu, Laura; Hacker, Michele R.; Rhee, Julie S.; Mitchell, John; Mahmood, Feroze; Hess, Philip; Farrell, Caitlin; Koulisis, Nicole; Khankin, Eliyahu V.; Burke, Suzanne D.; Tudorache, Igor; Bauersachs, Johann; del Monte, Federica; Hilfiker-Kleiner, Denise; Karumanchi, S. Ananth; Arany, Zoltan			Cardiac angiogenic imbalance leads to peripartum cardiomyopathy	NATURE			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; TYROSINE KINASE 1; HEART-FAILURE; MITOCHONDRIAL BIOGENESIS; EJECTION FRACTION; SKELETAL-MUSCLE; ANGIOTENSIN-II; UNITED-STATES; MICE LACKING; PREECLAMPSIA	Peripartum cardiomyopathy (PPCM) is an often fatal disease that affects pregnant women who are near delivery, and it occurs more frequently in women with pre-eclampsia and/or multiple gestation. The aetiology of PPCM, and why it is associated with pre-eclampsia, remain unknown. Here we show that PPCM is associated with a systemic angiogenic imbalance, accentuated by pre-eclampsia. Mice that lack cardiac PGC-1 alpha, a powerful regulator of angiogenesis, develop profound PPCM. Importantly, the PPCM is entirely rescued by pro-angiogenic therapies. In humans, the placenta in late gestation secretes VEGF inhibitors like soluble FLT1 (sFLT1), and this is accentuated by multiple gestation and pre-eclampsia. This anti-angiogenic environment is accompanied by subclinical cardiac dysfunction, the extent of which correlates with circulating levels of sFLT1. Exogenous sFLT1 alone caused diastolic dysfunction in wild-type mice, and profound systolic dysfunction in mice lacking cardiac PGC-1a. Finally, plasma samples from women with PPCM contained abnormally high levels of sFLT1. These data indicate that PPCM is mainly a vascular disease, caused by excess anti-angiogenic signalling in the peripartum period. The data also explain how late pregnancy poses a threat to cardiac homeostasis, and why pre-eclampsia and multiple gestation are important risk factors for the development of PPCM.	[Patten, Ian S.; Rowe, Glenn C.; Jang, Cholsoon; Liu, Laura; Farrell, Caitlin; Koulisis, Nicole; del Monte, Federica; Arany, Zoltan] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Cardiovasc Inst, Boston, MA 02115 USA; [Patten, Ian S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02115 USA; [Rana, Sarosh; Hacker, Michele R.; Rhee, Julie S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Maternal Fetal Med,Dept Obstet & Gynecol, Boston, MA 02115 USA; [Shahul, Sajid; Mitchell, John; Mahmood, Feroze; Hess, Philip] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Anesthesia & Crit Care, Boston, MA 02115 USA; [Khankin, Eliyahu V.; Burke, Suzanne D.; Karumanchi, S. Ananth] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02115 USA; [Tudorache, Igor] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, D-30625 Hannover, Germany; [Bauersachs, Johann; Hilfiker-Kleiner, Denise] Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany; [Burke, Suzanne D.] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Hannover Medical School; Hannover Medical School; Howard Hughes Medical Institute	Arany, Z (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Cardiovasc Inst, 330 Brookline Ave, Boston, MA 02115 USA.	hilfiker.denise@mh-hannover.de; zarany@bidmc.harvard.edu	Mahmood, Feroze/B-1383-2008; Hess, Philip/A-8577-2013; del Monte, Federica/AAF-3961-2020; Farrell, Caitlin/AAR-2799-2021; Rowe, Glenn/N-5314-2019; Karumanchi, Subbian Ananth/AAI-1694-2021; Khankin, Eli/M-7648-2013; del Monte, Federica/AAB-3982-2019; Hacker, Michele/ABC-5031-2021	Mahmood, Feroze/0000-0002-7071-0476; Hess, Philip/0000-0002-1206-0102; Mitchell, John/0000-0001-6087-5210; Burke, Suzanne/0000-0003-4594-4163; Patten, Ian/0000-0003-1888-656X; Rowe, Glenn/0000-0002-8195-9605; Hacker, Michele/0000-0003-0217-9991; del Monte, Federica/0000-0001-9506-9665; Farrell, Caitlin/0000-0001-8547-4659; Khankin, Eliyahu/0000-0002-1695-7267; Jang, Cholsoon/0000-0001-6651-4213	Harvard Faculty; John Hedley White grant; Merck; Harvard Catalyst; Clinical and Translational Science Center; Harvard University; NHLBI; Smith Family Foundation; Ellison Medical Foundation; March of Dimes Foundation; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094499] Funding Source: NIH RePORTER	Harvard Faculty; John Hedley White grant; Merck(Merck & Company); Harvard Catalyst; Clinical and Translational Science Center; Harvard University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Smith Family Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); March of Dimes Foundation(March of Dimes); Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.R. is supported by a Harvard Faculty Development and Diversity Award. S. S is supported by a John Hedley White grant. G. C. R. is supported by a Merck Fellowship. M. R. H. is supported by Harvard Catalyst, the Clinical and Translational Science Center, and Harvard University and affiliated academic health care centers. S. A. K. is an investigator of the Howard Hughes Medical Institute. Z.A. is supported by the NHLBI, the Smith Family Foundation, the Ellison Medical Foundation, the March of Dimes Foundation, and the Harvard Stem Cell Institute.	Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Amos AM, 2006, AM HEART J, V152, P509, DOI 10.1016/j.ahj.2006.02.008; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Bdolah Y, 2004, SEMIN NEPHROL, V24, P548, DOI 10.1016/S0270-9295(04)00125-1; Bdolah Y, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.783; Bruch C, 2000, EUR HEART J, V21, P1888, DOI 10.1053/euhj.2000.2246; Carmeliet P, 1999, NAT MED, V5, P495, DOI 10.1038/8379; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Cruz MO, 2010, OBSTET GYN CLIN N AM, V37, P283, DOI 10.1016/j.ogc.2010.02.003; DEMAKIS JG, 1971, CIRCULATION, V44, P964, DOI 10.1161/01.CIR.44.5.964; Elkayam U, 2011, J AM COLL CARDIOL, V58, P659, DOI 10.1016/j.jacc.2011.03.047; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fett JD, 2005, MAYO CLIN PROC, V80, P1602, DOI 10.4065/80.12.1602; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Goland S, 2011, J CARD FAIL, V17, P426, DOI 10.1016/j.cardfail.2011.01.007; Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Hilfiker-Kleiner D, 2007, CELL, V128, P589, DOI 10.1016/j.cell.2006.12.036; Horne B.D., 2004, CIRC-CARDIOVASC GENE, V4, P359; Hubel CA, 2007, HYPERTENSION, V49, P612, DOI 10.1161/01.HYP.0000256565.20983.d4; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Kasner M, 2007, CIRCULATION, V116, P637, DOI 10.1161/CIRCULATIONAHA.106.661983; Kuo CJ, 2001, P NATL ACAD SCI USA, V98, P4605, DOI 10.1073/pnas.081615298; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; May D, 2008, P NATL ACAD SCI USA, V105, P282, DOI 10.1073/pnas.0707778105; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Melchiorre K, 2011, HYPERTENSION, V57, P85, DOI 10.1161/HYPERTENSIONAHA.110.162321; Noori M, 2010, CIRCULATION, V122, P478, DOI 10.1161/CIRCULATIONAHA.109.895458; Ntusi NBA, 2009, INT J CARDIOL, V131, P168, DOI 10.1016/j.ijcard.2008.06.054; Pearson GD, 2000, JAMA-J AM MED ASSOC, V283, P1183, DOI 10.1001/jama.283.9.1183; Poulsen SH, 2000, AM J CARDIOL, V85, P19, DOI 10.1016/S0002-9149(99)00599-8; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rajakumar A, 2005, PLACENTA, V26, P563, DOI 10.1016/j.placenta.2004.09.001; Rajakumar A, 2012, HYPERTENSION, V59, P256, DOI 10.1161/HYPERTENSIONAHA.111.182170; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Rowe GC, 2010, CIRC RES, V107, P825, DOI 10.1161/CIRCRESAHA.110.223818; Saxena AR, 2010, HYPERTENSION, V55, P1239, DOI 10.1161/HYPERTENSIONAHA.109.147595; Schilling J, 2011, CIRC-HEART FAIL, V4, P474, DOI 10.1161/CIRCHEARTFAILURE.110.959833; Sliwa K, 2006, LANCET, V368, P687, DOI 10.1016/S0140-6736(06)69253-2; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Thadhani R, 2011, CIRCULATION, V124, P940, DOI 10.1161/CIRCULATIONAHA.111.034793; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Uraizee I, 2011, NEW ENGL J MED, V365, P1649, DOI 10.1056/NEJMc1108849; Venkatesha S, 2006, NAT MED, V12, P642, DOI 10.1038/nm1429; Vinkestijn AS, 2004, J CARDIOL, V23, P19; Weber GM, 2009, J AM MED INFORM ASSN, V16, P624, DOI 10.1197/jamia.M3191; Witlin AG, 1997, AM J OBSTET GYNECOL, V176, P182, DOI 10.1016/S0002-9378(97)80033-6; Wolf M, 2004, J CLIN ENDOCR METAB, V89, P6239, DOI 10.1210/jc.2004-0548; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X	53	341	353	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					333	U76		10.1038/nature11040	http://dx.doi.org/10.1038/nature11040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596155	Green Accepted, Green Submitted			2022-12-24	WOS:000304099100034
J	Goodarzi, H; Najafabadi, HS; Oikonomou, P; Greco, TM; Fish, L; Salavati, R; Cristea, IM; Tavazoie, S				Goodarzi, Hani; Najafabadi, Hamed S.; Oikonomou, Panos; Greco, Todd M.; Fish, Lisa; Salavati, Reza; Cristea, Ileana M.; Tavazoie, Saeed			Systematic discovery of structural elements governing stability of mammalian messenger RNAs	NATURE			English	Article							GENE-EXPRESSION; SECONDARY STRUCTURE; PREDICTION; MOTIFS; CHIP	Decoding post-transcriptional regulatory programs in RNA is a critical step towards the larger goal of developing predictive dynamical models of cellular behaviour. Despite recent efforts(1-3), the vast landscape of RNA regulatory elements remains largely uncharacterized. A long-standing obstacle is the contribution of local RNA secondary structure to the definition of interaction partners in a variety of regulatory contexts, including-but not limited to-transcript stability(3), alternative splicing(4) and localization(3). There are many documented instances where the presence of a structural regulatory element dictates alternative splicing patterns (for example, human cardiac troponin T) or affects other aspects of RNA biology(5). Thus, a full characterization of post-transcriptional regulatory programs requires capturing information provided by both local secondary structures and the underlying sequence(3,6). Here we present a computational framework based on context-free grammars(3,7) and mutual information(2) that systematically explores the immense space of small structural elements and reveals motifs that are significantly informative of genome-wide measurements of RNA behaviour. By applying this framework to genome-wide human mRNA stability data, we reveal eight highly significant elements with substantial structural information, for the strongest of which we show a major role in global mRNA regulation. Through biochemistry, mass spectrometry and in vivo binding studies, we identified human HNRPA2B1 (heterogeneous nuclear ribonucleoprotein A2/B1, also known as HNRNPA2B1) as the key regulator that binds this element and stabilizes a large number of its target genes. We created a global post-transcriptional regulatory map based on the identity of the discovered linear and structural cis-regulatory elements, their regulatory interactions and their target pathways. This approach could also be used to reveal the structural elements that modulate other aspects of RNA behaviour.	[Goodarzi, Hani; Oikonomou, Panos; Tavazoie, Saeed] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08540 USA; [Goodarzi, Hani; Oikonomou, Panos; Greco, Todd M.; Cristea, Ileana M.; Tavazoie, Saeed] Princeton Univ, Dept Mol Biol, Princeton, NJ 08540 USA; [Najafabadi, Hamed S.; Salavati, Reza] McGill Univ, Inst Parasitol, Montreal, PQ H3G 1Y6, Canada; [Najafabadi, Hamed S.; Salavati, Reza] McGill Univ, McGill Ctr Bioinformat, Montreal, PQ H3G 1Y6, Canada; [Fish, Lisa] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA; [Salavati, Reza] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	Princeton University; Princeton University; McGill University; McGill University; Rockefeller University; McGill University	Tavazoie, S (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, 630 W 168th St, New York, NY 10032 USA.	st2744@columbia.edu	Greco, Todd/E-8279-2010; Oikonomou, Panos/J-5106-2014	Greco, Todd/0000-0002-5845-713X; Oikonomou, Panos/0000-0001-7387-0312; Najafabadi, Hamed/0000-0003-2735-4231; Goodarzi, Hani/0000-0002-9648-8949; Fish, Lisa/0000-0001-9184-0512	Ruth L. Kirschstein National Research Service Award [T32-GM066699]; NHGRI [2R01HG003219]; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003219] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003787] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the Tavazoie laboratory for comments on the project and manuscript. We are also grateful to N. Pencheva, B. Tsui, S. Tavazoie and L. Dolken for their intellectual and technical contributions. L.F. was supported by a Ruth L. Kirschstein National Research Service Award (T32-GM066699). S.T. was supported by grants from NHGRI (2R01HG003219) and the NIH Director's Pioneer Award.	Barash Y, 2010, NATURE, V465, P53, DOI 10.1038/nature09000; Beer MA, 2004, CELL, V117, P185, DOI 10.1016/S0092-8674(04)00304-6; BIAMONTI G, 1994, NUCLEIC ACIDS RES, V22, P1996, DOI 10.1093/nar/22.11.1996; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Cutroneo KR, 2006, CRIT REV EUKAR GENE, V16, P23; Dolken L, 2008, RNA, V14, P1959, DOI 10.1261/rna.1136108; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Giannopoulou EG, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-277; Goodarzi H, 2009, MOL CELL, V36, P900, DOI 10.1016/j.molcel.2009.11.016; Greco TM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004317; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Jensen Kirk B., 2008, V488, P85, DOI 10.1007/978-1-60327-475-3_6; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, P3258, DOI 10.1093/nar/gkh650; Rabani M, 2008, P NATL ACAD SCI USA, V105, P14885, DOI 10.1073/pnas.0803169105; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Wan Y, 2011, NAT REV GENET, V12, P641, DOI 10.1038/nrg3049; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Windbichler N, 2006, NAT PROTOC, V1, P638, DOI 10.1038/nprot.2006.95; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Yang Y, 2011, NAT STRUCT MOL BIOL, V18, P159, DOI 10.1038/nsmb.1959	26	112	117	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					264	U160		10.1038/nature11013	http://dx.doi.org/10.1038/nature11013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22495308	Green Submitted, Green Accepted			2022-12-24	WOS:000303799800047
J	Tsadok, MA; Jackevicius, CA; Rahme, E; Humphries, KH; Behlouli, H; Pilote, L				Tsadok, Meytal Avgil; Jackevicius, Cynthia A.; Rahme, Elham; Humphries, Karin H.; Behlouli, Hassan; Pilote, Louise			Sex Differences in Stroke Risk Among Older Patients With Recently Diagnosed Atrial Fibrillation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EURO HEART SURVEY; PREDICTING STROKE; GENDER-DIFFERENCES; ISCHEMIC-STROKE; ANTICOAGULATION; POPULATION; PREVENTION; THERAPY; STRATIFICATION; GUIDELINE	Context Stroke is a serious complication associated with atrial fibrillation (AF). Women with AF are at higher risk of stroke compared with men. Reasons for this higher stroke risk in women remain unclear, although some studies suggest that undertreatment with warfarin may be a cause. Objective To compare utilization patterns of warfarin and the risk of subsequent stroke between older men and women with AF at the population level. Design, Setting, and Patients Population-based cohort study of patients 65 years or older admitted to the hospital with recently diagnosed AF in the province of Quebec, Canada, 1998-2007, using administrative data with linkage between hospital discharge, physicians, and prescription drug claims databases. Main Outcome Measures Risk of stroke. Results The cohort comprised 39 398 men (47.2%) and 44 115 women (52.8%). At admission, women were older and had a higher CHADS(2) (congestive heart failure, hypertension, age >= 75 years, diabetes mellitus, prior stroke or transient ischemic attack) score than men (1.99 [SD, 1.10] vs 1.74 [SD, 1.13], P<.001). At 30 days postdischarge, 58.2% of men and 60.6% of women had filled a warfarin prescription. In adjusted analysis, women appeared to fill more warfarin prescriptions compared with men (odds ratio, 1.07 [95% CI, 1.04-1.11]; P<.001). Adherence to warfarin treatment was good in both sexes. Crude stroke incidence was 2.02 per 100 person-years (95% CI, 1.95-2.10) in women vs 1.61 per 100 person-years (95% CI, 1.54-1.69) in men (P<.001). The sex difference was mainly driven by the population of patients 75 years or older. In multivariable Cox regression analysis, women had a higher risk of stroke than men (adjusted hazard ratio, 1.14 [95% CI, 1.07-1.22]; P<.001), even after adjusting for baseline comorbid conditions, individual components of the CHADS2 score, and warfarin treatment. Conclusion Among older patients admitted with recently diagnosed AF, the risk of stroke was greater in women than in men, regardless of warfarin use. JAMA. 2012;307(18):1952-1958 www.jama.com	[Tsadok, Meytal Avgil; Rahme, Elham; Behlouli, Hassan; Pilote, Louise] McGill Univ, Ctr Hlth, Div Clin Epidemiol, Montreal, PQ H3A 1A1, Canada; [Pilote, Louise] McGill Univ, Ctr Hlth, Div Gen Internal Med, Montreal, PQ H3A 1A1, Canada; [Jackevicius, Cynthia A.] Western Univ Hlth Sci, Coll Pharm, Dept Pharm Practice & Adm, Pomona, CA USA; [Jackevicius, Cynthia A.] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Univ Toronto, Fac Med, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Jackevicius, Cynthia A.] Univ Hlth Network, Toronto, ON, Canada; [Humphries, Karin H.] Univ British Columbia, Div Cardiol, Vancouver, BC V5Z 1M9, Canada	McGill University; McGill University; Western University of Health Sciences; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of British Columbia	Pilote, L (corresponding author), McGill Univ, Ctr Hlth, Div Clin Epidemiol, 687 Pine Ave W,5 Bldg, Montreal, PQ H3A 1A1, Canada.	louise.pilote@McGill.ca		Pilote, Louise/0000-0002-6159-0628	Canadian Institutes of Health Research (CIHR) [MOP-84304]; Fonds de recherche en sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Avgil Tsadok reported receiving a fellowship award from the Canadian Institutes of Health Research (CIHR) and receiving a travel award from the CIHR to present the study results at a conference (American Heart Association 2011 Scientific Sessions). Dr Humphries reported receiving a new investigator award from the CIHR. Dr Pilote reported serving as a James McGill Chair at McGill University and receiving a national investigator award from the Fonds de recherche en sante du Quebec.; This study was supported by operating grant MOP-84304 from the CIHR.	Dagres N, 2007, J AM COLL CARDIOL, V49, P572, DOI 10.1016/j.jacc.2006.10.047; Fang MC, 2005, CIRCULATION, V112, P1687, DOI 10.1161/CIRCULATIONAHA.105.553438; Friberg J, 2004, AM J CARDIOL, V94, P889, DOI 10.1016/j.amjcard.2004.06.023; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gage BF, 2000, STROKE, V31, P822, DOI 10.1161/01.STR.31.4.822; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Gomberg-Maitland M, 2006, EUR HEART J, V27, P1947, DOI 10.1093/eurheartj/ehl103; Gorin L, 2011, CHEST, V140, P911, DOI 10.1378/chest.10-2436; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Humphries KH, 2001, CIRCULATION, V103, P2365; Inoue H, 2010, CIRC J, V74, P650, DOI 10.1253/circj.CJ-09-0802; Lip GYH, 2010, CHEST, V137, P263, DOI 10.1378/chest.09-1584; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Mosca L, 2011, J AM COLL CARDIOL, V57, P1404, DOI [10.1016/j.jacc.2011.02.005, 10.1161/CIR.0b013e31820faaf8]; Niska R, 2009, J AM BOARD FAM MED, V22, P299, DOI 10.3122/jabfm.2009.03.080218; Pamboukian SV, 2008, CLIN CARDIOL, V31, P30, DOI 10.1002/clc.20175; Poli D, 2009, THROMB HAEMOSTASIS, V101, P938, DOI 10.1160/TH08-10-0635; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Sudlow M, 1998, LANCET, V352, P1167, DOI 10.1016/S0140-6736(98)01401-9; van Staa TP, 2011, J THROMB HAEMOST, V9, P39, DOI 10.1111/j.1538-7836.2010.04085.x; Wang TJ, 2003, JAMA-J AM MED ASSOC, V290, P1049, DOI 10.1001/jama.290.8.1049; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	23	175	180	1	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1952	1958		10.1001/jama.2012.3490	http://dx.doi.org/10.1001/jama.2012.3490			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570463	Bronze			2022-12-24	WOS:000303741900029
J	Chen, T; Heller, E; Beronja, S; Oshimori, N; Stokes, N; Fuchs, E				Chen, Ting; Heller, Evan; Beronja, Slobodan; Oshimori, Naoki; Stokes, Nicole; Fuchs, Elaine			An RNA interference screen uncovers a new molecule in stem cell self-renewal and long-term regeneration	NATURE			English	Article							DIFFERENTIATION; NICHE; TBX1; PROLIFERATION; INDUCTION; QUIESCENT; DISTINCT; MICE	Adult stem cells sustain tissue maintenance and regeneration throughout the lifetime of an animal(1,2). These cells often reside in specific signalling niches that orchestrate the stem cell's balancing act between quiescence and cell-cycle re-entry based on the demand for tissue regeneration(2-4). How stem cells maintain their capacity to replenish themselves after tissue regeneration is poorly understood. Here we use RNA-interference-based loss-of-function screening as a powerful approach to uncover transcriptional regulators that govern the self-renewal capacity and regenerative potential of stem cells. Hair follicle stem cells provide an ideal model. These cells have been purified and characterized from their native niche in vivo and, in contrast to their rapidly dividing progeny, they can be maintained and passaged long-term in vitro(5-7). Focusing on the nuclear proteins and/or transcription factors that are enriched in stem cells compared with their progeny(5,6), we screened similar to 2,000 short hairpin RNAs for their effect on long-term, but not short-term, stem cell self-renewal in vitro. To address the physiological relevance of our findings, we selected one candidate that was uncovered in the screen: TBX1. This transcription factor is expressed in many tissues but has not been studied in the context of stem cell biology. By conditionally ablating Tbx1 in vivo, we showed that during homeostasis, tissue regeneration occurs normally but is markedly delayed. We then devised an in vivo assay for stem cell replenishment and found that when challenged with repetitive rounds of regeneration, the Tbx1-deficient stem cell niche becomes progressively depleted. Addressing the mechanism of TBX1 action, we discovered that TBX1 acts as an intrinsic rheostat of BMP signalling: it is a gatekeeper that governs the transition between stem cell quiescence and proliferation in hair follicles. Our results validate the RNA interference screen and underscore its power in unearthing new molecules that govern stem cell self-renewal and tissue-regenerative potential.	[Chen, Ting; Heller, Evan; Beronja, Slobodan; Oshimori, Naoki; Stokes, Nicole; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchs@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Beronja, Slobodan/0000-0002-6769-9261	NYSTEM [C026722]; NYSDOH [C023046]; National Institutes of Health [R01-AR050452]; Empire State Stem Cell [NYSTEM N09G074]; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050452] Funding Source: NIH RePORTER	NYSTEM; NYSDOH; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Empire State Stem Cell; New York Stem Cell Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to A. Baldini for the Tbx1<SUP>fl/fl</SUP> mice, the Comparative Biology Centre (AAALAC-accredited) for expert handling and care of the mice, The Rockefeller University FCRC for FACS sorting (supported by NYSTEM funds through NYSDOH, contract C023046), S. Dewell and The Rockefeller University Genomic Resource Centre for high-throughput sequencing, The Memorial Sloan Kettering Genomics Core Facility for RNA and microarray processing, Fuchs' lab members Y. Hsu, B. Keyes, X. Wu, D. Devenport and L. Zhang for comments and suggestions, W. H. Lien for providing epigenetic ChIP-seq data for the Tbx1 gene in vivo and P. Janki for assisting in the production of the pooled virus for screening. This work was supported by grants from the National Institutes of Health (R01-AR050452; E. F.), the Empire State Stem Cell (NYSTEM N09G074; E. F.), a New York Stem Cell Foundation-Druckenmiller Fellowship (T. C.) and a NYSTEM Scholar Award (C026722; T. C.). E. F. is an Investigator of the Howard Hughes Medical Institute.	Aggarwal VS, 2010, DEV BIOL, V344, P669, DOI 10.1016/j.ydbio.2010.05.496; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Beronja S, 2010, NAT MED, V16, P821, DOI 10.1038/nm.2167; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; BLESSING M, 1993, GENE DEV, V7, P204, DOI 10.1101/gad.7.2.204; Botchkarev VA, 1999, NAT CELL BIOL, V1, P158, DOI 10.1038/11078; Chen L, 2009, CIRC RES, V105, P842, DOI 10.1161/CIRCRESAHA.109.200295; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Fulcoli FG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006049; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hollnagel A, 1999, J BIOL CHEM, V274, P19838, DOI 10.1074/jbc.274.28.19838; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200; Kulessa H, 2000, EMBO J, V19, P6664, DOI 10.1093/emboj/19.24.6664; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lien WH, 2011, CELL STEM CELL, V9, P219, DOI 10.1016/j.stem.2011.07.015; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005; Osorio KM, 2008, DEVELOPMENT, V135, P1059, DOI 10.1242/dev.012799; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Xu HS, 2004, DEVELOPMENT, V131, P3217, DOI 10.1242/dev.01174; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	31	76	80	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					104	U134		10.1038/nature10940	http://dx.doi.org/10.1038/nature10940			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22495305	Green Accepted			2022-12-24	WOS:000303451900043
J	Smith, GL; Xu, Y; Buchholz, TA; Giordano, SH; Jiang, J; Shih, YCT; Smith, BD				Smith, Grace L.; Xu, Ying; Buchholz, Thomas A.; Giordano, Sharon H.; Jiang, Jing; Shih, Ya-Chen Tina; Smith, Benjamin D.			Association Between Treatment With Brachytherapy vs Whole-Breast Irradiation and Subsequent Mastectomy, Complications, and Survival Among Older Women With Invasive Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CONSENSUS STATEMENT; RADIATION-THERAPY; AMERICAN SOCIETY; LOCAL RECURRENCE; CLAIMS DATA; RADIOTHERAPY; GUIDELINES; PATTERNS; TRIALS; CARE	Context Brachytherapy is a radiation treatment that uses an implanted radioactive source. In recent years, use of breast brachytherapy after lumpectomy for early breast cancer has increased substantially despite a lack of randomized trial data comparing its effectiveness with standard whole-breast irradiation (WBI). Because results of long-term randomized trials will not be reported for years, detailed analysis of clinical outcomes in a nonrandomized setting is warranted. Objective To compare the likelihood of breast preservation, complications, and survival for brachytherapy vs WBI among a nationwide cohort of older women with breast cancer with fee-for-service Medicare. Design Retrospective population-based cohort study of 92 735 women aged 67 years or older with incident invasive breast cancer, diagnosed between 2003 and 2007 and followed up through 2008. After lumpectomy 6952 patients were treated with brachytherapy vs 85 783 with WBI. Main Outcome Measures Cumulative incidence and adjusted risk of subsequent mastectomy (an indicator of failure to preserve the breast) and death were compared using the log-rank test and proportional hazards models. Odds of postoperative infectious and noninfectious complications within 1 year were compared using the chi(2) test and logistic models. Cumulative incidences of long-term complications were compared using the log-rank test. Results Five-year incidence of subsequent mastectomy was higher in women treated with brachytherapy (3.95%; 95% CI, 3.19%-4.88%) vs WBI (2.18%; 95% CI, 2.04%-2.33%; P<.001) and persisted after multivariate adjustment (hazard ratio [HR], 2.19; 95% CI, 1.84-2.61, P<.001). Brachytherapy was associated with more frequent infectious(16.20%; 95% CI, 15.34%-17.08% vs 10.33%; 95% CI, 10.13%-10.53%; P<.001; adjusted odds ratio [OR], 1.76; 1.64-1.88) and noninfectious (16.25%; 95% CI, 15.39%-17.14% vs 9.00%; 95% CI, 8.81%-9.19%; P<.001; adjusted OR, 2.03; 95% CI, 1.89-2.17) postoperative complications; and higher 5-year incidence of breast pain (14.55%, 95% CI, 13.39%-15.80% vs 11.92%; 95% CI, 11.63%-12.21%), fat necrosis (8.26%; 95% CI, 7.27-9.38 vs 4.05%; 95% CI, 3.87%-4.24%), and rib fracture (4.53%; 95% CI, 3.63%-5.64% vs 3.62%; 95% CI, 3.44%-3.82%; P <=.01 for all). Five-year overall survival was 87.66% (95% CI, 85.94%-89.18%) in patients treated with brachytherapy vs 87.04% (95% CI, 86.69%-87.39%) in patients treated with WBI (adjusted HR, 0.94; 95% CI, 0.84-1.05; P=.26). Conclusion In a cohort of older women with breast cancer, treatment with brachytherapy compared with WBI was associated worse with long-term breast preservation and increased complications but no difference in survival. JAMA. 2012;307(17):1827-1837 www.jama.com	[Smith, Grace L.; Buchholz, Thomas A.; Smith, Benjamin D.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Xu, Ying; Jiang, Jing] Univ Texas MD Anderson Canc Ctr, Div Quantitat Sci, Houston, TX 77030 USA; [Giordano, Sharon H.] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Shih, Ya-Chen Tina] Univ Chicago, Ctr Hlth & Social Sci, Chicago, IL 60637 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Chicago	Smith, BD (corresponding author), 1515 Holcombe Blvd,Unit 1202, Houston, TX 77030 USA.	bsmith3@mdanderson.org		Giordano, Sharon H./0000-0002-8700-2767; Shih, Ya-Chen Tina/0000-0001-7290-3864; Smith, Benjamin/0000-0001-7866-1093; Buchholz, Thomas/0000-0002-7859-5572; Smith, Grace/0000-0002-3171-2911	Varian Medical Systems; Cancer Prevention & Research Institute of Texas [RP101207]; Department of Defense; Agency for Healthcare Research and Quality [R01 HS018535]; National Cancer Institute [RC1CA145799, R21CA165092]; University of Chicago Cancer Research Foundation Women's Board; Department of Health and Human Services National Cancer Institute [CA16672, T32CA77050]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018535] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA077050, R21CA165092, P30CA016672, RC1CA145799] Funding Source: NIH RePORTER	Varian Medical Systems; Cancer Prevention & Research Institute of Texas; Department of Defense(United States Department of Defense); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Chicago Cancer Research Foundation Women's Board; Department of Health and Human Services National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Smith receives research support from Varian Medical Systems, but this support was not used for any portion of the current manuscript. None of the other coauthors have conflicts to report.; Dr B. Smith and Dr Giordano are supported by grant RP101207 from the Cancer Prevention & Research Institute of Texas. Dr G. Smith was supported by a Multidisciplinary Postdoctoral Award from the Department of Defense. Dr Shih is supported by grant R01 HS018535 from the Agency for Healthcare Research and Quality and by grants RC1CA145799 and R21CA165092 from the National Cancer Institute, and from the University of Chicago Cancer Research Foundation Women's Board. This study was also supported in part by grants CA16672 and T32CA77050 from the Department of Health and Human Services National Cancer Institute. This study was also supported by a philanthropic gift from Ann Cazalot and Clarence Cazalot.	Abbott AM, 2011, CANCER-AM CANCER SOC, V117, P3305, DOI 10.1002/cncr.25927; Abe O, 2005, LANCET, V366, P2087; [Anonymous], MED UT ENR; [Anonymous], AR RES FIL ARF 2009; [Anonymous], MAMMOSITE TARG RAD T; [Anonymous], AR RES FIL ARF 2007; Arvold ND, 2011, J CLIN ONCOL, V29, P3885, DOI 10.1200/JCO.2011.36.1105; Bender R, 2001, CONTROL CLIN TRIALS, V22, P102, DOI 10.1016/S0197-2456(00)00134-3; Buchholz TA, 2003, INT J RADIAT ONCOL, V57, P1214, DOI 10.1016/S0360-3016(03)00813-7; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Gold HT, 2007, HEALTH SERV RES, V42, P2056, DOI 10.1111/j.1475-6773.2007.00705.x; GRAY RJ, 1988, ANN STAT, V16, P1141, DOI 10.1214/aos/1176350951; Hattangadi JA, 2012, JNCI-J NATL CANCER I, V104, P29, DOI 10.1093/jnci/djr495; HOLLAND R, 1985, CANCER, V56, P979, DOI 10.1002/1097-0142(19850901)56:5<979::AID-CNCR2820560502>3.0.CO;2-N; Husain ZA, 2011, BRACHYTHERAPY, V10, P479, DOI 10.1016/j.brachy.2011.05.001; Klabunde CN, 2002, MED CARE, V40, P26; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Mandelblatt JS, 2008, MED CARE, V46, P759, DOI 10.1097/MLR.0b013e3181844867; Nattinger AB, 2004, HEALTH SERV RES, V39, P1733, DOI 10.1111/j.1475-6773.2004.00315.x; Norris D, 2008, ONCOLOGY ISSUES  JAN, P20; Parsons LS, 2001, SAS SUGI, P214; Polgar C, 2007, INT J RADIAT ONCOL, V69, P694, DOI 10.1016/j.ijrobp.2007.04.022; Punglia RS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c845; Shaitelman SF, 2010, CANCER-AM CANCER SOC, V116, P4677, DOI 10.1002/cncr.25383; Smith BD, 2006, JNCI-J NATL CANCER I, V98, P1302, DOI 10.1093/jnci/djj359; Smith BD, 2006, JNCI-J NATL CANCER I, V98, P681, DOI 10.1093/jnci/djj186; Smith BD, 2009, J AM COLL SURGEONS, V209, P269, DOI 10.1016/j.jamcollsurg.2009.02.066; Smith BD, 2009, INT J RADIAT ONCOL, V74, P987, DOI 10.1016/j.ijrobp.2009.02.031; Smith GL, 2011, J CLIN ONCOL, V29, P157, DOI 10.1200/JCO.2009.27.0942; Srokowski TR, 2008, CANCER-AM CANCER SOC, V113, P22, DOI 10.1002/cncr.23513; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; Vaidya JS, 1996, BRIT J CANCER, V74, P820, DOI 10.1038/bjc.1996.442; Vicini F, 2011, INT J RADIAT ONCOL, V79, P977, DOI 10.1016/j.ijrobp.2009.12.047; Warren JL, 2002, MED CARE, V40, P3	37	152	155	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1827	1837		10.1001/jama.2012.3481	http://dx.doi.org/10.1001/jama.2012.3481			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22550197	Bronze, Green Accepted			2022-12-24	WOS:000303386800022
J	Prasad, SM; Drazer, MW; Huo, DZ; Hu, JC; Eggener, SE				Prasad, Sandip M.; Drazer, Michael W.; Huo, Dezheng; Hu, Jim C.; Eggener, Scott E.			2008 US Preventive Services Task Force Recommendations and Prostate Cancer Screening Rates	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							MEN		[Prasad, Sandip M.; Drazer, Michael W.; Eggener, Scott E.] Univ Chicago, Med Ctr, Urol Sect, Chicago, IL 60637 USA; [Huo, Dezheng] Univ Chicago, Med Ctr, Dept Hlth Studies, Chicago, IL 60637 USA; [Hu, Jim C.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA	University of Chicago; University of Chicago Medical Center; University of Chicago; University of Chicago Medical Center; University of California System; University of California Los Angeles	Prasad, SM (corresponding author), Univ Chicago, Med Ctr, Urol Sect, Chicago, IL 60637 USA.	seggener@surgery.bsd.uchicago.edu						Chou R, 2011, ANN INTERN MED, V155, P762, DOI 10.7326/0003-4819-155-11-201112060-00375; Nelson DE, 2003, AM J PUBLIC HEALTH, V93, P1335, DOI 10.2105/AJPH.93.8.1335; Rauscher GH, 2008, CANCER EPIDEM BIOMAR, V17, P748, DOI 10.1158/1055-9965.EPI-07-2629; Sirovich BE, 2003, JAMA-J AM MED ASSOC, V289, P1414, DOI 10.1001/jama.289.11.1414; US Preventive Serv Task Force, 2008, ANN INTERN MED, V149, P185, DOI 10.7326/0003-4819-149-3-200808050-00008; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336	6	45	49	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1692	1694		10.1001/jama.2012.534	http://dx.doi.org/10.1001/jama.2012.534			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930OA	22535850				2022-12-24	WOS:000303147500015
J	Appleby, J				Appleby, John			Drinking nation: have we had enough?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London W1G 0AN, England		Appleby, J (corresponding author), Kings Fund, London W1G 0AN, England.	j.appleby@kingsfund.org.uk						Collis J., 2010, 10 HMRC; Hawkes N, 2012, ALCOHOL GUIDE PERPLE; HM Revenue and Customs, 2012, PERS INC STAT 2009 1; Purshouse R, 2009, MODELLING A IN PRESS; Secretary of State for the Home Department, 2012, CMND8336; The NHS and Social Care Information Centre, 2011, GP EARN EXP 2009 10	6	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 17	2012	344								e2634	10.1136/bmj.e2634	http://dx.doi.org/10.1136/bmj.e2634			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CN	22511304				2022-12-24	WOS:000303192100020
J	Redmond, SA; Chan, JR				Redmond, Stephanie A.; Chan, Jonah R.			Revitalizing Remyelination-the Answer Is Circulating	SCIENCE			English	Editorial Material							DIFFERENTIATION		[Redmond, Stephanie A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Redmond, SA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA.	jonah.chan@ucsf.edu		Redmond, Stephanie/0000-0002-5580-6269	NINDS NIH HHS [R01 NS062796] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062796] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chong SYC, 2012, P NATL ACAD SCI USA, V109, P1299, DOI 10.1073/pnas.1113540109; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Franklin RJM, 2002, NAT REV NEUROSCI, V3, P705, DOI 10.1038/nrn917; Kotter MR, 2006, J NEUROSCI, V26, P328, DOI 10.1523/JNEUROSCI.2615-05.2006; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shen SM, 2008, NAT NEUROSCI, V11, P1024, DOI 10.1038/nn.2172; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357	9	5	5	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					161	162		10.1126/science.1221689	http://dx.doi.org/10.1126/science.1221689			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499927				2022-12-24	WOS:000302703900028
J	Njau, J				Njau, Jackson			Reading Pliocene Bones	SCIENCE			English	Editorial Material							CARNIVORE TOOTH-MARKS; OLDUVAI GORGE; PERCUSSION MARKS; STONE TOOLS; FLK ZINJANTHROPUS; TANZANIA; HOMINID; ETHIOPIA; PLEISTOCENE; SURFACES		Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Njau, J (corresponding author), Indiana Univ, Dept Geol Sci, Bloomington, IN 47405 USA.	jknjau@indiana.edu						BEHRENSMEYER AK, 1986, NATURE, V319, P768, DOI 10.1038/319768a0; Binford L.R., 1981, BONES ANCIENT MEN MO; BLUMENSCHINE RJ, 1988, NATURE, V333, P763, DOI 10.1038/333763a0; BLUMENSCHINE RJ, 1995, J HUM EVOL, V29, P21, DOI 10.1006/jhev.1995.1046; Blumenschine RJ, 1996, J ARCHAEOL SCI, V23, P493, DOI 10.1006/jasc.1996.0047; Blumenschine RJ, 2007, J HUM EVOL, V53, P420, DOI 10.1016/j.jhevol.2007.01.011; BUNN HT, 1981, NATURE, V291, P574, DOI 10.1038/291574a0; Capaldo SD, 1997, J HUM EVOL, V33, P555, DOI 10.1006/jhev.1997.0150; Dominguez-Rodrigo M, 2006, J HUM EVOL, V50, P170, DOI 10.1016/j.jhevol.2005.09.005; Dominguez-Rodrigo M, 2005, J HUM EVOL, V48, P109, DOI 10.1016/j.jhevol.2004.09.004; Dominguez-Rodrigo M, 2010, P NATL ACAD SCI USA, V107, P20929, DOI 10.1073/pnas.1013711107; Fernandez-Jalvo Y, 2011, J HUM EVOL, V60, P117, DOI 10.1016/j.jhevol.2010.08.003; ISAAC GL, 1978, J ANTHROPOL RES, V34, P311; Lartet M.E., 1860, Q J GEOL SOC LOND, V16, P471, DOI DOI 10.1144/GSL.JGS.1860.016.01-02.63; McPherron SP, 2010, NATURE, V466, P857, DOI 10.1038/nature09248; Njau JK, 2006, J HUM EVOL, V50, P142, DOI 10.1016/j.jhevol.2005.08.008; OLIVER JS, 1994, J HUM EVOL, V27, P267, DOI 10.1006/jhev.1994.1046; OLSEN SL, 1988, J ARCHAEOL SCI, V15, P535, DOI 10.1016/0305-4403(88)90081-7; POTTS R, 1981, NATURE, V291, P577, DOI 10.1038/291577a0; Semaw S, 1997, NATURE, V385, P333, DOI 10.1038/385333a0; Turner C. G., 1983, CARNIVORES HUMAN SCA, P219	21	21	21	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					46	47		10.1126/science.1216221	http://dx.doi.org/10.1126/science.1216221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	920LG	22491846				2022-12-24	WOS:000302405400045
J	Guan, Y; Webby, R; Capua, I; Waldenstrom, J				Guan, Yi; Webby, Richard; Capua, Ilaria; Waldenstrom, Jonas			How to track a flu virus	NATURE			English	Editorial Material									[Guan, Yi] Shantou Univ, Coll Med, Joint Influenza Res Ctr, Shantou, Peoples R China; [Guan, Yi] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Webby, Richard] St Jude Childrens Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Capua, Ilaria] Vet Publ Hlth Inst, Int Reference Lab Avian Influenza & Newcastle Dis, Legnaro, Italy; [Waldenstrom, Jonas] Linnaeus Univ, Sch Nat Sci, Kalmar, Sweden	Shantou University; University of Hong Kong; St Jude Children's Research Hospital; Linnaeus University	Guan, Y (corresponding author), Shantou Univ, Coll Med, Joint Influenza Res Ctr, Shantou, Peoples R China.		Webby, Richard J/N-5657-2018; Waldenström, Jonas/E-4460-2013	Waldenström, Jonas/0000-0002-1152-4235; Guan, Yi/0000-0001-6057-9243					0	8	8	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					535	536						2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915EF	22460882	Bronze			2022-12-24	WOS:000302006100015
J	Perrone, J; Nelson, LS				Perrone, Jeanmarie; Nelson, Lewis S.			Medication Reconciliation for Controlled Substances - An "Ideal" Prescription-Drug Monitoring Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Perrone, Jeanmarie] Univ Penn, Dept Emergency Med, Div Med Toxicol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Nelson, Lewis S.] NYU, Sch Med, Dept Emergency Med, New York, NY USA	University of Pennsylvania; Pennsylvania Medicine; New York University	Perrone, J (corresponding author), Univ Penn, Dept Emergency Med, Div Med Toxicol, Perelman Sch Med, Philadelphia, PA 19104 USA.			Nelson, Lewis/0000-0001-9551-3922				Centers for Disease Control and Prevention (CDC), 2012, MMWR MORB MORTAL WKL, V61, P10; Feldman Lance, 2011, J Pain Palliat Care Pharmacother, V25, P313, DOI 10.3109/15360288.2011.606292; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Paulozzi LJ, 2012, PAIN MED, V13, P87, DOI 10.1111/j.1526-4637.2011.01260.x	4	66	66	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2341	2343		10.1056/NEJMp1204493	http://dx.doi.org/10.1056/NEJMp1204493			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961GH	22646509				2022-12-24	WOS:000305451700003
J	Hekstra, DR; Leibler, S				Hekstra, Doeke R.; Leibler, Stanislas			Contingency and Statistical Laws in Replicate Microbial Closed Ecosystems	CELL			English	Article							SPECIES-DEFINED MICROCOSM; ESCHERICHIA-COLI; FLUORESCENT PROTEIN; TAYLORS LAW; FOOD-WEB; DYNAMICS; EVOLUTION; SYSTEMS; DIVERSIFICATION; COMMUNITIES	Contingency, the persistent influence of past random events, pervades biology. To what extent, then, is each course of ecological or evolutionary dynamics unique, and to what extent are these dynamics subject to a common statistical structure? Addressing this question requires replicate measurements to search for emergent statistical laws. We establish a readily replicated microbial closed ecosystem (CES), sustaining its three species for years. We precisely measure the local population density of each species in many CES replicates, started from the same initial conditions and kept under constant light and temperature. The covariation among replicates of the three species densities acquires a stable structure, which could be decomposed into discrete eigenvectors, or "ecomodes.'' The largest ecomode dominates population density fluctuations around the replicate-average dynamics. These fluctuations follow simple power laws consistent with a geometric random walk. Thus, variability in ecological dynamics can be studied with CES replicates and described by simple statistical laws.	[Hekstra, Doeke R.; Leibler, Stanislas] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA; [Hekstra, Doeke R.; Leibler, Stanislas] Rockefeller Univ, Lab Living Matter, New York, NY 10065 USA; [Leibler, Stanislas] Inst Adv Study, Sch Nat Sci, Princeton, NJ 08540 USA; [Leibler, Stanislas] Inst Adv Study, Simons Ctr Syst Biol, Princeton, NJ 08540 USA	Rockefeller University; Rockefeller University; Institute for Advanced Study - USA; Institute for Advanced Study - USA	Hekstra, DR (corresponding author), Univ Texas SW Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA.	doeke.hekstra@utsouthwestern.edu		Hekstra, Doeke/0000-0003-2332-9223	Training Program in Chemical Biology	Training Program in Chemical Biology	We thank for comments and suggestions: S. Cocco, J. Cohen, S. Dutcher, J. Hopfield, D. Huse, G. Iyengar, A. Libchaber, J. McKinney, R. Monasson, R. Ranganathan, T.N. Siegel, and M.-C. Yao, as well as current and former members of our laboratory; for technical assistance: J. Chuang, Y. Liu, and S. Ram; and for distribution of genetic constructs and strains: the laboratories of C.D. Allis, J. Berman, and R. Tsien and the Yale Coli Genetic Stock Center, the National BioResource Project (NIG, Japan), and the Culture Collection of Algae (UT Austin). D.R.H. acknowledges support from the Training Program in Chemical Biology.	Asai DJ, 2000, METHODS CELL BIOL; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BAK P, 1995, P NATL ACAD SCI USA, V92, P6689, DOI 10.1073/pnas.92.15.6689; Becks L, 2005, NATURE, V435, P1226, DOI 10.1038/nature03627; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bretz M, 2006, EUROPHYS LETT, V74, P1116, DOI 10.1209/epl/i2006-10048-2; Brittain A.M., 1993, THESIS U HAWAII HONO; Buckling A, 2002, NATURE, V420, P496, DOI 10.1038/nature01164; CARLSON JM, 1989, PHYS REV A, V40, P6470, DOI 10.1103/PhysRevA.40.6470; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Eisler Z, 2008, ADV PHYS, V57, P89, DOI 10.1080/00018730801893043; Feder J, 1988, FRACTALS; Folsome C. E., 1986, ECOSYSTEM THEORY APP; Frentz Z, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3473937; Gerami-Nejad M, 2001, YEAST, V18, P859, DOI 10.1002/yea.738; Gitelson I. I., 2003, MANMADE CLOSED ECOLO; Gould S. J., 1989, WONDERFUL LIFE BURGE; Haldimann A, 2001, J BACTERIOL, V183, P6384, DOI 10.1128/JB.183.21.6384-6393.2001; Hasman H, 2000, J BACTERIOL, V182, P1089, DOI 10.1128/JB.182.4.1089-1095.2000; Hekstra D.R., 2009, THESIS ROCKEFELLER U; HERRNDORF N, 1984, ANN PROBAB, V12, P141, DOI 10.1214/aop/1176993379; Houlahan JE, 2007, P NATL ACAD SCI USA, V104, P3273, DOI 10.1073/pnas.0603798104; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; IVES AR, 1995, ECOL MONOGR, V65, P217, DOI 10.2307/2937138; Ives AR, 2003, ECOL MONOGR, V73, P301, DOI 10.1890/0012-9615(2003)073[0301:ECSAEI]2.0.CO;2; Jiang L, 2011, J ANIM ECOL, V80, P577, DOI 10.1111/j.1365-2656.2010.01799.x; Kantz H., 2004, NONLINEAR TIME SERIE; KAWABATA Z, 1995, J PROTOZOOL RES, V5, P23; Laloux L, 1999, PHYS REV LETT, V83, P1467, DOI 10.1103/PhysRevLett.83.1467; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Losos JB, 2009, NATURE, V457, P830, DOI 10.1038/nature07893; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mantegna RN, 1999, INTRO ECONOPHYSICS C; Matsui K, 2000, HYDROBIOLOGIA, V435, P109, DOI 10.1023/A:1004016907260; Melbourne BA, 2009, SCIENCE, V325, P1536, DOI 10.1126/science.1176138; Morris SC, 2010, PHILOS T R SOC B, V365, P133, DOI 10.1098/rstb.2009.0154; Mrozek S., 1968, UGUPU BIRD, P39; Nakajima T, 2009, BIOSYSTEMS, V96, P127, DOI 10.1016/j.biosystems.2008.12.006; Niwa HS, 2007, ICES J MAR SCI, V64, P496, DOI 10.1093/icesjms/fsm004; Price JE, 2009, ECOL RES, V24, P587, DOI 10.1007/s11284-008-0529-6; Ramsayer J, 2012, BIOL LETTERS, V8, P316, DOI 10.1098/rsbl.2011.0895; Sait SM, 2000, NATURE, V405, P448, DOI 10.1038/35013045; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Sethna JP, 2001, NATURE, V410, P242, DOI 10.1038/35065675; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SPRUGEL DG, 1983, ECOLOGY, V64, P209, DOI 10.2307/1937343; TAUB FB, 1964, LIMNOL OCEANOGR, V9, P61, DOI 10.4319/lo.1964.9.1.0061; TAYLOR LR, 1961, NATURE, V189, P732, DOI 10.1038/189732a0; Warren PH, 2003, ECOLOGY, V84, P1001, DOI 10.1890/0012-9658(2003)084[1001:MTAOPC]2.0.CO;2; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	50	68	70	2	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					1164	1173		10.1016/j.cell.2012.03.040	http://dx.doi.org/10.1016/j.cell.2012.03.040			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632978	Bronze			2022-12-24	WOS:000304453900020
J	Roy, H; Kallmeyer, J; Adhikari, RR; Pockalny, R; Jorgensen, BB; D'Hondt, S				Roy, Hans; Kallmeyer, Jens; Adhikari, Rishi Ram; Pockalny, Robert; Jorgensen, Bo Barker; D'Hondt, Steven			Aerobic Microbial Respiration in 86-Million-Year-Old Deep-Sea Red Clay	SCIENCE			English	Article							SULFATE-REDUCING BACTERIA; SOUTH-PACIFIC GYRE; MARINE-SEDIMENTS; NORTH PACIFIC; IN-SITU; MATTER; FLOOR; OCEAN; BIOSPHERE; PROFILES	Microbial communities can subsist at depth in marine sediments without fresh supply of organic matter for millions of years. At threshold sedimentation rates of 1 millimeter per 1000 years, the low rates of microbial community metabolism in the North Pacific Gyre allow sediments to remain oxygenated tens of meters below the sea floor. We found that the oxygen respiration rates dropped from 10 micromoles of O-2 liter(-1) year(-1) near the sediment-water interface to 0.001 micromoles of O-2 liter(-1) year(-1) at 30-meter depth within 86 million-year-old sediment. The cell-specific respiration rate decreased with depth but stabilized at around 10(-3) femtomoles of O-2 cell(-1) day(-1) 10 meters below the seafloor. This result indicated that the community size is controlled by the rate of carbon oxidation and thereby by the low available energy flux.	[Roy, Hans; Jorgensen, Bo Barker] Aarhus Univ, Dept Biosci, Cter Geomicrobiol, DK-8000 Aarhus C, Denmark; [Kallmeyer, Jens; Adhikari, Rishi Ram] Univ Potsdam, Inst Earth & Environm Sci, Potsdam, Germany; [Pockalny, Robert; D'Hondt, Steven] Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA	Aarhus University; University of Potsdam; University of Rhode Island	Roy, H (corresponding author), Aarhus Univ, Dept Biosci, Cter Geomicrobiol, Ny Munkegade 116, DK-8000 Aarhus C, Denmark.	hans.roy@biology.au.dk	Kallmeyer, Jens/I-3554-2012; Jorgensen, Bo B/C-2214-2013; Kallmeyer, Jens/AAF-6906-2020; Pockalny, Rob/HHZ-6845-2022; Røy, Hans/G-3842-2010	Kallmeyer, Jens/0000-0002-6440-1140; Jorgensen, Bo B/0000-0001-9398-8027; Kallmeyer, Jens/0000-0002-6440-1140; Røy, Hans/0000-0002-6477-3091; Adhikari, Rishi Ram/0000-0002-3624-9639	Danish National Research Foundation; German Max Planck Society, Aarhus University; German Federal Ministry of Research and Education; U.S NSF (OCE) [0752336]; U.S NSF; Division Of Ocean Sciences [0752336] Funding Source: National Science Foundation	Danish National Research Foundation(Danmarks Grundforskningsfond); German Max Planck Society, Aarhus University; German Federal Ministry of Research and Education; U.S NSF (OCE); U.S NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The assistance from E. Caporelli, B. Costello, and E. Benway at Woods Hole Oceanographic Institution (WHOI) was crucial for our participation in the R/V Knorr cruise. We thank B. Gribsholt, the shipboard science party, the WHOI long-coring team, and the crew of the R/V Knorr for cooperation at sea. Net primary production data were provided by R. O'Malley from Oregon State University (www.science.oregonstate.edu/ocean.productivity/index.php). Our study was funded by the Danish National Research Foundation, the German Max Planck Society, Aarhus University, the German Federal Ministry of Research and Education via the GeoEnergie Project, and the U.S NSF (OCE grant 0752336 and the NSF-funded C-DEBI Science and Technology Center). This is C-DEBI publication number 130.	Antia AN, 2001, GLOBAL BIOGEOCHEM CY, V15, P845, DOI 10.1029/2000GB001376; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1479, DOI 10.4319/lo.1997.42.7.1479; Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Berner A., 1980, C INT CNRS, V293, P35; BOUDREAU BP, 1991, AM J SCI, V291, P507, DOI 10.2475/ajs.291.5.507; Cai WJ, 1996, MAR CHEM, V52, P123, DOI 10.1016/0304-4203(95)00081-X; D'Hondt S, 2009, P NATL ACAD SCI USA, V106, P11651, DOI 10.1073/pnas.0811793106; Divins D. L., 2009, TOTAL SEDIMENT THICK; Finkel SE, 2006, NAT REV MICROBIOL, V4, P113, DOI 10.1038/nrmicro1340; Fischer JP, 2009, BIOGEOSCIENCES, V6, P1467, DOI 10.5194/bg-6-1467-2009; Holmkvist L, 2011, GEOCHIM COSMOCHIM AC, V75, P3581, DOI 10.1016/j.gca.2011.03.033; JAHNKE RA, 1987, NATURE, V329, P621, DOI 10.1038/329621a0; Jorgensen BB, 2006, SCIENCE, V314, P932, DOI 10.1126/science.1133796; Kallmeyer J, 2008, LIMNOL OCEANOGR-METH, V6, P236, DOI 10.4319/lom.2008.6.236; Knoblauch C, 1999, APPL ENVIRON MICROB, V65, P4230; KYTE FT, 1993, GEOCHIM COSMOCHIM AC, V57, P1719, DOI 10.1016/0016-7037(93)90109-A; KYTE FT, 1986, SCIENCE, V232, P1225, DOI 10.1126/science.232.4755.1225; MIDDELBURG JJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1577, DOI 10.1016/0016-7037(89)90239-1; PARKES RJ, 1994, NATURE, V371, P410, DOI 10.1038/371410a0; RASMUSSEN H, 1992, MAR ECOL PROG SER, V81, P289, DOI 10.3354/meps081289; Ravenschlag K, 2000, APPL ENVIRON MICROB, V66, P3592, DOI 10.1128/AEM.66.8.3592-3602.2000; Schippers A, 2005, NATURE, V433, P861, DOI 10.1038/nature03302; van Bodegom P, 2007, MICROB ECOL, V53, P513, DOI 10.1007/s00248-006-9049-5; Wenzhofer F, 2002, DEEP-SEA RES PT I, V49, P1255, DOI 10.1016/S0967-0637(02)00025-0; Wenzhofer F, 2001, DEEP-SEA RES PT I, V48, P1741, DOI 10.1016/S0967-0637(00)00108-4	25	126	131	2	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					922	925		10.1126/science.1219424	http://dx.doi.org/10.1126/science.1219424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605778				2022-12-24	WOS:000304145600067
J	Scheffran, J; Brzoska, M; Kominek, J; Link, PM; Schilling, J				Scheffran, Juergen; Brzoska, Michael; Kominek, Jasmin; Link, P. Michael; Schilling, Janpeter			CLIMATE CHANGE AND VIOLENT CONFLICT	SCIENCE			English	Editorial Material							NATURAL DISASTERS; CIVIL CONFLICT; LAST MILLENNIUM; AFRICA; BLAME; RISK; WAR	Current debates over the relation between climate change and conflict originate in a lack of data, as well as the complexity of pathways connecting the two phenomena.	[Scheffran, Juergen; Kominek, Jasmin; Link, P. Michael; Schilling, Janpeter] Univ Hamburg, Inst Geog, Res Grp Climate Change & Secur, D-20144 Hamburg, Germany; [Brzoska, Michael] Univ Hamburg, Inst Peace Res & Secur Policy, D-20144 Hamburg, Germany; [Scheffran, Juergen; Brzoska, Michael; Kominek, Jasmin; Link, P. Michael; Schilling, Janpeter] Univ Hamburg, KlimaCampus, D-20144 Hamburg, Germany; [Kominek, Jasmin] Univ Hamburg, Inst Sociol, D-20146 Hamburg, Germany; [Link, P. Michael] Univ Hamburg, Ctr Earth Syst Res & Sustainabil, Res Unit Sustainabil & Global Change, D-20146 Hamburg, Germany; [Schilling, Janpeter] Univ Hamburg, Sch Integrated Climate Syst Sci, D-20144 Hamburg, Germany	University of Hamburg; University of Hamburg; University of Hamburg; University of Hamburg; University of Hamburg; University of Hamburg	Scheffran, J (corresponding author), Univ Hamburg, Inst Geog, Res Grp Climate Change & Secur, Grindelberg 5, D-20144 Hamburg, Germany.	juergen.scheffran@zmaw.de	Scheffran, Jürgen/M-6876-2019; Link, Peter Michael/O-1616-2014; Carroll, Joseph/D-1158-2011; Brzoska, Michael/AAX-6310-2020; Link, Peter Michael/AAL-4171-2021	Scheffran, Jürgen/0000-0002-7171-3062; Carroll, Joseph/0000-0003-2656-1378; Brzoska, Michael/0000-0002-5227-1625	German Science Foundation (DFG) [EXC177]	German Science Foundation (DFG)(German Research Foundation (DFG))	Research for this study was funded in part by the German Science Foundation (DFG) through the Cluster of Excellence "CliSAP" (EXC177).	Adano WR, 2012, J PEACE RES, V49, P65, DOI 10.1177/0022343311427344; Bachler G., 1999, ENV CHANGE SECURITY, P107; Benjaminsen TA, 2012, J PEACE RES, V49, P97, DOI 10.1177/0022343311427343; Bergholt D, 2012, J PEACE RES, V49, P147, DOI 10.1177/0022343311426167; Bernauer T, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/015601; Bernauer T, 2012, J PEACE RES, V49, P227, DOI 10.1177/0022343311425843; Brochmann M, 2009, INT NEGOT, V14, P393, DOI 10.1163/157180609X432879; Brzoska, 2012, CLIMATE CHANGE HUMAN, DOI 10.1007/978-3-642-28626-1; Brzoska M., 2012, CLIMATE CHANGE HUMAN, P165, DOI DOI 10.1007/978-3-642-28626-1_8; Buhaug H., 2012, CLIMATE CHANGE HUMAN, V8; Buhaug H, 2010, P NATL ACAD SCI USA, V107, P16477, DOI 10.1073/pnas.1005739107; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Busby J.W., 2012, HEXAGON SERIES HUMAN, P463; De Stefano L, 2012, J PEACE RES, V49, P193, DOI 10.1177/0022343311427416; Gleditsch NP, 2012, J PEACE RES, V49, P3, DOI 10.1177/0022343311431288; HOMERDIXON TF, 1994, INT SECURITY, V19, P5, DOI 10.2307/2539147; Hsiang SM, 2011, NATURE, V476, P438, DOI 10.1038/nature10311; Intergovernmental Panel on Climate Change IPCC, 2007, CLIM CHANG 2007 CLIM; IPCC, 2007, CLIM CHANG 2007 PHYS; Johnstone S, 2011, SURVIVAL, V53, P11, DOI 10.1080/00396338.2011.571006; Kuper R, 2006, SCIENCE, V313, P803, DOI 10.1126/science.1130989; Marshall M., 2010, POLITY 4 PROJECT POL; Messer E., 2009, NAPA B, V32, P12; Nardulli P. F., 2012, CLIMATE CHANGE HUMAN, P57; Nel P, 2008, INT STUD QUART, V52, P159, DOI 10.1111/j.1468-2478.2007.00495.x; Opiyo F. E. O., 2012, AFRIC J ENV SCI TECH; Organization for Economic Cooperation and Development, 2012, AN AID MUCH AID IS D; Raleigh C, 2012, J PEACE RES, V49, P51, DOI 10.1177/0022343311427754; Scheffran J., 2012, CLIMATE CHANGE HUMAN, V8, P91; Scheffran J, 2011, REG ENVIRON CHANGE, V11, pS27, DOI 10.1007/s10113-010-0175-8; Slettebak RT, 2012, J PEACE RES, V49, P163, DOI 10.1177/0022343311425693; Themner L, 2011, J PEACE RES, V48, P525, DOI 10.1177/0022343311415302; Tol RSJ, 2010, CLIMATIC CHANGE, V99, P65, DOI 10.1007/s10584-009-9659-2; UCDP-PRIO, 2011, UCDP PRIO ARMED CONF; WBGU, 2008, WORLD TRANS CLIM CHA; Zhang DD, 2007, HUM ECOL, V35, P403, DOI 10.1007/s10745-007-9115-8; Zhang DD, 2011, P NATL ACAD SCI USA, V108, P17296, DOI 10.1073/pnas.1104268108	37	183	183	8	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					869	871		10.1126/science.1221339	http://dx.doi.org/10.1126/science.1221339			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	943SN	22605765				2022-12-24	WOS:000304145600051
J	DeWeerdt, S				DeWeerdt, Sarah			VACCINES The take-home lesson	NATURE			English	Editorial Material							MALARIA VACCINE; TRIAL											Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287; Dinglasan RR, 2008, TRENDS PARASITOL, V24, P364, DOI 10.1016/j.pt.2008.05.002; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Roestenberg M, 2011, LANCET, V377, P1770, DOI 10.1016/S0140-6736(11)60360-7; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636	5	9	9	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S24	S25		10.1038/484S24a	http://dx.doi.org/10.1038/484S24a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22534529	Bronze			2022-12-24	WOS:000303200400004
J	Floyd, JS; Heckbert, SR; Weiss, NS; Carrell, DS; Psaty, BM				Floyd, James S.; Heckbert, Susan R.; Weiss, Noel S.; Carrell, David S.; Psaty, Bruce M.			Use of Administrative Data to Estimate the Incidence of Statin-Related Rhabdomyolysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SIMVASTATIN; MYOPATHY		[Floyd, James S.; Heckbert, Susan R.; Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Carrell, David S.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Floyd, JS (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	jfloyd@uw.edu	Floyd, James/G-7563-2015		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085251, R01HL078888, T32HL007902] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375] Funding Source: NIH RePORTER; NHGRI NIH HHS [U01 HG006375] Funding Source: Medline; NHLBI NIH HHS [HL078888, HL085251, T32 HL007902, R01 HL085251, R01 HL078888] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Andrade SE, 2005, J CLIN EPIDEMIOL, V58, P171, DOI 10.1016/j.jclinepi.2004.10.004; Armitage J, 2010, LANCET, V376, P1658, DOI 10.1016/S0140-6736(10)60310-8; Egan A, 2011, NEW ENGL J MED, V365, P285, DOI 10.1056/NEJMp1106689; Graham DJ, 2004, JAMA-J AM MED ASSOC, V292, P2585, DOI 10.1001/jama.292.21.2585; Staffa JA, 2002, NEW ENGL J MED, V346, P539, DOI 10.1056/NEJM200202143460721	5	41	42	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1580	1582		10.1001/jama.2012.489	http://dx.doi.org/10.1001/jama.2012.489			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511681	Green Accepted			2022-12-24	WOS:000302896100015
J	Redberg, RF; Katz, MH				Redberg, Rita F.; Katz, Mitchell H.			Healthy Men Should Not Take Statins	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; WOMEN		[Redberg, Rita F.] Univ Calif San Francisco, Div Cardiol, Dept Med, San Francisco, CA 94143 USA; [Katz, Mitchell H.] Dept Hlth Serv, Los Angeles, CA USA	University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, Div Cardiol, Dept Med, 505 Parnassus Ave,M1180, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu						Culver AL, 2012, ARCH INTERN MED, V172, P144, DOI 10.1001/archinternmed.2011.625; Fernandez Genaro, 2011, Cleve Clin J Med, V78, P393, DOI 10.3949/ccjm.78a.10073; Gupta BP, 2011, ARCH INTERN MED, V171, P1797, DOI 10.1001/archinternmed.2011.440; Hippisley-Cox J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2197; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Muldoon MF, 2000, AM J MED, V108, P538, DOI 10.1016/S0002-9343(00)00353-3; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Ray KK, 2010, ARCH INTERN MED, V170, P1024, DOI 10.1001/archinternmed.2010.182; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4	10	62	64	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1491	1492		10.1001/jama.2012.423	http://dx.doi.org/10.1001/jama.2012.423			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496261				2022-12-24	WOS:000302538100020
J	Vash, P				Vash, Peter			Filling the Void	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Vash, P (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.	petervashmd@sbcglobal.net						FELITTI VJ, 1991, SOUTHERN MED J, V84, P328, DOI 10.1097/00007611-199103000-00008	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1381	1382		10.1001/jama.2012.403	http://dx.doi.org/10.1001/jama.2012.403			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474201				2022-12-24	WOS:000302294200024
J	Steele, A; McCubbin, FM; Fries, M; Kater, L; Boctor, NZ; Fogel, ML; Conrad, PG; Glamoclija, M; Spencer, M; Morrow, AL; Hammond, MR; Zare, RN; Vicenzi, EP; Siljestrom, S; Bowden, R; Herd, CDK; Mysen, BO; Shirey, SB; Amundsen, HEF; Treiman, AH; Bullock, ES; Jull, AJT				Steele, A.; McCubbin, F. M.; Fries, M.; Kater, L.; Boctor, N. Z.; Fogel, M. L.; Conrad, P. G.; Glamoclija, M.; Spencer, M.; Morrow, A. L.; Hammond, M. R.; Zare, R. N.; Vicenzi, E. P.; Siljestrom, S.; Bowden, R.; Herd, C. D. K.; Mysen, B. O.; Shirey, S. B.; Amundsen, H. E. F.; Treiman, A. H.; Bullock, E. S.; Jull, A. J. T.			A Reduced Organic Carbon Component in Martian Basalts	SCIENCE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; ALLAN HILLS 84001; ISOTOPIC EVIDENCE; OXYGEN FUGACITY; METEORITE; ORIGIN; MARS; MANTLE; GRAPHITE; IMPACT	The source and nature of carbon on Mars have been a subject of intense speculation. We report the results of confocal Raman imaging spectroscopy on 11 martian meteorites, spanning about 4.2 billion years of martian history. Ten of the meteorites contain abiotic macromolecular carbon (MMC) phases detected in association with small oxide grains included within high-temperature minerals. Polycyclic aromatic hydrocarbons were detected along with MMC phases in Dar al Gani 476. The association of organic carbon within magmatic minerals indicates that martian magmas favored precipitation of reduced carbon species during crystallization. The ubiquitous distribution of abiotic organic carbon in martian igneous rocks is important for understanding the martian carbon cycle and has implications for future missions to detect possible past martian life.	[Steele, A.; McCubbin, F. M.; Boctor, N. Z.; Fogel, M. L.; Glamoclija, M.; Bowden, R.; Mysen, B. O.] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [McCubbin, F. M.] Univ New Mexico, Inst Meteorit, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Fries, M.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Kater, L.] Witec GmbH, D-89081 Ulm, Germany; [Conrad, P. G.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Spencer, M.; Morrow, A. L.; Hammond, M. R.; Zare, R. N.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Vicenzi, E. P.] Smithsonian Inst, Museum Conservat Inst, Suitland, MD 20746 USA; [Siljestrom, S.] Stockholm Univ, Dept Geol Sci, S-10691 Stockholm, Sweden; [Siljestrom, S.] SP Tech Res Inst Sweden, Dept Chem & Mat, S-50115 Boras, Sweden; [Herd, C. D. K.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T6G 2E3, Canada; [Shirey, S. B.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Amundsen, H. E. F.] Earth Explorat Serv, N-0364 Oslo, Norway; [Amundsen, H. E. F.] Planetary Explorat Serv, N-0364 Oslo, Norway; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA; [Bullock, E. S.] Smithsonian Inst, Dept Mineral Sci, Washington, DC 20013 USA; [Jull, A. J. T.] Univ Arizona, Tucson, AZ 85721 USA	Carnegie Institution for Science; University of New Mexico; WITec; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Stanford University; Smithsonian Institution; Stockholm University; SP Technical Research Institute of Sweden; University of Alberta; Carnegie Institution for Science; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Arizona	Steele, A (corresponding author), Carnegie Inst Sci, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	asteele@ciw.edu	Steele, Andrew/A-3573-2013; Bullock, Emma/A-3870-2016; McCubbin, Francis/D-1698-2009; McCubbin, Francis/AAG-1095-2020; Fogel, Marilyn L/M-2395-2015; Glamoclija, Mihaela/GWQ-3360-2022; Vicenzi, Edward P/T-9430-2017	Steele, Andrew/0000-0001-9643-2841; Bullock, Emma/0000-0002-5678-3695; Fogel, Marilyn L/0000-0002-1176-3818; Glamoclija, Mihaela/0000-0003-4327-6480; Vicenzi, Edward P/0000-0003-2085-6546; Zare, Richard/0000-0001-5266-4253; Siljestrom, Sandra/0000-0002-4975-6074; Herd, Christopher/0000-0001-5210-4002	NASA Astrobiology Science and Technology for Exploring Planets [NNX09AB74G]; NASA Mars Fundamental Research Program [NNX08AN61G]; W. M. Keck Foundation [2007-6-29]; NASA Astrobiology Institute [NNA09DA81A]; Carnegie Institution of Washington; NASA Cosmochemistry [NNX11AG76G]; Natural Science and Engineering Research Council of Canada [261740]; Division Of Earth Sciences [0929458] Funding Source: National Science Foundation	NASA Astrobiology Science and Technology for Exploring Planets; NASA Mars Fundamental Research Program(National Aeronautics & Space Administration (NASA)); W. M. Keck Foundation(W.M. Keck Foundation); NASA Astrobiology Institute; Carnegie Institution of Washington; NASA Cosmochemistry(National Aeronautics & Space Administration (NASA)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by NASA Astrobiology Science and Technology for Exploring Planets (NNX09AB74G to A. S., P. G. C., A. H. T., and M. L. F.), NASA Mars Fundamental Research Program (NNX08AN61G to A. S.), the W. M. Keck Foundation (2007-6-29 to M. L. F. and A. S.), NASA Astrobiology Institute (NNA09DA81A to A. S., S. B. S., N.Z.B., B.O.M., and M. L. F.), and the Carnegie Institution of Washington. F. M. M. acknowledges financial support from NASA Cosmochemistry (NNX11AG76G to F. M. M.). A. S. thanks J. Strope for identification of suitable meteorite samples, C. Agee (University of New Mexico) for the Tissint sample, and L. Welzenbach, T. Gooding, and T. Rose for their assistance in thin-sectioning the meteorites and the use of the Scanning Electron Microscope in the Department of Mineral Sciences, National Museum of Natural History, Smithsonian Institution, Washington, DC. C. D. K. H. thanks D. Hnatyshin for assistance with oxygen fugacity calculations. This work was supported by Natural Science and Engineering Research Council of Canada grant 261740 "The Geology of Mars from Studies of Martian Meteorites" to C. D. K. H. L<SUP>2</SUP>MS, <SUP>14</SUP>C, and additional Raman data have been included in the supplementary materials.	Atreya SK, 2007, PLANET SPACE SCI, V55, P358, DOI 10.1016/j.pss.2006.02.005; Becker L, 1999, EARTH PLANET SC LETT, V167, P71, DOI 10.1016/S0012-821X(99)00014-X; Beyssac O, 2002, J METAMORPH GEOL, V20, P859, DOI 10.1046/j.1525-1314.2002.00408.x; Borg LE, 2003, METEORIT PLANET SCI, V38, P1713, DOI 10.1111/j.1945-5100.2003.tb00011.x; Cody GD, 2008, EARTH PLANET SC LETT, V272, P446, DOI 10.1016/j.epsl.2008.05.008; ECK RV, 1966, SCIENCE, V153, P628, DOI 10.1126/science.153.3736.628; Fries M, 2008, SCIENCE, V320, P91, DOI 10.1126/science.1153578; Grady M., 2004, INT J ASTROBIOL, V3, P117, DOI DOI 10.1017/S1473550404002071; Herd CDK, 2003, METEORIT PLANET SCI, V38, P1793, DOI 10.1111/j.1945-5100.2003.tb00015.x; Hirschmann MM, 2008, EARTH PLANET SC LETT, V270, P147, DOI 10.1016/j.epsl.2008.03.034; Jull A.J.T., 2006, METEORITES EARLY SOL, P889, DOI DOI 10.1038/293433A0; Jull AJT, 2000, GEOCHIM COSMOCHIM AC, V64, P3763, DOI 10.1016/S0016-7037(00)00458-0; Jull AJT, 1998, SCIENCE, V279, P366, DOI 10.1126/science.279.5349.366; Lapen TJ, 2010, SCIENCE, V328, P347, DOI 10.1126/science.1185395; McCubbin F. M., 2012, P 43 LUN PLAN SCI C, V43, P1121; McCubbin FM, 2010, EARTH PLANET SC LETT, V292, P132, DOI 10.1016/j.epsl.2010.01.028; McCubbin FM, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003165; McKay DS, 1996, SCIENCE, V273, P924, DOI 10.1126/science.273.5277.924; Messenger S, 1998, ASTROPHYS J, V502, P284, DOI 10.1086/305874; Michalski JR, 2010, NAT GEOSCI, V3, P751, DOI [10.1038/ngeo971, 10.1038/NGEO971]; Morris RV, 2010, SCIENCE, V329, P421, DOI 10.1126/science.1189667; Mumma MJ, 2009, SCIENCE, V323, P1041, DOI 10.1126/science.1165243; Musselwhite DS, 2006, METEORIT PLANET SCI, V41, P1271, DOI 10.1111/j.1945-5100.2006.tb00521.x; Pasteris JD, 2003, ASTROBIOLOGY, V3, P727, DOI 10.1089/153110703322736051; Righter K, 2008, METEORIT PLANET SCI, V43, P1709, DOI 10.1111/j.1945-5100.2008.tb00638.x; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Steele A, 2007, METEORIT PLANET SCI, V42, P1549, DOI 10.1111/j.1945-5100.2007.tb00590.x; Steele A, 2010, SCIENCE, V329, P51, DOI 10.1126/science.1190541; Steele A, 2000, METEORIT PLANET SCI, V35, P237, DOI 10.1111/j.1945-5100.2000.tb01772.x; Stephan T, 2003, METEORIT PLANET SCI, V38, P109, DOI 10.1111/j.1945-5100.2003.tb01049.x; Toporski J, 2007, ASTROBIOLOGY, V7, P389, DOI 10.1089/ast.2006.0009; Treiman AH, 2003, ASTROBIOLOGY, V3, P369, DOI 10.1089/153110703769016451; Wadhwa M, 2001, SCIENCE, V291, P1527, DOI 10.1126/science.1057594; Wadhwa M, 2008, REV MINERAL GEOCHEM, V68, P493, DOI 10.2138/rmg.2008.68.17; Zahnle K, 2011, ICARUS, V212, P493, DOI 10.1016/j.icarus.2010.11.027; Zipfel J, 2000, METEORIT PLANET SCI, V35, P95, DOI 10.1111/j.1945-5100.2000.tb01977.x; Zolotov MY, 2000, J GEOPHYS RES-SOL EA, V105, P539, DOI 10.1029/1999JB900369; Zolotov MY, 2000, METEORIT PLANET SCI, V35, P629, DOI 10.1111/j.1945-5100.2000.tb01443.x	38	161	164	4	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 13	2012	337	6091					212	215		10.1126/science.1220715	http://dx.doi.org/10.1126/science.1220715			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22628557				2022-12-24	WOS:000306323500053
J	Duffy, SK; Friesen, H; Baryshnikova, A; Lambert, JP; Chong, YT; Figeys, D; Andrews, B				Duffy, Supipi Kaluarachchi; Friesen, Helena; Baryshnikova, Anastasia; Lambert, Jean-Philippe; Chong, Yolanda T.; Figeys, Daniel; Andrews, Brenda			Exploring the Yeast Acetylome Using Functional Genomics	CELL			English	Article							SYNTHETIC DOSAGE LETHALITY; CYCLE-DEPENDENT TRANSCRIPTION; GENETIC INTERACTION NETWORK; HISTONE DEACETYLASE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; NONHISTONE PROTEINS; LYSINE ACETYLATION; G1-SPECIFIC TRANSCRIPTION; ORDERED RECRUITMENT	Lysine acetylation is a dynamic posttranslational modification with a well-defined role in regulating histones. The impact of acetylation on other cellular functions remains relatively uncharacterized. We explored the budding yeast acetylome with a functional genomics approach, assessing the effects of gene overexpression in the absence of lysine deacetylases (KDACs). We generated a network of 463 synthetic dosage lethal (SDL) interactions involving class I and II KDACs, revealing many cellular pathways regulated by different KDACs. A biochemical survey of genes interacting with the KDAC RPD3 identified 72 proteins acetylated in vivo. In-depth analysis of one of these proteins, Swi4, revealed a role for acetylation in G1-specific gene expression. Acetylation of Swi4 regulates interaction with its partner Swi6, both components of the SBF transcription factor. This study expands our view of the yeast acetylome, demonstrates the utility of functional genomic screens for exploring enzymatic pathways, and provides functional information that can be mined for future studies.	[Duffy, Supipi Kaluarachchi; Friesen, Helena; Baryshnikova, Anastasia; Chong, Yolanda T.; Andrews, Brenda] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, Toronto, ON M3S 3E1, Canada; [Duffy, Supipi Kaluarachchi; Baryshnikova, Anastasia; Andrews, Brenda] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Lambert, Jean-Philippe; Figeys, Daniel] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada	University of Toronto; University of Toronto; University of Ottawa	Andrews, B (corresponding author), Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet, 160 Coll St, Toronto, ON M3S 3E1, Canada.	brenda.andrews@utoronto.ca		Baryshnikova, Anastasia/0000-0002-0123-2052; Figeys, Daniel/0000-0002-5373-7546; Lambert, Jean-Philippe/0000-0002-0833-1221	Canadian Institutes of Health Research (CIHR) [MOP-11206, MOP97939, MOP-102629]; National Institutes of Health [US-R01HG005853-01]; Ontario Graduate Scholarship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005853] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Andrews group for helpful discussions. This work was supported by a grant from the Canadian Institutes of Health Research (CIHR) to B. A. and Tim Hughes (MOP-11206). The automated cell biology screens were supported by CIHR grant MOP97939 to B. A. and Charles Boone. Operation of our automated yeast genetics platform is supported by grants from the CIHR (MOP-102629) and the National Institutes of Health (US-R01HG005853-01). S. K. D. was the recipient of an Ontario Graduate Scholarship.	ANDREWS BJ, 1992, P NATL ACAD SCI USA, V89, P11852, DOI 10.1073/pnas.89.24.11852; ANDREWS BJ, 1989, NATURE, V342, P830, DOI 10.1038/342830a0; Archer SY, 1999, CURR OPIN GENET DEV, V9, P171, DOI 10.1016/S0959-437X(99)80026-4; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Basu A, 2009, P NATL ACAD SCI USA, V106, P13785, DOI 10.1073/pnas.0906801106; Beckouet F, 2010, MOL CELL, V39, P689, DOI 10.1016/j.molcel.2010.08.008; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Borges V, 2010, MOL CELL, V39, P677, DOI 10.1016/j.molcel.2010.08.009; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Carmen AA, 1999, P NATL ACAD SCI USA, V96, P12356, DOI 10.1073/pnas.96.22.12356; Carmen AA, 1996, J BIOL CHEM, V271, P15837, DOI 10.1074/jbc.271.26.15837; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Choi JK, 2008, MOL CELL BIOL, V28, P6967, DOI 10.1128/MCB.00570-08; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Cosma MP, 2002, MOL CELL, V10, P227, DOI 10.1016/S1097-2765(02)00604-4; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Costanzo M, 2011, CURR OPIN BIOTECH, V22, P66, DOI 10.1016/j.copbio.2010.11.001; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; CROSS FR, 1994, MOL CELL BIOL, V14, P4779, DOI 10.1128/MCB.14.7.4779; D'Mello SR, 2009, DRUG NEWS PERSPECT, V22, P513, DOI [10.1358/dnp.2009.22.9.1437959, 10.1358/dnp.2009.9.1428871]; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Das C, 2005, IUBMB LIFE, V57, P137, DOI 10.1080/15216540500090629; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dietz KC, 2010, PHARMACOL RES, V62, P11, DOI 10.1016/j.phrs.2010.01.011; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Fillingham J, 2009, MOL CELL, V35, P340, DOI 10.1016/j.molcel.2009.06.023; Funakoshi T, 1997, GENE, V192, P207, DOI 10.1016/S0378-1119(97)00031-0; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Heidinger-Pauli JM, 2009, MOL CELL, V34, P311, DOI 10.1016/j.molcel.2009.04.008; Huang DQ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000188; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jeong H, 2009, CELL, V137, P60, DOI 10.1016/j.cell.2009.03.018; Kavanaugh SA, 2010, AM J HEALTH-SYST PH, V67, P793, DOI 10.2146/ajhp090247; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim JH, 2010, GENE DEV, V24, P2766, DOI 10.1101/gad.1979710; Kim M, 2004, EMBO J, V23, P354, DOI 10.1038/sj.emboj.7600053; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kroll ES, 1996, GENETICS, V143, P95; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lambert Jean-Philippe, 2009, Mol Cell Proteomics, V8, P870, DOI 10.1074/mcp.M800447-MCP200; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Lin YY, 2008, GENE DEV, V22, P2062, DOI 10.1101/gad.1679508; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Liu C, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-75; Lu JY, 2011, CELL, V146, P968, DOI 10.1016/j.cell.2011.07.044; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Marzio G, 2000, J BIOL CHEM, V275, P10887, DOI 10.1074/jbc.275.15.10887; Measday V, 2005, P NATL ACAD SCI USA, V102, P13956, DOI 10.1073/pnas.0503504102; Measday V, 2002, METHOD ENZYMOL, V350, P316, DOI 10.1016/S0076-6879(02)50971-X; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Mitchell L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025336; NIKAWA J, 1991, J BIOL CHEM, V266, P11184; NIKAWA JI, 1986, J BACTERIOL, V166, P328, DOI 10.1128/jb.166.1.328-330.1986; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; OGAS J, 1991, CELL, V66, P1015, DOI 10.1016/0092-8674(91)90445-5; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Sardiu ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007310; Schaefer JB, 2004, CELL, V117, P849, DOI 10.1016/j.cell.2004.06.008; SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Sharifpoor S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r39; Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167; Shore D, 2000, P NATL ACAD SCI USA, V97, P14030, DOI 10.1073/pnas.011506198; Smith JJ, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100051; Smith JS, 2002, METHOD ENZYMOL, V353, P282; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Sopko R, 2007, EMBO J, V26, P4487, DOI 10.1038/sj.emboj.7601847; Sopko R, 2006, CELL CYCLE, V5, P1397, DOI 10.4161/cc.5.13.2922; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Takahata S, 2009, EMBO J, V28, P3378, DOI 10.1038/emboj.2009.270; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Utley RT, 2003, CURR TOP MICROBIOL, V274, P203; VanDemark AP, 2007, MOL CELL, V27, P817, DOI 10.1016/j.molcel.2007.08.018; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Wang A, 2002, SCIENCE, V298, P1412, DOI 10.1126/science.1077790; Wang CG, 2001, FRONT BIOSCI-LANDMRK, V6, pD610, DOI 10.2741/1wang1; Wang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000189; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Wu JS, 2001, P NATL ACAD SCI USA, V98, P4391, DOI 10.1073/pnas.081560698; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhou Q, 2010, PROTEOMICS, V10, P1029, DOI 10.1002/pmic.200900602; Zou J, 2009, MOL BIOL CELL, V20, P3239, DOI 10.1091/mbc.E08-12-1255	101	50	50	0	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					936	948		10.1016/j.cell.2012.02.064	http://dx.doi.org/10.1016/j.cell.2012.02.064			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579291	Bronze, Green Accepted			2022-12-24	WOS:000303934700024
J	Brown, D				Brown, David			Mutant flu - the view from the newsroom	NATURE			English	Editorial Material												browndm@washpost.com							0	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					7	7		10.1038/485007a	http://dx.doi.org/10.1038/485007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	934NV	22552053	Bronze			2022-12-24	WOS:000303451900004
J	Lutz, RA; Falkowski, PG				Lutz, Richard A.; Falkowski, Paul G.			A Dive to Challenger Deep	SCIENCE			English	Editorial Material							MARIANA TRENCH; SEA; BACTERIA		[Lutz, Richard A.; Falkowski, Paul G.] Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Lutz, RA (corresponding author), Rutgers State Univ, Inst Marine & Coastal Sci, New Brunswick, NJ 08901 USA.	rlutz@marine.rut-gers.edu; falko@marine.rutgers.edu						Fujikura K, 1999, MAR ECOL PROG SER, V190, P17, DOI 10.3354/meps190017; Huang HB, 2012, J NAT PROD, V75, P202, DOI 10.1021/np2008335; JONES ML, 1985, BIOL SOC WASH B, V6, P1; Kato C, 1998, APPL ENVIRON MICROB, V64, P1510; Li SM, 2011, MAR DRUGS, V9, P1428, DOI 10.3390/md9081428; LUTZ RA, 1994, NATURE, V371, P663, DOI 10.1038/371663a0; Lutz Richard A., 1994, National Geographic Magazine, V186, P114; Lutz RA, 2012, LIFE AT EXTREMES: ENVIRONMENTS, ORGANISMS AND STRATEGIES FOR SURVIVAL, P242, DOI 10.1079/9781845938147.0242; MCNEILL MM, 1994, CLIN MICROBIOL REV, V7, P357, DOI 10.1128/CMR.7.3.357-417.1994; Pathom-aree W, 2006, EXTREMOPHILES, V10, P181, DOI 10.1007/s00792-005-0482-z; YAYANOS AA, 1982, APPL ENVIRON MICROB, V44, P1356, DOI 10.1128/AEM.44.6.1356-1361.1982	11	14	14	4	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					301	302		10.1126/science.1222641	http://dx.doi.org/10.1126/science.1222641			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22499808				2022-12-24	WOS:000302995400029
J	Behrouzi, R; Roh, JH; Kilburn, D; Briber, RM; Woodson, SA				Behrouzi, Reza; Roh, Joon Ho; Kilburn, Duncan; Briber, R. M.; Woodson, Sarah A.			Cooperative Tertiary Interaction Network Guides RNA Folding	CELL			English	Article							GROUP-I RIBOZYME; TETRAHYMENA-THERMOPHILA RIBOZYME; COMPARATIVE SEQUENCE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CORE HELICES; ACTIVE-SITE; INTRON; STABILITY; COLLAPSE	Noncoding RNAs form unique 3D structures, which perform many regulatory functions. To understand how RNAs fold uniquely despite a small number of tertiary interaction motifs, we mutated the major tertiary interactions in a group I ribozyme by single-base substitutions. The resulting perturbations to the folding energy landscape were measured using SAXS, ribozyme activity, hydroxyl radical footprinting, and native PAGE. Double-and triple-mutant cycles show that most tertiary interactions have a small effect on the stability of the native state. Instead, the formation of core and peripheral structural motifs is cooperatively linked in near-native folding intermediates, and this cooperativity depends on the native helix orientation. The emergence of a cooperative interaction network at an early stage of folding suppresses nonnative structures and guides the search for the native state. We suggest that cooperativity in noncoding RNAs arose from natural selection of architectures conducive to forming a unique, stable fold.	[Behrouzi, Reza; Kilburn, Duncan; Woodson, Sarah A.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Roh, Joon Ho; Briber, R. M.] Univ Maryland, Dept Mat Sci & Engn, College Pk, MD 20742 USA; [Roh, Joon Ho] Natl Inst Stand & Technol, Ctr Neutron Res, Gaithersburg, MD 20899 USA	Johns Hopkins University; University System of Maryland; University of Maryland College Park; National Institute of Standards & Technology (NIST) - USA	Woodson, SA (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, 3400 N Charles St, Baltimore, MD 21218 USA.	swoodson@jhu.edu	Behrouzi, Reza/M-6604-2013; Briber, Robert M/A-3588-2012	Behrouzi, Reza/0000-0003-3064-9743; Briber, Robert M/0000-0002-8358-5942; Woodson, Sarah/0000-0003-0170-1987	National Institutes of Health (NIH) [GM60819, RR-08630]; National Institute of Standards and Technology; US Department of Energy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060819] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); US Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank L. Guo and T. Irving for assistance with SAXS experiments, and D. Barrick, D. Draper, E. Westhof, J. Lecomte, D. Zappulla, and members of the laboratory of S. A. W. for discussion and comments. This work was supported by grants from the National Institutes of Health (NIH) (GM60819) and National Institute of Standards and Technology. BioCAT is an NIH-supported Research Center (RR-08630). Access to the APS was made possible by support from the US Department of Energy. R. B. designed and performed experiments, analyzed the data, and wrote the paper, J. H. R. and D. K. performed SAXS experiments, R. M. B. designed SAXS experiments and edited the paper, and S. A. W. designed the experiments and wrote the paper.	Adams PL, 2004, RNA, V10, P1867, DOI 10.1261/rna.7140504; Adams PL, 2004, NATURE, V430, P45, DOI 10.1038/nature02642; Bailor MH, 2010, SCIENCE, V327, P202, DOI 10.1126/science.1181085; Baird NJ, 2010, J MOL BIOL, V397, P1298, DOI 10.1016/j.jmb.2010.02.025; Baird NJ, 2006, RNA, V12, P598, DOI 10.1261/rna.2186506; Baird NJ, 2005, J MOL BIOL, V352, P712, DOI 10.1016/j.jmb.2005.07.010; Battle DJ, 2002, P NATL ACAD SCI USA, V99, P11676, DOI 10.1073/pnas.182221799; Bevilacqua PC, 1996, BIOCHEMISTRY-US, V35, P648, DOI 10.1021/bi951962z; Bokinsky G, 2003, P NATL ACAD SCI USA, V100, P9302, DOI 10.1073/pnas.1133280100; Brion P, 1999, RNA, V5, P947, DOI 10.1017/S1355838299990477; Buchmueller KL, 2003, BIOCHEMISTRY-US, V42, P13869, DOI 10.1021/bi035476k; Butcher SE, 2011, ACCOUNTS CHEM RES, V44, P1302, DOI 10.1021/ar200098t; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chauhan S, 2005, J MOL BIOL, V353, P1199, DOI 10.1016/j.jmb.2005.09.015; Chauhan S, 2008, J AM CHEM SOC, V130, P1296, DOI 10.1021/ja076166i; Chauhan S, 2009, J MOL BIOL, V386, P1167, DOI 10.1016/j.jmb.2008.12.075; CREIGHTON TE, 1990, BIOCHEM J, V270, P1; Das R, 2003, J MOL BIOL, V332, P311, DOI 10.1016/S0022-2836(03)00854-4; Di Cera E, 1998, ADV PROTEIN CHEM, V51, P59; DOUDNA JA, 1995, RNA, V1, P36; Fang XW, 1999, NAT STRUCT BIOL, V6, P1091; Fang XW, 1999, BIOCHEMISTRY-US, V38, P16840, DOI 10.1021/bi991700n; Fang XW, 2001, P NATL ACAD SCI USA, V98, P4355, DOI 10.1073/pnas.071050698; Fiore JL, 2009, BIOCHEMISTRY-US, V48, P2550, DOI 10.1021/bi8019788; Fujita Y, 2009, RNA, V15, P877, DOI 10.1261/rna.1461309; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; Hogg R.V., 2006, PROBABILITY STAT INF, Vseventh; Holbrook SR, 2008, ANNU REV BIOPHYS, V37, P445, DOI 10.1146/annurev.biophys.36.040306.132755; Ikawa Y, 2000, NUCLEIC ACIDS RES, V28, P3269, DOI 10.1093/nar/28.17.3269; JAEGER L, 1994, J MOL BIOL, V236, P1271, DOI 10.1016/0022-2836(94)90055-8; Kilburn D, 2010, J AM CHEM SOC, V132, P8690, DOI 10.1021/ja101500g; Kuo LY, 1999, BBA-GENE STRUCT EXPR, V1489, P281, DOI 10.1016/S0167-4781(99)00200-6; Laing C, 2011, CURR OPIN STRUC BIOL, V21, P306, DOI 10.1016/j.sbi.2011.03.015; Lambert D, 2010, J MOL BIOL, V404, P138, DOI 10.1016/j.jmb.2010.09.043; Lehnert V, 1996, CHEM BIOL, V3, P993, DOI 10.1016/S1074-5521(96)90166-0; Leipply D, 2010, BIOCHEMISTRY-US, V49, P1843, DOI 10.1021/bi902036j; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Lescoute A, 2006, NUCLEIC ACIDS RES, V34, P6587, DOI 10.1093/nar/gkl963; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Moghaddam S, 2009, J MOL BIOL, V393, P753, DOI 10.1016/j.jmb.2009.08.044; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Pan J, 1999, P NATL ACAD SCI USA, V96, P6149, DOI 10.1073/pnas.96.11.6149; Perez-Salas UA, 2004, BIOCHEMISTRY-US, V43, P1746, DOI 10.1021/bi035642o; PYLE AM, 1991, NATURE, V350, P628, DOI 10.1038/350628a0; Rangan P, 2003, J MOL BIOL, V329, P229, DOI 10.1016/S0022-2836(03)00430-3; Rangan P, 2003, P NATL ACAD SCI USA, V100, P1574, DOI 10.1073/pnas.0337743100; Sattint BD, 2008, J AM CHEM SOC, V130, P6085, DOI 10.1021/ja800919q; Schultes EA, 2005, NAT STRUCT MOL BIOL, V12, P1130, DOI 10.1038/nsmb1014; Shank EA, 2010, NATURE, V465, P637, DOI 10.1038/nature09021; Siegfried NA, 2009, METHOD ENZYMOL, V455, P365, DOI 10.1016/S0076-6879(08)04213-4; Silverman SK, 1999, BIOCHEMISTRY-US, V38, P8691, DOI 10.1021/bi9906118; Strauss-Soukup JK, 2000, J MOL BIOL, V302, P339, DOI 10.1006/jmbi.2000.4056; Su LHJ, 2003, J MOL BIOL, V334, P639, DOI 10.1016/j.jmb.2003.09.071; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Szewczak AA, 1997, RNA, V3, P838; Tanner MA, 1996, RNA, V2, P74; Tanner MA, 1997, SCIENCE, V275, P847, DOI 10.1126/science.275.5301.847; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Thirumalai D, 2005, BIOCHEMISTRY-US, V44, P4957, DOI 10.1021/bi047314+; Toor N, 2008, NAT STRUCT MOL BIOL, V15, P1221, DOI 10.1038/nsmb.1509; Treiber DK, 1998, SCIENCE, V279, P1943, DOI 10.1126/science.279.5358.1943; Walter NG, 1999, NAT STRUCT BIOL, V6, P544; Wan YQ, 2011, BIOCHEMISTRY-US, V50, P864, DOI 10.1021/bi101467q; Watters AL, 2007, CELL, V128, P613, DOI 10.1016/j.cell.2006.12.042; Weber G, 1975, Adv Protein Chem, V29, P1, DOI 10.1016/S0065-3233(08)60410-6; Weinberg Z, 2009, NATURE, V462, P656, DOI 10.1038/nature08586; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Westhof E, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-108; Zarrinkar PP, 1996, NAT STRUCT BIOL, V3, P432, DOI 10.1038/nsb0596-432	70	74	75	2	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					348	357		10.1016/j.cell.2012.01.057	http://dx.doi.org/10.1016/j.cell.2012.01.057			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500801	Green Accepted, Bronze			2022-12-24	WOS:000302805600014
J	Kelly, DP				Kelly, Daniel P.			Irisin, Light My Fire	SCIENCE			English	Editorial Material							BROWN ADIPOSE-TISSUE; SKELETAL-MUSCLE; ADULT HUMANS; EXERCISE; PGC-1; FAT; DRIVES		Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA	Sanford Burnham Prebys Medical Discovery Institute	Kelly, DP (corresponding author), Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL 32827 USA.	dkelly@sanfordburnham.org	Kelly, Daniel/ABG-2056-2021		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK045416] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK045416] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Goto M, 2000, BIOCHEM BIOPH RES CO, V274, P350, DOI 10.1006/bbrc.2000.3134; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Speakman JR, 2003, P NUTR SOC, V62, P621, DOI 10.1079/PNS2003282; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008	14	103	121	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 6	2012	336	6077					42	43		10.1126/science.1221688	http://dx.doi.org/10.1126/science.1221688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491843				2022-12-24	WOS:000302405400042
J	Calderon, L; Boehm, T				Calderon, Lesly; Boehm, Thomas			Synergistic, Context-Dependent, and Hierarchical Functions of Epithelial Components in Thymic Microenvironments	CELL			English	Article							STEM-CELL-NICHE; DELTA-LIKE 4; T-CELL; BONE-MARROW; IMMATURE THYMOCYTES; LINEAGE COMMITMENT; BETA-SELECTION; SELF-RENEWAL; FETAL BLOOD; MAST-CELLS	Specialized niche environments specify and maintain stem and progenitor cells, but little is known about the identities and functional interactions of niche components in vivo. Here, we describe a modular system for the generation of artificial thymopoietic environments in the mouse embryo. Thymic epithelium that lacks hematopoietic function but is physiologically accessible for hematopoietic progenitor cells is functionalized by individual and combinatorial expression of four factors, the chemokines Ccl25 and Cxcl12, the cytokine Scf, and the Notch ligand DLL4. The distinct phenotypes and variable numbers of hematopoietic cells in the resulting epithelial environments reveal synergistic, context-dependent, and hierarchical interactions among effector molecules. The surprisingly simple rules determining hematopoietic properties enable the in vivo engineering of artificial environments conducive to the presence of distinct myeloid or T or B lymphoid lineage precursors; moreover, synthetic environments facilitate the procurement of physiological progenitor cell types for analytical purposes and future therapeutic applications.	[Calderon, Lesly; Boehm, Thomas] Max Planck Inst Immunbiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany	Max Planck Society	Boehm, T (corresponding author), Max Planck Inst Immunbiol & Epigenet, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de		Calderon, Lesly/0000-0001-5253-7369	Max-Planck Society; Deutsche Forschungsgemeinschaft	Max-Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank A. Haas-Assenbaum and B. Kanzler for help with the generation of transgenic mice, C. Happe, B. Hammerschmidt, and S. Birmelin for technical support, A. Wuerch and S. Hobitz for help with cell sorting, J.B. Swann, V. Taylor, and H.R. Rodewald for advice and helpful discussions, and R. Kemler and D. Vestweber for reagents. We also acknowledge the contributions of C. Hetzer-Egger during early stages of this project. Financial support for these studies was provided by the Max-Planck Society and the Deutsche Forschungsgemeinschaft. L.C. was a member of the International Max-Planck Research School for Molecular and Cellular Biology (IMPRS-MCB), a joint international PhD programme of the Max Planck Institute of Immunobiology and Epigenetics (MPI-IB) and the University of Freiburg, Germany.	Anderson G, 2006, IMMUNOL REV, V209, P10, DOI 10.1111/j.0105-2896.2006.00347.x; Ara T, 2003, J IMMUNOL, V170, P4649, DOI 10.4049/jimmunol.170.9.4649; Bajoghli B, 2011, NATURE, V470, P90, DOI 10.1038/nature09655; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Benz C, 2004, EUR J IMMUNOL, V34, P3652, DOI 10.1002/eji.200425248; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Bleul CC, 2000, EUR J IMMUNOL, V30, P3371, DOI 10.1002/1521-4141(2000012)30:12<3371::AID-IMMU3371>3.0.CO;2-L; Boehm T, 2008, CURR OPIN IMMUNOL, V20, P178, DOI 10.1016/j.coi.2008.03.001; Boehm T, 2011, NAT REV IMMUNOL, V11, P307, DOI 10.1038/nri2944; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Charbord P, 2002, EXP HEMATOL, V30, P1202, DOI 10.1016/S0301-472X(02)00895-0; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; Corbeaux T, 2010, P NATL ACAD SCI USA, V107, P16613, DOI 10.1073/pnas.1004623107; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Janas ML, 2010, J EXP MED, V207, P247, DOI 10.1084/jem.20091430; JENKINSON EJ, 1981, J EXP MED, V153, P280, DOI 10.1084/jem.153.2.280; Kawamoto H, 2000, IMMUNITY, V12, P441, DOI 10.1016/S1074-7613(00)80196-X; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; King AG, 2002, P NATL ACAD SCI USA, V99, P4508, DOI 10.1073/pnas.072087899; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Liu CL, 2006, BLOOD, V108, P2531, DOI 10.1182/blood-2006-05-024190; Martinic MM, 2006, P NATL ACAD SCI USA, V103, P14435, DOI 10.1073/pnas.0606707103; Moritz DR, 1998, J IMMUNOL, V161, P4866; Nagasawa T, 2000, INT J HEMATOL, V72, P408; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; Peerani R, 2010, J CLIN INVEST, V120, P60, DOI 10.1172/JCI41158; RODEWALD HR, 1995, IMMUNITY, V3, P313, DOI 10.1016/1074-7613(95)90116-7; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; RODEWALD HR, 1995, CURR OPIN IMMUNOL, V7, P176, DOI 10.1016/0952-7915(95)80002-6; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schlenner SM, 2010, TRENDS IMMUNOL, V31, P303, DOI 10.1016/j.it.2010.06.002; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Soza-Ried C, 2008, J IMMUNOL, V181, P5272, DOI 10.4049/jimmunol.181.8.5272; Terszowski G, 2006, SCIENCE, V312, P284, DOI 10.1126/science.1123497; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Trampont PC, 2010, NAT IMMUNOL, V11, P162, DOI 10.1038/ni.1830; Tsukamoto N, 2005, CELL IMMUNOL, V234, P77, DOI 10.1016/j.cellimm.2005.06.009; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; WORTIS HH, 1971, J EXP MED, V134, P681, DOI 10.1084/jem.134.3.681; Wurbel MA, 2001, BLOOD, V98, P2626, DOI 10.1182/blood.V98.9.2626; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Zamisch M, 2005, J IMMUNOL, V174, P60, DOI 10.4049/jimmunol.174.1.60	55	86	89	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					159	172		10.1016/j.cell.2012.01.049	http://dx.doi.org/10.1016/j.cell.2012.01.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464328	Bronze			2022-12-24	WOS:000302235400018
J	Williams, LA; Davis-Dusenbery, BN; Eggan, KC				Williams, Luis A.; Davis-Dusenbery, Brandi N.; Eggan, Kevin C.			SnapShot: Directed Differentiation of Pluripotent Stem Cells	CELL			English	Editorial Material							MOUSE		[Williams, Luis A.; Davis-Dusenbery, Brandi N.; Eggan, Kevin C.] Harvard Univ, HHMI, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Williams, LA (corresponding author), Harvard Univ, HHMI, Cambridge, MA 02138 USA.		Davis-Dusenbery, Brandi/N-2798-2013; Eggan, Kevin/P-7119-2018	Davis-Dusenbery, Brandi/0000-0001-7811-8613; 	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Eiraku M, 2012, CURR OPIN NEUROBIOL, V22, P768, DOI 10.1016/j.conb.2012.02.005; Han SSW, 2011, NEURON, V70, P626, DOI 10.1016/j.neuron.2011.05.003; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Kadzik RS, 2012, CELL STEM CELL, V10, P355, DOI 10.1016/j.stem.2012.03.013; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Panula S, 2011, HUM MOL GENET, V20, P752, DOI 10.1093/hmg/ddq520; Shi Y, 2012, NAT NEUROSCI, V15, pS1, DOI DOI 10.1038/NN.3041.; Shi YC, 2012, NAT NEUROSCI, V15, P477, DOI 10.1038/nn.3041; Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691	11	45	47	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					1174	U236	1174.e1	10.1016/j.cell.2012.05.015	http://dx.doi.org/10.1016/j.cell.2012.05.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632979	Bronze			2022-12-24	WOS:000304453900021
J	Bloomgren, G; Richman, S; Hotermans, C; Subramanyam, M; Goelz, S; Natarajan, A; Lee, S; Plavina, T; Scanlon, JV; Sandrock, A; Bozic, C				Bloomgren, Gary; Richman, Sandra; Hotermans, Christophe; Subramanyam, Meena; Goelz, Susan; Natarajan, Amy; Lee, Sophia; Plavina, Tatiana; Scanlon, James V.; Sandrock, Alfred; Bozic, Carmen			Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIPLE-SCLEROSIS; PREVALENCE	BACKGROUND Progressive multifocal leukoencephalopathy (PML) is associated with natalizumab treatment. We quantified the risk of PML in patients with multiple sclerosis, according to the presence or absence of three risk factors: positive status with respect to anti-JC virus antibodies, prior use of immunosuppressants, and increasing duration of natalizumab treatment. METHODS We used data from postmarketing sources, clinical studies, and an independent Swedish registry to estimate the incidence of PML among natalizumab-treated patients with multiple sclerosis, according to positive or negative status with respect to anti-JC virus antibodies, prior or no prior use of immunosuppressants, and duration of treatment (1 to 24 months vs. 25 to 48 months). Blood samples were available for anti-JC virus antibody testing from 5896 patients with multiple sclerosis and from 54 patients with multiple sclerosis who were treated with natalizumab and in whom PML later developed. RESULTS As of February 29, 2012, there were 212 confirmed cases of PML among 99,571 patients treated with natalizumab (2.1 cases per 1000 patients). All 54 patients with PML for whom samples were available before the diagnosis were positive for anti-JC virus antibodies. When the risk of PML was stratified according to three risk factors, the risk of PML was lowest among the patients who were negative for anti-JC virus antibodies, with the incidence estimated to be 0.09 cases or less per 1000 patients (95% confidence interval [CI], 0 to 0.48). Patients who were positive for anti-JC virus antibodies, had taken immunosuppressants before the initiation of natalizumab therapy, and had received 25 to 48 months of natalizumab treatment had the highest estimated risk (incidence, 11.1 cases per 1000 patients [95% CI, 8.3 to 14.5]). CONCLUSIONS Positive status with respect to anti-JC virus antibodies, prior use of immunosuppressants, and increased duration of natalizumab treatment, alone or in combination, were associated with distinct levels of PML risk in natalizumab-treated patients with multiple sclerosis.	[Bloomgren, Gary; Richman, Sandra; Hotermans, Christophe; Subramanyam, Meena; Goelz, Susan; Natarajan, Amy; Lee, Sophia; Plavina, Tatiana; Scanlon, James V.; Sandrock, Alfred; Bozic, Carmen] Biogen Idec Inc, Weston, MA USA	Biogen	Bloomgren, G (corresponding author), Biogen Idec Inc, 14 Cambridge Ctr, Cambridge, MA 02142 USA.	gary.bloomgren@biogenidec.com			Biogen Idec; Elan Pharmaceuticals	Biogen Idec(Biogen); Elan Pharmaceuticals	Funded by Biogen Idec and Elan Pharmaceuticals.	[Anonymous], 2012, TYS NAT; [Anonymous], 2011, SUMM PROD CHAR TYS N; Bozic C, 2011, MULT SCLER J, V17, pS355; Bozic C, 2011, ANN NEUROL, V70, P713, DOI 10.1002/ana.22606; Butzkueven H, 2011, MULT SCLER J, V17, pS519; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Egli A, 2009, J INFECT DIS, V199, P837, DOI 10.1086/597126; Gorelik L, 2010, MULT SCLER S10, V16, pS306; Gorelik L, 2010, ANN NEUROL, V68, P295, DOI 10.1002/ana.22128; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Major EO, 2010, ANNU REV MED, V61, P35, DOI 10.1146/annurev.med.080708.082655; Olsson T, 2011, MULT SCLER J, V17, pS134; Olsson T, 2010, MULT SCLER J S, V16, pS348; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Subramanyam M, 2010, MULT SCLER, V16, pS38; Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5; Van Assche G, 2005, NEW ENGL J MED, V353, P362, DOI 10.1056/NEJMoa051586; Vermersch P, 2011, NEUROLOGY, V76, P1697, DOI 10.1212/WNL.0b013e31821a446b; Warnke C, 2011, NERVENARZT, V82, P1314, DOI 10.1007/s00115-011-3319-2; Yousry TA, 2006, NEW ENGL J MED, V354, P924, DOI 10.1056/NEJMoa054693	21	855	890	0	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1870	1880		10.1056/NEJMoa1107829	http://dx.doi.org/10.1056/NEJMoa1107829			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591293				2022-12-24	WOS:000304083000006
J	Ma, R				Ma, Richard			Discrimination against doctors with HIV must end	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ma, Richard] Village Practice, London, England; [Ma, Richard] London Sch Hyg & Trop Med, Dept Hlth Serv Res & Policy, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Ma, R (corresponding author), Village Practice, London, England.	richard.ma@btinternet.com	Ma, Richard/Z-6047-2019	Ma, Richard/0000-0001-6877-2785					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 16	2012	344								e3440	10.1136/bmj.e3440	http://dx.doi.org/10.1136/bmj.e3440			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YO	22592852	Green Submitted			2022-12-24	WOS:000304087800011
J	Hawkes, C				Hawkes, Corinna			Food policies for healthy populations and healthy economies	BRITISH MEDICAL JOURNAL			English	Editorial Material							SOFT DRINKS; WORLDWIDE		City Univ London, Ctr Food Policy, London EC1V 0HB, England	City University London	Hawkes, C (corresponding author), City Univ London, Ctr Food Policy, London EC1V 0HB, England.	corinnahawkes@o2.co.uk						Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; FAO, 2002, BRAZ PROJ FOM ZER RE; FAO, 2011, STAT FOOD INS WORLD; Fulponi L, 2009, 14 OECD; Hawkes C, 2011, INT J PEDIATR OBES, V6, P83, DOI 10.3109/17477166.2010.486836; Hawkes C, 2010, WOODHEAD FOOD SERIES, V184; Hawkes C, 2012, FOOD POLICY, V37, P343, DOI 10.1016/j.foodpol.2012.02.011; Hawkes C, 2010, AM J PREV MED, V38, P457, DOI 10.1016/j.amepre.2010.01.011; International Food and Beverage Alliance, OUR COMM; Mendis S., 2011, GLOBAL ATLAS CARDIOV; Monteiro CA, 2009, REV SAUDE PUBL, V43, P35, DOI 10.1590/S0034-89102009000100005; Mozaffarian D, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d5747; NCD Alliance, 2011, PROP OUTC DOC UN HIG; Rudd Center for Food Policy and Obesity, PLEDG FOOD MARK CHIL; Thow AM, 2011, HEALTH PROMOT INT, V26, P55, DOI 10.1093/heapro/daq057; United Nations General Assembly, 2011, POL DECL HIGH LEV M; Webster JL, 2011, J HYPERTENS, V29, P1043, DOI 10.1097/HJH.0b013e328345ed83; WHO, 2011, GLOB STAT REP NONC D; WHO, DOC WHA65; World Bank, 2011, GROW DANG NONC DIS A; *WORLD BANK, WORLD DEV REP 2008 A; World Health Organization, 2011, 1 MIN C HLTH LIF NON	22	24	24	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 15	2012	344								e2801	10.1136/bmj.e2801	http://dx.doi.org/10.1136/bmj.e2801			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YF	22589521				2022-12-24	WOS:000304086900003
J	Yong, E				Yong, Ed			Trials at the ready: preparing for the next pandemic	BRITISH MEDICAL JOURNAL			English	Editorial Material												edyong209@gmail.com							0	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 3	2012	344								e2982	10.1136/bmj.e2982	http://dx.doi.org/10.1136/bmj.e2982			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NG	22556048				2022-12-24	WOS:000303817700011
J	Palty, R; Raveh, A; Kaminsky, I; Meller, R; Reuveny, E				Palty, Raz; Raveh, Adi; Kaminsky, Ido; Meller, Ruth; Reuveny, Eitan			SARAF Inactivates the Store Operated Calcium Entry Machinery to Prevent Excess Calcium Refilling	CELL			English	Article							FAST CA2+-DEPENDENT INACTIVATION; STROMAL INTERACTION MOLECULE-1; ACTIVATES CRAC CHANNELS; PLASMA-MEMBRANE; CA2+ ENTRY; ENDOPLASMIC-RETICULUM; ORAI CHANNELS; FRET MICROSCOPY; SENSOR STIM1; T-CELLS	Store operated calcium entry (SOCE) is a principal cellular process by which cells regulate basal calcium, refill intracellular Ca2+ stores, and execute a wide range of specialized activities. STIM and Orai proteins have been identified as the essential components enabling the reconstitution of Ca2+ release-activated Ca2+ (CRAC) channels that mediate SOCE. Here, we report the molecular identification of SARAF as a negative regulator of SOCE. Using heterologous expression, RNAi-mediated silencing and site directed mutagenesis combined with electrophysiological, biochemical and imaging techniques we show that SARAF is an endoplasmic reticulum membrane resident protein that associates with STIM to facilitate slow Ca2+-dependent inactivation of SOCE. SARAF plays a key role in shaping cytosolic Ca2+ signals and determining the content of the major intracellular Ca2+ stores, a role that is likely to be important in protecting cells from Ca2+ overfilling.	[Palty, Raz; Raveh, Adi; Kaminsky, Ido; Meller, Ruth; Reuveny, Eitan] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reuveny, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.reuveny@weizmann.ac.il	Palty, Raz/HCH-3978-2022		Clore postdoctoral fellowship; Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF) [207/09]; Minerva Foundation (Munich)	Clore postdoctoral fellowship; Josef Cohn Center for Biomembrane Research; Israeli Science Foundation (ISF)(Israel Science Foundation); Minerva Foundation (Munich)	The authors would like to thank Elisha Shalgi for technical help and Dr. Dan Minor for his helpful comments and critical reading of the manuscript. The work was supported in part by the Clore postdoctoral fellowship (RP), the Josef Cohn Center for Biomembrane Research, The Israeli Science Foundation (ISF grant 207/09) and the Minerva Foundation (Munich) all to ER.	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Barr VA, 2008, MOL BIOL CELL, V19, P2802, DOI 10.1091/mbc.E08-02-0146; Berry PA, 2011, PROSTATE, V71, P1646, DOI 10.1002/pros.21384; Bird GS, 2009, CURR BIOL, V19, P1724, DOI 10.1016/j.cub.2009.08.022; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; Cahalan MD, 2009, NAT CELL BIOL, V11, P669, DOI 10.1038/ncb0609-669; Camargo A, 2008, GENOMICS, V92, P404, DOI 10.1016/j.ygeno.2008.05.007; Derler I, 2009, J BIOL CHEM, V284, P24933, DOI 10.1074/jbc.C109.024083; Enyedi B, 2010, ANTIOXID REDOX SIGN, V13, P721, DOI 10.1089/ars.2009.2880; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; HARDIE RC, 1993, TRENDS NEUROSCI, V16, P371, DOI 10.1016/0166-2236(93)90095-4; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kawasaki T, 2009, BIOCHEM BIOPH RES CO, V385, P49, DOI 10.1016/j.bbrc.2009.05.020; Kiselyov K, 1998, NATURE, V396, P478, DOI 10.1038/24890; Korzeniowski MK, 2009, J BIOL CHEM, V284, P21027, DOI 10.1074/jbc.M109.012252; Lee KP, 2009, P NATL ACAD SCI USA, V106, P14687, DOI 10.1073/pnas.0904664106; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Litjens T, 2004, J PHYSIOL-LONDON, V558, P85, DOI 10.1113/jphysiol.2004.065870; Liu XB, 2007, P NATL ACAD SCI USA, V104, P17542, DOI 10.1073/pnas.0701254104; Louzao MC, 1996, J BIOL CHEM, V271, P14807, DOI 10.1074/jbc.271.25.14807; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Palty R, 2010, P NATL ACAD SCI USA, V107, P436, DOI 10.1073/pnas.0908099107; Pani B, 2009, P NATL ACAD SCI USA, V106, P20087, DOI 10.1073/pnas.0905002106; Parekh AB, 1998, J BIOL CHEM, V273, P14925, DOI 10.1074/jbc.273.24.14925; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Raveh A, 2010, CELL, V143, P750, DOI 10.1016/j.cell.2010.10.018; Rios E, 2010, J PHYSIOL SCI, V60, P81, DOI 10.1007/s12576-009-0069-z; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Romanuik TL, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-476; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Shen WW, 2011, J BIOL CHEM, V286, P36448, DOI 10.1074/jbc.M111.269415; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Srikanth S, 2010, NAT CELL BIOL, V12, P436, DOI 10.1038/ncb2045; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tomida T, 2003, EMBO J, V22, P3825, DOI 10.1093/emboj/cdg381; Twine NA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016266; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724; ZWEIFACH A, 1995, J BIOL CHEM, V270, P14445, DOI 10.1074/jbc.270.24.14445	61	200	206	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					425	438		10.1016/j.cell.2012.01.055	http://dx.doi.org/10.1016/j.cell.2012.01.055			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22464749	Bronze			2022-12-24	WOS:000302805600020
J	Xue, YX; Luo, YX; Wu, P; Shi, HS; Xue, LF; Chen, C; Zhu, WL; Ding, ZB; Bao, YP; Shi, J; Epstein, DH; Shaham, Y; Lu, L				Xue, Yan-Xue; Luo, Yi-Xiao; Wu, Ping; Shi, Hai-Shui; Xue, Li-Fen; Chen, Chen; Zhu, Wei-Li; Ding, Zeng-Bo; Bao, Yan-ping; Shi, Jie; Epstein, David H.; Shaham, Yavin; Lu, Lin			A Memory Retrieval-Extinction Procedure to Prevent Drug Craving and Relapse	SCIENCE			English	Article							LONG-TERM-MEMORY; COCAINE-SEEKING; DISRUPTING RECONSOLIDATION; BASOLATERAL AMYGDALA; PROTEIN-SYNTHESIS; FEAR MEMORIES; CUE-EXPOSURE; PKM-ZETA; MECHANISMS; ADDICTION	Drug use and relapse involve learned associations between drug-associated environmental cues and drug effects. Extinction procedures in the clinic can suppress conditioned responses to drug cues, but the extinguished responses typically reemerge after exposure to the drug itself (reinstatement), the drug-associated environment (renewal), or the passage of time (spontaneous recovery). We describe a memory retrieval-extinction procedure that decreases conditioned drug effects and drug seeking in rat models of relapse, and drug craving in abstinent heroin addicts. In rats, daily retrieval of drug-associated memories 10 minutes or 1 hour but not 6 hours before extinction sessions attenuated drug-induced reinstatement, spontaneous recovery, and renewal of conditioned drug effects and drug seeking. In heroin addicts, retrieval of drug-associated memories 10 minutes before extinction sessions attenuated cue-induced heroin craving 1, 30, and 180 days later. The memory retrieval-extinction procedure is a promising nonpharmacological method for decreasing drug craving and relapse during abstinence.	[Xue, Yan-Xue; Luo, Yi-Xiao; Wu, Ping; Shi, Hai-Shui; Xue, Li-Fen; Chen, Chen; Zhu, Wei-Li; Ding, Zeng-Bo; Bao, Yan-ping; Shi, Jie; Lu, Lin] Peking Univ, Natl Inst Drug Dependence, Beijing 100191, Peoples R China; [Shi, Hai-Shui] Hebei Med Univ, Basic Med Coll, Dept Biochem & Mol Biol, Shijiazhuang 050017, Peoples R China; [Epstein, David H.; Shaham, Yavin] NIDA, Intramural Res Program, NIH, Baltimore, MD 21224 USA	Peking University; Hebei Medical University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Lu, L (corresponding author), Peking Univ, Natl Inst Drug Dependence, Beijing 100191, Peoples R China.	linlu@bjmu.edu.cn	shaham, yavin/G-1306-2014; SHI, JIE/GXG-3394-2022		National Basic Research Program of China [2009CB522000, 2011CB707800]; Natural Science Foundation of China [91132716, 31070958]; National Institute on Drug Abuse; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000434, ZIADA000536] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported in part by the National Basic Research Program of China (No 2009CB522000 and 2011CB707800) and the Natural Science Foundation of China (No 91132716 and 31070958). The preparation of the manuscript was also supported in part by the Intramural Research Program of the National Institute on Drug Abuse. The authors declare that they do not have any conflicts of interest related to the data presented in this manuscript.	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; BOUTON ME, 1991, CLIN PSYCHOL REV, V11, P123, DOI 10.1016/0272-7358(91)90091-8; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Chan Wan Yee Macy, 2010, Learn Mem, V17, P512, DOI 10.1101/lm.1912510; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Conklin CA, 2002, ADDICTION, V97, P155, DOI 10.1046/j.1360-0443.2002.00014.x; Crombag HS, 2008, PHILOS T R SOC B, V363, P3233, DOI 10.1098/rstb.2008.0090; Crombag HS, 2002, BEHAV NEUROSCI, V116, P169, DOI 10.1037//0735-7044.116.1.169; Davis M, 2006, BIOL PSYCHIAT, V60, P369, DOI 10.1016/j.biopsych.2006.03.084; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; Diergaarde L, 2008, EUR J PHARMACOL, V585, P453, DOI 10.1016/j.ejphar.2008.03.010; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Graham BM, 2010, BEHAV NEUROSCI, V124, P337, DOI 10.1037/a0019582; He YY, 2011, NEUROPSYCHOPHARMACOL, V36, P1972, DOI 10.1038/npp.2011.63; Hernandez PJ, 2004, LEARN MEMORY, V11, P748, DOI 10.1101/lm.84904; Lee JLC, 2006, J NEUROSCI, V26, P5881, DOI 10.1523/JNEUROSCI.0323-06.2006; Lee JLC, 2005, NEURON, V47, P795, DOI 10.1016/j.neuron.2005.08.007; Li FQ, 2010, J NEUROSCI, V30, P10351, DOI 10.1523/JNEUROSCI.2112-10.2010; Li YQ, 2011, J NEUROSCI, V31, P5436, DOI 10.1523/JNEUROSCI.5884-10.2011; MARLATT GA, 1990, ADDICT BEHAV, V15, P395, DOI 10.1016/0306-4603(90)90048-3; Milekic MH, 2006, J NEUROSCI, V26, P3010, DOI 10.1523/JNEUROSCI.4818-05.2006; Miller CA, 2005, EUR J NEUROSCI, V21, P1385, DOI 10.1111/j.1460-9568.2005.03974.x; Milton AL, 2008, LEARN MEMORY, V15, P88, DOI 10.1101/lm.825008; Milton AL, 2010, EUR J NEUROSCI, V31, P2308, DOI 10.1111/j.1460-9568.2010.07249.x; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; OBrien Cp E.R., 1986, BEHAV ANAL DRUG DEPE, P329; Peters J, 2009, LEARN MEMORY, V16, P279, DOI 10.1101/lm.1041309; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Sacktor TC, 2011, NAT REV NEUROSCI, V12, P9, DOI 10.1038/nrn2949; Sanchez H, 2010, J NEUROSCI, V30, P4401, DOI 10.1523/JNEUROSCI.3149-09.2010; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; See RE, 2005, EUR J PHARMACOL, V526, P140, DOI 10.1016/j.ejphar.2005.09.034; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Shaham Y, 1997, PSYCHOPHARMACOLOGY, V130, P396, DOI 10.1007/s002130050256; Shalev U, 2002, PHARMACOL REV, V54, P1, DOI 10.1124/pr.54.1.1; Shema R, 2007, SCIENCE, V317, P951, DOI 10.1126/science.1144334; Sinha R, 2000, PSYCHOPHARMACOLOGY, V152, P140, DOI 10.1007/s002130000499; Soeter M, 2011, LEARN MEMORY, V18, P357, DOI 10.1101/lm.2148511; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Taylor JR, 2009, NEUROPHARMACOLOGY, V56, P186, DOI 10.1016/j.neuropharm.2008.07.027; Tronson NC, 2007, NAT REV NEUROSCI, V8, P262, DOI 10.1038/nrn2090; Wouda JA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00179	46	340	385	4	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					241	245		10.1126/science.1215070	http://dx.doi.org/10.1126/science.1215070			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	924PN	22499948	Green Accepted			2022-12-24	WOS:000302703900053
J	Hafler, DA				Hafler, David A.			Perspective: Deconstructing a disease	NATURE			English	Editorial Material																			0	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S6	S6		10.1038/nature11100	http://dx.doi.org/10.1038/nature11100			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509507	Bronze			2022-12-24	WOS:000303149900048
J	Zgierska, A; Miller, M; Rabago, D				Zgierska, Aleksandra; Miller, Michael; Rabago, David			Patient Satisfaction, Prescription Drug Abuse, and Potential Unintended Consequences	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CHRONIC NONCANCER PAIN		[Zgierska, Aleksandra; Rabago, David] Univ Wisconsin, Dept Family Med, Sch Med & Publ Hlth, Madison, WI 53715 USA; [Miller, Michael] Univ Wisconsin, Dept Psychiat, Sch Med & Publ Hlth, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zgierska, A (corresponding author), Univ Wisconsin, Dept Family Med, Sch Med & Publ Hlth, 1100 Delaplaine Ct, Madison, WI 53715 USA.	aleksandra.zgierska@fammed.wisc.edu			NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K23AA017508] Funding Source: NIH RePORTER; NIAAA NIH HHS [K23 AA017508] Funding Source: Medline	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Brett AS, 2012, JAMA-J AM MED ASSOC, V307, P149, DOI 10.1001/jama.2011.1999; Chou R, 2009, J PAIN, V10, P147, DOI 10.1016/j.jpain.2008.10.007; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Frantsve LME, 2007, PAIN MED, V8, P25, DOI 10.1111/j.1526-4637.2007.00250.x; Gugelmann HM, 2011, JAMA-J AM MED ASSOC, V306, P2258, DOI 10.1001/jama.2011.1712; Institute of Medicine, 2001, CROSSING QUALITY CHA; Matthias MS, 2010, PAIN MED, V11, P1688, DOI 10.1111/j.1526-4637.2010.00980.x; Office of National Drug Control Policy US Executive Office of the President, 2011, EP RESP AM PRESCR DR; Substance Abuse and Mental Health Services Administration, 2010, RES 2009 NAT SURV DR, VI	10	136	137	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1377	1378		10.1001/jama.2012.419	http://dx.doi.org/10.1001/jama.2012.419			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919AY	22474199	Green Accepted			2022-12-24	WOS:000302294200022
J	Prowell, TM; Pazdur, R				Prowell, Tatiana M.; Pazdur, Richard			Pathological Complete Response and Accelerated Drug Approval in Early Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHEMOTHERAPY; TRASTUZUMAB		[Prowell, Tatiana M.; Pazdur, Richard] US FDA, Off Hematol Oncol Prod, Silver Spring, MD USA; [Prowell, Tatiana M.] Johns Hopkins Univ, Breast Canc Program, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA	US Food & Drug Administration (FDA); Johns Hopkins University; Johns Hopkins Medicine	Prowell, TM (corresponding author), US FDA, Off Hematol Oncol Prod, Silver Spring, MD USA.							Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Mieog JSD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005002.pub2; Prowell T, DRAFT GUIDANCE FOR I; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595	6	253	267	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 28	2012	366	26					2438	2441		10.1056/NEJMp1205737	http://dx.doi.org/10.1056/NEJMp1205737			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	965DP	22646508				2022-12-24	WOS:000305747000003
J	Drmanac, R				Drmanac, Radoje			The Ultimate Genetic Test	SCIENCE			English	Editorial Material							GENOME; MUTATIONS; PATIENT		Complete Genom Inc, Mountain View, CA 94043 USA		Drmanac, R (corresponding author), Complete Genom Inc, Mountain View, CA 94043 USA.	rdrmanac@completegenomics.com						[Anonymous], DAT SEQ; Ashley EA, 2010, LANCET, V375, P1525, DOI 10.1016/S0140-6736(10)60452-7; Bainbridge MN, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002243; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Chen R, 2012, CELL, V148, P1293, DOI 10.1016/j.cell.2012.02.009; Ciszkowski C, 2009, NEW ENGL J MED, V361, P827, DOI 10.1056/NEJMc0904266; Dewey FE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002280; Drmanac R., 2006, international patent bibliographic data, Patent No. [WO/2006/138284, 2006138284, 2006/138284 A2]; Drmanac R, 2011, GENET MED, V13, P188, DOI 10.1097/GIM.0b013e31820f16e6; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Evans JP, 2011, JAMA-J AM MED ASSOC, V306, P2376, DOI 10.1001/jama.2011.1788; Gatke MR, 2001, ANESTHESIOLOGY, V95, P600; Kegel CAT, 2011, MIND BRAIN EDUC, V5, P71, DOI 10.1111/j.1751-228X.2011.01112.x; Lowe CB, 2011, SCIENCE, V333, P1019, DOI 10.1126/science.1202702; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; Rios J, 2010, HUM MOL GENET, V19, P4313, DOI 10.1093/hmg/ddq352; Roach JC, 2011, AM J HUM GENET, V89, P382, DOI 10.1016/j.ajhg.2011.07.023; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; Sanders SJ, 2012, NATURE, V485, P237, DOI 10.1038/nature10945; Smemo S, 2012, HUM MOL GENET, V21, P3255, DOI 10.1093/hmg/dds165; Strom CM, 2011, GENET MED, V13, P166, DOI 10.1097/GIM.0b013e3181fa24c4; Tewhey R, 2011, NAT REV GENET, V12, P215, DOI 10.1038/nrg2950; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712; Walsh T, 2010, P NATL ACAD SCI USA, V107, P12629, DOI 10.1073/pnas.1007983107; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497	27	25	25	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1110	1112		10.1126/science.1221037	http://dx.doi.org/10.1126/science.1221037			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	950KK	22654043				2022-12-24	WOS:000304647900030
J	Petherick, A				Petherick, Anna			ENVIRONMENT AND GENETICS Making sense of the noise	NATURE			English	Editorial Material							BREAST-CANCER; SUSCEPTIBILITY; RISK											Antonova L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2836; Begg CB, 2008, JAMA-J AM MED ASSOC, V299, P194, DOI 10.1001/jama.2007.55-a; Bell JT, 2011, TRENDS GENET, V27, P116, DOI 10.1016/j.tig.2010.12.005; Chen F, 2011, HUM MOL GENET, V20, P4491, DOI 10.1093/hmg/ddr367; Keinan-Boker L, 2009, JNCI-J NATL CANCER I, V101, P1489, DOI 10.1093/jnci/djp327; Mavaddat N, 2010, MOL ONCOL, V4, P174, DOI 10.1016/j.molonc.2010.04.011; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Morris DH, 2011, MENOPAUSE, V18, P956, DOI 10.1097/gme.0b013e31820ed6d2; Ritter HD, 2012, MOL CANCER RES, V10, P558, DOI 10.1158/1541-7786.MCR-11-0423-T	9	2	2	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S64	S65		10.1038/485S64a	http://dx.doi.org/10.1038/485S64a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648504	Bronze			2022-12-24	WOS:000304608000008
J	Steeg, PS				Steeg, Patricia S.			PERSPECTIVE The right trials	NATURE			English	Editorial Material							METASTASIS		NCI, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Steeg, PS (corresponding author), NCI, Womens Canc Sect, Mol Pharmacol Lab, Ctr Canc Res, Bethesda, MD 20892 USA.	steegp@mail.nih.gov			NATIONAL CANCER INSTITUTE [ZIASC000892] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Criscuoli ML, 2005, BLOOD, V105, P1508, DOI 10.1182/blood-2004-06-2246; Morton JP, 2010, GASTROENTEROLOGY, V139, P292, DOI 10.1053/j.gastro.2010.03.034; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Smith MR, 2012, LANCET, V379, P39, DOI 10.1016/S0140-6736(11)61226-9; Yang YA, 2002, J CLIN INVEST, V109, P1607, DOI 10.1172/JCI200215333	5	62	63	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S58	S59		10.1038/485S58a	http://dx.doi.org/10.1038/485S58a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648501	Bronze			2022-12-24	WOS:000304608000005
J	Dusheiko, G				Dusheiko, Geoffrey			Interruption of mother-to-infant transmission of hepatitis B: time to include selective antiviral prophylaxis?	LANCET			English	Editorial Material							PREVENT PERINATAL TRANSMISSION; VIRUS INFECTION; PREGNANCY; PHARMACOKINETICS; LAMIVUDINE; RISK		[Dusheiko, Geoffrey] Royal Free Hosp, Sheila Sherlock Ctr Hepatol, London NW3 2QG, England; [Dusheiko, Geoffrey] UCL, Sch Med, London W1N 8AA, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; UCL Medical School	Dusheiko, G (corresponding author), Royal Free Hosp, Ctr Hepatol, Pond St, London NW3 2QG, England.	g.dusheiko@medsch.ucl.ac.uk						Benaboud S, 2011, ANTIMICROB AGENTS CH, V55, P1315, DOI 10.1128/AAC.00514-10; BURK RD, 1994, J INFECT DIS, V170, P1418, DOI 10.1093/infdis/170.6.1418; Chen DS, 2009, J HEPATOL, V50, P805, DOI 10.1016/j.jhep.2009.01.002; Chotiyaputta W, 2009, J VIRAL HEPATITIS, V16, P91, DOI 10.1111/j.1365-2893.2008.01067.x; Han GR, 2011, J HEPATOL, V55, P1215, DOI 10.1016/j.jhep.2011.02.032; Hill JB, 2002, OBSTET GYNECOL, V99, P1049, DOI 10.1016/S0029-7844(02)02000-8; Johnson MA, 1999, CLIN PHARMACOKINET, V36, P41, DOI 10.2165/00003088-199936010-00004; Jonas MM, 2009, LIVER INT, V29, P133, DOI 10.1111/j.1478-3231.2008.01933.x; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Nguyen G, 2009, ALIMENT PHARM THER, V29, P755, DOI 10.1111/j.1365-2036.2009.03932.x; Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission, REC US ANT DRUGS PRE; RAWAL BK, 1991, LANCET, V337, P364, DOI 10.1016/0140-6736(91)90993-Y; Read JS, 2010, CLIN PERINATOL, V37, P765, DOI 10.1016/j.clp.2010.08.007; Shao ZJ, 2011, J MED VIROL, V83, P791, DOI 10.1002/jmv.22043; ter Borg MJ, 2008, J VIRAL HEPATITIS, V15, P37, DOI 10.1111/j.1365-2893.2007.00894.x; Van Rompay KKA, 2005, ANTIMICROB AGENTS CH, V49, P2093, DOI 10.1128/AAC.49.5.2093-2094.2005; van Zonneveld M, 2003, J VIRAL HEPATITIS, V10, P294, DOI 10.1046/j.1365-2893.2003.00440.x; Wiseman E, 2009, MED J AUSTRALIA, V190, P489, DOI 10.5694/j.1326-5377.2009.tb02524.x; Xu DZ, 2002, J MED VIROL, V67, P20, DOI 10.1002/jmv.2187; Xu WM, 2009, J VIRAL HEPATITIS, V16, P94, DOI 10.1111/j.1365-2893.2008.01056.x	20	20	20	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					2019	2021		10.1016/S0140-6736(11)61182-3	http://dx.doi.org/10.1016/S0140-6736(11)61182-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22549045				2022-12-24	WOS:000304757700037
J	Owen, R; Jobling, S				Owen, Richard; Jobling, Susan			The hidden costs of flexible fertility	NATURE			English	Editorial Material							FISH		[Owen, Richard] Univ Exeter, Sch Business, Exeter EX4 4PU, Devon, England; [Jobling, Susan] Brunel Univ, Inst Environm, Uxbridge UB8 3PH, Middx, England	University of Exeter; Brunel University	Owen, R (corresponding author), Univ Exeter, Sch Business, Exeter EX4 4PU, Devon, England.	r.j.owen@exeter.ac.uk		Owen, Richard/0000-0002-1767-3901				European Commission, 2000, COMMUNICATION; Gross-Sorokin MY, 2006, ENVIRON HEALTH PERSP, V114, P147, DOI 10.1289/ehp.8068; Jobling S., LATE LESSON IN PRESS; Kidd KA, 2007, P NATL ACAD SCI USA, V104, P8897, DOI 10.1073/pnas.0609568104; Royal Commission on Environmental Pollution, 1998, 21 RCEP	5	55	56	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					441	441		10.1038/485441a	http://dx.doi.org/10.1038/485441a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622553	Bronze			2022-12-24	WOS:000304344500018
J	White, PD; Rickards, H; Zeman, AZJ				White, P. D.; Rickards, H.; Zeman, A. Z. J.			Time to end the distinction between mental and neurological illnesses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							METAANALYSIS; DISORDER; BRAIN; SCHIZOPHRENIA; HIPPOCAMPAL; DEPRESSION; VOLUME		[White, P. D.] Queen Mary Univ London, Barts & London Sch Med, London, England; [Rickards, H.] Univ Birmingham, Dept Neuropsychiat, Birmingham B15 2TT, W Midlands, England; [Zeman, A. Z. J.] Univ Exeter, Peninsula Coll Med & Dent, Exeter EX4 4QJ, Devon, England	University of London; Queen Mary University London; University of Birmingham; University of Exeter; University of Plymouth	White, PD (corresponding author), St Bartholomews Hosp, Dept Psychol Med, London EC1A 7BE, England.	p.d.white@qmul.ac.uk		Zeman, Adam/0000-0003-4875-658X; White, Peter/0000-0002-8193-5355				Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Arnone D, 2009, BRIT J PSYCHIAT, V195, P194, DOI 10.1192/bjp.bp.108.059717; Bullmore ET, 2009, BRIT J PSYCHIAT, V194, P293, DOI 10.1192/bjp.bp.108.058479; Butler C, 2005, J NEUROL NEUROSUR PS, V76, pI31, DOI 10.1136/jnnp.2004.060459; Carson AJ, 2000, J NEUROL NEUROSUR PS, V68, P202, DOI 10.1136/jnnp.68.2.202; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Demertzi A, 2009, ANN NY ACAD SCI, V1157, P1, DOI 10.1111/j.1749-6632.2008.04117.x; Fitzgerald PB, 2008, HUM BRAIN MAPP, V29, P683, DOI 10.1002/hbm.20426; Giesecke T, 2005, ARTHRITIS RHEUM-US, V52, P1577, DOI 10.1002/art.21008; Goldberg D, 2010, BRIT J PSYCHIAT, V196, P255, DOI 10.1192/bjp.bp.109.072405; Hamilton WT, 2009, PSYCHOL MED, V39, P1913, DOI 10.1017/S0033291709005601; Kandel ER, 1998, AM J PSYCHIAT, V155, P457, DOI 10.1176/ajp.155.4.457; Kempton MJ, 2008, ARCH GEN PSYCHIAT, V65, P1017, DOI 10.1001/archpsyc.65.9.1017; Kendell RE, 2001, BRIT J PSYCHIAT, V178, P490, DOI 10.1192/bjp.178.6.490; Kupfer DJ, 2010, JAMA-J AM MED ASSOC, V303, P1974, DOI 10.1001/jama.2010.646; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; McKinnon MC, 2009, J PSYCHIATR NEUROSCI, V34, P41; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Radua J, 2009, BRIT J PSYCHIAT, V195, P393, DOI 10.1192/bjp.bp.108.055046; Schatzberg AF, 2009, TXB PSYCHOPHARMACOLO; Searle J.R., 2004, MIND BRIEF INTRO; Smith GD., 2005, BIOPSYCHOSOC MED; Steen RG, 2006, BRIT J PSYCHIAT, V188, P510, DOI 10.1192/bjp.188.6.510; Woon FL, 2008, HIPPOCAMPUS, V18, P729, DOI 10.1002/hipo.20437; World Health Organisation, 1993, ICD 10 CLASS MENT BE	26	56	58	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 24	2012	344								e3454	10.1136/bmj.e3454	http://dx.doi.org/10.1136/bmj.e3454			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QU	22628005				2022-12-24	WOS:000304591600007
J	Polikanov, YS; Blaha, GM; Steitz, TA				Polikanov, Yury S.; Blaha, Gregor M.; Steitz, Thomas A.			How Hibernation Factors RMF, HPF, and YfiA Turn Off Protein Synthesis	SCIENCE			English	Article							RIBOSOME-RECYCLING FACTOR; ESCHERICHIA-COLI; STATIONARY-PHASE; MESSENGER-RNA; TRANSLATION INITIATION; STRUCTURAL BASIS; 100S RIBOSOME; FACTOR RRF; SUBUNIT; STRESS	Eubacteria inactivate their ribosomes as 100S dimers or 70S monomers upon entry into stationary phase. In Escherichia coli, 100S dimer formation is mediated by ribosome modulation factor (RMF) and hibernation promoting factor (HPF), or alternatively, the YfiA protein inactivates ribosomes as 70S monomers. Here, we present high-resolution crystal structures of the Thermus thermophilus 70S ribosome in complex with each of these stationary-phase factors. The binding site of RMF overlaps with that of the messenger RNA (mRNA) Shine-Dalgarno sequence, which prevents the interaction between the mRNA and the 16S ribosomal RNA. The nearly identical binding sites of HPF and YfiA overlap with those of the mRNA, transfer RNA, and initiation factors, which prevents translation initiation. The binding of RMF and HPF, but not YfiA, to the ribosome induces a conformational change of the 30S head domain that promotes 100S dimer formation.	[Polikanov, Yury S.; Blaha, Gregor M.; Steitz, Thomas A.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Steitz, Thomas A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA; [Polikanov, Yury S.; Steitz, Thomas A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	Steitz, TA (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	thomas.steitz@yale.edu			NIH [GM022778]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM022778] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at the National Synchrotron Light Source (beamlines X29 and X25) and at the Advanced Photon Source (beamline 24ID) for help during data collection, the staff at the Center for Structural Biology at Yale University for computational support, and S. Seetharaman and M. Gagnon for valuable discussions. This work was supported by NIH grant GM022778 awarded to T.A.S. The structure factors and coordinates for both copies of the 70S ribosome in the asymmetric unit of all complexes have been deposited in the Research Collaboration for Structural Biology Protein Data Bank with the following accession codes: 3V22, 3V23, 3V24, and 3V25 for the RMF-ribosome complex; 3V26, 3V27, 3V28, and 3V29 for the HPF-ribosome complex; and 3V2C, 3V2D, 3V2F, and 3V2E for the YfiA-ribosome complex. T.A.S. owns stock in and is on the advisory board of Rib-X Pharmaceuticals, Inc., which does structure-based drug design targeted at the ribosome.	Agafonov DE, 1999, P NATL ACAD SCI USA, V96, P12345, DOI 10.1073/pnas.96.22.12345; Agafonov DE, 2001, EMBO REP, V2, P399; Janosi L, 1996, ADV BIOPHYS, V32, P121, DOI 10.1016/0065-227X(96)84743-5; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; Karamyshev AL, 2004, BIOCHIMIE, V86, P933, DOI 10.1016/j.biochi.2004.08.006; Kato T, 2010, STRUCTURE, V18, P719, DOI 10.1016/j.str.2010.02.017; Kivisaar M, 2003, ENVIRON MICROBIOL, V5, P814, DOI 10.1046/j.1462-2920.2003.00488.x; Martinez JL, 2000, ANTIMICROB AGENTS CH, V44, P1771, DOI 10.1128/AAC.44.7.1771-1777.2000; Moll I, 2004, NUCLEIC ACIDS RES, V32, P3354, DOI 10.1093/nar/gkh663; Ortiz JO, 2010, J CELL BIOL, V190, P613, DOI 10.1083/jcb.201005007; Pavlov MY, 2008, EMBO J, V27, P1706, DOI 10.1038/emboj.2008.99; Rak A, 2002, BIOCHEM BIOPH RES CO, V299, P710, DOI 10.1016/S0006-291X(02)02721-3; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sharma MR, 2010, J BIOL CHEM, V285, P4006, DOI 10.1074/jbc.M109.062299; SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342; STEITZ JA, 1975, P NATL ACAD SCI USA, V72, P4734, DOI 10.1073/pnas.72.12.4734; TISSIERES A, 1959, J MOL BIOL, V1, P221, DOI 10.1016/S0022-2836(59)80029-2; Ueta M, 2005, GENES CELLS, V10, P1103, DOI 10.1111/j.1365-2443.2005.00903.x; Ueta M, 2008, J BIOCHEM, V143, P425, DOI 10.1093/jb/mvm243; Vila-Sanjurjo A, 2004, NAT STRUCT MOL BIOL, V11, P1054, DOI 10.1038/nsmb850; WADA A, 1990, P NATL ACAD SCI USA, V87, P2657, DOI 10.1073/pnas.87.7.2657; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yoshida H, 2004, GENES CELLS, V9, P271, DOI 10.1111/j.1356-9597.2004.00723.x; Yoshida H, 2002, J BIOCHEM, V132, P983, DOI 10.1093/oxfordjournals.jbchem.a003313; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281	25	135	142	3	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					915	918		10.1126/science.1218538	http://dx.doi.org/10.1126/science.1218538			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605777	Green Accepted			2022-12-24	WOS:000304145600065
J	Seth, D; Hausladen, A; Wang, YJ; Stamler, JS				Seth, Divya; Hausladen, Alfred; Wang, Ya-Juan; Stamler, Jonathan S.			Endogenous Protein S-Nitrosylation in E. coli: Regulation by OxyR	SCIENCE			English	Article							ESCHERICHIA-COLI; NITRIC-OXIDE; NITROSATIVE STRESS; REDUCTASE; FNR; NITRATE; FLAVOHEMOGLOBIN; ACTIVATION; MECHANISM; CATALYSIS	Endogenous S-nitrosylation of proteins, a principal mechanism of cellular signaling in eukaryotes, has not been observed in microbes. We report that protein S-nitrosylation is an obligate concomitant of anaerobic respiration on nitrate in Escherichia coli. Endogenous S-nitrosylation during anaerobic respiration is controlled by the transcription factor OxyR, previously thought to operate only under aerobic conditions. Deletion of OxyR resulted in large increases in protein S-nitrosylation, and S-nitrosylation of OxyR induced transcription from a regulon that is distinct from the regulon induced by OxyR oxidation. Furthermore, products unique to the anaerobic regulon protected against S-nitrosothiols, and anaerobic growth of E. coli lacking OxyR was impaired on nitrate. Thus, OxyR serves as a master regulator of S-nitrosylation, and alternative posttranslational modifications of OxyR control distinct transcriptional responses.	[Seth, Divya; Hausladen, Alfred; Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA; [Seth, Divya; Hausladen, Alfred; Stamler, Jonathan S.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Seth, Divya; Hausladen, Alfred; Stamler, Jonathan S.] Univ Hosp, Case Med Ctr, Cleveland, OH 44106 USA; [Wang, Ya-Juan] Case Western Reserve Univ, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Case Western Reserve University	Stamler, JS (corresponding author), Case Western Reserve Univ, Sch Med, Inst Transformat Mol Med, Cleveland, OH 44106 USA.	jonathan.stamler@case.edu		Stamler, Jonathan/0000-0002-6866-1572; Wang, Yajuan (Megan)/0000-0002-3284-9012	NIH [R01-HL096673, R01-HL095463, R01-HL059130]; Defense Advanced Research Projects Agency [N66001-10-C-2015]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096673, R01HL095463, R01HL059130] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from the NIH (R01-HL096673, R01-HL095463, R01-HL059130) and Defense Advanced Research Projects Agency (N66001-10-C-2015). We thank D. Hess for helpful discussions and suggestions; P. McLaughlin for excellent technical assistance; M. Chance, G. Gokulrangan, and L. Wang for valuable assistance and discussion. The microarray data reported in this paper have been submitted in MIAME-compliant format to the Gene Expression Omnibus database (accession number GSE24524).	Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; Bosworth CA, 2009, P NATL ACAD SCI USA, V106, P4671, DOI 10.1073/pnas.0710416106; CALMELS S, 1988, J GEN MICROBIOL, V134, P221; Corker H, 2003, J BIOL CHEM, V278, P31584, DOI 10.1074/jbc.M303282200; Cruz-Ramos H, 2002, EMBO J, V21, P3235, DOI 10.1093/emboj/cdf339; Filenko N, 2007, J BACTERIOL, V189, P4410, DOI 10.1128/JB.00080-07; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Foster MW, 2009, BIOCHEMISTRY-US, V48, P792, DOI 10.1021/bi801813n; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Hausladen A, 1998, P NATL ACAD SCI USA, V95, P14100, DOI 10.1073/pnas.95.24.14100; Hausladen A, 1996, CELL, V86, P719, DOI 10.1016/S0092-8674(00)80147-6; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; JI XB, 1988, APPL ENVIRON MICROB, V54, P1791, DOI 10.1128/AEM.54.7.1791-1794.1988; Kim CC, 2003, INFECT IMMUN, V71, P3196, DOI 10.1128/IAI.71.6.3196-3205.2003; Kim SO, 2002, CELL, V109, P383, DOI 10.1016/S0092-8674(02)00723-7; KULLIK I, 1995, J BACTERIOL, V177, P1275, DOI 10.1128/jb.177.5.1275-1284.1995; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Nedospasov A, 2000, P NATL ACAD SCI USA, V97, P13543, DOI 10.1073/pnas.250398197; Overton TW, 2006, BIOCHEM SOC T, V34, P104, DOI 10.1042/BST0340104; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; RALT D, 1988, J BACTERIOL, V170, P359, DOI 10.1128/jb.170.1.359-364.1988; STEWART V, 1988, MICROBIOL REV, V52, P190, DOI 10.1128/MMBR.52.2.190-232.1988; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001	26	121	122	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					470	473		10.1126/science.1215643	http://dx.doi.org/10.1126/science.1215643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539721	Green Accepted			2022-12-24	WOS:000303233400046
J	Yi, C; Ma, MS; Ran, LL; Zheng, JX; Tong, JJ; Zhu, J; Ma, CY; Sun, YF; Zhang, SJ; Feng, WZ; Zhu, LY; Le, Y; Gong, XQ; Yan, XH; Hong, B; Jiang, FJ; Xie, ZP; Miao, D; Deng, H; Yu, L				Yi, Cong; Ma, Meisheng; Ran, Leili; Zheng, Jingxiang; Tong, Jingjing; Zhu, Jing; Ma, Chengying; Sun, Yufen; Zhang, Shaojin; Feng, Wenzhi; Zhu, Liyuan; Le, Yan; Gong, Xingqi; Yan, Xianghua; Hong, Bing; Jiang, Fen-Jun; Xie, Zhiping; Miao, Di; Deng, Haiteng; Yu, Li			Function and Molecular Mechanism of Acetylation in Autophagy Regulation	SCIENCE			English	Article							VACUOLE TARGETING PATHWAY; ACETYLTRANSFERASE; TRANSCRIPTION; CYTOPLASM	Protein acetylation emerged as a key regulatory mechanism for many cellular processes. We used genetic analysis of Saccharomyces cerevisiae to identify Esa1 as a histone acetyltransferase required for autophagy. We further identified the autophagy signaling component Atg3 as a substrate for Esa1. Specifically, acetylation of K19 and K48 of Atg3 regulated autophagy by controlling Atg3 and Atg8 interaction and lipidation of Atg8. Starvation induced transient K19-K48 acetylation through spatial and temporal regulation of the localization of acetylase Esa1 and the deacetylase Rpd3 on pre-autophagosomal structures (PASs) and their interaction with Atg3. Attenuation of K19-K48 acetylation was associated with attenuation of autophagy. Increased K19-K48 acetylation after deletion of the deacetylase Rpd3 caused increased autophagy. Thus, protein acetylation contributes to control of autophagy.	[Yi, Cong; Ma, Meisheng; Ran, Leili; Zheng, Jingxiang; Tong, Jingjing; Zhu, Jing; Sun, Yufen; Zhang, Shaojin; Feng, Wenzhi; Zhu, Liyuan; Le, Yan; Yu, Li] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Univ Peking Univ Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China; [Ma, Chengying; Gong, Xingqi; Yu, Li] Tsinghua Univ, Ctr Struct Biol, Beijing 100084, Peoples R China; [Yan, Xianghua] Huazhong Agr Univ, Coll Anim Sci & Technol, Wuhan 430070, Hubei, Peoples R China; [Hong, Bing; Jiang, Fen-Jun; Xie, Zhiping] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Miao, Di; Deng, Haiteng] Tsinghua Univ, Prote Facil, Sch Life Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Huazhong Agricultural University; Nankai University; Tsinghua University	Yu, L (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Tsinghua Univ Peking Univ Joint Ctr Life Sci, Sch Life Sci, Beijing 100084, Peoples R China.	liyulab@mail.tsinghua.edu.cn	Xie, Zhiping/A-1306-2015	Xie, Zhiping/0000-0001-5816-6159; Deng, Haiteng/0000-0001-9496-1280	973 Program [2011CB910101, 2010CB833704]; National Science Foundation [31030043, 31125018, 30971484, 30971441, 31172290, 31072036]; Tsinghua University [2010THZ0, 2009THZ03071]	973 Program(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); Tsinghua University	We are grateful to Y. Ohsumi and H. Nakatogawa for antibodies and plasmids, N. Gao for assistance with protein purification, B. Zhou for providing the yeast deletion library, J. Cote for EPL1 and epl1-1, L. Pillus for ESA1 and esa1-1, and G. Yang for image processing. This research was supported by 973 Program 2011CB910101 and 2010CB833704; National Science Foundation grants 31030043, 31125018, and 30971484; and Tsinghua University grants 2010THZ0 and 2009THZ03071 to L. Y.; National Science Foundation grant 30971441 to Z.X.; and National Science Foundation grants 31172290 and 31072036 to X.Y.	Galarneau L, 2000, MOL CELL, V5, P927, DOI 10.1016/S1097-2765(00)80258-0; Ichimura Y, 2004, J BIOL CHEM, V279, P40584, DOI 10.1074/jbc.M405860200; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lv L, 2011, MOL CELL, V42, P719, DOI 10.1016/j.molcel.2011.04.025; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Ohsumi Yoshinori, 2006, Tanpakushitsu Kakusan Koso, V51, P1453; Robert T, 2011, NATURE, V471, P74, DOI 10.1038/nature09803; Rundlett SE, 1996, P NATL ACAD SCI USA, V93, P14503, DOI 10.1073/pnas.93.25.14503; Shintani T, 2002, DEV CELL, V3, P825, DOI 10.1016/S1534-5807(02)00373-8; Suzuki K, 2010, FEBS LETT, V584, P1280, DOI 10.1016/j.febslet.2010.02.001; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Yamaguchi M, 2010, J BIOL CHEM, V285, P29599, DOI 10.1074/jbc.M110.113670; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zhao Y, 2010, NAT CELL BIOL, V12, P665, DOI 10.1038/ncb2069	15	176	198	6	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					474	477		10.1126/science.1216990	http://dx.doi.org/10.1126/science.1216990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539722				2022-12-24	WOS:000303233400047
J	Melzer, A; Cochran, S; Prentice, P; MacDonald, MP; Wang, ZG; Cuschieri, A				Melzer, Andreas; Cochran, Sandy; Prentice, Paul; MacDonald, Michael P.; Wang, Zhigang; Cuschieri, Alfred			Physics and Medicine 3 The importance of physics to progress in medical treatment	LANCET			English	Article							INTENSITY FOCUSED ULTRASOUND; SURGERY; CANCER; IMPLEMENTATION; LITHOTRIPSY; EXPERIENCE; THERAPY; BRAIN	Physics in therapy is as diverse as it is substantial. In this review, we highlight the role of physics-occasionally transitioning into engineering-through discussion of several established and emerging treatments. We specifically address minimal access surgery, ultrasound, photonics, and interventional MRI, identifying areas in which complementarity is being exploited. We also discuss some of the fundamental physical principles involved in the application of each treatment to medical practice.	[Melzer, Andreas; Cochran, Sandy; Prentice, Paul; MacDonald, Michael P.; Wang, Zhigang; Cuschieri, Alfred] Univ Dundee, Inst Med Sci & Technol, Dundee DD2 1FD, Scotland	University of Dundee	Cuschieri, A (corresponding author), Univ Dundee, Inst Med Sci & Technol, Dundee DD2 1FD, Scotland.	a.cuschieri@dundee.ac.uk	MacDonald, Michael P/F-5880-2011; Cochran, Sandy/M-4087-2017; Wang, Zhigang/A-5197-2013; Cuschieri, Alfred/O-4092-2019; Cuschieri, Alfred/A-7634-2013; Melzer, Andreas/D-7832-2012	MacDonald, Michael P/0000-0003-4415-5437; Cochran, Sandy/0000-0001-7324-7790; Wang, Zhigang/0000-0001-8309-7888; Cuschieri, Alfred/0000-0003-0764-5947; Prentice, Paul/0000-0003-2228-3622	Biotechnology and Biological Sciences Research Council; Medical Research Council; Engineering and Physical Sciences Research Council; European Research Council; Northern Research Partnership; European Regional Development Fund; European Union	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Northern Research Partnership; European Regional Development Fund(European Commission); European Union(European Commission)	We thank Janice Aitken (College of Art and Design University of Dundee) for the production of the figures in this report. Institute for Medical Science and Technology (University of Dundee) academic staff have received financial support from the following funding councils: Biotechnology and Biological Sciences Research Council, Medical Research Council, Engineering and Physical Sciences Research Council, European Research Council, Northern Research Partnership, European Regional Development Fund, European Union Seventh Framework Program.	Baker KG, 2001, PHYS THER, V81, P1351, DOI 10.1093/ptj/81.7.1351; Black PM, 1997, NEUROSURGERY, V41, P831, DOI 10.1097/00006123-199710000-00013; BOYLE WS, 1970, BELL SYST TECH J, V49, P587, DOI 10.1002/j.1538-7305.1970.tb01790.x; Burl M, 1996, MAGNET RESON MED, V36, P491, DOI 10.1002/mrm.1910360326; Christensen, 1997, INNOVATORS DILEMMA N; Cleary K, 2006, MINIM INVASIV THER, V15, P101, DOI 10.1080/13645700600674179; Curiel L, 2005, ULTRASOUND MED BIOL, V31, P1461, DOI 10.1016/j.ultrasmedbio.2005.06.013; Cuschieri A, 2005, SURG-J R COLL SURG E, V3, P125, DOI 10.1016/S1479-666X(05)80032-0; Dickinson A, 1998, US patent number, Patent No. 5631704; DOBSON SJ, 1989, J PHYS E SCI INSTRUM, V22, P450, DOI 10.1088/0022-3735/22/7/008; Dubinsky TJ, 2008, AM J ROENTGENOL, V190, P191, DOI 10.2214/AJR.07.2671; Ferrara KW, 2009, ACCOUNTS CHEM RES, V42, P881, DOI 10.1021/ar8002442; FISHER B, 1983, CANCER RES, V43, P1488; Furusawa H, 2006, J AM COLL SURGEONS, V203, P54, DOI 10.1016/j.jamcollsurg.2006.04.002; Gianfelice D, 2008, RADIOLOGY, V249, P355, DOI 10.1148/radiol.2491071523; Hand JW, 1998, ULTRASOUND MED; Hanna GB, 1998, ANN SURG, V227, P481, DOI 10.1097/00000658-199804000-00005; Hoffmann BA, 2010, EUR HEART J, V31, P450, DOI 10.1093/eurheartj/ehp460; Hopkins HH, 1964, UK patent number, Patent No. 954629; Hynynen KH, 2008, MRI GUIDED FOCUSED U; Iddan G, 2000, NATURE, V405, P417, DOI 10.1038/35013140; Immel E, 2006, MINIM INVASIV THER, V15, P85, DOI 10.1080/13645700600641004; Jolesz FA, 2002, CANCER J, V8, pS100; Kawamoto H, 2002, P IEEE, V90, P460, DOI 10.1109/JPROC.2002.1002521; Kennedy A, 1996, EUR J COGN PSYCHOL, V8, P831; Konig K, 2001, OPT LETT, V26, P819, DOI 10.1364/OL.26.000819; Konig K, 2003, J BIOMED OPT, V8, P432, DOI 10.1117/1.1577349; KREMKAU FW, 1979, J CLIN ULTRASOUND, V7, P287, DOI 10.1002/jcu.1870070410; LAUTERBUR PC, 1973, NATURE, V242, P190, DOI 10.1038/242190a0; Lewin JS, 2000, J MAGN RESON IMAGING, V12, P512, DOI 10.1002/1522-2586(200010)12:4<512::AID-JMRI2>3.0.CO;2-3; MAIMAN TH, 1960, NATURE, V187, P493, DOI 10.1038/187493a0; Manke C, 2001, RADIOLOGY, V219, P527, DOI 10.1148/radiology.219.2.r01ma03527; Melzer A, 2006, ISMRM P, V270, P61; Mitragotri S, 2005, NAT REV DRUG DISCOV, V4, P255, DOI 10.1038/nrd1662; Nimsky C, 2004, RADIOLOGY, V233, P67, DOI 10.1148/radiol.2331031352; Oar MA, 2005, CHEM MATER, V17, P2267, DOI 10.1021/cm047825i; Parsons JE, 2006, ULTRASOUND MED BIOL, V32, P115, DOI 10.1016/j.ultrasmedbio.2005.09.005; Pott Peter P, 2005, Comput Aided Surg, V10, P101, DOI 10.1080/10929080500228753; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Robertson VJ, 2001, PHYS THER, V81, P1339, DOI 10.1093/ptj/81.7.1339; Sakimoto T, 2006, LANCET, V367, P1432, DOI 10.1016/S0140-6736(06)68275-5; Schaefers G, 2006, MINIM INVASIV THER, V15, P71, DOI 10.1080/13645700600640865; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Sofer M, 2002, J UROLOGY, V167, P31, DOI 10.1016/S0022-5347(05)65376-1; Szabo TL, 2004, DIAGNOSTIC ULTRASOUN; Tang MX, 2010, P I MECH ENG H, V224, P291, DOI 10.1243/09544119JEIM598; THOMAS DGT, 1986, AM J NEURORADIOL, V7, P161; TOMPSETT MF, 1971, IEEE T ELECTRON DEV, VED18, P992, DOI 10.1109/T-ED.1971.17321; TOMPSETT MF, 1970, APPL PHYS LETT, V17, P111, DOI 10.1063/1.1653327; Truwit CL, 2006, NEUROSURGERY, V58, P338, DOI 10.1227/01.NEU.0000205284.04252.87; Vassar GJ, 1999, J ENDOUROL, V13, P181, DOI 10.1089/end.1999.13.181; Vogl TJ, 1997, MINIM INVASIV THER, V6, P53; Vykhodtseva N, 2008, ULTRASONICS, V48, P279, DOI 10.1016/j.ultras.2008.04.004; Wu J, 2008, ADV DRUG DELIVER REV, V60, P1103, DOI 10.1016/j.addr.2008.03.009; Xiong LL, 2009, J PANCREAS, V10, P123; YAMAGISHI M, 1991, IEEE T ELECTRON DEV, V38, P976, DOI 10.1109/16.78368; Zangos S, 2011, RADIOLOGY, V259, P903, DOI 10.1148/radiol.11101559	57	9	9	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 21	2012	379	9825					1534	1543		10.1016/S0140-6736(12)60428-0	http://dx.doi.org/10.1016/S0140-6736(12)60428-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930BJ	22516559				2022-12-24	WOS:000303110200032
J	Schroeder, E; Petrou, S; Patel, N; Hollowell, J; Puddicombe, D; Redshaw, M; Brocklehurst, P				Schroeder, Elizabeth; Petrou, Stavros; Patel, Nishma; Hollowell, Jennifer; Puddicombe, David; Redshaw, Maggie; Brocklehurst, Peter		Birthpl England Collaborative Grp	Cost effectiveness of alternative planned places of birth in woman at low risk of complications: evidence from the Birthplace in England national prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERINATAL-MORTALITY RATES; BOOKED HOME BIRTHS	Objectives To estimate the cost effectiveness of alternative planned places of birth. Design Economic evaluation with individual level data from the Birthplace national prospective cohort study. Setting 142 of 147 trusts providing home birth services, 53 of 56 freestanding midwifery units, 43 of 51 alongside midwifery units, and a random sample of 36 of 180 obstetric units, stratified by unit size and geographical region, in England, over varying periods of time within the study period 1 April 2008 to 30 April 2010. Participants 64 538 women at low risk of complications before the onset of labour. Interventions Planned birth in four alternative settings: at home, in freestanding midwifery units, in alongside midwifery units, and in obstetric units. Main outcome measures Incremental cost per adverse perinatal outcome avoided, adverse maternal morbidity avoided, and additional normal birth. The non-parametric bootstrap method was used to generate net monetary benefits and construct cost effectiveness acceptability curves at alternative thresholds for cost effectiveness. Results The total unadjusted mean costs were 1066 pound, 1435 pound, 1461 pound, and 1631 pound for births planned at home, in freestanding midwifery units, in alongside midwifery units, and in obstetric units, respectively (equivalent to about (sic)1274, $1701; (sic)1715, $2290; (sic)1747, $2332; and (sic)1950, $2603). Overall, and for multiparous women, planned birth at home generated the greatest mean net benefit with a 100% probability of being the optimal setting across all thresholds of cost effectiveness when perinatal outcomes were considered. There was, however, an increased incidence of adverse perinatal outcome associated with planned birth at home in nulliparous low risk women, resulting in the probability of it being the most cost effective option at a cost effectiveness threshold of 20 pound 000 declining to 0.63. With regards to maternal outcomes in nulliparous and multiparous women, planned birth at home generated the greatest mean net benefit with a 100% probability of being the optimal setting across all thresholds of cost effectiveness. Conclusions For multiparous women at low risk of complications, planned birth at home was the most cost effective option. For nulliparous low risk women, planned birth at home is still likely to be the most cost effective option but is associated with an increase in adverse perinatal outcomes.	[Schroeder, Elizabeth; Petrou, Stavros; Patel, Nishma; Hollowell, Jennifer; Puddicombe, David; Redshaw, Maggie; Brocklehurst, Peter] Univ Oxford, Dept Publ Hlth, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England; [Petrou, Stavros] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry CV4 7AL, W Midlands, England; [Brocklehurst, Peter] UCL, Inst Womens Hlth, London WC1E 6BT, England	University of Oxford; University of Warwick; University of London; University College London	Schroeder, E (corresponding author), Univ Oxford, Dept Publ Hlth, Natl Perinatal Epidemiol Unit, Oxford OX3 7LF, England.	liz.schroeder@npeu.ox.ac.uk	Puddicombe, David M/F-1354-2011; Hollowell, Jennifer/B-5052-2009; Petrou, Stavros/ABD-8323-2021; Sandall, Jane/D-4146-2009	Puddicombe, David M/0000-0003-4343-4522; Hollowell, Jennifer/0000-0002-4041-5732; Petrou, Stavros/0000-0003-3121-6050; Sandall, Jane/0000-0003-2000-743X; Patel, Nishma/0000-0002-2652-5185; Schroeder, Elizabeth-Ann/0000-0003-0236-2833	Department of Health; National Institute for Health Research Service Delivery and Organisation; National Institute for Health [PB-PG-0107-12209]; National Institute for Health Research [08/1604/140, 10/1008/35] Funding Source: researchfish	Department of Health; National Institute for Health Research Service Delivery and Organisation(National Institute for Health Research (NIHR)); National Institute for Health; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was part of a larger study jointly funded by the Department of Health's Policy Research Programme and the National Institute for Health Research Service Delivery and Organisation programme. The related study formed part of a project funded by the National Institute for Health Research Research for Patient Benefit Programme through grant PB-PG-0107-12209. The views expressed are not necessarily those of the funders.	[Anonymous], 2008, GUID METH TECHN APPR; British Medical Association and Royal Pharmaceutical Society of Great Britain, 2011, BRIT NAT FORM 61; Brocklehurst P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7400; Campbell R, 1994, BE BORN DEBATE EVIDE; Curtis L., 2010, UNIT COSTS HLTH SOCI; de Jonge A, 2009, BJOG-INT J OBSTET GY, V116, P1177, DOI 10.1111/j.1471-0528.2009.02175.x; Department of Health, 2010, 13456 DEP HLTH; Department of Health, 2004, 11 DEP HLTH; Department of Health, 2002, IMPR EXP REF NEXT 3; Dixon Philip M., 1993, P290; Drummond MF, 1996, BRIT MED J, V313, P275, DOI 10.1136/bmj.313.7052.275; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Gyte G, 2009, BJOG-INT J OBSTET GY, V116, P933, DOI 10.1111/j.1471-0528.2009.02147.x; Hodnett ED, 2010, ALTERNATIVE VERSUS C; Hollowell J, 2011, BIRTHPLACE NATL PROS; Janssen PA, 2009, CAN MED ASSOC J, V181, P377, DOI 10.1503/cmaj.081869; Lindgren HE, 2008, ACTA OBSTET GYN SCAN, V87, P751, DOI 10.1080/00016340802199903; Macfarlane A, 2011, ASSESSING IMPACT NEW; Maternity Care Working Party, 2007, MAK NORM BIRTH REAL; Mori R, 2008, BJOG-INT J OBSTET GY, V115, P554, DOI 10.1111/j.1471-0528.2008.01669.x; National Health Service Litigation Authority, 2010, NHSLA FACTSH 5; National Health Service Supply Chain, 2009, NHS SUPPL CHAIN CAT; NICE, 2007, INTR CAR HLTH WOM TH; Petrou S, 2003, BIRTH-ISS PERINAT C, V30, P217, DOI 10.1046/j.1523-536X.2003.0251a.x; Schroeder L, 2011, BIRTHPLACE COST EFFE; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Ungar W, 2009, EC EVALUATION CHILD; Wax J.R., 2010, AM J OBSTET GYNECOL, V243, pe1	28	79	79	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 19	2012	344								e2292	10.1136/bmj.e2292	http://dx.doi.org/10.1136/bmj.e2292			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931CU	22517916	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000303192900002
J	van der Zand, A; Gent, J; Braakman, I; Tabak, HF				van der Zand, Adabella; Gent, Jurgen; Braakman, Ineke; Tabak, Henk F.			Biochemically Distinct Vesicles from the Endoplasmic Reticulum Fuse to Form Peroxisomes	CELL			English	Article							MATRIX PROTEIN IMPORT; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEINS; FLUORESCENCE COMPLEMENTATION; ANCHORED PROTEINS; LIVING CELLS; BIOGENESIS; PATHWAY; PEX3P; YEAST	As a rule, organelles in eukaryotic cells can derive only from pre-existing organelles. Peroxisomes are unique because they acquire their lipids and membrane proteins from the endoplasmic reticulum (ER), whereas they import their matrix proteins directly from the cytosol. We have discovered that peroxisomes are formed via heterotypic fusion of at least two biochemically distinct preperoxisomal vesicle pools that arise from the ER. These vesicles each carry half a peroxisomal translocon complex. Their fusion initiates assembly of the full peroxisomal translocon and subsequent uptake of enzymes from the cytosol. Our findings demonstrate a remarkable mechanism to maintain biochemical identity of organelles by transporting crucial components via different routes to their final destination.	[van der Zand, Adabella; Gent, Jurgen; Braakman, Ineke; Tabak, Henk F.] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands	Utrecht University	van der Zand, A (corresponding author), Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands.	a.vanderzand@uu.nl	van der Zand, Adabella/F-8431-2013	van der Zand, Adabella/0000-0001-8980-7270; Braakman, Ineke/0000-0003-1592-4364	Netherlands Organisation of Scientific Research (NWO), Earth and Life Sciences (ALW) and Chemical Sciences (CW)	Netherlands Organisation of Scientific Research (NWO), Earth and Life Sciences (ALW) and Chemical Sciences (CW)	We thank D. Schildknegt for preparation of the GFP, Pex1p, and Pex6p antibodies and for excellent technical assistance. Drs. F. Chang, R. Erdman, D. Hoepfner, W. Huh, R. Rachubinski, and C. Stirling are gratefully acknowledged for providing reagents. We thank Drs. P. van der Sluijs and F. Reggiori for critically reading the manuscript. This work was supported by grants from the Netherlands Organisation of Scientific Research (NWO), Earth and Life Sciences (ALW) and Chemical Sciences (CW).	Agne B, 2003, MOL CELL, V11, P635, DOI 10.1016/S1097-2765(03)00062-5; Agrawal G, 2011, P NATL ACAD SCI USA, V108, P9113, DOI 10.1073/pnas.1018749108; Birschmann I, 2003, MOL BIOL CELL, V14, P2226, DOI 10.1091/mbc.E02-11-0752; Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x; Chang JL, 2009, J CELL BIOL, V187, P233, DOI 10.1083/jcb.200902117; Collins CS, 2000, MOL CELL BIOL, V20, P7516, DOI 10.1128/MCB.20.20.7516-7526.2000; de Duve C, 2007, NAT REV GENET, V8, P395, DOI 10.1038/nrg2071; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; Faber KN, 1998, MOL CELL BIOL, V18, P936, DOI 10.1128/MCB.18.2.936; Gabaldon T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-8; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hazra PP, 2002, TRAFFIC, V3, P560, DOI 10.1034/j.1600-0854.2002.30806.x; Hettema EH, 2009, J CELL SCI, V122, P2331, DOI 10.1242/jcs.034363; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kiel JAKW, 2005, J BIOL CHEM, V280, P1921, DOI 10.1074/jbc.M403632200; Kim PK, 2006, J CELL BIOL, V173, P521, DOI 10.1083/jcb.200601036; Knoblach B, 2010, J BIOL CHEM, V285, P6670, DOI 10.1074/jbc.M109.094805; Kragt A, 2005, J BIOL CHEM, V280, P34350, DOI 10.1074/jbc.M505432200; Lam SK, 2010, P NATL ACAD SCI USA, V107, P21523, DOI 10.1073/pnas.1013397107; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Ma CL, 2011, J CELL BIOL, V193, P7, DOI 10.1083/jcb.201010022; Motley AM, 2007, J CELL BIOL, V178, P399, DOI 10.1083/jcb.200702167; Munck JM, 2009, J CELL BIOL, V187, P463, DOI 10.1083/jcb.200906161; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; Nunnari J, 1996, CELL, V84, P389, DOI 10.1016/S0092-8674(00)81283-0; Nuttall JM, 2011, CURR OPIN CELL BIOL, V23, P421, DOI 10.1016/j.ceb.2011.05.005; Nyfeler B, 2007, BIOCHEM SOC T, V35, P970, DOI 10.1042/BST0350970; Platta HW, 2005, NAT CELL BIOL, V7, P817, DOI 10.1038/ncb1281; REXACH MF, 1994, J CELL BIOL, V126, P1133, DOI 10.1083/jcb.126.5.1133; Rosenkranz K, 2006, FEBS J, V273, P3804, DOI 10.1111/j.1742-4658.2006.05388.x; Rucktaschel R, 2011, BBA-BIOMEMBRANES, V1808, P892, DOI 10.1016/j.bbamem.2010.07.020; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Tam YYC, 2005, J BIOL CHEM, V280, P34933, DOI 10.1074/jbc.M506208200; Titorenko VI, 2000, J CELL BIOL, V148, P29, DOI 10.1083/jcb.148.1.29; Titorenko VI, 2000, J CELL BIOL, V150, P881, DOI 10.1083/jcb.150.4.881; van der Zand A, 2010, MOL BIOL CELL, V21, P2057, DOI 10.1091/mbc.E10-02-0082; Warren G, 1996, CELL, V84, P395, DOI 10.1016/S0092-8674(00)81284-2	41	132	132	2	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					397	409		10.1016/j.cell.2012.01.054	http://dx.doi.org/10.1016/j.cell.2012.01.054			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500805	Bronze			2022-12-24	WOS:000302805600018
J	Kuehn, BM				Kuehn, Bridget M.			Collaborative Effort Seeks to Curb Hospital Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1475	1475		10.1001/jama.2012.430	http://dx.doi.org/10.1001/jama.2012.430			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496254				2022-12-24	WOS:000302538100004
J	Katz, SJ; Morrow, M				Katz, Steven J.; Morrow, Monica			The Challenge of Individualizing Treatments for Patients With Breast Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WOMEN		[Katz, Steven J.] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; [Katz, Steven J.] Univ Michigan, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA; [Morrow, Monica] Mem Sloan Kettering Canc Ctr, Dept Clin Oncol, New York, NY 10021 USA; [Morrow, Monica] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Memorial Sloan Kettering Cancer Center; Cornell University	Katz, SJ (corresponding author), Univ Michigan, Dept Med, 300 N Ingalls,Room 7E10, Ann Arbor, MI 48109 USA.	skatz@umich.edu	KATZ, STEVEN/ABH-8886-2020					Anderson WF, 2007, J CLIN ONCOL, V25, P3923, DOI 10.1200/JCO.2007.11.6079; Haidt J., 2006, HAPPINESS HYPOTHESIS; HEWITT M, 1999, ENSURING QUALITY CAN, P97; Lantz PM, 2005, HEALTH SERV RES, V40, P745, DOI 10.1111/j.1475-6773.2005.00383.x; Morrow M, 2011, LANCET, V378, P1804, DOI 10.1016/S0140-6736(11)61350-0; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Patlak M., 2010, POLICY ISSUES DEV PE; Rozin P., 2002, HEURISTICS BIASES PS, P201, DOI DOI 10.1017/CBO9780511808098; Schwartz B., 2004, PARADOX CHOICE	9	27	27	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1379	1380		10.1001/jama.2012.409	http://dx.doi.org/10.1001/jama.2012.409			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474200				2022-12-24	WOS:000302294200023
J	Kellum, JA; Bellomo, R; Ronco, C				Kellum, John A.; Bellomo, Rinaldo; Ronco, Claudio			Kidney Attack	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE-RENAL-FAILURE; INJURY; MORTALITY; PNEUMONIA; OUTCOMES		[Kellum, John A.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness Ctr, Dept Crit Care Med, Pittsburgh, PA 15261 USA; [Bellomo, Rinaldo] Austin Hosp, Dept Intens Care & Med, Melbourne, Vic 3084, Australia; [Bellomo, Rinaldo] Univ Melbourne, Melbourne, Vic, Australia; [Ronco, Claudio] Osped San Bortolo, Int Renal Res Inst, Dept Nephrol, Vicenza, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; ULSS 8 Berica; Ospedale San Bortolo di Vicenza	Kellum, JA (corresponding author), Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness Ctr, Dept Crit Care Med, Room 604,Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kellumja@ccm.upmc.edu	Kellum, John/AAP-3072-2020; Kellum, John A/HCH-2944-2022	Kellum, John/0000-0003-1995-2653; Kellum, John A/0000-0003-1995-2653; Ronco, Claudio/0000-0002-6697-4065				Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Amdur RL, 2009, KIDNEY INT, V76, P1089, DOI 10.1038/ki.2009.332; Colpaert K, 2012, CRIT CARE MED, V40, P1164, DOI 10.1097/CCM.0b013e3182387a6b; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Kidney Disease: Improving Global Outcomes (KDIGO), 2012, KIDNEY INT S, V2, P89; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Ricci Z, 2008, KIDNEY INT, V73, P538, DOI 10.1038/sj.ki.5002743; Singbartl K, 2011, KIDNEY INT, V80, P633, DOI 10.1038/ki.2011.201; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813	9	72	73	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 6	2012	307	21					2265	2266		10.1001/jama.2012.4315	http://dx.doi.org/10.1001/jama.2012.4315			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	952OL	22572776				2022-12-24	WOS:000304801700019
J	Lok, ASF; Ward, JW; Perrillo, RP; McMahon, BJ; Liang, TJ				Lok, Anna S. F.; Ward, John W.; Perrillo, Robert P.; McMahon, Brian J.; Liang, T. Jake			Reactivation of Hepatitis B During Immunosuppressive Therapy: Potentially Fatal Yet Preventable	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VIRUS INFECTION; CYTOTOXIC CHEMOTHERAPY; LAMIVUDINE; RECOMMENDATIONS; IDENTIFICATION; MANAGEMENT; RITUXIMAB; DISEASES		Univ Michigan, Ann Arbor, MI 48109 USA; Ctr Dis Control & Prevent, Atlanta, GA USA; Baylor Med Ctr, Dallas, TX USA; Ctr Dis Control & Prevent, Liver Dis & Hepatitis Program, Alaska Native Med Ctr, Anchorage, AK USA; Ctr Dis Control & Prevent, Arctic Invest Programs, Anchorage, AK USA; Amer Assoc Study Liver Dis, Alexandria, VA USA	University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; Alaska Native Medical Center; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Lok, ASF (corresponding author), Univ Michigan Hlth Syst, Div Gastroenterol & Hepatol, 3110G Taubman Ctr,SPC 5368,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	aslok@umich.edu		Yang, Shuman/0000-0002-9638-0890	Intramural NIH HHS [ZIA DK054500-16] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054500] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Artz AS, 2010, J CLIN ONCOL, V28, P3199, DOI 10.1200/JCO.2010.30.0673; Carroll MB, 2010, CLIN RHEUMATOL, V29, P1021, DOI 10.1007/s10067-010-1523-2; Chan TM, 2002, HEPATOLOGY, V36, P1246, DOI 10.1053/jhep.2002.36156; Day FL, 2011, J ONCOL PRACT, V7, P141, DOI 10.1200/JOP.2010.000133; Evens AM, 2011, ANN ONCOL, V22, P1170, DOI 10.1093/annonc/mdq583; Grob P, 2000, J MED VIROL, V62, P450, DOI 10.1002/1096-9071(200012)62:4&lt;450::AID-JMV9&gt;3.0.CO;2-Y; Hoofnagle JH, 2009, HEPATOLOGY, V49, pS156, DOI 10.1002/hep.22945; Hsu C, 2008, HEPATOLOGY, V47, P844, DOI 10.1002/hep.22106; Institute of Medicine, 2010, HEP LIV CANC NAT STR; Leung C, 2011, ONCOLOGIST, V16, P579, DOI 10.1634/theoncologist.2010-0182; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Loomba R, 2008, ANN INTERN MED, V148, P519, DOI 10.7326/0003-4819-148-7-200804010-00008; MCQUILLAN GM, 1987, AM J EPIDEMIOL, V126, P484, DOI 10.1093/oxfordjournals.aje.a114680; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Sorrell MF, 2009, ANN INTERN MED, V150, P104, DOI 10.7326/0003-4819-150-2-200901200-00100; Stine JG, 2010, ARTHRIT CARE RES, V62, P704, DOI 10.1002/acr.20209; Tran TT, 2010, ALIMENT PHARM THER, V31, P240, DOI 10.1111/j.1365-2036.2009.04158.x; Wasley A, 2010, J INFECT DIS, V202, P192, DOI 10.1086/653622; Weinbaum Cindy M., 2008, Morbidity and Mortality Weekly Report, V57, P1, DOI 10.1002/hep.22882; Yeo W, 2000, J MED VIROL, V62, P299, DOI 10.1002/1096-9071(200011)62:3&lt;299::AID-JMV1&gt;3.0.CO;2-0	20	61	68	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 15	2012	156	10					743	745		10.7326/0003-4819-156-10-201205150-00013	http://dx.doi.org/10.7326/0003-4819-156-10-201205150-00013			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	944IQ	22586011	Green Accepted			2022-12-24	WOS:000304193400020
J	de Boer, IH; Levin, G; Robinson-Cohen, C; Biggs, ML; Hoofnagle, AN; Siscovick, DS; Kestenbaum, B				de Boer, Ian H.; Levin, Gregory; Robinson-Cohen, Cassianne; Biggs, Mary L.; Hoofnagle, Andy N.; Siscovick, David S.; Kestenbaum, Bryan			Serum 25-Hydroxyvitamin D Concentration and Risk for Major Clinical Disease Events in a Community-Based Population of Older Adults A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							VITAMIN-D DEFICIENCY; SEASONAL-VARIATION; TIME; AGE	Background: Circulating concentrations of 25-hydroxyvitamin D [25-(OH)D] are used to define vitamin D deficiency. Current clinical 25-(OH)D targets based on associations with intermediate markers of bone metabolism may not reflect optimal levels for other chronic diseases and do not account for known seasonal variation in 25(OH)D concentration. Objective: To evaluate the relationship of 25-(OH)D concentration with the incidence of major clinical disease events that are pathophysiologically relevant to vitamin D. Design: Cohort study. Setting: The Cardiovascular Health Study conducted in 4 U. S. communities. Data from 1992 to 2006 were included in this analysis. Participants: 1621 white older adults. Measurements: Serum 25-(OH)D concentration (using a high-performance liquid chromatography-tandem mass spectrometry assay that conforms to National Institute of Standards and Technology reference standards)and associations with time to a composite outcome of incident hip fracture, myocardial infarction, cancer, or death. Results: Over a median 11-year follow-up, the composite outcome occurred in 1018 participants (63%). Defining events included 137hip fractures, 186 myocardial infarctions, 335 incidences of cancer, and 360 deaths. The association of low 25-(OH)D concentration with risk for the composite outcome varied by season (P = 0.057). A concentration lower than a season-specific Z score of -0.54 best discriminated risk for the composite outcome and was associated with a 24% higher risk in adjusted analyses (95% CI, 9% to 42%). Corresponding season-specific 25-(OH) D concentrations were 43, 50, 61, and 55 nmol/L (17, 20, 24, and 22 ng/mL) in winter, spring, summer, and autumn, respectively. Limitation: The observational study was restricted to white participants. Conclusion: Threshold concentrations of 25-(OH) D associated with increased risk for relevant clinical disease events center near 50 nmol/L (20 ng/mL). Season-specific targets for 25-(OH) D concentration may be more appropriate than static targets when evaluating health risk.	[de Boer, Ian H.; Levin, Gregory; Robinson-Cohen, Cassianne; Biggs, Mary L.; Hoofnagle, Andy N.; Siscovick, David S.; Kestenbaum, Bryan] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	de Boer, IH (corresponding author), Box 359606,325 9th Ave, Seattle, WA 98104 USA.	deboer@u.washington.edu	de Boer, Ian/GYJ-3282-2022; Robinson-Cohen, Cassianne/ABB-4985-2021	Robinson-Cohen, Cassianne/0000-0003-4783-7046	National Heart, Lung, and Blood Institute [N01-HC-85239, N01-HC-85079, N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, N01-HC-45133, HL080295, R01HL084443, R01HL096875]; National Institute on Aging [AG-023629, AG-15928, AG-20098, AG-027058]; National Institute of Diabetes and Digestive and Kidney Diseases [R01DK088762]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085081, N01HC015103, N01HC075150, N01HC055222, N01HC085083, N01HC085082, N01HC045133, N01HC085084, N01HC085085, N01HC085080, N01HC085079, N01HC085086, N01HC035129] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080295, U01HL080295, R01HL096875, R01HL084443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015928, R56AG023629, R56AG020098, R01AG027058, R01AG023629, R01AG020098] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By the National Heart, Lung, and Blood Institute (contracts N01-HC-85239, N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01 HC-15103, N01 HC-55222, N01-HC-75150, and N01-HC-45133 and grant HL080295), with additional contribution from the National Institute of Neurologic Disorders and Stroke. Additional support was provided by the National Institute on Aging (AG-023629, AG-15928, AG-20098, and AG-027058); the National Heart, Lung, and Blood Institute (grants R01HL084443 and R01HL096875); and the National Institute of Diabetes and Digestive and Kidney Diseases (grant R01DK088762). A full list of principal CHS investigators and institutions can be found at www.chs-nhlbi.org/pi.htm.	Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Bolland MJ, 2007, AM J CLIN NUTR, V86, P959, DOI 10.1093/ajcn/86.4.959; Cauley JA, 2008, ANN INTERN MED, V149, P242, DOI 10.7326/0003-4819-149-4-200808190-00005; Chen C, 2005, CANCER, V103, P76, DOI 10.1002/cncr.20727; Contal C, 1999, COMPUT STAT DATA AN, V30, P253, DOI 10.1016/S0167-9473(98)00096-6; Dawson-Hughes B, 2010, Osteoporos Int, V21, P1151, DOI 10.1007/s00198-010-1285-3; Dawson-Hughes B, 2005, OSTEOPOROSIS INT, V16, P713, DOI 10.1007/s00198-005-1867-7; de Boer IH, 2009, J AM SOC NEPHROL, V20, P1805, DOI 10.1681/ASN.2008111157; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Efron B, 1994, INTRO BOOTSTRAP; Eilers PHC, 1996, STAT SCI, V11, P89, DOI 10.1214/ss/1038425655; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Kestenbaum B, 2011, J AM COLL CARDIOL, V58, P1433, DOI 10.1016/j.jacc.2011.03.069; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Phinney KW, 2008, AM J CLIN NUTR, V88, p511S, DOI 10.1093/ajcn/88.2.511S; Robinson-Cohen C, 2011, J CLIN ENDOCR METAB, V96, P2186, DOI 10.1210/jc.2010-2878; Robinson-Cohen C, 2009, ARCH INTERN MED, V169, P2116, DOI 10.1001/archinternmed.2009.438; Rosen CJ, 2011, NEW ENGL J MED, V364, P248, DOI 10.1056/NEJMcp1009570; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; SHERMAN SS, 1990, J CLIN ENDOCR METAB, V71, P405, DOI 10.1210/jcem-71-2-405; Shoben AB, 2011, AM J EPIDEMIOL, V174, P1363, DOI 10.1093/aje/kwr258; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Therneau T, PACKAGE SURVIVAL ANA; Vieth R, 2006, PROG BIOPHYS MOL BIO, V92, P26, DOI 10.1016/j.pbiomolbio.2006.02.003; Wang TJ, 2008, CIRCULATION, V117, P503, DOI 10.1161/CIRCULATIONAHA.107.706127; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086	34	79	82	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2012	156	9					627	U62		10.7326/0003-4819-156-9-201205010-00004	http://dx.doi.org/10.7326/0003-4819-156-9-201205010-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933YR	22547472				2022-12-24	WOS:000303403700003
J	Chin, JW				Chin, Jason W.			Reprogramming the Genetic Code	SCIENCE			English	Editorial Material							AMINO-ACIDS; DE-NOVO; RIBOSOME; MUTAGENESIS; GENOME		MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Chin, JW (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	chin@mrc-lmb.cam.ac.uk			Medical Research Council [MC_U105181009] Funding Source: Medline; MRC [MC_U105181009] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Beene DL, 2003, CURR OPIN NEUROBIOL, V13, P264, DOI 10.1016/S0959-4388(03)00068-0; Davis L, 2012, NAT REV MOL CELL BIO, V13, P168, DOI 10.1038/nrm3286; FAHNESTOCK S, 1971, SCIENCE, V173, P340, DOI 10.1126/science.173.3994.340; Forster AC, 2003, P NATL ACAD SCI USA, V100, P6353, DOI 10.1073/pnas.1132122100; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Greiss S, 2011, J AM CHEM SOC, V133, P14196, DOI 10.1021/ja2054034; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Isaacs FJ, 2011, SCIENCE, V333, P348, DOI 10.1126/science.1205822; Josephson K, 2005, J AM CHEM SOC, V127, P11727, DOI 10.1021/ja0515809; Kajihara D, 2006, NAT METHODS, V3, P923, DOI 10.1038/NMETH945; Liu CC, 2010, ANNU REV BIOCHEM, V79, P413, DOI 10.1146/annurev.biochem.052308.105824; MENDEL D, 1995, ANNU REV BIOPH BIOM, V24, P435, DOI 10.1146/annurev.biophys.24.1.435; Morimoto J, 2011, ACCOUNTS CHEM RES, V44, P1359, DOI 10.1021/ar2000953; Neumann H, 2010, J AM CHEM SOC, V132, P2142, DOI 10.1021/ja9068722; Neumann H, 2010, NATURE, V464, P441, DOI 10.1038/nature08817; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Wang KH, 2012, ANGEW CHEM INT EDIT, V51, P2288, DOI 10.1002/anie.201105016; Zhang G, 2011, CURR OPIN STRUC BIOL, V21, P25, DOI 10.1016/j.sbi.2010.10.008	18	36	38	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					428	429		10.1126/science.1221761	http://dx.doi.org/10.1126/science.1221761			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539711				2022-12-24	WOS:000303233400035
J	Denef, VJ; Banfield, JF				Denef, Vincent J.; Banfield, Jillian F.			In Situ Evolutionary Rate Measurements Show Ecological Success of Recently Emerged Bacterial Hybrids	SCIENCE			English	Article							ESCHERICHIA-COLI; DYNAMICS; ENVIRONMENT; ADAPTATION; COMMUNITIES; BIOFILMS; GENOMES	Few data are available on how quickly free-living microorganisms evolve. We analyzed biofilms collected from a well-defined acid mine drainage system over 9 years to investigate the processes and determine rates of bacterial evolution directly in the environment. Population metagenomic analyses of the dominant primary producer yielded the nucleotide substitution rate, which we used to show that proliferation of a series of recombinant bacterial strains occurred over the past few decades. The ecological success of hybrid bacterial types highlights the role of evolutionary processes in rapid adaptation within natural microbial communities.	[Denef, Vincent J.; Banfield, Jillian F.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Banfield, Jillian F.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Banfield, JF (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA.	jbanfield@berkeley.edu		Banfield, Jill/0000-0001-8203-8771	Office of Biological and Environmental Research, U.S. Department of Energy [DE-FG02-05ER64134, DE-FG02-10ER64996]	Office of Biological and Environmental Research, U.S. Department of Energy(United States Department of Energy (DOE))	We thank T. W. Arman (president, Iron Mountain Mines Inc.) and R. Sugarek (U.S. Environmental Protection Agency) for site access; R. Carver and M. Jones for on-site assistance; R. Carver for Richmond Mine flow data; J. Sickles (U.S. EPA) for providing site history documentation; Banfield laboratory members for their contributions to sample collection; C. Miller, C. Sun, and B. Thomas (University of California, Berkeley) for assistance with next-generation sequencing data analysis; and C. Miller and K. Vogel (University of Arizona) and three anonymous reviewers for constructive criticism. Supported by the Office of Biological and Environmental Research, U.S. Department of Energy, through the Genomic Sciences (DE-FG02-05ER64134) and Carbon-Cycling (DE-FG02-10ER64996) programs. The authors declare no conflict of interest. All 454 and Illumina sequencing reads generated for this study have been deposited in the NCBI sequence reads archive (accession number SRA047370). The Leptospirillum group II C75 strain genome has been deposited at DDBJ/EMBL/GenBank under the Whole Genome Shotgun project accession number AIJM00000000. The version described in this paper, containing the assembled and annotated contigs, is the first version, AIJM01000000.	Allen EE, 2007, P NATL ACAD SCI USA, V104, P1883, DOI 10.1073/pnas.0604851104; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Buckley M., 2011, MICROBIAL EVOLUTION; Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100; Denef VJ, 2010, ISME J, V4, P599, DOI 10.1038/ismej.2009.158; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; Denef VJ, 2009, ENVIRON MICROBIOL, V11, P313, DOI 10.1111/j.1462-2920.2008.01769.x; DRAKE JW, 1991, P NATL ACAD SCI USA, V88, P7160, DOI 10.1073/pnas.88.16.7160; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Eppley JM, 2007, GENETICS, V177, P407, DOI 10.1534/genetics.107.072892; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Giraud A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040002; Goltsman DSA, 2009, APPL ENVIRON MICROB, V75, P4599, DOI 10.1128/AEM.02943-08; Grant BR, 1996, ECOLOGY, V77, P500, DOI 10.2307/2265625; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hendry AP, 2006, P R SOC B, V273, P1887, DOI 10.1098/rspb.2006.3534; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Nubel U, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000855; Sheppard SK, 2008, SCIENCE, V320, P237, DOI 10.1126/science.1155532; Simmons SL, 2008, PLOS BIOL, V6, P1427, DOI 10.1371/journal.pbio.0060177; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108	24	73	74	0	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					462	466		10.1126/science.1218389	http://dx.doi.org/10.1126/science.1218389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539719				2022-12-24	WOS:000303233400044
J	Eisenstein, M				Eisenstein, Michael			Stem cells: Don't believe the hype	NATURE			English	Editorial Material																			0	2	2	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S5	S5		10.1038/nature11107	http://dx.doi.org/10.1038/nature11107			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509506	Bronze			2022-12-24	WOS:000303149900047
J	Yudkin, JS				Yudkin, John S.			PERSONAL VIEW The drug industry is a barrier to diabetes care in poor countries	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TIME		UCL, London WC1E 6BT, England	University of London; University College London	Yudkin, JS (corresponding author), UCL, London WC1E 6BT, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008					18th Expert Committee on the Selection and Use of Essential Medicines, 2011, REV EV COMP INS HUM; Access To Medicine Index, IND 2010; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Boussageon R, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4169; DeFronzo RA, 2011, NEW ENGL J MED, V364, P1104, DOI 10.1056/NEJMoa1010949; Desai NR, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.033; Gill GV, 2011, DIABETOLOGIA, V54, P19, DOI 10.1007/s00125-010-1897-3; Hemmingsen B, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008143.pub2; Lincoln P, 2011, LANCET, V378, pE6, DOI 10.1016/S0140-6736(11)61463-3; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; *NAT COLL CTR CHRO, 2008, TYP 2 DIAB NAT CLIN; NovoNordisk, 2012, OUR TRIPL BOTT LIN; Preiss D, 2011, LANCET, V378, P106, DOI 10.1016/S0140-6736(11)60819-2; World Health Organization, 2011, UN REP 18 EXP COMM S; Yudkin JS, 2010, DIABETOLOGIA, V53, P2079, DOI 10.1007/s00125-010-1864-z; Yudkin JS, 2011, LANCET, V377, P1220, DOI 10.1016/S0140-6736(10)61112-9; Yudkin JS, 2011, IDF DEB WORLD DIAB C	17	3	3	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 25	2012	344								e3018	10.1136/bmj.e3018	http://dx.doi.org/10.1136/bmj.e3018			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QV	22636786				2022-12-24	WOS:000304591800001
J	Wardill, TJ; List, O; Li, XF; Dongre, S; McCulloch, M; Ting, CY; O'Kane, CJ; Tang, SM; Lee, CH; Hardie, RC; Juusola, M				Wardill, Trevor J.; List, Olivier; Li, Xiaofeng; Dongre, Sidhartha; McCulloch, Marie; Ting, Chun-Yuan; O'Kane, Cahir J.; Tang, Shiming; Lee, Chi-Hon; Hardie, Roger C.; Juusola, Mikko			Multiple Spectral Inputs Improve Motion Discrimination in the Drosophila Visual System	SCIENCE			English	Article							PHOTORECEPTOR CELLS; WILD-TYPE; COLOR; MELANOGASTER; RHODOPSIN; PATHWAYS; CHANNEL; STIMULATION; DISSECTION; BEHAVIOR	Color and motion information are thought to be channeled through separate neural pathways, but it remains unclear whether and how these pathways interact to improve motion perception. In insects, such as Drosophila, it has long been believed that motion information is fed exclusively by one spectral class of photoreceptor, so-called R1 to R6 cells; whereas R7 and R8 photoreceptors, which exist in multiple spectral classes, subserve color vision. Here, we report that R7 and R8 also contribute to the motion pathway. By using electrophysiological, optical, and behavioral assays, we found that R7/R8 information converge with and shape the motion pathway output, explaining flies' broadly tuned optomotor behavior by its composite responses. Our results demonstrate that inputs from photoreceptors of different spectral sensitivities improve motion discrimination, increasing robustness of perception.	[Wardill, Trevor J.; List, Olivier; Li, Xiaofeng; Dongre, Sidhartha; McCulloch, Marie; Juusola, Mikko] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Li, Xiaofeng; Tang, Shiming; Juusola, Mikko] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Ting, Chun-Yuan; Lee, Chi-Hon] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD 20892 USA; [O'Kane, Cahir J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Hardie, Roger C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB3 2EG, England	University of Sheffield; Beijing Normal University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Cambridge; University of Cambridge	Juusola, M (corresponding author), Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England.	m.juusola@sheffield.ac.uk	Juusola, Mikko/E-6948-2011; O'Kane, Cahir/Q-6681-2019; List, Olivier/F-3049-2011; Ting, chun-yuan/F-6448-2013; Lee, Chi-Hon/G-9190-2012	O'Kane, Cahir/0000-0002-3488-2078; List, Olivier/0000-0002-8302-8089; Ting, chun-yuan/0000-0002-2302-4203; Lee, Chi-Hon/0000-0002-6138-711X; Dongre, Sidhartha/0000-0003-2575-4362; Hardie, Roger/0000-0001-5531-3264; Wardill, Trevor/0000-0002-2049-113X; Juusola, Mikko/0000-0002-4428-5330	Gatsby Charitable Foundation [GAT2839]; State Key Laboratory of Cognitive Neuroscience and Learning; Biotechnology and Biological Sciences Research Council [BB/H013849/1, BB/F012071/1, BB/G006865/1, BB/D007585/1]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD008776-06]; NSFC [30810103906]; Biotechnology and Biological Sciences Research Council [BB/D001900/1] Funding Source: researchfish; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008776] Funding Source: NIH RePORTER; BBSRC [BB/H013849/1, BB/G006865/1, BB/F012071/1, BB/D001900/1] Funding Source: UKRI	Gatsby Charitable Foundation; State Key Laboratory of Cognitive Neuroscience and Learning; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NSFC(National Natural Science Foundation of China (NSFC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank G. de Polavieja and people of the Juusola lab for discussions and I. Meinertzhagen and P. Gonzalez Bellido for assistance with electron microscopy. The work was supported by the Gatsby Charitable Foundation (GAT2839: M.J.), the open research fund of the State Key Laboratory of Cognitive Neuroscience and Learning (M.J. and S.T.), the Biotechnology and Biological Sciences Research Council grants (BB/H013849/1 and BB/F012071/1: M.J.) and (BB/G006865/1 and BB/D007585/1: R.C.H.), and the Intramural Research Program of Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD008776-06: C.H.L.), the NSFC project (30810103906: S.T. and M.J.). The authors declare no competing financial interests. Supplementary materials accompany the paper on Science Online. Author contributions: Project initiation: M.J.; genetics: T.J.W., O.L., C.H.L., R.C.H., C.J.O'K., X.L.; electrophysiology: X.L., M.J., R.C.H., T.J.W.; behavior: S.D., M.M.C., T.J.W., M.J., S.T.; imaging: O.L., T.J.W., S.D., M.J.; electronmicroscopy: T.J.W.; immunohistochemistry: C.Y.T.; wrote the paper: M.J., with contributions from all authors.	Barlow H, 2001, BEHAV BRAIN SCI, V24, P602, DOI 10.1017/S0140525X01000024; BAUSENWEIN B, 1986, J NEUROGENET, V3, P87, DOI 10.3109/01677068609106897; BRITT SG, 1993, NEURON, V11, P29, DOI 10.1016/0896-6273(93)90268-V; Chiappe ME, 2010, CURR BIOL, V20, P1470, DOI 10.1016/j.cub.2010.06.072; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; Clark DA, 2011, NEURON, V70, P1165, DOI 10.1016/j.neuron.2011.05.023; Cropper Simon J, 2005, Behav Cogn Neurosci Rev, V4, P192, DOI 10.1177/1534582305285120; de Polavieja GG, 2006, NEURAL COMPUT, V18, P2102, DOI 10.1162/neco.2006.18.9.2102; Derrington AM, 2000, CURR BIOL, V10, pR268, DOI 10.1016/S0960-9822(00)00403-6; Eichner H, 2011, NEURON, V70, P1155, DOI 10.1016/j.neuron.2011.03.028; FEILER R, 1992, J NEUROSCI, V12, P3862; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Gegenfurtner KR, 1996, TRENDS NEUROSCI, V19, P394, DOI 10.1016/S0166-2236(96)10036-9; Gengs CX, 2002, J BIOL CHEM, V277, P42113, DOI 10.1074/jbc.M207133200; Gonzalez-Bellido PT, 2011, P NATL ACAD SCI USA, V108, P4224, DOI 10.1073/pnas.1014438108; HARDIE RC, 1979, J COMP PHYSIOL, V129, P19, DOI 10.1007/BF00679908; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; Joesch M, 2010, NATURE, V468, P300, DOI 10.1038/nature09545; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; KAISER W, 1974, J COMP PHYSIOL, V89, P391, DOI 10.1007/BF00695355; Kaiser W., 1975, P359; KIRSCHFELD K, 1977, NATURE, V269, P386, DOI 10.1038/269386a0; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Liu CH, 2008, NEURON, V59, P778, DOI 10.1016/j.neuron.2008.07.007; MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206; Nishida S, 2007, CURR BIOL, V17, P366, DOI 10.1016/j.cub.2006.12.041; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; RIEHLE A, 1984, EXP BRAIN RES, V54, P390; Rister J, 2007, NEURON, V56, P155, DOI 10.1016/j.neuron.2007.09.014; SCAVARDA NJ, 1983, P NATL ACAD SCI-BIOL, V80, P4441, DOI 10.1073/pnas.80.14.4441; Schiller PH, 2010, P NATL ACAD SCI USA, V107, P17087, DOI 10.1073/pnas.1011782107; SHAW SR, 1984, J EXP BIOL, V112, P225; SHAW SR, 1989, CELL TISSUE RES, V257, P295, DOI 10.1007/BF00261833; SRINIVASAN MV, 1985, VISION RES, V25, P997, DOI 10.1016/0042-6989(85)90210-X; Takemura SY, 2008, J COMP NEUROL, V509, P493, DOI 10.1002/cne.21757; Takeuchi T, 2003, VISION RES, V43, P1159, DOI 10.1016/S0042-6989(03)00086-5; VANHATEREN JH, 1986, J COMP PHYSIOL A, V158, P795, DOI 10.1007/BF01324822; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105	42	83	84	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					925	931		10.1126/science.1215317	http://dx.doi.org/10.1126/science.1215317			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605779	Green Accepted			2022-12-24	WOS:000304145600068
J	Jonietz, E				Jonietz, Erika			Cause and effect	NATURE			English	Editorial Material																		Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; Herder C, 2011, EUR J CLIN INVEST, V41, P679, DOI 10.1111/j.1365-2362.2010.02454.x; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746	3	9	9	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					S10	S11		10.1038/485S10a	http://dx.doi.org/10.1038/485S10a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968AT	22616098	Bronze			2022-12-24	WOS:000305950100005
J	Twelvetrees, A; Hendricks, AG; Holzbaur, ELF				Twelvetrees, Alison; Hendricks, Adam G.; Holzbaur, Erika L. F.			SnapShot: Axonal Transport	CELL			English	Editorial Material							TUG-OF-WAR; NEURONS; MOTORS; DYNEIN; DISEASE		[Twelvetrees, Alison; Hendricks, Adam G.; Holzbaur, Erika L. F.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Twelvetrees, Alison] Canc Res UK London Res Inst, London WC2A 3LY, England	University of Pennsylvania; Pennsylvania Medicine; Cancer Research UK	Twelvetrees, A (corresponding author), Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.		Twelvetrees, Alison/K-8712-2019; Hendricks, Adam/B-3692-2009	Twelvetrees, Alison/0000-0002-1796-1508; Hendricks, Adam/0000-0003-3635-1577				Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Kapitein LC, 2010, CURR BIOL, V20, P290, DOI 10.1016/j.cub.2009.12.052; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Pilling AD, 2006, MOL BIOL CELL, V17, P2057, DOI 10.1091/mbc.E05-06-0526; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Sheng ZH, 2012, NAT REV NEUROSCI, V13, P77, DOI 10.1038/nrn3156; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Wang L, 2000, NAT CELL BIOL, V2, P137, DOI 10.1038/35004008	12	14	14	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					950	U251		10.1016/j.cell.2012.05.001	http://dx.doi.org/10.1016/j.cell.2012.05.001			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579292	Bronze			2022-12-24	WOS:000303934700025
J	Kumar, MS; Hancock, DC; Molina-Arcas, M; Steckel, M; East, P; Diefenbacher, M; Armenteros-Monterroso, E; Lassailly, F; Matthews, N; Nye, E; Stamp, G; Behrens, A; Downward, J				Kumar, Madhu S.; Hancock, David C.; Molina-Arcas, Miriam; Steckel, Michael; East, Phillip; Diefenbacher, Markus; Armenteros-Monterroso, Elena; Lassailly, Francois; Matthews, Nik; Nye, Emma; Stamp, Gordon; Behrens, Axel; Downward, Julian			The GATA2 Transcriptional Network Is Requisite for RAS Oncogene-Driven Non-Small Cell Lung Cancer	CELL			English	Article							KAPPA-B; ACTIVATION; MOUSE; INHIBITION; EXPRESSION; BINDING; ROCK; RHO	Non-small cell lung cancer (NSCLC) is the most frequent cause of cancer deaths worldwide; nearly half contain mutations in the receptor tyrosine kinase/RAS pathway. Here we show that RAS-pathway mutant NSCLC cells depend on the transcription factor GATA2. Loss of GATA2 reduced the viability of NSCLC cells with RAS-pathway mutations, whereas wild-type cells were unaffected. Integrated gene expression and genome occupancy analyses revealed GATA2 regulation of the proteasome, and IL-1-signaling, and Rho-signaling pathways. These pathways were functionally significant, as reactivation rescued viability after GATA2 depletion. In a Kras-driven NSCLC mouse model, Gata2 loss dramatically reduced tumor development. Furthermore, Gata2 deletion in established Kras mutant tumors induced striking regression. Although GATA2 itself is likely undruggable, combined suppression of GATA2-regulated pathways with clinically approved inhibitors caused marked tumor clearance. Discovery of the nononcogene addiction of KRAS mutant lung cancers to GATA2 presents a network of druggable pathways for therapeutic exploitation.	[Kumar, Madhu S.; Hancock, David C.; Molina-Arcas, Miriam; Steckel, Michael; Armenteros-Monterroso, Elena; Downward, Julian] Canc Res UK London Res Inst, Signal Transduct Lab, London WC2A 3LY, England; [East, Phillip] Canc Res UK London Res Inst, Bioinformat & Biostat Grp, London WC2A 3LY, England; [Diefenbacher, Markus; Behrens, Axel] Canc Res UK London Res Inst, Mammalian Genet Lab, London WC2A 3LY, England; [Nye, Emma; Stamp, Gordon] Canc Res UK London Res Inst, Expt Histopathol Lab, London WC2A 3LY, England; [Downward, Julian] Inst Canc Res, London SW3 6JB, England	Cancer Research UK; Cancer Research UK; Cancer Research UK; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Downward, J (corresponding author), Canc Res UK London Res Inst, Signal Transduct Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	julian.downward@cancer.org.uk	Diefenbacher, Markus Elmar/AAY-8650-2021; Molina-Arcas, Miriam/R-4908-2019	Diefenbacher, Markus Elmar/0000-0002-7402-7949; Molina-Arcas, Miriam/0000-0002-8176-8948; Downward, Julian/0000-0002-2331-4729; Behrens, Axel/0000-0002-1557-1143	Cancer Research UK; European Commission [HEALTH-F2-2010-259770]; Cancer Research UK [15680, 15679] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); European Commission(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK)	We thank S. M. Henshall for the GATA2 expression vector; D. Finley for the USP14 expression vector; R. Deshaies for the Nrf1 expression vector; D. Goubau for the NF-kappa B and control reporter plasmids; E. Meylan and W. Xue for the RelA expression vector; E. Sahai for the RhoA and ROCK: ER expression vectors; and F. Gouilleux for the STAT5<SUP>CA</SUP> expression vector. We thank the LRI FACS facility for cell-cycle assays and the Bart's Genome Centre for gene expression analysis. We thank C. Sheridan for micro-CT assistance. M. S. K. is a Long-Term Fellow of the Human Frontier Science Program and European Molecular Biology Organization. M. M. is a Marie Curie Postdoctoral Fellow. This work was supported by Cancer Research UK and by funding from the European Commission's Seventh Framework Programme (FP7/2007-2013) under the Lungtarget Grant agreement (HEALTH-F2-2010-259770).	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Blasco RB, 2011, CANCER CELL, V19, P652, DOI 10.1016/j.ccr.2011.04.002; Cao ZD, 1996, NATURE, V383, P443, DOI 10.1038/383443a0; Montero JC, 2011, CLIN CANCER RES, V17, P5546, DOI 10.1158/1078-0432.CCR-10-2616; Charles MA, 2006, MOL ENDOCRINOL, V20, P1366, DOI 10.1210/me.2005-0378; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Croft DR, 2004, CANCER RES, V64, P8994, DOI 10.1158/0008-5472.CAN-04-2052; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Dinarello CA, 2010, CANCER METAST REV, V29, P317, DOI 10.1007/s10555-010-9229-0; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Linnemann AK, 2011, P NATL ACAD SCI USA, V108, P13641, DOI 10.1073/pnas.1108440108; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Pitulescu ME, 2010, GENE DEV, V24, P2480, DOI 10.1101/gad.1973910; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Sanz-Moreno V, 2011, CANCER CELL, V20, P229, DOI 10.1016/j.ccr.2011.06.018; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Vicent S, 2010, J CLIN INVEST, V120, P3940, DOI 10.1172/JCI44165; Xue W, 2011, CANCER DISCOV, V1, P236, DOI 10.1158/2159-8290.CD-11-0073; Yamaoka S, 1998, CELL, V93, P1231, DOI 10.1016/S0092-8674(00)81466-X	36	209	217	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					642	655		10.1016/j.cell.2012.02.059	http://dx.doi.org/10.1016/j.cell.2012.02.059			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541434	Bronze			2022-12-24	WOS:000303443100015
J	Schrappe, M; Hunger, SP; Pui, CH; Saha, V; Gaynon, PS; Baruchel, A; Conter, V; Otten, J; Ohara, A; Versluys, AB; Escherich, G; Heyman, M; Silverman, LB; Horibe, K; Mann, G; Camitta, BM; Harbott, J; Riehm, H; Richards, S; Devidas, M; Zimmermann, M				Schrappe, Martin; Hunger, Stephen P.; Pui, Ching-Hon; Saha, Vaskar; Gaynon, Paul S.; Baruchel, Andre; Conter, Valentino; Otten, Jacques; Ohara, Akira; Versluys, Anne Birgitta; Escherich, Gabriele; Heyman, Mats; Silverman, Lewis B.; Horibe, Keizo; Mann, Georg; Camitta, Bruce M.; Harbott, Jochen; Riehm, Hansjoerg; Richards, Sue; Devidas, Meenakshi; Zimmermann, Martin			Outcomes after Induction Failure in Childhood Acute Lymphoblastic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MINIMAL RESIDUAL DISEASE; STEM-CELL TRANSPLANTATION; PROGNOSTIC VALUE; COMPLETE REMISSION; SALVAGE THERAPY; AIEOP-BFM; T-CELL; CHILDREN; RISK; CHEMOTHERAPY	BACKGROUND Failure of remission-induction therapy is a rare but highly adverse event in children and adolescents with acute lymphoblastic leukemia (ALL). METHODS We identified induction failure, defined by the persistence of leukemic blasts in blood, bone marrow, or any extramedullary site after 4 to 6 weeks of remission-induction therapy, in 1041 of 44,017 patients (2.4%) 0 to 18 years of age with newly diagnosed ALL who were treated by a total of 14 cooperative study groups between 1985 and 2000. We analyzed the relationships among disease characteristics, treatments administered, and outcomes in these patients. RESULTS Patients with induction failure frequently presented with high-risk features, including older age, high leukocyte count, leukemia with a T-cell phenotype, the Philadelphia chromosome, and 11q23 rearrangement. With a median follow-up period of 8.3 years (range, 1.5 to 22.1), the 10-year survival rate (+/- SE) was estimated at only 32 +/- 1%. An age of 10 years or older, T-cell leukemia, the presence of an 11q23 rearrangement, and 25% or more blasts in the bone marrow at the end of induction therapy were associated with a particularly poor outcome. High hyperdiploidy (a modal chromosome number >50) and an age of 1 to 5 years were associated with a favorable outcome in patients with precursor B-cell leukemia. Allogeneic stem-cell transplantation from matched, related donors was associated with improved outcomes in T-cell leukemia. Children younger than 6 years of age with precursor B-cell leukemia and no adverse genetic features had a 10-year survival rate of 72 +/- 5% when treated with chemotherapy only. CONCLUSIONS Pediatric ALL with induction failure is highly heterogeneous. Patients who have T-cell leukemia appear to have a better outcome with allogeneic stem-cell transplantation than with chemotherapy, whereas patients who have precursor B-cell leukemia without other adverse features appear to have a better outcome with chemotherapy. (Funded by Deutsche Krebshilfe and others.)	[Pui, Ching-Hon] St Jude Childrens Res Hosp, Dept Oncol, Memphis, TN 38105 USA; [Pui, Ching-Hon] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA; [Schrappe, Martin] Univ Kiel, Dept Pediat, Univ Med Ctr Schleswig Holstein, D-2300 Kiel, Germany; [Escherich, Gabriele] Univ Med Ctr Eppendorf, Dept Pediat Hematol & Oncol, Hamburg, Germany; [Harbott, Jochen] Univ Giessen, Dept Pediat Hematol & Oncol, Oncogenet Lab, Giessen, Germany; [Riehm, Hansjoerg; Zimmermann, Martin] Hannover Med Sch, Dept Pediat Hematol & Oncol, D-3000 Hannover, Germany; [Hunger, Stephen P.] Univ Colorado, Sch Med, Aurora, CO USA; [Hunger, Stephen P.] Univ Colorado, Ctr Canc, Aurora, CO USA; [Hunger, Stephen P.] Childrens Hosp Colorado, Aurora, CO USA; [Saha, Vaskar] Univ Manchester, Manchester Acad Hlth Sci Ctr, Sch Canc, Childrens Canc Grp, Manchester, Lancs, England; [Richards, Sue] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Gaynon, Paul S.] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Baruchel, Andre] Hop Robert Debre, Dept Pediat Hematoimmunol, F-75019 Paris, France; [Baruchel, Andre] Univ Paris Diderot, Paris, France; [Conter, Valentino] Univ Milano Bicocca, Pediat Clin, Osped San Gerardo, Monza, Italy; [Conter, Valentino] Osped Riuniti Bergamo, Dept Pediat, I-24100 Bergamo, Italy; [Otten, Jacques] Univ Ziekenhuis Brussel, Dept Pediat, Hematooncol Unit, Brussels, Belgium; [Ohara, Akira] Toho Univ, Dept Pediat 1, Tokyo, Japan; [Versluys, Anne Birgitta] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Versluys, Anne Birgitta] Dutch Childhood Oncol Grp, The Hague, Netherlands; [Heyman, Mats] Karolinska Inst, Astrid Lindgren Childrens Hosp, Childhood Canc Res Unit, Stockholm, Sweden; [Silverman, Lewis B.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Silverman, Lewis B.] Dana Farber Canc Inst, Div Hematol Oncol, Boston, MA 02115 USA; [Silverman, Lewis B.] Childrens Hosp Boston, Boston, MA USA; [Horibe, Keizo] Clin Res Ctr, Nagoya Med Ctr, Nagoya, Aichi, Japan; [Mann, Georg] Univ Med Sch, St Anna Childrens Hosp, Dept Pediat, Vienna, Austria; [Camitta, Bruce M.] Med Coll Wisconsin, Midwest Ctr Canc & Blood Disorders, Milwaukee, WI 53226 USA; [Camitta, Bruce M.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Camitta, Bruce M.] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Devidas, Meenakshi] Stat & Data Ctr, Childrens Oncol Grp, Gainesville, FL USA; [Devidas, Meenakshi] Univ Florida, Dept Biostat, Gainesville, FL USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Kiel; Schleswig Holstein University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Justus Liebig University Giessen; Hannover Medical School; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Manchester; University of Oxford; Children's Hospital Los Angeles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; San Gerardo Hospital; University of Milano-Bicocca; Ospedali Riuniti di Bergamo; University Hospital Brussels; Vrije Universiteit Brussel; Toho University; Utrecht University; Utrecht University Medical Center; Dutch Childhood Oncology Group; Karolinska Institutet; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Nagoya Medical Center; Saint Anna Children's Hospital; Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Children's Oncology Group (COG); State University System of Florida; University of Florida	Pui, CH (corresponding author), St Jude Childrens Res Hosp, Dept Oncol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	ching-hon.pui@stjude.org	Schrappe, Martin/ABA-6144-2020; Pui, Ching-Hon/N-8076-2018; Devidas, Meenakshi/H-1170-2019	Pui, Ching-Hon/0000-0003-0303-5658; Devidas, Meenakshi/0000-0002-1099-3478; Saha, Vaskar/0000-0002-2916-9649	Deutsche Krebshilfe; St. Anna Children's Cancer Research Institute, Austria; Deutsche Krebshilfe, Germany; Madeleine-Schickedanz-Kinderkrebsstiftung, Germany; Fordergemeinschaft Kinderkrebszentrum Hamburg, Germany; National Cancer Institute (NCI) [5PO1CA068484]; Assistance Publique-Hopitaux de Paris, INSERM, Institut Universitaire d'Hematologie and Centre de Recherche en Hematologie, Oncologie, et Pediatrie, France; American Lebanese Syrian Associated Charities; Medical Research Council, United Kingdom; Swedish Childhood Cancer Foundation; Danish Childhood Cancer Foundation; Norwegian Cancer Society; Fonds Cancer, Belgium; Ministry of Health, Labour, and Welfare, Japan; Children's Cancer Association of Japan;  [CA13539];  [CA98543];  [CA98413];  [CA30969];  [CA29139];  [CA21765]; MRC [MC_U137686856] Funding Source: UKRI; Cancer Research UK [14840] Funding Source: researchfish; Medical Research Council [MC_U137686856] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [U10CA098413, P01CA068484, U10CA013539, U10CA030969, P30CA021765, U10CA029139, U10CA098543] Funding Source: NIH RePORTER	Deutsche Krebshilfe(Deutsche Krebshilfe); St. Anna Children's Cancer Research Institute, Austria; Deutsche Krebshilfe, Germany(Deutsche Krebshilfe); Madeleine-Schickedanz-Kinderkrebsstiftung, Germany; Fordergemeinschaft Kinderkrebszentrum Hamburg, Germany; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Assistance Publique-Hopitaux de Paris, INSERM, Institut Universitaire d'Hematologie and Centre de Recherche en Hematologie, Oncologie, et Pediatrie, France; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Childhood Cancer Foundation(European Commission); Danish Childhood Cancer Foundation; Norwegian Cancer Society(Norwegian Cancer Society); Fonds Cancer, Belgium; Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Children's Cancer Association of Japan; ; ; ; ; ; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by Deutsche Krebshilfe and others.; Supported by St. Anna Children's Cancer Research Institute, Austria; Deutsche Krebshilfe, Germany; Madeleine-Schickedanz-Kinderkrebsstiftung, Germany; grants (CA13539, CA98543, and CA98413) to the Children's Cancer Group; Fordergemeinschaft Kinderkrebszentrum Hamburg, Germany; a grant (NCI 5PO1CA068484) from the National Cancer Institute to the Dana-Farber Cancer Institute; Assistance Publique-Hopitaux de Paris, INSERM, Institut Universitaire d'Hematologie and Centre de Recherche en Hematologie, Oncologie, et Pediatrie, France; grants (CA30969, CA29139, CA98543, and CA98413) to the Pediatric Oncology Group; a grant (CA21765) and funding from American Lebanese Syrian Associated Charities to St. Jude Children's Research Hospital; the Medical Research Council, United Kingdom; the Swedish Childhood Cancer Foundation; the Danish Childhood Cancer Foundation; the Norwegian Cancer Society; Fonds Cancer, Belgium; a Clinical Cancer Research grant from the Ministry of Health, Labour, and Welfare, Japan; and the Children's Cancer Association of Japan.	Arico M, 2000, NEW ENGL J MED, V342, P998, DOI 10.1056/NEJM200004063421402; Arico M, 2002, BLOOD, V100, P420, DOI 10.1182/blood.V100.2.420; Arico M, 2008, J CLIN ONCOL, V26, P283, DOI 10.1200/JCO.2007.12.3927; Bader P, 2009, J CLIN ONCOL, V27, P377, DOI 10.1200/JCO.2008.17.6065; Balduzzi A, 2005, LANCET, V366, P635, DOI 10.1016/S0140-6736(05)66998-X; Biondi A, 2000, BLOOD, V96, P24, DOI 10.1182/blood.V96.1.24; Cave H, 1998, NEW ENGL J MED, V339, P591, DOI 10.1056/NEJM199808273390904; CHESSELLS JM, 1995, LANCET, V345, P143, DOI 10.1016/S0140-6736(95)90164-7; Conter V, 2010, LEUKEMIA, V24, P255, DOI 10.1038/leu.2009.250; Conter V, 2010, BLOOD, V115, P3206, DOI 10.1182/blood-2009-10-248146; COX DR, 1972, J R STAT SOC B, V34, P187; Duval M, 2002, BLOOD, V99, P2734, DOI 10.1182/blood.V99.8.2734; Eckert C, 2001, LANCET, V358, P1239, DOI 10.1016/S0140-6736(01)06355-3; Einsiedel HG, 2005, J CLIN ONCOL, V23, P7942, DOI 10.1200/JCO.2005.01.1031; Einsiedel HG, 2008, J CLIN ONCOL, V26, P2238; Gaynon PS, 2010, LEUKEMIA, V24, P285, DOI 10.1038/leu.2009.262; Gaynon PS, 2005, BRIT J HAEMATOL, V131, P579, DOI 10.1111/j.1365-2141.2005.05773.x; Heerema NA, 2000, J CLIN ONCOL, V18, P1876, DOI 10.1200/JCO.2000.18.9.1876; JANKASCHAUB GE, 1992, HAEMATOL BLOOD TRANS, V34, P233; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KASPERS GJL, 1995, BLOOD, V85, P751, DOI 10.1182/blood.V85.3.751.bloodjournal853751; Ko RH, 2010, J CLIN ONCOL, V28, P648, DOI 10.1200/JCO.2009.22.2950; Mann G, 2010, BLOOD, V116, P2644, DOI 10.1182/blood-2010-03-273532; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Mitchell C, 2010, LEUKEMIA, V24, P406, DOI 10.1038/leu.2009.256; Moricke A, 2010, LEUKEMIA, V24, P265, DOI 10.1038/leu.2009.257; Moghrabi A, 2007, BLOOD, V109, P896, DOI 10.1182/blood-2006-06-027714; Moorman AV, 2010, LANCET ONCOL, V11, P429, DOI 10.1016/S1470-2045(10)70066-8; Moricke A, 2009, BLOOD, V113, P4478; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nachman JB, 2007, BLOOD, V110, P1112, DOI 10.1182/blood-2006-07-038299; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; Nguyen K, 2008, LEUKEMIA, V22, P2142, DOI 10.1038/leu.2008.251; Ottmann OG, 2007, CANCER-AM CANCER SOC, V109, P2068, DOI 10.1002/cncr.22631; Oudot C, 2008, J CLIN ONCOL, V26, P1496, DOI 10.1200/JCO.2007.12.2820; PIETERS R, 1991, LANCET, V338, P399, DOI 10.1016/0140-6736(91)91029-T; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Pui CH, 2002, LANCET, V359, P1909, DOI 10.1016/S0140-6736(02)08782-2; Pui CH, 2009, NEW ENGL J MED, V360, P2730, DOI 10.1056/NEJMoa0900386; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; RIEHM H, 1980, AM J PEDIAT HEMATOL, V2, P299; Salzer WL, 2010, LEUKEMIA, V24, P355, DOI 10.1038/leu.2009.261; Schmiegelow K, 2010, LEUKEMIA, V24, P345, DOI 10.1038/leu.2009.251; Schrappe M, 1998, BLOOD, V92, P2730; Schrappe M, 2000, BLOOD, V95, P3310; Schrappe M, 2011, BLOOD, V118, P2077, DOI 10.1182/blood-2011-03-338707; Schrauder A, 2006, J CLIN ONCOL, V24, P5742, DOI 10.1200/JCO.2006.06.2679; Schultz KR, 2007, BLOOD, V109, P926, DOI 10.1182/blood-2006-01-024729; Schultz KR, 2009, J CLIN ONCOL, V27, P5175, DOI 10.1200/JCO.2008.21.2514; Silverman LB, 2010, LEUKEMIA, V24, P320, DOI 10.1038/leu.2009.253; Silverman LB, 1999, CANCER-AM CANCER SOC, V85, P1395, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1395::AID-CNCR25>3.0.CO;2-2; Smith M, 1996, J CLIN ONCOL, V14, P680, DOI 10.1200/JCO.1996.14.2.680; SYNOLD TW, 1994, J CLIN INVEST, V94, P1996, DOI 10.1172/JCI117552; Tallen G, 2010, J CLIN ONCOL, V28, P2339, DOI 10.1200/JCO.2009.25.1983; Tsuchida M, 2010, LEUKEMIA, V24, P383, DOI 10.1038/leu.2009.260; van Dongen JJM, 1998, LANCET, V352, P1731, DOI 10.1016/S0140-6736(98)04058-6; Vignetti M, 2007, BLOOD, V109, P3676, DOI 10.1182/blood-2006-10-052746; Yanada M, 2006, J CLIN ONCOL, V24, P460, DOI 10.1200/JCO.2005.03.2177	58	197	209	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 12	2012	366	15					1371	1381		10.1056/NEJMoa1110169	http://dx.doi.org/10.1056/NEJMoa1110169			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GV	22494120	Green Accepted, Green Published			2022-12-24	WOS:000302608600001
J	Nuila, R				Nuila, Ricardo			Home: Palliation for Dying Undocumented Immigrants	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEALTH-CARE; TRENDS		Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Baylor College of Medicine	Nuila, R (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.							Brotman B, 2011, CHICAGO TRIBUNE 0102; DuBard CA, 2007, JAMA-J AM MED ASSOC, V297, P1774; DuBard CA, 2007, JAMA-J AM MED ASSOC, V297, P1085, DOI 10.1001/jama.297.10.1085; Gawande A, 2010, NEW YORKER      0802; Okie S, 2007, NEW ENGL J MED, V357, P525, DOI 10.1056/NEJMp078113; Stimpson JP, 2010, HEALTH AFFAIR, V29, P544, DOI 10.1377/hlthaff.2009.0400	6	14	14	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2047	2048						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949YE	22646628	Bronze			2022-12-24	WOS:000304613400002
J	Deng, HX; Grunder, S; Cordova, KE; Valente, C; Furukawa, H; Hmadeh, M; Gandara, F; Whalley, AC; Liu, Z; Asahina, S; Kazumori, H; O'Keeffe, M; Terasaki, O; Stoddart, JF; Yaghi, OM				Deng, Hexiang; Grunder, Sergio; Cordova, Kyle E.; Valente, Cory; Furukawa, Hiroyasu; Hmadeh, Mohamad; Gandara, Felipe; Whalley, Adam C.; Liu, Zheng; Asahina, Shunsuke; Kazumori, Hiroyoshi; O'Keeffe, Michael; Terasaki, Osamu; Stoddart, J. Fraser; Yaghi, Omar M.			Large-Pore Apertures in a Series of Metal-Organic Frameworks	SCIENCE			English	Article							CRYSTAL-STRUCTURE; BUILDING UNITS; CATALYSIS; STORAGE; DESIGN; POROSITY; PLATFORM; LIGAND; SITES; CAGES	We report a strategy to expand the pore aperture of metal-organic frameworks (MOFs) into a previously unattained size regime (>32 angstroms). Specifically, the systematic expansion of a well-known MOF structure, MOF-74, from its original link of one phenylene ring (I) to two, three, four, five, six, seven, nine, and eleven (II to XI, respectively), afforded an isoreticular series of MOF-74 structures (termed IRMOF-74-I to XI) with pore apertures ranging from 14 to 98 angstroms. All members of this series have non-interpenetrating structures and exhibit robust architectures, as evidenced by their permanent porosity and high thermal stability (up to 300 degrees C). The pore apertures of an oligoethylene glycol-functionalized IRMOF-74-VII and IRMOF-74-IX are large enough for natural proteins to enter the pores.	[Deng, Hexiang; Cordova, Kyle E.; Furukawa, Hiroyasu; Hmadeh, Mohamad; Gandara, Felipe; O'Keeffe, Michael; Yaghi, Omar M.] Univ Calif Los Angeles, Ctr Global Mentoring, Ctr Reticular Chem, US Dept Energy DOE,Inst Genom & Prote, Los Angeles, CA 90095 USA; [Deng, Hexiang; Cordova, Kyle E.; Furukawa, Hiroyasu; Hmadeh, Mohamad; Gandara, Felipe; O'Keeffe, Michael; Yaghi, Omar M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Grunder, Sergio; Valente, Cory; Whalley, Adam C.; Stoddart, J. Fraser] Northwestern Univ, Dept Chem, Ctr Chem Integrated Syst, Evanston, IL 60208 USA; [Liu, Zheng] Natl Inst Adv Ind Sci & Technol, Nanotube Res Ctr, Tsukuba, Ibaraki 3050046, Japan; [Asahina, Shunsuke; Kazumori, Hiroyoshi] JEOL, SMBU, Tokyo 1968558, Japan; [Terasaki, Osamu] Stockholm Univ, Dept Mat & Environm Chem, S-10691 Stockholm, Sweden; [Terasaki, Osamu] Stockholm Univ, EXSELENT, S-10691 Stockholm, Sweden; [Terasaki, Osamu; Stoddart, J. Fraser; Yaghi, Omar M.] World Class Univ, NanoCentury KAIST Inst, Taejon 305701, South Korea; [Terasaki, Osamu; Stoddart, J. Fraser; Yaghi, Omar M.] World Class Univ, Grad Sch Energy Environm Water & Sustainabil, Taejon 305701, South Korea	United States Department of Energy (DOE); University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University; National Institute of Advanced Industrial Science & Technology (AIST); Jeol Ltd; JEOL Japan; Stockholm University; Stockholm University; Korea Advanced Institute of Science & Technology (KAIST)	Yaghi, OM (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	yaghi@berkeley.edu	Liu, Zheng/E-6119-2018; Furukawa, Hiroyasu/C-5910-2008; Deng, Hexiang/N-5616-2017; Yaghi, Omar M/C-6749-2013; Terasaki, Osamu/Y-1137-2018; EFRC, CGS/I-6680-2012; Stoddart, James Fraser/H-1518-2011; Gandara, Felipe/H-3168-2017; Gándara, Felipe/B-9198-2013; Cordova, Kyle/I-2556-2014; Stangl, Kristin/D-1502-2015	Liu, Zheng/0000-0001-9095-7647; Furukawa, Hiroyasu/0000-0002-6082-1738; Deng, Hexiang/0000-0002-9398-7996; Terasaki, Osamu/0000-0001-5803-0817; Stoddart, James Fraser/0000-0003-3161-3697; Gandara, Felipe/0000-0002-1671-6260; Gándara, Felipe/0000-0002-1671-6260; Cordova, Kyle/0000-0002-4988-0497; Hmadeh, Mohamad/0000-0003-3027-3192; Yaghi, Omar/0000-0002-5611-3325	BASF SE (Ludwigshafen, Germany); Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center (EFRC); DOE, Office of Science, Office of Basic Energy Sciences (U.S. DOE-BES) [DE-SC0001015]; U.S. Department of Defense, Defense Threat Reduction Agency [HDTRA11-1-0018]; Non-equilibrium Energy Research Center, EFRC; U.S. DOE-BES [DE-SC0000989]; World Class University [R-31-2008-000-10055-0]; NIH-National Center for Research Resources [CJX1-443835-WS-29646]; NSF [CHE-0722519]; Swiss National Science Foundation; Spanish Ministry of Education	BASF SE (Ludwigshafen, Germany)(BASF); Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center (EFRC); DOE, Office of Science, Office of Basic Energy Sciences (U.S. DOE-BES)(United States Department of Energy (DOE)); U.S. Department of Defense, Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Non-equilibrium Energy Research Center, EFRC; U.S. DOE-BES(United States Department of Energy (DOE)); World Class University; NIH-National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NSF(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Spanish Ministry of Education(Spanish Government)	The research at UCLA was funded by BASF SE (Ludwigshafen, Germany) (synthesis of MOFs), the Center for Gas Separations Relevant to Clean Energy Technologies, an Energy Frontier Research Center (EFRC) funded by the DOE, Office of Science, Office of Basic Energy Sciences (U.S. DOE-BES) for adsorption (DE-SC0001015), and the U.S. Department of Defense, Defense Threat Reduction Agency for inclusion studies (HDTRA11-1-0018). The research conducted at Northwestern University was supported in part by the Non-equilibrium Energy Research Center, which is an EFRC funded by the U.S. DOE-BES (DE-SC0000989). We acknowledge the World Class University Program (R-31-2008-000-10055-0). We thank M. Zhao and D. Li from D. S. Eisenberg's group at UCLA for providing GFP and helpful discussions. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory, a national user facility operated by Stanford University on behalf of the U. S. DOE-BES. Confocal laser scanning microscopy was performed at the California NanoSystems Institute Advanced Light Microscopy/Spectroscopy Shared Resource Facility at UCLA, supported with funding from NIH-National Center for Research Resources shared resources grant (CJX1-443835-WS-29646) and NSF Major Research Instrumentation grant (CHE-0722519). We acknowledge JEOL for providing their latest LV-HRSEM instrument. We thank M. Schibler, S. Wan, L. Wang, A. Sue, C. Stevens, C. Knobler, and J. Brown for their invaluable assistance. Z.L. acknowledges K. Suenaga at AIST, Tsukuba, Japan, for his encouragement. S. G. acknowledges the Swiss National Science Foundation for financial support. F. G. acknowledges funding by the Spanish Ministry of Education through the "Programa de Movilidad de Recursos Humanos del Plan Nacional de I-D+i 2008-2011." All data and images are available in the body of the paper or as supplementary materials. Crystallographic data for the reported crystal structures have been deposited at the Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk with codes 841642 to 841651 (IRMOF-74-II to -XI, respectively).	BAGSHAW SA, 1995, SCIENCE, V269, P1242, DOI 10.1126/science.269.5228.1242; Bradshaw D, 2005, ACCOUNTS CHEM RES, V38, P273, DOI 10.1021/ar0401606; Chandler BD, 2008, NAT MATER, V7, P229, DOI 10.1038/nmat2101; Dietzel PDC, 2008, EUR J INORG CHEM, P3624, DOI 10.1002/ejic.200701284; Dinca M, 2006, J AM CHEM SOC, V128, P16876, DOI 10.1021/ja0656853; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Farha OK, 2010, NAT CHEM, V2, P944, DOI [10.1038/NCHEM.834, 10.1038/nchem.834]; Furukawa H, 2006, J AM CHEM SOC, V128, P8398, DOI 10.1021/ja062491e; Furukawa H, 2011, INORG CHEM, V50, P9147, DOI 10.1021/ic201376t; Furukawa H, 2010, SCIENCE, V329, P424, DOI 10.1126/science.1192160; Hanss D, 2009, EUR J INORG CHEM, P3778, DOI 10.1002/ejic.200900396; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Joo SH, 2001, NATURE, V412, P169, DOI 10.1038/35084046; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Lin MJ, 2011, CRYSTENGCOMM, V13, P776, DOI 10.1039/c0ce00777c; Lin X, 2009, J AM CHEM SOC, V131, P2159, DOI 10.1021/ja806624j; Lykourinou V, 2011, J AM CHEM SOC, V133, P10382, DOI 10.1021/ja2038003; Ma LQ, 2010, NAT CHEM, V2, P838, DOI [10.1038/NCHEM.738, 10.1038/nchem.738]; O'Keeffe M, 2012, CHEM REV, V112, P675, DOI 10.1021/cr200205j; Park YK, 2007, ANGEW CHEM INT EDIT, V46, P8230, DOI 10.1002/anie.200702324; Pasco ST, 1997, SYNTHETIC MET, V84, P275, DOI 10.1016/S0379-6779(97)80749-7; ROSI N L, 2002, ANGEW CHEM, V114, P294; Rosi NL, 2005, J AM CHEM SOC, V127, P1504, DOI 10.1021/ja045123o; Seo JS, 2000, NATURE, V404, P982, DOI 10.1038/35010088; Shekhah O, 2011, CHEM SOC REV, V40, P1081, DOI 10.1039/c0cs00147c; Sonnauer A, 2009, ANGEW CHEM INT EDIT, V48, P3791, DOI 10.1002/anie.200805980; Wang B, 2008, NATURE, V453, P207, DOI 10.1038/nature06900; Wang XS, 2006, J AM CHEM SOC, V128, P16474, DOI 10.1021/ja066616r; Wang ZQ, 2007, J AM CHEM SOC, V129, P12368, DOI 10.1021/ja074366o; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Zhang XJ, 2011, ANGEW CHEM INT EDIT, V50, P5728, DOI 10.1002/anie.201007277; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548	33	1431	1480	118	2638	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					1018	1023		10.1126/science.1220131	http://dx.doi.org/10.1126/science.1220131			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628651				2022-12-24	WOS:000304406800041
J	Harrison, EM; O'Neill, S; Meurs, TS; Wong, PL; Duxbury, M; Paterson-Brown, S; Wigmore, SJ; Garden, OJ				Harrison, Ewen M.; O'Neill, Stephen; Meurs, Thomas S.; Wong, Pang L.; Duxbury, Mark; Paterson-Brown, Simon; Wigmore, Stephen J.; Garden, O. James			Hospital volume and patient outcomes after cholecystectomy in Scotland: retrospective, national population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							QUALITY IMPROVEMENT; SURGICAL VOLUME; MORTALITY; SURGERY; OPERATIONS; IMPACT	Objectives To define associations between hospital volume and outcomes following cholecystectomy, after adjustment for case mix using a national database. Design Retrospective, national population based study using multilevel modelling and simulation. Setting Locally validated administrative dataset covering all NHS hospitals in Scotland. Participants All patients undergoing cholecystectomy between 1 January 1998 and 31 December 2007. Main outcome measures Mortality, 30 day reoperation rate, 30 day readmission rate, and length of stay. Results We identified 59 918 patients who had a cholecystectomy in one of 37 hospitals: five hospitals had high volumes (>244 cholecystectomies/year), 10 had medium volumes (173-244), and 22 had low volumes (<173). Compared with low and medium volume hospitals, high volume hospitals performed more procedures non-electively (17.1% and 19.5% v 32.8%), completed more procedures laparoscopically (64.7% and 73.8% v 80.9%), and used more operative cholangiography (11.2% and 6.3% v 21.2%; chi(2) test, all P<0.001). In a well performing multivariable analysis with bias correction for a low event rate, the odds ratio for death was greater in both the low volume (odds ratio 1.45, 95% confidence interval 1.06 to 2.00, P=0.022) and medium volume (1.52, 1.11 to 2.08, P=0.010) groups than in the high volume group. However, in simulation studies, absolute risk differences between volume groups were clinically negligible for patients with average risk (number needed to treat to harm, low v high volume, 3871, 1963 to 17 118), but were significant in patients with higher risk. In models accounting for the hierarchical structure of patients in hospitals, those in medium volume hospitals were more likely to undergo reoperation (odds ratio 1.74, 1.31 to 2.30, P<0.001) or be readmitted (1.17, 1.04 to 1.31, P=0.008) after cholecystectomy than those in high volume hospitals. Length of stay was shorter in high volume hospitals than in low (hazard ratio for discharge 0.78, 0.76 to 0.79, P<0.001) or medium volume hospitals (0.75, 0.74 to 0.77, P<0.001). These differences were also only of clinical significance in patients at higher risk. Conclusions There is wide variation among hospitals in the management of gallstone disease and an association between higher hospital volume and better outcome after a cholecystectomy. The relative risk of death is lower in high volume centres, and although absolute risk differences between volume groups are significant for elderly patients and patients with comorbidity, they are clinically negligible for those at average risk.	[Harrison, Ewen M.; O'Neill, Stephen; Wong, Pang L.; Duxbury, Mark; Paterson-Brown, Simon; Wigmore, Stephen J.; Garden, O. James] Univ Edinburgh, Royal Infirm Edinburgh, Dept Clin Surg, Edinburgh EH16 4SA, Midlothian, Scotland; [Meurs, Thomas S.] Leiden Univ, Med Ctr, Dept Surg, Leiden, Netherlands	Royal Infirmary of Edinburgh; University of Edinburgh; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Harrison, EM (corresponding author), Univ Edinburgh, Royal Infirm Edinburgh, Dept Clin Surg, Edinburgh EH16 4SA, Midlothian, Scotland.	mail@ewenharrison.com	Wigmore, Stephen/AAF-3562-2019; O'Neill, Stephen/L-4515-2013	Wigmore, Stephen/0000-0002-3614-8002; O'Neill, Stephen/0000-0002-3252-340X; Harrison, Ewen/0000-0002-5018-3066	University of Edinburgh; Chief Scientist Office [CZB/4/693] Funding Source: researchfish	University of Edinburgh; Chief Scientist Office	The study was funded by the University of Edinburgh, which had no direct role in the study. The corresponding author had full independence from the funding source.	Austin PC, 2002, HLTH SERV OUTCOME RE, V3, P107, DOI DOI 10.1023/A:1024260023851; Bateson MC, 2000, POSTGRAD MED J, V76, P700, DOI 10.1136/pmj.76.901.700; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Buanes T, 1998, SURG ENDOSC-ULTRAS, V12, P852, DOI 10.1007/s004649900728; Chowdhury MM, 2007, BRIT J SURG, V94, P145, DOI 10.1002/bjs.5714; Csikesz NG, 2010, DIGEST DIS SCI, V55, P2398, DOI 10.1007/s10620-009-1035-6; David GG, 2008, BRIT J SURG, V95, P472, DOI 10.1002/bjs.5984; ESCARCE JJ, 1995, JAMA-J AM MED ASSOC, V273, P1581, DOI 10.1001/jama.273.20.1581; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Flum DR, 2003, JAMA-J AM MED ASSOC, V290, P2168, DOI 10.1001/jama.290.16.2168; Ghaferi AA, 2009, ANN SURG, V250, P1029, DOI 10.1097/SLA.0b013e3181bef697; Gooiker GA, 2011, BRIT J SURG, V98, P485, DOI 10.1002/bjs.7413; Gurusamy K, 2010, BRIT J SURG, V97, P141, DOI 10.1002/bjs.6870; Harboe KM, 2011, INT J QUAL HEALTH C, V23, P565, DOI 10.1093/intqhc/mzr041; Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898; Imai Kosuke, 2007, ZELIG EVERYONES STAT; Khuri SF, 1999, ANN SURG, V230, P414, DOI 10.1097/00000658-199909000-00014; Kim SH, 2007, ANN SURG, V245, P201, DOI 10.1097/01.sla.0000245516.10349.c5; KING G, 2000, AM J POLIT SCI, V0044; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; Mayer EK, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1128; McMahon AJ, 2000, LANCET, V356, P1632, DOI 10.1016/S0140-6736(00)03156-1; Murphy MM, 2010, J AM COLL SURGEONS, V211, P73, DOI 10.1016/j.jamcollsurg.2010.02.050; Rosenmuller M, 2007, BMC GASTROENTEROL, V7, DOI 10.1186/1471-230X-7-35; Schilling PL, 2008, J AM COLL SURGEONS, V207, P698, DOI 10.1016/j.jamcollsurg.2008.06.138; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X	27	61	63	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2012	344								e3330	10.1136/bmj.e3330	http://dx.doi.org/10.1136/bmj.e3330			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QT	22623634	hybrid, Green Submitted			2022-12-24	WOS:000304591500004
J	Chan, PS; Nallamothu, BK				Chan, Paul S.; Nallamothu, Brahmajee K.			Improving Outcomes Following In-Hospital Cardiac Arrest Life After Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DEFIBRILLATION; SURVIVAL; TIME		[Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Chan, Paul S.] Univ Missouri, Kansas City, MO USA; [Nallamothu, Brahmajee K.] VA Ann Arbor Healthcare Syst, VA Hlth Serv Res & Dev Ctr Excellence, Ann Arbor, MI USA; [Nallamothu, Brahmajee K.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Nallamothu, Brahmajee K.] Univ Michigan, Ctr Healthcare Outcomes & Policy, Ann Arbor, MI 48109 USA	Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chan, PS (corresponding author), St Lukes Hosp, Mid Amer Heart Inst, 4401 Wornall Rd,5th Floor, Kansas City, MO 64111 USA.	pchan@saint-lukes.org			NHLBI NIH HHS [K23HL102224, K23 HL102224] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Becker LB, 2011, CIRCULATION, V124, P2158, DOI 10.1161/CIR.0b013e3182340239; Chan PS, 2008, NEW ENGL J MED, V358, P9, DOI 10.1056/NEJMoa0706467; Chan PS, 2009, JAMA-J AM MED ASSOC, V302, P1195, DOI 10.1001/jama.2009.1340; Chan PS, 2009, ARCH INTERN MED, V169, P1265, DOI 10.1001/archinternmed.2009.196; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Girotra S, 2011, CIRCULATION, V124; Merchant RM, 2011, CRIT CARE MED, V39, P2401, DOI 10.1097/CCM.0b013e3182257459; Peberdy MA, 2008, JAMA-J AM MED ASSOC, V299, P785, DOI 10.1001/jama.299.7.785; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645	9	22	23	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1917	1918		10.1001/jama.2012.3504	http://dx.doi.org/10.1001/jama.2012.3504			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570458	Green Accepted			2022-12-24	WOS:000303741900022
J	Quill, TE; Holloway, RG				Quill, Timothy E.; Holloway, Robert G.			Evidence, Preferences, Recommendations - Finding the Right Balance in Patient Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Quill, Timothy E.] Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA; [Holloway, Robert G.] Univ Rochester, Med Ctr, Dept Neurol, Palliat Care Div, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Quill, TE (corresponding author), Univ Rochester, Med Ctr, Dept Med, Rochester, NY 14642 USA.							Johnson DDP, 2011, NATURE, V477, P317, DOI 10.1038/nature10384; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; Schmaltz SP, 2011, J HOSP MED, V6, P454, DOI 10.1002/jhm.905; Ubel PA, 2005, HEALTH PSYCHOL, V24, pS57, DOI 10.1037/0278-6133.24.4.S57; Zikmund-Fisher BJ, 2010, MED DECIS MAKING, V30, p20S, DOI 10.1177/0272989X09353792	5	63	63	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1653	1655		10.1056/NEJMp1201535	http://dx.doi.org/10.1056/NEJMp1201535			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HH	22551123				2022-12-24	WOS:000303434300001
J	Gravitz, L				Gravitz, Lauren			VECTOR CONTROL The last bite	NATURE			English	Editorial Material																		Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Najera JA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000412	4	14	15	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S26	S27		10.1038/484S26a	http://dx.doi.org/10.1038/484S26a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22534530	Bronze			2022-12-24	WOS:000303200400005
J	Lee, IH; Kawai, Y; Fergusson, MM; Rovira, II; Bishop, AJR; Motoyama, N; Cao, L; Finkel, T				Lee, In Hye; Kawai, Yoshichika; Fergusson, Maria M.; Rovira, Ilsa I.; Bishop, Alexander J. R.; Motoyama, Noboru; Cao, Liu; Finkel, Toren			Atg7 Modulates p53 Activity to Regulate Cell Cycle and Survival During Metabolic Stress	SCIENCE			English	Article							DNA-DAMAGE RESPONSE; AUTOPHAGY; QUIESCENCE; APOPTOSIS	Withdrawal of nutrients triggers an exit from the cell division cycle, the induction of autophagy, and eventually the activation of cell death pathways. The relation, if any, among these events is not well characterized. We found that starved mouse embryonic fibroblasts lacking the essential autophagy gene product Atg7 failed to undergo cell cycle arrest. Independent of its E1-like enzymatic activity, Atg7 could bind to the tumor suppressor p53 to regulate the transcription of the gene encoding the cell cycle inhibitor p21(CDKN1A). With prolonged metabolic stress, the absence of Atg7 resulted in augmented DNA damage with increased p53-dependent apoptosis. Inhibition of the DNA damage response by deletion of the protein kinase Chk2 partially rescued postnatal lethality in Atg7(-/-) mice. Thus, when nutrients are limited, Atg7 regulates p53-dependent cell cycle and cell death pathways.	[Cao, Liu] China Med Univ, Key Lab Med Cell Biol, Shenyang 110001, Peoples R China; [Lee, In Hye; Kawai, Yoshichika; Fergusson, Maria M.; Rovira, Ilsa I.; Finkel, Toren] NHLBI, Ctr Mol Med, Bethesda, MD 20892 USA; [Bishop, Alexander J. R.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Motoyama, Noboru] Natl Ctr Geriatr & Gerontol, Res Inst, Dept Cognit Brain Sci, Aichi 4748511, Japan	China Medical University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Health San Antonio; National Center for Geriatrics & Gerontology	Cao, L (corresponding author), China Med Univ, Key Lab Med Cell Biol, Shenyang 110001, Peoples R China.	caoliu@mail.cmu.edu; finkelt@nih.gov	LEE, IN HYE/T-2714-2019; Kawai, Yoshichika/G-3231-2011	LEE, IN HYE/0000-0003-2334-3594; Bishop, Alexander/0000-0002-5742-4387	National Natural Science Foundation of China [81130042, 31171323]; NIH; Ellison Medical Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005012, ZICHL006019] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Komatsu for providing the Atg7<SUP>+/-</SUP> mice. Supported by National Natural Science Foundation of China grants 81130042 and 31171323 (L.C.), NIH intramural funds, and a grant from the Ellison Medical Foundation (T.F.).	Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Crighton D, 2006, CELL, V126, P121, DOI 10.1016/j.cell.2006.05.034; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; HARPER JW, 1993, CELL, V75, P805; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2001, J BIOL CHEM, V276, P9846, DOI 10.1074/jbc.M007737200; Kwon YH, 2002, J BIOL CHEM, V277, P41417, DOI 10.1074/jbc.M203388200; Ladha MH, 1998, MOL CELL BIOL, V18, P6605, DOI 10.1128/MCB.18.11.6605; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Pattison JS, 2011, CIRC RES, V109, P151, DOI 10.1161/CIRCRESAHA.110.237339; Perucca P, 2009, CELL CYCLE, V8, P105, DOI 10.4161/cc.8.1.7507; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Rivard N, 1996, J BIOL CHEM, V271, P18337, DOI 10.1074/jbc.271.31.18337; Schiaffino S, 2008, AUTOPHAGY, V4, P727, DOI 10.4161/auto.6143; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Tasdemir E, 2008, CELL CYCLE, V7, P3006, DOI 10.4161/cc.7.19.6702; Valentin M, 2008, CELL CYCLE, V7, P2762, DOI 10.4161/cc.7.17.6595; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005	25	229	243	2	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 13	2012	336	6078					225	228		10.1126/science.1218395	http://dx.doi.org/10.1126/science.1218395			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499945	Green Accepted			2022-12-24	WOS:000302703900049
J	Berglund, J				Berglund, Jennifer			Alternative therapies: Desperate measures	NATURE			English	Editorial Material																			0	3	3	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S11	S11		10.1038/nature11099	http://dx.doi.org/10.1038/nature11099			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509512	Bronze			2022-12-24	WOS:000303149900053
J	Cook, DJ				Cook, Diane J.			How Smart Is Your Home?	SCIENCE			English	Editorial Material									Washington State Univ, Pullman, WA 99164 USA	Washington State University	Cook, DJ (corresponding author), Washington State Univ, Pullman, WA 99164 USA.	cook@eecs.wsu.edu			NIBIB NIH HHS [R01 EB009675, R01 EB015853] Funding Source: Medline; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB009675, R01EB015853] Funding Source: NIH RePORTER	NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Alon J, 2009, IEEE T PATTERN ANAL, V31, P1685, DOI 10.1109/TPAMI.2008.203; Buracchio T, 2010, ARCH NEUROL-CHICAGO, V67, P980, DOI 10.1001/archneurol.2010.159; Das B, 2011, LECT NOTES COMPUT SC, V6719, P9, DOI 10.1007/978-3-642-21535-3_2; Dey AK, 2011, IEEE PERVAS COMPUT, V10, P4, DOI 10.1109/MPRV.2011.29; Kim E, 2010, IEEE PERVAS COMPUT, V9, P48, DOI 10.1109/MPRV.2010.7; O'Grady M, 2012, SCIENCE, V335, P1581, DOI 10.1126/science.1217637; Paradiso J, 2011, IEEE PERVAS COMPUT, V10, P11, DOI 10.1109/MPRV.2011.4; Pentland A, 2010, AM SCI, V98, P204, DOI 10.1511/2010.84.203; Song EY, 2008, IEEE INSTRU MEAS MAG, V11, P11, DOI 10.1109/MIM.2008.4483728; WEISER M, 1991, SCI AM, V265, P94, DOI 10.1038/scientificamerican0991-94; Youngblood GM, 2007, IEEE T SYST MAN CY C, V37, P561, DOI 10.1109/TSMCC.2007.897341	11	85	90	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1579	1581		10.1126/science.1217640	http://dx.doi.org/10.1126/science.1217640			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915YD	22461596	Green Accepted			2022-12-24	WOS:000302062600028
J	Brunham, LR; Hayden, MR				Brunham, Liam R.; Hayden, Michael R.			Whole-Genome Sequencing: The New Standard of Care?	SCIENCE			English	Editorial Material							HEREDITARY HEMOCHROMATOSIS; MUTATION		[Hayden, Michael R.] Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada; [Brunham, Liam R.] Univ British Columbia, Dept Med, Vancouver, BC V5Z 4H4, Canada; [Hayden, Michael R.] Natl Univ Singapore, Dept Med, TLGM, Singapore 117609, Singapore; [Hayden, Michael R.] ASTAR, Singapore 117609, Singapore	Child & Family Research Institute; University of British Columbia; University of British Columbia; National University of Singapore; Agency for Science Technology & Research (A*STAR)	Hayden, MR (corresponding author), Univ British Columbia, Child & Family Res Inst, Ctr Mol Med & Therapeut, Dept Med Genet, Vancouver, BC V5Z 4H4, Canada.	mrh@cmmt.ubc.ca	Hayden, Michael R/D-8581-2011	Hayden, Michael R/0000-0001-5159-1419				Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Berg JS, 2011, GENET MED, V13, P499, DOI 10.1097/GIM.0b013e318220aaba; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Ginsburg GS, 2009, TRANSL RES, V154, P277, DOI 10.1016/j.trsl.2009.09.005; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Mayer AN, 2011, GENET MED, V13, P195, DOI 10.1097/GIM.0b013e3182095089; Pelak K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001111; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Roberts NJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003380; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Wade N, 2010, NY TIMES, pA1; Welch JS, 2011, JAMA-J AM MED ASSOC, V305, P1577, DOI 10.1001/jama.2011.497; Worthey EA, 2011, GENET MED, V13, P255, DOI 10.1097/GIM.0b013e3182088158; Wright C., 2011, NEXT STEPS SEQUENCE	17	53	57	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1112	1113		10.1126/science.1220967	http://dx.doi.org/10.1126/science.1220967			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	950KK	22654044				2022-12-24	WOS:000304647900031
J	Schmidt, EF; Warner-Schmidt, JL; Otopalik, BG; Pickett, SB; Greengard, P; Heintz, N				Schmidt, Eric F.; Warner-Schmidt, Jennifer L.; Otopalik, Benjamin G.; Pickett, Sarah B.; Greengard, Paul; Heintz, Nathaniel			Identification of the Cortical Neurons that Mediate Antidepressant Responses	CELL			English	Article							TRANSLATIONAL PROFILING APPROACH; CNS CELL-TYPES; NEURAL CIRCUITS; ANIMAL-MODELS; DEPRESSION; P11; ABNORMALITIES; STIMULATION; MOOD; DISORDERS	Our understanding of current treatments for depression, and the development of more specific therapies, is limited by the complexity of the circuits controlling mood and the distributed actions of antidepressants. Although the therapeutic efficacy of serotonin-specific reuptake inhibitors (SSRIs) is correlated with increases in cortical activity, the cell types crucial for their action remain unknown. Here we employ bacTRAP translational profiling to show that layer 5 corticostriatal pyramidal cells expressing p11 (S100a10) are strongly and specifically responsive to chronic antidepressant treatment. This response requires p11 and includes the specific induction of Htr4 expression. Cortex-specific deletion of p11 abolishes behavioral responses to SSRIs, but does not lead to increased depression-like behaviors. Our data identify corticostriatal projection neurons as critical for the response to antidepressants, and suggest that the regulation of serotonergic tone in this single cell type plays a pivotal role in antidepressant therapy.	[Schmidt, Eric F.; Otopalik, Benjamin G.; Pickett, Sarah B.; Heintz, Nathaniel] Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, New York, NY 10065 USA; [Warner-Schmidt, Jennifer L.; Greengard, Paul] Rockefeller Univ, Lab Mol & Cellular Neurosci, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Heintz, N (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Mol Biol Lab, 1230 York Ave, New York, NY 10065 USA.	heintz@rockefeller.edu	Schmidt, Eric F./AAE-8723-2019	Schmidt, Eric F./0000-0002-7869-0270; Greengard, Paul/0000-0002-4437-0893	Howard Hughes Medical Institute; NIH/NIDA ARRA [PHS DA028968]; Conte Center [PHS MH090963]; USAMRAA [W81XWH-09-0401]; JPB Foundation; Fisher Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH090963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC2DA028968] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIDA ARRA; Conte Center; USAMRAA; JPB Foundation; Fisher Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Howard Hughes Medical Institute (N.H.), NIH/NIDA ARRA Grand Opportunity Grant PHS DA028968 (N.H., P.G.), Conte Center PHS MH090963 (P.G., N.H.), USAMRAA grant W81XWH-09-0401 (J.W.S.), the JPB Foundation (P.G.), and the Fisher Foundation (P.G.). We thank the Rockefeller University Genomics Resource Center, and Neuroscience Associates. We would further like to thank Tanya Stevens, Sujata Bupp, and George Skabardonis for their excellent advice and assistance, and Joseph Dougherty for providing the Snap25 bacTRAP mice. N.H. and P.G. are cofounders of, and consults for, Envoy Therapeutics.	Anisman H, 2008, J PSYCHIATR NEUROSCI, V33, P131; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Covington HE, 2010, J NEUROSCI, V30, P16082, DOI 10.1523/JNEUROSCI.1731-10.2010; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Delgado MR, 2007, ANN NY ACAD SCI, V1104, P70, DOI 10.1196/annals.1390.002; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2000, PROG BRAIN RES, V126, P413; Dulawa SC, 2005, NEUROSCI BIOBEHAV R, V29, P771, DOI 10.1016/j.neubiorev.2005.03.017; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Egeland M, 2011, NEUROPHARMACOLOGY, V61, P442, DOI 10.1016/j.neuropharm.2011.01.046; Egeland M, 2010, BIOL PSYCHIAT, V67, P1048, DOI 10.1016/j.biopsych.2010.01.024; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gong SC, 2002, GENOME RES, V12, P1992, DOI 10.1101/gr.476202; Gradin VB, 2011, BRAIN, V134, P1751, DOI 10.1093/brain/awr059; Groh A, 2010, CEREB CORTEX, V20, P826, DOI 10.1093/cercor/bhp152; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; KRISHNAN KRR, 1992, ARCH GEN PSYCHIAT, V49, P553; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Limousin P, 2008, NEUROTHERAPEUTICS, V5, P309, DOI 10.1016/j.nurt.2008.01.006; Lucas G, 2007, NEURON, V55, P712, DOI 10.1016/j.neuron.2007.07.041; Mayberg HS, 2009, J CLIN INVEST, V119, P717, DOI 10.1172/JCI38454; Mayberg HS, 1999, AM J PSYCHIAT, V156, P675; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Ressler KJ, 2007, NAT NEUROSCI, V10, P1116, DOI 10.1038/nn1944; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Svenningsson P, 2006, SCIENCE, V311, P77, DOI 10.1126/science.1117571; Voorn P, 2004, TRENDS NEUROSCI, V27, P468, DOI 10.1016/j.tins.2004.06.006; Warner-Schmidt JL, 2011, P NATL ACAD SCI USA, V108, P9262, DOI 10.1073/pnas.1104836108; Warner-Schmidt JL, 2010, BIOL PSYCHIAT, V68, P528, DOI 10.1016/j.biopsych.2010.04.029; Warner-Schmidt JL, 2009, J NEUROSCI, V29, P1937, DOI 10.1523/JNEUROSCI.5343-08.2009	31	92	94	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					1152	1163		10.1016/j.cell.2012.03.038	http://dx.doi.org/10.1016/j.cell.2012.03.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632977	Green Accepted, Bronze			2022-12-24	WOS:000304453900019
J	Yang, H; Shi, LY; Wang, BA; Liang, D; Zhong, CQ; Liu, W; Nie, YZ; Liu, J; Zhao, J; Gao, X; Li, DS; Xu, GL; Li, JS				Yang, Hui; Shi, Linyu; Wang, Bang-An; Liang, Dan; Zhong, Cuiqing; Liu, Wei; Nie, Yongzhan; Liu, Jie; Zhao, Jing; Gao, Xiang; Li, Dangsheng; Xu, Guo-Liang; Li, Jinsong			Generation of Genetically Modified Mice by Oocyte Injection of Androgenetic Haploid Embryonic Stem Cells	CELL			English	Article							MOUSE EMBRYOS; NUCLEAR TRANSFER; CLONED MICE; GENE-EXPRESSION; GENOME; METAPHASE; LINES; BLASTOCYSTS; METHYLATION; DERIVATION	Haploid cells are amenable for genetic analysis. Recent success in the derivation of mouse haploid embryonic stem cells (haESCs) via parthenogenesis has enabled genetic screening in mammalian cells. However, successful generation of live animals from these haESCs, which is needed to extend the genetic analysis to the organism level, has not been achieved. Here, we report the derivation of haESCs from androgenetic blastocysts. These cells, designated as AG-haESCs, partially maintain paternal imprints, express classical ESC pluripotency markers, and contribute to various tissues, including the germline, upon injection into diploid blastocysts. Strikingly, live mice can be obtained upon injection of AG-haESCs into MII oocytes, and these mice bear haESC-carried genetic traits and develop into fertile adults. Furthermore, gene targeting via homologous recombination is feasible in the AG-haESCs. Our results demonstrate that AG-haESCs can be used as a genetically tractable fertilization agent for the production of live animals via injection into oocytes.	[Wang, Bang-An; Liu, Wei; Xu, Guo-Liang] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Grp DNA Metab, Shanghai 200031, Peoples R China; [Yang, Hui; Shi, Linyu; Liang, Dan; Zhong, Cuiqing; Li, Jinsong] Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Grp Epigenet Reprogramming, Shanghai 200031, Peoples R China; [Li, Dangsheng] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Informat Ctr Life Sci, Shanghai 200031, Peoples R China; [Nie, Yongzhan; Liu, Jie] Fourth Mil Med Univ, Xijing Hosp, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Nie, Yongzhan; Liu, Jie] Fourth Mil Med Univ, Xijing Hosp, Inst Digest Dis, Xian 710032, Peoples R China; [Zhao, Jing; Gao, Xiang] Nanjing Univ, Model Anim Res Ctr, MOE Key Lab Model Anim Dis Study, Nanjing 210061, Jiangsu, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Information Center for Life Sciences; Air Force Military Medical University; Air Force Military Medical University; Nanjing University	Xu, GL (corresponding author), Chinese Acad Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, Grp DNA Metab, Shanghai 200031, Peoples R China.	glxu@sibs.ac.cn; jsli@sibs.ac.cn	zhao, jing/B-3868-2019; Liu, Dominic/AAH-5057-2021	Wang, Bang-An/0000-0003-4488-1738; Liang, Dan/0000-0003-2404-3075; yang, hui/0000-0003-3590-722X; li, jin song/0000-0003-3456-662X	Ministry of Science and Technology of China [2009CB941101, 2011CB811304]; National Natural Science Foundation of China [30730059]; Chinese Academy of Sciences [XDA01010403, XDA01010301]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	We thank M. Dym, X. Sun, and C. Walsh for critical reading of the manuscript. This study was supported by grants from the Ministry of Science and Technology of China (2009CB941101 to J.L. and G.-L. X., 2011CB811304), the National Natural Science Foundation of China (30730059 to G.-L. X.), and the "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDA01010403 to J.L.; XDA01010301 to G.-L.X.).	Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Dean W, 1998, DEVELOPMENT, V125, P2273; Du R, 2010, BIOCHEM BIOPH RES CO, V391, P135, DOI 10.1016/j.bbrc.2009.11.019; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hajkova Petra, 2002, Methods Mol Biol, V200, P143; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Jiang J, 2011, J MOL CELL BIOL, V3, P197, DOI 10.1093/jmcb/mjr012; KAUFMAN MH, 1983, J EMBRYOL EXP MORPH, V73, P249; KAUFMAN MH, 1978, J EMBRYOL EXP MORPH, V45, P85; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kim Y, 2011, SCIENCE, V334, P1706, DOI 10.1126/science.1211222; KIMURA Y, 1995, BIOL REPROD, V52, P709, DOI 10.1095/biolreprod52.4.709; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kotecki M, 1999, EXP CELL RES, V252, P273, DOI 10.1006/excr.1999.4656; Kuretake S, 1996, BIOL REPROD, V55, P789, DOI 10.1095/biolreprod55.4.789; Latham KE, 2002, BIOL REPROD, V67, P386, DOI 10.1095/biolreprod67.2.386; Latham KE, 2000, BIOL REPROD, V63, P64, DOI 10.1095/biolreprod63.1.64; Leeb M, 2011, NATURE, V479, P131, DOI 10.1038/nature10448; Li JS, 2008, BIOL REPROD, V79, P588, DOI 10.1095/biolreprod.108.069583; Lin JW, 2011, CELL STEM CELL, V8, P371, DOI 10.1016/j.stem.2011.02.007; Liu H, 2001, BIOL REPROD, V65, P1794, DOI 10.1095/biolreprod65.6.1794; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; MODLINSKI JA, 1975, J EMBRYOL EXP MORPH, V33, P897; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Ono Y, 2001, REPRODUCTION, V122, P731, DOI 10.1530/reprod/122.5.731; Ono Y, 2001, BIOL REPROD, V64, P44, DOI 10.1095/biolreprod64.1.44; Pesce M, 1998, MECH DEVELOP, V71, P89, DOI 10.1016/S0925-4773(98)00002-1; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Rugg-Gunn PJ, 2007, HUM MOL GENET, V16, pR243, DOI 10.1093/hmg/ddm245; Rugg-Gunn PJ, 2005, NAT GENET, V37, P585, DOI 10.1038/ng1556; Schimenti J, 2011, CELL STEM CELL, V9, P488, DOI 10.1016/j.stem.2011.11.006; Sukov WR, 2010, CANCER GENET CYTOGEN, V202, P123, DOI 10.1016/j.cancergencyto.2010.07.120; SURANI MA, 1990, DEVELOPMENT, P89; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tachibana M, 2012, CELL, V148, P285, DOI 10.1016/j.cell.2011.12.007; TARKOWSKI AK, 1976, NATURE, V259, P663, DOI 10.1038/259663a0; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Yan H, 2000, NATURE, V403, P723, DOI 10.1038/35001659; Yanagimachi R, 2005, REPROD BIOMED ONLINE, V10, P247, DOI 10.1016/S1472-6483(10)60947-9; Yang H, 2011, CELL RES, V21, P854, DOI 10.1038/cr.2011.45; Yang H, 2010, CELL RES, V20, P1034, DOI 10.1038/cr.2010.97; Yi MS, 2009, SCIENCE, V326, P430, DOI 10.1126/science.1175151; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	48	136	169	10	128	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					605	617		10.1016/j.cell.2012.04.002	http://dx.doi.org/10.1016/j.cell.2012.04.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541431	Bronze			2022-12-24	WOS:000303443100012
J	Chiang, N; Fredman, G; Backhed, F; Oh, SF; Vickery, T; Schmidt, BA; Serhan, CN				Chiang, Nan; Fredman, Gabrielle; Backhed, Fredrik; Oh, Sungwhan F.; Vickery, Thad; Schmidt, Birgitta A.; Serhan, Charles N.			Infection regulates pro-resolving mediators that lower antibiotic requirements	NATURE			English	Article							ACUTE LUNG INJURY; INFLAMMATION; RESOLUTION; ASPIRIN; INNATE; MICE; PHAGOCYTOSIS; MACROPHAGES; INHIBITION; RESPONSES	Underlying mechanisms for how bacterial infections contribute to active resolution of acute inflammation are unknown(1-4). Here, we performed exudate leukocyte trafficking and mediator-metabololipidomics of murine peritoneal Escherichia coli infections with temporal identification of pro-inflammatory (prostaglandins and leukotrienes) and specialized pro-resolving mediators (SPMs). In self-resolving E. coli exudates (10(5) colony forming units, c.f.u.), the dominant SPMs identified were resolvin (Rv) D5 and protectin D1 (PD1), which at 12 h were at significantly greater levels than in exudates from higher titre E. coli (10(7) c.f.u.)-challenged mice. Germfree mice had endogenous RvD1 and PD1 levels higher than in conventional mice. RvD1 and RvD5 (nanograms per mouse) each reduced bacterial titres in blood and exudates, E. coli-induced hypothermia and increased survival, demonstrating the first actions of RvD5. With human polymorphonuclear neutrophils and macrophages, RvD1, RvD5 and PD1 each directly enhanced phagocytosis of E. coli, and RvD5 counter-regulated a panel of pro-inflammatory genes, including NF-kappa B and TNF-alpha. RvD5 activated the RvD1 receptor, GPR32, to enhance phagocytosis. With self-limited E. coli infections, RvD1 and the antibiotic ciprofloxacin accelerated resolution, each shortening resolution intervals (R-i). Host-directed RvD1 actions enhanced ciprofloxacin's therapeutic actions. In 10(7) c.f.u. E. coli infections, SPMs (RvD1, RvD5, PD1) together with ciprofloxacin also heightened host antimicrobial responses. In skin infections, SPMs enhanced vancomycin clearance of Staphylococcus aureus. These results demonstrate that specific SPMs are temporally and differentially regulated during infections and that they are anti-phlogistic, enhance containment and lower antibiotic requirements for bacterial clearance.	[Chiang, Nan; Fredman, Gabrielle; Oh, Sungwhan F.; Vickery, Thad; Schmidt, Birgitta A.; Serhan, Charles N.] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Harvard Inst Med, Boston, MA 02115 USA; [Backhed, Fredrik] Univ Gothenburg, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, SE-41345 Gothenburg, Sweden	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Gothenburg	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, Harvard Inst Med, 75 Francis St, Boston, MA 02115 USA.	cnserhan@zeus.bwh.harvard.edu	Backhed, Fredrik/ABE-6613-2020; Chiang, Nan/ABA-4924-2021	Backhed, Fredrik/0000-0002-4871-8818; Chiang, Nan/0000-0003-1963-1585	NIH [P01GM095467, R01GM38765]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, P01GM095467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank M. Small for assistance with manuscript preparation, J. Lederer for cytokine measurements, J. Dalli for discussions, and N. Petasis for preparation of deuterium-labelled RvD1. This work was supported in part by NIH grants P01GM095467 and R01GM38765 (C.N.S.).	Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; El Kebir D, 2009, AM J RESP CRIT CARE, V180, P311, DOI 10.1164/rccm.200810-1601OC; Grkovich A, 2006, J BIOL CHEM, V281, P32978, DOI 10.1074/jbc.M605935200; Henneke P, 2004, J EXP MED, V199, P1, DOI 10.1084/jem.20031256; Houck J. C., 1979, CHEM MESSENGERS INFL; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; Klingensmith M. E., 1998, PHYSL BASIS MODERN S, P478; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Link A, 2008, CRIT CARE, V12, DOI 10.1186/cc7158; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Morris T, 2009, J IMMUNOL, V183, P2089, DOI 10.4049/jimmunol.0900477; Navarro-Xavier RA, 2010, J IMMUNOL, V184, P1516, DOI 10.4049/jimmunol.0902866; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Prescott D, 2011, AM J PHYSIOL-GASTR L, V301, pG487, DOI 10.1152/ajpgi.00042.2011; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Seki H, 2010, J IMMUNOL, V184, P836, DOI 10.4049/jimmunol.0901809; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Stables MJ, 2011, PROG LIPID RES, V50, P35, DOI 10.1016/j.plipres.2010.07.005; Stables MJ, 2010, BLOOD, V116, P2950, DOI 10.1182/blood-2010-05-284844; Winyard P. G., 2003, INFLAMMATION PROTOCO; World Health Organization (WHO), 2020, ANTIMICROBIAL RESIST; Xu YN, 2011, ANESTH ANALG, V112, P1403, DOI 10.1213/ANE.0b013e318213fbd3; Yang R., 2011, CURR PROTOC IMMUNOL, V95	30	456	467	6	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					524	U152		10.1038/nature11042	http://dx.doi.org/10.1038/nature11042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538616	Green Submitted, Green Accepted			2022-12-24	WOS:000303200400053
J	Athan, E; Chu, VH; Tattevin, P; Selton-Suty, C; Jones, P; Naber, C; Miro, JM; Ninot, S; Fernandez-Hidalgo, N; Durante-Mangoni, E; Spelman, D; Hoen, B; Lejko-Zupanc, T; Cecchi, E; Thuny, F; Hannan, MM; Pappas, P; Henry, M; Fowler, VG; Crowley, AL; Wang, A				Athan, Eugene; Chu, Vivian H.; Tattevin, Pierre; Selton-Suty, Christine; Jones, Phillip; Naber, Christoph; Miro, Jose M.; Ninot, Salvador; Fernandez-Hidalgo, Nuria; Durante-Mangoni, Emanuele; Spelman, Denis; Hoen, Bruno; Lejko-Zupanc, Tatjana; Cecchi, Enrico; Thuny, Franck; Hannan, Margaret M.; Pappas, Paul; Henry, Margaret; Fowler, Vance G., Jr.; Crowley, Anna Lisa; Wang, Andrew		ICE-PCS Investigators	Clinical Characteristics and Outcome of Infective Endocarditis Involving Implantable Cardiac Devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVERTER-DEFIBRILLATOR INFECTION; PERMANENT PACEMAKER; VALVE ENDOCARDITIS; RISK-FACTORS; MANAGEMENT; DIAGNOSIS; MORTALITY; PROGRESS	Context Infection of implantable cardiac devices is an emerging disease with significant morbidity, mortality, and health care costs. Objectives To describe the clinical characteristics and outcome of cardiac device infective endocarditis (CDIE) with attention to its health care association and to evaluate the association between device removal during index hospitalization and outcome. Design, Setting, and Patients Prospective cohort study using data from the International Collaboration on Endocarditis-Prospective Cohort Study (ICE-PCS), conducted June 2000 through August 2006 in 61 centers in 28 countries. Patients were hospitalized adults with definite endocarditis as defined by modified Duke endocarditis criteria. Main Outcome Measures In-hospital and 1-year mortality. Results CDIE was diagnosed in 177 (6.4% [95% CI, 5.5%-7.4%]) of a total cohort of 2760 patients with definite infective endocarditis. The clinical profile of CDIE included advanced patient age (median, 71.2 years [interquartile range, 59.8-77.6]); causation by staphylococci (62 [35.0% {95% CI, 28.0%-42.5%}] Staphylococcus aureus and 56 [31.6% {95% CI, 24.9%-39.0%}] coagulase-negative staphylococci); and a high prevalence of health care-associated infection (81 [45.8% {95% CI, 38.3%-53.4%}]). There was coexisting valve involvement in 66 (37.3% [95% CI, 30.2%-44.9%]) patients, predominantly tricuspid valve infection (43/177 [24.3%]), with associated higher mortality. In-hospital and 1-year mortality rates were 14.7% (26/177 [95% CI, 9.8%-20.8%]) and 23.2% (41/177 [95% CI, 17.2%-30.1%]), respectively. Proportional hazards regression analysis showed a survival benefit at 1 year for device removal during the initial hospitalization (28/141 patients [19.9%] who underwent device removal during the index hospitalization had died at 1 year, vs 13/34 [38.2%] who did not undergo device removal; hazard ratio, 0.42 [95% CI, 0.22-0.82]). Conclusions Among patients with CDIE, the rate of concomitant valve infection is high, as is mortality, particularly if there is valve involvement. Early device removal is associated with improved survival at 1 year. JAMA. 2012;307(16):1727-1735	[Athan, Eugene; Henry, Margaret] Barwon Hlth, Dept Infect Dis, Geelong, Vic, Australia; [Chu, Vivian H.; Pappas, Paul; Fowler, Vance G., Jr.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Crowley, Anna Lisa; Wang, Andrew] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Tattevin, Pierre] Pontchaillou Univ, ICU, Rennes, France; [Selton-Suty, Christine] CHU Nancy Brabois, Nancy, France; [Jones, Phillip] Univ New S Wales, Sydney, NSW, Australia; [Naber, Christoph] W German Heart Ctr, Dept Cardiol, Essen, Germany; [Miro, Jose M.; Ninot, Salvador] Univ Barcelona, Hosp Clin IDIBAPS, Barcelona, Spain; [Fernandez-Hidalgo, Nuria] Hosp Univ Vall Hebron, Barcelona, Spain; [Durante-Mangoni, Emanuele] Univ Naples 2, Monaldi Hosp, Naples, Italy; [Spelman, Denis] Alfred Hosp, Melbourne, Vic, Australia; [Hoen, Bruno] Univ Med Ctr Besancon, Besancon, France; [Lejko-Zupanc, Tatjana] Med Ctr Ljubljana, Ljubljana, Slovenia; [Cecchi, Enrico] Maria Vittoria Hosp, Turin, Italy; [Thuny, Franck] Fac Med Marseille, F-13385 Marseille, France; [Hannan, Margaret M.] Mater Univ Hosp, Dept Microbiol, Dublin, Ireland	Duke University; Duke University; CHU Rennes; CHU de Nancy; University of New South Wales Sydney; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Hospital Universitari Vall d'Hebron; Universita della Campania Vanvitelli; Florey Institute of Neuroscience & Mental Health; Universite de Franche-Comte; CHU Besancon; University Medical Centre Ljubljana; Maria Vittoria Hospital; UDICE-French Research Universities; Aix-Marseille Universite; Mater Misericordiae University Hospital	Wang, A (corresponding author), Duke Hosp, DUMC 3428,Room 7401,Erwin Rd, Durham, NC 27710 USA.	a.wang@duke.edu	Gonzalez Ramallo, Victor José/Y-6248-2018; Cervera, Carlos/U-4538-2018; Rudez, Igor/O-3950-2019; Rogers, Margaret/ABI-1852-2020; Bouza, Emilio/D-8661-2014; Thuny, Franck/ABC-7157-2020; Toniolo, Antonio Q./B-4103-2015; Fournier, Pierre-Edouard/AAC-6155-2021; Durante, Marco/K-1315-2014; RAOULT, Didier/A-8434-2008; Fowler, Vance/AAW-2017-2021; Thuny, Franck/ABB-2408-2021; Revest, Matthieu/L-9533-2015; Pericàs, Juan M/N-5674-2019; Marco, Francesc D/K-2900-2017; De Rosa, Francesco Giuseppe/J-3049-2013; Thuny, Franck/GSD-2668-2022; Muñoz, Patricia/E-9431-2017; yasmin, Mohamad/M-5472-2018; solis, jorge/E-2709-2018	Gonzalez Ramallo, Victor José/0000-0002-9867-1472; Cervera, Carlos/0000-0002-0161-1749; Rudez, Igor/0000-0002-7735-6721; Bouza, Emilio/0000-0001-6967-9267; Toniolo, Antonio Q./0000-0003-3008-2126; Fournier, Pierre-Edouard/0000-0001-8463-8885; Durante, Marco/0000-0002-4615-553X; RAOULT, Didier/0000-0002-0633-5974; Thuny, Franck/0000-0002-8727-7154; Pericàs, Juan M/0000-0002-3645-3293; Marco, Francesc D/0000-0002-1863-6379; Thuny, Franck/0000-0002-8727-7154; Muñoz, Patricia/0000-0001-5706-5583; yasmin, Mohamad/0000-0002-5859-1769; alla, francois/0000-0002-5793-7190; Henry, Assoc Prof Margaret J/0000-0002-1233-6754; Selton-Suty, Christine/0000-0003-4129-5784; Athan, Eugene/0000-0001-9838-6471; Fernandez-Hidalgo, Nuria/0000-0002-2115-344X; Durante-Mangoni, Emanuele/0000-0002-5381-3537; Wang, Andrew/0000-0001-8729-0933; solis, jorge/0000-0002-4227-7062; Gordon, David/0000-0003-3276-9685; Kanj, Souha/0000-0001-6413-3396; Samad, Zainab/0000-0003-2422-3199; Moreno Camacho, Asuncion/0000-0002-5850-5007; Israel, Sarah/0000-0001-5646-0071; Rizk, Hussien/0000-0001-5791-2359; ALAUZET, Corentine/0000-0001-7953-4870; Stryjewski, Martin/0000-0002-4986-6564; Falces, Carlos/0000-0002-3483-3786	American Heart Association; Cubist; Novartis; Fondo de Investigaciones Sanitarias (FIS, Spanish Ministry of Health); National Institutes of Health; RIS-III (Spanish Network for AIDS Research); Pfizer; MSD; Astellas; Merck; Theravance; Cerexa; Advanced Liquid Logic; MedImmune; Gilead Sciences; Edwards Lifesciences; Abbott Vascular; Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Madrid, Spain; Spanish Network for Research in Infectious Diseases [REIPI RD06/0008]; Instituto de Salud Carlos III, Madrid, Spain [INT10/219]; Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain	American Heart Association(American Heart Association); Cubist; Novartis(Novartis); Fondo de Investigaciones Sanitarias (FIS, Spanish Ministry of Health)(Instituto de Salud Carlos IIISpanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RIS-III (Spanish Network for AIDS Research); Pfizer(Pfizer); MSD; Astellas(Astellas Pharmaceuticals); Merck(Merck & Company); Theravance; Cerexa; Advanced Liquid Logic; MedImmune(AstraZenecaMedimmune); Gilead Sciences(Gilead Sciences); Edwards Lifesciences; Abbott Vascular(Abbott Laboratories); Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Spanish Network for Research in Infectious Diseases; Instituto de Salud Carlos III, Madrid, Spain(Instituto de Salud Carlos III); Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain(Generalitat de Catalunya)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Chu reported receiving a career development award from the American Heart Association. Dr Tattevin reported receiving travel support to attend a meeting from Novartis. Dr Miro reported serving on the advisory boards of Cubist and Novartis; serving as a consultant for Abbott, Bristol-Myers Squibb, Cubist, Gilead Sciences, Merck, Novartis, Pfizer, and Theravance; receiving grants or grants pending from Cubist, Novartis, Fondo de Investigaciones Sanitarias (FIS, Spanish Ministry of Health), the National Institutes of Health, and RIS-III (Spanish Network for AIDS Research); and receiving payment for lectures from Abbott, Boehringer-Ingelheim, Bristol-Myers Squibb, Cubist, GlaxoSmithKline, Gilead Sciences, Janssen-Cilag, MSD, Novartis, Pfizer, Roche, Schering-Plough, Theravance, and ViiV. Dr Durante-Mangoni reported receiving payment for lectures from Novartis. Dr Hannan reported receiving an educational travel grant from Pfizer and receiving travel grants to attend international meetings from Pfizer and MSD. Dr Fowler reported serving as a consultant for Astellas, Cubist, Merck, Johnson & Johnson, Galderma, NovaDigm, The Medicines Company, Biosynexus, MedImmune, Novartis, and Pfizer; receiving grants or grants pending from the National Institutes of Health, Astellas, Cubist, Merck, Theravance, Cerexa, Pfizer, Novartis, Advanced Liquid Logic, and MedImmune; holding a patent (planned, pending, or issued) for a diagnostic approach; receiving royalties from UpToDate; and receiving honoraria for development of educational presentations from Arpida, Astellas, Cubist, Inhibitex, Merck, Pfizer, Targanta, Theravance, Wyeth, Ortho-McNeil, Novartis, Vertex Pharmaceuticals, and MedImmune. Dr Wang reported providing expert testimony for trial defense; receiving grants or grants pending from Gilead Sciences, Edwards Lifesciences, and Abbott Vascular; receiving payment for lectures from American Physician; receiving royalties for serving as an editor from Springer; and receiving payment for development of educational presentations from the American College of Cardiology Foundation. No other authors reported disclosures. None of the investigators received compensation for participation in ICE-PCS.; This work was supported in part by grants from the Ministerio de Sanidad y Consumo, Instituto de Salud Carlos III, Madrid, Spain, and the Spanish Network for Research in Infectious Diseases (REIPI RD06/0008). Dr Miro holds an INT10/219 Intensification Research Grant (I3SNS & PRICS programs) from the Instituto de Salud Carlos III, Madrid, Spain, and the Departament de Salut de la Generalitat de Catalunya, Barcelona, Spain.	ARBER N, 1994, MEDICINE, V73, P299, DOI 10.1097/00005792-199411000-00003; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Baman TS, 2009, CIRC-ARRHYTHMIA ELEC, V2, P129, DOI 10.1161/CIRCEP.108.816868; Benito N, 2009, ANN INTERN MED, V150, P586, DOI 10.7326/0003-4819-150-9-200905050-00004; Cabell CH, 2004, AM HEART J, V147, P582, DOI 10.1016/j.ahj.2003.06.005; Cabell CH, 2002, ARCH INTERN MED, V162, P90, DOI 10.1001/archinte.162.1.90; Cabell CH, 2002, INFECT DIS CLIN N AM, V16, P255, DOI 10.1016/S0891-5520(01)00007-1; Cacoub P, 1998, AM J CARDIOL, V82, P480, DOI 10.1016/S0002-9149(98)00365-8; Chamis AL, 2001, CIRCULATION, V104, P1029, DOI 10.1161/hc3401.095097; Chua JD, 2000, ANN INTERN MED, V133, P604, DOI 10.7326/0003-4819-133-8-200010170-00011; Da Costa A, 1998, CIRCULATION, V97, P1791, DOI 10.1161/01.CIR.97.18.1791; Da Costa A, 1998, CIRCULATION, V97, P1796, DOI 10.1161/01.CIR.97.18.1796; DANIEL WG, 1991, NEW ENGL J MED, V324, P795, DOI 10.1056/NEJM199103213241203; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Duval X, 2004, CLIN INFECT DIS, V39, P68, DOI 10.1086/421493; Ferguson TB, 1996, J THORAC CARDIOV SUR, V111, P742, DOI 10.1016/S0022-5223(96)70334-3; Fowler VG, 2005, JAMA-J AM MED ASSOC, V293, P3012, DOI 10.1001/jama.293.24.3012; Friedman ND, 2002, ANN INTERN MED, V137, P791, DOI 10.7326/0003-4819-137-10-200211190-00007; Greenspon AJ, 2012, J AM COLL CARDIOL, V59, P681, DOI 10.1016/j.jacc.2011.11.011; Greenspon AJ, 2011, J AM COLL CARDIOL, V58, P1001, DOI 10.1016/j.jacc.2011.04.033; Jarcho JA, 2006, NEW ENGL J MED, V355, P288, DOI 10.1056/NEJMct055185; Klug D, 1997, CIRCULATION, V95, P2098, DOI 10.1161/01.CIR.95.8.2098; Klug D, 2007, CIRCULATION, V116, P1349, DOI 10.1161/CIRCULATIONAHA.106.678664; Le KY, 2011, PACE, V34, P450, DOI 10.1111/j.1540-8159.2010.02991.x; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Massoure PL, 2007, PACE, V30, P12; Murdoch DR, 2009, ARCH INTERN MED, V169, P463, DOI 10.1001/archinternmed.2008.603; Sohail MR, 2008, MAYO CLIN PROC, V83, P46, DOI 10.4065/83.1.46; Sohail MR, 2007, J AM COLL CARDIOL, V49, P1851, DOI 10.1016/j.jacc.2007.01.072; Uslan DZ, 2007, ARCH INTERN MED, V167, P669, DOI 10.1001/archinte.167.7.669; Wang A, 2007, JAMA-J AM MED ASSOC, V297, P1354, DOI 10.1001/jama.297.12.1354	31	185	187	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1727	1735		10.1001/jama.2012.497	http://dx.doi.org/10.1001/jama.2012.497			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930OA	22535857	Green Published			2022-12-24	WOS:000303147500026
J	Etminan, M; Forooghian, F; Brophy, JM; Bird, ST; Maberley, D				Etminan, Mahyar; Forooghian, Farzin; Brophy, James M.; Bird, Steven T.; Maberley, David			Oral Fluoroquinolones and the Risk of Retinal Detachment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TENDON-RUPTURE; OLDER-ADULTS; CIPROFLOXACIN; TENDINOPATHY; GATIFLOXACIN; COLLAGEN; THERAPY	Context Fluoroquinolones are commonly prescribed classes of antibiotics. Despite numerous case reports of ocular toxicity, a pharmacoepidemiological study of their ocular safety, particularly retinal detachment, has not been performed. Objective To examine the association between use of oral fluoroquinolones and the risk of developing a retinal detachment. Design, Setting, and Patients Nested case-control study of a cohort of patients in British Columbia, Canada, who had visited an ophthalmologist between January 2000 and December 2007. Retinal detachment cases were defined as a procedure code for retinal repair surgery within 14 days of a physician service code. Ten controls were selected for each case using risk-set sampling, matching on age and the month and year of cohort entry. Main Outcome Measure The association between retinal detachment and current, recent, or past use of an oral fluoroquinolone. Results From a cohort of 989 591 patients, 4384 cases of retinal detachment and 43 840 controls were identified. Current use of fluoroquinolones was associated with a higher risk of developing a retinal detachment (3.3% of cases vs 0.6% of controls; adjusted rate ratio [ARR], 4.50 [95% CI, 3.56-5.70]). Neither recent use (0.3% of cases vs 0.2% of controls; ARR, 0.92 [95% CI, 0.45-1.87]) nor past use (6.6% of cases vs 6.1% of controls; ARR, 1.03 [95% CI, 0.89-1.19]) was associated with a retinal detachment. The absolute increase in the risk of a retinal detachment was 4 per 10 000 person-years (number needed to harm=2500 computed for any use of fluoroquinolones). There was no evidence of an association between development of a retinal detachment and beta-lactam antibiotics (ARR, 0.74 [95% CI, 0.35-1.57]) or short-acting beta-agonists (ARR, 0.95 [95% CI, 0.68-1.33]). Conclusion Patients taking oral fluoroquinolones were at a higher risk of developing a retinal detachment compared with nonusers, although the absolute risk for this condition was small. JAMA. 2012;307(13):1414-1419	[Etminan, Mahyar] Child & Family Res Inst British Columbia, Therapeut Evaluat Unit, Vancouver, BC, Canada; [Etminan, Mahyar] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Forooghian, Farzin; Maberley, David] Univ British Columbia, Dept Ophthalmol & Visual Sci, Vancouver, BC V5Z 1M9, Canada; [Brophy, James M.] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Brophy, James M.] McGill Univ, Dept Biostat, Montreal, PQ, Canada; [Brophy, James M.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Bird, Steven T.] US FDA, Ctr Drug Evaluat & Res Off Management, Silver Spring, MD USA; [Bird, Steven T.] Acad Collaborat Program, Silver Spring, MD USA	Child & Family Research Institute; University of British Columbia; University of British Columbia; McGill University; McGill University; McGill University; US Food & Drug Administration (FDA)	Etminan, M (corresponding author), 950 W 28th Ave,Room A4-195, Vancouver, BC V5Z 1L8, Canada.	metminan@popi.ubc.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875	Canadian National Institute for the Blind	Canadian National Institute for the Blind	The study was funded by the Canadian National Institute for the Blind.	Al-Amri AM, 2008, CORNEA, V27, P370, DOI 10.1097/ICO.0b013e31815dcfc4; British Columbia Ministry of Health, PHARMANET; Falagas ME, 2007, INT J ANTIMICROB AG, V29, P374, DOI 10.1016/j.ijantimicag.2006.11.011; Harrell RM, 1999, SOUTHERN MED J, V92, P622, DOI 10.1097/00007611-199906000-00014; Health Canada, 1999, 126410 HLTH CAN; Huybrechts KF, 2011, CAN MED ASSOC J, V183, pE411, DOI 10.1503/cmaj.101406; KEREN G, 1991, INVEST OPHTH VIS SCI, V32, P2388; Khaliq Y, 2003, CLIN INFECT DIS, V36, P1404, DOI 10.1086/375078; Leone R, 2003, DRUG SAFETY, V26, P109, DOI 10.2165/00002018-200326020-00004; Ministry of Health, MED SERV PLAN BRIT C; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Ponsioen TL, 2008, INVEST OPHTH VIS SCI, V49, P4089, DOI 10.1167/iovs.07-1456; Population Data British Columbia, DISCH ABSTR DAT; Rampal S, 2008, HUM EXP TOXICOL, V27, P409, DOI 10.1177/0960327108092295; Reviglio Victor E, 2003, BMC Ophthalmol, V3, P10, DOI 10.1186/1471-2415-3-10; RODRIGUES L, 1990, INT J EPIDEMIOL, V19, P205, DOI 10.1093/ije/19.1.205; Samarakoon N, 2007, CLIN EXP OPHTHALMOL, V35, P102, DOI 10.1111/j.1442-9071.2007.01427.x; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sharma T, 2002, RETINA-J RET VIT DIS, V22, P423, DOI 10.1097/00006982-200208000-00005; SIRBAT D, 1983, J FR OPHTALMOL, V6, P829; Sodhi A, 2008, SURV OPHTHALMOL, V53, P50, DOI 10.1016/j.survophthal.2007.10.007; Solomon DH, 2011, JAMA-J AM MED ASSOC, V305, P2525, DOI 10.1001/jama.2011.878; SZARFMAN A, 1995, NEW ENGL J MED, V332, P193; Tsai WC, 2011, J ORTHOP RES, V29, P67, DOI 10.1002/jor.21196; US Department of Health and Human Services; US Food and Drug Administration, 21158S018 NDA US DEP; van der Linden PD, 2003, ARCH INTERN MED, V163, P1801, DOI 10.1001/archinte.163.15.1801; van der Linden PD, 2002, BRIT MED J, V324, P1306, DOI 10.1136/bmj.324.7349.1306; Williams JI, 1996, INVENTORY STUDIES AC; Williams RJ, 2000, AM J SPORT MED, V28, P364, DOI 10.1177/03635465000280031401	30	123	125	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1414	1419		10.1001/jama.2012.383	http://dx.doi.org/10.1001/jama.2012.383			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474205	Bronze			2022-12-24	WOS:000302294200028
J	McCloskey, A; Taniguchi, I; Shinmyozu, K; Ohno, M				McCloskey, Asako; Taniguchi, Ichiro; Shinmyozu, Kaori; Ohno, Mutsuhito			hnRNP C Tetramer Measures RNA Length to Classify RNA Polymerase II Transcripts for Export	SCIENCE			English	Article							NUCLEAR RIBONUCLEOPROTEIN-PARTICLES; CAP-BINDING COMPLEX; PRE-MESSENGER-RNA; PROTEINS	Specific RNA recognition is usually achieved by specific RNA sequences and/or structures. However, we show here a mechanism by which RNA polymerase II (Pol II) transcripts are classified according to their length. The heterotetramer of the heterogeneous nuclear ribonucleoprotein (hnRNP) C1/C2 measures the length of the transcripts like a molecular ruler, by selectively binding to the unstructured RNA regions longer than 200 to 300 nucleotides. Thus, the tetramer sorts the transcripts into two RNA categories, to be exported as either messenger RNA or uridine-rich small nuclear RNA (U snRNA), depending on whether or not they are longer than the threshold, respectively. Our findings reveal a new function of the C tetramer and highlight the biological importance of RNA recognition by the length.	[McCloskey, Asako; Taniguchi, Ichiro; Ohno, Mutsuhito] Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan; [Shinmyozu, Kaori] RIKEN Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	Kyoto University; RIKEN	Ohno, M (corresponding author), Kyoto Univ, Inst Virus Res, Kyoto 6068507, Japan.	hitoohno@virus.kyoto-u.ac.jp		taniguchi, ichiro/0000-0002-9364-2680	Ministry of Education, Culture, Sports, Science and Technology of Japan [20112007]; Grants-in-Aid for Scientific Research [20112001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank the members of our laboratory, especially M. Kitabatake and H. Kiriu, for useful suggestions and unpublished materials. We also thank M. Yoshida, H. Miyoshi, and T. Tani for providing us with spliceostatin A (SSA) and the p27 plasmid, the lentiviral transduction system, and pCDNA3.1GST-NES-NLS-GFP, respectively. This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas "RNA regulation" (20112007) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. A.M. and I.T. performed the experiments, except the mass spectrometric analyses, which were performed by K.S. I.T. initiated the in vitro system. M.O. obtained the funding, designed some experiments, and wrote the manuscript.	BARNETT SF, 1989, MOL CELL BIOL, V9, P492, DOI 10.1128/MCB.9.2.492; BEYER AL, 1977, CELL, V11, P127, DOI 10.1016/0092-8674(77)90323-3; Carmody SR, 2009, J CELL SCI, V122, P1933, DOI 10.1242/jcs.041236; Cheng H, 2006, CELL, V127, P1389, DOI 10.1016/j.cell.2006.10.044; Fuke H, 2008, NUCLEIC ACIDS RES, V36, P1037, DOI 10.1093/nar/gkm1120; HUANG M, 1994, MOL CELL BIOL, V14, P518, DOI 10.1128/MCB.14.1.518; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Masuyama K, 2004, GENE DEV, V18, P2074, DOI 10.1101/gad.1216204; McAfee JG, 1996, BIOCHEMISTRY-US, V35, P1212, DOI 10.1021/bi951974k; Nakielny S, 1996, J CELL BIOL, V134, P1365, DOI 10.1083/jcb.134.6.1365; Nojima T, 2007, J BIOL CHEM, V282, P15645, DOI 10.1074/jbc.M700629200; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Ohno M, 2002, MOL CELL, V9, P659, DOI 10.1016/S1097-2765(02)00454-9; Pawlicki JM, 2010, TRENDS CELL BIOL, V20, P52, DOI 10.1016/j.tcb.2009.10.004; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5	16	111	115	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1643	1646		10.1126/science.1218469	http://dx.doi.org/10.1126/science.1218469			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461616				2022-12-24	WOS:000302062600050
J	Pateman, RM; Hill, JK; Roy, DB; Fox, R; Thomas, CD				Pateman, Rachel M.; Hill, Jane K.; Roy, David B.; Fox, Richard; Thomas, Chris D.			Temperature-Dependent Alterations in Host Use Drive Rapid Range Expansion in a Butterfly	SCIENCE			English	Article							CLIMATE-CHANGE; BIOTIC INTERACTIONS; RESPONSES; DISTRIBUTIONS; MODELS; SHIFTS	Responses of species to climate change are extremely variable, perhaps because of climate-related changes to interactions among species. We show that temperature-related changes in the dependence of the butterfly Aricia agestis on different larval host plants have facilitated rapid range expansion. Historically, the butterfly was largely restricted to a single plant species, Helianthemum nummularium, but recent warmer conditions have enabled the butterfly to increasingly use the more widespread plant species Geranium molle. This has resulted in a substantial increase in available habitat and rapid range expansion by the butterfly (79 kilometers northward in Britain in 20 years). Interactions among species are often seen as constraints on species' responses to climate change, but we show that temperature-dependent changes to interspecific interactions can also facilitate change.	[Pateman, Rachel M.; Hill, Jane K.; Thomas, Chris D.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Pateman, Rachel M.; Roy, David B.] NERC, Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England; [Fox, Richard] Butterfly Conservat, Manor Yard, Wareham BH20 5QP, Dorset, England	University of York - UK; UK Centre for Ecology & Hydrology (UKCEH); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC)	Pateman, RM (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	rmp502@york.ac.uk; jane.hill@york.ac.uk; chris.thomas@york.ac.uk	Hill, Jane K./AAJ-3374-2021; Thomas, Chris D/A-1894-2012; Thomas, Chris D/A-1460-2014; Roy, David/A-6619-2009	Hill, Jane K./0000-0003-1871-7715; Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334; Roy, David/0000-0002-5147-0331; Fox, Richard/0000-0001-6992-3522; Pateman, Rachel/0000-0002-2260-170X	NERC Ecology and Hydrology Funding Initiative [NE/E012035]; Natural Environment Research Council [NE/E012035/1, NE/F018606/1, CEH010021] Funding Source: researchfish; NERC [NE/E012035/1, NE/F018606/1] Funding Source: UKRI	NERC Ecology and Hydrology Funding Initiative; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Work was funded through NERC Ecology and Hydrology Funding Initiative grant NE/E012035. Butterfly distribution data were derived from a database of records submitted by volunteers (www.butterfly-conservation.org/text/64/butterfly_distribution.html), and densities were derived from UK Butterfly Monitoring Scheme data (www.ukbms.org/obtaining.htm). Both schemes are operated by Butterfly Conservation and the Centre for Ecology & Hydrology and funded by a consortium of government agencies. Plant data were derived from a database of volunteer records managed by the Botanical Society for the British Isles (www.bsbi.org.uk/research.html). We are grateful to the volunteers who collected the original butterfly and plant data. Temperature data were derived from the Central England Temperature (CET) data set (www.metoffice.gov.uk/hadobs). Digital Elevation Models were provided by the NERC Earth Observation Data Centre (www.neodc.rl.ac.uk/browse/neodc/nextmap). Original data collected by authors is presented in the supplementary materials.	Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Asher J, 2001, MILLENNIUM ATLAS BUT; BOURN NAD, 1993, BIOL CONSERV, V63, P67, DOI 10.1016/0006-3207(93)90075-C; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Davis AJ, 1998, J ANIM ECOL, V67, P600, DOI 10.1046/j.1365-2656.1998.00223.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Grime JP., 2014, COMP PLANT ECOLOGY F; Heath J., 1984, ATLAS BUTTERFLIES BR; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill JK, 2001, ECOL LETT, V4, P313, DOI 10.1046/j.1461-0248.2001.00222.x; HUTCHINS RB, 1976, SOIL SCI, V121, P234, DOI 10.1097/00010694-197604000-00008; LAKHANI KH, 1982, J APPL ECOL, V19, P621, DOI 10.2307/2403494; Menendez R, 2008, ECOL ENTOMOL, V33, P413, DOI 10.1111/j.1365-2311.2008.00985.x; PARK T, 1954, PHYSIOL ZOOL, V27, P177, DOI 10.1086/physzool.27.3.30152164; POLLARD E, 1994, MONITORING BUTTERFLI; PROCTOR MCF, 1956, J ECOL, V44, P675, DOI 10.2307/2256855; Schweiger O, 2008, ECOLOGY, V89, P3472, DOI 10.1890/07-1748.1; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Tolman T., 1997, COLLINS FIELD GUIDE; Van der Putten WH, 2010, PHILOS T R SOC B, V365, P2025, DOI 10.1098/rstb.2010.0037; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054	21	116	118	2	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					1028	1030		10.1126/science.1216980	http://dx.doi.org/10.1126/science.1216980			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628653				2022-12-24	WOS:000304406800043
J	Davies, MJ; Moore, VM; Willson, KJ; Van Essen, P; Priest, K; Scott, H; Haan, EA; Chan, A				Davies, Michael J.; Moore, Vivienne M.; Willson, Kristyn J.; Van Essen, Phillipa; Priest, Kevin; Scott, Heather; Haan, Eric A.; Chan, Annabelle			Reproductive Technologies and the Risk of Birth Defects	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; INTRACYTOPLASMIC SPERM INJECTION; CHILDREN BORN; SAFETY ISSUES; CONGENITAL-MALFORMATIONS; IVF-METHODS; HEALTH; INFANTS; METAANALYSIS; FERTILITY	Background The extent to which birth defects after infertility treatment may be explained by underlying parental factors is uncertain. Methods We linked a census of treatment with assisted reproductive technology in South Australia to a registry of births and terminations with a gestation period of at least 20 weeks or a birth weight of at least 400 g and registries of birth defects (including cerebral palsy and terminations for defects at any gestational period). We compared risks of birth defects (diagnosed before a child's fifth birthday) among pregnancies in women who received treatment with assisted reproductive technology, spontaneous pregnancies (i.e., without assisted conception) in women who had a previous birth with assisted conception, pregnancies in women with a record of infertility but no treatment with assisted reproductive technology, and pregnancies in women with no record of infertility. Results Of the 308,974 births, 6163 resulted from assisted conception. The unadjusted odds ratio for any birth defect in pregnancies involving assisted conception (513 defects, 8.3%) as compared with pregnancies not involving assisted conception (17,546 defects, 5.8%) was 1.47 (95% confidence interval [CI], 1.33 to 1.62); the multivariate-adjusted odds ratio was 1.28 (95% CI, 1.16 to 1.41). The corresponding odds ratios with in vitro fertilization (IVF) (165 birth defects, 7.2%) were 1.26 ( 95% CI, 1.07 to 1.48) and 1.07 (95% CI, 0.90 to 1.26), and the odds ratios with intracytoplasmic sperm injection (ICSI) (139 defects, 9.9%) were 1.77 (95% CI, 1.47 to 2.12) and 1.57 (95% CI, 1.30 to 1.90). A history of infertility, either with or without assisted conception, was also significantly associated with birth defects. Conclusions The increased risk of birth defects associated with IVF was no longer significant after adjustment for parental factors. The risk of birth defects associated with ICSI remained increased after multivariate adjustment, although the possibility of residual confounding cannot be excluded.	[Davies, Michael J.] Univ Adelaide, Med Sch S, Robinson Inst, Adelaide, SA 5005, Australia; [Davies, Michael J.; Moore, Vivienne M.; Willson, Kristyn J.] Univ Adelaide, Res Ctr Early Origins Hlth & Dis, Adelaide, SA, Australia; [Moore, Vivienne M.; Willson, Kristyn J.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Davies, Michael J.; Haan, Eric A.] Univ Adelaide, Discipline Paediat & Reprod Hlth, Adelaide, SA, Australia; [Priest, Kevin; Chan, Annabelle] S Australian Dept Hlth, Epidemiol Branch, Adelaide, SA, Australia; [Haan, Eric A.] SA Pathol, S Australian Clin Genet Serv, Adelaide, SA, Australia; [Van Essen, Phillipa; Scott, Heather; Haan, Eric A.; Chan, Annabelle] Womens & Childrens Hosp, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide; University of Adelaide; University of Adelaide; SA Pathology; Womens & Childrens Hospital Australia	Davies, MJ (corresponding author), Univ Adelaide, Med Sch S, Robinson Inst, Frome Rd, Adelaide, SA 5005, Australia.	michael.davies@adelaide.edu.au	Davies, Michael/GWV-2527-2022; Davies, Michael John/Y-3542-2018	Davies, Michael John/0000-0003-1526-0801	National Health and Medical Research Council [349475, 349548, 453556, 465455]; Australian Research Council [FT100101018]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	Funded by the National Health and Medical Research Council and the Australian Research Council.; Supported by grants from the National Health and Medical Research Council (349475, 349548, 453556, and 465455) and the Australian Research Council (FT100101018).	Australian Bureau of Statistics, 2006, CENS POP HOUS SOC IN; Australian Standard Classification of Occupations (ASCO), 1990, AUSTR STAND CLASS OC; Bonduelle M, 2005, HUM REPROD, V20, P413, DOI 10.1093/humrep/deh592; CZEIZEL A, 1989, LANCET, V2, P167; Davies M, 2002, LANCET, V360, P718, DOI 10.1016/S0140-6736(02)09849-5; El-Chaar D, 2009, FERTIL STERIL, V92, P1557, DOI 10.1016/j.fertnstert.2008.08.080; Elizur SE, 2008, FERTIL STERIL, V89, P1595, DOI 10.1016/j.fertnstert.2008.02.092; Ericson A, 2001, HUM REPROD, V16, P504, DOI 10.1093/humrep/16.3.504; Halliday JL, 2010, HUM REPROD, V25, P59, DOI 10.1093/humrep/dep364; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; Hansen M, 2005, HUM REPROD, V20, P328, DOI 10.1093/humrep/deh593; Kallen B, 2005, FERTIL STERIL, V84, P611, DOI 10.1016/j.fertnstert.2005.02.038; Kallen B, 2005, BIRTH DEFECTS RES A, V73, P162, DOI 10.1002/bdra.20107; Kurinczuk JJ, 2004, CURR OPIN OBSTET GYN, V16, P201, DOI 10.1097/00001703-200406000-00002; Kurinczuk JJ, 2003, HUM REPROD, V18, P925, DOI 10.1093/humrep/deg217; Kurinczuk JJ, 1997, BRIT MED J, V315, P1260, DOI 10.1136/bmj.315.7118.1260; Lambert RD, 2003, HUM REPROD, V18, P1987, DOI 10.1093/humrep/deg361; Lambert RD, 2002, HUM REPROD, V17, P3011, DOI 10.1093/humrep/17.12.3011; Lidegaard O, 2006, CURR OPIN OBSTET GYN, V18, P293; Lie RT, 2005, INT J EPIDEMIOL, V34, P696, DOI 10.1093/ije/dyh363; Marino JL, 2011, HUM REPROD, V26, P473, DOI 10.1093/humrep/deq305; National Health and Medical Research Council, 2007, ETH GUID US ASS REPR; Pinborg A, 2010, FERTIL STERIL, V94, P1320, DOI 10.1016/j.fertnstert.2009.05.091; Reefhuis J, 2009, HUM REPROD, V24, P360, DOI 10.1093/humrep/den387; Reefhuis J, 2011, HUM REPROD, V26, P451, DOI 10.1093/humrep/deq313; Rimm AA, 2004, J ASSIST REPROD GEN, V21, P437, DOI 10.1007/s10815-004-8760-8; Schieve LA, 2005, FERTIL STERIL, V84, P1320, DOI 10.1016/j.fertnstert.2005.04.066; Schieve LA, 2004, OBSTET GYNECOL, V103, P1154, DOI 10.1097/01.AOG.0000124571.04890.67; Stromberg B, 2002, LANCET, V359, P461, DOI 10.1016/S0140-6736(02)07674-2; Wennerholm UB, 2009, HUM REPROD, V24, P2158, DOI 10.1093/humrep/dep125; Westergaard HB, 1999, HUM REPROD, V14, P1896, DOI 10.1093/humrep/14.7.1896; Yang Q, 2007, HUM REPROD, V22, P696, DOI 10.1093/humrep/del453; Zhu JL, 2006, BMJ-BRIT MED J, V333, P679, DOI 10.1136/bmj.38919.495718.AE	33	524	555	14	125	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1803	1813		10.1056/NEJMoa1008095	http://dx.doi.org/10.1056/NEJMoa1008095			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NB	22559061	Bronze			2022-12-24	WOS:000303817000009
J	Chen, HT; Xu, Z; Mei, C; Yu, DY; Small, S				Chen, Hongtao; Xu, Zhe; Mei, Constance; Yu, Danyang; Small, Stephen			A System of Repressor Gradients Spatially Organizes the Boundaries of Bicoid-Dependent Target Genes	CELL			English	Article							EARLY DROSOPHILA EMBRYO; DPP MORPHOGEN GRADIENT; 2 DISTINCT MECHANISMS; POSITIONAL INFORMATION; NEURAL-TUBE; EXPRESSION; SEGMENTATION; PROTEIN; PATTERN; DETERMINES	The homeodomain (HD) protein Bicoid (Bcd) is thought to function as a gradient morphogen that positions boundaries of target genes via threshold-dependent activation mechanisms. Here, we analyze 66 Bcd-dependent regulatory elements and show that their boundaries are positioned primarily by repressive gradients that antagonize Bcd-mediated activation. A major repressor is the pair-rule protein Runt (Run), which is expressed in an opposing gradient and is necessary and sufficient for limiting Bcd-dependent activation. Evidence is presented that Run functions with the maternal repressor Capicua and the gap protein Kruppel as the principal components of a repression system that correctly orders boundaries throughout the anterior half of the embryo. These results put conceptual limits on the Bcd morphogen hypothesis and demonstrate how the Bcd gradient functions within the gene network that patterns the embryo.	[Chen, Hongtao; Xu, Zhe; Mei, Constance; Yu, Danyang; Small, Stephen] NYU, Dept Biol, New York, NY 10003 USA	New York University	Small, S (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.	sjs1@nyu.edu			NIH [RO1 GM51946]; National Center for Research Resources, National Institutes of Health [C06 RR-15518-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051946] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jerry Huang for assistance with computer searches for clusters of Bcd-binding motifs, Hsiao-lan Liang for run expression data, and Peter Gergen, Stas Shvartsman, Jack Bateman, and Gary Struhl for fly stocks. We thank Claude Desplan, Justin Blau, Jens Rister, and Rhea Datta for suggestions that improved the manuscript; Thomas Gregor, Eric Wieschaus, Jim Jaynes, and Christine Rushlow for insightful discussions; and Kristin Gunsalus for help with the graphical abstract. This work was supported by NIH Grant RO1 GM51946 to S. S., and was conducted in a facility constructed with support from Research Facilities Improvement Grant C06 RR-15518-01 from the National Center for Research Resources, National Institutes of Health.	Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Ajuria L, 2011, DEVELOPMENT, V138, P915, DOI 10.1242/dev.057729; Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; Allen BL, 2011, DEV CELL, V20, P775, DOI 10.1016/j.devcel.2011.04.018; Andrioli LP, 2004, DEV BIOL, V276, P541, DOI 10.1016/j.ydbio.2004.09.025; Bailey TL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-179; Balaskas N, 2012, CELL, V148, P273, DOI 10.1016/j.cell.2011.10.047; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; Furriols M, 2003, EMBO J, V22, P1947, DOI 10.1093/emboj/cdg224; Gao Q, 1996, MECH DEVELOP, V56, P3, DOI 10.1016/0925-4773(96)00504-7; Gao Q, 1998, DEVELOPMENT, V125, P4185; GERGEN JP, 1988, GENE DEV, V2, P1179, DOI 10.1101/gad.2.9.1179; GERGEN JP, 1985, DEV BIOL, V109, P321, DOI 10.1016/0012-1606(85)90459-2; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Gurdon JB, 1998, CELL, V95, P159, DOI 10.1016/S0092-8674(00)81747-X; HOCH M, 1990, EMBO J, V9, P2587, DOI 10.1002/j.1460-2075.1990.tb07440.x; Hong JW, 2008, P NATL ACAD SCI USA, V105, P20072, DOI 10.1073/pnas.0806476105; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1; Jeong JH, 2005, DEVELOPMENT, V132, P143, DOI 10.1242/dev.01566; JIANG J, 1993, CELL, V72, P741, DOI 10.1016/0092-8674(93)90402-C; Jimenez G, 2000, GENE DEV, V14, P224; Kim Y, 2011, DEV CELL, V20, P880, DOI 10.1016/j.devcel.2011.05.009; Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247; Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184; LAWRENCE PA, 1987, NATURE, V328, P440, DOI 10.1038/328440a0; Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0; Li XY, 2008, PLOS BIOL, V6, P365, DOI 10.1371/journal.pbio.0060027; Liang HL, 2008, NATURE, V456, P400, DOI 10.1038/nature07388; Lifanov AP, 2003, GENOME RES, V13, P579, DOI 10.1101/gr.668403; Little SC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000596; Lohr U, 2009, P NATL ACAD SCI USA, V106, P21695, DOI 10.1073/pnas.0910225106; MELNIKOVA IN, 1993, J VIROL, V67, P2408, DOI 10.1128/JVI.67.4.2408-2411.1993; Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451; Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1; Namba R, 1997, DEVELOPMENT, V124, P1393; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; Noyes MB, 2008, NUCLEIC ACIDS RES, V36, P2547, DOI 10.1093/nar/gkn048; Ochoa-Espinosa A, 2005, P NATL ACAD SCI USA, V102, P4960, DOI 10.1073/pnas.0500373102; Ochoa-Espinosa A, 2009, P NATL ACAD SCI USA, V106, P3823, DOI 10.1073/pnas.0807878105; Robin S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-84; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; RONCHI E, 1993, CELL, V74, P347, DOI 10.1016/0092-8674(93)90425-P; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; Segal E, 2008, NATURE, V451, P535, DOI 10.1038/nature06496; Sinha S, 2006, NUCLEIC ACIDS RES, V34, pW555, DOI 10.1093/nar/gkl224; Small S, 2000, METHOD ENZYMOL, V326, P146; SMALL S, 1991, GENE DEV, V5, P827, DOI 10.1101/gad.5.5.827; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Struffi P, 2011, DEVELOPMENT, V138, P4291, DOI 10.1242/dev.065987; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; TSAI CC, 1994, DEVELOPMENT, V120, P1671; Tseng ASK, 2007, CURR BIOL, V17, P728, DOI 10.1016/j.cub.2007.03.023; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wolpert L, 1996, TRENDS GENET, V12, P359, DOI 10.1016/S0168-9525(96)80019-9; Wu XL, 1998, DEVELOPMENT, V125, P3765; Yu D, 2008, CURR BIOL, V18, P868, DOI 10.1016/j.cub.2008.05.050	62	104	105	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					618	629		10.1016/j.cell.2012.03.018	http://dx.doi.org/10.1016/j.cell.2012.03.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541432	Bronze, Green Accepted			2022-12-24	WOS:000303443100013
J	Shetty, P				Shetty, Priya			The numbers game	NATURE			English	Editorial Material																			0	23	23	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S14	S14		10.1038/484S14a	http://dx.doi.org/10.1038/484S14a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22534525	Bronze			2022-12-24	WOS:000303200400064
J	Vanin, S; Bhutani, S; Montelli, S; Menegazzi, P; Green, EW; Pegoraro, M; Sandrelli, F; Costa, R; Kyriacou, CP				Vanin, Stefano; Bhutani, Supriya; Montelli, Stefano; Menegazzi, Pamela; Green, Edward W.; Pegoraro, Mirko; Sandrelli, Federica; Costa, Rodolfo; Kyriacou, Charalambos P.			Unexpected features of Drosophila circadian behavioural rhythms under natural conditions	NATURE			English	Article							ENDOGENOUS CLOCK; TEMPERATURE; LIGHT; MELANOGASTER; NEURONS; ENTRAINMENT; OSCILLATORS; MOONLIGHT; FAVORS; ALLELE	Circadian clocks have evolved to synchronize physiology, metabolism and behaviour to the 24-h geophysical cycles of the Earth(1). Drosophila melanogaster's rhythmic locomotor behaviour provides the main phenotype for the identification of higher eukaryotic clock genes(2,3). Under laboratory light-dark cycles, flies show enhanced activity before lights on and off signals(4,5), and these anticipatory responses have defined the neuronal sites of the corresponding morning (M) and evening (E) oscillators(6,7). However, the natural environment provides much richer cycling environmental stimuli than the laboratory, so we sought to examine fly locomotor rhythms in the wild. Here we show that several key laboratory-based assumptions about circadian behaviour are not supported by natural observations. These include the anticipation of light transitions, the midday 'siesta', the fly's crepuscular activity, its nocturnal behaviour under moonlight, and the dominance of light stimuli over temperature. We also observe a third major locomotor component in addition to M and E, which we term 'A' (afternoon). Furthermore, we show that these natural rhythm phenotypes can be observed in the laboratory by using realistic temperature and light cycle simulations. Our results suggest that a comprehensive re-examination of circadian behaviour and its molecular readouts under simulated natural conditions will provide a more authentic interpretation of the adaptive significance of this important rhythmic phenotype. Such studies should also help to clarify the underlying molecular and neuroanatomical substrates of the clock under natural protocols.	[Vanin, Stefano; Montelli, Stefano; Menegazzi, Pamela; Pegoraro, Mirko; Sandrelli, Federica; Costa, Rodolfo] Univ Padua, Dept Biol, I-35131 Padua, Italy; [Bhutani, Supriya; Green, Edward W.; Pegoraro, Mirko; Kyriacou, Charalambos P.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Padua; University of Leicester	Costa, R (corresponding author), Univ Padua, Dept Biol, I-35131 Padua, Italy.	rodolfo.costa@unipd.it	Menegazzi, Pamela/AAE-3544-2020; Menegazzi, Pamela/M-7022-2017	Menegazzi, Pamela/0000-0001-5232-1920; Menegazzi, Pamela/0000-0001-5232-1920; Vanin, Stefano/0000-0003-1676-5916; Bhutani, Supriya/0000-0002-0855-2139; SANDRELLI, FEDERICA/0000-0002-5631-7467; Pegoraro, Mirko/0000-0001-9381-5249	European Community [018741]; Biotechnology and Biological Sciences Research Council; National Environmental Research Council; Royal Society; Medical Research Council; Italian Space Agency (DCMC); Ministero dell'Universita e delle Ricerca (MIUR); BBSRC [BB/J005169/1, BB/F008988/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J005169/1, BB/F008988/1] Funding Source: researchfish	European Community(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Italian Space Agency (DCMC)(Agenzia Spaziale Italiana (ASI)); Ministero dell'Universita e delle Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Bastianello for building the natural light simulator, and C. Helfrich-Forster for comments on the manuscript. This work was funded by grants from the European Community (the 6th Framework Project EUCLOCK no. 018741; to R. C. and C. P. K.), the Biotechnology and Biological Sciences Research Council and National Environmental Research Council (to C. P. K.), the Royal Society Wolfson Research Merit Award (to C. P. K.) and a Medical Research Council studentship (to E. W. G.) R. C. also thanks the Italian Space Agency (DCMC grant) and the Ministero dell'Universita e delle Ricerca (MIUR).	Bachleitner W, 2007, P NATL ACAD SCI USA, V104, P3538, DOI 10.1073/pnas.0606870104; Busza A, 2007, J NEUROSCI, V27, P10722, DOI 10.1523/JNEUROSCI.2479-07.2007; Collins BH, 2005, P NATL ACAD SCI USA, V102, P19021, DOI 10.1073/pnas.0505392102; Collins BH, 2004, P NATL ACAD SCI USA, V101, P1945, DOI 10.1073/pnas.0308240100; Currie J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-49; Daan S, 2011, J BIOL RHYTHM, V26, P118, DOI 10.1177/0748730410397645; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dowse H.B., 1987, Journal of Biological Rhythms, V2, P65, DOI 10.1177/074873048700200106; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Gattermann R, 2008, BIOL LETTERS, V4, P253, DOI 10.1098/rsbl.2008.0066; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Hardin PE, 2011, ADV GENET, V74, P141, DOI 10.1016/B978-0-12-387690-4.00005-2; HELFRICH C, 1987, Z NATURFORSCH C, V42, P1335; Helfrich-Forster C, 2001, J INSECT PHYSIOL, V47, P877, DOI 10.1016/S0022-1910(01)00060-9; Kempinger L, 2009, CHRONOBIOL INT, V26, P151, DOI 10.1080/07420520902747124; Low KH, 2008, NEURON, V60, P1054, DOI 10.1016/j.neuron.2008.10.048; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Miyasako Y, 2007, J BIOL RHYTHM, V22, P115, DOI 10.1177/0748730407299344; Nitabach MN, 2006, J NEUROSCI, V26, P479, DOI 10.1523/JNEUROSCI.3915-05.2006; Rieger D, 2007, J BIOL RHYTHM, V22, P387, DOI 10.1177/0748730407306198; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Tanoue S, 2004, CURR BIOL, V14, P638, DOI 10.1016/j.cub.2004.04.009; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; United. States Naval Observatory (USNO) Astronomy Application Department, 2011, RISC SET TWIL DEF; Yoshii T, 2007, J BIOL RHYTHM, V22, P103, DOI 10.1177/0748730406298176; Yoshii T, 2009, J BIOL RHYTHM, V24, P452, DOI 10.1177/0748730409348551; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	30	191	194	0	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 19	2012	484	7394					371	U108		10.1038/nature10991	http://dx.doi.org/10.1038/nature10991			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22495312				2022-12-24	WOS:000302946500032
J	Mohan, M; Herz, HM; Shilatifard, A				Mohan, Man; Herz, Hans-Martin; Shilatifard, Ali			SnapShot: Histone Lysine Methylase Complexes	CELL			English	Editorial Material							MARK		[Mohan, Man; Herz, Hans-Martin; Shilatifard, Ali] Stowers Inst Med Res, Kansas City, MO 64110 USA	Stowers Institute for Medical Research	Mohan, M (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.		Herz, Hans-Martin/N-2594-2018	Herz, Hans-Martin/0000-0003-4780-9176; Mohan, Man/0000-0002-8811-8542	NATIONAL CANCER INSTITUTE [R01CA150265, R01CA089455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069905] Funding Source: NIH RePORTER; NCI NIH HHS [R01CA150265, R01CA89455, R01 CA150265, R01 CA089455] Funding Source: Medline; NIGMS NIH HHS [R01GM069905, R01 GM069905] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Balakrishnan L, 2010, CRIT REV BIOCHEM MOL, V45, P440, DOI 10.3109/10409238.2010.504700; Buratowski S, 2010, COLD SH Q B, V75, P95, DOI 10.1101/sqb.2010.75.036; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Mohan M, 2010, NAT REV CANCER, V10, P720, DOI 10.1038/nrc2915	6	31	31	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					498	U259		10.1016/j.cell.2012.03.025	http://dx.doi.org/10.1016/j.cell.2012.03.025			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500810	Bronze, Green Accepted			2022-12-24	WOS:000302805600025
J	Farrar, J				Farrar, Jeremy			Shift expertise to where it matters	NATURE			English	Editorial Material									Oxford Univ Clin Res Unit, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam		Farrar, J (corresponding author), Oxford Univ Clin Res Unit, Hosp Trop Dis, Wellcome Trust Major Overseas Programme, Ho Chi Minh City, Vietnam.	jfarrar@oucru.org	Farrar, Jeremy J./HGA-7610-2022	Farrar, Jeremy/0000-0002-2700-623X	Wellcome Trust [093724] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	0	0	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 29	2012	483	7391					534	535		10.1038/483534a	http://dx.doi.org/10.1038/483534a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915EF	22460881	Green Published, Bronze			2022-12-24	WOS:000302006100014
J	Shahin, J; Harrison, DA; Rowan, KM				Shahin, Jason; Harrison, David A.; Rowan, Kathryn M.			Relation between volume and outcome for patients with severe sepsis in United Kingdom: retrospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							MIX PROGRAM DATABASE; CARE-NATIONAL-AUDIT; LENGTH-OF-STAY; INTENSIVE-CARE; MECHANICAL VENTILATION; HOSPITAL VOLUME; NORTHERN-IRELAND; HEALTH-CARE; MORTALITY; ORGANIZATION	Objective To evaluate whether a relation exists between volume and outcome for admissions with severe sepsis to adult general critical care units in the United Kingdom. Design Retrospective cohort study using data from a pooled case mix and outcome database. Setting Adult general critical care units participating in the case mix programme. Participants Consecutive admissions to participating units for the years 2008-09 meeting objective, standardised criteria for severe sepsis. Main outcome measures Mortality at ultimate discharge from acute hospital. Results The primary exposure was volume of admissions with severe sepsis per unit per year. A multivariable logistic regression analysis, using generalised estimating equations, was used to assess the association between volume, modelled using fractional polynomials, and ultimate acute hospital mortality while adjusting for potential confounders. No relation was seen between volume and outcome for admissions with severe sepsis to adult, general critical care units in the UK. Subgroup analyses tested for interactions between the effect of volume and acute severity of illness or receipt of mechanical ventilation. No significant interactions were found. Conclusions This study showed no relation between volume and outcome in admissions with severe sepsis treated in adult general critical care units in the UK.	[Shahin, Jason] McGill Univ, Dept Crit Care, Dept Med, Div Resp, Montreal, PQ H3G 1A4, Canada; [Shahin, Jason; Harrison, David A.; Rowan, Kathryn M.] ICNARC, London WC1H 9HR, England	McGill University; Intensive Care National Audit & Research Centre	Shahin, J (corresponding author), McGill Univ, Dept Crit Care, Dept Med, Div Resp, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	Jason.shahin@mcgill.ca	Harrison, David A/O-4355-2018	Harrison, David A/0000-0002-9002-9098; Rowan, Kathryn/0000-0001-8217-5602	Fonds de Recherche du Quebec-Sante	Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This research received no specific funding. JS was funded through a bursary provided by the Fonds de Recherche du Quebec-Sante.	Angus DC, 2004, LANCET, V363, P1314, DOI 10.1016/S0140-6736(04)16007-8; Castellanos-Ortega A, 2010, CRIT CARE MED, V38, P1036, DOI 10.1097/CCM.0b013e3181d455b6; Christian CK, 2005, WORLD J SURG, V29, P1241, DOI 10.1007/s00268-005-7993-8; Goldfrad CK, 2000, J EPIDEMIOL COMMUNIT, V54, P779; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Harrison DA, 2004, CRIT CARE, V8, pR99, DOI 10.1186/cc2834; Harrison DA, 2006, CRIT CARE, V10, DOI 10.1186/cc4854; Harrison DA, 2007, CRIT CARE MED, V35, P1091, DOI 10.1097/01.CCM.0000259468.24532.44; Jones J, 1995, INT J TECHNOL ASSESS, V11, P762, DOI 10.1017/S0266462300009193; Kahn JM, 2008, CRIT CARE MED, V36, P3085, DOI 10.1097/CCM.0b013e31818c37b2; Kahn JM, 2007, CRIT CARE, V11, DOI 10.1186/cc5776; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kahn JM, 2009, HEALTH SERV RES, V44, P862, DOI 10.1111/j.1475-6773.2009.00959.x; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; London Trauma Office, 2010, LOND TRAUM SYST; May Susanne, 2005, Dose-Response, V3, P474, DOI 10.2203/dose-response.003.04.004; Nathens AB, 2001, JAMA-J AM MED ASSOC, V285, P1164, DOI 10.1001/jama.285.9.1164; Needham DM, 2006, CRIT CARE MED, V34, P2349, DOI 10.1097/01.CCM.0000233858.85802.5C; Panageas KS, 2003, ANN INTERN MED, V139, P658, DOI 10.7326/0003-4819-139-8-200310210-00009; Parry G, 2003, BRIT MED J, V326, P280; Peelen L, 2007, CRIT CARE, V11, DOI 10.1186/cc5727; Ramnarayan P, 2010, LANCET, V376, P698, DOI 10.1016/S0140-6736(10)61113-0; Reinikainen M, 2010, INTENS CARE MED, V36, P673, DOI 10.1007/s00134-009-1688-9; Royston P., 2008, MULTIVARIABLE MODEL; The Information Centre, 2010, LIST DAT; Tilford JM, 2000, PEDIATRICS, V106, P289, DOI 10.1542/peds.106.2.289	26	40	40	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 29	2012	344								e3394	10.1136/bmj.e3394	http://dx.doi.org/10.1136/bmj.e3394			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953GT	22645208	hybrid, Green Published			2022-12-24	WOS:000304855700002
J	Ngaki, MN; Louie, GV; Philippe, RN; Manning, G; Pojer, F; Bowman, ME; Li, L; Larsen, E; Wurtele, ES; Noel, JP				Ngaki, Micheline N.; Louie, Gordon V.; Philippe, Ryan N.; Manning, Gerard; Pojer, Florence; Bowman, Marianne E.; Li, Ling; Larsen, Elise; Wurtele, Eve Syrkin; Noel, Joseph P.			Evolution of the chalcone-isomerase fold from fatty-acid binding to stereospecific catalysis	NATURE			English	Article							REACTION-MECHANISM; FUNCTIONAL GENOMICS; DIFFRACTION DATA; ARABIDOPSIS; GENE; IDENTIFICATION; TRANSFORMATION; BIOSYNTHESIS; ALIGNMENT; PROGRAM	Specialized metabolic enzymes biosynthesize chemicals of ecological importance, often sharing a pedigree with primary metabolic enzymes(1). However, the lineage of the enzyme chalcone isomerase (CHI) remained unknown. In vascular plants, CHI-catalysed conversion of chalcones to chiral (S)-flavanones is a committed step in the production of plant flavonoids, compounds that contribute to attraction, defence(2) and development(3). CHI operates near the diffusion limit with stereospecific control(4,5). Although associated primarily with plants, the CHI fold occurs in several other eukaryotic lineages and in some bacteria. Here we report crystal structures, ligand-binding properties and in vivo functional characterization of a non-catalytic CHI-fold family from plants. Arabidopsis thaliana contains five actively transcribed genes encoding CHI-fold proteins, three of which additionally encode amino-terminal chloroplast-transit sequences. These three CHI-fold proteins localize to plastids, the site of de novo fatty-acid biosynthesis in plant cells. Furthermore, their expression profiles correlate with those of core fatty-acid biosynthetic enzymes, with maximal expression occurring in seeds and coinciding with increased fatty-acid storage in the developing embryo. In vitro, these proteins are fatty-acid-binding proteins (FAPs). FAP knockout A. thaliana plants show elevated alpha-linolenic acid levels and marked reproductive defects, including aberrant seed formation. Notably, the FAP discovery defines the adaptive evolution of a stereospecific and catalytically 'perfected' enzyme(6) from a non-enzymatic ancestor over a defined period of plant evolution.	[Ngaki, Micheline N.; Li, Ling; Wurtele, Eve Syrkin] Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA; [Louie, Gordon V.; Philippe, Ryan N.; Pojer, Florence; Bowman, Marianne E.; Larsen, Elise; Noel, Joseph P.] Salk Inst Biol Studies, Howard Hughes Med Inst, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Manning, Gerard] Salk Inst Biol Studies, Razavi Newman Ctr Bioinformat, La Jolla, CA 92037 USA	Iowa State University; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Wurtele, ES (corresponding author), Iowa State Univ, Dept Genet Dev & Cell Biol, Ames, IA 50011 USA.	mash@iastate.edu; noel@salk.edu	Manning, Gerard/C-8308-2009; Li, Ling/B-6598-2012; Li, Ling/AGY-7810-2022; Noel, Joseph P/A-9459-2009	Li, Ling/0000-0003-2371-6215; Li, Ling/0000-0003-2371-6215; Wurtele, Eve/0000-0003-1552-9495; Manning, Gerard/0000-0002-5087-9151	Fulbright Fellowship; National Science Foundation [MCB-0645794, EEC-0813570, MCB-0951170]; National Cancer Institute [CA14195]; Plant Sciences Institute at Iowa State University; Department of Energy, Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER	Fulbright Fellowship; National Science Foundation(National Science Foundation (NSF)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Plant Sciences Institute at Iowa State University; Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Perera, B. Nikolau, H. Ilarsan and J. Peng for technical training (to M.N.N.), J. Peng for the fap1-1 homozygote mutant line, D. Nettleton and H. Wang for statistical analysis of initial seed fatty-acid data, and Eric Scheeff for assistance in Bayesian phylogenetic analysis. This research was supported in part by a Fulbright Fellowship (to M.N.N.). This material is based in part upon work supported by the National Science Foundation under award number MCB-0645794 (to J.P.N.), EEC-0813570 (to E. S. W.), MCB-0951170 (to E. S. W.), and by National Cancer Institute award number CA14195 (to G. M.) and the Plant Sciences Institute at Iowa State University (to E. S. W). J.P.N. is an investigator with the Howard Hughes Medical Institute. Portions of this research were conducted at the Advanced Light Source, a national user facility operated by Lawrence Berkeley National Laboratory, on behalf of the US Department of Energy, Office of Basic Energy Sciences. The Berkeley Center for Structural Biology is supported in part by the Department of Energy, Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences. We thank the staff at the Advanced Light Source for assistance with X-ray data collection. Any opinions, findings and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.	ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEDNAR RA, 1988, J BIOL CHEM, V263, P9582; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Davies N. A., 1998, NEW AUTOMATED MASS S; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Falcone Deane L., 2004, BMC Plant Biology, V4, P17, DOI 10.1186/1471-2229-4-17; Fatland BL, 2005, PLANT CELL, V17, P182, DOI 10.1105/tpc.104.026211; Ferrer JL, 2008, PLANT PHYSIOL BIOCH, V46, P356, DOI 10.1016/j.plaphy.2007.12.009; Gensheimer M, 2004, PROTEIN SCI, V13, P540, DOI 10.1110/ps.03395404; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Hartmann T, 2007, PHYTOCHEMISTRY, V68, P2831, DOI 10.1016/j.phytochem.2007.09.017; Hilson P, 2004, GENOME RES, V14, P2176, DOI 10.1101/gr.2544504; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Invitrogen, 2003, INVITROGEN GATEWAY T; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jez JM, 2002, BIOCHEMISTRY-US, V41, P5168, DOI 10.1021/bi0255266; Jez JM, 2002, J BIOL CHEM, V277, P1361, DOI 10.1074/jbc.M109224200; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Li L, 2007, J EXP BOT, V58, P3323, DOI 10.1093/jxb/erm180; Lohar DP, 2001, J EXP BOT, V52, P1697, DOI 10.1093/jexbot/52.361.1697; Markham JE, 2006, J BIOL CHEM, V281, P22684, DOI 10.1074/jbc.M604050200; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-99; Mentzen WI, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-76; Moon S., 2009, PLANTMETABOLOMICS PL; Murakami Y, 2000, SCIENCE, V287, P476, DOI 10.1126/science.287.5452.476; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Oursel D, 2007, RAPID COMMUN MASS SP, V21, P3229, DOI 10.1002/rcm.3177; Peer WA, 2007, TRENDS PLANT SCI, V12, P556, DOI 10.1016/j.tplants.2007.10.003; Perera MADN, 2003, ADVANCED RESEARCH ON PLANT LIPIDS, P225; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Ruuska SA, 2002, PLANT CELL, V14, P1191, DOI 10.1105/tpc.000877; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SHIRLEY BW, 1992, PLANT CELL, V4, P333, DOI 10.1105/tpc.4.3.333; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	56	122	135	7	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					530	U147		10.1038/nature11009	http://dx.doi.org/10.1038/nature11009			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622584	Green Accepted			2022-12-24	WOS:000304344500049
J	Garelli, A; Gontijo, AM; Miguela, V; Caparros, E; Dominguez, M				Garelli, Andres; Gontijo, Alisson M.; Miguela, Veronica; Caparros, Esther; Dominguez, Maria			Imaginal Discs Secrete Insulin-Like Peptide 8 to Mediate Plasticity of Growth and Maturation	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; GENES; DISKS; PUPARIATION; SIZE	Developing animals frequently adjust their growth programs and/or their maturation or metamorphosis to compensate for growth disturbances (such as injury or tumor) and ensure normal adult size. Such plasticity entails tissue and organ communication to preserve their proportions and symmetry. Here, we show that imaginal discs autonomously activate DILP8, a Drosophila insulin-like peptide, to communicate abnormal growth and postpone maturation. DILP8 delays metamorphosis by inhibiting ecdysone biosynthesis, slowing growth in the imaginal discs, and generating normal-sized animals. Loss of dilp8 yields asymmetric individuals with an unusually large variation in size and a more varied time of maturation. Thus, DILP8 is a fundamental element of the hitherto ill-defined machinery governing the plasticity that ensures developmental stability and robustness.	[Garelli, Andres; Gontijo, Alisson M.; Miguela, Veronica; Caparros, Esther; Dominguez, Maria] Univ Miguel Hernandez de Elche, CSIC, Inst Neurociencias, Alicante 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Dominguez, M (corresponding author), Univ Miguel Hernandez de Elche, CSIC, Inst Neurociencias, Alicante 03550, Spain.	m.dominguez@umh.es	Dominguez, Maria/G-2171-2014; Caparrós, Esther/AHD-3233-2022; Gontijo, Alisson/G-6719-2011	Dominguez, Maria/0000-0002-3329-7862; Caparrós, Esther/0000-0002-9681-0408; Gontijo, Alisson/0000-0002-2530-3708; Garelli, Andres/0000-0001-7023-0117	Marie Curie Fellowship; Fundacion Botin; Ministerio de Ciencia e Innovacion [BFU2009-09074, MEC-CONSOLIDER/CSD2007-00023]; Generalitat Valenciana [PROMETEO/2008/134]; European Commission [HEALTH-F2-2008-201666]	Marie Curie Fellowship(European Commission); Fundacion Botin; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank E. Hafen, L. Garcia-Alonso, B. Lakowski, and F. Heredia for their comments and suggestions; J. Colombani, D. S. Andersen, and P. Leopold for sharing unpublished data; and I. Gutierrez and E. Ballesta for technical help. V.M. is a Generalitat Valenciana fellow, and A.M.G. was supported by a Marie Curie Fellowship. This work was supported by grants from the Fundacion Botin, the Ministerio de Ciencia e Innovacion (BFU2009-09074 and MEC-CONSOLIDER/CSD2007-00023), Generalitat Valenciana (PROMETEO/2008/134), and the European Commission (HEALTH-F2-2008-201666) to M.D. The microarray data are deposited in the Gene Expression Omnibus (GEO) repository (accession GSE35471). A.M.G. and M.D. designed the research; A.G., A.M.G., V.M., E.C., and M.D. performed the experiments and analyzed the data. A.G., A.M.G., and M.D. wrote the manuscript.	ABBOTT LA, 1983, RADIAT RES, V96, P611, DOI 10.2307/3576126; BRYANT PJ, 1990, J CELL SCI, P169; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Halme A, 2010, CURR BIOL, V20, P458, DOI 10.1016/j.cub.2010.01.038; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Klebes A, 2005, DEVELOPMENT, V132, P3753, DOI 10.1242/dev.01927; Menut L, 2007, GENETICS, V177, P1667, DOI 10.1534/genetics.107.078360; Miron M, 2001, NAT CELL BIOL, V3, P596, DOI 10.1038/35078571; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; PALMER AR, 1986, ANNU REV ECOL SYST, V17, P391, DOI 10.1146/annurev.es.17.110186.002135; POODRY CA, 1990, ROUX ARCH DEV BIOL, V199, P219, DOI 10.1007/BF01682081; Shingleton AW, 2010, ORGANOGENESIS, V6, P76, DOI 10.4161/org.6.2.10375; SIMPSON P, 1980, J EMBRYOL EXP MORPH, V57, P155; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556; Tennessen JM, 2011, CURR BIOL, V21, pR750, DOI 10.1016/j.cub.2011.06.033; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4	19	323	334	1	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					579	582		10.1126/science.1216735	http://dx.doi.org/10.1126/science.1216735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556250				2022-12-24	WOS:000303498800043
J	Bradley, EH; Curry, LA; Spatz, ES; Herrin, J; Cherlin, EJ; Curtis, JP; Thompson, JW; Ting, HH; Wang, YF; Krumholz, HM				Bradley, Elizabeth H.; Curry, Leslie A.; Spatz, Erica S.; Herrin, Jeph; Cherlin, Emily J.; Curtis, Jeptha P.; Thompson, Jennifer W.; Ting, Henry H.; Wang, Yongfei; Krumholz, Harlan M.			Hospital Strategies for Reducing Risk-Standardized Mortality Rates in Acute Myocardial Infarction	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; ASSOCIATION TASK-FORCE; BETA-BLOCKER USE; AMERICAN-COLLEGE; 30-DAY MORTALITY; PERFORMING HOSPITALS; IMPROVE QUALITY; OUTCOMES; MANAGEMENT; GUIDELINES	Background: Despite recent improvements in survival after acute myocardial infarction (AMI), U. S. hospitals vary 2-fold in their 30-day risk-standardized mortality rates (RSMRs). Nevertheless, information is limited on hospital-level factors that may be associated with RSMRs. Objective: To identify hospital strategies that were associated with lower RSMRs. Design: Cross-sectional survey of 537 hospitals (91% response rate) and weighted multivariate regression by using data from the Centers for Medicare & Medicaid Services to determine the associations between hospital strategies and hospital RSMRs. Setting: Acute care hospitals with an annualized AMI volume of at least 25 patients. Participants: Patients hospitalized with AMI between 1 January 2008 and 31 December 2009. Measurements: Hospital performance improvement strategies, characteristics, and 30-day RSMRs. Results: In multivariate analysis, several hospital strategies were significantly associated with lower RSMRs and in aggregate were associated with clinically important differences in RSMRs. These strategies included holding monthly meetings to review AMI cases between hospital clinicians and staff who transported patients to the hospital (RSMR lower by 0.70 percentage points), having cardiologists always on site (lower by 0.54 percentage points), fostering an organizational environment in which clinicians are encouraged to solve problems creatively (lower by 0.84 percentage points), not cross-training nurses from intensive care units for the cardiac catheterization laboratory (lower by 0.44 percentage points), and having physician and nurse champions rather than nurse champions alone (lower by 0.88 percentage points). Fewer than 10% of hospitals reported using at least 4 of these 5 strategies. Limitation: The cross-sectional design demonstrates statistical associations but cannot establish causal relationships. Conclusion: Several strategies, which are currently implemented by relatively few hospitals, are associated with significantly lower 30-day RSMRs for patients with AMI.	Yale Univ, Sch Med, Sch Publ Hlth, New Haven, CT USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA; Mayo Clin, Rochester, MN USA	Yale University; Yale University; Mayo Clinic	Bradley, EH (corresponding author), 60 Coll St,POB 208034, New Haven, CT 06520 USA.	elizabeth.bradley@yale.edu	, Harlan/AAI-2875-2020; curry, leslie/AAA-6100-2022	curry, leslie/0000-0002-3419-4654	Agency for Healthcare Research and Quality [R01-HS0-16929]; United Health Foundation; Commonwealth Fund; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute [U01 HL105270-02]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS016929] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); United Health Foundation; Commonwealth Fund; (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	By the Agency for Healthcare Research and Quality (R01-HS0-16929), the United Health Foundation, and the Commonwealth Fund. Dr. Krumholz was supported by grant U01 HL105270-02 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute.	Allison JJ, 2000, JAMA-J AM MED ASSOC, V284, P1256, DOI 10.1001/jama.284.10.1256; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Baldwin LM, 2004, J RURAL HEALTH, V20, P99, DOI 10.1111/j.1748-0361.2004.tb00015.x; Beatty PC, 2007, PUBLIC OPIN QUART, V71, P287, DOI 10.1093/poq/nfm006; BELSLEY D. A, 1980, REGRESSION DIAGNOSTI; Bernheim SM, 2010, CIRC-CARDIOVASC QUAL, V3, P459, DOI 10.1161/CIRCOUTCOMES.110.957613; Bradley EH, 2004, MED CARE, V42, P591, DOI 10.1097/01.mlr.0000128006.27364.a9; Bradley EH, 2001, JAMA-J AM MED ASSOC, V285, P2604, DOI 10.1001/jama.285.20.2604; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Bradley EH, 2010, AM J CARDIOL, V106, P1108, DOI 10.1016/j.amjcard.2010.06.014; Bradley EH, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-25; Chassin MR, 1997, HEALTH AFFAIR, V16, P151, DOI 10.1377/hlthaff.16.3.151; Creswell JW, 2011, DESIGNING CONDUCTING; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Curry LA, 2009, CIRCULATION, V119, P1442, DOI 10.1161/CIRCULATIONAHA.107.742775; Daniels MJ, 1999, J AM STAT ASSOC, V94, P29, DOI 10.2307/2669675; Ellerbeck EF, 2006, AM HEART J, V152, P579, DOI 10.1016/j.ahj.2006.02.011; Ellrodt Gray, 2007, Crit Pathw Cardiol, V6, P106, DOI 10.1097/HPC.0b013e318073bd3c; Krause N, 2002, J GERONTOL B-PSYCHOL, V57, pS263, DOI 10.1093/geronb/57.5.S263; Krumholz HM, 2011, AM HEART J, V162, P981, DOI 10.1016/j.ahj.2011.09.004; Krumholz HM, 2009, CIRC-CARDIOVASC QUAL, V2, P407, DOI 10.1161/CIRCOUTCOMES.109.883256; Krumholz HM, 2009, JAMA-J AM MED ASSOC, V302, P767, DOI 10.1001/jama.2009.1178; Krumholz HM, 2006, CIRCULATION, V113, P1683, DOI 10.1161/CIRCULATIONAHA.105.611186; Krumholz HM, 2006, CIRCULATION, V113, P456, DOI 10.1161/CIRCULATIONAHA.105.170769; Krumholz HM, 1999, CIRCULATION, V99, P2986, DOI 10.1161/01.CIR.99.23.2986; Krumholz HM, 2003, AM HEART J, V146, P242, DOI 10.1016/S0002-8703(03)00237-0; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Normand SLT, 1996, JAMA-J AM MED ASSOC, V275, P1322, DOI 10.1001/jama.275.17.1322; Normand SLT, 1997, J AM STAT ASSOC, V92, P803, DOI 10.2307/2965545; O'Mahony S, 2007, J GEN INTERN MED, V22, P1073, DOI 10.1007/s11606-007-0225-1; Popescu I, 2009, CIRC-CARDIOVASC QUAL, V2, P221, DOI 10.1161/CIRCOUTCOMES.108.813790; Rivkin A, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.04.014; Ross JS, 2008, HEALTH AFFAIR, V27, P1707, DOI 10.1377/hlthaff.27.6.1707; Ross JS, 2007, HEALTH AFFAIR, V26, P238, DOI 10.1377/hlthaff.26.1.238; Ross JS, 2010, NEW ENGL J MED, V362, P1110, DOI 10.1056/NEJMsa0907130; SHORTELL SM, 1994, MED CARE, V32, P508, DOI 10.1097/00005650-199405000-00009; Thiemann DR, 1999, NEW ENGL J MED, V340, P1640, DOI 10.1056/NEJM199905273402106; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; U.S. Department of Health and Human Services, 2012, CALC 30 DAY RISK STA	39	91	92	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2012	156	9					618	U53		10.7326/0003-4819-156-9-201205010-00003	http://dx.doi.org/10.7326/0003-4819-156-9-201205010-00003			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	933YR	22547471	Green Accepted			2022-12-24	WOS:000303403700002
J	Eisenbarth, SC; Williams, A; Colegio, OR; Meng, HL; Strowig, T; Rongvaux, A; Henao-Mejia, J; Thaiss, CA; Joly, S; Gonzalez, DG; Xu, L; Zenewicz, LA; Haberman, AM; Elinav, E; Kleinstein, SH; Sutterwala, FS; Flavell, RA				Eisenbarth, Stephanie C.; Williams, Adam; Colegio, Oscar R.; Meng, Hailong; Strowig, Till; Rongvaux, Anthony; Henao-Mejia, Jorge; Thaiss, Christoph A.; Joly, Sophie; Gonzalez, David G.; Xu, Lan; Zenewicz, Lauren A.; Haberman, Ann M.; Elinav, Eran; Kleinstein, Steven H.; Sutterwala, Fayyaz S.; Flavell, Richard A.			NLRP10 is a NOD-like receptor essential to initiate adaptive immunity by dendritic cells	NATURE			English	Article							CUTTING EDGE; AUTOIMMUNE ENCEPHALOMYELITIS; LYMPH-NODES; DC SUBSETS; MIGRATION; ANTIGEN; INFLAMMASOME; EXPRESSION; CHEMOKINE; SPHINGOSINE-1-PHOSPHATE	NLRs (nucleotide-binding domain leucine-rich-repeat-containing receptors; NOD-like receptors) are a class of pattern recognition receptor (PRR) that respond to host perturbation from either infectious agents or cellular stress(1,2). The function of most NLR family members has not been characterized and their role in instructing adaptive immune responses remains unclear(2,3). NLRP10 (also known as PYNOD, NALP10, PAN5 and NOD8) is the only NLR lacking the putative ligand-binding leucine-rich-repeat domain, and has been postulated to be a negative regulator of other NLR members, including NLRP3 (refs 4-6). We did not find evidence that NLRP10 functions through an inflammasome to regulate caspase-1 activity nor that it regulates other inflammasomes. Instead, Nlrp10(-/-) mice had a profound defect in helper T-cell-driven immune responses to a diverse array of adjuvants, including lipopolysaccharide, aluminium hydroxide and complete Freund's adjuvant. Adaptive immunity was impaired in the absence of NLRP10 because of a dendritic cell (DC) intrinsic defect in emigration from inflamed tissues, whereas upregulation of DC costimulatory molecules and chemotaxis to CCR7-dependent and -independent ligands remained intact. The loss of antigen transport to the draining lymph nodes by a subset of migratory DCs resulted in an almost absolute loss in naive CD4(+) T-cell priming, highlighting the critical link between diverse innate immune stimulation, NLRP10 activity and the immune function of mature DCs.	[Eisenbarth, Stephanie C.; Gonzalez, David G.; Xu, Lan; Haberman, Ann M.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Williams, Adam; Strowig, Till; Rongvaux, Anthony; Henao-Mejia, Jorge; Thaiss, Christoph A.; Zenewicz, Lauren A.; Elinav, Eran; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Colegio, Oscar R.; Xu, Lan] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06520 USA; [Meng, Hailong; Kleinstein, Steven H.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Joly, Sophie; Sutterwala, Fayyaz S.] Univ Iowa, Dept Internal Med, Inflammat Program, Iowa City, IA 52242 USA; [Kleinstein, Steven H.] Yale Univ, Sch Med, Interdep Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Sutterwala, Fayyaz S.] Vet Affairs Med Ctr, Iowa City, IA 52241 USA	Yale University; Yale University; Yale University; Yale University; University of Iowa; Yale University; Howard Hughes Medical Institute; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Eisenbarth, SC (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06520 USA.	stephanie.eisenbarth@yale.edu; richard.flavell@yale.edu	Cassel, Suzanne/AAI-3947-2021; Elinav, Eran/ABE-8881-2020; Sutterwala, Fayyaz/AAH-5859-2021	Cassel, Suzanne/0000-0003-2492-1923; Elinav, Eran/0000-0002-5775-2110; Colegio, Oscar/0000-0002-9524-6235; Eisenbarth, Stephanie/0000-0002-1244-208X; Colegio, Oscar/0000-0002-6519-3718; Zenewicz, Lauren/0000-0002-8787-5955; Strowig, Till/0000-0003-0185-1459	Yale CTSA [UL1 RR024139, 5KL2RR024138]; Damon Runyon Cancer Research Foundation [DRG 108-09]; Yale SPORE in Skin Cancer [1 P50 CA121974]; Dermatology Foundation; Cancer Research Institute; American Physicians for Medicine in Israel Foundation; United States-Israel binational Foundation; Yale Rheumatologic Disease Research Core Center [P30AR053495]; Edward Mallinckrodt, Jr. Foundation;  [T32HL007974];  [K08AI085038];  [R01AI087630]; NATIONAL CANCER INSTITUTE [P50CA121974] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139, KL2RR024138] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087630, K08AI085038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495] Funding Source: NIH RePORTER	Yale CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Damon Runyon Cancer Research Foundation; Yale SPORE in Skin Cancer; Dermatology Foundation; Cancer Research Institute; American Physicians for Medicine in Israel Foundation; United States-Israel binational Foundation; Yale Rheumatologic Disease Research Core Center; Edward Mallinckrodt, Jr. Foundation; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We would like to thank R. Medzhitov and M. Albert for discussion and review of this manuscript, and F. Duffy for assistance with manuscript preparation. S. C. E. was supported by T32HL007974, K08AI085038 and Yale CTSA (UL1 RR024139). O.R.C. was supported by the Damon Runyon Cancer Research Foundation (DRG 108-09), the Yale CTSA (UL1 RR024139 and 5KL2RR024138), the Yale SPORE in Skin Cancer (1 P50 CA121974) and the Dermatology Foundation. E. E. is supported by Cancer Research Institute, the American Physicians for Medicine in Israel Foundation, and the United States-Israel binational Foundation grant. A. M. H., D. G. G. and in vivo imaging were supported by Yale Rheumatologic Disease Research Core Center P30AR053495. F. S. S. was supported by R01AI087630 and an Edward Mallinckrodt, Jr. Foundation scholarship. A. W. was a Howard Hughes fellow and R. A. F. is an Investigator of the Howard Hughes Medical Institute.	Arthur JC, 2010, J IMMUNOL, V185, P4515, DOI 10.4049/jimmunol.1002227; Bachmann MF, 1995, EUR J IMMUNOL, V25, P3445, DOI 10.1002/eji.1830251236; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628; Czeloth N, 2005, J IMMUNOL, V175, P2960, DOI 10.4049/jimmunol.175.5.2960; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Imamura R, 2010, J IMMUNOL, V184, P5874, DOI 10.4049/jimmunol.0900779; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Ippagunta SK, 2011, NAT IMMUNOL, V12, P1010, DOI 10.1038/ni.2095; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Jakubzick C, 2008, J IMMUNOL METHODS, V337, P121, DOI 10.1016/j.jim.2008.07.005; Jakubzick C, 2008, J EXP MED, V205, P2839, DOI 10.1084/jem.20081430; Laouar Y, 2008, P NATL ACAD SCI USA, V105, P10865, DOI 10.1073/pnas.0805058105; Li HF, 2008, J IMMUNOL, V181, P17, DOI 10.4049/jimmunol.181.1.17; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Medzhitov R, 1999, COLD SPRING HARB SYM, V64, P429, DOI 10.1101/sqb.1999.64.429; NobenTrauth N, 1997, P NATL ACAD SCI USA, V94, P10838, DOI 10.1073/pnas.94.20.10838; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Plantinga M, 2010, EUR J IMMUNOL, V40, P2112, DOI 10.1002/eji.201040562; Saeki H, 1999, J IMMUNOL, V162, P2472; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Wang YT, 2004, INT IMMUNOL, V16, P777, DOI 10.1093/intimm/dxh081; Williams A, 2010, CURR OPIN IMMUNOL, V22, P34, DOI 10.1016/j.coi.2010.01.004; Zheng B, 2003, P NATL ACAD SCI USA, V100, P1745, DOI 10.1073/pnas.0337605100	36	96	100	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					510	U133		10.1038/nature11012	http://dx.doi.org/10.1038/nature11012			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538615	Green Accepted			2022-12-24	WOS:000303200400050
J	Git, A				Git, Anna			A recipe for disaster	NATURE			English	Editorial Material							MINIMUM INFORMATION; MIQE GUIDELINES		Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Git, A (corresponding author), Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England.	anna.git@cancer.org.uk						Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Bustin SA, 2011, CLIN CHEM, V57, P919, DOI 10.1373/clinchem.2011.162958; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797	3	7	7	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					439	440		10.1038/484439a	http://dx.doi.org/10.1038/484439a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22538584	Bronze			2022-12-24	WOS:000303200400019
J	Gravitz, L				Gravitz, Lauren			Aetiology: The X factor	NATURE			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S2	S2		10.1038/nature11103	http://dx.doi.org/10.1038/nature11103			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509503	Bronze			2022-12-24	WOS:000303149900044
J	Rice, J				Rice, Jocelyn			Animal models: Not close enough	NATURE			English	Editorial Material																			0	62	63	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S9	S9		10.1038/nature11102	http://dx.doi.org/10.1038/nature11102			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509510	Bronze			2022-12-24	WOS:000303149900051
J	Rodriguez-Arias, D; Deballon, IO				Rodriguez-Arias, David; Ortega Deballon, Ivan			Protocols for uncontrolled donation after circulatory death	LANCET			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; HYPOTHERMIA; GUIDELINES; SUPPORT		[Rodriguez-Arias, David] CSIC, Inst Philosophy, Ctr Human & Social Sci, Madrid 28037, Spain; [Ortega Deballon, Ivan] Helicopter Emergency Med Serv, Madrid, Spain; [Ortega Deballon, Ivan] Univ Alcala de Henares, Sch Nursing, Alcala De Henares, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Ciencias Humanas y Sociales (CCHS); CSIC - Instituto de Filosofia (IFS); Universidad de Alcala	Rodriguez-Arias, D (corresponding author), CSIC, Inst Philosophy, Ctr Human & Social Sci, Madrid 28037, Spain.	david.rodriguezarias@cchs.csic.es	Rodríguez-Arias, David/K-5894-2014; ORTEGA, IVAN/C-6307-2017	Rodríguez-Arias, David/0000-0002-4555-5259; ORTEGA, IVAN/0000-0002-0819-2399				Bernat JL, 2010, CRIT CARE MED, V38, P963, DOI 10.1097/CCM.0b013e3181c58916; Bottiger BW, 2001, LANCET, V357, P1583, DOI 10.1016/S0140-6736(00)04726-7; Childress JF, 2008, J LAW MED ETHICS, V36, P766, DOI 10.1111/j.1748-720X.2008.00336.x; Conseil francais de reanimation cardiopulmonaire, 2009, Ann Fr Anesth Reanim, V28, P182, DOI 10.1016/j.annfar.2008.12.011; Lederer W, 2004, RESUSCITATION, V61, P123, DOI 10.1016/j.resuscitation.2003.12.016; Massetti M, 2005, ANN THORAC SURG, V79, P178, DOI 10.1016/j.athoracsur.2004.06.095; Nagao K, 2010, CIRC J, V74, P77, DOI 10.1253/circj.CJ-09-0502; Nielsen N, 2005, RESUSCITATION, V65, P111, DOI 10.1016/j.resuscitation.2004.11.007; Nolan JP, 2010, RESUSCITATION, V81, P1219, DOI 10.1016/j.resuscitation.2010.08.021; Olivecrona G, 2011, INTERV CARDIOL, V6, P12; Thiagarajan RR, 2009, ANN THORAC SURG, V87, P778, DOI 10.1016/j.athoracsur.2008.12.079; Vanden Hoek TL, 2010, CIRCULATION, V122, pS829, DOI 10.1161/CIRCULATIONAHA.110.971069; Wall SP, 2011, AM J TRANSPLANT, V11, P1417, DOI 10.1111/j.1600-6143.2011.03582.x; Zeiler K, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.021568	14	35	37	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	2012	379	9823					1275	1276		10.1016/S0140-6736(11)61784-4	http://dx.doi.org/10.1016/S0140-6736(11)61784-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	922FB	22483020				2022-12-24	WOS:000302531100004
J	Abraham, T				Abraham, Thomas			Polio eradication: a complex end game	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Abraham, T (corresponding author), Univ Hong Kong, Journalism & Media Studies Ctr, Hong Kong, Hong Kong, Peoples R China.	thomas@hku.hk						[Anonymous], 2011, WHO WKLY EPIDEMIOL R, V46, P510; Berhane Y, 2009, LANCET INFECT DIS, V9, P655, DOI 10.1016/S1473-3099(09)70268-3; Global Polio Eradication Initiative, CIRC VACC DER POL CV	3	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 2	2012	344								e2398	10.1136/bmj.e2398	http://dx.doi.org/10.1136/bmj.e2398			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GB	22474304				2022-12-24	WOS:000302606500010
J	Ivers, LC; Farmer, PE; Pape, WJ				Ivers, Louise C.; Farmer, Paul E.; Pape, William J.			Oral cholera vaccine and integrated cholera control in Haiti	LANCET			English	Editorial Material									[Ivers, Louise C.; Farmer, Paul E.] Partners Hlth, Boston, MA USA; [Ivers, Louise C.; Farmer, Paul E.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Ivers, Louise C.; Farmer, Paul E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Pape, William J.] GHESKIO, Port Au Prince, Haiti; [Pape, William J.] Weill Cornell Med Coll, New York, NY USA	Partners Healthcare System; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Cornell University	Ivers, LC (corresponding author), Partners Hlth, Boston, MA USA.	livers@pih.org	Ivers, Louise C/Q-4164-2018	Ivers, Louise C/0000-0003-2314-9230				Center for Economic and Policy Research, 2011, CHOL CAS AR MIST BEI; Farmer P, 2003, LANCET, V361, P420, DOI 10.1016/S0140-6736(03)12380-X; Harmon K, 2012, SCI AM          0112; Hinman A, 2011, HARVARD INT REV, V33, P51; Ivers LC, 2010, LANCET, V376, P2048, DOI 10.1016/S0140-6736(10)62243-X; Knox R, 2010, NPR             1028; Krishna A, 2006, WORLD DEV, V34, P271, DOI 10.1016/j.worlddev.2005.08.003; Ministere de la Sante et de la Population, RAPP 23 AVR 2012; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Trenton D, 2011, US TODAY NEWS   1109; US Centers for Disease Control and Prevention, 2012, MMWR-MORBID MORTAL W, V61, P309; World Health Organization, NUMB REP CHOL CAS GL	12	18	18	0	26	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 2	2012	379	9831					2026	2028		10.1016/S0140-6736(12)60832-0	http://dx.doi.org/10.1016/S0140-6736(12)60832-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951ZI	22656874				2022-12-24	WOS:000304759100008
J	Vize, R				Vize, Richard			Integrated care: a story of hard won success	BRITISH MEDICAL JOURNAL			English	Editorial Material												richard.vize@gmail.com							0	14	14	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 31	2012	344								e3529	10.1136/bmj.e3529	http://dx.doi.org/10.1136/bmj.e3529			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953HG	22654064				2022-12-24	WOS:000304857000005
J	Jenq, G; Tinetti, ME				Jenq, Grace; Tinetti, Mary E.			The Journey Across the Health Care (Dis)Continuum for Vulnerable Patients Policies, Pitfalls, and Possibilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Jenq, Grace; Tinetti, Mary E.] Yale Univ, Dept Internal Med, Sch Med, New Haven, CT 06520 USA	Yale University	Tinetti, ME (corresponding author), Yale Univ, Dept Internal Med, Sch Med, 333 Cedar St,POB 208025, New Haven, CT 06520 USA.	mary.tinetti@yale.edu						Berkowitz RE, 2011, J AM GERIATR SOC, V59, P1130, DOI 10.1111/j.1532-5415.2011.03417.x; Buntin MB, 2005, HEALTH SERV RES, V40, P413, DOI 10.1111/j.1475-6773.2005.0i366.x; Centers for Medicare & Medicaid Services, HOSP QUAL IN; Goodman DC, HOSPITALIZATION DART; Hartocollis A, 2012, NY TIMES, pA1; Hung WW, 2012, JAMA-J AM MED ASSOC, V307, P2185, DOI 10.1001/jama.2012.4842; (MedPAC) MPAC, 2012, REP C MED PAYM POL M; Samaras N, 2010, ANN EMERG MED, V56, P261, DOI 10.1016/j.annemergmed.2010.04.015	8	9	9	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2157	2158		10.1001/jama.2012.5566	http://dx.doi.org/10.1001/jama.2012.5566			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	945YX	22618921				2022-12-24	WOS:000304315200023
J	Cabianca, DS; Casa, V; Bodega, B; Xynos, A; Ginelli, E; Tanaka, Y; Gabellini, D				Cabianca, Daphne S.; Casa, Valentina; Bodega, Beatrice; Xynos, Alexandros; Ginelli, Enrico; Tanaka, Yujiro; Gabellini, Davide			A Long ncRNA Links Copy Number Variation to a Polycomb/Trithorax Epigenetic Switch in FSHD Muscular Dystrophy	CELL			English	Article							DROSOPHILA BITHORAX COMPLEX; GENE-EXPRESSION; NONCODING RNAS; TRITHORAX PROTEINS; RESPONSE ELEMENTS; POLYCOMB COMPLEX; MAMMALIAN-CELLS; TANDEM REPEATS; CANDIDATE GENE; HUMAN GENOME	Repetitive sequences account for more than 50% of the human genome. Facioscapulohumeral muscular dystrophy (FSHD) is an autosomal-dominant disease associated with reduction in the copy number of the D4Z4 repeat mapping to 4q35. By an unknown mechanism, D4Z4 deletion causes an epigenetic switch leading to de-repression of 4q35 genes. Here we show that the Polycomb group of epigenetic repressors targets D4Z4 in healthy subjects and that D4Z4 deletion is associated with reduced Polycomb silencing in FSHD patients. We identify DBE-T, a chromatin-associated noncoding RNA produced selectively in FSHD patients that coordinates de-repression of 4q35 genes. DBE-T recruits the Trithorax group protein Ash1L to the FSHD locus, driving histone H3 lysine 36 dimethylation, chromatin remodeling, and 4q35 gene transcription. This study provides insights into the biological function of repetitive sequences in regulating gene expression and shows how mutations of such elements can influence the progression of a human genetic disease.	[Cabianca, Daphne S.; Casa, Valentina; Xynos, Alexandros; Gabellini, Davide] Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy; [Casa, Valentina] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Bodega, Beatrice; Ginelli, Enrico] Univ Milan, Dept Biol & Genet Med Sci, I-20133 Milan, Italy; [Tanaka, Yujiro] Tokyo Med & Dent Univ, Med Res Inst, Sch Biomed Sci & Biochem Genet, Tokyo 1138510, Japan	Fondazione Telethon; Dulbecco Telethon Institute (DTI); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; University of Milan; Tokyo Medical & Dental University (TMDU)	Gabellini, D (corresponding author), Ist Sci San Raffaele, Dulbecco Telethon Inst, Div Regenerat Med Stem Cells & Gene Therapy, I-20132 Milan, Italy.	gabellini.davide@hsr.it	Bodega, Beatrice/I-4644-2018; Gabellini, Davide/I-4551-2018	Bodega, Beatrice/0000-0003-0527-9234; Gabellini, Davide/0000-0002-3811-4121; Cabianca, Daphne Selvaggia/0000-0002-1834-7868	Telethon [GGP07078]; Association Francaise contre les Myopathies (AFM) [13160, 14464]; European Research Council (ERC); Italian Ministry of Health; Muscular Dystrophy Association USA (MDA); AFM; FSHD Global Research Foundation; Facio Scapulo Humeral Muscular Dystrophy Society	Telethon(Fondazione Telethon); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); European Research Council (ERC)(European Research Council (ERC)); Italian Ministry of Health(Ministry of Health, Italy); Muscular Dystrophy Association USA (MDA)(Muscular Dystrophy Association); AFM(Association Francaise contre les Myopathies); FSHD Global Research Foundation; Facio Scapulo Humeral Muscular Dystrophy Society	We thank W. Bickmore, M. Carmo-Fonseca, C. Carvalho, G. Cavalli, M. Crippa, J. Mattick, T. Misteli, K. Morris, and V. Orlando for helpful discussions. Anti-Rae28 antibody was a kind gift of Y. Takihara. Part of this work was carried out in Alembic (Advanced Light and Electron Microscopy Bio-Imaging Centre), San Raffaele Scientific Instutute. This study is a partial fulfillment of Valentina Casa's PhD in Molecular Medicine, Program in Neuroscience, San Raffaele University, Milan, Italy. The Ginelli lab is supported by Telethon (GGP07078) and Association Francaise contre les Myopathies (AFM) (13160 and 14464). Support for the Gabellini lab came from the European Research Council (ERC), the Italian Ministry of Health, the Muscular Dystrophy Association USA (MDA), AFM, the FSHD Global Research Foundation, and the Facio Scapulo Humeral Muscular Dystrophy Society. D. G. is a Dulbecco Telethon Institute Assistant Scientist.	An S, 2011, J BIOL CHEM, V286, P8369, DOI 10.1074/jbc.M110.203380; Bae E, 2002, P NATL ACAD SCI USA, V99, P16847, DOI 10.1073/pnas.222671299; BAKKER E, 1995, MUSCLE NERVE, pS39; Beisel C, 2011, NAT REV GENET, V12, P123, DOI 10.1038/nrg2932; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bortolanza S, 2011, MOL THER, V19, P2055, DOI 10.1038/mt.2011.153; Bruce HA, 2009, PSYCHIAT GENET, V19, P64, DOI 10.1097/YPG.0b013e3283207ff6; Buschbeck M, 2009, NAT STRUCT MOL BIOL, V16, P1074, DOI 10.1038/nsmb.1665; Busturia A, 2001, DEVELOPMENT, V128, P2163; Cabianca DS, 2010, J CELL BIOL, V191, P1049, DOI 10.1083/jcb.201007028; Cacurri S, 1998, AM J HUM GENET, V63, P181, DOI 10.1086/301906; Chadwick BP, 2009, CHROMOSOMA, V118, P675, DOI 10.1007/s00412-009-0233-5; Clark LN, 1996, CHROMOSOMA, V105, P180, DOI 10.1007/BF02509499; Custodio N., 2006, CELL BIOL LAB MANUAL; Dahlberg JE, 2004, CURR OPIN CELL BIOL, V16, P335, DOI 10.1016/j.ceb.2004.03.006; Deidda G, 1996, J MED GENET, V33, P361, DOI 10.1136/jmg.33.5.361; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Eskeland R, 2010, COLD SH Q B, V75, P71, DOI 10.1101/sqb.2010.75.053; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Garrick D, 2008, BLOOD, V112, P3889, DOI 10.1182/blood-2008-06-161901; Gjerstorff MF, 2008, TISSUE ANTIGENS, V71, P187, DOI 10.1111/j.1399-0039.2007.00997.x; GREENBERG JR, 1979, NUCLEIC ACIDS RES, V6, P715, DOI 10.1093/nar/6.2.715; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Jeon Y, 2011, CELL, V146, P119, DOI 10.1016/j.cell.2011.06.026; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Landeira D, 2011, TRENDS CELL BIOL, V21, P74, DOI 10.1016/j.tcb.2010.10.004; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Lemmers RJLF, 2003, NEUROLOGY, V61, P178, DOI 10.1212/01.WNL.0000078889.51444.81; Lemmers RJLF, 1998, HUM MOL GENET, V7, P1207, DOI 10.1093/hmg/7.8.1207; LIPSHITZ HD, 1987, GENE DEV, V1, P307, DOI 10.1101/gad.1.3.307; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Matharu NK, 2010, J MOL BIOL, V400, P434, DOI 10.1016/j.jmb.2010.05.010; Mendenhall EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001244; Mihaly J, 1998, MOL CELL, V1, P1065, DOI 10.1016/S1097-2765(00)80107-0; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Neguembor MV, 2010, EPIGENOMICS-UK, V2, P271, DOI [10.2217/epi.10.8, 10.2217/EPI.10.8]; NORRIS J, 1995, J BIOL CHEM, V270, P22777, DOI 10.1074/jbc.270.39.22777; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Pirozhkova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003389; Rank G, 2002, MOL CELL BIOL, V22, P8026, DOI 10.1128/MCB.22.22.8026-8034.2002; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, PLOS BIOL, V7, P146, DOI 10.1371/journal.pbio.1000013; Schwartz YB, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000805; Shen SH, 2011, P NATL ACAD SCI USA, V108, P2837, DOI 10.1073/pnas.1012834108; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Snider L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001181; Tanaka Y, 2008, BIOCHEM BIOPH RES CO, V365, P589, DOI 10.1016/j.bbrc.2007.10.159; Tanaka Y, 2007, GENE, V397, P161, DOI 10.1016/j.gene.2007.04.027; Ting DT, 2011, SCIENCE, V331, P593, DOI 10.1126/science.1200801; Tremblay DC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-632; Turner AMW, 2010, BIOTECHNIQUES, V48, pIX, DOI 10.2144/000113442; van Overveld PGM, 2003, NAT GENET, V35, P315, DOI 10.1038/ng1262; Wallace LM, 2011, MOL THER, V19, P2048, DOI 10.1038/mt.2011.118; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Warburton PE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-533; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Wu SL, 2010, DEV DYNAM, V239, P927, DOI 10.1002/dvdy.22210; Yuan W, 2011, J BIOL CHEM, V286, P7983, DOI 10.1074/jbc.M110.194027; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	77	277	306	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4								10.1016/j.cell.2012.03.035	http://dx.doi.org/10.1016/j.cell.2012.03.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22541069	Green Published, hybrid			2022-12-24	WOS:000303934700015
J	Day, MS				Day, Matthew S.			Late presentation, late diagnosis, late stage diagnosis, delayed diagnosis, delayed presentation: terminology confuses the message in UK cancer policy	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Day, Matthew S.] Yorkshire & Humber Specialised Commissioning Grp, Barnsley S75 2PY, S Yorkshire, England; [Day, Matthew S.] Univ Sheffield, Sch Hlth & Related Res, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Day, MS (corresponding author), Yorkshire & Humber Specialised Commissioning Grp, Barnsley S75 2PY, S Yorkshire, England.	matthew.day2@nhs.net						Department of Health, 2011, IMPR OUTC STRAT CANC; Henley S. Jane, 2010, Morbidity and Mortality Weekly Report, V59, P1; National Patient Safety Agency, 2010, DEL DIAGN CANC THEM; Public Accounts Committee, 2011, 24 PUBL ACC COMM; Richards M., 2009, ACHIEVING WORLD CLAS	5	4	4	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 2	2012	344								e3017	10.1136/bmj.e3017	http://dx.doi.org/10.1136/bmj.e3017			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NC	22551805				2022-12-24	WOS:000303817200005
J	Nagornova, NS; Rizzo, TR; Boyarkin, OV				Nagornova, Natalia S.; Rizzo, Thomas R.; Boyarkin, Oleg V.			Interplay of Intra- and Intermolecular H-Bonding in a Progressively Solvated Macrocyclic Peptide	SCIENCE			English	Article							DIP INFRARED-SPECTROSCOPY; AROMATIC-AMINO-ACIDS; PHASE GRAMICIDIN-S; GAS-PHASE; VIBRATIONAL SPECTROSCOPY; PROTONATED TRYPTOPHAN; WATER CLUSTERS; HYDRATION; TYROSINE; COLD	Studying solvation of a large molecule on an atomic level is challenging because of the transient character and inhomogeneity of hydrogen bonding in liquid water. We studied water clusters of a protonated macrocyclic decapeptide, gramicidin S, which were prepared in the gas phase and then cooled to cryogenic temperatures. The experiment spectroscopically tracked fine structural changes of the clusters upon increasing the number of attached water molecules from 1 to 50 and distinguished vibrational fingerprints of different conformers. The data indicate that only the first two water molecules induce a substantial change of the gramicidin S structure by breaking two intramolecular noncovalent bonds. The peptide structure remains largely intact upon further solvation, reflecting the interplay between the strong intramolecular and weaker intermolecular hydrogen bonds.	[Nagornova, Natalia S.; Rizzo, Thomas R.; Boyarkin, Oleg V.] Ecole Polytech Fed Lausanne EPFL, Lab Chim Phys Mol, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Boyarkin, OV (corresponding author), Ecole Polytech Fed Lausanne EPFL, Lab Chim Phys Mol, CH-1015 Lausanne, Switzerland.	oleg.boiarkin@epfl.ch	Boyarkin, Oleg V/K-3458-2017; Rizzo, Thomas R/D-1554-2011	Rizzo, Thomas R/0000-0003-2796-905X	EPFL; Swiss National Science Foundation (FNS) [200020-130579]; Science and Technology Swiss-Russian cooperation program	EPFL; Swiss National Science Foundation (FNS)(Swiss National Science Foundation (SNSF)); Science and Technology Swiss-Russian cooperation program	We thank EPFL, Swiss National Science Foundation (FNS) (grant no. 200020-130579), and Science and Technology Swiss-Russian cooperation program for their generous support of this work; O.V.B. thanks T. Zwier and A. Vilesov for useful discussions.	Biswal HS, 2011, J AM CHEM SOC, V133, P3931, DOI 10.1021/ja108643p; Boyarkin OV, 2006, J AM CHEM SOC, V128, P2816, DOI 10.1021/ja058383u; Carcabal P, 2004, PHYS CHEM CHEM PHYS, V6, P4546, DOI 10.1039/b411757c; Ebata T, 2006, PHYS CHEM CHEM PHYS, V8, P4783, DOI 10.1039/b609229b; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Gao B, 2009, J AM CHEM SOC, V131, P4695, DOI 10.1021/ja8085017; Gruenloh CJ, 1998, J CHEM PHYS, V109, P6601, DOI 10.1063/1.477346; Gruenloh CJ, 1997, SCIENCE, V276, P1678, DOI 10.1126/science.276.5319.1678; Hamashima T, 2011, J PHYS CHEM A, V115, P620, DOI 10.1021/jp111586p; Headrick JM, 2005, SCIENCE, V308, P1765, DOI 10.1126/science.1113094; Kamariotis A, 2006, J AM CHEM SOC, V128, P905, DOI 10.1021/ja056079v; KAUZMANN W, 1959, ADV PROTEIN CHEM, V14, P1, DOI 10.1016/S0065-3233(08)60608-7; Liu DF, 2003, J AM CHEM SOC, V125, P8458, DOI 10.1021/ja034638x; Llamas-Saiz AL, 2007, ACTA CRYSTALLOGR D, V63, P401, DOI 10.1107/S0907444906056435; Manas ES, 2000, J AM CHEM SOC, V122, P9883, DOI 10.1021/ja001782z; Mercier SR, 2006, J AM CHEM SOC, V128, P16938, DOI 10.1021/ja065980n; Miyazaki M, 2004, SCIENCE, V304, P1134, DOI 10.1126/science.1096037; Nagornova NS, 2011, ANGEW CHEM INT EDIT, V50, P5383, DOI 10.1002/anie.201100702; Nagornova NS, 2010, J AM CHEM SOC, V132, P4040, DOI 10.1021/ja910118j; PAGE RH, 1988, J CHEM PHYS, V88, P5362, DOI 10.1063/1.454574; Polfer NC, 2009, MASS SPECTROM REV, V28, P468, DOI 10.1002/mas.20215; Prell JS, 2010, J AM CHEM SOC, V132, P7811, DOI 10.1021/ja102765w; Prenner EJ, 1999, BBA-BIOMEMBRANES, V1462, P201, DOI 10.1016/S0005-2736(99)00207-2; Robertson EG, 2001, PHYS CHEM CHEM PHYS, V3, P1, DOI 10.1039/b008225m; RodriguezCruz SE, 1997, J AM SOC MASS SPECTR, V8, P565, DOI 10.1016/S1044-0305(97)00020-2; Schwing K, 2011, CHEMPHYSCHEM, V12, P1981, DOI 10.1002/cphc.201001055; Shin JW, 2004, SCIENCE, V304, P1137, DOI 10.1126/science.1096466; Snoek LC, 2002, PHYS CHEM CHEM PHYS, V4, P2130, DOI 10.1039/b200059h; Stearns JA, 2007, J AM CHEM SOC, V129, P11814, DOI 10.1021/ja0736010; XU Y, 1995, J BIOMOL NMR, V5, P37, DOI 10.1007/BF00227468; YEH LI, 1989, J CHEM PHYS, V91, P7319, DOI 10.1063/1.457305; Zwier TS, 2001, J PHYS CHEM A, V105, P8827, DOI 10.1021/jp011659+	32	132	132	2	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					320	323		10.1126/science.1218709	http://dx.doi.org/10.1126/science.1218709			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517854				2022-12-24	WOS:000302995400038
J	Solimini, NL; Xu, QK; Mermel, CH; Liang, AC; Schlabach, MR; Luo, J; Burrows, AE; Anselmo, AN; Bredemeyer, AL; Li, MZ; Beroukhim, R; Meyerson, M; Elledge, SJ				Solimini, Nicole L.; Xu, Qikai; Mermel, Craig H.; Liang, Anthony C.; Schlabach, Michael R.; Luo, Ji; Burrows, Anna E.; Anselmo, Anthony N.; Bredemeyer, Andrea L.; Li, Mamie Z.; Beroukhim, Rameen; Meyerson, Matthew; Elledge, Stephen J.			Recurrent Hemizygous Deletions in Cancers May Optimize Proliferative Potential	SCIENCE			English	Article							LINEAGE-SURVIVAL ONCOGENE; LIVER-CANCER; IDENTIFICATION; PRINCIPLES; MUTATIONS; GENES	Tumors exhibit numerous recurrent hemizygous focal deletions that contain no known tumor suppressors and are poorly understood. To investigate whether these regions contribute to tumorigenesis, we searched genetically for genes with cancer-relevant properties within these hemizygous deletions. We identified STOP and GO genes, which negatively and positively regulate proliferation, respectively. STOP genes include many known tumor suppressors, whereas GO genes are enriched for essential genes. Analysis of their chromosomal distribution revealed that recurring deletions preferentially overrepresent STOP genes and underrepresent GO genes. We propose a hypothesis called the cancer gene island model, whereby gene islands encompassing high densities of STOP genes and low densities of GO genes are hemizygously deleted to maximize proliferative fitness through cumulative haploinsufficiencies. Because hundreds to thousands of genes are hemizygously deleted per tumor, this mechanism may help to drive tumorigenesis across many cancer types.	[Solimini, Nicole L.; Xu, Qikai; Liang, Anthony C.; Schlabach, Michael R.; Luo, Ji; Burrows, Anna E.; Anselmo, Anthony N.; Bredemeyer, Andrea L.; Li, Mamie Z.; Elledge, Stephen J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Solimini, Nicole L.; Xu, Qikai; Liang, Anthony C.; Schlabach, Michael R.; Luo, Ji; Burrows, Anna E.; Anselmo, Anthony N.; Bredemeyer, Andrea L.; Li, Mamie Z.; Elledge, Stephen J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Div Genet, Boston, MA 02115 USA; [Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02215 USA; [Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02215 USA; [Mermel, Craig H.; Beroukhim, Rameen; Meyerson, Matthew] Broad Inst MIT & Harvard, Canc Program, Cambridge, MA 02141 USA; [Beroukhim, Rameen] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Elledge, SJ (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	selledge@genetics.med.harvard.edu	Mermel, Craig/AAZ-7322-2020; Meyerson, Matthew L/E-7123-2012	Mermel, Craig/0000-0002-0816-3395; Meyerson, Matthew/0000-0002-9133-8108; Bredemeyer, Andrea/0000-0003-2970-5998	National Human Genome Research Institute; NIH [U54CA143798]; U.S. Department of Defense; Susan G. Komen for the Cure Foundation [KG080087]; American Cancer Society [116410-PF-09-078-01-MGO]; National Institute of General Medical Sciences Medical Scientist Training Program [T32GM07753]; NIH, Stand Up to Cancer; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); American Cancer Society(American Cancer Society); National Institute of General Medical Sciences Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, Stand Up to Cancer; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Forbes, A. Futreal, and M. Stratton for generously providing the whole-genome sequencing data from the COSMIC database, and C. Shaw, D. MacPherson, M. Emanuele, C. Thoma, T. Westbrook, and members of the Elledge lab for helpful discussions and critical reading of this manuscript. Supported by grants from the National Human Genome Research Institute-funded Cancer Genome Atlas project (M. M.); NIH grant U54CA143798 (R. B.); NIH, Stand Up to Cancer, and the U.S. Department of Defense (S.J.E.); Susan G. Komen for the Cure Foundation postdoctoral fellowship KG080087 (N.L.S.); American Cancer Society postdoctoral fellowship 116410-PF-09-078-01-MGO (Q. X.); and National Institute of General Medical Sciences Medical Scientist Training Program award T32GM07753 (C. H. M.). S.J.E. is an investigator of the Howard Hughes Medical Institute.	Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Berger AH, 2011, NATURE, V476, P163, DOI 10.1038/nature10275; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Bozic I, 2010, P NATL ACAD SCI USA, V107, P18545, DOI 10.1073/pnas.1010978107; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Nanjundan M, 2007, CANCER RES, V67, P3074, DOI 10.1158/0008-5472.CAN-06-2366; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Payne SR, 2005, CARCINOGENESIS, V26, P2031, DOI 10.1093/carcin/bgi223; Santarosa M, 2004, BBA-REV CANCER, V1654, P105, DOI 10.1016/j.bbcan.2004.01.001; Sawey ET, 2011, CANCER CELL, V19, P347, DOI 10.1016/j.ccr.2011.01.040; Schlabach MR, 2008, SCIENCE, V319, P620, DOI 10.1126/science.1149200; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Sherr CJ, 2004, CELL, V116, P235, DOI 10.1016/S0092-8674(03)01075-4; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zwemer LM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-2-r10	25	137	152	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2012	337	6090					104	109		10.1126/science.1219580	http://dx.doi.org/10.1126/science.1219580			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22628553	Green Accepted			2022-12-24	WOS:000306053100054
J	Tagliabracci, VS; Engel, JL; Wen, JZ; Wiley, SE; Worby, CA; Kinch, LN; Xiao, JY; Grishin, NV; Dixon, JE				Tagliabracci, Vincent S.; Engel, James L.; Wen, Jianzhong; Wiley, Sandra E.; Worby, Carolyn A.; Kinch, Lisa N.; Xiao, Junyu; Grishin, Nick V.; Dixon, Jack E.			Secreted Kinase Phosphorylates Extracellular Proteins That Regulate Biomineralization	SCIENCE			English	Article							APPARATUS CASEIN KINASE; LACTATING MAMMARY-GLAND; GOLGI-APPARATUS; SPECIFICITY DETERMINANTS; MASS-SPECTROMETRY; PHOSPHOPROTEOME; PURIFICATION; OSTEOPONTIN; INHIBITION; SEQUENCE	Protein phosphorylation is a fundamental mechanism regulating nearly every aspect of cellular life. Several secreted proteins are phosphorylated, but the kinases responsible are unknown. We identified a family of atypical protein kinases that localize within the Golgi apparatus and are secreted. Fam20C appears to be the Golgi casein kinase that phosphorylates secretory pathway proteins within S-x-E motifs. Fam20C phosphorylates the caseins and several secreted proteins implicated in biomineralization, including the small integrin-binding ligand, N-linked glycoproteins (SIBLINGs). Consequently, mutations in Fam20C cause an osteosclerotic bone dysplasia in humans known as Raine syndrome. Fam20C is thus a protein kinase dedicated to the phosphorylation of extracellular proteins.	[Tagliabracci, Vincent S.; Engel, James L.; Wen, Jianzhong; Wiley, Sandra E.; Worby, Carolyn A.; Xiao, Junyu; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Kinch, Lisa N.; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Grishin, Nick V.; Dixon, Jack E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	University of California System; University of California San Diego; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute	Dixon, JE (corresponding author), Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA.	jedixon@ucsd.edu	Wen, Jianzhong/AAI-4976-2020; Xiao, Junyu/ABE-2192-2020	Kinch, Lisa/0000-0003-3041-2615; Wiley, Sandra/0000-0003-3979-2474; Xiao, Junyu/0000-0003-1822-1701	NIH [DK018849-36, DK018024-37, GM094575]; NIH/National Cancer Institute [T32 CA009523]; Welch Foundation [I-1505]; NATIONAL CANCER INSTITUTE [T32CA009523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018849, R37DK018024, R01DK018024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094575] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by NIH grants DK018849-36 and DK018024-37 (to J.E.D.), GM094575 (to N.V.G), NIH/National Cancer Institute Training Grant T32 CA009523 (to V. S. T.), and the Welch Foundation I-1505 (to N.V.G). We thank J. Jewell, G. Taylor, X. Guo, S. Mattoo, A. Newton, S. Taylor, A. DePaoli-Roach, P. Roach, and members of the Dixon lab for insightful discussions and comments regarding the manuscript.	ALLENDE JE, 1995, FASEB J, V9, P313, DOI 10.1096/fasebj.9.5.7896000; Bahl JMC, 2008, ANAL CHEM, V80, P6308, DOI 10.1021/ac800835y; BENNETT HPJ, 1981, P NATL ACAD SCI-BIOL, V78, P4713, DOI 10.1073/pnas.78.8.4713; BINGHAM EW, 1972, J BIOL CHEM, V247, P8193; BINGHAM EW, 1974, J BIOL CHEM, V249, P3647; Blombaeck B., 1962, NATURE, V193, P833; Brunati AM, 2000, BIOCHEM J, V351, P765, DOI 10.1042/0264-6021:3510765; BURNETT G, 1954, J BIOL CHEM, V211, P969; Carrascal M, 2010, J PROTEOME RES, V9, P876, DOI 10.1021/pr900780s; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; DOCKRAY GJ, 1987, J BIOL CHEM, V262, P8643; Duncan JS, 2000, BIOCHEM J, V350, P463, DOI 10.1042/0264-6021:3500463; Fradin M, 2011, CLIN GENET, V80, P177, DOI 10.1111/j.1399-0004.2010.01516.x; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Hammarsten O., 1883, H-S Z PHYSIOL CHEM, V7, P227; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Kawasaki K, 2003, P NATL ACAD SCI USA, V100, P4060, DOI 10.1073/pnas.0638023100; Lasa M, 1997, EUR J BIOCHEM, V243, P719, DOI 10.1111/j.1432-1033.1997.00719.x; Lasa M, 1997, BIOCHEM BIOPH RES CO, V240, P602, DOI 10.1006/bbrc.1997.7702; LasaBenito M, 1996, FEBS LETT, V382, P149, DOI 10.1016/0014-5793(96)00136-6; MOORE A, 1985, EUR J BIOCHEM, V152, P729, DOI 10.1111/j.1432-1033.1985.tb09254.x; RAINE J, 1989, J MED GENET, V26, P786, DOI 10.1136/jmg.26.12.786; Salvi M, 2012, BIOCHEM BIOPH RES CO, V418, P156, DOI 10.1016/j.bbrc.2011.12.152; Salvi M, 2010, J PROTEOME RES, V9, P3335, DOI 10.1021/pr100058r; Schumacher MA, 2009, SCIENCE, V323, P396, DOI 10.1126/science.1163806; TANG J, 1973, P NATL ACAD SCI USA, V70, P3437, DOI 10.1073/pnas.70.12.3437; Tibaldi E, 2010, FEBS LETT, V584, P801, DOI 10.1016/j.febslet.2009.12.052; Zhou WD, 2009, J PROTEOME RES, V8, P5523, DOI 10.1021/pr900603n	29	320	328	11	167	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1150	1153		10.1126/science.1217817	http://dx.doi.org/10.1126/science.1217817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22582013	Green Accepted			2022-12-24	WOS:000304647900047
J	Patadia, S; Vasanawala, SS				Patadia, Sasha; Vasanawala, Shreyas S.			Splenic Spirals	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Patadia, Sasha; Vasanawala, Shreyas S.] Stanford Univ, Palo Alto, CA 94304 USA	Stanford University	Patadia, S (corresponding author), Stanford Univ, Palo Alto, CA 94304 USA.		Vasanawala, Shreyas/AAW-4385-2020	Vasanawala, Shreyas/0000-0002-1999-6595					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2111	2111						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22646633				2022-12-24	WOS:000304613400011
J	Edwards, SP				Edwards, Scott P.			Nipped in the bud	NATURE			English	Editorial Material							DIABETES PREVENTION; BARIATRIC SURGERY; MEDICAL THERAPY											Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Ludvigsson J, 2012, NEW ENGL J MED, V366, P433, DOI 10.1056/NEJMoa1107096; Mingrone G, 2012, NEW ENGL J MED, V366, P1577, DOI 10.1056/NEJMoa1200111; Schauer PR, 2012, NEW ENGL J MED, V366, P1567, DOI 10.1056/NEJMoa1200225; Vehik K, 2011, DIABETES CARE, V34, P1585, DOI 10.2337/dc11-0523; Wang LM, 2012, DIABETES CARE, V35, P465, DOI 10.2337/dc11-1236	6	0	1	1	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					S18	S19		10.1038/485S18a	http://dx.doi.org/10.1038/485S18a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968AT	22616102				2022-12-24	WOS:000305950100009
J	Mytton, OT; Clarke, D; Rayner, M				Mytton, Oliver T.; Clarke, Dushy; Rayner, Mike			Taxing unhealthy food and drinks to improve health	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SUGAR-SWEETENED BEVERAGES; REDUCE CONSUMPTION; PUBLIC-HEALTH; OBESITY; POLICY; TAXES; DIET; PRICE; INTERVENTION; STRATEGIES		[Mytton, Oliver T.; Clarke, Dushy; Rayner, Mike] Univ Oxford, Dept Publ Hlth, British Heart Fdn Hlth Promot Res Grp, Oxford OX3 7LF, England	University of Oxford	Mytton, OT (corresponding author), Univ Oxford, Dept Publ Hlth, British Heart Fdn Hlth Promot Res Grp, Oxford OX3 7LF, England.	oliver.mytton@dph.ox.ac.uk		Mytton, Oliver/0000-0003-3218-9912	National Institute for Health Research [ACF-2010-13-011] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Andreyeva T, 2011, PREV MED, V52, P413, DOI 10.1016/j.ypmed.2011.03.013; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], 2011, ADD DISCR FOOD TAX H; Bahl R, 2003, PUBLIC FINANC REV, V31, P510, DOI [10.1177/1091142103253753, 10.1177.1091142103253753, DOI 10.1177/1091142103253753]; Block JP, 2010, AM J PUBLIC HEALTH, V100, P1427, DOI 10.2105/AJPH.2009.175687; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Buck D., 2011, OBESITY PUBLIC HLTH; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Chouinard HH, 2007, FORUM HLTH EC POLICY, V10, P1, DOI DOI 10.2202/1558-9544.1071; Clark R, 2011, DAILY MAIL      1005; Colombini D, 2011, FOOD MANUFACTUR 1125; Crawford I, 2004, FAT TAX; Dharmasena S, 2011, HEALTH ECON, DOI [DOI 10.1002/HEC.1738, 10.1002/hec.1738]; Epstein LH, 2012, AM J CLIN NUTR, V95, P789, DOI 10.3945/ajcn.111.024380; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Holt E, 2011, LANCET, V378, P755, DOI 10.1016/S0140-6736(11)61359-7; Holt E, 2010, LANCET, V375, P1070, DOI 10.1016/S0140-6736(10)60462-X; Jensen JD, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-10; Kim D, 2006, AM J PREV MED, V30, P430, DOI 10.1016/j.amepre.2005.12.007; Kuchler F, 2005, REV AGR ECON, V27, P4, DOI 10.1111/j.1467-9353.2004.00204.x; Kuchler F, 2004, AGR INFO B, V747, P1; Lin BH, 2011, ECON HUM BIOL, V9, P329, DOI 10.1016/j.ehb.2011.08.007; Lock K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2403; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Marshall T, 2000, BRIT MED J, V320, P301, DOI 10.1136/bmj.320.7230.301; Medical Research Council, 2011, US NAT EXP EV POP HL; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; Ng SW, 2011, BR J NUTR, V108, P1; Nnoaham KE, 2009, INT J EPIDEMIOL, V38, P1324, DOI 10.1093/ije/dyp214; Powell LM, 2009, J ADOLESCENT HEALTH, V45, pS57, DOI 10.1016/j.jadohealth.2009.03.003; Powell LM, 2009, MILBANK Q, V87, P229, DOI 10.1111/j.1468-0009.2009.00554.x; Rose G., 1992, STRATEGY PREVENTIVE; Sacks G, 2011, INT J OBESITY, V35, P1001, DOI 10.1038/ijo.2010.228; Scarborough P, 2010, CORONARY HEART DIS S; Scarborough P, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000263; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Schroeter C, 2008, J HEALTH ECON, V27, P45, DOI 10.1016/j.jhealeco.2007.04.001; Smed S, 2007, FOOD POLICY, V32, P624, DOI 10.1016/j.foodpol.2007.03.002; Street-Porter J, 2011, DAILY MAIL      1010; Thow AM, 2010, B WORLD HEALTH ORGAN, V88, P609, DOI 10.2471/BLT.09.070987; Tiffin R, 2011, EUR J CLIN NUTR, V65, P427, DOI 10.1038/ejcn.2010.281; Tiffin R, 2010, EUR REV AGRIC ECON, V37, P501, DOI 10.1093/erae/jbq038; United Nations, 2011, REPORT SECRETARY GEN; Villanueva T, 2011, CAN MED ASSOC J, V183, pE1229, DOI 10.1503/cmaj.109-4031; World Health Organization, 2004, GLOB STRAT DIET PHYS; [No title captured]	48	207	210	0	110	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 15	2012	344								e2931	10.1136/bmj.e2931	http://dx.doi.org/10.1136/bmj.e2931			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YF	22589522				2022-12-24	WOS:000304086900005
J	Kwan, KY; Lam, MMS; Johnson, MB; Dube, U; Shim, S; Rasin, MR; Sousa, AMM; Fertuzinhos, S; Chen, JG; Arellano, JI; Chan, DW; Pletikos, M; Vasung, L; Rowitch, DH; Huang, EJ; Schwartz, ML; Willemsen, R; Oostra, BA; Rakic, P; Heffer, M; Kostovic, I; Judas, M; Sestan, N				Kwan, Kenneth Y.; Lam, Mandy M. S.; Johnson, Matthew B.; Dube, Umber; Shim, Sungbo; Rasin, Mladen-Roko; Sousa, Andre M. M.; Fertuzinhos, Sofia; Chen, Jie-Guang; Arellano, Jon I.; Chan, Daniel W.; Pletikos, Mihovil; Vasung, Lana; Rowitch, David H.; Huang, Eric J.; Schwartz, Michael L.; Willemsen, Rob; Oostra, Ben A.; Rakic, Pasko; Heffer, Marija; Kostovic, Ivica; Judas, Milos; Sestan, Nenad			Species-Dependent Posttranscriptional Regulation of NOS1 by FMRP in the Developing Cerebral Cortex	CELL			English	Article							FRAGILE-X-SYNDROME; NITRIC-OXIDE SYNTHASE; MENTAL-RETARDATION PROTEIN; ANTERIOR CINGULATE CORTEX; AUTISM SPECTRUM DISORDERS; NEURONAL NADPH DIAPHORASE; MESSENGER-RNAS; HUMAN BRAIN; S-NITROSYLATION; PSD-95	Fragile X syndrome (FXS), the leading monogenic cause of intellectual disability and autism, results from loss of function of the RNA-binding protein FMRP. Here, we show that FMRP regulates translation of neuronal nitric oxide synthase 1 (NOS1) in the developing human neocortex. Whereas NOS1 mRNA is widely expressed, NOS1 protein is transiently coexpressed with FMRP during early synaptogenesis in layer-and region-specific pyramidal neurons. These include midfetal layer 5 subcortically projecting neurons arranged into alternating columns in the prospective Broca's area and orofacial motor cortex. Human NOS1 translation is activated by FMRP via interactions with coding region binding motifs absent from mouse Nos1 mRNA, which is expressed in mouse pyramidal neurons, but not efficiently translated. Correspondingly, neocortical NOS1 protein levels are severely reduced in developing human FXS cases, but not FMRP-deficient mice. Thus, alterations in FMRP posttranscriptional regulation of NOS1 in developing neocortical circuits may contribute to cognitive dysfunction in FXS.	[Kwan, Kenneth Y.; Lam, Mandy M. S.; Johnson, Matthew B.; Dube, Umber; Shim, Sungbo; Rasin, Mladen-Roko; Sousa, Andre M. M.; Fertuzinhos, Sofia; Chen, Jie-Guang; Arellano, Jon I.; Chan, Daniel W.; Pletikos, Mihovil; Schwartz, Michael L.; Rakic, Pasko; Sestan, Nenad] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Kwan, Kenneth Y.; Lam, Mandy M. S.; Johnson, Matthew B.; Dube, Umber; Shim, Sungbo; Rasin, Mladen-Roko; Sousa, Andre M. M.; Fertuzinhos, Sofia; Chen, Jie-Guang; Arellano, Jon I.; Chan, Daniel W.; Pletikos, Mihovil; Schwartz, Michael L.; Rakic, Pasko; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA; [Rasin, Mladen-Roko] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA; [Sousa, Andre M. M.] Univ Porto, Abel Salazar Biomed Sci Inst, Grad Program Areas Basic & Appl Biol, P-4099022 Oporto, Portugal; [Chen, Jie-Guang] Wenzhou Med Coll, Sch Optometry & Ophthalmol, Wenzhou 325003, Zhejiang, Peoples R China; [Pletikos, Mihovil; Vasung, Lana; Kostovic, Ivica; Judas, Milos] Univ Zagreb, Sch Med, Croatian Inst Brain Res, Zagreb 10000, Croatia; [Rowitch, David H.] Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, Dept Pediat, San Francisco, CA 94143 USA; [Rowitch, David H.] Univ Calif San Francisco, Eli & Edythe Broad Inst Stem Cell Res & Regenerat, Dept Neurosurg, San Francisco, CA 94143 USA; [Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Huang, Eric J.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Willemsen, Rob; Oostra, Ben A.] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Heffer, Marija] Josip Juraj Strossmayer Univ Osijek, Dept Med Biol, Osijek 31000, Croatia	Yale University; Yale University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Universidade do Porto; Wenzhou Medical University; University of Zagreb; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC; University of JJ Strossmayer Osijek	Sestan, N (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	nenad.sestan@yale.edu	Kwan, Kenneth/AAI-2841-2021; Fertuzinhos, Sofia MS/G-8316-2011; Kwan, Kenneth Y/F-8489-2011; Vasung, Lana/AAE-8791-2019; Heffer, Marija/ABA-4694-2020; Huang, Eric J./AAH-7997-2019; Sousa, André M. M. M. M./C-1203-2015	Kwan, Kenneth/0000-0003-4711-071X; Kwan, Kenneth Y/0000-0003-4711-071X; Vasung, Lana/0000-0003-0172-3174; Huang, Eric J./0000-0002-5381-3801; Sousa, André M. M. M. M./0000-0003-1740-5066; Dube, Umber/0000-0001-9324-1927; Lam, Mandy/0000-0001-7984-9709; Rowitch, David/0000-0002-0079-0060; Chan, Daniel/0000-0002-8082-2316; Heffer, Marija/0000-0001-6770-7359	Pediatric Neuropathology Research Lab at University of California, San Francisco (UCOP) [142675]; Portuguese Foundation for Science and Technology; National Institutes of Health [K99NS064303, DA023999, MH081896, MH089929, NS054273]; ZonMw [912-07-022]; Kavli Foundation; NARSAD; James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089929, U01MH081896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054273, R01NS014841, U24NS051869, K99NS064303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023999] Funding Source: NIH RePORTER	Pediatric Neuropathology Research Lab at University of California, San Francisco (UCOP)(University of California System); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ZonMw(Netherlands Organization for Health Research and Development); Kavli Foundation; NARSAD(NARSAD); James S. McDonnell Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank D. Budinscak, Z. Cmuk, Z. Krsnik, S. Liu-Chen, B. Popovic, B. Poulos, and B. Sajin for help with tissue acquisition; M. Nakane, W. Sessa, and I. Grkovic for antibodies and reagents; F. Cheng and M. Li for analyzing transcriptome data; E. Gulcicek for help with mass spectrometry; and M. Brown, L. Kaczmarek, A. Louvi, M. Gunel, M. State, and members of the N.S. laboratory for discussions and comments. E.J.H. and D. H. R. received technical support from the Pediatric Neuropathology Research Lab at University of California, San Francisco (UCOP Award #142675). D. H. R. is a HHMI Investigator. A. M. M. S. is supported by a fellowship from the Portuguese Foundation for Science and Technology. This work was supported by grants from National Institutes of Health (to M-R. R., K99NS064303; to P. R., DA023999; to N.S., MH081896, MH089929, and NS054273), ZonMw 912-07-022 (to R. W.), Kavli Foundation, NARSAD, and James S. McDonnell Foundation Scholar Award (to N.S.).	Abbeduto L, 2007, MENT RETARD DEV D R, V13, P36, DOI 10.1002/mrdd.20142; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bechara EG, 2009, PLOS BIOL, V7, P133, DOI 10.1371/journal.pbio.1000016; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Britanova O, 2008, NEURON, V57, P378, DOI 10.1016/j.neuron.2007.12.028; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9; Buxhoeveden D, 1996, ANAT EMBRYOL, V194, P23; Casanova MF, 2002, NEUROLOGY, V58, P428, DOI 10.1212/WNL.58.3.428; Chen JG, 2005, P NATL ACAD SCI USA, V102, P17792, DOI 10.1073/pnas.0509032102; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Cui HX, 2010, SCHIZOPHR RES, V121, P172, DOI 10.1016/j.schres.2010.05.003; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Fertuzinhos S, 2009, CEREB CORTEX, V19, P2196, DOI 10.1093/cercor/bhp009; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Ho GPH, 2011, NEURON, V71, P131, DOI 10.1016/j.neuron.2011.05.033; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; Iioka H, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1316; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Judas M, 1999, MICROSC RES TECHNIQ, V45, P401, DOI 10.1002/(SICI)1097-0029(19990615)45:6<401::AID-JEMT7>3.0.CO;2-Q; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Keller SS, 2009, BRAIN LANG, V109, P29, DOI 10.1016/j.bandl.2008.11.005; KOSTOVIC I, 1990, J COMP NEUROL, V297, P441, DOI 10.1002/cne.902970309; Kraskov A, 2009, NEURON, V64, P922, DOI 10.1016/j.neuron.2009.12.010; Kwan KY, 2008, P NATL ACAD SCI USA, V105, P16021, DOI 10.1073/pnas.0806791105; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Menon V, 2004, P NATL ACAD SCI USA, V101, P3615, DOI 10.1073/pnas.0304544101; MOLLIVER ME, 1973, BRAIN RES, V50, P403, DOI 10.1016/0006-8993(73)90741-5; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nikonenko I, 2008, J CELL BIOL, V183, P1115, DOI 10.1083/jcb.200805132; Nott A, 2008, NATURE, V455, P411, DOI 10.1038/nature07238; ODonnell P, 1997, NEUROSCIENCE, V76, P1; Peters A, 2010, NEUROCHEMICAL BASIS OF AUTISM: FROM MOLECULES TO MINICOLUMNS, P45, DOI 10.1007/978-1-4419-1272-5_4; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Power JD, 2011, NEURON, V72, P665, DOI 10.1016/j.neuron.2011.09.006; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; Ramocki MB, 2008, NATURE, V455, P912, DOI 10.1038/nature07457; Reif A, 2006, MOL PSYCHIATR, V11, P286, DOI 10.1038/sj.mp.4001779; Reif A, 2009, ARCH GEN PSYCHIAT, V66, P41, DOI 10.1001/archgenpsychiatry.2008.510; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rogers SJ, 2001, J DEV BEHAV PEDIATR, V22, P409, DOI 10.1097/00004703-200112000-00008; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; SESTAN N, 1994, TRENDS NEUROSCI, V17, P105, DOI 10.1016/0166-2236(94)90115-5; Shinkai T, 2002, MOL PSYCHIATR, V7, P560, DOI 10.1038/sj.mp.4001041; SIOMI H, 1994, CELL, V77, P33, DOI 10.1016/0092-8674(94)90232-1; State MW, 2010, NEURON, V68, P254, DOI 10.1016/j.neuron.2010.10.004; Todd PK, 2003, P NATL ACAD SCI USA, V100, P14374, DOI 10.1073/pnas.2336265100; Tu PC, 2012, NEUROIMAGE, V59, P238, DOI 10.1016/j.neuroimage.2011.07.086; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Willemsen R, 2011, CLIN GENET, V80, P214, DOI 10.1111/j.1399-0004.2011.01723.x; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893	67	94	95	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					899	911		10.1016/j.cell.2012.02.060	http://dx.doi.org/10.1016/j.cell.2012.02.060			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579290	Bronze, Green Accepted			2022-12-24	WOS:000303934700021
J	Mohd-Sarip, A; Lagarou, A; Doyen, CM; van der Knaap, JA; Aslan, U; Bezstarosti, K; Yassin, Y; Brock, HW; Demmers, JAA; Verrijzer, CP				Mohd-Sarip, Adone; Lagarou, Anna; Doyen, Cecile M.; van der Knaap, Jan A.; Aslan, Ulku; Bezstarosti, Karel; Yassin, Yasmin; Brock, Hugh W.; Demmers, Jeroen A. A.; Verrijzer, C. Peter			Transcription-Independent Function of Polycomb Group Protein PSC in Cell Cycle Control	SCIENCE			English	Article							ANAPHASE-PROMOTING COMPLEX; H2A UBIQUITYLATION; DROSOPHILA EMBRYOS; DYNAMIC REGULATION; DESTRUCTION; MITOSIS; APC11; UBIQUITINATION; MECHANISMS; MUTANTS	Polycomb group (PcG) proteins control development and cell proliferation through chromatin-mediated transcriptional repression. We describe a transcription-independent function for PcG protein Posterior sex combs (PSC) in regulating the destruction of cyclin B (CYC-B). A substantial portion of PSC was found outside canonical PcG complexes, instead associated with CYC-B and the anaphase-promoting complex (APC). Cell-based experiments and reconstituted reactions established that PSC and Lemming (LMG, also called APC11) associate and ubiquitylate CYC-B cooperatively, marking it for proteosomal degradation. Thus, PSC appears to mediate both developmental gene silencing and posttranslational control of mitosis. Direct regulation of cell cycle progression might be a crucial part of the PcG system's function in development and cancer.	[Mohd-Sarip, Adone; Lagarou, Anna; Doyen, Cecile M.; van der Knaap, Jan A.; Aslan, Ulku; Verrijzer, C. Peter] Erasmus Univ, Med Ctr, Dept Biochem, NL-3000 DR Rotterdam, Netherlands; [Mohd-Sarip, Adone; Lagarou, Anna; Doyen, Cecile M.; van der Knaap, Jan A.; Aslan, Ulku; Verrijzer, C. Peter] Erasmus Univ, Med Ctr, Ctr Biomed Genet, NL-3000 DR Rotterdam, Netherlands; [Bezstarosti, Karel; Demmers, Jeroen A. A.] Erasmus Univ, Med Ctr, Prote Ctr, NL-3000 DR Rotterdam, Netherlands; [Yassin, Yasmin; Brock, Hugh W.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of British Columbia	Verrijzer, CP (corresponding author), Erasmus Univ, Med Ctr, Dept Biochem, POB 1738, NL-3000 DR Rotterdam, Netherlands.	c.verrijzer@erasmusmc.nl	Mohd-Sarip, Adone/AAI-7912-2020; Demmers, Jeroen AA/F-4046-2016	Mohd-Sarip, Adone/0000-0003-2932-954X; Demmers, Jeroen AA/0000-0002-8757-9611	Nederlandse Organisatie voor Wetenschappelijk Onderzoek [700.57.406]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek(Netherlands Organization for Scientific Research (NWO)European Commission)	We thank S. Bray, J. Svejstrup, and Y. Moshkin for valuable discussions. This work was supported in part by Nederlandse Organisatie voor Wetenschappelijk Onderzoek Chemical Sciences Veni grant 700.57.406 (to A.M.-S.).	Beck SA, 2010, DEV BIOL, V339, P320, DOI 10.1016/j.ydbio.2009.12.031; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buchenau P, 1998, J CELL BIOL, V141, P469, DOI 10.1083/jcb.141.2.469; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973; Kwong C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000178; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315; Martinez AM, 2006, GENE DEV, V20, P501, DOI 10.1101/gad.357106; Mills AA, 2010, NAT REV CANCER, V10, P669, DOI 10.1038/nrc2931; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; O'Dor E, 2006, DEV BIOL, V290, P312, DOI 10.1016/j.ydbio.2005.11.015; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Parry DH, 2003, CURR BIOL, V13, P647, DOI 10.1016/S0960-9822(03)00242-2; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839; Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; Voncken JW, 1999, J CELL SCI, V112, P4627; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985	29	26	26	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					744	747		10.1126/science.1215927	http://dx.doi.org/10.1126/science.1215927			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22491092				2022-12-24	WOS:000303872300056
J	Rosansky, SJ				Rosansky, Steven J.			The Sad Truth About Early Initiation of Dialysis in Elderly Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							KIDNEY-DISEASE; CARE		William Jennings Bryan Dorn VA Med Ctr, Dorn Res Inst, Columbia, SC 29206 USA		Rosansky, SJ (corresponding author), William Jennings Bryan Dorn VA Med Ctr, Dorn Res Inst, 526 N Trenholm Rd, Columbia, SC 29206 USA.	sjrcra@yahoo.com						Carson RC, 2009, CLIN J AM SOC NEPHRO, V4, P1611, DOI 10.2215/CJN.00510109; Demoulin N, 2011, NEPHROL DIAL TRANSPL, V26, P220, DOI 10.1093/ndt/gfq372; Fassett RG, 2011, NEPHROLOGY, V16, P4, DOI 10.1111/j.1440-1797.2010.01409.x; GHAVAMIAN M, 1972, J AMER MED ASSOC, V222, P1386, DOI 10.1001/jama.222.11.1386; National Institutes of Heath National Institute of Diabetes and Digestive and Kidney Diseases, 2010, US REN DAT SYST USRD; O'Hare AM, 2010, JAMA-J AM MED ASSOC, V304, P180, DOI 10.1001/jama.2010.924; Rosansky S, 2011, CLIN J AM SOC NEPHRO, V6, P1222, DOI 10.2215/CJN.09301010; Wong CF, 2007, RENAL FAILURE, V29, P653, DOI 10.1080/08860220701459634	8	23	25	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1919	1920		10.1001/jama.2012.3522	http://dx.doi.org/10.1001/jama.2012.3522			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570459				2022-12-24	WOS:000303741900023
J	Gonzalez-Perez, V; Zeng, XH; Henzler-Wildman, K; Lingle, CJ				Gonzalez-Perez, Vivian; Zeng, Xu-Hui; Henzler-Wildman, Katie; Lingle, Christopher J.			Stereospecific binding of a disordered peptide segment mediates BK channel inactivation	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; BETA-SUBUNIT; K+ CHANNEL; QUATERNARY AMMONIUM; RAPID INACTIVATION; MOLECULAR-BASIS; NMR STRUCTURE; VOLTAGE; MECHANISM; BLOCK	A number of functionally important actions of proteins are mediated by short, intrinsically disordered peptide segments(1), but the molecular interactions that allow disordered domains to mediate their effects remain a topic of active investigation(2-5). Many K+ channel proteins, after initial channel opening, show a time-dependent reduction in current flux, termed 'inactivation', which involves movement of mobile cytosolic peptide segments (approximately 20-30 residues) into a position that physically occludes ion permeation(6-8). Peptide segments that produce inactivation show little amino-acid identity(6,9-13) and tolerate appreciable mutational substitutions(13) without disrupting the inactivation process. Solution nuclear magnetic resonance of several isolated inactivation domains reveals substantial conformational heterogeneity with only minimal tendency to ordered structures(14-17). Channel inactivation mechanisms may therefore help us to decipher how intrinsically disordered regions mediate functional effects. Whereas many aspects of inactivation of voltage-dependent K+ channels (Kv) can be described by a simple one-step occlusion mechanism(6,7,18,19), inactivation of the voltage-dependent large-conductance Ca2+-gated K+ (BK) channel mediated by peptide segments of auxiliary beta-subunits involves two distinguishable kinetic steps(20,21). Here we show that two-step inactivation mediated by an intrinsically disordered BK beta-subunit peptide involves a stereospecific binding interaction that precedes blockade. In contrast, blocking mediated by a Shaker Kv inactivation peptide is consistent with direct, simple occlusion by a hydrophobic segment without substantial steric requirement. The results indicate that two distinct types of molecular interaction between disordered peptide segments and their binding sites produce qualitatively similar functions.	[Gonzalez-Perez, Vivian; Zeng, Xu-Hui; Lingle, Christopher J.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Henzler-Wildman, Katie] Washington Univ, Sch Med, Dept Biochem, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Lingle, CJ (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	clingle@morpheus.wustl.edu		Lingle, Christopher/0000-0002-9916-3795; Henzler-Wildman, Katherine/0000-0002-5295-2121	Searle Scholars Program;  [GM-081748]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081748] Funding Source: NIH RePORTER	Searle Scholars Program; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by GM-081748 to C.J.L. and the Searle Scholars Program to K.H.-W. We thank E. Morrison and P. Schlesinger for assistance with dynamic light scattering measurements, and C. Frieden and K. Garai for assistance with circular dichroism spectroscopy. We thank H. Jiang, A. Scott and J. Jones for care of oocytes, and J. H. Steinbach and R. Pappu for comments on the manuscript.	Bentrop D, 2001, J BIOL CHEM, V276, P42116, DOI 10.1074/jbc.M107118200; Brelidze TI, 2005, J GEN PHYSIOL, V126, P105, DOI 10.1085/jgp.200509286; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; De Sancho D, 2012, MOL BIOSYST, V8, P256, DOI 10.1039/c1mb05252g; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Dyson HJ, 2011, Q REV BIOPHYS, V44, P467, DOI 10.1017/S0033583511000060; Galea CA, 2008, J MOL BIOL, V376, P827, DOI 10.1016/j.jmb.2007.12.016; Gonzalez C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1446; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Kondoh S, 1997, J BIOL CHEM, V272, P19333, DOI 10.1074/jbc.272.31.19333; Li WY, 2004, J GEN PHYSIOL, V124, P43, DOI 10.1085/jgp.200409067; Lingle CJ, 2001, J GEN PHYSIOL, V117, P583, DOI 10.1085/jgp.117.6.583; MURRELLLAGNADO RD, 1993, J GEN PHYSIOL, V102, P949, DOI 10.1085/jgp.102.6.949; Prince-Carter A, 2009, J GEN PHYSIOL, V134, P15, DOI 10.1085/jgp.200910219; Rasmusson RL, 1997, ADV EXP MED BIOL, V430, P29; RUPPERSBERG JP, 1991, NATURE, V353, P657, DOI 10.1038/353657a0; Schott MK, 1998, EUR BIOPHYS J BIOPHY, V27, P99, DOI 10.1007/s002490050115; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Tang QY, 2009, J GEN PHYSIOL, V134, P409, DOI 10.1085/jgp.200910251; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003; TSENGCRANK J, 1993, J GEN PHYSIOL, V102, P1057, DOI 10.1085/jgp.102.6.1057; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wilkens CM, 2006, J GEN PHYSIOL, V128, P347, DOI 10.1085/jgp.200609579; Wissmann R, 2003, J BIOL CHEM, V278, P16142, DOI 10.1074/jbc.M210191200; Wissmann R, 1999, J BIOL CHEM, V274, P35521, DOI 10.1074/jbc.274.50.35521; Xia XM, 1999, J NEUROSCI, V19, P5255, DOI 10.1523/jneurosci.19-13-05255.1999; Xia XM, 2000, J NEUROSCI, V20, P4890; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zeng XH, 2003, NAT STRUCT BIOL, V10, P448, DOI 10.1038/nsb932; Zeng XH, 2007, J NEUROSCI, V27, P4707, DOI 10.1523/JNEUROSCI.0758-07.2007; Zeng XH, 2008, J GEN PHYSIOL, V132, P115, DOI 10.1085/jgp.200809969; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou Y, 2011, P NATL ACAD SCI USA, V108, P12161, DOI 10.1073/pnas.1104150108	35	16	16	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					133	U171		10.1038/nature10994	http://dx.doi.org/10.1038/nature10994			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22522931	Green Accepted			2022-12-24	WOS:000303451900049
J	van Ravesteyn, NT; Miglioretti, DL; Stout, NK; Lee, SJ; Schechter, CB; Buist, DSM; Huang, H; Heijnsdijk, EAM; Trentham-Dietz, A; Alagoz, O; Near, AM; Kerlikowske, K; Nelson, HD; Mandelblatt, JS; de Koning, HJ				van Ravesteyn, Nicolien T.; Miglioretti, Diana L.; Stout, Natasha K.; Lee, Sandra J.; Schechter, Clyde B.; Buist, Diana S. M.; Huang, Hui; Heijnsdijk, Eveline A. M.; Trentham-Dietz, Amy; Alagoz, Oguzhan; Near, Aimee M.; Kerlikowske, Karla; Nelson, Heidi D.; Mandelblatt, Jeanne S.; de Koning, Harry J.			Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years A Comparative Modeling Study of Risk	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST-CANCER MORTALITY; FALSE-POSITIVE RECALL; AMERICAN-COLLEGE; FOLLOW-UP; WOMEN; DENSITY; IMPACT; TRIAL; PERFORMANCE; THERAPY	Background: Timing of initiation of screening for breast cancer is controversial in the United States. Objective: To determine the threshold relative risk (RR) at which the harm-benefit ratio of screening women aged 40 to 49 years equals that of biennial screening for women aged 50 to 74 years. Design: Comparative modeling study. Data Sources: Surveillance, Epidemiology, and End Results program, Breast Cancer Surveillance Consortium, and medical literature. Target Population: A contemporary cohort of women eligible for routine screening. Time Horizon: Lifetime. Perspective: Societal. Intervention: Mammography screening starting at age 40 versus 50 years with different screening methods (film, digital) and screening intervals (annual, biennial). Outcome Measures: Benefits: life-years gained, breast cancer deaths averted; harms: false-positive mammography findings; harm-benefit ratios: false-positive findings/life-years gained, false-positive findings/deaths averted. Results of Base-Case Analysis: Screening average-risk women aged 50 to 74 years biennially yields the same false-positive findings/life-years gained as biennial screening with digital mammography starting at age 40 years for women with a 2-fold increased risk above average (median threshold RR, 1.9 [range across models, 1.5 to 4.4]). The threshold RRs are higher for annual screening with digital mammography (median, 4.3 [range, 3.3 to 10]) and when false-positive findings/deaths averted is used as an outcome measure instead of false-positive findings/life-years gained. The harm-benefit ratio for film mammography is more favorable than for digital mammography because film has a lower false-positive rate. Results of Sensitivity Analysis: The threshold RRs changed slightly when a more comprehensive measure of harm was used and were relatively insensitive to lower adherence assumptions. Limitation: Risk was assumed to influence onset of disease without influencing screening performance. Conclusion: Women aged 40 to 49 years with a 2-fold increased risk have similar harm-benefit ratios for biennial screening mammography as average-risk women aged 50 to 74 years. Threshold RRs required for favorable harm-benefit ratios vary by screening method, interval, and outcome measure.	[van Ravesteyn, Nicolien T.] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands; Univ Washington, Seattle, WA 98195 USA; Harvard Univ, Sch Med, Harvard Pilgrim Hlth Care Inst, Boston, MA USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Albert Einstein Coll Med, Bronx, NY 10467 USA; Univ Wisconsin, Madison, WI USA; Georgetown Univ, Med Ctr, Washington, DC 20007 USA; Lombardi Comprehens Canc Ctr, Canc Prevent & Control Program, Washington, DC USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; San Francisco VA Med Ctr, San Francisco, CA USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Providence Hlth & Serv, Providence Canc Ctr, Portland, OR USA	Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Yeshiva University; Albert Einstein College of Medicine; University of Wisconsin System; University of Wisconsin Madison; Georgetown University; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Oregon Health & Science University	van Ravesteyn, NT (corresponding author), Erasmus MC, Dept Publ Hlth, POB 2040, NL-3000 CA Rotterdam, Netherlands.	n.vanravesteyn@erasmusmc.nl	de+Koning, Harry/AAF-9062-2019	de+Koning, Harry/0000-0003-4682-3646; Alagoz, Oguzhan/0000-0002-5133-1382	National Cancer Institute [U01CA086076-10S1, U01CA88283, U01CA152958, KO5CA96940, U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, U01CA70040]; BCSC; NATIONAL CANCER INSTITUTE [K05CA096940, P01CA154292, U01CA086082, U01CA063736, U01CA069976, U01CA088283, U01CA070040, U01CA152958, U01CA086076, U01CA070013, U01CA063740, U01CA063731] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BCSC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The collection of BCSC cancer data used in this study was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of these sources, please see www.breastscreening.cancer.gov/work/acknowledgement.html. This research was supported by a National Cancer Institute Activities to Promote Research Collaboration supplement (U01CA086076-10S1), and, in part, by National Cancer Institute grants U01CA88283, U01CA152958, and KO5CA96940. Data collection was supported by the BCSC funded by the National Cancer Institute cooperative agreements U01CA63740, U01CA86076, U01CA86082, U01CA63736, U01CA70013, U01CA69976, U01CA63731, and U01CA70040.	Armstrong K, 2007, ANN INTERN MED, V146, P516, DOI 10.7326/0003-4819-146-7-200704030-00008; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; Bluekens AMJ, 2010, EUR RADIOL, V20, P2067, DOI 10.1007/s00330-010-1786-7; Buist DSM, 2004, JNCI-J NATL CANCER I, V96, P1432, DOI 10.1093/jnci/djh269; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Carney PA, 2003, ANN INTERN MED, V138, P168, DOI 10.7326/0003-4819-138-3-200302040-00008; Cronin Kathleen A, 2006, J Natl Cancer Inst Monogr, P26, DOI 10.1093/jncimonographs/lgj005; de Gelder R, 2011, BRIT J CANCER, V104, P1214, DOI 10.1038/bjc.2011.67; de Gelder R, 2008, INT J CANCER, V123, P680, DOI 10.1002/ijc.23540; DEHAES JCJM, 1991, INT J CANCER, V49, P538, DOI 10.1002/ijc.2910490411; Fryback Dennis G, 2006, J Natl Cancer Inst Monogr, P37, DOI 10.1093/jncimonographs/lgj007; Gilbert FJ, 1998, EUR J CANCER, V34, P2010, DOI 10.1016/S0959-8049(98)00294-9; Holford Theodore R, 2006, J Natl Cancer Inst Monogr, P19, DOI 10.1093/jncimonographs/lgj016; Hubbard RA, 2011, ANN INTERN MED, V155, P481, DOI 10.7326/0003-4819-155-8-201110180-00004; Karssemeijer N, 2009, RADIOLOGY, V253, P353, DOI 10.1148/radiol.2532090225; Kerlikowske K, 2000, ANN INTERN MED, V133, P855, DOI 10.7326/0003-4819-133-11-200012050-00009; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Kerlikowske K, 2009, ANN INTERN MED, V151, P750, DOI 10.7326/0003-4819-151-10-200911170-00012; Lee Sandra, 2006, J Natl Cancer Inst Monogr, P79, DOI 10.1093/jncimonographs/lgj011; Lee SJ, 2003, ANN ONCOL, V14, P1199, DOI 10.1093/annonc/mdg323; Mandelblatt Jeanne, 2006, J Natl Cancer Inst Monogr, P47, DOI 10.1093/jncimonographs/lgj008; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; MOSKOWITZ M, 1986, RADIOLOGY, V161, P37, DOI 10.1148/radiology.161.1.3532183; Moss SM, 2006, LANCET, V368, P2053, DOI 10.1016/S0140-6736(06)69834-6; Nelson HD, 2009, 1005142EF1 AHRQ; Nelson HD, 2012, ANN INTERN MED, V156, P635, DOI 10.7326/0003-4819-156-9-201205010-00006; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Otto SJ, 2003, LANCET, V361, P1411, DOI 10.1016/S0140-6736(03)13132-7; Partridge AH, 2009, NEW ENGL J MED, V361, P2499, DOI 10.1056/NEJMp0911288; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Rosenberg Marjorie A, 2006, J Natl Cancer Inst Monogr, P15, DOI 10.1093/jncimonographs/lgj004; Schousboe JT, 2011, ANN INTERN MED, V155, P10, DOI 10.7326/0003-4819-155-1-201107050-00003; Stout NK, 2006, JNCI-J NATL CANCER I, V98, P774, DOI 10.1093/jnci/djj210; Tabar L, 2000, RADIOL CLIN N AM, V38, P625, DOI 10.1016/S0033-8389(05)70191-3; TABAR L, 1995, CANCER, V75, P2507, DOI 10.1002/1097-0142(19950515)75:10<2507::AID-CNCR2820751017>3.0.CO;2-H; Tan Sita Y G L, 2006, J Natl Cancer Inst Monogr, P56, DOI 10.1093/jncimonographs/lgj009; Taylor P, 2010, J MED SCREEN, V17, P31, DOI 10.1258/jms.2009.009048; Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004; U.S. Food and Drug Administration, 2011, MAMM QUAL STAND ACT; U.S. Preventive Services Task Force, 2011, SCREEN BREAST CANC; van Ravesteyn NT, 2011, BRIT J CANCER, V105, P1082, DOI 10.1038/bjc.2011.300; Wai ES, 2005, BRIT J CANCER, V92, P961, DOI 10.1038/sj.bjc.6602393; White E, 2004, JNCI-J NATL CANCER I, V96, P1832, DOI 10.1093/jnci/djh337; Yaffe MJ, 2011, RADIOLOGY, V258, P98, DOI 10.1148/radiol.10100655	48	93	93	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	2012	156	9					609	U39		10.7326/0003-4819-156-9-201205010-00002	http://dx.doi.org/10.7326/0003-4819-156-9-201205010-00002			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933YR	22547470	Green Accepted			2022-12-24	WOS:000303403700001
J	Sommers, BD; Bindman, AB				Sommers, Benjamin D.; Bindman, Andrew B.			New Physicians, the Affordable Care Act, and the Changing Practice of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sommers, Benjamin D.; Bindman, Andrew B.] US Dept Hlth & Human Serv, Off Hlth Policy, Off Assistant Secretary Planning & Evaluat, Washington, DC 20201 USA; [Sommers, Benjamin D.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Bindman, Andrew B.] Univ Calif San Francisco, Dept Med Hlth Policy Epidemiol & Biostat, San Francisco, CA 94143 USA	Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco	Sommers, BD (corresponding author), US Dept Hlth & Human Serv, Off Hlth Policy, Off Assistant Secretary Planning & Evaluat, 200 Independence Ave SW,Room 447D, Washington, DC 20201 USA.	bsommers@hsph.harvard.edu						Association of American Medical Colleges, 2000, APPL 1 TIM APPL ACC; Deloitte Center for Health Solutions, PHYS PERSP HLTH CAR; Emanuel EJ, 2012, JAMA-J AM MED ASSOC, V307, P367, DOI 10.1001/jama.2012.19; Huntoon KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023557; National Resident Matching Program, RES MATCH DAT 2011; Thomson-Reuters, 2011 NAT PHYS SURV F	6	27	27	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1697	1698		10.1001/jama.2012.523	http://dx.doi.org/10.1001/jama.2012.523			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930OA	22535852				2022-12-24	WOS:000303147500020
J	Neudecker, P; Robustelli, P; Cavalli, A; Walsh, P; Lundstrom, P; Zarrine-Afsar, A; Sharpe, S; Vendruscolo, M; Kay, LE				Neudecker, Philipp; Robustelli, Paul; Cavalli, Andrea; Walsh, Patrick; Lundstroem, Patrik; Zarrine-Afsar, Arash; Sharpe, Simon; Vendruscolo, Michele; Kay, Lewis E.			Structure of an Intermediate State in Protein Folding and Aggregation	SCIENCE			English	Article							AMYLOID FORMATION; COMMON MECHANISM; OLIGOMERS; DYNAMICS; FIBRILS; PATHWAY; IMPLIES; DOMAIN	Protein-folding intermediates have been implicated in amyloid fibril formation involved in neurodegenerative disorders. However, the structural mechanisms by which intermediates initiate fibrillar aggregation have remained largely elusive. To gain insight, we used relaxation dispersion nuclear magnetic resonance spectroscopy to determine the structure of a low-populated, on-pathway folding intermediate of the A39V/N53P/V55L (A, Ala; V, Val; N, Asn; P, Pro; L, Leu) Fyn SH3 domain. The carboxyl terminus remains disordered in this intermediate, thereby exposing the aggregation-prone amino-terminal beta strand. Accordingly, mutants lacking the carboxyl terminus and thus mimicking the intermediate fail to safeguard the folding route and spontaneously form fibrillar aggregates. The structure provides a detailed characterization of the non-native interactions stabilizing an aggregation-prone intermediate under native conditions and insight into how such an intermediate can derail folding and initiate fibrillation.	[Neudecker, Philipp; Walsh, Patrick; Lundstroem, Patrik; Zarrine-Afsar, Arash; Sharpe, Simon; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Neudecker, Philipp; Lundstroem, Patrik; Zarrine-Afsar, Arash; Kay, Lewis E.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Neudecker, Philipp; Lundstroem, Patrik; Kay, Lewis E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Neudecker, Philipp] Univ Dusseldorf, Inst Phys, D-40225 Dusseldorf, Germany; [Neudecker, Philipp] Forschungszentrum Julich, D-52425 Julich, Germany; [Robustelli, Paul; Cavalli, Andrea; Vendruscolo, Michele] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Walsh, Patrick; Sharpe, Simon; Kay, Lewis E.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada	University of Toronto; University of Toronto; University of Toronto; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; University of Cambridge; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kay, LE (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada.	kay@pound.med.utoronto.ca	Neudecker, Philipp/G-5265-2013; Cavalli, Andrea/L-9147-2013; Vendruscolo, Michele/F-5901-2012; Neudecker, Philipp/AAP-9005-2020; Walsh, Patrick/ABG-2479-2020	Neudecker, Philipp/0000-0002-0557-966X; Vendruscolo, Michele/0000-0002-3616-1610; Neudecker, Philipp/0000-0002-0557-966X; Cavalli, Andrea/0000-0003-4063-4502; Robustelli, Paul/0000-0002-9282-8993	Gates Cambridge Scholarship; NSF; Natural Sciences and Engineering Research Council of Canada (NSERC); NSERC; Canadian Institutes of Health Research	Gates Cambridge Scholarship; NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank J. Forman-Kay and A. Davidson for providing laboratory space. S.S. and L.E.K. hold Canada Research Chairs in Biochemistry. P.R. was funded by a Gates Cambridge Scholarship and an NSF Graduate Research Fellowship, and P.W. is funded by a Natural Sciences and Engineering Research Council of Canada (NSERC) Canada Graduate Scholarship. This work was supported by grants from the NSERC and the Canadian Institutes of Health Research (L.E.K). The ensembles of 10 structures each representing the A39V/N53P/V55L Fyn SH3 domain native state from Ser<SUP>1</SUP> to Asp<SUP>59</SUP> and the folding intermediate from Ser<SUP>1</SUP> to Ala<SUP>56</SUP> have been deposited with the Protein Data Bank (accession codes 2LP5 and 2L2P, respectively).	Bai YW, 2006, CHEM REV, V106, P1757, DOI 10.1021/cr040432i; Bayro MJ, 2010, BIOCHEMISTRY-US, V49, P7474, DOI 10.1021/bi100864t; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Capaldi AP, 1998, CURR OPIN STRUC BIOL, V8, P86, DOI 10.1016/S0959-440X(98)80014-6; Carullaa N, 2009, P NATL ACAD SCI USA, V106, P7828, DOI 10.1073/pnas.0812227106; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Eakin CM, 2006, NAT STRUCT MOL BIOL, V13, P202, DOI 10.1038/nsmb1068; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Jahn TR, 2006, NAT STRUCT MOL BIOL, V13, P195, DOI 10.1038/nsmb1058; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Martin-Garcia JM, 2007, FEBS LETT, V581, P1701, DOI 10.1016/j.febslet.2007.03.059; Morel B, 2010, BIOPHYS J, V99, P3801, DOI 10.1016/j.bpj.2010.10.039; Neudecker P, 2007, P NATL ACAD SCI USA, V104, P15717, DOI 10.1073/pnas.0705097104; Neudecker P, 2006, J MOL BIOL, V363, P958, DOI 10.1016/j.jmb.2006.08.047; Neudecker P, 2009, BIOPHYS J, V96, P2045, DOI 10.1016/j.bpj.2008.12.3907; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Pechmann S, 2009, P NATL ACAD SCI USA, V106, P10159, DOI 10.1073/pnas.0812414106; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Riddle DS, 1999, NAT STRUCT BIOL, V6, P1016; Robustelli P, 2010, STRUCTURE, V18, P923, DOI 10.1016/j.str.2010.04.016; Roychaudhuri R, 2009, J BIOL CHEM, V284, P4749, DOI 10.1074/jbc.R800036200; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105; Varela L, 2009, FEBS LETT, V583, P801, DOI 10.1016/j.febslet.2009.01.033; Zarrine-Afsar A, 2008, P NATL ACAD SCI USA, V105, P9999, DOI 10.1073/pnas.0801874105	32	283	284	6	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					362	366		10.1126/science.1214203	http://dx.doi.org/10.1126/science.1214203			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517863				2022-12-24	WOS:000302995400051
J	Hellinger, WC; Bacalis, LP; Kay, RS; Thompson, ND; Xia, GL; Lin, YL; Khudyakov, YE; Perz, JF				Hellinger, Walter C.; Bacalis, Laura P.; Kay, Robyn S.; Thompson, Nicola D.; Xia, Guo-Liang; Lin, Yulin; Khudyakov, Yury E.; Perz, Joseph F.			Health Care-Associated Hepatitis C Virus Infections Attributed to Narcotic Diversion	ANNALS OF INTERNAL MEDICINE			English	Article							OPERATING-ROOM; UNITED-STATES; TRANSMISSION; ANESTHESIOLOGIST; PERSONNEL; PATIENT; WORKERS; SYSTEM; ORGAN; TIME	Background: Three cases of genetically related hepatitis C virus (HCV) infection that were unattributable to infection control breaches were identified at a health care facility. Objective: To investigate HCV transmission from an HCV-infected health care worker to patients through drug diversion. Design: Cluster and look-back investigations. Setting: Acute care hospital and affiliated multispecialty clinic. Patients: Inpatients and outpatients during the period of HCV transmission. Measurements: Employee work and narcotic dispensing records, blood testing for HCV antibody and RNA, and sequencing of the NS5B gene and the hypervariable region 1 of the E2 gene. Results: 21 employees were recorded as being at work or as retrieving a narcotic from an automated dispensing cabinet in an area where a narcotic was administered to each of the 3 case patients; all employees provided blood samples for HCV testing. One employee was infected with HCV that had more than 95% NS5B sequence homology with the HCV strains of the 3 case patients. Quasi-species analysis showed close genetic relatedness with variants from each of the case patients and more than 97.9% nucleotide identity. The employee acknowledged parenteral opiate diversion. An investigation identified 6132 patients at risk for exposure to HCV because of the drug diversion. Of the 3929 living patients, 3444 (87.7%) were screened for infection. Two additional cases of genetically related HCV infection attributable to the employee were identified. Limitation: Of the living patients at risk for HCV exposure, 12.3% were not tested. Conclusion: Five cases of HCV infection occurring over 3 to 4 years were attributed to drug diversion by an HCV-infected health care worker. Studies of drug diversion and assessments of strategies to prevent narcotics tampering in all health care settings are needed.	[Hellinger, Walter C.] Mayo Clin, Div Infect Dis, Jacksonville, FL 32224 USA; Florida Dept Hlth, Tallahassee, FL USA; Ctr Dis Control & Prevent, Atlanta, GA USA	Mayo Clinic; Florida Department of Health; Centers for Disease Control & Prevention - USA	Hellinger, WC (corresponding author), Mayo Clin, Div Infect Dis, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	helling@mayo.edu						Berge KH, 2008, ANESTHESIOLOGY, V109, P762, DOI 10.1097/ALN.0b013e31818a3814; Bosch X, 2000, LANCET, V355, P818, DOI 10.1016/S0140-6736(05)72446-6; Cody SH, 2002, ARCH INTERN MED, V162, P345, DOI 10.1001/archinte.162.3.345; Colorado Department of Public Health and Environment, 2009, FAQS COL HEP C INV; Domino KB, 2005, JAMA-J AM MED ASSOC, V293, P1453, DOI 10.1001/jama.293.12.1453; Dudzinski DM, 2010, NEW ENGL J MED, V363, P978, DOI 10.1056/NEJMhle1003134; Dunn D, 2005, AORN J, V82, P599; Dunn D, 2005, AORN J, V82, P592, DOI [DOI 10.1016/S0001-2092(06)60028-8, 10.1016/S0001-2092(06) 60028-8]; Dunn Debra, 2005, AORN J, V82, P573; Dunn S., 2005, AORN J, V82; Epstein RH, 2007, ANESTH ANALG, V105, P1053, DOI 10.1213/01.ane.0000281797.00935.08; Hadfield S, 2011, HEPATITIS C WOMAN LA; Henderson DK, 2010, INFECT CONT HOSP EP, V31, P203, DOI 10.1086/650298; Lee KC, 2005, 43 ANN M INF DIS SOC; MAKI DG, 1991, JAMA-J AM MED ASSOC, V265, P981, DOI 10.1001/jama.265.8.981; Nainan OV, 2006, GASTROENTEROLOGY, V131, P478, DOI 10.1053/j.gastro.2006.06.007; Ostrowsky BE, 2002, NEW ENGL J MED, V346, P1529, DOI 10.1056/NEJMoa012370; Perz Joseph F, 2010, Clin Liver Dis, V14, P137, DOI 10.1016/j.cld.2009.11.004; Ramachandran S, 2008, J VIROL METHODS, V151, P217, DOI 10.1016/j.jviromet.2008.05.005; Ross RS, 2000, NEW ENGL J MED, V343, P1851, DOI 10.1056/NEJM200012213432505; SCHMIDT KA, 1993, ANESTHESIOLOGY, V78, P184, DOI 10.1097/00000542-199301000-00025; SEHULSTER L, 1997, P INT C ANT AG CHEM, P293; Shemer-Avni Y, 2007, CLIN INFECT DIS, V45, pE32, DOI 10.1086/520014; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 1996, DHHS PUBL; Thompson ND, 2009, TRANSPL INFECT DIS, V11, P324, DOI 10.1111/j.1399-3062.2009.00406.x; Thompson ND, 2009, ANN INTERN MED, V150, P33, DOI 10.7326/0003-4819-150-1-200901060-00007; Tugwell BD, 2005, ANN INTERN MED, V143, P648, DOI 10.7326/0003-4819-143-9-200511010-00008; Williams IT, 2006, J CLIN VIROL, V36, pS43, DOI 10.1016/S1386-6532(06)80135-6; Williams IT, 2004, CLIN INFECT DIS, V38, P1592, DOI 10.1086/420935; Willock M, 1998, INT ANESTHESIOL CLIN, V36, P65, DOI 10.1097/00004311-199803610-00009	31	22	22	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					477	U34		10.7326/0003-4819-156-7-201204030-00002	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00002			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921GP	22473434				2022-12-24	WOS:000302466400001
J	Jacob, NP				Jacob, Nitya P.			Investigating Arabia Mountain: A Molecular Approach	SCIENCE			English	Editorial Material							COMMUNITIES		Emory Univ, Oxford Coll, Oxford, GA 30054 USA	Emory University	Jacob, NP (corresponding author), Emory Univ, Oxford Coll, Oxford, GA 30054 USA.	njacob@emory.edu						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ash C, 2008, SCIENCE, V320, P1027, DOI 10.1126/science.320.5879.1027; BURBANCK MP, 1964, ECOLOGY, V45, P292, DOI 10.2307/1933842; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; HOULE G, 1989, VEGETATIO, V80, P25, DOI 10.1007/BF00049138; Jacob N., 2008, J COLL SCI TEACH, V38, P54; Jacob N., 2008, COUNCIL UNDERGRAD RE, V29, P24; Morgan J. G., 2011, INVESTIGATING BIOL; Zul D, 2007, APPL ENVIRON MICROB, V73, P6916, DOI 10.1128/AEM.01533-07	9	5	5	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1588	1589		10.1126/science.1213692	http://dx.doi.org/10.1126/science.1213692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461602				2022-12-24	WOS:000302062600034
J	Kesselheim, AS; Karlawish, J				Kesselheim, Aaron S.; Karlawish, Jason			Biomarkers Unbound - The Supreme Court's Ruling on Diagnostic-Test Patents	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Karlawish, Jason] Univ Penn, Dept Med, Ctr Neurosci & Soc, Alzheimers Dis Ctr, Philadelphia, PA 19104 USA; [Karlawish, Jason] Univ Penn, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Kesselheim, Aaron S.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; University of Pennsylvania; University of Pennsylvania; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.		Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Kesselheim AS, 2006, NEW ENGL J MED, V355, P2036, DOI 10.1056/NEJMhpr063626; Williams H. L., 2010, W16213 NAT BUR EC RE	2	10	10	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 21	2012	366	25					2338	2340		10.1056/NEJMp1204164	http://dx.doi.org/10.1056/NEJMp1204164			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	961GH	22621421	Green Published			2022-12-24	WOS:000305451700002
J	Shibata, D				Shibata, Darryl			Heterogeneity and Tumor History	SCIENCE			English	Editorial Material							EVOLUTION; CANCER; GENOME; METASTASIS		Univ So Calif, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Shibata, D (corresponding author), Univ So Calif, Keck Sch Med, 1441 Eastlake Ave,NOR2424, Los Angeles, CA 90033 USA.	dshibata@usc.edu			NCI NIH HHS [R21 CA149990] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA149990] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Longo DL, 2012, NEW ENGL J MED, V366, P956, DOI 10.1056/NEJMe1200656; Navin N, 2010, GENOME RES, V20, P68, DOI 10.1101/gr.099622.109; Siegmund KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021657; Wang TL, 2002, P NATL ACAD SCI USA, V99, P3076, DOI 10.1073/pnas.261714699; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	10	73	76	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					304	305		10.1126/science.1222361	http://dx.doi.org/10.1126/science.1222361			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517848				2022-12-24	WOS:000302995400032
J	Mills, EJ; Barnighausen, T; Negin, J				Mills, Edward J.; Baernighausen, Till; Negin, Joel			HIV and Aging - Preparing for the Challenges Ahead	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							AFRICA		[Mills, Edward J.] Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada; [Baernighausen, Till] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Baernighausen, Till] Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Negin, Joel] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Ottawa; Harvard University; Harvard T.H. Chan School of Public Health; University of Kwazulu Natal; University of Sydney	Mills, EJ (corresponding author), Univ Ottawa, Fac Hlth Sci, Ottawa, ON K1N 6N5, Canada.		Bärnighausen, Till/Y-2388-2019		EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD058482] Funding Source: Medline; Wellcome Trust [097410] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Hontelez JAC, 2011, AIDS, V25, P1665, DOI 10.1097/QAD.0b013e32834982ea; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; UNAIDS, 2010, REP GLOB AIDS EP	5	104	107	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1270	1273		10.1056/NEJMp1113643	http://dx.doi.org/10.1056/NEJMp1113643			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475591				2022-12-24	WOS:000302343000004
J	Liu, LD; Ulbrich, J; Muller, J; Wustefeld, T; Aeberhard, L; Kress, TR; Muthalagu, N; Rycak, L; Rudalska, R; Moll, R; Kempa, S; Zender, L; Eilers, M; Murphy, DJ				Liu, Lidan; Ulbrich, Jannes; Mueller, Judith; Wuestefeld, Torsten; Aeberhard, Lukas; Kress, Theresia R.; Muthalagu, Nathiya; Rycak, Lukas; Rudalska, Ramona; Moll, Roland; Kempa, Stefan; Zender, Lars; Eilers, Martin; Murphy, Daniel J.			Deregulated MYC expression induces dependence upon AMPK-related kinase 5	NATURE			English	Article							SYNTHETIC LETHAL INTERACTION; C-MYC; MITOCHONDRIAL BIOGENESIS; CANCER-CELLS; B KINASE; METABOLISM; SUPPRESSION; GLUTAMINE; ADDICTION; GROWTH	Deregulated expression of the MYC oncoprotein contributes to the genesis of many human tumours, yet strategies to exploit this for a rational tumour therapy are scarce. MYC promotes cell growth and proliferation, andalters cellularmetabolismto enhance the provision of precursors for phospholipids and cellularmacromolecules(1,2). Here we showinhuman andmurine cell lines thatoncogenic levels ofMYC establish a dependence on AMPK-related kinase 5 (ARK5; also known as NUAK1) for maintaining metabolic homeostasis and for cell survival. ARK5 is an upstream regulator of AMPK and limits protein synthesis via inhibition of the mammalian target of rapamycin 1 (mTORC1) signalling pathway. ARK5 also maintains expression of mitochondrial respiratory chain complexes and respiratory capacity, which is required for efficient glutamine metabolism. Inhibition of ARK5 leads to a collapse of cellular ATP levels in cells expressing deregulated MYC, inducing multiple pro-apoptotic responses as a secondary consequence. Depletion of ARK5 prolongs survival in MYC-driven mouse models of hepatocellular carcinoma, demonstrating that targeting cellular energy homeostasis is a valid therapeutic strategy to eliminate tumour cells that express deregulated MYC.	[Liu, Lidan; Ulbrich, Jannes; Mueller, Judith; Kress, Theresia R.; Muthalagu, Nathiya; Eilers, Martin; Murphy, Daniel J.] Univ Wurzburg, Bioctr, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Wuestefeld, Torsten; Rudalska, Ramona; Zender, Lars] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Wuestefeld, Torsten; Zender, Lars] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Aeberhard, Lukas; Kempa, Stefan] Berlin Inst Med Syst Biol, Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Rycak, Lukas] Inst Mol Biol & Tumor Res, D-35037 Marburg, Germany; [Moll, Roland] Univ Marburg, Inst Pathol, D-35033 Marburg, Germany	University of Wurzburg; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Philipps University Marburg	Eilers, M (corresponding author), Univ Wurzburg, Bioctr, Theodor Boveri Inst, Hubland, D-97074 Wurzburg, Germany.	martin.eilers@biozentrum.uni-wuerzburg.de; daniel.murphy@biozentrum.uni-wuerzburg.de	kempa, stefan/C-5213-2008; Murphy, Daniel/V-1079-2019	kempa, stefan/0000-0002-0696-9299; Murphy, Daniel/0000-0002-5538-5468; Eilers, Martin/0000-0002-0376-6533	GROWTHSTOP consortium of the European Union; Deutsche Forschungsgemeinschaft [Transregio 17, Transregio 77]; Emmy Noether Programme [ZE 545/2-1]; Bundesministerium fur Bildung und Forschung; Senate of Berlin; University of Wuerzburg Graduate School of Life Sciences and the "Rebirth" Cluster of Excellence	GROWTHSTOP consortium of the European Union; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Emmy Noether Programme(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Senate of Berlin; University of Wuerzburg Graduate School of Life Sciences and the "Rebirth" Cluster of Excellence	We thank R. Baumann for immunohistochemical staining, B. Samans, A. Filmer and M. Krause for help with the siRNA screen and expression array analysis, A. Rath for help with analysis of human tumour samples, W. Kolch for siRNA targeting LATS1, S. Lowe and J. Zuber for providing the tTGMP vector, S. Martin for His-tagged annexin V expression vector, P. Schirmacher for human HCC cell lines, V. Ellenrieder for human pancreatic cancer cell lines, H. Riedesel and the staff of the Helmholtz Centre for Infection Research animal facility for technical assistance. We thank P. Gallant and all members of the Eilers laboratory for critical reading of the manuscript. Funding for this work was provided by the GROWTHSTOP consortium of the European Union, the Deutsche Forschungsgemeinschaft via the Transregio 17 (M. E.), the Transregio 77 (L.Z.) and the Emmy Noether Programme ZE 545/2-1 (L.Z.), the Bundesministerium fur Bildung und Forschung, the Senate of Berlin, the University of Wuerzburg Graduate School of Life Sciences and the "Rebirth" Cluster of Excellence.	Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; BISSONNETTE RP, 1992, NATURE, V359, P552, DOI 10.1038/359552a0; Campaner S, 2010, NAT CELL BIOL, V12, P54, DOI 10.1038/ncb2004; Carayol N, 2010, P NATL ACAD SCI USA, V107, P12469, DOI 10.1073/pnas.1005114107; Choo AY, 2010, MOL CELL, V38, P487, DOI 10.1016/j.molcel.2010.05.007; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Humbert N, 2010, EMBO J, V29, P376, DOI 10.1038/emboj.2009.342; Kempa S, 2007, PLANT J, V49, P1076, DOI 10.1111/j.1365-313X.2006.03025.x; Kempa S, 2009, J BASIC MICROB, V49, P82, DOI 10.1002/jobm.200800337; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Suzuki A, 2004, MOL CELL BIOL, V24, P3526, DOI 10.1128/MCB.24.8.3526-3535.2004; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zender L, 2008, CELL, V135, P852, DOI 10.1016/j.cell.2008.09.061; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zuber J, 2011, NAT BIOTECHNOL, V29, P79, DOI 10.1038/nbt.1720	33	198	211	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					608	U131		10.1038/nature10927	http://dx.doi.org/10.1038/nature10927			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460906	Bronze			2022-12-24	WOS:000302006100041
J	Corliss, J				Corliss, Julie			EXERCISE Powering up	NATURE			English	Editorial Material							AEROBIC EXERCISE; MECHANISMS											Friedenreich CM, 2011, RECENT RESULTS CANC, V188, P125, DOI 10.1007/978-3-642-10858-7_11; Ibrahim EM, 2011, MED ONCOL, V28, P753, DOI 10.1007/s12032-010-9536-x; Irwin ML, 2009, CANCER EPIDEM BIOMAR, V18, P306, DOI 10.1158/1055-9965.EPI-08-0531; Scott JM, 2011, CIRCULATION, V124, P642, DOI 10.1161/CIRCULATIONAHA.111.021774; Zeng HM, 2012, BREAST CANCER RES TR, V133, P127, DOI 10.1007/s10549-011-1716-7	5	0	0	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S62	S63		10.1038/485S62a	http://dx.doi.org/10.1038/485S62a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648503	Bronze			2022-12-24	WOS:000304608000007
J	Whitaker, M; Guo, J; Kehoe, T; Benson, G				Whitaker, Marcea; Guo, Jia; Kehoe, Theresa; Benson, George			Bisphosphonates for Osteoporosis - Where Do We Go from Here?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FRACTURE; TRIAL; ALENDRONATE; EXTENSION; WOMEN; FLEX		[Whitaker, Marcea; Kehoe, Theresa; Benson, George] US FDA, Div Reprod & Urol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Guo, Jia] US FDA, Div Biometr 3, Off Biostat, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Whitaker, M (corresponding author), US FDA, Div Reprod & Urol Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; Food and Drug Administration, 2011, BACKGR DOC M ADV COM; Mellstrom DD, 2004, CALCIFIED TISSUE INT, V75, P462, DOI 10.1007/s00223-004-0286-7; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11	5	246	253	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2048	2051		10.1056/NEJMp1202619	http://dx.doi.org/10.1056/NEJMp1202619			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22571168				2022-12-24	WOS:000304613400003
J	Park, PG; Frankl, FEK				Park, Peter G., Jr.; Frankl, Fiona E. Karet			Gitelman syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Frankl, Fiona E. Karet] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Frankl, Fiona E. Karet] Addenbrookes Hosp, Cambridge Inst Med Res, Div Renal Med, Cambridge CB2 0XY, England; [Park, Peter G., Jr.] RAF Molesworth, Huntingdon, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Frankl, FEK (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England.	fek1000@cam.ac.uk		Karet, Fiona/0000-0002-2457-2869					0	4	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 29	2012	344								e3590	10.1136/bmj.e3590	http://dx.doi.org/10.1136/bmj.e3590			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953GT	22645210	Bronze			2022-12-24	WOS:000304855700013
J	Kamerow, D				Kamerow, Douglas			YANKEE DOODLING Television shows and education about sexually transmitted infections: no laughing matter	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957				CDC, GEN HPV INF FACT SHE; Centers for Disease Control and Prevention (CDC), GAT HLTH COMM SOC MA; Murphy ST, 2008, HLTH IS PRIME TIME A; Rabin RC, 2012, NY TIMES, pD5	4	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 23	2012	344								e3614	10.1136/bmj.e3614	http://dx.doi.org/10.1136/bmj.e3614			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QT	22623638				2022-12-24	WOS:000304591500014
J	Shiomi, H; Nakagawa, Y; Morimoto, T; Furukawa, Y; Nakano, A; Shirai, S; Taniguchi, R; Yamaji, K; Nagao, K; Suyama, T; Mitsuoka, H; Araki, M; Takashima, H; Mizoguchi, T; Eisawa, H; Sugiyama, S; Kimura, T				Shiomi, Hiroki; Nakagawa, Yoshihisa; Morimoto, Takeshi; Furukawa, Yutaka; Nakano, Akira; Shirai, Shinichi; Taniguchi, Ryoji; Yamaji, Kyohei; Nagao, Kazuya; Suyama, Tamaki; Mitsuoka, Hirokazu; Araki, Makoto; Takashima, Hiroyuki; Mizoguchi, Tetsu; Eisawa, Hiroshi; Sugiyama, Seigo; Kimura, Takeshi		CREDO-Kyoto AMI Investigators	Association of onset to balloon and door to balloon time with long term clinical outcome in patients with ST elevation acute myocardial infarction having primary percutaneous coronary intervention: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TO-BALLOON; REPERFUSION STRATEGIES; MORTALITY; ANGIOPLASTY; TRENDS; MANAGEMENT; IMPROVE	Objective To evaluate the relation of symptom onset to balloon time and door to balloon time with long term clinical outcome in patients with ST segment elevation myocardial infarction (STEMI) having primary percutaneous coronary intervention. Design Observation of large cohort of patients with acute myocardial infarction. Setting 26 tertiary hospitals in Japan. Participants 3391 patients with STEMI who had primary percutaneous coronary intervention within 24 hours of symptom onset. Main outcome measures Composite of death and congestive heart failure, compared by onset to balloon time and door to balloon time. Results Compared with an onset to balloon time greater than 3 hours, a time of less than 3 hours was associated with a lower incidence of a composite of death and congestive heart failure (13.5% (123/964) v 19.2% (429/2427), P<0.001; relative risk reduction 29.7%). After adjustment for confounders, a short onset to balloon time was independently associated with a lower risk of the composite endpoint (adjusted hazard ratio 0.70, 95% confidence interval 0.56 to 0.88; P=0.002). However, no significant difference was found in the incidence of a composite of death and congestive heart failure between the two groups of patients with short (<= 90 minutes) and long (>90 minutes) door to balloon time (16.7% (270/1671) v 18.4% (282/1720), P=0.54; relative risk reduction 9.2%). After adjustment for confounders, no significant difference was seen in the risk of the composite endpoint between the two groups of patients with short and long door to balloon time (adjusted hazard ratio: 0.98, 0.78 to 1.24: P=0.87). A door to balloon time of less than 90 minutes was associated with a lower incidence of a composite of death and congestive heart failure in patients who presented within 2 hours of symptom onset (11.9% (74/883) v 18.1% (147/655), P=0.01; relative risk reduction 34.3%) but not in patients who presented later (19.7% (196/788) v 18.7% (135/1065), P=0.44; -5.3%). Short door to balloon time was independently associated with a lower risk of a composite of death and congestive heart failure in patients with early presentation (adjusted hazard ratio 0.58, 0.38 to 0.87; P=0.009) but not in patients with delayed presentation (1.57, 1.12 to 2.18; P=0.008). A significant interaction was seen between door to balloon time and time to presentation (interaction P=0.01). Conclusions Short onset to balloon time was associated with better 3 year clinical outcome in patients with STEMI having primary percutaneous coronary intervention, whereas the benefit of short door to balloon time was limited to patients who presented early. Efforts to minimise onset to balloon time, including reduction of patient related delay, should be recommended to improve clinical outcome in STEMI patients.	[Nakagawa, Yoshihisa] Tenri Hosp, Div Cardiol, Tenri, Nara 6328552, Japan; [Shiomi, Hiroki; Kimura, Takeshi] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan; [Morimoto, Takeshi] Kinki Univ, Sch Med, Ctr Gen Internal Med & Emergency Care, Sayama, Osaka 5898511, Japan; [Furukawa, Yutaka] Gen Hosp, Kobe City Med Ctr, Div Cardiol, Chuo Ku, Kobe, Hyogo 6500046, Japan; [Nakano, Akira] Univ Fukui Hosp, Div Cardiol, Fukui 9101193, Japan; [Shirai, Shinichi; Yamaji, Kyohei] Kokura Mem Hosp, Div Cardiol, Kitakyushu, Fukuoka 8028555, Japan; [Taniguchi, Ryoji] Hyogo Kenritsu Amagasaki Hosp, Div Cardiol, Amagasaki, Hyogo 6600828, Japan; [Nagao, Kazuya] Osaka Red Cross Hosp, Div Cardiol, Tennoji Ku, Osaka 5438555, Japan; [Suyama, Tamaki] Sapporo Higashi Tokushukai Hosp, Div Cardiol, Higashi Ku, Sapporo, Hokkaido 0650033, Japan; [Mitsuoka, Hirokazu] Kishiwada City Hosp, Div Cardiol, Kishiwada, Osaka 5968501, Japan; [Araki, Makoto] Shimada Municipal Hosp, Div Cardiol, Shizuoka 4278502, Japan; [Takashima, Hiroyuki] Shiga Univ Med Sci Hosp, Dept Cardiovasc & Resp Med, Shiga 5202192, Japan; [Mizoguchi, Tetsu] Mitsubishi Kyoto Hosp, Div Cardiol, Nishigyo Ku, Kyoto 6158087, Japan; [Eisawa, Hiroshi] Nishi Kobe Med Ctr, Div Cardiol, Nishi Ku, Kobe, Hyogo 6512273, Japan; [Sugiyama, Seigo] Kumamoto Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Kumamoto 8608556, Japan	Tenri Hospital; Kyoto University; Kindai University (Kinki University); Kobe City Medical Center General Hospital; University of Fukui; Kokura Memorial Hospital; Osaka Red Cross Hospital; Shiga University of Medical Science; Kobe City Medical Center General Hospital; Kumamoto University	Nakagawa, Y (corresponding author), Tenri Hosp, Div Cardiol, 200 Mishimacho, Tenri, Nara 6328552, Japan.	nakagawa@tenriyorozu.jp	Shiomi, Hiroki/ADJ-9510-2022	Shiomi, Hiroki/0000-0001-7234-023X	Pharmaceuticals and Medical Devices Agency (PMDA) in Japan; Grants-in-Aid for Scientific Research [22390103] Funding Source: KAKEN	Pharmaceuticals and Medical Devices Agency (PMDA) in Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. The PMDA had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the reports; or in the decision to submit the article for publication.	Altman DG, 2006, BRIT MED J, V332, P1080, DOI 10.1136/bmj.332.7549.1080; Antman Elliott M., 2004, J Am Coll Cardiol, V44, pE1, DOI 10.1016/j.jacc.2004.07.014; Boden WE, 2007, J AM COLL CARDIOL, V50, P917, DOI 10.1016/j.jacc.2007.04.084; Bradley EH, 2009, J AM COLL CARDIOL, V54, P2423, DOI 10.1016/j.jacc.2009.11.003; Brodie BR, 2006, J AM COLL CARDIOL, V47, P289, DOI 10.1016/j.jacc.2005.08.065; Brodie BR, 1998, J AM COLL CARDIOL, V32, P1312, DOI 10.1016/S0735-1097(98)00395-7; Brodie BR, 2010, J AM COLL CARDIOL, V56, P407, DOI 10.1016/j.jacc.2010.04.020; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; De Luca G, 2003, J AM COLL CARDIOL, V42, P991, DOI 10.1016/S0735-1097(03)00919-7; Eagle KA, 2008, EUR HEART J, V29, P609, DOI 10.1093/eurheartj/ehn069; Flynn A, 2010, ARCH INTERN MED, V170, P1842, DOI 10.1001/archinternmed.2010.381; GERSH BJ, 1993, CIRCULATION, V88, P296, DOI 10.1161/01.CIR.88.1.296; Gersh BJ, 2005, JAMA-J AM MED ASSOC, V293, P979, DOI 10.1001/jama.293.8.979; Gibson CM, 2008, AM HEART J, V156, P1035, DOI 10.1016/j.ahj.2008.07.029; Hannan EL, 2010, AM J CARDIOL, V106, P143, DOI 10.1016/j.amjcard.2010.02.029; Jacobs AK, 2007, CIRCULATION, V116, P217, DOI 10.1161/CIRCULATIONAHA.107.184043; Krumholz HM, 2008, JACC-CARDIOVASC INTE, V1, P97, DOI 10.1016/j.jcin.2007.10.006; McNamara RL, 2006, J AM COLL CARDIOL, V47, P2180, DOI 10.1016/j.jacc.2005.12.072; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416	19	131	137	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2012	344								e3257	10.1136/bmj.e3257	http://dx.doi.org/10.1136/bmj.e3257			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QT	22623632	Green Submitted, hybrid			2022-12-24	WOS:000304591500002
J	Lerner, BH				Lerner, Barron H.			The art of medicine Drunk driving across the globe: let's learn from one another	LANCET			English	Editorial Material									Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA	Columbia University	Lerner, BH (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA.							Committee for the Study of Traffic Safety, 2011, ACH TRAFF SAF GOALS; Homel R.J., 1990, ALCOHOL HEALTH RES W, V14, P70; Lerner B. H, 2011, ONE ROAD DRUNK DRIVI; Luckin B, 2010, ADDICTION, V105, P1538, DOI 10.1111/j.1360-0443.2010.02983.x	4	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 19	2012	379	9829					1870	1871		10.1016/S0140-6736(12)60798-3	http://dx.doi.org/10.1016/S0140-6736(12)60798-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	944IW	22616105				2022-12-24	WOS:000304194200015
J	Schuetz, R; Zamboni, N; Zampieri, M; Heinemann, M; Sauer, U				Schuetz, Robert; Zamboni, Nicola; Zampieri, Mattia; Heinemann, Matthias; Sauer, Uwe			Multidimensional Optimality of Microbial Metabolism	SCIENCE			English	Article							GENOME-SCALE MODELS; ESCHERICHIA-COLI; INTRACELLULAR FLUXES; OBJECTIVE FUNCTIONS; OPTIMAL-GROWTH; NETWORKS; DIVERSIFICATION; MICROORGANISMS; PERTURBATIONS; MINIMIZATION	Although the network topology of metabolism is well known, understanding the principles that govern the distribution of fluxes through metabolism lags behind. Experimentally, these fluxes can be measured by C-13-flux analysis, and there has been a long-standing interest in understanding this functional network operation from an evolutionary perspective. On the basis of C-13-determined fluxes from nine bacteria and multi-objective optimization theory, we show that metabolism operates close to the Pareto-optimal surface of a three-dimensional space defined by competing objectives. Consistent with flux data from evolved Escherichia coli, we propose that flux states evolve under the trade-off between two principles: optimality under one given condition and minimal adjustment between conditions. These principles form the forces by which evolution shapes metabolic fluxes in microorganisms' environmental context.	[Schuetz, Robert; Zamboni, Nicola; Zampieri, Mattia; Heinemann, Matthias; Sauer, Uwe] ETH, Inst Mol Syst Biol, Zurich, Switzerland; [Heinemann, Matthias] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Groningen	Sauer, U (corresponding author), ETH, Inst Mol Syst Biol, Zurich, Switzerland.	sauer@ethz.ch	Sauer, Uwe/Y-3556-2019; Heinemann, Matthias/B-9421-2008; Zamboni, Nicola/K-3042-2012; Zampieri, Mattia/ABF-5590-2020	Heinemann, Matthias/0000-0002-5512-9077; Zamboni, Nicola/0000-0003-1271-1021; Zampieri, Mattia/0000-0002-9339-068X	ETH	ETH(ETH Zurich)	R.S. is in the Life Science Zurich Ph.D. program on Systems Physiology and Metabolic Diseases, Zurich, Switzerland. We thank M. Doebeli for the mutants, E. Michlig for flux analysis, J. Banga for initial discussion on Pareto optimality, and V. Chubukov for proofreading. We acknowledge financial support via an ETH grant to U.S. Data and model described in this paper are presented in the supplementary materials.	Burgard AP, 2003, BIOTECHNOL BIOENG, V82, P670, DOI 10.1002/bit.10617; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Emmerling M, 2002, J BACTERIOL, V184, P152, DOI 10.1128/JB.184.1.152-164.2002; Feist AM, 2010, CURR OPIN MICROBIOL, V13, P344, DOI 10.1016/j.mib.2010.03.003; Feist AM, 2009, NAT REV MICROBIOL, V7, P129, DOI 10.1038/nrmicro1949; Fischer E, 2003, EUR J BIOCHEM, V270, P880, DOI 10.1046/j.1432-1033.2003.03448.x; Fuhrer T, 2005, J BACTERIOL, V187, P1581, DOI 10.1128/JB.187.5.1581-1590.2005; Holzhutter HG, 2004, EUR J BIOCHEM, V271, P2905, DOI 10.1111/j.1432-1033.2004.04213.x; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kaufman DE, 1998, OPER RES, V46, P84, DOI 10.1287/opre.46.1.84; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; Lu SY, 2009, J BIOTECHNOL, V143, P213, DOI 10.1016/j.jbiotec.2009.07.012; Mitchell A, 2009, NATURE, V460, P220, DOI 10.1038/nature08112; Nagrath D, 2007, ANN BIOMED ENG, V35, P863, DOI 10.1007/s10439-007-9283-0; Nanchen A, 2006, APPL ENVIRON MICROB, V72, P1164, DOI 10.1128/AEM.72.2.1164-1172.2006; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Sauer U, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100109; Schuetz R, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100162; Segre D, 2002, P NATL ACAD SCI USA, V99, P15112, DOI 10.1073/pnas.232349399; Shlomi T, 2005, P NATL ACAD SCI USA, V102, P7695, DOI 10.1073/pnas.0406346102; Spencer CC, 2008, P NATL ACAD SCI USA, V105, P1585, DOI 10.1073/pnas.0708504105; Spencer CC, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030015; Tannler S, 2008, J BACTERIOL, V190, P6178, DOI 10.1128/JB.00552-08; Zamboni N, 2009, NAT PROTOC, V4, P878, DOI 10.1038/nprot.2009.58	27	270	271	2	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					601	604		10.1126/science.1216882	http://dx.doi.org/10.1126/science.1216882			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556256				2022-12-24	WOS:000303498800049
J	Squyres, SW; Arvidson, RE; Bell, JF; Calef, F; Clark, BC; Cohen, BA; Crumpler, LA; de Souza, PA; Farrand, WH; Gellert, R; Grant, J; Herkenhoff, KE; Hurowitz, JA; Johnson, JR; Jolliff, BL; Knoll, AH; Li, R; McLennan, SM; Ming, DW; Mittlefehldt, DW; Parker, TJ; Paulsen, G; Rice, MS; Ruff, SW; Schroder, C; Yen, AS; Zacny, K				Squyres, S. W.; Arvidson, R. E.; Bell, J. F., III; Calef, F., III; Clark, B. C.; Cohen, B. A.; Crumpler, L. A.; de Souza, P. A., Jr.; Farrand, W. H.; Gellert, R.; Grant, J.; Herkenhoff, K. E.; Hurowitz, J. A.; Johnson, J. R.; Jolliff, B. L.; Knoll, A. H.; Li, R.; McLennan, S. M.; Ming, D. W.; Mittlefehldt, D. W.; Parker, T. J.; Paulsen, G.; Rice, M. S.; Ruff, S. W.; Schroeder, C.; Yen, A. S.; Zacny, K.			Ancient Impact and Aqueous Processes at Endeavour Crater, Mars	SCIENCE			English	Article							MERIDIANI-PLANUM; SUEVITE BRECCIA; RIES CRATER; GERMANY; ORIGIN; VEINS; HISTORY; GYPSUM; WATER; ROCK	The rover Opportunity has investigated the rim of Endeavour Crater, a large ancient impact crater on Mars. Basaltic breccias produced by the impact form the rim deposits, with stratigraphy similar to that observed at similar-sized craters on Earth. Highly localized zinc enrichments in some breccia materials suggest hydrothermal alteration of rim deposits. Gypsum-rich veins cut sedimentary rocks adjacent to the crater rim. The gypsum was precipitated from low-temperature aqueous fluids flowing upward from the ancient materials of the rim, leading temporarily to potentially habitable conditions and providing some of the waters involved in formation of the ubiquitous sulfate-rich sandstones of the Meridiani region.	[Squyres, S. W.; Rice, M. S.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Arvidson, R. E.; Jolliff, B. L.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63031 USA; [Bell, J. F., III; Ruff, S. W.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Calef, F., III; Hurowitz, J. A.; Parker, T. J.; Yen, A. S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Clark, B. C.; Farrand, W. H.] Space Sci Inst, Boulder, CO 80301 USA; [Cohen, B. A.] NASA, George C Marshall Space Flight Ctr, Huntsville, AL 35812 USA; [Crumpler, L. A.] New Mexico Museum Nat Hist & Sci, Albuquerque, NM 87104 USA; [de Souza, P. A., Jr.] Univ Tasmania, Human Interface Technol Lab, Launceston, Tas 7250, Australia; [Gellert, R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Grant, J.] Smithsonian Inst, Ctr Earth & Planetary Studies, Washington, DC 20560 USA; [Herkenhoff, K. E.] US Geol Survey, Astrogeol Sci Ctr, Flagstaff, AZ 86001 USA; [Johnson, J. R.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Knoll, A. H.] Harvard Univ, Bot Museum, Cambridge, MA 02138 USA; [Li, R.] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [McLennan, S. M.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA; [Ming, D. W.; Mittlefehldt, D. W.] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Paulsen, G.; Zacny, K.] Honeybee Robot & Spacecraft Mech Corp, Pasadena, CA 91103 USA; [Schroeder, C.] Univ Bayreuth, D-72076 Tubingen, Germany; [Schroeder, C.] Univ Tubingen, D-72076 Tubingen, Germany	Cornell University; Washington University (WUSTL); Arizona State University; Arizona State University-Tempe; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; University of Tasmania; University of Guelph; Smithsonian Institution; United States Department of the Interior; United States Geological Survey; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Harvard University; University System of Ohio; Ohio State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; University of Bayreuth; Eberhard Karls University of Tubingen	Squyres, SW (corresponding author), Cornell Univ, Dept Astron, Ithaca, NY 14853 USA.	squyres@astro.cornell.edu	Schröder, Christian/B-3870-2009; de Souza, Paulo/W-2993-2019; de Souza, Paulo/P-7294-2019; Johnson, Jeffrey R/F-3972-2015; de Souza, Paulo A/B-8961-2008; COHEN, BARBARA/AAV-8199-2021	Schröder, Christian/0000-0002-7935-6039; de Souza, Paulo/0000-0002-0091-8925; Johnson, Jeffrey R/0000-0002-5586-4901; de Souza, Paulo A/0000-0002-0091-8925; Cohen, Barbara/0000-0001-5896-5903; Rice, Melissa/0000-0002-8370-4139; McLennan, Scott/0000-0003-4259-7178; Grant, John/0000-0001-8276-1281	NASA	NASA(National Aeronautics & Space Administration (NASA))	This research was carried out for the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA.	Arvidson RE, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003746; Arvidson RE, 2004, SCIENCE, V306, P1730, DOI 10.1126/science.1104211; Bell JF, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002070; Bons PD, 2005, J STRUCT GEOL, V27, P231, DOI 10.1016/j.jsg.2004.08.009; BUNDY WM, 1956, J SEDIMENT PETROL, V26, P240; Clark R. N., 2007, 06 USGS DIG SPECTR L; DEEVEY ES, 1970, SCI AM, V223, P148, DOI 10.1038/scientificamerican0970-148; Durney D.W., 1973, GRAVITY TECTONICS, P67; Ehlmann BL, 2011, NATURE, V479, P53, DOI 10.1038/nature10582; El Tabakh M, 1998, J SEDIMENT RES, V68, P88, DOI 10.2110/jsr.68.88; Franklin J.M., 1981, EC GEOL, P485; Freyer D, 2003, MONATSH CHEM, V134, P693, DOI 10.1007/s00706-003-0590-3; GUSTAVSON TC, 1994, J SEDIMENT RES A, V64, P88; HORZ F, 1983, REV GEOPHYS, V21, P1667, DOI 10.1029/RG021i008p01667; Meyer C, 2011, GEOL SOC AM BULL, V123, P2312, DOI 10.1130/B30393.1; Mittlefehldt D. W., 2009, LUNAR PLANET SCI, V41, P2109; Myrick T., 2004, P AIAA SPAC 2004 C E, P1; NEWSOM HE, 1986, J GEOPHYS RES-SOLID, V91, pE239, DOI 10.1029/JB091iB13p0E239; Philipp SL, 2008, GEOL MAG, V145, P831, DOI 10.1017/S0016756808005451; Pohl J., 1977, IMPACT EXPLOSION CRA, P343; Rathbun JA, 2002, ICARUS, V157, P362, DOI 10.1006/icar.2002.6838; Rice MS, 2010, ICARUS, V205, P375, DOI 10.1016/j.icarus.2009.03.035; Schmidt ME, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003027; Squyres SW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2006JE002771; Squyres SW, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002562; Squyres SW, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002121; Stoffler D., 2007, METAMORPHIC ROCKS CL; Taber S, 1918, J GEOL, V26, P56, DOI 10.1086/622561; Tosca NJ, 2008, SCIENCE, V320, P1204, DOI 10.1126/science.1155432; VONENGELHARDT W, 1990, TECTONOPHYSICS, V171, P259, DOI 10.1016/0040-1951(90)90104-G; VONENGELHARDT W, 1995, METEORITICS, V30, P279, DOI 10.1111/j.1945-5100.1995.tb01126.x; vonEngelhardt W, 1997, METEORIT PLANET SCI, V32, P545; Wang A, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003126; Wheat CG, 1996, GEOCHIM COSMOCHIM AC, V60, P3593, DOI 10.1016/0016-7037(96)00189-5; Wray JJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040734; Zipfel J, 2011, METEORIT PLANET SCI, V46, P1, DOI 10.1111/j.1945-5100.2010.01127.x	36	152	153	2	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					570	576		10.1126/science.1220476	http://dx.doi.org/10.1126/science.1220476			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556248	Green Submitted			2022-12-24	WOS:000303498800041
J	Svanstrom, H; Pasternak, B; Hviid, A				Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders			Association of Treatment With Losartan vs Candesartan and Mortality Among Patients With Heart Failure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIAGNOSIS; REGISTERS	Context The benefit of angiotensin II-receptor blockers (ARBs) in heart failure is thought to be a class effect, but no head-to-head randomized trials have compared individual ARBs. Results from observational studies suggest that losartan may be associated with increased mortality in patients with heart failure compared with other ARBs. Objective To assess the hypothesis that losartan use is associated with increased all-cause mortality in heart failure patients as compared with candesartan. Design, Setting, and Participants We conducted a nationwide Danish registry-based cohort study, linking individual-level information on hospital contacts, filled prescriptions, and potential confounders. Patients aged 45 years and older with first-time hospitalization for heart failure in 1998-2008 were identified from the Danish National Patient Registry. New users of losartan and candesartan were selected for inclusion in the study cohort. Main Outcome Measures We used Cox proportional hazards regression to compare the risk of all-cause mortality in users of losartan and candesartan. Results Among 4397 users of losartan, 1212 deaths occurred during 11 347 person-years of follow-up (unadjusted incidence rate [IR]/100 person-years, 10.7; 95% CI, 10.1-11.3) compared with 330 deaths during 3675 person-years among 2082 users of candesartan (unadjusted IR/100 person-years, 9.0; 95% CI, 8.1-10.0). Compared with candesartan, losartan was not associated with increased all-cause mortality (adjusted hazard ratio [HR], 1.10; 95% CI, 0.96-1.25) or cardiovascular mortality (adjusted HR, 1.14; 95% CI, 0.96-1.36). Compared with high doses of candesartan (16-32 mg), low-dose (12.5 mg) and medium-dose losartan (50 mg) were associated with increased mortality (HR, 2.79; 95% CI, 2.19-3.55 and HR, 1.39; 95% CI, 1.11-1.73, respectively); use of high-dose losartan (100 mg) was similar in risk (HR, 0.71; 95% CI, 0.50-1.00). Conclusions Among patients with heart failure, overall use of losartan compared with candesartan was not associated with an increased mortality risk. Although low doses of losartan were associated with increased mortality, there was no increased mortality comparing high-dose losartan against the highest doses of candesartan. JAMA. 2012;307(14):1506-1512	[Svanstrom, Henrik; Pasternak, Bjorn; Hviid, Anders] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark	Statens Serum Institut	Svanstrom, H (corresponding author), Statens Serum Inst, Orestads Blvd 5,206-305, DK-2300 Copenhagen S, Denmark.	htr@ssi.dk	Pasternak, Bjorn/H-5739-2012; Hviid, Anders/AAH-4319-2020	Pasternak, Bjorn/0000-0002-2097-8466; Hviid, Anders/0000-0002-7509-9127	Danish Medical Research Council	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Danish Medical Research Council.	Andersen TF, 1999, DAN MED BULL, V46, P263; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Desai RJ, 2012, PHARMACOEPIDEM DR S, V21, P233, DOI 10.1002/pds.2175; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Eklind-Cervenka M, 2011, JAMA-J AM MED ASSOC, V305, P175, DOI 10.1001/jama.2010.1949; Eshaghian S, 2006, AM J CARDIOL, V97, P1759, DOI 10.1016/j.amjcard.2005.12.072; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Hudson M, 2007, PHARMACOTHERAPY, V27, P526, DOI 10.1592/phco.27.4.526; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Juel K, 1999, DAN MED BULL, V46, P354; Kaplan N, 2011, JAMA-J AM MED ASSOC, V305, P1541, DOI 10.1001/jama.2011.463; Kildemoes HW, 2011, SCAND J PUBLIC HEALT, V39, P38, DOI 10.1177/1403494810394717; Konstam MA, 2005, AM HEART J, V150, P123, DOI 10.1016/j.ahj.2004.10.035; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Mard Shan, 2010, Clin Epidemiol, V2, P235, DOI 10.2147/CLEP.S12457; McMurray JJV, 2005, LANCET, V365, P1877, DOI 10.1016/S0140-6736(05)66621-4; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Sturmer T, 2010, AM J EPIDEMIOL, V172, P843, DOI 10.1093/aje/kwq198; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83	22	32	32	1	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1506	1512		10.1001/jama.2012.452	http://dx.doi.org/10.1001/jama.2012.452			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496265	Bronze			2022-12-24	WOS:000302538100024
J	Hernandez, JM; Stein, A; Behrmann, E; Riedel, D; Cypionka, A; Farsi, Z; Walla, PJ; Raunser, S; Jahn, R				Hernandez, Javier M.; Stein, Alexander; Behrmann, Elmar; Riedel, Dietmar; Cypionka, Anna; Farsi, Zohreh; Walla, Peter J.; Raunser, Stefan; Jahn, Reinhard			Membrane Fusion Intermediates via Directional and Full Assembly of the SNARE Complex	SCIENCE			English	Article							HEMIFUSION; EXOCYTOSIS; PROMOTES; VISUALIZATION; SYNAPTOTAGMIN; MECHANISMS; RESOLUTION; RELEASE; DOCKING; LIPIDS	Cellular membrane fusion is thought to proceed through intermediates including docking of apposed lipid bilayers, merging of proximal leaflets to form a hemifusion diaphragm, and fusion pore opening. A membrane-bridging four-helix complex of soluble N-ethylmaleimide-sensitive factor attachment protein receptors (SNAREs) mediates fusion. However, how assembly of the SNARE complex generates docking and other fusion intermediates is unknown. Using a cell-free reaction, we identified intermediates visually and then arrested the SNARE fusion machinery when fusion was about to begin. Partial and directional assembly of SNAREs tightly docked bilayers, but efficient fusion and an extended form of hemifusion required assembly beyond the core complex to the membrane-connecting linkers. We propose that straining of lipids at the edges of an extended docking zone initiates fusion.	[Hernandez, Javier M.; Stein, Alexander; Riedel, Dietmar; Cypionka, Anna; Farsi, Zohreh; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany; [Cypionka, Anna; Walla, Peter J.] Max Planck Inst Biophys Chem, AG Biomol Spect & Single Mol Detect, D-37077 Gottingen, Germany; [Walla, Peter J.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, Dept Biophys Chem, D-38106 Braunschweig, Germany; [Behrmann, Elmar; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Phys Biochem, D-44227 Dortmund, Germany	Max Planck Society; Max Planck Society; Braunschweig University of Technology; Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Raunser, Stefan/AHE-1573-2022; Stein, Alexander/I-4950-2012; Behrmann, Elmar/I-5808-2015	Stein, Alexander/0000-0002-2696-0611; Behrmann, Elmar/0000-0001-6794-3669; Farsi, Zohreh/0000-0001-7274-981X; Raunser, Stefan/0000-0001-9373-3016; Jahn, Reinhard/0000-0003-1542-3498	National Institutes of Health [3P01GM072694-05S1]; German Research Foundation [RA 1781/1-1, SFB 803]; Fonds der Chemischen Industrie [684052, 166660, 661218]; National Commission for Scientific and Technological Research of Chile; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); National Commission for Scientific and Technological Research of Chile; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. van den Bogaart, J. Risselada, J. Chua, R. Klemm, and T. Rapoport for critical review; G. Weber for providing the ribbon structure; and O. Hofnagel and U. Ries for valuable technical assistance. Funding was generously provided by the National Institutes of Health (3P01GM072694-05S1 to R. J.), the German Research Foundation (RA 1781/1-1 to S. R. and SFB 803 to R. J. and P. J. W.), the "Fonds der Chemischen Industrie" grant 684052 to E. B. and grants 166660 and 661218 to P. J. W., and a doctoral fellowship from the National Commission for Scientific and Technological Research of Chile to J. M. H. Additional data described in the manuscript are presented in the supplementary materials.	Bhalla A, 2006, NAT STRUCT MOL BIOL, V13, P323, DOI 10.1038/nsmb1076; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Cypionka A, 2009, P NATL ACAD SCI USA, V106, P18575, DOI 10.1073/pnas.0906677106; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Grafmuller A, 2009, BIOPHYS J, V96, P2658, DOI 10.1016/j.bpj.2008.11.073; Hofmann MW, 2006, J MOL BIOL, V364, P1048, DOI 10.1016/j.jmb.2006.09.077; Kinnunen PKJ, 2000, BIOSCIENCE REP, V20, P465, DOI 10.1023/A:1010402819509; Malinin VS, 2004, BIOPHYS J, V86, P2951, DOI 10.1016/S0006-3495(04)74346-5; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Nikolaus J, 2010, BIOPHYS J, V98, P1192, DOI 10.1016/j.bpj.2009.11.042; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Risselada HJ, 2011, CHEMBIOCHEM, V12, P1049, DOI 10.1002/cbic.201100020; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; Scheidt HA, 2004, BBA-BIOMEMBRANES, V1663, P97, DOI 10.1016/j.bbamem.2004.02.004; Schwartz ML, 2009, J CELL BIOL, V185, P535, DOI 10.1083/jcb.200811082; Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stevens MJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.188102; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; van den Bogaart G, 2011, NAT STRUCT MOL BIOL, V18, P805, DOI 10.1038/nsmb.2061; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wong JL, 2007, DEV CELL, V12, P653, DOI 10.1016/j.devcel.2007.02.007; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Xu Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022012; Yang Y, 2010, P NATL ACAD SCI USA, V107, P22145, DOI 10.1073/pnas.1006899108; Yoon TY, 2006, P NATL ACAD SCI USA, V103, P19731, DOI 10.1073/pnas.0606032103	30	158	159	0	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 22	2012	336	6088					1581	1584		10.1126/science.1221976	http://dx.doi.org/10.1126/science.1221976			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961ZE	22653732	Green Accepted, Green Submitted			2022-12-24	WOS:000305507500058
J	Watts, G				Watts, Geoff			Down on the "pharm": do genetically modified plants hold the key to cheaper drugs?	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						Chidambaram A, 2011, PROD BIOPH US PLANT; NICE, 2012, CET BEV PAN MET COL; Robinson JC, 2006, HEALTH AFFAIR, V25, P1205, DOI 10.1377/hlthaff.25.5.1205	3	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 31	2012	344								e3829	10.1136/bmj.e3829	http://dx.doi.org/10.1136/bmj.e3829			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953HG	22654068				2022-12-24	WOS:000304857000013
J	Thompson, AA; Liu, W; Chun, E; Katritch, V; Wu, HX; Vardy, E; Huang, XP; Trapella, C; Guerrini, R; Calo, G; Roth, BL; Cherezov, V; Stevens, RC				Thompson, Aaron A.; Liu, Wei; Chun, Eugene; Katritch, Vsevolod; Wu, Huixian; Vardy, Eyal; Huang, Xi-Ping; Trapella, Claudio; Guerrini, Remo; Calo, Girolamo; Roth, Bryan L.; Cherezov, Vadim; Stevens, Raymond C.			Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic	NATURE			English	Article							ORL1 RECEPTOR; ORPHANIN-FQ; CRYSTALLIZING MEMBRANE; PROTEIN; BINDING; ANTAGONIST; AGONIST; SITE; IDENTIFICATION; MUTAGENESIS	Members of the opioid receptor family of G-protein-coupled receptors (GPCRs) are found throughout the peripheral and central nervous system, where they have key roles in nociception and analgesia. Unlike the 'classical' opioid receptors, delta, kappa and mu (delta-OR, kappa-OR and mu-OR), which were delineated by pharmacological criteria in the 1970s and 1980s, the nociceptin/orphanin FQ (N/OFQ) peptide receptor (NOP, also known as ORL-1) was discovered relatively recently by molecular cloning and characterization of an orphan GPCR(1). Although it shares high sequence similarity with classical opioid GPCR subtypes (similar to 60%), NOP has a markedly distinct pharmacology, featuring activation by the endogenous peptide N/OFQ, and unique selectivity for exogenous ligands(2,3). Here we report the crystal structure of human NOP, solved in complex with the peptide mimetic antagonist compound-24 (C-24) (ref. 4), revealing atomic details of ligand-receptor recognition and selectivity. Compound-24 mimics the first four amino-terminal residues of the NOP-selective peptide antagonist UFP-101, a close derivative of N/OFQ, and provides important clues to the binding of these peptides. The X-ray structure also shows substantial conformational differences in the pocket regions between NOP and the classical opioid receptors k (ref. 5) and m (ref. 6), and these are probably due to a small number of residues that vary between these receptors. The NOP-compound-24 structure explains the divergent selectivity profile of NOP and provides a new structural template for the design of NOP ligands.	[Thompson, Aaron A.; Liu, Wei; Chun, Eugene; Katritch, Vsevolod; Wu, Huixian; Cherezov, Vadim; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Vardy, Eyal; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Chapel Hill Med Sch, Natl Inst Mental Hlth Psychoact Drug Screening Pr, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Vardy, Eyal; Huang, Xi-Ping; Roth, Bryan L.] Univ N Carolina, Chapel Hill Med Sch, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA; [Trapella, Claudio; Guerrini, Remo] Univ Ferrara, Dept Pharmaceut Sci, I-44121 Ferrara, Italy; [Trapella, Claudio; Guerrini, Remo] Univ Ferrara, LTTA, I-44121 Ferrara, Italy; [Calo, Girolamo] Univ Ferrara, Pharmacol Sect, Dept Expt & Clin Med, I-44121 Ferrara, Italy; [Calo, Girolamo] Univ Ferrara, Natl Inst Neurosci, I-44121 Ferrara, Italy	Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; Roth, Bryan L/F-3928-2010; Wu, Huixian/N-6353-2014; Katritch, Vsevolod/Q-8357-2016; Katritch, Vsevolod/Y-2721-2019; Roth, Bryan/ABE-7032-2020; Trapella, Claudio/I-2128-2012	Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; Wu, Huixian/0000-0003-1357-9747; Katritch, Vsevolod/0000-0003-3883-4505; Roth, Bryan/0000-0002-0561-6520; Trapella, Claudio/0000-0002-6666-143X; Huang, Xi-Ping/0000-0002-2585-653X; Thompson, Aaron/0000-0003-4314-4242; Guerrini, Remo/0000-0002-7619-0918	PSI:Biology [U54 GM094618]; NIH [P50 GM073197, R01 DA017204, R01 DA27170]; NIMH; Michael Hooker Chair of Pharmacology; University of Ferrara (FAR); Italian Ministry of University (FIRB); National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094618, P50GM073197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027170, R01DA017204] Funding Source: NIH RePORTER	PSI:Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Michael Hooker Chair of Pharmacology; University of Ferrara (FAR); Italian Ministry of University (FIRB)(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by PSI:Biology grant U54 GM094618 for biological studies and structure production, NIH Roadmap grant P50 GM073197 for technology development and R01 DA017204, R01 DA27170, and the NIMH Psychoactive Drug Screening Program(X.-P. H., E. V. and B. L. R.) and the Michael Hooker Chair of Pharmacology (B. L. R.), University of Ferrara (FAR grant to G. C.), Italian Ministry of University (FIRB Futuro in Ricerca 2010 grant to C. T.). We thank J. Francis for suggesting the idea to pursue the NOP receptor; J. Velasquez for help on molecular biology; T. Trinh, K. Allin and M. Chu for help on baculovirus expression; A. Walker and E. Abola for assistance with manuscript preparation; J. Smith, R. Fischetti and N. Sanishvili for assistance in development and use of the minibeam and beamtime at GM/CA-CAT beamline 23-ID at the Advanced Photon Source, which is supported by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akuzawa N, 2007, J BIOCHEM, V141, P907, DOI 10.1093/jb/mvm100; [Anonymous], 2011, PYMOL MOL GRAPHICS S; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bes B, 2003, BIOCHEM BIOPH RES CO, V310, P992, DOI 10.1016/j.bbrc.2003.09.113; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Calo G, 2002, BRIT J PHARMACOL, V136, P303, DOI 10.1038/sj.bjp.0704706; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Chu R, 2002, J MOL BIOL, V323, P253, DOI 10.1016/S0022-2836(02)00884-7; Dore AS, 2011, STRUCTURE, V19, P1283, DOI 10.1016/j.str.2011.06.014; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischetti C, 2009, EUR J PHARMACOL, V614, P50, DOI 10.1016/j.ejphar.2009.04.054; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Goto Y, 2006, J MED CHEM, V49, P847, DOI 10.1021/jm0509851; Guerrini R, 2000, J MED CHEM, V43, P2805, DOI 10.1021/jm990075h; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Katritch V, 2009, J MOL RECOGNIT, V22, P307, DOI 10.1002/jmr.949; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Lambert DG, 2008, NAT REV DRUG DISCOV, V7, P694, DOI 10.1038/nrd2572; Lapalu S, 1997, FEBS LETT, V417, P333, DOI 10.1016/S0014-5793(97)01318-5; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng F, 1996, J BIOL CHEM, V271, P32016, DOI 10.1074/jbc.271.50.32016; Meng F, 1998, MOL PHARMACOL, V53, P772, DOI 10.1124/mol.53.4.772; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Mouledous L, 2000, MOL PHARMACOL, V57, P495, DOI 10.1124/mol.57.3.495; Orsini MJ, 2005, J BIOL CHEM, V280, P8134, DOI 10.1074/jbc.M406405200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Tancredi T, 2005, CHEM-EUR J, V11, P2061, DOI 10.1002/chem.200401095; Topham CM, 1998, PROTEIN ENG, V11, P1163, DOI 10.1093/protein/11.12.1163; Totrov M, 1997, PROTEINS, P215; Trapella C, 2009, BIOORGAN MED CHEM, V17, P5080, DOI 10.1016/j.bmc.2009.05.068; Varty GB, 2008, J PHARMACOL EXP THER, V326, P672, DOI 10.1124/jpet.108.136937; Volta M, 2011, EXP NEUROL, V228, P126, DOI 10.1016/j.expneurol.2010.12.024; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	41	377	390	5	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					395	U150		10.1038/nature11085	http://dx.doi.org/10.1038/nature11085			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596163	Green Accepted, Green Submitted			2022-12-24	WOS:000304099100048
J	Offit, PA				Offit, Paul A.			Studying Complementary and Alternative Therapies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Offit, Paul A.] Childrens Hosp Philadelphia, Div Infect Dis, Philadelphia, PA 19104 USA; [Offit, Paul A.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania	Offit, PA (corresponding author), Childrens Hosp Philadelphia, Div Infect Dis, 34th St & Civ Ctr Blvd,ARB,Room 1202C, Philadelphia, PA 19104 USA.	offit@email.chop.edu						Bjelakovic G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007176; Mielczarek E. V., 2012, SKEPTICAL INQUIRER, V36, P36; Moyer CS, 2012, AMEDNEWS        0220; Offit PaulA., 2008, AUTISMS FALSE PROPHE, DOI 10.7312/offi14636; Park Robert L., 2000, VOODOO SCI ROAD FOOL; Shapiro R., 2008, SUCKERS ALTERNATIVE; Wang SS, 2011, WALL STREET J   1025, pD1	7	22	22	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1803	1804		10.1001/jama.2012.518	http://dx.doi.org/10.1001/jama.2012.518			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22550193				2022-12-24	WOS:000303386800017
J	Gale, C; Santhakumaran, S; Nagarajan, S; Statnikov, Y; Modi, N				Gale, C.; Santhakumaran, S.; Nagarajan, S.; Statnikov, Y.; Modi, N.		Neonatal Data Anal Unit; Med Neonates Investigator Grp	Impact of managed clinical networks on NHS specialist neonatal services in England: population based study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; PRETERM INFANTS; MORTALITY; CARE; LEVEL; TRANSPORT; RISK	Objective To assess the impact of reorganisation of neonatal specialist care services in England after a UK Department of Health report in 2003. Design A population-wide observational comparison of outcomes over two epochs, before and after the establishment of managed clinical neonatal networks. Setting Epoch one: 294 maternity and neonatal units in England, Wales, and Northern Ireland, 1 September 1998 to 31 August 2000, as reported by the Confidential Enquiry into Stillbirths and Sudden Deaths in Infancy Project 27/28. Epoch two: 146 neonatal units in England contributing data to the National Neonatal Research Database at the Neonatal Data Analysis Unit, 1 January 2009 to 31 December 2010. Participants Babies born at a gestational age of 27(+0)-28(+6) (weeks+days): 3522 live births in epoch one; 2919 babies admitted to a neonatal unit within 28 days of birth in epoch two. Intervention The national reorganisation of neonatal services into managed clinical networks. Main outcome measures The proportion of babies born at hospitals providing the highest volume of neonatal specialist care (>= 2000 neonatal intensive care days annually), having an acute transfer (within the first 24 hours after birth) and/or a late transfer (between 24 hours and 28 days after birth) to another hospital, assessed by change in distribution of transfer category ("none," "acute," "late"), and babies from multiple births separated by transfer. For acute transfers in epoch two, the level of specialist neonatal care provided at the destination hospital (British Association of Perinatal Medicine criteria). Results After reorganisation, there were increases in the proportions of babies born at 27-28 weeks' gestation in hospitals providing the highest volume of neonatal specialist care (18% (631/3495) v 49% (1325/2724); odds ratio 4.30, 95% confidence interval 3.83 to 4.82; P < 0.001) and in acute and late postnatal transfers (7% (235) v 12% (360) and 18% (579) v 22% (640), respectively; P < 0.001). There was no significant change in the proportion of babies from multiple births separated by transfer (33% (39) v 29% (38); 0.86, 0.50 to 1.46; P = 0.57). In epoch two, 32% of acute transfers were to a neonatal unit providing either an equivalent (n = 87) or lower (n = 26) level of specialist care. Conclusions There is evidence of some improvement in the delivery of neonatal specialist care after reorganisation. The increase in acute transfers in epoch two, in conjunction with the high proportion transferred to a neonatal unit providing an equivalent or lower level of specialist care, and the continued separation of babies from multiple births, are indicative of poor coordination between maternity and neonatal services to facilitate in utero transfer before delivery, and continuing inadequacies in capacity of intensive care cots. Historical data representing epoch one are available only in aggregate form, preventing examination of temporal trends or confounding factors. This limits the extent to which differences between epochs can be attributed to reorganisation and highlights the importance of routine, prospective data collection for evaluation of future health service reorganisations.	[Gale, C.; Santhakumaran, S.; Nagarajan, S.; Statnikov, Y.; Modi, N.; Neonatal Data Anal Unit; Med Neonates Investigator Grp] Univ London Imperial Coll Sci Technol & Med, Sect Neonatal Med, Dept Med, London SW10 9NH, England	Imperial College London	Modi, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Neonatal Med, Dept Med, Chelsea & Westminster Campus, London SW10 9NH, England.	n.modi@imperial.ac.uk	Gale, Chris/F-1833-2010	Gale, Chris/0000-0003-0707-876X; Greenough, Anne/0000-0002-8672-5349; Majeed, Azeem/0000-0002-2357-9858	National Institute of Health Research (NIHR) [RP-PG-0707-10010]; Department of Health; Danone; Abbott International; Royal College of Paediatrics and Child Health (RCPCH); Child Growth Foundation (CGF); Westminster Medical School Research Trust; Medical Research Council [G1000758, G1000758B] Funding Source: researchfish; National Institute for Health Research [RP-PG-0707-10010] Funding Source: researchfish	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Department of Health; Danone(Danone Nutricia); Abbott International(Abbott Laboratories); Royal College of Paediatrics and Child Health (RCPCH); Child Growth Foundation (CGF); Westminster Medical School Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The Neonatal Data Analysis Unit is supported by a Programme Grant for Applied Research (RP-PG-0707-10010) from the National Institute of Health Research (NIHR) and unrestricted funding from the Department of Health, Danone, and Abbott International. The study funders had no role in study design, collection, analysis, and interpretation of data, writing of the report, or in the decision to submit the article for publication; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare financial support for the submitted work from the National Institute for Health Research (NIHR) through a Programme Grant for Applied Research (RP-PG-0707-10010). SN receives part funding from the Royal College of Paediatrics and Child Health (RCPCH) National Neonatal Audit Programme. CG receives part funding though an unrelated award to NM from the Child Growth Foundation (CGF) and support from the Westminster Medical School Research Trust. SS and YS are funded by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the RCPCH, CGF, Westminster Medical School Research Trust, NHS, NIHR, or Department of Health.	[Anonymous], 2007, PROVISION NEONATAL S; Binder S, 2011, PEDIATRICS, V127, P487, DOI 10.1542/peds.2010-1064; British Association of Perinatal Medicine (BAPM), 2001, STAND HOSP PROV NEON STAND HOSP PROV NEON, V2nd; Chien LY, 2001, OBSTET GYNECOL, V98, P247, DOI 10.1016/S0029-7844(01)01438-7; Chung JH, 2011, J PERINATOL, V31, P770, DOI 10.1038/jp.2011.29; COOKE RWI, 1992, ARCH DIS CHILD-FETAL, V67, P868; Crump C, 2011, JAMA-J AM MED ASSOC, V306, P1233, DOI 10.1001/jama.2011.1331; Goodwin N, 2004, MANAGING DIVERSE NET; Greene A, 2009, QUAL SAF HEALTH CARE, V18, P456, DOI 10.1136/qshc.2007.023119; Guthrie BG, 2010, DELIVERING HLTH CARE; Honest H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13430; Kirrane H, 2010, CHANCE LIFETIME BLIS; KOLLEE LAA, 1992, OBSTET GYNECOL, V80, P635; Langhoff-Roos J, 2006, BMJ-BRIT MED J, V332, P937, DOI 10.1136/bmj.38751.524132.2F; Lasswell SM, 2010, JAMA-J AM MED ASSOC, V304, P992, DOI 10.1001/jama.2010.1226; Lui K, 2006, PEDIATRICS, V118, P2076, DOI 10.1542/peds.2006-1540; March of Dimes, 2012, PERISTATS; Marlow N, 2007, ARCH DIS CHILD-FETAL, V92, pF137, DOI 10.1136/adc.2005.086413; Mohamed MA, 2010, ARCH DIS CHILD-FETAL, V95, pF403, DOI 10.1136/adc.2010.183236; National Audit Office, 2007, CAR VULN BAB REORG N; National Institute for Health and Clinical Excellence, 2011, SPEC NEON CAR QUAL S; National Neonatal Audit Programme (NNAP), 2009, ANN REP NNAP; Norman JE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000153; Phibbs CS, 2007, NEW ENGL J MED, V356, P2165, DOI 10.1056/NEJMsa065029; Provan KG, 2007, J MANAGE, V33, P479, DOI 10.1177/0149206307302554; Roberts C, 2005, CLIN TRIALS, V2, P152, DOI 10.1191/1740774505cn076oa; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Santhakumaran S, 2010, NEONATAL SPECIALIST; Scottish Executive, 1999, INTR MAN CLIN NETW N; Shlossman PA, 1997, AM J PERINAT, V14, P449, DOI 10.1055/s-2007-994178; Sterne JAC, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2393; Thomas EL, 2011, PEDIATR RES, V70, P507, DOI 10.1203/PDR.0b013e31822d7860; Towers CV, 2000, OBSTET GYNECOL, V95, P291, DOI 10.1016/S0029-7844(99)00528-1; Zeitlin J, 2010, ARCH DIS CHILD-FETAL, V95, pF188, DOI 10.1136/adc.2008.156745	34	44	44	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e2105	10.1136/bmj.e2105	http://dx.doi.org/10.1136/bmj.e2105			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GM	22490978	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000302607700001
J	Kalager, M; Adami, HO; Bretthauer, M; Tamimi, RM				Kalager, Mette; Adami, Hans-Olov; Bretthauer, Michael; Tamimi, Rulla M.			Overdiagnosis of Invasive Breast Cancer Due to Mammography Screening: Results From the Norwegian Screening Program	ANNALS OF INTERNAL MEDICINE			English	Article							CARCINOMA IN-SITU; SOJOURN TIME; LEAD TIME; OVERDETECTION; OVERTREATMENT; COMPLETENESS; SENSITIVITY; PROGESTIN; ESTROGEN; REGISTRY	Background: Precise quantification of overdiagnosis of breast cancer (defined as the percentage of cases of cancer that would not have become clinically apparent in a woman's lifetime without screening) due to mammography screening has been hampered by lack of valid comparison groups that identify incidence trends attributable to screening versus those due to temporal trends in incidence. Objective: To estimate the percentage of overdiagnosis of breast cancer attributable to mammography screening. Design: Comparison of invasive breast cancer incidence with and without screening. Setting: A nationwide mammography screening program in Norway (inviting women aged 50 to 69 years), gradually implemented from 1996 to 2005. Participants: The Norwegian female population. Measurements: Concomitant incidence of invasive breast cancer from 1996 to 2005 in counties where the screening program was implemented compared with that in counties where the program was not yet implemented. To adjust for changes in temporal trends in breast cancer incidence, incidence rates during the preceding decade were also examined. The percentage of overdiagnosis was calculated by accounting for the expected decrease in incidence following cessation of screening after age 69 years (approach 1) and by comparing incidence in the current screening group with incidence among women 2 and 5 years older in the historical screening groups, accounting for average lead time (approach 2). Results: A total of 39 888 patients with invasive breast cancer were included, 7793 of whom were diagnosed after the screening program started. The estimated rate of overdiagnosis attributable to the program was 18% to 25% (P < 0.001) for approach 1 and 15% to 20% (P < 0.001) for approach 2. Thus, 15% to 25% of cases of cancer are overdiagnosed, translating to 6 to 10 women overdiagnosed for every 2500 women invited. Limitation: The study was registry-based. Conclusion: Mammography screening entails a substantial amount of overdiagnosis.	[Kalager, Mette] Brigham & Womens Hosp, Harvard Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Karolinska Inst, Stockholm, Sweden; Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard T.H. Chan School of Public Health; Karolinska Institutet; University of Oslo; National Hospital Norway; Harvard University; Harvard Medical School	Kalager, M (corresponding author), Brigham & Womens Hosp, Harvard Sch Publ Hlth, Dept Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	mkalager@hsph.harvard.edu			Norwegian Research Council and Frontier Science	Norwegian Research Council and Frontier Science	Norwegian Research Council and Frontier Science.	Autier P, 2011, ANN ONCOL, V22, P1726, DOI 10.1093/annonc/mdq633; Autier P, 2009, J CLIN ONCOL, V27, P5919, DOI 10.1200/JCO.2009.22.7041; Bakken L, 2004, INT J CANCER, V112, P130, DOI 10.1002/ijc.20389; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Biesheuvel C, 2007, LANCET ONCOL, V8, P1129, DOI 10.1016/S1470-2045(07)70380-7; BOER R, 1994, LANCET, V343, P979, DOI 10.1016/S0140-6736(94)90105-8; de Koning HJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1369; Duffy SW, 2008, BRIT J CANCER, V99, P1176, DOI 10.1038/sj.bjc.6604638; Duffy SW, 2005, BREAST CANCER RES, V7, P258, DOI 10.1186/bcr1354; Gotzsche PC, 2009, BRIT J CANCER, V100, P219, DOI 10.1038/sj.bjc.6604762; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Gotzsche PC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b86; Jatoi I, 2005, CURR PROB SURG, V42, P616, DOI 10.1067/j.cpsurg.2005.06.002; Jensen A, 2005, INT J CANCER, V113, P464, DOI 10.1002/ijc.20604; Jorgensen Karsten J, 2009, BMC Womens Health, V9, P36, DOI 10.1186/1472-6874-9-36; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Kalager M, 2010, NEW ENGL J MED, V363, P1203, DOI 10.1056/NEJMoa1000727; Kalager Mette, 2009, Tidsskr Nor Laegeforen, V129, P2595, DOI 10.4045/tidsskr.09.0024; Larsen IK, 2009, EUR J CANCER, V45, P1218, DOI 10.1016/j.ejca.2008.10.037; MacMahon B., 1996, EPIDEMIOLOGY PRINCIP, V2nd; Magnusson C, 1999, INT J CANCER, V81, P339, DOI 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.3.CO;2-Y; Morrell S, 2010, CANCER CAUSE CONTROL, V21, P275, DOI 10.1007/s10552-009-9459-z; Paci E, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1625; PERRY NM, 1996, EUROPEAN GUIDELINES; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Rostgaard K, 2010, ACTA ONCOL, V49, P313, DOI 10.3109/02841861003602074; Shen Y, 2005, BIOSTATISTICS, V6, P604, DOI 10.1093/biostatistics/kxi030; Sorum R, 2010, BREAST, V19, P499, DOI 10.1016/j.breast.2010.05.014; Statistics Norway, STAT NORW; Tingulstad S, 2002, INT J CANCER, V98, P907, DOI 10.1002/ijc.10254; Vainio H., 2001, IARC HDB CANC PREVEN; Waaseth M, 2009, MATURITAS, V63, P220, DOI 10.1016/j.maturitas.2009.03.017; Weedon-Fekjaer H, 2008, J MED SCREEN, V15, P83, DOI 10.1258/jms.2008.007071; Weedon-Fekjaer H, 2009, ARCH INTERN MED, V169, P996, DOI 10.1001/archinternmed.2009.90; Welch HG, 2008, JNCI-J NATL CANCER I, V100, P228, DOI 10.1093/jnci/djn013; Welch HG, 2006, BRIT MED J, V332, P727, DOI 10.1136/bmj.332.7543.727; Welch HG, 1997, ANN INTERN MED, V127, P1023, DOI 10.7326/0003-4819-127-11-199712010-00014; Widmark A, 1995, 19955 STAT SAL, V5; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C; Zahl PH, 2008, ARCH INTERN MED, V168, P2311, DOI 10.1001/archinte.168.21.2311; Zahl PH, 2008, LANCET ONCOL, V9, P199, DOI 10.1016/S1470-2045(08)70049-4; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	42	168	171	1	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 3	2012	156	7					491	U61		10.7326/0003-4819-156-7-201204030-00005	http://dx.doi.org/10.7326/0003-4819-156-7-201204030-00005			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	921GP	22473436				2022-12-24	WOS:000302466400003
J	Farago, AF; Snyder, EL; Jacks, T				Farago, Anna F.; Snyder, Eric L.; Jacks, Tyler			SnapShot: Lung Cancer Models	CELL			English	Editorial Material							RAPAMYCIN COMBINATION THERAPY; SOMATIC MUTATIONS; MOUSE; ADENOCARCINOMA; CELL		[Farago, Anna F.; Snyder, Eric L.; Jacks, Tyler] MIT, Cambridge, MA 02139 USA; [Farago, Anna F.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Farago, Anna F.] Dana Farber Partners Canc Care, Boston, MA 02215 USA; [Snyder, Eric L.] Brigham & Womens Hosp, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Farago, AF (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.							Chen Z, 2010, CANCER RES, V70, P9827, DOI 10.1158/0008-5472.CAN-10-1671; de Seranno S, 2010, EUR RESPIR J, V35, P426, DOI 10.1183/09031936.00124709; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Schaffer BE, 2010, CANCER RES, V70, P3877, DOI 10.1158/0008-5472.CAN-09-4228; Sutherland KD, 2011, CANCER CELL, V19, P754, DOI 10.1016/j.ccr.2011.04.019; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595	10	29	31	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					246	+	246.e1	10.1016/j.cell.2012.03.015	http://dx.doi.org/10.1016/j.cell.2012.03.015			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464334	Bronze			2022-12-24	WOS:000302235400025
J	Janda, CY; Waghray, D; Levin, AM; Thomas, C; Garcia, KC				Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher			Structural Basis of Wnt Recognition by Frizzled	SCIENCE			English	Article							SIGNALING INHIBITION; CATENIN PATHWAY; PROTEINS; RECEPTORS; ACTIVATE; BINDING; FAMILY; CANCER; DOMAIN; LRP6	Wnts are lipid-modified morphogens that play critical roles in development principally through engagement of Frizzled receptors. The 3.25 angstrom structure of Xenopus Wnt8 (XWnt8) in complex with mouse Frizzled-8 (Fz8) cysteine-rich domain (CRD) reveals an unusual two-domain Wnt structure, not obviously related to known protein folds, resembling a "hand" with "thumb" and "index" fingers extended to grasp the Fz8-CRD at two distinct binding sites. One site is dominated by a palmitoleic acid lipid group projecting from serine 187 at the tip of Wnt's thumb into a deep groove in the Fz8-CRD. In the second binding site, the conserved tip of Wnt's "index finger" forms hydrophobic amino acid contacts with a depression on the opposite side of the Fz8-CRD. The conservation of amino acids in both interfaces appears to facilitate ligand-receptor cross-reactivity, which has important implications for understanding Wnt's functional pleiotropy and for developing Wnt-based drugs for cancer and regenerative medicine.	[Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Janda, Claudia Y.; Waghray, Deepa; Levin, Aron M.; Thomas, Christoph; Garcia, K. Christopher] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Thomas, Christoph/0000-0001-7441-1089	Howard Hughes Medical Institute; Jane Coffin Childs Fund;  [NIH-RO1-GM097015]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097015] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Jane Coffin Childs Fund; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge advice and reagents from J. Nathans, as well as helpful discussions with F. Bazan, P. Beachy, J. Nathans, A. Brunger, and R. Nusse. We thank the staff of the Stanford Synchrotron Radiation Laboratory for support and access to beamline 11-1. This work was supported by NIH-RO1-GM097015 and the Howard Hughes Medical Institute (K. C. G.). C. J. is supported by a postdoctoral fellowship from the Jane Coffin Childs Fund. Structure factors and coordinates have been deposited in the Protein Data Bank with accession no. 4F0A. K. C. G. and A. M. L. have applied for a patent covering the discovery and use of mini-Wnt. K. C. G. is a cofounder of Eleven Biotherapeutics, which is engaged in the rational design of protein therapeutics.	Ahn VE, 2011, DEV CELL, V21, P862, DOI 10.1016/j.devcel.2011.09.003; Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bazan JF, 2009, CELL, V138, P1055, DOI 10.1016/j.cell.2009.09.006; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bourhis E, 2010, J BIOL CHEM, V285, P9172, DOI 10.1074/jbc.M109.092130; Carron C, 2003, J CELL SCI, V116, P2541, DOI 10.1242/jcs.00451; Chen S, 2011, DEV CELL, V21, P848, DOI 10.1016/j.devcel.2011.09.007; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hausmann G, 2006, DEV CELL, V11, P751, DOI 10.1016/j.devcel.2006.11.007; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Holmen SL, 2002, J BIOL CHEM, V277, P34727, DOI 10.1074/jbc.M204989200; Hsieh JC, 1999, NATURE, V398, P431, DOI 10.1038/18899; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kim JB, 2007, J BONE MINER RES, V22, P1913, DOI 10.1359/JBMR.070802; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Liepinsh E, 2006, J MOL BIOL, V357, P942, DOI 10.1016/j.jmb.2006.01.047; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Malinauskas T, 2011, NAT STRUCT MOL BIOL, V18, P886, DOI 10.1038/nsmb.2081; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Moon Randall T, 2005, Sci STKE, V2005, pcm1; Mulligan KA, 2012, P NATL ACAD SCI USA, V109, P370, DOI 10.1073/pnas.1119197109; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; NUSSE R, 1991, CELL, V64, P231, DOI 10.1016/0092-8674(91)90633-A; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schwarz-Romond T, 2007, NAT STRUCT MOL BIOL, V14, P484, DOI 10.1038/nsmb1247; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Smallwood PM, 2007, J BIOL CHEM, V282, P4057, DOI 10.1074/jbc.M609618200; Stroud Robert M, 2004, Sci STKE, V2004, pre7, DOI 10.1126/stke.2312004re7; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert Karl H., 2008, V468, P17, DOI 10.1007/978-1-59745-249-6_2	43	531	559	4	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2012	337	6090					59	64		10.1126/science.1222879	http://dx.doi.org/10.1126/science.1222879			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22653731	Green Accepted			2022-12-24	WOS:000306053100042
J	Shang, H; Xu, JJ; Han, XX; Li, JS; Arledge, KC; Zhang, LQ				Shang, Hong; Xu, Junjie; Han, Xiaoxu; Li, Jessica Spero; Arledge, Kelly C.; Zhang, Linqi			Bring safe sex to China	NATURE			English	Editorial Material							BEHAVIOR; HIV; MEN		[Shang, Hong; Xu, Junjie; Han, Xiaoxu] China Med Univ, Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Minist Hlth, Shenyang 110001, Peoples R China; [Li, Jessica Spero; Arledge, Kelly C.; Zhang, Linqi] Tsinghua Univ, Sch Med, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Li, Jessica Spero; Arledge, Kelly C.; Zhang, Linqi] Tsinghua Univ, Sch Med, Res Ctr Publ Hlth, Beijing 100084, Peoples R China	China Medical University; Tsinghua University; Tsinghua University	Shang, H (corresponding author), China Med Univ, Hosp 1, Dept Lab Med, Key Lab AIDS Immunol,Minist Hlth, Shenyang 110001, Peoples R China.	hongshang100@hotmail.com; zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022	xu, junjie/0000-0003-4303-7295				China Ministry of Health, 2010, CHIN 2010 UNGASS COU; Chinese Ministry of Health, 2012, 2010 CHIN AIDS RESP; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Song Y, 2011, AIDS CARE, V23, P179, DOI 10.1080/09540121.2010.487088; UNAIDS, 2010, REP GLOB AIDS EP UNA; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Yun K, 2011, SEX TRANSM INFECT, V87, P563, DOI 10.1136/sextrans-2011-050079; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443	11	83	94	5	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					576	577		10.1038/485576a	http://dx.doi.org/10.1038/485576a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22660303	Bronze			2022-12-24	WOS:000304608000025
J	Freedman, ND; Park, Y; Abnet, CC; Hollenbeck, AR; Sinha, R				Freedman, Neal D.; Park, Yikyung; Abnet, Christian C.; Hollenbeck, Albert R.; Sinha, Rashmi			Association of Coffee Drinking with Total and Cause-Specific Mortality	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-HEART-DISEASE; HEALTH-AMERICAN-ASSOCIATION; RETIRED-PERSONS DIET; TEA CONSUMPTION; CARDIOVASCULAR-DISEASE; NATIONAL-INSTITUTES; FOLLOW-UP; RISK; METAANALYSIS; CAFFEINE	BACKGROUND Coffee is one of the most widely consumed beverages, but the association between coffee consumption and the risk of death remains unclear. METHODS We examined the association of coffee drinking with subsequent total and cause-specific mortality among 229,119 men and 173,141 women in the National Institutes of Health-AARP Diet and Health Study who were 50 to 71 years of age at baseline. Participants with cancer, heart disease, and stroke were excluded. Coffee consumption was assessed once at baseline. RESULTS During 5,148,760 person-years of follow-up between 1995 and 2008, a total of 33,731 men and 18,784 women died. In age-adjusted models, the risk of death was increased among coffee drinkers. However, coffee drinkers were also more likely to smoke, and, after adjustment for tobacco-smoking status and other potential confounders, there was a significant inverse association between coffee consumption and mortality. Adjusted hazard ratios for death among men who drank coffee as compared with those who did not were as follows: 0.99 (95% confidence interval [CI], 0.95 to 1.04) for drinking less than 1 cup per day, 0.94 (95% CI, 0.90 to 0.99) for 1 cup, 0.90 (95% CI, 0.86 to 0.93) for 2 or 3 cups, 0.88 (95% CI, 0.84 to 0.93) for 4 or 5 cups, and 0.90 (95% CI, 0.85 to 0.96) for 6 or more cups of coffee per day (P<0.001 for trend); the respective hazard ratios among women were 1.01 (95% CI, 0.96 to 1.07), 0.95 (95% CI, 0.90 to 1.01), 0.87 (95% CI, 0.83 to 0.92), 0.84 (95% CI, 0.79 to 0.90), and 0.85 (95% CI, 0.78 to 0.93) (P<0.001 for trend). Inverse associations were observed for deaths due to heart disease, respiratory disease, stroke, injuries and accidents, diabetes, and infections, but not for deaths due to cancer. Results were similar in subgroups, including persons who had never smoked and persons who reported very good to excellent health at baseline. CONCLUSIONS In this large prospective study, coffee consumption was inversely associated with total and cause-specific mortality. Whether this was a causal or associational finding cannot be determined from our data.	[Freedman, Neal D.; Park, Yikyung; Abnet, Christian C.; Sinha, Rashmi] NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, Rockville, MD 20852 USA; [Hollenbeck, Albert R.] AARP, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American Association of Retired Persons (AARP)	Freedman, ND (corresponding author), NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Serv, 6120 Execut Blvd,EPS 320,MSC 7232, Rockville, MD 20852 USA.	freedmanne@mail.nih.gov	Freedman, Neal David/B-9741-2015; Hollenbeck, Albert/AAG-9461-2020; Abnet, Christian C/C-4111-2015; Sinha, Rashmi/G-7446-2015	Freedman, Neal David/0000-0003-0074-1098; Abnet, Christian C/0000-0002-3008-7843; Sinha, Rashmi/0000-0002-2466-7462; Park, Yikyung/0000-0002-6281-489X	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics; NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics.Supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics.	Arion WJ, 1997, ARCH BIOCHEM BIOPHYS, V339, P315, DOI 10.1006/abbi.1996.9874; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Andersen LF, 2006, AM J CLIN NUTR, V83, P1039, DOI 10.1093/ajcn/83.5.1039; Gomez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P8284, DOI 10.1021/jf078006w; Gomez-Ruiz JA, 2007, J AGR FOOD CHEM, V55, P6962, DOI 10.1021/jf0710985; Greenberg JA, 2008, AM J CARDIOL, V102, P1502, DOI 10.1016/j.amjcard.2008.07.046; GREENLAND S, 1993, EPIDEMIOLOGY, V4, P366, DOI 10.1097/00001648-199307000-00013; Happonen P, 2008, BRIT J NUTR, V99, P1354, DOI 10.1017/S0007114507871650; HEYDEN S, 1978, ARCH INTERN MED, V138, P1472, DOI 10.1001/archinte.138.10.1472; Huxley R, 2009, ARCH INTERN MED, V169, P2053, DOI 10.1001/archinternmed.2009.439; Iwai Nobuo, 2002, J Epidemiol, V12, P191; JACOBSEN BK, 1986, J NATL CANCER I, V76, P823; Jee SH, 2001, AM J EPIDEMIOL, V153, P353, DOI 10.1093/aje/153.4.353; JICK H, 1973, NEW ENGL J MED, V289, P63, DOI 10.1056/NEJM197307122890203; Kawachi I, 1996, ARCH INTERN MED, V156, P521, DOI 10.1001/archinte.156.5.521; Klatsky A L, 1993, Ann Epidemiol, V3, P375, DOI 10.1016/1047-2797(93)90064-B; Kleemola P, 2000, ARCH INTERN MED, V160, P3393, DOI 10.1001/archinte.160.22.3393; Larsson SC, 2008, STROKE, V39, P1681, DOI 10.1161/STROKEAHA.107.504183; Larsson SC, 2011, STROKE, V42, P908, DOI 10.1161/STROKEAHA.110.603787; LEGRADY D, 1987, AM J EPIDEMIOL, V126, P803, DOI 10.1093/oxfordjournals.aje.a114717; LINDSTED KD, 1992, J CLIN EPIDEMIOL, V45, P733, DOI 10.1016/0895-4356(92)90051-N; Lopez-Garcia E, 2006, CIRCULATION, V113, P2045, DOI 10.1161/CIRCULATIONAHA.105.598664; Lopez-Garcia E, 2008, ANN INTERN MED, V148, P904, DOI 10.7326/0003-4819-148-12-200806170-00003; Lopez-Garcia E, 2006, AM J CLIN NUTR, V84, P888, DOI 10.1093/ajcn/84.4.888; Lopez-Garcia E, 2009, CIRCULATION, V119, P1116, DOI 10.1161/CIRCULATIONAHA.108.826164; Mineharu Y, 2011, J EPIDEMIOL COMMUN H, V65, P230, DOI 10.1136/jech.2009.097311; Noordzij M, 2005, J HYPERTENS, V23, P921, DOI 10.1097/01.hjh.0000166828.94699.1d; Oza S, 2011, PREV MED, V52, P428, DOI 10.1016/j.ypmed.2011.04.007; Paganini-Hill A, 2007, PREV MED, V44, P305, DOI 10.1016/j.ypmed.2006.12.011; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Sugiyama K, 2010, J NUTR, V140, P1007, DOI 10.3945/jn.109.109314; Tamakoshi A, 2011, EUR J EPIDEMIOL, V26, P285, DOI 10.1007/s10654-011-9548-7; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; VESSEY MP, 1972, LANCET, V2, P1278; Woodward M, 1999, J EPIDEMIOL COMMUN H, V53, P481, DOI 10.1136/jech.53.8.481; Wu JN, 2009, INT J CARDIOL, V137, P216, DOI 10.1016/j.ijcard.2008.06.051; Yanagimoto K, 2002, J AGR FOOD CHEM, V50, P5480, DOI 10.1021/jf025616h; Zaridze D, 2009, LANCET, V373, P2201, DOI 10.1016/S0140-6736(09)61034-5	39	359	368	4	98	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1891	1904		10.1056/NEJMoa1112010	http://dx.doi.org/10.1056/NEJMoa1112010			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591295	Green Accepted			2022-12-24	WOS:000304083000008
J	Kourtis, AP; Bulterys, M; Hu, DJ; Jamieson, DJ				Kourtis, Athena P.; Bulterys, Marc; Hu, Dale J.; Jamieson, Denise J.			HIV-HBV Coinfection - A Global Challenge	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HEPATITIS-B; TRANSMISSION		[Kourtis, Athena P.; Jamieson, Denise J.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA; [Hu, Dale J.] Ctr Dis Control & Prevent, Div Viral Hepatitis, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA USA; [Bulterys, Marc] Ctr Dis Control & Prevent, Div Global HIV AIDS, Ctr Global Hlth, Atlanta, GA USA; [Bulterys, Marc] CDC Global AIDS Program, Beijing, Peoples R China	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Kourtis, AP (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.			Jamieson, Denise/0000-0003-2597-1201; Hu, Dale/0000-0002-0519-1032; Kourtis, Athena/0000-0003-1585-1310	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Kourtis AP, 2001, JAMA-J AM MED ASSOC, V285, P709, DOI 10.1001/jama.285.6.709; Thio CL, 2009, HEPATOLOGY, V49, pS138, DOI 10.1002/hep.22883; Unal ER, 2011, OBSTET GYNECOL, V118, P655, DOI 10.1097/AOG.0b013e31822ad2c2; Xu WM, 2009, J VIRAL HEPATITIS, V16, P94, DOI 10.1111/j.1365-2893.2008.01056.x	5	141	155	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1749	1752		10.1056/NEJMp1201796	http://dx.doi.org/10.1056/NEJMp1201796			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NB	22571198	Green Accepted			2022-12-24	WOS:000303817000001
J	M'Gonigle, LK; Mazzucco, R; Otto, SP; Dieckmann, U				M'Gonigle, Leithen K.; Mazzucco, Rupert; Otto, Sarah P.; Dieckmann, Ulf			Sexual selection enables long-term coexistence despite ecological equivalence	NATURE			English	Article							SYMPATRIC SPECIATION; INCIPIENT SPECIATION; FEMALE CHOICE; HYBRID ZONES; EVOLUTION; PREFERENCE; DIVERSITY; MODELS; SPACE	Empirical data indicate that sexual preferences are critical for maintaining species boundaries(1-4), yet theoretical work has suggested that, on their own, they can have only a minimal role in maintaining biodiversity(5-9). This is because long-term coexistence within overlapping ranges is thought to be unlikely in the absence of ecological differentiation(9). Here we challenge this widely held view by generalizing a standard model of sexual selection to include two ubiquitous features of populations with sexual selection: spatial variation in local carrying capacity, and mate-search costs in females. We show that, when these two features are combined, sexual preferences can single-handedly maintain coexistence, even when spatial variation in local carrying capacity is so slight that it might go unnoticed empirically. This theoretical study demonstrates that sexual selection alone can promote the long-term coexistence of ecologically equivalent species with overlapping ranges, and it thus provides a novel explanation for the maintenance of species diversity.	[M'Gonigle, Leithen K.; Otto, Sarah P.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Mazzucco, Rupert; Dieckmann, Ulf] Int Inst Appl Syst Anal, Evolut & Ecol Program, A-2361 Laxenburg, Austria	University of British Columbia; International Institute for Applied Systems Analysis (IIASA)	M'Gonigle, LK (corresponding author), Univ Calif Berkeley, Dept Environm Sci, 130 Mulford Hall, Berkeley, CA 94720 USA.	mgonigle@zoology.ubc.ca	Otto, Sarah Perin/K-5625-2012; Dieckmann, Ulf/E-1424-2011	Otto, Sarah Perin/0000-0003-3042-0818; Mazzucco, Rupert/0000-0002-7608-0196; Dieckmann, Ulf/0000-0001-7089-0393	Natural Sciences and Engineering Research Council (Canada); European Science Foundation; WWTF; European Commission; Austrian Science Fund; Austrian Ministry of Science and Research; Austrian Science Fund (FWF) [I 106] Funding Source: researchfish	Natural Sciences and Engineering Research Council (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); European Science Foundation(European Science Foundation (ESF)European Commission); WWTF; European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry of Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We thank J. S. Brown, R. G. Fitz John, D. E. Irwin, J. Ohlberger, J. L. Payne, A. Pomiankowski and G. S. van Doorn for discussions. Funding was provided by a Natural Sciences and Engineering Research Council (Canada) grant to L. K. M. (CGS-D) and S.P.O. (Discovery Grant). L. K. M. received additional support from the European Science Foundation Research Networking Programme 'Frontiers of Speciation Research'. R. M. and U. D. gratefully acknowledge support by the Vienna Science and Technology Fund (WWTF). U. D. received additional financial support from the European Commission, the European Science Foundation, the Austrian Science Fund and the Austrian Ministry of Science and Research.	BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; BARTON NH, 1989, NATURE, V341, P497, DOI 10.1038/341497a0; Dieckmann U., 2004, ADAPTIVE SPECIATION, P306; Eberhard WG, 1985, SEXUAL SELECTION ANI; Feulner PGD, 2008, J PHYSIOLOGY-PARIS, V102, P340, DOI 10.1016/j.jphysparis.2008.10.002; Fisher R.A., 1930, GENETICAL THEORY NAT; Gray DA, 2000, P NATL ACAD SCI USA, V97, P14449, DOI 10.1073/pnas.97.26.14449; Hollocher H, 1997, EVOLUTION, V51, P1175, DOI 10.1111/j.1558-5646.1997.tb03965.x; Johansson J, 2006, AM NAT, V168, P572, DOI 10.1086/507996; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; LANDE R, 1982, EVOLUTION, V36, P213, DOI 10.1111/j.1558-5646.1982.tb05034.x; Mallet J, 2009, J EVOLUTION BIOL, V22, P2332, DOI 10.1111/j.1420-9101.2009.01816.x; Mallet J, 2008, PHILOS T R SOC B, V363, P2971, DOI 10.1098/rstb.2008.0081; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; Payne RJH, 1997, EVOLUTION, V51, P1, DOI 10.1111/j.1558-5646.1997.tb02382.x; RYAN MJ, 1988, SCIENCE, V240, P1786, DOI 10.1126/science.240.4860.1786; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; Seehausen O, 1999, ECOL LETT, V2, P262; SEGER J, 1985, EVOLUTION, V39, P1185, DOI 10.2307/2408776; Tregenza T, 2000, EVOLUTION, V54, P1687, DOI 10.1111/j.0014-3820.2000.tb00713.x; TURNER GF, 1995, P ROY SOC B-BIOL SCI, V260, P287, DOI 10.1098/rspb.1995.0093; van Doorn GS, 2004, AM NAT, V163, P709, DOI 10.1086/383619; Weissing FJ, 2011, BEHAV ECOL SOCIOBIOL, V65, P461, DOI 10.1007/s00265-010-1125-7; Wilson AB, 2000, P ROY SOC B-BIOL SCI, V267, P2133, DOI 10.1098/rspb.2000.1260	26	61	61	0	80	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					506	509		10.1038/nature10971	http://dx.doi.org/10.1038/nature10971			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22466286	Green Submitted			2022-12-24	WOS:000303200400049
J	Herman, MA; Peroni, OD; Villoria, J; Schon, MR; Abumrad, NA; Bluher, M; Klein, S; Kahn, BB				Herman, Mark A.; Peroni, Odile D.; Villoria, Jorge; Schoen, Michael R.; Abumrad, Nada A.; Blueher, Matthias; Klein, Samuel; Kahn, Barbara B.			A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism	NATURE			English	Article							CARBOHYDRATE-RESPONSE ELEMENT; FATTY-ACID SYNTHESIS; BINDING-PROTEIN CHREBP; UCSC GENOME BROWSER; INSULIN-RESISTANCE; DIABETES-MELLITUS; TRANSGENIC MICE; LIVER; GENE; LIPOGENESIS	The prevalence of obesity and type 2 diabetes is increasing worldwide and threatens to shorten lifespan. Impaired insulin action in peripheral tissues is a major pathogenic factor. Insulin stimulates glucose uptake in adipose tissue through the GLUT4 (also known as SLC2A4) glucose transporter, and alterations in adipose tissue GLUT4 expression or function regulate systemic insulin sensitivity. Downregulation of human and mouse adipose tissue GLUT4 occurs early in diabetes development. Here we report that adipose tissue GLUT4 regulates the expression of carbohydrate-responsive-element-binding protein (ChREBP; also known as MLXIPL), a transcriptional regulator of lipogenic and glycolytic genes. Furthermore, adipose ChREBP is a major determinant of adipose tissue fatty acid synthesis and systemic insulin sensitivity. We find a new mechanism for glucose regulation of ChREBP: glucose-mediated activation of the canonical ChREBP isoform (ChREBP-alpha) induces expression of a novel, potent isoform (ChREBP-beta) that is transcribed from an alternative promoter. ChREBP-beta expression in human adipose tissue predicts insulin sensitivity, indicating that it may be an effective target for treating diabetes.	[Herman, Mark A.; Peroni, Odile D.; Villoria, Jorge; Kahn, Barbara B.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Herman, Mark A.; Peroni, Odile D.; Villoria, Jorge; Kahn, Barbara B.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02215 USA; [Schoen, Michael R.] Stadt Klinikum Karlsruhe, Clin Visceral Surg, D-76133 Karlsruhe, Germany; [Abumrad, Nada A.; Klein, Samuel] Washington Univ, Sch Med, Ctr Human Nutr, St Louis, MO 63110 USA; [Blueher, Matthias] Univ Leipzig, Dept Med, D-04103 Leipzig, Germany	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Municipal Hospital Karlsruhe; Washington University (WUSTL); Leipzig University	Kahn, BB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.	bkahn@bidmc.harvard.edu	Herman, Mark/H-3232-2012	Herman, Mark/0000-0001-6979-103X; Schon, Michael/0000-0002-0698-4130	NIH [R37 DK43051, K08 DK076726]; BADERC [DK057521]; BNORC [DK046200]; Picower and JPB Foundations; Radcliffe Institute for Advanced Study; Nutrition and Obesity Research Unit [DK056341, DK037948]; Deutsche Forschungsgemeinschft DFG [KFO152, BL833/1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056341, R37DK043051, P30DK046200, P30DK057521, K08DK076726, R01DK037948, R01DK098002] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BADERC; BNORC; Picower and JPB Foundations; Radcliffe Institute for Advanced Study; Nutrition and Obesity Research Unit; Deutsche Forschungsgemeinschft DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank H. Towle for providing reagents and discussion. We thank P. Pissios, I. Astapova, E. Rosen and the Rosen laboratory for discussions, K. Uyeda for providing ChREBP KO mice, and E. Shu for technical assistance. This work was supported by NIH R37 DK43051 (B.B.K.), K08 DK076726 (M.A.H.), BADERC DK057521 (B.B.K., M.A.H.), BNORC DK046200 (M.A.H.), the Picower and JPB Foundations (B.B.K.), a Fellowship from the Radcliffe Institute for Advanced Study (B.B.K.), DK056341 (Nutrition and Obesity Research Unit) (S.K.), DK037948 (S.K.), and the Deutsche Forschungsgemeinschft DFG, KFO152, BL833/1 (M.B.).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Attie AD, 2009, J LIPID RES, V50, pS395, DOI 10.1194/jlr.R800057-JLR200; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Caesar R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011525; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carvalho E, 2005, AM J PHYSIOL-ENDOC M, V289, pE551, DOI 10.1152/ajpendo.00116.2005; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Denechaud PD, 2008, CURR OPIN LIPIDOL, V19, P301, DOI 10.1097/MOL.0b013e3282ffafaa; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Eguchi J, 2011, CELL METAB, V13, P249, DOI 10.1016/j.cmet.2011.02.005; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Fukasawa M, 2010, BIOCHEM BIOPH RES CO, V391, P1166, DOI 10.1016/j.bbrc.2009.11.115; GNUDI L, 1995, ENDOCRINOLOGY, V136, P995, DOI 10.1210/en.136.3.995; HEMS DA, 1975, BIOCHEM J, V150, P167, DOI 10.1042/bj1500167; Hoffstedt J, 2007, J INTERN MED, V262, P131, DOI 10.1111/j.1365-2796.2007.01811.x; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2009, BIOCHEM BIOPH RES CO, V379, P499, DOI 10.1016/j.bbrc.2008.12.100; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Kursawe R, 2010, DIABETES, V59, P2288, DOI 10.2337/db10-0113; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Minn AH, 2005, ENDOCRINOLOGY, V146, P2397, DOI 10.1210/en.2004-1378; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Pashkov V, 2011, J BIOL CHEM, V286, P15116, DOI 10.1074/jbc.M110.216234; Ranganathan G, 2006, J LIPID RES, V47, P2444, DOI 10.1194/jlr.M600248-JLR200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Sanchez J, 2009, ENDOCRINOLOGY, V150, P5341, DOI 10.1210/en.2009-0466; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; SHIH HM, 1995, J BIOL CHEM, V270, P21991, DOI 10.1074/jbc.270.37.21991; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Stoeckman AK, 2004, J BIOL CHEM, V279, P15662, DOI 10.1074/jbc.M311301200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsatsos NG, 2006, BIOCHEM BIOPH RES CO, V340, P449, DOI 10.1016/j.bbrc.2005.12.029	46	397	418	2	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					333	U66		10.1038/nature10986	http://dx.doi.org/10.1038/nature10986			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22466288	Green Submitted, Green Accepted			2022-12-24	WOS:000302946500024
J	McCartney, M				McCartney, Margaret			Streptococcus B in pregnancy: to screen or not to screen?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020; Mohan, Manoj/ABG-7231-2020	Mohan, Manoj/0000-0001-8818-7268; McCartney, Margaret/0000-0002-7238-6358				Carroll H, 2012, DAILY MAIL      0320; McKeegan A, 2012, MANCHESTER EVEN 0402; Royal College of Obstetricians and Gynaecologists, PREV EARL ONS NEON G; Russell ARB, 2006, BJOG-INT J OBSTET GY, V113, P758, DOI 10.1111/j.1471-0528.2006.00952.x; Stew M, 2012, ITV NEWS ANGLIA 0312; UK National Screening Committee, UK NSC POL GROUP B S	6	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 18	2012	344								e2803	10.1136/bmj.e2803	http://dx.doi.org/10.1136/bmj.e2803			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CQ	22514232				2022-12-24	WOS:000303192400005
J	Sparrow, DB; Chapman, G; Smith, AJ; Mattar, MZ; Major, JA; O'Reilly, VC; Saga, Y; Zackai, EH; Dormans, JP; Alman, BA; McGregor, L; Kageyama, R; Kusumi, K; Dunwoodie, SL				Sparrow, Duncan B.; Chapman, Gavin; Smith, Allanceson J.; Mattar, Muhammad Z.; Major, Joelene A.; O'Reilly, Victoria C.; Saga, Yumiko; Zackai, Elaine H.; Dormans, John P.; Alman, Benjamin A.; McGregor, Lesley; Kageyama, Ryoichiro; Kusumi, Kenro; Dunwoodie, Sally L.			A Mechanism for Gene-Environment Interaction in the Etiology of Congenital Scoliosis	CELL			English	Article							LUNATIC-FRINGE EXPRESSION; SOMITE SEGMENTATION CLOCK; PRESOMITIC MESODERM; SPONDYLOCOSTAL DYSOSTOSIS; VERTEBRAL SEGMENTATION; MOUSE SOMITOGENESIS; BOUNDARY FORMATION; DELTA-HOMOLOG; NOTCH; FGF8	Congenital scoliosis, a lateral curvature of the spine caused by vertebral defects, occurs in approximately 1 in 1,000 live births. Here we demonstrate that haploinsufficiency of Notch signaling pathway genes in humans can cause this congenital abnormality. We also show that in a mouse model, the combination of this genetic risk factor with an environmental condition (short-term gestational hypoxia) significantly increases the penetrance and severity of vertebral defects. We demonstrate that hypoxia disrupts FGF signaling, leading to a temporary failure of embryonic somitogenesis. Our results potentially provide a mechanism for the genesis of a host of common sporadic congenital abnormalities through gene-environment interaction.	[Sparrow, Duncan B.; Chapman, Gavin; Mattar, Muhammad Z.; Major, Joelene A.; O'Reilly, Victoria C.; Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Sydney, NSW 2010, Australia; [Sparrow, Duncan B.; Chapman, Gavin; Dunwoodie, Sally L.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Sydney, NSW 2052, Australia; [Smith, Allanceson J.; Kusumi, Kenro] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Saga, Yumiko] Natl Inst Genet, Mammalian Dev Lab, Mishima, Shizuoka 4118540, Japan; [Zackai, Elaine H.] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA; [Dormans, John P.] Childrens Hosp Philadelphia, Div Orthopaed Surg, Philadelphia, PA 19104 USA; [Zackai, Elaine H.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Dormans, John P.] Univ Penn, Sch Med, Dept Orthopaed Surg, Philadelphia, PA 19104 USA; [Alman, Benjamin A.] Univ Toronto, Inst Med Sci, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Alman, Benjamin A.] Univ Toronto, Div Orthopaed Surg, Toronto, ON M5G 1L5, Canada; [Alman, Benjamin A.] Univ Toronto, Dept Surg, Toronto, ON M5G 1L5, Canada; [Alman, Benjamin A.] Univ Toronto, Hosp Sick Children, Fac Med, Toronto, ON M5G 1X8, Canada; [McGregor, Lesley] Womens & Childrens Hosp, SA Pathol, S Australian Clin Genet Serv, Adelaide, SA 5006, Australia; [Kageyama, Ryoichiro] Kyoto Univ, Inst Virus Res, Kageyama Lab, Kyoto 6068507, Japan	Victor Chang Cardiac Research Institute; University of New South Wales Sydney; Arizona State University; Arizona State University-Tempe; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); SA Pathology; Kyoto University	Sparrow, DB (corresponding author), Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Sydney, NSW 2010, Australia.	d.sparrow@victorchang.edu.au; s.dunwoodie@victorchang.edu.au	Sparrow, Duncan/B-3994-2008; Dunwoodie, Sally L/M-4019-2018; Kusumi, Kenro/J-2626-2012; Chapman, Gavin/A-9534-2012	Sparrow, Duncan/0000-0002-1141-6613; Dunwoodie, Sally L/0000-0002-2069-7349; Kusumi, Kenro/0000-0002-1458-4540; Chapman, Gavin/0000-0002-3513-723X	National Health and Medical Research Council [635500, 514900]; Westfield-Belconnen Fellowship; Hitchings-Elion Fellowship of the Burroughs Wellcome Fund; Cervical Spine Research Society; Ethel Brown Foerderer Fund for Excellence; Florence R.C. Murray Fund	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Westfield-Belconnen Fellowship; Hitchings-Elion Fellowship of the Burroughs Wellcome Fund; Cervical Spine Research Society; Ethel Brown Foerderer Fund for Excellence; Florence R.C. Murray Fund	We thank patients, their families, and clinicians for their contribution and cooperation; D. Chapman, S. Mansour, G. Martin, T. Vogt, and K. Willert for plasmids; K. Hozumi, R. Kopan, S. Piccolo, and P. Tam for mouse lines; E. Thompson and C. Barnett for assessment of family B; BioCORE staff, L. Tomlinson, S. Goettl, J.-S. Han, L. Lunny, and M. Maisenbacher for technical assistance; Herbert Smith for donating the confocal microscopes used in this study; and R. Harvey and K. Anderson for comments on the text. Work was supported by National Health and Medical Research Council Project grant 635500 (S. L. D. and D. B. S.); NHMRC Senior Research Fellowship 514900 (S. L. D.); a Westfield-Belconnen Fellowship (D. B. S.); and a Hitchings-Elion Fellowship of the Burroughs Wellcome Fund, Cervical Spine Research Society, Ethel Brown Foerderer Fund for Excellence and Florence R.C. Murray Fund (K. K.). D. B. S. dedicates this article to David Sparrow (December 11, 1927-March 22, 2012) an inspiring geneticist and loving father.	Alexander PG, 2010, BIRTH DEFECTS RES C, V90, P118, DOI 10.1002/bdrc.20179; [Anonymous], C SERIES DEV BIOL; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; BAGNALL KM, 1988, DEVELOPMENT, V103, P69; Bellen HJ, 2010, NAT REV NEUROSCI, V11, P514, DOI 10.1038/nrn2839; Bessho Y, 2003, GENE DEV, V17, P1451, DOI 10.1101/gad.1092303; Bessho Y, 2001, GENE DEV, V15, P2642, DOI 10.1101/gad.930601; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; BURKE AC, 1995, DEVELOPMENT, V121, P333; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Chapman DL, 1996, DEV BIOL, V180, P534, DOI 10.1006/dbio.1996.0326; Chapman G, 2011, HUM MOL GENET, V20, P905, DOI 10.1093/hmg/ddq529; Christ B, 2007, DEV DYNAM, V236, P2382, DOI 10.1002/dvdy.21189; Cordes R, 2004, DEVELOPMENT, V131, P1221, DOI 10.1242/dev.01030; Daxinger L, 2010, GENOME RES, V20, P1623, DOI 10.1101/gr.106138.110; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Ferjentsik Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000662; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Frank DU, 2002, DEVELOPMENT, V129, P4591; Garg V, 2006, CURR OPIN CARDIOL, V21, P180, DOI 10.1097/01.hco.0000221578.18254.70; Geffers I, 2007, J CELL BIOL, V178, P465, DOI 10.1083/jcb.200702009; Geoffroy Saint-Hilaire Etienne, 1820, J COMPLEMENTAIRE SCI, V7, P271; Giampietro PF, 2009, ANN NY ACAD SCI, V1151, P38, DOI 10.1111/j.1749-6632.2008.03452.x; Gibb S, 2010, TRENDS CELL BIOL, V20, P593, DOI 10.1016/j.tcb.2010.07.001; Hedequist D, 2007, J PEDIATR ORTHOPED, V27, P106, DOI 10.1097/BPO.0b013e31802b4993; Huang R, 1996, ACTA ANAT, V155, P231; Huppert SS, 2005, DEV CELL, V8, P677, DOI 10.1016/j.devcel.2005.02.019; Hutter D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/401323; INGALLS TH, 1957, NEW ENGL J MED, V257, P1121, DOI 10.1056/NEJM195712052572306; INGALLS TH, 1952, NEW ENGL J MED, V247, P758, DOI 10.1056/NEJM195211132472004; JEGALIAN BG, 1992, CELL, V71, P901, DOI 10.1016/0092-8674(92)90387-R; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Maisenbacher MK, 2005, HUM GENET, V116, P416, DOI 10.1007/s00439-005-1253-8; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; Morales AV, 2002, DEV CELL, V3, P63, DOI 10.1016/S1534-5807(02)00211-3; Morimoto M, 2005, NATURE, V435, P354, DOI 10.1038/nature03591; Naiche LA, 2011, P NATL ACAD SCI USA, V108, P4018, DOI 10.1073/pnas.1007417108; Niwa Y, 2007, DEV CELL, V13, P298, DOI 10.1016/j.devcel.2007.07.013; Niwa Y, 2011, GENE DEV, V25, P1115, DOI [10.1101/gad.2035311, 10.1101/gad.2035311.]; Nomura-Kitabayashi A, 2002, DEVELOPMENT, V129, P2473; Oginuma M, 2008, DEVELOPMENT, V135, P2555, DOI 10.1242/dev.019877; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Pourquie O, 2011, CELL, V145, P650, DOI 10.1016/j.cell.2011.05.011; Riedel-Kruse IH, 2007, SCIENCE, V317, P1911, DOI 10.1126/science.1142538; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shifley ET, 2008, DEVELOPMENT, V135, P899, DOI 10.1242/dev.006742; Solomon BD, 2010, HUM GENET, V127, P731, DOI 10.1007/s00439-010-0814-7; Sparrow DB, 2011, MAMM GENOME, V22, P362, DOI 10.1007/s00335-011-9335-5; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Takahashi Y, 2000, NAT GENET, V25, P390, DOI 10.1038/78062; TAM PPL, 1981, J EMBRYOL EXP MORPH, V65, P103; TAM PPL, 1982, DIFFERENTIATION, V21, P109, DOI 10.1111/j.1432-0436.1982.tb01203.x; Turnpenny PD, 2012, EUR J HUM GENET, V20, P251, DOI 10.1038/ejhg.2011.181; Verras M, 2008, MOL CELL BIOL, V28, P7212, DOI 10.1128/MCB.00947-08; Wahl MB, 2007, DEVELOPMENT, V134, P4033, DOI 10.1242/dev.009167; William DA, 2007, DEV BIOL, V305, P172, DOI 10.1016/j.ydbio.2007.02.007; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yasuhiko Y, 2006, P NATL ACAD SCI USA, V103, P3651, DOI 10.1073/pnas.0508238103	61	147	159	1	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					295	306		10.1016/j.cell.2012.02.054	http://dx.doi.org/10.1016/j.cell.2012.02.054			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22484060	Bronze			2022-12-24	WOS:000302805600010
J	Zhang, JLA; Mortazavi, A; Williams, BA; Wold, BJ; Rothenberg, EV				Zhang, Jingli A.; Mortazavi, Ali; Williams, Brian A.; Wold, Barbara J.; Rothenberg, Ellen V.			Dynamic Transformations of Genome-wide Epigenetic Marking and Transcriptional Control Establish T Cell Identity	CELL			English	Article							CIS-REGULATORY ELEMENTS; GENE-EXPRESSION; LINEAGE COMMITMENT; INTERLEUKIN-7 RECEPTOR; FATE DETERMINATION; RNA-SEQ; PU.1; CHROMATIN; IDENTIFICATION; GATA-3	T cell development comprises a stepwise process of commitment from a multipotent precursor. To define molecular mechanisms controlling this progression, we probed five stages spanning the commitment process using RNA-seq and ChIP-seq to track genome-wide shifts in transcription, cohorts of active transcription factor genes, histone modifications at diverse classes of cis-regulatory elements, and binding repertoire of GATA-3 and PU.1, transcription factors with complementary roles in T cell development. The results highlight potential promoter-distal cis-regulatory elements in play and reveal both activation sites and diverse mechanisms of repression that silence genes used in alternative lineages. Histone marking is dynamic and reversible, and though permissive marks anticipate, repressive marks often lag behind changes in transcription. In vivo binding of PU.1 and GATA-3 relative to epigenetic marking reveals distinctive factor-specific rules for recruitment of these crucial transcription factors to different subsets of their potential sites, dependent on dose and developmental context.	[Zhang, Jingli A.; Mortazavi, Ali; Williams, Brian A.; Wold, Barbara J.; Rothenberg, Ellen V.] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; [Mortazavi, Ali; Williams, Brian A.; Wold, Barbara J.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	evroth@its.caltech.edu	Matsuo, Keitaro/H-6758-2019	Matsuo, Keitaro/0000-0003-1761-6314; Rothenberg, Ellen/0000-0002-3901-347X	NIH [R33HL089123, R01CA090233, R01CA090233-08S1, RC2CA148278]; Beckman Institute; Millard and Muriel Jacobs Genetics and Genomics Center; L.A. Garfinkle Memorial Laboratory; Al Sherman Foundation; Bren Professorship; A.B. Ruddock Professorship; NATIONAL CANCER INSTITUTE [RC2CA148278, R01CA090233] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095943] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Institute; Millard and Muriel Jacobs Genetics and Genomics Center; L.A. Garfinkle Memorial Laboratory; Al Sherman Foundation; Bren Professorship; A.B. Ruddock Professorship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Lorian Schaeffer and Vijaya Kumar for library preparation and sequencing, Henry Amrhein and Diane Trout for data curation, Igor Antoshechkin for sequencing facility management, Diana Perez, Josh Verceles, and Rochelle Diamond for cell sorting and advice, Tian Ling, Georgi Marinov, and Hao Yuan Kueh for statistical advice and programming, Rothenberg group members for sharing advice and unpublished data, and Robert Butler, Lorena Sandoval, and Scott Washburn for care of the mice. Support was from NIH grants R33HL089123, R01CA090233, R01CA090233-08S1, and RC2CA148278, the Beckman Institute, the Millard and Muriel Jacobs Genetics and Genomics Center, the L.A. Garfinkle Memorial Laboratory Fund, the Al Sherman Foundation, the Bren Professorship (B.J.W.), and the A.B. Ruddock Professorship (E.V.R.).	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Decker T, 2009, IMMUNITY, V30, P508, DOI 10.1016/j.immuni.2009.01.012; DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Franco CB, 2006, P NATL ACAD SCI USA, V103, P11993, DOI 10.1073/pnas.0601188103; GEORGOPOULOS K, 1988, EMBO J, V7, P2401, DOI 10.1002/j.1460-2075.1988.tb03085.x; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hosoya T, 2010, IMMUNOL REV, V238, P110, DOI 10.1111/j.1600-065X.2010.00954.x; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Natoli G, 2010, IMMUNITY, V33, P12, DOI 10.1016/j.immuni.2010.07.006; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pepke S, 2009, NAT METHODS, V6, pS22, DOI [10.1038/NMETH.1371, 10.1038/nmeth.1371]; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rothenberg EV, 2008, SEMIN IMMUNOL, V20, P236, DOI 10.1016/j.smim.2008.07.006; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2011, J IMMUNOL, V186, P6649, DOI 10.4049/jimmunol.1003703; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Taghon T, 2007, NAT IMMUNOL, V8, P845, DOI 10.1038/ni1486; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xue HH, 2004, NAT IMMUNOL, V5, P1036, DOI 10.1038/ni1117; Yang Q, 2010, IMMUNOL REV, V238, P12, DOI 10.1111/j.1600-065X.2010.00956.x; Yannoutsos N, 2004, NAT IMMUNOL, V5, P443, DOI 10.1038/ni1053; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679; Zarnegar MA, 2010, MOL CELL BIOL, V30, P4922, DOI 10.1128/MCB.00354-10	40	251	254	0	31	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					467	482		10.1016/j.cell.2012.01.056	http://dx.doi.org/10.1016/j.cell.2012.01.056			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500808	Green Accepted, Bronze			2022-12-24	WOS:000302805600023
J	Hardy, J; Revesz, T				Hardy, John; Revesz, Tamas			The Spread of Neurodegenerative Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ALZHEIMERS-DISEASE; PATHOLOGY		[Hardy, John] UCL, Inst Neurol, Reta Lila Weston Labs, London WC1E 6BT, England; UCL, Inst Neurol, Dept Mol Neurosci, London WC1E 6BT, England	University of London; University College London; University of London; University College London	Hardy, J (corresponding author), UCL, Inst Neurol, Reta Lila Weston Labs, Queen Sq, London WC1E 6BT, England.		Revesz, Tamas/A-8732-2010; Hardy, John/C-2451-2009	Revesz, Tamas/0000-0003-2501-0259; Hardy, John/0000-0002-3122-0423	Medical Research Council [G0701075] Funding Source: Medline; Parkinson&apos;s UK [G-0907] Funding Source: Medline; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Parkinson&quot;s UK [G-0907] Funding Source: researchfish; MRC [G0701075] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson&apos;s UK(Parkinson&apos;s UK); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Parkinson&quot;s UK(Parkinson&apos;s UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BAKER HF, 1994, MOL NEUROBIOL, V8, P25, DOI 10.1007/BF02778005; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Collinge J, 2008, PHILOS T R SOC B, V363, P3607, DOI 10.1098/rstb.2008.0103; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302	6	68	68	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2126	2128						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22646635				2022-12-24	WOS:000304613400016
J	Bennett, MI; Graham, J; Schmidt-Hansen, M; Prettyjohns, M; Arnold, S				Bennett, Michael I.; Graham, John; Schmidt-Hansen, Mia; Prettyjohns, Matthew; Arnold, Stephanie		Guideline Dev Grp	GUIDELINES Prescribing strong opioids for pain in adult palliative care: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PREVALENCE; CANCER		[Bennett, Michael I.] Univ Leeds, Leeds Inst Hlth Sci, Leeds LS2 9LJ, W Yorkshire, England; [Graham, John; Schmidt-Hansen, Mia; Prettyjohns, Matthew; Arnold, Stephanie] Natl Collaborating Ctr Canc, Cardiff CF10 3AF, S Glam, Wales	University of Leeds	Bennett, MI (corresponding author), Univ Leeds, Leeds Inst Hlth Sci, Leeds LS2 9LJ, W Yorkshire, England.	m.i.bennett@leeds.ac.uk	Bennett, Michael I/A-1620-2009	Bennett, Michael I/0000-0002-8369-8349; Taubert, Mark/0000-0003-0454-5609; Graham, John/0000-0003-3381-9787				Bennett MI, 2009, PAIN, V143, P192, DOI 10.1016/j.pain.2009.01.016; Deandrea S, 2008, ANN ONCOL, V19, P1985, DOI 10.1093/annonc/mdn419; Everdingen MHJVDBV, 2007, ANN ONCOL, V18, P1437, DOI 10.1093/annonc/mdm056; National Institute for Health and Clinical Excellence, 2012, SAF EFF PRESCR STRON; Oldenmenger WH, 2009, EUR J CANCER, V45, P1370, DOI 10.1016/j.ejca.2009.01.007; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007	6	23	23	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 23	2012	344								e2806	10.1136/bmj.e2806	http://dx.doi.org/10.1136/bmj.e2806			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	949QT	22623631				2022-12-24	WOS:000304591500001
J	Bick, AG; Calvo, SE; Mootha, VK				Bick, Alexander G.; Calvo, Sarah E.; Mootha, Vamsi K.			Evolutionary Diversity of the Mitochondrial Calcium Uniporter	SCIENCE			English	Article							RAT KIDNEY MITOCHONDRIA; PROTEIN		[Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; Broad Inst, Cambridge, MA 02142 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Mootha, VK (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	vamsi@hms.harvard.edu		Bick, Alexander/0000-0001-5824-9595	NIH [R01GM077465, R01GM097136, T32GM007753-33]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097136, T32GM007753, R01GM077465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Pringle, K. Zimmerman, E. Koonin, and E. Lander for critical reading of the manuscript. Protein sequences were obtained from the KEGG Organisms Database, Release 58, or the Origins of Multicellularity Sequencing Project at the Broad Institute. This work was supported by NIH funds (R01GM077465 and R01GM097136 to V.K.M. and T32GM007753-33 to A.G.B.). Alignments and tree available at TreeBASE (accession S12416).	Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; Hajnoczky G, 2010, CURR BIOL, V20, pR888, DOI 10.1016/j.cub.2010.09.035; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; VASINGTON FD, 1962, J BIOL CHEM, V237, P2670	7	124	128	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					886	886		10.1126/science.1214977	http://dx.doi.org/10.1126/science.1214977			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605770	Green Accepted			2022-12-24	WOS:000304145600056
J	Snyder, EY; Teng, YD				Snyder, Evan Y.; Teng, Yang D.			Stem Cells and Spinal Cord Repair	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RECOVERY; INJURY		[Snyder, Evan Y.] Sanford Burnham Med Res Inst, La Jolla, CA USA; [Teng, Yang D.] Harvard Univ, Sch Med, Dept Neurosurg, Boston, MA USA; [Teng, Yang D.] Harvard Univ, Sch Med, Dept Phys Med & Rehabil, Boston, MA USA; [Teng, Yang D.] Vet Affairs Boston Healthcare Syst, Div Spinal Cord Injury Res, Boston, MA USA	Sanford Burnham Prebys Medical Discovery Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Snyder, EY (corresponding author), Sanford Burnham Med Res Inst, La Jolla, CA USA.							Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; Redmond DE, 2007, P NATL ACAD SCI USA, V104, P12175, DOI 10.1073/pnas.0704091104; Sakai K, 2012, J CLIN INVEST, V122, P80, DOI 10.1172/JCI59251; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899	5	48	52	1	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1940	1942		10.1056/NEJMcibr1200138	http://dx.doi.org/10.1056/NEJMcibr1200138			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WU	22591301				2022-12-24	WOS:000304083000015
J	Pacanowski, M; Amur, S; Zineh, I				Pacanowski, Michael; Amur, Shashi; Zineh, Issam			New Genetic Discoveries and Treatment for Hepatitis C	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFECTION		[Pacanowski, Michael; Amur, Shashi; Zineh, Issam] US FDA, Genom Grp, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Pacanowski, M (corresponding author), US FDA, Genom Grp, Off Clin Pharmacol, Off Translat Sci,Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,White Oak Bldg 51,Room 31, Silver Spring, MD 20993 USA.	michael.pacanowski@fda.hhs.gov						Armstrong K, 2012, JAMA-J AM MED ASSOC, V307, P1031, DOI 10.1001/jama.2012.261; Clark PJ, 2011, AM J GASTROENTEROL, V106, P38, DOI 10.1038/ajg.2010.370; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; US Food and Drug Administration, GUID IND CHRON HEP C	6	9	10	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1921	1922		10.1001/jama.2012.3516	http://dx.doi.org/10.1001/jama.2012.3516			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	938OD	22570460				2022-12-24	WOS:000303741900024
J	Swanson, SJ; Phares, CR; Mamo, B; Smith, KE; Cetron, MS; Stauffer, WM				Swanson, Stephen J.; Phares, Christina R.; Mamo, Blain; Smith, Kirk E.; Cetron, Martin S.; Stauffer, William M.			Albendazole Therapy and Enteric Parasites in United States-Bound Refugees	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRANSMITTED HELMINTH INFECTIONS; PRE-DEPARTURE TREATMENT; SUB-SAHARAN AFRICA; INTESTINAL PARASITES; MONTAGNARD REFUGEES; SUDANESE REFUGEES; HIGH-PREVALENCE; EFFICACY; SCHISTOSOMIASIS; POPULATION	Background Beginning on May 1, 1999, the Centers for Disease Control and Prevention (CDC) recommended presumptive treatment of refugees for intestinal parasites with a single dose of albendazole (600 mg), administered overseas before departure for the United States. Methods We conducted a retrospective cohort study involving 26,956 African and Southeast Asian refugees who were screened by means of microscopical examination of stool specimens for intestinal parasites on resettlement in Minnesota between 1993 and 2007. Adjusted prevalence ratios for intestinal nematodes, schistosoma species, giardia, and entamoeba were calculated among refugees who migrated before versus those who migrated after the CDC recommendation of presumptive predeparture albendazole treatment. Results Among 4370 untreated refugees, 20.8% had at least one stool nematode, most commonly hookworm (in 9.2%). Among 22,586 albendazole-treated refugees, only 4.7% had one or more nematodes, most commonly trichuris (in 3.9%). After adjustment for sex, age, and region, albendazole-treated refugees were less likely than untreated refugees to have any nematodes (prevalence ratio, 0.19), ascaris (prevalence ratio, 0.06), hookworm (prevalence ratio, 0.07), or trichuris (prevalence ratio, 0.27) but were not less likely to have giardia or entamoeba. Schistosoma ova were identified exclusively among African refugees and were less prevalent among those treated with albendazole (prevalence ratio, 0.60). After implementation of the albendazole protocol, the most common pathogens among 17,011 African refugees were giardia (in 5.7%), trichuris (in 5.0%), and schistosoma (in 1.8%); among 5575 Southeast Asian refugees, only giardia remained highly prevalent (present in 17.2%). No serious adverse events associated with albendazole use were reported. Conclusions Presumptive albendazole therapy administered overseas before departure for the United States was associated with a decrease in the prevalence of intestinal nematodes among newly arrived African and Southeast Asian refugees.	[Swanson, Stephen J.] Epidem Intelligence Serv, Atlanta, GA USA; [Phares, Christina R.; Cetron, Martin S.; Stauffer, William M.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Swanson, Stephen J.; Mamo, Blain; Smith, Kirk E.] Minnesota Dept Hlth, St Paul, MN USA; [Swanson, Stephen J.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Swanson, Stephen J.; Stauffer, William M.] Univ Minnesota, Minneapolis, MN USA	Centers for Disease Control & Prevention - USA; Minnesota Department of Health (MHD); Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities	Swanson, SJ (corresponding author), Hennepin Cty Med Ctr, Dept Pediat, 701 Pk Ave,G7, Minneapolis, MN 55415 USA.	stephen.swanson@hcmed.org						Abramowicz ME, 2010, DRUGS PARASITIC INFE; [Anonymous], 2004, PRED ANT ANT PAR TRE; Bennett A, 2000, PARASITOL TODAY, V16, P71, DOI 10.1016/S0169-4758(99)01544-6; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bethony J, 2002, CLIN INFECT DIS, V35, P1336, DOI 10.1086/344268; Boulware DR, 2007, AM J MED, V120, P545, DOI 10.1016/j.amjmed.2006.05.072; Brodine SK, 2009, AM J TROP MED HYG, V80, P425, DOI 10.4269/ajtmh.2009.80.425; BUCHWALD D, 1995, J CLIN PHARM THER, V20, P271, DOI 10.1111/j.1365-2710.1995.tb00662.x; Cartwright CP, 1999, J CLIN MICROBIOL, V37, P2408, DOI 10.1128/JCM.37.8.2408-2411.1999; Centers for Disease Control and Prevention, OV REF HLTH GUID INT; CHUNG WC, 1991, INT J PARASITOL, V21, P269, DOI 10.1016/0020-7519(91)90021-X; de Silva NR, 2003, TRENDS PARASITOL, V19, P547, DOI 10.1016/j.pt.2003.10.002; Department of Health and Human Services Administration for Children and Families, REF ARR DAT; Department of Health and Human Services Administration for Children and Families, 1998, MMWR-MORBID MORTAL W; Dreyer G, 1996, J CLIN MICROBIOL, V34, P2569, DOI 10.1128/JCM.34.10.2569-2571.1996; Franco-Paredes C, 2007, AM J TROP MED HYG, V77, P633, DOI 10.4269/ajtmh.2007.77.633; Garg PK, 2005, AM J TROP MED HYG, V73, P386, DOI 10.4269/ajtmh.2005.73.386; Geltman PL, 2003, AM J TROP MED HYG, V69, P657, DOI 10.4269/ajtmh.2003.69.657; GODUE CB, 1990, CAN J PUBLIC HEALTH, V81, P191; Goswami ND, 2009, AM J TROP MED HYG, V81, P302, DOI 10.4269/ajtmh.2009.81.302; GYORKOS TW, 1992, J INFECT DIS, V166, P413, DOI 10.1093/infdis/166.2.413; HALL A, 1993, T ROY SOC TROP MED H, V87, P84, DOI 10.1016/0035-9203(93)90435-S; HALL A, 1994, T ROY SOC TROP MED H, V88, P110, DOI 10.1016/0035-9203(94)90525-8; Horton J, 2000, PARASITOLOGY, V121, pS113, DOI 10.1017/S0031182000007290; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Hotez PJ, 2004, NEW ENGL J MED, V351, P799, DOI 10.1056/NEJMra032492; Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937; Lifson AR, 2002, PUBLIC HEALTH REP, V117, P69, DOI 10.1093/phr/117.1.69; Lurio J, 1991, J Am Board Fam Pract, V4, P71; Miller JM, 2000, AM J TROP MED HYG, V62, P115, DOI 10.4269/ajtmh.2000.62.115; Muennig P, 1999, NEW ENGL J MED, V340, P773, DOI 10.1056/NEJM199903113401006; Newberry AM, 2005, CHEST, V128, P3681, DOI 10.1378/chest.128.5.3681; Olds GR, 1999, J INFECT DIS, V179, P996, DOI 10.1086/314686; Pancera Christiane Finardi, 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P159, DOI 10.1590/S0036-46651997000300007; Pengsaa Krisana, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P78; Peterson MH, 2001, DIAGN MICR INFEC DIS, V40, P75, DOI 10.1016/S0732-8893(01)00244-9; Posey DL, 2007, CLIN INFECT DIS, V45, P1310, DOI 10.1086/522529; RACCURT CP, 1990, TROP MED PARASITOL, V41, P46; Shah JJ, 2008, AM J TROP MED HYG, V78, P754, DOI 10.4269/ajtmh.2008.78.754; Stauffer WM, 2008, AM J TROP MED HYG, V79, P141, DOI 10.4269/ajtmh.2008.79.141	41	36	38	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					1498	1507		10.1056/NEJMoa1103360	http://dx.doi.org/10.1056/NEJMoa1103360			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927UE	22512482				2022-12-24	WOS:000302934800007
J	Treiber, CD; Salzer, MC; Riegler, J; Edelman, N; Sugar, C; Breuss, M; Pichler, P; Cadiou, H; Saunders, M; Lythgoe, M; Shaw, J; Keays, DA				Treiber, Christoph Daniel; Salzer, Marion Claudia; Riegler, Johannes; Edelman, Nathaniel; Sugar, Cristina; Breuss, Martin; Pichler, Paul; Cadiou, Herve; Saunders, Martin; Lythgoe, Mark; Shaw, Jeremy; Keays, David Anthony			Clusters of iron-rich cells in the upper beak of pigeons are macrophages not magnetosensitive neurons	NATURE			English	Article							MAGNETITE-BASED MAGNETORECEPTION; HOMING PIGEONS; PUTATIVE MAGNETORECEPTOR; TRIGEMINAL MEDIATION; MIGRATORY BIRD; ORIENTATION; MECHANISM; FERRITIN; COMPASS; TISSUES	Understanding the molecular and cellular mechanisms that mediate magnetosensation in vertebrates is a formidable scientific problem(1,2). One hypothesis is that magnetic information is transduced into neuronal impulses by using a magnetite-based magnetoreceptor(3,4). Previous studies claim to have identified a magnetic sense system in the pigeon, common to avian species, which consists of magnetite-containing trigeminal afferents located at six specific loci in the rostral subepidermis of the beak(5-8). These studies have been widely accepted in the field and heavily relied upon by both behavioural biologists and physicists(9-11). Here we show that clusters of iron-rich cells in the rostro-medial upper beak of the pigeon Columbia livia are macrophages, not magnetosensitive neurons. Our systematic characterization of the pigeon upper beak identified iron-rich cells in the stratum laxum of the subepidermis, the basal region of the respiratory epithelium and the apex of feather follicles. Using a three-dimensional blueprint of the pigeon beak created by magnetic resonance imaging and computed tomography, we mapped the location of iron-rich cells, revealing unexpected variation in their distribution and number-an observation that is inconsistent with a role in magnetic sensation. Ultrastructure analysis of these cells, which are not unique to the beak, showed that their subcellular architecture includes ferritin-like granules, siderosomes, haemosiderin and filopodia, characteristics of iron-rich macrophages. Our conclusion that these cells are macrophages and not magnetosensitive neurons is supported by immunohistological studies showing co-localization with the antigen-presenting molecule major histocompatibility complex class II. Our work necessitates a renewed search for the true magnetite-dependent magnetoreceptor in birds.	[Treiber, Christoph Daniel; Salzer, Marion Claudia; Edelman, Nathaniel; Sugar, Cristina; Breuss, Martin; Pichler, Paul; Keays, David Anthony] Inst Mol Pathol, A-1030 Vienna, Austria; [Riegler, Johannes; Lythgoe, Mark] UCL, Ctr Adv Biomed Imaging, Dept Med, London WC1E 6DD, England; [Riegler, Johannes; Lythgoe, Mark] UCL, Inst Child Hlth, London WC1E 6DD, England; [Cadiou, Herve] Univ Strasbourg, INCI, CNRS, UPR 3212, F-67084 Strasbourg, France; [Breuss, Martin; Shaw, Jeremy] Univ Western Australia, Ctr Microscopy Characterisat & Anal, Crawley 6009, Australia	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of London; University College London; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Western Australia	Keays, DA (corresponding author), Inst Mol Pathol, A-1030 Vienna, Austria.	keays@imp.ac.at	Saunders, Martin/B-3082-2011; Breuss, Martin/AAL-9509-2021; Shaw, Jeremy A/B-4156-2011; Edelman, Nathaniel/AAH-1804-2021; Salzer, Marion/AAB-1844-2020; Treiber, Christoph/D-6266-2018	Saunders, Martin/0000-0001-6873-7816; Shaw, Jeremy A/0000-0002-5140-457X; Edelman, Nathaniel/0000-0002-5142-6760; Treiber, Christoph/0000-0002-6994-091X; Breuss, Martin Werner/0000-0003-2200-8604; Lythgoe, Mark/0000-0002-4945-0171	Boehringer Ingelheim; Engineering and Physical Sciences Research Council [EP/I014667/1] Funding Source: researchfish; EPSRC [EP/I014667/1] Funding Source: UKRI	Boehringer Ingelheim(Boehringer Ingelheim); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We would like to thank M. Busslinger, M. Wild and J. Flint for their critical comments on earlier drafts of this manuscript. Thanks also to T. Iancu who commented on our electron micrographs and S. Soto who remarked on the inflammatory lesion in P199. Gratitude is owed to the bio-optics and electron microscopy facilities at the Institute of Molecular Pathology for their assistance in performing experiments. We wish to acknowledge the Centre for Microscopy, Characterisation and Analysis and the Australian Microscopy and Microanalysis Research Facility at the University of Western Australia, a facility funded by the University, State and Commonwealth Governments. Finally, we wish to thank Boehringer Ingelheim, which funds basic science at the Institute of Molecular Pathology.	BEASON RC, 1987, NEUROSCI LETT, V80, P229, DOI 10.1016/0304-3940(87)90659-8; Cadiou H, 2010, J R SOC INTERFACE, V7, pS193, DOI 10.1098/rsif.2009.0423.focus; Davila AF, 2005, BIOPHYS J, V89, P56, DOI 10.1529/biophysj.104.049346; Falkenberg G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009231; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; Fleissner G, 2007, NATURWISSENSCHAFTEN, V94, P631, DOI 10.1007/s00114-007-0236-0; Hanzlik M, 2000, BIOMETALS, V13, P325, DOI 10.1023/A:1009214526685; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; Horng YM, 2006, THERIOGENOLOGY, V65, P1759, DOI 10.1016/j.theriogenology.2005.10.011; IANCU TC, 1992, ELECTRON MICROSC REV, V5, P209, DOI 10.1016/0892-0354(92)90011-E; Igyarto BZ, 2006, IMMUNOLOGY, V119, P278, DOI 10.1111/j.1365-2567.2006.02432.x; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Kirschvink JL, 2001, CURR OPIN NEUROBIOL, V11, P462, DOI 10.1016/S0959-4388(00)00235-X; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Meguro R, 2005, ARCH HISTOL CYTOL, V68, P171, DOI 10.1679/aohc.68.171; MOOS T, 1993, HISTOCHEMISTRY, V99, P471; Mora CV, 2004, NATURE, V432, P508, DOI 10.1038/nature03077; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; RICHTER GW, 1978, AM J PATHOL, V91, P361; Ritz T, 2004, NATURE, V429, P177, DOI 10.1038/nature02534; SIMSON JV, 1972, J CELL BIOL, V52, P536, DOI 10.1083/jcb.52.3.536; Solov'yov IA, 2007, BIOPHYS J, V93, P1493, DOI 10.1529/biophysj.107.105098; Solov'yov IA, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041919; Stapput K, 2008, CURR BIOL, V18, P602, DOI 10.1016/j.cub.2008.03.046; Walker MM, 1997, NATURE, V390, P371, DOI 10.1038/37057; Wang JA, 2011, BIOCHEM J, V434, P365, DOI 10.1042/BJ20101825; Williams MN, 2001, BRAIN RES, V889, P243, DOI 10.1016/S0006-8993(00)03114-0; Wiltschko R, 2010, CURR BIOL, V20, P1534, DOI 10.1016/j.cub.2010.06.073; Wiltschko W, 2009, P ROY SOC B-BIOL SCI, V276, P2227, DOI 10.1098/rspb.2009.0050; Winklhofer M., 2008, DOES AVIAN MAGNETORE; Zapka M, 2009, NATURE, V461, P1274, DOI 10.1038/nature08528	31	125	135	4	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					367	U102		10.1038/nature11046	http://dx.doi.org/10.1038/nature11046			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22495303				2022-12-24	WOS:000302946500031
J	Psaty, BM; Meslin, EM; Breckenridge, A				Psaty, Bruce M.; Meslin, Eric M.; Breckenridge, Alasdair			A Lifecycle Approach to the Evaluation of FDA Approval Methods and Regulatory Actions Opportunities Provided by a New IOM Report	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Meslin, Eric M.] Indiana Univ, Ctr Bioeth, Indianapolis, IN 46204 USA; [Breckenridge, Alasdair] Med & Healthcare Prod Regulatory Agcy MHRA, London, England	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Indiana University System; Indiana University-Purdue University Indianapolis; The Medicines & Healthcare Products Regulatory Agency	Psaty, BM (corresponding author), Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NCRR NIH HHS [UL1RR025761-01] Funding Source: Medline; NHLBI NIH HHS [HL080295, HL078888, HL103612, HL087652, HL105756, HL085251] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085251, U01HL080295, R01HL087652, R01HL078888, R01HL080295, R01HL105756, R01HL103612] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], POT SIGN SER RISKS N; Briesacher BA, 2012, METHODS EVALUATE IMP; Committee on Ethical and Scientific Issues in Studying the Safety of Approved Drugs Institute of Medicine, 2012, ETH SCI ISS STUD SAF; Food and Drug Administration, 2008, GUID IND DIAB MELL E; [Institute of Medicine of the National Academies Committee on the Assessment of the U. S. Drug Safety System], 2006, FUT DRUG SAF PROM PR; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Powers A, 2012, ARCH INTERN MED, V172, P72, DOI 10.1001/archinternmed.2011.525; U.S. Department of Health and Human Services; U.S. Food and Drug Administration, 2011, ADV REG SCI FDA STRA	8	30	30	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 20	2012	307	23					2491	2492		10.1001/jama.2012.5545	http://dx.doi.org/10.1001/jama.2012.5545			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	960MB	22563032				2022-12-24	WOS:000305391400022
J	Montpetit, B; Weis, K				Montpetit, Ben; Weis, Karsten			An Alternative Route for Nuclear mRNP Export by Membrane Budding	SCIENCE			English	Editorial Material							PORE; RECRUITMENT; TRANSPORT; DYNAMICS		[Montpetit, Ben; Weis, Karsten] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Montpetit, B (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	bmontpet@berkeley.edu; kweis@berkeley.edu	Weis, Karsten/F-5719-2011; Montpetit, Ben/L-6456-2019	Weis, Karsten/0000-0001-7224-925X; Montpetit, Ben/0000-0002-8317-983X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058065] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM058065] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aitchison JD, 2012, GENETICS, V190, P855, DOI 10.1534/genetics.111.127803; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Grunwald D, 2011, NATURE, V475, P333, DOI 10.1038/nature10318; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; MEHLIN H, 1992, CELL, V69, P605, DOI 10.1016/0092-8674(92)90224-Z; Mettenleiter TC, 2006, CURR OPIN MICROBIOL, V9, P423, DOI 10.1016/j.mib.2006.06.013; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032	11	15	15	1	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					809	810		10.1126/science.1222243	http://dx.doi.org/10.1126/science.1222243			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605737				2022-12-24	WOS:000304145600025
J	Koskela, HLM; Eldfors, S; Ellonen, P; van Adrichem, AJ; Kuusanmaki, H; Andersson, EI; Lagstrom, S; Clemente, MJ; Olson, T; Jalkanen, SE; Majumder, MM; Almusa, H; Edgren, H; Lepisto, M; Mattila, P; Guinta, K; Koistinen, P; Kuittinen, T; Penttinen, K; Parsons, A; Knowles, J; Saarela, J; Wennerberg, K; Kallioniemi, O; Porkka, K; Loughran, TP; Heckman, CA; Maciejewski, JP; Mustjoki, S				Koskela, Hanna L. M.; Eldfors, Samuli; Ellonen, Pekka; van Adrichem, Arjan J.; Kuusanmaki, Heikki; Andersson, Emma I.; Lagstrom, Sonja; Clemente, Michael J.; Olson, Thomas; Jalkanen, Sari E.; Majumder, Muntasir Mamun; Almusa, Henrikki; Edgren, Henrik; Lepisto, Maija; Mattila, Pirkko; Guinta, Kathryn; Koistinen, Pirjo; Kuittinen, Taru; Penttinen, Kati; Parsons, Alun; Knowles, Jonathan; Saarela, Janna; Wennerberg, Krister; Kallioniemi, Olli; Porkka, Kimmo; Loughran, Thomas P., Jr.; Heckman, Caroline A.; Maciejewski, Jaroslaw P.; Mustjoki, Satu			Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LGL LEUKEMIA; ACTIVATION; APOPTOSIS; CELLS; NEUTROPENIA; EXPANSION; SURVIVAL; TRANSPLANTATION; CYTOKINES; PROTECTS	BACKGROUND T-cell large granular lymphocytic leukemia is a rare lymphoproliferative disorder characterized by the expansion of clonal CD3+CD8+ cytotoxic T lymphocytes (CTLs) and often associated with autoimmune disorders and immune-mediated cytopenias. METHODS We used next-generation exome sequencing to identify somatic mutations in CTLs from an index patient with large granular lymphocytic leukemia. Targeted resequencing was performed in a well-characterized cohort of 76 patients with this disorder, characterized by clonal T-cell-receptor rearrangements and increased numbers of large granular lymphocytes. RESULTS Mutations in the signal transducer and activator of transcription 3 gene (STAT3) were found in 31 of 77 patients (40%) with large granular lymphocytic leukemia. Among these 31 patients, recurrent mutational hot spots included Y640F in 13 (17%), D661V in 7 (9%), D661Y in 7 (9%), and N647I in 3 (4%). All mutations were located in exon 21, encoding the Src homology 2 (SH2) domain, which mediates the dimerization and activation of STAT protein. The amino acid changes resulted in a more hydrophobic protein surface and were associated with phosphorylation of STAT3 and its localization in the nucleus. In vitro functional studies showed that the Y640F and D661V mutations increased the transcriptional activity of STAT3. In the affected patients, downstream target genes of the STAT3 pathway (IFNGR2, BCL2L1, and JAK2) were up-regulated. Patients with STAT3 mutations presented more often with neutropenia and rheumatoid arthritis than did patients without these mutations. CONCLUSIONS The SH2 dimerization and activation domain of STAT3 is frequently mutated in patients with large granular lymphocytic leukemia; these findings suggest that aberrant STAT3 signaling underlies the pathogenesis of this disease.	[Koskela, Hanna L. M.; Andersson, Emma I.; Jalkanen, Sari E.; Penttinen, Kati; Porkka, Kimmo; Mustjoki, Satu] Univ Helsinki, Hematol Res Unit Helsinki, Dept Med, FIN-00029 Helsinki, Finland; [Koskela, Hanna L. M.; Andersson, Emma I.; Jalkanen, Sari E.; Penttinen, Kati; Porkka, Kimmo; Mustjoki, Satu] Univ Helsinki, Cent Hosp, FIN-00029 Helsinki, Finland; [Eldfors, Samuli; Ellonen, Pekka; van Adrichem, Arjan J.; Kuusanmaki, Heikki; Lagstrom, Sonja; Majumder, Muntasir Mamun; Almusa, Henrikki; Edgren, Henrik; Lepisto, Maija; Mattila, Pirkko; Parsons, Alun; Knowles, Jonathan; Saarela, Janna; Wennerberg, Krister; Kallioniemi, Olli; Heckman, Caroline A.] Univ Helsinki, Inst Mol Med Finland, FIN-00029 Helsinki, Finland; [Mattila, Pirkko] Univ Helsinki, Haartman Inst, FIN-00029 Helsinki, Finland; [Koistinen, Pirjo] Oulu Univ Hosp, Dept Med, Oulu, Finland; [Koistinen, Pirjo] Univ Oulu, Oulu, Finland; [Kuittinen, Taru] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Clemente, Michael J.; Guinta, Kathryn; Maciejewski, Jaroslaw P.] Cleveland Clin, Dept Translat Hematol & Oncol Res, Taussig Canc Inst, Cleveland, OH 44195 USA; [Olson, Thomas; Loughran, Thomas P., Jr.] Penn State Coll Med, Penn State Hershey Canc Inst, Hershey, PA USA	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; University of Oulu; University of Oulu; Kuopio University Hospital; University of Eastern Finland; Cleveland Clinic Foundation; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Mustjoki, S (corresponding author), Univ Helsinki, Hematol Res Unit Helsinki, Dept Med, POB 700,Haartmaninkatu 8, FIN-00029 Helsinki, Finland.	satu.mustjoki@helsinki.fi	He, Liye/C-8843-2015; Wennerberg, Krister/AFM-0539-2022; Mustjoki, Satu/AAD-9974-2020; Eldfors, Samuli/AAB-3029-2019; Kallioniemi, Olli P/H-5111-2011; Wennerberg, Krister/AAH-2919-2022; Saarela, Janna S/E-5369-2014; Porkka, Kimmo/O-2323-2016	He, Liye/0000-0002-6632-2112; Wennerberg, Krister/0000-0002-1352-4220; Mustjoki, Satu/0000-0002-0816-8241; Eldfors, Samuli/0000-0001-5056-4750; Kallioniemi, Olli P/0000-0002-3231-0332; Wennerberg, Krister/0000-0002-1352-4220; Clemente, Michael/0000-0003-4345-3934; Andersson, Emma/0000-0002-3986-9892; Olson, Thomas/0000-0001-7906-205X; Saarela, Janna/0000-0002-0853-6219; Lepisto, Maija Helena/0000-0002-2595-1465; Ellonen, Pekka/0000-0001-6072-0489; Kuusanmaki, Heikki/0000-0002-1903-0408; Rajala, Hanna/0000-0003-2675-2385; Porkka, Kimmo/0000-0003-4112-5902; Heckman, Caroline/0000-0002-4324-8706; Majumder, Muntasir Mamun/0000-0002-5550-2951	Academy of Finland and others; Finnish government; Academy of Finland; Finnish Cancer Societies; Sigrid Juselius Foundation; Finnish Association of Hematology; National Clinical Graduate School; Finnish Funding Agency for Technology and Innovation; European Regional Development Fund; Jane and Aatos Erkko Foundation; K.A. Johansson Foundation; Signe and Ane Gyllenberg Foundation; National Institutes of Health [R01 CA127264A, R01AI085578, CA98472, 2K24HL077522]; Cancer Foundation Finland sr [100118, 110101] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA127264, R01CA098472] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL077522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085578] Funding Source: NIH RePORTER	Academy of Finland and others; Finnish government; Academy of Finland(Academy of Finland); Finnish Cancer Societies; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finnish Association of Hematology; National Clinical Graduate School; Finnish Funding Agency for Technology and Innovation(Finnish Funding Agency for Technology & Innovation (TEKES)); European Regional Development Fund(European Commission); Jane and Aatos Erkko Foundation; K.A. Johansson Foundation; Signe and Ane Gyllenberg Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Foundation Finland sr; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Academy of Finland and others.; Supported by a special subsidy for health sciences, research, and training provided by the Finnish government and by grants from the Academy of Finland, the Finnish Cancer Societies, the Sigrid Juselius Foundation, the Finnish Association of Hematology, the National Clinical Graduate School, the Finnish Funding Agency for Technology and Innovation, the European Regional Development Fund, the Jane and Aatos Erkko Foundation, the K.A. Johansson Foundation, and the Signe and Ane Gyllenberg Foundation, and by grants from the National Institutes of Health (R01 CA127264A, to Mr. Clemente; R01AI085578, to Ms. Guinta; CA98472, to Dr. Loughran; and 2K24HL077522, to Dr. Maciejewski).	Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Burks EJ, 2006, BLOOD REV, V20, P245, DOI 10.1016/j.blre.2006.01.003; Chen XH, 2009, BLOOD, V113, P3226, DOI 10.1182/blood-2008-07-168245; Clemente MJ, 2011, BLOOD, V118, P4384, DOI 10.1182/blood-2011-02-338517; Epling-Burnett PK, 2004, ONCOGENE, V23, P9220, DOI 10.1038/sj.onc.1208122; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Gentile TC, 1998, BRIT J HAEMATOL, V101, P507, DOI 10.1046/j.1365-2141.1998.00712.x; Haga S, 2003, J CLIN INVEST, V112, P989, DOI 10.1172/JCI200317970; Hayakawa F, 2011, 53 AM SOC HEM ANN M; Kothapalli R, 2005, INT J ONCOL, V26, P529; Lamy T, 1998, BLOOD, V92, P4771, DOI 10.1182/blood.V92.12.4771.424k32_4771_4777; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Liu JH, 2000, BLOOD, V95, P3219; LOUGHRAN TP, 1985, ANN INTERN MED, V102, P169, DOI 10.7326/0003-4819-102-2-169; LOUGHRAN TP, 1993, BLOOD, V82, P1; Lovato P, 2003, J BIOL CHEM, V278, P16777, DOI 10.1074/jbc.M207999200; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Mohty M, 2002, LEUKEMIA, V16, P2129, DOI 10.1038/sj.leu.2402645; Mustjoki S, 2009, LEUKEMIA, V23, P1398, DOI 10.1038/leu.2009.46; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pilati C, 2011, J EXP MED, V208, P1359, DOI 10.1084/jem.20110283; Ramos HL, 2008, SCAND J RHEUMATOL, V37, P35, DOI 10.1080/03009740701606010; Rossi D, 2007, AM J HEMATOL, V82, P1103, DOI 10.1002/ajh.20981; Scarzello AJ, 2007, MOL BIOL CELL, V18, P2455, DOI 10.1091/mbc.E06-09-0843; Schade AE, 2006, CELL CYCLE, V5, P2571, DOI 10.4161/cc.5.22.3449; Schade AE, 2006, BLOOD, V107, P4834, DOI 10.1182/blood-2005-08-3076; Shah MV, 2008, BLOOD, V112, P770, DOI 10.1182/blood-2007-11-121871; Sokol L, 2006, ONCOLOGIST, V11, P263, DOI 10.1007/s11899-007-0038-7; Takeda K, 1998, J IMMUNOL, V161, P4652; Tiacci E, 2011, NEW ENGL J MED, V364, P2305, DOI 10.1056/NEJMoa1014209; WANG F, 1995, J EXP MED, V182, P1825, DOI 10.1084/jem.182.6.1825; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016; Yang J, 2008, BLOOD, V111, P1610, DOI 10.1182/blood-2007-06-093823; Zhang RR, 2008, P NATL ACAD SCI USA, V105, P16308, DOI 10.1073/pnas.0806447105	35	519	538	3	45	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 17	2012	366	20					1905	1913		10.1056/NEJMoa1114885	http://dx.doi.org/10.1056/NEJMoa1114885			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942WU	22591296	Bronze, Green Accepted			2022-12-24	WOS:000304083000009
J	McCartney, M				McCartney, Margaret			MEDICINE AND THE MEDIA Can a simple blood test really predict breast cancer?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Breast Cancer Campaign, 2012, BREAST CANC RISK CAN; Brennan K, 2012, CANCER RES, V72, P2304, DOI 10.1158/0008-5472.CAN-11-3157; Hope J., 2012, DAILY MAIL      0501; In Touch, 2012, BBC RADIO 4     0501; Quinn B, 2012, GUARDIAN        0430; Smith R., 2012, TELEGRAPH       0430	6	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 15	2012	344								e3374	10.1136/bmj.e3374	http://dx.doi.org/10.1136/bmj.e3374			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942YF	22589526				2022-12-24	WOS:000304086900020
J	Khademi, H; Malekzadeh, R; Pourshams, A; Jafari, E; Salahi, R; Semnani, S; Abaie, B; Islami, F; Nasseri-Moghaddam, S; Etemadi, A; Byrnes, G; Abnet, CC; Dawsey, SM; Day, NE; Pharoah, PD; Boffetta, P; Brennan, P; Kamangar, F				Khademi, Hooman; Malekzadeh, Reza; Pourshams, Akram; Jafari, Elham; Salahi, Rasool; Semnani, Shahryar; Abaie, Behrooz; Islami, Farhad; Nasseri-Moghaddam, Siavosh; Etemadi, Arash; Byrnes, Graham; Abnet, Christian C.; Dawsey, Sanford M.; Day, Nicholas E.; Pharoah, Paul D.; Boffetta, Paolo; Brennan, Paul; Kamangar, Farin			Opium use and mortality in Golestan Cohort Study: prospective cohort study of 50 000 adults in Iran	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ESOPHAGEAL CANCER; HIGH-RISK; SOCIOECONOMIC-STATUS; BLADDER-CANCER; MORPHINE; ADDICTION; RELIABILITY; POPULATION; METABOLISM; CARCINOMA	Objectives To investigate the association between opium use and subsequent risk of death. Design Prospective cohort study. Setting The Golestan Cohort Study in north-eastern Iran collected detailed validated data on opium use and other exposures at baseline. Participants were enrolled between January 2004 and June 2008 and were followed to May 2011, with a follow-up success rate of over 99%. Participants 50 045 participants aged 40-75 at baseline. Main outcomes Mortality, all cause and major subcategories. Results 17% (n=8487) of the participants reported opium use, with a mean duration of 12.7 years. During the follow-up period 2145 deaths were reported. The adjusted hazard ratio for all cause mortality associated with ever use of opium was 1.86 (95% confidence interval 1.68 to 2.06). Opium consumption was significantly associated with increased risks of deaths from several causes including circulatory diseases (hazard ratio 1.81) and cancer (1.61). The strongest associations were seen with deaths from asthma, tuberculosis, and chronic obstructive pulmonary disease (11.0, 6.22, and 5.44, respectively). After exclusion of people who self prescribed opium after the onset of major chronic illnesses, the associations remained strong with a dose-response relation. Conclusion Opium users have an increased risk of death from multiple causes compared with non-users. Increased risks were also seen in people who used low amounts of opium for a long period and those who had no major illness before use.	[Khademi, Hooman; Malekzadeh, Reza; Pourshams, Akram; Jafari, Elham; Abaie, Behrooz; Islami, Farhad; Nasseri-Moghaddam, Siavosh; Etemadi, Arash; Kamangar, Farin] Univ Tehran Med Sci, Digest Dis Res Ctr, Shariati Hosp, Tehran, Iran; [Khademi, Hooman; Byrnes, Graham; Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Salahi, Rasool; Semnani, Shahryar] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran; [Islami, Farhad; Boffetta, Paolo] Mt Sinai Sch Med, Inst Translat Epidemiol, New York, NY USA; [Islami, Farhad; Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Etemadi, Arash; Abnet, Christian C.; Dawsey, Sanford M.; Kamangar, Farin] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Day, Nicholas E.; Pharoah, Paul D.] Univ Cambridge, Dept Oncol & Publ Hlth, Cambridge, England; [Day, Nicholas E.; Pharoah, Paul D.] Univ Cambridge, Dept Primary Care, Cambridge, England; [Boffetta, Paolo] Int Prevent Res Inst, Lyon, France; [Kamangar, Farin] Morgan State Univ, Dept Publ Hlth Anal, Sch Community Hlth & Policy, Baltimore, MD 21239 USA	Tehran University of Medical Sciences; World Health Organization; International Agency for Research on Cancer (IARC); Golestan University of Medical Sciences; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Cambridge; University of Cambridge; Morgan State University	Malekzadeh, R (corresponding author), Univ Tehran Med Sci, Digest Dis Res Ctr, Shariati Hosp, Tehran, Iran.	malek@ams.ac.ir; brennan@iarc.fr	Etemadi, Arash/C-1386-2016; Semnani, Shahryar/N-2270-2016; Malekzadeh, Reza/U-1382-2017; Abnet, Christian C/C-4111-2015; Etemadi, Arash/Y-7082-2018; Khademi, Hooman/AAZ-8798-2020; Boffetta, Paolo/AAI-7767-2021; Pharoah, Paul/V-6658-2019	Etemadi, Arash/0000-0002-3458-1072; Semnani, Shahryar/0000-0002-8768-6142; Malekzadeh, Reza/0000-0002-9820-6335; Abnet, Christian C/0000-0002-3008-7843; Etemadi, Arash/0000-0002-3458-1072; Boffetta, Paolo/0000-0002-3811-2791; Pharoah, Paul/0000-0001-8494-732X; Byrnes, Graham/0000-0003-3893-7539; Malekzadeh, Reza/0000-0003-1043-3814; Islami, Farhad/0000-0002-7357-5994; Pourshams, Akram/0000-0002-7950-3983	Tehran University of medical sciences [81/15]; Cancer Research UK [C20/A5860]; NCI, National Institutes of Health; IARC; Social Security Organization of Iran Golestan Branch; NATIONAL CANCER INSTITUTE [ZIACP000185] Funding Source: NIH RePORTER	Tehran University of medical sciences(Tehran University of Medical Sciences); Cancer Research UK(Cancer Research UK); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); IARC; Social Security Organization of Iran Golestan Branch; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The Golestan Cohort Study was supported by Tehran University of medical sciences (grant No: 81/15), Cancer Research UK (grant No: C20/A5860), the Intramural Research Program of the NCI, National Institutes of Health, and through various collaborative research agreements with the IARC. The study has also received special support from the Social Security Organization of Iran Golestan Branch.	Abnet CC, 2004, CANCER EPIDEM BIOMAR, V13, P1068; Aliasgari M A, 2004, Urol J, V1, P253; Atici S, 2005, J BIOSCIENCES, V30, P245, DOI 10.1007/BF02703705; Bekheet SHM, 2010, TISSUE CELL, V42, P266, DOI 10.1016/j.tice.2010.06.001; BORZELLECA JF, 1994, J APPL TOXICOL, V14, P435, DOI 10.1002/jat.2550140609; Bosshart Herbert, 2011, J Opioid Manag, V7, P93; DACOSTA JL, 1971, THORAX, V26, P555, DOI 10.1136/thx.26.5.555; Elia Davide, 2010, Acta Biomed, V81, P63; Fewell Z, 2007, AM J EPIDEMIOL, V166, P646, DOI 10.1093/aje/kwm165; Fimiani C, 1999, CANCER LETT, V146, P45, DOI 10.1016/S0304-3835(99)00227-X; FRIESEN M, 1985, MUTAT RES, V150, P177, DOI 10.1016/0027-5107(85)90114-9; GHADIRIAN P, 1985, INT J CANCER, V35, P593, DOI 10.1002/ijc.2910350505; HEWER T, 1978, LANCET, V2, P494; Hosseini SY, 2010, UROL ONCOL-SEMIN ORI, V28, P610, DOI 10.1016/j.urolonc.2008.10.016; Islami F, 2009, INT J EPIDEMIOL, V38, P978, DOI 10.1093/ije/dyp195; Kalant H, 1997, ADDICTION, V92, P267; Khademi H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011183; Malekshah AF, 2006, EUR J CLIN NUTR, V60, P971, DOI 10.1038/sj.ejcn.1602407; Maslov LN, 2009, LIFE SCI, V84, P657, DOI 10.1016/j.lfs.2009.02.016; Masoomi M, 2010, INT J PREVENTIVE MED, V1, P182; Masoomi M, 2010, BLOOD COAGUL FIBRIN, V21, P109, DOI 10.1097/MBC.0b013e32832f2b1e; Masoumi M, 2010, J RES MED SCI, V15, P27; Mccandless LC, 2008, J CLIN EPIDEMIOL, V61, P247, DOI 10.1016/j.jclinepi.2007.05.006; McCrimmon DR, 2003, AM J PHYSIOL-REG I, V285, pR1274, DOI 10.1152/ajpregu.00428.2003; Meine TJ, 2005, AM HEART J, V149, P1043, DOI 10.1016/j.ahj.2005.02.010; Mousavi MRA, 2003, LARYNGOSCOPE, V113, P1939, DOI 10.1097/00005537-200311000-00016; NAGAMATSU K, 1986, BIOCHEM PHARMACOL, V35, P3543, DOI 10.1016/0006-2952(86)90624-6; Nasrollahzadeh D, 2008, BRIT J CANCER, V98, P1857, DOI 10.1038/sj.bjc.6604369; PACIFICI GM, 1986, XENOBIOTICA, V16, P123, DOI 10.3109/00498258609043514; Pinto LFR, 1997, CARCINOGENESIS, V18, P365; Pourshams A, 2005, BRIT J CANCER, V92, P176, DOI 10.1038/sj.bjc.6602249; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Sadeghian S, 2010, INT J CARDIOL, V141, P116, DOI 10.1016/j.ijcard.2008.11.063; Safaii N, 2010, GEN THORAC CARDIOVAS, V58, P62, DOI 10.1007/s11748-009-0529-7; Schiff PL, 2002, AM J PHARM EDUC, V66, P186; Shakhssalim N, 2010, ASIAN PAC J CANCER P, V11, P601; SIEMIATYCKI J, 1988, J OCCUP ENVIRON MED, V30, P617, DOI 10.1097/00043764-198808000-00004; Sumathi T, 2009, PHYTOMEDICINE, V16, P897, DOI 10.1016/j.phymed.2009.03.005; UNODC United Nations Office on Drugs and Crime Vienna, 2010, WORLD DRUG REP 2010; Vallejo Ricardo, 2004, Am J Ther, V11, P354, DOI 10.1097/01.mjt.0000132250.95650.85; VANDERLAAN JW, 1995, INT J IMMUNOPHARMACO, V17, P535, DOI 10.1016/0192-0561(95)00010-Y	41	107	107	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 17	2012	344								e2502	10.1136/bmj.e2502	http://dx.doi.org/10.1136/bmj.e2502			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	931CN	22511302	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000303192100003
J	Auer, R; Bauer, DC; Marques-Vidal, P; Butler, J; Min, LJ; Cornuz, J; Satterfield, S; Newman, AB; Vittinghoff, E; Rodondi, N				Auer, Reto; Bauer, Douglas C.; Marques-Vidal, Pedro; Butler, Javed; Min, Lauren J.; Cornuz, Jacques; Satterfield, Suzanne; Newman, Anne B.; Vittinghoff, Eric; Rodondi, Nicolas		Hlth ABC Study	Association of Major and Minor ECG Abnormalities With Coronary Heart Disease Events	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ST-T ABNORMALITIES; CARDIOVASCULAR EVENTS; PREDICTIVE ABILITY; ROC CURVE; RISK; MORTALITY; ELECTROCARDIOGRAMS; RECLASSIFICATION; ATHEROSCLEROSIS; MARKERS	Context In populations of older adults, prediction of coronary heart disease (CHD) events through traditional risk factors is less accurate than in middle-aged adults. Electrocardiographic (ECG) abnormalities are common in older adults and might be of value for CHD prediction. Objective To determine whether baseline ECG abnormalities or development of new and persistent ECG abnormalities are associated with increased CHD events. Design, Setting, and Participants A population-based study of 2192 white and black older adults aged 70 to 79 years from the Health, Aging, and Body Composition Study (Health ABC Study) without known cardiovascular disease. Adjudicated CHD events were collected over 8 years between 1997-1998 and 2006-2007. Baseline and 4-year ECG abnormalities were classified according to the Minnesota Code as major and minor. Using Cox proportional hazards regression models, the addition of ECG abnormalities to traditional risk factors were examined to predict CHD events. Main Outcome Measure Adjudicated CHD events (acute myocardial infarction [MI], CHD death, and hospitalization for angina or coronary revascularization). Results At baseline, 276 participants (13%) had minor and 506 (23%) had major ECG abnormalities. During follow-up, 351 participants had CHD events (96 CHD deaths, 101 acute MIs, and 154 hospitalizations for angina or coronary revascularizations). Both baseline minor and major ECG abnormalities were associated with an increased risk of CHD after adjustment for traditional risk factors (17.2 per 1000 person-years among those with no abnormalities; 29.3 per 1000 person-years; hazard ratio [HR], 1.35; 95% CI, 1.02-1.81; for minor abnormalities; and 31.6 per 1000 person-years; HR, 1.51; 95% CI, 1.20-1.90; for major abnormalities). When ECG abnormalities were added to a model containing traditional risk factors alone, 13.6% of intermediate-risk participants with both major and minor ECG abnormalities were correctly reclassified (overall net reclassification improvement [NRI], 7.4%; 95% CI, 3.1%-19.0%; integrated discrimination improvement, 0.99%; 95% CI, 0.32%-2.15%). After 4 years, 208 participants had new and 416 had persistent abnormalities. Both new and persistent ECG abnormalities were associated with an increased risk of subsequent CHD events (HR, 2.01; 95% CI, 1.33-3.02; and HR, 1.66; 95% CI, 1.18-2.34; respectively). When added to the Framingham Risk Score, the NRI was not significant (5.7%; 95% CI, -0.4% to 11.8%). Conclusions Major and minor ECG abnormalities among older adults were associated with an increased risk of CHD events. Depending on the model, adding ECG abnormalities was associated with improved risk prediction beyond traditional risk factors. JAMA. 2012;307(14):1497-1505	[Auer, Reto; Bauer, Douglas C.; Vittinghoff, Eric] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94107 USA; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94107 USA; [Auer, Reto; Cornuz, Jacques] Univ Lausanne, Dept Ambulatory Care & Community Med, Lausanne, Switzerland; [Marques-Vidal, Pedro] Univ Lausanne, Inst Social & Prevent Med, Lausanne, Switzerland; [Marques-Vidal, Pedro] Univ Lausanne, Clin Res Ctr, Lausanne, Switzerland; [Butler, Javed] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Min, Lauren J.] US FDA, Silver Spring, MD USA; [Satterfield, Suzanne] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Newman, Anne B.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Rodondi, Nicolas] Univ Bern, Dept Gen Internal Med, Bern, Switzerland	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Lausanne; University of Lausanne; University of Lausanne; Emory University; US Food & Drug Administration (FDA); University of Tennessee System; University of Tennessee Health Science Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Bern	Auer, R (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, 185 Berry St,Ste 5700, San Francisco, CA 94107 USA.	reto.auer@ucsf.edu	Newman, Anne B./C-6408-2013; Marques-Vidal, Pedro/C-9449-2009	Newman, Anne B./0000-0002-0106-1150; Auer, Reto/0000-0003-4222-4849; Marques-Vidal, Pedro/0000-0002-4548-8500; Rodondi, Nicolas/0000-0001-9083-6896; Kritchevsky, Stephen/0000-0003-3336-6781	Novartis; Amgen; National Institutes of Health; Medtronic; GE Healthcare; Boston Scientific; National Institute on Aging [R01-AG028050]; National Institute on Aging (NIA), National Institutes of Health (NIH) [N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]; National Institute of Nursing Research [R01-R012459]; Swiss National Science Foundation [SPUM33CM30-124112, PBLAP3-136774]; Swiss Heart Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR051895] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG062103, R01AG028050, N01AG062106, N01AG062101] Funding Source: NIH RePORTER	Novartis(Novartis); Amgen(Amgen); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medtronic(Medtronic); GE Healthcare(General ElectricGE Healthcare); Boston Scientific(Boston Scientific); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging (NIA), National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Heart Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Bauer reported receiving grants from Novartis and Amgen. Dr Butler reported receiving research support from National Institutes of Health, Amgen, Medtronic, GE Healthcare, and Boston Scientific; and being a consultant to Bayer, Cardiomems, Trevena, Takeda, Ono Pharmaceutical, and Events Committee Corthera and World Heart. Dr Satterfield reported receiving a grant contract for Health ABC Study from the National Institute on Aging. Dr Vittinghoff reported receiving a grant for support as consulting statistician for training program from the National Institutes of Health. No other authors reported any disclosures.; This work was supported by grants N01-AG-6-2101, N01-AG-6-2103, and N01-AG-6-2106 from the National Institute on Aging (NIA), National Institutes of Health (NIH); grant R01-AG028050 from the NIA, grant R01-R012459 from the National Institute of Nursing Research, and in part by the Intramural Research Program of the NIH, NIA. The NIA funded the Health ABC Study, reviewed the manuscript, and approved its publication. Dr Auer's research on cardiovascular prevention is supported by grants SPUM33CM30-124112 and PBLAP3-136774 from the Swiss National Science Foundation and the Swiss Heart Foundation.	USA Pooling Project Research Group, 1978, Journal of Chronic Diseases, V31, P201; Ashley EA, 2001, PROG CARDIOVASC DIS, V44, P55, DOI 10.1053/pcad.2001.24683; Ashley EA, 2000, CURR PROB CARDIOLOGY, V25, P7, DOI 10.1016/S0146-2806(00)70020-X; Chou R, 2011, ANN INTERN MED, V155, P375, DOI 10.7326/0003-4819-155-6-201109200-00006; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2008, STAT MED, V27, P191, DOI 10.1002/sim.2987; Cook NR, 2011, BIOMETRICAL J, V53, P237, DOI 10.1002/bimj.201000078; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Daviglus ML, 1999, JAMA-J AM MED ASSOC, V281, P530, DOI 10.1001/jama.281.6.530; De Bacquer D, 1998, HEART, V80, P570, DOI 10.1136/hrt.80.6.570; De Ruijter W, 2008, SCAND J PRIM HEALTH, V26, P147, DOI 10.1080/02813430802095812; de Ruijter W, 2007, J AM GERIATR SOC, V55, P872, DOI 10.1111/j.1532-5415.2007.01180.x; Denes P, 2007, JAMA-J AM MED ASSOC, V297, P978, DOI 10.1001/jama.297.9.978; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Folsom AR, 2006, ARCH INTERN MED, V166, P1368, DOI 10.1001/archinte.166.13.1368; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Greenland P, 2003, AM J CARDIOL, V91, P1068, DOI 10.1016/S0002-9149(03)00150-4; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Ingelsson E, 2007, JAMA-J AM MED ASSOC, V298, P776, DOI 10.1001/jama.298.7.776; KANNEL WB, 1987, AM HEART J, V113, P370, DOI 10.1016/0002-8703(87)90280-8; Kim KP, 2009, ARCH INTERN MED, V169, P1188, DOI 10.1001/archinternmed.2009.162; Lauer MS, 2011, ANN INTERN MED, V155, P395, DOI 10.7326/0003-4819-155-6-201109200-00011; Lauer MS, 2009, NEW ENGL J MED, V361, P841, DOI 10.1056/NEJMp0904735; Lee CD, 2004, CIRCULATION, V109, P855, DOI 10.1161/01.CIR.0000116389.61864.DE; LIAO YL, 1987, CIRCULATION, V75, P347, DOI 10.1161/01.CIR.75.2.347; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; O'Malley PG, 2010, ARCH INTERN MED, V170, P1602, DOI 10.1001/archinternmed.2010.327; Parzen M, 1999, BIOMETRICS, V55, P580, DOI 10.1111/j.0006-341X.1999.00580.x; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Polonsky TS, 2010, JAMA-J AM MED ASSOC, V303, P1610, DOI 10.1001/jama.2010.461; Prineas R., 1982, MINNESOTA CODE MANUA; Psaty BM, 2004, J AM GERIATR SOC, V52, P1639, DOI 10.1111/j.1532-5415.2004.52455.x; RAJALA S, 1985, EUR HEART J, V6, P247, DOI 10.1093/oxfordjournals.eurheartj.a061848; Rodondi N, 2005, ARCH INTERN MED, V165, P2460, DOI 10.1001/archinte.165.21.2460; Rodondi N, 2010, AM J EPIDEMIOL, V171, P540, DOI 10.1093/aje/kwp428; Salerno SM, 2003, ANN INTERN MED, V138, P751, DOI 10.7326/0003-4819-138-9-200305060-00013; Wang TJ, 2006, NEW ENGL J MED, V355, P2631, DOI 10.1056/NEJMoa055373	38	124	130	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1497	1505		10.1001/jama.2012.434	http://dx.doi.org/10.1001/jama.2012.434			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496264	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000302538100023
J	Eisenstein, M				Eisenstein, Michael			PREGNANCY Delivery from breast cancer	NATURE			English	Editorial Material																		Amant F, 2012, LANCET ONCOL, V13, P256, DOI 10.1016/S1470-2045(11)70363-1; Azim HA, 2012, ACTA ONCOL, V51, P653, DOI 10.3109/0284186X.2011.636069; Stensheim H, 2009, J CLIN ONCOL, V27, P45, DOI 10.1200/JCO.2008.17.4110	3	2	2	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S54	S54		10.1038/485S54a	http://dx.doi.org/10.1038/485S54a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648499	Bronze			2022-12-24	WOS:000304608000003
J	Schmitt, J; Schneider, R; Elsig, J; Leuenberger, D; Lourantou, A; Chappellaz, J; Kohler, P; Joos, F; Stocker, TF; Leuenberger, M; Fischer, H				Schmitt, Jochen; Schneider, Robert; Elsig, Joachim; Leuenberger, Daiana; Lourantou, Anna; Chappellaz, Jerome; Koehler, Peter; Joos, Fortunat; Stocker, Thomas F.; Leuenberger, Markus; Fischer, Hubertus			Carbon Isotope Constraints on the Deglacial CO2 Rise from Ice Cores	SCIENCE			English	Article							ATMOSPHERIC CO2; SOUTHERN-OCEAN; LAST; AGE; VENTILATION; EXCHANGE; CYCLES; RECORD	The stable carbon isotope ratio of atmospheric CO2 (delta C-13(atm)) is a key parameter in deciphering past carbon cycle changes. Here we present delta C-13(atm) data for the past 24,000 years derived from three independent records from two Antarctic ice cores. We conclude that a pronounced 0.3 per mil decrease in delta C-13(atm) during the early deglaciation can be best explained by upwelling of old, carbon-enriched waters in the Southern Ocean. Later in the deglaciation, regrowth of the terrestrial biosphere, changes in sea surface temperature, and ocean circulation governed the delta C-13(atm) evolution. During the Last Glacial Maximum, delta C-13(atm) and atmospheric CO2 concentration were essentially constant, which suggests that the carbon cycle was in dynamic equilibrium and that the net transfer of carbon to the deep ocean had occurred before then.	[Schmitt, Jochen; Schneider, Robert; Elsig, Joachim; Leuenberger, Daiana; Joos, Fortunat; Stocker, Thomas F.; Leuenberger, Markus; Fischer, Hubertus] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Schmitt, Jochen; Schneider, Robert; Elsig, Joachim; Leuenberger, Daiana; Joos, Fortunat; Stocker, Thomas F.; Leuenberger, Markus; Fischer, Hubertus] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Schmitt, Jochen; Koehler, Peter; Fischer, Hubertus] Alfred Wegener Inst Polar & Marine Res, D-27570 Bremerhaven, Germany; [Lourantou, Anna; Chappellaz, Jerome] Univ Grenoble 1, CNRS, LGGE, UMR 5183, F-38041 Grenoble, France	University of Bern; University of Bern; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Schmitt, J (corresponding author), Univ Bern, Inst Phys, CH-3012 Bern, Switzerland.	schmitt@climate.unibe.ch	Fischer, Hubertus/A-1211-2014; Köhler, Peter/F-7293-2010; Schmitt, Jochen/B-7893-2009; Stocker, Thomas/B-1273-2013; Chappellaz, Jérôme A./A-4872-2011; Joos, Fortunat/B-4118-2018; Leuenberger, Markus C/K-9655-2016	Fischer, Hubertus/0000-0002-2787-4221; Köhler, Peter/0000-0003-0904-8484; Schmitt, Jochen/0000-0003-4695-3029; Joos, Fortunat/0000-0002-9483-6030; Leuenberger, Markus C/0000-0003-4299-6793	Deutsche Forschungsgemeinschaft; Helmholtz Gemeinschaft; Schweizerischer Nationalfonds; EC	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Gemeinschaft(Helmholtz Association); Schweizerischer Nationalfonds(Swiss National Science Foundation (SNSF)); EC(European CommissionEuropean Commission Joint Research Centre)	We thank two anonymous reviewers for carefully reviewing the manuscript. Supported in part by Deutsche Forschungsgemeinschaft, Helmholtz Gemeinschaft, and Schweizerischer Nationalfonds. This work is a contribution to EPICA, a joint European Science Foundation/European Commission (EC) scientific program, funded by the EC under the Environment and Climate Program and by national contributions from Belgium, Denmark, France, Germany, Italy, the Netherlands, Norway, Sweden, Switzerland, and the UK. The main logistic support at Dome C was provided by the Institut Polaire Francais-Paul Emile Victor (IPEV) and PNRA. Ice core material was also used from TALDICE, a joint European program led by Italy and funded by national contributions from Italy, France, Germany, Switzerland, and the UK. The main logistical support at Talos Dome was provided by PNRA. This is EPICA publication 284. The data are accessible online at http://doi.pangaea.de/10.1594/PANGAEA.772713.	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Broecker W, 2007, EARTH PLANET SC LETT, V256, P90, DOI 10.1016/j.epsl.2007.01.015; Broecker W, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043969; Burke A, 2012, SCIENCE, V335, P557, DOI 10.1126/science.1208163; Ciais P, 2012, NAT GEOSCI, V5, P74, DOI [10.1038/NGEO1324, 10.1038/ngeo1324]; Elsig J, 2009, NATURE, V461, P507, DOI 10.1038/nature08393; Fischer H, 2010, QUATERNARY SCI REV, V29, P193, DOI 10.1016/j.quascirev.2009.06.007; Hodell DA, 2001, EARTH PLANET SC LETT, V192, P109, DOI 10.1016/S0012-821X(01)00430-7; Kohler P, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001703; Kohler P, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001228; Kohler P, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002345; Laj C, 2004, GEOPHYS MONOGR SER, V145, P255, DOI 10.1029/145GM19; Lemieux-Dudon B, 2010, QUATERNARY SCI REV, V29, P8, DOI 10.1016/j.quascirev.2009.11.010; LEUENBERGER M, 1992, NATURE, V357, P488, DOI 10.1038/357488a0; Lourantou A, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2009GB003545; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lund DC, 2011, NAT GEOSCI, V4, P771, DOI [10.1038/NGEO1272, 10.1038/ngeo1272]; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Muscheler R, 2005, QUATERNARY SCI REV, V24, P1849, DOI 10.1016/j.quascirev.2005.01.012; Oliver KIC, 2010, CLIM PAST, V6, P645, DOI 10.5194/cp-6-645-2010; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Schmitt J, 2011, ATMOS MEAS TECH, V4, P1445, DOI 10.5194/amt-4-1445-2011; Sigman DM, 2010, NATURE, V466, P47, DOI 10.1038/nature09149; Smith HJ, 1999, NATURE, V400, P248, DOI 10.1038/22291; Southon J, 2012, QUATERNARY SCI REV, V33, P32, DOI 10.1016/j.quascirev.2011.11.022; Stenni B, 2001, SCIENCE, V293, P2074, DOI 10.1126/science.1059702; Stott L, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001690; Tschumi T, 2011, CLIM PAST, V7, P771, DOI 10.5194/cp-7-771-2011; Yu JM, 2010, SCIENCE, V330, P1084, DOI 10.1126/science.1193221; Zech R, 2011, CLIM PAST, V7, P501, DOI 10.5194/cp-7-501-2011; Zeng N, 2007, CLIM PAST, V3, P135, DOI 10.5194/cp-3-135-2007; ZHANG J, 1995, GEOCHIM COSMOCHIM AC, V59, P107, DOI 10.1016/00167-0379(59)1550D-	35	267	270	6	197	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					711	714		10.1126/science.1217161	http://dx.doi.org/10.1126/science.1217161			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22461496	Green Submitted			2022-12-24	WOS:000303872300047
J	Lidegaard, O; Nielsen, LH; Skovlund, CW; Lokkegaard, E				Lidegaard, Ojvind; Nielsen, Lars Hougaard; Skovlund, Charlotte Wessel; Lokkegaard, Ellen			Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ORAL-CONTRACEPTIVES; TRANSDERMAL PATCH; VAGINAL RING; RISK; THROMBOEMBOLISM; NORGESTIMATE	Objective To assess the risk of venous thrombosis in current users of non-oral hormonal contraception. Design Historical national registry based cohort study. Setting Four national registries in Denmark. Participants All Danish non-pregnant women aged 15-49 (n=1 626 158), free of previous thrombotic disease or cancer, were followed from 2001 to 2010. Main outcome measures Incidence rate of venous thrombosis in users of transdermal, vaginal, intrauterine, or subcutaneous hormonal contraception, relative risk of venous thrombosis compared with non-users, and rate ratios of venous thrombosis in current users of non-oral products compared with the standard reference oral contraceptive with levonorgestrel and 30-40 mu g oestrogen. Diagnoses were confirmed by at least four weeks of anticoagulation therapy after the diagnosis. Results Within 9 429 128 woman years of observation, 5287 first ever venous thrombosis events were recorded, of which 3434 were confirmed. In non-users of hormonal contraception the incidence rate of confirmed events was 2.1 per 10 000 woman years. Compared with non-users of hormonal contraception, and after adjustment for age, calendar year, and education, the relative risk of confirmed venous thrombosis in users of transdermal combined contraceptive patches was 7.9 (95% confidence interval 3.5 to 17.7) and of the vaginal ring was 6.5 (4.7 to 8.9). The corresponding incidences per 10 000 exposure years were 9.7 and 7.8 events. The relative risk was increased in women who used subcutaneous implants (1.4, 0.6 to 3.4) but not in those who used the levonorgestrel intrauterine system (0.6, 0.4 to 0.8). Compared with users of combined oral contraceptives containing levonorgestrel, the adjusted relative risk of venous thrombosis in users of transdermal patches was 2.3 (1.0 to 5.2) and of the vaginal ring was 1.9 (1.3 to 2.7). Conclusion Women who use transdermal patches or vaginal rings for contraception have a 7.9 and 6.5 times increased risk of confirmed venous thrombosis compared with non-users of hormonal contraception of the same age, corresponding to 9.7 and 7.8 events per 10 000 exposure years. The risk was slightly increased in women using subcutaneous implants but not in those using the levonorgestrel intrauterine system.	[Lidegaard, Ojvind; Nielsen, Lars Hougaard; Skovlund, Charlotte Wessel] Gynaecol Clin 4232, DK-2100 Copenhagen O, Denmark; [Lidegaard, Ojvind; Nielsen, Lars Hougaard; Skovlund, Charlotte Wessel] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, DK-1168 Copenhagen, Denmark; [Lokkegaard, Ellen] Univ Copenhagen, Hillerod Hosp, Dept Obstet & Gynaecol, DK-1168 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Lidegaard, O (corresponding author), Gynaecol Clin 4232, Blegdamsvej 9, DK-2100 Copenhagen O, Denmark.	Lidegaard@rh.regionh.dk		Lokkegaard, Ellen/0000-0003-4149-5663	Gynaecological Clinic, Juliane Marie Centre, Rigshospitalet; Bayer Pharma Denmark; MSD Denmark; Theramex, Monaco	Gynaecological Clinic, Juliane Marie Centre, Rigshospitalet; Bayer Pharma Denmark; MSD Denmark; Theramex, Monaco	The expenses were covered by the Gynaecological Clinic, Juliane Marie Centre, Rigshospitalet.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work. The primary investigator has within the last three years received honorariums for speeches in pharmacoepidemiological issues, including fees from Bayer Pharma Denmark, MSD Denmark, and Theramex, Monaco, and has been expert witness for plaintiff in a legal US case in 2011. EL has within the last three years participated in two congresses the expenses of which were covered by pharmaceutical companies. LHN and CWS declared no financial relationships with any organisations that might have an interest in the submitted work in the previous three years, and no other relationships or activities that could appear to have influenced the submitted work.	Bloemenkamp KWM, 1999, ARCH INTERN MED, V159, P65, DOI 10.1001/archinte.159.1.65; Cole JA, 2007, OBSTET GYNECOL, V109, P339, DOI 10.1097/01.AOG.0000250968.82370.04; Dore DD, 2010, CONTRACEPTION, V81, P408, DOI 10.1016/j.contraception.2009.12.009; Farmer RDT, 1997, LANCET, V349, P83, DOI 10.1016/S0140-6736(96)07496-X; Fleischer K, 2009, THROMB RES, V123, P429, DOI 10.1016/j.thromres.2008.04.022; Food and Drug Administration Office of Surveillance and Epidemiology, 2011, COMB HORM CONTR CHCS; Gronich N, 2011, CAN MED ASSOC J, V183, pE1319, DOI 10.1503/cmaj.110463; JICK H, 1995, LANCET, V346, P1589, DOI 10.1016/S0140-6736(95)91928-7; Jick SS, 2006, CONTRACEPTION, V73, P223, DOI 10.1016/j.contraception.2006.01.001; Jick S, 2007, CONTRACEPTION, V76, P4, DOI 10.1016/j.contraception.2007.03.003; Jick SS, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2151; Jick SS, 2010, CONTRACEPTION, V81, P452, DOI 10.1016/j.contraception.2009.12.016; Lidegaard O, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6423; Lidegaard O, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2890; Odlind V, 2002, ACTA OBSTET GYN SCAN, V81, P482, DOI 10.1034/j.1600-0412.2002.810603.x; Parkin L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d2139; POULTER NR, 1995, LANCET, V346, P1575; Spitzer WO, 1996, BRIT MED J, V312, P83; van den Heuvel MW, 2005, CONTRACEPTION, V72, P168, DOI 10.1016/j.contraception.2005.03.005; Vlieg AV, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2921	20	136	145	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 10	2012	344								e2990	10.1136/bmj.e2990	http://dx.doi.org/10.1136/bmj.e2990			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XR	22577198	Green Published, hybrid			2022-12-24	WOS:000304085400004
J	Rao, VS				Rao, Veena S.			PERSONAL VIEW India's food bill will not provide the security it claims	BRITISH MEDICAL JOURNAL			English	Editorial Material									Govt Karnataka, Dept Hlth & Family Welf, Karnataka Nutr Mission, Bangalore 560009, Karnataka, India		Rao, VS (corresponding author), Govt Karnataka, Dept Hlth & Family Welf, Karnataka Nutr Mission, Bangalore 560009, Karnataka, India.	nobel_6@hotmail.com						*COAL SUST NUTR SE, 2008, OV CURS MALN IND LEA; International Food Policy Research Institute, 2011 GLOB HUNG IND; International Institute for Population Sciences, 2007, NAT FAM HLTH SURV; Jones Gareth, 2006, Indian Journal of Pediatrics, V73, P479, DOI 10.1007/BF02759891; Programme Evaluation Organisation Planning Commission Government of India, 2005, PERF EV TARG PUBL DI; *UNICEF, STAT WORLDS CHILDR 2	6	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 8	2012	344								e3194	10.1136/bmj.e3194	http://dx.doi.org/10.1136/bmj.e3194			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	942WY	22569866				2022-12-24	WOS:000304083400011
J	Campbell, RJ; Dhalla, IA; Gill, SS; Bell, CM				Campbell, Robert J.; Dhalla, Irfan A.; Gill, Sudeep S.; Bell, Chaim M.			Implications of "not me" drugs for health systems: lessons from age related macular degeneration	BRITISH MEDICAL JOURNAL			English	Editorial Material							RANIBIZUMAB; BEVACIZUMAB; COVERAGE		[Campbell, Robert J.] Hop Hotel Dieu, Dept Ophthalmol, Kingston, ON K7L 5G2, Canada; [Campbell, Robert J.; Gill, Sudeep S.] Queens Univ, Kingston, ON K7L 5G2, Canada; [Dhalla, Irfan A.; Bell, Chaim M.] Univ Toronto, Toronto, ON, Canada; [Dhalla, Irfan A.; Bell, Chaim M.] St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada; [Gill, Sudeep S.] St Marys Lake Hosp, Div Geriatr Med, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Campbell, RJ (corresponding author), Hop Hotel Dieu, Dept Ophthalmol, 166 Brock St, Kingston, ON K7L 5G2, Canada.	rob.campbell@queensu.ca	Bell, Chaim/C-4611-2015	Bell, Chaim/0000-0002-3778-9469	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		[Anonymous], 2012, BMJ, V344, pe2959; Aron I, 2009, AVASTIN LUCENTIS UPD; Brechner RJ, 2011, AM J OPHTHALMOL, V151, P887, DOI 10.1016/j.ajo.2010.11.017; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Campbell RJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P359, DOI 10.1001/archophthalmol.2010.19; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Foote SB, 2004, HEALTH AFFAIR, V23, P108, DOI 10.1377/hlthaff.23.4.108; Ip MS, 2008, OPHTHALMOLOGY, V115, P1837, DOI 10.1016/j.ophtha.2008.08.012; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Lee TH, 2004, NEW ENGL J MED, V350, P211, DOI 10.1056/NEJMp038215; Levinson DR, 2011, REV MEDICARE B; Levy AR, 2010, PHARMACOECONOMICS, V28, P813, DOI 10.2165/11536150-000000000-00000; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; National Institute for Health and Clinical Excellence, 2010, EXPL WORK BEV EYE CO; Pollack A, 2011, NY TIMES        1004; Pollack A, 2009, NY TIMES        1001; Pollack A, 2010, NY TIMES        1103; Pollack A, 2007, NY TIMES        1012; Roche, 2010, FIN REP 2010; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Tufail A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2459	21	5	5	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 1	2012	344								e2941	10.1136/bmj.e2941	http://dx.doi.org/10.1136/bmj.e2941			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939MZ	22549055				2022-12-24	WOS:000303816700013
J	Lin, SM; Tsai, JY; Hsiao, CD; Huang, YT; Chiu, CL; Liu, MH; Tung, JY; Liu, TH; Pan, RL; Sun, YJ				Lin, Shih-Ming; Tsai, Jia-Yin; Hsiao, Chwan-Deng; Huang, Yun-Tzu; Chiu, Chen-Liang; Liu, Mu-Hsuan; Tung, Jung-Yu; Liu, Tseng-Huang; Pan, Rong-Long; Sun, Yuh-Ju			Crystal structure of a membrane-embedded H+-translocating pyrophosphatase	NATURE			English	Article							SUBSTRATE-BINDING SUBUNIT; INORGANIC PYROPHOSPHATASE; MOLECULAR-CLONING; PURIFICATION; RESIDUES; ORGANIZATION; INHIBITION; STRATEGY; SEQUENCE; DOMAINS	H+-translocating pyrophosphatases (H+-PPases) are active proton transporters that establish a proton gradient across the endomembrane by means of pyrophosphate (PPi) hydrolysis(1,2). H+-PPases are found primarily as homodimers in the vacuolar membrane of plants and the plasma membrane of several protozoa and prokaryotes(2,3). The three-dimensional structure and detailed mechanisms underlying the enzymatic and proton translocation reactions of H+-PPases are unclear. Here we report the crystal structure of a Vigna radiata H+-PPase (VrH(+)-PPase) in complex with a non-hydrolysable substrate analogue, imidodiphosphate (IDP), at 2.35 angstrom resolution. Each VrH(+)-PPase subunit consists of an integral membrane domain formed by 16 transmembrane helices. IDP is bound in the cytosolic region of each subunit and trapped by numerous charged residues and five Mg2+ ions. A previously undescribed proton translocation pathway is formed by six core transmembrane helices. Proton pumping can be initialized by PPi hydrolysis, and H+ is then transported into the vacuolar lumen through a pathway consisting of Arg 242, Asp 294, Lys 742 and Glu 301. We propose a working model of the mechanism for the coupling between proton pumping and PPi hydrolysis by H+-PPases.	[Lin, Shih-Ming; Huang, Yun-Tzu; Chiu, Chen-Liang; Liu, Mu-Hsuan; Tung, Jung-Yu; Liu, Tseng-Huang; Pan, Rong-Long; Sun, Yuh-Ju] Natl Tsing Hua Univ, Dept Life Sci, Coll Life Sci, Hsinchu 30013, Taiwan; [Lin, Shih-Ming; Huang, Yun-Tzu; Chiu, Chen-Liang; Liu, Mu-Hsuan; Tung, Jung-Yu; Liu, Tseng-Huang; Pan, Rong-Long; Sun, Yuh-Ju] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Coll Life Sci, Hsinchu 30013, Taiwan; [Tsai, Jia-Yin; Hsiao, Chwan-Deng] Acad Sinica, Inst Mol Biol, Taipei 11529, Taiwan	National Tsing Hua University; National Tsing Hua University; Academia Sinica - Taiwan	Sun, YJ (corresponding author), Natl Tsing Hua Univ, Dept Life Sci, Coll Life Sci, Hsinchu 30013, Taiwan.	rlpan@life.nthu.edu.tw; yjsun@life.nthu.edu.tw	Hsiao, Chwan-Deng/AAZ-8869-2021	Hsiao, Chwan-Deng/0000-0002-7012-1532	National Science Council of Taiwan [NSC 99-2311-B-007-007-MY3, NSC 100-2311-B-007-001-MY3, NSC 100-2627-M-007-012]; National Tsing Hua University, Taiwan [99N82416E1]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); National Tsing Hua University, Taiwan	We thank M. F. Tam, P. C. Huang and H. J. Kung for their critical reading of the manuscript and for useful comments. The X-ray diffraction data were collected from the in-house X-ray facility at National Tsing Hua University and from beamlines BL13B1/BL13C1 at the National Synchrotron Radiation Research Center, Taiwan, and BL44XU/BL12B2 at SPring-8, Japan. This work was supported by grants from the National Science Council of Taiwan (NSC 99-2311-B-007-007-MY3 to Y.-J.S.; NSC 100-2311-B-007-001-MY3 and NSC 100-2627-M-007-012 to R.-L.P.) and National Tsing Hua University, Taiwan (99N82416E1 to Y.-J.S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BALTSCHEFFSKY H, 1966, SCIENCE, V153, P1120, DOI 10.1126/science.153.3740.1120; Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; BRITTEN CJ, 1989, FEBS LETT, V256, P200, DOI 10.1016/0014-5793(89)81748-X; Buch-Pedersen MJ, 2009, PFLUG ARCH EUR J PHY, V457, P573, DOI 10.1007/s00424-008-0503-8; CHANSON A, 1985, PLANT PHYSIOL, V79, P159, DOI 10.1104/pp.79.1.159; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferjani A, 2011, PLANT CELL, V23, P2895, DOI 10.1105/tpc.111.085415; GordonWeeks R, 1996, PLANT PHYSIOL, V111, P195, DOI 10.1104/pp.111.1.195; Guo SL, 2006, PLANT MOL BIOL, V60, P41, DOI 10.1007/s11103-005-2417-6; Hirono M, 2007, BBA-BIOENERGETICS, V1767, P930, DOI 10.1016/j.bbabio.2007.03.014; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hsu SH, 2009, BOT STUD, V50, P291; Huang YT, 2010, J BIOL CHEM, V285, P23655, DOI 10.1074/jbc.M110.134916; KIM EJ, 1994, P NATL ACAD SCI USA, V91, P6128, DOI 10.1073/pnas.91.13.6128; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee CH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.190215; Li JS, 2005, SCIENCE, V310, P121, DOI 10.1126/science.1115711; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; MAESHIMA M, 1989, J BIOL CHEM, V264, P20068; Maeshima M, 2001, ANNU REV PLANT PHYS, V52, P469, DOI 10.1146/annurev.arplant.52.1.469; MCPHERSON A, 1990, EUR J BIOCHEM, V189, P1, DOI 10.1111/j.1432-1033.1990.tb15454.x; Nakanishi Y, 2001, J BIOL CHEM, V276, P7654, DOI 10.1074/jbc.M009743200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan YJ, 2011, BBA-BIOENERGETICS, V1807, P59, DOI 10.1016/j.bbabio.2010.10.006; Park S, 2005, P NATL ACAD SCI USA, V102, P18830, DOI 10.1073/pnas.0509512102; Pedersen BP, 2007, NATURE, V450, P1111, DOI 10.1038/nature06417; REA PA, 1992, TRENDS BIOCHEM SCI, V17, P348, DOI 10.1016/0968-0004(92)90313-X; REA PA, 1993, ANNU REV PLANT PHYS, V44, P157, DOI 10.1146/annurev.pp.44.060193.001105; REA PA, 1985, PLANT PHYSIOL, V77, P46, DOI 10.1104/pp.77.1.46; Samygina VR, 2007, J MOL BIOL, V366, P1305, DOI 10.1016/j.jmb.2006.11.082; SARAFIAN V, 1992, P NATL ACAD SCI USA, V89, P1775, DOI 10.1073/pnas.89.5.1775; Serrano A, 2004, J BIOENERG BIOMEMBR, V36, P127, DOI 10.1023/B:JOBB.0000019604.49875.b3; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tzeng CM, 1996, BIOCHEM J, V316, P143, DOI 10.1042/bj3160143; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van RC, 2005, BBA-BIOENERGETICS, V1709, P84, DOI 10.1016/j.bbabio.2005.05.011; Zhen RG, 1997, J BIOL CHEM, V272, P22340, DOI 10.1074/jbc.272.35.22340	43	112	122	4	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					399	403		10.1038/nature10963	http://dx.doi.org/10.1038/nature10963			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22456709				2022-12-24	WOS:000302946500038
J	Faini, M; Prinz, S; Beck, R; Schorb, M; Riches, JD; Bacia, K; Brugger, B; Wieland, FT; Briggs, JAG				Faini, Marco; Prinz, Simone; Beck, Rainer; Schorb, Martin; Riches, James D.; Bacia, Kirsten; Brugger, Britta; Wieland, Felix T.; Briggs, John A. G.			The Structures of COPI-Coated Vesicles Reveal Alternate Coatomer Conformations and Interactions	SCIENCE			English	Article							CRYOELECTRON TOMOGRAPHY; CLATHRIN; TRANSPORT; COMPLEXES; MECHANISM; CAGE	Transport between compartments of eukaryotic cells is mediated by coated vesicles. The archetypal protein coats COPI, COPII, and clathrin are conserved from yeast to human. Structural studies of COPII and clathrin coats assembled in vitro without membranes suggest that coat components assemble regular cages with the same set of interactions between components. Detailed three-dimensional structures of coated membrane vesicles have not been obtained. Here, we solved the structures of individual COPI-coated membrane vesicles by cryoelectron tomography and subtomogram averaging of in vitro reconstituted budding reactions. The coat protein complex, coatomer, was observed to adopt alternative conformations to change the number of other coatomers with which it interacts and to form vesicles with variable sizes and shapes. This represents a fundamentally different basis for vesicle coat assembly.	[Faini, Marco; Prinz, Simone; Schorb, Martin; Riches, James D.; Briggs, John A. G.] European Mol Biol Lab, Struct & Computat Biol Unit, Meyerhofstrasse 1, D-69117 Heidelberg, Germany; [Beck, Rainer; Brugger, Britta; Wieland, Felix T.] Heidelberg Univ Biochem Ctr, Univ Heidelberg, Neuenheimer Feld 328, D-69120 Heidelberg, Germany; [Bacia, Kirsten] Univ Halle, HALOmem, Kurt Mothes Strasse 3, D-06120 Halle, Germany; [Briggs, John A. G.] European Mol Biol Lab, Cell Biol & Biophys Unit, Meyerhofstrasse 1, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Martin Luther University Halle Wittenberg; European Molecular Biology Laboratory (EMBL)	Riches, JD (corresponding author), Queensland Univ Technol, Analyt Elect Microscopy Facil, Brisbane, Qld, Australia.		Riches, James/M-3873-2013; Briggs, John/J-3096-2012	Riches, James/0000-0001-8494-4743; Beck, Rainer/0000-0001-9304-2733; Faini, Marco/0000-0001-8131-7648; Schorb, Martin/0000-0003-4910-1868; Briggs, John/0000-0003-3990-6910	Deutsche Forschungsgemeinschaft [SFB638 (A16)]; Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	We thank M. Beck, J. Ellenberg, M. Kaksonen, and S. Welsch for critically reading the manuscript and F. Thommen, T. Bharat, and A. de Marco for technical assistance. This work was funded by the Deutsche Forschungsgemeinschaft within SFB638 (A16) to J.A.G.B. and F.T.W., by Bundesministerium fur Bildung und Forschung to K.B., and was technically supported by use of the European Molecular Biology Laboratory EM Core Facility and Information Technology Services. EM maps are deposited in the Electron Microscopy Data Bank (EMDB) (accession codes from EMD-2084 to EMD-2088). J.A.G.B. and F.T.W. conceived and administered the study. S.P., M.F., and R.B. reconstituted budding reactions, supported by K.B. and B.B. S.P., R.B., and K. B. prepared reagents. M.F., S.P., and J.D.R. collected data. M.F., M.S., and J.A.G.B. developed image processing routines. M.F. and J.A.G.B. analyzed data. M.F., F.T.W. and J.A.G.B. interpreted data. M.F. and J.A.G.B. wrote the paper, supported by all authors.	Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; GRIFFITHS G, 1995, J CELL SCI, V108, P2839; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; Harrison SC, 2010, NATURE, V466, P1048, DOI 10.1038/4661048a; Hsia KC, 2010, P NATL ACAD SCI USA, V107, P11271, DOI 10.1073/pnas.1006297107; Jackson LP, 2010, CELL, V141, P1220, DOI 10.1016/j.cell.2010.05.006; Lee C, 2010, CELL, V142, P123, DOI 10.1016/j.cell.2010.05.030; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; ORCI L, 1986, CELL, V46, P171, DOI 10.1016/0092-8674(86)90734-8; Sahlmuller MC, 2011, TRAFFIC, V12, P682, DOI 10.1111/j.1600-0854.2011.01177.x; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; Sirotkin V, 2010, MOL BIOL CELL, V21, P2894, DOI 10.1091/mbc.E10-02-0157; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; Yip CK, 2011, J MOL BIOL, V408, P825, DOI 10.1016/j.jmb.2011.03.029; Yu XC, 2012, CELL, V148, P530, DOI 10.1016/j.cell.2012.01.015	22	60	61	0	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	2012	336	6087					1451	+		10.1126/science.1221443	http://dx.doi.org/10.1126/science.1221443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22628556				2022-12-24	WOS:000305211700049
J	Rice, J				Rice, Jocelyn			METASTASIS The rude awakening	NATURE			English	Editorial Material							CANCER											Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Banys M, 2012, BREAST CANCER RES TR, V131, P801, DOI 10.1007/s10549-011-1478-2; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Kim RS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035569; Lim PK, 2011, CANCER RES, V71, P1550, DOI 10.1158/0008-5472.CAN-10-2372; Sosa MS, 2011, CLIN CANCER RES, V17, P5850, DOI 10.1158/1078-0432.CCR-10-2574; Suzuki M, 2006, AM J PATHOL, V169, P673, DOI 10.2353/ajpath.2006.060053	7	27	29	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S55	S57		10.1038/485S55a	http://dx.doi.org/10.1038/485S55a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648500				2022-12-24	WOS:000304608000004
J	Liu, Q; Dahmane, T; Zhang, Z; Assur, Z; Brasch, J; Shapiro, L; Mancia, F; Hendrickson, WA				Liu, Qun; Dahmane, Tassadite; Zhang, Zhen; Assur, Zahra; Brasch, Julia; Shapiro, Lawrence; Mancia, Filippo; Hendrickson, Wayne A.			Structures from Anomalous Diffraction of Native Biological Macromolecules	SCIENCE			English	Article							SOFT X-RAYS; CRYSTAL-STRUCTURE; RADIATION-DAMAGE; SULFUR; SIGNAL; RESOLUTION; CRYSTALLOGRAPHY; REDUNDANCY; MAD	Crystal structure analyses for biological macromolecules without known structural relatives entail solving the crystallographic phase problem. Typical de novo phase evaluations depend on incorporating heavier atoms than those found natively; most commonly, multi- or single-wavelength anomalous diffraction (MAD or SAD) experiments exploit selenomethionyl proteins. Here, we realize routine structure determination using intrinsic anomalous scattering from native macromolecules. We devised robust procedures for enhancing the signal-to-noise ratio in the slight anomalous scattering from generic native structures by combining data measured from multiple crystals at lower-than-usual x-ray energy. Using this multicrystal SAD method (5 to 13 equivalent crystals), we determined structures at modest resolution (2.8 to 2.3 angstroms) for native proteins varying in size (127 to 1148 unique residues) and number of sulfur sites (3 to 28). With no requirement for heavy-atom incorporation, such experiments provide an attractive alternative to selenomethionyl SAD experiments.	[Liu, Qun; Hendrickson, Wayne A.] Brookhaven Natl Lab, Natl Synchrotron Light Source NSLS X4, New York Struct Biol Ctr, Upton, NY 11973 USA; [Dahmane, Tassadite; Zhang, Zhen; Assur, Zahra; Brasch, Julia; Shapiro, Lawrence; Hendrickson, Wayne A.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Mancia, Filippo; Hendrickson, Wayne A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Hendrickson, Wayne A.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Hendrickson, WA (corresponding author), Brookhaven Natl Lab, Natl Synchrotron Light Source NSLS X4, New York Struct Biol Ctr, Bldg 725, Upton, NY 11973 USA.	wayne@convex.hhmi.columbia.edu	Liu, Qun/A-8757-2011; Shapiro, Lawrence/AAE-7172-2019	Liu, Qun/0000-0002-1179-290X; Mancia, Filippo/0000-0003-3293-2200	Protein Structure Initiative (CysZ) [GM095315]; NIH [GM034102, GM062270]; New York Structural Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM095315, U54GM075026, R01GM062270, R01GM034102, R37GM034102] Funding Source: NIH RePORTER	Protein Structure Initiative (CysZ); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Structural Biology Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Abramowitz and J. Schwanof for help with synchrotron data collection. This work was supported in part by cooperative agreement GM095315 from the Protein Structure Initiative (CysZ), and by NIH grants GM034102 (HK9<INF>s</INF> and TorT/TorS<INF>s</INF>) and GM062270 (netrin G2). Beamline X4A of the NSLS at Brookhaven National Laboratory, a U.S. Department of Energy facility, is supported by the New York Structural Biology Center. Accession codes for PDB deposits are listed in Table 1. DNA constructs and cell lines may require a material transfer agreement with Columbia University.	Brasch J, 2011, J MOL BIOL, V414, P723, DOI 10.1016/j.jmb.2011.10.030; Cianci M, 2008, ACTA CRYSTALLOGR D, V64, P1196, DOI 10.1107/S0907444908030503; COWTAN KD, 1993, ACTA CRYSTALLOGR D, V49, P148, DOI 10.1107/S0907444992007698; Dauter Z, 1999, J MOL BIOL, V289, P83, DOI 10.1006/jmbi.1999.2743; Dauter Z, 2002, ACTA CRYSTALLOGR D, V58, P494, DOI 10.1107/S090744490200118X; Dauter Z, 2001, ACTA CRYSTALLOGR D, V57, P990, DOI 10.1107/S0907444901006382; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Garman E, 1999, ACTA CRYSTALLOGR D, V55, P1641, DOI 10.1107/S0907444999008653; Garman EF, 2010, ACTA CRYSTALLOGR D, V66, P339, DOI 10.1107/S0907444910008656; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1981, NATURE, V290, P107, DOI 10.1038/290107a0; Hendrickson WA, 1999, J SYNCHROTRON RADIAT, V6, P845, DOI 10.1107/S0909049599007591; HENDRICKSON WA, 1989, P NATL ACAD SCI USA, V86, P2190, DOI 10.1073/pnas.86.7.2190; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Liu Q, 2011, ACTA CRYSTALLOGR D, V67, P45, DOI 10.1107/S0907444910046573; Liu ZJ, 2000, PROTEIN SCI, V9, P2085, DOI 10.1110/ps.9.11.2085; Moore JO, 2012, STRUCTURE, V20, P729, DOI 10.1016/j.str.2012.02.021; Mueller-Dieckmann C, 2005, ACTA CRYSTALLOGR D, V61, P1263, DOI 10.1107/S0907444905021475; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Weiss MS, 2005, J SYNCHROTRON RADIAT, V12, P304, DOI 10.1107/S0909049505003328; Weiss MS, 2001, STRUCTURE, V9, P771, DOI 10.1016/S0969-2126(01)00647-5; Yang C, 2003, ACTA CRYSTALLOGR D, V59, P1943, DOI 10.1107/S0907444903018547	23	139	140	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					1033	1037		10.1126/science.1218753	http://dx.doi.org/10.1126/science.1218753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628655	Green Accepted			2022-12-24	WOS:000304406800045
J	Denardo, SJ; Carpinone, PL; Vock, DM; Batich, CD; Pepine, CJ				Denardo, Scott J.; Carpinone, Paul L.; Vock, David M.; Batich, Christopher D.; Pepine, Carl J.			Changes to Polymer Surface of Drug-Eluting Stents During Balloon Expansion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Denardo, Scott J.; Carpinone, Paul L.; Vock, David M.; Batich, Christopher D.; Pepine, Carl J.] Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC 27710 USA	Duke University	Denardo, SJ (corresponding author), Duke Univ, Med Ctr, Div Cardiovasc Med, Durham, NC 27710 USA.	scott.denardo@duke.edu	Batich, Chris/H-3966-2017	Vock, David M/0000-0002-5459-9579	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029890] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR029890] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Basalus MWZ, 2009, EUROINTERVENTION, V5, P157, DOI 10.4244/EIJV5I1A24; Boden M, 2009, J MATER SCI-MATER M, V20, P1553, DOI 10.1007/s10856-009-3705-5; Malenka DJ, 2008, JAMA-J AM MED ASSOC, V299, P2868, DOI 10.1001/jama.299.24.2868; Mehta RI, 2010, MODERN PATHOL, V23, P921, DOI 10.1038/modpathol.2010.74; Otsuka Yoritaka, 2007, J Invasive Cardiol, V19, P71; van den Heuvel M, 2009, Minerva Cardioangiol, V57, P629	6	24	24	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2148	2150		10.1001/jama.2012.4111	http://dx.doi.org/10.1001/jama.2012.4111			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945YX	22618916	Green Accepted, Bronze			2022-12-24	WOS:000304315200018
J	Gerszten, RE; Tager, AM				Gerszten, Robert E.; Tager, Andrew M.			The Monocyte in Atherosclerosis-Should I Stay or Should I Go Now?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEFICIENT MICE; REGRESSION; PROMOTES; PLAQUES; CELLS		[Gerszten, Robert E.] Massachusetts Gen Hosp, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gerszten, RE (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.		Franzeck, Fabian C/B-5055-2011		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108975] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL108975] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Feig JE, 2010, J CLIN INVEST, V120, P4415, DOI 10.1172/JCI38911; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Khan JA, 2011, GENE THER, V18, P437, DOI 10.1038/gt.2010.155; Trogan E, 2006, P NATL ACAD SCI USA, V103, P3781, DOI 10.1073/pnas.0511043103; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205	6	34	37	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1734	1736		10.1056/NEJMcibr1200164	http://dx.doi.org/10.1056/NEJMcibr1200164			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HH	22551134				2022-12-24	WOS:000303434300016
J	Schyma, BM; Kerr, R; Alam, S				Schyma, Barry M.; Kerr, Robin; Alam, Shirjel			At either end of the tube	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Schyma, Barry M.] Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland; [Alam, Shirjel] Univ Edinburgh, Sch Med, Edinburgh EH8 9AG, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh	Schyma, BM (corresponding author), Royal Infirm Edinburgh NHS Trust, Edinburgh EH16 4SA, Midlothian, Scotland.	Barryschyma@hotmail.com; robinkerr@nhs.net; shirjel@doctors.org.uk		Schyma, Barry/0000-0002-8333-2339; Kerr, Robin/0000-0003-2480-2748					0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 3	2012	344								e2971	10.1136/bmj.e2971	http://dx.doi.org/10.1136/bmj.e2971			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NG	22556047	Bronze			2022-12-24	WOS:000303817700008
J	Moynihan, R				Moynihan, Ray			Times like these you need some "One Four Five"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Newcastle, Callaghan, NSW 2308, Australia	University of Newcastle	Moynihan, R (corresponding author), Univ Newcastle, Callaghan, NSW 2308, Australia.	Ray.Moynihan@newcastle.edu.au	Moynihan, Ray/ABC-3010-2020					Bradt J, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD006911.pub2, 10.1002/14651858.CD006911]; Gold C, 2009, CLIN PSYCHOL REV, V29, P193, DOI 10.1016/j.cpr.2009.01.001; Music In Hospitals, 2011, AB MUS HOSP; Procter S, 2011, NORD J MUSIC THER, V20, P242, DOI 10.1080/08098131.2010.489998	4	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 28	2012	344								e2342	10.1136/bmj.e2342	http://dx.doi.org/10.1136/bmj.e2342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923FF	22457444				2022-12-24	WOS:000302604100006
J	Yoshida, N; Kanda, J				Yoshida, Naohiro; Kanda, Jota			Tracking the Fukushima Radionuclides	SCIENCE			English	Editorial Material							PLANT; CONTAMINATION; DISPERSION; CESIUM-137; SOILS; I-131; OCEAN		[Yoshida, Naohiro] Tokyo Inst Technol, Dept Environm Chem & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan; [Kanda, Jota] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Minato Ku, Tokyo 1088477, Japan	Tokyo Institute of Technology; Tokyo University of Marine Science & Technology	Yoshida, N (corresponding author), Tokyo Inst Technol, Dept Environm Chem & Engn, Midori Ku, Yokohama, Kanagawa 2268502, Japan.	yoshida.n.aa@m.titech.ac.jp; jkanda@kaiyodai.ac.jp	Kanda, Jota/O-1881-2014; Ley, Sarah/Y-9216-2019; Yoshida, Naohiro/A-8335-2010	Kanda, Jota/0000-0002-5099-6278; Yoshida, Naohiro/0000-0003-0454-3849				Aoyama M., 2012, OC SCI M 21 FEBR SAL; Buesseler K, 2011, ENVIRON SCI TECHNOL, V45, P9931, DOI 10.1021/es202816c; Buesseler KO, 2012, P NATL ACAD SCI USA, V109, P5984, DOI 10.1073/pnas.1120794109; Burns PC, 2012, SCIENCE, V335, P1184, DOI 10.1126/science.1211285; Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; Honda MC, 2012, GEOCHEM J, V46, pE1; Kawamura H, 2011, J NUCL SCI TECHNOL, V48, P1349, DOI 10.3327/jnst.48.1349; Kinoshita N, 2011, P NATL ACAD SCI USA, V108, P19526, DOI 10.1073/pnas.1111724108; Priyadarshi A, 2011, P NATL ACAD SCI USA, V108, P14422, DOI 10.1073/pnas.1109449108; Stohl A., 2011, ATMOS CHEM PHYS DISC, V11, P28319, DOI DOI 10.5194/ACPD-11-28319-2011; Tanaka K, 2012, GEOCHEM J, V46, P73, DOI 10.2343/geochemj.1.0137; Tsumune D, 2012, J ENVIRON RADIOACTIV, V111, P100, DOI 10.1016/j.jenvrad.2011.10.007; Weiss R, 2012, SCIENCE, V336, P1117, DOI 10.1126/science.1221452; Yamamoto M., 2011, MINERAL MAG, V75, P2296; Yasunari TJ, 2011, P NATL ACAD SCI USA, V108, P19530, DOI 10.1073/pnas.1112058108; Yoshida N, 2012, ELEMENTS, V8, P201, DOI 10.2113/gselements.8.3.201; Zheng J, 2012, SCI REP-UK, V2, DOI 10.1038/srep00304	17	212	229	5	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1115	1116		10.1126/science.1219493	http://dx.doi.org/10.1126/science.1219493			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654046				2022-12-24	WOS:000304647900033
J	D'Angiolella, V; Donato, V; Forrester, FM; Jeong, YT; Pellacani, C; Kudo, Y; Saraf, A; Florens, L; Washburn, MP; Pagano, M				D'Angiolella, Vincenzo; Donato, Valerio; Forrester, Frances M.; Jeong, Yeon-Tae; Pellacani, Claudia; Kudo, Yasusei; Saraf, Anita; Florens, Laurence; Washburn, Michael P.; Pagano, Michele			Cyclin F-Mediated Degradation of Ribonucleotide Reductase M2 Controls Genome Integrity and DNA Repair	CELL			English	Article							NORMAL-CELL CYCLE; SEQUENCE-ANALYSIS; R2 PROTEIN; DTTP POOL; DAMAGE; REPLICATION; SUBUNIT; CHECKPOINT; MUTATIONS; KINASE	F-box proteins are the substrate binding subunits of SCF (Skp1-Cul1-F-box protein) ubiquitin ligase complexes. Using affinity purifications and mass spectrometry, we identified RRM2 (the ribonucleotide reductase family member 2) as an interactor of the F-box protein cyclin F. Ribonucleotide reductase (RNR) catalyzes the conversion of ribonucleotides to deoxyribonucleotides (dNTPs), which are necessary for both replicative and repair DNA synthesis. We found that, during G2, following CDK-mediated phosphorylation of Thr33, RRM2 is degraded via SCFcyclin (F) to maintain balanced dNTP pools and genome stability. After DNA damage, cyclin F is downregulated in an ATR-dependent manner to allow accumulation of RRM2. Defective elimination of cyclin F delays DNA repair and sensitizes cells to DNA damage, a phenotype that is reverted by expressing a nondegradable RRM2 mutant. In summary, we have identified a biochemical pathway that controls the abundance of dNTPs and ensures efficient DNA repair in response to genotoxic stress.	[D'Angiolella, Vincenzo; Donato, Valerio; Forrester, Frances M.; Jeong, Yeon-Tae; Pellacani, Claudia; Kudo, Yasusei; Pagano, Michele] NYU, Sch Med, Dept Pathol, Inst Canc, New York, NY 10016 USA; [Kudo, Yasusei] Univ Tokushima, Grad Sch, Inst Hlth Biosci, Dept Oral Mol Pathol, Tokushima 7708501, Japan; [Saraf, Anita; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Pagano, Michele] Howard Hughes Med Inst, Bethesda, MD USA	New York University; Tokushima University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Howard Hughes Medical Institute	Pagano, M (corresponding author), NYU, Sch Med, Dept Pathol, Inst Canc, 522 1st Ave,SRB 1107, New York, NY 10016 USA.	michele.pagano@nyumc.org		Washburn, Michael/0000-0001-7568-2585; Kudo, Yasusei/0000-0002-0392-7720; pagano, michele/0000-0003-3210-2442; Florens, Laurence/0000-0002-9310-6650; Pellacani, Claudia/0000-0002-6818-1229	American Italian Cancer Foundation; National Institutes of Health [R01-GM057587, R37-CA076584, R21-CA161108]; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [R37CA076584, R21CA161108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER	American Italian Cancer Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank S. Elledge, L. Gardner and N. Zheng for reagents, V. Bianchi for suggestions, and J.R. Skaar for reading the manuscript. M. P. is grateful to T.M. Thor for continuous support. V.D'A. was a Leukemia and Lymphoma Society Scholar. V.D'A. and V.D. received support from the American Italian Cancer Foundation. This work was supported by grants from the National Institutes of Health to M.P. (R01-GM057587, R37-CA076584, and R21-CA161108). A.S., L.F., and M.P.W. are supported by the Stowers Institute for Medical Research. M.P. is an Investigator with the Howard Hughes Medical Institute.	ANDERSSON B, 1992, ENVIRON MOL MUTAGEN, V20, P89, DOI 10.1002/em.2850200204; Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Chabes A, 2000, J BIOL CHEM, V275, P17747, DOI 10.1074/jbc.M000799200; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chabes AL, 2004, J BIOL CHEM, V279, P10796, DOI 10.1074/jbc.M312482200; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Chan AK, 1999, BBA-MOL CELL RES, V1448, P363, DOI 10.1016/S0167-4889(98)00115-3; CHAN AK, 1993, BIOCHEMISTRY-US, V32, P12835, DOI 10.1021/bi00210a036; Cortez D, 2001, SCIENCE, V294, P1713, DOI 10.1126/science.1065521; D'Angiolella V, 2010, NATURE, V466, P138, DOI 10.1038/nature09140; DARE E, 1995, J MOL BIOL, V252, P514, DOI 10.1006/jmbi.1995.0516; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Ferrandina G, 2010, CANCER CHEMOTH PHARM, V65, P679, DOI 10.1007/s00280-009-1073-y; Florens Laurence, 2006, V328, P159; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; Grade M, 2011, INT J CANCER, V128, P1069, DOI 10.1002/ijc.25453; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hu CM, 2007, J BIOMED SCI, V14, P491, DOI 10.1007/s11373-007-9175-1; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Jones RJ, 2011, BLOOD, V118, P4140, DOI 10.1182/blood-2011-03-340323; Ke PY, 2005, GENE DEV, V19, P1920, DOI 10.1101/gad.1322905; Kretschmer C, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-15; Kunz BA, 1998, GENETICS, V148, P1491; KUNZ BA, 1988, MUTAT RES, V200, P133, DOI 10.1016/0027-5107(88)90076-0; KUNZ BA, 1994, MUTAT RES-REV GENET, V318, P1, DOI 10.1016/0165-1110(94)90006-X; Lin ZP, 2007, BIOCHEM PHARMACOL, V73, P760, DOI 10.1016/j.bcp.2006.11.014; Lin ZP, 2004, J BIOL CHEM, V279, P27030, DOI 10.1074/jbc.M402056200; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Martin L., 2011, ONCOGENE, V2011, P19; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mayya V, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000007; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; MEUTH M, 1989, EXP CELL RES, V181, P305, DOI 10.1016/0014-4827(89)90090-6; Morikawa T, 2010, HISTOPATHOLOGY, V57, P885, DOI 10.1111/j.1365-2559.2010.03725.x; Morikawa T, 2010, HUM PATHOL, V41, P1742, DOI 10.1016/j.humpath.2010.06.001; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Park JH, 2006, EMBO J, V25, P3986, DOI 10.1038/sj.emboj.7601291; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; PHEAR G, 1989, MUTAT RES, V214, P201, DOI 10.1016/0027-5107(89)90164-4; REICHARD P, 1988, ANNU REV BIOCHEM, V57, P349, DOI 10.1146/annurev.bi.57.070188.002025; Satow R, 2010, CLIN CANCER RES, V16, P2518, DOI 10.1158/1078-0432.CCR-09-2214; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; SHERMAN PA, 1989, ANAL BIOCHEM, V180, P222, DOI 10.1016/0003-2697(89)90420-X; Skaar JR, 2009, CELL, V137, DOI 10.1016/j.cell.2009.05.039; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Tetzlaff MT, 2004, MOL CELL BIOL, V24, P2487, DOI 10.1128/MCB.24.6.2487-2498.2004; Wang XC, 2011, BIOCHEM BIOPH RES CO, V410, P102, DOI 10.1016/j.bbrc.2011.05.114; Xu X, 2008, CANCER RES, V68, P2652, DOI 10.1158/0008-5472.CAN-07-5873; Xue LJ, 2003, CANCER RES, V63, P980; Zhang YW, 2009, J BIOL CHEM, V284, P18085, DOI 10.1074/jbc.M109.003020	63	244	245	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1023	1034		10.1016/j.cell.2012.03.043	http://dx.doi.org/10.1016/j.cell.2012.03.043			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632967	Green Accepted, Bronze			2022-12-24	WOS:000304453900009
J	Dikshit, R; Gupta, PC; Ramasundarahettige, C; Gajalakshmi, V; Aleksandrowicz, L; Badwe, R; Kumar, R; Roy, S; Suraweera, W; Bray, F; Mallath, M; Singh, PK; Sinha, DN; Shet, AS; Gelband, H; Jha, P				Dikshit, Rajesh; Gupta, Prakash C.; Ramasundarahettige, Chinthanie; Gajalakshmi, Vendhan; Aleksandrowicz, Lukasz; Badwe, Rajendra; Kumar, Rajesh; Roy, Sandip; Suraweera, Wilson; Bray, Freddie; Mallath, Mohandas; Singh, Poonam K.; Sinha, Dhirendra N.; Shet, Arun S.; Gelband, Hellen; Jha, Prabhat		Million Death Study Collaborators	Cancer mortality in India: a nationally representative survey	LANCET			English	Article							CERVICAL-CANCER; DEATHS; COUNTRIES; SMOKING; BREAST	Background The age-specific mortality rates and total deaths from specific cancers have not been documented for the various regions and subpopulations of India. We therefore assessed the cause of death in 2001-03 in homes in small areas that were chosen to be representative of all the parts of India. Methods At least 130 trained physicians independently assigned causes to 122 429 deaths, which occurred in 1.1 million homes in 6671 small areas that were randomly selected to be representative of all of India, based on a structured non-medical surveyor's field report. Findings 7137 of 122 429 study deaths were due to cancer, corresponding to 556 400 national cancer deaths in India in 2010. 395 400 (71%) cancer deaths occurred in people aged 30-69 years (200 100 men and 195 300 women). At 30-69 years, the three most common fatal cancers were oral (including lip and pharynx, 45 800 [22.9%]), stomach (25 200 [12.6%]), and lung (including trachea and larynx, 22 900 [11.4%]) in men, and cervical (33 400 [17.1%]), stomach (27 500 [14.1%]), and breast (19 900 [10.2%]) in women. Tobacco-related cancers represented 42.0% (84 000) of male and 18.3% (35 700) of female cancer deaths and there were twice as many deaths from oral cancers as lung cancers. Age-standardised cancer mortality rates per 100 000 were similar in rural (men 95.6 [99% CI 89.6-101.7] and women 96.6 [90.7-102.6]) and urban areas (men 102.4 [92.7-112.1] and women 91.2 [81.9-100.5]), but varied greatly between the states, and were two times higher in the least educated than in the most educated adults (men, illiterate 106.6 [97.4-115.7] vs most educated 45.7 [37.8-53.6]; women, illiterate 106.7 [99.9-113.6] vs most educated 43.4 [30.7-56.1]). Cervical cancer was far less common in Muslim than in Hindu women (study deaths 24, age-standardised mortality ratio 0.68 [0.64-0.71] vs 340, 1.06 [1.05-1.08]). Interpretation Prevention of tobacco-related and cervical cancers and earlier detection of treatable cancers would reduce cancer deaths in India, particularly in the rural areas that are underserved by cancer services. The substantial variation in cancer rates in India suggests other risk factors or causative agents that remain to be discovered.	[Ramasundarahettige, Chinthanie; Aleksandrowicz, Lukasz; Suraweera, Wilson; Jha, Prabhat] Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada; [Ramasundarahettige, Chinthanie; Aleksandrowicz, Lukasz; Suraweera, Wilson; Jha, Prabhat] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5B 1W8, Canada; [Dikshit, Rajesh; Badwe, Rajendra; Mallath, Mohandas] Tata Mem Hosp, Bombay 400012, Maharashtra, India; [Gajalakshmi, Vendhan] Epidemiol Res Ctr, Madras, Tamil Nadu, India; [Gupta, Prakash C.] Healis Seskaria Inst Publ Hlth, Navi Mumbai, India; [Kumar, Rajesh] Post Grad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh, India; [Roy, Sandip] Kolkata Med Coll, Kolkata, India; [Shet, Arun S.] St Johns Natl Acad Hlth Sci, Bangalore, Karnataka, India; [Bray, Freddie] Int Agcy Res Canc, F-69372 Lyon, France; [Gelband, Hellen] Ctr Dis Dynam Econ & Policy, Washington, DC USA	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Tata Memorial Centre (TMC); Tata Memorial Hospital; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; St. John's National Academy of Health Sciences; World Health Organization; International Agency for Research on Cancer (IARC)	Jha, P (corresponding author), Univ Toronto, St Michaels Hosp, Li Ka Shing Knowledge Inst, Ctr Global Hlth Res, Toronto, ON M5B 1W8, Canada.	jhap@smh.ca	Suraweera, Wilson MG/O-8962-2014	Aleksandrowicz, Lukasz/0000-0002-3644-1372; Suraweera, Wilson/0000-0001-9673-5746; Shet, Anita/0000-0002-7204-8164; Shet, Arun/0000-0002-4146-0703; Bray, Freddie/0000-0002-3248-7787; Jha, Prabhat/0000-0001-7067-8341	John E Fogarty International Center of the National Institutes of Health [R01-TW05991-01, TW07939-01]; Bill & Melinda Gates Foundation; Canada Research chair programme; University of Toronto; US National Institutes of Health; FOGARTY INTERNATIONAL CENTER [R01TW007939, R01TW005991] Funding Source: NIH RePORTER	John E Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Canada Research chair programme(Canada Research Chairs); University of Toronto(University of Toronto); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Bill & Melinda Gates Foundation and US National Institutes of Health.; This study is supported by grants from the John E Fogarty International Center of the National Institutes of Health (R01-TW05991-01 and TW07939-01), Bill & Melinda Gates Foundation (Catalytic Grant for Tobacco Control in India, and Disease Control Priorities Network), Canada Research chair programme and the University of Toronto (to PJ). The opinions expressed in this report are those of the authors and do not necessarily represent those of the Government of India, Office of the RGI or study sponsors. We thank the Office of the RGI for the productive collaboration on the MDS; A Bernstein, S Rathi, and A Wong for their helpful comments on the report; and B Pezzack for graphics and J Tieulent for providing International Agency for Research Cancer mortality estimates.	[Anonymous], CAUS DEATH IND 2001; [Anonymous], 2005, SPEC FERT MORT SURV; [Anonymous], 2010, GLOB AD TOB SURV GAT; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Dhillon PK, 2011, BRIT J CANCER, V105, P723, DOI 10.1038/bjc.2011.301; Dhingra N, 2010, LANCET, V376, P1768, DOI 10.1016/S0140-6736(10)60831-8; Doll R., 1966, CANC INCIDENCE 5 CON, VI; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; GAJALAKSHMI CK, 1993, ACTA ONCOL, V32, P617, DOI 10.3109/02841869309092439; Gajalakshmi V, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-47; Gupta P C, 1996, Tob Control, V5, P114, DOI 10.1136/tc.5.2.114; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P., 2011, Economic and Political Weekly, V46, P44; Jha P, 2002, NATL MED J INDIA, V15, P32; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Jha P, 2006, LANCET, V368, P367, DOI 10.1016/S0140-6736(06)68975-7; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Jussawalla DJ, 1973, INDIAN J CANC S1; Kumar R, 2006, Indian J Public Health, V50, P90; MALHORTR.SL, 1967, GUT, V8, P361, DOI 10.1136/gut.8.4.361; Murthy NS, 2011, ASIAN PAC J CANCER P, V12, P387; National AIDS Control Organization, 2005, NAT AIDS CONTR ORG A; National Cancer Registry Programme. Indian Council of Medical Research, 2010, 3 YEAR REP POP BAS C; PETO R, 1992, LANCET, V339, P1268, DOI 10.1016/0140-6736(92)91600-D; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Rao D. N., 1998, Indian Journal of Cancer, V35, P10; Registrar General of India, 2010, SAMPL REG SYST STAT; Registrar General of India, SPEC B MAT MORT IND; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sgaier SK, 2007, SCIENCE, V318, P1074, DOI 10.1126/science.1149157; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; SUTNICK AI, 1980, NEW ENGL J MED, V303, P945; Takiar R, 2010, ASIAN PAC J CANCER P, V11, P1045; United Nations Population Division, 2011, WORLD POP PROSP; Varmus H, 2002, NAT GENET, V32, P3, DOI 10.1038/ng963; World Health Organisation, 1993, ICD 10 CLASS MENT BE; World Health Organisation, 2002, PREV HEP B IND OV; [No title captured]	40	312	315	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	2012	379	9828					1807	1816		10.1016/S0140-6736(12)60358-4	http://dx.doi.org/10.1016/S0140-6736(12)60358-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	941BR	22460346				2022-12-24	WOS:000303937700035
J	James, BD; Bennett, DA; Boyle, PA; Leurgans, S; Schneider, JA				James, Bryan D.; Bennett, David A.; Boyle, Patricia A.; Leurgans, Sue; Schneider, Julie A.			Dementia From Alzheimer Disease and Mixed Pathologies in the Oldest Old	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							NEUROPATHOLOGY; AGE		[James, Bryan D.; Bennett, David A.; Boyle, Patricia A.; Leurgans, Sue; Schneider, Julie A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA	Rush University	James, BD (corresponding author), Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA.	bryan_james@rush.edu		James, Bryan/0000-0003-1932-151X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG009466, P01AG014449, P30AG010161, RC2AG036547, R01AG034374, R01AG033678, R01AG017917, R01AG015819] Funding Source: NIH RePORTER; NIA NIH HHS [RC2 AG036547, R01AG17917, P01 AG009466, P01AG09466, R01 AG033678, R01AG15819, P01AG14449, R01AG33678, P30 AG010161, R01AG34374, R01 AG017917, R01 AG015819, R01 AG034374, RC2AG36547, P01 AG014449, P30AG10161] Funding Source: Medline; NINDS NIH HHS [R01NS028127, R01 NS028127] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Haroutunian V, 2008, ARCH NEUROL-CHICAGO, V65, P1211, DOI 10.1001/archneur.65.9.1211; Imhof A, 2007, J NEUROL SCI, V257, P72, DOI 10.1016/j.jns.2007.01.025; Middleton LE, 2011, NEUROLOGY, V77, P1737, DOI 10.1212/WNL.0b013e318236f0cf; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24	5	106	107	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 2	2012	307	17					1798	1800		10.1001/jama.2012.3556	http://dx.doi.org/10.1001/jama.2012.3556			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	933TV	22550192	Green Accepted, Bronze			2022-12-24	WOS:000303386800015
J	Graber, C				Graber, Cynthia			Diagnostics: Getting a clear picture	NATURE			English	Editorial Material																			0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S7	S7		10.1038/nature11101	http://dx.doi.org/10.1038/nature11101			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509508	Bronze			2022-12-24	WOS:000303149900049
J	Gaffga, NH; Behravesh, CB; Ettestad, PJ; Smelser, CB; Rhorer, AR; Cronquist, AB; Comstock, NA; Bidol, SA; Patel, NJ; Gerner-Smidt, P; Keene, WE; Gomez, TM; Hopkins, BA; Sotir, MJ; Angulo, FJ				Gaffga, Nicholas H.; Behravesh, Casey Barton; Ettestad, Paul J.; Smelser, Chad B.; Rhorer, Andrew R.; Cronquist, Alicia B.; Comstock, Nicole A.; Bidol, Sally A.; Patel, Nehal J.; Gerner-Smidt, Peter; Keene, William E.; Gomez, Thomas M.; Hopkins, Brett A.; Sotir, Mark J.; Angulo, Frederick J.			Outbreak of Salmonellosis Linked to Live Poultry from a Mail-Order Hatchery	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES	BACKGROUND Outbreaks of human salmonella infections are increasingly associated with contact with live poultry, but effective control measures are elusive. In 2005, a cluster of human salmonella Montevideo infections with a rare pattern on pulsed-field gel electrophoresis (the outbreak strain) was identified by PulseNet, a national subtyping network. METHODS In cooperation with public health and animal health agencies, we conducted multistate investigations involving patient interviews, trace-back investigations, and environmental testing at a mail-order hatchery linked to the outbreak in order to identify the source of infections and prevent additional illnesses. A case was defined as an infection with the outbreak strain between 2004 and 2011. RESULTS From 2004 through 2011, we identified 316 cases in 43 states. The median age of the patient was 4 years. Interviews were completed with 156 patients (or their caretakers) (49%), and 36 of these patients (23%) were hospitalized. Among the 145 patients for whom information was available, 80 (55%) had bloody diarrhea. Information on contact with live young poultry was available for 159 patients, and 122 of these patients (77%) reported having such contact. A mail-order hatchery in the western United States was identified in 81% of the trace-back investigations, and the outbreak strain was isolated from samples collected at the hatchery. After interventions at the hatchery, the number of human infections declined, but transmission continued. CONCLUSIONS We identified a prolonged multistate outbreak of salmonellosis, predominantly affecting young children and associated with contact with live young poultry from a mail-order hatchery. Interventions performed at the hatchery reduced, but did not eliminate, associated human infections, demonstrating the difficulty of eliminating salmonella transmission from live poultry.	[Gaffga, Nicholas H.; Behravesh, Casey Barton; Patel, Nehal J.; Gerner-Smidt, Peter; Sotir, Mark J.; Angulo, Frederick J.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Water Borne & Environm Dis, Atlanta, GA 30333 USA; [Ettestad, Paul J.; Smelser, Chad B.] New Mexico Dept Hlth, Santa Fe, NM USA; [Rhorer, Andrew R.] Natl Poultry Improvement Plan, Anim & Plant Hlth Inspect Serv, Washington, DC USA; [Gomez, Thomas M.] Vet Serv, Washington, DC USA; [Gomez, Thomas M.] Dept Agr, Washington, DC USA; [Cronquist, Alicia B.; Comstock, Nicole A.] Colorado Dept Publ Hlth & Environm, Denver, CO USA; [Bidol, Sally A.] Michigan Dept Community Hlth, Lansing, MI USA; [Keene, William E.] Oregon Publ Hlth Div, Portland, OR USA; [Hopkins, Brett A.] Pfizer Anim Hlth, Overland Pk, KS USA	Centers for Disease Control & Prevention - USA; New Mexico Department of Health; Colorado Department of Public Health & Environment; MDHHS - Michigan Department of Health & Human Services; Pfizer	Gaffga, NH (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div Foodborne Water Borne & Environm Dis, 1600 Clifton Rd,NE MS E 02, Atlanta, GA 30333 USA.	ngaffga@cdc.gov	BARTON BEHRAVESH, Casey/HDL-8040-2022	BARTON BEHRAVESH, Casey/0000-0003-2270-5573				ANDERSON AS, 1955, JAMA-J AM MED ASSOC, V158, P1153, DOI 10.1001/jama.1955.02960130007003; [Anonymous], RISK HUM SALM INF LI; [Anonymous], 1992, MMWR MORB MORTAL WKL, V41, P185; [Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P25; [Anonymous], 2011, 2011 COMP HANDW MAT; [Anonymous], 2009, HUM IS FIN REP 2007; [Anonymous], 2006, NAT POULTR IMPR PLAN; [Anonymous], 1997, MMWR MORB MORTAL WKL, V46, P237; [Anonymous], 2007, MMWR MORB MORTAL WKL, V56, P273; Neuman W, 2009, NY TIMES        0814; Roy P, 2001, AVIAN DIS, V45, P922, DOI 10.2307/1592871; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.P11101; Swaminathan B, 2001, EMERG INFECT DIS, V7, P382; Wilkins MJ, 2002, EPIDEMIOL INFECT, V129, P19, DOI 10.1017/S0950268802007112; 2000, MMWR MORB MORTAL WKL, V49, P297	15	41	43	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2065	2073						9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22646629	Bronze			2022-12-24	WOS:000304613400006
J	Cheung, KMC; Cheung, JPY; Samartzis, D; Mak, KC; Wong, YW; Cheung, WY; Akbarnia, BA; Luk, KDK				Cheung, Kenneth Man-Chee; Cheung, Jason Pui-Yin; Samartzis, Dino; Mak, Kin-Cheung; Wong, Yat-Wa; Cheung, Wai-Yuen; Akbarnia, Behrooz A.; Luk, Keith Dip-Kei			Magnetically controlled growing rods for severe spinal curvature in young children: a prospective case series	LANCET			English	Article							EARLY-ONSET SCOLIOSIS; IDIOPATHIC SCOLIOSIS; CONGENITAL SCOLIOSIS; INFANTILE SCOLIOSIS; PULMONARY-FUNCTION; OUTCOMES; GROWTH; FUSION; MANAGEMENT; ANESTHESIA	Background Scoliosis in skeletally immature children is often treated by implantation of a rod to straighten the spine. Rods can be distracted (lengthened) as the spine grows, but patients need many invasive operations under general anaesthesia. Such operations are costly and associated with negative psychosocial outcomes. We assessed the effectiveness and safety of a new magnetically controlled growing rod (MCGR) for non-invasive outpatient distractions. Methods We implanted the MCGR in five patients, two of whom have now reached 24 months' follow-up. Each patient underwent monthly outpatient distractions. We used radiography to measure the magnitude of the spinal curvature, rod distraction length, and spinal length. We assessed clinical outcome by measuring the degree of pain, function, mental health, satisfaction with treatment, and procedure-related complications. Findings In the two patients with 24 months' follow-up, the mean degree of scoliosis, measured by Cobb angle, was 67 degrees (SD 10 degrees) before implantation and 29 degrees (4 degrees) at 24 months. Length of the instrumented segment of the spine increased by a mean of 1.9 mm (0.4 mm) with each distraction. Mean predicted versus actual rod distraction lengths were 2.3 mm (1.2 mm) versus 1.4 mm (0.7 mm) for patient 1, and 2.0 mm (0.2 mm) and 2.1 mm (0.7 mm) versus 1.9 mm (0.6 mm) and 1.7 mm (0.8 mm) for patient 2's right and left rods, respectively. Throughout follow-up, both patients had no pain, had good functional outcome, and were satisfied with the procedure. No MCGR-related complications were noted. Interpretation The MCGR procedure can be safely and effectively used in outpatient settings, and minimises surgical scarring and psychological distress, improves quality of life, and is more cost-effective than is the traditional growing rod procedure. The technique could be used for non-invasive correction of abnormalities in other disorders.	[Cheung, Kenneth Man-Chee] Univ Hong Kong, Queen Mary Hosp, Dept Orthopaed & Traumatol, Div Spine Surg, Pokfulam, Hong Kong, Peoples R China; [Akbarnia, Behrooz A.] San Diego Ctr Spinal Disorders, La Jolla, CA USA	University of Hong Kong	Cheung, KMC (corresponding author), Univ Hong Kong, Queen Mary Hosp, Dept Orthopaed & Traumatol, Div Spine Surg, 102 Pokfulam Rd, Pokfulam, Hong Kong, Peoples R China.	cheungmc@hku.hk	Cheung, Jason Pui Yin/J-2214-2012; Cheung, Jason Pui Yin/AAJ-2016-2020; Akbarnia, Behrooz/AAL-8255-2021	Cheung, Jason Pui Yin/0000-0002-7052-0875; Cheung, Kenneth/0000-0001-8304-0419; Samartzis, Dino/0000-0002-7473-1311	Ellipse Technologies	Ellipse Technologies	Ellipse Technologies.	Akbarnia BA, 2005, SPINE, V30, pS46, DOI 10.1097/01.brs.0000175190.08134.73; Akbarnia BA, 2011, SPINE, DOI [10.1097/BRS.0b013e318240ff67, DOI 10.1097/BRS.0B013E318240FF]; Akbarnia BA, 2009, J CHILD ORTHOP, V3, P530; Akbarnia BA, 2008, SPINE, V33, P984, DOI 10.1097/BRS.0b013e31816c8b4e; Bess S, 2010, J BONE JOINT SURG AM, V92A, P2533, DOI 10.2106/JBJS.I.01471; Cahill PJ, 2010, SPINE, V35, pE1199, DOI 10.1097/BRS.0b013e3181e21b50; Caldas JCS, 2004, PEDIATR ANESTH, V14, P910, DOI 10.1111/j.1460-9592.2004.01350.x; COBB JR, 1960, J BONE JOINT SURG AM, V42, P1413, DOI 10.2106/00004623-196042080-00012; DIMEGLIO A, 1992, J PEDIATR ORTHOP B, V1, P102, DOI 10.1097/01202412-199201020-00003; Dimeglio A., 2001, J PEDIATR ORTHOPED, V21, P459; Elsebai HB, J PEDIAT ORTHOP, V31, P1; Goldberg CJ, 2003, SPINE, V28, P2397, DOI 10.1097/01.BRS.0000085367.24266.CA; JAMES JIP, 1959, J BONE JOINT SURG BR, V41, P719, DOI 10.1302/0301-620X.41B4.719; JAMES JIP, 1954, J BONE JOINT SURG BR, V36, P36, DOI 10.1302/0301-620X.36B1.36; Kain ZN, 1999, ANESTH ANALG, V88, P1042, DOI 10.1097/00000539-199905000-00013; Kain ZN, 1996, ARCH PEDIAT ADOL MED, V150, P1238, DOI 10.1001/archpedi.1996.02170370016002; Karol LA, 2008, J BONE JOINT SURG AM, V90A, P1272, DOI 10.2106/JBJS.G.00184; MCMASTER MJ, 1979, J BONE JOINT SURG BR, V61, P36, DOI 10.1302/0301-620X.61B1.422633; Mehta MH, 2005, J BONE JOINT SURG BR, V87B, P1237, DOI 10.1302/0301-620X.87B9.16124; Robinson CM, 1996, J BONE JOINT SURG AM, V78A, P1140, DOI 10.2106/00004623-199608000-00003; Sankar WN, 2011, SPINE, V36, P806, DOI 10.1097/BRS.0b013e318214d78f; Scoliosis Research Society, SRS 30 QUEST; Sponseller PD, 2007, SPINE, V32, pS81, DOI 10.1097/BRS.0b013e3181453073; Sponseller PD, 2009, SPINE, V34, P1711, DOI 10.1097/BRS.0b013e3181a9ece5; Thompson GH, 2007, J PEDIATR ORTHOPED, V27, P354, DOI 10.1097/BPO.0b013e3180333eea; Thompson GH, 2005, SPINE, V30, P2039, DOI 10.1097/01.brs.0000179082.92712.89; Vitale MG, 2008, SPINE, V33, P1242, DOI 10.1097/BRS.0b013e3181714536; WINTER RB, 1984, J BONE JOINT SURG AM, V66A, P1188, DOI 10.2106/00004623-198466080-00006; Yang JS, 2011, SPINE, V36, P1639, DOI 10.1097/BRS.0b013e31822a982f; Yilmaz G, 2010, SPINE, V35, P730, DOI 10.1097/BRS.0b013e3181bcc3a3	30	194	209	1	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	2012	379	9830					1967	1974		10.1016/S0140-6736(12)60112-3	http://dx.doi.org/10.1016/S0140-6736(12)60112-3			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	951YV	22520264	Green Submitted			2022-12-24	WOS:000304757700031
J	Lin, SY; Li, TY; Liu, Q; Zhang, CX; Li, XT; Chen, Y; Zhang, SM; Lian, GL; Liu, Q; Ruan, K; Wang, Z; Zhang, CS; Chien, KY; Wu, JW; Li, QX; Han, JH; Lin, SC				Lin, Shu-Yong; Li, Terytty Yang; Liu, Qing; Zhang, Cixiong; Li, Xiaotong; Chen, Yan; Zhang, Shi-Meng; Lian, Guili; Liu, Qi; Ruan, Ka; Wang, Zhen; Zhang, Chen-Song; Chien, Kun-Yi; Wu, Jiawei; Li, Qinxi; Han, Jiahuai; Lin, Sheng-Cai			GSK3-TIP60-ULK1 Signaling Pathway Links Growth Factor Deprivation to Autophagy	SCIENCE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; CELL-SURVIVAL; MTOR; PHOSPHORYLATION; INACTIVATION; INHIBITION; INSULIN	In metazoans, cells depend on extracellular growth factors for energy homeostasis. We found that glycogen synthase kinase-3 (GSK3), when deinhibited by default in cells deprived of growth factors, activates acetyltransferase TIP60 through phosphorylating TIP60-Ser(86), which directly acetylates and stimulates the protein kinase ULK1, which is required for autophagy. Cells engineered to express TIP60(S86A) that cannot be phosphorylated by GSK3 could not undergo serum deprivation-induced autophagy. An acetylation-defective mutant of ULK1 failed to rescue autophagy in ULK1(-/-) mouse embryonic fibroblasts. Cells used signaling from GSK3 to TIP60 and ULK1 to regulate autophagy when deprived of serum but not glucose. These findings uncover an activating pathway that integrates protein phosphorylation and acetylation to connect growth factor deprivation to autophagy.	[Lin, Shu-Yong; Li, Terytty Yang; Liu, Qing; Zhang, Cixiong; Li, Xiaotong; Chen, Yan; Lian, Guili; Liu, Qi; Ruan, Ka; Wang, Zhen; Zhang, Chen-Song; Li, Qinxi; Han, Jiahuai; Lin, Sheng-Cai] Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China; [Zhang, Shi-Meng] Beijing Inst Radiat Med, Beijing 100850, Peoples R China; [Chien, Kun-Yi] Chang Gung Univ, Mol Med Res Ctr, Grad Inst Biomed Sci, Coll Med, Tao Yuan 333, Taiwan; [Wu, Jiawei] Tsinghua Univ, Sch Life Sci, Beijing 100101, Peoples R China	Xiamen University; Academy of Military Medical Sciences - China; Chang Gung University; Tsinghua University	Lin, SC (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen 361005, Fujian, Peoples R China.	linsc@xmu.edu.cn	Li, Terytty Yang/HCI-2446-2022; Li, xiaotong/GYV-4890-2022; Han, J/G-4671-2010; Li, QX/G-4669-2010; Lin, Shu-Yong/B-7726-2012; Lin, SC/G-4666-2010	Li, Terytty Yang/0000-0003-3684-7935; Lin, Shu-Yong/0000-0002-4419-1713; 	973 Program [2011CB910800]; National Natural Science Foundation of China [31130016, 30921005, 31000621]; Fundamental Research Funds for the Central Universities [2010121094]; Ministry of Education of China [B06016]	973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Ministry of Education of China(Ministry of Education, China)	We thank D. Luo for help with statistical analyses, M. Kundu and H. Zhang for providing ULK1<SUP>-/-</SUP> and TSC2<SUP>-/-</SUP> MEFs, and B. Viollet and K. R. Laderoute for providing AMPK alpha 1/2-DKO MEFs. This work was supported by grants from the 973 Program (2011CB910800), National Natural Science Foundation of China (31130016, 30921005, and 31000621), Fundamental Research Funds for the Central Universities (2010121094), and the 111 Project of Ministry of Education of China (B06016). S.-C. L. is a Cheung Kong Scholar.	Brazil DP, 2004, TRENDS BIOCHEM SCI, V29, P233, DOI 10.1016/j.tibs.2004.03.006; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; ELDARFINKELMAN H, 1995, J BIOL CHEM, V270, P987, DOI 10.1074/jbc.270.3.987; Ganley IG, 2009, J BIOL CHEM, V284, P12297, DOI 10.1074/jbc.M900573200; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Hu YF, 2009, DEV DYNAM, V238, P2912, DOI 10.1002/dvdy.22110; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lemercier C, 2003, J BIOL CHEM, V278, P4713, DOI 10.1074/jbc.M211811200; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Lum JJ, 2005, CELL, V120, P237, DOI 10.1016/j.cell.2004.11.046; MORTIMORE GE, 1987, ANNU REV NUTR, V7, P539, DOI 10.1146/annurev.nu.07.070187.002543; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Tsukamoto S, 2008, SCIENCE, V321, P117, DOI 10.1126/science.1154822; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	27	245	261	9	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					477	481		10.1126/science.1217032	http://dx.doi.org/10.1126/science.1217032			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539723				2022-12-24	WOS:000303233400048
J	Epstein, K				Epstein, Keith			Is spending on proton beam therapy for cancer going too far, too fast?	BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS; RADIATION-THERAPY; PROSTATE					keith@kepstein.com						Chen R, 2012, JAMA            0418; Jakel O, 2007, RADIOTHER ONCOL, V83, P133, DOI 10.1016/j.radonc.2007.03.010; Kim S, 2011, EUR UROL, V60, P908, DOI 10.1016/j.eururo.2011.05.052; Konski A, 2007, J CLIN ONCOL, V25, P3603, DOI 10.1200/JCO.2006.09.0811; Lundkvist J, 2005, CANCER-AM CANCER SOC, V103, P793, DOI 10.1002/cncr.20844	5	11	12	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 17	2012	344								e2488	10.1136/bmj.e2488	http://dx.doi.org/10.1136/bmj.e2488			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	931CN	22511301				2022-12-24	WOS:000303192100019
J	Rankin, EB; Wu, C; Khatri, R; Wilson, TLS; Andersen, R; Araldi, E; Rankin, AL; Yuan, J; Kuo, CJ; Schipani, E; Giaccia, AJ				Rankin, Erinn B.; Wu, Colleen; Khatri, Richa; Wilson, Tremika L. S.; Andersen, Rebecca; Araldi, Elisa; Rankin, Andrew L.; Yuan, Jenny; Kuo, Calvin J.; Schipani, Emestina; Giaccia, Amato J.			The HIF Signaling Pathway in Osteoblasts Directly Modulates Erythropoiesis through the Production of EPO	CELL			English	Article							HYPOXIA-INDUCIBLE-FACTOR; HEMATOPOIETIC STEM-CELLS; TUMOR-SUPPRESSOR; MICE; NICHE; HIF-1-ALPHA; ANEMIA; DIFFERENTIATION; PROGENITORS; DEFICIENCY	Osteoblasts are an important component of the hematopoietic microenvironment in bone. However, the mechanisms by which osteoblasts control hematopoiesis remain unknown. We show that augmented HIF signaling in osteoprogenitors results in HSC niche expansion associated with selective expansion of the erythroid lineage. Increased red blood cell production occurred in an EPO-dependent manner with increased EPO expression in bone and suppressed EPO expression in the kidney. In contrast, inactivation of HIF in osteoprogenitors reduced EPO expression in bone. Importantly, augmented HIF activity in osteoprogenitors protected mice from stress-induced anemia. Pharmacologic or genetic inhibition of prolyl hydroxylases1/2/3 in osteoprogenitors elevated EPO expression in bone and increased hematocrit. These data reveal an unexpected role for osteoblasts in the production of EPO and modulation of erythropoiesis. Furthermore, these studies demonstrate a molecular role for osteoblastic PHD/VHL/HIF signaling that can be targeted to elevate both HSCs and erythroid progenitors in the local hematopoietic microenvironment.	[Rankin, Erinn B.; Wu, Colleen; Andersen, Rebecca; Giaccia, Amato J.] Stanford Univ, Div Radiat & Canc Biol, Dept Radiat Oncol, Ctr Clin Sci Res, Stanford, CA 94303 USA; [Yuan, Jenny; Kuo, Calvin J.] Stanford Univ, Div Hematol, Stanford, CA 94303 USA; [Khatri, Richa; Wilson, Tremika L. S.; Araldi, Elisa; Schipani, Emestina] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA 02114 USA; [Rankin, Andrew L.] Pfizer, Inflammat & Immunol, Cambridge, MA 02140 USA	Stanford University; Stanford University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Pfizer	Giaccia, AJ (corresponding author), Stanford Univ, Div Radiat & Canc Biol, Dept Radiat Oncol, Ctr Clin Sci Res, Stanford, CA 94303 USA.	giaccia@stanford.edu	Araldi, Elisa/AAZ-5946-2021	Rankin, Erinn/0000-0002-2045-2296; Araldi, Elisa/0000-0002-6596-6784; Kuo, Calvin/0000-0002-7427-5985; Andersen, Rebecca/0000-0002-0702-3120	NIH [CA67166, CA088480, AR048191-06]; Sydney Frank Foundation; NIH National Research Service from the National Cancer Institute [T32 CA09151]; Canadian Institutes of Health Research; NATIONAL CANCER INSTITUTE [P01CA067166, R01CA116685, T32CA009151, R37CA088480, R01CA088480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048191] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085527] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sydney Frank Foundation; NIH National Research Service from the National Cancer Institute; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants CA67166 and CA088480 and the Sydney Frank Foundation (A.J.G.) and NIH AR048191-06 (A.J.G. and E.S.). E.B.R. is supported by the NIH National Research Service Award T32 CA09151 from the National Cancer Institute. C.W. is supported by a Canadian Institutes of Health Research Fellowship. The authors would like to thank all of the investigators that generated and made the floxed/transgenic mice available for these studies: Dr. Volker Haase (Vhlh floxed), Dr. Randall Johnson (Hif-1 floxed), Drs. Brian Keith and Celeste Simon (Hif-2 floxed), Dr. Guo-Hua Fong (Phd1,2,3 floxed), and Dr. Andrew McMahon (Osterix-Cre).	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Akeno N, 2002, ENDOCRINOLOGY, V143, P420, DOI 10.1210/en.143.2.420; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Flygare J, 2011, BLOOD, V117, P3435, DOI 10.1182/blood-2010-07-295550; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Haase VH, 2010, AM J PHYSIOL-RENAL, V299, pF1, DOI 10.1152/ajprenal.00174.2010; Hsieh MM, 2007, BLOOD, V110, P2140, DOI 10.1182/blood-2007-02-073254; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Maes C, 2010, EMBO J, V29, P424, DOI 10.1038/emboj.2009.361; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Minamishima YA, 2010, SCIENCE, V329, P407, DOI 10.1126/science.1192811; Murray JK, 2010, J COMB CHEM, V12, P676, DOI 10.1021/cc100073a; Obara N, 2008, BLOOD, V111, P5223, DOI 10.1182/blood-2007-10-115857; Ohishi M, 2009, AM J PATHOL, V174, P2160, DOI 10.2353/ajpath.2009.081026; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Takeda K, 2008, BLOOD, V111, P3229, DOI 10.1182/blood-2007-09-114561; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020; Tam BYY, 2006, NAT MED, V12, P793, DOI 10.1038/nm1428; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; WU H, 1995, CELL, V83, P59, DOI 10.1016/0092-8674(95)90234-1; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Yan L, 2010, EXPERT OPIN THER PAT, V20, P1219, DOI 10.1517/13543776.2010.510836; Yoon D, 2006, J BIOL CHEM, V281, P25703, DOI 10.1074/jbc.M602329200; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Zhan Yuxia, 2008, V430, P161, DOI 10.1007/978-1-59745-182-6_11; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	43	198	219	3	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					63	74		10.1016/j.cell.2012.01.051	http://dx.doi.org/10.1016/j.cell.2012.01.051			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464323	Bronze, Green Accepted			2022-12-24	WOS:000302235400010
J	Westfall, CS; Zubieta, C; Herrmann, J; Kapp, U; Nanao, MH; Jez, JM				Westfall, Corey S.; Zubieta, Chloe; Herrmann, Jonathan; Kapp, Ulrike; Nanao, Max H.; Jez, Joseph M.			Structural Basis for Prereceptor Modulation of Plant Hormones by GH3 Proteins	SCIENCE			English	Article							CONJUGATES AMINO-ACIDS; SALICYLIC-ACID; EVOLUTIONARY HISTORY; FAMILY; JASMONATE; AUXIN; HYPOCOTYL; RECEPTOR; MEMBER; ASSAY	Acyl acid amido synthetases of the GH3 family act as critical prereceptor modulators of plant hormone action; however, the molecular basis for their hormone selectivity is unclear. Here, we report the crystal structures of benzoate-specific Arabidopsis thaliana AtGH3.12/PBS3 and jasmonic acid-specific AtGH3.11/JAR1. These structures, combined with biochemical analysis, define features for the conjugation of amino acids to diverse acyl acid substrates and highlight the importance of conformational changes in the carboxyl-terminal domain for catalysis. We also identify residues forming the acyl acid binding site across the GH3 family and residues critical for amino acid recognition. Our results demonstrate how a highly adaptable three-dimensional scaffold is used for the evolution of promiscuous activity across an enzyme family for modulation of plant signaling molecules.	[Westfall, Corey S.; Herrmann, Jonathan; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Zubieta, Chloe; Kapp, Ulrike] European Synchrotron Radiat Facil, F-38000 Grenoble, France; [Nanao, Max H.] European Mol Biol Lab, F-38042 Grenoble, France; [Nanao, Max H.] Univ Grenoble 1, CNRS, European Mol Biol Lab, Unit Virus Host Cell Interact, Grenoble, France	Washington University (WUSTL); European Synchrotron Radiation Facility (ESRF); European Molecular Biology Laboratory (EMBL); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Jez, JM (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	jjez@biology2.wustl.edu	Nanao, Max/ABA-9292-2021	Nanao, Max/0000-0002-6340-1376; Zubieta, Chloe/0000-0003-4558-9333	NSF [MCB-1157771]; U.S. Department of Agriculture-National Institute of Food and Agriculture [MOW-2010-05240]; American Society of Plant Biologists; Howard Hughes Medical Institute-Washington University; Direct For Biological Sciences [1157771] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); U.S. Department of Agriculture-National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); American Society of Plant Biologists; Howard Hughes Medical Institute-Washington University(Howard Hughes Medical Institute); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF grant MCB-1157771 to J.M.J. C. S. W. was supported by a U.S. Department of Agriculture-National Institute of Food and Agriculture predoctoral fellowship (MOW-2010-05240), and J.H. was supported by an American Society of Plant Biologists-Summer Undergraduate Research Fellowship award and the Howard Hughes Medical Institute-Washington University Summer Scholars Program in Biology and Biomedical Research. Portions of this research were carried out at the European Synchrotron Radiation Facility and the Argonne National Laboratory Structural Biology Center of the Advanced Photon Source, a national user facility operated by the Univ. of Chicago for the U. S. Department of Energy Office of Biological and Environmental Research (DE-AC02-06CH11357). Atomic coordinates and structure factors have been deposited in the PDB (accession codes are noted in table S2).	Browse J, 2009, ANNU REV PLANT BIOL, V60, P183, DOI 10.1146/annurev.arplant.043008.092007; Chen QF, 2010, J BIOL CHEM, V285, P29780, DOI 10.1074/jbc.M110.146431; Chen QF, 2009, ANAL BIOCHEM, V390, P149, DOI 10.1016/j.ab.2009.04.027; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; HAGEN G, 1984, PLANTA, V162, P147, DOI 10.1007/BF00410211; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; Ljung K, 2002, PLANT MOL BIOL, V50, P309, DOI 10.1023/A:1016024017872; Loake G, 2007, CURR OPIN PLANT BIOL, V10, P466, DOI 10.1016/j.pbi.2007.08.008; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Okrent RA, 2011, PLANT MOL BIOL, V76, P489, DOI 10.1007/s11103-011-9776-y; Okrent RA, 2009, J BIOL CHEM, V284, P9742, DOI 10.1074/jbc.M806662200; Santner A, 2009, NAT CHEM BIOL, V5, P301, DOI 10.1038/nchembio.165; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Staswick PE, 2005, PLANT CELL, V17, P616, DOI 10.1105/tpc.104.026690; Staswick PE, 2002, PLANT CELL, V14, P1405, DOI 10.1105/tpc.000885; Suza WP, 2008, PLANTA, V227, P1221, DOI 10.1007/s00425-008-0694-4; Takase T, 2003, PLANT CELL PHYSIOL, V44, P1071, DOI 10.1093/pcp/pcg130; Terol J, 2006, GENE, V371, P279, DOI 10.1016/j.gene.2005.12.014; Westfall CS, 2010, PLANT SIGNAL BEHAV, V5, P1607, DOI 10.4161/psb.5.12.13941; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083	22	102	110	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	2012	336	6089					1708	1711		10.1126/science.1221863	http://dx.doi.org/10.1126/science.1221863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22628555				2022-12-24	WOS:000305794500051
J	Graham-Rowe, D				Graham-Rowe, Duncan			RISK ANALYSIS A dense issue	NATURE			English	Editorial Material																		Assi V, 2012, NAT REV CLIN ONCOL, V9, P33, DOI 10.1038/nrclinonc.2011.173; Boyd N, 2009, CANCER EPIDEM BIOMAR, V18, P1754, DOI 10.1158/1055-9965.EPI-09-0107; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Jorgensen KJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1241; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Richards M, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d6843	6	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S60	S61		10.1038/485S60a	http://dx.doi.org/10.1038/485S60a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648502	Bronze			2022-12-24	WOS:000304608000006
J	Maxmen, A				Maxmen, Amy			THE HARD FACTS	NATURE			English	Editorial Material																			0	40	40	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S50	S51		10.1038/485S50a	http://dx.doi.org/10.1038/485S50a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22648497	Bronze			2022-12-24	WOS:000304608000001
J	Johnson, K; Zhu, ST; Tremblay, MS; Payette, JN; Wang, JN; Bouchez, LC; Meeusen, S; Althage, A; Cho, CY; Wu, X; Schultz, PG				Johnson, Kristen; Zhu, Shoutian; Tremblay, Matthew S.; Payette, Joshua N.; Wang, Jianing; Bouchez, Laure C.; Meeusen, Shelly; Althage, Alana; Cho, Charles Y.; Wu, Xu; Schultz, Peter G.			A Stem Cell-Based Approach to Cartilage Repair	SCIENCE			English	Article							ARTICULAR-CARTILAGE; CHONDROCYTE DIFFERENTIATION; TRANSCRIPTION FACTOR; OSTEOARTHRITIS; BONE; PATHOGENESIS; FILAMIN; GENE; CHONDROGENESIS; EXPRESSION	Osteoarthritis (OA) is a degenerative joint disease that involves the destruction of articular cartilage and eventually leads to disability. Molecules that promote the selective differentiation of multipotent mesenchymal stem cells (MSCs) into chondrocytes may stimulate the repair of damaged cartilage. Using an image-based high-throughput screen, we identified the small molecule kartogenin, which promotes chondrocyte differentiation (median effective concentration = 100 nM), shows chondroprotective effects in vitro, and is efficacious in two OA animal models. Kartogenin binds filamin A, disrupts its interaction with the transcription factor core-binding factor beta subunit (CBF beta), and induces chondrogenesis by regulating the CBF beta-RUNX1 transcriptional program. This work provides new insights into the control of chondrogenesis that may ultimately lead to a stem cell-based therapy for osteoarthritis.	[Johnson, Kristen; Tremblay, Matthew S.; Meeusen, Shelly; Althage, Alana; Cho, Charles Y.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Zhu, Shoutian; Tremblay, Matthew S.; Payette, Joshua N.; Wang, Jianing; Bouchez, Laure C.; Schultz, Peter G.] Scripps Res Inst, La Jolla, CA 92037 USA; [Wu, Xu] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA	Novartis; Scripps Research Institute; Harvard University; Massachusetts General Hospital	Johnson, K (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.	kjohnson@gnf.org; schultz@scripps.edu	Zhu, Shoutian/M-2108-2018	Zhu, Shoutian/0000-0001-6748-225X; Johnson, Kristen/0000-0003-0788-7217; bouchez, laure/0000-0003-4583-6760	California Institute for Regenerative Medicine [TR2-01829]	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	This work was funded by grants from the California Institute for Regenerative Medicine (TR2-01829 to P.G.S.). We are grateful to J. Walker for help in gene expression analysis. Microarray data have been deposited in the National Center for Biotechnology Information's Gene Expression Omnibus with accession number GSE35546. A patent application has been submitted by the authors on the use of kartogenin for chondrogenesis.	Adya N, 2000, SEMIN CELL DEV BIOL, V11, P361, DOI 10.1006/scdb.2000.0189; Charbord P, 2010, HUM GENE THER, V21, P1045, DOI 10.1089/hum.2010.115; Coluet J, 2009, DRUG DISCOV TODAY, V14, P913, DOI 10.1016/j.drudis.2009.07.012; Connelly JT, 2008, J CELL PHYSIOL, V217, P145, DOI 10.1002/jcp.21484; Drissi H, 2002, J CELL BIOCHEM, V86, P403, DOI 10.1002/jcb.10238; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Goldring MB, 2010, ANN NY ACAD SCI, V1192, P230, DOI 10.1111/j.1749-6632.2009.05240.x; GORLIN JB, 1990, J CELL BIOL, V111, P1089, DOI 10.1083/jcb.111.3.1089; Grogan SP, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2719; Hunter DJ, 2011, NAT REV RHEUMATOL, V7, P13, DOI 10.1038/nrrheum.2010.178; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670; LOHMANDER LS, 1994, ANN RHEUM DIS, V53, P8, DOI 10.1136/ard.53.1.8; Lotz MK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3046; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Read SJ, 2008, EXPERT OPIN INV DRUG, V17, P619, DOI 10.1517/13543784.17.5.619 ; Reginster JY, 2002, RHEUMATOLOGY, V41, P1, DOI 10.1093/rheumatology/41.suppl_1.1; Reijman M, 2004, ARTHRITIS RHEUM-US, V50, P2471, DOI 10.1002/art.20332; Rutgers M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3050; Smith GN, 2006, FRONT BIOSCI-LANDMRK, V11, P3081, DOI 10.2741/2034; Soung DY, 2007, J BONE MINER RES, V22, P1260, DOI 10.1359/JBMR.070502; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; van der Kraan PM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2896; VANDERKRAAN PM, 1989, AM J PATHOL, V135, P1001; Wang Y, 2007, ONCOGENE, V26, P6061, DOI 10.1038/sj.onc.1210435; Wang YJ, 2005, J BONE MINER RES, V20, P1624, DOI 10.1359/JBMR.050516; Wotton S, 2008, ONCOGENE, V27, P5856, DOI 10.1038/onc.2008.195; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Yoshida N, 2005, MOL CELL BIOL, V25, P1003, DOI 10.1128/MCB.25.3.1003-1012.2005; Zhu ST, 2009, CELL STEM CELL, V4, P416, DOI 10.1016/j.stem.2009.04.001	35	458	508	8	306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					717	721		10.1126/science.1215157	http://dx.doi.org/10.1126/science.1215157			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22491093				2022-12-24	WOS:000303872300049
J	Mulholland, EK; Griffiths, UK; Biellik, R				Mulholland, E. Kim; Griffiths, Ulla Kou; Biellik, Robin			Measles in the 21st Century	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mulholland, E. Kim; Griffiths, Ulla Kou] London Sch Hyg & Trop Med, London, England; [Mulholland, E. Kim] Menzies Sch Hlth Res, Darwin, NT, Australia; [Mulholland, E. Kim] Murdoch Childrens Res Inst, Parkville, Vic, Australia	University of London; London School of Hygiene & Tropical Medicine; Charles Darwin University; Menzies School of Health Research; Murdoch Children's Research Institute	Mulholland, EK (corresponding author), London Sch Hyg & Trop Med, London, England.							[Anonymous], 2011, WKLY EPIDEMIOL REC, V86, P86; Martins CL, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a661; Moss WJ, 2012, LANCET, V379, P153, DOI 10.1016/S0140-6736(10)62352-5; MULHOLLAND K, 1995, LANCET, V345, P305, DOI 10.1016/S0140-6736(95)90282-1; Wolfson LJ, 2007, LANCET, V369, P191, DOI 10.1016/S0140-6736(07)60107-X	5	33	34	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 10	2012	366	19					1755	1757		10.1056/NEJMp1202396	http://dx.doi.org/10.1056/NEJMp1202396			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939NB	22571199	Green Published			2022-12-24	WOS:000303817000003
J	Mortimer, P				Mortimer, Philip			PERSONAL VIEW As with tuberculosis, earlier identification and treatment is the way to tackle HIV	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTION					pandjmortimer@gmail.com						Blattner WA, 2004, J INFECT DIS, V189, P1793, DOI 10.1086/386306; *HLTH PROT AG, NOT INF DIS NOIDS; Hoffstaedt EGW, 1950, LANCET, V256, P756; House of Lords Select Committee on HIV and AIDs in the United Kingdom, 2011, NO VACC NO CUR HIV A; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 27	2012	344								e2874	10.1136/bmj.e2874	http://dx.doi.org/10.1136/bmj.e2874			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HE	22544833				2022-12-24	WOS:000303434000002
J	Maxmen, A				Maxmen, Amy			PUBLIC HEALTH Death at the doorstep	NATURE			English	Editorial Material																		Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Okiro EA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-37; US President's Malaria Initiative, 2011, MAL OP PLAN RWAND FI	3	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S19	S21		10.1038/484S19a	http://dx.doi.org/10.1038/484S19a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22534527	Bronze			2022-12-24	WOS:000303200400002
J	Bhaskaran, K; Douglas, I; Evans, S; van Staa, T; Smeeth, L				Bhaskaran, Krishnan; Douglas, Ian; Evans, Stephen; van Staa, Tjeerd; Smeeth, Liam			Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEDICATION; ANGIOGENESIS; METAANALYSIS; TESTS	Objectives To investigate whether there is an association between use of angiotensin receptor blockers and risk of cancer. Design Cohort study of risk of cancer in people treated with angiotensin receptor blockers compared with angiotensin converting enzyme (ACE) inhibitors. Effects were explored with time updated covariates in Cox models adjusted for age, sex, body mass index (BMI), diabetes and metformin/insulin use, hypertension, heart failure, statin use, socioeconomic status, alcohol, smoking, and calendar year. Absolute changes in risk were predicted from a Poisson model incorporating the strongest determinants of risk from the main analysis. Setting UK primary care practices contributing to the General Practice Research Database. Participants 377 649 new users of angiotensin receptor blockers or ACE inhibitors with at least one year of initial treatment. Main outcome measures Adjusted hazard ratios for all cancer and major site specific cancers (breast, lung, colon, prostate) by exposure to angiotensin receptor blockers and by cumulative duration of use. Results Follow-up ended a median of 4.6 years after the start of treatment; 20 203 cancers were observed. There was no evidence of any increase in overall risk of cancer among those ever exposed to angiotensin receptor blockers (adjusted hazard ratio 1.03, 95% confidence interval 0.99 to 1.06, P=0.10). For specific cancers, there was some evidence of an increased risk of breast and prostate cancer (1.11, 1.01 to 1.21, P=0.02; and 1.10, 1.00 to 1.20, P=0.04; respectively), which in absolute terms corresponded to an estimated 0.5 and 1.1 extra cases, respectively, per 1000 person years of follow-up among those with the highest baseline risk. Longer duration of treatment did not seem to be associated with higher risk (P> 0.15 in each case). There was a decreased risk of lung cancer (0.84, 0.75 to 0.94), but no effect on colon cancer (1.02, 0.91 to 1.16). Conclusions Use of angiotensin receptor blockers was not associated with an increased risk of cancer overall. Observed increased risks for breast and prostate cancer were small in absolute terms, and the lack of association with duration of treatment meant that non-causal explanations could not be excluded.	[Bhaskaran, Krishnan; Douglas, Ian; Smeeth, Liam] Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London WC1E 7HT, England; [Evans, Stephen] Univ London London Sch Hyg & Trop Med, Dept Med Stat, London WC1E 7HT, England; [van Staa, Tjeerd] Med & Healthcare Prod Regulatory Agcy, Gen Practice Res Database, London, England; [van Staa, Tjeerd] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; The Medicines & Healthcare Products Regulatory Agency; Utrecht University	Bhaskaran, K (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England.	krishnan.bhaskaran@lshtm.ac.uk	; Smeeth, Liam/X-5862-2018	Bhaskaran, Krishnan/0000-0001-5364-8757; Smeeth, Liam/0000-0002-9168-6022; Evans, Stephen/0000-0002-1474-2596; van Staa, Tjeerd/0000-0001-9363-742X	National Institute for Health Research; Wellcome Trust; MRC; Takeda; General Practice Research Database (GPRD); MHRA; Medical Research Council; NIHR; Innovative Medicine Initiative; UK Department of Health; Technology Strategy Board; EU; Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences; GlaxoSmithKline; Novo Nordisk; Dutch Medicines Evaluation Board; Dutch Ministry of Health; MRC [G0802403] Funding Source: UKRI; Medical Research Council [G0802403] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090, PDF-2011-04-007] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Takeda(Takeda Pharmaceutical Company Ltd); General Practice Research Database (GPRD); MHRA; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR(National Institute for Health Research (NIHR)); Innovative Medicine Initiative; UK Department of Health; Technology Strategy Board; EU(European Commission); Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences; GlaxoSmithKline(GlaxoSmithKline); Novo Nordisk(Novo Nordisk); Dutch Medicines Evaluation Board; Dutch Ministry of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This report is independent research arising from a postdoctoral fellowship (for KB) supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research, or the Department of Health. LS is supported by a Wellcome Trust senior research fellowship in clinical science. ID is supported by an MRC methodology research fellowship. General Practice Research Database (GPRD) is owned by the Secretary of State of the UK Department of Health and operates within the MHRA (Medicines and Healthcare products Regulatory Agency). The views expressed in this paper are those of the authors and do not reflect the official policy or position of the MHRA. The funding sources detailed above had no role in the design, conduct, analysis, or reporting of the study. All authors carried out this research independently of the funding bodies; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: ID has previously received consultancy fees from Takeda (unrelated to the submitted work); the General Practice Research Database (GPRD) has received funding from the MHRA, Wellcome Trust, Medical Research Council, NIHR Health Technology Assessment programme, Innovative Medicine Initiative, UK Department of Health, Technology Strategy Board, Seventh Framework Programme EU, various universities, contract research organisations and pharmaceutical companies; the Department of Pharmacoepidemiology and Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, has received unrestricted funding for pharmacoepidemiological research from GlaxoSmithKline, Novo Nordisk, Top Institute Pharma (www.tipharma.nl, includes co-funding from universities, government, and industry), the Dutch Medicines Evaluation Board, and the Dutch Ministry of Health.	[Anonymous], 2011, READ COD; Bangalore S, 2011, LANCET ONCOL, V12, P65, DOI 10.1016/S1470-2045(10)70260-6; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; [British Medical Association Royal Pharmaceutical Society of Great Britain], 2011, 61 BMA RPS BRIT NAT; Coleman CI, 2008, J HYPERTENS, V26, P622, DOI 10.1097/HJH.0b013e3282f3ef5e; Department for Communities and Local Government, 2011, IND MULT DEPR; Deshayes F, 2005, TRENDS ENDOCRIN MET, V16, P293, DOI 10.1016/j.tem.2005.07.009; Fryzek JP, 2006, BREAST CANCER RES TR, V97, P231, DOI 10.1007/s10549-005-9091-x; Fryzek JP, 2005, BRIT J CANCER, V92, P1302, DOI 10.1038/sj.bjc.6602490; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Gong QK, 2010, PANCREAS, V39, P581, DOI 10.1097/MPA.0b013e3181c314cd; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greene AS, 2002, CURR HYPERTENS REP, V4, P56, DOI 10.1007/s11906-002-0054-x; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Huang CC, 2011, AM J CARDIOL, V107, P1028, DOI 10.1016/j.amjcard.2010.11.026; Koomen ER, 2009, CANCER EPIDEMIOL, V33, P391, DOI 10.1016/j.canep.2009.10.005; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189; Munzenmaier DH, 1996, HYPERTENSION, V27, P760, DOI 10.1161/01.HYP.27.3.760; Parkinson J, 2007, PHARMACOVIGILANCE, P341, DOI DOI 10.1002/9780470059210.CH27; Pasternak B, 2011, CIRCULATION, V123, P1729, DOI 10.1161/CIRCULATIONAHA.110.007336; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; SADOSHIMA J, 1993, CIRC RES, V73, P424, DOI 10.1161/01.RES.73.3.424; Sipahi I, 2010, LANCET ONCOL, V11, P627, DOI 10.1016/S1470-2045(10)70106-6; Teo KK, 2011, J HYPERTENS, V29, P623, DOI 10.1097/HJH.0b013e328344a7de; Walther T, 2003, FASEB J, V17, P2061, DOI 10.1096/fj.03-0129com; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	28	75	77	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2012	344								e2697	10.1136/bmj.e2697	http://dx.doi.org/10.1136/bmj.e2697			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HB	22531797	Green Published, Green Accepted, hybrid			2022-12-24	WOS:000303433700004
J	So, AD; Ruiz-Esparza, Q; Gupta, N; Cars, O				So, Anthony D.; Ruiz-Esparza, Quentin; Gupta, Neha; Cars, Otto			3Rs for innovating novel antibiotics: sharing resources, risks, and rewards	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[So, Anthony D.; Ruiz-Esparza, Quentin; Gupta, Neha] Duke Univ, Program Global Hlth & Technol Access, Sanford Sch Publ Policy, Durham, NC 27708 USA; [Cars, Otto] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Duke University; Uppsala University	So, AD (corresponding author), Duke Univ, Program Global Hlth & Technol Access, Sanford Sch Publ Policy, Durham, NC 27708 USA.	anthony.so@duke.edu						Aronsson B., 2009, BACTERIAL CHALLENGE; Austin CP, 2004, SCIENCE, V306, P1138, DOI 10.1126/science.1105511; BCC Research, 2010, THER DRUGS CENTR NER; BCC Research, 2010, CARD THER DRUGS TECH; BCC Research, 2010, INF DIS TREATM GLOB; Bergstrom R, 2011, DRUG RESIST UPDATE, V14, P77, DOI 10.1016/j.drup.2011.01.005; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Collins FS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002747; DiMasi JA, 2004, DRUG INF J, V38, P211, DOI 10.1177/009286150403800301; Fikes B, 2010, N COUNTY TIMES  0920; Fischer A, 2005, PLOS MED, V2, P845, DOI 10.1371/journal.pmed.0020243; Ghosh S, 2010, HINDU; Goss CH, 2008, CHILD HEALTH CARE, V37, P5, DOI 10.1080/02739610701766859; Hamad B, 2006, NAT REV DRUG DISCOV, V9, P675; Hamad B, 2010, NAT REV DRUG DISCOV, V9, P675, DOI 10.1038/nrd3267; Innovative Medicines Initiative, NEWDRUGS4BADBUGS ND4; Kesselheim AS, 2010, HEALTH AFFAIR, V29, P1689, DOI 10.1377/hlthaff.2009.0439; Laxminarayan R, 2001, ANTIBIOTIC RESISTANC; Mossialos E, POLICIES INCENTIVES; Nwaka S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000293; Nwaka S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000440; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Rai A, 2008, YALE J HLTH POLICY L, V8, P53; ReAct, 2011, REACT POL SEM 23 MAY; Schmid M, 2004, NATURE, V2, P239; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; Wellcome Trust, 2010, THER	28	21	21	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e1782	10.1136/bmj.e1782	http://dx.doi.org/10.1136/bmj.e1782			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GM	22491076	Green Submitted			2022-12-24	WOS:000302607700011
J	Liu, FQ; Bakht, S; Dean, C				Liu, Fuquan; Bakht, Saleha; Dean, Caroline			Cotranscriptional Role for Arabidopsis DICER-LIKE 4 in Transcription Termination	SCIENCE			English	Article							RNA-POLYMERASE-II; SIRNA BIOGENESIS; FLC; DICER-LIKE-4; PHASE; DCL4; FCA	Transcription termination is emerging as an important component of gene regulation necessary to partition the genome and minimize transcriptional interference. We have discovered a role for the Arabidopsis RNA silencing enzyme DICER-LIKE 4 (DCL4) in transcription termination of an endogenous Arabidopsis gene, FCA. DCL4 directly associates with FCA chromatin in the 3' region and promotes cleavage of the nascent transcript in a domain downstream of the canonical polyA site. In a dcl4 mutant, the resulting transcriptional read-through triggers an RNA interference-mediated gene silencing of a transgene containing the same 3' region. We conclude that DCL4 promotes transcription termination of the Arabidopsis FCA gene, reducing the amount of aberrant RNA produced from the locus.	[Liu, Fuquan; Bakht, Saleha; Dean, Caroline] John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich NR4 7UH, Norfolk, England; [Liu, Fuquan] Queens Univ Belfast, Sch Biol Sci, Belfast, Antrim, North Ireland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Queens University Belfast	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Dept Cell & Dev Biol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	caroline.dean@jic.ac.uk	Liu, Fuquan/AGD-6751-2022	Dean, Caroline/0000-0002-6555-3525	UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/D010799/1]; EU [LSHG-CT-2006-037900]; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA447, BB/D010799/1, BB/G01406X/1] Funding Source: researchfish; BBSRC [BB/D010799/1, BB/G01406X/1, BBS/E/J/000CA447] Funding Source: UKRI	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a UK Biotechnology and Biological Sciences Research Council (BBSRC) Core Strategic grant to John Innes Centre, UK BBSRC grant BB/D010799/1 (C.D.), and EU Framework VI program Integrated Project LSHG-CT-2006-037900. We thank C. Melnyk and I. Searle in D. C. Baulcombe's group at Cambridge University for dcl3-7 seeds; O. Voinnet (ETH Zurich) for seeds of dcl4-3, dcl4-4, and dcl4-6; T. Fukuhara (Tokyo University of Agriculture and Technology) for the DCL4 antibody; and G. Szittya for excellent comments on the manuscript.	Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; Du QS, 2007, J VIROL, V81, P9142, DOI 10.1128/JVI.02885-06; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Ghazal G, 2009, MOL CELL, V36, P99, DOI 10.1016/j.molcel.2009.07.029; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Kuehner JN, 2011, NAT REV MOL CELL BIO, V12, P283, DOI 10.1038/nrm3098; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Macknight R, 2002, PLANT CELL, V14, P877, DOI 10.1105/tpc.010456; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Vazquez F, 2006, TRENDS PLANT SCI, V11, P460, DOI 10.1016/j.tplants.2006.07.006; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; West S, 2008, MOL CELL, V29, P600, DOI 10.1016/j.molcel.2007.12.019; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Zaratiegui M, 2011, NATURE, V479, P135, DOI 10.1038/nature10501	21	31	38	0	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1621	1623		10.1126/science.1214402	http://dx.doi.org/10.1126/science.1214402			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461611				2022-12-24	WOS:000302062600044
J	Khalil, AM; Cambier, JC; Shlomchik, MJ				Khalil, Ashraf M.; Cambier, John C.; Shlomchik, Mark J.			B Cell Receptor Signal Transduction in the GC Is Short-Circuited by High Phosphatase Activity	SCIENCE			English	Article							ANTIGEN-RECEPTOR; TYROSINE-PHOSPHATASE; GERMINAL-CENTER; SHP-1; SELECTION; SHIP; PROMOTES; MEMORY; CD22	Germinal centers (GCs) generate memory B and plasma cells, which are essential for long-lived humoral immunity. GC B cells with high-affinity B cell receptors (BCRs) are selectively expanded. To enable this selection, BCRs of such cells are thought to signal differently from those with lower affinity. We show that, surprisingly, most proliferating GC B cells did not demonstrate active BCR signaling. Rather, spontaneous and induced signaling was limited by increased phosphatase activity. Accordingly, both SH2 domain-containing phosphatase-1 (SHP-1) and SH2 domain-containing inositol 5 phosphatase were hyperphosphorylated in GC cells and remained colocalized with BCRs after ligation. Furthermore, SHP-1 was required for GC maintenance. Intriguingly, GC B cells in the cell-cycle G(2) period regained responsiveness to BCR stimulation. These data have implications for how higher-affinity B cells are selected in the GC.	[Khalil, Ashraf M.; Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Shlomchik, Mark J.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Cambier, John C.] Natl Jewish Hlth, Integrated Dept Immunol, Denver, CO 80206 USA; [Cambier, John C.] Univ Colorado, Hlth Sci Ctr, Denver, CO 80206 USA	Yale University; Yale University; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Shlomchik, MJ (corresponding author), Yale Univ, Sch Med, Dept Lab Med, 333 Cedar St, New Haven, CT 06520 USA.	mark.shlomchik@yale.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959; Cambier, John/0000-0002-7803-242X	NIH [AI43603, AR44077]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043603, R56AI043603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank A. Haberman for critical reading of the manuscript; J. Bezbradica for assistance and advice on Western blotting, immunoprecipitation, and LiCor imaging; and G. Nolan for advice and protocols for flow cytometric detection of intracellular phosphoproteins. The data are tabulated in the main paper and in the supplementary materials. This work was supported by NIH grants AI43603 and AR44077 (to M. J. S.). A. M. K. performed experiments; A. M. K., J. C. C., and M. J. S. designed experiments, interpreted data, and wrote the manuscript; and J. C. C. contributed key reagents.	Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Anderson SM, 2009, J IMMUNOL, V183, P7314, DOI 10.4049/jimmunol.0902452; Batista FD, 2000, EMBO J, V19, P513, DOI 10.1093/emboj/19.4.513; BERBERICH I, 1994, J IMMUNOL, V153, P4357; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Cornall RJ, 2000, P NATL ACAD SCI USA, V97, P1713, DOI 10.1073/pnas.97.4.1713; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; CYSTER JG, 1995, IMMUNITY, V2, P13, DOI 10.1016/1074-7613(95)90075-6; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Hou P, 2006, PLOS BIOL, V4, P1147, DOI 10.1371/journal.pbio.0040200; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Okada H, 1998, J IMMUNOL, V161, P5129; PANI G, 1995, J EXP MED, V181, P2077, DOI 10.1084/jem.181.6.2077; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Phee H, 2001, MOL CELL BIOL, V21, P8615, DOI 10.1128/MCB.21.24.8615-8625.2001; Rickert RC, 2011, IMMUNOL REV, V244, P115, DOI 10.1111/j.1600-065X.2011.01067.x; Shlomchik MJ, 1998, CURR TOP MICROBIOL, V229, P173; Tamir I, 2000, CURR OPIN IMMUNOL, V12, P307, DOI 10.1016/S0952-7915(00)00092-3; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Waisman A, 2007, J EXP MED, V204, P747, DOI 10.1084/jem.20062024; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; Wienands J, 1996, P NATL ACAD SCI USA, V93, P7865, DOI 10.1073/pnas.93.15.7865; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang ZS, 2003, J BIOL CHEM, V278, P4668, DOI 10.1074/jbc.M210028200	27	172	173	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1178	1181		10.1126/science.1213368	http://dx.doi.org/10.1126/science.1213368			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22555432	Green Accepted			2022-12-24	WOS:000304647900055
J	Black, DM; Bauer, DC; Schwartz, AV; Cummings, SR; Rosen, CJ				Black, Dennis M.; Bauer, Douglas C.; Schwartz, Ann V.; Cummings, Steven R.; Rosen, Clifford J.			Continuing Bisphosphonate Treatment for Osteoporosis - For Whom and for How Long?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FRACTURE; TRIAL; ALENDRONATE; EXTENSION; FLEX		[Black, Dennis M.; Bauer, Douglas C.; Schwartz, Ann V.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bauer, Douglas C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cummings, Steven R.] Calif Pacific Med Ctr, Res Inst, San Francisco, CA USA; [Rosen, Clifford J.] Maine Med Ctr, Res Inst, Ctr Clin & Translat Res, Scarborough, ME 04074 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; California Pacific Medical Center; California Pacific Medical Center Research Institute; Maine Medical Center	Black, DM (corresponding author), Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA.				NIAMS NIH HHS [K24 AR051895] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR051895] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Black DM, 2012, J BONE MINER RES, V27, P243, DOI 10.1002/jbmr.1494; Black DM, 2006, JAMA-J AM MED ASSOC, V296, P2927, DOI 10.1001/jama.296.24.2927; *FOOD DRUG ADM, 2009, BACKGR DOC M ADV COM; Schwartz AV, 2010, J BONE MINER RES, V25, P976, DOI 10.1002/jbmr.11	4	199	213	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2051	2053		10.1056/NEJMp1202623	http://dx.doi.org/10.1056/NEJMp1202623			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22571169	Green Accepted			2022-12-24	WOS:000304613400004
J	Toledano, H; D'Alterio, C; Czech, B; Levine, E; Jones, DL				Toledano, Hila; D'Alterio, Cecilia; Czech, Benjamin; Levine, Erel; Jones, D. Leanne			The let-7-Imp axis regulates ageing of the Drosophila testis stem-cell niche	NATURE			English	Article							RNA-BINDING PROTEIN; MESSENGER-RNA; SELF-RENEWAL; MICRORNA; DIFFERENTIATION; EXPRESSION; IDENTIFICATION; CONTRIBUTES; LIBRARY; REGION	Adult stem cells support tissue homeostasis and repair throughout the life of an individual. During ageing, numerous intrinsic and extrinsic changes occur that result in altered stem-cell behaviour and reduced tissue maintenance and regeneration. In the Drosophila testis, ageing results in a marked decrease in the self-renewal factor Unpaired (Upd), leading to a concomitant loss of germline stem cells. Here we demonstrate that IGF-II messenger RNA binding protein (Imp) counteracts endogenous small interfering RNAs to stabilize upd (also known as os) RNA. However, similar to upd, Imp expression decreases in the hub cells of older males, which is due to the targeting of Imp by the heterochronic microRNA let-7. In the absence of Imp, upd mRNA therefore becomes unprotected and susceptible to degradation. Understanding the mechanistic basis for ageing-related changes in stem-cell behaviour will lead to the development of strategies to treat age-onset diseases and facilitate stem-cell-based therapies in older individuals.	[Toledano, Hila; D'Alterio, Cecilia; Jones, D. Leanne] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Czech, Benjamin] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Levine, Erel] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Levine, Erel] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA	Salk Institute; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Harvard University; Harvard University	Jones, DL (corresponding author), Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA.	ljones@salk.edu	Toledano, Hila/AGY-6574-2022; Czech, Benjamin/AAJ-8592-2020	Czech, Benjamin/0000-0001-8471-0007; Toledano, Hila/0000-0001-9409-7728	G. Harold and Leila Y. Mathers Charitable Foundation; Ellison Medical Foundation; Emerald Foundation; American Federation for Aging Research; National Institutes of Health; Boehringer Ingelheim Fonds; National Science Foundation; NATIONAL INSTITUTE ON AGING [R01AG040288, R01AG028092] Funding Source: NIH RePORTER	G. Harold and Leila Y. Mathers Charitable Foundation; Ellison Medical Foundation(Lawrence Ellison Foundation); Emerald Foundation; American Federation for Aging Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim Fonds(Boehringer Ingelheim); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to D. St Johnston, W. Chia, P. Macdonald, R. Carthew, E. Bach, D. Harrison, T. Volk, U. Heberlein, A. Spradling, J. Kadonaga, G. Hannon, T. Hays, N. Sokol, H. Siomi and P. Lasko for reagents and fly stocks, to C. Doe, R. Hans, G. Volohonsky, T. Juven-Gershon, A. Pasquinelli, R. Zhou and S. Aigner for guidance on methods used in this manuscript, to O. Tam for computational support, and to C. Koehler for technical assistance. This work was supported by the G. Harold and Leila Y. Mathers Charitable Foundation, the Ellison Medical Foundation, the Emerald Foundation, the American Federation for Aging Research, and the National Institutes of Health (to D. L. J.). B. C. is supported by a PhD fellowship from the Boehringer Ingelheim Fonds. E. L. is supported by the National Science Foundation.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Boylan KLM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040036; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Caldwell JC, 2007, FLY, V1, P146, DOI 10.4161/fly.4562; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Czech B, 2009, MOL CELL, V36, P445, DOI 10.1016/j.molcel.2009.09.028; Elcheva I, 2009, MOL CELL, V35, P240, DOI 10.1016/j.molcel.2009.06.007; Fabrizio JJ, 2008, FLY, V2, P47, DOI 10.4161/fly.5659; Fuller Margaret T., 1993, P71; Geng CY, 2006, MOL CELL BIOL, V26, P9508, DOI 10.1128/MCB.01136-06; Golden DE, 2008, MOL CELL, V31, P309, DOI 10.1016/j.molcel.2008.07.008; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Haley B, 2010, P NATL ACAD SCI USA, V107, P11435, DOI 10.1073/pnas.1006689107; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; Hime GR, 1996, J CELL SCI, V109, P2779; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jones DL, 2011, NAT CELL BIOL, V13, P506, DOI 10.1038/ncb0511-506; Kitadate Y, 2007, DEV CELL, V13, P151, DOI 10.1016/j.devcel.2007.05.001; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li X, 2009, CELL, V137, P273, DOI 10.1016/j.cell.2009.01.058; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; Nabel-Rosen H, 1999, MOL CELL, V4, P573, DOI 10.1016/S1097-2765(00)80208-7; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Sokol NS, 2008, GENE DEV, V22, P1591, DOI 10.1101/gad.1671708; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wang L, 2011, EXP GERONTOL, V46, P340, DOI 10.1016/j.exger.2010.10.005; Yisraeli JK, 2005, BIOL CELL, V97, P87; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhao C, 2010, P NATL ACAD SCI USA, V107, P1876, DOI 10.1073/pnas.0908750107; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	45	121	130	2	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					605	+		10.1038/nature11061	http://dx.doi.org/10.1038/nature11061			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660319	Green Accepted			2022-12-24	WOS:000304608000040
J	Hippisley-Cox, J; Coupland, C				Hippisley-Cox, Julia; Coupland, Carol			Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WALES PROSPECTIVE DERIVATION; HIP FRACTURE; EXTERNAL VALIDATION; CARDIOVASCULAR RISK; OLDER-PEOPLE; MISSING DATA; WOMEN; MEN; IMPUTATION; SMOKING	Objective To develop and validate an updated version of the QFracture algorithm for estimating the risk of a patient sustaining an osteoporotic fracture or hip fracture in a primary care population. Design Prospective open cohort study using routinely collected data from 420 general practices in the United Kingdom to develop updated QFracture scores and 207 practices to validate scores. Cox's proportional hazards model was used in the derivation cohort to derive risk equations using several explanatory variables. We calculated measures of calibration and discrimination using the validation cohort. Participants 3 142 673 patients in derivation cohort and 1 583 373 in validation cohort, aged 30-100 years, who contributed 23 608 337 and 11 732 106 person years of observation, respectively. We identified 59 772 incident diagnoses of osteoporotic fracture in the derivation cohort and 28 685 in the validation cohort. Outcomes Incident diagnosis of osteoporotic fracture (vertebral, distal radius, proximal humerus, or hip) and incident hip fracture recorded in general practice records or linked cause of death records. Results We found significant independent associations with overall fracture risk in women for age, body mass index, ethnic origin, alcohol intake, smoking status, chronic obstructive pulmonary disease or asthma, any cancer, cardiovascular disease, dementia, diagnosis or treatment for epilepsy, history of falls, chronic liver disease, Parkinson's disease, rheumatoid arthritis or systemic lupus erythematosus, chronic renal disease, type 1 diabetes, type 2 diabetes, previous fracture, endocrine disorders, gastrointestinal malabsorption, any antidepressants, corticosteroids, unopposed hormone replacement therapy, and parental history of osteoporosis. Risk factors for hip fracture in women were similar except for gastrointestinal malabsorption and parental history of hip fracture. Risk factors for men were largely the same as those for women but also included care home residence. The updated hip fracture algorithm explained 71.7% (95% confidence interval 71.1% to 72.3%) of the variation in women and 70.4% (69.3% to 71.5%) in men. D statistic values for hip fracture were high for women (3.26, 3.21 to 3.31) and men 3.15, 3.06 to 3.24), and higher than for osteoporotic fracture. Values for the area under the receiver operating characteristics curves for hip fracture were 0.89 for women and 0.88 for men, compared with 0.79 and 0.71 for osteoporotic fracture, respectively. The updated algorithms performed better than the 2009 algorithms. Conclusions Two QFracture algorithms were updated to predict risk of osteoporotic and hip fracture in primary care populations to include ethnic origin, all classes of antidepressants, chronic obstructive pulmonary disease, epilepsy, dementia, Parkinson's disease, cancer, systemic lupus erythematosus, chronic renal disease, type 1 diabetes, previous fragility fracture, and care home residence. These updated algorithms showed improved performance compared with previous QFracture algorithms reported in 2009.	[Hippisley-Cox, Julia; Coupland, Carol] Div Primary Care, Nottingham NG2 7RD, England		Hippisley-Cox, J (corresponding author), Div Primary Care, Univ Pk, Nottingham NG2 7RD, England.	julia.hippisley-cox@nottingham.ac.uk	Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Coupland, Carol/0000-0002-2327-3306				Brennan J, 2003, OSTEOPOROSIS INT, V14, P515, DOI 10.1007/s00198-003-1404-5; Cauley JA, 2011, CLIN ORTHOP RELAT R, V469, P1891, DOI 10.1007/s11999-011-1863-5; Chen YY, 2012, PARKINSONISM RELAT D, V18, P506, DOI 10.1016/j.parkreldis.2012.01.014; Collins GS, 2011, DIABETIC MED, V28, P599, DOI 10.1111/j.1464-5491.2011.03237.x; Collins GS, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3651; Cornuz J, 1999, AM J MED, V106, P311, DOI 10.1016/S0002-9343(99)00022-4; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Dawson-Hughes B, 2008, OSTEOPOROSIS INT, V19, P449, DOI 10.1007/s00198-008-0559-5; De Laet C, 2005, OSTEOPOROSIS INT, V16, P1330, DOI 10.1007/s00198-005-1863-y; Diaz MN, 1997, BONE, V20, P145, DOI 10.1016/S8756-3282(96)00331-6; Godden S, 2001, HEALTH SOC CARE COMM, V9, P367, DOI 10.1046/j.1365-2524.2001.00314.x; Hippisley-Cox J, 2008, HEART, V94, P34, DOI 10.1136/hrt.2007.134890; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Hippisley-Cox J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4656; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b880; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; HOLLENBACH KA, 1993, AM J PUBLIC HEALTH, V83, P1265, DOI 10.2105/AJPH.83.9.1265; Hubbard R, 2003, AM J EPIDEMIOL, V158, P77, DOI 10.1093/aje/kwg114; Janghorbani M, 2007, AM J EPIDEMIOL, V166, P495, DOI 10.1093/aje/kwm106; Jette N, 2011, ARCH NEUROL-CHICAGO, V68, P107, DOI 10.1001/archneurol.2010.341; Kanis J, 2001, STROKE, V32, P702, DOI 10.1161/01.STR.32.3.702; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI [10.1007/s00198-004-1734-y, 10.1007/s00198-004-1640-3]; Kush RD, 2008, NEW ENGL J MED, V358, P1738, DOI 10.1056/NEJMsb0800209; McCann M, 2009, AGE AGEING, V38, P711, DOI 10.1093/ageing/afp173; Miao JM, 2005, DIABETES CARE, V28, P2850, DOI 10.2337/diacare.28.12.2850; Michaelsson K, 1998, BMJ-BRIT MED J, V316, P1858; Moons KGM, 2006, J CLIN EPIDEMIOL, V59, P1092, DOI 10.1016/j.jclinepi.2006.01.009; National Institute for Health and Clinical Excellence, 2008, SYST REV CLIN EFF PR, P205; National Institute for Health and Clinical Excellence, 2012, OST FRAG FRACT RISK, P90; National Osteoporosis Guideline Group, 2008, GUID DIAGN MAN OST P, P12; Nitsch D, 2009, NEPHROL DIAL TRANSPL, V24, P1539, DOI 10.1093/ndt/gfn678; Robbins J, 2007, JAMA-J AM MED ASSOC, V298, P2389, DOI 10.1001/jama.298.20.2389; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 1999, INT J EPIDEMIOL, V28, P964, DOI 10.1093/ije/28.5.964; Royston P, 2005, STATA J, V5, P527, DOI 10.1177/1536867X0500500404; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; SPECTOR TD, 1993, BRIT MED J, V306, P558, DOI 10.1136/bmj.306.6877.558; Steyerberg E., 2009, CLIN PREDICTION MODE; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Van Staa TP, 2000, J BONE MINER RES, V15, P993, DOI 10.1359/jbmr.2000.15.6.993; Vestergaard P, 2003, J INTERN MED, V254, P572, DOI 10.1111/j.1365-2796.2003.01232.x	45	200	205	1	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 22	2012	344								e3427	10.1136/bmj.e3427	http://dx.doi.org/10.1136/bmj.e3427			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949QS	22619194	hybrid			2022-12-24	WOS:000304591400007
J	Neupert, W				Neupert, Walter			SnapShot: Mitochondrial Architecture	CELL			English	Editorial Material							MEMBRANE ORGANIZATION; COMPLEX; MITOFILIN; CRISTAE; FUSION		Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Neupert, W (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.							Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; Fawcett D.W., 1981, CELL; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Harner M, 2011, EMBO J, V30, P4356, DOI 10.1038/emboj.2011.379; Head BP, 2011, MOL BIOL CELL, V22, P831, DOI 10.1091/mbc.E10-07-0600; Hoppins S, 2011, J CELL BIOL, V195, P323, DOI 10.1083/jcb.201107053; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Rabl R, 2009, J CELL BIOL, V185, P1047, DOI 10.1083/jcb.200811099; Sesaki H, 2001, J CELL BIOL, V152, P1123, DOI 10.1083/jcb.152.6.1123; von der Malsburg K, 2011, DEV CELL, V21, P694, DOI 10.1016/j.devcel.2011.08.026; Wong ED, 2003, J CELL BIOL, V160, P303, DOI 10.1083/jcb.200209015; Xie J, 2007, FEBS LETT, V581, P3545, DOI 10.1016/j.febslet.2007.06.052	12	15	15	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					722	+		10.1016/j.cell.2012.04.010	http://dx.doi.org/10.1016/j.cell.2012.04.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541440	Bronze			2022-12-24	WOS:000303443100021
J	Crabb, BS; Beeson, JG; Amino, R; Menard, R; Waters, A; Winzeler, EA; Wahlgren, M; Fidock, DA; Nwaka, S				Crabb, Brendan S.; Beeson, James G.; Amino, Rogerio; Menard, Robert; Waters, Andy; Winzeler, Elizabeth A.; Wahlgren, Mats; Fidock, David A.; Nwaka, Solomon			PERSPECTIVES The missing pieces	NATURE			English	Editorial Material									[Crabb, Brendan S.; Beeson, James G.] Burnet Inst, Melbourne, Vic, Australia; [Amino, Rogerio; Menard, Robert] Inst Pasteur, Unite Biol & Genet Paludisme, Paris, France; [Waters, Andy] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8QQ, Lanark, Scotland; [Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumour & Cell Biol, Stockholm, Sweden; [Fidock, David A.] Columbia Univ, Dept Microbiol & Immunol, Med Ctr, New York, NY USA; [Fidock, David A.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Nwaka, Solomon] WHO, African Network Drugs & Diagnost Innovat ANDI, Geneva, Switzerland; [Nwaka, Solomon] WHO, Special Programme Res & Training Trop Dis, Geneva, Switzerland	Burnet Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Glasgow; University of California System; University of California San Diego; Karolinska Institutet; Columbia University; Columbia University; World Health Organization; World Health Organization	Crabb, BS (corresponding author), Burnet Inst, Melbourne, Vic, Australia.		Winzeler, Elizabeth/AAP-6752-2020; Crabb, Brendan/F-5287-2013	Winzeler, Elizabeth/0000-0002-4049-2113; Fidock, David/0000-0001-6753-8938	Wellcome Trust [085349, 083811] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)			0	10	10	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					S22	S23		10.1038/484S22a	http://dx.doi.org/10.1038/484S22a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22534528	Bronze			2022-12-24	WOS:000303200400003
J	Arie, S				Arie, Sophie			What can we learn from asthma in elite athletes?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFORMANCE					mail@sophiearie.com						Asthma UK, KEY FACTS STAT; BBC Sport Academy, PAUL OV ASTHM; Dickinson JW, 2005, THORAX, V60, P629, DOI 10.1136/thx.2004.037499; McKenzie DC, 2011, CLIN J SPORT MED, V21, P46, DOI 10.1097/IAE.0b013e318203c0ef; NHS Choices, PAUL RADCL ASTHM; Pluim BM, 2011, SPORTS MED, V41, P39, DOI 10.2165/11537540-000000000-00000; Weiler JM, 2000, J ALLERGY CLIN IMMUN, V106, P267, DOI 10.1067/mai.2000.108605	7	7	7	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 24	2012	344								e2556	10.1136/bmj.e2556	http://dx.doi.org/10.1136/bmj.e2556			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	934HB	22531868				2022-12-24	WOS:000303433700002
J	Henry, M; Beguin, M; Requier, F; Rollin, O; Odoux, JF; Aupinel, P; Aptel, J; Tchamitchian, S; Decourtye, A				Henry, Mickael; Beguin, Maxime; Requier, Fabrice; Rollin, Orianne; Odoux, Jean-Francois; Aupinel, Pierrick; Aptel, Jean; Tchamitchian, Sylvie; Decourtye, Axel			A Common Pesticide Decreases Foraging Success and Survival in Honey Bees	SCIENCE			English	Article							APIS-MELLIFERA; SYSTEMIC INSECTICIDES; RECEPTORS; BEHAVIOR; MEMORY; DANCE	Nonlethal exposure of honey bees to thiamethoxam (neonicotinoid systemic pesticide) causes high mortality due to homing failure at levels that could put a colony at risk of collapse. Simulated exposure events on free-ranging foragers labeled with a radio-frequency identification tag suggest that homing is impaired by thiamethoxam intoxication. These experiments offer new insights into the consequences of common neonicotinoid pesticides used worldwide.	[Henry, Mickael; Aptel, Jean; Tchamitchian, Sylvie] INRA, Abeilles & Environm UR406, F-84914 Avignon, France; [Henry, Mickael; Beguin, Maxime; Rollin, Orianne; Aptel, Jean; Tchamitchian, Sylvie; Decourtye, Axel] UMT Protect Abeilles Environm, F-84914 Avignon, France; [Beguin, Maxime] Assoc Dev Apiculture Provencale, F-13626 Aix En Provence, France; [Requier, Fabrice] CNRS, Ctr Etud Biol Chize, USC INRA 1339, UPR1934, F-79360 Beauvoir Sur Niort, France; [Requier, Fabrice; Odoux, Jean-Francois; Aupinel, Pierrick] INRA, UE Entomol, UE1255, F-17700 Surgeres, France; [Rollin, Orianne; Decourtye, Axel] Assoc Coordinat Tech Agr, F-84914 Avignon, France	INRAE; Centre National de la Recherche Scientifique (CNRS); INRAE; INRAE	Henry, M (corresponding author), INRA, Abeilles & Environm UR406, F-84914 Avignon, France.	mickael.henry@avignon.inra.fr	Aupinel, Pierrick/Y-5436-2019; Rollin, Orianne/R-9705-2019; ODOUX, Jean-François/AAB-3596-2019	Rollin, Orianne/0000-0002-1455-9302; ODOUX, Jean-François/0000-0002-6264-4376; Tchamitchian, Marc/0000-0002-9251-2403; Requier, Fabrice/0000-0003-1638-3141	European Community [797/2004]; French Ministry of Agriculture [11-45R]	European Community(European Commission); French Ministry of Agriculture	This study was funded by the European Community program (797/2004) for French beekeeping coordinated by the French Ministry of Agriculture (convention FranceAgriMer 11-45R). Special thanks go to L. Belzunces, J. L. Brunet, B. Vaissie re, A. Maisonnasse, D. Fortini, Y. Le Conte, C. McDonnell, P. Jourdan, J. P. Vermandere, and V. Bretagnolle for valuable help and corrections, as well as three anonymous reviewers for useful comments on the manuscript. We are grateful to M. Grijolot for allowing experiments to take place in his fields. RFID devices were designed by Tag Tracing Solutions, Valence, France, and adapted to honey bees with the help of J. Fourrier, F. Brun, J. Devillers, M. Gauthier, and the ECOBEE monitoring facility. Data are in the supporting online material.	Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2011, ECOTOXICOLOGY, V20, P429, DOI 10.1007/s10646-011-0594-4; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dukas R, 2008, INSECT SOC, V55, P252, DOI 10.1007/s00040-008-0995-4; Henry M, 2012, ECOL MODEL, V225, P103, DOI 10.1016/j.ecolmodel.2011.11.015; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Maienfisch P, 2001, PEST MANAG SCI, V57, P165, DOI 10.1002/1526-4998(200102)57:2<165::AID-PS289>3.0.CO;2-G; Menzel R, 2006, J COMP PHYSIOL A, V192, P889, DOI 10.1007/s00359-006-0136-3; Millar Neil S., 2007, Invertebrate Neuroscience, V7, P53, DOI 10.1007/s10158-006-0040-0; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Riley JR, 2005, NATURE, V435, P205, DOI 10.1038/nature03526; Rortais A, 2005, APIDOLOGIE, V36, P71, DOI 10.1051/apido:2004071; Schmickl T, 2007, ECOL MODEL, V204, P219, DOI 10.1016/j.ecolmodel.2007.01.001; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Vidau C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021550; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	27	892	954	38	1306	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					348	350		10.1126/science.1215039	http://dx.doi.org/10.1126/science.1215039			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22461498	Green Submitted			2022-12-24	WOS:000302995400046
J	Zhu, JY; Sharma, DB; Gray, SW; Chen, AB; Weeks, JC; Schrag, D				Zhu, Junya; Sharma, Dhruv B.; Gray, Stacy W.; Chen, Aileen B.; Weeks, Jane C.; Schrag, Deborah			Carboplatin and Paclitaxel With vs Without Bevacizumab in Older Patients With Advanced Non-Small Cell Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEER-MEDICARE DATA; PROPENSITY SCORE; TARGETED THERAPIES; COMORBIDITY INDEX; SUPPORTIVE CARE; CHEMOTHERAPY; CLAIMS; BIAS; EPIDEMIOLOGY; METAANALYSIS	Context A previous randomized trial demonstrated that adding bevacizumab to carboplatin and paclitaxel improved survival in advanced non-small cell lung cancer (NSCLC). However, longer survival was not observed in the subgroup of patients aged 65 years or older. Objective To examine whether adding bevacizumab to carboplatin and paclitaxel chemotherapy is associated with improved survival in older patients with NSCLC. Design, Setting, and Participants Retrospective cohort study of 4168 Medicare beneficiaries aged 65 years or older with stage IIIB or stage IV non-squamous cell NSCLC diagnosed in 2002-2007 in a Surveillance, Epidemiology, and End Results (SEER) region. Patients were categorized into 3 cohorts based on diagnosis year and type of initial chemotherapy administered within 4 months of diagnosis: (1) diagnosis in 2006-2007 and bevacizumab-carboplatin-paclitaxel therapy; (2) diagnosis in 2006-2007 and carboplatin-paclitaxel therapy; or (3) diagnosis in 2002-2005 and carboplatin-paclitaxel therapy. The associations between carboplatin-paclitaxel with vs without bevacizumab and overall survival were compared using Cox proportional hazards models and propensity score analyses including information about patient characteristics recorded in SEER-Medicare. Main Outcome Measure Overall survival measured from the first date of chemotherapy treatment until death or the censoring date of December 31, 2009. Results The median survival estimates were 9.7 (interquartile range [IQR], 4.4-18.6) months for bevacizumab-carboplatin-paclitaxel, 8.9 (IQR, 3.5-19.3) months for carboplatin-paclitaxel in 2006-2007, and 8.0 (IQR, 3.7-17.2) months for carboplatin-paclitaxel in 2002-2005. One-year survival probabilities were 39.6% (95% CI, 34.6%-45.4%) for bevacizumab-carboplatin-paclitaxel vs 40.1% (95% CI, 37.4%-43.0%) for carboplatin-paclitaxel in 2006-2007 and 35.6% (95% CI, 33.8%-37.5%) for carboplatin-paclitaxel in 2002-2005. Neither multivariable nor propensity score-adjusted Cox models demonstrated a survival advantage for bevacizumab-carboplatin-paclitaxel compared with carboplatin-paclitaxel cohorts. In propensity score-stratified models, the hazard ratio for overall survival for bevacizumab-carboplatin-paclitaxel compared with carboplatin-paclitaxel in 2006-2007 was 1.01 (95% CI, 0.89-1.16; P=.85) and compared with carboplatin-paclitaxel in 2002-2005 was 0.93 (95% CI, 0.83-1.06; P=.28). The propensity score-weighted model and propensity score-matching model similarly failed to demonstrate a statistically significant superiority for bevacizumab-carboplatin-paclitaxel. Subgroup and sensitivity analyses for key variables did not change these findings. Conclusion Adding bevacizumab to carboplatin and paclitaxel chemotherapy was not associated with better survival among Medicare patients with advanced NSCLC. JAMA. 2012; 307(15):1593-1601	[Chen, Aileen B.; Weeks, Jane C.; Schrag, Deborah] Dana Farber Canc Inst, Ctr Outcomes & Policy Res, Boston, MA 02215 USA; [Zhu, Junya] Dana Farber Canc Inst, Ctr Patient Safety, Boston, MA 02215 USA; [Sharma, Dhruv B.] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02215 USA; [Gray, Stacy W.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Chen, Aileen B.] Dana Farber Canc Inst, Dept Radiat Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute	Schrag, D (corresponding author), Dana Farber Canc Inst, Ctr Outcomes & Policy Res, 450 Brookline Ave, Boston, MA 02215 USA.	deb_schrag@dfci.harvard.edu	Gray, Stacy/AAJ-2956-2020; Gray, Stacy/GRF-6833-2022	Gray, Stacy/0000-0001-6948-0143; Chen, Aileen/0000-0002-5385-3360	National Cancer Institute (NCI) [RC2CA148185-01, PO1-CA134294]; Agency for Healthcare Research and Quality (AHRQ) [HHSA290201000006I]; NCI's SEER [N01-PC-35136, N01-PC-35139, N02-PC-15105]; Centers for Disease Control and Prevention [U55/CCR921930-02]; Center for Patient Safety, Dana-Farber Cancer Institute; Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Center for Outcomes and Evidence, AHRQ; NATIONAL CANCER INSTITUTE [K05CA166208, P01CA134294, RC2CA148185] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCI's SEER; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Center for Patient Safety, Dana-Farber Cancer Institute; Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; Center for Outcomes and Evidence, AHRQ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Project support was obtained from the National Cancer Institute (NCI) RC2CA148185-01 (to Dr Weeks). This project was also funded under contract HHSA290201000006I (to Dr Schrag) from the Agency for Healthcare Research and Quality (AHRQ) as part of the Developing Evidence to Inform Decisions about Effectiveness (DEcIDE) program. Dr Sharma was supported by NCI grant PO1-CA134294. The collection of the California cancer incidence data used in this study was supported by the California Department of Public Health as part of the statewide cancer reporting program mandated by California Health and Safety Code Section 103885; the NCI's SEER program under contract N01-PC-35136 awarded to the Northern California Cancer Center, contract N01-PC-35139 awarded to the University of Southern California, and contract N02-PC-15105 awarded to the Public Health Institute; and the Centers for Disease Control and Prevention's National Program of Cancer Registries under agreement U55/CCR921930-02 awarded to the Public Health Institute.; We acknowledge support from Saul Weingart, MD, PhD, Center for Patient Safety, Dana-Farber Cancer Institute; Sebastian Schneeweiss, MD, ScD, Division of Pharmacoepidemiology, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School; and William Lawrence, MD, MS, Center for Outcomes and Evidence, AHRQ. No financial compensation was received. This study used the linked SEER-Medicare database. This resource has been made available to the research community through collaborative efforts of the NCI and CMS. We acknowledge the efforts of the Applied Research Program, NCI; the Office of Research, Development and Information, CMS; Information Management Services (IMS) Inc; and the SEER program tumor registries in the creation and ongoing maintenance of the SEER-Medicare database.	Altekruse S. F., 1975, SEER CANC STAT REV 1; Bach PB, 2002, MED CARE, V40, P19; Burdett S, 2008, J CLIN ONCOL, V26, P4617, DOI 10.1200/JCO.2008.17.7162; Centers for Medicaid and Medicare Services, MED NAT COV DET MA 2; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen MH, 2007, ONCOLOGIST, V12, P713, DOI 10.1634/theoncologist.12-6-713; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Davidoff AJ, 2010, J CLIN ONCOL, V28, P2191, DOI 10.1200/JCO.2009.25.4052; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Engels EA, 2011, AM J EPIDEMIOL, V174, P860, DOI 10.1093/aje/kwr146; Goulart B, 2011, VALUE HEALTH, V14, P836, DOI 10.1016/j.jval.2011.04.004; Greene FL, 2002, AJCC CANC STAGING HD; Gridelli C, 2008, J CLIN ONCOL, V26, P13, DOI 10.1200/JCO.2007.14.1820; Gridelli C, 2007, ONCOLOGIST, V12, P1183, DOI 10.1634/theoncologist.12-10-1183; Gridelli C, 2009, LUNG CANCER, V66, P282, DOI 10.1016/j.lungcan.2009.08.006; Grusenmeyer PA, 2006, J CLIN ONCOL S, V24, p18S; Iannettoni MD, 2010, JAMA-J AM MED ASSOC, V304, P2296, DOI 10.1001/jama.2010.1723; Jacobson M, 2006, HEALTH AFFAIR, V25, P437, DOI 10.1377/hlthaff.25.2.437; Jatoi A, 2005, J CLIN ONCOL, V23, P9113, DOI 10.1200/JCO.2005.03.7465; Klabunde CN, 2007, ANN EPIDEMIOL, V17, P584, DOI 10.1016/j.annepidem.2007.03.011; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lamont EB, 2005, J NATL CANCER I, V97, P1080, DOI 10.1093/jnci/dji189; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; MERZA T, 2007, J CLIN ONCOL S, V25, pS687; Mitka M, 2010, JAMA-J AM MED ASSOC, V304, P624, DOI 10.1001/jama.2010.1055; National Cancer Institute, SURV EP END RES; Ramalingam SS, 2008, J CLIN ONCOL, V26, P60, DOI 10.1200/JCO.2007.13.1144; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Warren JL, 2002, MED CARE, V40, P3; Warren JL, 2002, MED CARE, V40, P55; Yang K, 2010, CLIN DRUG INVEST, V30, P229, DOI 10.2165/11532260-000000000-00000	37	95	97	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	2012	307	15					1593	1601		10.1001/jama.2012.454	http://dx.doi.org/10.1001/jama.2012.454			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	927GU	22511687	Green Accepted, Bronze			2022-12-24	WOS:000302896100021
J	Hollenberg, AN				Hollenberg, Anthony N.			Metabolic Health and Nuclear-Receptor Sensitivity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INSULIN SENSITIVITY; IN-VIVO; NCOR		[Hollenberg, Anthony N.] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Hollenberg, Anthony N.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hollenberg, AN (corresponding author), Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA.							Astapovaa I, 2008, P NATL ACAD SCI USA, V105, P19544, DOI 10.1073/pnas.0804604105; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Nofsinger RR, 2008, P NATL ACAD SCI USA, V105, P20021, DOI 10.1073/pnas.0811012105; Sutanto MM, 2010, J BIOL CHEM, V285, P18485, DOI 10.1074/jbc.M110.107680; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017	5	9	9	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1345	1347		10.1056/NEJMcibr1114529	http://dx.doi.org/10.1056/NEJMcibr1114529			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475600				2022-12-24	WOS:000302343000015
J	Smith, AJ; Dieppe, P; Porter, M; Blom, AW				Smith, Alison J.; Dieppe, Paul; Porter, Martyn; Blom, Ashley W.		Natl Joint Registry England & Wale	Risk of cancer in first seven years after metal-on-metal hip replacement compared with other bearings and general population: linkage study between the National Joint Registry of England and Wales and hospital episode statistics	BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; ARTHROPLASTY; METAANALYSIS; MORTALITY; IMPLANTS; COBALT; KNEE	Objective To determine whether use of metal-on-metal bearing surfaces is associated with an increased risk of a diagnosis of cancer in the early years after total hip replacement and specifically with an increase in malignant melanoma and haematological, prostate, and renal tract cancers. Design Linkage study with multivariable competing risks flexible parametric survival model to examine the incidence of new diagnoses of cancer in patients with metal-on-metal hip replacement compared with those with alternative bearings and to compare the observed incidence of diagnoses in patients undergoing hip replacement with that predicted by national incidence rates in the general population. Setting National Joint Registry of England and Wales (NJR) linked to NHS hospital episode statistics data. Participants 40 576 patients with hip replacement with metal-on-metal bearing surfaces and 248 995 with alternative bearings. Main outcome measures Incidence of all cancers and incidence of malignant melanoma and prostate, renal tract, and haematological cancers. Results The incidence of new diagnoses of cancer was low after hip replacement (1.25% at one year, 95% confidence interval 1.21% to 1.30%) and lower than that predicted from the age and sex matched normal population (1.65%, 1.60% to 1.70%). Compared with alternative bearings, there was no evidence that metal-on-metal bearing surfaces were associated with an increased risk of any cancer diagnosis in the seven years after surgery (mean follow-up of three years, 23% (n = 67 361) of patients observed for five years or more). Similarly, there was no increase in the risk of malignant melanoma or haematological, prostate, and renal tract cancers. The adjusted five year incidence of all cancers for men aged 60 was 4.8% (4.4% to 5.3%) with resurfacing, 6.2% (5.7% to 6.7%) with stemmed metal-on-metal, and 6.7% (6.5% to 7.0%) for other bearing surfaces. Equivalent rates for women aged 60 were lower: 3.1% (2.8% to 3.4%) with resurfacing, 4.0% (3.7% to 4.3%) with stemmed metal-on-metal, and 4.4% (4.2% to 4.5%) with other bearings. Conclusions These data are reassuring, but the findings are observational with short follow-up. The use of hospital episode statistics data might underestimate cancer diagnoses, and there is the possibility of confounding by indication. Furthermore, as some cancers have a long latency period it is important that we study the longer term outcomes and continue to investigate the effects of exposure to orthopaedic metals.	[Smith, Alison J.; Blom, Ashley W.] Univ Bristol, Musculosketal Res Unit, Sch Clin Sci, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England; [Dieppe, Paul] Univ Plymouth, Peninsula Med Sch, Exeter EX1 2LU, Devon, England; [Dieppe, Paul] Univ Exeter, Exeter EX1 2LU, Devon, England; [Porter, Martyn] Ctr Hip Surg, Wigan WN6 9EP, Lancs, England	University of Bristol; University of Exeter; University of Plymouth; University of Exeter	Smith, AJ (corresponding author), Univ Bristol, Musculosketal Res Unit, Sch Clin Sci, Avon Orthopaed Ctr, Bristol BS10 5NB, Avon, England.	alison.smith@bristol.ac.uk		Blom, Ashley/0000-0002-9940-1095	National Joint Registry for England and Wales Steering Committee (NJRSC); DePuy	National Joint Registry for England and Wales Steering Committee (NJRSC); DePuy	This study was funded by the National Joint Registry for England and Wales Steering Committee (NJRSC) as one of several specialist topic areas included in its ongoing work programme. MP is a member of the NJRSC and is chair of the Editorial Board. Decisions over the design, data analysis, and data interpretation were made independently by the authors. The decision to submit for publication was made by AWB.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: MP receives royalties from the manufacturer DePuy for a cemented hip prosthesis.	AOANJRR, 2010, ANN REP AOANJRR; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P2357, DOI 10.1007/s11999-010-1262-3; CASE CP, 1994, J BONE JOINT SURG BR, V76B, P701, DOI 10.1302/0301-620X.76B5.8083255; Coviello E., 2009, STCOMPADJ STATA MODU; Doherty AT, 2001, J BONE JOINT SURG BR, V83B, P1075, DOI 10.1302/0301-620X.83B7.10102; Dowson D, 2004, J ARTHROPLASTY, V19, P124, DOI 10.1016/j.arth.2004.09.016; GARDNER MJ, 1986, BMJ-BRIT MED J, V292, P746, DOI 10.1136/bmj.292.6522.746; Haddad FS, 2011, J BONE JOINT SURG BR, V93B, P572, DOI 10.1302/0301-620X.93B4.26429; Hart AJ, 2011, J BONE JOINT SURG BR, V93B, P1308, DOI 10.1302/0301-620X.93B10.26249; Jameson SS, 2011, J BONE JOINT SURG BR, V93B, P876, DOI 10.1302/0301-620X.93B7.26657; Judge A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4092; Keegan GM, 2007, J BONE JOINT SURG BR, V89B, P567, DOI 10.1302/0301-620X.89B5.18903; Keegan GM, 2008, CRIT REV TOXICOL, V38, P645, DOI [10.1080/10408440701845534, 10.1080/10408440701845534 ]; Lie SA, 2000, ACTA ORTHOP SCAND, V71, P19, DOI 10.1080/00016470052943838; LUMB GD, 1994, SCI TOTAL ENVIRON, V148, P185, DOI 10.1016/0048-9697(94)90395-6; National Joint Registry for England and Wales, 2011, 8 ANN REP NJR; Office for National Statistics, 2011, CANC STAT REG REG CA; Onega T, 2006, CANCER EPIDEM BIOMAR, V15, P1532, DOI 10.1158/1055-9965.EPI-06-0127; Parry MC, 2010, BIOMATERIALS, V31, P4477, DOI 10.1016/j.biomaterials.2010.02.038; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Smith AJ, 2012, LANCET          0312; Thomas E, 2000, INT J CANCER, V88, P497, DOI 10.1002/1097-0215(20001101)88:3<497::AID-IJC27>3.3.CO;2-A; Visuri T, 2003, ACTA ORTHOP SCAND, V74, P351, DOI 10.1080/00016470310014300; Visuri T, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-78; Wagner P, 2011, EUR J CANCER, V47, P1061, DOI 10.1016/j.ejca.2010.11.023; World Health Organisation Global Health Observatory, 2012, CANC MORT MORB	26	96	98	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 3	2012	344								e2383	10.1136/bmj.e2383	http://dx.doi.org/10.1136/bmj.e2383			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GM	22490979	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000302607700002
J	Gasper, BJ; Minchella, DJ; Weaver, GC; Csonka, LN; Gardner, SM				Gasper, Brittany J.; Minchella, Dennis J.; Weaver, Gabriela C.; Csonka, Laszlo N.; Gardner, Stephanie M.			Adapting to Osmotic Stress and the Process of Science	SCIENCE			English	Editorial Material							INQUIRY		[Gasper, Brittany J.; Minchella, Dennis J.; Csonka, Laszlo N.; Gardner, Stephanie M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Weaver, Gabriela C.] Purdue Univ, Discovery Learning Res Ctr, W Lafayette, IN 47907 USA; [Weaver, Gabriela C.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Gardner, SM (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.	sgardne@purdue.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		American Association for the Advancement of Science, 2011, VIS CHANG UND BIOL E; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Culham DE, 2008, BIOCHEMISTRY-US, V47, P13584, DOI 10.1021/bi801576x; DUNLAP VJ, 1985, J BACTERIOL, V163, P296, DOI 10.1128/JB.163.1.296-304.1985; Gardner SM, 2011, J UNDERGRAD NEUROSCI, V10, pA24; Gasper B. J., 2011, J MICROBIOL BIOL ED, V12; Gasper B. J., 2012, DNA CELL BIOL; Lindgren C. A., 2010, CHRONICLE HIGHE 0418; Luckie DB, 2004, ADV PHYSIOL EDUC, V28, P199, DOI 10.1152/advan.00025.2004; Weaver G., 2006, CHEM ED, V11, P125, DOI DOI 10.1333/S00897061008A; Weaver GC, 2008, NAT CHEM BIOL, V4, P577, DOI 10.1038/nchembio1008-577	11	7	7	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1590	1591		10.1126/science.1215582	http://dx.doi.org/10.1126/science.1215582			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461603				2022-12-24	WOS:000302062600035
J	Sachlos, E; Risueno, RM; Laronde, S; Shapovalova, Z; Lee, JH; Russell, J; Malig, M; McNicol, JD; Fiebig-Comyn, A; Graham, M; Levadoux-Martin, M; Lee, JB; Giacomelli, AO; Hassell, JA; Fischer-Russell, D; Trus, MR; Foley, R; Leber, B; Xenocostas, A; Brown, ED; Collins, TJ; Bhatia, M				Sachlos, Eleftherios; Risueno, Ruth M.; Laronde, Sarah; Shapovalova, Zoya; Lee, Jong-Hee; Russell, Jennifer; Malig, Monika; McNicol, Jamie D.; Fiebig-Comyn, Aline; Graham, Monica; Levadoux-Martin, Marilyne; Lee, Jung Bok; Giacomelli, Andrew O.; Hassell, John A.; Fischer-Russell, Daniela; Trus, Michael R.; Foley, Ronan; Leber, Brian; Xenocostas, Anargyros; Brown, Eric D.; Collins, Tony J.; Bhatia, Mickie			Identification of Drugs Including a Dopamine Receptor Antagonist that Selectively Target Cancer Stem Cells	CELL			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; DIFFERENTIATION; EXPRESSION; INDUCTION; FEATURES; COHORT	Selective targeting of cancer stem cells (CSCs) offers promise for a new generation of therapeutics. However, assays for both human CSCs and normal stem cells that are amenable to robust biological screens are limited. Using a discovery platform that reveals differences between neoplastic and normal human pluripotent stem cells (hPSC), we identify small molecules from libraries of known compounds that induce differentiation to overcome neoplastic self-renewal. Surprisingly, thioridazine, an antipsychotic drug, selectively targets the neoplastic cells, and impairs human somatic CSCs capable of in vivo leukemic disease initiation while having no effect on normal blood SCs. The drug antagonizes dopamine receptors that are expressed on CSCs and on breast cancer cells as well. These results suggest that dopamine receptors may serve as a biomarker for diverse malignancies, demonstrate the utility of using neoplastic hPSCs for identifying CSC-targeting drugs, and provide support for the use of differentiation as a therapeutic strategy.	[Sachlos, Eleftherios; Risueno, Ruth M.; Laronde, Sarah; Shapovalova, Zoya; Lee, Jong-Hee; Russell, Jennifer; Malig, Monika; McNicol, Jamie D.; Fiebig-Comyn, Aline; Graham, Monica; Levadoux-Martin, Marilyne; Lee, Jung Bok; Fischer-Russell, Daniela; Collins, Tony J.; Bhatia, Mickie] McMaster Univ, Fac Hlth Sci, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8S 4L8, Canada; [Giacomelli, Andrew O.; Hassell, John A.; Brown, Eric D.; Bhatia, Mickie] McMaster Univ, Fac Hlth Sci, Dept Biochem & Biomed Sci, Hamilton, ON L8S 4L8, Canada; [Trus, Michael R.; Foley, Ronan; Leber, Brian] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L8, Canada; [Xenocostas, Anargyros] Univ Western Ontario, Dept Med, Div Hematol, Schulich Sch Med, London, ON N6A 3K7, Canada	McMaster University; McMaster University; McMaster University; Western University (University of Western Ontario)	Bhatia, M (corresponding author), McMaster Univ, Fac Hlth Sci, McMaster Stem Cell & Canc Res Inst, 1280 Main St W,MDCL 5029, Hamilton, ON L8S 4L8, Canada.	mbhatia@mcmaster.ca	Xenocostas, Anargyros/G-3358-2011; Risueño, Ruth Muñoz/G-9969-2015	Risueño, Ruth Muñoz/0000-0003-4048-9536; Leber, Brian/0000-0001-5502-1480	Canadian Institute of Health Research; Canadian Cancer Society Research Institute (CCSRI); Ontario Ministry of Economic Development; Innovation's Ontario Consortium for Regeneration inducing Therapeutics; Canadian Chair; CCS-TFF	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Ontario Ministry of Economic Development; Innovation's Ontario Consortium for Regeneration inducing Therapeutics; Canadian Chair; CCS-TFF	This work was supported by grants from the Canadian Institute of Health Research, Canadian Cancer Society Research Institute (CCSRI) to M.B, and foremost by the Ontario Ministry of Economic Development and Innovation's Ontario Consortium for Regeneration inducing Therapeutics. M.B. is supported by the Canadian Chair Program and holds the Canada Research Chair in human stem cell biology. R.M.R is supported by a CCS-TFF fellowship. The McMaster University Animal Care Council approved all in vivo procedures and protocols. We thank Ryan Mitchell, Dr. Tamra Werbowetski-Ogilvie, and Dr. DongCheng Wu from the Bhatia lab for technical assistance and constructive input; Dr. Mark D. Minden of the Department of Medical Oncology and Hematology, Princess Margaret Hospital, Toronto, ON, Canada, for providing AML cell lines (OCI-AML2, OCI-AML3); and members of the Labour and Delivery clinic at the McMaster Children's Hospital for supplying cord blood samples. We also thank Peter Cmorej and Robin Hallet from Dr. John Hassell's lab for technical assistance in breast tumor preparation and guidance with breast tumor biology, respectively; Dr. Eric Brown, Jan Blanchard, and staff of the McMaster HTS laboratory and Centre for Microbial Chemical Biology for supplying a portion of the Canadian Compound Collection library; Dr. Rima Al-war from the Ontario Institute of Cancer Research for supplying the OICR kinase library; Dr. Ahmed Aman from the Al-war lab for assistance with HPLC analysis; Dr. Gerry Wright from the Institute for Infectious Disease Research, McMaster University, and Dr. Geoff Tranmer and Inga Kireeva from the Wright lab for their assistance with NMR and HRMS analysis. E.S and R.M.R. designed and performed experiments, analyzed data, and wrote the paper; S.L, Z.S, J.H.L, J.R, M.M, J.M designed and performed experiments and analyzed data; A.F and M.G performed experiments; M.L.M. sorted samples and assisted with flow cytometry analysis; M.T, R.F and B.L supplied AML samples; A.O.G and J.A.H supplied breast tumor samples. T.J.C and D.F.R designed experiments, analyzed data, and wrote the paper. M.B. designed experiments, analyzed data, supervised the project and wrote the paper.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Atkinson JM, 2011, CANCER CELL, V20, P384, DOI 10.1016/j.ccr.2011.08.013; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; Carlo RD, 1986, ANN NY ACAD SCI, V464, P559, DOI DOI 10.1111/J.1749-6632.1986.TB16068.X; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Dalton SO, 2005, SCHIZOPHR RES, V75, P315, DOI 10.1016/j.schres.2004.11.009; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Driver JA, 2007, CANCER EPIDEM BIOMAR, V16, P1260, DOI 10.1158/1055-9965.EPI-07-0038; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Estey EH, 1999, BLOOD, V93, P2478, DOI 10.1182/blood.V93.8.2478.408k04_2478_2484; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Recher C, 2005, BLOOD, V105, P2527, DOI 10.1182/blood-2004-06-2494; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; SACHS L, 1978, NATURE, V274, P535, DOI 10.1038/274535a0; SEEMAN P, 1983, EUR J PHARMACOL, V94, P145, DOI 10.1016/0014-2999(83)90452-1; SEEMAN P, 1975, SCIENCE, V188, P1217, DOI 10.1126/science.1145194; Self DW, 1996, SCIENCE, V271, P1586, DOI 10.1126/science.271.5255.1586; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; Smith BD, 2004, BLOOD, V103, P3669, DOI 10.1182/blood-2003-11-3775; Smith TJ, 2006, J CLIN ONCOL, V24, P3187, DOI 10.1200/JCO.2006.06.4451; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshida H, 1996, CANCER RES, V56, P2945; Zhelev Z, 2004, CANCER CHEMOTH PHARM, V53, P267, DOI 10.1007/s00280-003-0738-1; Zheng R, 2002, BLOOD, V100, P4154, DOI 10.1182/blood-2002-03-0936	43	364	405	0	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1284	1297		10.1016/j.cell.2012.03.049	http://dx.doi.org/10.1016/j.cell.2012.03.049			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22632761	Bronze			2022-12-24	WOS:000305119600013
J	Vos, M; Esposito, G; Edirisinghe, JN; Vilain, S; Haddad, DM; Slabbaert, JR; Van Meensel, S; Schaap, O; De Strooper, B; Meganathan, R; Morais, VA; Verstreken, P				Vos, Melissa; Esposito, Giovanni; Edirisinghe, Janaka N.; Vilain, Sven; Haddad, Dominik M.; Slabbaert, Jan R.; Van Meensel, Stefanie; Schaap, Onno; De Strooper, Bart; Meganathan, R.; Morais, Vanessa A.; Verstreken, Patrik			Vitamin K-2 Is a Mitochondrial Electron Carrier That Rescues Pink1 Deficiency	SCIENCE			English	Article							CRYSTALLINE CORNEAL-DYSTROPHY; PARKINSONS-DISEASE; UBIAD1 GENE; MUTATIONS; SCHNYDER; DROSOPHILA-PINK1; IDENTIFICATION; MENAQUINONE-4; DYSFUNCTION	Human UBIAD1 localizes to mitochondria and converts vitamin K-1 to vitamin K-2. Vitamin K-2 is best known as a cofactor in blood coagulation, but in bacteria it is a membrane-bound electron carrier. Whether vitamin K-2 exerts a similar carrier function in eukaryotic cells is unknown. We identified Drosophila UBIAD1/Heix as a modifier of pink1, a gene mutated in Parkinson's disease that affects mitochondrial function. We found that vitamin K-2 was necessary and sufficient to transfer electrons in Drosophila mitochondria. Heix mutants showed severe mitochondrial defects that were rescued by vitamin K-2, and, similar to ubiquinone, vitamin K-2 transferred electrons in Drosophila mitochondria, resulting in more efficient adenosine triphosphate (ATP) production. Thus, mitochondrial dysfunction was rescued by vitamin K-2 that serves as a mitochondrial electron carrier, helping to maintain normal ATP production.	[Vos, Melissa; Esposito, Giovanni; Vilain, Sven; Haddad, Dominik M.; Slabbaert, Jan R.; Van Meensel, Stefanie; Schaap, Onno; De Strooper, Bart; Morais, Vanessa A.; Verstreken, Patrik] VIB, Ctr Biol Dis, B-3000 Louvain, Belgium; [Vos, Melissa; Esposito, Giovanni; Vilain, Sven; Haddad, Dominik M.; Slabbaert, Jan R.; Van Meensel, Stefanie; Schaap, Onno; De Strooper, Bart; Morais, Vanessa A.; Verstreken, Patrik] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Vos, Melissa; Esposito, Giovanni; Vilain, Sven; Haddad, Dominik M.; Slabbaert, Jan R.; Van Meensel, Stefanie; Schaap, Onno; De Strooper, Bart; Morais, Vanessa A.; Verstreken, Patrik] Leuven Res Inst Neurodegenerat Dis LIND, B-3000 Louvain, Belgium; [Edirisinghe, Janaka N.; Meganathan, R.] No Illinois Univ, Dept Biol Sci, De Kalb, IL 60115 USA	Flanders Institute for Biotechnology (VIB); KU Leuven; Northern Illinois University	Verstreken, P (corresponding author), VIB, Ctr Biol Dis, B-3000 Louvain, Belgium.	patrik.verstreken@med.kuleuven.be	Verstreken, Patrik/AAC-7591-2022; Vilain, Sven/AHA-7944-2022; de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	Verstreken, Patrik/0000-0002-5073-5393; De Strooper, Bart/0000-0001-5455-5819; Morais, Vanessa/0000-0002-0830-0548	Agentschap voor Innovatie door Wetenschap en Technologie (IWT)-Vlaanderen; European Research Council [260678]; Fonds Voor Wetenschappelijk Onderzoek [G074709-G095511-G094011]; KU Leuven; Methusalem grant; Hercules foundation; Francqui foundation; VIB	Agentschap voor Innovatie door Wetenschap en Technologie (IWT)-Vlaanderen; European Research Council(European Research Council (ERC)European Commission); Fonds Voor Wetenschappelijk Onderzoek(FWO); KU Leuven(KU Leuven); Methusalem grant; Hercules foundation; Francqui foundation; VIB	We thank H. Bellen, J. Park, J. Chung, the Bloomington Drosophila stock center, and the Yale E. coli stock center. Support was provided by an Agentschap voor Innovatie door Wetenschap en Technologie (IWT)-Vlaanderen to M.V., a European Research Council Starting Grant (no. 260678), Fonds Voor Wetenschappelijk Onderzoek (G074709-G095511-G094011), the Research Fund KU Leuven, a Methusalem grant, KU Leuven, the Hercules and Francqui foundations, and VIB. The data reported in this paper are tabulated in the main paper and in the supplementary materials. B.D.S. is a paid consultant for Janssen Pharmaceutica (Johnson and Johnson) with regard to Alzheimer's disease and Parkinson's disease.	Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; CONLY JM, 1994, AM J GASTROENTEROL, V89, P915; De Paepe B, 2006, PEDIATR RES, V59, P2, DOI 10.1203/01.pdr.0000191294.34122.ab; Deng HS, 2008, P NATL ACAD SCI USA, V105, P14503, DOI 10.1073/pnas.0803998105; GARNER A, 1972, BRIT J OPHTHALMOL, V56, P400, DOI 10.1136/bjo.56.5.400; Hebert SL, 2010, MECH AGEING DEV, V131, P451, DOI 10.1016/j.mad.2010.03.007; Hiesinger PR, 2005, CELL, V121, P607, DOI 10.1016/j.cell.2005.03.012; Lin E. C. C., 1987, ESCHERICHIA COLI SAL, P202; Mandemakers W, 2007, J CELL SCI, V120, P1707, DOI 10.1242/jcs.03443; McCarthy S, 2004, TOXICOL APPL PHARM, V201, P21, DOI 10.1016/j.taap.2004.04.019; Morais VA, 2009, EMBO MOL MED, V1, P99, DOI 10.1002/emmm.200900006; Nakagawa K, 2010, NATURE, V468, P117, DOI 10.1038/nature09464; Nickerson ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010760; Orr A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000685; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Suvarna K, 1998, J BACTERIOL, V180, P2782, DOI 10.1128/JB.180.10.2782-2787.1998; THIJSSEN HHW, 1994, BRIT J NUTR, V72, P415, DOI 10.1079/BJN19940043; USUI Y, 1989, J CHROMATOGR-BIOMED, V489, P291, DOI 10.1016/S0378-4347(00)82907-2; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Verstreken P, 2009, NEURON, V63, P203, DOI 10.1016/j.neuron.2009.06.017; Vila M, 2004, NAT MED, V10, pS58, DOI 10.1038/nm1068; Vilain S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002456; Weiss JS, 2007, INVEST OPHTH VIS SCI, V48, P5007, DOI 10.1167/iovs.07-0845; Yellore VS, 2007, MOL VIS, V13, P1777	25	246	265	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 8	2012	336	6086					1306	1310		10.1126/science.1218632	http://dx.doi.org/10.1126/science.1218632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22582012	Green Accepted			2022-12-24	WOS:000304905300047
J	Heath, I				Heath, Iona			What's wrong with assisted dying	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath22@yahoo.co.uk						Carrere E, 2012, OTHER LIVES MINE; Rieff D, 2008, SWIMMING SEA GRIEF S	2	10	10	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 29	2012	344								e3755	10.1136/bmj.e3755	http://dx.doi.org/10.1136/bmj.e3755			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	953GT	22645214				2022-12-24	WOS:000304855700020
J	Allen, RJ; Sherwood, SC; Norris, JR; Zender, CS				Allen, Robert J.; Sherwood, Steven C.; Norris, Joel R.; Zender, Charles S.			Recent Northern Hemisphere tropical expansion primarily driven by black carbon and tropospheric ozone	NATURE			English	Article								Observational analyses have shown the width of the tropical belt increasing in recent decades as the world has warmed(1). This expansion is important because it is associated with shifts in large-scale atmospheric circulation(2-4) and major climate zones(5,6). Although recent studies have attributed tropical expansion in the Southern Hemisphere to ozone depletion(7-10), the drivers of Northern Hemisphere expansion are not well known and the expansion has not so far been reproduced by climate models(11). Here we use a climate model with detailed aerosol physics to show that increases in heterogeneous warming agents-including black carbon aerosols and tropospheric ozone-are noticeably better than greenhouse gases at driving expansion, and can account for the observed summertime maximum in tropical expansion. Mechanistically, atmospheric heating from black carbon and tropospheric ozone has occurred at the mid-latitudes, generating a poleward shift of the tropospheric jet(12), thereby relocating the main division between tropical and temperate air masses. Although we still underestimate tropical expansion, the true aerosol forcing is poorly known and could also be underestimated. Thus, although the insensitivity of models needs further investigation, black carbon and tropospheric ozone, both of which are strongly influenced by human activities, are the most likely causes of observed Northern Hemisphere tropical expansion.	[Allen, Robert J.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Sherwood, Steven C.] Univ New S Wales, Climate Change Res Ctr, Sydney, NSW 2052, Australia; [Sherwood, Steven C.] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW 2052, Australia; [Norris, Joel R.] Univ Calif San Diego, Scripps Inst Oceanog, San Diego, CA 92093 USA; [Zender, Charles S.] Univ Calif Irvine, Irvine, CA 92697 USA	University of California System; University of California Riverside; University of New South Wales Sydney; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California Irvine	Allen, RJ (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	rjallen@ucr.edu	Sherwood, Steven/B-5673-2008; Norris, Joel R/A-9785-2008; Zender, Charles S/D-4485-2012	Sherwood, Steven/0000-0001-7420-8216; Norris, Joel R/0000-0003-4384-0977; Zender, Charles S/0000-0003-0129-8024; Allen, Robert/0000-0003-1616-9719	University of California at Riverside	University of California at Riverside	This study was funded by R.J.A.'s University of California at Riverside initial complement. We acknowledge the individual modelling groups, the Program for Climate Model Diagnosis and Intercomparison and the Working Group on Coupled Modeling of the World Climate Research Programme (WCRP) for their part in making available the WCRP CMIP3 multimodel data set. Support of this data set is provided by the Office of Science, US Department of Energy.	Adler RF, 2003, J HYDROMETEOROL, V4, P1147, DOI 10.1175/1525-7541(2003)004<1147:TVGPCP>2.0.CO;2; Allen R. J., 2011, ATMOS CHEM PHYS DISC, V11, P31643; Allen RJ, 2011, CLIM DYNAM, V36, P1959, DOI 10.1007/s00382-010-0898-8; Anderson JL, 2004, J CLIMATE, V17, P4641, DOI 10.1175/JCLI-3223.1; Bender F., 2011, CLIM DYNAM; Bond TC, 2006, AEROSOL SCI TECH, V40, P27, DOI 10.1080/02786820500421521; Chung SH, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD001397; Clement AC, 2009, SCIENCE, V325, P460, DOI 10.1126/science.1171255; Collins W.D., 2004, NCARTTN464STR226, DOI 10.5065/ D63N21CH; Durre I, 2006, J CLIMATE, V19, P53, DOI 10.1175/JCLI3594.1; Dwyer JG, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2009JD012945; Flanner MG, 2009, ATMOS CHEM PHYS, V9, P2481, DOI 10.5194/acp-9-2481-2009; Flanner MG, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008003; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fu Q, 2006, SCIENCE, V312, P1179, DOI 10.1126/science.1125566; Fu Q, 2011, J CLIMATE, V24, P5597, DOI 10.1175/JCLI-D-11-00027.1; Hu Y, 2007, ATMOS CHEM PHYS, V7, P5229, DOI 10.5194/acp-7-5229-2007; Jacobowitz H, 2003, B AM METEOROL SOC, V84, P785, DOI 10.1175/BAMS-84-6-785; Johanson CM, 2009, J CLIMATE, V22, P2713, DOI 10.1175/2008JCLI2620.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631; Kang SM, 2011, SCIENCE, V332, P951, DOI 10.1126/science.1202131; Lu J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028443; Lu J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036076; Ming Y, 2011, J CLIMATE, V24, P6077, DOI 10.1175/2011JCLI4111.1; Pavolonis MJ, 2005, J APPL METEOROL, V44, P804, DOI 10.1175/JAM2236.1; Polvani LM, 2011, J CLIMATE, V24, P795, DOI 10.1175/2010JCLI3772.1; Quaas J, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008962; Ramanathan V, 2008, NAT GEOSCI, V1, P221, DOI 10.1038/ngeo156; Rienecker MM, 2011, J CLIMATE, V24, P3624, DOI 10.1175/JCLI-D-11-00015.1; Rossow WB, 1999, B AM METEOROL SOC, V80, P2261, DOI 10.1175/1520-0477(1999)080<2261:AIUCFI>2.0.CO;2; ROSSOW WB, 1991, B AM METEOROL SOC, V72, P2, DOI 10.1175/1520-0477(1991)072<0002:ICDP>2.0.CO;2; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Sato M, 2003, P NATL ACAD SCI USA, V100, P6319, DOI 10.1073/pnas.0731897100; Schulz M, 2006, ATMOS CHEM PHYS, V6, P5225, DOI 10.5194/acp-6-5225-2006; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Shindell D, 2012, SCIENCE, V335, P183, DOI 10.1126/science.1210026; Son SW, 2010, J GEOPHYS RES-ATMOS, V115, DOI 10.1029/2010JD014271; Son SW, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038671; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176; Wilks DS., 2006, STAT METHODS ATMOSPH, V3, P133; Yu LS, 2007, B AM METEOROL SOC, V88, P527, DOI 10.1175/BAMS-88-4-527; Zhou YP, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015197	43	174	176	3	133	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					350	U93		10.1038/nature11097	http://dx.doi.org/10.1038/nature11097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596159	Green Published			2022-12-24	WOS:000304099100038
J	Dolgin, E				Dolgin, Elie			Managed by machine	NATURE			English	Editorial Material																			0	18	19	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					S6	S8		10.1038/485S6a	http://dx.doi.org/10.1038/485S6a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968AT	22616096	Bronze			2022-12-24	WOS:000305950100003
J	Feng, F; Yang, F; Rong, W; Wu, XG; Zhang, J; Chen, S; He, CZ; Zhou, JM				Feng, Feng; Yang, Fan; Rong, Wei; Wu, Xiaogang; Zhang, Jie; Chen, She; He, Chaozu; Zhou, Jian-Min			A Xanthomonas uridine 5 '-monophosphate transferase inhibits plant immune kinases	NATURE			English	Article							PSEUDOMONAS-SYRINGAE EFFECTOR; INNATE IMMUNITY; FIC DOMAIN; CYTOPLASMIC KINASE; III EFFECTORS; HOST TARGET; RECEPTOR; ARABIDOPSIS; CAMPESTRIS; AMPYLATION	Plant innate immunity is activated on the detection of pathogen-associated molecular patterns (PAMPs) at the cell surface, or of pathogen effector proteins inside the plant cell(1-4). Together, PAMP-triggered immunity and effector-triggered immunity constitute powerful defences against various phytopathogens. Pathogenic bacteria inject a variety of effector proteins into the host cell to assist infection or propagation. A number of effector proteins have been shown to inhibit plant immunity(5), but the biochemical basis remains unknown for the vast majority of these effectors. Here we show that the Xanthomonas campestris pathovar campestris type III effector AvrAC enhances virulence and inhibits plant immunity by specifically targeting Arabidopsis BIK1 and RIPK, two receptor-like cytoplasmic kinases known to mediate immune signalling(6-8). AvrAC is a uridylyl transferase that adds uridine 5'-monophosphate to and conceals conserved phosphorylation sites in the activation loop of BIK1 and RIPK, reducing their kinase activity and consequently inhibiting downstream signalling.	[Feng, Feng; Yang, Fan; Wu, Xiaogang; Zhang, Jie; Chen, She; Zhou, Jian-Min] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Feng, Feng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Feng, Feng; He, Chaozu] Tsinghua Univ, Grad Sch Shenzhen, Shenzhen 518055, Peoples R China; [Rong, Wei; He, Chaozu] Hainan Univ, Hainan Key Lab Sustainable Utilizat Trop Bioresou, Haikou 570228, Hainan, Peoples R China; [Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China	National Institute of Biological Sciences, Beijing; Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Hainan University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Zhou, JM (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	czhe@hainu.edu.cn; zhoujianmin@nibs.ac.cn	Zhou, Jian-Min/A-3140-2013	Zhou, Jian-Min/0000-0002-9943-2975	Chinese Ministry of Science and Technology [2011CB100700, 2010CB835301, 2010CB835204]; Hainan University	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Hainan University	The authors thank J. Chai for sharing plasmids before publication, A. Bent for the XccB186 strain, S. Y. He and F. White for helpful comments. J.-M.Z. was supported by grants from the Chinese Ministry of Science and Technology (2011CB100700; 2010CB835301). S. C. was supported by a grant from the Chinese Ministry of Science and Technology (2010CB835204) C. H. was supported by Funds from Hainan University.	Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253; Block A, 2011, CURR OPIN MICROBIOL, V14, P39, DOI 10.1016/j.mib.2010.12.011; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Cheng W, 2011, CELL HOST MICROBE, V10, P616, DOI 10.1016/j.chom.2011.10.013; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Chung EH, 2011, CELL HOST MICROBE, V9, P125, DOI 10.1016/j.chom.2011.01.009; Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kinch LN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005818; Laluk K, 2011, PLANT CELL, V23, P2831, DOI 10.1105/tpc.111.087122; Li XY, 2005, P NATL ACAD SCI USA, V102, P12990, DOI 10.1073/pnas.0502425102; Liu J, 2011, CELL HOST MICROBE, V9, P137, DOI 10.1016/j.chom.2011.01.010; Lu DP, 2010, P NATL ACAD SCI USA, V107, P496, DOI 10.1073/pnas.0909705107; Luong P, 2010, J BIOL CHEM, V285, P20155, DOI 10.1074/jbc.M110.114884; Macho AP, 2007, MOL PLANT PATHOL, V8, P437, DOI 10.1111/J.1364-3703.2007.00404.X; Mattoo S, 2011, J BIOL CHEM, V286, P32834, DOI 10.1074/jbc.M111.227603; Muller MP, 2010, SCIENCE, V329, P946, DOI 10.1126/science.1192276; Mukherjee S, 2011, NATURE, V477, P103, DOI 10.1038/nature10335; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Schechter LM, 2004, J BACTERIOL, V186, P543, DOI 10.1128/JB.186.2.543-555.2004; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Segonzac C, 2011, CURR OPIN MICROBIOL, V14, P54, DOI 10.1016/j.mib.2010.12.005; Sun WX, 2006, PLANT CELL, V18, P764, DOI 10.1105/tpc.105.037648; Veronese P, 2006, PLANT CELL, V18, P257, DOI 10.1105/tpc.105.035576; Wang LF, 2007, MOL PLANT PATHOL, V8, P491, DOI 10.1111/J.1364-3703.2007.00409.X; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Woolery AR, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00113; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Xiao JY, 2010, NAT STRUCT MOL BIOL, V17, P1004, DOI 10.1038/nsmb.1867; Xu RQ, 2008, J BACTERIOL, V190, P343, DOI 10.1128/JB.00978-07; Yarbrough ML, 2009, SCIENCE, V323, P269, DOI 10.1126/science.1166382; Yuan J, 1996, J BACTERIOL, V178, P6399, DOI 10.1128/jb.178.21.6399-6402.1996; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhang J, 2010, CELL HOST MICROBE, V7, P290, DOI 10.1016/j.chom.2010.03.007; Zuo JR, 2000, PLANT J, V24, P265, DOI 10.1046/j.1365-313x.2000.00868.x	39	229	250	11	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					114	U149		10.1038/nature10962	http://dx.doi.org/10.1038/nature10962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22504181				2022-12-24	WOS:000303451900045
J	Lake, ET; Staiger, D; Horbar, J; Cheung, R; Kenny, MJ; Patrick, T; Rogowski, JA				Lake, Eileen T.; Staiger, Douglas; Horbar, Jeffrey; Cheung, Robyn; Kenny, Michael J.; Patrick, Thelma; Rogowski, Jeannette A.			Association Between Hospital Recognition for Nursing Excellence and Outcomes of Very Low-Birth-Weight Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEONATAL INTENSIVE-CARE; MORTALITY; VOLUME; INFECTIONS; LEVEL	Context Infants born at very low birth weight (VLBW) require high levels of nursing intensity. The role of nursing in outcomes for these infants in the United States is not known. Objective To examine the relationships between hospital recognition for nursing excellence (RNE) and VLBW infant outcomes. Design, Setting, and Patients Cohort study of 72 235 inborn VLBW infants weighing 501 to 1500 g born in 558 Vermont Oxford Network hospital neonatal intensive care units between January 1, 2007, and December 31, 2008. Hospital RNE was determined from the American Nurses Credentialing Center. The RNE designation is awarded when nursing care achieves exemplary practice or leadership in 5 areas. Main Outcome Measures Seven-day, 28-day, and hospital stay mortality; nosocomial infection, defined as an infection in blood or cerebrospinal fluid culture occurring more than 3 days after birth; and severe (grade 3 or 4) intraventricular hemorrhage. Results Overall, the outcome rates were as follows: for 7-day mortality, 7.3% (5258/71 955); 28-day mortality, 10.4% (7450/71 953); hospital stay mortality, 12.9% (9278/71 936); severe intraventricular hemorrhage, 7.6% (4842/63 525); and infection, 17.9% (11 915/66 496). The 7-day mortality was 7.0% in RNE hospitals and 7.4% in non-RNE hospitals (adjusted odds ratio [OR], 0.87; 95% CI, 0.76-0.99; P=.04). The 28-day mortality was 10.0% in RNE hospitals and 10.5% in non-RNE hospitals (adjusted OR, 0.90; 95% CI, 0.80-1.01; P=.08). Hospital stay mortality was 12.4% in RNE hospitals and 13.1% in non-RNE hospitals (adjusted OR, 0.90; 95% CI, 0.81-1.01; P=.06). Severe intraventricular hemorrhage was 7.2% in RNE hospitals and 7.8% in non-RNE hospitals (adjusted OR, 0.88; 95% CI, 0.77-1.00; P=.045). Infection was 16.7% in RNE hospitals and 18.3% in non-RNE hospitals (adjusted OR, 0.86; 95% CI, 0.75-0.99; P=.04). Compared with RNE hospitals, the adjusted absolute decrease in risk of outcomes in RNE hospitals ranged from 0.9% to 2.1%. All 5 outcomes were jointly significant (P<.001). The mean effect across all 5 outcomes was OR, 0.88 (95% CI, 0.83-0.94; P<.001). In a subgroup of 68 253 infants with gestational age of 24 weeks or older, the ORs for RNE for all 3 mortality outcomes and infection were statistically significant. Conclusion Among VLBW infants born in RNE hospitals compared with non-RNE hospitals, there was a significantly lower risk-adjusted rate of 7-day mortality, nosocomial infection, and severe intraventricular hemorrhage but not of 28-day mortality or hospital stay mortality. JAMA. 2012; 307(16):1709-1716 www.jama.com	[Lake, Eileen T.] Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Dept Sociol, Philadelphia, PA 19104 USA; [Lake, Eileen T.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Staiger, Douglas] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA; [Staiger, Douglas; Rogowski, Jeannette A.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Horbar, Jeffrey] Univ Vermont, Dept Pediat, Burlington, VT 05405 USA; [Kenny, Michael J.] Univ Vermont, Dept Med Biostat, Burlington, VT 05405 USA; [Horbar, Jeffrey] Vermont Oxford Network, Burlington, VT USA; [Cheung, Robyn] UK Healthcare Enterprise, Lexington, KY USA; [Patrick, Thelma] Ohio State Univ, Coll Nursing, Columbus, OH 43210 USA; [Rogowski, Jeannette A.] Univ Med & Dent New Jersey, Dept Hlth Syst & Policy, Sch Publ Hlth, Piscataway, NJ 08854 USA	University of Pennsylvania; University of Pennsylvania; Dartmouth College; National Bureau of Economic Research; University of Vermont; University of Vermont; University System of Ohio; Ohio State University; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lake, ET (corresponding author), Univ Penn, Sch Nursing, Ctr Hlth Outcomes & Policy Res, Dept Sociol, 418 Curie Blvd, Philadelphia, PA 19104 USA.	elake@nursing.upenn.edu	Patrick, Thelma/D-1423-2013; Patrick, Thelma/D-2482-2013; Kenny, Michael/N-3244-2013	Kenny, Michael/0000-0002-7750-654X	Robert Wood Johnson Foundation Interdisciplinary Nursing Quality Research Initiative; National Institute of Nursing Research, National Institutes of Health [R01NR010357]; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010357] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation Interdisciplinary Nursing Quality Research Initiative; National Institute of Nursing Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by a Robert Wood Johnson Foundation Interdisciplinary Nursing Quality Research Initiative grant (to Dr Lake) and grant R01NR010357 (to Dr Rogowski) from the National Institute of Nursing Research, National Institutes of Health.	AIKEN LH, 1994, MED CARE, V32, P771, DOI 10.1097/00005650-199408000-00002; American Hospital Association, 2010, AHA ANN SURV DAT; American Nurses Credentialing Center, MAGN REC PROGR OV; American Nurses Credentialing Center, HLTH CAR ORG MAGN RE; American Nurses Credentialing Center, 2011, APPL MAN MAGN REC PR; American Nurses Credentialing Center, JOURN MAGN EXC; *ASS WOM HLTH OBST, 2010, GUID PROF REG NURS S; BECKER PT, 1991, NURS RES, V40, P150; Boardman JD, 2002, DEMOGRAPHY, V39, P353, DOI 10.2307/3088343; Boxwell G., 2010, NEONATAL INTENSIVE C, V2nd; Chung JH, 2011, J PERINATOL, V31, P770, DOI 10.1038/jp.2011.29; Cimiotti JP, 2006, ARCH PEDIAT ADOL MED, V160, P832, DOI 10.1001/archpedi.160.8.832; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Eichenwald EC, 2008, NEW ENGL J MED, V358, P1700, DOI 10.1056/NEJMra0707601; Grandi C, 2010, ARCH ARGENT PEDIATR, V108, P499, DOI 10.1590/S0325-00752010000600005; Hack M, 2002, NEW ENGL J MED, V346, P149, DOI 10.1056/NEJMoa010856; Hamilton KES, 2007, ARCH DIS CHILD-FETAL, V92, pF99, DOI 10.1136/adc.2006.102988; Hickey P, 2010, J NURS ADMIN, V40, P226, DOI 10.1097/NNA.0b013e3181da3f71; *I MED, 2006, PRET BIRTH CAUS CONS; Lemnos JA, 2007, GUIDELINES PERINATAL; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kilbride HW, 2003, PEDIATRICS, V111; Lake ET, 2010, RES NURS HEALTH, V33, P413, DOI 10.1002/nur.20399; March of Dimes, 2010, IMPR OUTC PREGN; Maternal and Child Health Bureau Health Resources and Services Administration US Department of Health and Human Services, 2010, CHILD HLTH US 2010; Mathews TJ, 2011, PEDIATRICS, V127, P146, DOI 10.1542/peds.2010-3175; McCourt M, 1994, J Perinat Neonatal Nurs, V7, P52; Medlock S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023441; Mitchell P H, 1998, Image J Nurs Sch, V30, P43; Murphy J, 2011, US NEWS WORLD REPORT; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Phibbs CS, 2007, NEW ENGL J MED, V356, P2165, DOI 10.1056/NEJMsa065029; Pollack MM, 2003, CRIT CARE MED, V31, P1620, DOI 10.1097/01.CCM.0000063302.76602.86; Rogowski JA, 2004, JAMA-J AM MED ASSOC, V291, P202, DOI 10.1001/jama.291.2.202; *STAT CORP, 2007, STAT STAT SOFTW REL; Stoll BJ, 2004, JAMA-J AM MED ASSOC, V292, P2357, DOI 10.1001/jama.292.19.2357; Stoll BJ, 2002, PEDIATRICS, V110, P285, DOI 10.1542/peds.110.2.285; Vohr BR, 2005, PEDIATRICS, V116, P635, DOI 10.1542/peds.2004-2247; Volpe JJ., 2001, NEUROLOGY NEWBORN, V4	39	65	69	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	2012	307	16					1709	1716		10.1001/jama.2012.504	http://dx.doi.org/10.1001/jama.2012.504			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	930OA	22535856	Green Accepted			2022-12-24	WOS:000303147500024
J	Blaha, MJ; Nasir, K; Blumenthal, RS				Blaha, Michael J.; Nasir, Khurram; Blumenthal, Roger S.			Statin Therapy for Healthy Men Identified as "Increased Risk"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							C-REACTIVE PROTEIN; PRIMARY PREVENTION; EVENTS; WOMEN; ROSUVASTATIN		[Blaha, Michael J.; Nasir, Khurram; Blumenthal, Roger S.] Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Blumenthal, RS (corresponding author), Johns Hopkins Ciccarone Ctr Prevent Heart Dis, Blalock 524C Cardiol,600 N Wolfe St, Baltimore, MD 21287 USA.	rblument@jhmi.edu	Blumenthal, Roger S/H-3223-2018	Blumenthal, Roger S/0000-0003-1910-3168				Bernick C, 2005, NEUROLOGY, V65, P1388, DOI 10.1212/01.wnl.0000182897.18229.ec; Blaha MJ, 2011, LANCET, V378, P684, DOI 10.1016/S0140-6736(11)60784-8; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Kostis WJ, 2012, J AM COLL CARDIOL, V59, P572, DOI 10.1016/j.jacc.2011.09.067; Kostis WJ, 2011, J CLIN LIPIDOL, V5, P97, DOI 10.1016/j.jacl.2011.01.006; Lytsy P, 2012, INT J BEHAV MED, V19, P134, DOI 10.1007/s12529-011-9157-6; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2010, CIRC-CARDIOVASC QUAL, V3, P447, DOI 10.1161/CIRCOUTCOMES.110.938118; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001	10	24	25	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 11	2012	307	14					1489	1490		10.1001/jama.2012.425	http://dx.doi.org/10.1001/jama.2012.425			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	922HN	22496260				2022-12-24	WOS:000302538100019
J	Le Fanu, J				Le Fanu, James			Mathematics is bad for you: population risk reduction medicalises us all	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE; GLUCOSE		Mawbey Brough Hlth Ctr, London SW8 2UD, England		Le Fanu, J (corresponding author), Mawbey Brough Hlth Ctr, London SW8 2UD, England.	james.lefanu@btinternet.com						Byrne CD, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5004; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Jackson R, 2008, HEART, V94, P1, DOI 10.1136/hrt.2007.138040; Lanchester J., 2010, WHOOPS WHY EVERYONE; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Le Fanu J., 2011, RISE FALL MODERN MED; ROSE G, 1985, INT J EPIDEMIOL, V14, P32, DOI 10.1093/ije/14.1.32; Toop L, 2001, BRIT MED J, V323, P246, DOI 10.1136/bmj.323.7307.246; Westin S, 2005, BRIT MED J, V330, P1461, DOI 10.1136/bmj.330.7506.1461; 1983, EUR HEART J, V4, P141; 1999, BRIT MED J, V319, P1276, DOI DOI 10.1136/BMJ.319.7219.1276	11	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 11	2012	344								e2612	10.1136/bmj.e2612	http://dx.doi.org/10.1136/bmj.e2612			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UH	22496306				2022-12-24	WOS:000302935200013
J	Garwood, R				Garwood, Russell			Reach out to defend evolution	NATURE			English	Editorial Material									Univ Manchester, Dept Mat, Manchester M13 9PL, Lancs, England	University of Manchester	Garwood, R (corresponding author), Univ Manchester, Dept Mat, Harwell Complex, Manchester M13 9PL, Lancs, England.	russell.garwood@manchester.ac.uk		Garwood, Russell/0000-0002-2803-9471	Engineering and Physical Sciences Research Council [EP/I02249X/1] Funding Source: researchfish; EPSRC [EP/I02249X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))			0	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					281	281		10.1038/485281a	http://dx.doi.org/10.1038/485281a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596116	Bronze			2022-12-24	WOS:000304099100004
J	Shetty, P				Shetty, Priya			India's diabetes time bomb	NATURE			English	Editorial Material																		HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Kinra S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a605; Mohan Deepa, 2005, J Assoc Physicians India, V53, P283; Sachdev HPS, 2009, ARCH DIS CHILD, V94, P768, DOI 10.1136/adc.2008.140905	4	64	66	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					S14	S16		10.1038/485S14a	http://dx.doi.org/10.1038/485S14a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968AT	22616100				2022-12-24	WOS:000305950100007
J	Turcu, S; Sonnappa, S				Turcu, Simona; Sonnappa, Samatha			A teenager with a cough, fever, and poor appetite	BRITISH MEDICAL JOURNAL			English	Editorial Material							LUNG ABSCESS; CHILDREN		[Turcu, Simona; Sonnappa, Samatha] Great Ormond St Hosp Sick Children, London WC1N 3JH, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Turcu, S (corresponding author), Great Ormond St Hosp Sick Children, London WC1N 3JH, England.	sfturcu@googlemail.com						Brook I., 2006, KENDIGS DISORDERS RE, P478; Chan Pei-Chun, 2005, Journal of Microbiology Immunology and Infection, V38, P183; Levison J, 2004, J PAEDIATR CHILD H, V40, P474, DOI 10.1111/j.1440-1754.2004.00433.x; Patradoon-Ho P, 2007, PAEDIATR RESPIR REV, V8, P77, DOI 10.1016/j.prrv.2006.10.002; Puligandla PS, 2008, SEMIN PEDIATR SURG, V17, P42, DOI 10.1053/j.sempedsurg.2007.10.007; Tseng YL, 2001, J PEDIATR SURG, V36, P470, DOI 10.1053/jpsu.2001.21611; Wali SO, 2002, SCAND J INFECT DIS, V34, P673, DOI 10.1080/00365540210147660; Yen Chen-Chieh, 2004, Journal of Microbiology Immunology and Infection, V37, P45	8	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 26	2012	344								e2821	10.1136/bmj.e2821	http://dx.doi.org/10.1136/bmj.e2821			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HD	22539177				2022-12-24	WOS:000303433900008
J	Pedersen, BK				Pedersen, Bente Klarlund			A Muscular Twist on the Fate of Fat	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Pedersen, Bente Klarlund] Rigshosp, Ctr Inflammat & Metab, Dept Infect Dis, DK-2100 Copenhagen, Denmark; [Pedersen, Bente Klarlund] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen	Pedersen, BK (corresponding author), Rigshosp, Ctr Inflammat & Metab, Dept Infect Dis, DK-2100 Copenhagen, Denmark.		Pedersen, Bente Klarlund/AGR-3217-2022	Pedersen, Bente Klarlund/0000-0001-6508-6288				Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106	5	25	27	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	2012	366	16					1544	1545		10.1056/NEJMcibr1201024	http://dx.doi.org/10.1056/NEJMcibr1201024			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	927UE	22512488				2022-12-24	WOS:000302934800016
J	Zhao, YY; Weir, MA; Manno, M; Cordy, P; Gomes, T; Hackam, DG; Juurlink, DN; Mamdani, M; Moist, L; Parikh, CR; Paterson, JM; Wald, R; Yao, Z; Garg, AX				Zhao, Ying Y.; Weir, Matthew A.; Manno, Michael; Cordy, Peter; Gomes, Tara; Hackam, Daniel G.; Juurlink, David N.; Mamdani, Muhammad; Moist, Louise; Parikh, Chirag R.; Paterson, J. Michael; Wald, Ron; Yao, Zhan; Garg, Amit X.			New Fibrate Use and Acute Renal Outcomes in Elderly Adults A Population-Based Study	ANNALS OF INTERNAL MEDICINE			English	Article							FENOFIBRATE INCREASES CREATININEMIA; EXTREMITY ARTERIAL-DISEASE; GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR EVENTS; SERUM CREATININE; CLINICAL-TRIALS; THERAPY; PROGRESSION; GEMFIBROZIL; PREVENTION	Background: Fibric acid derivatives (fibrates) have been shown to increase serum creatinine level in randomized trials. Objective: To assess renal outcomes in elderly adults within 90 days of a new fibrate prescription. Design: Population-based cohort study. Setting: Ontario, Canada. Patients: Patients aged 66 years or older with a new outpatient prescription for a fibrate or ezetimibe (comparator drug) between January 2004 and December 2008. Measurements: Hospitalization for an increase in serum creatinine level (primary outcome) and consultation with a nephrologist, receipt of dialysis for severe acute kidney injury, all-cause mortality, and increases in serum creatinine level (secondary outcomes). All outcomes were assessed within 90 days of a new prescription for ezetimibe or a fibrate. Results: Compared with ezetimibe users (n = 61 831), fibrate users (n = 19 072) were more likely to be hospitalized for an increase in serum creatinine level (adjusted odds ratio, 2.4 [95% CI, 1.7 to 3.3]) and were more likely to consult a nephrologist (absolute risk difference, 0.15% [CI, 0.01% to 0.29%]; adjusted odds ratio, 1.3 [CI, 1.0 to 1.6]). There were no differences between groups in the risk for all-cause mortality or receiving dialysis for severe acute kidney injury. In a subpopulation of 1110 patients (fibrates, n = 220; ezetimibe, n = 890), 9.1% of fibrate users and 0.3% of ezetimibe users had an increase in serum creatinine level of 50% or more (absolute difference, 8.8% [CI, 4.5% to 13.1%]; odds ratio, 29.6 [CI, 8.7 to 100.5]). Risks were greater among fibrate users with chronic kidney disease. Limitations: Because hospitalizations for an increase in serum creatinine level were underestimated, absolute differences may be misleading. Most patients (91%) were prescribed fenofibrate. Serum creatinine levels were measured as part of routine care and were not available for everyone or at predefined times. Conclusion: New fibrate use in elderly adults was associated with an increase in serum creatinine level and a small 90-day absolute increase in hospitalizations and nephrologist consultations. There was no detectable effect on dialysis for severe acute kidney injury or on mortality. The mechanism and clinical significance of the increase in serum creatinine level with fibrates is unclear.	Yale Univ, Sch Med, New Haven, CT USA; Univ Western Ontario, London, ON, Canada; Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Mamdani, Muhammad] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; McMaster Univ, Hamilton, ON, Canada	Yale University; Western University (University of Western Ontario); University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; McMaster University	Garg, AX (corresponding author), London Hlth Sci Ctr, Room ELL-101,800 Commissioners Rd E, London, ON N6A 4G5, Canada.	amit.garg@lhsc.on.ca	Garg, Amit X/G-3295-2011; Weir, Matthew/G-3354-2011; Moist, Louise/G-3334-2011; Hackam, Dan G/A-1143-2009	Gomes, Tara/0000-0002-1468-1965; Parikh, Chirag/0000-0001-9051-7385	Ontario Ministry of Health; Long-Term Care Drug Innovation Fund; University of Western Ontario; Ministry of Health and Long-Term Care; Canadian Institutes of Health Research	Ontario Ministry of Health(Ministry of Health and Long-Term Care, Ontario); Long-Term Care Drug Innovation Fund; University of Western Ontario; Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project was conducted at the Institute for Clinical Evaluative Sciences and was supported by a grant from the Ontario Ministry of Health and Long-Term Care Drug Innovation Fund. The Institute for Clinical Evaluative Sciences is funded by an annual grant from the Ministry of Health and Long-Term Care. Dr. Weir was supported by the Clinician Investigator Program at the University of Western Ontario. He also receives funding from the Ministry of Health and Long-Term Care. Dr. Hackam was supported by a Canadian Institutes of Health Research New Investigator Award. Dr. Wald was supported by the Randomized Controlled Trial Mentoring Program of Canadian Institutes of Health Research. Dr. Garg was supported by a Canadian Institutes of Health Research Clinician-Scientist Award.	Abourbih S, 2009, AM J MED, V122, DOI 10.1016/j.amjmed.2009.03.030; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Angeles C, 2004, AM J KIDNEY DIS, V44, P543, DOI 10.1053/j.ajkd.2004.05.040; Ansquer JC, 2005, AM J KIDNEY DIS, V45, P485, DOI 10.1053/j.ajkd.2004.11.004; Ansquer JC, 2008, AM J KIDNEY DIS, V51, P904, DOI 10.1053/j.ajkd.2008.01.014; Austin PC, 2003, JAMA-J AM MED ASSOC, V289, P3241, DOI 10.1001/jama.289.24.3241; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Broeders N, 2000, NEPHROL DIAL TRANSPL, V15, P1993, DOI 10.1093/ndt/15.12.1993; Bruce R, 1996, NEPHRON, V73, P490; Charach G, 2005, NEPHRON CLIN PRACT, V100, pC120, DOI 10.1159/000085291; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; Davis TME, 2011, DIABETOLOGIA, V54, P280, DOI 10.1007/s00125-010-1951-1; Forsblom C, 2010, DIABETES CARE, V33, P215, DOI 10.2337/dc09-0621; Gajdos M, 2003, CLIN NEPHROL, V60, P65; Genest J, 2004, AM J CARDIOL, V93, P848, DOI 10.1016/j.amjcard.2003.12.022; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hottelart C, 2002, NEPHRON, V92, P536, DOI 10.1159/000064083; Hottelart C, 1999, NEPHROLOGIE, V20, P41; Jha P, 1996, J AM COLL CARDIOL, V27, P1335, DOI 10.1016/0735-1097(96)00018-6; Jun M, 2010, LANCET, V375, P1875, DOI 10.1016/S0140-6736(10)60656-3; Juurlink D, 2006, CANADIAN I HLTH INFO; Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kazumi T, 2003, CURR THER RES CLIN E, V64, P434, DOI 10.1016/S0011-393X(03)00127-9; Keech A, 2005, LANCET, V366, P1849, DOI 10.1016/S0140-6736(05)67667-2; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Levy Adrian R, 2003, Can J Clin Pharmacol, V10, P67; Lipscombe J, 2001, CLIN NEPHROL, V55, P39; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Mamdani M, 2004, LANCET, V363, P1751, DOI 10.1016/S0140-6736(04)16299-5; Mamdani MM, 2001, CAN MED ASSOC J, V164, P1695; Mcquade CR, 2008, AM J HEALTH-SYST PH, V65, P138, DOI 10.2146/ajhp070005; Meade T, 2002, BRIT MED J, V325, P1139, DOI 10.1136/bmj.325.7373.1139; Meade TW, 2001, CURR CONTR TRIALS C, V2, P195, DOI 10.1186/CVM-2-4-195; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Merck Canada Inc, 2011, EZ PROD MON; Ritter JL, 2001, PHARMACOTHERAPY, V21, P1145, DOI 10.1592/phco.21.13.1145.34623; Rizos Evangelos, 2002, Journal of Cardiovascular Pharmacology and Therapeutics, V7, P219, DOI 10.1177/107424840200700404; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Sica DA, 2009, CURR ATHEROSCLER REP, V11, P338, DOI 10.1007/s11883-009-0051-5; Smulders YM, 1997, EUR J CLIN INVEST, V27, P997, DOI 10.1046/j.1365-2362.1997.2330779.x; Statistics Canada, 2010, POP SEX AG GROUP PRO; Tonelli M, 2004, AM J KIDNEY DIS, V44, P832, DOI 10.1053/j.ajkd.2004.07.009; Tonelli M, 2004, KIDNEY INT, V66, P1123, DOI 10.1111/j.1523-1755.2004.00862.x; Tu K, 2003, CAN MED ASSOC J, V168, P553; U.S. Food and Drug Administration, 2011, END MET DRUGS ADV CO; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Waikar SS, 2006, J AM SOC NEPHROL, V17, P1688, DOI 10.1681/ASN.2006010073	54	79	81	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8					560	+		10.7326/0003-4819-156-8-201204170-00401	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-00401			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	930PO	22508733	Green Accepted			2022-12-24	WOS:000303151800015
J	Remais, JV; Eisenberg, JNS				Remais, Justin V.; Eisenberg, Joseph N. S.			Balance between clinical and environmental responses to infectious diseases	LANCET			English	Editorial Material							NEGLECTED TROPICAL DISEASES; HEALTH; CHINA		[Remais, Justin V.] Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Eisenberg, Joseph N. S.] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA	Emory University; Rollins School Public Health; University of Michigan System; University of Michigan	Remais, JV (corresponding author), Emory Univ, Dept Environm Hlth, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	justin.remais@emory.edu	Remais, Justin/V-3207-2019	Remais, Justin/0000-0002-0223-4615	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI091864, R01AI050038] Funding Source: NIH RePORTER; NIAID NIH HHS [R01AI050038, R01 AI050038, K01 AI091864, K01AI091864] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boone SA, 2007, APPL ENVIRON MICROB, V73, P1687, DOI 10.1128/AEM.02051-06; Chadwick E, 1843, REPORT SANITARY CO S; Charest S, 1969, Clin Proc Child Hosp Dist Columbia, V25, P308; Feingold BJ, 2010, ENVIRON HEALTH PERSP, V118, P1165, DOI 10.1289/ehp.0901866; Gould IM, 2006, LANCET, V368, P824, DOI 10.1016/S0140-6736(06)69303-3; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; HARE R, 1961, BRIT MED J, V2, P333, DOI 10.1136/bmj.2.5248.333; Huang SS, 2006, ARCH INTERN MED, V166, P1945, DOI 10.1001/archinte.166.18.1945; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Lerer LB, 1999, LANCET, V354, P1123, DOI 10.1016/S0140-6736(05)76917-8; Li T, 2010, TRENDS PARASITOL, V26, P264, DOI 10.1016/j.pt.2010.02.007; Mahmoud A, 2009, HEALTH AFFAIR, V28, P1726, DOI 10.1377/hlthaff.28.6.1726; Platt R, 2011, NEW ENGL J MED, V364, P1464, DOI 10.1056/NEJMe1014292; Silbergeld EK, 2008, ANNU REV PUBL HEALTH, V29, P151, DOI 10.1146/annurev.publhealth.29.020907.090904; Singer BH, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000104; Snow J., 1855, MODE COMMUNICATION C; Spear RC, 2006, SCIENCE, V314, P1081, DOI 10.1126/science.314.5802.1081c; Sripa B, 2007, PLOS MED, V4, P1148, DOI 10.1371/journal.pmed.0040201; Stiles C, 1939, J PARASITOL, V25, P296; Wang LD, 2009, NEW ENGL J MED, V360, P121, DOI 10.1056/NEJMoa0800135; WOOLLEY PV, 1957, AMER J ROENTGENOL RA, V78, P547; Worrell C, 2011, APPL ENVIRON MICROB, V77, P2192, DOI 10.1128/AEM.01561-10	22	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 14	2012	379	9824					1457	1459		10.1016/S0140-6736(11)61227-0	http://dx.doi.org/10.1016/S0140-6736(11)61227-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	926BR	22475491	Green Accepted			2022-12-24	WOS:000302806800034
J	Grainger, J; Dufau, S; Montant, M; Ziegler, JC; Fagot, J				Grainger, Jonathan; Dufau, Stephane; Montant, Marie; Ziegler, Johannes C.; Fagot, Joel			Orthographic Processing in Baboons (Papio papio)	SCIENCE			English	Article							WORD FORM AREA; MODEL; MONKEYS	Skilled readers use information about which letters are where in a word (orthographic information) in order to access the sounds and meanings of printed words. We asked whether efficient processing of orthographic information could be achieved in the absence of prior language knowledge. To do so, we trained baboons to discriminate English words from nonsense combinations of letters that resembled real words. The results revealed that the baboons were using orthographic information in order to efficiently discriminate words from letter strings that were not words. Our results demonstrate that basic orthographic processing skills can be acquired in the absence of preexisting linguistic representations.	[Grainger, Jonathan] CNRS, F-13331 Marseille, France; Aix Marseille Univ, Lab Psychol Cognit, Federat Rech 3C, Brain & Language Res Inst, F-13331 Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Grainger, J (corresponding author), CNRS, 3 Pl Victor Hugo, F-13331 Marseille, France.	jonathan.grainger@univ-amu.fr	Dufau, Stephane/B-6349-2008; fagot, joel/H-6412-2011; Grainger, Jonathan/C-9299-2009; Ziegler, Johannes/C-2234-2008	Dufau, Stephane/0000-0002-2692-2084; Ziegler, Johannes/0000-0002-2061-5729; fagot, joel/0000-0002-9824-9685	European Research Council (ERC) [230313]; Provence regional council	European Research Council (ERC)(European Research Council (ERC)); Provence regional council	J.G. was supported by the European Research Council (ERC grant 230313). J.F. was supported by research grant Volet Exploratoire 2008 from the Provence regional council. This research was conducted at the Rousset-sur-Arc primate center (CNRS-UPS846), France. The authors thank its staff for technical support. Data are available at (dryad/science Supporting Online Material). J.G., J.F., and J.C.Z. conceived the study and designed the experiment; J.F., M. M., and S. D. implemented the experiment; S. D. analyzed the data; J.F. wrote the test program and conducted the experiment; J.G. wrote the first draft; and all authors contributed equally to latter versions of this article.	Brincat SL, 2006, NEURON, V49, P17, DOI 10.1016/j.neuron.2005.11.026; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dehaene S, 2009, READING BRAIN; Dehaene S, 2007, NEURON, V56, P384, DOI 10.1016/j.neuron.2007.10.004; Dehaene S, 2011, TRENDS COGN SCI, V15, P254, DOI 10.1016/j.tics.2011.04.003; Fagot J, 2010, BEHAV RES METHODS, V42, P507, DOI 10.3758/BRM.42.2.507; Fobes J.L., 1982, P219; Grainger J, 1996, PSYCHOL REV, V103, P518, DOI 10.1037/0033-295X.103.3.518; Grainger J, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00054; Keuleers E, 2012, BEHAV RES METHODS, V44, P287, DOI 10.3758/s13428-011-0118-4; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; Nation K, 2008, Q J EXP PSYCHOL, V61, P1121, DOI 10.1080/17470210802034603; Parron C, 2010, LEARN BEHAV, V38, P374, DOI 10.3758/LB.38.4.374; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Seyfarth RM, 2010, BRAIN LANG, V115, P92, DOI 10.1016/j.bandl.2009.10.003; Whitney C, 2001, PSYCHON B REV, V8, P221, DOI 10.3758/BF03196158; Yarkoni T, 2008, PSYCHON B REV, V15, P971, DOI 10.3758/PBR.15.5.971; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	21	101	101	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					245	248		10.1126/science.1218152	http://dx.doi.org/10.1126/science.1218152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499949				2022-12-24	WOS:000302703900054
J	Graham-Rowe, D				Graham-Rowe, Duncan			Drugs: An injection of hope	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S4	S4		10.1038/nature11109	http://dx.doi.org/10.1038/nature11109			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509505				2022-12-24	WOS:000303149900046
J	Szent-Gyorgyi, LE; Desai, S; Kim, D; Sax, PE; Greenberg, JO				Szent-Gyorgyi, Lara E.; Desai, Sonali; Kim, Daniel; Sax, Paul E.; Greenberg, Jeffrey O.			Removing Legal Barriers to High-Quality Care for HIV-Infected Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Szent-Gyorgyi, Lara E.; Desai, Sonali; Greenberg, Jeffrey O.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Sax, Paul E.] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA; [Desai, Sonali; Kim, Daniel; Sax, Paul E.; Greenberg, Jeffrey O.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Szent-Gyorgyi, LE (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.							LIFSON AR, 1992, CLIN INFECT DIS, V14, P966, DOI 10.1093/clinids/14.4.966-a; May M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6016; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; 2006, MMWR MORB MORTAL WKL, V55, P1	4	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1268	1270		10.1056/NEJMp1114446	http://dx.doi.org/10.1056/NEJMp1114446			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475590				2022-12-24	WOS:000302343000003
J	Kitsios, GD; Kent, DM				Kitsios, Georgios D.; Kent, David M.			Personalised medicine: not just in our genes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GENOME-WIDE ASSOCIATION; PERCUTANEOUS CORONARY INTERVENTION; CLINICAL-TRIALS; INDIVIDUAL PATIENTS; RISK; PHARMACOGENOMICS; HETEROGENEITY; PREDICTION; BENEFIT		[Kent, David M.] Tufts Univ, Sackler Sch Grad Biomed Sci, Clin & Translat Sci Program, Boston, MA 02111 USA; [Kitsios, Georgios D.; Kent, David M.] Tufts Med Ctr, Inst Clin Res & Hlth Policy Studies, Boston, MA USA; [Kitsios, Georgios D.] Lahey Clin Med Ctr, Dept Gen Internal Med, Burlington, MA 01803 USA	Tufts University; Tufts Medical Center; Lahey Hospital & Medical Center	Kent, DM (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Clin & Translat Sci Program, Boston, MA 02111 USA.	dkent1@tuftsmedicalcenter.org		Kitsios, Georgios/0000-0002-1018-948X	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025752] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR025752] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Aradi D, 2010, AM HEART J, V160, P543, DOI 10.1016/j.ahj.2010.06.004; Barber MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009763; Becquement L, 2011, PHARMACOGENOMICS, V12, P113, DOI 10.2217/PGS.10.147; Combescure C, 2010, J THROMB HAEMOST, V8, P923, DOI 10.1111/j.1538-7836.2010.03809.x; Dahabreh IJ, 2011, ANN INTERN MED, V154, P37, DOI 10.7326/0003-4819-154-1-201101040-00006; Flockhart DA, 2008, GENET MED, V10, P139, DOI 10.1097/GIM.0b013e318163c35f; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Hayward RA, 2005, HEALTH AFFAIR, V24, P1571, DOI 10.1377/hlthaff.24.6.1571; Hayward Rodney A, 2006, BMC Med Res Methodol, V6, P18, DOI 10.1186/1471-2288-6-18; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Holmes DR, 2010, J AM COLL CARDIOL, V56, P321, DOI 10.1016/j.jacc.2010.05.013; Holmes MV, 2011, JAMA-J AM MED ASSOC, V306, P2704, DOI 10.1001/jama.2011.1880; Holmes MV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007960; Imai K, 2011, CLIN CHEM, V57, P518, DOI 10.1373/clinchem.2010.158220; Institute for Clinical Systems Improvement, 2010, DIAGN TREATM CHEST P; Institute for Clinical Systems Improvement, 2011, ANT THER SUPPL GUID; Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392; Janssens A Cecile Jw, 2010, Investig Genet, V1, P10, DOI 10.1186/2041-2223-1-10; Kangelaris KN, 2009, J GEN INTERN MED, V24, P656, DOI 10.1007/s11606-009-0949-1; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Kent DM, 2002, AM J MED, V113, P104, DOI 10.1016/S0002-9343(02)01160-9; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Medical Services Commission, 2011, WARF THER MAN INV PR; Nissen SE, 2011, JAMA-J AM MED ASSOC, V306, P2727, DOI 10.1001/jama.2011.1865; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; ROTHWELL PM, 1995, LANCET, V345, P1616, DOI 10.1016/S0140-6736(95)90120-5; Snoep JD, 2007, AM HEART J, V154, P221, DOI 10.1016/j.ahj.2007.04.014; Sofi F, 2010, THROMB HAEMOSTASIS, V103, P841, DOI 10.1160/TH09-06-0418; Swen JJ, 2007, PLOS MED, V4, P1317, DOI 10.1371/journal.pmed.0040209; US FDA, 2011, TABL PHARM BIOM DRUG; Veenstra DL, 2000, AAPS PHARMSCI, V2, part. no.	34	29	30	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e2161	10.1136/bmj.e2161	http://dx.doi.org/10.1136/bmj.e2161			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	923GM	22491484	Green Published			2022-12-24	WOS:000302607700012
J	Gardner, C				Gardner, Caleb			Where all the ladders start	LANCET			English	Editorial Material									Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Johns Hopkins University	Gardner, C (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA.	cgardn12@jhmi.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1190	1191		10.1016/S0140-6736(12)60500-5	http://dx.doi.org/10.1016/S0140-6736(12)60500-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	22470930	Bronze			2022-12-24	WOS:000302230400020
J	Ku, CJ; Wang, YQ; Weiner, OD; Altschuler, SJ; Wu, LNF				Ku, Chin-Jen; Wang, Yanqin; Weiner, Orion D.; Altschuler, Steven J.; Wu, Lani F.			Network Crosstalk Dynamically Changes during Neutrophil Polarization	CELL			English	Article							RHOA ACTIVITY; SIGNALING NETWORKS; CHEMOTAXIS; POLARITY; MICROTUBULES; CELLS; ACTIVATION; MIGRATION; TALK; ADAPTATION	How complex signaling networks shape highly coordinated, multistep cellular responses is poorly understood. Here, we made use of a network-perturbation approach to investigate causal influences, or "crosstalk,'' among signaling modules involved in the cytoskeletal response of neutrophils to chemoattractant. We quantified the intensity and polarity of cytoskeletal marker proteins over time to characterize stereotyped cellular responses. Analyzing the effects of network disruptions revealed that, not only does crosstalk evolve rapidly during polarization, but also that intensity and polarity responses are influenced by different patterns of crosstalk. Interestingly, persistent crosstalk is arranged in a surprisingly simple circuit: a linear cascade from front to back to microtubules influences intensities, and a feed-forward network in the reverse direction influences polarity. Our approach provided a rational strategy for decomposing a complex, dynamically evolving signaling system and revealed evolving paths of causal influence that shape the neutrophil polarization response.	[Ku, Chin-Jen; Wang, Yanqin; Altschuler, Steven J.; Wu, Lani F.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Green Ctr Syst Biol, Simmons Canc Ctr, Dallas, TX 75390 USA; [Weiner, Orion D.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Weiner, Orion D.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Altschuler, SJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Green Ctr Syst Biol, Simmons Canc Ctr, Dallas, TX 75390 USA.	steven.altschuler@utsouthwestern.edu; lani.wu@utsouthwestern.edu	Weiner, Orion D/F-2576-2011	Weiner, Orion D/0000-0002-1778-6543	NIH [GM084040, GM081549, GM071794]; Searle Scholars Foundation; UTSW Medical Center; Welch Foundation [I-1644, I-1619]; Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084040, R01GM081549, R01GM071794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholars Foundation; UTSW Medical Center; Welch Foundation(The Welch Foundation); Rita Allen Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Neal Alto, Al Gilman, Sasha Jilkine, David Mangelsdorf, Benjamin Pavie, Rama Ranganathan, Mike Rosen, and all other members of the Altschuler, Weiner, and Wu labs. O.D.W. was supported by NIH GM084040 and the Searle Scholars Foundation. L.F.W. and S.J.A. were supported by the Endowed Scholars Program at UTSW Medical Center. L.F.W. was supported by NIH GM081549 and the Welch Foundation I-1644. S.J.A. was supported by NIH GM071794, the Welch Foundation I-1619, and the Rita Allen Foundation.	Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Eddy RJ, 2002, MOL BIOL CELL, V13, P4470, DOI 10.1091/mbc.E02-04-0241; FINCH EA, 1991, SCIENCE, V252, P443, DOI 10.1126/science.2017683; Fraser IDC, 2009, NAT IMMUNOL, V10, P327, DOI 10.1038/ni.1711; Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041; Kalir S, 2004, CELL, V117, P713, DOI 10.1016/j.cell.2004.05.010; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Ku CJ, 2010, I S BIOMED IMAGING, P1029, DOI 10.1109/ISBI.2010.5490165; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Levine H, 2006, P NATL ACAD SCI USA, V103, P9761, DOI 10.1073/pnas.0601302103; Loose M, 2007, CURR OPIN HEMATOL, V14, P307, DOI 10.1097/MOH.0b013e3281900eee; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Marco E, 2007, CELL, V129, P411, DOI 10.1016/j.cell.2007.02.043; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; Niggli V, 2003, J CELL SCI, V116, P813, DOI 10.1242/jcs.00306; Odell GM, 2008, J CELL BIOL, V183, P471, DOI 10.1083/jcb.200807129; Oleksiuk O, 2011, CELL, V145, P312, DOI 10.1016/j.cell.2011.03.013; Pe'er D, 2011, CELL, V144, P864, DOI 10.1016/j.cell.2011.03.001; Perlman ZE, 2004, SCIENCE, V306, P1194, DOI 10.1126/science.1100709; Pestonjamasp KN, 2006, BLOOD, V108, P2814, DOI 10.1182/blood-2006-01-010363; Rasband W., 2006, IMAGEJ; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; SCHLIWA M, 1982, CELL, V31, P705, DOI 10.1016/0092-8674(82)90325-7; Schneider IC, 2006, CELL CYCLE, V5, P1130, DOI 10.4161/cc.5.11.2770; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Small JV, 2002, NAT REV MOL CELL BIO, V3, P957, DOI 10.1038/nrm971; Srinivasan S, 2003, J CELL BIOL, V160, P375, DOI 10.1083/jcb.200208179; Tkachenko E, 2011, NAT CELL BIOL, V13, P660, DOI 10.1038/ncb2231; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Weiner OD, 2006, PLOS BIOL, V4, P186, DOI 10.1371/journal.pbio.0040038; Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Wong K, 2007, J CELL BIOL, V179, P1141, DOI 10.1083/jcb.200706167; Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yu RC, 2008, NATURE, V456, P755, DOI 10.1038/nature07513; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585; ZIGMOND SH, 1979, J CELL BIOL, V82, P517, DOI 10.1083/jcb.82.2.517	46	39	40	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1073	1083		10.1016/j.cell.2012.03.044	http://dx.doi.org/10.1016/j.cell.2012.03.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632971	Green Accepted, Bronze			2022-12-24	WOS:000304453900013
J	Johnson, DJ; Beaulieu, WT; Bever, JD; Clay, K				Johnson, Daniel J.; Beaulieu, Wesley T.; Bever, James D.; Clay, Keith			Conspecific Negative Density Dependence and Forest Diversity	SCIENCE			English	Article							PLANT-SOIL FEEDBACKS; TROPICAL FORESTS; SPECIES COEXISTENCE; TEMPERATE TREE; COMMUNITY; PATTERNS; ABUNDANCES; MORTALITY; SEEDLINGS	Conspecific negative density-dependent establishment, in which local abundance negatively affects establishment of conspecific seedlings through host-specific enemies, can influence species diversity of plant communities, but the generality of this process is not well understood. We tested the strength of density dependence using the United States Forest Service's Forest Inventory and Analysis database containing 151 species from more than 200,000 forest plots spanning 4,000,000 square kilometers. We found that most species experienced conspecific negative density dependence (CNDD), but there was little effect of heterospecific density. Additionally, abundant species exhibited weaker CNDD than rarer species, and species-rich regions exhibited stronger CNDD than species-poor regions. Collectively, our results provide evidence that CNDD is a pervasive mechanism driving diversity across a gradient from boreal to subtropical forests.	[Johnson, Daniel J.; Beaulieu, Wesley T.; Bever, James D.; Clay, Keith] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Johnson, DJ (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	dj4@indiana.edu	Johnson, Daniel J./L-4899-2019; Beaulieu, Wesley T/A-9298-2013; Johnson, Daniel/K-8661-2012; Clay, Keith/C-8730-2012	Johnson, Daniel J./0000-0002-8585-2143; Beaulieu, Wesley T/0000-0002-0082-1242; 				Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Chen L, 2010, ECOL LETT, V13, P695, DOI 10.1111/j.1461-0248.2010.01468.x; Chisholm RA, 2011, THEOR ECOL-NETH, V4, P241, DOI 10.1007/s12080-011-0119-z; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; Clay Keith, 2008, P145; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Connell H., 1971, DYNAMICS POPULATIONS, P298; CURRIE DJ, 1987, NATURE, V329, P326, DOI 10.1038/329326a0; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell Stephen P., 2001, V32, pi; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kobe RK, 2011, ECOL LETT, V14, P503, DOI 10.1111/j.1461-0248.2011.01612.x; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	24	278	290	16	340	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					904	907		10.1126/science.1220269	http://dx.doi.org/10.1126/science.1220269			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605774				2022-12-24	WOS:000304145600062
J	Fridley, JD				Fridley, Jason D.			Extended leaf phenology and the autumn niche in deciduous forest invasions	NATURE			English	Article							NORTHERN HARDWOOD FOREST; EASTERN UNITED-STATES; EARTHWORM INVASION; SEASONAL-VARIATION; UNDERSTORY SHRUBS; NUTRIENT DYNAMICS; PLANT INVASIONS; CARBON-DIOXIDE; WOODY-PLANTS; TEMPERATE	The phenology of growth in temperate deciduous forests, including the timing of leaf emergence and senescence, has strong control over ecosystem properties such as productivity(1,2) and nutrient cycling(3,4), and has an important role in the carbon economy of understory plants(5-7). Extended leaf phenology, whereby understory species assimilate carbon in early spring before canopy closure or in late autumn after canopy fall, has been identified as a key feature of many forest species invasions(5,8-10), but it remains unclear whether there are systematic differences in the growth phenology of native and invasive forest species(11) or whether invaders are more responsive to warming trends that have lengthened the duration of spring or autumn growth(12). Here, in a 3-year monitoring study of 43 native and 30 non-native shrub and liana species common to deciduous forests in the eastern United States, I show that extended autumn leaf phenology is a common attribute of eastern US forest invasions, where non-native species are extending the autumn growing season by an average of 4 weeks compared with natives. In contrast, there was no consistent evidence that non-natives as a group show earlier spring growth phenology, and non-natives were not better able to track interannual variation in spring temperatures. Seasonal leaf production and photosynthetic data suggest that most non-native species capture a significant proportion of their annual carbon assimilate after canopy leaf fall, a behaviour that was virtually absent in natives and consistent across five phylogenetic groups. Pronounced differences in how native and non-native understory species use pre- and post-canopy environments suggest eastern US invaders are driving a seasonal redistribution of forest productivity that may rival climate change in its impact on forest processes.	Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Syracuse University	Fridley, JD (corresponding author), Syracuse Univ, Dept Biol, 107 Coll Pl, Syracuse, NY 13244 USA.	fridley@syr.edu			Syracuse University	Syracuse University	I acknowledge technical assistance and advice from A. Craddock, S. Anderson, E. Fridley, S. Kelley, A. Surace, L. Giencke and D. Frank, and project support from Syracuse University.	ABER JD, 1989, BIOSCIENCE, V39, P378, DOI 10.2307/1311067; Augspurger CK, 2005, FUNCT ECOL, V19, P537, DOI 10.1111/j.1365-2435.2005.01027.x; Augspurger CK, 2003, TREE PHYSIOL, V23, P517, DOI 10.1093/treephys/23.8.517; CANHAM CD, 1990, CAN J FOREST RES, V20, P620, DOI 10.1139/x90-084; CHAPIN FS, 1983, CAN J FOREST RES, V13, P773, DOI 10.1139/x83-107; Ehlers J, 2007, QUATERN INT, V164-65, P6, DOI 10.1016/j.quaint.2006.10.008; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Frelich LE, 2006, BIOL INVASIONS, V8, P1235, DOI 10.1007/s10530-006-9019-3; Fridley JD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003630; Gill DS, 1998, TREE PHYSIOL, V18, P281; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; HARRINGTON RA, 1989, OECOLOGIA, V80, P356, DOI 10.1007/BF00379037; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Hothorn T, 2010, EXACTRANKTESTS EXACT; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HUTCHISON BA, 1977, ECOL MONOGR, V47, P185, DOI 10.2307/1942616; Koenker R., 2009, QUANTREG QUANTILE RE; Lambers H., 2008, PLANT PHYSL ECOLOGY, DOI DOI 10.1007/978-0-387-78341-3_9; LECHOWICZ MJ, 1984, AM NAT, V124, P821, DOI 10.1086/284319; Liao CZ, 2008, NEW PHYTOL, V177, P706, DOI 10.1111/j.1469-8137.2007.02290.x; Mack RN, 2003, ANN MO BOT GARD, V90, P77, DOI 10.2307/3298528; Mack RN, 2003, INT J PLANT SCI, V164, pS185, DOI 10.1086/368399; MAY JD, 1992, ECOLOGY, V73, P1868, DOI 10.2307/1940038; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MORGAN DC, 1979, PLANTA, V145, P253, DOI 10.1007/BF00454449; MULLER RN, 1976, SCIENCE, V193, P1126, DOI 10.1126/science.193.4258.1126; Myers CV, 2003, AM MIDL NAT, V150, P231, DOI 10.1674/0003-0031(2003)150[0231:SVIPRI]2.0.CO;2; Nuzzo VA, 2009, CONSERV BIOL, V23, P966, DOI 10.1111/j.1523-1739.2009.01168.x; Piao SL, 2008, NATURE, V451, P49, DOI 10.1038/nature06444; Pinheiro J., 2011, NLME LINEAR NONLINEA; Polgar CA, 2011, NEW PHYTOL, V191, P926, DOI 10.1111/j.1469-8137.2011.03803.x; Richardson AD, 2002, NEW PHYTOL, V153, P185, DOI 10.1046/j.0028-646X.2001.00289.x; Richardson AD, 2010, PHILOS T R SOC B, V365, P3227, DOI 10.1098/rstb.2010.0102; Rothstein DE, 2001, FUNCT ECOL, V15, P722, DOI 10.1046/j.0269-8463.2001.00584.x; Saxe H, 2001, NEW PHYTOL, V149, P369, DOI 10.1046/j.1469-8137.2001.00057.x; SCHIERENBECK KA, 1993, AM J BOT, V80, P1292, DOI 10.2307/2445713; Webster CR, 2006, J FOREST, V104, P366; Willis CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008878; Wolkovich EM, 2011, FRONT ECOL ENVIRON, V9, P287, DOI 10.1890/100033; Wood SN, 2008, J R STAT SOC B, V70, P495, DOI 10.1111/j.1467-9868.2007.00646.x; Xu CY, 2007, OECOLOGIA, V154, P11, DOI 10.1007/s00442-007-0807-y	41	236	248	10	332	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					359	U105		10.1038/nature11056	http://dx.doi.org/10.1038/nature11056			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22535249				2022-12-24	WOS:000304099100040
J	Greenbaum, C				Greenbaum, Carla			Rethink the immune connection	NATURE			English	Editorial Material							TYPE-1 DIABETES-MELLITUS; CONTROLLED-TRIAL; DOUBLE-BLIND; INSULIN		Benaroya Res Inst, Diabet program, Seattle, WA USA	Benaroya Research Institute	Greenbaum, C (corresponding author), Benaroya Res Inst, Diabet program, Seattle, WA USA.	cjgreen@benaroyaresearch.org						Karvonen M, 2000, DIABETES CARE, V23, P1516, DOI 10.2337/diacare.23.10.1516; Kimmelman J, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001010; Nanto-Salonen K, 2008, LANCET, V372, P1746, DOI 10.1016/S0140-6736(08)61309-4; Orban T, 2011, LANCET, V378, P412, DOI 10.1016/S0140-6736(11)60886-6; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568	6	1	1	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					S9	S9		10.1038/485S9a	http://dx.doi.org/10.1038/485S9a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	968AT	22616097	Bronze			2022-12-24	WOS:000305950100004
J	Lee, MJ; Ye, AS; Gardino, AK; Heijink, AM; Sorger, PK; MacBeath, G; Yaffe, MB				Lee, Michael J.; Ye, Albert S.; Gardino, Alexandra K.; Heijink, Anne Margriet; Sorger, Peter K.; MacBeath, Gavin; Yaffe, Michael B.			Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling Networks	CELL			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION PATTERNS; NEGATIVE BREAST-CANCER; ANTITUMOR-ACTIVITY; EGFR MUTATIONS; LINES; RESISTANCE; LAPATINIB; INHIBITION; ACTIVATION	Crosstalk and complexity within signaling pathways and their perturbation by oncogenes limit component-by-component approaches to understanding human disease. Network analysis of how normal and oncogenic signaling can be rewired by drugs may provide opportunities to target tumors with high specificity and efficacy. Using targeted inhibition of oncogenic signaling pathways, combined with DNA-damaging chemotherapy, we report that time-staggered EGFR inhibition, but not simultaneous coadministration, dramatically sensitizes a subset of triple-negative breast cancer cells to genotoxic drugs. Systems-level analysis-using high-density time-dependent measurements of signaling networks, gene expression profiles, and cell phenotypic responses in combination with mathematical modeling-revealed an approach for altering the intrinsic state of the cell through dynamic rewiring of oncogenic signaling pathways. This process converts these cells to a less tumorigenic state that is more susceptible to DNA damage-induced cell death by reactivation of an extrinsic apoptotic pathway whose function is suppressed in the oncogene-addicted state.	[Lee, Michael J.; Gardino, Alexandra K.; Heijink, Anne Margriet; Yaffe, Michael B.] MIT, Dept Biol, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Lee, Michael J.; Gardino, Alexandra K.; Heijink, Anne Margriet; Yaffe, Michael B.] MIT, Dept Biol Engn, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Lee, Michael J.; Ye, Albert S.; Gardino, Alexandra K.; Sorger, Peter K.; MacBeath, Gavin; Yaffe, Michael B.] MIT, Cell Decis Proc Ctr, Cambridge, MA 02139 USA; [Lee, Michael J.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Sorger, Peter K.; MacBeath, Gavin] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Harvard Medical School	Yaffe, MB (corresponding author), MIT, Dept Biol, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	myaffe@mit.edu		Sorger, Peter/0000-0002-3364-1838; Heijink, Anne Margriet/0000-0001-9229-0575; MacBeath, Gavin/0000-0003-2585-6772; Lee, Michael/0000-0003-3378-6196	NIH [CA112967, GM68762, ES015339]; DOD [BC097884]; NATIONAL CANCER INSTITUTE [U54CA112967] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Sandra Morandell, Kylie Huang, Jose McFaline, and Jessica Reddy for technical assistance in the early stages of this study and the Swanson Biotechnology Center at the Koch Institute for their technical support, including Eliza Vasile (microscopy), Glen Paradis (flow cytometry), and especially Charlie Whittaker (bioinformatics) for his guidance in analyzing microarray experiments. We further thank Doug Lauffenburger and members of the CDP community for fruitful discussions and advice throughout the development and execution of this study. This work was supported by NIH grants CA112967 and GM68762 to P. K. S. and M.B.Y, ES015339 to M.B.Y., and DOD fellowship BC097884 to M.J.L. P. K. S., G. M., and M.B.Y. are founders and shareholders of Merrimack Pharmaceuticals. P. K. S. and M.B.Y. are scientific advisory board members, and G. M. is a current employee. G. M. is also a scientific advisory board member of Aushon Biosystems.	Abeloff M. D., 2008, CLIN ONCOLOGY, P1875; Albeck JG, 2008, PLOS BIOL, V6, P2831, DOI 10.1371/journal.pbio.0060299; Balko JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-289; Bosch A, 2010, CANCER TREAT REV, V36, P206, DOI 10.1016/j.ctrv.2009.12.002; Carey L., 2008, J CLIN ONCOL, V26, P26; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Corkery B, 2009, ANN ONCOL, V20, P862, DOI 10.1093/annonc/mdn710; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Diaz R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-188; Ekins S, 2007, METH MOL B, V356, P319; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Helfrich BA, 2006, CLIN CANCER RES, V12, P7117, DOI 10.1158/1078-0432.CCR-06-0760; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2008, CELL, V135, P343, DOI 10.1016/j.cell.2008.08.034; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Kang N, 2010, CANCER LETT, V294, P147, DOI 10.1016/j.canlet.2010.01.032; Kim R, 2005, CANCER-AM CANCER SOC, V103, P1551, DOI 10.1002/cncr.20947; LICHTER AS, 1995, NEW ENGL J MED, V332, P371, DOI 10.1056/NEJM199502093320607; Lopez JP, 2007, ARCH OTOLARYNGOL, V133, P1022, DOI 10.1001/archotol.133.10.1022; MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037; MONTESANO R, 1977, J NATL CANCER I, V59, P1651, DOI 10.1093/jnci/59.6.1651; Morgillo F, 2011, LUNG CANCER, V71, P283, DOI 10.1016/j.lungcan.2010.06.005; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pawson T, 2008, FEBS LETT, V582, P1266, DOI 10.1016/j.febslet.2008.02.011; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rusnak DW, 2007, CELL PROLIFERAT, V40, P580, DOI 10.1111/j.1365-2184.2007.00455.x; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; Sevecka M, 2006, NAT METHODS, V3, P825, DOI 10.1038/nmeth931; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Turner JG, 2006, BLOOD, V108, P3881, DOI 10.1182/blood-2005-10-009084; Winer E.P., 2007, SABCS 2007 IMPROVING; Woehlecke H, 2003, INT J CANCER, V107, P721, DOI 10.1002/ijc.11444; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yoon CH, 2009, MOL CANCER RES, V7, P361, DOI 10.1158/1541-7786.MCR-08-0069	42	479	490	1	120	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					780	794		10.1016/j.cell.2012.03.031	http://dx.doi.org/10.1016/j.cell.2012.03.031			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579283	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000303934700012
J	Van Langenhove, L				Van Langenhove, Luk			Make social sciences relevant	NATURE			English	Editorial Material									[Van Langenhove, Luk] United Nations Univ, Inst Comparat Reg Integrat Studies, Brugge, Belgium		Van Langenhove, L (corresponding author), United Nations Univ, Inst Comparat Reg Integrat Studies, Brugge, Belgium.	lvanlangenhove@cris.unu.edu		Van Langenhove, Luk/0000-0002-8202-5804				[Anonymous], 2010, WORLD SOC SCI REP 20; Jonkers K., 2011, BIBLIOMETRIC REPORT; Van Langenhove L., 2007, INNOVATING SOCIAL SC	3	9	9	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					442	442		10.1038/484442a	http://dx.doi.org/10.1038/484442a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	931FF	22538586	Bronze			2022-12-24	WOS:000303200400021
J	Lewis, SL				Lewis, Simon L.			We must set planetary boundaries wisely	NATURE			English	Editorial Material									[Lewis, Simon L.] UCL, London WC1E 6BT, England; [Lewis, Simon L.] Univ Leeds, Leeds LS2 9JT, W Yorkshire, England	University of London; University College London; University of Leeds	Lewis, SL (corresponding author), UCL, London WC1E 6BT, England.	s.l.lewis@leeds.ac.uk		Lewis, Simon/0000-0002-8066-6851					0	53	61	3	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					417	417		10.1038/485417a	http://dx.doi.org/10.1038/485417a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622531	Bronze			2022-12-24	WOS:000304344500006
J	Herzig, SJ; Rothberg, MB				Herzig, Shoshana J.; Rothberg, Michael B.			Prophylaxis rates for venous thromboembolism and gastrointestinal bleeding in general medical patients: too low or too high?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							STRESS-ULCER PROPHYLAXIS; AMERICAN-COLLEGE; RISK; PREVENTION; PLACEBO; METAANALYSIS		[Herzig, Shoshana J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Herzig, Shoshana J.] Harvard Univ, Sch Med, Boston, MA USA; [Rothberg, Michael B.] Baystate Med Ctr, Div Gen Med, Springfield, MA USA; [Rothberg, Michael B.] Tufts Univ, Sch Med, Boston, MA 02111 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Baystate Medical Center; Tufts University	Herzig, SJ (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA.	sherzig@bidmc.harvard.edu						ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Cohen AT, 2008, LANCET, V371, P387, DOI 10.1016/S0140-6736(08)60202-0; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; COOK DJ, 1994, NEW ENGL J MED, V330, P377, DOI 10.1056/NEJM199402103300601; Cook DJ, 1996, JAMA-J AM MED ASSOC, V275, P308, DOI 10.1001/jama.275.4.308; Dentali F, 2007, ANN INTERN MED, V146, P278, DOI 10.7326/0003-4819-146-4-200702200-00007; Department of Health, 2010, US COMM QUAL INN CQU; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Erstad BL, 1999, AM J HEALTH-SYST PH, V56, P347; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Heidelbaugh JJ, 2006, AM J GASTROENTEROL, V101, P2200, DOI 10.1111/j.1572-0241.2006.00839.x; Herzig SJ, 2011, ARCH INTERN MED, V171, P991, DOI 10.1001/archinternmed.2011.14; Herzig SJ, 2009, JAMA-J AM MED ASSOC, V301, P2120, DOI 10.1001/jama.2009.722; Howell MD, 2010, ARCH INTERN MED, V170, P784, DOI 10.1001/archinternmed.2010.89; Janicki T, 2007, J HOSP MED, V2, P86, DOI 10.1002/jhm.177; Joint Commission on the Accreditation of Healthcare Organizations, 2011, VEN THROMB VEN THROM; Lederle FA, 2011, ANN INTERN MED, V155, P602, DOI 10.7326/0003-4819-155-9-201111010-00008; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Maynard G, 2008, AHRQ PUBLICATION; Nardino RJ, 2000, AM J GASTROENTEROL, V95, P3118; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Rothberg MB, 2011, J HOSP MED, V6, P202, DOI 10.1002/jhm.888; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Sanofi UK, 2010, SPONS 2010; Straube S, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-41; Tapson VF, 2007, CHEST, V132, P936, DOI 10.1378/chest.06-2993; Treasure T, 2010, J ROY SOC MED, V103, P210, DOI 10.1258/jrsm.2010.100086; Wein L, 2007, ARCH INTERN MED, V167, P1476, DOI 10.1001/archinte.167.14.1476	28	5	5	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 18	2012	344								e3248	10.1136/bmj.e3248	http://dx.doi.org/10.1136/bmj.e3248			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946NV	22611168				2022-12-24	WOS:000304359600003
J	Gravitz, L				Gravitz, Lauren			The critters within	NATURE			English	Editorial Material																		Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Vrieze A, 2010, DIABETOLOGIA, V53, P606, DOI 10.1007/s00125-010-1662-7	4	26	42	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					S12	S13		10.1038/485S12a	http://dx.doi.org/10.1038/485S12a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	968AT	22616099				2022-12-24	WOS:000305950100006
J	Gill, PJ; Harnden, A; Karpe, F				Gill, Peter J.; Harnden, Anthony; Karpe, Fredrik			EASILY MISSED? Familial hypercholesterolaemia	BRITISH MEDICAL JOURNAL			English	Editorial Material							PROSPECTIVE REGISTRY; DIAGNOSIS; MANAGEMENT; MORTALITY; IDENTIFICATION; CHILDREN; DISEASE; COHORT		[Gill, Peter J.; Harnden, Anthony] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England; [Gill, Peter J.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Karpe, Fredrik] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	University of Oxford; University of Alberta; University of Oxford	Gill, PJ (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England.	peter.gill@phc.ox.ac.uk	Gill, Peter J./A-6021-2012	Gill, Peter J./0000-0002-6253-1312; Karpe, Fredrik/0000-0002-2751-1770				ASSOULINE L, 1995, PEDIATRICS, V96, P239; Beeharry D, 2006, ANN RHEUM DIS, V65, P312, DOI 10.1136/ard.2005.040766; Campagna F, 2008, ATHEROSCLEROSIS, V196, P356, DOI 10.1016/j.atherosclerosis.2006.11.015; Civeira F, 2008, AM J CARDIOL, V102, P1187, DOI 10.1016/j.amjcard.2008.06.056; Durrington PN, 2003, OXFORD TXB MED, P74; Goldberg AC, 2011, J CLIN LIPIDOL, V5, pS1, DOI 10.1016/j.jacl.2011.04.003; Junyent M, 2005, ARTERIOSCL THROM VAS, V25, P2203, DOI 10.1161/01.ATV.0000183888.48105.d1; Mant D, 2009, BRIT J GEN PRACT, V59, P777, DOI 10.3399/bjgp09X472683; Marks D, 2006, J MED SCREEN, V13, P156, DOI 10.1258/096914106778440617; Marks D, 2004, J PUBLIC HEALTH-UK, V26, P353, DOI 10.1093/pubmed/fdh176; Marks D, 2003, ATHEROSCLEROSIS, V168, P1, DOI 10.1016/S0021-9150(02)00330-1; National Institute for Health and Clinical Excellence, 2008, ID MAN FAM HYP; Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422; Neil HAW, 2000, BRIT MED J, V321, P148, DOI 10.1136/bmj.321.7254.148; Nherera L, 2011, HEART, V97, P1175, DOI 10.1136/hrt.2010.213975; Qureshi N, 2009, BRIT J GEN PRACT, V59, P773, DOI 10.3399/bjgp09X472674; Raal FJ, 2011, CIRCULATION, V124, P2202, DOI 10.1161/CIRCULATIONAHA.111.042523; Rodenburg J, 2007, CIRCULATION, V116, P664, DOI 10.1161/CIRCULATIONAHA.106.671016; SLACK J, 1969, LANCET, V2, P1380; Starr B, 2008, CLIN CHEM LAB MED, V46, P791, DOI 10.1515/CCLM.2008.135; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423; 1991, BMJ CLIN RES ED, V303, P893; 1999, ATHEROSCLEROSIS, V142, P105	24	12	12	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 11	2012	344								e3228	10.1136/bmj.e3228	http://dx.doi.org/10.1136/bmj.e3228			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	942XU	22581572				2022-12-24	WOS:000304085700002
J	Duncan, JL; Harrild, KA; Iversen, L; Lee, AJ; Godden, DJ				Duncan, John L.; Harrild, Kirsten A.; Iversen, Lisa; Lee, Amanda J.; Godden, David J.			Long term outcomes in men screened for abdominal aortic aneurysm: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; FOLLOW-UP; MORTALITY; RISK; SURVEILLANCE; DIAMETER	Objective To determine whether there is a relation between aortic diameter and morbidity and mortality in men screened for abdominal aortic aneurysm. Design Prospective cohort study. Setting Highland and Western Isles (a large, sparsely populated area of Scotland). Participants 8146 men aged 65-74. Main outcome measures Morbidity and mortality in relation to presence of abdominal aortic aneurysm and three categories of aortic diameter (<= 24 mm, 25-29 mm, and >= 30 mm). Results When screened, 414 men (5.1%) had an aneurysm (diameter >= 30 mm), 669 (8.2%) an aortic diameter of 25-29 mm, and 7063 (86.7%) an aortic diameter of <= 24 mm. The cohort was followed up for a median of 7.4 (interquartile range 6.9-8.2) years. Mortality was significantly associated with aortic diameter: 512 (7.2%) men in the <= 24 mm group died compared with 69 (10.3%) in the 25-29 mm group and 73 (17.6%) in the >= 30 mm group. The mortality risk in men with an aneurysm or with an aorta measuring 25-29 mm was significantly higher than in men with an aorta of <= 24 mm. The increased mortality risk in the 25-29 mm group was reduced when taking confounders such as smoking and known heart disease into account. After adjustment, compared with men with an aortic diameter of <= 24 mm, the risk of hospital admission for cardiovascular disease and chronic obstructive pulmonary disease was significantly higher in men with aneurysm and those with aortas measuring 25-29 mm. Men with an aneurysm also had an increased risk of hospital admission for cerebrovascular disease, atherosclerosis, peripheral arterial disease, and respiratory disease. In men with aortas measuring 25-29 mm, the risk of hospital admission with abdominal aortic aneurysm was significantly higher than in men with an aorta of <= 24 mm (adjusted hazard ratio 6.7, 99% confidence interval 3.4 to 13.2) and this increased risk became apparent two years after screening. Conclusions Men with abdominal aortic aneurysm and those with aortic diameters measuring 25-29 mm have an increased risk of mortality and subsequent hospital admissions compared with men with an aorta diameter of <= 24 mm. Consideration should be given to control of risk factors and to rescreening men with aortas measuring 25-29 mm at index scanning.	[Duncan, John L.] Raigmore Hosp, Dept Surg, Inverness IV2 3UJ, Scotland; [Harrild, Kirsten A.; Lee, Amanda J.] Univ Aberdeen, Div Appl Hlth Sci, Med Stat Team, Aberdeen, Scotland; [Godden, David J.] Univ Aberdeen, Ctr Hlth Sci, Ctr Rural Hlth, Inverness, Scotland	University of Aberdeen; UHI Millennium Institute; University of Aberdeen	Duncan, JL (corresponding author), Raigmore Hosp, Dept Surg, Inverness IV2 3UJ, Scotland.	john.duncan3@nhs.net		Iversen, Lisa/0000-0002-2524-5229	Chief Scientist Office, Scotland [CZG/2/485]; Chief Scientist Office [CZG/2/485] Funding Source: researchfish	Chief Scientist Office, Scotland; Chief Scientist Office	The project was funded by a grant from the Chief Scientist Office, Scotland (CZG/2/485). The funder had no role in the study design; the collection, analysis, and interpretation of data; the writing of the article; or the decision to submit the article for publication.	[Anonymous], 2012, NHS ABD AORT AN SCRE; Ashton HA, 2002, LANCET, V360, P1531, DOI 10.1016/S0140-6736(02)11522-4; Ashton HA, 2002, BMJ-BRIT MED J, V325, P1135; Brady AR, 2001, ARTERIOSCL THROM VAS, V21, P1203, DOI 10.1161/hq0701.091999; Cosford PA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002945.pub2; Duncan JL, 2005, BRIT J SURG, V92, P984, DOI 10.1002/bjs.5120; Forsdahl SH, 2009, CIRCULATION, V119, P2202, DOI 10.1161/CIRCULATIONAHA.108.817619; Freiberg MS, 2008, CIRCULATION, V117, P1010, DOI 10.1161/CIRCULATIONAHA.107.720219; Lindholt JS, 2007, EUR J VASC ENDOVASC, V33, P94, DOI 10.1016/j.ejvs.2006.06.007; Lindholt JS, 2011, BRIT J SURG, V98, P619, DOI 10.1002/bjs.7464; Lindholt JS, 2000, EUR J VASC ENDOVASC, V20, P369, DOI 10.1053/ejvs.2000.1191; Lindsay SM, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-80; McCarthy RJ, 2003, BRIT J SURG, V90, P821, DOI 10.1002/bjs.4216; Newman AB, 2001, ANN INTERN MED, V134, P182, DOI 10.7326/0003-4819-134-3-200102060-00008; Powell JT, 2007, BRIT J SURG, V94, P702, DOI 10.1002/bjs.5778; REED D, 1992, CIRCULATION, V85, P205, DOI 10.1161/01.CIR.85.1.205; Scott RAP, 2001, EUR J VASC ENDOVASC, V21, P535, DOI 10.1053/ejvs.2001.1368; Scottish Government, 2008, SCOTT GOV URB RUR CL; Scottish Government, 2004, SCOTT IND MULT DEPR; Takagi H, 2010, J VASC SURG, V52, P1103, DOI 10.1016/j.jvs.2010.02.283; The Scottish Government, 2010, SCOTT ABD AORT AN SC; Thompson SG, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2307	22	46	46	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 4	2012	344								e2958	10.1136/bmj.e2958	http://dx.doi.org/10.1136/bmj.e2958			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	939NN	22563092	Green Submitted, hybrid, Green Published			2022-12-24	WOS:000303818500001
J	Torjesen, I				Torjesen, Ingrid			Why using Avastin for eye disease is so difficult	BRITISH MEDICAL JOURNAL			English	Editorial Material												ingrid_torjesen@hotmail.com						[Anonymous], 2012, MOORFIELDS PHARM REC; [Anonymous], 2011, INPHARM         1007; European Alliance for Access to Safe Medicines, MEMB FUND; Macular Disease Society, GOV MUST ACT AV; North Yorkshire and York PCT, MIN BOARD M 24 JAN 2; North Yorkshire and York PCT, 2012, RAN LUC BEV AV OPHTH; Royal College of Ophthalmologists, 2011, RCOPHTH REV CONCL AV	7	9	10	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAY 1	2012	344								e3012	10.1136/bmj.e3012	http://dx.doi.org/10.1136/bmj.e3012			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939MZ	22549057				2022-12-24	WOS:000303816700016
J	Lasserson, D; Fox, R; Farmer, A				Lasserson, Daniel; Fox, Robin; Farmer, Andrew			Late onset type 1 diabetes	BRITISH MEDICAL JOURNAL			English	Editorial Material							YOUNG-ADULTS; MORTALITY; DIAGNOSIS; CHILDREN		[Lasserson, Daniel; Farmer, Andrew] Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England; [Fox, Robin] Ctr Hlth, Bicester, Oxon, England	University of Oxford	Lasserson, D (corresponding author), Univ Oxford, Dept Primary Care Hlth Sci, Oxford OX1 2ET, England.	daniel.lasserson@phc.ox.ac.uk	Lasserson, Daniel S/T-8978-2017	Lasserson, Daniel/0000-0001-8274-5580				Bruno G, 2005, DIABETES CARE, V28, P2613, DOI 10.2337/diacare.28.11.2613; Bruno G, 2009, NUTR METAB CARDIOVAS, V19, P340, DOI 10.1016/j.numecd.2008.03.010; Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y; Harjutsalo V, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5364; Imkampe AK, 2011, DIABETIC MED, V28, P811, DOI 10.1111/j.1464-5491.2011.03288.x; Royal College of General Practitioners NHS Diabetes, 2011, NHS DIAB COD CLASS D; Sabbah E, 2000, DIABETES CARE, V23, P1326, DOI 10.2337/diacare.23.9.1326; The National Collaborating Centre for Chronic Conditions, 2004, FEN MICR EV TYP 1 DI; Tuomi T, 2005, DIABETES, V54, pS40, DOI 10.2337/diabetes.54.suppl_2.S40; Usher-Smith JA, 2011, BMJ-BRIT MED J, V343, pd4092, DOI DOI 10.1136/BMJ.D4092; Zimmet P, 1999, DIABETES CARE, V22, pB59	11	6	6	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	APR 30	2012	344								e2827	10.1136/bmj.e2827	http://dx.doi.org/10.1136/bmj.e2827			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	939MY	22547644				2022-12-24	WOS:000303816600005
J	Baker, M				Baker, Monya			THE INTERACTION MAP	NATURE			English	Editorial Material							PROTEIN-PROTEIN INTERACTIONS											Bandyopadhyay S, 2010, NAT METHODS, V7, P801, DOI 10.1038/NMETH.1506; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jager S, 2012, NATURE, V481, P365, DOI 10.1038/nature10719; Lievens S, 2009, J PROTEOME RES, V8, P877, DOI 10.1021/pr8005167; Suter B., 2012, 2 HYBRID TECHNOLOGIE; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106	12	17	19	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					271	275		10.1038/484271a	http://dx.doi.org/10.1038/484271a			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498631	Bronze			2022-12-24	WOS:000303149900041
J	Ransohoff, RM				Ransohoff, Richard M.			Perspective: Let the sunshine in!	NATURE			English	Editorial Material																			0	0	1	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S8	S8		10.1038/nature11106	http://dx.doi.org/10.1038/nature11106			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509509	Bronze			2022-12-24	WOS:000303149900050
J	Zomer, E; Owen, A; Magliano, DJ; Liew, D; Reid, CM				Zomer, Ella; Owen, Alice; Magliano, Dianna J.; Liew, Danny; Reid, Christopher M.			The effectiveness and cost effectiveness of dark chocolate consumption as prevention therapy in people at high risk of cardiovascular disease: best case scenario analysis using a Markov model	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE; DEPENDENT VASODILATION; INSULIN-RESISTANCE; DIABETES-MELLITUS; HEALTHY HUMANS; NITRIC-OXIDE; COCOA; HYPERTENSION; METAANALYSIS	Objective To model the long term effectiveness and cost effectiveness of daily dark chocolate consumption in a population with metabolic syndrome at high risk of cardiovascular disease. Design Best case scenario analysis using a Markov model. Setting Australian Diabetes, Obesity and Lifestyle study. Participants 2013 people with hypertension who met the criteria for metabolic syndrome, with no history of cardiovascular disease and not receiving antihypertensive therapy. Main outcome measures Treatment effects associated with dark chocolate consumption derived from published meta-analyses were used to determine the absolute number of cardiovascular events with and without treatment. Costs associated with cardiovascular events and treatments were applied to determine the potential amount of funding required for dark chocolate therapy to be considered cost effective. Results Daily consumption of dark chocolate (polyphenol content equivalent to 100 g of dark chocolate) can reduce cardiovascular events by 85 (95% confidence interval 60 to 105) per 10 000 population treated over 10 years. $A40 (25; pound (sic)31; $42) could be cost effectively spent per person per year on prevention strategies using dark chocolate. These results assume 100% compliance and represent a best case scenario. Conclusions The blood pressure and cholesterol lowering effects of dark chocolate consumption are beneficial in the prevention of cardiovascular events in a population with metabolic syndrome. Daily dark chocolate consumption could be an effective cardiovascular preventive strategy in this population.	[Zomer, Ella; Owen, Alice; Reid, Christopher M.] Monash Univ, Alfred Ctr, Dept Epidemiol & Prevent Med, CCRE Therapeut, Melbourne, Vic 3004, Australia; [Magliano, Dianna J.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Liew, Danny] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne EpiCtr, Melbourne, Vic 3010, Australia	Monash University; Baker Heart and Diabetes Institute; Royal Melbourne Hospital; University of Melbourne	Reid, CM (corresponding author), Monash Univ, Alfred Ctr, Dept Epidemiol & Prevent Med, CCRE Therapeut, Melbourne, Vic 3004, Australia.	Chris.Reid@monash.edu	Reid, Christopher M/AAP-8135-2021; Zomer, Ella/AAE-2462-2019	Reid, Christopher/0000-0001-9173-3944; Magliano, Dianna/0000-0002-9507-6096; Zomer, Ella/0000-0002-9993-4297; Liew, Danny/0000-0002-0131-623X; Magliano, Dianna Josephine/0000-0002-6026-5065	Australian Research Council [LP0775329]; Sanofi-Aventis Australia	Australian Research Council(Australian Research Council); Sanofi-Aventis Australia(Sanofi-Aventis)	This research was supported by an Australian Research Council linkage grant (LP0775329) with Sanofi-Aventis Australia.	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Australian Institute of Health and Welfare, 2011, NAT GRIM BOOKS; Balzer J, 2008, J AM COLL CARDIOL, V51, P2141, DOI 10.1016/j.jacc.2008.01.059; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Egan BM, 2010, HYPERTENSION, V55, P1289, DOI 10.1161/HYPERTENSIONAHA.110.151522; Field DT, 2011, PHYSIOL BEHAV, V103, P255, DOI 10.1016/j.physbeh.2011.02.013; Fisher NDL, 2003, J HYPERTENS, V21, P2281, DOI 10.1097/00004872-200312000-00016; Fraga CG, 2011, J CLIN BIOCHEM NUTR, V48, P63, DOI 10.3164/jcbn.11-010FR; Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70; Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671; Hollenberg N.K., 2004, BRIT J CARDIOLOGY, V11, P379; Huynh Tai, 2004, Physician Exec, V30, P56; Jia L, 2010, AM J CLIN NUTR, V92, P218, DOI 10.3945/ajcn.2009.28202; Jones PH, 2003, AM J CARDIOL, V92, P152, DOI 10.1016/S0002-9149(03)00530-7; Katz DL, 2011, ANTIOXID REDOX SIGN, V15, P2779, DOI 10.1089/ars.2010.3697; Law MR, 2003, BRIT MED J, V326, P1427, DOI 10.1136/bmj.326.7404.1427; Li R, 2010, DIABETES CARE, V33, P1872, DOI 10.2337/dc10-0843; Lippi G, 2009, J THROMB THROMBOLYS, V28, P482, DOI 10.1007/s11239-008-0273-3; Macht M, 2006, APPETITE, V46, P332, DOI 10.1016/j.appet.2006.01.014; Muniyappa R, 2008, AM J CLIN NUTR, V88, P1685, DOI 10.3945/ajcn.2008.26457; Mursu J, 2004, FREE RADICAL BIO MED, V37, P1351, DOI 10.1016/j.freeradbiomed.2004.06.002; O'Hagan A, 2005, PHARMACOECONOMICS, V23, P529, DOI 10.2165/00019053-200523060-00001; Ohman EM, 2006, AM HEART J, V295, P180; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Ried K, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-39; Ried K, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-22; Salkeld G, 1997, HEALTH POLICY, V41, P105, DOI 10.1016/S0168-8510(97)00015-8; Serafini M, 2003, NATURE, V424, P1013, DOI 10.1038/4241013a; Severens JL, 2004, VALUE HEALTH, V7, P397, DOI 10.1111/j.1524-4733.2004.74002.x; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Steinberg FM, 2003, J AM DIET ASSOC, V103, P215, DOI 10.1053/jada.2003.50028; Sun X, 2008, EUR J HEALTH ECON, V9, P313, DOI 10.1007/s10198-007-0078-x; Taubert D, 2003, JAMA-J AM MED ASSOC, V290, P1029, DOI 10.1001/jama.290.8.1029; Taubert D, 2007, JAMA-J AM MED ASSOC, V298, P49, DOI 10.1001/jama.298.1.49; Taubert D, 2007, ARCH INTERN MED, V167, P626, DOI 10.1001/archinte.167.7.626; Walker A, 2010, INT J SIMUL PROCESS, V6, P137; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; World Health Organization, 2007, CARD DIS FACT SHEET	39	29	29	0	68	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2012	344								e3657	10.1136/bmj.e3657	http://dx.doi.org/10.1136/bmj.e3657			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953HG	22653982	Green Published, hybrid			2022-12-24	WOS:000304857000007
J	de Waal, FBM				de Waal, Frans B. M.			THE ANTIQUITY OF EMPATHY	SCIENCE			English	Editorial Material							CHIMPANZEES; ALTRUISM; CONSOLATION	The view of humans as violent war-prone apes is poorly supported by archaeological evidence and only partly supported by the behavior of our closest primate relatives, chimpanzees and bonobos. Whereas the first species is marked by xenophobia, the second is relatively peaceful and highly empathic in both behavior and brain organization. Animal empathy is best regarded as a multilayered phenomenon, built around motor mirroring and shared neural representations at basal levels, that develops into more advanced cognitive perspective-taking in large-brained species. As indicated by both observational and experimental studies on our closest relatives, empathy may be the main motivator of prosocial behavior.	[de Waal, Frans B. M.] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA; [de Waal, Frans B. M.] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	Emory University; Emory University	de Waal, FBM (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.	dewaal@emory.edu	Carroll, Joseph/D-1158-2011	Carroll, Joseph/0000-0003-2656-1378				Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Boesch C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008901; Boyd R, 2006, SCIENCE, V314, P1555, DOI 10.1126/science.1136841; Campbell MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018283; Coolidge HJ, 1933, AM J PHYS ANTHROPOL, V18, P1, DOI 10.1002/ajpa.1330180113; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; DEWAAL FBM, 1979, BEHAV ECOL SOCIOBIOL, V5, P55, DOI 10.1007/BF00302695; Dimberg U, 2000, PSYCHOL SCI, V11, P86, DOI 10.1111/1467-9280.00221; Fry DP., 2006, HUMAN POTENTIAL PEAC; Grossman Dave, 1995, KILLING PSYCHOL COST; Harbaugh WT, 2007, SCIENCE, V316, P1622, DOI 10.1126/science.1140738; Harcourt AH., 1992, COALITIONS ALLIANCES; Horner V, 2011, P NATL ACAD SCI USA, V108, P13847, DOI 10.1073/pnas.1111088108; Langergraber KE, 2007, P NATL ACAD SCI USA, V104, P7786, DOI 10.1073/pnas.0611449104; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175834; Panksepp J, 2011, SCIENCE, V334, P1358, DOI 10.1126/science.1216480; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Smuts B. B., 1999, SEX FRIENDSHIP BABOO; Thorpe IJN, 2003, WORLD ARCHAEOL, V35, P145, DOI 10.1080/0043824032000079198; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Wrangham RW, 2012, HUM NATURE-INT BIOS, V23, P5, DOI 10.1007/s12110-012-9132-1; Yamamoto S, 2012, P NATL ACAD SCI USA, V109, P3588, DOI 10.1073/pnas.1108517109; Zak PJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001128	28	126	132	10	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					874	876		10.1126/science.1220999	http://dx.doi.org/10.1126/science.1220999			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605767				2022-12-24	WOS:000304145600053
J	Ethier, C; Oby, ER; Bauman, MJ; Miller, LE				Ethier, C.; Oby, E. R.; Bauman, M. J.; Miller, L. E.			Restoration of grasp following paralysis through brain-controlled stimulation of muscles	NATURE			English	Article							FUNCTIONAL ELECTRICAL-STIMULATION; IMPLANTED NEUROPROSTHESIS; MOTOR; PREDICTION; RECOVERY	Patients with spinal cord injury lack the connections between brain and spinal cord circuits that are essential for voluntary movement. Clinical systems that achieve muscle contraction through functional electrical stimulation (FES) have proven to be effective in allowing patients with tetraplegia to regain control of hand movements and to achieve a greater measure of independence in daily activities(1,2). In existing clinical systems, the patient uses residual proximal limb movements to trigger pre-programmed stimulation that causes the paralysed muscles to contract, allowing use of one or two basic grasps. Instead, we have developed an FES system in primates that is controlled by recordings made from microelectrodes permanently implanted in the brain. We simulated some of the effects of the paralysis caused by C5 or C6 spinal cord injury(3) by injecting rhesus monkeys with a local anaesthetic to block the median and ulnar nerves at the elbow. Then, using recordings from approximately 100 neurons in the motor cortex, we predicted the intended activity of several of the paralysed muscles, and used these predictions to control the intensity of stimulation of the same muscles. This process essentially bypassed the spinal cord, restoring to the monkeys voluntary control of their paralysed muscles. This achievement is a major advance towards similar restoration of hand function in human patients through brain-controlled FES. We anticipate that in human patients, this neuroprosthesis would allow much more flexible and dexterous use of the hand than is possible with existing FES systems.	[Ethier, C.; Oby, E. R.; Miller, L. E.] Northwestern Univ, Feinberg Sch Med, Dept Physiol, Chicago, IL 60611 USA; [Bauman, M. J.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Miller, L. E.] Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA; [Miller, L. E.] Northwestern Univ, Feinberg Sch Med, Dept Phys Med & Rehabil, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Northwestern University; Northwestern University; Feinberg School of Medicine	Miller, LE (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Physiol, 303 E Chicago Ave, Chicago, IL 60611 USA.	lm@northwestern.edu		Ethier, Christian/0000-0002-5048-6884	National Institute of Neurological Disorders and Stroke [NS053603]; Fonds de la Recherche en Sante du Quebec; Chicago Community Trust through Rehabilitation Institute of Chicago; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS071737, R01NS053603] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Chicago Community Trust through Rehabilitation Institute of Chicago; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by grant NS053603 from the National Institute of Neurological Disorders and Stroke to L. E. M. and a post-doctoral fellowship from the Fonds de la Recherche en Sante du Quebec to C. E., with further support from the Chicago Community Trust through the Searle Program for Neurological Restoration at the Rehabilitation Institute of Chicago. We also acknowledge the technical assistance of D. Tyler and K. Kilgore as well as the surgical assistance of J. Ko and S. Paisley Agnew.	Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Agarwal S, 2003, J REHABIL RES DEV, V40, P241; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Bryden AM, 2005, TOP SPINAL CORD INJ, V10, P38, DOI DOI 10.1310/G9T5-CCK9-Y0WT-4714; Carmena JM, 2003, PLOS BIOL, V1, P193, DOI 10.1371/journal.pbio.0000042; Cherian A, 2011, J NEUROPHYSIOL, V106, P564, DOI 10.1152/jn.00553.2010; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Fagg AH, 2009, IEEE T NEUR SYS REH, V17, P487, DOI 10.1109/TNSRE.2009.2029313; Fitzwater R, 2002, ARTIF ORGANS, V26, P284, DOI 10.1046/j.1525-1594.2002.06936.x; Gupta R, 2009, IEEE T NEUR SYS REH, V17, P254, DOI 10.1109/TNSRE.2009.2023290; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; KEITH MW, 1989, J HAND SURG-AM, V14A, P524, DOI 10.1016/S0363-5023(89)80017-6; Kern H, 2002, ARTIF ORGANS, V26, P216, DOI 10.1046/j.1525-1594.2002.06933.x; Kilgore KL, 1997, J BONE JOINT SURG AM, V79A, P533, DOI 10.2106/00004623-199704000-00008; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Nightingale EJ, 2007, SPINAL CORD, V45, P646, DOI 10.1038/sj.sc.3102101; Oby ER, 2010, STATISTICAL SIGNAL PROCESSING FOR NEUROSCIENCE AND NEUROTECHNOLOGY, P369, DOI 10.1016/B978-0-12-375027-3.00011-9; Peckham PH, 2001, ARCH PHYS MED REHAB, V82, P1380, DOI 10.1053/apmr.2001.25910; Pohlmeyer EA, 2007, INT C REHAB ROBOT, P454, DOI 10.1109/ICORR.2007.4428464; Pohlmeyer EA, 2007, J NEURAL ENG, V4, P369, DOI 10.1088/1741-2560/4/4/003; Pohlmeyer EA, 2009, J NEUROSCI METH, V182, P165, DOI 10.1016/j.jneumeth.2009.06.006; Pohlmeyer EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005924; Popovic MR, 2002, NEUROL RES, V24, P443, DOI 10.1179/016164102101200311; WATERS RL, 1993, ARCH PHYS MED REHAB, V74, P242	24	301	313	3	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					368	371		10.1038/nature10987	http://dx.doi.org/10.1038/nature10987			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22522928	Green Accepted			2022-12-24	WOS:000304099100042
J	Nora, EP; Lajoie, BR; Schulz, EG; Giorgetti, L; Okamoto, I; Servant, N; Piolot, T; van Berkum, NL; Meisig, J; Sedat, J; Gribnau, J; Barillot, E; Bluthgen, N; Dekker, J; Heard, E				Nora, Elphege P.; Lajoie, Bryan R.; Schulz, Edda G.; Giorgetti, Luca; Okamoto, Ikuhiro; Servant, Nicolas; Piolot, Tristan; van Berkum, Nynke L.; Meisig, Johannes; Sedat, John; Gribnau, Joost; Barillot, Emmanuel; Bluethgen, Nils; Dekker, Job; Heard, Edith			Spatial partitioning of the regulatory landscape of the X-inactivation centre	NATURE			English	Article							CHROMOSOME INACTIVATION; GENE-EXPRESSION; NONCODING RNAS; GENOME; CONFORMATION; ARCHITECTURE; METHYLATION; PRINCIPLES; REVEALS; CELLS	In eukaryotes transcriptional regulation often involves multiple long-range elements and is influenced by the genomic environment(1). A prime example of this concerns the mouse X-inactivation centre (Xic), which orchestrates the initiation of X-chromosome inactivation (XCI) by controlling the expression of the non-protein-coding Xist transcript. The extent of Xic sequences required for the proper regulation of Xist remains unknown. Here we use chromosome conformation capture carbon-copy (5C)(2) and super-resolution microscopy to analyse the spatial organization of a 4.5-megabases (Mb) region including Xist. We discover a series of discrete 200-kilobase to 1Mb topologically associating domains (TADs), present both before and after cell differentiation and on the active and inactive X. TADs align with, but do not rely on, several domain-wide features of the epigenome, such as H3K27me3 or H3K9me2 blocks and lamina-associated domains. TADs also align with coordinately regulated gene clusters. Disruption of a TAD boundary causes ectopic chromosomal contacts and long-range transcriptional misregulation. The Xist/Tsix sense/antisense unit illustrates how TADs enable the spatial segregation of oppositely regulated chromosomal neighbourhoods, with the respective promoters of Xist and Tsix lying in adjacent TADs, each containing their known positive regulators. We identify a novel distal regulatory region of Tsix within its TAD, which produces a long intervening RNA, Linx. In addition to uncovering a new principle of cis-regulatory architecture of mammalian chromosomes, our study sets the stage for the full genetic dissection of the X-inactivation centre.	[Nora, Elphege P.; Schulz, Edda G.; Giorgetti, Luca; Okamoto, Ikuhiro; Servant, Nicolas; Piolot, Tristan; Barillot, Emmanuel; Heard, Edith] Inst Curie, F-75248 Paris, France; [Nora, Elphege P.; Schulz, Edda G.; Giorgetti, Luca; Okamoto, Ikuhiro; Piolot, Tristan; Heard, Edith] CNRS, UMR3215, F-75248 Paris, France; [Nora, Elphege P.; Schulz, Edda G.; Giorgetti, Luca; Okamoto, Ikuhiro; Piolot, Tristan; Heard, Edith] INSERM, U934, F-75248 Paris, France; [Lajoie, Bryan R.; van Berkum, Nynke L.; Dekker, Job] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Programs Syst Biol & Gene Funct & Express, Worcester, MA 01605 USA; [Servant, Nicolas; Barillot, Emmanuel] INSERM, U900, F-75248 Paris, France; [Servant, Nicolas; Barillot, Emmanuel] Mines ParisTech, F-77300 Fontainebleau, France; [Meisig, Johannes; Bluethgen, Nils] Charite, Inst Pathol, D-10117 Berlin, Germany; [Meisig, Johannes; Bluethgen, Nils] Humboldt Univ, Inst Theoret Biol, D-10115 Berlin, Germany; [Sedat, John] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Gribnau, Joost] Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); University of Massachusetts System; University of Massachusetts Worcester; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; University of California System; University of California San Francisco; Erasmus University Rotterdam; Erasmus MC	Heard, E (corresponding author), Inst Curie, 26 Rue Ulm, F-75248 Paris, France.	job.dekker@umassmed.edu; edith.heard@curie.fr	Bluthgen, Nils/A-1711-2011; Nora, Elphège/AAW-9646-2021; Heard, Edith/D-7197-2017	Bluthgen, Nils/0000-0002-0171-7447; Nora, Elphège/0000-0002-8347-4396; Heard, Edith/0000-0001-8052-7117; BARILLOT, Emmanuel/0000-0003-2724-2002; Servant, Nicolas/0000-0003-1678-7410	Ministere de la Recherche et de l'Enseignement Superieur; ARC; HFSP [LT000597/2010-L]; EU EpiGeneSys FP7 Network of Excellence [257082]; Fondation pour la Recherche Medicale; ANR; ERC [250367]; EU [242129]; BMBF (FORSYS); EMBO [ASTF 307-2011]; NIH [R01 HG003143]; W. M. Keck Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER	Ministere de la Recherche et de l'Enseignement Superieur; ARC(Australian Research Council); HFSP(Human Frontier Science Program); EU EpiGeneSys FP7 Network of Excellence; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); ANR(French National Research Agency (ANR)); ERC(European Research Council (ERC)European Commission); EU(European Commission); BMBF (FORSYS)(Federal Ministry of Education & Research (BMBF)); EMBO(European Molecular Biology Organization (EMBO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Pollex and T. Forne for experimental help; the imaging facility PICTIBiSA@BDD for technical assistance, D. Gentien and C. Hego for microarray hybridizations. We thank K. Bernhard, F. Stewart and A. Smith for protocols and material for 2i culture and EpiSC differentiation. We are grateful to members of the E. H. laboratory for critical input. This work was funded by grants from the Ministere de la Recherche et de l'Enseignement Superieur and the ARC (to E.P.N.); a HFSP Long term fellowship (LT000597/2010-L) (to E. G. S.). EU EpiGeneSys FP7 Network of Excellence no. 257082, the Fondation pour la Recherche Medicale, ANR, ERC Advanced Investigator award no. 250367 and EU FP7 SYBOSS grant no. 242129 (to E. H.). N.B. was supported by BMBF (FORSYS) and EMBO (fellowship ASTF 307-2011). J.D., B. R. L. and N.L.v.B. were supported by NIH (R01 HG003143) and a W. M. Keck Foundation Distinguished Young Scholar Award.	Anguera MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002248; Augui S, 2011, NAT REV GENET, V12, P429, DOI 10.1038/nrg2987; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heard E, 1996, HUM MOL GENET, V5, P441, DOI 10.1093/hmg/5.4.441; Heard E, 1999, MOL CELL BIOL, V19, P3156; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kikuta H, 2007, GENOME RES, V17, P545, DOI 10.1101/gr.6086307; Kleinjan DA, 2008, ADV GENET, V61, P339, DOI 10.1016/S0065-2660(07)00013-2; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lienert F, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002090; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Mercier R, 2008, CELL, V135, P475, DOI 10.1016/j.cell.2008.08.031; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Ruf S, 2011, NAT GENET, V43, P379, DOI 10.1038/ng.790; Seidl CIM, 2006, EMBO J, V25, P3565, DOI 10.1038/sj.emboj.7601245; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Spencer R. J., 2011, GENETICS; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297	30	1726	1762	3	187	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					381	385		10.1038/nature11049	http://dx.doi.org/10.1038/nature11049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22495304	Green Accepted, Green Published			2022-12-24	WOS:000304099100045
J	Ding, DQ; Okamasa, K; Yamane, M; Tsutsumi, C; Haraguchi, T; Yamamoto, M; Hiraoka, Y				Ding, Da-Qiao; Okamasa, Kasumi; Yamane, Miho; Tsutsumi, Chihiro; Haraguchi, Tokuko; Yamamoto, Masayuki; Hiraoka, Yasushi			Meiosis-Specific Noncoding RNA Mediates Robust Pairing of Homologous Chromosomes in Meiosis	SCIENCE			English	Article							MEIOTIC REGULATOR MEI2P; FISSION YEAST; RECOMBINATION; DYNAMICS; RECOGNITION; MOVEMENT; PROPHASE	Pairing and recombination of homologous chromosomes are essential for ensuring reductional segregation in meiosis. However, the mechanisms by which chromosomes recognize their homologous partners are poorly understood. Here, we report that the sme2 gene encodes a meiosis-specific noncoding RNA that mediates homologous recognition in the fission yeast Schizosaccharomyces pombe. The sme2 locus shows robust pairing from early in meiotic prophase. The sme2 RNA transcripts accumulate at their respective gene loci and greatly enhance pairing of homologous loci: Deletion of the sme2 sequence eliminates this robust pairing, whereas transposition to other chromosomal sites confers robust pairing at those ectopic sites. Thus, we propose that RNA transcripts retained on the chromosome play an active role in recognition of homologous chromosomes for pairing.	[Ding, Da-Qiao; Okamasa, Kasumi; Yamane, Miho; Tsutsumi, Chihiro; Haraguchi, Tokuko; Hiraoka, Yasushi] Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo 6512492, Japan; [Haraguchi, Tokuko; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Yamamoto, Masayuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan	National Institute of Information & Communications Technology (NICT) - Japan; Osaka University; University of Tokyo	Hiraoka, Y (corresponding author), Natl Inst Informat & Commun Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo 6512492, Japan.	hiraoka@fbs.osaka-u.ac.jp	Hiraoka, Yasushi/B-5111-2009	Hiraoka, Yasushi/0000-0001-9407-8228; Ding, Da-Qiao/0000-0003-4403-2760	KAKENHI from MEXT of Japan; Grants-in-Aid for Scientific Research [21227007] Funding Source: KAKEN	KAKENHI from MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Andoh and T. Tani for providing the RNA visualizing system; J. Nakayama for S. pombe strains; A. Yamashita for discussions; C. Mori and N. Sakurai for technical support. This work was supported by KAKENHI grants from MEXT of Japan to D.-Q.D., T.H., M. Yamamoto, and Y.H.	Andoh T, 2006, BIOCHEM BIOPH RES CO, V351, P999, DOI 10.1016/j.bbrc.2006.10.139; Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; CHIKASHIGE Y, 1994, SCIENCE, V264, P270, DOI 10.1126/science.8146661; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Chikashige Y, 2007, CHROMOSOMA, V116, P497, DOI 10.1007/s00412-007-0114-8; Ding DQ, 2010, FEBS J, V277, P565, DOI 10.1111/j.1742-4658.2009.07501.x; Ding DQ, 2004, DEV CELL, V6, P329, DOI 10.1016/S1534-5807(04)00059-0; Ellermeier C, 2005, P NATL ACAD SCI USA, V102, P10952, DOI 10.1073/pnas.0504805102; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hiraoka Y, 2009, DEV CELL, V17, P598, DOI 10.1016/j.devcel.2009.10.014; Koszul R, 2009, TRENDS CELL BIOL, V19, P716, DOI 10.1016/j.tcb.2009.09.007; McKee BD, 2004, BBA-GENE STRUCT EXPR, V1677, P165, DOI 10.1016/j.bbaexp.2003.11.017; McKim KS, 2005, CELL, V123, P989, DOI 10.1016/j.cell.2005.11.031; Provost P, 2002, P NATL ACAD SCI USA, V99, P16648, DOI 10.1073/pnas.212633199; Shimada T, 2003, MOL BIOL CELL, V14, P2461, DOI 10.1091/mbc.E02-11-0738; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; WATANABE Y, 1994, CELL, V78, P487, DOI 10.1016/0092-8674(94)90426-X; Watanabe Y, 1997, NATURE, V386, P187, DOI 10.1038/386187a0; Yamamoto A, 1999, J CELL BIOL, V145, P1233, DOI 10.1083/jcb.145.6.1233; Yamashita A, 1998, CELL, V95, P115, DOI 10.1016/S0092-8674(00)81787-0; Yamashita A, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120014; Zickler D, 2006, CHROMOSOMA, V115, P158, DOI 10.1007/s00412-006-0048-6	23	89	91	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					732	736		10.1126/science.1219518	http://dx.doi.org/10.1126/science.1219518			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582262				2022-12-24	WOS:000303872300053
J	Hu, LY; Crawford, SE; Czako, R; Cortes-Penfield, NW; Smith, DF; Le Pendu, J; Estes, MK; Prasad, BVV				Hu, Liya; Crawford, Sue E.; Czako, Rita; Cortes-Penfield, Nicolas W.; Smith, David F.; Le Pendu, Jacques; Estes, Mary K.; Prasad, B. V. Venkataram			Cell attachment protein VP8*of a human rotavirus specifically interacts with A-type histo-blood group antigen	NATURE			English	Article							SIALIC-ACID BINDING; MOLECULAR CHARACTERIZATION; STRAINS; RECEPTOR; RECOGNITION; DIVERSITY; SEROTYPE; SYSTEM; DOMAIN; SUITE	As with many other viruses, the initial cell attachment of rotaviruses, which are the major causative agent of infantile gastroenteritis, is mediated by interactions with specific cellular glycans(1-4). The distally located VP8* domain of the rotavirus spike protein VP4 (ref. 5) mediates such interactions. The existing paradigm is that 'sialidase-sensitive' animal rotavirus strains bind to glycans with terminal sialic acid (Sia), whereas 'sialidase-insensitive' human rotavirus strains bind to glycans with internal Sia such as GM1 (ref. 3). Although the involvement of Sia in the animal strains is firmly supported by crystallographic studies(1,3,6,7), it is not yet known how VP8* of human rotaviruses interacts with Sia and whether their cell attachment necessarily involves sialoglycans. Here we show that VP8* of a human rotavirus strain specifically recognizes A-type histo-blood group antigen (HBGA) using a glycan array screen comprised of 511 glycans, and that virus infectivity in HT-29 cells is abrogated by anti-A-type antibodies as well as significantly enhanced in Chinese hamster ovary cells genetically modified to express the A-type HBGA, providing a novel paradigm for initial cell attachment of human rotavirus. HBGAs are genetically determined glycoconjugates present in mucosal secretions, epithelia and on red blood cells(8), and are recognized as susceptibility and cell attachment factors for gastric pathogens like Helicobacter pylori(9) and noroviruses(10). Our crystallographic studies show that the A-type HBGA binds to the human rotavirus VP8* at the same location as the Sia in the VP8* of animal rotavirus, and suggest how subtle changes within the same structural framework allow for such receptor switching. These results raise the possibility that host susceptibility to specific human rotavirus strains and pathogenesis are influenced by genetically controlled expression of different HBGAs among the world's population.	[Hu, Liya; Prasad, B. V. Venkataram] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Crawford, Sue E.; Czako, Rita; Cortes-Penfield, Nicolas W.; Estes, Mary K.; Prasad, B. V. Venkataram] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Smith, David F.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Le Pendu, Jacques] Univ Nantes, INSERM, UMR892, F-44007 Nantes, France; [Le Pendu, Jacques] Univ Nantes, CNRS, UMR 6299, F-44007 Nantes, France	Baylor College of Medicine; Baylor College of Medicine; Emory University; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite	Prasad, BVV (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	vprasad@bcm.edu	Cortes-Penfield, Nicolas/ACS-1833-2022; Le Pendu, Jacques/F-4760-2013	Le Pendu, Jacques/0000-0002-4856-0387; Czako, Rita/0000-0001-8686-0260; Prasad, B.V.Venkataram/0000-0002-1172-2071	NIH [AI36040, AI 080656, P30 DK56338, GM62116]; Robert Welch foundation [Q1279]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI036040, R56AI080656, R01AI036040, R01AI080656] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116, P41GM103694] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the support from NIH grants AI36040 (to B.V.V.P.), AI 080656 and P30 DK56338 (to M.K.E.), GM62116 (to the Consortium for Functional Glycomics), and the Robert Welch foundation (Q1279) to B.V.V.P. We thank R. Atmar and S. Shanker for helpful discussions and BCM X-ray core facility for data collection.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angel J, 2007, NAT REV MICROBIOL, V5, P529, DOI 10.1038/nrmicro1692; Blanchard H, 2007, J MOL BIOL, V367, P1215, DOI 10.1016/j.jmb.2007.01.028; Bohne A, 1999, BIOINFORMATICS, V15, P767, DOI 10.1093/bioinformatics/15.9.767; Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Chitambar SD, 2011, VET MICROBIOL, V148, P384, DOI 10.1016/j.vetmic.2010.08.027; Ciarlet M, 1999, J GEN VIROL, V80, P943, DOI 10.1099/0022-1317-80-4-943; Crawford SE, 2006, J VIROL, V80, P4820, DOI 10.1128/JVI.80.10.4820-4832.2006; Dormitzer PR, 2002, J VIROL, V76, P10512, DOI 10.1128/JVI.76.20.10512-10517.2002; Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESTES MK, 2007, FIELDS VIROLOGY, V2, P1917; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fukai K, 2004, VIRUS RES, V105, P101, DOI 10.1016/j.virusres.2004.04.016; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; GERNA G, 1994, VIROLOGY, V200, P66, DOI 10.1006/viro.1994.1163; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Gray J, 2011, METHODS MOL BIOL, V665, P325, DOI 10.1007/978-1-60761-817-1_18; Guillon P, 2008, GLYCOBIOLOGY, V18, P1085, DOI 10.1093/glycob/cwn093; Haselhorst T, 2009, NAT CHEM BIOL, V5, P91, DOI 10.1038/nchembio.134; Hutson AM, 2003, J VIROL, V77, P405, DOI 10.1128/JVI.77.1.405-415.2003; Ilver D, 1998, SCIENCE, V279, P373, DOI 10.1126/science.279.5349.373; Kraschnefski MJ, 2009, GLYCOBIOLOGY, V19, P194, DOI 10.1093/glycob/cwn119; Lopez S, 2006, CURR TOP MICROBIOL, V309, P39; Lutteke T, 2005, NUCLEIC ACIDS RES, V33, pD242; Marionneau S, 2001, BIOCHIMIE, V83, P565, DOI 10.1016/S0300-9084(01)01321-9; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Matthijnssens J, 2009, J VIROL, V83, P2917, DOI 10.1128/JVI.02246-08; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Midgley SE, 2012, EPIDEMIOL INFECT, V140, P1013, DOI 10.1017/S0950268811001981; Monnier N, 2006, J VIROL, V80, P1513, DOI 10.1128/JVI.80.3.1513-1523.2006; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Neu U, 2010, CELL HOST MICROBE, V8, P309, DOI 10.1016/j.chom.2010.09.004; Parashar UD, 2006, EMERG INFECT DIS, V12, P304; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Settembre EC, 2011, EMBO J, V30, P408, DOI 10.1038/emboj.2010.322; Smith DF, 2010, METHOD ENZYMOL, V480, P417, DOI 10.1016/S0076-6879(10)80033-3; Stevens J, 2006, J MOL BIOL, V355, P1143, DOI 10.1016/j.jmb.2005.11.002; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	41	230	249	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					256	U147		10.1038/nature10996	http://dx.doi.org/10.1038/nature10996			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22504179	Green Accepted			2022-12-24	WOS:000303799800045
J	Reich, PB; Tilman, D; Isbell, F; Mueller, K; Hobbie, SE; Flynn, DFB; Eisenhauer, N				Reich, Peter B.; Tilman, David; Isbell, Forest; Mueller, Kevin; Hobbie, Sarah E.; Flynn, Dan F. B.; Eisenhauer, Nico			Impacts of Biodiversity Loss Escalate Through Time as Redundancy Fades	SCIENCE			English	Article							DIVERSITY-PRODUCTIVITY RELATIONSHIP; PLANT DIVERSITY; GRASSLAND EXPERIMENT; COMPLEMENTARITY; MECHANISMS; NITROGEN; COMMUNITIES; STABILITY; SELECTION; SERVICES	Plant diversity generally promotes biomass production, but how the shape of the response curve changes with time remains unclear. This is a critical knowledge gap because the shape of this relationship indicates the extent to which loss of the first few species will influence biomass production. Using two long-term (>= 13 years) biodiversity experiments, we show that the effects of diversity on biomass productivity increased and became less saturating over time. Our analyses suggest that effects of diversity-dependent ecosystem feedbacks and interspecific complementarity accumulate over time, causing high-diversity species combinations that appeared functionally redundant during early years to become more functionally unique through time. Consequently, simplification of diverse ecosystems will likely have greater negative impacts on ecosystem functioning than has been suggested by short-term experiments.	[Reich, Peter B.; Eisenhauer, Nico] Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA; [Reich, Peter B.] Univ Western Sydney, Hawkesbury Inst Environm, Penrith, NSW 2753, Australia; [Tilman, David; Isbell, Forest; Mueller, Kevin; Hobbie, Sarah E.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Tilman, David] Univ Calif Santa Barbara, Bren Sch Environm, Santa Barbara, CA 93106 USA; [Flynn, Dan F. B.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Eisenhauer, Nico] Tech Univ Munich, Dept Ecol & Ecosyst Management, D-85354 Freising Weihenstephan, Germany	University of Minnesota System; University of Minnesota Twin Cities; Western Sydney University; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Santa Barbara; University of Zurich; Technical University of Munich	Reich, PB (corresponding author), Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA.		Mueller, Kevin E/I-3633-2019; Flynn, Dan/A-4200-2008; Flynn, Dan/AAT-7028-2020; Eisenhauer, Nico/I-5932-2012; Eisenhauer, Nico/I-3191-2019; Isbell, Forest/C-6915-2012; Tilman, David/ABD-5309-2021	Mueller, Kevin E/0000-0002-0739-7472; Flynn, Dan/0000-0002-2978-5257; Flynn, Dan/0000-0002-2978-5257; Eisenhauer, Nico/0000-0002-0371-6720; Eisenhauer, Nico/0000-0002-0371-6720; Isbell, Forest/0000-0001-9689-769X; Hobbie, Sarah/0000-0001-5159-031X; Reich, Peter/0000-0003-4424-662X	U.S. Department of Energy [DE-FG02-96ER62291]; National Institute for Climatic Change Research [DE-FC02-06ER64158]; National Science Foundation [DEB-9411972, DEB-0080382, DEB-0620652, DEB-0322057, DEB-0716587]; University of Minnesota	U.S. Department of Energy(United States Department of Energy (DOE)); National Institute for Climatic Change Research; National Science Foundation(National Science Foundation (NSF)); University of Minnesota(University of Minnesota System)	We thank the U.S. Department of Energy Program for Ecosystem Research (DE-FG02-96ER62291) and the National Institute for Climatic Change Research (DE-FC02-06ER64158); the National Science Foundation Long-Term Ecological Research (DEB-9411972, DEB-0080382, and DEB-0620652), Biocomplexity Coupled Biogeochemical Cycles (DEB-0322057) and Long-Term Research in Environmental Biology Programs (DEB-0716587), and the University of Minnesota for supporting this research. The data sets used in this study are available at the Cedar Creek Ecosystem Science Reserve Web site. The authors declare no conflicts of interest.	Allan E, 2011, P NATL ACAD SCI USA, V108, P17034, DOI 10.1073/pnas.1104015108; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Fargione J, 2007, P ROY SOC B-BIOL SCI, V274, P871, DOI 10.1098/rspb.2006.0351; Fornara DA, 2009, ECOLOGY, V90, P408, DOI 10.1890/08-0325.1; Haddad NM, 2011, ECOL LETT, V14, P42, DOI 10.1111/j.1461-0248.2010.01548.x; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hector A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017434; Hooper DU, 1998, ECOL MONOGR, V68, P121, DOI 10.1890/0012-9615(1998)068[0121:EOPCAD]2.0.CO;2; Isbell F, 2011, NATURE, V477, P199, DOI 10.1038/nature10282; Isbell FI, 2009, ECOLOGY, V90, P1821, DOI 10.1890/08-0514.1; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Marquard E, 2009, ECOLOGY, V90, P3290, DOI 10.1890/09-0069.1; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Schnitzer SA, 2011, ECOLOGY, V92, P296, DOI 10.1890/10-0773.1; Tilman D, 1997, SCIENCE, V278, P1866; Tilman D, 2001, SCIENCE, V294, P843, DOI 10.1126/science.1060391; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; van Ruijven J, 2009, OIKOS, V118, P101, DOI 10.1111/j.1600-0706.2008.17119.x; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	27	529	546	26	641	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					589	592		10.1126/science.1217909	http://dx.doi.org/10.1126/science.1217909			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556253				2022-12-24	WOS:000303498800046
J	Chen, CY; Chi, YH; Mutalif, RA; Starost, MF; Myers, TG; Anderson, SA; Stewart, CL; Jeang, KT				Chen, Chia-Yen; Chi, Ya-Hui; Mutalif, Rafidah Abdul; Starost, Matthew F.; Myers, Timothy G.; Anderson, Stasia A.; Stewart, Colin L.; Jeang, Kuan-Teh			Accumulation of the Inner Nuclear Envelope Protein Sun1 Is Pathogenic in Progeric and Dystrophic Laminopathies	CELL			English	Article							GIRDLE MUSCULAR-DYSTROPHY; CHARCOT-MARIE-TOOTH; LAMIN-A/C GENE; MISSENSE MUTATION; MIGRATION; DEFECTS; LMNA; ORGANIZATION; ARCHITECTURE; EXPRESSION	Human LMNA gene mutations result in laminopathies that include Emery-Dreifuss muscular dystrophy (AD-EDMD) and Hutchinson-Gilford progeria, the premature aging syndrome (HGPS). The Lmna null (Lmna(-/-)) and progeroid Lmna Delta 9 mutant mice are models for AD-EDMD and HGPS, respectively. Both animals develop severe tissue pathologies with abbreviated life spans. Like HGPS cells, Lmna(-/-) and Lmna Delta 9 fibroblasts have typically misshapen nuclei. Unexpectedly, Lmna(-/-) or Lmna Delta 9 mice that are also deficient for the inner nuclear membrane protein Sun1 show markedly reduced tissue pathologies and enhanced longevity. Concordantly, reduction of SUN1 overaccumulation in LMNA mutant fibroblasts and in cells derived from HGPS patients corrected nuclear defects and cellular senescence. Collectively, these findings implicate Sun1 protein accumulation as a common pathogenic event in Lmna(-/-), Lmna Delta 9, and HGPS disorders.	[Chi, Ya-Hui] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Taiwan; [Chen, Chia-Yen; Jeang, Kuan-Teh] NIAID, Natl Inst Hlth, Bethesda, MD 20892 USA; [Starost, Matthew F.] Natl Inst Hlth, Div Vet Resources, Bethesda, MD 20892 USA; [Myers, Timothy G.] NIAID, Genom Technol Sect, Natl Inst Hlth, Bethesda, MD 20892 USA; [Anderson, Stasia A.] Natl Heart Lung & Blood Inst Anim MRI Core, Natl Inst Hlth, Bethesda, MD 20892 USA; [Mutalif, Rafidah Abdul; Stewart, Colin L.] Inst Med Biol, Singapore 138648, Singapore; [Stewart, Colin L.] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	National Health Research Institutes - Taiwan; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Chi, YH (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan 35053, Taiwan.	ychi@nhri.org.tw; kjeang@nih.gov	Chi, Ya-Hui/ABE-8550-2020; Chi, Ya-Hui/B-1080-2010; Jeang, Kuan-Teh/A-2424-2008	Chi, Ya-Hui/0000-0002-9216-0938; Anderson, Stasia/0000-0002-2566-6947; Myers, Timothy Gene/0000-0002-7059-5906	NIAID; IATAP, NIAID; NHRI, Taiwan [NHRI 99A1-CSPP11-014]; NSC, Taiwan [NSC 98-2320-B-400-009-MY3]; Singapore Biomedical Research Council; Agency for Science, Technology and Research (AstarSTAR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005909] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001051, ZIAAI001023] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); IATAP, NIAID; NHRI, Taiwan(National Health Research Institutes - Taiwan); NSC, Taiwan(Ministry of Science and Technology, Taiwan); Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Agency for Science, Technology and Research (AstarSTAR)(Agency for Science Technology & Research (A*STAR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work was supported by NIAID intramural funds, the IATAP, NIAID contract to SoBran, Inc., the NHRI, Taiwan (NHRI 99A1-CSPP11-014), and NSC, Taiwan (NSC 98-2320-B-400-009-MY3), and the Singapore Biomedical Research Council and Agency for Science, Technology and Research (A<SUP>star</SUP>STAR). We thank S.-Y. Chuang, E. Miyagi, J.M. Ward, L. I. Cheng, Z.J. Chen, J. Kabat, S. Becker, S. Bradford, Q. Su, and D. Donahue for assistance; and W. Leonard, J. Hanover, A. Dayton, Y.B. Shi, and D. Camerini-Otero for reading the manuscript.	Alsheimer M, 2004, J CELL SCI, V117, P1173, DOI 10.1242/jcs.00975; Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Burke B, 2001, TRAFFIC, V2, P675, DOI 10.1034/j.1600-0854.2001.21001.x; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Cao H, 2000, HUM MOL GENET, V9, P109, DOI 10.1093/hmg/9.1.109; Cao K, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002346; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Chaouch M, 2003, NEUROMUSCULAR DISORD, V13, P60, DOI 10.1016/S0960-8966(02)00196-7; Chen LS, 2003, LANCET, V362, P440, DOI 10.1016/S0140-6736(03)14069-X; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Chi YH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-96; Chi YH, 2009, DEVELOPMENT, V136, P965, DOI 10.1242/dev.029868; Crews L, 2010, HUM MOL GENET, V19, pR12, DOI 10.1093/hmg/ddq160; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; DEBUSK FL, 1972, J PEDIATR-US, V80, P697, DOI 10.1016/S0022-3476(72)80229-4; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Guttinger S, 2009, NAT REV MOL CELL BIO, V10, P178, DOI 10.1038/nrm2641; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Haque F, 2010, J BIOL CHEM, V285, P3487, DOI 10.1074/jbc.M109.071910; Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013; Kitaguchi T, 2001, NEUROMUSCULAR DISORD, V11, P542, DOI 10.1016/S0960-8966(01)00207-3; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Marie M, 2008, CELL MOL LIFE SCI, V65, P2859, DOI 10.1007/s00018-008-8355-0; Mattioli E, 2011, CELL DEATH DIFFER, V18, P1305, DOI 10.1038/cdd.2010.183; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Metz TF, 2011, CLIN CHEM, V57, P1286, DOI 10.1373/clinchem.2011.164640; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453; Nagano A, 2000, CURR OPIN NEUROL, V13, P533, DOI 10.1097/00019052-200010000-00005; Novelli G, 2002, AM J HUM GENET, V71, P426, DOI 10.1086/341908; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Plasilova M, 2004, J MED GENET, V41, P609, DOI 10.1136/jmg.2004.019661; Rutishauser J, 2002, SWISS MED WKLY, V132, P211; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Szentpetery Z, 2010, P NATL ACAD SCI USA, V107, P8225, DOI 10.1073/pnas.1000157107; Thyberg J, 1999, EXP CELL RES, V246, P263, DOI 10.1006/excr.1998.4326; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Worman HJ, 2004, J CLIN INVEST, V113, P349, DOI 10.1172/JCI200420832; Yu JH, 2011, HUM MOL GENET, V20, P1061, DOI 10.1093/hmg/ddq549; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018	57	143	148	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					565	577		10.1016/j.cell.2012.01.059	http://dx.doi.org/10.1016/j.cell.2012.01.059			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541428	Green Accepted, Bronze			2022-12-24	WOS:000303443100009
J	Palm, NW; Rosenstein, RK; Medzhitov, R				Palm, Noah W.; Rosenstein, Rachel K.; Medzhitov, Ruslan			Allergic host defences	NATURE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; MAST-CELLS; IMMUNOLOGICAL INDUCTION; MOLECULAR-MECHANISMS; STRUCTURAL BIOLOGY; FLAVOR AVERSION; DENDRITIC CELLS; MURINE MODEL; INNATE; TISSUE	Allergies are generally thought to be a detrimental outcome of a mistargeted immune response that evolved to provide immunity to macroparasites. Here we present arguments to suggest that allergic immunity has an important role in host defence against noxious environmental substances, including venoms, haematophagous fluids, environmental xenobiotics and irritants. We argue that appropriately targeted allergic reactions are beneficial, although they can become detrimental when excessive. Furthermore, we suggest that allergic hypersensitivity evolved to elicit anticipatory responses and to promote avoidance of suboptimal environments.	[Palm, Noah W.; Rosenstein, Rachel K.; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Immunobiol, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu		Palm, Noah/0000-0001-7262-9455	Howard Hughes Medical Institute; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055502, R01AI089771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071754] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work in R.M.'s laboratory is supported by the Howard Hughes Medical Institute and grants from the National Institutes of Health.	Aalberse RC, 2000, J ALLERGY CLIN IMMUN, V106, P228, DOI 10.1067/mai.2000.108434; Allen JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002003; Allen JE, 2011, NAT REV IMMUNOL, V11, P375, DOI 10.1038/nri2992; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bernstein JA, 2004, J ALLERGY CLIN IMMUN, V114, P1116, DOI 10.1016/j.jaci.2004.08.030; Bertrand PP, 2010, AUTON NEUROSCI-BASIC, V153, P47, DOI 10.1016/j.autneu.2009.08.002; Bessac BF, 2008, PHYSIOLOGY, V23, P360, DOI 10.1152/physiol.00026.2008; Burton OT, 2011, IMMUNOL REV, V242, P128, DOI 10.1111/j.1600-065X.2011.01024.x; Cara DC, 1997, SCAND J IMMUNOL, V45, P16, DOI 10.1046/j.1365-3083.1997.d01-363.x; CARA DC, 1994, BRAZ J MED BIOL RES, V27, P1331; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Costa-Pinto FA, 2005, BRAIN BEHAV IMMUN, V19, P52, DOI 10.1016/j.bbi.2004.02.005; Costa-Pinto FA, 2007, BRAIN BEHAV IMMUN, V21, P783, DOI 10.1016/j.bbi.2007.01.002; DUDLER T, 1995, J IMMUNOL, V155, P2605; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Fry BG, 2006, NATURE, V439, P584, DOI 10.1038/nature04328; Fry BG, 2009, ANNU REV GENOM HUM G, V10, P483, DOI 10.1146/annurev.genom.9.081307.164356; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Harris N, 2011, TRENDS IMMUNOL, V32, P80, DOI 10.1016/j.it.2010.11.005; HIGGINBOTHAM RD, 1971, J IMMUNOL, V106, P233; HIGGINBOTHAM RD, 1965, J IMMUNOL, V95, P867; Hsu CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011944; Idzko M, 2007, NAT MED, V13, P913, DOI 10.1038/nm1617; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Jeffry J, 2011, PHYSIOLOGY, V26, P286, DOI 10.1152/physiol.00007.2011; JUSTESEN DR, 1970, SCIENCE, V170, P864, DOI 10.1126/science.170.3960.864; Kalish RS, 1999, J ALLERGY CLIN IMMUN, V103, P192, DOI 10.1016/S0091-6749(99)70489-6; Karp CL, 2010, J ALLERGY CLIN IMMUN, V125, P955, DOI 10.1016/j.jaci.2010.03.002; Kavaliers M, 2004, HORM BEHAV, V46, P272, DOI 10.1016/j.yhbeh.2004.03.005; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kondo H, 1998, EUR J IMMUNOL, V28, P769, DOI 10.1002/(SICI)1521-4141(199803)28:03<769::AID-IMMU769>3.0.CO;2-H; Lang PM, 2006, J NEUROPHYSIOL, V96, P2963, DOI 10.1152/jn.00716.2006; Li Jinze, 2010, Handb Exp Pharmacol, P493, DOI 10.1007/978-3-642-00663-0_18; Liu YJ, 2006, J EXP MED, V203, P269, DOI 10.1084/jem.20051745; Loukas A, 2011, OMICS, V15, P567, DOI 10.1089/omi.2010.0150; MACKENZIE M, 1961, ANN ALLERGY, V19, P298; MACQUEEN G, 1989, SCIENCE, V243, P83, DOI 10.1126/science.2911721; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Matthews KR, 2011, SCIENCE, V331, P1149, DOI 10.1126/science.1198077; McKenzie, 1896, AM J MED SCI, V91, P45, DOI DOI 10.1097/00000441-188601000-00004; McKerrow JH, 2006, ANNU REV PATHOL-MECH, V1, P497, DOI 10.1146/annurev.pathol.1.110304.100151; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Mirotti L, 2010, J ALLERGY CAIRO, V2010; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1038/ni.2131, 10.1031/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Muller UR, 2010, CHEM IMMUNOL ALLERGY, V95, P141, DOI 10.1159/000315948; Muller-Doblies UU, 2007, PARASITE IMMUNOL, V29, P485, DOI 10.1111/j.1365-3024.2007.00966.x; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Navarro-Zorraquino M, 2001, WORLD J SURG, V25, P585, DOI 10.1007/s002680020089; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Oyoshi MK, 2010, J ALLERGY CLIN IMMUN, V126, P976, DOI 10.1016/j.jaci.2010.08.041; Palm NW, 2009, P NATL ACAD SCI USA, V106, P4782, DOI 10.1073/pnas.0809403105; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Raap U, 2011, CURR OPIN ALLERGY CL, V11, P420, DOI 10.1097/ACI.0b013e32834a41c2; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; Schuijt TJ, 2011, TRENDS PARASITOL, V27, P40, DOI 10.1016/j.pt.2010.06.006; Shreffler WG, 2006, J IMMUNOL, V177, P3677, DOI 10.4049/jimmunol.177.6.3677; Siegel S, 1997, ENVIRON HEALTH PERSP, V105, P521, DOI 10.2307/3433363; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Steinfelder S, 2009, J EXP MED, V206, P1681, DOI 10.1084/jem.20082462; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Thomas WR, 2005, CURR ALLERGY ASTHM R, V5, P388, DOI 10.1007/s11882-005-0012-1; THORPE SC, 1989, IMMUNOLOGY, V68, P307; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Wada T, 2010, J CLIN INVEST, V120, P2867, DOI 10.1172/JCI42680; Zacharia B, 2003, MED HYPOTHESES, V60, P1, DOI 10.1016/S0306-9877(02)00217-7; Zarzana EC, 2009, NEUROIMMUNOMODULAT, V16, P19, DOI 10.1159/000179663; Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001; Zhao WH, 2010, CELL MOL IMMUNOL, V7, P260, DOI 10.1038/cmi.2010.3; Ziegler SF, 2010, NAT IMMUNOL, V11, P289, DOI 10.1038/ni.1852	86	259	275	0	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2012	484	7395					465	472		10.1038/nature11047	http://dx.doi.org/10.1038/nature11047			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538607	Green Accepted			2022-12-24	WOS:000303200400041
J	Foti, JJ; Devadoss, B; Winkler, JA; Collins, JJ; Walker, GC				Foti, James J.; Devadoss, Babho; Winkler, Jonathan A.; Collins, James J.; Walker, Graham C.			Oxidation of the Guanine Nucleotide Pool Underlies Cell Death by Bactericidal Antibiotics	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; MUTT-TYPE ENZYME; ESCHERICHIA-COLI; DNA-POLYMERASES; HYDROGEN-PEROXIDE; PROTEIN; REPLICATION; MECHANISMS; DAMAGE; MUTAGENESIS	A detailed understanding of the mechanisms that underlie antibiotic killing is important for the derivation of new classes of antibiotics and clinically useful adjuvants for current antimicrobial therapies. Our efforts to understand why DinB (DNA polymerase IV) overproduction is cytotoxic to Escherichia coli led to the unexpected insight that oxidation of guanine to 8-oxo-guanine in the nucleotide pool underlies much of the cell death caused by both DinB overproduction and bactericidal antibiotics. We propose a model in which the cytotoxicity of beta-lactams and quinolones predominantly results from lethal double-strand DNA breaks caused by incomplete repair of closely spaced 8-oxo-deoxyguanosine lesions, whereas the cytotoxicity of aminoglycosides might additionally result from mistranslation due to the incorporation of 8-oxo-guanine into newly synthesized RNAs.	[Foti, James J.; Devadoss, Babho; Walker, Graham C.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Winkler, Jonathan A.] Boston Univ, Program Mol Biol Cell Biol & Biochem, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Howard Hughes Med Inst, Dept Biomed Engn, Boston, MA 02215 USA; [Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02118 USA	Massachusetts Institute of Technology (MIT); Boston University; Boston University; Howard Hughes Medical Institute; Boston University; Harvard University	Walker, GC (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gwalker@mit.edu		/0000-0001-7243-8261	NIH [R01 CA021615, F32 GM079885, DP1 OD003644, P30 ES002019]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA021615] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM079885] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003644] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank S. Bell and D. Kim for use of equipment and S. Lovett for strains. This work was supported by NIH grants R01 CA021615 (to G.C.W.), F32 GM079885 (to J.J.F.), DP1 OD003644 (to J.C.C.), and P30 ES002019 (to the Massachusetts Institute of Technology Center for Environmental Sciences) as well as the Howard Hughes Medical Institute. G.C.W. is an American Cancer Society Professor.	BONURA T, 1975, RADIAT RES, V63, P567, DOI 10.2307/3574108; BRENNER DJ, 1992, INT J RADIAT BIOL, V61, P737, DOI 10.1080/09553009214551591; Caldon CE, 2001, MOL MICROBIOL, V41, P289, DOI 10.1046/j.1365-2958.2001.02536.x; Cooper MA, 2011, NATURE, V472, P32, DOI 10.1038/472032a; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; FIJALKOWSKA IJ, 1993, GENETICS, V134, P1023; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Fujikawa K, 1999, J BIOL CHEM, V274, P18201, DOI 10.1074/jbc.274.26.18201; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Haghdoost S, 2006, FREE RADICAL BIO MED, V41, P620, DOI 10.1016/j.freeradbiomed.2006.05.003; Hori M, 2005, DNA REPAIR, V4, P33, DOI 10.1016/j.dnarep.2004.07.010; Hori M, 2006, BIOL PHARM BULL, V29, P1087, DOI 10.1248/bpb.29.1087; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Indiani C, 2009, P NATL ACAD SCI USA, V106, P6031, DOI 10.1073/pnas.0901403106; Ito R, 2005, BIOCHEMISTRY-US, V44, P6670, DOI 10.1021/bi047550k; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Katafuchi A, 2010, NUCLEIC ACIDS RES, V38, P859, DOI 10.1093/nar/gkp1095; Kobayashi M, 1998, J BIOL CHEM, V273, P26394, DOI 10.1074/jbc.273.41.26394; Kohanski MA, 2008, CELL, V135, P679, DOI 10.1016/j.cell.2008.09.038; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Morel Chantal M, 2010, BMJ, V340, pc2115, DOI 10.1136/bmj.c2115; Neeley WL, 2006, CHEM RES TOXICOL, V19, P491, DOI 10.1021/tx0600043; NOVOGRODSKY A, 1982, P NATL ACAD SCI-BIOL, V79, P1171, DOI 10.1073/pnas.79.4.1171; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Pursell ZF, 2008, NUCLEIC ACIDS RES, V36, P2174, DOI 10.1093/nar/gkn062; REPINE JE, 1981, J BIOL CHEM, V256, P7094; Rotman E, 2007, J BACTERIOL, V189, P6976, DOI 10.1128/JB.00776-07; Taddei F, 1997, SCIENCE, V278, P128, DOI 10.1126/science.278.5335.128; Tassotto ML, 2002, J BIOL CHEM, V277, P15807, DOI 10.1074/jbc.M200965200; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Uchida K, 2008, MOL MICROBIOL, V70, P608, DOI 10.1111/j.1365-2958.2008.06423.x; Wagner J, 2000, EMBO REP, V1, P484; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; WARD JF, 1987, BR J CANC S, V8, P105; Wu J, 2009, J CELL PHYSIOL, V220, P297, DOI 10.1002/jcp.21797	37	314	324	9	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					315	319		10.1126/science.1219192	http://dx.doi.org/10.1126/science.1219192			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517853	Green Accepted, Green Submitted			2022-12-24	WOS:000302995400037
J	Fleishman, SJ; Baker, D				Fleishman, Sarel J.; Baker, David			Role of the Biomolecular Energy Gap in Protein Design, Structure, and Evolution	CELL			English	Review							INTRINSICALLY UNSTRUCTURED PROTEINS; DE-NOVO DESIGN; COMPUTATIONAL DESIGN; STRUCTURE PREDICTION; CRYSTAL-STRUCTURE; HIGH-AFFINITY; SPECIFICITY; SEQUENCE; BINDING; DIVERSITY	The folding of natural biopolymers into unique three-dimensional structures that determine their function is remarkable considering the vast number of alternative states and requires a large gap in the energy of the functional state compared to the many alternatives. This Perspective explores the implications of this energy gap for computing the structures of naturally occurring biopolymers, designing proteins with new structures and functions, and optimally integrating experiment and computation in these endeavors. Possible parallels between the generation of functional molecules in computational design and natural evolution are highlighted.	[Fleishman, Sarel J.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98199 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98199 USA	Weizmann Institute of Science; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Fleishman, SJ (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	sarel@weizmann.ac.il; dabaker@uw.edu	Baker, David/K-8941-2012	Baker, David/0000-0001-7896-6217; Fleishman, Sarel/0000-0003-3177-7560	Geffen Trust; Yeda-Sela Center for Basic Research; National Institutes of Health; Defense Advanced Research Program Agency; Defense Threat Reduction Agency; Howard Hughes Medical Institute	Geffen Trust; Yeda-Sela Center for Basic Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Program Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The authors thank Yibing Shan, David E. Shaw, Vladimir Yarov-Yarovoy, Mike Tyka, Oliver Lange, Rhiju Das, and Ingemar Andre for providing the data used to produce Figure 2 and Ingemar Andre, Gira Bhabha, Rhiju Das, Sagar Khare, Olga Khersonsky, Tanja Kortemme, Eva-Maria Strauch, and Dan S Tawfik for critical reading. S.J.F. is supported by a grant from the Geffen Trust, the Yeda-Sela Center for Basic Research, a donation from Sam Switzer and Family, and the Human Frontier Science Program. Research in the Baker lab was supported by grants from the National Institutes of Health, the Defense Advanced Research Program Agency, the Defense Threat Reduction Agency, and the Howard Hughes Medical Institute.	Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Ambroggio XI, 2006, J AM CHEM SOC, V128, P1154, DOI 10.1021/ja054718w; Andre I, 2007, P NATL ACAD SCI USA, V104, P17656, DOI 10.1073/pnas.0702626104; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Ashworth J, 2010, NUCLEIC ACIDS RES, V38, P5601, DOI 10.1093/nar/gkq283; Baker ML, 2010, NAT PROTOC, V5, P1697, DOI 10.1038/nprot.2010.126; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Borgia MB, 2011, NATURE, V474, P662, DOI 10.1038/nature10099; Bouvignies G, 2011, NATURE, V477, P111, DOI 10.1038/nature10349; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Brady GP, 1997, CURR OPIN STRUC BIOL, V7, P215, DOI 10.1016/S0959-440X(97)80028-0; Cochran FV, 2005, J AM CHEM SOC, V127, P1346, DOI 10.1021/ja044129a; Collins CH, 2006, NAT BIOTECHNOL, V24, P708, DOI 10.1038/nbt1209; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; Correll CC, 2003, NUCLEIC ACIDS RES, V31, P6806, DOI 10.1093/nar/gkg908; Cozzetto D, 2008, MOL BIOTECHNOL, V39, P1, DOI 10.1007/s12033-007-9023-6; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Das R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020044; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; DiMaio F, 2009, J MOL BIOL, V392, P181, DOI 10.1016/j.jmb.2009.07.008; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eichner T, 2011, MOL CELL, V43, P8, DOI 10.1016/j.molcel.2011.05.012; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; EKINS S, 2006, COMPUTER APPL PHARM; EPSTEIN CJ, 1962, J BIOL CHEM, V237, P2175; Feher M, 2003, J CHEM INF COMP SCI, V43, P218, DOI 10.1021/ci0200467; Fleishman SJ, 2011, J MOL BIOL, V414, P289, DOI 10.1016/j.jmb.2011.09.031; Fleishman SJ, 2011, J MOL BIOL, V413, P1047, DOI 10.1016/j.jmb.2011.09.001; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Fleishman SJ, 2011, PROTEIN SCI, V20, P753, DOI 10.1002/pro.604; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; INGRAM VM, 1956, NATURE, V178, P792, DOI 10.1038/178792a0; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jones AK, 2007, J AM CHEM SOC, V129, P14844, DOI 10.1021/ja075116a; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Khersonsky O, 2011, J MOL BIOL, V407, P391, DOI 10.1016/j.jmb.2011.01.041; Kinch L., 2011, PROTEINS S10, V79, P59; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; Korendovych IV, 2011, P NATL ACAD SCI USA, V108, P6823, DOI 10.1073/pnas.1018191108; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Levin KB, 2009, NAT STRUCT MOL BIOL, V16, P1049, DOI 10.1038/nsmb.1670; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Meenan NAG, 2010, P NATL ACAD SCI USA, V107, P10080, DOI 10.1073/pnas.0910756107; Miller ME, 2001, J CELL SCI, V114, P1811; Mizianty MJ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-245; Moran U, 2010, CELL, V141, P1262, DOI 10.1016/j.cell.2010.06.019; Morgan D. O., 2007, CELL CYCLE PRINCIPLE; Murata T, 2005, SCIENCE, V308, P654, DOI 10.1126/science.1110064; Newman JRS, 2003, SCIENCE, V300, P2097, DOI 10.1126/science.1084648; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; PAULING L, 1948, NATURE, V161, P707, DOI 10.1038/161707a0; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Perutz MF, 1998, ANNU REV BIOPH BIOM, V27, P1, DOI 10.1146/annurev.biophys.27.1.1; Raman S, 2010, SCIENCE, V327, P1014, DOI 10.1126/science.1183649; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Samish I, 2011, ANNU REV PHYS CHEM, V62, P129, DOI 10.1146/annurev-physchem-032210-103509; Scalley-Kim M, 2004, J MOL BIOL, V338, P573, DOI 10.1016/j.jmb.2004.02.055; Scalley-Kim M, 2003, PROTEIN SCI, V12, P197, DOI 10.1110/ps.0232003; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schroder GF, 2010, NATURE, V464, P1218, DOI 10.1038/nature08892; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Shapiro L, 2000, CELL, V100, P89, DOI 10.1016/S0092-8674(00)81686-4; SHARP KA, 1990, ANNU REV BIOPHYS BIO, V19, P301, DOI 10.1146/annurev.bb.19.060190.001505; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tyka MD, 2011, J MOL BIOL, V405, P607, DOI 10.1016/j.jmb.2010.11.008; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Wang L, 2012, J MOL BIOL, V415, P615, DOI 10.1016/j.jmb.2011.10.043; Watters AL, 2007, CELL, V128, P613, DOI 10.1016/j.cell.2006.12.042; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu GF, 2001, P NATL ACAD SCI USA, V98, P3652, DOI 10.1073/pnas.071400098; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zarrinpar A, 2003, NATURE, V426, P676, DOI 10.1038/nature02178	90	77	80	1	59	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					262	273		10.1016/j.cell.2012.03.016	http://dx.doi.org/10.1016/j.cell.2012.03.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500796	Bronze			2022-12-24	WOS:000302805600008
J	Howell, AS; Jin, M; Wu, CF; Zyla, TR; Elston, TC; Lew, DJ				Howell, Audrey S.; Jin, Meng; Wu, Chi-Fang; Zyla, Trevin R.; Elston, Timothy C.; Lew, Daniel J.			Negative Feedback Enhances Robustness in the Yeast Polarity Establishment Circuit	CELL			English	Article							FUNGUS ASHBYA-GOSSYPII; CELL POLARITY; SACCHAROMYCES-CEREVISIAE; SYMMETRY-BREAKING; SEPTIN RING; BUDDING YEAST; CDC42P; POLARIZATION; GROWTH; ACTIN	Many cells undergo symmetry-breaking polarization toward a randomly oriented "front" in the absence of spatial cues. In budding yeast, such polarization involves a positive feedback loop that enables amplification of stochastically arising clusters of polarity factors. Previous mathematical modeling suggested that, if more than one cluster were amplified, the clusters would compete for limiting resources and the largest would "win," explaining why yeast cells always make one and only one bud. Here, using imaging with improved spatiotemporal resolution, we show the transient coexistence of multiple clusters during polarity establishment, as predicted by the model. Unexpectedly, we also find that initial polarity factor clustering is oscillatory, revealing the presence of a negative feedback loop that disperses the factors. Mathematical modeling predicts that negative feedback would confer robustness to the polarity circuit and make the kinetics of competition between polarity factor clusters relatively insensitive to polarity factor concentration. These predictions are confirmed experimentally.	[Howell, Audrey S.; Wu, Chi-Fang; Zyla, Trevin R.; Lew, Daniel J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Jin, Meng] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Elston, Timothy C.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lew, DJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	daniel.lew@duke.edu	Jin, Meng/W-3206-2017	Jin, Meng/0000-0002-2579-3823	NIH [GM79271, GM84071, GM62300]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062300, R01GM084071, R01GM079271] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Nick Buchler, Beverle Errede, Steve Haase, Joe Heitman, Sally Kornbluth, and members of the Lew lab for stimulating discussions and comments on the manuscript. Thanks to Sam Johnson and the Light Microscopy Core Facility at Duke University for making experiments possible and for providing assistance. We thank Rong Li and Erfei Bi for providing Cdc42p probes and Peter Pryciak for the estrogen-responsive Gal4p. This work was supported by NIH grants GM79271 and GM84071 (T. C. E.) and GM62300 (D.J.L.), as well as a supplement for collaborative science (D.J.L. and T.C.E.).	Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; BENDER A, 1989, P NATL ACAD SCI USA, V86, P9976, DOI 10.1073/pnas.86.24.9976; Bi EF, 2000, MOL BIOL CELL, V11, P773, DOI 10.1091/mbc.11.2.773; Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Carlton PM, 2010, P NATL ACAD SCI USA, V107, P16016, DOI 10.1073/pnas.1004037107; CHANT J, 1991, CELL, V65, P1203, DOI 10.1016/0092-8674(91)90015-Q; Chen H, 2011, BIOL CHEM, V392, P689, DOI 10.1515/BC.2011.075; Cheong R, 2010, CURR OPIN GENET DEV, V20, P665, DOI 10.1016/j.gde.2010.08.007; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Feijo JA, 2001, BIOESSAYS, V23, P86, DOI 10.1002/1521-1878(200101)23:1&lt;86::AID-BIES1011&gt;3.0.CO;2-D; Goryachev AB, 2008, FEBS LETT, V582, P1437, DOI 10.1016/j.febslet.2008.03.029; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159; Howell AS, 2009, CELL, V139, P731, DOI 10.1016/j.cell.2009.10.024; Irazoqui JE, 2005, MOL BIOL CELL, V16, P1296, DOI 10.1091/mbc.E04-05-0430; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Johnson JM, 2011, CURR OPIN GENET DEV, V21, P740, DOI 10.1016/j.gde.2011.09.007; Kadota J, 2004, MOL BIOL CELL, V15, P5329, DOI 10.1091/mbc.E04-03-0254; Knaus M, 2007, EMBO J, V26, P4501, DOI 10.1038/sj.emboj.7601873; Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167; Kozubowski L, 2005, MOL BIOL CELL, V16, P3455, DOI 10.1091/mbc.E04-09-0764; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; Layton AT, 2011, CURR BIOL, V21, P184, DOI 10.1016/j.cub.2011.01.012; McMurray MA, 2009, CELL DIV, V4, DOI 10.1186/1747-1028-4-18; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; Oh Y, 2011, TRENDS CELL BIOL, V21, P141, DOI 10.1016/j.tcb.2010.11.006; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06; Riquelme M, 2004, FUNGAL GENET BIOL, V41, P842, DOI 10.1016/j.fgb.2004.04.006; Schmitz HP, 2006, MOL BIOL CELL, V17, P130, DOI 10.1091/mbc.e05-06-0479; Takahashi S, 2008, CURR BIOL, V18, P1184, DOI 10.1016/j.cub.2008.07.050; Tong ZT, 2007, J CELL BIOL, V179, P1375, DOI 10.1083/jcb.200705160; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Yamamoto T, 2010, MOL BIOL CELL, V21, P1237, DOI 10.1091/mbc.E09-05-0412; Yan A, 2009, P NATL ACAD SCI USA, V106, P22002, DOI 10.1073/pnas.0910811106; ZIMAN M, 1994, YEAST, V10, P463, DOI 10.1002/yea.320100405	40	136	136	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					322	333		10.1016/j.cell.2012.03.012	http://dx.doi.org/10.1016/j.cell.2012.03.012			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500799	Green Accepted, Bronze, Green Published			2022-12-24	WOS:000302805600012
J	Melo, JA; Ruvkun, G				Melo, Justine A.; Ruvkun, Gary			Inactivation of Conserved C. elegans Genes Engages Pathogen- and Xenobiotic-Associated Defenses	CELL			English	Article							CAENORHABDITIS-ELEGANS; SIGNALING PATHWAY; PROTEIN; INFECTION; KINASE; MAPK; RNAI; SURVIVAL; IMMUNITY; DAMAGE	The nematode C. elegans is attracted to nutritious bacteria and is repelled by pathogens and toxins. Here we show that RNAi and toxin-mediated disruption of core cellular activities, including translation, respiration, and protein turnover, stimulate behavioral avoidance of normally attractive bacteria. RNAi of these and other essential processes induces expression of detoxification and innate immune effectors, even in the absence of toxins or pathogens. Disruption of core processes in non-neuronal tissues was sufficient to stimulate aversion behavior, revealing a neuroendocrine axis of control that additionally required serotonergic and Jnk kinase signaling pathways. We propose that surveillance pathways overseeing core cellular activities allow animals to detect invading pathogens that deploy toxins and virulence factors to undermine vital host functions. Variation in cellular surveillance and endocrine pathways controlling behavior, detoxification, and immunity selected by past toxin or microbial interactions could underlie aberrant responses to foods, medicines, and microbes.	[Melo, Justine A.; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Melo, Justine A.; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu	Melo, Justine/AAH-4339-2021	Melo, Justine/0000-0002-7476-0470	Jane Coffin Childs Memorial Fund; Bank of America Charles King Trust; MGH; NIH [DK070147]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070147] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043184] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; Bank of America Charles King Trust; MGH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Ausubel, D. McEwan, R. Pukkila-Worley, E. Troemel, S. Curran, A. Frand, J. Kim, D. Kim, Y. Tabach, B. Cezairliyan, A. Jose, J. Gray, B. Shtonda, L. Avery, C. Bargmann, and D. Hopwood for helpful discussions, D. Shore for participation in stress reporter assays, E. O'Rourke and B. Samuel for assistance with pharyngeal pumping assays, and Rusty Howson for figure support. We thank the CGC, OMRF knockout consortium, National Bioresource Project of Japan, F. Ausubel, D. Kim, E. Troemel, J. Irazoqui, J. Kaplan, J. Kim, A. Soukas, L. Avery, and R. Losick for strains, and the C. elegans resource Wormbase. For sharing unpublished results, we thank F. Ausubel, D. Kim, E. Troemel, Y. Tabach, L. Avery, and S. Politz. Salary support for J. A. M. was provided by the Jane Coffin Childs Memorial Fund, the Bank of America Charles King Trust, and the MGH Fund for Medical Discovery. This work was funded by NIH grant DK070147.	Bargmann C.I., 2006, CHEMOSENSATION C ELG, DOI [10.1895/wormbook.1.7.1, DOI 10.1895/WORMBOOK.1.7.1]; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Calixto A, 2010, NAT METHODS, V7, P554, DOI [10.1038/NMETH.1463, 10.1038/nmeth.1463]; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Hao LM, 2006, DEV DYNAM, V235, P1469, DOI 10.1002/dvdy.20721; Hart A. C., 2006, WORMBOOK; Haynes CM, 2010, J CELL SCI, V123, P3849, DOI 10.1242/jcs.075119; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iordanov MS, 1997, MOL CELL BIOL, V17, P3373, DOI 10.1128/MCB.17.6.3373; Iser WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017369; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jose AM, 2009, P NATL ACAD SCI USA, V106, P2283, DOI 10.1073/pnas.0809760106; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Lamitina T, 2006, P NATL ACAD SCI USA, V103, P12173, DOI 10.1073/pnas.0602987103; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Mizuno T, 2004, EMBO J, V23, P2226, DOI 10.1038/sj.emboj.7600226; Mizuno T, 2008, MOL CELL BIOL, V28, P7041, DOI 10.1128/MCB.00938-08; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Powell JR, 2009, P NATL ACAD SCI USA, V106, P2782, DOI 10.1073/pnas.0813048106; Prahlad V, 2008, SCIENCE, V320, P811, DOI 10.1126/science.1156093; Prahlad V, 2011, P NATL ACAD SCI USA, V108, P14204, DOI 10.1073/pnas.1106557108; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Pujol N, 2008, CURR BIOL, V18, P481, DOI 10.1016/j.cub.2008.02.079; Qadota H, 2007, GENE, V400, P166, DOI 10.1016/j.gene.2007.06.020; Schulenburg H, 2004, PARASITOLOGY, V128, P433, DOI 10.1017/S003118200300461X; Schulenburg H, 2007, MOL MICROBIOL, V66, P563, DOI 10.1111/j.1365-2958.2007.05946.x; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	42	239	244	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					452	466		10.1016/j.cell.2012.02.050	http://dx.doi.org/10.1016/j.cell.2012.02.050			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500807	Green Accepted, Bronze			2022-12-24	WOS:000302805600022
J	Cremades, N; Cohen, SIA; Deas, E; Abramov, AY; Chen, AY; Orte, A; Sandal, M; Clarke, RW; Dunne, P; Aprile, FA; Bertoncini, CW; Wood, NW; Knowles, TPJ; Dobson, CM; Klenerman, D				Cremades, Nunilo; Cohen, Samuel I. A.; Deas, Emma; Abramov, Andrey Y.; Chen, Allen Y.; Orte, Angel; Sandal, Massimo; Clarke, Richard W.; Dunne, Paul; Aprile, Francesco A.; Bertoncini, Carlos W.; Wood, Nicholas W.; Knowles, Tuomas P. J.; Dobson, Christopher M.; Klenerman, David			Direct Observation of the Interconversion of Normal and Toxic Forms of alpha-Synuclein	CELL			English	Article							AMYLOID FIBRIL FORMATION; PARKINSONS-DISEASE; SINGLE-MOLECULE; PROTEIN AGGREGATION; SECONDARY STRUCTURE; COMMON MECHANISM; OLIGOMERS; FIBRILLOGENESIS; POLYMERIZATION; FIBRILLIZATION	Here, we use single-molecule techniques to study the aggregation of alpha-synuclein, the protein whose misfolding and deposition is associated with Parkinson's disease. We identify a conformational change from the initially formed oligomers to stable, more compact proteinase-K-resistant oligomers as the key step that leads ultimately to fibril formation. The oligomers formed as a result of the structural conversion generate much higher levels of oxidative stress in rat primary neurons than do the oligomers formed initially, showing that they are more damaging to cells. The structural conversion is remarkably slow, indicating a high kinetic barrier for the conversion and suggesting that there is a significant period of time for the cellular protective machinery to operate and potentially for therapeutic intervention, prior to the onset of cellular damage. In the absence of added soluble protein, the assembly process is reversed and fibrils disaggregate to form stable oligomers, hence acting as a source of cytotoxic species.	[Cremades, Nunilo; Cohen, Samuel I. A.; Chen, Allen Y.; Orte, Angel; Sandal, Massimo; Clarke, Richard W.; Dunne, Paul; Aprile, Francesco A.; Bertoncini, Carlos W.; Knowles, Tuomas P. J.; Dobson, Christopher M.; Klenerman, David] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Deas, Emma; Abramov, Andrey Y.; Wood, Nicholas W.] UCL, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Orte, Angel] Univ Granada, Fac Pharm, Dept Phys Chem, E-18071 Granada, Spain; [Aprile, Francesco A.] Univ Milano Bicocca, Dept Biotechnol & Biosci, I-20126 Milan, Italy; [Bertoncini, Carlos W.] Inst Res Biomed, Barcelona 08028, Spain	University of Cambridge; University of London; University College London; University of Granada; University of Milano-Bicocca; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Dobson, CM (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	cmd44@cam.ac.uk; dk10012@cam.ac.uk	Orte, Angel/J-4810-2012; Knowles, Tuomas/C-6663-2009; Abramov, Andrey/AAC-6712-2019; Wood, Nicholas W/C-2505-2009; Cremades, Nunilo/F-9634-2015; Abramov, Andrey Y/H-9053-2012	Orte, Angel/0000-0003-1905-4183; Knowles, Tuomas/0000-0002-7879-0140; Abramov, Andrey/0000-0002-7646-7235; Wood, Nicholas W/0000-0002-9500-3348; Cremades, Nunilo/0000-0002-9138-6687; Abramov, Andrey Y/0000-0002-7646-7235; /0000-0003-0929-0393; Clarke, Richard/0000-0003-3152-0423; Bertoncini, Carlos/0000-0001-7695-2882; Klenerman, David/0000-0001-7116-6954; Aprile, Francesco Antonio/0000-0002-5040-4420	Human Frontier Science Program [LT000795/2009]; Schiff Foundation; EU; Gates Cambridge Scholarship; FEBS Fellowship; Italian Ministry of Education; University and Research; Marie Curie IEF; Wellcome/MRC Parkinson's Disease Consortium; University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee [WT089698]; Augustus Newman Foundation; Wellcome Trust; Leverhulme Trust; Medical Research Council (UK); Engineering and Physical Sciences Research Council; BBSRC [BB/E019927/1]; European Commission [LSHM-CT-2006-037525]; MRC [MC_G1000735, MC_G1000734] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E019927/1] Funding Source: researchfish; Medical Research Council [MC_G1000735, MC_G1000734] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Schiff Foundation; EU(European Commission); Gates Cambridge Scholarship; FEBS Fellowship; Italian Ministry of Education; University and Research; Marie Curie IEF(European Commission); Wellcome/MRC Parkinson's Disease Consortium(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Sheffield; MRC Protein Phosphorylation Unit at the University of Dundee(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Augustus Newman Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Francisco Mateo and Priyanka Narayan for their helpful comments and discussions. N.C. is the recipient of a Human Frontier Science Program Long-term Fellowship (LT000795/2009). S.I.A.C. is supported by a Schiff Foundation Scholarship, A.O. acknowledges an ERG from the EU 7th FP, A.Y.C. was supported by a Gates Cambridge Scholarship, and M. S. was supported by a FEBS Fellowship. F.A.A. was recipient of a PhD Fellowship from the Italian Ministry of Education, University and Research, and C.W.B. is the recipient of a FP7 Marie Curie IEF grant. E.D., A.Y.A., and N.W.W. are supported by the Wellcome/MRC Parkinson's Disease Consortium grant to UCL/IoN, the University of Sheffield and the MRC Protein Phosphorylation Unit at the University of Dundee (grant number WT089698). C.M.D. and D.K. acknowledge with gratitude support from the Augustus Newman Foundation, the Wellcome Trust, the Leverhulme Trust, BBSRC (BB/E019927/1), the European Commission (project LSHM-CT-2006-037525), the Medical Research Council (UK), and the Engineering and Physical Sciences Research Council.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Apetri MM, 2006, J MOL BIOL, V355, P63, DOI 10.1016/j.jmb.2005.10.071; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bolognesi B, 2010, ACS CHEM BIOL, V5, P735, DOI 10.1021/cb1001203; Bonini NM, 2005, CELL, V123, P359, DOI 10.1016/j.cell.2005.10.017; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Calamai M, 2005, J MOL BIOL, V346, P603, DOI 10.1016/j.jmb.2004.11.067; Campioni S, 2010, NAT CHEM BIOL, V6, P140, DOI [10.1038/NCHEMBIO.283, 10.1038/nchembio.283]; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; Chiou A, 2009, BIOPHYS J, V97, P2306, DOI 10.1016/j.bpj.2009.07.057; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; Goldberg MS, 2000, NAT CELL BIOL, V2, pE115, DOI 10.1038/35017124; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Hong DP, 2008, J MOL BIOL, V383, P214, DOI 10.1016/j.jmb.2008.08.039; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Hoyer WG, 2004, J MOL BIOL, V340, P127, DOI 10.1016/j.jmb.2004.04.051; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; JARRETT JT, 1992, BIOCHEMISTRY-US, V31, P12345, DOI 10.1021/bi00164a008; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Jenner P, 1998, ANN NEUROL, V44, pS72, DOI 10.1002/ana.410440712; Junker M, 2010, PROTEINS, V78, P812, DOI 10.1002/prot.22609; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; KOCISKO DA, 1995, P NATL ACAD SCI USA, V92, P3923, DOI 10.1073/pnas.92.9.3923; Kostka M, 2008, J BIOL CHEM, V283, P10992, DOI 10.1074/jbc.M709634200; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Luheshi LM, 2007, PLOS BIOL, V5, P2493, DOI 10.1371/journal.pbio.0050290; MacPhee CE, 2000, J MOL BIOL, V297, P1203, DOI 10.1006/jmbi.2000.3600; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Miake H, 2002, J BIOL CHEM, V277, P19213, DOI 10.1074/jbc.M110551200; Morimoto RI, 2008, GENE DEV, V22, P1427, DOI 10.1101/gad.1657108; Nath S, 2010, BIOPHYS J, V98, P1302, DOI 10.1016/j.bpj.2009.12.4290; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; NORDSTEDT C, 1994, J BIOL CHEM, V269, P30773; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Onuchic JN, 1997, ANNU REV PHYS CHEM, V48, P545, DOI 10.1146/annurev.physchem.48.1.545; Orte A, 2008, P NATL ACAD SCI USA, V105, P14424, DOI 10.1073/pnas.0803086105; Orte A, 2006, ANAL CHEM, V78, P7707, DOI 10.1021/ac061122y; Parihar MS, 2009, INT J BIOCHEM CELL B, V41, P2015, DOI 10.1016/j.biocel.2009.05.008; Picotti P, 2007, J MOL BIOL, V367, P1237, DOI 10.1016/j.jmb.2007.01.072; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tabner Brian J., 2001, Current Topics in Medicinal Chemistry, V1, P507, DOI 10.2174/1568026013394822; Thirunavukkuarasu S, 2008, J MOL BIOL, V378, P1064, DOI 10.1016/j.jmb.2008.03.034; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Vilar M, 2008, P NATL ACAD SCI USA, V105, P8637, DOI 10.1073/pnas.0712179105; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zampagni M, 2011, J CELL MOL MED, V15, P2106, DOI 10.1111/j.1582-4934.2010.01239.x	58	579	589	8	203	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1048	1059		10.1016/j.cell.2012.03.037	http://dx.doi.org/10.1016/j.cell.2012.03.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632969	Green Published, hybrid			2022-12-24	WOS:000304453900011
J	Freitag, J; Ast, J; Bolker, M				Freitag, Johannes; Ast, Julia; Boelker, Michael			Cryptic peroxisomal targeting via alternative splicing and stop codon read-through in fungi	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; PROTEINS; YEAST; IDENTIFICATION; DEHYDROGENASE; COORDINATION; MICROBODIES; TRANSPORT; MEMBRANE; SIGNAL-1	Peroxisomes are eukaryotic organelles important for the metabolism of long-chain fatty acids(1,2). Here we show that in numerous fungal species, several core enzymes of glycolysis, including glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and 3-phosphoglycerate kinase (PGK), reside in both the cytoplasm and peroxisomes. We detected in these enzymes cryptic type 1 peroxisomal targeting signals (PTS1)(3), which are activated by post-transcriptional processes. Notably, the molecular mechanisms that generate the peroxisomal isoforms vary considerably among different species. In the basidiomycete plant pathogen Ustilago maydis, peroxisomal targeting of Pgk1 results from ribosomal read-through, whereas alternative splicing generates the PTS1 of Gapdh. In the filamentous ascomycete Aspergillus nidulans, peroxisomal targeting of these enzymes is achieved by exactly the opposite mechanisms. We also detected PTS1 motifs in the glycolytic enzymes triose-phosphate isomerase and fructose-bisphosphate aldolase. U. maydis mutants lacking the peroxisomal isoforms of Gapdh or Pgk1 showed reduced virulence. In addition, mutational analysis suggests that GAPDH, together with other peroxisomal NADH-dependent dehydrogenases, has a role in redox homeostasis. Owing to its hidden nature, partial peroxisomal targeting of well-studied cytoplasmic enzymes has remained undetected. Thus, we anticipate that further bona fide cytoplasmic proteins exhibit similar dual targeting.	[Freitag, Johannes; Ast, Julia; Boelker, Michael] Univ Marburg, Dept Biol, D-35032 Marburg, Germany	Philipps University Marburg	Bolker, M (corresponding author), Univ Marburg, Dept Biol, Karl von Frisch Str 8, D-35032 Marburg, Germany.	boelker@uni-marburg.de		Bolker, Michael/0000-0002-7366-3855; Freitag, Johannes/0000-0002-8251-4878; Ast, Julia/0000-0002-0039-4762	Deutsche Forschungsgemeinschaft [DFG-GK1216]; Marburg University Research Academy (MARA)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Marburg University Research Academy (MARA)	We are indebted to J. Heitman and W. K. Holloman for reading of the manuscript. We thank R. Fischer and G. Barth for providing strains and DNA. We acknowledge technical assistance by M. Piscator. We thank D. Lanver and T. Stehlik for discussions. This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG-GK1216). J. A. received a fellowship from the Marburg University Research Academy (MARA).	Baranov PV, 2002, GENE, V286, P187, DOI 10.1016/S0378-1119(02)00423-7; Bernhardt K, 2012, PLANT J, V69, P1, DOI 10.1111/j.1365-313X.2011.04775.x; Brachmann A, 2004, MOL GENET GENOMICS, V272, P216, DOI 10.1007/s00438-004-1047-z; Brocard C, 2006, BBA-MOL CELL RES, V1763, P1565, DOI 10.1016/j.bbamcr.2006.08.022; DEDUVE C, 1966, PHYSIOL REV, V46, P323, DOI 10.1152/physrev.1966.46.2.323; Gabaldon T, 2010, PHILOS T R SOC B, V365, P765, DOI 10.1098/rstb.2009.0240; Girzalsky W, 2010, BBA-MOL CELL RES, V1803, P724, DOI 10.1016/j.bbamcr.2010.01.002; GOULD SJ, 1989, J CELL BIOL, V108, P1657, DOI 10.1083/jcb.108.5.1657; Graham IA, 2008, ANNU REV PLANT BIOL, V59, P115, DOI 10.1146/annurev.arplant.59.032607.092938; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gurvitz A, 1997, J BIOL CHEM, V272, P22140, DOI 10.1074/jbc.272.35.22140; Guthrie C., 2002, GUIDE YEAST GENETICS; Haanstra JR, 2008, P NATL ACAD SCI USA, V105, P17718, DOI 10.1073/pnas.0806664105; Hoepfner D, 2005, CELL, V122, P85, DOI 10.1016/j.cell.2005.04.025; HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4; Idnurm A, 2007, EUKARYOT CELL, V6, P60, DOI 10.1128/EC.00214-06; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jedd G, 2011, TRENDS CELL BIOL, V21, P12, DOI 10.1016/j.tcb.2010.09.001; Jones JM, 1999, J BIOL CHEM, V274, P9216, DOI 10.1074/jbc.274.14.9216; Kabran P, 2012, DNA RES, V19, P231, DOI 10.1093/dnares/dss007; Kamper J, 2006, NATURE, V444, P97, DOI 10.1038/nature05248; Kiel JAKW, 2006, TRAFFIC, V7, P1291, DOI 10.1111/j.1600-0854.2006.00479.x; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Lazarow PB, 2006, BBA-MOL CELL RES, V1763, P1599, DOI 10.1016/j.bbamcr.2006.08.011; Loubradou G, 2001, MOL MICROBIOL, V40, P719, DOI 10.1046/j.1365-2958.2001.02424.x; Managadze D, 2010, PROTEOMICS, V10, P3222, DOI 10.1002/pmic.201000095; Michels PAM, 2006, BBA-MOL CELL RES, V1763, P1463, DOI 10.1016/j.bbamcr.2006.08.019; Neuberger G, 2003, J MOL BIOL, V328, P581, DOI 10.1016/S0022-2836(03)00319-X; Poirier Y, 2006, BBA-MOL CELL RES, V1763, P1413, DOI 10.1016/j.bbamcr.2006.08.034; Purdue PE, 2001, ANNU REV CELL DEV BI, V17, P701, DOI 10.1146/annurev.cellbio.17.1.701; Rottensteiner H, 2006, BBA-MOL CELL RES, V1763, P1527, DOI 10.1016/j.bbamcr.2006.08.012; Sambrook J, 2001, MOL CLONING LAB MANU; Schink KO, 2009, MOL BIOL CELL, V20, P1081, DOI 10.1091/mbc.E08-03-0280; SCHULZ B, 1990, CELL, V60, P295, DOI 10.1016/0092-8674(90)90744-Y; Spellig T, 1996, MOL GEN GENET, V252, P503, DOI 10.1007/BF02172396; Strijbis K, 2012, FEMS YEAST RES, V12, P61, DOI 10.1111/j.1567-1364.2011.00761.x; Tabak HF, 2006, BBA-MOL CELL RES, V1763, P1647, DOI 10.1016/j.bbamcr.2006.08.045; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; VANROERMUND CWT, 1995, EMBO J, V14, P3480, DOI 10.1002/j.1460-2075.1995.tb07354.x; Visser WF, 2007, BIOCHEM J, V401, P365, DOI 10.1042/BJ20061352	40	112	112	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					522	U135		10.1038/nature11051	http://dx.doi.org/10.1038/nature11051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622582				2022-12-24	WOS:000304344500047
J	Vannier, JB; Pavicic-Kaltenbrunner, V; Petalcorin, MIR; Ding, H; Boulton, SJ				Vannier, Jean-Baptiste; Pavicic-Kaltenbrunner, Visnja; Petalcorin, Mark I. R.; Ding, Hao; Boulton, Simon J.			RTEL1 Dismantles T Loops and Counteracts Telomeric G4-DNA to Maintain Telomere Integrity	CELL			English	Article							HOLLIDAY JUNCTION RESOLUTION; STRUCTURE-SPECIFIC NUCLEASES; HOMOLOGOUS RECOMBINATION; FRAGILE SITES; FANCONI-ANEMIA; DNA-REPAIR; LENGTH; SLX4; PROTEIN; CELLS	T loops and telomeric G-quadruplex (G4) DNA structures pose a potential threat to genome stability and must be dismantled to permit efficient telomere replication. Here we implicate the helicase RTEL1 in the removal of telomeric DNA secondary structures, which is essential for preventing telomere fragility and loss. In the absence of RTEL1, T loops are inappropriately resolved by the SLX4 nuclease complex, resulting in loss of the telomere as a circle. Depleting SLX4 or blocking DNA replication abolished telomere circles (TCs) and rescued telomere loss in RTEL1(-/-) cells but failed to suppress telomere fragility. Conversely, stabilization of telomeric G4-DNA or loss of BLM dramatically enhanced telomere fragility in RTEL1-deficient cells but had no impact on TC formation or telomere loss. We propose that RTEL1 performs two distinct functions at telomeres: it disassembles T loops and also counteracts telomeric G4-DNA structures, which together ensure the dynamics and stability of the telomere.	[Vannier, Jean-Baptiste; Pavicic-Kaltenbrunner, Visnja; Petalcorin, Mark I. R.; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Ding, Hao] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB R3E 3J7, Canada	Cancer Research UK; University of Manitoba	Boulton, SJ (corresponding author), Canc Res UK, London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk		Petalcorin, Mark/0000-0001-8211-9440	Cancer Research UK; ERC; Royal Society; EMBO; CIHR (Canada Institute of Health Research); Terry Fox foundation; Cancer Research UK [11581] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); ERC(European Research Council (ERC)European Commission); Royal Society(Royal Society of London); EMBO(European Molecular Biology Organization (EMBO)); CIHR (Canada Institute of Health Research)(Canadian Institutes of Health Research (CIHR)); Terry Fox foundation; Cancer Research UK(Cancer Research UK)	We wish to thank the Biological Research Unit at Clare Hall for mouse breeding, Clare McGowan and Alan Bradley for providing mouse strains, Titia de Lange for providing conditional TRF1-deficient cells and plasmids, and John Rouse for antibodies. The lab of S.J.B. is funded by Cancer Research UK and by an ERC Advanced Investigator Grant (RecMitMei). S.J.B. is a recipient of a Royal Society Wolfson Research Merit Award. J.-B.V. is funded by a long-term fellowship from EMBO. H. D. is a holder of Canada Research Chair and is funded by CIHR (Canada Institute of Health Research) and the Terry Fox foundation.	Amiard S, 2007, NAT STRUCT MOL BIOL, V14, P147, DOI 10.1038/nsmb1192; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bayani J., 2005, CURR PROTOC CELL BIO; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Cesare AJ, 2003, PLANT J, V36, P271, DOI 10.1046/j.1365-313X.2003.01882.x; Crossan GP, 2011, NAT GENET, V43, P147, DOI 10.1038/ng.752; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Dendouga N, 2005, MOL CELL BIOL, V25, P7569, DOI 10.1128/MCB.25.17.7569-7579.2005; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; Egan KM, 2011, J NEURO-ONCOL, V104, P535, DOI 10.1007/s11060-010-0506-0; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; GLOVER TW, 1987, AM J HUM GENET, V41, P882; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Henson JD, 2002, ONCOGENE, V21, P598, DOI 10.1038/sj.onc.1205058; Henson JD, 2009, NAT BIOTECHNOL, V27, P1181, DOI 10.1038/nbt.1587; Izbicka E, 1999, CANCER RES, V59, P639; Jenkins RB, 2011, CANCER GENET-NY, V204, P13, DOI 10.1016/j.cancergencyto.2010.10.002; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Luo GB, 2000, NAT GENET, V26, P424, DOI 10.1038/82548; Marini V, 2010, DNA REPAIR, V9, P268, DOI 10.1016/j.dnarep.2010.01.007; Miller KM, 2006, NATURE, V440, P824, DOI 10.1038/nature04638; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Munoz-Jordan JL, 2001, EMBO J, V20, P579, DOI 10.1093/emboj/20.3.579; Paeschke K, 2010, FEBS LETT, V584, P3760, DOI 10.1016/j.febslet.2010.07.007; Raices M, 2008, CELL, V132, P745, DOI 10.1016/j.cell.2007.12.039; Ribeyre C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000475; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Silvestre DC, 2011, STEM CELLS, V29, P440, DOI 10.1002/stem.600; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Svendsen JM, 2010, GENE DEV, V24, P521, DOI 10.1101/gad.1903510; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Verdun RE, 2006, CELL, V127, P709, DOI 10.1016/j.cell.2006.09.034; Wang RC, 2004, CELL, V119, P355, DOI 10.1016/j.cell.2004.10.011; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; Wu XL, 2007, GENESIS, V45, P788, DOI 10.1002/dvg.20359; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112; Zellinger B, 2007, MOL CELL, V27, P163, DOI 10.1016/j.molcel.2007.05.025; Zhu LX, 1998, P NATL ACAD SCI USA, V95, P8648, DOI 10.1073/pnas.95.15.8648	45	322	327	0	33	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					795	806		10.1016/j.cell.2012.03.030	http://dx.doi.org/10.1016/j.cell.2012.03.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579284	Bronze			2022-12-24	WOS:000303934700013
J	Teeling, H; Fuchs, BM; Becher, D; Klockow, C; Gardebrecht, A; Bennke, CM; Kassabgy, M; Huang, SX; Mann, AJ; Waldmann, J; Weber, M; Klindworth, A; Otto, A; Lange, J; Bernhardt, J; Reinsch, C; Hecker, M; Peplies, J; Bockelmann, FD; Callies, U; Gerdts, G; Wichels, A; Wiltshire, KH; Glockner, FO; Schweder, T; Amann, R				Teeling, Hanno; Fuchs, Bernhard M.; Becher, Doerte; Klockow, Christine; Gardebrecht, Antje; Bennke, Christin M.; Kassabgy, Mariette; Huang, Sixing; Mann, Alexander J.; Waldmann, Jost; Weber, Marc; Klindworth, Anna; Otto, Andreas; Lange, Jana; Bernhardt, Joerg; Reinsch, Christine; Hecker, Michael; Peplies, Joerg; Bockelmann, Frank D.; Callies, Ulrich; Gerdts, Gunnar; Wichels, Antje; Wiltshire, Karen H.; Gloeckner, Frank Oliver; Schweder, Thomas; Amann, Rudolf			Substrate-Controlled Succession of Marine Bacterioplankton Populations Induced by a Phytoplankton Bloom	SCIENCE			English	Article							BACTERIAL COMMUNITY; SP NOV.; ORGANIC-MATTER; OCEAN; CARBON; GAMMAPROTEOBACTERIUM; DEGRADATION; DIVERSITY; TRANSPORT; DYNAMICS	Phytoplankton blooms characterize temperate ocean margin zones in spring. We investigated the bacterioplankton response to a diatom bloom in the North Sea and observed a dynamic succession of populations at genus-level resolution. Taxonomically distinct expressions of carbohydrate-active enzymes (transporters; in particular, TonB-dependent transporters) and phosphate acquisition strategies were found, indicating that distinct populations of Bacteroidetes, Gammaproteobacteria, and Alphaproteobacteria are specialized for successive decomposition of algal-derived organic matter. Our results suggest that algal substrate availability provided a series of ecological niches in which specialized populations could bloom. This reveals how planktonic species, despite their seemingly homogeneous habitat, can evade extinction by direct competition.	[Becher, Doerte; Waldmann, Jost; Lange, Jana; Reinsch, Christine; Hecker, Michael; Wiltshire, Karen H.] Inst Marine Biotechnol, D-17489 Greifswald, Germany; [Teeling, Hanno; Fuchs, Bernhard M.; Klockow, Christine; Bennke, Christin M.; Kassabgy, Mariette; Huang, Sixing; Mann, Alexander J.; Waldmann, Jost; Weber, Marc; Klindworth, Anna; Gloeckner, Frank Oliver; Amann, Rudolf] Max Planck Inst Marine Microbiol, D-28359 Bremen, Germany; [Klockow, Christine; Mann, Alexander J.; Waldmann, Jost; Weber, Marc; Klindworth, Anna; Gloeckner, Frank Oliver] Jacobs Univ Bremen, D-28759 Bremen, Germany; [Gerdts, Gunnar; Wichels, Antje; Wiltshire, Karen H.] Biol Anstalt Helgoland, Alfred Wegener Inst Polar & Marine Res, D-27483 Helgoland, Germany; [Becher, Doerte; Otto, Andreas; Bernhardt, Joerg; Hecker, Michael] Ernst Moritz Arndt Univ Greifswald, Inst Microbiol, D-17487 Greifswald, Germany; [Bernhardt, Joerg] DECODON, D-17489 Greifswald, Germany; [Peplies, Joerg] Ribocon, D-28359 Bremen, Germany; [Bockelmann, Frank D.; Callies, Ulrich] HZG Res Ctr, D-21502 Geesthacht, Germany	Max Planck Society; Jacobs University; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Ernst Moritz Arndt Universitat Greifswald; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung	Schweder, T (corresponding author), Inst Marine Biotechnol, Walther Rathenau Str 49A, D-17489 Greifswald, Germany.	schweder@uni-greifswald.de; ramann@mpi-bremen.de	Amann, Rudolf I/C-6534-2014; Becher, Doerte/B-4454-2015; Wichels, Antje/R-6992-2016; Gerdts, Gunnar/R-7000-2016; Wiltshire, Karen H./N-9494-2017	Amann, Rudolf I/0000-0002-0846-7372; Becher, Doerte/0000-0002-9630-5735; Wichels, Antje/0000-0002-2060-1845; Gerdts, Gunnar/0000-0003-0872-3927; Schweder, Thomas/0000-0002-7213-3596; Bockelmann, Frank-Detlef/0000-0003-4900-6780; Fuchs, Bernhard/0000-0001-9828-1290; Wiltshire, Karen/0000-0002-7148-0529	European Bioinformatics Institute [ERP001227]; German Federal Ministry of Education and Research (BMBF) [03F0480A]	European Bioinformatics Institute; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank T. Hammer and T. Ferdelman for critical reading of the manuscript; M. Meiners, E. Karamehmedovic, B. Voigt, and V. Damare for sample processing; F. Ruhnau and L. Sayavedra for work on transporters; M. Zeder for automated counting; and R. Hahnke and J. Harder for help with probe testing. We are also grateful to our colleagues from the Bundesamt fur Seeschifffahrt und Hydrographie for provision of operational model output. Analyses and visualizations used in fig. S1, D to F, were produced with the Giovanni online data system, developed and maintained by the NASA Goddard Earth Sciences Data and Information Service Center. We acknowledge the Moderate Resolution Imaging Spectroradiometer mission scientists and associated NASA personnel for these data. The sequence data reported in this study can be obtained from the European Bioinformatics Institute (study number ERP001227; www.ebi.ac.uk/ena/data/view/ERP001227). The German Federal Ministry of Education and Research (BMBF) supported this study by funding the Microbial Interactions in Marine Systems project (MIMAS, project 03F0480A, http://mimas-project.de).	Arnosti C, 2011, ANNU REV MAR SCI, V3, P401, DOI 10.1146/annurev-marine-120709-142731; Azam F, 1998, SCIENCE, V280, P694, DOI 10.1126/science.280.5364.694; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Bauer M, 2006, ENVIRON MICROBIOL, V8, P2201, DOI 10.1111/j.1462-2920.2006.01152.x; Braun V, 2011, CURR OPIN CHEM BIOL, V15, P328, DOI 10.1016/j.cbpa.2011.01.005; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Choi A, 2010, INT J SYST EVOL MICR, V60, P2813, DOI 10.1099/ijs.0.018739-0; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924, DOI 10.4319/lo.1993.38.5.0924; Edwards JL, 2010, GENES-BASEL, V1, P371, DOI 10.3390/genes1030371; Fandino LB, 2001, AQUAT MICROB ECOL, V23, P119, DOI 10.3354/ame023119; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Gattuso JP, 1998, ANNU REV ECOL SYST, V29, P405, DOI 10.1146/annurev.ecolsys.29.1.405; Giebel HA, 2011, ISME J, V5, P8, DOI 10.1038/ismej.2010.87; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Gomez-Pereira PR, 2012, ENVIRON MICROBIOL, V14, P52, DOI 10.1111/j.1462-2920.2011.02555.x; Hopkinson BM, 2012, ENVIRON MICROBIOL, V14, P114, DOI 10.1111/j.1462-2920.2011.02539.x; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Khodse VB, 2010, BIOFOULING, V26, P527, DOI 10.1080/08927014.2010.492468; Krewulak KD, 2011, BIOCHEM CELL BIOL, V89, P87, DOI [10.1139/o10-141, 10.1139/O10-141]; Lau WWY, 2007, APPL ENVIRON MICROB, V73, P2440, DOI 10.1128/AEM.01965-06; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Morris RM, 2010, ISME J, V4, P673, DOI 10.1038/ismej.2010.4; Newton RJ, 2010, ISME J, V4, P784, DOI 10.1038/ismej.2009.150; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Pinhassi J, 1999, AQUAT MICROB ECOL, V17, P13, DOI 10.3354/ame017013; Pinhassi J, 2007, INT J SYST EVOL MICR, V57, P2370, DOI 10.1099/ijs.0.65091-0; Reisch CR, 2011, NATURE, V473, P208, DOI 10.1038/nature10078; Riemann L, 2000, APPL ENVIRON MICROB, V66, P578, DOI 10.1128/AEM.66.2.578-587.2000; Rinta-Kanto JM, 2012, ENVIRON MICROBIOL, V14, P228, DOI 10.1111/j.1462-2920.2011.02602.x; Romanenko LA, 2004, INT J SYST EVOL MICR, V54, P669, DOI 10.1099/ijs.0.02846-0; Rostovtseva TK, 2002, BIOPHYS J, V82, P160, DOI 10.1016/S0006-3495(02)75383-6; Schauer K, 2008, TRENDS BIOCHEM SCI, V33, P330, DOI 10.1016/j.tibs.2008.04.012; Sowell SM, 2009, ISME J, V3, P93, DOI 10.1038/ismej.2008.83; Sun J., 2011, PLOS ONE, V6; Tada Y, 2011, APPL ENVIRON MICROB, V77, P4055, DOI 10.1128/AEM.02952-10; Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093; Tittel J, 2012, J PLANKTON RES, V34, P102, DOI 10.1093/plankt/fbr094; Woebken D, 2007, APPL ENVIRON MICROB, V73, P4648, DOI 10.1128/AEM.02774-06; Wustman BA, 1997, PLANT PHYSIOL, V113, P1059, DOI 10.1104/pp.113.4.1059	41	852	881	36	394	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					608	611		10.1126/science.1218344	http://dx.doi.org/10.1126/science.1218344			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556258				2022-12-24	WOS:000303498800051
J	Pearson, RA; Barber, AC; Rizzi, M; Hippert, C; Xue, T; West, EL; Duran, Y; Smith, AJ; Chuang, JZ; Azam, SA; Luhmann, UFO; Benucci, A; Sung, CH; Bainbridge, JW; Carandini, M; Yau, KW; Sowden, JC; Ali, RR				Pearson, R. A.; Barber, A. C.; Rizzi, M.; Hippert, C.; Xue, T.; West, E. L.; Duran, Y.; Smith, A. J.; Chuang, J. Z.; Azam, S. A.; Luhmann, U. F. O.; Benucci, A.; Sung, C. H.; Bainbridge, J. W.; Carandini, M.; Yau, K. -W.; Sowden, J. C.; Ali, R. R.			Restoration of vision after transplantation of photoreceptors	NATURE			English	Article							RETINITIS-PIGMENTOSA; VISUAL-ACUITY; CONE VISION; WILD-TYPE; MOUSE; MICE; PRECURSORS; ADULT; CELLS; INTEGRATION	Cell transplantation is a potential strategy for treating blindness caused by the loss of photoreceptors. Although transplanted rod-precursor cells are able to migrate into the adult retina and differentiate to acquire the specialized morphological features of mature photoreceptor cells(1), the fundamental question remains whether transplantation of photoreceptor cells can actually improve vision. Here we provide evidence of functional rod-mediated vision after photoreceptor transplantation in adult Gnat1(-/-) mice, which lack rod function and are a model of congenital stationary night blindness(2). We show that transplanted rod precursors form classic triad synaptic connections with second-order bipolar and horizontal cells in the recipient retina. The newly integrated photoreceptor cells are light-responsive with dim-flash kinetics similar to adult wild-type photoreceptors. By using intrinsic imaging under scotopic conditions we demonstrate that visual signals generated by transplanted rods are projected to higher visual areas, including V1. Moreover, these cells are capable of driving optokinetic head tracking and visually guided behaviour in the Gnat1(-/-) mouse under scotopic conditions. Together, these results demonstrate the feasibility of photoreceptor transplantation as a therapeutic strategy for restoring vision after retinal degeneration.	[Pearson, R. A.; Barber, A. C.; Rizzi, M.; Hippert, C.; West, E. L.; Duran, Y.; Smith, A. J.; Azam, S. A.; Luhmann, U. F. O.; Bainbridge, J. W.; Ali, R. R.] UCL, Dept Genet, UCL Inst Ophthalmol, London EC1V 9EL, England; [Benucci, A.; Carandini, M.] UCL, UCL Inst Ophthalmol, Dept Visual Neurosci, London EC1V 9EL, England; [Xue, T.; Yau, K. -W.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Chuang, J. Z.; Sung, C. H.] Cornell Univ, Weill Med Coll, Dept Cell & Dev Biol, Dyson Vision Res Inst,Dept Ophthalmol, New York, NY 10021 USA; [Sowden, J. C.] UCL, UCL Inst Child Hlth, Dev Biol Unit, London WC1N 1EH, England; [Ali, R. R.] UCL, UCL Inst Child Hlth, Mol Immunol Unit, London WC1N 1EH, England	University of London; University College London; University of London; University College London; Johns Hopkins University; Cornell University; University of London; University College London; University of London; University College London	Pearson, RA (corresponding author), UCL, Dept Genet, UCL Inst Ophthalmol, 11-43 Bath St, London EC1V 9EL, England.	rachael.pearson@ucl.ac.uk; r.ali@ucl.ac.uk	Benucci, Andrea/N-6361-2015; Smith, Alexander/A-5142-2009; Xue, Tian/G-9009-2018; West, Emma L/C-5252-2013; Carandini, Matteo/ABD-8296-2021; Luhmann, Ulrich/D-8905-2012; Pearson, Rachael/Y-3339-2018	Benucci, Andrea/0000-0002-7698-6289; Carandini, Matteo/0000-0003-4880-7682; Pearson, Rachael/0000-0002-1107-1969; Rizzi, Matteo/0000-0003-4922-397X; Sowden, Jane/0000-0003-0937-2479; Ali, Robin/0000-0003-3126-6517; Bainbridge, James/0000-0003-1318-8201; West, Emma/0000-0002-7006-3686	Medical Research Council UK [G03000341]; Wellcome Trust [082217]; Royal Society [RG080398]; British Retinitis Pigmentosa Society [GR566]; Miller's Trust; Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital; Alcon Research Institute; Great Ormond Street Hospital Children's Charity; US National Institutes of Health [EY06837]; Antonio Champalimaud Vision Award (Portugal); Research to Prevent Blindness [EY11307, EY016805]; European Research Council; NATIONAL EYE INSTITUTE [R01EY011307, R37EY006837, R01EY016805, F32EY006837, R01EY006837] Funding Source: NIH RePORTER; Medical Research Council [MR/J004553/1, G0800791, G0901550, G0700438] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-003, NF-SI-0508-10130] Funding Source: researchfish; Fight for Sight [1779/80, 1351/52] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V1221, V1257] Funding Source: researchfish; MRC [G0700438, G0901550, MR/J004553/1, G0800791] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); British Retinitis Pigmentosa Society; Miller's Trust; Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital(National Institute for Health Research (NIHR)); Alcon Research Institute(Novartis); Great Ormond Street Hospital Children's Charity; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Antonio Champalimaud Vision Award (Portugal); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); European Research Council(European Research Council (ERC)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Fight for Sight; Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK (G03000341), the Wellcome Trust (082217), the Royal Society (RG080398), the British Retinitis Pigmentosa Society (GR566) and The Miller's Trust. R. A. P. is a Royal Society University Research Fellow. R. R. A is partly funded by the Department of Health's National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital and Alcon Research Institute. J.C.S. is supported by Great Ormond Street Hospital Children's Charity. T. X. and K.-W.Y. were supported by a US National Institutes of Health grant (EY06837) and the Antonio Champalimaud Vision Award (Portugal). C. H. S. was supported by grants EY11307, EY016805, Research to Prevent Blindness. M. C. holds the GlaxoSmithKline/Fight for Sight Chair in Visual Neuroscience and is supported by the European Research Council. We thank Y. Umino and the late R. Barlow for advice and training with optomotor recordings, A. Eddaoudi for FACS assistance, G. Holder for advice on ERG recordings, C. Hogg for light calibrations, L. Cao for technical suggestions on suction-pipette recordings, and the Department of Genetics, UCL Institute of Ophthalmology, for discussions on the data.	Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Bartsch U, 2008, EXP EYE RES, V86, P691, DOI 10.1016/j.exer.2008.01.018; Berson EL, 2007, EXP EYE RES, V85, P7, DOI 10.1016/j.exer.2007.03.001; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Elias R, 2004, MOL VIS, V10, P672; Fu YB, 2008, NAT NEUROSCI, V11, P565, DOI 10.1038/nn.2110; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Maeda T, 2005, INVEST OPHTH VIS SCI, V46, P4320, DOI 10.1167/iovs.05-0478; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Pearson RA, 2010, CELL TRANSPLANT, V19, P487, DOI 10.3727/096368909X486057; Prusky GT, 2000, VISION RES, V40, P2201, DOI 10.1016/S0042-6989(00)00081-X; Prusky GT, 2004, INVEST OPHTH VIS SCI, V45, P4611, DOI 10.1167/iovs.04-0541; Schuett S, 2002, J NEUROSCI, V22, P6549; Tan MH, 2009, HUM MOL GENET, V18, P2099, DOI 10.1093/hmg/ddp133; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; West EL, 2008, EXP EYE RES, V86, P601, DOI 10.1016/j.exer.2008.01.004; West EL, 2010, STEM CELLS, V28, P1997, DOI 10.1002/stem.520; Wong AA, 2007, NEUROBIOL AGING, V28, P1577, DOI 10.1016/j.neurobiolaging.2006.07.023	22	336	348	0	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					99	103		10.1038/nature10997	http://dx.doi.org/10.1038/nature10997			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22522934	Green Accepted			2022-12-24	WOS:000303451900042
J	Pauli, H; Gottfried, M; Dullinger, S; Abdaladze, O; Akhalkatsi, M; Alonso, JLB; Coldea, G; Dick, J; Erschbamer, B; Calzado, RF; Ghosn, D; Holten, JI; Kanka, R; Kazakis, G; Kollar, J; Larsson, P; Moiseev, P; Moiseev, D; Molau, U; Mesa, JM; Nagy, L; Pelino, G; Puscas, M; Rossi, G; Stanisci, A; Syverhuset, AO; Theurillat, JP; Tomaselli, M; Unterluggauer, P; Villar, L; Vittoz, P; Grabherr, G				Pauli, Harald; Gottfried, Michael; Dullinger, Stefan; Abdaladze, Otari; Akhalkatsi, Maia; Benito Alonso, Jose Luis; Coldea, Gheorghe; Dick, Jan; Erschbamer, Brigitta; Fernandez Calzado, Rosa; Ghosn, Dany; Holten, Jarle I.; Kanka, Robert; Kazakis, George; Kollar, Jozef; Larsson, Per; Moiseev, Pavel; Moiseev, Dmitry; Molau, Ulf; Molero Mesa, Joaquin; Nagy, Laszlo; Pelino, Giovanni; Puscas, Mihai; Rossi, Graziano; Stanisci, Angela; Syverhuset, Anne O.; Theurillat, Jean-Paul; Tomaselli, Marcello; Unterluggauer, Peter; Villar, Luis; Vittoz, Pascal; Grabherr, Georg			Recent Plant Diversity Changes on Europe's Mountain Summits	SCIENCE			English	Article							CLIMATE-CHANGE; RANGE SHIFTS; VEGETATION; ALPS	In mountainous regions, climate warming is expected to shift species' ranges to higher altitudes. Evidence for such shifts is still mostly from revisitations of historical sites. We present recent (2001 to 2008) changes in vascular plant species richness observed in a standardized monitoring network across Europe's major mountain ranges. Species have moved upslope on average. However, these shifts had opposite effects on the summit floras' species richness in boreal-temperate mountain regions (+3.9 species on average) and Mediterranean mountain regions (-1.4 species), probably because recent climatic trends have decreased the availability of water in the European south. Because Mediterranean mountains are particularly rich in endemic species, a continuation of these trends might shrink the European mountain flora, despite an average increase in summit species richness across the region.	[Gottfried, Michael; Dullinger, Stefan] Univ Vienna, Fac Ctr Biodivers, A-1030 Vienna, Austria; [Pauli, Harald; Grabherr, Georg] Univ Vienna, Austrian Acad Sci, Inst Mt Res, A-1030 Vienna, Austria; [Dullinger, Stefan] Vienna Inst Nat Conservat & Analyses, A-1090 Vienna, Austria; [Abdaladze, Otari; Akhalkatsi, Maia] Ilia State Univ, Inst Ecol, GE-0162 Tbilisi, Georgia; [Benito Alonso, Jose Luis; Villar, Luis] CSIC, Inst Pirenaico Ecol, Jaca 22700, Spain; [Coldea, Gheorghe] Inst Biol Res, Dept Taxon & Plant Ecol, Cluj Napoca 400015, Romania; [Dick, Jan] Ctr Ecol & Hydrol, Penicuik EH26 0QB, Midlothian, Scotland; [Erschbamer, Brigitta] Univ Innsbruck, A-6020 Innsbruck, Austria; [Fernandez Calzado, Rosa; Molero Mesa, Joaquin; Unterluggauer, Peter] Univ Granada, Fac Pharm, Dept Bot, E-18071 Granada, Spain; [Ghosn, Dany; Kazakis, George] Mediterranean Agron Inst Chania, Deptment Environm Management, Khania 73100, Greece; [Holten, Jarle I.; Syverhuset, Anne O.] Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway; [Kanka, Robert; Kollar, Jozef] Slovak Acad Sci, Inst Landscape Ecol, Bratislava 81499, Slovakia; [Larsson, Per; Molau, Ulf] Univ Goteborg, Dept Plant & Environm Sci, S-40530 Gothenburg, Sweden; [Moiseev, Pavel; Moiseev, Dmitry] Russian Acad Sci, Inst Plant & Anim Ecol, Ekaterinburg 620144, Russia; [Nagy, Laszlo] EcoSci Scotland, Glasgow G41 4QP, Lanark, Scotland; [Nagy, Laszlo] Inst Nacl de Pesquisas da Amazonia, BR-2936 Manaus, Amazonas, Brazil; [Pelino, Giovanni; Stanisci, Angela] Univ Molise, Lab Environmetr, I-86090 Pesche, Italy; [Puscas, Mihai] Univ Babes Bolyai, Alexandru Borza Bot Garden, Cluj Napoca 400015, Romania; [Rossi, Graziano] Univ Pavia, Dept Earth & Environm Sci, I-27100 Pavia, Italy; [Theurillat, Jean-Paul] Fdn JM Aubert, Ctr Alpien Phytogeog, CH-1938 Champex Lac, Switzerland; [Theurillat, Jean-Paul] Univ Geneva, Sect Biol, CH-1292 Chambesy, Switzerland; [Tomaselli, Marcello] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy; [Vittoz, Pascal] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland	University of Vienna; Austrian Academy of Sciences; University of Vienna; Ilia State University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Pirenaico de Ecologia (IPE); National Research Institute for Biological Sciences; UK Centre for Ecology & Hydrology (UKCEH); University of Innsbruck; University of Granada; CIHEAM; CIHEAM IAM Chania; Norwegian University of Science & Technology (NTNU); Slovak Academy of Sciences; University of Gothenburg; Russian Academy of Sciences; Institute of Plant & Animal Ecology of the Russian Academy of Sciences; Institute Nacional de Pesquisas da Amazonia; University of Molise; Babes Bolyai University from Cluj; University of Pavia; University of Geneva; University of Parma; University of Lausanne	Gottfried, M (corresponding author), Univ Vienna, Fac Ctr Biodivers, A-1030 Vienna, Austria.	michael.gottfried@univie.ac.at	Gottfried, Michael/C-2923-2011; Akhalkatsi, Maia/B-2187-2008; Theurillat, Jean-Paul/AAS-4676-2021; Puscas, Mihai/C-4689-2012; Stanisci, Angela/F-4725-2012; Garden, Alexandru Borza Botanic/J-8087-2012; Coldea, Gheorghe/C-3929-2012; Ghosn, Dany/AAL-9131-2020; Moiseev, Pavel A/M-9132-2013; Dick, Jan/I-6839-2012; Mesa, Joaquín Molero/L-2790-2014; Nagy, Laszlo/A-7689-2014; Rossi, Graziano/P-3353-2015	Akhalkatsi, Maia/0000-0002-9770-7840; Theurillat, Jean-Paul/0000-0002-1843-5809; Puscas, Mihai/0000-0002-2632-640X; Ghosn, Dany/0000-0003-1898-9681; Moiseev, Pavel A/0000-0003-4808-295X; Rossi, Graziano/0000-0002-5102-5019; Stanisci, Angela/0000-0002-5302-0932; tomaselli, marcello/0000-0003-4208-3433; Molero Mesa, Joaquin/0000-0003-3106-8414; Vittoz, Pascal/0000-0003-4218-4517; Pauli, Harald/0000-0002-9842-9934; Benito Alonso, Jose Luis/0000-0003-1086-8834; Dullinger, Stefan/0000-0003-3919-0887	Switzerland (OFES) [00.0184-1]; Swiss MAVA Foundation for Nature Conservation; Austrian Federal Ministry of Science and Research; Austrian Academy of Sciences (Institute of Mountain Research); University of Vienna; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Switzerland (OFES); Swiss MAVA Foundation for Nature Conservation; Austrian Federal Ministry of Science and Research; Austrian Academy of Sciences (Institute of Mountain Research); University of Vienna; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Baseline data were collected within the European Union FP-5 project GLORIA-Europe (EVK2-CT-2000-0006) and with the support of Switzerland (OFES 00.0184-1). Resurvey was supported by the Swiss MAVA Foundation for Nature Conservation and by a number of national funding agencies, and analysis was supported by the Austrian Federal Ministry of Science and Research; the Austrian Academy of Sciences (Institute of Mountain Research); and the University of Vienna, where data are archived in the central GLORIA database and are available from the authors upon request. We thank the European Topic Centre on Biological Diversity for ambituos discussions in the early stage, C. Klettner for data compilation, S. Laimer for administration assistance, 17 GLORIA-Europe field teams with more than 80 fieldworkers for species recording, and protected-area authorities for logistic support. We also thank three anonymous referees for their valuable comments and suggestions.	Benito B, 2011, CLIMATIC CHANGE, V108, P471, DOI 10.1007/s10584-010-0015-3; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Crimmins SM, 2011, SCIENCE, V331, P324, DOI 10.1126/science.1199040; del Rio S, 2011, INT J CLIMATOL, V31, P656, DOI 10.1002/joc.2111; Engler R, 2011, GLOBAL CHANGE BIOL, V17, P2330, DOI 10.1111/j.1365-2486.2010.02393.x; Feeley KJ, 2011, J BIOGEOGR, V38, P783, DOI 10.1111/j.1365-2699.2010.02444.x; Gottfried M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/1/014013; Gottfried M, 2012, NAT CLIM CHANGE, V2, P111, DOI [10.1038/NCLIMATE1329, 10.1038/nclimate1329]; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Klanderud K, 2003, HOLOCENE, V13, P1, DOI 10.1191/0959683603hl589ft; Mariotti A, 2008, ENVIRON RES LETT, V3, DOI 10.1088/1748-9326/3/4/044001; McCain CM, 2011, ECOL LETT, V14, P1236, DOI 10.1111/j.1461-0248.2011.01695.x; Bravo DN, 2008, AMBIO, V37, P280, DOI 10.1579/0044-7447(2008)37[280:CCIMMD]2.0.CO;2; Pauli H, 2004, GLORIA FIELD MANUAL; Pauli H, 2007, GLOBAL CHANGE BIOL, V13, P147, DOI 10.1111/j.1365-2486.2006.01282.x; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; Thompson, 2003, ALPINE BIODIVERSITY, V167; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Toreti A, 2009, INT J CLIMATOL, V29, P1976, DOI 10.1002/joc.1840; Van de Ven CM, 2007, EARTH INTERACT, V11, DOI 10.1175/EI205.1; Vittoz P, 2008, J VEG SCI, V19, P671, DOI 10.3170/2008-8-18434; Walter H., 1991, SPEZIELLE OKOLOGIE G; Walther GR, 2005, J VEG SCI, V16, P541, DOI 10.1111/j.1654-1103.2005.tb02394.x	26	582	615	19	446	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					353	355		10.1126/science.1219033	http://dx.doi.org/10.1126/science.1219033			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517860	Green Submitted			2022-12-24	WOS:000302995400048
J	Maurer, SP; Fourniol, FJ; Bohner, G; Moores, CA; Surrey, T				Maurer, Sebastian P.; Fourniol, Franck J.; Bohner, Gergo; Moores, Carolyn A.; Surrey, Thomas			EBs Recognize a Nucleotide-Dependent Structural Cap at Growing Microtubule Ends	CELL			English	Article							ALPHA-BETA-TUBULIN; TRACKING PROTEINS; GTP HYDROLYSIS; DYNAMICS; LATTICE; CLIP-170; HOMOLOG; STABILIZES; ACTIVATION; MECHANISM	Growing microtubule ends serve as transient binding platforms for essential proteins that regulate microtubule dynamics and their interactions with cellular substructures. End-binding proteins (EBs) autonomously recognize an extended region at growing microtubule ends with unknown structural characteristics and then recruit other factors to the dynamic end structure. Using cryo-electron microscopy, subnanometer single-particle reconstruction, and fluorescence imaging, we present a pseudoatomic model of how the calponin homology (CH) domain of the fission yeast EB Mal3 binds to the end regions of growing microtubules. The Mal3 CH domain bridges protofilaments except at the microtubule seam. By binding close to the exchangeable GTP-binding site, the CH domain is ideally positioned to sense the microtubule's nucleotide state. The same microtubule-end region is also a stabilizing structural cap protecting the microtubule from depolymerization. This insight supports a common structural link between two important biological phenomena, microtubule dynamic instability and end tracking.	[Moores, Carolyn A.] Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England; [Maurer, Sebastian P.; Fourniol, Franck J.; Bohner, Gergo; Surrey, Thomas] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, London WC2A 3LY, England; [Maurer, Sebastian P.; Surrey, Thomas] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	University of London; Birkbeck University London; Cancer Research UK; European Molecular Biology Laboratory (EMBL)	Moores, CA (corresponding author), Univ London Birkbeck Coll, Inst Struct & Mol Biol, London WC1E 7HX, England.	c.moores@mail.cryst.bbk.ac.uk; thomas.surrey@cancer.org.uk	Moores, Carolyn A/R-2497-2019; Maurer, Sebastian P/D-4727-2009; Surrey, Thomas/AAC-4608-2021	Moores, Carolyn A/0000-0001-5686-6290; Maurer, Sebastian P/0000-0003-4532-1994; Surrey, Thomas/0000-0001-9082-1870	Cancer Research UK; Marie Curie fellowship [PIEF-GA-2009-253043]; EMBO [ALTF 1032-2009, ALTF 219-2011]; Wellcome Trust [WT085945, WT079605]; MRC [MR/J000973/1] Funding Source: UKRI; Cancer Research UK [14256] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Marie Curie fellowship(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	We thank Charles Sindelar for his microtubule-processing scripts; Maya Topf for assistance with Flex-EM; Kevin Slep for sharing unpublished data; Claude Antony, Rachel Santarella, and James Riches for EM support and discussions; Nicholas Cade for support with TIRF microscopy; and Peter Bieling, Jan Ellenberg, Takashi Toda, Frank Uhlmann, and Gabriel Waksman for critical comments on the manuscript. This work was supported by Cancer Research UK. S. P. M. is supported by Marie Curie (PIEF-GA-2009-253043) and EMBO (ALTF 1032-2009) fellowships. F.J.F. is supported by an EMBO fellowship (ALTF 219-2011). C. A. M. is supported by a Wellcome Trust University Award (WT085945) and a Wellcome Trust Equipment Grant (WT079605).	Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Browning H, 2003, NAT CELL BIOL, V5, P812, DOI 10.1038/ncb1034; Busch KE, 2004, CURR BIOL, V14, P548, DOI 10.1016/j.cub.2004.03.029; Caplow M, 1996, MOL BIOL CELL, V7, P663, DOI 10.1091/mbc.7.4.663; CARLIER MF, 1984, P NATL ACAD SCI-BIOL, V81, P771, DOI 10.1073/pnas.81.3.771; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; DRECHSEL DN, 1994, CURR BIOL, V4, P1053, DOI 10.1016/S0960-9822(00)00243-8; Fourniol FJ, 2010, J CELL BIOL, V191, P463, DOI 10.1083/jcb.201007081; Galjart N, 2010, CURR BIOL, V20, pR528, DOI 10.1016/j.cub.2010.05.022; Gardner MK, 2011, CELL, V146, P582, DOI 10.1016/j.cell.2011.06.053; Gouveia SM, 2010, CURR BIOL, V20, P1717, DOI 10.1016/j.cub.2010.08.020; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2003, J BIOL CHEM, V278, P36430, DOI 10.1074/jbc.M305773200; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Honnappa S, 2009, CELL, V138, P366, DOI 10.1016/j.cell.2009.04.065; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Iimori M, 2012, EXP CELL RES, V318, P262, DOI 10.1016/j.yexcr.2011.11.006; Katsuki M, 2009, J BIOL CHEM, V284, P29246, DOI 10.1074/jbc.C109.052159; Komarova YA, 2002, J CELL BIOL, V159, P589, DOI 10.1083/jcb.200208058; Komarova Y, 2009, J CELL BIOL, V184, P691, DOI 10.1083/jcb.200807179; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Kukulski W, 2011, J CELL BIOL, V192, P111, DOI 10.1083/jcb.201009037; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Maurer SP, 2011, P NATL ACAD SCI USA, V108, P3988, DOI 10.1073/pnas.1014758108; McIntosh JR, 2009, J MOL BIOL, V394, P177, DOI 10.1016/j.jmb.2009.09.033; Meurer-Grob P, 2001, BIOCHEMISTRY-US, V40, P8000, DOI 10.1021/bi010343p; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Nawrotek A, 2011, J MOL BIOL, V412, P35, DOI 10.1016/j.jmb.2011.07.029; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; REIJO RA, 1994, MOL BIOL CELL, V5, P29, DOI 10.1091/mbc.5.1.29; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Richards KL, 2000, MOL BIOL CELL, V11, P1887, DOI 10.1091/mbc.11.5.1887; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Sui HX, 2010, STRUCTURE, V18, P1022, DOI 10.1016/j.str.2010.05.010; Tirnauer JS, 2002, MOL BIOL CELL, V13, P3614, DOI 10.1091/mbc.E02-04-0210; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Zanic M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007585; Zimniak T, 2009, J CELL BIOL, V186, P379, DOI 10.1083/jcb.200901036	58	246	249	0	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					371	382		10.1016/j.cell.2012.02.049	http://dx.doi.org/10.1016/j.cell.2012.02.049			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500803	Green Published, hybrid			2022-12-24	WOS:000302805600016
J	Begley, CG; Ellis, LM				Begley, C. Glenn; Ellis, Lee M.			Raise standards for preclinical cancer research	NATURE			English	Editorial Material									[Begley, C. Glenn] Amgen Inc, Thousand Oaks, CA 91359 USA; [Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Amgen; University of Texas System; UTMD Anderson Cancer Center	Begley, CG (corresponding author), Amgen Inc, Thousand Oaks, CA 91359 USA.	lellis@mdanderson.org	Coles, Simon/A-1795-2009	Coles, Simon/0000-0001-8414-9272				Fanelli D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010271; Francia G, 2010, NAT BIOTECHNOL, V28, P561, DOI 10.1038/nbt0610-561; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1; Rubin E. H., 2012, NATURE REV CLIN ONCO	5	1742	1780	1	173	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					531	533		10.1038/483531a	http://dx.doi.org/10.1038/483531a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	915EF	22460880				2022-12-24	WOS:000302006100013
J	Curtis, C; Shah, SP; Chin, SF; Turashvili, G; Rueda, OM; Dunning, MJ; Speed, D; Lynch, AG; Samarajiwa, S; Yuan, YY; Graf, S; Ha, G; Haffari, G; Bashashati, A; Russell, R; McKinney, S; Langerod, A; Green, A; Provenzano, E; Wishart, G; Pinder, S; Watson, P; Markowetz, F; Murphy, L; Ellis, I; Purushotham, A; Borresen-Dale, AL; Brenton, JD; Tavare, S; Caldas, C; Aparicio, S				Curtis, Christina; Shah, Sohrab P.; Chin, Suet-Feung; Turashvili, Gulisa; Rueda, Oscar M.; Dunning, Mark J.; Speed, Doug; Lynch, Andy G.; Samarajiwa, Shamith; Yuan, Yinyin; Graef, Stefan; Ha, Gavin; Haffari, Gholamreza; Bashashati, Ali; Russell, Roslin; McKinney, Steven; Langerod, Anita; Green, Andrew; Provenzano, Elena; Wishart, Gordon; Pinder, Sarah; Watson, Peter; Markowetz, Florian; Murphy, Leigh; Ellis, Ian; Purushotham, Arnie; Borresen-Dale, Anne-Lise; Brenton, James D.; Tavare, Simon; Caldas, Carlos; Aparicio, Samuel		METABRIC Grp	The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups	NATURE			English	Article							GENE-EXPRESSION; CANCER; PROTEIN; SUPPRESSOR; CARCINOMA; SUBTYPE	The elucidation of breast cancer subgroups and their molecular drivers requires integrated views of the genome and transcriptome from representative numbers of patients. We present an integrated analysis of copy number and gene expression in a discovery and validation set of 997 and 995 primary breast tumours, respectively, with long-term clinical follow-up. Inherited variants (copy number variants and single nucleotide polymorphisms) and acquired somatic copy number aberrations (CNAs) were associated with expression in similar to 40% of genes, with the landscape dominated by cis-and trans-acting CNAs. By delineating expression outlier genes driven in cis by CNAs, we identified putative cancer genes, including deletions in PPP2R2A, MTAP and MAP2K4. Unsupervised analysis of paired DNA-RNA profiles revealed novel subgroups with distinct clinical outcomes, which reproduced in the validation cohort. These include a high-risk, oestrogen-receptor-positive 11q13/14 cis-acting subgroup and a favourable prognosis subgroup devoid of CNAs. Trans-acting aberration hotspots were found to modulate subgroup-specific gene networks, including a TCR deletion-mediated adaptive immune response in the 'CNA-devoid' subgroup and a basal-specific chromosome 5 deletion-associated mitotic network. Our results provide a novel molecular stratification of the breast cancer population, derived from the impact of somatic CNAs on the transcriptome.	[Curtis, Christina; Chin, Suet-Feung; Rueda, Oscar M.; Lynch, Andy G.; Samarajiwa, Shamith; Yuan, Yinyin; Graef, Stefan; Markowetz, Florian; Tavare, Simon; Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge CB2 2XZ, England; [Curtis, Christina; Chin, Suet-Feung; Rueda, Oscar M.; Dunning, Mark J.; Speed, Doug; Lynch, Andy G.; Samarajiwa, Shamith; Yuan, Yinyin; Graef, Stefan; Russell, Roslin; Markowetz, Florian; Brenton, James D.; Tavare, Simon; Caldas, Carlos] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Shah, Sohrab P.; Turashvili, Gulisa; Ha, Gavin; Haffari, Gholamreza; Bashashati, Ali; McKinney, Steven; Watson, Peter; Aparicio, Samuel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Shah, Sohrab P.; Turashvili, Gulisa; McKinney, Steven; Watson, Peter; Aparicio, Samuel] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Speed, Doug; Tavare, Simon] Univ Cambridge, Dept Appl Math & Theoret Phys, Ctr Math Sci, Cambridge CB3 0WA, England; [Langerod, Anita; Borresen-Dale, Anne-Lise] Radiumhosp, Dept Genet, Inst Canc Res, Oslo Univ Hosp, N-0310 Oslo, Norway; [Green, Andrew; Ellis, Ian] Univ Nottingham, Dept Histopathol, Sch Mol Med Sci, Nottingham NG5 1PB, England; [Provenzano, Elena; Wishart, Gordon; Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Breast Unit, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Pinder, Sarah; Purushotham, Arnie] Kings Coll London, Breakthrough Breast Canc Res Unit, London WC2R 2LS, England; [Pinder, Sarah; Borresen-Dale, Anne-Lise] NIHR Cambridge Biomed Res Ctr, London WC2R 2LS, England; [Watson, Peter; Murphy, Leigh] Univ Manitoba, Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; [Purushotham, Arnie] Guys & St Thomas NHS Fdn Trust, NIHR Comprehens Biomed Res Ctr, London WC2R 2LS, England; [Borresen-Dale, Anne-Lise] Univ Oslo, Inst Clin Med, Fac Med, N-0316 Oslo, Norway; [Brenton, James D.; Caldas, Carlos] Cambridge Expt Canc Med Ctr, Cambridge CB2 0RE, England; [Tavare, Simon] Univ So Calif, Mol & Computat Biol Program, Los Angeles, CA 90089 USA	University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of British Columbia; British Columbia Cancer Agency; University of Cambridge; University of Oslo; University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; King's College London; University of Manitoba; Guy's & St Thomas' NHS Foundation Trust; University of Oslo; University of Southern California	Caldas, C (corresponding author), Univ Cambridge, Dept Oncol, Hills Rd, Cambridge CB2 2XZ, England.	carlos.caldas@cancer.org.uk; saparicio@bccrc.ca	Speed, Doug/AAM-1032-2021; Hadfield, James/A-1874-2013; Samarajiwa, Shamith/B-1601-2013; Caldas, Carlos/U-7250-2019; Rueda, Oscar/ABF-5479-2020; Caldas, Carlos/A-7543-2008; Maia, Ana-Teresa/F-4404-2012; Brenton, James D/B-3174-2008; Ha, Gavin/N-1984-2019; Green, Andrew/AAF-1991-2020	Hadfield, James/0000-0001-9868-4989; Samarajiwa, Shamith/0000-0003-1046-0601; Caldas, Carlos/0000-0003-3547-1489; Rueda, Oscar/0000-0003-0008-4884; Maia, Ana-Teresa/0000-0002-0454-9207; Brenton, James D/0000-0002-5738-6683; Ha, Gavin/0000-0001-7578-7272; /0000-0003-4167-8910; Purushotham, Arnie/0000-0001-8577-9655; Aparicio, Samuel/0000-0002-0487-9599; Rakha, Emad/0000-0002-5009-5525; Ding, Zhihao/0000-0003-0961-2284; Chan, Derek Steven/0000-0002-6350-9993; Ellis, Ian/0000-0001-5292-8474; Sammut, Stephen John/0000-0003-4472-904X; Lynch, Andy/0000-0002-7876-7338; Curtis, Christina/0000-0003-0166-3802; Watson, Peter/0000-0002-1642-0638; Papatheodorou, Irene/0000-0001-7270-5470; Yuan, Yinyin/0000-0002-8556-4707; Green, Andrew/0000-0002-0488-5913; Dunning, Mark/0000-0002-8853-9435; Speed, Doug/0000-0002-0096-9765; Grigoriadis, Anita/0000-0003-3434-201X; Turashvili, Gulisa/0000-0001-6125-5865; chin, suet-feung/0000-0001-5697-1082; Murphy, Leigh C/0000-0002-7676-6032	Cancer Research UK; British Columbia Cancer Foundation; Canadian Breast Cancer Foundation BC/Yukon; University of Cambridge; Hutchinson Whampoa; NIHR Cambridge Biomedical Research Centre; Cambridge Experimental Cancer Medicine Centre; Centre for Translational Genomics (CTAG) Vancouver; BCCA Breast Cancer Outcomes Unit; Canada Research Chair; National Institutes of Health Centers of Excellence in Genomics Science [P50 HG02790]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; Cancer Research UK [15601, 19556] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10154, ACF-2012-14-006] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); British Columbia Cancer Foundation; Canadian Breast Cancer Foundation BC/Yukon; University of Cambridge(University of Cambridge); Hutchinson Whampoa; NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Cambridge Experimental Cancer Medicine Centre; Centre for Translational Genomics (CTAG) Vancouver; BCCA Breast Cancer Outcomes Unit; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); National Institutes of Health Centers of Excellence in Genomics Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	The METABRIC project was funded by Cancer Research UK, the British Columbia Cancer Foundation and Canadian Breast Cancer Foundation BC/Yukon. The authors also acknowledge the support of the University of Cambridge, Hutchinson Whampoa, the NIHR Cambridge Biomedical Research Centre, the Cambridge Experimental Cancer Medicine Centre, the Centre for Translational Genomics (CTAG) Vancouver and the BCCA Breast Cancer Outcomes Unit. S. P. S. is a Michael Smith Foundation for Health Research fellow. S. A. is supported by a Canada Research Chair. This work was supported by the National Institutes of Health Centers of Excellence in Genomics Science grant P50 HG02790 (S. T.). The authors thank C. Perou and J. Parker for discussions on the use of the PAM50 centroids. They also acknowledge the patients who donated tissue and the associated pseudo-anonymized clinical data for this project.	Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Brown LA, 2008, GENE CHROMOSOME CANC, V47, P481, DOI 10.1002/gcc.20549; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin SF, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r215; Christopher SA, 2002, CANCER RES, V62, P6639; Daniel J, 2011, P NATL ACAD SCI USA, V108, P5384, DOI 10.1073/pnas.1007645108; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Holland DG, 2011, EMBO MOL MED, V3, P167, DOI 10.1002/emmm.201100122; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hughes-Davies L, 2003, CELL, V115, P523, DOI 10.1016/S0092-8674(03)00930-9; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; McConechy MK, 2011, J PATHOL, V223, P567, DOI 10.1002/path.2848; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Russnes HG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000611; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Shen RL, 2009, BIOINFORMATICS, V25, P2906, DOI 10.1093/bioinformatics/btp543; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tan J, 2010, CANCER CELL, V18, P459, DOI 10.1016/j.ccr.2010.10.021; Teng DHF, 1997, CANCER RES, V57, P4177; Teschendorff AE, 2006, BIOINFORMATICS, V22, P2269, DOI 10.1093/bioinformatics/btl174; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299	29	3494	3571	18	445	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					346	352		10.1038/nature10983	http://dx.doi.org/10.1038/nature10983			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22522925	Green Published, Green Accepted			2022-12-24	WOS:000305466800033
J	Shah, SP; Roth, A; Goya, R; Oloumi, A; Ha, G; Zhao, YJ; Turashvili, G; Ding, JR; Tse, K; Haffari, G; Bashashati, A; Prentice, LM; Khattra, J; Burleigh, A; Yap, D; Bernard, V; McPherson, A; Shumansky, K; Crisan, A; Giuliany, R; Heravi-Moussavi, A; Rosner, J; Lai, D; Birol, I; Varhol, R; Tam, A; Dhalla, N; Zeng, T; Ma, K; Chan, SK; Griffith, M; Moradian, A; Cheng, SWG; Morin, GB; Watson, P; Gelmon, K; Chia, S; Chin, SF; Curtis, C; Rueda, OM; Pharoah, PD; Damaraju, S; Mackey, J; Hoon, K; Harkins, T; Tadigotla, V; Sigaroudinia, M; Gascard, P; Tlsty, T; Costello, JF; Meyer, IM; Eaves, CJ; Wasserman, WW; Jones, S; Huntsman, D; Hirst, M; Caldas, C; Marra, MA; Aparicio, S				Shah, Sohrab P.; Roth, Andrew; Goya, Rodrigo; Oloumi, Arusha; Ha, Gavin; Zhao, Yongjun; Turashvili, Gulisa; Ding, Jiarui; Tse, Kane; Haffari, Gholamreza; Bashashati, Ali; Prentice, Leah M.; Khattra, Jaswinder; Burleigh, Angela; Yap, Damian; Bernard, Virginie; McPherson, Andrew; Shumansky, Karey; Crisan, Anamaria; Giuliany, Ryan; Heravi-Moussavi, Alireza; Rosner, Jamie; Lai, Daniel; Birol, Inanc; Varhol, Richard; Tam, Angela; Dhalla, Noreen; Zeng, Thomas; Ma, Kevin; Chan, Simon K.; Griffith, Malachi; Moradian, Annie; Cheng, S. -W. Grace; Morin, Gregg B.; Watson, Peter; Gelmon, Karen; Chia, Stephen; Chin, Suet-Feung; Curtis, Christina; Rueda, Oscar M.; Pharoah, Paul D.; Damaraju, Sambasivarao; Mackey, John; Hoon, Kelly; Harkins, Timothy; Tadigotla, Vasisht; Sigaroudinia, Mahvash; Gascard, Philippe; Tlsty, Thea; Costello, Joseph F.; Meyer, Irmtraud M.; Eaves, Connie J.; Wasserman, Wyeth W.; Jones, Steven; Huntsman, David; Hirst, Martin; Caldas, Carlos; Marra, Marco A.; Aparicio, Samuel			The clonal and mutational evolution spectrum of primary triple-negative breast cancers	NATURE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; SQUAMOUS-CELL CARCINOMA; BASAL-LIKE; GENOME; GENES; TP53; HEAD	Primary triple-negative breast cancers (TNBCs), a tumour type defined by lack of oestrogen receptor, progesterone receptor and ERBB2 gene amplification, represent approximately 16% of all breast cancers(1). Here we show in 104 TNBC cases that at the time of diagnosis these cancers exhibit a wide and continuous spectrum of genomic evolution, with some having only a handful of coding somatic aberrations in a few pathways, whereas others contain hundreds of coding somatic mutations. High-throughput RNA sequencing (RNA-seq) revealed that only approximately 36% of mutations are expressed. Using deep re-sequencing measurements of allelic abundance for 2,414 somatic mutations, we determine for the first time-to our knowledge-in an epithelial tumour subtype, the relative abundance of clonal frequencies among cases representative of the population. We show that TNBCs vary widely in their clonal frequencies at the time of diagnosis, with the basal subtype of TNBC2,3 showing more variation than non-basal TNBC. Although p53 (also known as TP53), PIK3CA and PTEN somatic mutations seem to be clonally dominant compared to other genes, in some tumours their clonal frequencies are incompatible with founder status. Mutations in cytoskeletal, cell shape and motility proteins occurred at lower clonal frequencies, suggesting that they occurred later during tumour progression. Taken together, our results show that understanding the biology and therapeutic responses of patients with TNBC will require the determination of individual tumour clonal genotypes.	[Shah, Sohrab P.; Roth, Andrew; Oloumi, Arusha; Ha, Gavin; Turashvili, Gulisa; Ding, Jiarui; Haffari, Gholamreza; Bashashati, Ali; Prentice, Leah M.; Khattra, Jaswinder; Burleigh, Angela; Yap, Damian; McPherson, Andrew; Shumansky, Karey; Crisan, Anamaria; Giuliany, Ryan; Heravi-Moussavi, Alireza; Rosner, Jamie; Lai, Daniel; Watson, Peter; Huntsman, David; Aparicio, Samuel] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Shah, Sohrab P.; Roth, Andrew; Oloumi, Arusha; Ha, Gavin; Turashvili, Gulisa; Ding, Jiarui; Haffari, Gholamreza; Bashashati, Ali; Prentice, Leah M.; Khattra, Jaswinder; Burleigh, Angela; Yap, Damian; McPherson, Andrew; Shumansky, Karey; Crisan, Anamaria; Giuliany, Ryan; Heravi-Moussavi, Alireza; Rosner, Jamie; Lai, Daniel; Huntsman, David; Aparicio, Samuel] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Goya, Rodrigo; Zhao, Yongjun; Tse, Kane; Birol, Inanc; Varhol, Richard; Tam, Angela; Dhalla, Noreen; Zeng, Thomas; Ma, Kevin; Chan, Simon K.; Griffith, Malachi; Moradian, Annie; Cheng, S. -W. Grace; Morin, Gregg B.; Jones, Steven; Hirst, Martin; Marra, Marco A.] Canadas Michael Smith Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Bernard, Virginie; Wasserman, Wyeth W.] Ctr Mol Med & Therapeut, Vancouver, BC V5Z 4H4, Canada; [Morin, Gregg B.; Meyer, Irmtraud M.; Wasserman, Wyeth W.; Jones, Steven; Marra, Marco A.] Univ British Columbia, Dept Med Genet, Vancouver, BC V6T 1Z3, Canada; [Chin, Suet-Feung; Curtis, Christina; Rueda, Oscar M.; Pharoah, Paul D.; Caldas, Carlos] Cancer Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England; [Chin, Suet-Feung; Curtis, Christina; Rueda, Oscar M.; Caldas, Carlos] Univ Cambridge, Dept Oncol, Cambridge CB2 2XZ, England; [Curtis, Christina] Univ So Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90033 USA; [Damaraju, Sambasivarao; Mackey, John] Univ Alberta, Dept Oncol, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Damaraju, Sambasivarao; Mackey, John] Univ Alberta, Dept Lab Med & Pathol, Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Hoon, Kelly; Harkins, Timothy; Tadigotla, Vasisht] Life Technol, Foster City, CA 94404 USA; [Sigaroudinia, Mahvash; Gascard, Philippe; Tlsty, Thea] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Costello, Joseph F.] Univ Calif San Francisco, Brain Tumor Res Ctr, Dept Neurosurg, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Meyer, Irmtraud M.] Univ British Columbia, Dept Comp Sci, Vancouver, BC V6T 1Z4, Canada; [Meyer, Irmtraud M.; Hirst, Martin] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Jones, Steven] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Huntsman, David] British Columbia Canc Agcy, Ctr Translat & Appl Gen, Vancouver, BC V5Z 4E6, Canada; [Hirst, Martin] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Caldas, Carlos] Cambridge Univ Hosp NHS Fdn Trust, Cambridge Breast Unit, Addenbrookes Hosp, Cambridge CB2 2QQ, England; [Caldas, Carlos] NIHR Cambridge Biomed Res Ctr, Cambridge CB2 2QQ, England; [Caldas, Carlos] Cambridge Expt Canc Med Ctr ECMC, Cambridge CB2 0RE, England	University of British Columbia; British Columbia Cancer Agency; University of British Columbia; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Cambridge; University of Southern California; University of Alberta; University of Alberta; Thermo Fisher Scientific; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of British Columbia; University of British Columbia; British Columbia Cancer Agency; Simon Fraser University; British Columbia Cancer Agency; University of British Columbia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Aparicio, S (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada.	carlos.caldas@cancer.org.uk; mmarra@bcgsc.ca; saparicio@bccrc.ca	Rueda, Oscar/ABF-5479-2020; Pharoah, Paul/V-6658-2019; Huntsman, David/ABE-6082-2020; Birol, Inanc/G-5440-2011; Marra, Marco A/B-5987-2008; Wasserman, Wyeth/I-4866-2015; Jones, Steven J/C-3621-2009; Caldas, Carlos/U-7250-2019; Morin, Gregg B/E-9123-2012; Ha, Gavin/N-1984-2019; Caldas, Carlos/A-7543-2008; Hirst, Martin/B-7684-2016; Griffith, Malachi/P-1285-2014	Rueda, Oscar/0000-0003-0008-4884; Pharoah, Paul/0000-0001-8494-732X; Birol, Inanc/0000-0003-0950-7839; Marra, Marco A/0000-0001-7146-7175; Jones, Steven J/0000-0003-3394-2208; Caldas, Carlos/0000-0003-3547-1489; Morin, Gregg B/0000-0001-8949-4374; Ha, Gavin/0000-0001-7578-7272; Griffith, Malachi/0000-0002-6388-446X; chin, suet-feung/0000-0001-5697-1082; Curtis, Christina/0000-0003-0166-3802; Watson, Peter/0000-0002-1642-0638; Gascard, Philippe/0000-0001-5912-5228; Turashvili, Gulisa/0000-0001-6125-5865; Rosner, Jamie/0000-0001-8901-7228; Eaves, Connie/0000-0002-3452-1926; Wasserman, Wyeth/0000-0001-6098-6412; Lai, Daniel/0000-0001-9203-6323; Aparicio, Samuel/0000-0002-0487-9599; Yap, Damian/0000-0002-5370-4592	BC Cancer Agency Tumour Bank; CBCF Breast Tumour Bank Alberta; Addenbrookes Tumour bank supported by NIHR; Addenbrookes Tumour bank supported by ECMC; BC Cancer Foundation; US Department of Defense CDMRP program; Canadian Breast Cancer Foundation; Michael Smith Foundation for Health Research; US National Institutes of Health (NIH) Roadmap Epigenomics Program; NIH [5U01ES017154-02]; Cancer Research UK; National Institute of General Medical Sciences [R01GM084875]; Canadian Breast Cancer Research Alliance; Canadian Cancer Society; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084875] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0611-10154] Funding Source: researchfish	BC Cancer Agency Tumour Bank; CBCF Breast Tumour Bank Alberta; Addenbrookes Tumour bank supported by NIHR; Addenbrookes Tumour bank supported by ECMC; BC Cancer Foundation; US Department of Defense CDMRP program; Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); US National Institutes of Health (NIH) Roadmap Epigenomics Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK(Cancer Research UK); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Canadian Breast Cancer Research Alliance; Canadian Cancer Society(Canadian Cancer Society (CCS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute for Health Research(National Institute for Health Research (NIHR))	The support of the BC Cancer Agency Tumour Bank, CBCF Breast Tumour Bank Alberta and the Addenbrookes Tumour bank (supported by NIHR and ECMC) is acknowledged. Technical support is acknowledged from the Centre for Translational Genomics, the Michael Smith Genome Sciences Centre technical group, the BCCA Flow Cytometry Core Facility in the Terry Fox Laboratory and the Cancer Research UK Cambridge Research Institute. Supported by the BC Cancer Foundation, US Department of Defense CDMRP program, Canadian Breast Cancer Foundation (BC Yukon) (to S. A. and S. S.), Michael Smith Foundation for Health Research (to S. S.), US National Institutes of Health (NIH) Roadmap Epigenomics Program, NIH grant 5U01ES017154-02 (to M. H., M. A. M., J.C. and T. T.), Cancer Research UK (to C. Caldas and P. D. P.) and the National Institute of General Medical Sciences (R01GM084875 to W. W. W.), the Canadian Breast Cancer Research Alliance and the Canadian Cancer Society (to S. A. and C. E.). We thank B. Reva, Y. Antipin and C. Sander (Memorial Sloan Kettering Cancer Center) for assistance with MutationAssessor, and G. Wu (Ontario Institute for Cancer Research) for assistance with Reactome.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Borresen-Dale AL, 2003, HUM MUTAT, V21, P292, DOI 10.1002/humu.10174; Chicas A, 2010, CANCER CELL, V17, P376, DOI 10.1016/j.ccr.2010.01.023; Ding JR, 2012, BIOINFORMATICS, V28, P167, DOI 10.1093/bioinformatics/btr629; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Langerod A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1675; Morin RD, 2011, NATURE, V476, P298, DOI 10.1038/nature10351; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poulogiannis G, 2010, P NATL ACAD SCI USA, V107, P15145, DOI 10.1073/pnas.1009941107; Roth A., 2012, BIOINFORMATICS  0127; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Wu GM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r53; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630	22	1374	1413	11	272	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 21	2012	486	7403					395	399		10.1038/nature10933	http://dx.doi.org/10.1038/nature10933			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	961LV	22495314	Green Accepted, Green Published			2022-12-24	WOS:000305466800042
J	Soto, C				Soto, Claudio			Transmissible Proteins: Expanding the Prion Heresy	CELL			English	Review							BETA-AMYLOID DEPOSITION; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; IN-VITRO; NEURODEGENERATIVE-DISEASES; SACCHAROMYCES-CEREVISIAE; APLYSIA CPEB; YEAST; PROPAGATION; MECHANISM	The once heretical concept that a misfolded protein is the infectious agent responsible for prion diseases is now widely accepted. Recent exciting research has led not only to the end of the skepticism that proteins can transmit disease, but also to expanding the concept that transmissible proteins might be at the root of some of the most prevalent human illnesses. At the same time, the idea that biological information can be transmitted by propagation of protein (mis) folding raises the possibility that heritable protein agents may be operating as epigenetic factors in normal biological functions and participating in evolutionary adaptation.	Univ Texas Houston, Sch Med, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Soto, C (corresponding author), Univ Texas Houston, Sch Med, Dept Neurol, Mitchell Ctr Alzheimers Dis & Related Brain Disor, Houston, TX 77030 USA.	claudio.soto@uth.tmc.edu			NIH [R01 NS49173, R01 GM100453, P01 AI077774]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	I thank my lab members Rodrigo Morales, Dennisse Gonzalez-Romero, Marcelo Barria, Akihiko Urayama, Abhisek Mukherjee, and Rodrigo Diaz-Espinoza for critical reading of the manuscript and inspiring discussions and Karina Cuanalo-Contreras for help in drafting the figure. This work was partially supported by NIH grants R01 NS49173, R01 GM100453, and P01 AI077774.	Aguzzi A, 2009, NEURON, V64, P783, DOI 10.1016/j.neuron.2009.12.016; Aguzzi A, 2009, PHYSIOL REV, V89, P1105, DOI 10.1152/physrev.00006.2009; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Bieler S, 2005, J BIOL CHEM, V280, P26880, DOI 10.1074/jbc.M502031200; Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Brundin P, 2008, NAT REV NEUROSCI, V9, P741, DOI 10.1038/nrn2477; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; CULLIE J, 1939, CR HEBD ACAD SCI, V208, P1058; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Derkatch IL, 1996, GENETICS, V144, P1375; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furukawa Y, 2011, J BIOL CHEM, V286, P18664, DOI 10.1074/jbc.M111.231209; GAJDUSEK DC, 1966, NATURE, V209, P794, DOI 10.1038/209794a0; Grad LI, 2011, P NATL ACAD SCI USA, V108, P16398, DOI 10.1073/pnas.1102645108; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Halfmann R, 2010, TRENDS CELL BIOL, V20, P125, DOI 10.1016/j.tcb.2009.12.003; Hansen C, 2011, J CLIN INVEST, V121, P715, DOI 10.1172/JCI43366; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Heinrich SU, 2011, P NATL ACAD SCI USA, V108, P2999, DOI 10.1073/pnas.1019368108; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Iconomidou VA, 2000, FEBS LETT, V479, P141, DOI 10.1016/S0014-5793(00)01888-3; Kane MD, 2000, J NEUROSCI, V20, P3606, DOI 10.1523/JNEUROSCI.20-10-03606.2000; Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x; Kordower JH, 2008, NAT MED, V14, P504, DOI 10.1038/nm1747; Korenaga T, 2006, AM J PATHOL, V168, P898, DOI 10.2353/ajpath.2006.050350; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; LANSBURY PT, 1995, CHEM BIOL, V2, P1, DOI 10.1016/1074-5521(95)90074-8; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Lindquist S, 1997, CELL, V89, P495, DOI 10.1016/S0092-8674(00)80231-7; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Luk KC, 2012, J EXP MED, V209, P975, DOI 10.1084/jem.20112457; Luk KC, 2009, P NATL ACAD SCI USA, V106, P20051, DOI 10.1073/pnas.0908005106; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Masison DC, 1997, P NATL ACAD SCI USA, V94, P12503, DOI 10.1073/pnas.94.23.12503; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Morales R, 2012, MOL PSYCHIATR, V17, P1347, DOI 10.1038/mp.2011.120; Morales R, 2009, CNS NEUROL DISORD-DR, V8, P363, DOI 10.2174/187152709789541998; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014; Nonaka T, 2010, J BIOL CHEM, V285, P34885, DOI 10.1074/jbc.M110.148460; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patino MM, 1996, SCIENCE, V273, P622, DOI 10.1126/science.273.5275.622; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; Rosen RF, 2012, J NEUROCHEM, V120, P660, DOI 10.1111/j.1471-4159.2011.07551.x; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Soto C, 2006, TRENDS BIOCHEM SCI, V31, P150, DOI 10.1016/j.tibs.2006.01.002; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Soto C, 2011, TRENDS BIOCHEM SCI, V36, P151, DOI 10.1016/j.tibs.2010.11.001; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wegrzyn RD, 2001, MOL CELL BIOL, V21, P4656, DOI 10.1128/MCB.21.14.4656-4669.2001; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2004, GENE DEV, V18, P470, DOI 10.1101/gad.1177104; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Xing YM, 2001, LAB INVEST, V81, P493, DOI 10.1038/labinvest.3780257; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105	87	169	172	1	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					968	977		10.1016/j.cell.2012.05.007	http://dx.doi.org/10.1016/j.cell.2012.05.007			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632966	Bronze, Green Accepted			2022-12-24	WOS:000304453900005
J	Ramrath, DJF; Yamamoto, H; Rother, K; Wittek, D; Pech, M; Mielke, T; Loerke, J; Scheerer, P; Ivanov, P; Teraoka, Y; Shpanchenko, O; Nierhaus, KH; Spahn, CMT				Ramrath, David J. F.; Yamamoto, Hiroshi; Rother, Kristian; Wittek, Daniela; Pech, Markus; Mielke, Thorsten; Loerke, Justus; Scheerer, Patrick; Ivanov, Pavel; Teraoka, Yoshika; Shpanchenko, Olga; Nierhaus, Knud H.; Spahn, Christian M. T.			The complex of tmRNA-SmpB and EF-G on translocating ribosomes	NATURE			English	Article							TRANSFER-MESSENGER-RNA; BACTERIAL RIBOSOME; HYBRID-STATE; CRYO-EM; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; STALLED RIBOSOME; STRUCTURAL BASIS; 70S RIBOSOME; SYSTEM	Bacterial ribosomes stalled at the 3' end of malfunctioning messenger RNAs can be rescued by transfer-messenger RNA (tmRNA)-mediated trans-translation(1,2). The SmpB protein forms a complex with the tmRNA, and the transfer-RNA-like domain (TLD) of the tmRNA then enters the A site of the ribosome. Subsequently, the TLD-SmpB module is translocated to the P site, a process that is facilitated by the elongation factor EF-G, and translation is switched to the mRNA-like domain (MLD) of the tmRNA. Accurate loading of the MLD into the mRNA path is an unusual initiation mechanism. Despite various snapshots of different ribosome-tmRNA complexes at low to intermediate resolution(3-7), it is unclear how the large, highly structured tmRNA is translocated and how the MLD is loaded. Here we present a cryo-electron microscopy reconstruction of a fusidic-acid-stalled ribosomal 70S-tmRNA-SmpB-EF-G complex (carrying both of the large ligands, that is, EF-G and tmRNA) at 8.3 angstrom resolution. This post-translocational intermediate (TIPOST) presents the TLD-SmpB module in an intrasubunit ap/P hybrid site and a tRNA(fMet) in an intrasubunit pe/E hybrid site. Conformational changes in the ribosome and tmRNA occur in the intersubunit space and on the solvent side. The key underlying event is a unique extra-large swivel movement of the 30S head, which is crucial for both tmRNA-SmpB translocation and MLD loading, thereby coupling translocation to MLD loading. This mechanism exemplifies the versatile, dynamic nature of the ribosome, and it shows that the conformational modes of the ribosome that normally drive canonical translation can also be used in a modified form to facilitate more complex tasks in specialized non-canonical pathways.	[Ramrath, David J. F.; Yamamoto, Hiroshi; Pech, Markus; Mielke, Thorsten; Loerke, Justus; Scheerer, Patrick; Nierhaus, Knud H.; Spahn, Christian M. T.] Charite, Inst Med Phys & Biophys, D-10117 Berlin, Germany; [Yamamoto, Hiroshi; Wittek, Daniela; Pech, Markus; Ivanov, Pavel; Teraoka, Yoshika; Shpanchenko, Olga; Nierhaus, Knud H.] Max Planck Inst Mol Genet, Abt Vingron, AG Ribosomen, D-14195 Berlin, Germany; [Rother, Kristian] Adam Mickiewicz Univ, Coll Biol, Inst Biol & Mol Biotechnol, PL-61614 Poznan, Poland; [Mielke, Thorsten] Max Planck Inst Mol Genet, UltraStrukturNetzwerk, D-14195 Berlin, Germany; [Ivanov, Pavel; Shpanchenko, Olga] Moscow MV Lomonosov State Univ, Dept Chem, Moscow 119899, Russia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Adam Mickiewicz University; Max Planck Society; Lomonosov Moscow State University	Spahn, CMT (corresponding author), Charite, Inst Med Phys & Biophys, Ziegelstr 5-9, D-10117 Berlin, Germany.	christian.spahn@charite.de	Shpanchenko, Olga/C-7813-2015; Ivanov, Pavel/AAZ-9197-2021; Ivanov, Pavel/F-3339-2016; Yamamoto, Hiroshi/Z-5912-2019	Ivanov, Pavel/0000-0002-7986-7760; Ivanov, Pavel/0000-0002-7986-7760; Loerke, Justus/0000-0002-3424-8536; Scheerer, Patrick/0000-0001-5028-2075	Deutsche Forschungsgemeinschaft DFG [SP 1130/2-1, SFB740]; German Academic Exchange Service [D/09/42768]; European Union; Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); Alexander-von-Humboldt grant [GAN 1127366 STP-2]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); European Union(European Commission); Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum); Alexander-von-Humboldt grant	We thank M. Muhs, T. Budkevich, M. Sommer and A. Korostelev for discussions. The strain for tmRNA overexpression and the plasmid for SmpB were provided by A. Muto. We also thank J. Buerger for his assistance during the cryo-EM data collection, E. Einfeldt for tRNA preparation and R. Albrecht for the preparation of the reassociated 70S ribosomes. This work was supported by grants from the Deutsche Forschungsgemeinschaft DFG (SP 1130/2-1 to C. M. T. S. and K.H.N., and SFB740 to C. M. T. S.), the German Academic Exchange Service (D/09/42768 to K. R.) and the European Union and Senatsverwaltung fur Wissenschaft, Forschung und Kultur Berlin (UltraStructureNetwork, Anwenderzentrum) and the Alexander-von-Humboldt grant (GAN 1127366 STP-2 to H.Y.).	Bessho Y, 2007, P NATL ACAD SCI USA, V104, P8293, DOI 10.1073/pnas.0700402104; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Crandall J, 2010, J BACTERIOL, V192, P553, DOI 10.1128/JB.01178-09; Dorner S, 2006, NAT STRUCT MOL BIOL, V13, P234, DOI 10.1038/nsmb1060; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Ermolenko DN, 2011, NAT STRUCT MOL BIOL, V18, P457, DOI 10.1038/nsmb.2011; Felden B, 1997, RNA, V3, P89; Flores S. C., 2010, S BIOCOMPUT, V2010, P216; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Fu J, 2010, EMBO J, V29, P3819, DOI 10.1038/emboj.2010.255; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Gutmann S, 2003, NATURE, V424, P699, DOI 10.1038/nature01831; Jin H, 2011, P NATL ACAD SCI USA, V108, P15798, DOI 10.1073/pnas.1112185108; Kaur S, 2006, P NATL ACAD SCI USA, V103, P16484, DOI 10.1073/pnas.0607438103; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Loerke J, 2010, METHOD ENZYMOL, V483, P161, DOI 10.1016/S0076-6879(10)83008-3; Marquez V, 2004, CELL, V118, P45, DOI 10.1016/j.cell.2004.06.012; Michiels PJA, 2001, J MOL BIOL, V310, P1109, DOI 10.1006/jmbi.2001.4823; Moore SD, 2007, ANNU REV BIOCHEM, V76, P101, DOI 10.1146/annurev.biochem.75.103004.142733; Nameki N, 2000, FEBS LETT, V470, P345, DOI 10.1016/S0014-5793(00)01349-1; Passmore LA, 2007, MOL CELL, V26, P41, DOI 10.1016/j.molcel.2007.03.018; Penczek PA, 2006, J STRUCT BIOL, V154, P184, DOI 10.1016/j.jsb.2005.12.013; Petry S, 2005, CELL, V123, P1255, DOI 10.1016/j.cell.2005.09.039; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ratje AH, 2010, NATURE, V468, P713, DOI 10.1038/nature09547; Rother M, 2011, NUCLEIC ACIDS RES, V39, P4007, DOI 10.1093/nar/gkq1320; Schuette JC, 2009, EMBO J, V28, P755, DOI 10.1038/emboj.2009.26; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; SHEN LX, 1995, J MOL BIOL, V247, P963, DOI 10.1006/jmbi.1995.0193; Shpanchenko OV, 2005, J BIOL CHEM, V280, P18368, DOI 10.1074/jbc.M409094200; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Spiegel PC, 2007, RNA, V13, P1473, DOI 10.1261/rna.601507; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Theimer CA, 2005, MOL CELL, V17, P671, DOI 10.1016/j.molcel.2005.01.017; Valle M, 2003, SCIENCE, V300, P127, DOI 10.1126/science.1081798; Weis F, 2010, EMBO J, V29, P3810, DOI 10.1038/emboj.2010.252; Weis F, 2010, RNA, V16, P299, DOI 10.1261/rna.1757410; Wower IK, 2009, RNA, V15, P128, DOI 10.1261/rna.1192409; Yang HW, 2003, NUCLEIC ACIDS RES, V31, P3450, DOI 10.1093/nar/gkg529; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281	42	63	66	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					526	U140		10.1038/nature11006	http://dx.doi.org/10.1038/nature11006			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622583				2022-12-24	WOS:000304344500048
J	Rajasethupathy, P; Antonov, I; Sheridan, R; Frey, S; Sander, C; Tuschl, T; Kandel, ER				Rajasethupathy, Priyamvada; Antonov, Igor; Sheridan, Robert; Frey, Sebastian; Sander, Chris; Tuschl, Thomas; Kandel, Eric R.			A Role for Neuronal piRNAs in the Epigenetic Control of Memory-Related Synaptic Plasticity	CELL			English	Article							LONG-TERM FACILITATION; SMALL RNAS; DNA DEMETHYLATION; MOLECULAR TURNOVER; FEEDBACK LOOP; APLYSIA CPEB; TRANSCRIPTION; METHYLATION; PROTEIN; TESTES	Small RNA-mediated gene regulation during development causes long-lasting changes in cellular phenotypes. To determine whether small RNAs of the adult brain can regulate memory storage, a process that requires stable and long-lasting changes in the functional state of neurons, we generated small RNA libraries from the Aplysia CNS. In these libraries, we discovered an unexpectedly abundant expression of a 28 nucleotide sized class of piRNAs in brain, which had been thought to be germline specific. These piRNAs have unique biogenesis patterns, predominant nuclear localization, and robust sensitivity to serotonin, a modulatory transmitter that is important for memory. We find that the Piwi/piRNA complex facilitates serotonin-dependent methylation of a conserved CpG island in the promoter of CREB2, the major inhibitory constraint of memory in Aplysia, leading to enhanced long-term synaptic facilitation. These findings provide a small RNA-mediated gene regulatory mechanism for establishing stable long-term changes in neurons for the persistence of memory.	[Frey, Sebastian; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA; [Rajasethupathy, Priyamvada; Antonov, Igor; Kandel, Eric R.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Kavli Inst Brain Sci, New York, NY 10032 USA; [Sheridan, Robert; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Ctr, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; Memorial Sloan Kettering Cancer Center	Tuschl, T (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, 1230 York Ave, New York, NY 10065 USA.	ttuschl@rockefeller.edu; erk5@columbia.edu			HHMI [P50 HG002806]; NIH [P01 GM073047]; NRSA [5F30MH086267]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM073047, T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F30MH086267] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We would like to thank Tom Maniatis and Praveen Sethupathy for comments on the manuscript and for helpful discussions throughout. We also thank Ferdinando Fiumara, Doron Betel, Pavankumar Puvulla, and Pierre Trifilieff for experimental advice and discussions and Frank Grasso for gifting invertebrate CNS samples. We thank Vivian Zhu and Edward Konstantinov for technical assistance with cell cultures. This work is supported by an HHMI grant P50 HG002806, NIH grant P01 GM073047, and NRSA training grant 5F30MH086267.	Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bailey CH, 2004, NEURON, V44, P49, DOI 10.1016/j.neuron.2004.09.017; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BARTSCH D, 1995, CELL, V83, P979, DOI 10.1016/0092-8674(95)90213-9; Betel D, 2007, PLOS COMPUT BIOL, V3, P2219, DOI 10.1371/journal.pcbi.0030222; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Callinan PA, 2006, HUM MOL GENET, V15, pR95, DOI 10.1093/hmg/ddl095; CRICK F, 1984, NATURE, V312, P101, DOI 10.1038/312101a0; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Feng J, 2010, NAT NEUROSCI, V13, P423, DOI 10.1038/nn.2514; Fiore R, 2009, EMBO J, V28, P697, DOI 10.1038/emboj.2009.10; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; Guan ZH, 2002, CELL, V111, P483, DOI 10.1016/S0092-8674(02)01074-7; Guang SH, 2010, NATURE, V465, P1097, DOI 10.1038/nature09095; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Hayer A, 2005, PLOS COMPUT BIOL, V1, P137, DOI 10.1371/journal.pcbi.0010020; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Liu RY, 2008, J NEUROSCI, V28, P1970, DOI 10.1523/JNEUROSCI.3848-07.2008; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Price JC, 2010, P NATL ACAD SCI USA, V107, P14508, DOI 10.1073/pnas.1006551107; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Saito K, 2010, DEV CELL, V19, P687, DOI 10.1016/j.devcel.2010.10.011; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Song H, 2007, BIOPHYS J, V92, P3407, DOI 10.1529/biophysj.106.096891; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Wassenegger M, 2005, CELL, V122, P13, DOI 10.1016/j.cell.2005.06.034; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Won J, 2008, NEUROBIOL LEARN MEM, V89, P285, DOI 10.1016/j.nlm.2007.08.017	46	380	400	0	67	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					693	707		10.1016/j.cell.2012.02.057	http://dx.doi.org/10.1016/j.cell.2012.02.057			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541438	Bronze, Green Accepted			2022-12-24	WOS:000303443100019
J	Juusola, JL; Brandeau, ML; Owens, DK; Bendavid, E				Juusola, Jessie L.; Brandeau, Margaret L.; Owens, Douglas K.; Bendavid, Eran			The Cost-Effectiveness of Preexposure Prophylaxis for HIV Prevention in the United States in Men Who Have Sex With Men	ANNALS OF INTERNAL MEDICINE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NEW-YORK-CITY; ANTIRETROVIRAL THERAPY; VIRAL LOAD; CASUAL PARTNERSHIPS; CLINICAL-OUTCOMES; LIMITED KNOWLEDGE; RISK BEHAVIORS; HEALTHY-ADULTS; YOUNG MEN	Background: A recent randomized, controlled trial showed that daily oral preexposure chemoprophylaxis (PrEP) was effective for HIV prevention in men who have sex with men (MSM). The Centers for Disease Control and Prevention recently provided interim guidance for PrEP in MSM at high risk for HIV. Previous studies did not reach a consistent estimate of its cost-effectiveness. Objective: To estimate the effectiveness and cost-effectiveness of PrEP in MSM in the United States. Design: Dynamic model of HIV transmission and progression combined with a detailed economic analysis. Data Sources: Published literature. Target Population: MSM aged 13 to 64 years in the United States. Time Horizon: Lifetime. Perspective: Societal. Intervention: PrEP was evaluated in both the general MSM population and in high-risk MSM and was assumed to reduce infection risk by 44% on the basis of clinical trial results. Outcome Measures: New HIV infections, discounted quality-adjusted life-years (QALYs) and costs, and incremental cost-effectiveness ratios. Results of Base-Case Analysis: Initiating PrEP in 20% of MSM in the United States would reduce new HIV infections by an estimated 13% and result in a gain of 550 166 QALYs over 20 years at a cost of $172 091 per QALY gained. Initiating PrEP in a larger proportion of MSM would prevent more infections but at an increasing cost per QALY gained (up to $216 480 if all MSM receive PrEP). Pre-exposure chemoprophylaxis in only high-risk MSM can improve cost-effectiveness. For MSM with an average of 5 partners per year, PrEP costs approximately $50 000 per QALY gained. Providing PrEP to all high-risk MSM for 20 years would cost $75 billion more in health care-related costs than the status quo and $600 000 per HIV infection prevented, compared with incremental costs of $95 billion and $2 million per infection prevented for 20% coverage of all MSM. Results of Sensitivity Analysis: PrEP in the general MSM population would cost less than $100 000 per QALY gained if the daily cost of antiretroviral drugs for PrEP was less than $15 or if PrEP efficacy was greater than 75%. Limitation: When examining PrEP in high-risk MSM, the investigators did not model a mix of low-and high-risk MSM because of lack of data on mixing patterns. Conclusion: PrEP in the general MSM population could prevent a substantial number of HIV infections, but it is expensive. Use in high-risk MSM compares favorably with other interventions that are considered cost-effective but could result in annual PrEP expenditures of more than $4 billion.	[Juusola, Jessie L.] Stanford Univ, Dept Management Sci & Engn, Huang Engn Ctr, Stanford, CA 94305 USA; Stanford Univ, Med Ctr, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Juusola, JL (corresponding author), Stanford Univ, Dept Management Sci & Engn, Huang Engn Ctr, Suite 263,475 Via Ortega, Stanford, CA 94305 USA.	jjuusola@stanford.edu		Juusola, Jessie/0000-0002-2885-2008	National Institute on Drug Abuse [R01-DA15612]; Department of Veterans Affairs; National Institute of Allergy and Infectious Diseases [K01-AI084582]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA015612, R01DA015612] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By grant R01-DA15612 from the National Institute on Drug Abuse and the Department of Veterans Affairs (Dr. Owens), and grant K01-AI084582 from the National Institute of Allergy and Infectious Diseases (Dr. Bendavid).	Abbas UL, 2006, JAIDS-J ACQ IMM DEF, V41, P632, DOI 10.1097/01.qai.0000194234.31078.bf; Alistar SS, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000423; [Anonymous], 2011, GUID US ANT AG HIV 1, P1; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Barash EA, 2010, AIDS PATIENT CARE ST, V24, P689, DOI 10.1089/apc.2010.0173; Barnett PG, 2011, MED CARE, V49, P848, DOI 10.1097/MLR.0b013e31821b34c0; Bollinger RC, 1997, JAMA-J AM MED ASSOC, V278, P2085, DOI 10.1001/jama.278.23.2085; Bozzette SA, 2001, NEW ENGL J MED, V344, P817, DOI 10.1056/NEJM200103153441107; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Campsmith M. L., 2008, Morbidity and Mortality Weekly Report, V57, P1073; Celentano DD, 1998, SCIENCE, V280, P1889, DOI 10.1126/science.280.5371.1889; CensusScope, 2000, US AG DISTR; Centers for Disease Control and Prevention, 2010, HIV AIDS GAY BIS MEN; Centers for Disease Control and Prevention, 2008, EST NEW HIV INF US; Centers for Disease Control and Prevention, 2006, 5 CDCP; Centers for Disease Control and Prevention, 2011, CDC TRIAL AN MAJ STU; Centers for Medicare & Medicaid Services, 2010, MED INF PROV PARTN H; Cohen MS, 2007, ANN INTERN MED, V146, P591, DOI 10.7326/0003-4819-146-8-200704170-00010; Cohen MS, 2011, NEW ENGL J MED, V365, P493, DOI [10.1056/NEJMoa1105243, 10.1056/NEJMoa1600693]; Colfax GN, 2002, AIDS, V16, P1529, DOI 10.1097/00002030-200207260-00010; Daar ES, 2001, ANN INTERN MED, V134, P25, DOI 10.7326/0003-4819-134-1-200101020-00010; Desai K, 2008, AIDS, V22, P1829, DOI 10.1097/QAD.0b013e32830e00f5; Dunn D, 2008, J INFECT DIS, V197, P398, DOI 10.1086/524686; Farnham PG, 2008, PUBLIC HEALTH REP, V123, P51, DOI 10.1177/00333549081230S307; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Gebo KA, 1999, AIDS, V13, P963, DOI 10.1097/00002030-199905280-00013; Gold MR, 1996, COST EFFECTIVENESS H; Golub Sarit A, 2010, Curr HIV/AIDS Rep, V7, P201, DOI 10.1007/s11904-010-0057-1; Golub SA, 2010, JAIDS-J ACQ IMM DEF, V54, P548, DOI 10.1097/QAI.0b013e3181e19a54; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Greenwald Jeffrey L, 2006, Curr Infect Dis Rep, V8, P125, DOI 10.1007/s11908-006-0008-6; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Harawa NT, 2004, JAIDS-J ACQ IMM DEF, V35, P526, DOI 10.1097/00126334-200404150-00011; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Holtgrave DR, 1997, J ACQ IMMUN DEF SYND, V16, P54, DOI 10.1097/00042560-199709010-00009; Honiden S, 2006, QUAL LIFE RES, V15, P69, DOI 10.1007/s11136-005-8485-x; Hutchinson AB, 2006, JAIDS-J ACQ IMM DEF, V43, P451, DOI 10.1097/01.qai.0000243090.32866.4e; Juusola JL, 2011, AIDS, V25, P1779, DOI 10.1097/QAD.0b013e328349f067; Kamb ML, 1998, JAMA-J AM MED ASSOC, V280, P1161, DOI 10.1001/jama.280.13.1161; KAPLAN EH, 1995, AIDS, V9, P1113, DOI 10.1097/00002030-199510000-00001; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Koblin BA, 2003, AM J PUBLIC HEALTH, V93, P926, DOI 10.2105/AJPH.93.6.926; Liu AY, 2008, JAIDS-J ACQ IMM DEF, V47, P241, DOI 10.1097/QAI.0b013e31815e4041; Long EF, 2006, AIDS, V20, P2207, DOI 10.1097/QAD.0b013e328010c7d0; Long EF, 2010, ANN INTERN MED, V153, P778, DOI 10.7326/0003-4819-153-12-201012210-00004; Long EF, 2009, VACCINE, V27, P5402, DOI 10.1016/j.vaccine.2009.06.063; MacKellar DA, 2006, AIDS, V20, P1637, DOI 10.1097/01.aids.0000238410.67700.d1; Manning SE, 2007, J URBAN HEALTH, V84, P212, DOI 10.1007/s11524-006-9135-5; Marks G, 2005, JAIDS-J ACQ IMM DEF, V39, P446, DOI 10.1097/01.qai.0000151079.33935.79; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; McCormick AW, 2007, CLIN INFECT DIS, V44, P1115, DOI 10.1086/512816; Meara E, 2004, HEALTH AFFAIR, V23, P176, DOI 10.1377/hlthaff.23.4.176; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Mimiaga MJ, 2009, JAIDS-J ACQ IMM DEF, V50, P77, DOI 10.1097/QAI.0b013e31818d5a27; Myers GM, 2011, AIDS PATIENT CARE ST, V25, P63, DOI 10.1089/apc.2010.0222; Mylonakis E, 2000, AM J MED, V109, P568, DOI 10.1016/S0002-9343(00)00583-0; Neuner JM, 2003, ANN INTERN MED, V139, P113, DOI 10.7326/0003-4819-139-2-200307150-00011; Nyman JA, 2007, MED CARE, V45, P618, DOI 10.1097/MLR.0b013e31803dce05; O'Brien BJ, 2003, VALUE HEALTH, V6, P116, DOI 10.1046/j.1524-4733.2003.00213.x; Owens DK, 1996, ARCH INTERN MED, V156, P394, DOI 10.1001/archinte.156.4.394; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2009, CLIN INFECT DIS, V48, P806, DOI 10.1086/597095; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Pathela P, 2006, ANN INTERN MED, V145, P416, DOI 10.7326/0003-4819-145-6-200609190-00005; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Pinkerton SD, 2007, AIDS, V21, P1625, DOI 10.1097/QAD.0b013e32826fb6a6; Prejean J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017502; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Rietmeijer CA, 1998, SEX TRANSM DIS, V25, P353, DOI 10.1097/00007435-199808000-00006; Rose CD, 2010, JAIDS-J ACQ IMM DEF, V55, P572, DOI 10.1097/QAI.0b013e3181ee4c62; Sanchez Travis, 2006, Morbidity and Mortality Weekly Report, V55, P1; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Schackman BR, 2006, MED CARE, V44, P990, DOI 10.1097/01.mlr.0000228021.89490.2a; Smith D. K., 2011, Morbidity and Mortality Weekly Report, V60, P65; Steward WT, 2009, AIDS BEHAV, V13, P1054, DOI 10.1007/s10461-009-9582-6; Sullivan PW, 2006, MED DECIS MAKING, V26, P401, DOI 10.1177/0272989X06290496; Tengs TO, 2002, MED DECIS MAKING, V22, P475, DOI 10.1177/0272989X02238300; Teshale E., 2005, 12 C RETR OPP INF BO; Thomson PDR, 2010, RED BOOK PHARM FUNDA; Turner DA, 2006, VACCINE, V24, P1035, DOI 10.1016/j.vaccine.2004.12.033; U. S. Census Bureau, 2008, NAT POP PROJ REL 200; Vergis EN, 2000, INFECT DIS CLIN N AM, V14, P809, DOI 10.1016/S0891-5520(05)70135-5; Vernazza P, 2008, LANCET, V372, P1806, DOI 10.1016/S0140-6736(08)61753-5; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wilson DP, 2008, LANCET, V372, P314, DOI 10.1016/S0140-6736(08)61115-0; Xiridou M, 2004, AIDS, V18, P1311, DOI 10.1097/00002030-200406180-00010; Xiridou M, 2003, AIDS, V17, P1029, DOI 10.1097/00002030-200305020-00012; Xu FJ, 2010, SEX TRANSM DIS, V37, P399, DOI 10.1097/OLQ.0b013e3181ce122b	91	108	108	1	53	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2012	156	8					541	U144		10.7326/0003-4819-156-8-201204170-00004	http://dx.doi.org/10.7326/0003-4819-156-8-201204170-00004			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	930PO	22508731				2022-12-24	WOS:000303151800013
J	Barretina, J; Caponigro, G; Stransky, N; Venkatesan, K; Margolin, AA; Kim, S; Wilson, CJ; Lehar, J; Kryukov, GV; Sonkin, D; Reddy, A; Liu, MW; Murray, L; Berger, MF; Monahan, JE; Morais, P; Meltzer, J; Korejwa, A; Jane-Valbuena, J; Mapa, FA; Thibault, J; Bric-Furlong, E; Raman, P; Shipway, A; Engels, IH; Cheng, J; Yu, GYK; Yu, JJ; Aspesi, P; de Silva, M; Jagtap, K; Jones, MD; Wang, L; Hatton, C; Palescandolo, E; Gupta, S; Mahan, S; Sougnez, C; Onofrio, RC; Liefeld, T; MacConaill, L; Winckler, W; Reich, M; Li, NX; Mesirov, JP; Gabriel, SB; Getz, G; Ardlie, K; Chan, V; Myer, VE; Weber, BL; Porter, J; Warmuth, M; Finan, P; Harris, JL; Meyerson, M; Golub, TR; Morrissey, MP; Sellers, WR; Schlegel, R; Garraway, LA				Barretina, Jordi; Caponigro, Giordano; Stransky, Nicolas; Venkatesan, Kavitha; Margolin, Adam A.; Kim, Sungjoon; Wilson, Christopher J.; Lehar, Joseph; Kryukov, Gregory V.; Sonkin, Dmitriy; Reddy, Anupama; Liu, Manway; Murray, Lauren; Berger, Michael F.; Monahan, John E.; Morais, Paula; Meltzer, Jodi; Korejwa, Adam; Jane-Valbuena, Judit; Mapa, Felipa A.; Thibault, Joseph; Bric-Furlong, Eva; Raman, Pichai; Shipway, Aaron; Engels, Ingo H.; Cheng, Jill; Yu, Guoying K.; Yu, Jianjun; Aspesi, Peter, Jr.; de Silva, Melanie; Jagtap, Kalpana; Jones, Michael D.; Wang, Li; Hatton, Charles; Palescandolo, Emanuele; Gupta, Supriya; Mahan, Scott; Sougnez, Carrie; Onofrio, Robert C.; Liefeld, Ted; MacConaill, Laura; Winckler, Wendy; Reich, Michael; Li, Nanxin; Mesirov, Jill P.; Gabriel, Stacey B.; Getz, Gad; Ardlie, Kristin; Chan, Vivien; Myer, Vic E.; Weber, Barbara L.; Porter, Jeff; Warmuth, Markus; Finan, Peter; Harris, Jennifer L.; Meyerson, Matthew; Golub, Todd R.; Morrissey, Michael P.; Sellers, William R.; Schlegel, Robert; Garraway, Levi A.			The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity	NATURE			English	Article							MALIGNANT-MELANOMA; INHIBITOR; KINASE; RECEPTOR; ANTAGONIST; EXPRESSION	The systematic translation of cancer genomic data into knowledge of tumour biology and therapeutic possibilities remains challenging. Such efforts should be greatly aided by robust preclinical model systems that reflect the genomic diversity of human cancers and for which detailed genetic and pharmacological annotation is available(1). Here we describe the Cancer Cell Line Encyclopedia (CCLE): a compilation of gene expression, chromosomal copy number and massively parallel sequencing data from947 human cancer cell lines. When coupled with pharmacological profiles for 24 anticancer drugs across 479 of the cell lines, this collection allowed identification of genetic, lineage, and gene-expression-based predictors of drug sensitivity. In addition to known predictors, we found that plasma cell lineage correlated with sensitivity to IGF1 receptor inhibitors; AHR expression was associated with MEK inhibitor efficacy in NRAS-mutant lines; and SLFN11 expression predicted sensitivity to topoisomerase inhibitors. Together, our results indicate that large, annotated cell-line collections may help to enable preclinical stratification schemata for anticancer agents. The generation of genetic predictions of drug response in the preclinical setting and their incorporation into cancer clinical trial design could speed the emergence of 'personalized' therapeutic regimens(2).	[Barretina, Jordi; Stransky, Nicolas; Margolin, Adam A.; Kryukov, Gregory V.; Murray, Lauren; Berger, Michael F.; Morais, Paula; Korejwa, Adam; Jane-Valbuena, Judit; Gupta, Supriya; Mahan, Scott; Sougnez, Carrie; Onofrio, Robert C.; Liefeld, Ted; Winckler, Wendy; Reich, Michael; Mesirov, Jill P.; Gabriel, Stacey B.; Getz, Gad; Ardlie, Kristin; Meyerson, Matthew; Golub, Todd R.; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Barretina, Jordi; Jane-Valbuena, Judit; Meyerson, Matthew; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Barretina, Jordi; Hatton, Charles; Palescandolo, Emanuele; MacConaill, Laura; Meyerson, Matthew; Golub, Todd R.; Garraway, Levi A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Caponigro, Giordano; Venkatesan, Kavitha; Wilson, Christopher J.; Lehar, Joseph; Sonkin, Dmitriy; Reddy, Anupama; Liu, Manway; Monahan, John E.; Meltzer, Jodi; Mapa, Felipa A.; Bric-Furlong, Eva; Raman, Pichai; Aspesi, Peter, Jr.; de Silva, Melanie; Jagtap, Kalpana; Jones, Michael D.; Wang, Li; Myer, Vic E.; Weber, Barbara L.; Porter, Jeff; Warmuth, Markus; Finan, Peter; Morrissey, Michael P.; Sellers, William R.; Schlegel, Robert] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Kim, Sungjoon; Thibault, Joseph; Shipway, Aaron; Engels, Ingo H.; Li, Nanxin; Harris, Jennifer L.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Cheng, Jill; Yu, Guoying K.; Yu, Jianjun; Chan, Vivien] Novartis Inst Biomed Res, Emeryville, CA 94608 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Novartis; Novartis; Novartis; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute	Garraway, LA (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	robert.schlegel@novartis.com; Levi_Garraway@dfci.harvard.edu	Chan, Vivien W/N-7980-2019; Meyerson, Matthew L/E-7123-2012; Kryukov, Gregory V/A-9592-2008; Morrissey, Michael/C-6792-2013; Mesirov, Jill/AGF-7626-2022; Barretina, Jordi/A-7192-2013	Chan, Vivien W/0000-0001-7663-1130; Kryukov, Gregory/0000-0002-6131-9483; Reich, Michael/0000-0003-4735-5514; Barretina, Jordi/0000-0002-3478-4080; Meyerson, Matthew/0000-0002-9133-8108; Monahan, John/0000-0002-3125-8704; Jones, Michael/0000-0001-7541-7634; Sonkin, Dmitriy/0000-0002-1649-0652; Hatton, Charlie/0000-0001-9903-4291; Keskula, Paula/0000-0002-0458-9153; Wilson, Christopher/0000-0002-9146-522X	Novartis Institutes for Biomedical Research; National Cancer Institute; Starr Cancer Consortium; NIH; NATIONAL CANCER INSTITUTE [R33CA155554, R33CA126674] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	Novartis Institutes for Biomedical Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Starr Cancer Consortium; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the staff of the Biological Samples Platform, the Genetic Analysis Platform and the Sequencing Platform at the Broad Institute. We thank S. Banerji, J. Che, C. M. Johannessen, A. Su and N. Wagle for advice and discussion. We are grateful for the technical assistance and support of G. Bonamy, R. Brusch III, E. Gelfand, K. Gravelin, T. Huynh, S. Kehoe, K. Matthews, J. Nedzel, L. Niu, R. Pinchback, D. Roby, J. Slind, T. R. Smith, L. Tan, V. Trinh, C. Vickers, G. Yang, Y. Yao and X. Zhang. The Cancer Cell Line Encyclopedia project was enabled by a grant from the Novartis Institutes for Biomedical Research. Additional funding support was provided by the National Cancer Institute (M. M., L. A. G.), the Starr Cancer Consortium (M. F. B., L. A. G.), and the NIH Director's New Innovator Award (L.A.G.).	Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Caponigro G, 2011, NAT REV DRUG DISCOV, V10, P179, DOI 10.1038/nrd3385; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Greshock J, 2010, CANCER RES, V70, P3677, DOI 10.1158/0008-5472.CAN-09-3788; Guo WC, 2005, CANCER RES, V65, P10006, DOI 10.1158/0008-5472.CAN-05-2029; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; MacConaill LE, 2010, J CLIN ONCOL, V28, P5219, DOI 10.1200/JCO.2009.27.4944; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Moreau P, 2011, LEUKEMIA, V25, P872, DOI 10.1038/leu.2011.4; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nishio M, 2011, J THORAC ONCOL, V6, P1889, DOI 10.1097/JTO.0b013e3182286d41; Reiners JJ, 1998, MOL PHARMACOL, V53, P438, DOI 10.1124/mol.53.3.438; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wagner LM, 2007, PEDIATR BLOOD CANCER, V48, P132, DOI 10.1002/pbc.20697; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	26	4613	4729	19	537	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					603	607		10.1038/nature11003	http://dx.doi.org/10.1038/nature11003			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460905	Green Accepted			2022-12-24	WOS:000302006100040
J	Edgar, RS; Green, EW; Zhao, YW; van Ooijen, G; Olmedo, M; Qin, XM; Xu, Y; Pan, M; Valekunja, UK; Feeney, KA; Maywood, ES; Hastings, MH; Baliga, NS; Merrow, M; Millar, AJ; Johnson, CH; Kyriacou, CP; O'Neill, JS; Reddy, AB				Edgar, Rachel S.; Green, Edward W.; Zhao, Yuwei; van Ooijen, Gerben; Olmedo, Maria; Qin, Ximing; Xu, Yao; Pan, Min; Valekunja, Utham K.; Feeney, Kevin A.; Maywood, Elizabeth S.; Hastings, Michael H.; Baliga, Nitin S.; Merrow, Martha; Millar, Andrew J.; Johnson, Carl H.; Kyriacou, Charalambos P.; O'Neill, John S.; Reddy, Akhilesh B.			Peroxiredoxins are conserved markers of circadian rhythms	NATURE			English	Article							SUPRACHIASMATIC NUCLEUS; 2-CYS PEROXIREDOXIN; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; REDOX STATE; CLOCK; GENE; EVOLUTION; TIME; METABOLISM	Cellular life emerged similar to 3.7 billion years ago. With scant exception, terrestrial organisms have evolved under predictable daily cycles owing to the Earth's rotation. The advantage conferred on organisms that anticipate such environmental cycles has driven the evolution of endogenous circadian rhythms that tune internal physiology to external conditions. The molecular phylogeny of mechanisms driving these rhythms has been difficult to dissect because identified clock genes and proteins are not conserved across the domains of life: Bacteria, Archaea and Eukaryota. Here we show that oxidation-reduction cycles of peroxiredoxin proteins constitute a universal marker for circadian rhythms in all domains of life, by characterizing their oscillations in a variety of model organisms. Furthermore, we explore the interconnectivity between these metabolic cycles and transcription-translation feedback loops of the clockwork in each system. Our results suggest an intimate co-evolution of cellular timekeeping with redox homeostatic mechanisms after the Great Oxidation Event similar to 2.5 billion years ago.	[Edgar, Rachel S.; Valekunja, Utham K.; Feeney, Kevin A.; O'Neill, John S.; Reddy, Akhilesh B.] Univ Cambridge, Addenbrookes Hosp, NIHR Biomed Res Ctr, Inst Metab Sci,Metab Res Labs,Dept Clin Neurosci, Cambridge CB2 0QQ, England; [Green, Edward W.; Kyriacou, Charalambos P.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Zhao, Yuwei; Qin, Ximing; Xu, Yao; Johnson, Carl H.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [van Ooijen, Gerben; Millar, Andrew J.] Synthet & Syst Biol SynthSys, Edinburgh EH9 3JD, Midlothian, Scotland; [Olmedo, Maria; Merrow, Martha] Univ Groningen, Ctr Life Sci, Dept Mol Chronobiol, NL-9700 CC Groningen, Netherlands; [Pan, Min; Baliga, Nitin S.] Inst Syst Biol, Seattle, WA 98109 USA; [Maywood, Elizabeth S.; Hastings, Michael H.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Millar, Andrew J.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JR, Midlothian, Scotland	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Leicester; Vanderbilt University; University of Groningen; Institute for Systems Biology (ISB); MRC Laboratory Molecular Biology; University of Edinburgh	Reddy, AB (corresponding author), Univ Cambridge, Addenbrookes Hosp, NIHR Biomed Res Ctr, Inst Metab Sci,Metab Res Labs,Dept Clin Neurosci, Cambridge CB2 0QQ, England.	jso22@medschl.cam.ac.uk; areddy@cantab.net	van Ooijen, Gerben/E-9371-2013; Qin, Ximing/J-6485-2012; Olmedo, Maria/N-3708-2019; Olmedo, Maria/E-1824-2012; Johnson, Carl H/I-4655-2014; Millar, Andrew J/G-2423-2012	van Ooijen, Gerben/0000-0001-7967-0637; Olmedo, Maria/0000-0002-5701-2665; Olmedo, Maria/0000-0002-5701-2665; Millar, Andrew J/0000-0003-1756-3654; Hastings, Michael Harvey/0000-0001-8576-6651; Edgar, Rachel/0000-0002-3348-0851; Valekunja, Utham Kashyap/0000-0003-2385-4239; Qin, Ximing/0000-0003-2496-2434; O'Neill, John Stuart/0000-0003-2204-6096; baliga, nitin/0000-0001-9157-5974	Wellcome Trust [083643/Z/07/Z, 093734/Z/10/Z]; European Research Council (ERC) [281348]; EMBO; Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC CORD); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre; European Commission [018741]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C006941/1]; Engineering and Physical Sciences Research Council (EPSRC) [BB/D019621]; ENIGMA; US Department of Energy [DE-AC02-05CH11231]; National Institutes of Health (NIH) [P50GM076547, R01GM088595, R01GM067152, R21HL102492]; Netherlands Organisation for Scientific Research (NWO); Dutch Science Foundation VICI; University of Groningen; BBSRC [BB/D019621/1] Funding Source: UKRI; MRC [MC_U105170643, MC_UP_1201/4] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D019621/1, BB/C006941/1] Funding Source: researchfish; Medical Research Council [MC_U105170643, G0600717B, MC_UP_1201/4] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL102492] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088595, R37GM067152, P50GM076547, R01GM067152] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); EMBO(European Molecular Biology Organization (EMBO)); Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ENIGMA(European Commission); US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Science Foundation VICI; University of Groningen; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was primarily supported by the Wellcome Trust (083643/Z/07/Z and 093734/Z/10/Z), the European Research Council (ERC Starting Grant No. 281348, MetaCLOCK), and EMBO Young Investigators Programme, as well as the Medical Research Council Centre for Obesity and Related metabolic Disorders (MRC CORD), and the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre. C. P. K. and M. H. H. acknowledge European Commission grant EUCLOCK (no. 018741) and Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/C006941/1. SynthSys is funded by BBSRC and Engineering and Physical Sciences Research Council (EPSRC) award BB/D019621 to A.J.M. and others. N.S.B. was supported by ENIGMA, US Department of Energy, under contract no. DE-AC02-05CH11231, and by a grant from the National Institutes of Health (NIH; P50GM076547). C.H.J. was supported by the NIH (R01GM088595, R01GM067152 and R21HL102492). M. M. was supported by the Netherlands Organisation for Scientific Research (NWO; Dutch Science Foundation VICI award and Open Programma) and the University of Groningen (Rosalind Franklin Fellowship Program). We thank M. Jain, G. O'Neill and J. Chambers for discussion about the manuscript, and S. G. Rhee, F. Rouyer and R. Stanewsky for the gifts of antisera.	Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BAMFORTH SS, 1962, LIMNOL OCEANOGR, V7, P348, DOI 10.4319/lo.1962.7.3.0348; Barger LK, 2009, CURR NEUROL NEUROSCI, V9, P155, DOI 10.1007/s11910-009-0024-7; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Declercq JP, 2001, J MOL BIOL, V311, P751, DOI 10.1006/jmbi.2001.4853; Ditty JL, 2005, MICROBIOL-SGM, V151, P2605, DOI 10.1099/mic.0.28030-0; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dunlap JC, 2006, CURR OPIN MICROBIOL, V9, P579, DOI 10.1016/j.mib.2006.10.008; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Dvornyk V, 2003, P NATL ACAD SCI USA, V100, P2495, DOI 10.1073/pnas.0130099100; Gould PD, 2009, PLANT J, V58, P893, DOI 10.1111/j.1365-313X.2009.03819.x; Granshaw T, 2003, J BIOL RHYTHM, V18, P287, DOI 10.1177/0748730403255934; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Hardin PE, 2005, CURR BIOL, V15, pR714, DOI 10.1016/j.cub.2005.08.019; Hastings MH, 2005, METHOD ENZYMOL, V393, P579, DOI 10.1016/S0076-6879(05)93030-9; House SB, 1998, J NEUROENDOCRINOL, V10, P849; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; Lakin-Thomas PL, 2004, ANNU REV MICROBIOL, V58, P489, DOI 10.1146/annurev.micro.58.030603.123744; LopezMolina L, 1997, EMBO J, V16, P6762, DOI 10.1093/emboj/16.22.6762; Mas P, 2003, PLANT CELL, V15, P223, DOI 10.1105/tpc.006734; Maywood ES, 2006, CURR BIOL, V16, P599, DOI 10.1016/j.cub.2006.02.023; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Mulholland PJ, 2005, ECOL INDIC, V5, P243, DOI 10.1016/j.ecolind.2005.03.004; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nathan C, 2010, CELL, V140, DOI 10.1016/j.cell.2010.03.008; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; O'Neill JS, 2011, NATURE, V469, P554, DOI 10.1038/nature09654; Ochoa D, 2010, BIOINFORMATICS, V26, P1370, DOI 10.1093/bioinformatics/btq137; Olmedo M, 2010, FUNGAL GENET BIOL, V47, P939, DOI 10.1016/j.fgb.2010.08.001; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; PEIXOTO AA, 1993, MOL BIOL EVOL, V10, P127; Pulido P, 2010, J EXP BOT, V61, P4043, DOI 10.1093/jxb/erq218; Qin XM, 2010, P NATL ACAD SCI USA, V107, P14805, DOI 10.1073/pnas.1002119107; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Shima S, 2004, BIOCHEM SOC T, V32, P269, DOI 10.1042/BST0320269; Stork T, 2009, ARCH MICROBIOL, V191, P141, DOI 10.1007/s00203-008-0438-7; Venkiteswaran JJ, 2007, OECOLOGIA, V153, P385, DOI 10.1007/s00442-007-0744-9; Wang ML, 2011, MOL BIOL EVOL, V28, P567, DOI 10.1093/molbev/msq232; Whitehead K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005485; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2010, METHODS IN REDOX SIGNALING, P19; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Xu Y, 2003, EMBO J, V22, P2117, DOI 10.1093/emboj/cdg168; Xu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007509; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshida Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028227; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zheng XZ, 2008, GENETICS, V178, P1147, DOI 10.1534/genetics.107.088658	67	570	589	12	188	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					459	U65		10.1038/nature11088	http://dx.doi.org/10.1038/nature11088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622569	Green Accepted, Green Published, Green Submitted			2022-12-24	WOS:000304344500034
J	Booth, MJ; Branco, MR; Ficz, G; Oxley, D; Krueger, F; Reik, W; Balasubramanian, S				Booth, Michael J.; Branco, Miguel R.; Ficz, Gabriella; Oxley, David; Krueger, Felix; Reik, Wolf; Balasubramanian, Shankar			Quantitative Sequencing of 5-Methylcytosine and 5-Hydroxymethylcytosine at Single-Base Resolution	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; DNA METHYLATION; MOUSE; BRAIN; TET1; HYDROXYMETHYLCYTOSINE; TRANSCRIPTION; CONVERSION; 5HMC; 5MC	5-Methylcytosine can be converted to 5-hydroxymethylcytosine (5hmC) in mammalian DNA by the ten-eleven translocation (TET) enzymes. We introduce oxidative bisulfite sequencing (oxBS-Seq), the first method for quantitative mapping of 5hmC in genomic DNA at single-nucleotide resolution. Selective chemical oxidation of 5hmC to 5-formylcytosine (5fC) enables bisulfite conversion of 5fC to uracil. We demonstrate the utility of oxBS-Seq to map and quantify 5hmC at CpG islands (CGIs) in mouse embryonic stem (ES) cells and identify 800 5hmC-containing CGIs that have on average 3.3% hydroxymethylation. High levels of 5hmC were found in CGIs associated with transcriptional regulators and in long interspersed nuclear elements, suggesting that these regions might undergo epigenetic reprogramming in ES cells. Our results open new questions on 5hmC dynamics and sequence-specific targeting by TETs.	[Branco, Miguel R.; Ficz, Gabriella; Reik, Wolf] Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England; [Booth, Michael J.; Balasubramanian, Shankar] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Branco, Miguel R.; Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Oxley, David] Babraham Inst, Prote Res Grp, Cambridge CB22 3AT, England; [Krueger, Felix] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Balasubramanian, Shankar] Univ Cambridge, Sch Clin Med, Cambridge CB2 0SP, England; [Balasubramanian, Shankar] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Reik, W (corresponding author), Babraham Inst, Epigenet Programme, Cambridge CB22 3AT, England.	wolf.reik@babraham.ac.uk; sb10031@cam.ac.uk	Ficz, Gabriella/HCH-3771-2022; Reik, Wolf/I-6794-2012; Branco, Miguel/H-9509-2019; Balasubramanian, Shankar/C-1671-2009; Krueger, Felix/J-3340-2019	Branco, Miguel/0000-0001-9447-1548; Balasubramanian, Shankar/0000-0002-0281-5815; Krueger, Felix/0000-0002-5513-3324; Reik, Wolf/0000-0003-0216-9881; Booth, Michael/0000-0002-4224-798X; Ficz, Gabriella/0000-0001-9313-9578	Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council; Wellcome Trust; European Union EpiGeneSys; BLUEPRINT; Cancer Research UK; MRC [G0801156] Funding Source: UKRI; Medical Research Council [G0801156] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Union EpiGeneSys; BLUEPRINT; Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank T. Green and R. Rodriguez for helpful discussions and J. Webster for help with mass spectrometry. We thank the Biotechnology and Biological Sciences Research Council (BBSRC) for a studentship (M.J.B.). The W.R. lab is supported by BBSRC, Medical Research Council, the Wellcome Trust, European Union EpiGeneSys, and BLUEPRINT. The S.B. lab is supported by core funding from Cancer Research UK. M.J.B. and S.B. are inventors on provisional applications filed for U.S. patents on oxBS-Seq (patent applications US61/605702; US61/641134; US61/623461; and US61/513356). OxRRBS data are deposited in the European Molecular Biology Laboratory-European Bioinformatics Institute ArrayExpress Archive (http://www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-1042. S.B. is an advisor to Illumina.	Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; GREEN G, 1984, J CHEM SOC PERK T 1, P681, DOI 10.1039/p19840000681; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Illingworth RS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001134; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jin SG, 2011, NUCLEIC ACIDS RES, V39, P5015, DOI 10.1093/nar/gkr120; Kinney SM, 2011, J BIOL CHEM, V286, P24685, DOI 10.1074/jbc.M110.217083; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Nestor C, 2010, BIOTECHNIQUES, V48, P317, DOI 10.2144/000113403; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Song CX, 2012, NAT METHODS, V9, P75, DOI [10.1038/NMETH.1779, 10.1038/nmeth.1779]; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Wallace EVB, 2010, CHEM COMMUN, V46, P8195, DOI 10.1039/c0cc02864a; Wanunu M, 2011, J AM CHEM SOC, V133, P486, DOI 10.1021/ja107836t; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005	25	626	679	13	224	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					934	937		10.1126/science.1220671	http://dx.doi.org/10.1126/science.1220671			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22539555				2022-12-24	WOS:000304145600070
J	Hawley, SA; Fullerton, MD; Ross, FA; Schertzer, JD; Chevtzoff, C; Walker, KJ; Peggie, MW; Zibrova, D; Green, KA; Mustard, KJ; Kemp, BE; Sakamoto, K; Steinberg, GR; Hardie, DG				Hawley, Simon A.; Fullerton, Morgan D.; Ross, Fiona A.; Schertzer, Jonathan D.; Chevtzoff, Cyrille; Walker, Katherine J.; Peggie, Mark W.; Zibrova, Darya; Green, Kevin A.; Mustard, Kirsty J.; Kemp, Bruce E.; Sakamoto, Kei; Steinberg, Gregory R.; Hardie, D. Grahame			The Ancient Drug Salicylate Directly Activates AMP-Activated Protein Kinase	SCIENCE			English	Article							MECHANISM; ASPIRIN; PHOSPHORYLATION; INHIBITION; METABOLISM; SALSALATE; A-769662; CELLS; BETA	Salicylate, a plant product, has been in medicinal use since ancient times. More recently, it has been replaced by synthetic derivatives such as aspirin and salsalate, both of which are rapidly broken down to salicylate in vivo. At concentrations reached in plasma after administration of salsalate or of aspirin at high doses, salicylate activates adenosine monophosphate-activated protein kinase (AMPK), a central regulator of cell growth and metabolism. Salicylate binds at the same site as the synthetic activator A-769662 to cause allosteric activation and inhibition of dephosphorylation of the activating phosphorylation site, threonine-172. In AMPK knockout mice, effects of salicylate to increase fat utilization and to lower plasma fatty acids in vivo were lost. Our results suggest that AMPK activation could explain some beneficial effects of salsalate and aspirin in humans.	[Hawley, Simon A.; Ross, Fiona A.; Chevtzoff, Cyrille; Walker, Katherine J.; Green, Kevin A.; Mustard, Kirsty J.; Hardie, D. Grahame] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland; [Fullerton, Morgan D.; Schertzer, Jonathan D.; Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Fullerton, Morgan D.; Schertzer, Jonathan D.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Div Endocrinol, Hamilton, ON L8N 3Z5, Canada; [Fullerton, Morgan D.; Schertzer, Jonathan D.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Div Metab, Hamilton, ON L8N 3Z5, Canada; [Peggie, Mark W.; Zibrova, Darya; Sakamoto, Kei] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [Kemp, Bruce E.; Steinberg, Gregory R.] St Vincents Inst Med Res, Fitzroy, Vic 3065, Australia; [Kemp, Bruce E.; Steinberg, Gregory R.] Univ Melbourne, Dept Med, Fitzroy, Vic 3065, Australia	University of Dundee; McMaster University; McMaster University; McMaster University; University of Dundee; St. Vincent's Institute of Medical Research; University of Melbourne	Hardie, DG (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland.	d.g.hardie@dundee.ac.uk	Kemp, Bruce E/L-2633-2014; sakamoto, kei/C-8806-2019; Kemp, Bruce/G-9602-2019; Hardie, David/Z-1979-2019; Schertzer, Jonathan/P-3395-2017	Kemp, Bruce E/0000-0001-6735-5082; sakamoto, kei/0000-0001-8839-5980; Kemp, Bruce/0000-0001-6735-5082; Schertzer, Jonathan/0000-0002-1547-5856; Steinberg, Gregory/0000-0001-5425-8275; Hardie, Grahame/0000-0002-8373-7379	Wellcome Trust [080982]; Medical Research Council; AstraZeneca; Boehringer-Ingelheim; GlaxoSmithKline; Merck Serono; Pfizer; Canadian Institutes of Health Research (CIHR); Canadian Diabetes Association; National Health and Medical Research Council of Australia; Australian Research Council; Victorian Government; Medical Research Council [MC_U127088492] Funding Source: researchfish; MRC [MC_U127088492] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck Serono(Merck & Company); Pfizer(Pfizer); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Victorian Government; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	D.G.H. was supported by a Programme Grant (080982) from the Wellcome Trust and K.S. by the Medical Research Council. D.G.H. and K.S. were also funded by the companies (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck Serono, and Pfizer) supporting the Division of Signal Transduction Therapy, Univ. of Dundee. The studies were also supported by grants and fellowship from the Canadian Institutes of Health Research (CIHR) (M.D.F. and G.R.S.), the Canadian Diabetes Association (J.D.S. and G.R.S.), the National Health and Medical Research Council of Australia (G.R.S. and B.E.K.), and the Australian Research Council and the Victorian Government's Operational Infrastructure Support Program (B.E.K.). J.D.S. is a DeGroote Academic Fellow (McMaster Univ.), and M.D.F. a Banting Postdoctoral Fellow (CIHR). G.R.S. is a Canada Research Chair in Metabolism and Obesity.	Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; BRODY TM, 1956, J PHARMACOL EXP THER, V117, P39; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Cronstein BN, 1999, P NATL ACAD SCI USA, V96, P6377, DOI 10.1073/pnas.96.11.6377; Davies SP, 1995, FEBS LETT, V377, P421, DOI 10.1016/0014-5793(95)01368-7; DAY RO, 1989, BRIT J CLIN PHARMACO, V28, P695, DOI 10.1111/j.1365-2125.1989.tb03562.x; Dzamko N, 2010, J BIOL CHEM, V285, P115, DOI 10.1074/jbc.M109.056762; Fleischman A, 2008, DIABETES CARE, V31, P289, DOI 10.2337/dc07-1338; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; HAWLEY SA, 1995, J BIOL CHEM, V270, P27186, DOI 10.1074/jbc.270.45.27186; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; HIGGS GA, 1984, ANN CLIN RES, V16, P287; HIGGS GA, 1987, P NATL ACAD SCI USA, V84, P1417, DOI 10.1073/pnas.84.5.1417; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Oakhill JS, 2010, P NATL ACAD SCI USA, V107, P19237, DOI 10.1073/pnas.1009705107; Ogunleye AA, 2009, BRIT J CANCER, V101, P1199, DOI 10.1038/sj.bjc.6605240; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; WILLIAMS FM, 1985, CLIN PHARMACOKINET, V10, P392, DOI 10.2165/00003088-198510050-00002; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	30	522	544	3	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					918	922		10.1126/science.1215327	http://dx.doi.org/10.1126/science.1215327			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22517326	Green Accepted			2022-12-24	WOS:000304145600066
J	Akhtar-Zaidi, B; Lari, RCS; Corradin, O; Saiakhova, A; Bartels, CF; Balasubramanian, D; Myeroff, L; Lutterbaugh, J; Jarrar, A; Kalady, MF; Willis, J; Moore, JH; Tesar, PJ; Laframboise, T; Markowitz, S; Lupien, M; Scacheri, PC				Akhtar-Zaidi, Batool; Lari, Richard Cowper-Sal; Corradin, Olivia; Saiakhova, Alina; Bartels, Cynthia F.; Balasubramanian, Dheepa; Myeroff, Lois; Lutterbaugh, James; Jarrar, Awad; Kalady, Matthew F.; Willis, Joseph; Moore, Jason H.; Tesar, Paul J.; Laframboise, Thomas; Markowitz, Sanford; Lupien, Mathieu; Scacheri, Peter C.			Epigenomic Enhancer Profiling Defines a Signature of Colon Cancer	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; SUSCEPTIBILITY LOCI; HUMAN BREAST; RISK; 8Q24; METAANALYSIS; CHROMATIN	Cancer is characterized by gene expression aberrations. Studies have largely focused on coding sequences and promoters, even though distal regulatory elements play a central role in controlling transcription patterns. We used the histone mark H3K4me1 to analyze gain and loss of enhancer activity genome-wide in primary colon cancer lines relative to normal colon crypts. We identified thousands of variant enhancer loci (VELs) that comprise a signature that is robustly predictive of the in vivo colon cancer transcriptome. Furthermore, VELs are enriched in haplotype blocks containing colon cancer genetic risk variants, implicating these genomic regions in colon cancer pathogenesis. We propose that reproducible changes in the epigenome at enhancer elements drive a specific transcriptional program to promote colon carcinogenesis.	[Akhtar-Zaidi, Batool; Corradin, Olivia; Saiakhova, Alina; Bartels, Cynthia F.; Balasubramanian, Dheepa; Tesar, Paul J.; Laframboise, Thomas; Markowitz, Sanford; Scacheri, Peter C.] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Akhtar-Zaidi, Batool; Scacheri, Peter C.] Case Western Reserve Univ, Dept Mol Med, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Lari, Richard Cowper-Sal; Moore, Jason H.; Lupien, Mathieu] Dartmouth Med Sch, Dept Genet, Norris Cotton Canc Ctr, Inst Quantitat Biomed Sci, Lebanon, NH 03756 USA; [Myeroff, Lois; Lutterbaugh, James; Kalady, Matthew F.; Willis, Joseph; Tesar, Paul J.; Laframboise, Thomas; Markowitz, Sanford; Scacheri, Peter C.] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA; [Jarrar, Awad; Kalady, Matthew F.] Cleveland Clin Fdn, Dept Colorectal Surg, Cleveland, OH 44195 USA; [Kalady, Matthew F.] Cleveland Clin Fdn, Lerner Res Inst, Canc Biol Dept, Cleveland, OH 44195 USA; [Willis, Joseph] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA; [Markowitz, Sanford] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Lupien, Mathieu] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Lupien, Mathieu] Univ Toronto, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 1L7, Canada	Case Western Reserve University; Case Western Reserve University; Cleveland Clinic Foundation; Dartmouth College; Norris Cotton Cancer Center; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Case Western Reserve University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Scacheri, PC (corresponding author), Case Western Reserve Univ, Dept Genet, Sch Med, 10900 Euclid Ave,BRB 627, Cleveland, OH 44106 USA.	pxs183@case.edu	Moore, Jason H./AAV-9645-2021; Tesar, Paul/GPK-5942-2022; Tesar, Paul J/C-9848-2014	Moore, Jason H./0000-0002-5015-1099; Tesar, Paul/0000-0003-1532-3155; Tesar, Paul J/0000-0003-1532-3155; Corradin, Olivia/0000-0002-9484-0873; Lupien, Mathieu/0000-0003-0929-9478	NIH [R01HD056369, R01CA160356, R01CA1555004, R01-LM009012, R01-LM010098, 1P50CA150964, UO1 CA152756, 5T32GM008056-29]; Med into Grad initiative of the Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD056369] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA152756, R01CA160356, R01CA155004, P50CA150964] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056, P20GM103534] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009012, R01LM010098] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Med into Grad initiative of the Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank A. Ting and K. Guda for helpful comments and discussion; Z. Zhang for providing Perl scripts for data analysis; P. Manaenkov for assistance with data visualization; and S. Edelheit, N. Beckloff, and N. Molyneaux from the Case Western Reserve University Genomics Core for sequencing and informatics assistance. This work was supported in part by NIH grants R01HD056369 and R01CA160356 (to P.C.S.), R01CA1555004 (to M.L.), R01-LM009012 and R01-LM010098 (to J.H.M. and R.C.-S.), 1P50CA150964 and NIH UO1 CA152756 (to S.M.), and 5T32GM008056-29 (to O.C.). B.A.-Z. is a predoctoral student in the Molecular Medicine Ph. D. Program of Cleveland Clinic and Case Western Reserve University, funded in part by the Med into Grad initiative of the Howard Hughes Medical Institute. All data are available in Gene Expression Omnibus through the accession numbers GSE36401, GSE36204, and GSE36400.	Bass AJ, 2011, NAT GENET, V43, P964, DOI 10.1038/ng.936; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Cui R, 2011, GUT, V60, P799, DOI 10.1136/gut.2010.215947; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Figueiredo JC, 2011, CANCER EPIDEM BIOMAR, V20, P758, DOI 10.1158/1055-9965.EPI-10-0675; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Houlston RS, 2010, NAT GENET, V42, P973, DOI 10.1038/ng.670; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Lascorz J, 2010, CARCINOGENESIS, V31, P1612, DOI 10.1093/carcin/bgq146; Lubbe SJ, 2012, ONCOGENE, V31, P3777, DOI 10.1038/onc.2011.564; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Peters U, 2012, HUM GENET, V131, P217, DOI 10.1007/s00439-011-1055-0; Poynter JN, 2007, CANCER RES, V67, P11128, DOI 10.1158/0008-5472.CAN-07-3239; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zentner GE, 2011, GENOME RES, V21, P1273, DOI 10.1101/gr.122382.111	21	241	248	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					736	739		10.1126/science.1217277	http://dx.doi.org/10.1126/science.1217277			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22499810	Green Accepted			2022-12-24	WOS:000303872300054
J	Hayashi, M; Nakashima, T; Taniguchi, M; Kodama, T; Kumanogoh, A; Takayanagi, H				Hayashi, Mikihito; Nakashima, Tomoki; Taniguchi, Masahiko; Kodama, Tatsuhiko; Kumanogoh, Atsushi; Takayanagi, Hiroshi			Osteoprotection by semaphorin 3A	NATURE			English	Article							TERMINAL DIFFERENTIATION; BONE-FORMATION; OSTEOCLAST; EXPRESSION; GROWTH; RANKL; WNT; OSTEOPOROSIS; NEUROPILIN-1; ACTIVATION	The bony skeleton is maintained by local factors that regulate bone-forming osteoblasts and bone-resorbing osteoclasts, in addition to hormonal activity. Osteoprotegerin protects bone by inhibiting osteoclastic bone resorption, but no factor has yet been identified as a local determinant of bone mass that regulates both osteoclasts and osteoblasts. Here we show that semaphorin 3A (Sema3A) exerts an osteoprotective effect by both suppressing osteoclastic bone resorption and increasing osteoblastic bone formation. The binding of Sema3A to neuropilin-1 (Nrp1) inhibited receptor activator of nuclear factor-kappa B ligand (RANKL)-induced osteoclast differentiation by inhibiting the immunoreceptor tyrosine-based activation motif (ITAM) and RhoA signalling pathways. In addition, Sema3A and Nrp1 binding stimulated osteoblast and inhibited adipocyte differentiation through the canonical Wnt/beta-catenin signalling pathway. The osteopenic phenotype in Sema3a(-/-) mice was recapitulated by mice in which the Sema3A-binding site of Nrp1 had been genetically disrupted. Intravenous Sema3A administration in mice increased bone volume and expedited bone regeneration. Thus, Sema3A is a promising new therapeutic agent in bone and joint diseases.	[Hayashi, Mikihito; Nakashima, Tomoki; Takayanagi, Hiroshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Tokyo 1138549, Japan; [Hayashi, Mikihito; Nakashima, Tomoki; Takayanagi, Hiroshi] Japan Sci & Technol Agcy, Exploratory Res Adv Technol Program, Takayanagi Osteonetwork Project, Bunkyo Ku, Tokyo 1138549, Japan; [Hayashi, Mikihito; Nakashima, Tomoki; Takayanagi, Hiroshi] Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Bunkyo Ku, Tokyo 1138549, Japan; [Taniguchi, Masahiko] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Mol Med Sci,Chuo Ku, Sapporo, Hokkaido 0608556, Japan; [Kodama, Tatsuhiko] Univ Tokyo, Dept Mol Biol & Med, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med,Meguro Ku, Tokyo 1538904, Japan; [Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med Allergy & Rheumat Dis, Suita, Osaka 5650871, Japan; [Kumanogoh, Atsushi] Osaka Univ, Immunol Frontier Res Ctr, Dept Immunopathol, Suita, Osaka 5650871, Japan; [Takayanagi, Hiroshi] Univ Western Australia, Sch Surg, Ctr Orthopaed Res, Nedlands, WA 6009, Australia	Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST); Sapporo Medical University; University of Tokyo; Osaka University; Osaka University; University of Western Australia	Takayanagi, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cell Signaling, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138549, Japan.	taka.csi@tmd.ac.jp			Japan Science and Technology Agency; Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology of Japan; Tokyo Biochemical Research Foundation; Life Science Foundation of Japan; Takeda Science Foundation; Uehara Memorial Foundation; Naito Foundation; BMKK RA; Astellas Foundation for Research on Metabolic Disorders	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Tokyo Biochemical Research Foundation; Life Science Foundation of Japan(Life Science Foundation of Japan); Takeda Science Foundation(Takeda Science Foundation (TSF)); Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); BMKK RA; Astellas Foundation for Research on Metabolic Disorders	We are grateful to D. D. Ginty and A. L. Kolodkin for providing the Nrp1<SUP>Serna-</SUP> knockin mice. We thank Y. Goshima for providing vectors and technical help. We thank A. Yamaguchi, H. Asahara and F. Suto for providing reagents and technical help. We also thank K. Okamoto, T. Negishi-Koga, K. Nishikawa, H. Inoue, T. Suda, T. Ando, Y. Kunisawa, Y. Ogihara and S. Fukuse for discussion and assistance. This work was supported in part by a grant for the Exploratory Research for Advanced Technology Program, the Takayanagi Osteonetwork Project from the Japan Science and Technology Agency; Grant-in-Aid for Young Scientist A from the Japan Society for the Promotion of Science (JSPS); a Grant-in-Aid for Challenging Exploratory Research from the JSPS; grants for the Global Center of Excellence Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and grants from the Tokyo Biochemical Research Foundation, the Life Science Foundation of Japan, Takeda Science Foundation, Uehara Memorial Foundation, Naito Foundation, BMKK RA Research Fund and Astellas Foundation for Research on Metabolic Disorders.	Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gomez C, 2005, DEV DYNAM, V234, P393, DOI 10.1002/dvdy.20512; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hayashi M, 2010, BIOCHEM BIOPH RES CO, V393, P432, DOI 10.1016/j.bbrc.2010.02.013; HAYDEN JM, 1995, BONE, V17, pS93, DOI 10.1016/8756-3282(95)00186-H; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Kaifu T, 2003, J CLIN INVEST, V111, P323, DOI 10.1172/JCI200316923; Kawai M, 2011, NAT REV DRUG DISCOV, V10, P141, DOI 10.1038/nrd3299; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lewiecki EM, 2011, NAT REV RHEUMATOL, V7, P631, DOI 10.1038/nrrheum.2011.130; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Mizuno A, 1998, BIOCHEM BIOPH RES CO, V247, P610, DOI 10.1006/bbrc.1998.8697; Nagashima M, 2005, BONE, V36, P502, DOI 10.1016/j.bone.2004.11.013; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Narazaki M, 2006, BLOOD, V107, P3892, DOI 10.1182/blood-2005-10-4113; Negishi-Koga T, 2011, NAT MED, V17, P1473, DOI 10.1038/nm.2489; Neufeld G, 2008, NAT REV CANCER, V8, P632, DOI 10.1038/nrc2404; Nishikawa K, 2010, J CLIN INVEST, V120, P3455, DOI 10.1172/JCI42528; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Rachner TD, 2011, LANCET, V377, P1276, DOI 10.1016/S0140-6736(10)62349-5; Reid IR, 2010, J BONE MINER RES, V25, P2256, DOI 10.1002/jbmr.149; Seeman E, 2006, NEW ENGL J MED, V354, P2250, DOI 10.1056/NEJMra053077; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Takegahara N, 2010, FASEB J, V24, P4782, DOI 10.1096/fj.10-158212; Takegahara N, 2006, NAT CELL BIOL, V8, P615, DOI 10.1038/ncb1416; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448	46	387	417	10	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					69	U96		10.1038/nature11000	http://dx.doi.org/10.1038/nature11000			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22522930				2022-12-24	WOS:000303451900035
J	Suzuki, G; Shimazu, N; Tanaka, M				Suzuki, Genjiro; Shimazu, Naoyuki; Tanaka, Motomasa			A Yeast Prion, Mod5, Promotes Acquired Drug Resistance and Cell Survival Under Environmental Stress	SCIENCE			English	Article							RNA-MODIFYING ENZYMES; SACCHAROMYCES-CEREVISIAE; GENETIC-VARIATION; PROTEIN; AGGREGATION; INHERITANCE; GENERATION; MECHANISM; TRAITS; VITRO	Prion conversion from a soluble protein to an aggregated state may be involved in the cellular adaptation of yeast to the environment. However, it remains unclear whether and how cells actively use prion conversion to acquire a fitness advantage in response to environmental stress. We identified Mod5, a yeast transfer RNA isopentenyltransferase lacking glutamine/asparagine-rich domains, as a yeast prion protein and found that its prion conversion in yeast regulated the sterol biosynthetic pathway for acquired cellular resistance against antifungal agents. Furthermore, selective pressure by antifungal drugs on yeast facilitated the de novo appearance of Mod5 prion states for cell survival. Thus, phenotypic changes caused by active prion conversion under environmental selection may contribute to cellular adaptation in living organisms.	[Suzuki, Genjiro; Shimazu, Naoyuki; Tanaka, Motomasa] RIKEN Brain Sci Inst, Lab Prot Conformat Dis, Wako, Saitama 3510198, Japan	RIKEN	Tanaka, M (corresponding author), RIKEN Brain Sci Inst, Lab Prot Conformat Dis, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	motomasa@brain.riken.jp	Tanaka, Motomasa/N-5064-2015	Tanaka, Motomasa/0000-0002-2994-7703	Japan Science and Technology Agency PRESTO; Ministry of Education, Culture, Sports, Science and Technology of Japan (Priority Area on Protein Society); Next Program; Sumitomo Foundation (Japan); Novartis Foundation (Japan) for the Promotion of Science	Japan Science and Technology Agency PRESTO(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan (Priority Area on Protein Society); Next Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation (Japan); Novartis Foundation (Japan) for the Promotion of Science(Novartis)	We thank J. Weissman (Univ. of California, San Francisco) for providing plasmids and yeast stains, C. Yokoyama for critical reading of the manuscript, Y. Komi and M. Yoshizawa for help with the construction of plasmids and yeast strains and drug-sensitivity assays, Y. Ohhashi for advice on structural analyses of amyloids, Y. Nekooki for providing huntingtin-exon1 Q62 protein, N. Takahashi for help with the screen for QIN, and Y. Sakamaki for transmission electron microscopy analysis. DNA sequencing and mass spectrometry were performed at the RIKEN Brain Science Institute Research Resources Center facility. Funding was provided by Japan Science and Technology Agency PRESTO; grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Priority Area on Protein Society); the Next Program; and the Sumitomo Foundation and the Novartis Foundation (Japan) for the Promotion of Science (M.T.).	Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Benko AL, 2000, P NATL ACAD SCI USA, V97, P61, DOI 10.1073/pnas.97.1.61; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; BREIVIK ON, 1957, J AGR FOOD CHEM, V5, P360, DOI 10.1021/jf60075a005; Chernoff Y, 2004, CURR OPIN CHEM BIOL, V8, P665, DOI 10.1016/j.cbpa.2004.09.002; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; DIHANICH ME, 1987, MOL CELL BIOL, V7, P177, DOI 10.1128/MCB.7.1.177; Du ZQ, 2008, NAT GENET, V40, P460, DOI 10.1038/ng.112; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gustavsson M, 2008, RNA, V14, P666, DOI 10.1261/rna.966208; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Kryndushkin DS, 2003, J BIOL CHEM, V278, P49636, DOI 10.1074/jbc.M307996200; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Nakayashiki T, 2005, P NATL ACAD SCI USA, V102, P10575, DOI 10.1073/pnas.0504882102; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Ness F, 2002, MOL CELL BIOL, V22, P5593, DOI 10.1128/MCB.22.15.5593-5605.2002; Olzscha H, 2011, CELL, V144, P67, DOI 10.1016/j.cell.2010.11.050; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Patel BK, 2009, NAT CELL BIOL, V11, P344, DOI 10.1038/ncb1843; Robbins N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002257; Suzuki T, 2007, METHOD ENZYMOL, V425, P211, DOI 10.1016/S0076-6876(07)25009-8; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; True HL, 2004, NATURE, V431, P184, DOI 10.1038/nature02885; TUITE MF, 1981, GENETICS, V98, P691; Tuite MF, 2010, NAT REV MOL CELL BIO, V11, P823, DOI 10.1038/nrm3007; Tyedmers J, 2008, PLOS BIOL, V6, P2605, DOI 10.1371/journal.pbio.0060294; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wickner RB, 2007, NAT REV MICROBIOL, V5, P611, DOI 10.1038/nrmicro1708	31	172	177	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					355	359		10.1126/science.1219491	http://dx.doi.org/10.1126/science.1219491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517861				2022-12-24	WOS:000302995400049
J	Zakharyevich, K; Tang, SM; Ma, YM; Hunter, N				Zakharyevich, Kseniya; Tang, Shangming; Ma, Yunmei; Hunter, Neil			Delineation of Joint Molecule Resolution Pathways in Meiosis Identifies a Crossover-Specific Resolvase	CELL			English	Article							DOUBLE-STRAND BREAK; HOLLIDAY JUNCTION RESOLUTION; STRUCTURE-SPECIFIC NUCLEASES; CROSSING-OVER; MEIOTIC RECOMBINATION; MISMATCH REPAIR; BLM HELICASE; KINASE CDC5; D-LOOPS; MUS81/MMS4 ENDONUCLEASE	At the final step of homologous recombination, Holliday junction-containing joint molecules (JMs) are resolved to form crossover or noncrossover products. The enzymes responsible for JM resolution in vivo remain uncertain, but three distinct endonucleases capable of resolving JMs in vitro have been identified: Mus81-Mms4(EME1), Slx1-Slx4(BTBD12), and Yen1(GEN1). Using physical monitoring of recombination during budding yeast meiosis, we show that all three endonucleases are capable of promoting JM resolution in vivo. However, in mms4 slx4 yen1 triple mutants, JM resolution and crossing over occur efficiently. Paradoxically, crossing over in this background is strongly dependent on the Blooms helicase ortholog Sgs1, a component of a well-characterized anticrossover activity. Sgs1-dependent crossing over, but not JM resolution per se, also requires XPG family nuclease Exo1 and the MutLg complex Mlh1-Mlh3. Thus, Sgs1, Exo1, and MutLg together define a previously undescribed meiotic JM resolution pathway that produces the majority of crossovers in budding yeast and, by inference, in mammals.	[Zakharyevich, Kseniya; Tang, Shangming; Ma, Yunmei; Hunter, Neil] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Zakharyevich, Kseniya; Hunter, Neil] Univ Calif Davis, Microbiol Grad Grp, Davis, CA 95616 USA; [Tang, Shangming; Hunter, Neil] Univ Calif Davis, Biochem Mol Cellular & Dev Biol Grad Grp, Davis, CA 95616 USA; [Ma, Yunmei; Hunter, Neil] Univ Calif Davis, Howard Hughes Med Inst, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Hunter, Neil] Univ Calif Davis, Dept Cell Biol & Human Anat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Howard Hughes Medical Institute; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hunter, N (corresponding author), Univ Calif Davis, Dept Microbiol, 1 Shields Ave, Davis, CA 95616 USA.	nhunter@ucdavis.edu			 [GM074223]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074223] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Thanks to Eric Alani for the mlh3-D523N::KanMX cassette, Chu-Chun Huang for help with tetrad analysis, Wolf Heyer for valuable input, and Arnaud Muyt and Michael Lichten for communication of unpublished data and stimulating discussions. This work was supported by grant GM074223. N.H. is an Early Career Scientist of the Howard Hughes Medical Institute.	Agmon N, 2011, NUCLEIC ACIDS RES, V39, P7009, DOI 10.1093/nar/gkr277; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Andersen SL, 2009, MOL CELL, V35, P128, DOI 10.1016/j.molcel.2009.06.019; Bachrati CZ, 2006, NUCLEIC ACIDS RES, V34, P2269, DOI 10.1093/nar/gkl258; BELL LR, 1982, COLD SPRING HARB SYM, V47, P829, DOI 10.1101/SQB.1983.047.01.095; Berchowitz LE, 2007, PLOS GENET, V3, P1355, DOI 10.1371/journal.pgen.0030132; Berchowitz LE, 2010, CURR GENOMICS, V11, P91, DOI 10.2174/138920210790886835; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Bzymek M, 2010, NATURE, V464, P937, DOI 10.1038/nature08868; Cejka P, 2010, NAT STRUCT MOL BIOL, V17, P1377, DOI 10.1038/nsmb.1919; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Cha RS, 2000, GENE DEV, V14, P493; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; Chu WK, 2009, NAT REV CANCER, V9, P644, DOI 10.1038/nrc2682; Clyne RK, 2003, NAT CELL BIOL, V5, P480, DOI 10.1038/ncb977; Cromie GA, 2008, GENETICS, V179, P1157, DOI 10.1534/genetics.108.088955; Cromie GA, 2006, CELL, V127, P1167, DOI 10.1016/j.cell.2006.09.050; de los Santos T, 2003, GENETICS, V164, P81; De Muyt A, 2012, MOL CELL, V46, P43, DOI 10.1016/j.molcel.2012.02.020; Dunin-Horkawicz S, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-98; Edelmann W, 1999, NAT GENET, V21, P123, DOI 10.1038/5075; Fricke WM, 2003, GENE DEV, V17, P1768, DOI 10.1101/gad.1105203; Furukawa T, 2003, PLANT MOL BIOL, V51, P59, DOI 10.1023/A:1020789314722; Gilbertson LA, 1996, GENETICS, V144, P27; Hickson ID, 2011, CELL CYCLE, V10, DOI 10.4161/cc.10.18.16919; Higgins JD, 2008, PLANT J, V55, P28, DOI 10.1111/j.1365-313X.2008.03470.x; Higgins JD, 2008, PLANT J, V54, P152, DOI 10.1111/j.1365-313X.2008.03403.x; Ho CK, 2010, MOL CELL, V40, P988, DOI 10.1016/j.molcel.2010.11.016; Holloway JK, 2010, J CELL BIOL, V188, P779, DOI 10.1083/jcb.200909048; Holloway JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000186; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N., 2006, MOL GENETICS RECOMBI, P381, DOI 10.1007/978-3-540-71021-9_14; Hunter N, 2011, CELL CYCLE, V10, P2607, DOI 10.4161/cc.10.16.16452; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ishikawa G, 2004, NUCLEIC ACIDS RES, V32, P6251, DOI 10.1093/nar/gkh962; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Keelagher RE, 2011, DNA REPAIR, V10, P126, DOI 10.1016/j.dnarep.2010.09.024; Kneitz B, 2000, GENE DEV, V14, P1085; Kolas NK, 2004, CYTOGENET GENOME RES, V107, P216, DOI 10.1159/000080600; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Lyndaker AM, 2009, BIOESSAYS, V31, P315, DOI 10.1002/bies.200800195; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Martini E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002305; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; Mcvey M, 2007, GENETICS, V176, P1979, DOI 10.1534/genetics.106.070052; Mimitou EP, 2009, TRENDS BIOCHEM SCI, V34, P264, DOI 10.1016/j.tibs.2009.01.010; Moens PB, 2002, J CELL SCI, V115, P1611; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Nishant KT, 2008, GENETICS, V179, P747, DOI 10.1534/genetics.108.086645; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Oh SD, 2009, METHODS MOL BIOL, V557, P209, DOI 10.1007/978-1-59745-527-5_14; Pluciennik A, 2010, P NATL ACAD SCI USA, V107, P16066, DOI 10.1073/pnas.1010662107; Prakash R, 2009, GENE DEV, V23, P67, DOI 10.1101/gad.1737809; Rass U, 2010, GENE DEV, V24, P1559, DOI 10.1101/gad.585310; Saito TT, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000735; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Schwartz EK, 2011, CHROMOSOMA, V120, P109, DOI 10.1007/s00412-010-0304-7; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Smith GR, 2003, GENETICS, V165, P2289; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Sourirajan A, 2008, GENE DEV, V22, P2627, DOI 10.1101/gad.1711408; Stahl FW, 2004, GENETICS, V168, P35, DOI 10.1534/genetics.104.027789; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Tay YD, 2010, J BIOL CHEM, V285, P11427, DOI 10.1074/jbc.M110.108399; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Xu DY, 2008, GENE DEV, V22, P2843, DOI 10.1101/gad.1708608; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Yildiz O, 2002, MOL CELL, V10, P1503, DOI 10.1016/S1097-2765(02)00782-7; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112; Zakharyevich K, 2010, MOL CELL, V40, P1001, DOI 10.1016/j.molcel.2010.11.032; Zalevsky J, 1999, GENETICS, V153, P1271; ZETKA MC, 1995, GENETICS, V141, P1339	82	192	196	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					334	347		10.1016/j.cell.2012.03.023	http://dx.doi.org/10.1016/j.cell.2012.03.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500800	Green Accepted, Bronze			2022-12-24	WOS:000302805600013
J	Castello, A; Fischer, B; Eichelbaum, K; Horos, R; Beckmann, BM; Strein, C; Davey, NE; Humphreys, DT; Preiss, T; Steinmetz, LM; Krijgsveld, J; Hentze, MW				Castello, Alfredo; Fischer, Bernd; Eichelbaum, Katrin; Horos, Rastislav; Beckmann, Benedikt M.; Strein, Claudia; Davey, Norman E.; Humphreys, David T.; Preiss, Thomas; Steinmetz, Lars M.; Krijgsveld, Jeroen; Hentze, Matthias W.			Insights into RNA Biology from an Atlas of Mammalian mRNA-Binding Proteins	CELL			English	Article							NUCLEIC-ACIDS; CROSS-LINKING; IRE-BP; CYCLOPHILIN; DEHYDROGENASE; EXPRESSION; IDENTIFICATION; INTERACTS; ACONITASE; DISORDER	RNA-binding proteins (RBPs) determine RNA fate from synthesis to decay. Employing two complementary protocols for covalent UV crosslinking of RBPs to RNA, we describe a systematic, unbiased, and comprehensive approach, termed "interactome capture,'' to define the mRNA interactome of proliferating human HeLa cells. We identify 860 proteins that qualify as RBPs by biochemical and statistical criteria, adding more than 300 RBPs to those previously known and shedding light on RBPs in disease, RNA-binding enzymes of intermediary metabolism, RNA-binding kinases, and RNA-binding architectures. Unexpectedly, we find that many proteins of the HeLa mRNA interactome are highly intrinsically disordered and enriched in short repetitive amino acid motifs. Interactome capture is broadly applicable to study mRNA interactome composition and dynamics in varied biological settings.	[Castello, Alfredo; Fischer, Bernd; Eichelbaum, Katrin; Horos, Rastislav; Beckmann, Benedikt M.; Strein, Claudia; Davey, Norman E.; Steinmetz, Lars M.; Krijgsveld, Jeroen; Hentze, Matthias W.] EMBL, D-69117 Heidelberg, Germany; [Humphreys, David T.; Preiss, Thomas; Hentze, Matthias W.] Victor Chang Cardiac Res Inst, Div Mol Genet, Sydney, NSW 2010, Australia; [Preiss, Thomas] Australian Natl Univ, John Curtin Sch Med Res, Genome Biol Dept, Canberra, ACT 0200, Australia	European Molecular Biology Laboratory (EMBL); Victor Chang Cardiac Research Institute; Australian National University; John Curtin School of Medical Research	Krijgsveld, J (corresponding author), EMBL, Meyerhofstr 1, D-69117 Heidelberg, Germany.	jeroen.krijgsveld@embl.de; hentze@embl.de	Fischer, Bernd/E-7461-2011; Palomares, Alfredo Castello/K-8062-2019; Castello, Alfredo/U-6317-2018; Hentze, Matthias W/V-3980-2017; Preiss, Thomas/F-7355-2010; Krijgsveld, Jeroen/F-5974-2011; Davey, Norman E/D-5362-2013	Fischer, Bernd/0000-0001-9437-2099; Palomares, Alfredo Castello/0000-0002-1499-4662; Castello, Alfredo/0000-0002-1499-4662; Hentze, Matthias W/0000-0002-4023-7876; Preiss, Thomas/0000-0001-6273-784X; Davey, Norman/0000-0001-6988-4850; Horos, Rastislav/0000-0001-7730-9557; Krijgsveld, Jeroen/0000-0001-7549-9326; Beckmann, Benedikt/0000-0001-7566-4408; Humphreys, David/0000-0003-4140-0089; Steinmetz, Lars/0000-0002-3962-2865	National Health and Medical Research Council [514904, 573731, 632757]; Australian Research Council [DP0878224]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank Drs. Toby Gibson, Teresa Carlomagno, Wolfgang Huber, and Maria Moreno (EMBL) for expert advice and helpful discussions, and we also thank Dr. Markus Landthaler (MCD, Berlin) for generously sharing his expertise on PAR-CL. We are grateful to Drs. Jan Ellenberg, Rainer Pepperkok (EMBL), Stefan Pusch, and Andreas von Deimling (Universitatsklinikum Heidelberg) for plasmids; Dr. Iain Mattaj (EMBL) for the rabbit GFP antibody; and Dr. Matthias Gromeier (Duke University Medical Center, Durham, USA) for the HeLa Flip-In TRex cell line. We acknowledge Alexis Perez and the EMBL Flow Cytometry Core Facility for FACS experiments and EMBL Gene Core Facility for support throughout this work. This work was supported by grants 514904, 573731, and 632757 from the National Health and Medical Research Council and was also supported by DP0878224 from the Australian Research Council awarded to T.P.A.C. is the beneficiary of a Marie Curie postdoctoral fellowship (FP7).	Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Phan AT, 2011, NAT STRUCT MOL BIOL, V18, P796, DOI 10.1038/nsmb.2064; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; BRIMACOMBE R, 1988, METHOD ENZYMOL, V164, P287; Brunner E, 2007, NAT BIOTECHNOL, V25, P576, DOI 10.1038/nbt1300; Butter F, 2009, P NATL ACAD SCI USA, V106, P10626, DOI 10.1073/pnas.0812099106; Ciesla J, 2006, ACTA BIOCHIM POL, V53, P11; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Darnell RB, 2010, CANCER RES TREAT, V42, P125, DOI 10.4143/crt.2010.42.3.125; DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; ELZINGA SDJ, 1993, NUCLEIC ACIDS RES, V21, P5328, DOI 10.1093/nar/21.23.5328; Elzinga SDJ, 2000, CURR GENET, V38, P87, DOI 10.1007/s002940000132; Foster TL, 2011, J VIROL, V85, P7460, DOI 10.1128/JVI.00393-11; Ghezzi D, 2008, AM J HUM GENET, V83, P415, DOI 10.1016/j.ajhg.2008.08.009; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; GREENBERG JR, 1979, NUCLEIC ACIDS RES, V6, P715, DOI 10.1093/nar/6.2.715; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hentze MW, 2010, TRENDS BIOCHEM SCI, V35, P423, DOI 10.1016/j.tibs.2010.05.009; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HENTZE MW, 1994, TRENDS BIOCHEM SCI, V19, P101, DOI 10.1016/0968-0004(94)90198-8; HENTZE MW, 1991, NUCLEIC ACIDS RES, V19, P1739, DOI 10.1093/nar/19.8.1739; HOCKENSMITH JW, 1986, J BIOL CHEM, V261, P3512; Hunt ME, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011517, 10.1371/journal.pone.0015499]; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kiri A, 2002, J MUSCLE RES CELL M, V23, P119, DOI 10.1023/A:1020211729728; Lau CK, 2009, NAT STRUCT MOL BIOL, V16, P486, DOI 10.1038/nsmb.1584; Lee I, 2004, TRENDS BIOCHEM SCI, V29, P567, DOI 10.1016/j.tibs.2004.09.005; Lessard L, 2010, BBA-PROTEINS PROTEOM, V1804, P613, DOI 10.1016/j.bbapap.2009.09.018; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Liu XW, 2001, BIOCHEMISTRY-US, V40, P4932, DOI 10.1021/bi002598t; Lukong KE, 2008, TRENDS GENET, V24, P416, DOI 10.1016/j.tig.2008.05.004; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; McBryant SJ, 2010, CELL RES, V20, P519, DOI 10.1038/cr.2010.35; Mesa A, 2008, FEBS LETT, V582, P2345, DOI 10.1016/j.febslet.2008.06.006; Mi HF, 1996, FEBS LETT, V398, P201, DOI 10.1016/S0014-5793(96)01248-3; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; NAKAGAWA J, 1995, P NATL ACAD SCI USA, V92, P2051, DOI 10.1073/pnas.92.6.2051; Niessing D, 2004, CELL, V119, P491, DOI 10.1016/j.cell.2004.10.018; Pan H, 2008, J BIOL CHEM, V283, P623, DOI 10.1074/jbc.M704934200; PASHEV IG, 1991, TRENDS BIOCHEM SCI, V16, P323, DOI 10.1016/0968-0004(91)90133-G; Pioli PA, 2002, J BIOL CHEM, V277, P35738, DOI 10.1074/jbc.M204002200; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Rammelt C, 2011, RNA, V17, P1737, DOI 10.1261/rna.2787011; Rothbauer U, 2008, MOL CELL PROTEOMICS, V7, P282, DOI 10.1074/mcp.M700342-MCP200; ROUAULT TA, 1991, CELL, V64, P881, DOI 10.1016/0092-8674(91)90312-M; Schrimpf SP, 2009, PLOS BIOL, V7, P616, DOI 10.1371/journal.pbio.1000048; Shetty S, 2004, AM J RESP CELL MOL, V31, P100, DOI 10.1165/rcmb.2003-0104OC; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stirnimann CU, 2010, TRENDS BIOCHEM SCI, V35, P565, DOI 10.1016/j.tibs.2010.04.003; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tsvetanova NG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012671; Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x; Vuzman D, 2012, MOL BIOSYST, V8, P47, DOI 10.1039/c1mb05273j; Vuzman D, 2010, P NATL ACAD SCI USA, V107, P21004, DOI 10.1073/pnas.1011775107; Vuzman D, 2010, J MOL BIOL, V396, P674, DOI 10.1016/j.jmb.2009.11.056; WETZEL R, 1977, NUCLEIC ACIDS RES, V4, P1681, DOI 10.1093/nar/4.5.1681; Yang XC, 2006, J BIOL CHEM, V281, P30447, DOI 10.1074/jbc.M602947200; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zeng L, 2001, CYTOGENET CELL GENET, V95, P43, DOI 10.1159/000057015	62	1301	1331	10	199	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1393	1406		10.1016/j.cell.2012.04.031	http://dx.doi.org/10.1016/j.cell.2012.04.031			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22658674	Bronze			2022-12-24	WOS:000305119600021
J	Kamada, N; Kim, YG; Sham, HP; Vallance, BA; Puente, JL; Martens, EC; Nunez, G				Kamada, Nobuhiko; Kim, Yun-Gi; Sham, Ho Pan; Vallance, Bruce A.; Puente, Jose L.; Martens, Eric C.; Nunez, Gabriel			Regulated Virulence Controls the Ability of a Pathogen to Compete with the Gut Microbiota	SCIENCE			English	Article							CITROBACTER-RODENTIUM; ENTEROCYTE EFFACEMENT; ESCHERICHIA-COLI; EFFACING PATHOGEN; INFECTION; LOCUS; CELLS; MODEL; MICE; LER	The virulence mechanisms that allow pathogens to colonize the intestine remain unclear. Here, we show that germ-free animals are unable to eradicate Citrobacter rodentium, a model for human infections with attaching and effacing bacteria. Early in infection, virulence genes were expressed and required for pathogen growth in conventionally raised mice but not germ-free mice. Virulence gene expression was down-regulated during the late phase of infection, which led to relocation of the pathogen to the intestinal lumen where it was outcompeted by commensals. The ability of commensals to outcompete C. rodentium was determined, at least in part, by the capacity of the pathogen and commensals to grow on structurally similar carbohydrates. Thus, pathogen colonization is controlled by bacterial virulence and through competition with metabolically related commensals.	[Kamada, Nobuhiko; Kim, Yun-Gi; Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Kamada, Nobuhiko; Kim, Yun-Gi; Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Sham, Ho Pan; Vallance, Bruce A.] Univ British Columbia, BC Childrens Hosp, Div Gastroenterol, Vancouver, BC V6H 3V4, Canada; [Puente, Jose L.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Mol Microbiol, Cuernavaca 62210, Morelos, Mexico; [Martens, Eric C.] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; BC Childrens Hospital; University of British Columbia; Universidad Nacional Autonoma de Mexico; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	bclx@umich.edu	Kamada, Nobuhiko/AAW-3299-2020; Nuñez, Gabriel/A-7160-2014	Kamada, Nobuhiko/0000-0002-1980-4178; Vallance, Bruce/0000-0003-1345-6747; Puente, Jose/0000-0002-8411-4974	University of Michigan Germ-Free Animal Core, Microscopy and Image Analysis Laboratory; Center for Molecular Imaging; NIH [DK61707, DK091191]; Consejo Nacional de Ciencia y Tecnologia, CONACyT; Canadian Institutes of Health Research; Uehara Memorial Foundation; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191, R01DK095782, R01DK061707] Funding Source: NIH RePORTER	University of Michigan Germ-Free Animal Core, Microscopy and Image Analysis Laboratory; Center for Molecular Imaging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Consejo Nacional de Ciencia y Tecnologia, CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Uehara Memorial Foundation(Uehara Memorial Foundation); Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the University of Michigan Germ-Free Animal Core, Microscopy and Image Analysis Laboratory, and the Center for Molecular Imaging for support; S. Koonse for animal husbandry; A. Huerta-Saquero for constructing the pler-lux plasmid; N. Pudlo for anaerobic bacteria culture; T. Stappenbeck for mouse commensal strains; J. Rousseau for technical assistance; and M. H. Shaw and G. Chen for expert review of the manuscript. B. A. V. is the Canada Research Chair (Tier 2) in Pediatric Gastroenterology and the CH. I. L. D. Foundation Chair in Pediatric Inflammatory Bowel Disease Research. This work was supported by grants from the NIH, grants DK61707 and DK091191 (G.N.); Consejo Nacional de Ciencia y Tecnologia, CONACyT (J.L.P.); Canadian Institutes of Health Research (B. A. V.); and the Uehara Memorial Foundation and Crohn's and Colitis Foundation of America Fellowship Awards (N.K). N.K. and G.N. hold U. S. provisional patent application no. 61/616,707 regarding inhibition of LEE virulence as a potential therapeutic for infection with AE pathogens. The data reported in this paper are tabulated in the main paper and in the supplementary materials.	Barba J, 2005, J BACTERIOL, V187, P7918, DOI 10.1128/JB.187.23.7918-7930.2005; Bergstrom KSB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000902; Bjarnason J, 2003, J BACTERIOL, V185, P4973, DOI 10.1128/JB.185.16.4973-4982.2003; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; Borenshtein D, 2008, CURR OPIN GASTROEN, V24, P32, DOI 10.1097/MOG.0b013e3282f2b0fb; Bry L, 2004, J IMMUNOL, V172, P433, DOI 10.4049/jimmunol.172.1.433; COOPER HS, 1993, LAB INVEST, V69, P238; Deng WY, 2004, P NATL ACAD SCI USA, V101, P3597, DOI 10.1073/pnas.0400326101; Deng WY, 2001, INFECT IMMUN, V69, P6323, DOI 10.1128/IAI.69.10.6323-6335.2001; Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Luperchio SA, 2000, J CLIN MICROBIOL, V38, P4343, DOI 10.1128/JCM.38.12.4343-4350.2000; Lupp C, 2007, CELL HOST MICROBE, V2, P204, DOI 10.1016/j.chom.2007.08.002; Maaser C, 2004, INFECT IMMUN, V72, P3315, DOI 10.1128/IAI.72.6.3315-3324.2004; Mellies JL, 1999, MOL MICROBIOL, V33, P296, DOI 10.1046/j.1365-2958.1999.01473.x; Mundy R, 2005, CELL MICROBIOL, V7, P1697, DOI 10.1111/j.1462-5822.2005.00625.x; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Simmons CP, 2003, INFECT IMMUN, V71, P5077, DOI 10.1128/IAI.71.9.5077-5086.2003	19	387	400	4	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 8	2012	336	6086					1325	1329		10.1126/science.1222195	http://dx.doi.org/10.1126/science.1222195			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953WV	22582016	Green Accepted			2022-12-24	WOS:000304905300052
J	Golzio, C; Willer, J; Talkowski, ME; Oh, EC; Taniguchi, Y; Jacquemont, S; Reymond, A; Sun, M; Sawa, A; Gusella, JF; Kamiya, A; Beckmann, JS; Katsanis, N				Golzio, Christelle; Willer, Jason; Talkowski, Michael E.; Oh, Edwin C.; Taniguchi, Yu; Jacquemont, Sebastien; Reymond, Alexandre; Sun, Mei; Sawa, Akira; Gusella, James F.; Kamiya, Atsushi; Beckmann, Jacques S.; Katsanis, Nicholas			KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant	NATURE			English	Article							TOOTH DISEASE TYPE-1A; MICRODELETION SYNDROME; CHROMOSOME 16P11.2; SYNDROME REGION; AUTISM; GENE; SCHIZOPHRENIA; DUPLICATIONS; ASSOCIATION; DELETIONS	Copy number variants (CNVs) are major contributors to genetic disorders(1). We have dissected a region of the 16p11.2 chromosome-which encompasses 29 genes-that confers susceptibility to neurocognitive defects when deleted or duplicated(2,3). Overexpression of each human transcript in zebrafish embryos identified KCTD13 as the sole message capable of inducing the microcephaly phenotype associated with the 16p11.2 duplication(2-5), whereas suppression of the same locus yielded the macrocephalic phenotype associated with the 16p11.2 deletion(5,6), capturing the mirror phenotypes of humans. Analyses of zebrafish and mouse embryos suggest that microcephaly is caused by decreased proliferation of neuronal progenitors with concomitant increase in apoptosis in the developing brain, whereas macrocephaly arises by increased proliferation and no changes in apoptosis. A role for KCTD13 dosage changes is consistent with autism in both a recently reported family with a reduced 16p11.2 deletion and a subject reported here with a complex 16p11.2 rearrangement involving de novo structural alteration of KCTD13. Our data suggest that KCTD13 is a major driver for the neurodevelopmental phenotypes associated with the 16p11.2 CNV, reinforce the idea that one or a small number of transcripts within a CNV can underpin clinical phenotypes, and offer an efficient route to identifying dosage-sensitive loci.	[Golzio, Christelle; Willer, Jason; Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA; [Golzio, Christelle; Willer, Jason; Oh, Edwin C.; Katsanis, Nicholas] Duke Univ, Dept Cell Biol, Durham, NC 27710 USA; [Talkowski, Michael E.; Sun, Mei; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; [Talkowski, Michael E.; Gusella, James F.] Harvard Univ, Sch Med, Dept Neurol & Genet, Boston, MA 02115 USA; [Taniguchi, Yu; Sawa, Akira; Kamiya, Atsushi] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21287 USA; [Jacquemont, Sebastien; Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Reymond, Alexandre] Univ Lausanne, Ctr Integrat Gen, CH-1015 Lausanne, Switzerland; [Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1005 Lausanne, Switzerland; [Katsanis, Nicholas] Duke Univ, Dept Pediat, Durham, NC 27710 USA	Duke University; Duke University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Lausanne; Duke University	Katsanis, N (corresponding author), Duke Univ, Ctr Human Dis Modeling, Durham, NC 27710 USA.	katsanis@cellbio.duke.edu	Jacquemont, Sebastien/AAS-5060-2021; Kutalik, Zoltan/HHZ-5697-2022; Katsanis, Nicholas/E-1837-2012; Beckmann, Jacques S/A-9772-2008; kamiya, atsushi/L-8550-2016	Jacquemont, Sebastien/0000-0001-6838-8767; Kutalik, Zoltan/0000-0001-8285-7523; Beckmann, Jacques S/0000-0002-9741-1900; kamiya, atsushi/0000-0002-4274-5567; Willer, Jason/0000-0002-5869-3992; Katsanis, Nicholas/0000-0002-2480-0171; Talkowski, Michael/0000-0003-2889-0992; Reymond, Alexandre/0000-0003-1030-8327; Golzio, Christelle/0000-0002-4420-3921	Silvo O. Conte center from the National Institute of Mental Health (NIMH), National Institutes of Health [MH-094268, MH-084018, MH-091230, HD06286]; Simon's Foundation; Autism Consortium of Boston; Leenaards Foundation; Swiss National Science Foundation; Swiss National Science Foundation Sinergia; NIMH National Research Service [F32MH087123]; bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne; NATIONAL INSTITUTE OF MENTAL HEALTH [P20MH084018, P50MH094268, R01MH091230, R01MH092443, F32MH087123] Funding Source: NIH RePORTER	Silvo O. Conte center from the National Institute of Mental Health (NIMH), National Institutes of Health; Simon's Foundation; Autism Consortium of Boston; Leenaards Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); NIMH National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Hanscom for technical assistance. We also thank J. Black, J. Whetstine, K. Brown and C. Lee for assistance with the initial and confirmatory array CGH experiments, S. Santagelo for analysis of clinical phenotype data, and M. State, M. Daley and R. Gibbs for sharing unpublished exome sequencing data. This work was supported by a Silvo O. Conte center grant (MH-094268) from the National Institute of Mental Health (NIMH), National Institutes of Health grant MH-084018 (A. S., A. K. and N.K.), grant MH-091230 (A. K.), grant HD06286 (J. F. G.), the Simon's Foundation, the Autism Consortium of Boston (J. F. G.), the Leenaards Foundation Prize (S. J. and A. R.), the Swiss National Science Foundation (A. R. and J. S. B.), a Swiss National Science Foundation Sinergia grant (S. J., J. S. B. and A. R.). M. E. T. was supported by an NIMH National Research Service Award (F32MH087123). S. J. is a recipient of a bourse de releve academique de la Faculte de Biologie et Medecine de l'Universite de Lausanne. N.K. is a Distinguished Brumley Professor.	Azizieh R, 2011, MOL NEUROBIOL, V44, P111, DOI 10.1007/s12035-011-8194-0; Baldini A, 2005, CURR OPIN GENET DEV, V15, P279, DOI 10.1016/j.gde.2005.03.001; Barge-Schaapveld DQCM, 2011, AM J MED GENET A, V155A, P1066, DOI 10.1002/ajmg.a.33991; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Ceol CJ, 2011, NATURE, V471, P513, DOI 10.1038/nature09806; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638; Crepel A, 2011, AM J MED GENET B, V156B, P243, DOI 10.1002/ajmg.b.31163; Crespi B, 2010, P NATL ACAD SCI USA, V107, P1736, DOI 10.1073/pnas.0906080106; Detrich HW, 1999, METHODS CELL BIOL, V59, P3, DOI 10.1016/S0091-679X(08)61816-6; He H, 2001, P NATL ACAD SCI USA, V98, P11979, DOI 10.1073/pnas.221452098; Horev G, 2011, P NATL ACAD SCI USA, V108, P17076, DOI 10.1073/pnas.1114042108; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lindsay EA, 2001, NATURE, V410, P97, DOI 10.1038/35065105; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shinawi M, 2010, J MED GENET, V47, P332, DOI 10.1136/jmg.2009.073015; Slager RE, 2003, NAT GENET, V33, P466, DOI 10.1038/ng1126; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; TAKEDA H, 1994, GENE DEV, V8, P45, DOI 10.1101/gad.8.1.45; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Walters RG, 2010, NATURE, V463, P671, DOI 10.1038/nature08727; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	31	266	274	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					363	U111		10.1038/nature11091	http://dx.doi.org/10.1038/nature11091			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596160	Green Accepted, Green Submitted			2022-12-24	WOS:000304099100041
J	Solt, LA; Wang, YJ; Banerjee, S; Hughes, T; Kojetin, DJ; Lundasen, T; Shin, Y; Liu, J; Cameron, MD; Noel, R; Yoo, SH; Takahashi, JS; Butler, AA; Kamenecka, TM; Burris, TP				Solt, Laura A.; Wang, Yongjun; Banerjee, Subhashis; Hughes, Travis; Kojetin, Douglas J.; Lundasen, Thomas; Shin, Youseung; Liu, Jin; Cameron, Michael D.; Noel, Romain; Yoo, Seung-Hee; Takahashi, Joseph S.; Butler, Andrew A.; Kamenecka, Theodore M.; Burris, Thomas P.			Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists	NATURE			English	Article							ORPHAN NUCLEAR RECEPTORS; ALPHA; CLOCK; HEME; COMPONENTS; LIGAND; BETA; IDENTIFICATION; TRANSCRIPTION; EXPRESSION	Synchronizing rhythms of behaviour and metabolic processes is important for cardiovascular health and preventing metabolic diseases. The nuclear receptors REV-ERB-alpha and REV-ERB-beta have an integral role in regulating the expression of core clock proteins driving rhythms in activity and metabolism. Here we describe the identification of potent synthetic REV-ERB agonists with in vivo activity. Administration of synthetic REV-ERB ligands alters circadian behaviour and the circadian pattern of core clock gene expression in the hypothalami of mice. The circadian pattern of expression of an array of metabolic genes in the liver, skeletal muscle and adipose tissue was also altered, resulting in increased energy expenditure. Treatment of diet-induced obese mice with a REV-ERB agonist decreased obesity by reducing fat mass and markedly improving dyslipidaemia and hyperglycaemia. These results indicate that synthetic REV-ERB ligands that pharmacologically target the circadian rhythm may be beneficial in the treatment of sleep disorders as well as metabolic diseases.	[Solt, Laura A.; Wang, Yongjun; Banerjee, Subhashis; Hughes, Travis; Kojetin, Douglas J.; Lundasen, Thomas; Liu, Jin; Burris, Thomas P.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Shin, Youseung; Cameron, Michael D.; Noel, Romain; Kamenecka, Theodore M.] Scripps Res Inst, Translat Res Inst, Jupiter, FL 33458 USA; [Yoo, Seung-Hee; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Yoo, Seung-Hee; Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Butler, Andrew A.] Scripps Res Inst, Dept Metab & Aging, Jupiter, FL 33458 USA; [Burris, Thomas P.] Scripps Res Inst, Ctr Diabet & Metab Dis, Jupiter, FL 33458 USA	Scripps Research Institute; Scripps Research Institute; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Scripps Research Institute; Scripps Research Institute	Burris, TP (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA.	tburris@scripps.edu	NOEL, Romain/AAR-2564-2021; Burris, Thomas P/B-3886-2016; Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Burris, Thomas P/0000-0003-2922-4449; Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Hughes, Travis/0000-0002-5764-5884; Butler, Andrew/0000-0001-7196-0170; Cameron, Michael/0000-0003-3154-4775	National Institutes of Health [DK080201, MH092769, DK089984]; Howard Hughes Medical Institute; individual National Research Service Award [DK088499]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080201, R24DK089984, R01DK073189, F32DK088499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH093429, R01MH092769] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); individual National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grants (DK080201, MH092769 and DK089984) and the Howard Hughes Medical Institute. L. A. S. is the recipient of an individual National Research Service Award (DK088499).	Asher G, 2011, CELL METAB, V13, P125, DOI 10.1016/j.cmet.2011.01.006; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Bray MS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.R110.214643; Burris TP, 2008, MOL ENDOCRINOL, V22, P1509, DOI 10.1210/me.2007-0519; Busby SA, 2011, ACS CHEM BIOL, V6, P618, DOI 10.1021/cb100396s; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Duez H, 2009, J APPL PHYSIOL, V107, P1972, DOI 10.1152/japplphysiol.00570.2009; Gimble JM, 2011, NAT REV ENDOCRINOL, V7, P98, DOI 10.1038/nrendo.2010.214; Grant D, 2010, ACS CHEM BIOL, V5, P925, DOI 10.1021/cb100141y; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Kumar N, 2010, MOL PHARMACOL, V77, P228, DOI 10.1124/mol.109.060905; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Meng QJ, 2008, J CELL SCI, V121, P3629, DOI 10.1242/jcs.035048; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Wang J, 2006, J BIOL CHEM, V281, P33842, DOI 10.1074/jbc.M607873200; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin Lei, 2010, Nucl Recept Signal, V8, pe001, DOI 10.1621/nrs.08001; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	28	484	508	10	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					62	68		10.1038/nature11030	http://dx.doi.org/10.1038/nature11030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22460951	Green Accepted			2022-12-24	WOS:000303451900034
J	Whitehorn, PR; O'Connor, S; Wackers, FL; Goulson, D				Whitehorn, Penelope R.; O'Connor, Stephanie; Wackers, Felix L.; Goulson, Dave			Neonicotinoid Pesticide Reduces Bumble Bee Colony Growth and Queen Production	SCIENCE			English	Article							BOMBUS-TERRESTRIS HYMENOPTERA; APIS-MELLIFERA; LANDSCAPE-SCALE; NEST DENSITY; APIDAE; INSECTICIDES; POLLINATION; SUNFLOWER; HAZARDS; CROPS	Growing evidence for declines in bee populations has caused great concern because of the valuable ecosystem services they provide. Neonicotinoid insecticides have been implicated in these declines because they occur at trace levels in the nectar and pollen of crop plants. We exposed colonies of the bumble bee Bombus terrestris in the laboratory to field-realistic levels of the neonicotinoid imidacloprid, then allowed them to develop naturally under field conditions. Treated colonies had a significantly reduced growth rate and suffered an 85% reduction in production of new queens compared with control colonies. Given the scale of use of neonicotinoids, we suggest that they may be having a considerable negative impact on wild bumble bee populations across the developed world.	[Whitehorn, Penelope R.; O'Connor, Stephanie; Goulson, Dave] Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland; [Wackers, Felix L.] Univ Lancaster, Lancaster Environm Ctr LEC, Lancaster LA1 4YQ, England	University of Stirling; Lancaster University	Goulson, D (corresponding author), Univ Stirling, Sch Nat Sci, Stirling FK9 4LA, Scotland.	dave.goulson@stir.ac.uk	Serrano, Jose/A-2854-2009; Goulson, David/A-2462-2010	Serrano, Jose/0000-0002-1565-5216; Goulson, David/0000-0003-4421-2876; Whitehorn, Penelope/0000-0001-9852-1012				Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Brittain C, 2011, BASIC APPL ECOL, V12, P321, DOI 10.1016/j.baae.2010.12.004; Cresswell JE, 2011, ECOTOXICOLOGY, V20, P149, DOI 10.1007/s10646-010-0566-0; Diekotter T, 2010, J APPL ECOL, V47, P209, DOI 10.1111/j.1365-2664.2009.01759.x; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; FELL RD, 1986, J KANSAS ENTOMOL SOC, V59, P72; Gels JA, 2002, J ECON ENTOMOL, V95, P722, DOI 10.1603/0022-0493-95.4.722; Goulson D, 2010, J APPL ECOL, V47, P1207, DOI 10.1111/j.1365-2664.2010.01872.x; Hayter KE, 2006, J APPL ECOL, V43, P1196, DOI 10.1111/j.1365-2664.2006.01219.x; Knight ME, 2005, MOL ECOL, V14, P1811, DOI 10.1111/j.1365-294X.2005.02540.x; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Mommaerts V, 2010, ECOTOXICOLOGY, V19, P207, DOI 10.1007/s10646-009-0406-2; Morandin LA, 2003, ENVIRON ENTOMOL, V32, P555, DOI 10.1603/0046-225X-32.3.555; MULLER CB, 1992, ECOL ENTOMOL, V17, P343, DOI 10.1111/j.1365-2311.1992.tb01068.x; Osborne JL, 2008, J ANIM ECOL, V77, P406, DOI 10.1111/j.1365-2656.2007.01333.x; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Tasei JN, 2000, PEST MANAG SCI, V56, P784, DOI 10.1002/1526-4998(200009)56:9<784::AID-PS208>3.0.CO;2-T; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623	20	785	830	27	1137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 20	2012	336	6079					351	352		10.1126/science.1215025	http://dx.doi.org/10.1126/science.1215025			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22461500				2022-12-24	WOS:000302995400047
J	Smith, ZD; Chan, MM; Mikkelsen, TS; Gu, HC; Gnirke, A; Regev, A; Meissner, A				Smith, Zachary D.; Chan, Michelle M.; Mikkelsen, Tarjei S.; Gu, Hongcang; Gnirke, Andreas; Regev, Aviv; Meissner, Alexander			A unique regulatory phase of DNA methylation in the early mammalian embryo	NATURE			English	Article							NON-CPG METHYLATION; GENE-EXPRESSION; PATERNAL GENOME; MOUSE EMBRYO; WIDE; 5-HYDROXYMETHYLCYTOSINE; DEMETHYLATION; CELLS; PLURIPOTENT; PATTERNS	DNA methylation is highly dynamic during mammalian embryogenesis. It is broadly accepted that the paternal genome is actively depleted of 5-methylcytosine at fertilization, followed by passive loss that reaches a minimum at the blastocyst stage. However, this model is based on limited data, and so far no base-resolution maps exist to support and refine it. Here we generate genome-scale DNA methylation maps in mouse gametes and from the zygote through post-implantation. We find that the oocyte already exhibits global hypomethylation, particularly at specific families of long interspersed element 1 and long terminal repeat retroelements, which are disparately methylated between gametes and have lower methylation values in the zygote than in sperm. Surprisingly, the oocyte contributes a unique set of differentially methylated regions (DMRs)-including many CpG island promoters-that are maintained in the early embryo but are lost upon specification and absent from somatic cells. In contrast, sperm-contributed DMRs are largely intergenic and become hypermethylated after the blastocyst stage. Our data provide a genome-scale, base-resolution timeline of DNA methylation in the pre-specified embryo, when this epigenetic modification is most dynamic, before returning to the canonical somatic pattern.	[Smith, Zachary D.; Chan, Michelle M.; Mikkelsen, Tarjei S.; Gu, Hongcang; Gnirke, Andreas; Regev, Aviv; Meissner, Alexander] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Smith, Zachary D.; Mikkelsen, Tarjei S.; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Smith, Zachary D.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Chan, Michelle M.] MIT, Computat & Syst Biol Program, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Meissner, A (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu	Mikkelsen, Tarjei S/A-1306-2007	Mikkelsen, Tarjei S/0000-0002-8133-3135; Gu, Hongcang/0000-0002-1439-7606	NIH [5DP1OD003958, 5RC1AA019317, U01ES017155, P01GM099117]; HHMI; Harvard Stem Cell Institute; Massachusetts Life Science Center; Pew Charitable Trusts; Center for Excellence in Genome Science from the NHGRI [1P50HG006193-01]; Burroughs Wellcome Career Award at the Scientific Interface; NATIONAL CANCER INSTITUTE [DP1CA174427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG006193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099117] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC1AA019317] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003958] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Harvard Stem Cell Institute; Massachusetts Life Science Center; Pew Charitable Trusts; Center for Excellence in Genome Science from the NHGRI; Burroughs Wellcome Career Award at the Scientific Interface(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank all members of the Meissner and Regev laboratories. M. Garber, N. Yosef, J. Ye, R. Koche, C. Bock, R. Maehr and D. Egli for technical advice and discussion. We thank all members of the Broad Sequencing Platform, in particular F. Kelly and J. Meldrim, T. Fennel, K. Tibbetts and J. Fostel. We also thank S. Levine, M. Gravina and K. Thai from the MIT BioMicro Center. A.R. is an investigator of the Merkin Foundation for Stem Cell Research at the Broad Institute. This work was supported by the NIH Pioneer Award (5DP1OD003958), the Burroughs Wellcome Career Award at the Scientific Interface and HHMI (to A.R.), the Harvard Stem Cell Institute (to T.S.M.) and the NIH (5RC1AA019317, U01ES017155 and P01GM099117), the Massachusetts Life Science Center and the Pew Charitable Trusts (to A.M.) and a Center for Excellence in Genome Science from the NHGRI (1P50HG006193-01, to A.R. and A.M.).	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Beraldi R, 2006, MOL REPROD DEV, V73, P279, DOI 10.1002/mrd.20423; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Branco MR, 2012, NAT REV GENET, V13, P7, DOI 10.1038/nrg3080; Davis T, 2011, JOVE-J VIS EXP, DOI 10.3791/2661; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Goodier JL, 2001, GENOME RES, V11, P1677, DOI 10.1101/gr.198301; Gu HC, 2011, NAT PROTOC, V6, P468, DOI 10.1038/nprot.2010.190; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Haines TR, 2001, DEV BIOL, V240, P585, DOI 10.1006/dbio.2001.0504; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Harris RA, 2010, NAT BIOTECHNOL, V28, P1097, DOI 10.1038/nbt.1682; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Ichiyanagi K, 2011, GENOME RES, V21, P2058, DOI 10.1101/gr.123679.111; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kigami D, 2003, BIOL REPROD, V68, P651, DOI 10.1095/biolreprod.102.007906; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lucifero D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-36; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; MONK M, 1987, DEVELOPMENT, V99, P371; Nagy A., 2003, MANIPULATING MOUSE E; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; RAZIN A, 1995, HUM MOL GENET, V4, P1751, DOI 10.1093/hmg/4.suppl_1.1751; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rougier N, 1998, GENE DEV, V12, P2108, DOI 10.1101/gad.12.14.2108; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Smallwood SA, 2011, NAT GENET, V43, P811, DOI 10.1038/ng.864; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Tomizawa S, 2011, DEVELOPMENT, V138, P811, DOI 10.1242/dev.061416; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wossidlo M, 2010, EMBO J, V29, P1877, DOI 10.1038/emboj.2010.80; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Ziller MJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002389	55	693	719	7	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					339	U74		10.1038/nature10960	http://dx.doi.org/10.1038/nature10960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22456710	Green Accepted, Green Submitted			2022-12-24	WOS:000302946500025
J	Lindenauer, PK; Lagu, T; Shieh, MS; Pekow, PS; Rothberg, MB				Lindenauer, Peter K.; Lagu, Tara; Shieh, Meng-Shiou; Pekow, Penelope S.; Rothberg, Michael B.			Association of Diagnostic Coding With Trends in Hospitalizations and Mortality of Patients With Pneumonia, 2003-2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEVERE SEPSIS; PERFORMANCE-MEASURES; UNITED-STATES; OUTCOMES; CARE; GUIDELINES; MANAGEMENT; OLDER	Context Recent reports suggest that the mortality rate of patients hospitalized with pneumonia has steadily declined. While this may be the result of advances in clinical care or improvements in quality, it may also represent an artifact of changes in diagnostic coding. Objective To compare estimates of trends in hospitalizations and inpatient mortality among patients with pneumonia using 2 approaches to case definition: one limited to patients with a principal diagnosis of pneumonia, and another that includes patients with a secondary diagnosis of pneumonia if the principal diagnosis is sepsis or respiratory failure. Design, Setting, and Participants Trends study using data from the 2003-2009 releases of the Nationwide Inpatient Sample. Main Outcome Measures Change in the annual hospitalization rate and change in inpatient mortality over time. Results From 2003 to 2009, the annual hospitalization rate for patients with a principal diagnosis of pneumonia declined 27.4%, from 5.5 to 4.0 per 1000, while the age-and sex-adjusted mortality decreased from 5.8% to 4.2% (absolute risk reduction [ARR], 1.6%; 95% CI, 1.4%-1.9%; relative risk reduction [RRR], 28.2%; 95% CI, 25.2%-31.2%). Over the same period, hospitalization rates of patients with a principal diagnosis of sepsis and a secondary diagnosis of pneumonia increased 177.6% from 0.4 to 1.1 per 1000, while inpatient mortality decreased from 25.1% to 22.2% (ARR, 3.0%; 95% CI, 1.6%-4.4%; RRR, 12%; 95% CI, 7.5%-16.1%); hospitalization rates for patients with a principal diagnosis of respiratory failure and a secondary diagnosis of pneumonia increased 9.3% from 0.44 to 0.48 per 1000 and mortality declined from 25.1% to 19.2% (ARR, 6.0%; 95% CI, 4.6%-7.3%; RRR, 23.7%; 95% CI, 19.7%-27.8%). However, when the 3 groups were combined, the hospitalization rate declined only 12.5%, from 6.3 to 5.6 per 1000, while the age-and sex-adjusted inpatient mortality rate increased from 8.3% to 8.8% (AR increase, 0.5%; 95% CI, 0.1%-0.9%; RR increase, 6.0%; 95% CI, 3.3%-8.8%). Over this same time frame, the age-, sex-, and comorbidity-adjusted mortality rate declined from 8.3% to 7.8% (ARR, 0.5%; 95% CI, 0.2%-0.9%; RRR, 6.3%; 95% CI, 3.8%-8.8%). Conclusions From 2003 to 2009, hospitalization and inpatient mortality rates for patients with a principal diagnosis of pneumonia decreased substantially, whereas hospitalizations with a principal diagnosis of sepsis or respiratory failure accompanied by a secondary diagnosis of pneumonia increased and mortality declined. However, when the 3 pneumonia diagnoses were combined, the decline in the hospitalization rate was attenuated and inpatient mortality was little changed, suggesting an association of these results with temporal trends in diagnostic coding. JAMA. 2012;307(13):1405-1413	[Lindenauer, Peter K.; Lagu, Tara; Shieh, Meng-Shiou; Pekow, Penelope S.; Rothberg, Michael B.] Baystate Med Ctr, Ctr Qual Care Res, Springfield, MA 01199 USA; [Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.] Baystate Med Ctr, Div Gen Med & Geriatr, Springfield, MA 01199 USA; [Lindenauer, Peter K.; Lagu, Tara; Rothberg, Michael B.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Pekow, Penelope S.] Univ Massachusetts, Dept Publ Hlth, Div Biostat & Epidemiol, Amherst, MA 01003 USA	Baystate Medical Center; Baystate Medical Center; Tufts University; Massachusetts Department of Public Health; University of Massachusetts System; University of Massachusetts Amherst	Lindenauer, PK (corresponding author), Baystate Med Ctr, Ctr Qual Care Res, 280 Chestnut St,3rd Floor, Springfield, MA 01199 USA.	peter.lindenauer@bhs.org	Lagu, Tara/GPT-5173-2022	Lagu, Tara/0000-0001-6155-5796				[Anonymous], 2007, ICD 9 CM COD GUID PU; [Anonymous], 2007, ICD 9 CM COD GUID SE; [Anonymous], 2007, ICD 9 CM COD GUID PN; Baker DW, 2002, MED CARE, V40, P879, DOI 10.1097/00005650-200210000-00006; Bratzler DW, 2008, CLIN INFECT DIS, V47, pS193, DOI 10.1086/591404; Bratzler DW, 2007, CURR OPIN INFECT DIS, V20, P182, DOI 10.1097/QCO.0b013e3280495468; Bratzler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017401; Centers for Medicare and Medicaid Services, PREM HOSP QUAL INC D; Dellinger RP, 2004, CRIT CARE MED, V32, P858, DOI 10.1097/01.CCM.0000117317.18092.E4; Dellinger RP, 2004, CRIT CARE MED, V32, P1448; Drye EE, 2012, ANN INTERN MED, V156, P19, DOI 10.7326/0003-4819-156-1-201201030-00004; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; FastStats, FASTSTATS PNEUM; FEINSTEIN AR, 1985, NEW ENGL J MED, V312, P1604, DOI 10.1056/NEJM198506203122504; Fry AM, 2005, JAMA-J AM MED ASSOC, V294, P2712, DOI 10.1001/jama.294.21.2712; Healthcare Cost and Utilization Project, OV NAT IMP SAMPL; Kumar G, 2011, CHEST, V140, P1223, DOI 10.1378/chest.11-0352; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Lindenauer Peter K, 2010, J Hosp Med, V5, pE12, DOI 10.1002/jhm.822; Meehan TP, 2001, AM J MED, V111, P203, DOI 10.1016/S0002-9343(01)00803-8; Metersky ML, 2000, ARCH INTERN MED, V160, P3385, DOI 10.1001/archinte.160.22.3385; NIEDERMAN MS, 1993, AM REV RESPIR DIS, V148, P1418, DOI 10.1164/ajrccm/148.5.1418; Rothberg MB, 2010, HEALTH AFFAIR, V29, P1523, DOI 10.1377/hlthaff.2009.0287; Ruhnke GW, 2011, AM J MED, V124, P171, DOI 10.1016/j.amjmed.2010.08.019; The Joint Commission, IMPR AM HOSP JOINT C; The Joint Commission, FACTS ORYX HOSP NAT; Venditti M, 2009, ANN INTERN MED, V150, P19, DOI 10.7326/0003-4819-150-1-200901060-00005; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Whittle J, 1997, Am J Med Qual, V12, P187, DOI 10.1177/0885713X9701200404; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778; Yealy DM, 2005, ANN INTERN MED, V143, P881, DOI 10.7326/0003-4819-143-12-200512200-00006; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	35	228	230	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 4	2012	307	13					1405	1413		10.1001/jama.2012.384	http://dx.doi.org/10.1001/jama.2012.384			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	919AY	22474204	Bronze			2022-12-24	WOS:000302294200027
J	Boutet, S; Lomb, L; Williams, GJ; Barends, TRM; Aquila, A; Doak, RB; Weierstall, U; DePonte, DP; Steinbrener, J; Shoeman, RL; Messerschmidt, M; Barty, A; White, TA; Kassemeyer, S; Kirian, RA; Seibert, MM; Montanez, PA; Kenney, C; Herbst, R; Hart, P; Pines, J; Haller, G; Gruner, SM; Philipp, HT; Tate, MW; Hromalik, M; Koerner, LJ; van Bakel, N; Morse, J; Ghonsalves, W; Arnlund, D; Bogan, MJ; Caleman, C; Fromme, R; Hampton, CY; Hunter, MS; Johansson, LC; Katona, G; Kupitz, C; Liang, MN; Martin, AV; Nass, K; Redecke, L; Stellato, F; Timneanu, N; Wang, DJ; Zatsepin, NA; Schafer, D; Defever, J; Neutze, R; Fromme, P; Spence, JCH; Chapman, HN; Schlichting, I				Boutet, Sebastien; Lomb, Lukas; Williams, Garth J.; Barends, Thomas R. M.; Aquila, Andrew; Doak, R. Bruce; Weierstall, Uwe; DePonte, Daniel P.; Steinbrener, Jan; Shoeman, Robert L.; Messerschmidt, Marc; Barty, Anton; White, Thomas A.; Kassemeyer, Stephan; Kirian, Richard A.; Seibert, M. Marvin; Montanez, Paul A.; Kenney, Chris; Herbst, Ryan; Hart, Philip; Pines, Jack; Haller, Gunther; Gruner, Sol M.; Philipp, Hugh T.; Tate, Mark W.; Hromalik, Marianne; Koerner, Lucas J.; van Bakel, Niels; Morse, John; Ghonsalves, Wilfred; Arnlund, David; Bogan, Michael J.; Caleman, Carl; Fromme, Raimund; Hampton, Christina Y.; Hunter, Mark S.; Johansson, Linda C.; Katona, Gergely; Kupitz, Christopher; Liang, Mengning; Martin, Andrew V.; Nass, Karol; Redecke, Lars; Stellato, Francesco; Timneanu, Nicusor; Wang, Dingjie; Zatsepin, Nadia A.; Schafer, Donald; Defever, James; Neutze, Richard; Fromme, Petra; Spence, John C. H.; Chapman, Henry N.; Schlichting, Ilme			High-Resolution Protein Structure Determination by Serial Femtosecond Crystallography	SCIENCE			English	Article							DIFFRACTION DATA; LYSOZYME	Structure determination of proteins and other macromolecules has historically required the growth of high-quality crystals sufficiently large to diffract x-rays efficiently while withstanding radiation damage. We applied serial femtosecond crystallography (SFX) using an x-ray free-electron laser (XFEL) to obtain high-resolution structural information from microcrystals (less than 1 micrometer by 1 micrometer by 3 micrometers) of the well-characterized model protein lysozyme. The agreement with synchrotron data demonstrates the immediate relevance of SFX for analyzing the structure of the large group of difficult-to-crystallize molecules.	[Boutet, Sebastien; Bogan, Michael J.; Hampton, Christina Y.] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Lomb, Lukas; Barends, Thomas R. M.; Steinbrener, Jan; Shoeman, Robert L.; Kassemeyer, Stephan; Schlichting, Ilme] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Lomb, Lukas; Barends, Thomas R. M.; Steinbrener, Jan; Shoeman, Robert L.; Kassemeyer, Stephan; Schlichting, Ilme] Ctr Free Electron Laser Sci, Max Planck Adv Study Grp, D-22607 Hamburg, Germany; [Aquila, Andrew; DePonte, Daniel P.; Barty, Anton; White, Thomas A.; Caleman, Carl; Liang, Mengning; Martin, Andrew V.; Stellato, Francesco; Chapman, Henry N.] Deutsch Elektronen Synchrotron DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Doak, R. Bruce; Weierstall, Uwe; Kirian, Richard A.; Wang, Dingjie; Zatsepin, Nadia A.; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Gruner, Sol M.; Philipp, Hugh T.; Tate, Mark W.] Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Gruner, Sol M.] Cornell Univ, Cornell High Energy Synchrotron Source, Wilson Lab, Ithaca, NY 14853 USA; [Hromalik, Marianne] SUNY Coll Oswego, Oswego, NY 13126 USA; [Koerner, Lucas J.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [van Bakel, Niels] Natl Inst Subatom Phys, Nikhef, NL-1098 XG Amsterdam, Netherlands; [Morse, John] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Arnlund, David; Johansson, Linda C.; Katona, Gergely; Neutze, Richard] Univ Gothenburg, Dept Chem & Mol Biol, SE-40530 Gothenburg, Sweden; [Fromme, Raimund; Hunter, Mark S.; Kupitz, Christopher; Fromme, Petra] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Redecke, Lars] Univ Hamburg, Inst Biochem & Mol Biol, Joint Lab Struct Biol Infect & Inflammat, D-22761 Hamburg, Germany; [Redecke, Lars] Univ Lubeck, Inst Biochem, DESY, Hamburg, Germany; [Redecke, Lars] Univ Lubeck, German Ctr Infect Res, D-23538 Lubeck, Germany; [Timneanu, Nicusor] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Max Planck Society; Max Planck Society; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Arizona State University; Arizona State University-Tempe; Cornell University; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) - Oswego; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; FOM National Institute for Subatomic Physics; European Synchrotron Radiation Facility (ESRF); University of Gothenburg; Arizona State University; Arizona State University-Tempe; University of Hamburg; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Lubeck; German Center for Infection Research; University of Lubeck; Uppsala University	Boutet, S (corresponding author), SLAC Natl Accelerator Lab, PULSE Inst, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	sboutet@slac.stanford.edu	Bogan, Mike/I-6962-2012; Neutze, Richard/A-7573-2010; Gruner, Sol/G-2924-2010; Kirian, Richard/M-3750-2013; Nass, Karol/K-1970-2012; Williams, Garth/H-1606-2012; Johansson, Linda/B-1240-2011; Katona, Gergely/B-3491-2008; Stellato, Francesco/AAZ-4379-2020; Redecke, Lars/A-5611-2013; Arnlund, David/B-1246-2011; van Bakel, Niels/B-6233-2015; Fromme, Raimund/W-5838-2019; Johansson, Linda/O-6893-2019; Messerschmidt, Marc/F-3796-2010; Fromme, Raimund/AAG-6578-2019; Timneanu, Nicusor/C-7691-2012; Zatsepin, Nadia/AAF-2451-2019; Messerschmidt, Marc/Y-8929-2019; FRS, Henry N Chapman/G-2153-2010; Fromme, Raimund/C-8885-2012; Schlichting, Ilme/I-1339-2013; Barty, Anton/K-5137-2014	Bogan, Mike/0000-0001-9318-3333; Neutze, Richard/0000-0003-0986-6153; Gruner, Sol/0000-0002-1171-4426; Nass, Karol/0000-0001-8843-1566; Johansson, Linda/0000-0003-4776-5142; Katona, Gergely/0000-0002-2031-8716; van Bakel, Niels/0000-0002-4053-7588; Fromme, Raimund/0000-0003-4835-1080; Johansson, Linda/0000-0003-4776-5142; Messerschmidt, Marc/0000-0002-8641-3302; Timneanu, Nicusor/0000-0001-7328-0400; Messerschmidt, Marc/0000-0002-8641-3302; FRS, Henry N Chapman/0000-0002-4655-1743; Fromme, Raimund/0000-0003-4835-1080; Barty, Anton/0000-0003-4751-2727; Kirian, Richard/0000-0001-7197-3086; Seibert, Mark Marvin/0000-0003-0251-0744; Koerner, Lucas/0000-0002-7236-7202; Zatsepin, Nadia/0000-0003-1757-0205; White, Thomas/0000-0002-8407-0270; MARTIN, ANDREW/0000-0003-3704-1829; Johansson, Linda/0000-0002-8931-0683; Aquila, Andrew/0000-0003-0358-2774	LCLS Ultrafast Science Instruments (LUSI) project; DOE, OBES; Max Planck Society; Hamburg Ministry of Science and Research; Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics in Infection; U.S. NSF [0417142, MCB-1021557]; NIH [1R01GM095583]; German Federal Ministry for Education and Research [01KX0806, 01KX0807]; Deutsche Forschungsgemeinschaft Cluster of Excellence [EXC 306]; AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the OBES, Office of Science, U.S. DOE; Swedish Research Council; Swedish Foundation for International Cooperation in Research and Higher Education; Direct For Biological Sciences [1120997, 1021557] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583] Funding Source: NIH RePORTER	LCLS Ultrafast Science Instruments (LUSI) project; DOE, OBES(United States Department of Energy (DOE)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Hamburg Ministry of Science and Research; Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics in Infection; U.S. NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry for Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft Cluster of Excellence(German Research Foundation (DFG)); AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the OBES, Office of Science, U.S. DOE(United States Department of Energy (DOE)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Portions of this research were carried out at the LCLS, a National User Facility operated by Stanford University on behalf of the U.S. Department of Energy (DOE), Office of Basic Energy Sciences (OBES) and at the Swiss Light Source, beamline X10SA, Paul Scherrer Institute, Villigen, Switzerland. The CXI instrument was funded by the LCLS Ultrafast Science Instruments (LUSI) project funded by DOE, OBES. We acknowledge support from the Max Planck Society, the Hamburg Ministry of Science and Research, and the Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); the Hamburg School for Structure and Dynamics in Infection; the U.S. NSF (awards 0417142 and MCB-1021557); the NIH (award 1R01GM095583); the German Federal Ministry for Education and Research (grants 01KX0806 and 01KX0807); the Deutsche Forschungsgemeinschaft Cluster of Excellence EXC 306; AMOS program within the Chemical Sciences, Geosciences, and Biosciences Division of the OBES, Office of Science, U.S. DOE; the Swedish Research Council; the Swedish Foundation for International Cooperation in Research and Higher Education. We thank A. Meinhart and E. Hofmann for collecting the synchrotron data set, M. Gebhart for help preparing the crystals, and M. Hayes and the technical staff of SLAC and the LCLS for their great support in carrying out these experiments. Special thanks to G. M. Stewart, T. Anderson, and SLAC Infomedia for generating Fig. 1. The structure factors and coordinates have been deposited with the Protein Data Bank (accession codes 4ET8, 4ET9, 4ETA, 4ETB, 4ETC, 4ETD, and 4ETE). The diffraction patterns have been deposited with the Coherent X-ray Imaging Data Bank cxidb.org (accession code ID-17). The Arizona Board of Regents, acting for and on behalf of Arizona State University and in conjunction with R. B. D., U. W., D. P. D., and J.C.H.S., has filed U.S. and international patent applications on the nozzle technology applied herein.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barty A, 2012, NAT PHOTONICS, V6, P35, DOI [10.1038/nphoton.2011.297, 10.1038/NPHOTON.2011.297]; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Boutet S, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035024; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/nphoton.2010.176, 10.1038/NPHOTON.2010.176]; Holton JM, 2010, ACTA CRYSTALLOGR D, V66, P393, DOI 10.1107/S0907444910007262; Johansson LC, 2012, NAT METHODS, V9, P263, DOI [10.1038/NMETH.1867, 10.1038/nmeth.1867]; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koopmann R, 2012, NAT METHODS, V9, P259, DOI [10.1038/NMETH.1859, 10.1038/nmeth.1859]; Lomb L, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.214111; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Philipp HT, 2011, NUCL INSTRUM METH A, V649, P67, DOI 10.1016/j.nima.2010.11.189; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Southworth-Davies RJ, 2007, STRUCTURE, V15, P1531, DOI 10.1016/j.str.2007.10.013; Wang JW, 2007, ACTA CRYSTALLOGR D, V63, P1254, DOI 10.1107/S0907444907054224; White TA, 2012, J APPL CRYSTALLOGR, V45, P335, DOI 10.1107/S0021889812002312; Young L, 2010, NATURE, V466, P56, DOI 10.1038/nature09177	21	613	623	14	440	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 20	2012	337	6092					362	364		10.1126/science.1217737	http://dx.doi.org/10.1126/science.1217737			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	975WQ	22653729	Green Accepted, Green Published			2022-12-24	WOS:000306542600057
J	Hopf, TA; Colwell, LJ; Sheridan, R; Rost, B; Sander, C; Marks, DS				Hopf, Thomas A.; Colwell, Lucy J.; Sheridan, Robert; Rost, Burkhard; Sander, Chris; Marks, Debora S.			Three-Dimensional Structures of Membrane Proteins from Genomic Sequencing	CELL			English	Article							CRYSTAL-STRUCTURE; RESIDUE CONTACTS; ABC TRANSPORTER; GLYCEROL-3-PHOSPHATE TRANSPORTER; PREDICTION; MUTATION; IDENTIFICATION; COVARIANCE; CHANNEL; CRYSTALLOGRAPHY	We show that amino acid covariation in proteins, extracted from the evolutionary sequence record, can be used to fold transmembrane proteins. We use this technique to predict previously unknown 3D structures for 11 transmembrane proteins (with up to 14 helices) from their sequences alone. The prediction method (EVfold_membrane) applies a maximum entropy approach to infer evolutionary covariation in pairs of sequence positions within a protein family and then generates all-atom models with the derived pairwise distance constraints. We benchmark the approach with blinded de novo computation of known transmembrane protein structures from 23 families, demonstrating unprecedented accuracy of the method for large transmembrane proteins. We show how the method can predict oligomerization, functional sites, and conformational changes in transmembrane proteins. With the rapid rise in large-scale sequencing, more accurate and more comprehensive information on evolutionary constraints can be decoded from genetic variation, greatly expanding the repertoire of transmembrane proteins amenable to modeling by this method.	[Hopf, Thomas A.; Marks, Debora S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Hopf, Thomas A.; Rost, Burkhard] Tech Univ Munich, Dept Informat, D-85748 Garching, Germany; [Colwell, Lucy J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Sheridan, Robert; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA	Harvard University; Harvard Medical School; Technical University of Munich; MRC Laboratory Molecular Biology; Memorial Sloan Kettering Cancer Center	Marks, DS (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	evfold_membrane@cbio.mskcc.org	Rost, Burkhard/A-1908-2016	Rost, Burkhard/0000-0003-0179-8424	Dana-Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center [NIH U54-CA143798]; Engineering and Physical Sciences Research Council [EP/H028064/1]; German National Academic Foundation; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER; EPSRC [EP/H028064/1, EP/H028064/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H028064/2] Funding Source: researchfish	Dana-Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); German National Academic Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank Guy Montelione, Rebecca Ward, Nicholas Stroustrup, Steven Long, Nikola Pavletich, Anil Korkut, Edda Kloppman, Marc Offman, Yitzak Pilpel, Andrea Pagnani, Riccardo Zecchina, David Baker, Richard Stein, James Thompson, and Michael Lappe for scientific discussions; Johannes Soeding and Michael Remmert for help with HHblits; Marco Punta and Jaina Mistry for help with PFAM numbers; and Nathan Marks-Forder for graphical abstract image. C. S. and R. S. have support from the Dana-Farber Cancer Institute-Memorial Sloan-Kettering Cancer Center Physical Sciences Oncology Center (NIH U54-CA143798). L.J.C. is supported by an Engineering and Physical Sciences Research Council fellowship (EP/H028064/1). T. A. H. has support from the German National Academic Foundation. D. S. M. thanks the Systems Biology Department at Harvard Medical School for their generous support.	Aldahmesh MA, 2011, AM J HUM GENET, V89, P745, DOI 10.1016/j.ajhg.2011.10.011; Bakheet TM, 2009, BIOINFORMATICS, V25, P451, DOI 10.1093/bioinformatics/btp002; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Boudker O, 2010, TRENDS PHARMACOL SCI, V31, P418, DOI 10.1016/j.tips.2010.06.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Chen YH, 2010, NATURE, V467, P1074, DOI 10.1038/nature09487; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; CRONET P, 1993, PROTEIN ENG, V6, P59, DOI 10.1093/protein/6.1.59; Dang SY, 2010, NATURE, V467, P734, DOI 10.1038/nature09406; DEMPSTER AP, 1972, BIOMETRICS, V28, P157, DOI 10.2307/2528966; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Fatakia SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004681; Fernandez-Martinez J, 2012, J CELL BIOL, V196, P419, DOI 10.1083/jcb.201109008; Fersht AR, 2008, NAT REV MOL CELL BIO, V9, P650, DOI 10.1038/nrm2446; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Fuchs A, 2007, BIOINFORMATICS, V23, P3312, DOI 10.1093/bioinformatics/btm515; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Horn F, 1998, RECEPTOR CHANNEL, V5, P305; HOWELL N, 1991, AM J HUM GENET, V49, P939; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jaksch M, 1996, HUM MUTAT, V7, P358, DOI 10.1002/(SICI)1098-1004(1996)7:4<358::AID-HUMU11>3.3.CO;2-V; JOHNS DR, 1992, BIOCHEM BIOPH RES CO, V187, P1551, DOI 10.1016/0006-291X(92)90479-5; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Katritch V, 2012, TRENDS PHARMACOL SCI, V33, P17, DOI 10.1016/j.tips.2011.09.003; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kosel D, 2010, J CELL SCI, V123, P1320, DOI 10.1242/jcs.057919; Lapedes A.S., 1997, CORRELATED MUTATIONS; Law CJ, 2008, J MOL BIOL, V378, P828, DOI 10.1016/j.jmb.2008.03.029; Lemieux MJ, 2004, CURR OPIN STRUC BIOL, V14, P405, DOI 10.1016/j.sbi.2004.06.003; Livesay DR, 2012, METHODS MOL BIOL, V796, P385, DOI 10.1007/978-1-61779-334-9_21; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MacCallum JL, 2011, PROTEINS, V79, P74, DOI 10.1002/prot.23131; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Miller CS, 2008, BIOINFORMATICS, V24, P1575, DOI 10.1093/bioinformatics/btn248; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; MURZIN AG, 1993, EMBO J, V12, P861, DOI 10.1002/j.1460-2075.1993.tb05726.x; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; Nemoto W, 2004, PROTEIN J, V23, P427, DOI 10.1023/B:JOPC.0000039556.95629.cf; Neumann S, 2012, PROTEINS, V80, P839, DOI 10.1002/prot.23242; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074; Pei JM, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-37; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Radestock S, 2011, J MOL BIOL, V407, P698, DOI 10.1016/j.jmb.2011.02.008; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776; Skerker JM, 2008, CELL, V133, P1043, DOI 10.1016/j.cell.2008.04.040; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; VALIQUETTE M, 1995, EMBO J, V14, P5542, DOI 10.1002/j.1460-2075.1995.tb00241.x; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zhang K, 2001, NAT GENET, V27, P89, DOI 10.1038/83817; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	75	358	368	2	79	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1607	1621		10.1016/j.cell.2012.04.012	http://dx.doi.org/10.1016/j.cell.2012.04.012			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22579045	Bronze, Green Accepted			2022-12-24	WOS:000305753800024
J	Jiao, BW; Ma, H; Shokhirev, MN; Drung, A; Yang, Q; Shin, JD; Lu, SL; Byron, M; Kalantry, S; Mercurio, AM; Lawrence, JB; Hoffmann, A; Bach, I				Jiao, Baowei; Ma, Hong; Shokhirev, Maxim N.; Drung, Alexander; Yang, Qin; Shin, JongDae; Lu, Shaolei; Byron, Meg; Kalantry, Sundeep; Mercurio, Arthur M.; Lawrence, Jeanne B.; Hoffmann, Alexander; Bach, Ingolf			Paternal RLIM/Rnf12 Is a Survival Factor for Milk-Producing Alveolar Cells	CELL			English	Article							X-CHROMOSOME INACTIVATION; MAMMARY-GLAND; TRANSCRIPTION FACTORS; DOSAGE COMPENSATION; LIM COFACTORS; EXPRESSION; GROWTH; MORPHOGENESIS; DEPLETION; SELECTION	In female mouse embryos, somatic cells undergo a random form of X chromosome inactivation (XCI), whereas extraembryonic trophoblast cells in the placenta undergo imprinted XCI, silencing exclusively the paternal X chromosome. Initiation of imprinted XCI requires a functional maternal allele of the X-linked gene Rnf12, which encodes the ubiquitin ligase Rnf12/RLIM. We find that knockout (KO) of Rnf12 in female mammary glands inhibits alveolar differentiation and milk production upon pregnancy, with alveolar cells that lack RLIM undergoing apoptosis as they begin to differentiate. Genetic analyses demonstrate that these functions are mediated primarily by the paternal Rnf12 allele due to non-random maternal XCI in mammary epithelial cells. These results identify paternal Rnf12/RLIM as a critical survival factor for milk-producing alveolar cells and, together with population models, reveal implications of transgenerational epigenetic inheritance.	[Jiao, Baowei; Ma, Hong; Drung, Alexander; Yang, Qin; Shin, JongDae; Bach, Ingolf] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Lu, Shaolei; Mercurio, Arthur M.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Byron, Meg; Lawrence, Jeanne B.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; [Bach, Ingolf] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Shokhirev, Maxim N.; Hoffmann, Alexander] Univ Calif San Diego, BioCircuits Inst, San Diego Ctr Syst Biol Cellular Stress Responses, La Jolla, CA 92093 USA; [Shokhirev, Maxim N.; Hoffmann, Alexander] Univ Calif San Diego, Program Bioinformat & Syst Biol, La Jolla, CA 92093 USA; [Kalantry, Sundeep] Univ Michigan, Sch Med, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Michigan System; University of Michigan	Bach, I (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	ingolf.bach@umassmed.edu		JIAO, BAOWEI/0000-0001-8559-9160; Lu, Shaolei/0000-0003-2870-5793; Lawrence, Jeanne/0000-0001-6572-3128	NIH [R01CA131158, R01GM053234, R01CA89209]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD055333] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA131158, R01CA089209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053234] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008646] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Andersen, E. Baehrecke, T. Fazzio, D. Haig, O. Rando, W. Robinson, L. Shaw, and S. Sinha for advice, comments, and/or reagents and T. Fazzio for critically reading the manuscript. I. B. is a member of the UMass DERC (DK32520). This work was supported by NIH grants R01CA131158 to I. B., R01GM053234 to J.B.L., and R01CA89209 to A.M.M.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Breen G, 2000, BIOTECHNIQUES, V28, P464, DOI 10.2144/00283st03; Brisken C, 2006, J MAMMARY GLAND BIOL, V11, P239, DOI 10.1007/s10911-006-9026-0; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Chadwick LH, 2006, GENETICS, V173, P2103, DOI 10.1534/genetics.105.054882; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Cui Y, 2004, MOL CELL BIOL, V24, P8037, DOI 10.1128/MCB.24.18.8037-8047.2004; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Flint D, 2008, J MAMMARY GLAND BIOL, V13, P443, DOI 10.1007/s10911-008-9095-3; Gown AM, 2002, J HISTOCHEM CYTOCHEM, V50, P449, DOI 10.1177/002215540205000401; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Gungor C, 2007, P NATL ACAD SCI USA, V104, P15000, DOI 10.1073/pnas.0703738104; Hadjantonakis AK, 2001, GENESIS, V29, P133, DOI 10.1002/gene.1016; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hennighausen L, 2008, GENE DEV, V22, P711, DOI 10.1101/gad.1643908; Johnsen SA, 2009, CANCER RES, V69, P128, DOI 10.1158/0008-5472.CAN-08-1630; Kalantry S, 2009, NATURE, V460, P647, DOI 10.1038/nature08161; Korslund L, 2006, J ANIM ECOL, V75, P156, DOI 10.1111/j.1365-2656.2005.01031.x; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Langdon SP, 2004, METH MOLEC MED, V88, P133; Li W, 2009, P NATL ACAD SCI USA, V106, P4725, DOI 10.1073/pnas.0807640106; LIDICKER WZ, 1966, ECOL MONOGR, V36, P27, DOI 10.2307/1948487; MacLean JA, 2011, MOL CELL BIOL, V31, P1275, DOI 10.1128/MCB.00734-10; Mohanty AK, 2009, PROTEIN EXPRES PURIF, V64, P213, DOI 10.1016/j.pep.2008.11.001; Ostendorff HP, 2006, DEV DYNAM, V235, P786, DOI 10.1002/dvdy.20669; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Pereira F.A., 2001, CURR PROTOC MOL  MAY; PULLIAM HR, 1991, AM NAT, V137, pS50, DOI 10.1086/285139; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Sutherland KD, 2007, CELL CYCLE, V6, P799, DOI 10.4161/cc.6.7.4037; Sutherland KD, 2007, J MAMMARY GLAND BIOL, V12, P15, DOI 10.1007/s10911-007-9034-8; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wang X, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r79	45	23	23	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					630	641		10.1016/j.cell.2012.02.056	http://dx.doi.org/10.1016/j.cell.2012.02.056			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541433	Green Accepted, Bronze			2022-12-24	WOS:000303443100014
J	Jensen, MO; Jogini, V; Borhani, DW; Leffler, AE; Dror, RO; Shaw, DE				Jensen, Morten O.; Jogini, Vishwanath; Borhani, David W.; Leffler, Abba E.; Dror, Ron O.; Shaw, David E.			Mechanism of Voltage Gating in Potassium Channels	SCIENCE			English	Article							SHAKER K+-CHANNEL; MOLECULAR-DYNAMICS; SENSOR MUTATIONS; SODIUM-CHANNELS; ION-PERMEATION; S4 SEGMENT; WILD-TYPE; CHARGE; PORE; DOMAIN	The mechanism of ion channel voltage gating-how channels open and close in response to voltage changes-has been debated since Hodgkin and Huxley's seminal discovery that the crux of nerve conduction is ion flow across cellular membranes. Using all-atom molecular dynamics simulations, we show how a voltage-gated potassium channel (KV) switches between activated and deactivated states. On deactivation, pore hydrophobic collapse rapidly halts ion flow. Subsequent voltage-sensing domain (VSD) relaxation, including inward, 15-angstrom S4-helix motion, completes the transition. On activation, outward S4 motion tightens the VSD-pore linker, perturbing linker-S6-helix packing. Fluctuations allow water, then potassium ions, to reenter the pore; linker-S6 repacking stabilizes the open pore. We propose a mechanistic model for the sodium/potassium/calcium voltage-gated ion channel superfamily that reconciles apparently conflicting experimental data.	[Jensen, Morten O.; Jogini, Vishwanath; Borhani, David W.; Leffler, Abba E.; Dror, Ron O.; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; Columbia University	Jensen, MO (corresponding author), DE Shaw Res, New York, NY 10036 USA.	morten.jensen@DEShawResearch.com; david.shaw@DEShawResearch.com	Borhani, David/O-2692-2019	Borhani, David/0000-0002-8486-8792; Dror, Ron/0000-0002-6418-2793				Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Ando H, 2005, J GEN PHYSIOL, V126, P529, DOI 10.1085/jgp.200509377; Banerjee A, 2008, J MOL BIOL, V381, P569, DOI 10.1016/j.jmb.2008.06.010; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Cannon SC, 2010, J PHYSIOL-LONDON, V588, P1887, DOI 10.1113/jphysiol.2010.186874; Catterall WA, 2010, NEURON, V67, P915, DOI 10.1016/j.neuron.2010.08.021; Delemotte L, 2010, BIOPHYS J, V99, pL72, DOI 10.1016/j.bpj.2010.08.069; Dror RO, 2009, P C HIGH PERF COMP N; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Hong KH, 2000, J GEN PHYSIOL, V115, P51, DOI 10.1085/jgp.115.1.51; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jensen MO, 2010, P NATL ACAD SCI USA, V107, P5833, DOI 10.1073/pnas.0911691107; Khalili-Araghi F, 2012, BIOPHYS J, V102, P258, DOI 10.1016/j.bpj.2011.10.057; Kobertz WR, 1999, NAT STRUCT BIOL, V6, P1122; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Loboda A, 2001, BIOPHYS J, V81, P905, DOI 10.1016/S0006-3495(01)75750-5; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MCCORMACK K, 1991, P NATL ACAD SCI USA, V88, P2931, DOI 10.1073/pnas.88.7.2931; Nelson R D, 1999, J Mol Microbiol Biotechnol, V1, P281; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Rodriguez BM, 1996, NEUROPHARMACOLOGY, V35, P775, DOI 10.1016/0028-3908(96)00111-6; Rodriguez BM, 1998, J GEN PHYSIOL, V112, P223, DOI 10.1085/jgp.112.2.223; Ruta V, 2005, CELL, V123, P463, DOI 10.1016/j.cell.2005.08.041; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; Sigworth FJ, 2003, NATURE, V423, P21, DOI 10.1038/423021a; Sokolov S, 2005, NEURON, V47, P183, DOI 10.1016/j.neuron.2005.06.012; Sokolov S, 2007, NATURE, V446, P76, DOI 10.1038/nature05598; Starace DM, 2004, NATURE, V427, P548, DOI 10.1038/nature02270; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Tao X, 2008, J MOL BIOL, V382, P24, DOI 10.1016/j.jmb.2008.06.085; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; TEMPEL BL, 1987, SCIENCE, V237, P770, DOI 10.1126/science.2441471; Tombola F, 2005, NEURON, V45, P379, DOI 10.1016/j.neuron.2004.12.047; Tombola F, 2007, NATURE, V445, P546, DOI 10.1038/nature05396; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZIMMERBERG J, 1990, BIOPHYS J, V57, P1049, DOI 10.1016/S0006-3495(90)82623-0	48	426	430	17	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					229	233		10.1126/science.1216533	http://dx.doi.org/10.1126/science.1216533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499946				2022-12-24	WOS:000302703900050
J	Jensen, M; Hoerndli, FJ; Brockie, PJ; Wang, R; Johnson, E; Maxfield, D; Francis, MM; Madsen, DM; Maricq, AV				Jensen, Michael; Hoerndli, Frederic J.; Brockie, Penelope J.; Wang, Rui; Johnson, Erica; Maxfield, Dane; Francis, Michael M.; Madsen, David M.; Maricq, Andres V.			Wnt Signaling Regulates Acetylcholine Receptor Translocation and Synaptic Plasticity in the Adult Nervous System	CELL			English	Article							TYROSINE KINASE; NICOTINIC RECEPTOR; PROTEIN; TRANSMISSION; MECHANISMS; CAM-1	The adult nervous system is plastic, allowing us to learn, remember, and forget. Experience-dependent plasticity occurs at synapses-the specialized points of contact between neurons where signaling occurs. However, the mechanisms that regulate the strength of synaptic signaling are not well understood. Here, we define a Wnt-signaling pathway that modifies synaptic strength in the adult nervous system by regulating the translocation of one class of acetylcholine receptors (AChRs) to synapses. In Caenorhabditis elegans, we show that mutations in CWN-2 (Wnt ligand), LIN-17 (Frizzled), CAM-1 (Ror receptor tyrosine kinase), or the downstream effector DSH-1 (disheveled) result in similar sub-synaptic accumulations of ACR-16/alpha 7 AChRs, a consequent reduction in synaptic current, and predictable behavioral defects. Photoconversion experiments revealed defective translocation of ACR-16/alpha 7 to synapses in Wnt-signaling mutants. Using optogenetic nerve stimulation, we demonstrate activity-dependent synaptic plasticity and its dependence on ACR-16/alpha 7 translocation mediated by Wnt signaling via LIN-17/CAM-1 heteromeric receptors.	[Jensen, Michael; Hoerndli, Frederic J.; Brockie, Penelope J.; Wang, Rui; Johnson, Erica; Maxfield, Dane; Francis, Michael M.; Madsen, David M.; Maricq, Andres V.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Maricq, AV (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	maricq@biology.utah.edu	Wang, Rui/C-8424-2011	jensen, michael/0000-0002-4517-822X; Hoerndli, Frederic/0000-0001-6838-0386; francis, michael/0000-0002-8076-6668	National Institutes of Health [NIH] [R01 NS070280]; American Heart Association [09PRE2060730]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070280, R01NS064263] Funding Source: NIH RePORTER	National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Maricq laboratory for comments on the manuscript, Kang Shen and Erik Jorgensen for plasmids and transgenic strains, and the Caenorhabditis Genetics Center (funded by the National Institutes of Health [NIH]) for providing worm strains. This research was made possible by support from NIH Grant R01 NS070280 and American Heart Association Predoctoral Grant 09PRE2060730 (M.J.).	Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Boulin T, 2008, P NATL ACAD SCI USA, V105, P18590, DOI 10.1073/pnas.0806933105; Brown D, 2009, TRAFFIC, V10, P275, DOI 10.1111/j.1600-0854.2008.00867.x; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Ciani L, 2011, P NATL ACAD SCI USA, V108, P10732, DOI 10.1073/pnas.1018132108; Cuitino L, 2010, J NEUROSCI, V30, P8411, DOI 10.1523/JNEUROSCI.5736-09.2010; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Fang-Yen C, 2009, WORM BREED GAZ, V18, P32; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Farias GG, 2010, DEV DYNAM, V239, P94, DOI 10.1002/dvdy.22065; Francis MM, 2005, NEURON, V46, P581, DOI 10.1016/j.neuron.2005.04.010; Gleason JE, 2006, DEV BIOL, V298, P442, DOI 10.1016/j.ydbio.2006.06.050; Gottschalk A, 2005, EMBO J, V24, P2566, DOI 10.1038/sj.emboj.7600741; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Green JL, 2007, DEVELOPMENT, V134, P4053, DOI 10.1242/dev.005363; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Henriquez JP, 2008, P NATL ACAD SCI USA, V105, P18812, DOI 10.1073/pnas.0806300105; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jin Y, 2008, ANNU REV CELL DEV BI, V24, P237, DOI 10.1146/annurev.cellbio.23.090506.123417; Kennedy MJ, 2011, NEURON, V69, P856, DOI 10.1016/j.neuron.2011.02.032; Kennerdell JR, 2009, DEVELOPMENT, V136, P3801, DOI 10.1242/dev.038109; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kim C, 2003, DEV BIOL, V264, P376, DOI 10.1016/j.ydbio.2003.09.007; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681; Kourtis N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004547; Liewald JF, 2008, NAT METHODS, V5, P895, DOI 10.1038/NMETH.1252; Liu Q, 2009, P NATL ACAD SCI USA, V106, P10823, DOI 10.1073/pnas.0903570106; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Minami Y, 2010, DEV DYNAM, V239, P1, DOI 10.1002/dvdy.21991; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Sahores M, 2010, DEVELOPMENT, V137, P2215, DOI 10.1242/dev.046722; Shyu YJ, 2008, NAT PROTOC, V3, P588, DOI 10.1038/nprot.2008.16; Touroutine D, 2005, J BIOL CHEM, V280, P27013, DOI 10.1074/jbc.M502818200; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Wiedenmann J, 2004, P NATL ACAD SCI USA, V101, P15905, DOI 10.1073/pnas.0403668101; Wu HT, 2010, DEVELOPMENT, V137, P1017, DOI 10.1242/dev.038711; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244; Zinovyeva AY, 2008, GENETICS, V179, P1357, DOI 10.1534/genetics.108.090290	44	71	85	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					173	187		10.1016/j.cell.2011.12.038	http://dx.doi.org/10.1016/j.cell.2011.12.038			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464329	Bronze, Green Accepted			2022-12-24	WOS:000302235400019
J	Dixon, SJ; Lemberg, KM; Lamprecht, MR; Skouta, R; Zaitsev, EM; Gleason, CE; Patel, DN; Bauer, AJ; Cantley, AM; Yang, WS; Morrison, B; Stockwell, BR				Dixon, Scott J.; Lemberg, Kathryn M.; Lamprecht, Michael R.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Morrison, Barclay, III; Stockwell, Brent R.			Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death	CELL			English	Article							SMALL-MOLECULE; ORGANOTYPIC CULTURES; CANCER-CELLS; IN-VITRO; K-RAS; PROTEIN; GROWTH; NEURODEGENERATION; IDENTIFICATION; TRANSPORTER	Nonapoptotic forms of cell death may facilitate the selective elimination of some tumor cells or be activated in specific pathological states. The oncogenic RAS-selective lethal small molecule erastin triggers a unique iron-dependent form of nonapoptotic cell death that we term ferroptosis. Ferroptosis is dependent upon intracellular iron, but not other metals, and is morphologically, biochemically, and genetically distinct from apoptosis, necrosis, and autophagy. We identify the small molecule ferrostatin-1 as a potent inhibitor of ferroptosis in cancer cells and glutamate-induced cell death in organotypic rat brain slices, suggesting similarities between these two processes. Indeed, erastin, like glutamate, inhibits cystine uptake by the cystine/glutamate antiporter (system x(c)(-)), creating a void in the antioxidant defenses of the cell and ultimately leading to iron-dependent, oxidative death. Thus, activation of ferroptosis results in the nonapoptotic destruction of certain cancer cells, whereas inhibition of this process may protect organisms from neurodegeneration.	[Dixon, Scott J.; Lemberg, Kathryn M.; Skouta, Rachid; Zaitsev, Eleina M.; Gleason, Caroline E.; Patel, Darpan N.; Bauer, Andras J.; Cantley, Alexandra M.; Yang, Wan Seok; Stockwell, Brent R.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Lamprecht, Michael R.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Stockwell, Brent R.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute	Stockwell, BR (corresponding author), Columbia Univ, Dept Biol Sci, 550 W 120th St,NW Corner Bldg,MC 4846, New York, NY 10027 USA.	bstockwell@columbia.edu	Stockwell, Brent R/AAE-7200-2019; Morrison, Barclay/B-7132-2008; Skouta, Rachid/M-2690-2019; Skouta, Rachid/Q-7132-2016	Stockwell, Brent R/0000-0002-3532-3868; Morrison, Barclay/0000-0001-7676-0864; Dixon, Scott/0000-0001-6230-8199; Skouta, Rachid/0000-0003-3324-4362	NSF [CHE-0840451]; Columbia University; Canadian Institutes of Health Research; US National Institutes of Health [5R01CA097061, 5R01GM085081, R01CA161061]; Arnold and Mabel Beckman Foundation; NYSTAR; NATIONAL CANCER INSTITUTE [R01CA097061, R01CA161061, R00CA166517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085081] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Columbia University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; NYSTAR; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Vamsi Mootha, Joshua Baughman, and David Root for sharing the custom shRNA library; Kristy Brown and Elma Zaganjor for assistance with electron microscopy; Darnelle Delva for help with qPCR; Rohitha SriRamaratnam for help with cell death assays; Eric Schon for providing the 143B cell lines; Craig Thompson for providing Bax<SUP>-/-</SUP> Bak<SUP>-/-</SUP> MEFs; and Patrick Page (GenKyoTex S.A.) for providing GKT137831. We thank David Clarke for comments on the manuscript. Certain shRNA collections used in this work were generated with the assistance of the Scientific Planning and Allocation of Resources Committee (SPARC, to Vamsi Mootha). NSF grant CHE-0840451 supported the purchase and operation of equipment used in the chemical characterization of ferrostatin-1. M.R.L. was supported by a fellowship from the National Science Foundation. K.M.L. was supported by the Medical Scientist Training Program (Columbia University). S.J.D. was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research. This research was supported by grants from the US National Institutes of Health (5R01CA097061, 5R01GM085081, and R01CA161061), the Arnold and Mabel Beckman Foundation, and NYSTAR. B.R.S. is an Early Career Scientist of the Howard Hughes Medical Institute.	Banjac A, 2008, ONCOGENE, V27, P1618, DOI 10.1038/sj.onc.1210796; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Cater HL, 2007, J NEUROCHEM, V101, P434, DOI 10.1111/j.1471-4159.2006.04379.x; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Chonghaile TN, 2011, SCIENCE, V334, P1129, DOI 10.1126/science.1206727; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Guo W, 2008, CANCER RES, V68, P7403, DOI 10.1158/0008-5472.CAN-08-1449; ISHII T, 1981, J BIOL CHEM, V256, P2387; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Kanai Yoshikatsu, 2003, J Toxicol Sci, V28, P1, DOI 10.2131/jts.28.1; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Li YH, 1997, NEURON, V19, P453, DOI 10.1016/S0896-6273(00)80953-8; Lo M, 2008, BRIT J CANCER, V99, P464, DOI 10.1038/sj.bjc.6604485; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Macarron R, 2011, NAT REV DRUG DISCOV, V10, P188, DOI 10.1038/nrd3368; Morrison B, 2002, BRIT J PHARMACOL, V137, P1255, DOI 10.1038/sj.bjp.0704986; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pinnix ZK, 2010, SCI TRANSL MED, V2, DOI [10.1126/scitranslmed.3001127, 10.1126/scisignal.3001127]; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; Ramanathan A, 2009, P NATL ACAD SCI USA, V106, P22229, DOI 10.1073/pnas.0912074106; RATAN RR, 1994, J NEUROCHEM, V62, P376; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Shaw AT, 2011, P NATL ACAD SCI USA, V108, P8773, DOI 10.1073/pnas.1105941108; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Watkins PA, 2007, J LIPID RES, V48, P2736, DOI 10.1194/jlr.M700378-JLR200; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wolpaw AJ, 2011, P NATL ACAD SCI USA, V108, pE771, DOI 10.1073/pnas.1106149108; Yagoda N, 2007, NATURE, V447, P864, DOI 10.1038/nature05859; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yonezawa M, 1996, J NEUROCHEM, V67, P566	47	4879	5147	353	1726	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1060	1072		10.1016/j.cell.2012.03.042	http://dx.doi.org/10.1016/j.cell.2012.03.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632970	Green Accepted, Bronze			2022-12-24	WOS:000304453900012
J	Ahrens, MB; Li, JM; Orger, MB; Robson, DN; Schier, AF; Engert, F; Portugues, R				Ahrens, Misha B.; Li, Jennifer M.; Orger, Michael B.; Robson, Drew N.; Schier, Alexander F.; Engert, Florian; Portugues, Ruben			Brain-wide neuronal dynamics during motor adaptation in zebrafish	NATURE			English	Article							FUNCTIONAL GROUND PLAN; CELLULAR RESOLUTION; ODOR REPRESENTATIONS; NEURAL ACTIVITY; HINDBRAIN; BEHAVIOR; DROSOPHILA; MOTION; CEREBELLUM; EXPRESSION	A fundamental question in neuroscience is how entire neural circuits generate behaviour and adapt it to changes in sensory feedback. Here we use two-photon calcium imaging to record the activity of large populations of neurons at the cellular level, throughout the brain of larval zebrafish expressing a genetically encoded calcium sensor, while the paralysed animals interact fictively with a virtual environment and rapidly adapt their motor output to changes in visual feedback. We decompose the network dynamics involved in adaptive locomotion into four types of neuronal response properties, and provide anatomical maps of the corresponding sites. A subset of these signals occurred during behavioural adjustments and are candidates for the functional elements that drive motor learning. Lesions to the inferior olive indicate a specific functional role for olivocerebellar circuitry in adaptive locomotion. This study enables the analysis of brain-wide dynamics at single-cell resolution during behaviour.	[Ahrens, Misha B.; Li, Jennifer M.; Robson, Drew N.; Schier, Alexander F.; Engert, Florian; Portugues, Ruben] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ahrens, Misha B.] Univ Cambridge, Dept Engn, Computat & Biol Learning Lab, Cambridge CB2 1PZ, England; [Orger, Michael B.] Champalimaud Ctr Unknown, Champalimaud Neurosci Programme, P-1400038 Lisbon, Portugal	Harvard University; University of Cambridge; Fundacao Champalimaud	Engert, F (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	florian@mcb.harvard.edu	Portugues, Ruben/N-4900-2019; Portugues, Ruben/C-3600-2012	Portugues, Ruben/0000-0002-1495-9314; Portugues, Ruben/0000-0002-1495-9314; Schier, Alexander Franz/0000-0001-7645-5325; Robson, Drew/0000-0002-0150-1515; Orger, Michael/0000-0002-9763-8902	Wellcome Trust; K99 [5K99NS62780-2]; National Institutes of Health [5R01EY014429, RC2NS069407]; NATIONAL EYE INSTITUTE [R01EY014429] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS082121, K99NS062780, RC2NS069407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA030304] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); K99; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We are grateful to D. Schoppik for teaching M. B. A. the fictive swimming preparation, to K.-H. Huang for carrying out spinal calcium green injections, and to M. Concha, R. Baker and L.-H. Ma for advice on anatomy. We thank M. Meister, B. Olveczky, D. Wolpert, E. Mukamel, M. Yartsev, D. Schoppik, D. Hildebrand, E. Naumann, A. Kampff, P. Latham, T. Dunn and members of the Engert laboratory for useful discussions and comments on the manuscript. We thank P. Oteiza and R. Hellmiss for help with anatomy and figures, and A. Viel for use of laboratory space. M. B. A. thanks D. Wolpert and E. Santos for support. This work was supported by a Sir Henry Wellcome Fellowship from the Wellcome Trust (M. B. A.), a K99 grant no. 5K99NS62780-2 (M.B.O.) and National Institutes of Health grants 5R01EY014429 and RC2NS069407 (F.E.).	Aizenberg M, 2011, J NEUROSCI, V31, P8708, DOI 10.1523/JNEUROSCI.6565-10.2011; ALBUS J S, 1971, Mathematical Biosciences, V10, P25, DOI 10.1016/0025-5564(71)90051-4; Bae YK, 2009, DEV BIOL, V330, P406, DOI 10.1016/j.ydbio.2009.04.013; BENNETT AF, 1985, J EXP BIOL, V115, P333; Boyden ES, 2003, NEURON, V39, P1031, DOI 10.1016/S0896-6273(03)00562-2; Chong M, 2007, DEV NEUROBIOL, V67, P933, DOI 10.1002/dneu.20398; COHEN AH, 1980, EXP BRAIN RES, V41, P11; De Zeeuw CI, 1998, TRENDS NEUROSCI, V21, P391, DOI 10.1016/S0166-2236(98)01310-1; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077; DULAC S, 1995, ANNU REV NEUROSCI, V18, P409, DOI 10.1146/annurev.neuro.18.1.409; Flusberg BA, 2008, NAT METHODS, V5, P935, DOI 10.1038/nmeth.1256; Fry SN, 2009, J EXP BIOL, V212, P1120, DOI 10.1242/jeb.020768; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; GILBERT PFC, 1977, BRAIN RES, V128, P309, DOI 10.1016/0006-8993(77)90997-0; Hieber V, 1998, J NEUROBIOL, V37, P429, DOI 10.1002/(SICI)1097-4695(19981115)37:3<429::AID-NEU8>3.0.CO;2-N; Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003; ITO M, 1974, BRAIN RES, V65, P170, DOI 10.1016/0006-8993(74)90344-8; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Kinkhabwala A, 2011, P NATL ACAD SCI USA, V108, P1164, DOI 10.1073/pnas.1012185108; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Koyama M, 2011, P NATL ACAD SCI USA, V108, P1170, DOI 10.1073/pnas.1012189108; Ma LH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005944; Maimon G, 2010, NAT NEUROSCI, V13, P393, DOI 10.1038/nn.2492; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Masino MA, 2005, J NEUROPHYSIOL, V93, P3177, DOI 10.1152/jn.01248.2004; Matsumoto N, 2007, BRAIN BEHAV EVOLUT, V70, P105, DOI 10.1159/000102972; Mazor O, 2005, NEURON, V48, P661, DOI 10.1016/j.neuron.2005.09.032; Miri A, 2011, NAT NEUROSCI, V14, P1150, DOI 10.1038/nn.2888; MOHL B, 1988, J COMP PHYSIOL A, V163, P803, DOI 10.1007/BF00604057; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; Naumann EA, 2010, NAT NEUROSCI, V13, P513, DOI 10.1038/nn.2518; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Portugues R, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00072; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; ROBERTS BL, 1992, J EXP BIOL, V167, P171; ROCK I, 1986, PERCEPTION, V15, P497, DOI 10.1068/p150497; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Tallini YN, 2006, P NATL ACAD SCI USA, V103, P4753, DOI 10.1073/pnas.0509378103; Volkmann K, 2010, J COMP NEUROL, V518, P2794, DOI 10.1002/cne.22364; WALL PD, 1967, EXP NEUROL, V19, P519, DOI 10.1016/0014-4886(67)90172-0; WOLF R, 1992, PHILOS T R SOC B, V337, P261, DOI 10.1098/rstb.1992.0104; Wullimann MF, 1996, NEUROANATOMY ZEBRAFI, DOI 10.1007/978-3-0348-8979-7_6; Yaksi E, 2009, NAT NEUROSCI, V12, P474, DOI 10.1038/nn.2288	52	399	401	7	151	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					471	U80		10.1038/nature11057	http://dx.doi.org/10.1038/nature11057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622571	Green Accepted			2022-12-24	WOS:000304344500036
J	Chotirmall, SH; Smith, SG; Gunaratnam, C; Cosgrove, S; Dimitrov, BD; O'Neill, SJ; Harvey, BJ; Greene, CM; McElvaney, NG				Chotirmall, Sanjay H.; Smith, Stephen G.; Gunaratnam, Cedric; Cosgrove, Sonya; Dimitrov, Borislav D.; O'Neill, Shane J.; Harvey, Brian J.; Greene, Catherine M.; McElvaney, Noel G.			Effect of Estrogen on Pseudomonas Mucoidy and Exacerbations in Cystic Fibrosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LUNG INFECTION; AERUGINOSA INFECTION; GENDER-DIFFERENCES; HYDROGEN-PEROXIDE; MOUSE MODEL; ALGINATE; 17-BETA-ESTRADIOL; MORTALITY; SURVIVORSHIP; PREVALENCE	Background Women with cystic fibrosis are at increased risk for mucoid conversion of Pseudomonas aeruginosa, which contributes to a sexual dichotomy in disease severity. Methods We evaluated the effects of estradiol and its metabolite estriol on P. aeruginosa in vitro and in vivo and determined the effect of estradiol on disease exacerbations in women with cystic fibrosis. Results Estradiol and estriol induced alginate production in P. aeruginosa strain 01 and in clinical isolates obtained from patients with and those without cystic fibrosis. After prolonged exposure to estradiol, P. aeruginosa adopted early mucoid morphology, whereas short-term exposure inhibited bacterial catalase activity and increased levels of hydrogen peroxide, which is potentially damaging to DNA. Consequently, a frameshift mutation was identified in mucA, a key regulator of alginate biosynthesis in P. aeruginosa. In vivo levels of estradiol correlated with infective exacerbations in women with cystic fibrosis, with the majority occurring during the follicular phase (P<0.05). A review of the Cystic Fibrosis Registry of Ireland revealed that the use of oral contraceptives was associated with a decreased need for antibiotics. Predominantly nonmucoid P. aeruginosa was isolated from sputum during exacerbations in the luteal phase (low estradiol). Increased proportions of mucoid bacteria were isolated during exacerbations occurring in the follicular phase (high estradiol), with a variable P. aeruginosa phenotype evident in vivo during the course of the menstrual cycle corresponding to fluctuating estradiol levels. Conclusions Estradiol and estriol induced mucoid conversion of P. aeruginosa in women with cystic fibrosis through a mutation of mucA in vitro and were associated with selectivity for mucoid isolation, increased exacerbations, and mucoid conversion in vivo.	[Greene, Catherine M.] Beaumont Hosp, Educ & Res Ctr, Royal Coll Surg Ireland, Dept Med,Resp Res Div, Dublin 9, Ireland; [Dimitrov, Borislav D.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Gen Practice, Dublin, Ireland; [Harvey, Brian J.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Mol Med, Dublin, Ireland; [Chotirmall, Sanjay H.; Gunaratnam, Cedric; O'Neill, Shane J.; McElvaney, Noel G.] Beaumont Hosp, Royal Coll Surg Ireland, Dept Resp Med, Dublin, Ireland; [Smith, Stephen G.] Trinity Coll Dublin, Sch Med, Dept Clin Microbiol, Dublin, Ireland	Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland; Trinity College Dublin	Greene, CM (corresponding author), Beaumont Hosp, Educ & Res Ctr, Royal Coll Surg Ireland, Dept Med,Resp Res Div, Dublin 9, Ireland.	cmgreene@rcsi.ie	Smith, Stephen/C-8523-2014; Harvey, Brian J/A-5120-2010; McElvaney, Noel/A-6809-2010; Harvey, Brian/AAJ-4085-2020; Chotirmall, Sanjay Haresh/K-4127-2015; Greene, Catherine M/D-3513-2012; Dimitrov, Borislav D/A-1246-2010	Smith, Stephen/0000-0001-7807-2176; Harvey, Brian J/0000-0002-7388-8034; Harvey, Brian/0000-0002-7388-8034; Chotirmall, Sanjay Haresh/0000-0003-0417-7607; Greene, Catherine M/0000-0003-2549-2569; Dimitrov, Borislav D/0000-0002-5896-2072; mcelvaney, Noel/0000-0002-0152-4370	Molecular Medicine Ireland Clinician-Scientist Fellowship Programme; Higher Education Authority Programme for Research in Third Level Institutions (PRTLI) Cycle 4 from the Molecular Medicine Ireland Clinician-Scientist Fellowship Programme	Molecular Medicine Ireland Clinician-Scientist Fellowship Programme; Higher Education Authority Programme for Research in Third Level Institutions (PRTLI) Cycle 4 from the Molecular Medicine Ireland Clinician-Scientist Fellowship Programme	Funded by the Molecular Medicine Ireland Clinician-Scientist Fellowship Programme.; Supported by the Higher Education Authority Programme for Research in Third Level Institutions (PRTLI) Cycle 4 through a grant (2008-2011) from the Molecular Medicine Ireland Clinician-Scientist Fellowship Programme.	BAKER ME, 1989, FASEB J, V3, P2086, DOI 10.1096/fasebj.3.9.2663583; BENISEK WF, 1982, BIOCHEMISTRY-US, V21, P5816, DOI 10.1021/bi00266a015; Bragonzi A, 2005, J INFECT DIS, V192, P410, DOI 10.1086/431516; Chotirmall SH, 2010, AM J RESP CRIT CARE, V182, P62, DOI 10.1164/rccm.201001-0053OC; Coakley RD, 2008, J CLIN INVEST, V118, P4025, DOI 10.1172/JCI33893; Corey M, 1996, AM J EPIDEMIOL, V143, P1007, DOI 10.1093/oxfordjournals.aje.a008664; DEMKO CA, 1995, J CLIN EPIDEMIOL, V48, P1041, DOI 10.1016/0895-4356(94)00230-N; Dodge JA, 2007, EUR RESPIR J, V29, P522, DOI 10.1183/09031936.00099506; Farrell PM, 2008, J CYST FIBROS, V7, P450, DOI 10.1016/j.jcf.2008.03.007; FISHMAN J, 1960, J BIOL CHEM, V235, P3104; Freestone PPE, 1999, FEMS MICROBIOL LETT, V172, P53, DOI 10.1111/j.1574-6968.1999.tb13449.x; Freestone PPE, 2008, TRENDS MICROBIOL, V16, P55, DOI 10.1016/j.tim.2007.11.005; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Gosselin D, 1998, AM J RESP CRIT CARE, V157, P1253, DOI 10.1164/ajrccm.157.4.9702081; Hentzer M, 2001, J BACTERIOL, V183, P5395, DOI 10.1128/JB.183.18.5395-5401.2001; HERSHBERGER CD, 1995, P NATL ACAD SCI USA, V92, P7941, DOI 10.1073/pnas.92.17.7941; HOIBY N, 1975, ACTA PATH MICRO IM B, V83, P549; HOLLOWAY BW, 1986, ANNU REV MICROBIOL, V40, P79, DOI 10.1146/annurev.mi.40.100186.000455; Jackson AD, 2011, THORAX, V66, P674, DOI 10.1136/thoraxjnl-2011-200038; KNUTSON CA, 1968, ANAL BIOCHEM, V24, P470, DOI 10.1016/0003-2697(68)90154-1; KRIEG DP, 1986, J CLIN MICROBIOL, V24, P986, DOI 10.1128/JCM.24.6.986-990.1986; Lee Tim W R, 2003, J Cyst Fibros, V2, P29, DOI 10.1016/S1569-1993(02)00141-8; Levy H, 2008, PEDIATR PULM, V43, P463, DOI 10.1002/ppul.20794; Li ZH, 2005, JAMA-J AM MED ASSOC, V293, P581, DOI 10.1001/jama.293.5.581; LIEHR JG, 1990, FREE RADICAL BIO MED, V8, P415, DOI 10.1016/0891-5849(90)90108-U; Liou TG, 2001, AM J EPIDEMIOL, V153, P345, DOI 10.1093/aje/153.4.345; Maselli JH, 2003, PEDIATR PULM, V35, P257, DOI 10.1002/ppul.10230; Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349; Olesen HV, 2010, PEDIATR PULM, V45, P959, DOI 10.1002/ppul.21265; Oliver A, 2000, SCIENCE, V288, P1251, DOI 10.1126/science.288.5469.1251; Pier GB, 2007, J IMMUNOL, V178, P7485, DOI 10.4049/jimmunol.178.11.7485; Pier GB, 2004, J IMMUNOL, V173, P5671, DOI 10.4049/jimmunol.173.9.5671; Pittman JE, 2011, PEDIATR PULM, V46, P497, DOI 10.1002/ppul.21397; Rosenfeld M, 1997, AM J EPIDEMIOL, V145, P794; ROWLAND SS, 1992, J STEROID BIOCHEM, V42, P721, DOI 10.1016/0960-0760(92)90113-W; Schallreuter KU, 2006, J INVEST DERMATOL, V126, P1036, DOI 10.1038/sj.jid.5700257; Song ZJ, 2003, J MED MICROBIOL, V52, P731, DOI 10.1099/jmm.0.05122-0; Stapper AP, 2004, J MED MICROBIOL, V53, P679, DOI 10.1099/jmm.0.45539-0; SUGARMAN B, 1990, J MED MICROBIOL, V32, P227, DOI 10.1099/00222615-32-4-227; Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100; Xie ZD, 1996, J BACTERIOL, V178, P4990, DOI 10.1128/jb.178.16.4990-4996.1996; Xu YD, 2010, RESP RES, V11, DOI [10.1186/1465-9921-11-166, 10.1186/1465-9921-11-107]	42	125	128	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 24	2012	366	21					1978	1986		10.1056/NEJMoa1106126	http://dx.doi.org/10.1056/NEJMoa1106126			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	946LL	22607135	Green Published			2022-12-24	WOS:000304353000008
J	Speese, SD; Ashley, J; Jokhi, V; Nunnari, J; Barria, R; Li, YH; Ataman, B; Koon, A; Chang, YT; Li, Q; Moore, MJ; Budnik, V				Speese, Sean D.; Ashley, James; Jokhi, Vahbiz; Nunnari, John; Barria, Romina; Li, Yihang; Ataman, Bulent; Koon, Alex; Chang, Young-Tae; Li, Qian; Moore, Melissa J.; Budnik, Vivian			Nuclear Envelope Budding Enables Large Ribonucleoprotein Particle Export during Synaptic Wnt Signaling	CELL			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; VIRUS TYPE-1 EGRESS; PROTEIN-KINASE-C; NUCLEOPLASMIC RETICULUM; NEUROMUSCULAR-JUNCTION; GENETIC-ANALYSIS; MAMMALIAN-CELLS; DROSOPHILA; WINGLESS; ORGANIZATION	Localized protein synthesis requires assembly and transport of translationally silenced ribonucleoprotein particles (RNPs), some of which are exceptionally large. Where in the cell such large RNP granules first assemble was heretofore unknown. We previously reported that during synapse development, a fragment of the Wnt-1 receptor, DFrizzled2, enters postsynaptic nuclei where it forms prominent foci. Here we show that these foci constitute large RNP granules harboring synaptic protein transcripts. These granules exit the nucleus by budding through the inner and the outer nuclear membranes in a nuclear egress mechanism akin to that of herpes viruses. This budding involves phosphorylation of A-type lamin, a protein linked to muscular dystrophies. Thus nuclear envelope budding is an endogenous nuclear export pathway for large RNP granules.	[Moore, Melissa J.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, RNA & Neuro Therapeut Inst,Dept Biochem & Mol Ph, Worcester, MA 01605 USA; [Speese, Sean D.; Ashley, James; Jokhi, Vahbiz; Nunnari, John; Barria, Romina; Li, Yihang; Ataman, Bulent; Koon, Alex; Budnik, Vivian] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Chang, Young-Tae] A STAR Biopolis, Singapore Bioimaging Consortium, Lab Bioimaging Probe Dev, Singapore 117543, Singapore; [Chang, Young-Tae] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Chang, Young-Tae] Natl Univ Singapore, Med Chem Program, Singapore 117543, Singapore; [Li, Qian] NYU, Dept Chem, New York, NY 10003 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore; New York University	Moore, MJ (corresponding author), Univ Massachusetts, Sch Med, Howard Hughes Med Inst, RNA & Neuro Therapeut Inst,Dept Biochem & Mol Ph, Worcester, MA 01605 USA.	melissa.moore@umassmed.edu; vivian.budnik@umassmed.edu	Chang, Young-Tae/B-2780-2010	Chang, Young-Tae/0000-0002-1927-3688; Speese, Sean/0000-0002-3965-9828; Koon, Alex/0000-0002-4274-7052; Ashley, James/0000-0002-6693-1014	NRSA; NIH [RO1NS063228]; DERC [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063228] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DERC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Drs. Thoru Pederson and Jeanne Lawrence for helpful advice and discussions. We also thank Dr. Kate Koles and Ms. Yuly Fuentes-Medel for support in some of the molecular studies, as well as Stefanie Kaech Petrie and Aurelie Snyder of the Jungers Center Advance Microscopy Core for help with structured illumination images. Finally, we are grateful to the UMassMed Electron Microscopy Facility for support on ultrastructural studies, and Aaron DiAntonio, Martine Simonelig, and Lori Wallrath for reagent sharing. This work was supported by an NRSA to S. D. S., NIH grant RO1NS063228 to V. B., and core resources from DERC grant DK32520. M.J.M. is a HHMI investigator. S. D. S. designed and conducted many of the experiments and contributed intellectually to the project and manuscript writing. J.A. conducted FISH, live imaging, and contributed intellectually to the project and manuscript editing. J.N. conducted EM. R. B. and Y.L. provided technical support. V.J. performed experiments related to aPKC, and contributed to experimental design. B. A. was the first to discover that nuclear DFz2C foci where localized at LamC foci, and that synaptic activity regulated the number of LamC foci in conjunction with DFz2C foci. A. K. contributed to live imaging. Y.-T.C. and Q. L. supplied the E36 dye. M.J.M. provided intellectual input, contributed to experimental design, and collaborated in writing the manuscript. V. B. directed the project and contributed to experimental design, discussions, and manuscript writing.	Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Benoit B, 1999, NUCLEIC ACIDS RES, V27, P3771, DOI 10.1093/nar/27.19.3771; BERNHARD W, 1969, J ULTRA MOL STRUCT R, V27, P250, DOI 10.1016/S0022-5320(69)80016-X; Betschinger J, 2003, NATURE, V422, P326, DOI 10.1038/nature01486; Bjerke SL, 2006, VIROLOGY, V347, P261, DOI 10.1016/j.virol.2005.11.053; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Budnik V, 2011, CURR OPIN NEUROBIOL, V21, P151, DOI 10.1016/j.conb.2010.12.002; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Buser C, 2007, J VIROL, V81, P3042, DOI 10.1128/JVI.01564-06; Cerpa W, 2011, J NEUROSCI, V31, P9466, DOI 10.1523/JNEUROSCI.6311-10.2011; DARLINGTON RW, 1968, J VIROL, V2, P48, DOI 10.1128/JVI.2.1.48-55.1968; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; DICKINSON H G, 1971, Grana, V11, P117; GAY H, 1956, COLD SPRING HARB SYM, V21, P257, DOI 10.1101/SQB.1956.021.01.021; Gehrig K, 2008, MOL BIOL CELL, V19, P237, DOI 10.1091/mbc.E07-02-0179; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Granata A, 2008, J BIOL CHEM, V283, P7568, DOI 10.1074/jbc.M704097200; Granzow H, 2001, J VIROL, V75, P3675, DOI 10.1128/JVI.75.8.3675-3684.2001; HAAS M, 1993, EUR J CELL BIOL, V62, P237; HADEK R, 1962, J CELL BIOL, V13, P445, DOI 10.1083/jcb.13.3.445; Hans S, 2011, DEV DYNAM, V240, P108, DOI 10.1002/dvdy.22497; HERBERT JM, 1990, BIOCHEM BIOPH RES CO, V172, P993, DOI 10.1016/0006-291X(90)91544-3; HOCHSTRASSER M, 1987, J CELL BIOL, V104, P1471, DOI 10.1083/jcb.104.6.1471; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600; Klupp BG, 2007, P NATL ACAD SCI USA, V104, P7241, DOI 10.1073/pnas.0701757104; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; Lagace TA, 2005, MOL BIOL CELL, V16, P1120, DOI 10.1091/mbc.E04-10-0874; Leach NR, 2010, VIROLOGY, V406, P127, DOI 10.1016/j.virol.2010.07.002; Lee CP, 2010, REV MED VIROL, V20, P214, DOI 10.1002/rmv.643; Li Q, 2006, CHEM BIOL, V13, P615, DOI 10.1016/j.chembiol.2006.04.007; Lim ECH, 2010, NAT REV NEUROL, V6, P624, DOI 10.1038/nrneurol.2010.149; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Maric M, 2011, J VIROL, V85, P9667, DOI 10.1128/JVI.05314-11; Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051; Mejat A, 2009, J CELL BIOL, V184, P31, DOI 10.1083/jcb.200811035; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; Milbradt J, 2010, J BIOL CHEM, V285, P13979, DOI 10.1074/jbc.M109.063628; MONNERON A, 1969, J ULTRA MOL STRUCT R, V27, P266, DOI 10.1016/S0022-5320(69)80017-1; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Mosca TJ, 2010, NAT NEUROSCI, V13, P935, DOI 10.1038/nn.2593; Ostlund C, 2001, J CELL SCI, V114, P4435; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Park R, 2006, J VIROL, V80, P494, DOI 10.1128/JVI.80.1.494-504.2006; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Ramachandran P, 2009, DEV NEUROBIOL, V69, P583, DOI 10.1002/dneu.20728; Reynolds AE, 2004, J VIROL, V78, P5564, DOI 10.1128/JVI.78.11.5564-5575.2004; Richard J. Roller, 2008, [Virologica Sinica, 中国病毒学], V23, P406, DOI 10.1007/s12250-008-3004-1; Robottom Bradley J, 2011, Handb Clin Neurol, V100, P465, DOI 10.1016/B978-0-444-52014-2.00036-7; Ruiz-Canada C, 2004, NEURON, V42, P567, DOI 10.1016/S0896-6273(04)00255-7; Ryckman BJ, 2004, J VIROL, V78, P399, DOI 10.1128/JVI.78.1.399-412.2004; Schulze SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007564; Schulze SR, 2005, GENETICS, V171, P185, DOI 10.1534/genetics.105.043208; SIEGFRIED E, 1994, BIOESSAYS, V16, P395, DOI 10.1002/bies.950160607; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; SZOLLOSI D, 1965, J CELL BIOL, V25, P545, DOI 10.1083/jcb.25.3.545; SZOLLOSI MS, 1988, J CELL SCI, V91, P257; Tam R., 2002, FISH PRACTICAL APPRO, P93; Varela-Nallar L, 2010, P NATL ACAD SCI USA, V107, P21164, DOI 10.1073/pnas.1010011107; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; WU CF, 1983, SCIENCE, V220, P1076, DOI 10.1126/science.6302847; Yamashita S, 2009, J ELECTRON MICROSC, V58, P267, DOI 10.1093/jmicro/dfp017; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200	66	238	243	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					832	846		10.1016/j.cell.2012.03.032	http://dx.doi.org/10.1016/j.cell.2012.03.032			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579286	Bronze, Green Accepted			2022-12-24	WOS:000303934700016
J	Sanders, SJ; Murtha, MT; Gupta, AR; Murdoch, JD; Raubeson, MJ; Willsey, AJ; Ercan-Sencicek, AG; DiLullo, NM; Parikshak, NN; Stein, JL; Walker, MF; Ober, GT; Teran, NA; Song, Y; El-Fishawy, P; Murtha, RC; Choi, M; Overton, JD; Bjornson, RD; Carriero, NJ; Meyer, KA; Bilguvar, K; Mane, SM; Sestan, N; Lifton, RP; Gunel, M; Roeder, K; Geschwind, DH; Devlin, B; State, MW				Sanders, Stephan J.; Murtha, Michael T.; Gupta, Abha R.; Murdoch, John D.; Raubeson, Melanie J.; Willsey, A. Jeremy; Ercan-Sencicek, A. Gulhan; DiLullo, Nicholas M.; Parikshak, Neelroop N.; Stein, Jason L.; Walker, Michael F.; Ober, Gordon T.; Teran, Nicole A.; Song, Youeun; El-Fishawy, Paul; Murtha, Ryan C.; Choi, Murim; Overton, John D.; Bjornson, Robert D.; Carriero, Nicholas J.; Meyer, Kyle A.; Bilguvar, Kaya; Mane, Shrikant M.; Sestan, Nenad; Lifton, Richard P.; Guenel, Murat; Roeder, Kathryn; Geschwind, Daniel H.; Devlin, Bernie; State, Matthew W.			De novo mutations revealed by whole-exome sequencing are strongly associated with autism	NATURE			English	Article							SPECTRUM DISORDERS; GENE SCN2A; SCHIZOPHRENIA; COMPONENTS; CONSTRAINT; EVOLUTION; PROTEOME; EPILEPSY	Multiple studies have confirmed the contribution of rare de novo copy number variations to the risk for autism spectrum disorders(1-3). But whereas de novo single nucleotide variants have been identified in affected individuals(4), their contribution to risk has yet to be clarified. Specifically, the frequency and distribution of these mutations have not been well characterized in matched unaffected controls, and such data are vital to the interpretation of de novo coding mutations observed in probands. Here we show, using whole-exome sequencing of 928 individuals, including 200 phenotypically discordant sibling pairs, that highly disruptive (nonsense and splice-site) de novo mutations in brain-expressed genes are associated with autism spectrum disorders and carry large effects. On the basis of mutation rates in unaffected individuals, we demonstrate that multiple independent de novo single nucleotide variants in the same gene among unrelated probands reliably identifies risk alleles, providing a clear path forward for gene discovery. Among a total of 279 identified de novo coding mutations, there is a single instance in probands, and none in siblings, in which two independent nonsense variants disrupt the same gene, SCN2A (sodium channel, voltage-gated, type II, alpha subunit), a result that is highly unlikely by chance.	[Sanders, Stephan J.; Murtha, Michael T.; Murdoch, John D.; Raubeson, Melanie J.; Willsey, A. Jeremy; Ercan-Sencicek, A. Gulhan; DiLullo, Nicholas M.; Walker, Michael F.; Ober, Gordon T.; Teran, Nicole A.; Song, Youeun; El-Fishawy, Paul; Murtha, Ryan C.; State, Matthew W.] Yale Univ, Sch Med, Dept Genet, Ctr Child Study,Dept Psychiat,Program Neurogenet, New Haven, CT 06520 USA; [Gupta, Abha R.] Yale Univ, Sch Med, Dept Pediat, Ctr Child Study, New Haven, CT 06520 USA; [Parikshak, Neelroop N.; Stein, Jason L.; Geschwind, Daniel H.] Univ Calif Los Angeles, Neurogenet Program, Los Angeles, CA 90095 USA; [Choi, Murim; Overton, John D.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Bjornson, Robert D.; Carriero, Nicholas J.] Yale Univ, Dept Comp Sci, Yale Ctr Genome Anal, New Haven, CT 06511 USA; [Meyer, Kyle A.; Sestan, Nenad] Yale Univ, Sch Med, Kavli Inst Neurosci, Dept Neurobiol, New Haven, CT 06520 USA; [Bilguvar, Kaya; Guenel, Murat] Yale Univ, Sch Med, Program Neurogenet, Ctr Human Genet & Genom,Dept Neurosurg, New Haven, CT 06520 USA; [Mane, Shrikant M.] Yale Ctr Genome Anal, West Haven, CT 06516 USA; [Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15213 USA; [Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat & Human Genet, Pittsburgh, PA 15213 USA	Yale University; Yale University; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Yale University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	State, MW (corresponding author), Yale Univ, Sch Med, Dept Genet, Ctr Child Study,Dept Psychiat,Program Neurogenet, 230 S Frontage Rd, New Haven, CT 06520 USA.	dhg@mednet.ucla.edu; devlinbj@upmc.edu; matthew.state@yale.edu	State, Matthew/W-2256-2019; Sanders, Stephan/S-8645-2019; Willsey, A Jeremy/H-3001-2019; Choi, Murim/AAP-9120-2021	Willsey, A Jeremy/0000-0002-9922-3612; Sanders, Stephan/0000-0001-9112-5148; Stein, Jason/0000-0003-4829-0513; State, Matthew/0000-0003-1624-8302; Roeder, Kathryn/0000-0002-8869-6254; Parikshak, Neel/0000-0003-2027-1871	Simons Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH077823, K08MH087639, U01MH081896] Funding Source: NIH RePORTER	Simons Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to all of the families participating in the Simons Foundation Autism Research Initiative (SFARI) Simplex Collection (SSC). This work was supported by a grant from the Simons Foundation. R. P. L. is an Investigator of the Howard Hughes Medical Institute. We thank the SSC principal investigators A. L. Beaudet, R. Bernier, J. Constantino, E. H. Cook Jr, E. Fombonne, D. Geschwind, D. E. Grice, A. Klin, D. H. Ledbetter, C. Lord, C. L. Martin, D. M. Martin, R. Maxim, J. Miles, O. Ousley, B. Peterson, J. Piggot, C. Saulnier, M. W. State, W. Stone, J. S. Sutcliffe, C. A. Walsh and E. Wijsman and the coordinators and staff at the SSC sites for the recruitment and comprehensive assessment of simplex families; the SFARI staff, in particular M. Benedetti, for facilitating access to the SSC; Prometheus Research for phenotypic data management and Prometheus Research and the Rutgers University Cell and DNA repository for accessing biomaterials; the Yale Center of Genomic Analysis, in particular M. Mahajan, S. Umlauf, I. Tikhonova and A. Lopez, for generating sequencing data; T. Brooks-Boone, N. Wright-Davis and M. Wojciechowski for their help in administering the project at Yale; I. Hart for support; G. D. Fischbach, A. Packer, J. Spiro, M. Benedetti and M. Carlson for their suggestions throughout; and B. Neale and M. Daly for discussions regarding de novo variation. We also acknowledge T. Lehner and the Autism Sequencing Consortium for providing an opportunity for pre-publication data exchange among the participating groups.	Abul-Husn NS, 2009, PROTEOMICS, V9, P3303, DOI 10.1002/pmic.200800767; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Collins MO, 2006, J NEUROCHEM, V97, P16, DOI 10.1111/j.1471-4159.2005.03507.x; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Cooper GM, 2010, NAT METHODS, V7, P250, DOI 10.1038/nmeth0410-250; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Girard SL, 2011, NAT GENET, V43, P860, DOI 10.1038/ng.886; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Kamiya K, 2004, J NEUROSCI, V24, P2690, DOI 10.1523/JNEUROSCI.3089-03.2004; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ogiwara I, 2009, NEUROLOGY, V73, P1046, DOI 10.1212/WNL.0b013e3181b9cebc; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Weiss LA, 2003, MOL PSYCHIATR, V8, P186, DOI 10.1038/sj.mp.4001241; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	23	1371	1411	3	244	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2012	485	7397					237	U124		10.1038/nature10945	http://dx.doi.org/10.1038/nature10945			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22495306	Green Accepted			2022-12-24	WOS:000303799800041
J	Kawamoto, S; Tran, TH; Maruya, M; Suzuki, K; Doi, Y; Tsutsui, Y; Kato, LM; Fagarasan, S				Kawamoto, Shimpei; Tran, Thinh H.; Maruya, Mikako; Suzuki, Keiichiro; Doi, Yasuko; Tsutsui, Yumi; Kato, Lucia M.; Fagarasan, Sidonia			The Inhibitory Receptor PD-1 Regulates IgA Selection and Bacterial Composition in the Gut	SCIENCE			English	Article							HELPER T-CELLS; GERMINAL CENTER; GENERATION; AFFINITY; HYPERMUTATION; DYNAMICS; MUTATION; MICE	Immunoglobulin A (IgA) is essential to maintain the symbiotic balance between gut bacterial communities and the host immune system. Here we provide evidence that the inhibitory co-receptor programmed cell death-1 (PD-1) regulates the gut microbiota through appropriate selection of IgA plasma cell repertoires. PD-1 deficiency generates an excess number of T follicular helper (T-FH) cells with altered phenotypes, which results in dysregulated selection of IgA precursor cells in the germinal center of Peyer's patches. Consequently, the IgAs produced in PD-1-deficient mice have reduced bacteria-binding capacity, which causes alterations of microbial communities in the gut. Thus, PD-1 plays a critical role in regulation of antibody diversification required for the maintenance of intact mucosal barrier.	[Kawamoto, Shimpei; Tran, Thinh H.; Maruya, Mikako; Suzuki, Keiichiro; Doi, Yasuko; Tsutsui, Yumi; Kato, Lucia M.; Fagarasan, Sidonia] RIKEN, Lab Mucosal Immun, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; [Tran, Thinh H.] Hanoi Med Univ, Dept Biochem, Hanoi, Vietnam; [Suzuki, Keiichiro] Kyoto Univ, AK Project, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan; [Kato, Lucia M.] Kyoto Univ, Dept Immunol & Genom Med, Grad Sch Med, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; Hanoi Medical University; Kyoto University; Kyoto University	Fagarasan, S (corresponding author), RIKEN, Lab Mucosal Immun, Res Ctr Allergy & Immunol, 1-7-22 Tsurumi, Yokohama, Kanagawa 2300045, Japan.	sidonia-f@rcai.riken.jp	Fagarasan, Sidonia/A-5258-2016	Fagarasan, Sidonia/0000-0003-2086-6402	RIKEN; Special Postdoctoral Researchers Program	RIKEN; Special Postdoctoral Researchers Program	We thank T. Honjo, T. Okazaki, T. Okada, I. Taniuchi, O. Kanagawa, N. Minato, and S. Casola for inspiring discussions, suggestions, and critical comments; M. Miyajima and D. Sutherland for critically reading of the manuscript; and Y. Murahashi and T. Kaji for technical assistance. The data reported in this paper are tabulated in the main paper and the supplementary materials. Supported by Grants-in-Aid for Scientific Research in Priority Areas (S. F.) and by RIKEN President's Discretionary Fund (S. F.) and Special Postdoctoral Researchers Program (S.K.).	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Fagarasan S, 2010, ANNU REV IMMUNOL, V28, P243, DOI 10.1146/annurev-immunol-030409-101314; Good-Jacobson KL, 2010, NAT IMMUNOL, V11, P535, DOI 10.1038/ni.1877; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hershberg U, 2008, INT IMMUNOL, V20, P683, DOI 10.1093/intimm/dxn026; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kwon H, 2009, IMMUNITY, V31, P941, DOI 10.1016/j.immuni.2009.10.008; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Mei HE, 2010, BLOOD, V116, P5181, DOI 10.1182/blood-2010-01-266536; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Okazaki T, 2011, J EXP MED, V208, P395, DOI 10.1084/jem.20100466; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991; Yuvaraj S, 2009, J IMMUNOL, V183, P4871, DOI 10.4049/jimmunol.0901315	23	308	335	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					485	489		10.1126/science.1217718	http://dx.doi.org/10.1126/science.1217718			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539724				2022-12-24	WOS:000303233400050
J	Khila, A; Abouheif, E; Rowe, L				Khila, Abderrahman; Abouheif, Ehab; Rowe, Locke			Function, Developmental Genetics, and Fitness Consequences of a Sexually Antagonistic Trait	SCIENCE			English	Article							SEX DETERMINATION; BEETLE HORNS; EVOLUTION; DROSOPHILA; CONFLICT; DIVERSIFICATION; HETEROPTERA; COEVOLUTION; APPENDAGES; PHYLOGENY	Sexual conflict is thought to be a potent force driving the evolution of sexually dimorphic traits. In the water strider Rheumatobates rileyi, we show that elaborated traits on male antennae function to grasp resistant females during premating struggles. Using RNA interference, we uncovered novel roles of the gene distal-less (dll) in generating these male-specific traits. Furthermore, graded reduction of the grasping traits resulted in a graded reduction of mating success in males, thus demonstrating both selection for elaboration of the traits and the role of dll in their evolution. By establishing developmental genetic tools in model systems where sexual selection and conflict are understood, we can begin to reveal how selection can exploit ancient developmental genes to enable the evolution of sexually dimorphic traits.	[Khila, Abderrahman; Rowe, Locke] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada; [Khila, Abderrahman; Abouheif, Ehab] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Khila, Abderrahman] Ecole Normale Super Lyon, CNRS, UMR 5242, Inst Genom Fonct Lyon, F-69364 Lyon 07, France	University of Toronto; McGill University; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Rowe, L (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON M5S 3B2, Canada.	locke.rowe@utoronto.ca		Abouheif, Ehab/0000-0001-7651-1737; Khila, Abderrahman/0000-0003-0908-483X	Canada Research Chairs program; Natural Sciences and Engineering Research Council of Canada; ATIP-Avenir CNRS France	Canada Research Chairs program(Canada Research Chairs); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ATIP-Avenir CNRS France	Supported by the Canada Research Chairs program and the Natural Sciences and Engineering Research Council of Canada (L.R. and E.A.) and by ATIP-Avenir program CNRS France (A.K.). We thank G. Arnqvist, A. Bruce, and M. Sokolowski for comments; H. Rodd and A. Agrawal for sharing their high-speed camera; and S. B. Carroll for the Dll antibody. DNA sequences were deposited in GenBank (accession nos. JQ639098, JQ639093, JQ639097, JQ639094, JN936863, JQ639092, JQ639096, and JQ639095).	Angelini DR, 2005, DEV BIOL, V286, P57, DOI 10.1016/j.ydbio.2005.07.006; Arnqvist G, 2002, NATURE, V415, P787, DOI 10.1038/415787a; Arnqvist Goran, 2005, pUnpaginated; Beermann A, 2001, DEVELOPMENT, V128, P287; Bonduriansky R, 2009, TRENDS ECOL EVOL, V24, P280, DOI 10.1016/j.tree.2008.12.005; Buaas FW, 2009, HUM MOL GENET, V18, P2989, DOI 10.1093/hmg/ddp237; Clifford R, 2000, DEVELOPMENT, V127, P5265; Damgaard J, 2005, SYST ENTOMOL, V30, P289, DOI 10.1111/j.1365-3113.2004.00275.x; Emlen DJ, 2007, P NATL ACAD SCI USA, V104, P8661, DOI 10.1073/pnas.0701209104; Hosken D, 2005, AM NAT, V165, pS1, DOI 10.1086/429355; Khila A, 2007, DEV GENES EVOL, V217, P241, DOI 10.1007/s00427-007-0132-9; Khila A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000583; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Moczek AP, 2009, P NATL ACAD SCI USA, V106, P8992, DOI 10.1073/pnas.0809668106; Panganiban G, 1997, P NATL ACAD SCI USA, V94, P5162, DOI 10.1073/pnas.94.10.5162; Panganiban G, 2000, DEV DYNAM, V218, P554, DOI 10.1002/1097-0177(200008)218:4<554::AID-DVDY1023>3.0.CO;2-#; ROWE L, 1994, TRENDS ECOL EVOL, V9, P289, DOI 10.1016/0169-5347(94)90032-9; Rowe L, 2002, EVOLUTION, V56, P754; Rowe L, 2006, CAN ENTOMOL, V138, P568; Tanaka K, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001131; Tregenza T, 2006, PHILOS T R SOC B, V361, P229, DOI 10.1098/rstb.2005.1796; Werner T, 2010, NATURE, V464, P1143, DOI 10.1038/nature08896; Westlake KP, 2000, SYST ENTOMOL, V25, P125, DOI 10.1046/j.1365-3113.2000.00098.x; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Williams TM, 2009, NAT REV GENET, V10, P797, DOI 10.1038/nrg2687	25	66	66	0	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					585	589		10.1126/science.1217258	http://dx.doi.org/10.1126/science.1217258			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556252				2022-12-24	WOS:000303498800045
J	Sfeir, A; de Lange, T				Sfeir, Agnel; de lange, Titia			Removal of Shelterin Reveals the Telomere End-Protection Problem	SCIENCE			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; DYSFUNCTIONAL TELOMERES; MAMMALIAN TELOMERES; JOINING PATHWAY; POT1 PROTEINS; YEAST KU; DNA; SGS1; NHEJ	The telomere end-protection problem is defined by the aggregate of DNA damage signaling and repair pathways that require repression at telomeres. To define the end-protection problem, we removed the whole shelterin complex from mouse telomeres through conditional deletion of TRF1 and TRF2 in nonhomologous end-joining (NHEJ) deficient cells. The data reveal two DNA damage response pathways not previously observed upon deletion of individual shelterin proteins. The shelterin-free telomeres are processed by microhomology-mediated alternative-NHEJ when Ku70/80 is absent and are attacked by nucleolytic degradation in the absence of 53BP1. The data establish that the end-protection problem is specified by six pathways [ATM (ataxia telangiectasia mutated) and ATR (ataxia telangiectasia and Rad3 related) signaling, classical-NHEJ, alt-NHEJ, homologous recombination, and resection] and show how shelterin acts with general DNA damage response factors to solve this problem.	[Sfeir, Agnel; de lange, Titia] Rockefeller Univ, Lab Cell Biol & Genet, New York, NY 10065 USA	Rockefeller University	de Lange, T (corresponding author), Rockefeller Univ, Lab Cell Biol & Genet, 1230 York Ave, New York, NY 10065 USA.	delange@mail.rockefeller.edu	de Lange, Titia/B-8263-2011	de Lange, Titia/0000-0002-9267-367X	NIH [GM49046, AG016642]; NATIONAL CANCER INSTITUTE [R01CA076027] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049046, R37GM049046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016642] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank D. White for exceptional dedication to the mouse husbandry involved in this project and members of the de Lange laboratory for comments on this manuscript. This work was supported by grants from the NIH to T.dL. (GM49046 and AG016642). T.dL. is an American Cancer Society Research Professor.	Baumann P, 2000, MOL BIOL CELL, V11, P3265, DOI 10.1091/mbc.11.10.3265; Boboila C, 2010, J EXP MED, V207, P417, DOI 10.1084/jem.20092449; Bouwman P, 2010, NAT STRUCT MOL BIOL, V17, P688, DOI 10.1038/nsmb.1831; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Celli GB, 2006, NAT CELL BIOL, V8, P885, DOI 10.1038/ncb1444; de Lange T, 2009, SCIENCE, V326, P948, DOI 10.1126/science.1170633; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Dimitrova N, 2008, NATURE, V456, P524, DOI 10.1038/nature07433; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Hockemeyer D, 2006, CELL, V126, P63, DOI 10.1016/j.cell.2006.04.044; Kibe T, 2010, MOL CELL BIOL, V30, P1059, DOI 10.1128/MCB.01498-09; Mansour WY, 2010, NUCLEIC ACIDS RES, V38, P6065, DOI 10.1093/nar/gkq387; Martinez P, 2009, GENE DEV, V23, P2060, DOI 10.1101/gad.543509; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Palm W, 2009, MOL CELL BIOL, V29, P471, DOI 10.1128/MCB.01352-08; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Polotnianka RM, 1998, CURR BIOL, V8, P831, DOI 10.1016/S0960-9822(98)70325-2; Rai R, 2010, EMBO J, V29, P2598, DOI 10.1038/emboj.2010.142; Riha K, 2003, P NATL ACAD SCI USA, V100, P611, DOI 10.1073/pnas.0236128100; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Simsek D, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002080; Simsek D, 2010, NAT STRUCT MOL BIOL, V17, P410, DOI 10.1038/nsmb.1773; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Wang ML, 2006, NUCLEIC ACIDS RES, V34, P6170, DOI 10.1093/nar/gkl840; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	30	394	405	1	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					593	597		10.1126/science.1218498	http://dx.doi.org/10.1126/science.1218498			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556254	Green Accepted			2022-12-24	WOS:000303498800047
J	Brugues, J; Nuzzo, V; Mazur, E; Needleman, DJ				Brugues, Jan; Nuzzo, Valeria; Mazur, Eric; Needleman, Daniel J.			Nucleation and Transport Organize Microtubules in Metaphase Spindles	CELL			English	Article							ULTRAVIOLET MICROBEAM IRRADIATION; CHROMOSOMAL PASSENGER COMPLEX; EGG EXTRACT SPINDLES; MITOTIC-SPINDLE; MEIOTIC SPINDLE; IN-VITRO; SELF-ORGANIZATION; HUMAN-CELLS; DYNAMICS; REVEALS	Spindles are arrays of microtubules that segregate chromosomes during cell division. It has been difficult to validate models of spindle assembly due to a lack of information on the organization of microtubules in these structures. Here we present a method, based on femtosecond laser ablation, capable of measuring the detailed architecture of spindles. We used this method to study the metaphase spindle in Xenopus laevis egg extracts and found that microtubules are shortest near poles and become progressively longer toward the center of the spindle. These data, in combination with mathematical modeling, imaging, and biochemical perturbations, are sufficient to reject previously proposed mechanisms of spindle assembly. Our results support a model of spindle assembly in which microtubule polymerization dynamics are not spatially regulated, and the proper organization of microtubules in the spindle is determined by nonuniform microtubule nucleation and the local sorting of microtubules by transport.	[Brugues, Jan; Needleman, Daniel J.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Brugues, Jan; Needleman, Daniel J.] Harvard Univ, Ctr Syst Biol, Cambridge, MA 02138 USA; [Brugues, Jan; Nuzzo, Valeria; Mazur, Eric; Needleman, Daniel J.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University	Brugues, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	jbrugues@fas.harvard.edu	Brugues, Jan/C-7727-2017	Brugues, Jan/0000-0002-6731-4130	Nation Science Foundation [PHY-0847188, DMR-0820484, CBET-0854288, PHY-0555583]; Human Frontiers Science Program	Nation Science Foundation(National Science Foundation (NSF)); Human Frontiers Science Program(Human Frontier Science Program)	We thank Tim Mitchison for advice; Martin Wuehr, Ryoma Ohi, and Marija Zanic for providing us with P150-CC1, MCAK antibodies, and GFP-EB1, respectively; Ramon Xulvi-Brunet for useful discussions on error estimation and numerical fits; and Simone Reber, Tim Mitchison, Philippe Cluzel, Reza Farhadifar, Pierre Sens, and Bodo Stern for valuable comments on the manuscript. This work was supported by Nation Science Foundation grants PHY-0847188, DMR-0820484, CBET-0854288 and PHY-0555583 and a fellowship (to J.B.) from the Human Frontiers Science Program.	Athale CA, 2008, SCIENCE, V322, P1243, DOI 10.1126/science.1161820; Botvinick EL, 2004, BIOPHYS J, V87, P4203, DOI 10.1529/biophysj.104.049528; Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; Burbank KS, 2007, CURR BIOL, V17, P1373, DOI 10.1016/j.cub.2007.07.058; Burbank KS, 2006, J CELL BIOL, V175, P369, DOI 10.1083/jcb.200511112; Carazo-Salas RE, 2001, NAT CELL BIOL, V3, P228, DOI 10.1038/35060009; Caudron M, 2005, SCIENCE, V309, P1373, DOI 10.1126/science.1115964; Clausen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000244; COLOMBELLI J, 2005, MED LASER APPL, V20, P217; COUE M, 1991, J CELL BIOL, V112, P1165, DOI 10.1083/jcb.112.6.1165; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Dumont S, 2009, CURR BIOL, V19, pR749, DOI 10.1016/j.cub.2009.07.028; EUTENEUER U, 1982, J CELL BIOL, V94, P644, DOI 10.1083/jcb.94.3.644; EUTENEUER U, 1980, J CELL BIOL, V87, P509, DOI 10.1083/jcb.87.2.509; FORER A, 1965, J CELL BIOL, V25, P95, DOI 10.1083/jcb.25.1.95; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Ganem NJ, 2005, CURR BIOL, V15, P1827, DOI 10.1016/j.cub.2005.08.065; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2010, ANNU REV CELL DEV BI, V26, P21, DOI 10.1146/annurev-cellbio-100109-104006; Greenan G, 2010, CURR BIOL, V20, P353, DOI 10.1016/j.cub.2009.12.050; Groen AC, 2008, J CELL SCI, V121, P2293, DOI 10.1242/jcs.024018; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1997, J CELL BIOL, V138, P615, DOI 10.1083/jcb.138.3.615; Heisterkamp A, 2005, OPT EXPRESS, V13, P3690, DOI 10.1364/OPEX.13.003690; Howard J, 2007, CURR OPIN CELL BIOL, V19, P31, DOI 10.1016/j.ceb.2006.12.009; Inoue S., 1964, PRIMITIVE MOTILE SYS, P549; Karsenti E, 2001, SCIENCE, V294, P543, DOI 10.1126/science.1063488; Khodjakov A, 2004, CURR BIOL, V14, P1330, DOI 10.1016/j.cub.2004.07.028; LESLIE RJ, 1984, CELL, V36, P717, DOI 10.1016/0092-8674(84)90352-0; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Maiato H, 2005, NAT CELL BIOL, V7, P42, DOI 10.1038/ncb1207; MASTRONARDE DN, 1993, J CELL BIOL, V123, P1475, DOI 10.1083/jcb.123.6.1475; MCINTOSH JR, 1971, J CELL BIOL, V49, P468, DOI 10.1083/jcb.49.2.468; Miyamoto DT, 2004, J CELL BIOL, V167, P813, DOI 10.1083/jcb.200407126; Mogilner A, 2010, J CELL SCI, V123, P3435, DOI 10.1242/jcs.062208; Murray A. W., 1993, METHOD CELL BIOL, P581; Needleman DJ, 2010, MOL BIOL CELL, V21, P323, DOI 10.1091/mbc.E09-09-0816; NICKLAS RB, 1989, J CELL SCI, V94, P415; Sampath SC, 2004, CELL, V118, P187, DOI 10.1016/j.cell.2004.06.026; SAWIN KE, 1991, J CELL BIOL, V112, P925, DOI 10.1083/jcb.112.5.925; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; SPURCK TP, 1990, J CELL BIOL, V111, P1505, DOI 10.1083/jcb.111.4.1505; Srayko M, 2006, CURR BIOL, V16, P1944, DOI 10.1016/j.cub.2006.08.029; Tirnauer JS, 2004, MOL BIOL CELL, V15, P1776, DOI 10.1091/mbc.E03-11-0824; Tournebize R, 2000, NAT CELL BIOL, V2, P13, DOI 10.1038/71330; Tseng BS, 2010, DEV CELL, V18, P903, DOI 10.1016/j.devcel.2010.05.018; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; WALKER RA, 1989, J CELL BIOL, V108, P931, DOI 10.1083/jcb.108.3.931; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Winey M, 2005, MOL BIOL CELL, V16, P1178, DOI 10.1091/mbc.E04-09-0765; Yang G, 2008, J CELL BIOL, V182, P631, DOI 10.1083/jcb.200801105; Yang G, 2007, NAT CELL BIOL, V9, P1233, DOI 10.1038/ncb1643	53	110	111	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					554	564		10.1016/j.cell.2012.03.027	http://dx.doi.org/10.1016/j.cell.2012.03.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541427	Bronze			2022-12-24	WOS:000303443100008
J	Hailer, F; Kutschera, VE; Hallstrom, BM; Klassert, D; Fain, SR; Leonard, JA; Arnason, U; Janke, A				Hailer, Frank; Kutschera, Verena E.; Hallstroem, Bjoern M.; Klassert, Denise; Fain, Steven R.; Leonard, Jennifer A.; Arnason, Ulfur; Janke, Axel			Nuclear Genomic Sequences Reveal that Polar Bears Are an Old and Distinct Bear Lineage	SCIENCE			English	Article							MITOCHONDRIAL-DNA; ANCIENT HYBRIDIZATION; GENETIC-STRUCTURE; INFERENCE; URSIDAE; SPECIATION; PHYLOGENY; HISTORY; ORIGIN; WOLVES	Recent studies have shown that the polar bear matriline (mitochondrial DNA) evolved from a brown bear lineage since the late Pleistocene, potentially indicating rapid speciation and adaption to arctic conditions. Here, we present a high-resolution data set from multiple independent loci across the nuclear genomes of a broad sample of polar, brown, and black bears. Bayesian coalescent analyses place polar bears outside the brown bear clade and date the divergence much earlier, in the middle Pleistocene, about 600 (338 to 934) thousand years ago. This provides more time for polar bear evolution and confirms previous suggestions that polar bears carry introgressed brown bear mitochondrial DNA due to past hybridization. Our results highlight that multilocus genomic analyses are crucial for an accurate understanding of evolutionary history.	[Hailer, Frank; Kutschera, Verena E.; Hallstroem, Bjoern M.; Klassert, Denise; Janke, Axel] Senckenberg Gesell Naturforsch, Biodivers & Climate Res Ctr BiK F, D-60325 Frankfurt, Germany; [Fain, Steven R.] Natl Fish & Wildlife Forens Lab, Ashland, OR USA; [Leonard, Jennifer A.] Estn Biol Donana EBD CSIC, Conservat & Evolutionary Genet Grp, Seville 41092, Spain; [Arnason, Ulfur] Univ Lund Hosp, S-22100 Lund, Sweden; [Janke, Axel] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, D-60438 Frankfurt, Germany	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Lund University; Skane University Hospital; Goethe University Frankfurt	Hailer, F (corresponding author), Senckenberg Gesell Naturforsch, Biodivers & Climate Res Ctr BiK F, Senckenberganlage 25, D-60325 Frankfurt, Germany.	frashai@gmx.net; ajanke@senckenberg.de	Kutschera, Verena E./H-8706-2013; Hailer, Frank/Y-3595-2019; Hailer, Frank/C-9114-2012; Janke, Axel/M-2135-2013; Leonard, Jennifer/A-7894-2010	Kutschera, Verena E./0000-0002-8930-534X; Hailer, Frank/0000-0002-2340-1726; Hailer, Frank/0000-0002-2340-1726; Janke, Axel/0000-0002-9394-1904; Leonard, Jennifer/0000-0003-0291-7819	Hesse's LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz	Hesse's LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz	The study was supported by Hesse's LOEWE, Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz. We thank E. W. Born, H.-G. Eiken, C. Frosch, S. Hagen, A. Kopatz, C. Nowak, M. Onucsan, M. Pfenninger, K. Skirnisson, F. Zachos, and P. Beerli for providing samples and for discussions. Obtained sequences have been deposited in the EMBL database (accession nos. HE657192 to HE657234 and HE657776 to HE658979). The authors declare no competing financial interests.	Amstrup SC., 2003, WILD MAMMALS N AM BI, P587; Anderson TM, 2009, SCIENCE, V323, P1339, DOI 10.1126/science.1165448; Beerli P, 2006, BIOINFORMATICS, V22, P341, DOI 10.1093/bioinformatics/bti803; Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Davison J, 2011, QUATERNARY SCI REV, V30, P418, DOI 10.1016/j.quascirev.2010.11.023; Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; Funk DJ, 2003, ANNU REV ECOL EVOL S, V34, P397, DOI 10.1146/annurev.ecolsys.34.011802.132421; Good JM, 2008, MOL ECOL, V17, P1313, DOI 10.1111/j.1365-294X.2007.03640.x; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Kelly B, 2010, NATURE, V468, P891, DOI 10.1038/468891a; Kurten B., 1964, Acta Zoologica Fennica, V108, P1; Larsen PA, 2010, P NATL ACAD SCI USA, V107, P11447, DOI 10.1073/pnas.1000133107; Leonard JA, 2000, P NATL ACAD SCI USA, V97, P1651, DOI 10.1073/pnas.040453097; Lindqvist C, 2010, P NATL ACAD SCI USA, V107, P5053, DOI 10.1073/pnas.0914266107; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Nakagome S, 2008, MOL BIOL EVOL, V25, P1344, DOI 10.1093/molbev/msn086; Paetkau D, 1999, MOL ECOL, V8, P1571, DOI 10.1046/j.1365-294x.1999.00733.x; Pages M, 2008, MOL PHYLOGENET EVOL, V47, P73, DOI 10.1016/j.ympev.2007.10.019; Perini FA, 2010, J EVOLUTION BIOL, V23, P311, DOI 10.1111/j.1420-9101.2009.01901.x; Pilot M, 2006, MOL ECOL, V15, P4533, DOI 10.1111/j.1365-294X.2006.03110.x; Pritchard JK, 2000, GENETICS, V155, P945; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; SHIELDS GF, 1991, EVOLUTION, V45, P218, DOI 10.1111/j.1558-5646.1991.tb05279.x; Slater GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013870; Uyeda JC, 2011, P NATL ACAD SCI USA, V108, P15908, DOI 10.1073/pnas.1014503108; Welch AJ, 2011, MOL ECOL, V20, P1364, DOI 10.1111/j.1365-294X.2011.05008.x; Yu L, 2004, MOL PHYLOGENET EVOL, V32, P480, DOI 10.1016/j.ympev.2004.02.015; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	31	166	170	9	345	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					344	347		10.1126/science.1216424	http://dx.doi.org/10.1126/science.1216424			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517859	Green Submitted			2022-12-24	WOS:000302995400045
J	Yuan, JH; Branch, RW; Hosu, BG; Berg, HC				Yuan, Junhua; Branch, Richard W.; Hosu, Basarab G.; Berg, Howard C.			Adaptation at the output of the chemotaxis signalling pathway	NATURE			English	Article							ESCHERICHIA-COLI CHEMOTAXIS; BACTERIAL FLAGELLAR MOTOR; RESONANCE ENERGY-TRANSFER; ROTARY MOTOR; ZERO LOAD; IN-VIVO; SENSITIVITY; PROTEIN; EXPRESSION; RECEPTORS	In the bacterial chemotaxis network, receptor clusters process input(1-3), and flagellar motors generate output(4). Receptor and motor complexes are coupled by the diffusible protein CheY-P. Receptor output (the steady-state concentration of CheY-P) varies from cell to cell(5). However, the motor is ultrasensitive, with a narrow operating range of CheY-P concentrations(6). How the match between receptor output and motor input might be optimized is unclear. Here we show that the motor can shift its operating range by changing its composition. The number of FliM subunits in the C-ring increases in response to a decrement in the concentration of CheY-P, increasing motor sensitivity. This shift in sensitivity explains the slow partial adaptation observed in mutants that lack the receptor methyltransferase and methylesterase(7,8) and why motors show signal-dependent FliM turnover(9). Adaptive remodelling is likely to be a common feature in the operation of many molecular machines.	[Yuan, Junhua; Branch, Richard W.; Hosu, Basarab G.; Berg, Howard C.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Berg, HC (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	hberg@mcb.harvard.edu			National Institutes of Health [AI016478]; EMBO; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI016478, R37AI016478] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant AI016478. R.W.B. is a recipient of an EMBO Long-Term Fellowship.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737; BERG HC, 1984, J GEN MICROBIOL, V130, P2915; BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208; Blat Y, 1996, J BIOL CHEM, V271, P1226, DOI 10.1074/jbc.271.2.1226; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Delalez NJ, 2010, P NATL ACAD SCI USA, V107, P11347, DOI 10.1073/pnas.1000284107; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; Fukuoka H, 2010, BIOCHEM BIOPH RES CO, V394, P130, DOI 10.1016/j.bbrc.2010.02.129; Greenfield D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000137; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hansen CH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040001; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Leake MC, 2006, NATURE, V443, P355, DOI 10.1038/nature05135; Levin MD, 1998, BIOPHYS J, V74, P175, DOI 10.1016/S0006-3495(98)77777-X; Lipkow K, 2006, PLOS COMPUT BIOL, V2, P301, DOI 10.1371/journal.pcbi.0020039; Mello BA, 2007, BIOPHYS J, V92, P2329, DOI 10.1529/biophysj.106.097808; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; PARKINSON JS, 1978, J BACTERIOL, V135, P45, DOI 10.1128/JB.135.1.45-53.1978; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; SEGALL JE, 1986, P NATL ACAD SCI USA, V83, P8987, DOI 10.1073/pnas.83.23.8987; Shimizu TS, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.37; Shimizu TS, 2006, P NATL ACAD SCI USA, V103, P2093, DOI 10.1073/pnas.0510958103; Sourjik V, 2004, TRENDS MICROBIOL, V12, P569, DOI 10.1016/j.tim.2004.10.003; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; STOCK J, 1985, CELL, V42, P683, DOI 10.1016/0092-8674(85)90125-4; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tumer L, 1996, BIOPHYS J, V71, P2227, DOI 10.1016/S0006-3495(96)79425-0; Yuan JH, 2008, P NATL ACAD SCI USA, V105, P1182, DOI 10.1073/pnas.0711539105; Yuan JH, 2010, P NATL ACAD SCI USA, V107, P12846, DOI 10.1073/pnas.1007333107; Yuan JH, 2009, J MOL BIOL, V390, P394, DOI 10.1016/j.jmb.2009.05.039	36	110	113	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					233	U115		10.1038/nature10964	http://dx.doi.org/10.1038/nature10964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498629	Green Submitted, Green Accepted			2022-12-24	WOS:000303149900033
J	Fang, F; Fall, K; Mittleman, MA; Sparen, P; Ye, WM; Adami, HO; Valdimarsdottir, U				Fang, Fang; Fall, Katja; Mittleman, Murray A.; Sparen, Par; Ye, Weimin; Adami, Hans-Olov; Valdimarsdottir, Unnur			Suicide and Cardiovascular Death after a Cancer Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER; PSYCHOLOGICAL DISTRESS; PROSTATE-CANCER; CASE-CROSSOVER; RISK; PREVALENCE; DISORDERS; THERAPY; ILLNESS; DISEASE	BACKGROUND Receiving a diagnosis of cancer is a traumatic experience that may trigger immediate adverse health consequences beyond the effects of the disease or treatment. METHODS Using Poisson and negative binomial regression models, we conducted a historical cohort study involving 6,073,240 Swedes to examine the associations between a cancer diagnosis and the immediate risk of suicide or death from cardiovascular causes from 1991 through 2006. To adjust for unmeasured confounders, we also performed a nested, self-matched case-crossover analysis among all patients with cancer who died from suicide or cardiovascular diseases in the cohort. RESULTS As compared with cancer-free persons, the relative risk of suicide among patients receiving a cancer diagnosis was 12.6 (95% confidence interval [CI], 8.6 to 17.8) during the first week (29 patients; incidence rate, 2.50 per 1000 person-years) and 3.1 (95% CI, 2.7 to 3.5) during the first year (260 patients; incidence rate, 0.60 per 1000 personyears). The relative risk of cardiovascular death after diagnosis was 5.6 (95% CI, 5.2 to 5.9) during the first week (1318 patients; incidence rate, 116.80 per 1000 person-years) and 3.3 (95% CI, 3.1 to 3.4) during the first 4 weeks (2641 patients; incidence rate, 65.81 per 1000 person-years). The risk elevations decreased rapidly during the first year after diagnosis. Increased risk was particularly prominent for cancers with a poor prognosis. The case-crossover analysis largely confirmed results from the main analysis. CONCLUSIONS In this large cohort study, patients who had recently received a cancer diagnosis had increased risks of both suicide and death from cardiovascular causes, as compared with cancer-free persons. (Funded by the Swedish Council for Working Life and Social Research and others.)	[Fang, Fang; Sparen, Par; Ye, Weimin; Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Fall, Katja] Univ Orebro, Clin Epidemiol & Biostat Unit, Orebro, Sweden; [Fall, Katja] Orebro Univ Hosp, Orebro, Sweden; [Mittleman, Murray A.] Beth Israel Deaconess Med Ctr, Dept Med, Cardiovasc Epidemiol Res Unit, Boston, MA 02215 USA; [Mittleman, Murray A.] Harvard Univ, Sch Med, Boston, MA USA; [Fall, Katja; Mittleman, Murray A.; Adami, Hans-Olov; Valdimarsdottir, Unnur] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Fall, Katja; Valdimarsdottir, Unnur] Univ Iceland, Ctr Publ Hlth Sci, Reykjavik, Iceland	Karolinska Institutet; Orebro University; Orebro University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Iceland	Fang, F (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Box 281, S-17177 Stockholm, Sweden.	fang.fang@ki.se	Fall, Katja/AAE-1876-2021; Papadopoulos, Fotios/H-1319-2019	Fall, Katja/0000-0002-3649-2639; Papadopoulos, Fotios/0000-0002-8692-3652; Valdimarsdottir, Unnur/0000-0001-5382-946X; Fang, Fang/0000-0002-3310-6456; Sparen, Par/0000-0002-5184-8971; Mittleman, Murray/0000-0001-9788-7274	Swedish Council for Working Life and Social Research [2008-1310, 2011-0473]; Swedish Research Council [SIMSAM 80748301]; Hjarnfonden and Svenska Sallskapet for Medicinsk Forskning	Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Hjarnfonden and Svenska Sallskapet for Medicinsk Forskning	Supported by grants from the Swedish Council for Working Life and Social Research (2008-1310 and 2011-0473) and the Swedish Research Council (SIMSAM 80748301) and by postdoctoral fellowships (to Dr. Fang) from Hjarnfonden and Svenska Sallskapet for Medicinsk Forskning.	ALLEBECK P, 1989, J CLIN EPIDEMIOL, V42, P611, DOI 10.1016/0895-4356(89)90003-6; Annunziata MA, 2011, SUPPORT CARE CANCER, V19, P291, DOI 10.1007/s00520-010-0818-9; Carlson LE, 2010, J CLIN ONCOL, V28, P4884, DOI 10.1200/JCO.2009.27.3698; Collier A, 2011, AM J CLIN ONCOL 0203; Fall K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000197; Fang F, 2010, JNCI-J NATL CANCER I, V102, P307, DOI 10.1093/jnci/djp537; Hem E, 2004, J CLIN ONCOL, V22, P4209, DOI 10.1200/jco.2004.02.052; Ikeda RM, 2001, SUICIDE LIFE-THREAT, V32, P60, DOI 10.1521/suli.32.1.5.60.24207; Johnson TV, 2011, PSYCHOONCOLOGY  0124; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P763, DOI 10.1037/0022-006X.73.4.763; Keating NL, 2010, J NATL CANCER I, V102, P39, DOI 10.1093/jnci/djp404; Llorente MD, 2005, AM J GERIAT PSYCHIAT, V13, P195, DOI 10.1176/appi.ajgp.13.3.195; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Mehnert A, 2007, PSYCHO-ONCOLOGY, V16, P181, DOI 10.1002/pon.1057; Millar K, 2005, J PSYCHOSOM RES, V58, P335, DOI 10.1016/j.jpsychores.2004.10.005; Miller M, 2008, J CLIN ONCOL, V26, P4720, DOI 10.1200/JCO.2007.14.3990; Misono S, 2008, J CLIN ONCOL, V26, P4731, DOI 10.1200/JCO.2007.13.8941; MITTLEMAN MA, 1995, AM J EPIDEMIOL, V142, P91, DOI 10.1093/oxfordjournals.aje.a117550; Mouridsen H, 2007, J CLIN ONCOL, V25, P5715, DOI 10.1200/JCO.2007.12.1665; Norton TR, 2004, J CLIN ONCOL, V22, P919, DOI 10.1200/JCO.2004.07.028; Quan H, 2002, SOC PSYCH PSYCH EPID, V37, P190, DOI 10.1007/s001270200014; Schairer C, 2006, JNCI-J NATL CANCER I, V98, P1416, DOI 10.1093/jnci/djj377; Sellick SM, 2007, PSYCHO-ONCOL, V16, P534, DOI 10.1002/pon.1085; Senf B, 2010, SUPPORT CARE CANCER, V18, P957, DOI 10.1007/s00520-010-0850-9; Thurlimann B, 2005, NEW ENGL J MED, V353, P2747; Turner J, 2005, PSYCHO-ONCOLOGY, V14, P396, DOI 10.1002/pon.856; Van Hemelrijck M, 2010, J CLIN ONCOL, V28, P3448, DOI 10.1200/JCO.2010.29.1567	27	278	284	4	34	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 5	2012	366	14					1310	1318		10.1056/NEJMoa1110307	http://dx.doi.org/10.1056/NEJMoa1110307			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	919QJ	22475594				2022-12-24	WOS:000302343000008
J	Berger, MF; Hodis, E; Heffernan, TP; Deribe, YL; Lawrence, MS; Protopopov, A; Ivanova, E; Watson, IR; Nickerson, E; Ghosh, P; Zhang, HL; Zeid, R; Ren, XJ; Cibulskis, K; Sivachenko, AY; Wagle, N; Sucker, A; Sougnez, C; Onofrio, R; Ambrogio, L; Auclair, D; Fennell, T; Carter, SL; Drier, Y; Stojanov, P; Singer, MA; Voet, D; Jing, R; Saksena, G; Barretina, J; Ramos, AH; Pugh, TJ; Stransky, N; Parkin, M; Winckler, W; Mahan, S; Ardlie, K; Baldwin, J; Wargo, J; Schadendorf, D; Meyerson, M; Gabriel, SB; Golub, TR; Wagner, SN; Lander, ES; Getz, G; Chin, L; Garraway, LA				Berger, Michael F.; Hodis, Eran; Heffernan, Timothy P.; Deribe, Yonathan Lissanu; Lawrence, Michael S.; Protopopov, Alexei; Ivanova, Elena; Watson, Ian R.; Nickerson, Elizabeth; Ghosh, Papia; Zhang, Hailei; Zeid, Rhamy; Ren, Xiaojia; Cibulskis, Kristian; Sivachenko, Andrey Y.; Wagle, Nikhil; Sucker, Antje; Sougnez, Carrie; Onofrio, Robert; Ambrogio, Lauren; Auclair, Daniel; Fennell, Timothy; Carter, Scott L.; Drier, Yotam; Stojanov, Petar; Singer, Meredith A.; Voet, Douglas; Jing, Rui; Saksena, Gordon; Barretina, Jordi; Ramos, Alex H.; Pugh, Trevor J.; Stransky, Nicolas; Parkin, Melissa; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Wargo, Jennifer; Schadendorf, Dirk; Meyerson, Matthew; Gabriel, Stacey B.; Golub, Todd R.; Wagner, Stephan N.; Lander, Eric S.; Getz, Gad; Chin, Lynda; Garraway, Levi A.			Melanoma genome sequencing reveals frequent PREX2 mutations	NATURE			English	Article							HUMAN CANCER; MALIGNANT-MELANOMA; SOMATIC MUTATIONS; INHIBITION; PATTERNS; BRAF; REARRANGEMENTS; SPECIFICITY; ACTIVATION; SURVIVAL	Melanoma is notable for its metastatic propensity, lethality in the advanced setting and association with ultraviolet exposure early in life(1). To obtain a comprehensive genomic view of melanoma in humans, we sequenced the genomes of 25 metastatic melanomas and matched germline DNA. A wide range of point mutation rates was observed: lowest in melanomas whose primaries arose on non-ultraviolet-exposed hairless skin of the extremities (3 and 14 per megabase (Mb) of genome), intermediate in those originating from hair-bearing skin of the trunk (5-55 per Mb), and highest in a patient with a documented history of chronic sun exposure (111 per Mb). Analysis of whole-genome sequence data identified PREX2 (phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 2)-a PTEN-interacting protein and negative regulator of PTEN in breast cancer(2)-as a significantly mutated gene with a mutation frequency of approximately 14% in an independent extension cohort of 107 human melanomas. PREX2 mutations are biologically relevant, as ectopic expression of mutant PREX2 accelerated tumour formation of immortalized human melanocytes in vivo. Thus, whole-genome sequencing of human melanoma tumours revealed genomic evidence of ultraviolet pathogenesis and discovered a new recurrently mutated gene in melanoma.	[Berger, Michael F.; Hodis, Eran; Lawrence, Michael S.; Nickerson, Elizabeth; Cibulskis, Kristian; Sivachenko, Andrey Y.; Sougnez, Carrie; Onofrio, Robert; Ambrogio, Lauren; Auclair, Daniel; Fennell, Timothy; Carter, Scott L.; Stojanov, Petar; Voet, Douglas; Jing, Rui; Saksena, Gordon; Barretina, Jordi; Ramos, Alex H.; Pugh, Trevor J.; Stransky, Nicolas; Parkin, Melissa; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Meyerson, Matthew; Gabriel, Stacey B.; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Chin, Lynda; Garraway, Levi A.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Heffernan, Timothy P.; Deribe, Yonathan Lissanu; Protopopov, Alexei; Ivanova, Elena; Watson, Ian R.; Ghosh, Papia; Zhang, Hailei; Zeid, Rhamy; Ren, Xiaojia; Wagle, Nikhil; Singer, Meredith A.; Pugh, Trevor J.; Meyerson, Matthew; Chin, Lynda; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wagle, Nikhil; Ramos, Alex H.; Pugh, Trevor J.; Meyerson, Matthew; Chin, Lynda; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Sucker, Antje; Schadendorf, Dirk] Univ Hosp Essen, Dept Dermatol, D-45122 Essen, Germany; [Drier, Yotam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Wargo, Jennifer] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Meyerson, Matthew; Golub, Todd R.; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Wagner, Stephan N.] Med Univ Vienna, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria; [Wagner, Stephan N.] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Duisburg Essen; Weizmann Institute of Science; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Medical University of Vienna; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Massachusetts Institute of Technology (MIT); Whitehead Institute	Chin, L (corresponding author), Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Dept Genom Med, Houston, TX 77030 USA.	LChin@mdanderson.org; levi_garraway@dfci.harvard.edu	Wagle, Nikhil/Q-7428-2019; Stojanov, Petar/GQI-4462-2022; Pugh, Trevor/Y-2535-2019; Lawrence, Michael/AAC-8202-2020; Meyerson, Matthew L/E-7123-2012; Drier, Yotam/K-5208-2012; Cibulskis, Kristian/AAC-7380-2019; Schadendorf, Dirk/AAE-8206-2019; Barretina, Jordi/A-7192-2013	Stojanov, Petar/0000-0001-7815-776X; Pugh, Trevor/0000-0002-8073-5888; Drier, Yotam/0000-0003-1725-2995; Ivanova, Elena/0000-0002-5069-4974; Cibulskis, Kristian/0000-0003-1343-1582; Wagner, Stephan/0000-0003-4941-7029; Meyerson, Matthew/0000-0002-9133-8108; Barretina, Jordi/0000-0002-3478-4080; Watson, Ian/0000-0002-6025-3080	National Human Genome Research Institute; National Cancer Institute; FWF-Austrian Science Fund; NIH; Melanoma Research Alliance; Starr Cancer Consortium; Burroughs-Wellcome Fund; Austrian Science Fund (FWF) [L 590] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [T32CA009172, R33CA126674, R33CA155554] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FWF-Austrian Science Fund(Austrian Science Fund (FWF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; Starr Cancer Consortium; Burroughs-Wellcome Fund(Burroughs Wellcome Fund); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Illumina sequencing was performed at the Broad Institute and array-based genomic characterization and functional studies were performed at the Belfer Institute of DFCI. We are grateful to the Broad Institute Genome Sequencing Platform, Genome Analysis Platform and Biological Samples Platform. This work was supported by the National Human Genome Research Institute (S. B. G., E. S. L.), National Cancer Institute (M. M., L. C.), FWF-Austrian Science Fund (S.N.W.), NIH Director's New Innovator Award (L. A. G.), Melanoma Research Alliance (L. A. G., L. C.), Starr Cancer Consortium (L.A.G.) and the Burroughs-Wellcome Fund (L.A.G.).	Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; DROBETSKY EA, 1987, P NATL ACAD SCI USA, V84, P9103, DOI 10.1073/pnas.84.24.9103; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Flaherty KT, 2010, CURR OPIN ONCOL, V22, P178, DOI 10.1097/CCO.0b013e32833888ee; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Jane-Valbuena J, 2010, CANCER RES, V70, P2075, DOI 10.1158/0008-5472.CAN-09-3092; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kloosterman WP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r103; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Rausch T, 2012, CELL, V148, P59, DOI 10.1016/j.cell.2011.12.013; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Rubin AF, 2009, P NATL ACAD SCI USA, V106, P21766, DOI 10.1073/pnas.0912499106; Solit DB, 2011, NEW ENGL J MED, V364, P772, DOI 10.1056/NEJMcibr1013704; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; VRIELING H, 1991, NUCLEIC ACIDS RES, V19, P2411, DOI 10.1093/nar/19.9.2411; Wei XM, 2011, NAT GENET, V43, P442, DOI 10.1038/ng.810	29	523	545	1	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					502	506		10.1038/nature11071	http://dx.doi.org/10.1038/nature11071			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622578	Green Submitted, Green Accepted, hybrid			2022-12-24	WOS:000304344500043
J	Shan, YB; Eastwood, MP; Zhang, XW; Kim, ET; Arkhipov, A; Dror, RO; Jumper, J; Kuriyan, J; Shaw, DE				Shan, Yibing; Eastwood, Michael P.; Zhang, Xuewu; Kim, Eric T.; Arkhipov, Anton; Dror, Ron O.; Jumper, John; Kuriyan, John; Shaw, David E.			Oncogenic Mutations Counteract Intrinsic Disorder in the EGFR Kinase and Promote Receptor Dimerization	CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; LUNG-CANCER; MOLECULAR-DYNAMICS; SIGNAL PROPAGATION; TYROSINE KINASES; PROTEIN DYNAMICS; BINDING-SITE; DRUG-BINDING; ACTIVATION; DOMAIN	The mutation and overexpression of the epidermal growth factor receptor (EGFR) are associated with the development of a variety of cancers, making this prototypical dimerization-activated receptor tyrosine kinase a prominent target of cancer drugs. Using long-timescale molecular dynamics simulations, we find that the N lobe dimerization interface of the wild-type EGFR kinase domain is intrinsically disordered and that it becomes ordered only upon dimerization. Our simulations suggest, moreover, that some cancer-linked mutations distal to the dimerization interface, particularly the widespread L834R mutation (also referred to as L858R), facilitate EGFR dimerization by suppressing this local disorder. Corroborating these findings, our biophysical experiments and kinase enzymatic assays indicate that the L834R mutation causes abnormally high activity primarily by promoting EGFR dimerization rather than by allowing activation without dimerization. We also find that phosphorylation of EGFR kinase domain at Tyr845 may suppress the intrinsic disorder, suggesting a molecular mechanism for autonomous EGFR signaling.	[Shan, Yibing; Eastwood, Michael P.; Kim, Eric T.; Arkhipov, Anton; Dror, Ron O.; Jumper, John; Shaw, David E.] DE Shaw Res, New York, NY 10036 USA; [Zhang, Xuewu] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Zhang, Xuewu] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Kuriyan, John] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kuriyan, John] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Shaw, David E.] Columbia Univ, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA	D. E. Shaw Research; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Columbia University	Shan, YB (corresponding author), DE Shaw Res, New York, NY 10036 USA.	yibing.shan@deshawresearch.com; david.shaw@deshawresearch.com	Arkhipov, Anton/AAE-7801-2020	Arkhipov, Anton/0000-0003-1106-8310; Dror, Ron/0000-0002-6418-2793	National Cancer Institute [R01 CA96504]; NATIONAL CANCER INSTITUTE [R01CA096504] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Natalia Jura, Kate Engel, and Markus Seeliger for generously providing samples of EGFR and Src kinases, Stevan R. Hubbard and Kresten Lindorff-Larsen for helpful discussions, and Rebecca Kastleman and Mollie Kirk for editorial assistance. Author contributions: Y.S., M. P. E, and D. E. S. designed research; Y.S., E. T. K., A. A., and J.J. performed simulations; X.Z. and J.K. designed, and X.Z. performed, native gel and light scattering experiments; Y.S. analyzed data; Y.S., M. P. E., R.O.D., and D. E. S. wrote the article. J.K. and X.Z. were supported by the National Cancer Institute (R01 CA96504).	Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Banavali NK, 2009, PROTEINS, V74, P378, DOI 10.1002/prot.22153; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Biscardi JS, 1999, J BIOL CHEM, V274, P8335, DOI 10.1074/jbc.274.12.8335; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Choi SH, 2007, ONCOGENE, V26, P1567, DOI 10.1038/sj.onc.1209957; Cortese MS, 2008, PROG BIOPHYS MOL BIO, V98, P85, DOI 10.1016/j.pbiomolbio.2008.05.007; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Dror RO, 2009, P C HIGH PERF COMP N; Dror RO, 2011, P NATL ACAD SCI USA, V108, P13118, DOI 10.1073/pnas.1104614108; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Gilmer TM, 2008, CANCER RES, V68, P571, DOI 10.1158/0008-5472.CAN-07-2404; GOTOH N, 1992, BIOCHEM BIOPH RES CO, V186, P768, DOI 10.1016/0006-291X(92)90812-Y; Huang PH, 2010, MOL BIOSYST, V6, P1227, DOI 10.1039/c001196g; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ichinose J, 2004, BIOCHEM BIOPH RES CO, V324, P1143, DOI 10.1016/j.bbrc.2004.09.173; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Khan EM, 2008, FASEB J, V22, P910, DOI 10.1096/fj.06-7729com; Levy Y, 2005, J MOL BIOL, V346, P1121, DOI 10.1016/j.jmb.2004.12.021; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu B, 2006, PROTEINS, V65, P331, DOI 10.1002/prot.21111; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Mitsudomi T, 2010, FEBS J, V277, P301, DOI 10.1111/j.1742-4658.2009.07448.x; Mittag T, 2010, J MOL RECOGNIT, V23, P105, DOI 10.1002/jmr.961; Monsey J, 2010, J BIOL CHEM, V285, P7035, DOI 10.1074/jbc.M109.096032; Odaka M, 1997, J BIOCHEM-TOKYO, V122, P116; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Papakyriakou A, 2009, PROTEINS, V76, P375, DOI 10.1002/prot.22353; Qiu C, 2009, BIOCHEMISTRY-US, V48, P6624, DOI 10.1021/bi900755n; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Schlessinger A, 2005, PROTEINS, V61, P115, DOI 10.1002/prot.20587; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Seco J, 2009, J MED CHEM, V52, P2363, DOI 10.1021/jm801385d; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Sharma SV, 2009, EXP CELL RES, V315, P557, DOI 10.1016/j.yexcr.2008.07.026; Telesco SE, 2009, BIOPHYS J, V96, P2321, DOI 10.1016/j.bpj.2008.12.3912; Tompa P., 2010, STRUCTURE FUNCTION I; Verveer PJ, 2000, SCIENCE, V290, P1567, DOI 10.1126/science.290.5496.1567; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhou HX, 2012, TRENDS BIOCHEM SCI, V37, P43, DOI 10.1016/j.tibs.2011.11.002	54	236	242	3	69	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					860	870		10.1016/j.cell.2012.02.063	http://dx.doi.org/10.1016/j.cell.2012.02.063			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579287	Bronze			2022-12-24	WOS:000303934700018
J	Kenny, EE; Timpson, NJ; Sikora, M; Yee, MC; Moreno-Estrada, A; Eng, C; Huntsman, S; Burchard, EG; Stoneking, M; Bustamante, CD; Myles, S				Kenny, Eimear E.; Timpson, Nicholas J.; Sikora, Martin; Yee, Muh-Ching; Moreno-Estrada, Andres; Eng, Celeste; Huntsman, Scott; Burchard, Esteban Gonzalez; Stoneking, Mark; Bustamante, Carlos D.; Myles, Sean			Melanesian Blond Hair Is Caused by an Amino Acid Change in TYRP1	SCIENCE			English	Article							OCULOCUTANEOUS ALBINISM; PIGMENTATION; TYROSINASE; MUTATION; SKIN		[Kenny, Eimear E.; Sikora, Martin; Yee, Muh-Ching; Moreno-Estrada, Andres; Bustamante, Carlos D.; Myles, Sean] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Timpson, Nicholas J.] Univ Bristol, Sch Social & Community Med, Ctr Causal Analyses Translat Epidemiol, MRC, Bristol BS8 2BN, Avon, England; [Eng, Celeste; Huntsman, Scott; Burchard, Esteban Gonzalez] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci & Med, San Francisco, CA 94143 USA; [Stoneking, Mark] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, D-04103 Leipzig, Germany; [Bustamante, Carlos D.; Myles, Sean] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Myles, Sean] Nova Scotia Agr Coll, Dept Plant & Anim Sci, Truro, NS B2N 5E3, Canada	Stanford University; University of Bristol; University of California System; University of California San Francisco; Max Planck Society; Cornell University; Dalhousie University	Bustamante, CD (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	cdbustam@stanford.edu; smyles@nsac.ca	Sikora, Martin/C-8609-2015; Attrill, Lauren/V-1688-2018; Moreno-Estrada, Andres/R-3950-2017; Fox, Laura J/C-6249-2016; Timpson, Nicholas John/O-7548-2015; Moreno-Estrada, Andres/AAP-4657-2021	Sikora, Martin/0000-0003-2818-8319; Moreno-Estrada, Andres/0000-0001-8329-8292; Timpson, Nicholas John/0000-0002-7141-9189; Moreno-Estrada, Andres/0000-0001-8329-8292; Myles, Sean/0000-0001-9754-5987	Wenner-Gren Foundation for Anthropological Research; MRC Centre for Causal Analyses in Translational Epidemiology [RD1634]; National Heart, Lung, and Blood Institute; National Human Genome Research Institute; Max Planck Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078885, R01HL088133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015794] Funding Source: NIH RePORTER; Medical Research Council [G0600705] Funding Source: researchfish; MRC [G0600705] Funding Source: UKRI	Wenner-Gren Foundation for Anthropological Research; MRC Centre for Causal Analyses in Translational Epidemiology(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Max Planck Society(Max Planck SocietyFoundation CELLEX); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the people of the Solomon Islands for their participation in this study. We thank the Kosrae consortium for access to genetic data, G. Coop and G. Barsh for helpful comments, and C. Wegener for technical assistance. Funded by a Wenner-Gren Foundation for Anthropological Research grant to S.M., MRC Centre for Causal Analyses in Translational Epidemiology grant RD1634 to N.J.T., National Heart, Lung, and Blood Institute and National Human Genome Research Institute funding to C.D.B., and the Max Planck Society. Allele frequency data for this study are available from dbGAP (study accession phs000493.v1.p1). De-identified genotype data are available through a data access agreement for transfer of genetic data by contacting C.D.B.	Boissy RE, 1996, AM J HUM GENET, V58, P1145; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; delMarmol V, 1996, FEBS LETT, V381, P165, DOI 10.1016/0014-5793(96)00109-3; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; JOHNSON R, 1992, NAT GENET, V1, P226, DOI 10.1038/ng0692-226; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; Norton HL, 2006, AM J PHYS ANTHROPOL, V130, P254, DOI 10.1002/ajpa.20343	7	66	72	1	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					554	554		10.1126/science.1217849	http://dx.doi.org/10.1126/science.1217849			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556244	Green Accepted			2022-12-24	WOS:000303498800036
J	Stanley, SA; Gagner, JE; Damanpour, S; Yoshida, M; Dordick, JS; Friedman, JM				Stanley, Sarah A.; Gagner, Jennifer E.; Damanpour, Shadi; Yoshida, Mitsukuni; Dordick, Jonathan S.; Friedman, Jeffrey M.			Radio-Wave Heating of Iron Oxide Nanoparticles Can Regulate Plasma Glucose in Mice	SCIENCE			English	Article							GENE-EXPRESSION; FERRITIN; HYPERTHERMIA; STIMULATION; FREQUENCY; CALCIUM; NEURONS; PROTEIN	Medical applications of nanotechnology typically focus on drug delivery and biosensors. Here, we combine nanotechnology and bioengineering to demonstrate that nanoparticles can be used to remotely regulate protein production in vivo. We decorated a modified temperature-sensitive channel, TRPV1, with antibody-coated iron oxide nanoparticles that are heated in a low-frequency magnetic field. When local temperature rises, TRPV1 gates calcium to stimulate synthesis and release of bioengineered insulin driven by a Ca2+-sensitive promoter. Studying tumor xenografts expressing the bioengineered insulin gene, we show that exposure to radio waves stimulates insulin release from the tumors and lowers blood glucose in mice. We further show that cells can be engineered to synthesize genetically encoded ferritin nanoparticles and inducibly release insulin. These approaches provide a platform for using nanotechnology to activate cells.	[Stanley, Sarah A.; Damanpour, Shadi; Friedman, Jeffrey M.] Rockefeller Univ, Mol Genet Lab, New York, NY 10065 USA; [Gagner, Jennifer E.] Rensselaer Polytech Inst, Dept Mat Sci & Engn, Rensselaer Nanotechnol Ctr, Troy, NY 12180 USA; [Yoshida, Mitsukuni] Rockefeller Univ, Elizabeth & Vincent Meyer Lab Syst Canc Biol, New York, NY 10065 USA; [Dordick, Jonathan S.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Dept Biol, Dept Chem & Biol Engn, Troy, NY 12180 USA; [Friedman, Jeffrey M.] Howard Hughes Med Inst, New York, NY 10065 USA	Rockefeller University; Rensselaer Polytechnic Institute; Rockefeller University; Rensselaer Polytechnic Institute; Howard Hughes Medical Institute	Friedman, JM (corresponding author), Rockefeller Univ, Mol Genet Lab, New York, NY 10065 USA.	friedj@mail.rockefeller.edu		Yoshida, Mitsukuni/0000-0002-2752-1231	JPB Foundation; NIH [R01 GM095654]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095654] Funding Source: NIH RePORTER	JPB Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Friedman laboratory members for helpful discussions, S. Korres for assistance with manuscript preparation, S. Tavazoie for helpful discussions, R. Toledo-Crow and S. Abeytunge for assistance with RF technology, and the staff of the Rockefeller University Electron Microscopy Resource center for their technical support in imaging. This project was supported by funding from the JPB Foundation and grant no. R01 GM095654 from the NIH. The authors have filed a patent related to this work.	Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Butts CA, 2008, BIOCHEMISTRY-US, V47, P12729, DOI 10.1021/bi8016735; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; FARRANT JL, 1954, BIOCHIM BIOPHYS ACTA, V13, P569, DOI 10.1016/0006-3002(54)90376-5; Fortin JP, 2007, J AM CHEM SOC, V129, P2628, DOI 10.1021/ja067457e; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gellhorn E, 1940, Science, V92, P288, DOI 10.1126/science.92.2387.288; Halperin D, 2008, P IEEE S SECUR PRIV, P129, DOI 10.1109/SP.2008.31; Hamad-Schifferli K, 2002, NATURE, V415, P152, DOI 10.1038/415152a; Hanna S, 2009, 3 INT S MED INF COMM; Hardingham GE, 1999, MICROSC RES TECHNIQ, V46, P348, DOI 10.1002/(SICI)1097-0029(19990915)46:6<348::AID-JEMT3>3.3.CO;2-1; Huang H, 2010, NAT NANOTECHNOL, V5, P602, DOI [10.1038/nnano.2010.125, 10.1038/NNANO.2010.125]; Iordanova B, 2010, J BIOL INORG CHEM, V15, P957, DOI 10.1007/s00775-010-0657-7; McIntyre CC, 2002, J NEUROPHYSIOL, V88, P1592, DOI 10.1152/jn.2002.88.4.1592; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; Rao A, 2009, NAT IMMUNOL, V10, P3, DOI 10.1038/ni0109-3; Richardson HH, 2006, NANO LETT, V6, P783, DOI 10.1021/nl060105l; Samanta B, 2008, J MATER CHEM, V18, P1204, DOI 10.1039/b718745a; Sana B, 2010, BIOINTERPHASES, V5, pFA48, DOI 10.1116/1.3483216; Shifrin AL, 2001, GENE THER, V8, P1480, DOI 10.1038/sj.gt.3301544; STOCK G, 1979, ACTA NEUROCHIR, V47, P123, DOI 10.1007/BF01404668; Strauffer P. R., 1984, IEEE T BIOMED ENG, V31, P235; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thorne RG, 2006, P NATL ACAD SCI USA, V103, P5567, DOI 10.1073/pnas.0509425103; Wang AZ, 2008, EXPERT OPIN BIOL TH, V8, P1063, DOI 10.1517/14712598.8.8.1063 ; YOUNG JH, 1980, ELECTRON LETT, V16, P358, DOI 10.1049/el:19800255; Ziv K, 2010, NMR BIOMED, V23, P523, DOI 10.1002/nbm.1491	27	353	374	8	288	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					604	608		10.1126/science.1216753	http://dx.doi.org/10.1126/science.1216753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556257	Green Accepted			2022-12-24	WOS:000303498800050
J	Cho, H; Zhao, X; Hatori, M; Yu, RT; Barish, GD; Lam, MT; Chong, LW; DiTacchio, L; Atkins, AR; Glass, CK; Liddle, C; Auwerx, J; Downes, M; Panda, S; Evans, RM				Cho, Han; Zhao, Xuan; Hatori, Megumi; Yu, Ruth T.; Barish, Grant D.; Lam, Michael T.; Chong, Ling-Wa; DiTacchio, Luciano; Atkins, Annette R.; Glass, Christopher K.; Liddle, Christopher; Auwerx, Johan; Downes, Michael; Panda, Satchidananda; Evans, Ronald M.			Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta	NATURE			English	Article							CLOCK; RECEPTOR; TRANSCRIPTION; RHYTHMS; GENES; ROLES; OSCILLATOR; MOUSE; LIVER; MICE	The circadian clock acts at the genomic level to coordinate internal behavioural and physiological rhythms via the CLOCK-BMAL1 transcriptional heterodimer. Although the nuclear receptors REV-ERB-alpha and REV-ERB-beta have been proposed to form an accessory feedback loop that contributes to clock function(1,2), their precise roles and importance remain unresolved. To establish their regulatory potential, we determined the genome-wide cis-acting targets (cistromes) of both REV-ERB isoforms in murine liver, which revealed shared recognition at over 50% of their total DNA binding sites and extensive overlap with the master circadian regulator BMAL1. Although REV-ERB-alpha has been shown to regulate Bmal1 expression directly(1,2), our cistromic analysis reveals a more profound connection between BMAL1 and the REV-ERB-alpha and REV-ERB-beta genomic regulatory circuits than was previously suspected. Genes within the intersection of the BMAL1, REV-ERB-alpha and REV-ERB-beta cistromes are highly enriched for both clock and metabolic functions. As predicted by the cistromic analysis, dual depletion of Rev-erb-alpha and Rev-erb-beta function by creating double-knockout mice profoundly disrupted circadian expression of core circadian clock and lipid homeostatic gene networks. As a result, double-knockout mice show markedly altered circadian wheel-running behaviour and deregulated lipid metabolism. These data now unite REV-ERB-alpha and REV-ERB-beta with PER, CRY and other components of the principal feedback loop that drives circadian expression and indicate a more integral mechanism for the coordination of circadian rhythm and metabolism.	[Cho, Han; Zhao, Xuan; Yu, Ruth T.; Barish, Grant D.; Chong, Ling-Wa; Atkins, Annette R.; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Hatori, Megumi; DiTacchio, Luciano; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Lam, Michael T.; Glass, Christopher K.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Liddle, Christopher] Westmead Millennium Inst, Storr Liver Unit, Westmead, NSW 2145, Australia; [Liddle, Christopher] Univ Sydney, Westmead Hosp, Westmead, NSW 2145, Australia; [Auwerx, Johan] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland; [Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego; University of Sydney; Westmead Institute for Medical Research; University of Sydney; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Howard Hughes Medical Institute; Salk Institute	Evans, RM (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	evans@salk.edu	Glass, Christopher/AAI-3933-2021; Hatori, Megumi/GTY-3770-2022; Panda, Satchidananda/J-6891-2012; DiTacchio, Luciano/D-6341-2011; Auwerx, Johan/ABE-9307-2021; Evans, Ronald/AAF-4001-2019	Glass, Christopher/0000-0003-4344-3592; DiTacchio, Luciano/0000-0001-9570-7348; Evans, Ronald/0000-0002-9986-5965; Auwerx, Johan/0000-0002-5065-5393; Chong, Ling Wa/0000-0002-8571-5413; Hatori, Megumi/0000-0001-7888-158X; Yu, Ruth/0000-0002-9527-9627	National Research Service Award [T32-HL007770]; National Institutes of Health [DK062434, DK057978, DK090962, DK091618, HL105278]; National Health and Medical Research Council of Australia [NHMRC 512354, 632886]; Helmsley Charitable Trust; Glenn Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007770, R01HL105278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434, R37DK057978, R24DK090962, R01DK091618] Funding Source: NIH RePORTER	National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Helmsley Charitable Trust; Glenn Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Kaufman, J. Alvarez, E. Banayo, H. Juguilon, S. Jacinto and H. Le for technical assistance; and L. Ong and S. Ganley for administrative assistance. We also thank L. Pei for discussion. R. M. E is an Investigator of the Howard Hughes Medical Institute at The Salk Institute for Biological Studies and March of Dimes Chair in Molecular and Developmental Biology. H. C. is a recipient of National Research Service Award (T32-HL007770). This work was supported by National Institutes of Health Grants (DK062434, DK057978, DK090962, DK091618 and HL105278), National Health and Medical Research Council of Australia Project Grants (NHMRC 512354 and 632886), the Helmsley Charitable Trust, the Glenn Foundation and the Howard Hughes Medical Institute.	Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chomez P, 2000, DEVELOPMENT, V127, P1489; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Feng D, 2011, SCIENCE, V331, P1315, DOI 10.1126/science.1198125; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Hatanaka F, 2010, MOL CELL BIOL, V30, P5636, DOI 10.1128/MCB.00781-10; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Huang WY, 2011, J CLIN INVEST, V121, P2133, DOI 10.1172/JCI46043; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Lamia KA, 2011, NATURE, V480, P552, DOI 10.1038/nature10700; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Ukai-Tadenuma M, 2011, CELL, V144, P268, DOI 10.1016/j.cell.2010.12.019; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4	29	667	697	12	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					123	127		10.1038/nature11048	http://dx.doi.org/10.1038/nature11048			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22460952	Green Accepted			2022-12-24	WOS:000303451900047
J	Yu, M; Hon, GC; Szulwach, KE; Song, CX; Zhang, L; Kim, A; Li, XK; Dai, Q; Shen, Y; Park, B; Min, JH; Jin, P; Ren, B; He, C				Yu, Miao; Hon, Gary C.; Szulwach, Keith E.; Song, Chun-Xiao; Zhang, Liang; Kim, Audrey; Li, Xuekun; Dai, Qing; Shen, Yin; Park, Beomseok; Min, Jung-Hyun; Jin, Peng; Ren, Bing; He, Chuan			Base-Resolution Analysis of 5-Hydroxymethylcytosine in the Mammalian Genome	CELL			English	Article							DNA METHYLATION; THYMINE DNA; CELLS; REPLICATION; PLURIPOTENT; GLYCOSYLASE; ARABIDOPSIS; EXPRESSION; EPIGENOME; BINDING	The study of 5-hydroxylmethylcytosines (5hmC) has been hampered by the lack of a method to map it at single-base resolution on a genome-wide scale. Affinity purification-based methods cannot precisely locate 5hmC nor accurately determine its relative abundance at each modified site. We here present a genome-wide approach, Tet-assisted bisulfite sequencing (TAB-Seq), that when combined with traditional bisulfite sequencing can be used for mapping 5hmC at base resolution and quantifying the relative abundance of 5hmC as well as 5mC. Application of this method to embryonic stem cells not only confirms widespread distribution of 5hmC in the mammalian genome but also reveals sequence bias and strand asymmetry at 5hmC sites. We observe high levels of 5hmC and reciprocally low levels of 5mC near but not on transcription factor-binding sites. Additionally, the relative abundance of 5hmC varies significantly among distinct functional sequence elements, suggesting different mechanisms for 5hmC deposition and maintenance.	[Szulwach, Keith E.; Li, Xuekun; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Yu, Miao; Song, Chun-Xiao; Zhang, Liang; Dai, Qing; He, Chuan] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [Yu, Miao; Song, Chun-Xiao; Zhang, Liang; Dai, Qing; He, Chuan] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA; [Hon, Gary C.; Kim, Audrey; Shen, Yin; Ren, Bing] Univ Calif San Diego, San Diego Sch Med, UCSD Moores Canc Canc, Dept Cellular & Mol Med,Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Hon, Gary C.; Kim, Audrey; Shen, Yin; Ren, Bing] Univ Calif San Diego, Inst Genome Med, San Diego Sch Med, La Jolla, CA 92093 USA; [Park, Beomseok; Min, Jung-Hyun] Univ Illinois, Dept Chem, Chicago, IL 60606 USA	Emory University; University of Chicago; University of Chicago; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jin, P (corresponding author), Emory Univ, Sch Med, Dept Human Genet, 615 Michael St, Atlanta, GA 30322 USA.	peng.jin@emory.edu; biren@ucsd.edu; chuanhe@uchicago.edu	Zhang, Liang/F-8064-2013; Dai, Qing/ABD-8444-2021; Jin, Peng/B-5977-2012	Zhang, Liang/0000-0002-7672-1168; Jin, Peng/0000-0001-6137-6659; Min, Jung-Hyun/0000-0002-4221-9321; Song, Chun-Xiao/0000-0002-7781-6521	National Institutes of Health [GM071440, NS051630, P50AG025688, U01ES017166]; Chicago Biomedical Consortium; The Chicago Community Trust; Emory Genetics Discovery Fund; Simons Foundation Autism Research Initiative; Autism Speaks grant [7660]; Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG006699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH076090, R56MH076090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067461, R01NS051630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG025688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; The Chicago Community Trust; Emory Genetics Discovery Fund; Simons Foundation Autism Research Initiative; Autism Speaks grant; Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by National Institutes of Health (GM071440 to C.H., NS051630 and P50AG025688 to P.J., U01ES017166 to B.R.), a Catalyst Award (C.H. and J.-H.M.) from the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust, the Emory Genetics Discovery Fund (P.J.), the Simons Foundation Autism Research Initiative (P.J.), the Autism Speaks grant (#7660 to X.L.), and the Ludwig Institute for Cancer Research (B.R.).	Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2011, J MOL BIOL, V409, P47, DOI 10.1016/j.jmb.2011.01.056; Chen ZX, 2011, J BIOL CHEM, V286, P18347, DOI 10.1074/jbc.R110.205286; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Cortellino S, 2011, CELL, V146, P67, DOI 10.1016/j.cell.2011.06.020; Dawlaty MM, 2011, CELL STEM CELL, V9, P166, DOI 10.1016/j.stem.2011.07.010; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Iqbal K, 2011, P NATL ACAD SCI USA, V108, P3642, DOI 10.1073/pnas.1014033108; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maiti A, 2011, J BIOL CHEM, V286, P35334, DOI 10.1074/jbc.C111.284620; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Munzel M, 2010, ANGEW CHEM INT EDIT, V49, P5375, DOI 10.1002/anie.201002033; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Pelizzola M, 2011, FEBS LETT, V585, P1994, DOI 10.1016/j.febslet.2010.10.061; Pfaffeneder T, 2011, ANGEW CHEM INT EDIT, V50, P7008, DOI 10.1002/anie.201103899; Quenneville S, 2011, MOL CELL, V44, P361, DOI 10.1016/j.molcel.2011.08.032; Robertson AB, 2012, NAT PROTOC, V7, P340, DOI 10.1038/nprot.2011.443; Robertson AB, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr051; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Szulwach KE, 2011, NAT NEUROSCI, V14, P1607, DOI 10.1038/nn.2959; Szulwach KE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002154; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Valinluck V, 2004, NUCLEIC ACIDS RES, V32, P4100, DOI 10.1093/nar/gkh739; WIGLER M, 1981, CELL, V24, P33, DOI 10.1016/0092-8674(81)90498-0; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yildirim O, 2011, CELL, V147, P1498, DOI 10.1016/j.cell.2011.11.054; Zhang L, 2012, NAT CHEM BIOL, V8, P328, DOI [10.1038/NCHEMBIO.914, 10.1038/nchembio.914]	55	729	768	5	176	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 8	2012	149	6					1368	1380		10.1016/j.cell.2012.04.027	http://dx.doi.org/10.1016/j.cell.2012.04.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	956WF	22608086	Bronze, Green Accepted			2022-12-24	WOS:000305119600019
J	Nik-Zainal, S; Alexandrov, LB; Wedge, DC; Van Loo, P; Greenman, CD; Raine, K; Jones, D; Hinton, J; Marshall, J; Stebbings, LA; Menzies, A; Martin, S; Leung, K; Chen, L; Leroy, C; Ramakrishna, M; Rance, R; Lau, KW; Mudie, LJ; Varela, I; McBride, DJ; Bignell, GR; Cooke, SL; Shlien, A; Gamble, J; Whitmore, I; Maddison, M; Tarpey, PS; Davies, HR; Papaemmanuil, E; Stephens, PJ; McLaren, S; Butler, AP; Teague, JW; Jonsson, G; Garber, JE; Silver, D; Miron, P; Fatima, A; Boyault, S; Langerod, A; Tutt, A; Martens, JWM; Aparicio, SAJR; Borg, A; Salomon, AV; Thomas, G; Borresen-Dale, AL; Richardson, AL; Neuberger, MS; Futreal, PA; Campbell, PJ; Stratton, MR				Nik-Zainal, Serena; Alexandrov, Ludmil B.; Wedge, David C.; Van Loo, Peter; Greenman, Christopher D.; Raine, Keiran; Jones, David; Hinton, Jonathan; Marshall, John; Stebbings, Lucy A.; Menzies, Andrew; Martin, Sancha; Leung, Kenric; Chen, Lina; Leroy, Catherine; Ramakrishna, Manasa; Rance, Richard; Lau, King Wai; Mudie, Laura J.; Varela, Ignacio; McBride, David J.; Bignell, Graham R.; Cooke, Susanna L.; Shlien, Adam; Gamble, John; Whitmore, Ian; Maddison, Mark; Tarpey, Patrick S.; Davies, Helen R.; Papaemmanuil, Elli; Stephens, Philip J.; McLaren, Stuart; Butler, Adam P.; Teague, Jon W.; Jonsson, Goran; Garber, Judy E.; Silver, Daniel; Miron, Penelope; Fatima, Aquila; Boyault, Sandrine; Langerod, Anita; Tutt, Andrew; Martens, John W. M.; Aparicio, Samuel A. J. R.; Borg, Ake; Salomon, Anne Vincent; Thomas, Gilles; Borresen-Dale, Anne-Lise; Richardson, Andrea L.; Neuberger, Michael S.; Futreal, P. Andrew; Campbell, Peter J.; Stratton, Michael R.		Int Canc Genome Consortium	Mutational Processes Molding the Genomes of 21 Breast Cancers	CELL			English	Article							DNA-DAMAGE; HEPATOCELLULAR-CARCINOMA; SOMATIC HYPERMUTATION; P53 MUTATIONS; GENE; PATTERNS; REARRANGEMENT; TRANSVERSIONS; SIGNATURES; PROGRESS	All cancers carry somatic mutations. The patterns of mutation in cancer genomes reflect the DNA damage and repair processes to which cancer cells and their precursors have been exposed. To explore these mechanisms further, we generated catalogs of somatic mutation from 21 breast cancers and applied mathematical methods to extract mutational signatures of the underlying processes. Multiple distinct single- and double-nucleotide substitution signatures were discernible. Cancers with BRCA1 or BRCA2 mutations exhibited a characteristic combination of substitution mutation signatures and a distinctive profile of deletions. Complex relationships between somatic mutation prevalence and transcription were detected. A remarkable phenomenon of localized hypermutation, termed "kataegis,'' was observed. Regions of kataegis differed between cancers but usually colocalized with somatic rearrangements. Base substitutions in these regions were almost exclusively of cytosine at TpC dinucleotides. The mechanisms underlying most of these mutational signatures are unknown. However, a role for the APOBEC family of cytidine deaminases is proposed.	[Nik-Zainal, Serena; Alexandrov, Ludmil B.; Wedge, David C.; Van Loo, Peter; Greenman, Christopher D.; Raine, Keiran; Jones, David; Hinton, Jonathan; Marshall, John; Stebbings, Lucy A.; Menzies, Andrew; Martin, Sancha; Leung, Kenric; Chen, Lina; Leroy, Catherine; Ramakrishna, Manasa; Rance, Richard; Lau, King Wai; Mudie, Laura J.; Varela, Ignacio; McBride, David J.; Bignell, Graham R.; Cooke, Susanna L.; Shlien, Adam; Gamble, John; Whitmore, Ian; Maddison, Mark; Tarpey, Patrick S.; Davies, Helen R.; Papaemmanuil, Elli; Stephens, Philip J.; McLaren, Stuart; Butler, Adam P.; Teague, Jon W.; Futreal, P. Andrew; Campbell, Peter J.; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Van Loo, Peter] VIB, Ctr Biol Dis, B-3000 Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Greenman, Christopher D.] Univ E Anglia, Dept Comp, Norwich NR4 7TJ, Norfolk, England; [Greenman, Christopher D.] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Aparicio, Samuel A. J. R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Garber, Judy E.; Silver, Daniel; Miron, Penelope; Fatima, Aquila; Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Boyault, Sandrine; Thomas, Gilles] Ctr Leon Berard, INCa Synergie, Fac Med, Lyon 08, France; [Langerod, Anita; Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Tutt, Andrew] Kings Coll London, Breakthrough Breast Canc Res Unit, London SE1 9RT, England; [Martens, John W. M.] Erasmus MC, Dept Med Oncol, NL-3000 CA Rotterdam, Netherlands; [Aparicio, Samuel A. J. R.] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Jonsson, Goran; Borg, Ake] Lund Univ, Dept Oncol, SE-22184 Lund, Sweden; [Salomon, Anne Vincent] Inst Curie, Dept Pathol, F-75248 Paris 05, France; [Salomon, Anne Vincent] INSERM, U830, F-75248 Paris 05, France; [Borresen-Dale, Anne-Lise] Univ Oslo, KG Jebsen Ctr Breast Canc Res, Inst Clin Med, Fac Med, N-0310 Oslo, Norway; [Richardson, Andrea L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Neuberger, Michael S.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; University of East Anglia; The Genome Analysis Centre (TGAC); University of British Columbia; Harvard University; Dana-Farber Cancer Institute; Institut National du Cancer (INCA) France; UNICANCER; Centre Leon Berard; University of Oslo; University of London; King's College London; Erasmus University Rotterdam; Erasmus MC; British Columbia Cancer Agency; Lund University; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; University of Oslo; Harvard University; Brigham & Women's Hospital; Harvard Medical School; MRC Laboratory Molecular Biology; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	mrs@sanger.ac.uk	Alexandrov, Ludmil/AAS-1454-2021; Jönsson, Göran/D-1212-2014; Varela, Ignacio/AAA-7680-2021; Wedge, David/AAC-4977-2021; Alexandrov, Ludmil/B-6582-2014; Van Loo, Peter/A-3287-2012; Varela, Ignacio/G-1699-2016; Silver, Daniel/P-3443-2019; Nik-Zainal, Serena/ABD-4437-2020	Alexandrov, Ludmil/0000-0003-3596-4515; Varela, Ignacio/0000-0002-0969-506X; Alexandrov, Ludmil/0000-0003-3596-4515; Varela, Ignacio/0000-0002-0969-506X; Wedge, David/0000-0002-7572-3196; Nik-Zainal, Serena/0000-0001-5054-1727; Raine, Keiran/0000-0002-5634-1539; Tutt, Andrew/0000-0001-8715-2901; Aparicio, Samuel/0000-0002-0487-9599; Martin, Sancha/0000-0001-6213-5259; Van Loo, Peter/0000-0003-0292-1949	Wellcome Trust [098051]; Breakthrough Breast Cancer Research [ICGC 08/09]; Wellcome Trust Clinical Research; Wellcome Trust Senior Clinical Research [WT088340MA]; Research Foundation - Flanders [FWO]; National Research Council Canada; EMBO; International Human Frontier Science Program Organization; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research; Norwegian Research Council; The Norwegian Cancer Society; The Radium Hospital Foundation; Health Region South-East; European Community [242006]; Breast Cancer Somatic Genetics Study [BASIS]; Wellcome Trust Sanger Institute; Breakthrough Breast Cancer Unit; ICGC Breast Cancer Working Group; Oslo University Hospital; United States National Cancer Institute Specialized Program Of Research Excellence [CA089393]; Centre for Translational Genomics (CTAG); Department of Health via NIHR comprehensive Biomedical Research Centre; NHS Foundation Trust, King's College London; King's College Hospital NHS Foundation Trust; BBSRC [BBS/E/T/000PR6193] Funding Source: UKRI; MRC [MC_U105178806] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/T/000PR6193] Funding Source: researchfish; Medical Research Council [MC_U105178806] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Breakthrough Breast Cancer Research; Wellcome Trust Clinical Research; Wellcome Trust Senior Clinical Research(Wellcome Trust); Research Foundation - Flanders [FWO](FWO); National Research Council Canada; EMBO(European Molecular Biology Organization (EMBO)); International Human Frontier Science Program Organization(Human Frontier Science Program); Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Norwegian Research Council(Research Council of NorwayEuropean Commission); The Norwegian Cancer Society(Norwegian Cancer SocietyEuropean Commission); The Radium Hospital Foundation; Health Region South-East; European Community(European Commission); Breast Cancer Somatic Genetics Study [BASIS]; Wellcome Trust Sanger Institute(Wellcome Trust); Breakthrough Breast Cancer Unit; ICGC Breast Cancer Working Group; Oslo University Hospital; United States National Cancer Institute Specialized Program Of Research Excellence; Centre for Translational Genomics (CTAG); Department of Health via NIHR comprehensive Biomedical Research Centre; NHS Foundation Trust, King's College London; King's College Hospital NHS Foundation Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Wellcome Trust (grant reference 098051) and Breakthrough Breast Cancer Research (ICGC 08/09). Individual support: S.N.Z. (Wellcome Trust Clinical Research Training Fellow); P.J.C. (Wellcome Trust Senior Clinical Research Fellow grant reference WT088340MA); P.V.L. (Research Foundation - Flanders [FWO]); A.S. (National Research Council Canada [HL Holmes Award] and EMBO); I.V. (International Human Frontier Science Program Organization); J.W.M.M. (Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research); A.L.B.D. and A.L. (Norwegian Research Council, The Norwegian Cancer Society, The Radium Hospital Foundation and Health Region South-East); S.M (European Community's Seventh Framework Programme [FP7/2010-2014] grant reference 242006 Breast Cancer Somatic Genetics Study [BASIS]). We thank Nancy Miller for her activities related to the curation and collection of the clinical data associated with this study. We acknowledge the Core Sequencing Facility and IT groups of the Wellcome Trust Sanger Institute, the Breakthrough Breast Cancer Unit, members of the ICGC Breast Cancer Working Group, the OSBREAC Consortium of Oslo University Hospital, the United States National Cancer Institute Specialized Program Of Research Excellence (grant reference CA089393) and Dr. Peter Watson of the BCCA Tumour Tissue Repository and the Centre for Translational Genomics (CTAG). The authors acknowledge financial support from the Department of Health via NIHR comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust, King's College London, and King's College Hospital NHS Foundation Trust. We thank George Vassiliou for pointing us to the term "kataegis.'' J.E.G. is a consultant for Generation Health.	Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Berry MW, 2007, COMPUT STAT DATA AN, V52, P155, DOI 10.1016/j.csda.2006.11.006; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen JM, 2012, MUTAT RES-REV MUTAT, V750, P52, DOI 10.1016/j.mrrev.2011.10.002; Deem A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000594; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Forster MD, 2011, NAT REV CLIN ONCOL, V8, P302, DOI 10.1038/nrclinonc.2011.42; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hainaut P, 2001, CARCINOGENESIS, V22, P367, DOI 10.1093/carcin/22.3.367; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Hicks WM, 2010, SCIENCE, V329, P82, DOI 10.1126/science.1191125; Hori M, 2011, MUTAT RES-FUND MOL M, V714, P11, DOI 10.1016/j.mrfmmm.2011.05.015; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hultquist JF, 2011, J VIROL, V85, P11220, DOI 10.1128/JVI.05238-11; Jansen JG, 2006, J EXP MED, V203, P319, DOI 10.1084/jem.20052227; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; Mace K, 1997, CARCINOGENESIS, V18, P1291, DOI 10.1093/carcin/18.7.1291; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Nedelko T, 2009, INT J CANCER, V124, P987, DOI 10.1002/ijc.24006; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Nussenzweig A, 2010, CELL, V141, P27, DOI 10.1016/j.cell.2010.03.016; Palacios J, 2008, PATHOBIOLOGY, V75, P85, DOI 10.1159/000123846; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ross AL, 2006, MOL IMMUNOL, V43, P1587, DOI 10.1016/j.molimm.2005.09.017; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spencer WA, 2012, CHEM RES TOXICOL, V25, P305, DOI 10.1021/tx200356v; Stenglein MD, 2010, NAT STRUCT MOL BIOL, V17, P222, DOI 10.1038/nsmb.1744; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Tao Y, 2011, P NATL ACAD SCI USA, V108, P12042, DOI 10.1073/pnas.1108715108; TENG BB, 1993, SCIENCE, V260, P1816, DOI 10.1126/science.8511591; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104; Waters TR, 2000, MUTAT RES-REV MUTAT, V462, P137, DOI 10.1016/S1383-5742(00)00031-4; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	60	1207	1230	4	143	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					979	993		10.1016/j.cell.2012.04.024	http://dx.doi.org/10.1016/j.cell.2012.04.024			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22608084	Green Submitted, Green Published, Green Accepted, hybrid			2022-12-24	WOS:000304453900006
J	Martincorena, I; Seshasayee, ASN; Luscombe, NM				Martincorena, Inigo; Seshasayee, Aswin S. N.; Luscombe, Nicholas M.			Evidence of non-random mutation rates suggests an evolutionary risk management strategy	NATURE			English	Article							ESCHERICHIA-COLI; ENTEROBACTERIAL GENES; DNA-REPAIR; TRANSCRIPTION; SELECTION; GENOME; SEQUENCES; SPECTRUM; INCREASE; SITE	A central tenet in evolutionary theory is that mutations occur randomly with respect to their value to an organism; selection then governs whether they are fixed in a population. This principle has been challenged by long-standing theoretical models predicting that selection could modulate the rate of mutation itself(1,2). However, our understanding of how the mutation rate varies between different sites within a genome has been hindered by technical difficulties in measuring it. Here we present a study that overcomes previous limitations by combining phylogenetic and population genetic techniques. Upon comparing 34 Escherichia coli genomes, we observe that the neutral mutation rate varies by more than an order of magnitude across 2,659 genes, with mutational hot and cold spots spanning several kilobases. Importantly, the variation is not random: we detect a lower rate in highly expressed genes and in those undergoing stronger purifying selection. Our observations suggest that the mutation rate has been evolutionarily optimized to reduce the risk of deleterious mutations. Current knowledge of factors influencing the mutation rate-including transcription-coupled repair and context-dependent mutagenesis-do not explain these observations, indicating that additional mechanisms must be involved. The findings have important implications for our understanding of evolution and the control of mutations.	[Martincorena, Inigo; Seshasayee, Aswin S. N.; Luscombe, Nicholas M.] EMBL European Bioinformat Inst, Cambridge CB10 1SD, England; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol, Onna Son, Okinawa 9040495, Japan; [Luscombe, Nicholas M.] UCL, Dept Genet Environm & Evolut, UCL Genet Inst, London WC1E 6BT, England; [Luscombe, Nicholas M.] Canc Res UK London Res Inst, London WC2A 3LY, England	European Molecular Biology Laboratory (EMBL); Okinawa Institute of Science & Technology Graduate University; University of London; University College London; Cancer Research UK	Martincorena, I (corresponding author), EMBL European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.	martinco@ebi.ac.uk; luscombe@ebi.ac.uk		Martincorena, Inigo/0000-0003-1122-4416	EMBL; Spanish Ministry of Science and Innovation; Caja Madrid Foundation; BBSRC [BB/E01075X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E01075X/1] Funding Source: researchfish; Cancer Research UK [16358] Funding Source: researchfish	EMBL; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Caja Madrid Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK)	We thank M. Ackermann, S. Brenner, G. Dougan, A. Eyre-Walker, N. Goldman, B. Lenhard, J. Marioni, J. Parkhill, O. Tenaillon, C. Tyler-Smith and F. Ulhmann for their suggestions during the preparation of this manuscript. The work was funded by EMBL, the Spanish Ministry of Science and Innovation and the Caja Madrid Foundation.	Andolfatto P, 2001, CURR OPIN GENET DEV, V11, P635, DOI 10.1016/S0959-437X(00)00246-X; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; Bustamante CD, 2003, THEOR POPUL BIOL, V63, P91, DOI 10.1016/S0040-5809(02)00050-3; Chuang JH, 2004, PLOS BIOL, V2, P253, DOI 10.1371/journal.pbio.0020029; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; EYREWALKER A, 1995, GENETICS, V140, P1407; EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599; Francino MP, 1996, SCIENCE, V272, P107, DOI 10.1126/science.272.5258.107; HARTL DL, 1994, GENETICS, V138, P227; Hodgkinson A, 2009, PLOS BIOL, V7, P226, DOI 10.1371/journal.pbio.1000027; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; KIMURA M, 1967, GENET RES, V9, P23, DOI 10.1017/S0016672300010284; Klapacz J, 2002, J BACTERIOL, V184, P6866, DOI 10.1128/JB.184.24.6866-6872.2002; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; LEVINS R, 1967, GENETICS, V56, P163; McVean GAT, 1999, GENET RES, V74, P145, DOI 10.1017/S0016672399003912; McVean GT, 1997, NATURE, V386, P388, DOI 10.1038/386388a0; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; O'Fallon BD, 2010, MOL BIOL EVOL, V27, P2406, DOI 10.1093/molbev/msq132; Ochman H, 2003, MOL BIOL EVOL, V20, P2091, DOI 10.1093/molbev/msg229; Pal C, 2007, NATURE, V450, P1079, DOI 10.1038/nature06350; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Sniegowski PD, 2000, BIOESSAYS, V22, P1057, DOI 10.1002/1521-1878(200012)22:12&lt;1057::AID-BIES3&gt;3.0.CO;2-W; Tenaillon O, 2001, RES MICROBIOL, V152, P11, DOI 10.1016/S0923-2508(00)01163-3; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Tu YQ, 1996, EMBO J, V15, P675, DOI 10.1002/j.1460-2075.1996.tb00400.x; Wagner A, 2003, J THEOR BIOL, V225, P45, DOI 10.1016/S0022-5193(03)00219-4	30	115	116	2	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					95	98		10.1038/nature10995	http://dx.doi.org/10.1038/nature10995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22522932				2022-12-24	WOS:000303451900041
J	Ying, HQ; Kimmelman, AC; Lyssiotis, CA; Hua, SJ; Chu, GC; Fletcher-Sananikone, E; Locasale, JW; Son, J; Zhang, HL; Coloff, JL; Yan, HY; Wang, W; Chen, SJ; Viale, A; Zheng, HW; Paik, JH; Lim, C; Guimaraes, AR; Martin, ES; Chang, J; Hezel, AF; Perry, SR; Hu, J; Gan, BY; Xiao, YH; Asara, JM; Weissleder, R; Wang, YA; Chin, L; Cantley, LC; DePinho, RA				Ying, Haoqiang; Kimmelman, Alec C.; Lyssiotis, Costas A.; Hua, Sujun; Chu, Gerald C.; Fletcher-Sananikone, Eliot; Locasale, Jason W.; Son, Jaekyoung; Zhang, Hailei; Coloff, Jonathan L.; Yan, Haiyan; Wang, Wei; Chen, Shujuan; Viale, Andrea; Zheng, Hongwu; Paik, Ji-hye; Lim, Carol; Guimaraes, Alexander R.; Martin, Eric S.; Chang, Jeffery; Hezel, Aram F.; Perry, Samuel R.; Hu, Jian; Gan, Boyi; Xiao, Yonghong; Asara, John M.; Weissleder, Ralph; Wang, Y. Alan; Chin, Lynda; Cantley, Lewis C.; DePinho, Ronald A.			Oncogenic Kras Maintains Pancreatic Tumors through Regulation of Anabolic Glucose Metabolism	CELL			English	Article							N-LINKED CARBOHYDRATE; K-RAS ADDICTION; CANCER; INDUCTION; MYC; EXPRESSION; BIOLOGY; PATHWAY; CELLS; MICE	Tumor maintenance relies on continued activity of driver oncogenes, although their rate-limiting role is highly context dependent. Oncogenic Kras mutation is the signature event in pancreatic ductal adenocarcinoma (PDAC), serving a critical role in tumor initiation. Here, an inducible Kras(G12D)-driven PDAC mouse model establishes that advanced PDAC remains strictly dependent on Kras(G12D) expression. Transcriptome and metabolomic analyses indicate that Kras(G12D) serves a vital role in controlling tumor metabolism through stimulation of glucose uptake and channeling of glucose intermediates into the hexosamine biosynthesis and pentose phosphate pathways (PPP). These studies also reveal that oncogenic Kras promotes ribose biogenesis. Unlike canonical models, we demonstrate that Kras(G12D) drives glycolysis intermediates into the nonoxidative PPP, thereby decoupling ribose biogenesis from NADP/NADPH-mediated redox control. Together, this work provides in vivo mechanistic insights into how oncogenic Kras promotes metabolic reprogramming in native tumors and illuminates potential metabolic targets that can be exploited for therapeutic benefit in PDAC.	[Kimmelman, Alec C.; Son, Jaekyoung] Dana Farber Canc Inst, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Boston, MA 02215 USA; [Ying, Haoqiang; Hua, Sujun; Chu, Gerald C.; Fletcher-Sananikone, Eliot; Zhang, Hailei; Yan, Haiyan; Wang, Wei; Chen, Shujuan; Viale, Andrea; Zheng, Hongwu; Paik, Ji-hye; Lim, Carol; Martin, Eric S.; Chang, Jeffery; Hezel, Aram F.; Perry, Samuel R.; Hu, Jian; Gan, Boyi; Xiao, Yonghong; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02215 USA; [Ying, Haoqiang; Hua, Sujun; Chu, Gerald C.; Fletcher-Sananikone, Eliot; Yan, Haiyan; Wang, Wei; Viale, Andrea; Zheng, Hongwu; Paik, Ji-hye; Lim, Carol; Martin, Eric S.; Chang, Jeffery; Hezel, Aram F.; Perry, Samuel R.; Hu, Jian; Gan, Boyi; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lyssiotis, Costas A.; Locasale, Jason W.; Weissleder, Ralph; Cantley, Lewis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Coloff, Jonathan L.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Asara, John M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Lyssiotis, Costas A.; Locasale, Jason W.; Asara, John M.; Cantley, Lewis C.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02115 USA; [Chu, Gerald C.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Wang, Wei] Brigham & Womens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Chin, Lynda] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Guimaraes, Alexander R.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Chin, Lynda] Univ Texas MD Anderson Canc Ctr, Dept Med Genet, Houston, TX 77030 USA; [DePinho, Ronald A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Kimmelman, AC (corresponding author), Dana Farber Canc Inst, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Boston, MA 02215 USA.	alec_kimmelman@dfci.harvard.edu; rdepinho@mdanderson.org	Locasale, Jason W/ABE-6505-2020; Cantley, Lewis C/D-1800-2014; Ying, Haoqiang/AAK-4325-2020; Gan, Boyi/HDM-4206-2022; Lyssiotis, Costas A/AAI-1923-2019	Locasale, Jason W/0000-0002-7766-3502; Cantley, Lewis C/0000-0002-1298-7653; Lyssiotis, Costas A/0000-0001-9309-6141; DePinho, Ronald/0000-0002-5625-577X; Zheng, Hongwu/0000-0002-5823-4913; /0000-0003-0828-4143	NIH [T32 CA009382-26, P01 CA117969]; BIDMC; National Cancer Institute [R01 CA157490]; Kimmel Scholar Award; AACR; Damon Runyon Fellowship; NATIONAL CANCER INSTITUTE [U24CA092782, P01CA117969, P30CA006516, R01CA157490, P50CA086355, P01CA120964, T32CA009382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [K08EB012859] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056203] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BIDMC; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kimmel Scholar Award; AACR; Damon Runyon Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Christopher Wright for the p48-Cre mice; Shan Zhou and Shan Jiang for expert monitoring of the mouse colony; Yingchun Liu, Yuxiang Zheng, Ning Wu, Alexandra Grassian, Joan Brugge, Min Yuan, and Susanne Breitkopf for helpful suggestions and technical support. Grant support derives from NIH grants T32 CA009382-26 (H.Y.) and P01 CA117969 (R. W., L. C., L. C. C., R. A. D.). Imaging was supported by U24 CA092782 and P50 CA86355 (R. W.). Mass spectrometry was supported by 5P01CA120964-05 (L. C. C. and J.A.), 5P30CA006516-46 (J.A.), and the BIDMC Research Capital Fund. A. C. K. is supported by the National Cancer Institute Grant R01 CA157490, Kimmel Scholar Award and AACR-PanCAN Career Development Award. C. A. L. is the Amgen Fellow of the Damon Runyon Cancer Research Foundation (DRG-2056-10). S. H. is supported by a Damon Runyon Fellowship. A. C. K. is a Consultant for Forma Therapeutics. L. C. C. is a founder of Agios Pharmaceuticals, a company developing drugs to target metabolic enzymes for cancer therapy.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Belteki G, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni051; BOLSCHER JGM, 1988, EMBO J, V7, P3361, DOI 10.1002/j.1460-2075.1988.tb03208.x; Boros LG, 2005, PANCREAS, V31, P337, DOI 10.1097/01.mpa.0000186524.53253.fb; Boros LG, 1998, MED HYPOTHESES, V50, P55, DOI 10.1016/S0306-9877(98)90178-5; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Clasquin MF, 2011, CELL, V145, P969, DOI 10.1016/j.cell.2011.05.022; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DENNIS JW, 1989, ONCOGENE, V4, P853; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fujita H, 2010, PANCREAS, V39, P1254, DOI 10.1097/MPA.0b013e3181dbf647; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Fuster MM, 2005, NAT REV CANCER, V5, P526, DOI 10.1038/nrc1649; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Gysin Stephan, 2011, Genes Cancer, V2, P359, DOI 10.1177/1947601911412376; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Jiang P, 2011, NAT CELL BIOL, V13, P310, DOI 10.1038/ncb2172; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Marino S, 2000, GENE DEV, V14, P994; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; RACKER E, 1985, P NATL ACAD SCI USA, V82, P3535, DOI 10.1073/pnas.82.11.3535; RAK JW, 1991, CANCER LETT, V57, P27, DOI 10.1016/0304-3835(91)90059-Q; Recktenwald CV, 2008, CANCER RES, V68, P10086, DOI 10.1158/0008-5472.CAN-08-0360; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Singh A, 2009, CELL CYCLE, V8, P2676, DOI 10.4161/cc.8.17.9336; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002; Vizan P, 2005, CANCER RES, V65, P5512, DOI 10.1158/0008-5472.CAN-05-0074; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wellen KE, 2010, GENE DEV, V24, P2784, DOI 10.1101/gad.1985910; WILLIAMS JF, 1987, INT J BIOCHEM, V19, P749, DOI 10.1016/0020-711X(87)90239-4; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; WOJCIECHOWICZ DC, 1995, BIOCHEM BIOPH RES CO, V212, P758, DOI 10.1006/bbrc.1995.2034; Yuan M., 2012, NAT PROTOC IN PRESS; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zhou WD, 2011, J PROTEOME RES, V10, P1944, DOI 10.1021/pr101179t	52	1196	1227	9	233	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 27	2012	149	3					656	670		10.1016/j.cell.2012.01.058	http://dx.doi.org/10.1016/j.cell.2012.01.058			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541435	Green Accepted, Bronze			2022-12-24	WOS:000303443100016
J	Nakamura, K; Greenwood, A; Binder, L; Bigio, EH; Denial, S; Nicholson, L; Zhou, XZ; Lu, KP				Nakamura, Kazuhiro; Greenwood, Alex; Binder, Lester; Bigio, Eileen H.; Denial, Sarah; Nicholson, Linda; Zhou, Xiao Zhen; Lu, Kun Ping			Proline Isomer-Specific Antibodies Reveal the Early Pathogenic Tau Conformation in Alzheimer's Disease	CELL			English	Article							CIS-TRANS ISOMERIZATION; PHOSPHORYLATED-TAU; PROLYL ISOMERIZATION; REGULATORY MECHANISM; MOUSE MODEL; PIN1; PROTEIN; CANCER; MICE; NEURODEGENERATION	cis-trans isomerization of proteins phosphorylated by proline-directed kinases is proposed to control numerous signaling molecules and is implicated in the pathogenesis of Alzheimer's and other diseases. However, there is no direct evidence for the existence of cis-trans protein isomers in vivo or for their conformation-specific function or regulation. Here we develop peptide chemistries that allow the generation of cis- and trans-specific antibodies and use them to raise antibodies specific for isomers of phosphorylated tau. cis, but not trans, p-tau appears early in the brains of humans with mild cognitive impairment, accumulates exclusively in degenerated neurons, and localizes to dystrophic neurites during Alzheimer's progression. Unlike trans p-tau, the cis isomer cannot promote microtubule assembly, is more resistant to dephosphorylation and degradation, and is more prone to aggregation. Pin1 converts cis to trans p-tau to prevent Alzheimer's tau pathology. Isomer-specific antibodies and vaccines may therefore have value for the early diagnosis and treatment of Alzheimer's disease.	[Nakamura, Kazuhiro; Zhou, Xiao Zhen; Lu, Kun Ping] Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [Greenwood, Alex; Denial, Sarah; Nicholson, Linda] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Binder, Lester] Northwestern Univ Feinberg, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Bigio, Eileen H.] Northwestern Univ Feinberg, Sch Med, Dept Pathol, Chicago, IL 60611 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Cornell University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Zhou, XZ (corresponding author), Harvard Univ, Sch Med, Dept Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	xzhou@bidmc.harvard.edu; klu@bidmc.harvard.edu	Greenwood, Alex/GWU-8292-2022		NIH [P30 AG13854, R01CA122434, R01AG029385, R01AG039405, R01AG17870, R01CA167677]; NATIONAL CANCER INSTITUTE [R01CA167677, R01CA122434] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039405, R01AG029385, R01AG017870, P30AG013854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Lew Cantley and Tony Hunter for insightful advice, Peter Davies for some tau antibodies, Virginia Lee for tau transgenic mice, and the members of the Lu/Zhou laboratories for stimulating discussions. This study was supported by NIH grants P30 AG13854 to the Northwestern Alzheimer Disease Center, R01CA122434 to X.Z.Z., R01AG029385 to L.N. and K.P.L. and R01AG039405, R01AG17870, and R01CA167677 to K.P.L.	An SSA, 1999, J AM CHEM SOC, V121, P11558, DOI 10.1021/ja9930317; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Boimel M, 2010, EXP NEUROL, V224, P472, DOI 10.1016/j.expneurol.2010.05.010; Boutajangout A, 2011, J NEUROCHEM, V118, P658, DOI 10.1111/j.1471-4159.2011.07337.x; Boutajangout A, 2010, J NEUROSCI, V30, P16559, DOI 10.1523/JNEUROSCI.4363-10.2010; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Butterfield DA, 2006, J NEUROCHEM, V98, P1697, DOI 10.1111/j.1471-4159.2006.03995.x; Cruz JC, 2004, TRENDS MOL MED, V10, P452, DOI 10.1016/j.molmed.2004.07.001; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Davies P, 2000, METH MOLEC MED, V32, P361, DOI 10.1385/1-59259-195-7:361; Dawson HN, 2001, J CELL SCI, V114, P1179; de Calignon A, 2010, NATURE, V464, P1201, DOI 10.1038/nature08890; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Ewers M, 2007, NEUROLOGY, V69, P2205, DOI 10.1212/01.wnl.0000286944.22262.ff; Girardini JE, 2011, CANCER CELL, V20, P79, DOI 10.1016/j.ccr.2011.06.004; Goedert M, 2006, SCIENCE, V314, P777, DOI 10.1126/science.1132814; Hamdane M, 2006, MOL CELL NEUROSCI, V32, P155, DOI 10.1016/j.mcn.2006.03.006; Hampel H, 2001, ANN NEUROL, V49, P545, DOI 10.1002/ana.111; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Jicha GA, 1997, J NEUROCHEM, V69, P2087; Lee TH, 2011, MOL CELL, V42, P147, DOI 10.1016/j.molcel.2011.03.005; Lee TH, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001906; Li YH, 2006, HUM MOL GENET, V15, P2560, DOI 10.1093/hmg/ddl178; Lim J, 2008, J CLIN INVEST, V118, P1877, DOI 10.1172/JCI34308; Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832; Liou YC, 2011, TRENDS BIOCHEM SCI, V36, P501, DOI 10.1016/j.tibs.2011.07.001; Lu KP, 1996, NATURE, V380, P544; Lu KP, 2002, TRENDS CELL BIOL, V12, P164, DOI 10.1016/S0962-8924(02)02253-5; Lu KP, 2007, NAT CHEM BIOL, V3, P619, DOI 10.1038/nchembio.2007.35; Lu PJ, 1999, NATURE, V399, P784; Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Luna-Munoz J, 2007, J ALZHEIMERS DIS, V12, P365; Ma SL, 2012, J BIOL CHEM, V287, P6969, DOI 10.1074/jbc.C111.298596; Ma SL, 2012, NEUROBIOL AGING, V33, P804, DOI 10.1016/j.neurobiolaging.2010.05.018; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Nakamura M, 2001, CURR BIOL, V11, P1512, DOI 10.1016/S0960-9822(01)00456-0; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Shen MH, 1998, GENE DEV, V12, P706, DOI 10.1101/gad.12.5.706; Spires-Jones TL, 2009, TRENDS NEUROSCI, V32, P150, DOI 10.1016/j.tins.2008.11.007; Theuerkorn M, 2011, CURR OPIN PHARMACOL, V11, P281, DOI 10.1016/j.coph.2011.03.007; Tun-Kyi A, 2011, NAT IMMUNOL, V12, P733, DOI 10.1038/ni.2069; Wintjens R, 2001, J BIOL CHEM, V276, P25150, DOI 10.1074/jbc.M010327200; Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957; Yuan WC, 2011, CANCER CELL, V20, P214, DOI 10.1016/j.ccr.2011.07.008; Yukawa K, 2006, INT J MOL MED, V17, P869; Zhou XZ, 2000, MOL CELL, V6, P873, DOI 10.1016/S1097-2765(00)00085-X; Zhou XZ, 1999, CELL MOL LIFE SCI, V56, P788, DOI 10.1007/s000180050026	53	183	199	0	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					232	244		10.1016/j.cell.2012.02.016	http://dx.doi.org/10.1016/j.cell.2012.02.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464332	Green Accepted, Bronze			2022-12-24	WOS:000302235400023
J	Qian, L; Huang, Y; Spencer, CI; Foley, A; Vedantham, V; Liu, L; Conway, SJ; Fu, JD; Srivastava, D				Qian, Li; Huang, Yu; Spencer, C. Ian; Foley, Amy; Vedantham, Vasanth; Liu, Lei; Conway, Simon J.; Fu, Ji-dong; Srivastava, Deepak			In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes	NATURE			English	Article							DEFINED FACTORS; STEM-CELLS; DIRECT CONVERSION; GENE-TRANSFER; ADULT; HEART; INJURY; REPAIR; DIFFERENTIATION; EXPRESSION	The reprogramming of adult cells into pluripotent cells or directly into alternative adult cell types holds great promise for regenerative medicine. We reported previously that cardiac fibroblasts, which represent 50% of the cells in the mammalian heart, can be directly reprogrammed to adult cardiomyocyte-like cells in vitro by the addition of Gata4, Mef2c and Tbx5 (GMT). Here we use genetic lineage tracing to show that resident non-myocytes in the murine heart can be reprogrammed into cardiomyocyte-like cells in vivo by local delivery of GMT after coronary ligation. Induced cardiomyocytes became binucleate, assembled sarcomeres and had cardiomyocyte-like gene expression. Analysis of single cells revealed ventricular cardiomyocyte-like action potentials, beating upon electrical stimulation, and evidence of electrical coupling. In vivo delivery of GMT decreased infarct size and modestly attenuated cardiac dysfunction up to 3 months after coronary ligation. Delivery of the pro-angiogenic and fibroblast-activating peptide, thymosin beta 4, along with GMT, resulted in further improvements in scar area and cardiac function. These findings demonstrate that cardiac fibroblasts can be reprogrammed into cardiomyocyte-like cells in their native environment for potential regenerative purposes.	[Qian, Li; Huang, Yu; Spencer, C. Ian; Foley, Amy; Vedantham, Vasanth; Liu, Lei; Fu, Ji-dong; Srivastava, Deepak] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Qian, Li; Huang, Yu; Spencer, C. Ian; Foley, Amy; Liu, Lei; Fu, Ji-dong; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Qian, Li; Huang, Yu; Spencer, C. Ian; Foley, Amy; Liu, Lei; Fu, Ji-dong; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Vedantham, Vasanth] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA; [Vedantham, Vasanth] Univ Calif San Francisco, Dept Med, San Francisco, CA 94158 USA; [Conway, Simon J.] Indiana Univ Sch Med, Dev Biol & Neonatal Med Res Program, Indianapolis, IN 46202 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Indiana University System; Indiana University Bloomington	Srivastava, D (corresponding author), Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu	Fu, Jidong/E-8173-2012	Vedantham, Vasanth/0000-0003-1032-700X; Fu, Jidong/0000-0003-2797-5193	GlaxoSmithKline Research and Education Foundation; NIH/NHLBI [K08HL101989, R01 HL060714]; American Heart Association; CIRM; Younger Family Foundation; Roddenberry Foundation; L.K. Whittier Foundation; NIH/NCRR [C06 RR018928]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR018928] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060714, K08HL101989] Funding Source: NIH RePORTER	GlaxoSmithKline Research and Education Foundation; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); CIRM(California Institute for Regenerative Medicine); Younger Family Foundation; Roddenberry Foundation; L.K. Whittier Foundation; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful for technical assistance from the Gladstone Histology Core (C. Miller), Gladstone Genomics Core (L. Ta, Y. Hao, B. Chadwick), UCSF MRI Core (M. Wendland, J. Hawkins) and Laboratory for Cell Analysis at UCSF (S. Elmes). We thank all the members of the Srivastava laboratory for helpful discussions; G. Howard and B. Taylor for editorial help; and B. Bruneau and B. Conklin for helpful discussions and critical reviews of the manuscript. We also thank J. Nerbonne, N. Foeger, and members of the Nerbonne laboratory for assistance with the adult myocyte isolation protocol. L. Q. is a postdoctoral scholar of the California Institute for Regenerative Medicine (CIRM). V. V. is supported by grants from the GlaxoSmithKline Research and Education Foundation and the NIH/NHLBI (K08HL101989). J.-d.F. is supported by a postdoctoral fellowship from American Heart Association. S. J. C. was supported by R01 HL060714 from NHLBI/NIH. D. S. was supported by grants from NHLBI/NIH, CIRM, the Younger Family Foundation, Roddenberry Foundation and the L.K. Whittier Foundation. This work was supported by NIH/NCRR grant (C06 RR018928) to the Gladstone Institutes.	Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bock-Marquette I, 2004, NATURE, V432, P466, DOI 10.1038/nature03000; Bock-Marquette I, 2009, J MOL CELL CARDIOL, V46, P728, DOI 10.1016/j.yjmcc.2009.01.017; Byun JH, 2000, J GENE MED, V2, P2; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; Fenske S, 2011, CIRC RES, V109, P1015, DOI 10.1161/CIRCRESAHA.111.246173; Goldstein AL, 2005, TRENDS MOL MED, V11, P421, DOI 10.1016/j.molmed.2005.07.004; Hinkel R, 2008, CIRCULATION, V117, P2232, DOI 10.1161/CIRCULATIONAHA.107.758904; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Huang PY, 2011, NATURE, V475, P386, DOI 10.1038/nature10116; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; LARSEN TH, 1986, RES EXP MED, V186, P295, DOI 10.1007/BF01852306; Leda M, 2009, DEV CELL, V16, P233, DOI 10.1016/j.devcel.2008.12.007; Li JF, 2005, CIRC RES, V97, P474, DOI 10.1161/01.RES.0000181132.11393.18; Ljubojevic S, 2011, BIOPHYS J, V100, P2356, DOI 10.1016/j.bpj.2011.03.060; Murry CE, 1996, J CLIN INVEST, V98, P2209, DOI 10.1172/JCI119030; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Saffitz JE, 2000, CIRC RES, V86, P723, DOI 10.1161/01.RES.86.7.723; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smart N, 2007, NATURE, V445, P177, DOI 10.1038/nature05383; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srivastava D, 2006, NATURE, V441, P1097, DOI 10.1038/nature04961; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeda N, 2010, J CLIN INVEST, V120, P254, DOI 10.1172/JCI40295; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Xu HD, 1999, J GEN PHYSIOL, V113, P661, DOI 10.1085/jgp.113.5.661; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	40	922	980	10	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					593	+		10.1038/nature11044	http://dx.doi.org/10.1038/nature11044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22522929	Green Submitted, Green Accepted			2022-12-24	WOS:000304608000038
J	Han, TNW; Kato, M; Xie, SH; Wu, LC; Mirzaei, H; Pei, JM; Chen, M; Xie, Y; Allen, J; Xiao, GH; McKnight, SL				Han, Tina W.; Kato, Masato; Xie, Shanhai; Wu, Leeju C.; Mirzaei, Hamid; Pei, Jimin; Chen, Min; Xie, Yang; Allen, Jeffrey; Xiao, Guanghua; McKnight, Steven L.			Cell-free Formation of RNA Granules: Bound RNAs Identify Features and Components of Cellular Assemblies	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MESSENGER-RNA; INTRACELLULAR-LOCALIZATION; DENDRITIC LOCALIZATION; BINDING PROTEINS; AMPA RECEPTOR; APLYSIA CPEB; DROSOPHILA; NEURONS; PUMILIO	Cellular granules lacking boundary membranes harbor RNAs and their associated proteins and play diverse roles controlling the timing and location of protein synthesis. Formation of such granules was emulated by treatment of mouse brain extracts and human cell lysates with a biotinylated isoxazole (b-isox) chemical. Deep sequencing of the associated RNAs revealed an enrichment for mRNAs known to be recruited to neuronal granules used for dendritic transport and localized translation at synapses. Precipitated mRNAs contain extended 30 UTR sequences and an enrichment in binding sites for known granule-associated proteins. Hydrogels composed of the low complexity (LC) sequence domain of FUS recruited and retained the same mRNAs as were selectively precipitated by the b-isox chemical. Phosphorylation of the LC domain of FUS prevented hydrogel retention, offering a conceptual means of dynamic, signal-dependent control of RNA granule assembly.	[Han, Tina W.; Kato, Masato; Xie, Shanhai; Wu, Leeju C.; Mirzaei, Hamid; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Chen, Min; Xie, Yang; Allen, Jeffrey; Xiao, Guanghua] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Pei, Jimin] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu		Chen, Min/0000-0002-0676-3143	NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; [Anonymous], 2010, R LANG ENV STAT COMP; BERNARDI A, 1972, P NATL ACAD SCI USA, V69, P3033, DOI 10.1073/pnas.69.10.3033; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Bramham CR, 2007, NAT REV NEUROSCI, V8, P776, DOI 10.1038/nrn2150; BURGIN KE, 1990, J NEUROSCI, V10, P1788; CACERES A, 1983, P NATL ACAD SCI-BIOL, V80, P1738, DOI 10.1073/pnas.80.6.1738; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; Feng Y, 1997, J NEUROSCI, V17, P1539; Gardiner M, 2008, BIOCHEM J, V415, P297, DOI 10.1042/BJ20081135; Grooms SY, 2006, J NEUROSCI, V26, P8339, DOI 10.1523/JNEUROSCI.0472-06.2006; Hegner RW, 1908, BIOL BULL-US, V16, P19, DOI 10.2307/1536121; Hegner RW, 1911, BIOL BULL-US, V20, P237, DOI 10.2307/1536101; Herb A, 1997, MOL CELL NEUROSCI, V8, P367, DOI 10.1006/mcne.1996.0594; Hoell JI, 2011, NAT STRUCT MOL BIOL, V18, P1428, DOI 10.1038/nsmb.2163; ILLMENSEE K, 1974, P NATL ACAD SCI USA, V71, P1016, DOI 10.1073/pnas.71.4.1016; Kaiser TE, 2008, SCIENCE, V322, P1713, DOI 10.1126/science.1165216; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; KISLAUSKIS EH, 1993, J CELL BIOL, V123, P165, DOI 10.1083/jcb.123.1.165; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; Knowles RB, 1996, J NEUROSCI, V16, P7812; Koyano S, 1999, NEUROSCI LETT, V273, P117, DOI 10.1016/S0304-3940(99)00656-4; Kuhl D, 1998, CURR OPIN NEUROBIOL, V8, P600, DOI 10.1016/S0959-4388(98)80087-1; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; LEHMANN R, 1987, NATURE, V329, P167, DOI 10.1038/329167a0; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; MAHOWALD AP, 1962, J EXP ZOOL, V151, P201, DOI 10.1002/jez.1401510302; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; NOVER L, 1983, MOL CELL BIOL, V3, P1648, DOI 10.1128/MCB.3.9.1648; OKADA M, 1974, DEV BIOL, V37, P43, DOI 10.1016/0012-1606(74)90168-7; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Shevtsov SP, 2011, NAT CELL BIOL, V13, P167, DOI 10.1038/ncb2157; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2010, CELL, V140, P421, DOI 10.1016/j.cell.2010.01.008; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vessey JP, 2010, P NATL ACAD SCI USA, V107, P3222, DOI 10.1073/pnas.0907128107; WANG H, 1994, J NEUROSCI, V14, P4588; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; Ye B, 2004, CURR BIOL, V14, P314, DOI 10.1016/j.cub.2004.01.052; Zamore PD, 1997, RNA, V3, P1421; Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9	53	530	535	7	105	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					768	779		10.1016/j.cell.2012.04.016	http://dx.doi.org/10.1016/j.cell.2012.04.016			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579282	Bronze			2022-12-24	WOS:000303934700011
J	Kose, S; Furuta, M; Imamoto, N				Kose, Shingo; Furuta, Maiko; Imamoto, Naoko			Hikeshi, a Nuclear Import Carrier for Hsp70s, Protects Cells from Heat Shock-Induced Nuclear Damage	CELL			English	Article							PORE-TARGETING COMPLEX; MOLECULAR CHAPERONES; MAMMALIAN-CELLS; TRANSPORT; STRESS; INHIBITION; MECHANISM; CYTOPLASM; GRADIENT; RECOVERY	During heat shock stress, importin beta family-mediated nucleocytoplasmic trafficking is downregulated, whereas nuclear import of the molecular chaperone Hsp70s is upregulated. Here, we identify a nuclear import pathway that operates during heat shock stress and is mediated by an evolutionarily conserved protein named "Hikeshi," which does not belong to the importin beta family. Hikeshi binds to FG-Nups and translocates through nuclear pores on its own, showing characteristic features of nuclear transport carriers. In reconstituted transport, Hikeshi supports the nuclear import of the ATP form of Hsp70s, but not the ADP form, indicating the importance of the Hsp70 ATPase cycle in the import cycle. In living cells, depletion of Hikeshi inhibits heat shock-induced nuclear import of Hsp70s, reduces cell viability after heat shock stress, and significantly delays the attenuation and reversion of multiple heat shock-induced nuclear phenotypes. Nuclear Hsp70s rescue the effect of Hikeshi depletion at least in part. Thus, Hsp70s counteract heat shock-induced damage by acting inside of the nucleus.	[Kose, Shingo; Furuta, Maiko; Imamoto, Naoko] RIKEN, Adv Sci Inst, Cellular Dynam Lab, Wako, Saitama 3510198, Japan	RIKEN	Kose, S (corresponding author), RIKEN, Adv Sci Inst, Cellular Dynam Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	skose@riken.jp; nimamoto@riken.jp	Imamoto, Naoko/A-7458-2015	Imamoto, Naoko/0000-0002-2886-3022	Japanese Ministry of Education, Culture, Sports, Science, and Technology; RIKEN; Japan Society for the Promotion of Science (JSPS)	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Ai Watanabe and Tomoko Funakoshi for their efficient technical assistance with this work and the members of the Cellular Dynamics Laboratory for discussions throughout the experiments. This work was supported by a Japanese Ministry of Education, Culture, Sports, Science, and Technology Grants-in-Aid (to N.I. and S. K.), RIKEN Special Funding for Basic Science (Cellular System), and funding was awarded to N.I. by the Japan Society for the Promotion of Science (JSPS) through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (CSTP).	Cotto JJ, 1997, J CELL SCI, V110, P2925; Czubryt MP, 2000, J CELL BIOL, V148, P7, DOI 10.1083/jcb.148.1.7; Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100; Fernandez-Valdivia R, 2006, GENETICS, V172, P389, DOI 10.1534/genetics.105.048736; Furuta M, 2004, GENES CELLS, V9, P429, DOI 10.1111/j.1356-9597.2004.00734.x; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Hancock LC, 2006, GENETICS, V173, P621, DOI 10.1534/genetics.106.057489; HATTORI H, 1993, J CELL SCI, V104, P629; Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kelley JB, 2007, MOL BIOL CELL, V18, P4365, DOI 10.1091/mbc.E07-01-0089; Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432; Kodiha M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008420; Kosako H, 2009, NAT STRUCT MOL BIOL, V16, P1026, DOI 10.1038/nsmb.1656; Kose S, 1999, J BIOL CHEM, V274, P3946, DOI 10.1074/jbc.274.7.3946; Kose S, 1997, J CELL BIOL, V139, P841, DOI 10.1083/jcb.139.4.841; Lamian V, 1996, EXP CELL RES, V228, P84, DOI 10.1006/excr.1996.0302; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; Miyamoto Y, 2004, J CELL BIOL, V165, P617, DOI 10.1083/jcb.200312008; Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622; Nakielny S, 1998, CURR BIOL, V8, P89, DOI 10.1016/S0960-9822(98)70039-9; Patel SS, 2008, MOL CELL PROTEOMICS, V7, P121, DOI 10.1074/mcp.M700407-MCP200; PELHAM HRB, 1984, EMBO J, V3, P3095, DOI 10.1002/j.1460-2075.1984.tb02264.x; Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; VELAZQUEZ JM, 1984, CELL, V36, P655, DOI 10.1016/0092-8674(84)90345-3; Voellmy R, 2004, PROG NUCLEIC ACID RE, V78, P143, DOI 10.1016/S0079-6603(04)78004-6; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; WELCH WJ, 1984, J BIOL CHEM, V259, P4501; WILBANKS SM, 1994, J BIOL CHEM, V269, P12893	34	98	102	3	29	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					578	589		10.1016/j.cell.2012.02.058	http://dx.doi.org/10.1016/j.cell.2012.02.058			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541429	Bronze			2022-12-24	WOS:000303443100010
J	Shenoy, AR; Wellington, DA; Kumar, P; Kassa, H; Booth, CJ; Cresswell, P; MacMicking, JD				Shenoy, Avinash R.; Wellington, David A.; Kumar, Pradeep; Kassa, Hilina; Booth, Carmen J.; Cresswell, Peter; MacMicking, John D.			GBP5 Promotes NLRP3 Inflammasome Assembly and Immunity in Mammals	SCIENCE			English	Article							DIFFERENTIAL REQUIREMENT; CUTTING EDGE; HOST-DEFENSE; CELL-DEATH; ACTIVATION; CASPASE-1; INTERLEUKIN-1-BETA; CRYSTALS; ROLES; ASC	Inflammasomes are sensory complexes that alert the immune system to the presence of infection or tissue damage. These complexes assemble NLR (nucleotide binding and oligomerization, leucine-rich repeat) or ALR (absent in melanoma 2-like receptor) proteins to activate caspase-1 cleavage and interleukin (IL)-1 beta/IL-18 secretion. Here, we identified a non-NLR/ALR human protein that stimulates inflammasome assembly: guanylate binding protein 5 (GBP5). GBP5 promoted selective NLRP3 inflammasome responses to pathogenic bacteria and soluble but not crystalline inflammasome priming agents. Generation of Gbp5(-/-) mice revealed pronounced caspase-1 and IL-1 beta/IL-18 cleavage defects in vitro and impaired host defense and Nlrp3-dependent inflammatory responses in vivo. Thus, GBP5 serves as a unique rheostat for NLRP3 inflammasome activation and extends our understanding of the inflammasome complex beyond its core machinery.	[Shenoy, Avinash R.; Wellington, David A.; Kumar, Pradeep; Kassa, Hilina; MacMicking, John D.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, New Haven, CT 06510 USA; [Wellington, David A.; Booth, Carmen J.] Yale Univ, Sch Med, Sect Comparat Med, New Haven, CT 06510 USA; [Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Yale University; Howard Hughes Medical Institute; Yale University	MacMicking, JD (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, Boyer Ctr Mol Med, 333 Cedar St, New Haven, CT 06510 USA.	john.macmicking@yale.edu		Shenoy, Avinash/0000-0001-6228-9303	Yale Brown-Coxe fellowship; Anna Fuller postdoctoral fellowship; Howard Hughes Medical Institute; NIH National Institute of Allergy and Infectious Diseases [R01 AI068041-06]; Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award [1007845]; Searle Foundation [05-F-114]; Cancer Research Institute [CRI06-10]; Chrohn's and Colitis Foundation of America [R09928]; W. W. Winchester Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068041] Funding Source: NIH RePORTER	Yale Brown-Coxe fellowship; Anna Fuller postdoctoral fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award; Searle Foundation; Cancer Research Institute; Chrohn's and Colitis Foundation of America; W. W. Winchester Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Tschopp, M. Karin, W. Mothes, and C. Roy for plasmids. All data are tabulated in the main paper and the supplementary materials. A. R. S. was supported by Yale Brown-Coxe and Anna Fuller postdoctoral fellowships, P. C. by Howard Hughes Medical Institute, and J.D.M. by NIH National Institute of Allergy and Infectious Diseases (R01 AI068041-06), Burroughs Wellcome Fund Investigator in Pathogenesis of Infectious Disease Award (1007845), Searle Foundation Scholars Program (05-F-114), Cancer Research Institute Investigator Award Program (CRI06-10), Chrohn's and Colitis Foundation of America Senior Investigator Award (R09928), and W. W. Winchester Foundation.	Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Dombrowski Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002001; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Shiohara M, 2002, BIOCHEM BIOPH RES CO, V293, P1314, DOI 10.1016/S0006-291X(02)00384-4; Tsuji NM, 2004, INT IMMUNOL, V16, P335, DOI 10.1093/intimm/dxh041; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	26	302	313	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					481	485		10.1126/science.1217141	http://dx.doi.org/10.1126/science.1217141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22461501				2022-12-24	WOS:000303233400049
J	Eisenhoffer, GT; Loftus, PD; Yoshigi, M; Otsuna, H; Chien, CB; Morcos, PA; Rosenblatt, J				Eisenhoffer, George T.; Loftus, Patrick D.; Yoshigi, Masaaki; Otsuna, Hideo; Chien, Chi-Bin; Morcos, Paul A.; Rosenblatt, Jody			Crowding induces live cell extrusion to maintain homeostatic cell numbers in epithelia	NATURE			English	Article							APOPTOTIC CELLS; PROLIFERATION; EXTRUDE; JNK	For an epithelium to provide a protective barrier, it must maintain homeostatic cell numbers by matching the number of dividing cells with the number of dying cells. Although compensatory cell division can be triggered by dying cells(1-3), it is unknown how cell death might relieve overcrowding due to proliferation. When we trigger apoptosis in epithelia, dying cells are extruded to preserve a functional barrier(4). Extrusion occurs by cells destined to die signalling to surrounding epithelial cells to contract an actomyosin ring that squeezes the dying cell out(4-6). However, it is not clear what drives cell death during normal homeostasis. Here we show in human, canine and zebrafish cells that overcrowding due to proliferation and migration induces extrusion of live cells to control epithelial cell numbers. Extrusion of live cells occurs at sites where the highest crowding occurs in vivo and can be induced by experimentally overcrowding monolayers in vitro. Like apoptotic cell extrusion, live cell extrusion resulting from overcrowding also requires sphingosine 1-phosphate signalling and Rho-kinase-dependent myosin contraction, but is distinguished by signalling through stretch-activated channels. Moreover, disruption of a stretch-activated channel, Piezo1, in zebrafish prevents extrusion and leads to the formation of epithelial cell masses. Our findings reveal that during homeostatic turnover, growth and division of epithelial cells on a confined substratum cause overcrowding that leads to their extrusion and consequent death owing to the loss of survival factors. These results suggest that live cell extrusion could be a tumour-suppressive mechanism that prevents the accumulation of excess epithelial cells.	[Eisenhoffer, George T.; Loftus, Patrick D.; Rosenblatt, Jody] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA; [Yoshigi, Masaaki] Univ Utah, Dept Pediat, Salt Lake City, UT 84108 USA; [Otsuna, Hideo; Chien, Chi-Bin] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA; [Morcos, Paul A.] Gene Tools LLC, Philomath, OR 97370 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Rosenblatt, J (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA.	jody.rosenblatt@hci.utah.edu	Rosenblatt, Jody/AAD-4260-2019	Rosenblatt, Jody/0000-0001-9460-5868	National Institute of Biomedical Imaging and Bioengineering [EB-4443]; NIH-NIGMS NIH [1 DP2OD002056-01]; Laura and Arthur Colwin Endowed Marine Biology Laboratories Summer Research Fellowship Fund; NIH [5T32 CA03247-8, MH092256]; American Cancer Society [120464-PF-11-095-01 CSM]; University of Utah;  [P30 CA042014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB004443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092256] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002056] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIH-NIGMS NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Laura and Arthur Colwin Endowed Marine Biology Laboratories Summer Research Fellowship Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); University of Utah; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank B. Welm, M. Redd and K. Ullman for valuable input on our manuscript and T. Marshall and D. Andrade for Lifeact- and BCL2-expressing MDCK lines. The custom-designed cell culture device was made with the support of National Institute of Biomedical Imaging and Bioengineering Grant EB-4443 to M.Y. (patent pending). This work was supported by a NIH-NIGMS NIH Director's New Innovator Award 1 DP2OD002056-01 and a Laura and Arthur Colwin Endowed Marine Biology Laboratories Summer Research Fellowship Fund to J.R., and a P30 CA042014 awarded to The Huntsman Cancer Institute for core facilities. An NIH Multidisciplinary Cancer Training Program Grant 5T32 CA03247-8 and American Cancer Society Salt Lake City Postdoctoral Fellowship (120464-PF-11-095-01 CSM) supported G. T. E., the University of Utah Undergraduate Research Opportunities Program Parent Fund Assistantship supported P. D. L., and an NIH R01 Grant MH092256 supported H.O. and C.B.C.	Andrade D, 2011, APOPTOSIS, V16, P491, DOI 10.1007/s10495-011-0587-z; Bhattacharya MRC, 2008, P NATL ACAD SCI USA, V105, P20015, DOI 10.1073/pnas.0810801105; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Davison JM, 2007, DEV BIOL, V304, P811, DOI 10.1016/j.ydbio.2007.01.033; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Fan Y, 2008, DEV CELL, V14, P399, DOI 10.1016/j.devcel.2008.01.003; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Gu YP, 2011, J CELL BIOL, V193, P667, DOI 10.1083/jcb.201010075; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Holgate Stephen T, 2008, Allergol Int, V57, P1, DOI 10.2332/allergolint.R-07-154; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Monks J, 2008, BIOL REPROD, V78, P586, DOI 10.1095/biolreprod.107.065045; Olsen SM, 2011, ANN BIOMED ENG, V39, P688, DOI 10.1007/s10439-010-0203-3; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; Slattum G, 2009, J CELL BIOL, V186, P693, DOI 10.1083/jcb.200903079; Swindle EJ, 2009, J ALLERGY CLIN IMMUN, V124, P23, DOI 10.1016/j.jaci.2009.05.037; Tallafuss A, DEVELOPMENT IN PRESS; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018; Yoshigi M, 2003, CYTOM PART A, V55A, P109, DOI 10.1002/cyto.a.10076	27	497	508	5	112	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 26	2012	484	7395					546	U183		10.1038/nature10999	http://dx.doi.org/10.1038/nature10999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22504183	Green Accepted			2022-12-24	WOS:000303200400058
J	Xu, X; Wang, KB; Zhang, K; Ma, QY; Xing, LD; Sullivan, C; Hu, DY; Cheng, SQ; Wang, S				Xu, Xing; Wang, Kebai; Zhang, Ke; Ma, Qingyu; Xing, Lida; Sullivan, Corwin; Hu, Dongyu; Cheng, Shuqing; Wang, Shuo			A gigantic feathered dinosaur from the Lower Cretaceous of China	NATURE			English	Article							TYRANNOSAUROID DINOSAUR; NORTH-AMERICA; THEROPODA; AGE	Numerous feathered dinosaur specimens have recently been recovered from the Middle-Upper Jurassic and Lower Cretaceous deposits of northeastern China, but most of them represent small animals(1). Here we report the discovery of a gigantic new basal tyrannosauroid, Yutyrannus huali gen. et sp. nov., based on three nearly complete skeletons representing two distinct ontogenetic stages from the Lower Cretaceous Yixian Formation of Liaoning Province, China. Y. huali shares some features, particularly of the cranium, with derived tyrannosauroids(2,3), but is similar to other basal tyrannosauroids(4-12) in possessing a three-fingered manus and a typical theropod pes. Morphometric analysis suggests that Y. huali differed from tyrannosaurids in its growth strategy(13,14). Most significantly, Y. huali bears long filamentous feathers, thus providing direct evidence for the presence of extensively feathered gigantic dinosaurs and offering new insights into early feather evolution.	[Xu, Xing; Ma, Qingyu; Sullivan, Corwin; Wang, Shuo] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Xu, Xing; Hu, Dongyu] Shenyang Normal Univ, Liaoning Paleontol Museum, Shenyang 110034, Peoples R China; [Wang, Kebai; Cheng, Shuqing] Zhucheng Dinosaur Museum, Zhucheng 262200, Shandong, Peoples R China; [Zhang, Ke] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Xing, Lida] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Wang, Shuo] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Shenyang Normal University; China University of Geosciences; University of Alberta; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, X (corresponding author), Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, 142 Xiwai St, Beijing 100044, Peoples R China.	xingxu@vip.sina.com	Wang, Shuo/AAX-8516-2020	Wang, Shuo/0000-0002-4076-0202; Xing, Lida/0000-0003-3923-9206; Sullivan, Corwin/0000-0002-5488-6797	Zhucheng Municipal Government; Erlianhaote Municipal Government; National Natural Science Foundation of China; Special Funds For Major State Basic Research Projects of China	Zhucheng Municipal Government; Erlianhaote Municipal Government; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Funds For Major State Basic Research Projects of China	We thank L. Zhang for discussions, R. Li, H. Zang and X. Ding for illustrations, and H. Wang, L. Xiang and R. Cao for preparing the specimens. We thank the Zhucheng Municipal Government and Erlianhaote Municipal Government for support. This study was supported by grants from the National Natural Science Foundation of China and Special Funds For Major State Basic Research Projects of China.	Amiot R, 2011, P NATL ACAD SCI USA, V108, P5179, DOI 10.1073/pnas.1011369108; Averianov A.O., 2010, Trudy Zoologicheskogo Instituta, V314, P42; Benson RBJ, 2008, J VERTEBR PALEONTOL, V28, P732, DOI 10.1671/0272-4634(2008)28[732:NIOSAT]2.0.CO;2; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Brusatte SL, 2010, SCIENCE, V329, P1481, DOI 10.1126/science.1193304; Brusatte SL, 2009, P NATL ACAD SCI USA, V106, P17261, DOI 10.1073/pnas.0906911106; Christiansen P., 2004, Historical Biology, V16, P85, DOI 10.1080/08912960412331284313; Currie Philip J., 2003, Ichnos, V10, P1, DOI 10.1080/10420940390235071; Currie PJ, 2003, ACTA PALAEONTOL POL, V48, P191; Currie PJ, 2003, CAN J EARTH SCI, V40, P651, DOI 10.1139/E02-083; Deng T, 2011, SCIENCE, V333, P1285, DOI 10.1126/science.1206594; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Fiorillo AR, 2000, J VERTEBR PALEONTOL, V20, P675, DOI 10.1671/0272-4634(2000)020[0675:TTFTPC]2.0.CO;2; Fowler DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021376; Holtz TR, 2004, DINOSAURIA, 2ND EDITION, P111; Hutt S, 2001, CRETACEOUS RES, V22, P227, DOI 10.1006/cres.2001.0252; Ji Qiang, 2009, Dizhi Tongbao, V28, P1369; Li DQ, 2010, P ROY SOC B-BIOL SCI, V277, P183, DOI 10.1098/rspb.2009.0249; Ortega F, 2010, NATURE, V467, P203, DOI 10.1038/nature09181; Paul G. S., 2008, TYRANNOSAURUS REX TY, P354; Rauhut OWM, 2010, ZOOL J LINN SOC-LOND, V158, P155, DOI 10.1111/j.1096-3642.2009.00591.x; Rauhut OWM, 2003, PALAEONTOLOGY, V46, P903, DOI 10.1111/1475-4983.00325; Sereno PC, 2009, SCIENCE, V326, P418, DOI 10.1126/science.1177428; Spicer RA, 2010, PALAEOGEOGR PALAEOCL, V295, P423, DOI 10.1016/j.palaeo.2010.02.025; Swisher CC, 2002, CHINESE SCI BULL, V47, P135; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2004, NATURE, V431, P680, DOI 10.1038/nature02855; Xu X, 2007, NATURE, V447, P844, DOI 10.1038/nature05849; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311	30	89	101	3	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					92	95		10.1038/nature10906	http://dx.doi.org/10.1038/nature10906			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481363				2022-12-24	WOS:000302343400040
J	Herzig, S; Raemy, E; Montessuit, S; Veuthey, JL; Zamboni, N; Westermann, B; Kunji, ERS; Martinou, JC				Herzig, Sebastien; Raemy, Etienne; Montessuit, Sylvie; Veuthey, Jean-Luc; Zamboni, Nicola; Westermann, Benedikt; Kunji, Edmund R. S.; Martinou, Jean-Claude			Identification and Functional Expression of the Mitochondrial Pyruvate Carrier	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; LIPOIC ACID; LACTOCOCCUS-LACTIS; DEHYDROGENASE; SPECIFICITY; CATABOLISM; TRANSPORT; MEMBRANE	The transport of pyruvate, the end product of glycolysis, into mitochondria is an essential process that provides the organelle with a major oxidative fuel. Although the existence of a specific mitochondrial pyruvate carrier (MPC) has been anticipated, its molecular identity remained unknown. We report that MPC is a heterocomplex formed by two members of a family of previously uncharacterized membrane proteins that are conserved from yeast to mammals. Members of the MPC family were found in the inner mitochondrial membrane, and yeast mutants lacking MPC proteins showed severe defects in mitochondrial pyruvate uptake. Coexpression of mouse MPC1 and MPC2 in Lactococcus lactis promoted transport of pyruvate across the membrane. These observations firmly establish these proteins as essential components of the MPC.	[Herzig, Sebastien; Raemy, Etienne; Montessuit, Sylvie; Martinou, Jean-Claude] Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland; [Veuthey, Jean-Luc] Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva 4, Switzerland; [Zamboni, Nicola] Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Westermann, Benedikt] Univ Bayreuth, D-95440 Bayreuth, Germany; [Kunji, Edmund R. S.] MRC, Mitochondria Biol Unit, Cambridge CB2 0XY, England	University of Geneva; University of Geneva; University of Bayreuth	Martinou, JC (corresponding author), Univ Geneva, Dept Cell Biol, CH-1211 Geneva 4, Switzerland.	jean-claude.martinou@unige.ch	Kunji, Edmund/AAH-2362-2020; Zamboni, Nicola/K-3042-2012; Westermann, Benedikt/H-7766-2013; Herzig, Sebastien/AAA-8853-2019	Kunji, Edmund/0000-0002-0610-4500; Zamboni, Nicola/0000-0003-1271-1021; Westermann, Benedikt/0000-0002-2991-1604; Herzig, Sebastien/0000-0002-9329-2860; martinou, Jean-claude/0000-0002-9847-2051; Veuthey, Jean-Luc/0000-0002-7513-3241	Novartis Science Foundation; Swiss National Science Foundation [31003A-141068/1]; state of Geneva; MRC [MC_U105663139] Funding Source: UKRI; Medical Research Council [MC_U105663139] Funding Source: researchfish	Novartis Science Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); state of Geneva; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to R. Loewith and F. Stutz for strains and technical help, L. Szweda for antibodies, A. Kastaniotis for technical help on lipoic acid determination, Y. Que for erythromycin resistance cassette, and H. Riezman, A. Jourdain, and the Martinou lab for fruitful discussions. This work was supported by Novartis Science Foundation (S. H.), the Swiss National Science Foundation (subsidy 31003A-141068/1 to J.-C.M.), and the state of Geneva.	Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; DICKINSON JR, 1986, MOL GEN GENET, V204, P103; DICKINSON JR, 1992, J GEN MICROBIOL, V138, P2029, DOI 10.1099/00221287-138-10-2029; HALESTRAP AP, 1975, BIOCHEM J, V148, P97, DOI 10.1042/bj1480097; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; Harris RA, 2005, J NUTR, V135, p1527S, DOI 10.1093/jn/135.6.1527S; Hiltunen JK, 2010, PROG LIPID RES, V49, P27, DOI 10.1016/j.plipres.2009.08.001; Hoja U, 2004, J BIOL CHEM, V279, P21779, DOI 10.1074/jbc.M401071200; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5; KUNJI ERS, 1993, J BACTERIOL, V175, P2052, DOI 10.1128/JB.175.7.2052-2059.1993; LAWSON JE, 1991, BIOCHEMISTRY-US, V30, P2834, DOI 10.1021/bi00225a015; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Wada H, 1997, P NATL ACAD SCI USA, V94, P1591, DOI 10.1073/pnas.94.4.1591	17	432	457	10	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2012	337	6090					93	96		10.1126/science.1218530	http://dx.doi.org/10.1126/science.1218530			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22628554				2022-12-24	WOS:000306053100051
J	Pyenson, ND; Goldbogen, JA; Vogl, AW; Szathmary, G; Drake, RL; Shadwick, RE				Pyenson, Nicholas D.; Goldbogen, Jeremy A.; Vogl, A. Wayne; Szathmary, Gabor; Drake, Richard L.; Shadwick, Robert E.			Discovery of a sensory organ that coordinates lunge feeding in rorqual whales	NATURE			English	Article							FIN WHALES; MYSTICETE; MECHANICS; CETACEA; BALEEN	Top ocean predators have evolved multiple solutions to the challenges of feeding in the water(1-3). At the largest scale, rorqual whales (Balaenopteridae) engulf and filter prey-laden water by lunge feeding(4), a strategy that is unique among vertebrates(1). Lunge feeding is facilitated by several morphological specializations, including bilaterally separate jaws that loosely articulate with the skull(5,6), hyper-expandable throat pleats, or ventral groove blubber(7), and a rigid y-shaped fibrocartilage structure branching from the chin into the ventral groove blubber(8). The linkages and functional coordination among these features, however, remain poorly understood. Here we report the discovery of a sensory organ embedded within the fibrous symphysis between the unfused jaws that is present in several rorqual species, at both fetal and adult stages. Vascular and nervous tissue derived from the ancestral, anterior-most tooth socket insert into this organ, which contains connective tissue and papillae suspended in a gel-like matrix. These papillae show the hallmarks of a mechanoreceptor, containing nerves and encapsulated nerve termini. Histological, anatomical and kinematic evidence indicate that this sensory organ responds to both the dynamic rotation of the jaws during mouth opening and closure, and ventral groove blubber(7) expansion through direct mechanical linkage with the y-shaped fibrocartilage structure. Along with vibrissae on the chin(9), providing tactile prey sensation, this organ provides the necessary input to the brain for coordinating the initiation, modulation and end stages of engulfment, a paradigm that is consistent with unsteady hydrodynamic models and tag data from lunge-feeding rorquals(10-13). Despite the antiquity of unfused jaws in baleen whales since the late Oligocene(14) (similar to 23-28 million years ago), this organ represents an evolutionary novelty for rorquals, based on its absence in all other lineages of extant baleen whales. This innovation has a fundamental role in one of the most extreme feeding methods in aquatic vertebrates, which facilitated the evolution of the largest vertebrates ever.	[Pyenson, Nicholas D.] Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, Washington, DC 20013 USA; [Pyenson, Nicholas D.] Burke Museum Nat Hist & Culture, Dept Mammal, Seattle, WA 98195 USA; [Pyenson, Nicholas D.] Burke Museum Nat Hist & Culture, Dept Paleontol, Seattle, WA 98195 USA; [Goldbogen, Jeremy A.] Cascadia Res Collect, Olympia, WA 98501 USA; [Vogl, A. Wayne] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Szathmary, Gabor] FPInnovations, Vancouver, BC V6T 1W5, Canada; [Drake, Richard L.] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44195 USA; [Shadwick, Robert E.] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Smithsonian Institution; Smithsonian National Museum of Natural History; University of British Columbia; Case Western Reserve University; Cleveland Clinic Foundation; University of British Columbia	Pyenson, ND (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Paleobiol, POB 37012, Washington, DC 20013 USA.	pyensonn@si.edu	Goldbogen, Jeremy A./H-4287-2019	Goldbogen, Jeremy A./0000-0002-4170-7294; Pyenson, Nicholas/0000-0003-4678-5782	Natural Sciences and Engineering Research Council of Canada; Smithsonian Institution; Remington Kellogg Fund; University of British Columbia; Scripps Postdoctoral Research Fellowship; NSERC	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Smithsonian Institution(Smithsonian Institution); Remington Kellogg Fund; University of British Columbia; Scripps Postdoctoral Research Fellowship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	For logistical support, we thank K. Loftsson and the staff at Hvalur hf; D. Olafsdottir, S. D. Halldorsson and G. A. Vikingsson at the Marine Research Institute, Reykjavik; G. Bergmann and the staff at Hrefnuveioimenn ehf; S. Raverty; P. F. Brodie; and A. Trites. For additional samples and data, we also thank P.-Y. Daoust, G. Williams, the Amarok Hunters and Trappers Organization of Iqaluit, Captain S. Awa and the Inuit whaling crew from Iqaluit, J. Higgins and the Cascadia Research Collective, M. R. Buono, A. van Helden and the Museum of New Zealand Te Papa Tongarewa, and R. E. Fordyce. We also thank T. S. Hunter for assistance with laboratory samples. Comments from D. J. Bohaska, M. T. Carrano, R. B. Irmis, J. G. Mead, J. F. Parham, C. W. Potter and J. Velez-Juarbe improved this manuscript. N.D.P. was supported by a postdoctoral research fellowship from the Natural Sciences and Engineering Research Council of Canada and by funding from the Smithsonian Institution and its Remington Kellogg Fund. J. A. G. was supported by a University Graduate Fellowship for Research from the University of British Columbia, a Scripps Postdoctoral Research Fellowship and NSERC funding to R.E.S.	BEST RC, 1981, CAN J ZOOL, V59, P2386, DOI 10.1139/z81-319; Brodie Paul F., 2001, P345; BRODIE PF, 1993, CAN J ZOOL, V71, P2546, DOI 10.1139/z93-348; Canning C, 2011, ANIM BEHAV, V82, P901, DOI 10.1016/j.anbehav.2011.07.031; Catania KC, 2008, P NATL ACAD SCI USA, V105, P571, DOI 10.1073/pnas.0709534104; Currey J.D., 2002, BONES STRUCTURE MECH; Czech-Damal NU, 2012, P ROY SOC B-BIOL SCI, V279, P663, DOI 10.1098/rspb.2011.1127; Demere TA, 2008, SYST BIOL, V57, P15, DOI 10.1080/10635150701884632; Fitzgerald EMG, 2012, BIOL LETTERS, V8, P94, DOI 10.1098/rsbl.2011.0690; Fitzgerald EMG, 2010, ZOOL J LINN SOC-LOND, V158, P367, DOI 10.1111/j.1096-3642.2009.00572.x; Friedman M, 2010, SCIENCE, V327, P990, DOI 10.1126/science.1184743; Goldbogen JA, 2011, J EXP BIOL, V214, P131, DOI 10.1242/jeb.048157; Goldbogen JA, 2007, MAR ECOL PROG SER, V349, P289, DOI 10.3354/meps07066; Goldbogen JA, 2012, FUNCT ECOL, V26, P216, DOI 10.1111/j.1365-2435.2011.01905.x; Goldbogen JA, 2010, AM SCI, V98, P124, DOI 10.1511/2010.83.124; Johnston C, 2010, MAR MAMMAL SCI, V26, P186, DOI 10.1111/j.1748-7692.2009.00305.x; LAMBERTSEN R, 1995, J MAMMAL, V76, P877, DOI 10.2307/1382758; LAMBERTSEN RH, 1983, J MAMMAL, V64, P76, DOI 10.2307/1380752; Ling J. K., 1977, P387; McKenna M. F., 2011, MAR MAMM SCI; ORTON LS, 1987, CAN J ZOOL, V65, P2898, DOI 10.1139/z87-440; PIVORUNAS A, 1977, J MORPHOL, V151, P299, DOI 10.1002/jmor.1051510207; Potvin J, 2010, J THEOR BIOL, V267, P437, DOI 10.1016/j.jtbi.2010.08.026; Potvin J, 2009, J R SOC INTERFACE, V6, P1005, DOI 10.1098/rsif.2008.0492; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P82; SANDERSON SL, 1993, SKULL, V3, P37; SCAPINO R, 1981, J MORPHOL, V167, P339, DOI 10.1002/jmor.1051670308; TERSHY BR, 1992, MAR MAMMAL SCI, V8, P315, DOI 10.1111/j.1748-7692.1992.tb00416.x; Thewissen JGM, 2008, SENSORY EVOLUTION ON THE THRESHOLD: ADAPTATIONS IN SECONDARILY AQUATIC VERTEBRATES, P1; Werth AJ., 2000, FEEDING FORM FUNCTIO, P475, DOI [10.1016/B978-012632590-4/50017-4, DOI 10.1016/B978-012632590-4/50017-4]	30	71	71	3	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					498	501		10.1038/nature11135	http://dx.doi.org/10.1038/nature11135			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622577				2022-12-24	WOS:000304344500042
J	Bosveld, F; Bonnet, I; Guirao, B; Tlili, S; Wang, ZM; Petitalot, A; Marchand, R; Bardet, PL; Marcq, P; Graner, F; Bellaiche, Y				Bosveld, Floris; Bonnet, Isabelle; Guirao, Boris; Tlili, Sham; Wang, Zhimin; Petitalot, Ambre; Marchand, Raphael; Bardet, Pierre-Luc; Marcq, Philippe; Graner, Francois; Bellaiche, Yohanns			Mechanical Control of Morphogenesis by Fat/Dachsous/Four-Jointed Planar Cell Polarity Pathway	SCIENCE			English	Article							FAT; DROSOPHILA; GROWTH; DACHS; EXPRESSION; DIVISIONS; AFFINITY; ENCODES; MYOSIN; MEMBER	During animal development, several planar cell polarity (PCP) pathways control tissue shape by coordinating collective cell behavior. Here, we characterize by means of multiscale imaging epithelium morphogenesis in the Drosophila dorsal thorax and show how the Fat/Dachsous/Four-jointed PCP pathway controls morphogenesis. We found that the proto-cadherin Dachsous is polarized within a domain of its tissue-wide expression gradient. Furthermore, Dachsous polarizes the myosin Dachs, which in turn promotes anisotropy of junction tension. By combining physical modeling with quantitative image analyses, we determined that this tension anisotropy defines the pattern of local tissue contraction that contributes to shaping the epithelium mainly via oriented cell rearrangements. Our results establish how tissue planar polarization coordinates the local changes of cell mechanical properties to control tissue morphogenesis.	[Bosveld, Floris; Bonnet, Isabelle; Guirao, Boris; Tlili, Sham; Wang, Zhimin; Petitalot, Ambre; Marchand, Raphael; Bardet, Pierre-Luc; Graner, Francois; Bellaiche, Yohanns] Inst Curie, CNRS, Polar Div & Morphogenesis Team, INSERM,UMR 3215,U934, F-75248 Paris 05, France; [Marcq, Philippe] Univ Paris 06, Inst Curie, Lab Phys Chim Curie, CNRS,UMR 168, F-75248 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS)	Bellaiche, Y (corresponding author), Inst Curie, CNRS, Polar Div & Morphogenesis Team, INSERM,UMR 3215,U934, 26 Rue Ulm, F-75248 Paris 05, France.	yohanns.bellaiche@curie.fr		Bonnet, Isabelle/0000-0003-2343-3784; Bardet, Pierre-Luc/0000-0003-1766-1318; Marcq, Philippe/0000-0002-3232-9156; bosveld, floris/0000-0002-4733-9074; Guirao, Boris/0000-0002-5583-0226; bellaiche, yohanns/0000-0003-1686-2943	L'Agence Nationale de la Recherche-MorphoDro [ARC-4830]; European Research Council-CePoDro; Fondation pour la Recherche Medicale; Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Rubicon	L'Agence Nationale de la Recherche-MorphoDro(French National Research Agency (ANR)); European Research Council-CePoDro; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Rubicon	We thank J. Axelrod, S. Blair, Y. Hong, K. Irvine, E. Martin-Blanco, M. Simon, D. Strutt, S. Tsukita, the Bloomington Drosophila Stock Center, Transgenic RNAi Project, and Vienna Drosophila RNAi Center for reagents; M. Coppey, A. Houdusse, F. Molino, S. Ritzenthaler, F. Serman, J. Shi, and the PICT-IBiSA@BDD for help; V. Hakim, E. Heard, J. Lopez-Gay, M. Labouesse, and A-M. Lennon for comments. This work was supported by ARC-4830, L'Agence Nationale de la Recherche-MorphoDro, and European Research Council-CePoDro grants; a Fondation pour la Recherche Medicale grant to I.B.; and a Nederlandse Organisatie voor Wetenschappelijk Onderzoek-Rubicon grant to F.B.	Aigouy B, 2010, CELL, V142, P773, DOI 10.1016/j.cell.2010.07.042; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Brittle AL, 2010, CURR BIOL, V20, P803, DOI 10.1016/j.cub.2010.03.056; Brodsky MH, 1996, DEV BIOL, V173, P428, DOI 10.1006/dbio.1996.0038; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315; CLARK HF, 1995, GENE DEV, V9, P1530, DOI 10.1101/gad.9.12.1530; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Grusche FA, 2010, CURR BIOL, V20, pR574, DOI 10.1016/j.cub.2010.05.023; Ishikawa HO, 2008, SCIENCE, V321, P401, DOI 10.1126/science.1158159; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2008, CURR BIOL, V18, P1390, DOI 10.1016/j.cub.2008.07.067; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Schwank G, 2011, DEV CELL, V20, P123, DOI 10.1016/j.devcel.2010.11.007; Simon MA, 2010, CURR BIOL, V20, P811, DOI 10.1016/j.cub.2010.04.016; Strutt H, 2002, DEV CELL, V3, P851, DOI 10.1016/S1534-5807(02)00363-5; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X	23	242	244	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					724	727		10.1126/science.1221071	http://dx.doi.org/10.1126/science.1221071			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22499807	Green Submitted			2022-12-24	WOS:000303872300051
J	Dennis, MY; Nuttle, X; Sudmant, PH; Antonacci, F; Graves, TA; Nefedov, M; Rosenfeld, JA; Sajjadian, S; Malig, M; Kotkiewicz, H; Curry, CJ; Shafer, S; Shaffer, LG; de Jong, PJ; Wilson, RK; Eichler, EE				Dennis, Megan Y.; Nuttle, Xander; Sudmant, Peter H.; Antonacci, Francesca; Graves, Tina A.; Nefedov, Mikhail; Rosenfeld, Jill A.; Sajjadian, Saba; Malig, Maika; Kotkiewicz, Holland; Curry, Cynthia J.; Shafer, Susan; Shaffer, Lisa G.; de Jong, Pieter J.; Wilson, Richard K.; Eichler, Evan E.			Evolution of Human-Specific Neural SRGAP2 Genes by Incomplete Segmental Duplication	CELL			English	Article							COPY-NUMBER VARIATION; UPPER MIOCENE; DNA-SEQUENCE; HOMINID; GENOME; CONSTRUCTION; POLYMORPHISM; MIGRATION; RESOURCE; ORIGIN	Gene duplication is an important source of phenotypic change and adaptive evolution. We leverage a haploid hydatidiform mole to identify highly identical sequences missing from the reference genome, confirming that the cortical development gene Slit-Robo RhoGTPase-activating protein 2 (SRGAP2) duplicated three times exclusively in humans. We show that the promoter and first nine exons of SRGAP2 duplicated from 1q32.1 (SRGAP2A) to 1q21.1 (SRGAP2B) similar to 3.4 million years ago (mya). Two larger duplications later copied SRGAP2B to chromosome 1p12 (SRGAP2C) and to proximal 1q21.1 (SRGAP2D) similar to 2.4 and similar to 1 mya, respectively. Sequence and expression analyses show that SRGAP2C is the most likely duplicate to encode a functional protein and is among the most fixed human-specific duplicate genes. Our data suggest a mechanism where incomplete duplication created a novel gene function-antagonizing parental SRGAP2 function-immediately "at birth'' 2-3 mya, which is a time corresponding to the transition from Australopithecus to Homo and the beginning of neocortex expansion.	[Dennis, Megan Y.; Nuttle, Xander; Sudmant, Peter H.; Antonacci, Francesca; Sajjadian, Saba; Malig, Maika; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Graves, Tina A.; Kotkiewicz, Holland; Wilson, Richard K.] Washington Univ, Sch Med, Genome Inst, St Louis, MO 63110 USA; [Nefedov, Mikhail; de Jong, Pieter J.] Childrens Hosp & Res Ctr Oakland, Childrens Hosp Oakland Res Inst, Oakland, CA 94609 USA; [Rosenfeld, Jill A.; Shaffer, Lisa G.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Curry, Cynthia J.] Univ Calif San Francisco, Fresno, CA 93701 USA; [Shafer, Susan] Carle Clin Assoc, Urbana, IL 61801 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Washington University (WUSTL); Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco; University of California San Francisco at Fresno	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	eee@gs.washington.edu	Wilson, Richard K./AAF-4139-2019; Antonacci, Francesca/F-5457-2013	Wilson, Richard K./0000-0002-1992-1358; Sudmant, Peter/0000-0002-9573-8248; Antonacci, Francesca/0000-0002-5833-6186	U.S. National Institutes of Health (NIH) [1F32HD071698-01]; NIH NRSA [2T32HG000035-16]; NIH [HG002385, GM058815]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [F32HD071698] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, R01HG002385, P01HG004120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058815] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. Coe for assistance in CNV analysis and the 1000 Genomes Project for access to sequence data of the SRGAP2 loci. For DNA samples used in paralog-specific CNV screening and detailed phenotypic information of patients, we would like to thank C. Romano, M. Fichera, J. Gecz, B. de Vries, R. Bernier, the Simons Foundation, Autism Speaks, the National Institute of Mental Health, and the ClinSeq Project. We acknowledge C. Baker, L. Vives, and J. Huddleston for technical assistance, T. Brown for manuscript editing, and the laboratory of S. Fields for use of their Roche LC480. We also thank J. Akey, T. Marques-Bonet, A. Andres, S. Girirajan, and K. Meltz Steinberg for helpful discussion, as well as the laboratory of F. Polleux for comments and kindly sharing human RNA samples for expression studies. The BAC clones from the complete hydatidiform mole were derived from a cell line created by U. Surti. M.Y.D. is supported by U.S. National Institutes of Health (NIH) Ruth L. Kirchstein National Research Service Award (NRSA) Fellowship (1F32HD071698-01). X.N. is supported by an NIH NRSA Genome Training Grant to the University of Washington (2T32HG000035-16). P. H. S. is a Howard Hughes Medical Institute International Student Research Fellow. This work was supported by NIH Grants HG002385 and GM058815. E. E. E. is an investigator of the Howard Hughes Medical Institute. J. A. R. and L. G. S. are employees of Signature Genomic Laboratories, a subsidiary of PerkinElmer, Inc. E. E. E. is on the scientific advisory boards for Pacific Biosciences, Inc. and SynapDx Corp.	Antonacci F, 2010, NAT GENET, V42, P745, DOI 10.1038/ng.643; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Blekhman R, 2010, GENOME RES, V20, P180, DOI 10.1101/gr.099226.109; Brunet M, 2005, NATURE, V434, P752, DOI 10.1038/nature03392; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Brunetti-Pierri N, 2008, NAT GENET, V40, P1466, DOI 10.1038/ng.279; Charrier C, 2012, CELL, V149, P923, DOI 10.1016/j.cell.2012.03.034; Chen LT, 1999, J BIOL CHEM, V274, P26931, DOI 10.1074/jbc.274.38.26931; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; DOPAZO J, 1994, J MOL EVOL, V38, P300, DOI 10.1007/BF00176092; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Fan JB, 2002, GENOMICS, V79, P58, DOI 10.1006/geno.2001.6676; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Gregory SG, 2006, NATURE, V441, P315, DOI 10.1038/nature04727; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo SS, 2010, J BIOL CHEM, V285, P35133, DOI 10.1074/jbc.M110.153429; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Liu S, 2011, NUCLEIC ACIDS RES, V39, P578, DOI 10.1093/nar/gkq817; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2004, TRENDS GENET, V20, P544, DOI 10.1016/j.tig.2004.09.001; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Ohno S., 1970, P1; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; RZHETSKY A, 1994, COMPUT APPL BIOSCI, V10, P409; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saitsu H, 2012, AM J MED GENET A, V158A, P199, DOI 10.1002/ajmg.a.34363; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stedman HH, 2004, NATURE, V428, P415, DOI 10.1038/nature02358; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Szamalek JM, 2006, HUM GENET, V120, P126, DOI 10.1007/s00439-006-0209-y; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson J.D., 2002, CURRENT PROTOCOLS BI; Vignaud P, 2002, NATURE, V418, P152, DOI 10.1038/nature00880; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wu DD, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002379; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhou Y, 2005, P NATL ACAD SCI USA, V102, P4051, DOI 10.1073/pnas.0407957102	55	233	241	0	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4								10.1016/j.cell.2012.03.033	http://dx.doi.org/10.1016/j.cell.2012.03.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22559943	Green Accepted, Bronze			2022-12-24	WOS:000303934700022
J	Hao, HX; Xie, Y; Zhang, Y; Charlat, O; Oster, E; Avello, M; Lei, H; Mickanin, C; Liu, D; Ruffner, H; Mao, XH; Ma, QC; Zamponi, R; Bouwmeester, T; Finan, PM; Kirschner, MW; Porter, JA; Serluca, FC; Cong, F				Hao, Huai-Xiang; Xie, Yang; Zhang, Yue; Charlat, Olga; Oster, Emma; Avello, Monika; Lei, Hong; Mickanin, Craig; Liu, Dong; Ruffner, Heinz; Mao, Xiaohong; Ma, Qicheng; Zamponi, Raffaella; Bouwmeester, Tewis; Finan, Peter M.; Kirschner, Marc W.; Porter, Jeffery A.; Serluca, Fabrizio C.; Cong, Feng			ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner	NATURE			English	Article							BETA-CATENIN FUNCTION; WNT/BETA-CATENIN; LENS MORPHOGENESIS; R-SPONDIN1; PATHWAY; LRP6; LGR5; PHOSPHORYLATION; INHIBITION; DISRUPTION	R-spondin proteins strongly potentiate Wnt signalling and function as stem-cell growth factors. Despite the biological and therapeutic significance, the molecular mechanism of R-spondin action remains unclear. Here we show that the cell-surface transmembrane E3 ubiquitin ligase zinc and ring finger 3 (ZNRF3) and its homologue ring finger 43 (RNF43) are negative feedback regulators of Wnt signalling. ZNRF3 is associated with the Wnt receptor complex, and inhibits Wnt signalling by promoting the turnover of frizzled and LRP6. Inhibition of ZNRF3 enhances Wnt/beta-catenin signalling and disrupts Wnt/ planar cell polarity signalling in vivo. Notably, R-spondin mimics ZNRF3 inhibition by increasing the membrane level of Wnt receptors. Mechanistically, R-spondin interacts with the extracellular domain of ZNRF3 and induces the association between ZNRF3 and LGR4, which results in membrane clearance of ZNRF3. These data suggest that R-spondin enhances Wnt signalling by inhibiting ZNRF3. Our study provides new mechanistic insights into the regulation of Wnt receptor turnover, and reveals ZNRF3 as a tractable target for therapeutic exploration.	[Hao, Huai-Xiang; Xie, Yang; Zhang, Yue; Charlat, Olga; Oster, Emma; Avello, Monika; Lei, Hong; Mickanin, Craig; Liu, Dong; Mao, Xiaohong; Ma, Qicheng; Zamponi, Raffaella; Finan, Peter M.; Porter, Jeffery A.; Serluca, Fabrizio C.; Cong, Feng] Novartis Inst Biomed Res, Cambridge, MA 02139 USA; [Ruffner, Heinz; Bouwmeester, Tewis] Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Kirschner, Marc W.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Novartis; Novartis; Harvard University; Harvard Medical School	Cong, F (corresponding author), Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA.	feng.cong@novartis.com	Zamponi, Raffaella/V-5683-2018	Zamponi, Raffaella/0000-0002-3313-1387				Aoki M, 2007, DEV BIOL, V301, P218, DOI 10.1016/j.ydbio.2006.08.018; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Blaydon DC, 2006, NAT GENET, V38, P1245, DOI 10.1038/ng1883; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Goentoro L, 2009, MOL CELL, V36, P872, DOI 10.1016/j.molcel.2009.11.017; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Gurney A. L., 2011, US patent, Patent No. 201037041; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kazanskaya O, 2008, DEVELOPMENT, V135, P3655, DOI 10.1242/dev.027284; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim KA, 2008, MOL BIOL CELL, V19, P2588, DOI 10.1091/mbc.E08-02-0187; Kreslova J, 2007, GENESIS, V45, P157, DOI 10.1002/dvg.20277; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Machon O, 2010, GENESIS, V48, P86, DOI 10.1002/dvg.20583; Mukai A, 2010, EMBO J, V29, P2114, DOI 10.1038/emboj.2010.100; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nasevicius A, 1998, DEVELOPMENT, V125, P4283; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Ootani A, 2009, NAT MED, V15, P1, DOI 10.1038/nm.1951; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wei Q, 2007, J BIOL CHEM, V282, P15903, DOI 10.1074/jbc.M701927200; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wu J, 2011, P NATL ACAD SCI USA, V108, P21188, DOI 10.1073/pnas.1118046108; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106	37	581	626	12	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					195	U76		10.1038/nature11019	http://dx.doi.org/10.1038/nature11019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22575959				2022-12-24	WOS:000303799800032
J	Thoreen, CC; Chantranupong, L; Keys, HR; Wang, T; Gray, NS; Sabatini, DM				Thoreen, Carson C.; Chantranupong, Lynne; Keys, Heather R.; Wang, Tim; Gray, Nathanael S.; Sabatini, David M.			A unifying model for mTORC1-mediated regulation of mRNA translation	NATURE			English	Article							RIBOSOME ENTRY SITES; LARGE GENE LISTS; CELL-PROLIFERATION; INDEPENDENT MANNER; MAMMALIAN TARGET; MTOR PATHWAY; AKT ACTIVITY; CYCLIN D1; RAPAMYCIN; INHIBITION	The mTOR complex 1 (mTORC1) kinase nucleates a pathway that promotes cell growth and proliferation and is the target of rapamycin, a drug with many clinical uses(1). mTORC1 regulates messenger RNA translation, but the overall translational program is poorly defined and no unifying model exists to explain how mTORC1 differentially controls the translation of specific mRNAs. Here we use high-resolution transcriptome-scale ribosome profiling to monitor translation in mouse cells acutely treated with the mTOR inhibitor Torin 1, which, unlike rapamycin, fully inhibits mTORC1 (ref. 2). Our data reveal a surprisingly simple model of the mRNA features and mechanisms that confer mTORC1-dependent translation control. The subset of mRNAs that are specifically regulated by mTORC1 consists almost entirely of transcripts with established 5' terminal oligopyrimidine (TOP) motifs, or, like Hsp90ab1 and Ybx1, with previously unrecognized TOP or related TOP-like motifs that we identified. We find no evidence to support proposals that mTORC1 preferentially regulates mRNAs with increased 5' untranslated region length or complexity(3). mTORC1 phosphorylates a myriad of translational regulators, but how it controls TOP mRNA translation is unknown(4). Remarkably, loss of just the 4E-BP family of translational repressors, arguably the best characterized mTORC1 substrates, is sufficient to render TOP and TOP-like mRNA translation resistant to Torin 1. The 4E-BPs inhibit translation initiation by interfering with the interaction between the cap-binding protein eIF4E and eIF4G1. Loss of this interaction diminishes the capacity of eIF4E to bind TOP and TOP-like mRNAs much more than other mRNAs, explaining why mTOR inhibition selectively suppresses their translation. Our results clarify the translational program controlled by mTORC1 and identify 4E-BPs and eIF4G1 as its master effectors.	[Thoreen, Carson C.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Thoreen, Carson C.; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Thoreen, Carson C.; Chantranupong, Lynne; Keys, Heather R.; Wang, Tim; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Chantranupong, Lynne; Keys, Heather R.; Wang, Tim; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Chantranupong, Lynne; Keys, Heather R.; Wang, Tim; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Chantranupong, Lynne; Keys, Heather R.; Sabatini, David M.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, 250 Longwood Ave, Boston, MA 02115 USA.	nathanael_gray@dfci.harvard.edu; sabatini@wi.mit.edu		/0000-0002-1446-7256; Wang, Timothy/0000-0001-5730-3019	National Institutes of Health [CA103866, CA129105]; Department of Defense [W81XWH-07-0448]; W.M. Keck Foundation; LAM Foundation; Dana Farber Cancer Institute; American Cancer Society; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA103866, R01CA129105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); W.M. Keck Foundation(W.M. Keck Foundation); LAM Foundation; Dana Farber Cancer Institute; American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of the Gray and Sabatini laboratories for helpful discussions, H. Guo, S. Hawthorne, G. Brar, J. Damon, C. Miller and W. Gilbert for advice and N. Sonenberg for providing 4EBP1/2 wild-type and double-knockout MEFs. This work was supported by the National Institutes of Health (CA103866 and CA129105 to D. M. S.), Department of Defense (W81XWH-07-0448 to D. M. S.), the W.M. Keck Foundation (D. M. S.), LAM Foundation (D. M. S.), Dana Farber Cancer Institute (N. S. G., C. C. T.), and fellowship support from the American Cancer Society (C. C. T.), and the National Science Foundation (L. C. and T. W.). D. M. S. is an investigator of the Howard Hughes Medical Institute.	Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200; Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Grolleau A, 2002, J BIOL CHEM, V277, P22175, DOI 10.1074/jbc.M202014200; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iadevaia V, 2008, RNA, V14, P1730, DOI 10.1261/rna.1037108; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Kozak M, 2005, NUCLEIC ACIDS RES, V33, P6593, DOI 10.1093/nar/gki958; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lee SH, 2006, EMBO J, V25, P4008, DOI 10.1038/sj.emboj.7601268; LEVINE EM, 1965, P NATL ACAD SCI USA, V53, P350, DOI 10.1073/pnas.53.2.350; Liu QS, 2010, J MED CHEM, V53, P7146, DOI 10.1021/jm101144f; Markham NR, 2005, NUCLEIC ACIDS RES, V33, pW577, DOI 10.1093/nar/gki591; Martin F, 2011, MOL CELL, V41, P197, DOI 10.1016/j.molcel.2010.12.019; Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mokrejs M, 2010, NUCLEIC ACIDS RES, V38, pD131, DOI 10.1093/nar/gkp981; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004; Ptushkina M, 1998, EMBO J, V17, P4798, DOI 10.1093/emboj/17.16.4798; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Yamashita R, 2010, NUCLEIC ACIDS RES, V38, pD98, DOI 10.1093/nar/gkp1017; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	39	935	953	2	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					109	U142		10.1038/nature11083	http://dx.doi.org/10.1038/nature11083			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22552098	Green Accepted, Green Submitted			2022-12-24	WOS:000303451900044
J	Collins, R				Collins, Rory			What makes UK Biobank special?	LANCET			English	Editorial Material							COHORT		UK Biobank, Stockport SK3 0SA, Lancs, England		Collins, R (corresponding author), UK Biobank, Stockport SK3 0SA, Lancs, England.	ukbiobank@ukbiobank.ac.uk			Wellcome Trust [093707] Funding Source: Medline; Medical Research Council [MC_qA137853] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Burton PR, 2009, INT J EPIDEMIOL, V38, P263, DOI 10.1093/ije/dyn147; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Elliott P, 2008, INT J EPIDEMIOL, V37, P234, DOI 10.1093/ije/dym276; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; Manolio TA, 2006, NAT REV GENET, V7, P812, DOI 10.1038/nrg1919; Manolio TA, 2010, JAMA-J AM MED ASSOC, V304, P2290, DOI 10.1001/jama.2010.1686; Palmer LJ, 2007, LANCET, V369, P1980, DOI 10.1016/S0140-6736(07)60924-6; Riboli E, 1997, INT J EPIDEMIOL, V26, pS6, DOI 10.1093/ije/26.suppl_1.S6; Tapia-Conyer R, 2006, INT J EPIDEMIOL, V35, P243, DOI 10.1093/ije/dyl042; UK Biobank, 2007, UKBBPROT0906; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4	12	426	435	3	44	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 31	2012	379	9822					1173	1174		10.1016/S0140-6736(12)60404-8	http://dx.doi.org/10.1016/S0140-6736(12)60404-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	918DV	22463865				2022-12-24	WOS:000302230400008
J	Duffy, MA; Ochs, JH; Penczykowski, RM; Civitello, DJ; Klausmeier, CA; Hall, SR				Duffy, Meghan A.; Ochs, Jessica Housley; Penczykowski, Rachel M.; Civitello, David J.; Klausmeier, Christopher A.; Hall, Spencer R.			Ecological Context Influences Epidemic Size and Parasite-Driven Evolution	SCIENCE			English	Article							RAPID EVOLUTION; SELECTIVE PREDATION; RESISTANCE; DAPHNIA; LIMITATION; PHOSPHORUS; FEEDBACKS; NITROGEN; LAKES	The occurrence and magnitude of disease outbreaks can strongly influence host evolution. In particular, when hosts face a resistance-fecundity trade-off, they might evolve increased resistance to infection during larger epidemics but increased susceptibility during smaller ones. We tested this theoretical prediction by using a zooplankton-yeast host-parasite system in which ecological factors determine epidemic size. Lakes with high productivity and low predation pressure had large yeast epidemics; during these outbreaks, hosts became more resistant to infection. However, with low productivity and high predation, epidemics remained small and hosts evolved increased susceptibility. Thus, by modulating disease outbreaks, ecological context (productivity and predation) shaped host evolution during epidemics. Consequently, anthropogenic alteration of productivity and predation might strongly influence both ecological and evolutionary outcomes of disease.	[Duffy, Meghan A.; Ochs, Jessica Housley; Penczykowski, Rachel M.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Civitello, David J.; Hall, Spencer R.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Klausmeier, Christopher A.] Michigan State Univ, WK Kellogg Biol Stn KBS, Hickory Corners, MI 49060 USA; [Klausmeier, Christopher A.] Michigan State Univ, Dept Zool, Hickory Corners, MI 49060 USA	University System of Georgia; Georgia Institute of Technology; Indiana University System; Indiana University Bloomington; Michigan State University; Michigan State University	Duffy, MA (corresponding author), Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA.	duffy@gatech.edu	Klausmeier, Christopher A/J-9339-2012; Duffy, Meghan/AFN-5376-2022; Penczykowski, Rachel/AAH-4208-2019; Duffy, Meghan A/E-6867-2016; Penczykowski, Rachel/K-4007-2015; Duffy, Meghan A/A-9376-2008	Duffy, Meghan/0000-0002-8142-0802; Penczykowski, Rachel/0000-0003-4559-0609; Duffy, Meghan A/0000-0002-8142-0802; Penczykowski, Rachel/0000-0003-4559-0609; Klausmeier, Christopher/0000-0002-6987-5871	NSF [DEB-0841679, DEB-0841817, DEB-0845825, OCE-0928819]; James S. McDonnell Foundation	NSF(National Science Foundation (NSF)); James S. McDonnell Foundation	We thank S. Hernandez, K. Jansen, K. Kenline, A. Reynolds, B. Sarrell, K. van Rensburg, and C. Washington for assistance in the lab; K. Boatman, Z. Brown, A. Bowling, C. White, and P. Forys for their help with the field survey; and S. Auld and two anonymous reviewers for comments on the manuscript. This work was supported by NSF (grants DEB-0841679 to M.A.D., DEB-0841817 to S.R.H., and DEB-0845825 and OCE-0928819 to C.A.K.) and by a grant from the James S. McDonnell Foundation (to C.A.K.). We appreciate cooperation from S. Siscoe at the Indiana Department of Natural Resources's Division of Forestry and R. Ronk at the Division of Fish and Wildlife for the field survey. This is KBS contribution no. 1607. Data are available in the SOM and from the lead author (M.A.D.).	ANDERSON R M, 1991; ANTONOVICS J, 1994, P ROY SOC B-BIOL SCI, V257, P105, DOI 10.1098/rspb.1994.0101; Boots M, 1999, AM NAT, V153, P359, DOI 10.1086/303181; Boots M, 2009, PHILOS T R SOC B, V364, P27, DOI 10.1098/rstb.2008.0160; BOWERS RG, 1994, P ROY SOC B-BIOL SCI, V257, P247, DOI 10.1098/rspb.1994.0122; BROOKS JL, 1965, SCIENCE, V150, P28, DOI 10.1126/science.150.3692.28; Duffy MA, 2005, LIMNOL OCEANOGR, V50, P412, DOI 10.4319/lo.2005.50.2.0412; Duffy MA, 2008, AM NAT, V171, P499, DOI 10.1086/528998; Duffy MA, 2007, ECOL LETT, V10, P44, DOI 10.1111/j.1461-0248.2006.00995.x; Duffy MA, 2009, J ANIM ECOL, V78, P1106, DOI 10.1111/j.1365-2656.2009.01568.x; Duffy MA, 2009, ECOLOGY, V90, P1441, DOI 10.1890/08-1130.1; Duffy MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-80; Dybdahl MF, 1998, EVOLUTION, V52, P1057, DOI [10.1111/j.1558-5646.1998.tb01833.x, 10.2307/2411236]; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Greenberg AE, 1995, STANDARD METHODS EXA; Guildford SJ, 2000, LIMNOL OCEANOGR, V45, P1213, DOI 10.4319/lo.2000.45.6.1213; Hall SR, 2011, OECOLOGIA, V166, P833, DOI 10.1007/s00442-011-1905-4; Hall SR, 2010, AM NAT, V176, P557, DOI 10.1086/656523; Hall SR, 2010, BIOSCIENCE, V60, P363, DOI 10.1525/bio.2010.60.5.6; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Keeling MJ., 2008, MODELING INFECT DIS, DOI [DOI 10.1515/9781400841035, 10.1515/9781400841035]; KITCHELL JA, 1980, LIMNOL OCEANOGR, V25, P389, DOI 10.4319/lo.1980.25.3.0389; Lafferty KD, 2003, ECOL LETT, V6, P654, DOI 10.1046/j.1461-0248.2003.00480.x; Overholt EP, 2012, ECOL LETT, V15, P47, DOI 10.1111/j.1461-0248.2011.01707.x; Packer C, 2003, ECOL LETT, V6, P797, DOI 10.1046/j.1461-0248.2003.00500.x; PARKER MA, 1991, EVOLUTION, V45, P1209, DOI 10.1111/j.1558-5646.1991.tb04387.x; Penczykowski RM, 2011, FRESHWATER BIOL, V56, P689, DOI 10.1111/j.1365-2427.2010.02499.x	27	76	76	2	110	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1636	1638		10.1126/science.1215429	http://dx.doi.org/10.1126/science.1215429			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461614				2022-12-24	WOS:000302062600048
J	Meyer, KD; Saletore, Y; Zumbo, P; Elemento, O; Mason, CE; Jaffrey, SR				Meyer, Kate D.; Saletore, Yogesh; Zumbo, Paul; Elemento, Olivier; Mason, Christopher E.; Jaffrey, Samie R.			Comprehensive Analysis of mRNA Methylation Reveals Enrichment in 3 ' UTRs and near Stop Codons	CELL			English	Article							N-6-METHYLADENOSINE RESIDUES; SEQUENCE SPECIFICITY; N6-METHYLADENOSINE; IDENTIFICATION; LOCALIZATION; SYSTEM; GENES; MOUSE; ACID; DNA	Methylation of the N-6 position of adenosine (m(6)A) is a posttranscriptional modification of RNA with poorly understood prevalence and physiological relevance. The recent discovery that FTO, an obesity risk gene, encodes an m(6)A demethylase implicates m(6)A as an important regulator of physiological processes. Here, we present a method for transcriptome-wide m(6)A localization, which combines m(6)A-specific methylated RNA immunoprecipitation with next-generation sequencing (MeRIP-Seq). We use this method to identify mRNAs of 7,676 mammalian genes that contain m(6)A, indicating that m(6)A is a common base modification of mRNA. The m(6)A modification exhibits tissue-specific regulation and is markedly increased throughout brain development. We find that m(6)A sites are enriched near stop codons and in 3' UTRs, and we uncover an association between m 6 A residues and microRNA-binding sites within 3' UTRs. These findings provide a resource for identifying transcripts that are substrates for adenosine methylation and reveal insights into the epigenetic regulation of the mammalian transcriptome.	[Saletore, Yogesh; Zumbo, Paul; Elemento, Olivier; Mason, Christopher E.] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA; [Meyer, Kate D.; Jaffrey, Samie R.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10065 USA; [Saletore, Yogesh; Zumbo, Paul; Elemento, Olivier; Mason, Christopher E.] Cornell Univ, Weill Med Coll, HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsau, New York, NY 10065 USA	Cornell University; Cornell University; Cornell University	Mason, CE (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA.	chm2042@med.cornell.edu; srj2003@med.cornell.edu	Mason, Christopher/HCH-3977-2022	Jaffrey, Samie/0000-0003-3615-6958; Meyer, Kate/0000-0001-7197-4054	NIH [T32CA062948, 1F32MH095353-01, 1R01NS076465-01, MH080420]; NSF [1054964]; Starr Cancer Consortium [I4-A411]; NATIONAL CANCER INSTITUTE [T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080420, F32MH095353] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Richard Roberts and New England Biolabs for generously providing the m<SUP>6</SUP>A (NEB) antibody. We also thank members of the Jaffrey and Mason laboratories for helpful comments and suggestions. This work was supported by NIH grants T32CA062948 (K. D. M.), 1F32MH095353-01 (K. D. M.), 1R01NS076465-01 (C. E. M.), and MH080420 (S.R.J.); NSF CAREER grant 1054964 (O.E.); and the Starr Cancer Consortium (I4-A411; C.E.M.).	BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X; Bodi Z, 2010, NUCLEIC ACIDS RES, V38, P5327, DOI 10.1093/nar/gkq266; BRINGMANN P, 1987, FEBS LETT, V213, P309, DOI 10.1016/0014-5793(87)81512-0; Brockman JM, 2005, BIOINFORMATICS, V21, P3691, DOI 10.1093/bioinformatics/bti589; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879; CARROLL SM, 1990, MOL CELL BIOL, V10, P4456, DOI 10.1128/MCB.10.9.4456; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; CSEPANY T, 1990, J BIOL CHEM, V265, P20117; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021; DUBIN DT, 1975, NUCLEIC ACIDS RES, V2, P1653, DOI 10.1093/nar/2.10.1653; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Falnes PO, 2007, NEUROSCIENCE, V145, P1222, DOI 10.1016/j.neuroscience.2006.11.018; Fawcett KA, 2010, TRENDS GENET, V26, P266, DOI 10.1016/j.tig.2010.02.006; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667; IWANAMI Y, 1968, ARCH BIOCHEM BIOPHYS, V126, P8, DOI 10.1016/0003-9861(68)90553-5; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; KLAGSBRUN M, 1973, Journal of Biological Chemistry, V248, P2612; Kong HM, 2000, NUCLEIC ACIDS RES, V28, P3216, DOI 10.1093/nar/28.17.3216; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; MUNNS TW, 1977, BIOCHEMISTRY-US, V16, P2163, DOI 10.1021/bi00629a019; NARAYAN P, 1988, SCIENCE, V242, P1159, DOI 10.1126/science.3187541; Pang KC, 2005, NUCLEIC ACIDS RES, V33, pD125, DOI 10.1093/nar/gri089; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; PROUDFOOT N, 1991, CELL, V64, P671, DOI 10.1016/0092-8674(91)90495-K; SANEYOSHI M, 1969, BIOCHIM BIOPHYS ACTA, V190, P264, DOI 10.1016/0005-2787(69)90078-1; STOLTZFUS CM, 1982, J VIROL, V42, P918, DOI 10.1128/JVI.42.3.918-931.1982; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024	41	2118	2234	26	297	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 22	2012	149	7					1635	1646		10.1016/j.cell.2012.05.003	http://dx.doi.org/10.1016/j.cell.2012.05.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	965FY	22608085	Green Published, Bronze, Green Accepted			2022-12-24	WOS:000305753800026
J	Song, KH; Nam, YJ; Luo, X; Qi, XX; Tan, W; Huang, GN; Acharya, A; Smith, CL; Tallquist, MD; Neilson, EG; Hill, JA; Bassel-Duby, R; Olson, EN				Song, Kunhua; Nam, Young-Jae; Luo, Xiang; Qi, Xiaoxia; Tan, Wei; Huang, Guo N.; Acharya, Asha; Smith, Christopher L.; Tallquist, Michelle D.; Neilson, Eric G.; Hill, Joseph A.; Bassel-Duby, Rhonda; Olson, Eric N.			Heart repair by reprogramming non-myocytes with cardiac transcription factors	NATURE			English	Article							FIBROBLASTS; EXPRESSION; DISEASE; ADULT; CELLS; CARDIOMYOCYTES; GENERATION; REGULATOR; THERAPY; NEURONS	The adult mammalian heart possesses little regenerative potential following injury. Fibrosis due to activation of cardiac fibroblasts impedes cardiac regeneration and contributes to loss of contractile function, pathological remodelling and susceptibility to arrhythmias. Cardiac fibroblasts account for a majority of cells in the heart and represent a potential cellular source for restoration of cardiac function following injury through phenotypic reprogramming to a myocardial cell fate. Here we show that four transcription factors, GATA4, HAND2, MEF2C and TBX5, can cooperatively reprogram adult mouse tail-tip and cardiac fibroblasts into beating cardiac-like myocytes in vitro. Forced expression of these factors in dividing non-cardiomyocytes in mice reprograms these cells into functional cardiac-like myocytes, improves cardiac function and reduces adverse ventricular remodelling following myocardial infarction. Our results suggest a strategy for cardiac repair through reprogramming fibroblasts resident in the heart with cardiogenic transcription factors or other molecules.	[Song, Kunhua; Nam, Young-Jae; Qi, Xiaoxia; Huang, Guo N.; Acharya, Asha; Smith, Christopher L.; Tallquist, Michelle D.; Hill, Joseph A.; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Nam, Young-Jae; Luo, Xiang; Tan, Wei; Hill, Joseph A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Neilson, Eric G.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Vanderbilt University	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Tallquist, Michelle/AAU-5277-2021	Tallquist, Michelle/0000-0002-1383-144X; Huang, Guo/0000-0002-4335-9123	NIH; Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation [I-0025]; Leducq Fondation-Transatlantic Network of Excellence in Cardiovascular Research; American Heart Association-Jon Holden DeHaan Foundation; Cancer Prevention & Research Institute of Texas (CPRIT); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019137] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL114738, R01HL053351, R01HL111665, R01HL061544, R01HL074257, R01HL083371, K08HL111420, P50HL061033, R37HL053351, R01HL077439, R01HL093039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040339] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation(The Welch Foundation); Leducq Fondation-Transatlantic Network of Excellence in Cardiovascular Research; American Heart Association-Jon Holden DeHaan Foundation(American Heart Association); Cancer Prevention & Research Institute of Texas (CPRIT); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank J. Cabrera for graphics. We are grateful to members of the Olson lab for critical reading of the manuscript. We thank D. Sosic, W. Tang, J. O'Rourke, N. Liu, M. Xin, A. Johnson and J. McAnally for discussions; J. Shelton and J. A. Richardson for histology. We are grateful to I. Bezprozvanny for the PTI Ca<SUP>2+</SUP> Imaging System, and D. Srivastava for lentiviral plasmids. We thank the microarray core at University of Texas Southwestern Medical Center for collecting gene expression data. E.N.O. is supported by grants from NIH, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the Robert A. Welch Foundation (grant I-0025), the Leducq Fondation-Transatlantic Network of Excellence in Cardiovascular Research Program, the American Heart Association-Jon Holden DeHaan Foundation and the Cancer Prevention & Research Institute of Texas (CPRIT).	Acharya A, 2011, GENESIS, V49, P870, DOI 10.1002/dvg.20750; Beyer E C, 1993, Int Rev Cytol, V137C, P1; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Byun JH, 2000, J GENE MED, V2, P2; Caiazzo M, 2011, NATURE, V476, P224, DOI 10.1038/nature10284; Dai YS, 2002, J BIOL CHEM, V277, P24390, DOI 10.1074/jbc.M202490200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Ghosh TK, 2009, MOL CELL BIOL, V29, P2205, DOI 10.1128/MCB.01923-08; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hardy Matthew E. L., 2009, Journal of Pharmacological and Toxicological Methods, V60, P94, DOI 10.1016/j.vascn.2009.03.005; Hoover-Plow J, 2012, VASC HEALTH RISK MAN, V8, P99, DOI 10.2147/VHRM.S25665; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Loffredo FS, 2011, CELL STEM CELL, V8, P389, DOI 10.1016/j.stem.2011.02.002; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Luo X, 2005, J BIOL CHEM, V280, P12668, DOI 10.1074/jbc.M411973200; Menasche P, 2009, MOL THER, V17, P758, DOI 10.1038/mt.2009.40; Olson EN, 2006, SCIENCE, V313, P1922, DOI 10.1126/science.1132292; Perin E. C., 2012, J AM MED ASS; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Porter KE, 2009, PHARMACOL THERAPEUT, V123, P255, DOI 10.1016/j.pharmthera.2009.05.002; Russell JL, 2011, CIRC RES, V108, P51, DOI 10.1161/CIRCRESAHA.110.233262; Saffitz JE, 2000, AM J PHYSIOL-HEART C, V278, pH1662, DOI 10.1152/ajpheart.2000.278.5.H1662; Schneider M, 2007, CARDIOVASC RES, V75, P40, DOI 10.1016/j.cardiores.2007.03.027; Sohal DS, 2001, CIRC RES, V89, P20, DOI 10.1161/hh1301.092687; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tandan S, 2009, CIRC RES, V105, P51, DOI 10.1161/CIRCRESAHA.109.199828; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yacoub Magdi, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS133, DOI 10.1038/ncpcardio0401; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zang MX, 2004, J BIOL CHEM, V279, P54258, DOI 10.1074/jbc.M408502200; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	41	798	844	7	198	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					599	+		10.1038/nature11139	http://dx.doi.org/10.1038/nature11139			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660318	Green Submitted, Green Accepted, Green Published			2022-12-24	WOS:000304608000039
J	Wheeler, DG; Groth, RD; Ma, H; Barrett, CF; Owen, SF; Safa, P; Tsien, RW				Wheeler, Damian G.; Groth, Rachel D.; Ma, Huan; Barrett, Curtis F.; Owen, Scott F.; Safa, Parsa; Tsien, Richard W.			Ca(v)1 and Ca(v)2 Channels Engage Distinct Modes of Ca2+ Signaling to Control CREB-Dependent Gene Expression	CELL			English	Article							BULLFROG SYMPATHETIC NEURONS; SENSITIVE CALCIUM-CHANNELS; PROTEIN-KINASE-II; NUCLEAR; DEPOLARIZATION; PHOSPHORYLATION; TRANSCRIPTION; MITOCHONDRIA; STIMULATION; MODULATION	Activity-dependent gene expression triggered by Ca2+ entry into neurons is critical for learning and memory, but whether specific sources of Ca2+ act distinctly or merely supply Ca2+ to a common pool remains uncertain. Here, we report that both signaling modes coexist and pertain to Ca(v)1 and Ca(v)2 channels, respectively, coupling membrane depolarization to CREB phosphorylation and gene expression. Ca(v)1 channels are advantaged in their voltage-dependent gating and use nanodomain Ca2+ to drive local CaMKII aggregation and trigger communication with the nucleus. In contrast, Ca(v)2 channels must elevate [Ca2+](i) microns away and promote CaMKII aggregation at Ca(v)1 channels. Consequently, Ca(v)2 channels are similar to 10-fold less effective in signaling to the nucleus than are Ca(v)1 channels for the same bulk [Ca2+](i) increase. Further-more, Ca(v)2-mediated Ca2+ rises are preferentially curbed by uptake into the endoplasmic reticulum and mitochondria. This source-biased buffering limits the spatial spread of Ca2+, further attenuating Ca(v)2-mediated gene expression.	[Wheeler, Damian G.; Groth, Rachel D.; Ma, Huan; Barrett, Curtis F.; Owen, Scott F.; Safa, Parsa; Tsien, Richard W.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Ma, Huan; Tsien, Richard W.] NYU Langone Med Ctr, NYU Neurosci Inst, New York, NY 10016 USA	Stanford University; NYU Langone Medical Center	Ma, H (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	huan.ma@nyumc.org; richard.tsien@nyumc.org	Ma, Huan/A-1379-2012	Owen, Scott/0000-0001-6294-7513	NIGMS; NINDS; Mathers Foundation; Burnett Family Foundation; NIMH [F31MH084430]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH084430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024067] Funding Source: NIH RePORTER	NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Mathers Foundation; Burnett Family Foundation; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Rich Lewis, David Friel, Michael Tadross, Damon Poburko, Yulong Li, Hyokeun Park, Haruhiko Bito, S. Brian Andrews, Paul De Koninck, and George Miljanich for helpful discussions and Atsushi Miyawaki for PericamMT. This work was supported by research grants to R.W.T. from NIGMS, NINDS, and the Mathers Foundation. S.F.O. is supported by the Burnett Family Foundation and an NRSA from the NIMH (F31MH084430).	Adams JP, 2005, NAT REV NEUROSCI, V6, P737, DOI 10.1038/nrn1749; Akita T, 2000, J GEN PHYSIOL, V116, P697, DOI 10.1085/jgp.116.5.697; Alonso MT, 2009, ACTA PHYSIOL, V195, P37, DOI 10.1111/j.1748-1716.2008.01920.x; Babcock DF, 1998, CURR OPIN NEUROBIOL, V8, P398, DOI 10.1016/S0959-4388(98)80067-6; Berridge MJ, 2008, J PHYSIOL-LONDON, V586, P5047, DOI 10.1113/jphysiol.2008.160440; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Colegrove SL, 2000, J GEN PHYSIOL, V115, P371, DOI 10.1085/jgp.115.3.371; Colegrove SL, 2000, J GEN PHYSIOL, V115, P351, DOI 10.1085/jgp.115.3.351; Deisseroth K, 2003, CURR OPIN NEUROBIOL, V13, P354, DOI 10.1016/S0959-4388(03)00076-X; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; Dolphin AC, 2006, BRIT J PHARMACOL, V147, pS56, DOI 10.1038/sj.bjp.0706442; Eder A, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-57; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Friel DD, 2000, CELL CALCIUM, V28, P307, DOI 10.1054/ceca.2000.0172; FRIEL DD, 1994, J NEUROSCI, V14, P4007; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Groth RD, 2011, P NATL ACAD SCI USA, V108, P828, DOI 10.1073/pnas.1018022108; Grueter CE, 2006, MOL CELL, V23, P641, DOI 10.1016/j.molcel.2006.07.006; Gyorgy H, 2006, CELL CALCIUM, V40, P553, DOI 10.1016/j.ceca.2006.08.016; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; HENKART M, 1976, J CELL BIOL, V70, P338, DOI 10.1083/jcb.70.2.338; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; INESI G, 1990, PHYSIOL REV, V70, P749, DOI 10.1152/physrev.1990.70.3.749; Jenkins MA, 2010, J NEUROSCI, V30, P5125, DOI 10.1523/JNEUROSCI.4367-09.2010; Jiang X, 2008, P NATL ACAD SCI USA, V105, P341, DOI 10.1073/pnas.0710213105; KASAI H, 1992, J PHYSIOL-LONDON, V448, P161, DOI 10.1113/jphysiol.1992.sp019035; Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Liu Z, 2003, J PHYSIOL-LONDON, V553, P473, DOI 10.1113/jphysiol.2003.051110; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; McDonough SI, 2000, J NEUROSCI, V20, P9059; Montero M, 2000, NAT CELL BIOL, V2, P57, DOI 10.1038/35000001; MORGAN JI, 1986, NATURE, V322, P552, DOI 10.1038/322552a0; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; MURPHY TH, 1991, NEURON, V7, P625, DOI 10.1016/0896-6273(91)90375-A; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Neher E., 1986, EXPT BRAIN RES SERIE, P80; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Oliveria SF, 2007, NEURON, V55, P261, DOI 10.1016/j.neuron.2007.06.032; RANDALL A, 1995, J NEUROSCI, V15, P2995; REGAN LJ, 1991, NEURON, V6, P269, DOI 10.1016/0896-6273(91)90362-4; RIZZUTO R, 1993, SCIENCE, V262, P744, DOI 10.1126/science.8235595; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; Saha RN, 2008, EXP BIOL MED, V233, P385, DOI 10.3181/0709-MR-241; Satoh K, 2011, J BIOL CHEM, V286, P20591, DOI 10.1074/jbc.M110.204685; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Strack S, 2000, J BIOL CHEM, V275, P25061, DOI 10.1074/jbc.C000319200; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton KG, 1999, NATURE, V401, P800, DOI 10.1038/44586; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; THAYER SA, 1990, J PHYSIOL-LONDON, V425, P85, DOI 10.1113/jphysiol.1990.sp018094; TSIEN RW, 1991, TRENDS PHARMACOL SCI, V12, P349, DOI 10.1016/0165-6147(91)90595-J; Twede VD, 2009, IDRUGS, V12, P231; VALENTINO K, 1993, P NATL ACAD SCI USA, V90, P7894, DOI 10.1073/pnas.90.16.7894; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Weick JP, 2003, J NEUROSCI, V23, P3446; Wheeler DG, 2006, NEUROPHARMACOLOGY, V51, P27, DOI 10.1016/j.neuropharm.2006.02.010; Wheeler DG, 2008, J CELL BIOL, V183, P849, DOI 10.1083/jcb.200805048; Wheeler DG, 2001, J BIOL CHEM, V276, P31978, DOI 10.1074/jbc.M103667200; Yenari MA, 1996, BRAIN RES, V739, P36, DOI 10.1016/S0006-8993(96)00808-6	66	188	192	1	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1112	1124		10.1016/j.cell.2012.03.041	http://dx.doi.org/10.1016/j.cell.2012.03.041			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632974	Green Accepted, Bronze			2022-12-24	WOS:000304453900016
J	Marin, JM; Agusti, A; Villar, I; Forner, M; Nieto, D; Carrizo, SJ; Barbe, F; Vicente, E; Wei, Y; Nieto, FJ; Jelic, S				Marin, Jose M.; Agusti, Alvar; Villar, Isabel; Forner, Marta; Nieto, David; Carrizo, Santiago J.; Barbe, Ferran; Vicente, Eugenio; Wei, Ying; Nieto, F. Javier; Jelic, Sanja			Association Between Treated and Untreated Obstructive Sleep Apnea and Risk of Hypertension	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; MULTIPLE IMPUTATION; ADHERENCE; REGRESSION; COMMITTEE; THERAPY; STROKE; MEN	Context Systemic hypertension is prevalent among patients with obstructive sleep apnea (OSA). Short-term studies indicate that continuous positive airway pressure (CPAP) therapy reduces blood pressure in patients with hypertension and OSA. Objective To determine whether CPAP therapy is associated with a lower risk of incident hypertension. Design, Setting, and Participants A prospective cohort study of 1889 participants without hypertension who were referred to a sleep center in Zaragoza, Spain, for nocturnal polysomnography between January 1, 1994, and December 31, 2000. Incident hypertension was documented at annual follow-up visits up to January 1, 2011. Multivariable models adjusted for confounding factors, including change in body mass index from baseline to censored time, were used to calculate hazard ratios (HRs) of incident hypertension in participants without OSA (controls), with untreated OSA, and in those treated with CPAP therapy according to national guidelines. Main Outcome Measure Incidence of new-onset hypertension. Results During 21 003 person-years of follow-up (median, 12.2 years), 705 cases (37.3%) of incident hypertension were observed. The crude incidence of hypertension per 100 person-years was 2.19 (95% CI, 1.71-2.67) in controls, 3.34 (95% CI, 2.85-3.82) in patients with OSA ineligible for CPAP therapy, 5.84 (95% CI, 4.82-6.86) in patients with OSA who declined CPAP therapy, 5.12 (95% CI, 3.76-6.47) in patients with OSA nonadherent to CPAP therapy, and 3.06 (95% CI, 2.70-3.41) in patients with OSA and treated with CPAP therapy. Compared with controls, the adjusted HRs for incident hypertension were greater among patients with OSA ineligible for CPAP therapy (1.33; 95% CI, 1.01-1.75), among those who declined CPAP therapy (1.96; 95% CI, 1.44-2.66), and among those nonadherent to CPAP therapy (1.78; 95% CI, 1.23-2.58), whereas the HR was lower in patients with OSA who were treated with CPAP therapy (0.71; 95% CI, 0.53-0.94). Conclusion Compared with participants without OSA, the presence of OSA was associated with increased adjusted risk of incident hypertension; however, treatment with CPAP therapy was associated with a lower risk of hypertension. JAMA. 2012;307(20):2169-2176	[Marin, Jose M.; Nieto, David; Carrizo, Santiago J.; Vicente, Eugenio] Hosp Univ Miguel Servet, Resp Dept, Zaragoza 50006, Spain; [Marin, Jose M.; Villar, Isabel; Forner, Marta] Aragon Inst Hlth Sci, Zaragoza, Spain; [Agusti, Alvar] Hosp Clin Barcelona, Inst Invest Biomed Pi Sunyer, Thorax Inst, Barcelona, Spain; [Wei, Ying; Jelic, Sanja] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Barbe, Ferran] Hosp Arnau Vilanova, Lleida, Spain; [Marin, Jose M.; Agusti, Alvar; Barbe, Ferran] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Nieto, F. Javier] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	Miguel Servet University Hospital; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Columbia University; University Hospital Arnau de Vilanova; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Wisconsin System; University of Wisconsin Madison	Marin, JM (corresponding author), Hosp Univ Miguel Servet, Resp Dept, Avda Isabel Catolica,1-3, Zaragoza 50006, Spain.	jmmarint@unizar.es	Barbé, Ferran/A-5988-2010; Lavu, Madhav/A-9409-2013; Garcia-Navarro, Alvar Agusti/F-4474-2015; CARRIZO SIERRA, SANTIAGO/AAO-1780-2021	Barbé, Ferran/0000-0002-2340-8928; Garcia-Navarro, Alvar Agusti/0000-0003-3271-3788; Marin Trigo, Jose Maria/0000-0001-9096-2294	National Institutes of Health, National Heart, Lung, and Blood Institute [1R01HL106041-01A1]; Instituto Carlos III, Ministry of Health, Madrid, Spain [FISS PI04/1684, FISS PS09/02449]; Spanish Society of Respiratory Medicine [SEPAR/2007]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106041] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Instituto Carlos III, Ministry of Health, Madrid, Spain; Spanish Society of Respiratory Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Jelic reported receiving grants/pending grants from the National Institutes of Health, National Heart, Lung, and Blood Institute (1R01HL106041-01A1). No other authors reported any financial disclosures.; This work was supported by grants FISS PI04/1684 and FISS PS09/02449 from the Instituto Carlos III, Ministry of Health, Madrid, Spain, and SEPAR/2007 from the Spanish Society of Respiratory Medicine.	Barbe F, 2010, AM J RESP CRIT CARE, V181, P718, DOI 10.1164/rccm.200901-0050OC; CARLSON JT, 1994, AM J RESP CRIT CARE, V150, P72, DOI 10.1164/ajrccm.150.1.8025776; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; HLA KM, 1994, ANN INTERN MED, V120, P382, DOI 10.7326/0003-4819-120-5-199403010-00005; Ip MSM, 2004, AM J RESP CRIT CARE, V169, P348, DOI 10.1164/rccm.200306-767OC; Jelic S, 2010, CIRCULATION, V121, P1014, DOI 10.1161/CIRCULATIONAHA.109.900357; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kales A, 1968, MANUAL STANDARDIZED; Kapur Vishesh, 2002, Sleep Breath, V6, P49, DOI 10.1055/s-2002-32318; LaFleur J, 2011, HEART, V97, P1862, DOI 10.1136/hrt.2011.223289; Lavie P, 2000, BRIT MED J, V320, P479, DOI 10.1136/bmj.320.7233.479; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; Montserrat J M, 1998, Arch Bronconeumol, V34, P204; Narkiewicz K, 1998, CIRCULATION, V98, P772, DOI 10.1161/01.CIR.98.8.772; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; O'Connor GT, 2009, AM J RESP CRIT CARE, V179, P1159, DOI 10.1164/rccm.200712-1809OC; Pan W, 2000, BIOMETRICS, V56, P199, DOI 10.1111/j.0006-341X.2000.00199.x; Markus MRP, 2010, J AM COLL CARDIOL, V56, P65, DOI 10.1016/j.jacc.2010.01.056; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Platt AB, 2010, CHEST, V137, P102, DOI 10.1378/chest.09-0842; Punjabi NM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000132; SCHOENFELD D, 1981, BIOMETRIKA, V68, P316, DOI 10.1093/biomet/68.1.316; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; Somers VK, 2008, J AM COLL CARDIOL, V52, P686, DOI 10.1016/j.jacc.2008.05.002; Villar I, 2009, SLEEP, V32, P623, DOI 10.1093/sleep/32.5.623; WEI GCG, 1991, BIOMETRICS, V47, P1297, DOI 10.2307/2532387; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Young T, 1997, SLEEP, V20, P705, DOI 10.1093/sleep/20.9.705; Young T, 2008, SLEEP, V31, P1071	32	478	499	1	40	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 23	2012	307	20					2169	2176		10.1001/jama.2012.3418	http://dx.doi.org/10.1001/jama.2012.3418			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	945YX	22618924	Bronze, Green Accepted			2022-12-24	WOS:000304315200026
J	O'Roak, BJ; Vives, L; Girirajan, S; Karakoc, E; Krumm, N; Coe, BP; Levy, R; Ko, A; Lee, C; Smith, JD; Turner, EH; Stanaway, IB; Vernot, B; Malig, M; Baker, C; Reilly, B; Akey, JM; Borenstein, E; Rieder, MJ; Nickerson, DA; Bernier, R; Shendure, J; Eichler, EE				O'Roak, Brian J.; Vives, Laura; Girirajan, Santhosh; Karakoc, Emre; Krumm, Niklas; Coe, Bradley P.; Levy, Roie; Ko, Arthur; Lee, Choli; Smith, Joshua D.; Turner, Emily H.; Stanaway, Ian B.; Vernot, Benjamin; Malig, Maika; Baker, Carl; Reilly, Beau; Akey, Joshua M.; Borenstein, Elhanan; Rieder, Mark J.; Nickerson, Deborah A.; Bernier, Raphael; Shendure, Jay; Eichler, Evan E.			Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations	NATURE			English	Article							GENOME-WIDE ASSOCIATION; COPY-NUMBER VARIATION; SPECTRUM; CHD8; INTEGRATION; STRATEGIES; REGION; GENES; NIMH; CNVS	It is well established that autism spectrum disorders (ASD) have a strong genetic component; however, for at least 70% of cases, the underlying genetic cause is unknown(1). Under the hypothesis that de novo mutations underlie a substantial fraction of the risk for developing ASD in families with no previous history of ASD or related phenotypes-so-called sporadic or simplex families(2,3)-we sequenced all coding regions of the genome (the exome) for parent-child trios exhibiting sporadic ASD, including 189 new trios and 20 that were previously reported(4). Additionally, we also sequenced the exomes of 50 unaffected siblings corresponding to these new (n = 531) and previously reported trios (n = 19)(4), for a total of 677 individual exomes from 209 families. Here we show that de novo point mutations are overwhelmingly paternal in origin (4:1 bias) and positively correlated with paternal age, consistent with the modest increased risk for children of older fathers to develop ASD(5). Moreover, 39% (49 of 126) of the most severe or disruptive de novo mutations map to a highly interconnected beta-catenin/chromatin remodelling protein network ranked significantly for autism candidate genes. In proband exomes, recurrent protein-altering mutations were observed in two genes: CHD8 and NTNG1. Mutation screening of six candidate genes in 1,703 ASD probands identified additional de novo, protein-altering mutations in GRIN2B, LAMC3 and SCN1A. Combined with copy number variant (CNV) data, these results indicate extreme locus heterogeneity but also provide a target for future discovery, diagnostics and therapeutics.	[O'Roak, Brian J.; Vives, Laura; Girirajan, Santhosh; Karakoc, Emre; Krumm, Niklas; Coe, Bradley P.; Levy, Roie; Ko, Arthur; Lee, Choli; Smith, Joshua D.; Turner, Emily H.; Stanaway, Ian B.; Vernot, Benjamin; Malig, Maika; Baker, Carl; Akey, Joshua M.; Borenstein, Elhanan; Rieder, Mark J.; Nickerson, Deborah A.; Shendure, Jay; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Reilly, Beau; Bernier, Raphael] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Borenstein, Elhanan] Univ Washington, Dept Comp Sci & Engn, Seattle, WA 98195 USA; [Borenstein, Elhanan] Santa Fe Inst, Santa Fe, NM 87501 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; The Santa Fe Institute; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.	shendure@uw.edu; eee@gs.washington.edu	Shendure, Jay/AAU-3684-2021; Coe, Bradley/A-2878-2009; Vernot, Benjamin/ABH-1495-2021	Vernot, Benjamin/0000-0002-6820-2181; Shendure, Jay/0000-0002-1516-1865; Coe, Bradley/0000-0001-8471-4016; O'Roak, Brian/0000-0002-4141-0095; Turner, Emily/0000-0001-9040-9229; Akey, Joshua/0000-0002-4411-1330	Simons Foundation Autism Research Initiative (SFARI) [137578, 191889]; NIH [HD065285]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD065285] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102926, R01HL094976, UC2HL102926, UC2HL102924, RC2HL102923, RC2HL102924] Funding Source: NIH RePORTER	Simons Foundation Autism Research Initiative (SFARI); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank and recognize the following ongoing studies that produced and provided exome variant calls for comparison: NHLBI Lung Cohort Sequencing Project (HL 1029230), NHLBI WHI Sequencing Project (HL 102924), NIEHS SNPs (HHSN273200800010C), NHLBI/NHGRI SeattleSeq (HL 094976), and the Northwest Genomics Center (HL102926). We are grateful to all of the families at the participating Simons Simplex Collection (SSC) sites, as well as the principal investigators (A. Beaudet, R. Bernier, J. Constantino, E. Cook, E. Fombonne, D. Geschwind, E. Hanson, D. Grice, A. Klin, R. Kochel, D. Ledbetter, C. Lord, C. Martin, D. Martin, R. Maxim, J. Miles, O. Ousley, K. Pelphrey, B. Peterson, J. Piggot, C. Saulnier, M. State, W. Stone, J. Sutcliffe, C. Walsh, Z. Warren and E. Wijsman). We also acknowledge M. State and the Simons Simplex Collection Genetics Consortium for providing Illumina genotyping data, T. Lehner and the Autism Sequencing Consortium for providing an opportunity for pre-publication data exchange among the participating groups. We appreciate obtaining access to phenotypic data on SFARI Base. This work was supported by the Simons Foundation Autism Research Initiative (SFARI 137578 and 191889; E.E.E., J.S. and R.B.) and NIH HD065285 (E.E.E. and J.S.). E.B. is an Alfred P. Sloan Research Fellow. E.E.E. is an Investigator of the Howard Hughes Medical Institute.	Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Bedogni F, 2010, P NATL ACAD SCI USA, V107, P13129, DOI 10.1073/pnas.1002285107; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Biesecker LG, 2009, GENOME RES, V19, P1665, DOI 10.1101/gr.092841.109; Borg I, 2005, EUR J HUM GENET, V13, P921, DOI 10.1038/sj.ejhg.5201429; BUNGE J, 1993, J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Buysse K, 2008, AM J MED GENET A, V146A, P1330, DOI 10.1002/ajmg.a.32267; CHAO A, 1992, J AM STAT ASSOC, V87, P210, DOI 10.2307/2290471; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064; DePristo MA, 2011, NAT GENET, V43; Erten S, 2011, BIODATA MIN, V4, DOI 10.1186/1756-0381-4-19; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Hach F, 2010, NAT METHODS, V7, P576, DOI 10.1038/nmeth0810-576; Hehir-Kwa JY, 2011, J MED GENET, V48, P776, DOI 10.1136/jmedgenet-2011-100147; Hoischen A, 2010, NAT GENET, V42, P483, DOI 10.1038/ng.581; Hultman CM, 2011, MOL PSYCHIATR, V16, P1203, DOI 10.1038/mp.2010.121; Ille F, 2005, CELL MOL LIFE SCI, V62, P1100, DOI 10.1007/s00018-005-4552-2; Itsara A, 2009, AM J HUM GENET, V84, P148, DOI 10.1016/j.ajhg.2008.12.014; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Levy D, 2011, NEURON, V70, P886, DOI 10.1016/j.neuron.2011.05.015; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Moldin SO, 2003, AM J PSYCHIAT, V160, P621, DOI 10.1176/appi.ajp.160.4.621; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nishimura-Akiyoshi S, 2007, P NATL ACAD SCI USA, V104, P14801, DOI 10.1073/pnas.0706919104; Nishiyama M, 2009, NAT CELL BIOL, V11, P172, DOI 10.1038/ncb1831; O'Roak BJ, 2008, AUTISM RES, V1, P4, DOI 10.1002/aur.3; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Sakai Y, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002166; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Schaaf CP, 2011, NEURON, V70, P806, DOI 10.1016/j.neuron.2011.05.025; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Talati A, 2008, MOL PSYCHIATR, V13, P122, DOI 10.1038/sj.mp.4002114; Tedeschi A, 2009, EMBO REP, V10, P576, DOI 10.1038/embor.2009.89; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Turner EH, 2009, NAT METHODS, V6, P315, DOI 10.1038/nmeth.f.248; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xu B, 2011, NAT GENET, V43, P864, DOI 10.1038/ng.902	46	1469	1510	5	261	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					246	U136		10.1038/nature10989	http://dx.doi.org/10.1038/nature10989			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22495309	Green Published, Green Accepted			2022-12-24	WOS:000303799800043
J	Couradeau, E; Benzerara, K; Gerard, E; Moreira, D; Bernard, S; Brown, GE; Lopez-Garcia, P				Couradeau, Estelle; Benzerara, Karim; Gerard, Emmanuelle; Moreira, David; Bernard, Sylvain; Brown, Gordon E., Jr.; Lopez-Garcia, Purificacion			An Early-Branching Microbialite Cyanobacterium Forms Intracellular Carbonates	SCIENCE			English	Article							CONCENTRATING MECHANISMS; CALCIFICATION; BARIUM	Cyanobacteria have affected major geochemical cycles (carbon, nitrogen, and oxygen) on Earth for billions of years. In particular, they have played a major role in the formation of calcium carbonates (i.e., calcification), which has been considered to be an extracellular process. We identified a cyanobacterium in modern microbialites in Lake Alchichica (Mexico) that forms intracellular amorphous calcium-magnesium-strontium-barium carbonate inclusions about 270 nanometers in average diameter, revealing an unexplored pathway for calcification. Phylogenetic analyses place this cyanobacterium within the deeply divergent order Gloeobacterales. The chemical composition and structure of the intracellular precipitates suggest some level of cellular control on the biomineralization process. This discovery expands the diversity of organisms capable of forming amorphous calcium carbonates.	[Couradeau, Estelle; Benzerara, Karim] Univ Paris 06, Inst Mineral & Phys Matiere Condensee, CNRS, UMR 7590, F-75005 Paris, France; [Couradeau, Estelle; Gerard, Emmanuelle] Univ Paris Diderot, CNRS, IPGP, UMR 7154, F-75005 Paris, France; [Couradeau, Estelle; Moreira, David; Lopez-Garcia, Purificacion] Univ Paris Sud, Unite Ecol Systemat & Evolut, CNRS, UMR 8079, F-91405 Orsay, France; [Bernard, Sylvain] CNRS, LMCM MNHN, UMR 7202, F-75231 Paris 5, France; [Brown, Gordon E., Jr.] Stanford Univ, Surface & Aqueous Geochem Grp, Dept Geol & Environm Sci, Stanford, CA 94305 USA; [Brown, Gordon E., Jr.] SLAC Natl Accelerator Lab, Dept Photon Sci, Menlo Pk, CA 94025 USA; [Brown, Gordon E., Jr.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Benzerara, K (corresponding author), Univ Paris 06, Inst Mineral & Phys Matiere Condensee, CNRS, UMR 7590, F-75005 Paris, France.	karim.benzerara@impmc.upmc.fr	GERARD, Emmanuelle/A-3828-2013; IMPMC, ROCKS @/U-8478-2017; Lopez-Garcia, Purificacion/B-6775-2012; Bernard, Sylvain/B-6756-2013; Moreira, David/F-7445-2012; Couradeau, Estelle/Q-6874-2018; Benzerara, Karim/J-1532-2016	GERARD, Emmanuelle/0000-0002-4910-747X; Lopez-Garcia, Purificacion/0000-0002-0927-0651; Moreira, David/0000-0002-2064-5354; Couradeau, Estelle/0000-0002-3947-2529; Benzerara, Karim/0000-0002-0553-0137	French Ministere de la Recherche et de l'Enseignement Superieur; CNRS; Institut National des Sciences de l'Univers (INSU); Region Ile de France [SESAME 2006 I-07-593/R]; INSU-CNRS; INP-CNRS; University Pierre et Marie Curie, Paris; NSF; U.S. Environmental Protection Agency through the Center for Environmental Implications of Nanotechnology [EF-0830093]; Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences and Materials Sciences Division, U.S. Department of Energy, at the Lawrence Berkeley National Laboratory; Office of Basic Energy Sciences of the U.S. Department of Energy [DE-AC02-05CH11231]	French Ministere de la Recherche et de l'Enseignement Superieur; CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut National des Sciences de l'Univers (INSU); Region Ile de France(Region Ile-de-France); INSU-CNRS(Centre National de la Recherche Scientifique (CNRS)); INP-CNRS(Centre National de la Recherche Scientifique (CNRS)); University Pierre et Marie Curie, Paris; NSF(National Science Foundation (NSF)); U.S. Environmental Protection Agency through the Center for Environmental Implications of Nanotechnology; Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences and Materials Sciences Division, U.S. Department of Energy, at the Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	E.C. was recipient of a fellowship from the French Ministere de la Recherche et de l'Enseignement Superieur. This project was financed by the CNRS interdisciplinary program "Environnements planetaires et origines de la vie" (PID EPOV) and Institut National des Sciences de l'Univers (INSU) program "InteractionsTerre/Vie" (InterrVie). The SEM facility of the Institut de Mineralogie et de Physique des Milieux Condenses is supported by Region Ile de France grant SESAME 2006 I-07-593/R, INSU-CNRS, INP-CNRS, University Pierre et Marie Curie, Paris. Support was also provided by NSF and the U.S. Environmental Protection Agency under cooperative agreement EF-0830093 through the Center for Environmental Implications of Nanotechnology. Advanced Light Source (ALS) Molecular Environmental Science beamline 11.0.2 is supported by the Office of Science, Office of Basic Energy Sciences, Division of Chemical Sciences, Geosciences, and Biosciences and Materials Sciences Division, U.S. Department of Energy, at the Lawrence Berkeley National Laboratory. Beamline 5.3.2 at ALS is supported by the Office of Basic Energy Sciences of the U.S. Department of Energy under contract DE-AC02-05CH11231. We thank R. Tavera (Universidad Autononoma de Mexico) for providing help as a field guide and the Laboratoire de Geochimie des Eaux at IPGP for providing the facility for Gran measurements. The sequence of the 16S rRNA gene of Candidatus Gloeomargarita lithophora has been deposited in GenBank under accession no. JQ733894. Data and enrichment cultures are available upon request.	Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381; Altermann W, 2006, GEOBIOLOGY, V4, P147, DOI 10.1111/j.1472-4669.2006.00076.x; Arp G, 2001, SCIENCE, V292, P1701, DOI 10.1126/science.1057204; Badger MR, 2002, FUNCT PLANT BIOL, V29, P161, DOI 10.1071/PP01213; Bath GE, 2000, GEOCHIM COSMOCHIM AC, V64, P1705, DOI 10.1016/S0016-7037(99)00419-6; Benzerara K, 2004, GEOBIOLOGY, V2, P249, DOI 10.1111/j.1472-4677.2004.00039.x; Bittarello E, 2007, EUR J MINERAL, V19, P345, DOI 10.1127/0935-1221/2007/0019-1730; Couradeau E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028767; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Dupraz C, 2009, EARTH-SCI REV, V96, P141, DOI 10.1016/j.earscirev.2008.10.005; Falcon LI, 2010, ISME J, V4, P777, DOI 10.1038/ismej.2010.2; Farquhar J, 2011, PHOTOSYNTH RES, V107, P11, DOI 10.1007/s11120-010-9594-0; Fleet ME, 2009, AM MINERAL, V94, P1235, DOI 10.2138/am.2009.3228; Herrero A., 2008, CYANOBACTERIA MOL BI; Jansson C, 2010, CURR OPIN BIOTECH, V21, P365, DOI 10.1016/j.copbio.2010.03.017; Kazmierczak J, 2011, FACIES, V57, P543, DOI 10.1007/s10347-010-0255-8; Krejci MR, 2011, J STRUCT BIOL, V176, P192, DOI 10.1016/j.jsb.2011.08.006; Kupriyanova E, 2007, MICROBIOL-SGM, V153, P1149, DOI 10.1099/mic.0.2006/003905-0; Merz M.U., 1992, FACIES, V26, P81, DOI [10.1007/BF02539795, DOI 10.1007/BF02539795]; Obst M, 2009, GEOCHIM COSMOCHIM AC, V73, P4180, DOI 10.1016/j.gca.2009.04.013; Planavsky N, 2009, GEOBIOLOGY, V7, P566, DOI 10.1111/j.1472-4669.2009.00216.x; Rez P, 2011, J PHYS CHEM B, V115, P11193, DOI 10.1021/jp203057y; RIDING R, 2006, GEOBIOLOGY, V4, P299, DOI DOI 10.1111/J.1472-4669.2006.00087.X; RIPPKA R, 1974, ARCH MICROBIOL, V100, P419, DOI 10.1007/BF00446333; WALSBY AE, 1995, EUR J PHYCOL, V30, P87, DOI 10.1080/09670269500650851	25	158	168	7	148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					459	462		10.1126/science.1216171	http://dx.doi.org/10.1126/science.1216171			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539718				2022-12-24	WOS:000303233400043
J	Marinari, E; Mehonic, A; Curran, S; Gale, J; Duke, T; Baum, B				Marinari, Eliana; Mehonic, Aida; Curran, Scott; Gale, Jonathan; Duke, Thomas; Baum, Buzz			Live-cell delamination counterbalances epithelial growth to limit tissue overcrowding	NATURE			English	Article							DROSOPHILA; MORPHOGENESIS; MECHANISM	The development and maintenance of an epithelium requires finely balanced rates of growth and cell death. However, the mechanical and biochemical mechanisms that ensure proper feedback control of tissue growth(1-4), which when deregulated contribute to tumorigenesis, are poorly understood. Here we use the fly notum as a model system(5) to identify a novel process of crowding-induced cell delamination that balances growth to ensure the development of well-ordered cell packing. In crowded regions of the tissue, a proportion of cells undergo a serial loss of cell-cell junctions and a progressive loss of apical area, before being squeezed out by their neighbours. This path of delamination is recapitulated by a simple computational model of epithelial mechanics, in which stochastic cell loss relieves overcrowding as the system tends towards equilibrium. We show that this process of delamination is mechanistically distinct from apoptosis-mediated cell extrusion(6-8) and precedes the first signs of cell death. Overall, this analysis reveals a simple mechanism that buffers epithelia against variations in growth. Because live-cell delamination constitutes a mechanistic link between epithelial hyperplasia and cell invasion, this is likely to have important implications for our understanding of the early stages of cancer development.	[Marinari, Eliana; Curran, Scott; Baum, Buzz] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; [Mehonic, Aida; Duke, Thomas] UCL, London Ctr Nanotechnol, London WC1E 6BT, England; [Mehonic, Aida; Duke, Thomas] UCL, Dept Phys & Astron, London WC1E 6BT, England; [Gale, Jonathan] UCL, UCL Ear Inst, London WC1X 8EE, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Baum, B (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	b.baum@ucl.ac.uk	Gale, Jonathan/AAG-6874-2019	Baum, Buzz/0000-0002-9201-6186; Gale, Jonathan/0000-0003-4678-4878; Curran, Scott/0000-0002-7996-8764	Cancer Research UK; University College London, Wellcome and the Royal Society; Medical Research Council [MC_CF12266] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); University College London, Wellcome and the Royal Society; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank J. Rosenblatt for communicating results before publication; N. Tapon, F. Pichaud, G. Charras and J. Rohn for helpful comments on the text; and the members of the Baum laboratory, in particular K. Van Hegan, J. Bellis and J. Beira. B. B. and E. M. thank Cancer Research UK for funding. B. B. also thanks University College London, Wellcome and the Royal Society for financial support.	Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; BRAND AH, 1994, METHOD CELL BIOL, V44, P635, DOI 10.1016/S0091-679X(08)60936-X; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Emoto Y, 2008, J PHYSIOL SCI, V58, P371, DOI 10.2170/physiolsci.RP011108; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; FRISTROM D, 1988, TISSUE CELL, V20, P645, DOI 10.1016/0040-8166(88)90015-8; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; IRVINE KD, 1994, DEVELOPMENT, V120, P827; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Koto A, 2011, CURR BIOL, V21, P278, DOI 10.1016/j.cub.2011.01.015; Leevers SJ, 1996, EMBO J, V15, P6584, DOI 10.1002/j.1460-2075.1996.tb01049.x; Manjon C, 2007, NAT CELL BIOL, V9, P57, DOI 10.1038/ncb1518; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Oda H, 2001, J CELL SCI, V114, P493; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; Zeitlinger J, 1999, DEVELOPMENT, V126, P3947	19	283	285	3	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					542	U177		10.1038/nature10984	http://dx.doi.org/10.1038/nature10984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22504180				2022-12-24	WOS:000303200400057
J	Zielinski, CE; Mele, F; Aschenbrenner, D; Jarrossay, D; Ronchi, F; Gattorno, M; Monticelli, S; Lanzavecchia, A; Sallusto, F				Zielinski, Christina E.; Mele, Federico; Aschenbrenner, Dominik; Jarrossay, David; Ronchi, Francesca; Gattorno, Marco; Monticelli, Silvia; Lanzavecchia, Antonio; Sallusto, Federica			Pathogen-induced human T(H)17 cells produce IFN-gamma or IL-10 and are regulated by IL-1 beta	NATURE			English	Article							GROWTH-FACTOR-BETA; HYPER-IGE SYNDROME; CD4(+) T-CELLS; TH17 CELLS; TGF-BETA; HELPER-CELLS; DIFFERENTIATION; MEMORY; INTERLEUKIN-1-BETA; PROSTAGLANDIN-E2	IL-17-producing CD4(+) T helper cells (T(H)17) have been extensively investigated in mouse models of autoimmunity(1). However, the requirements for differentiation and the properties of pathogen-induced human T(H)17 cells remain poorly defined. Using an approach that combines the in vitro priming of naive T cells with the ex vivo analysis of memory T cells, we describe here two types of human T(H)17 cells with distinct effector function and differentiation requirements. Candida albicans-specific T(H)17 cells produced IL-17 and IFN-gamma, but no IL-10, whereas Staphylococcus aureus-specific T(H)17 cells produced IL-17 and could produce IL-10 upon restimulation. IL-6, IL-23 and IL-1 beta contributed to T(H)17 differentiation induced by both pathogens, but IL-1 beta was essential in C. albicans-induced T(H)17 differentiation to counteract the inhibitory activity of IL-12 and to prime IL-17/IFN-gamma double-producing cells. In addition, IL-1 beta inhibited IL-10 production in differentiating and in memory T(H)17 cells, whereas blockade of IL-1 beta in vivo led to increased IL-10 production by memory T(H)17 cells. We also show that, after restimulation, T(H)17 cells transiently downregulated IL-17 production through a mechanism that involved IL-2-induced activation of STAT5 and decreased expression of ROR-gamma t. Taken together these findings demonstrate that by eliciting different cytokines C. albicans and S. aureus prime T(H)17 cells that produce either IFN-gamma or IL-10, and identify IL-1 beta and IL-2 as pro-and anti-inflammatory regulators of T(H)17 cells both at priming and in the effector phase.	[Zielinski, Christina E.; Mele, Federico; Aschenbrenner, Dominik; Jarrossay, David; Ronchi, Francesca; Monticelli, Silvia; Lanzavecchia, Antonio; Sallusto, Federica] Inst Res Biomed, CH-6500 Bellinzona, Switzerland; [Gattorno, Marco] G Gaslini Sci Inst, I-16147 Genoa, Italy; [Lanzavecchia, Antonio] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland	Universita della Svizzera Italiana; University of Genoa; IRCCS Istituto Giannina Gaslini; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sallusto, F (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.	christina.zielinski@charite.de; federica.sallusto@irb.usi.ch	Zielinski, Christina/Y-3362-2019; Gattorno, Marco/AAL-2974-2020; Monticelli, Silvia/ABE-7054-2020	Gattorno, Marco/0000-0003-0704-1916; Monticelli, Silvia/0000-0002-5909-8802; Aschenbrenner, Dominik/0000-0001-7580-2567; Zielinski, Christina/0000-0002-8184-0858; Ronchi, Francesca/0000-0002-2035-6528	German Research Foundation (DFG) [Zi 1262/1-1]; Swiss National Science Foundation [131092, 126027]; Institute of Arthritis Research (IAR); Helmut Horten Foundation	German Research Foundation (DFG)(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Institute of Arthritis Research (IAR); Helmut Horten Foundation	We thank O. Petrini and C. Fragoso for providing microorganisms, and M. Levings for providing the RORC lentiviral vector. We thank A. Rossetti for technical assistance, D. Baumjohann for artwork and S. Jacob and M. Uguccioni for critical reading of the manuscript. This work was supported by a fellowship of the German Research Foundation (DFG) to C.E.Z (Zi 1262/1-1) and by grants from the Swiss National Science Foundation (N. 131092 to F. S. and 126027 to A. L.) and the Institute of Arthritis Research (IAR). A. L. is supported by the Helmut Horten Foundation.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Crome SQ, 2009, EUR J IMMUNOL, V39, P1480, DOI 10.1002/eji.200838908; Gattorno M, 2007, ARTHRITIS RHEUM, V56, P3138, DOI 10.1002/art.22842; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hoyer KK, 2008, IMMUNOL REV, V226, P19, DOI 10.1111/j.1600-065X.2008.00697.x; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jankovic D, 2007, J EXP MED, V204, P273, DOI 10.1084/jem.20062175; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Mayoral RJ, 2010, METHODS MOL BIOL, V667, P205, DOI 10.1007/978-1-60761-811-9_14; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Napolitani G, 2009, EUR J IMMUNOL, V39, P1301, DOI 10.1002/eji.200838969; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Smeekens SP, 2010, INT IMMUNOL, V22, P889, DOI 10.1093/intimm/dxq442; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Yang L, 2008, NATURE, V454, P350, DOI 10.1038/nature07021; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995	30	654	676	2	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					514	U139		10.1038/nature10957	http://dx.doi.org/10.1038/nature10957			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22466287				2022-12-24	WOS:000303200400051
J	Yokoo, R; Zawadzki, KA; Nabeshima, K; Drake, M; Arur, S; Villeneuve, AM				Yokoo, Rayka; Zawadzki, Karl A.; Nabeshima, Kentaro; Drake, Melanie; Arur, Swathi; Villeneuve, Anne M.			COSA-1 Reveals Robust Homeostasis and Separable Licensing and Reinforcement Steps Governing Meiotic Crossovers	CELL			English	Article							CROSSING-OVER; CAENORHABDITIS-ELEGANS; C-ELEGANS; MUTS HOMOLOG; MAMMALIAN MEIOSIS; CHIASMA FORMATION; BUDDING YEAST; RECOMBINATION; SYNAPSIS; MECHANISM	Crossovers (COs) between homologous chromosomes ensure their faithful segregation during meiosis. We identify C. elegans COSA-1, a cyclin-related protein conserved in metazoa, as a key component required to convert meiotic double-strand breaks (DSBs) into COs. During late meiotic prophase, COSA-1 localizes to foci that correspond to the single CO site on each homolog pair and indicate sites of eventual concentration of other conserved CO proteins. Chromosomes gain and lose competence to load CO proteins during meiotic progression, with competence to load COSA-1 requiring prior licensing. Our data further suggest a self-reinforcing mechanism maintaining CO designation. Modeling of a nonlinear dose-response relationship between IR-induced DSBs and COSA-1 foci reveals efficient conversion of DSBs into COs when DSBs are limiting and a robust capacity to limit cytologically differentiated CO sites when DSBs are in excess. COSA-1 foci serve as a unique live cell readout for investigating CO formation and CO interference.	[Yokoo, Rayka; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Zawadzki, Karl A.; Nabeshima, Kentaro; Villeneuve, Anne M.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Drake, Melanie; Arur, Swathi] Univ Texas Houston, MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	Stanford University; Stanford University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Villeneuve, AM (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	annev@stanford.edu			NIH [HG00044, R01GM67268]; Leukemia and Lymphoma Society [5381-12]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000044, K22HG000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067268] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Mitani (National Institute of Genetics, Japan) and S. Rosu (Villeneuve lab) for cosa-1(tm3298) and zhp-3(me95); N. Bhalla, A. Dernburg, A. la Volpe, B. Meyer, S. Boulton, M. Zetka, and the Caenorhabditis Genetics Center for strains and antibodies; and J. Bessler for technical support. We thank A.D. Kaiser, M. AlQuaraishi, C. Janda, C. Thomas, D. Riordan, S. Clarke, and members of the Villeneuve lab for discussions and D. Libuda and A. Fire for comments on the manuscript. This work was supported by Stanford Genome Training Program NIH HG00044 Training Grant for R.Y., Leukemia and Lymphoma Society Postdoctoral Fellowship 5381-12 to K.A.Z., and NIH grant R01GM67268 to A.M.V.	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Anderson LK, 1999, GENETICS, V151, P1569; Ashley T, 2001, J CELL SCI, V114, P685; Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Baudat F, 2007, CHROMOSOME RES, V15, P565, DOI 10.1007/s10577-007-1140-3; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; CARPENTER ATC, 1975, P NATL ACAD SCI USA, V72, P3186, DOI 10.1073/pnas.72.8.3186; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; de los Santos T, 2003, GENETICS, V164, P81; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Hammarlund M, 2005, GENETICS, V171, P1047, DOI 10.1534/genetics.105.044834; Hayashi M, 2007, PLOS GENET, V3, P2068, DOI 10.1371/journal.pgen.0030191; Henzel JV, 2011, GENETICS, V187, P685, DOI 10.1534/genetics.110.124958; Higgins JD, 2008, PLANT J, V55, P28, DOI 10.1111/j.1365-313X.2008.03470.x; Higgins JD, 2004, GENE DEV, V18, P2557, DOI 10.1101/gad.317504; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; HODGKIN J, 1979, GENETICS, V91, P67; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Jantsch V, 2004, MOL CELL BIOL, V24, P7998, DOI 10.1128/MCB.24.18.7998-8006.2004; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jones G.H., 1984, Symposia of the Society for Experimental Biology, P293; Kelly KO, 2000, GENETICS, V156, P617; Kneitz B, 2000, GENE DEV, V14, P1085; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Lynn A, 2007, CHROMOSOME RES, V15, P591, DOI 10.1007/s10577-007-1150-1; Macqueen AJ, 2005, CELL, V123, P1037, DOI 10.1016/j.cell.2005.09.034; MacQueen AJ, 2002, GENE DEV, V16, P2428, DOI 10.1101/gad.1011602; MacQueen AJ, 2009, CURR BIOL, V19, P1519, DOI 10.1016/j.cub.2009.08.048; Martinez-Perez E, 2005, GENE DEV, V19, P2727, DOI 10.1101/gad.1338505; Martinez-Perez E, 2008, GENE DEV, V22, P2886, DOI 10.1101/gad.1694108; Martinez-Perez E, 2009, CURR OPIN GENET DEV, V19, P105, DOI 10.1016/j.gde.2009.02.005; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Muller HJ, 1916, AM NAT, V50, P350, DOI 10.1086/279547; Muller HJ, 1916, AM NAT, V50, P284, DOI 10.1086/279541; Muller HJ, 1916, AM NAT, V50, P421, DOI 10.1086/279553; Nabeshima K, 2004, GENETICS, V168, P1275, DOI 10.1534/genetics.104.030700; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Petri ET, 2007, CELL CYCLE, V6, P1342, DOI 10.4161/cc.6.11.4297; Phillips CM, 2005, CELL, V123, P1051, DOI 10.1016/j.cell.2005.09.035; Pochart P, 1997, J BIOL CHEM, V272, P30345, DOI 10.1074/jbc.272.48.30345; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; Rosu S, 2011, SCIENCE, V334, P1286, DOI 10.1126/science.1212424; Santucci-Darmanin S, 2000, FASEB J, V14, P1539, DOI 10.1096/fj.14.11.1539; Schurko AM, 2010, INSECT MOL BIOL, V19, P165, DOI 10.1111/j.1365-2583.2009.00948.x; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Thompson L.H., 2000, ORIGIN RECOGNITION S; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; Viera A, 2009, J CELL SCI, V122, P2149, DOI 10.1242/jcs.046706; Ward JO, 2007, PLOS GENET, V3, P1550, DOI 10.1371/journal.pgen.0030139; Youds JL, 2010, SCIENCE, V327, P1254, DOI 10.1126/science.1183112; Zalevsky J, 1999, GENETICS, V153, P1271; Zetka MC, 1999, GENE DEV, V13, P2258, DOI 10.1101/gad.13.17.2258; ZICKLER D, 1992, GENETICS, V132, P135	55	147	149	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					75	87		10.1016/j.cell.2012.01.052	http://dx.doi.org/10.1016/j.cell.2012.01.052			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464324	Green Accepted, Bronze			2022-12-24	WOS:000302235400011
J	Moissiard, G; Cokus, SJ; Cary, J; Feng, SH; Billi, AC; Stroud, H; Husmann, D; Zhan, Y; Lajoie, BR; McCord, RP; Hale, CJ; Feng, W; Michaels, SD; Frand, AR; Pellegrini, M; Dekker, J; Kim, JK; Jacobsen, SE				Moissiard, Guillaume; Cokus, Shawn J.; Cary, Joshua; Feng, Suhua; Billi, Allison C.; Stroud, Hume; Husmann, Dylan; Zhan, Ye; Lajoie, Bryan R.; McCord, Rachel Patton; Hale, Christopher J.; Feng, Wei; Michaels, Scott D.; Frand, Alison R.; Pellegrini, Matteo; Dekker, Job; Kim, John K.; Jacobsen, Steven E.			MORC Family ATPases Required for Heterochromatin Condensation and Gene Silencing	SCIENCE			English	Article							DNA METHYLATION; RNA INTERFERENCE; C-ELEGANS; ARABIDOPSIS; GENOME; METHYLTRANSFERASE; SPERMATOGENESIS; REACTIVATION; MOUSE	Transposable elements (TEs) and DNA repeats are commonly targeted by DNA and histone methylation to achieve epigenetic gene silencing. We isolated mutations in two Arabidopsis genes, AtMORC1 and AtMORC6, which cause derepression of DNA-methylated genes and TEs but no losses of DNA or histone methylation. AtMORC1 and AtMORC6 are members of the conserved Microrchidia (MORC) adenosine triphosphatase (ATPase) family, which are predicted to catalyze alterations in chromosome superstructure. The atmorc1 and atmorc6 mutants show decondensation of pericentromeric heterochromatin, increased interaction of pericentromeric regions with the rest of the genome, and transcriptional defects that are largely restricted to loci residing in pericentromeric regions. Knockdown of the single MORC homolog in Caenorhabditis elegans also impairs transgene silencing. We propose that the MORC ATPases are conserved regulators of gene silencing in eukaryotes.	[Moissiard, Guillaume; Cokus, Shawn J.; Cary, Joshua; Feng, Suhua; Stroud, Hume; Husmann, Dylan; Hale, Christopher J.; Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Billi, Allison C.; Kim, John K.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Billi, Allison C.; Kim, John K.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Zhan, Ye; Lajoie, Bryan R.; McCord, Rachel Patton; Dekker, Job] Univ Massachusetts, Sch Med, Syst Biol & Gene Funct & Express, Worcester, MA 01605 USA; [Feng, Wei; Michaels, Scott D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Frand, Alison R.; Jacobsen, Steven E.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Worcester; Indiana University System; Indiana University Bloomington; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Terasaki Life Sci Bldg,610 Charles Young Dr E, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu	Michaels, Scott/D-5458-2009; Billi, Allison/AAP-1684-2021; Stroud, Hume/ABF-1325-2021	McCord, Rachel/0000-0003-0010-5323; Frand, Alison/0000-0001-5972-989X; Michaels, Scott/0000-0001-5248-3487; Pellegrini, Matteo/0000-0001-9355-9564	Ruth L. Kirschstein National Research Service Award [GM007185]; National Institute of General Medical Sciences [F32GM100617]; W. M. Keck Foundation; NIH [GM60398, GM088565, GM075060, HG003143]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088565, R01GM075060, R01GM060398, F32GM100617, R37GM060398, T32GM007544, T32GM007185] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); W. M. Keck Foundation(W.M. Keck Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Akhavan for sequencing, L. Goddard and L. Iruela-Arispe for assistance with confocal microscopy, and P. Fransz and I. Schubert for helpful discussions. S.F. is a Special Fellow of the Leukemia and Lymphoma Society. J.C. is supported by the Ruth L. Kirschstein National Research Service Award GM007185. R.P.M. is supported by the National Institute of General Medical Sciences (grant F32GM100617), and J.D. is supported by a W. M. Keck Foundation Distinguished Young Scholar in Medical Research Award. Research in the Jacobsen, Kim, Michaels, and Dekker laboratories was supported by NIH grants GM60398, GM088565, GM075060, and HG003143, respectively. Sequencing files have been deposited at Gene Expression Omnibus (GEO) (accession code GSE37644). The authors declare no competing financial interests. S.E.J. is an investigator of the Howard Hughes Medical Institute. Correspondence and requests for materials should be addressed to S.E.J.	Amedeo P, 2000, NATURE, V405, P203, DOI 10.1038/35012108; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Fransz P, 2002, P NATL ACAD SCI USA, V99, P14584, DOI 10.1073/pnas.212325299; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Inoue N, 1999, HUM MOL GENET, V8, P1201, DOI 10.1093/hmg/8.7.1201; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-8; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Kang HG, 2008, CELL HOST MICROBE, V3, P48, DOI 10.1016/j.chom.2007.11.006; Kang HG, 2010, PLANT CELL, V22, P918, DOI 10.1105/tpc.109.071662; Kankel MW, 2003, GENETICS, V163, P1109; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Law JA, 2010, NAT REV GENET, V11, P204, DOI 10.1038/nrg2719; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Probst AV, 2003, PLANT J, V33, P743, DOI 10.1046/j.1365-313X.2003.01667.x; SIMPSON VJ, 1986, NUCLEIC ACIDS RES, V14, P6711, DOI 10.1093/nar/14.16.6711; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watson ML, 1998, P NATL ACAD SCI USA, V95, P14361, DOI 10.1073/pnas.95.24.14361; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	23	215	226	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1448	1451		10.1126/science.1221472	http://dx.doi.org/10.1126/science.1221472			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22555433	Green Accepted			2022-12-24	WOS:000305211700048
J	Zhao, TT; Graham, OS; Raposo, A; St Johnston, D				Zhao, Tongtong; Graham, Owen S.; Raposo, Alexandre; St Johnston, Daniel			Growing Microtubules Push the Oocyte Nucleus to Polarize the Drosophila Dorsal-Ventral Axis	SCIENCE			English	Article							LIVING CELLS; CYTOPLASMIC DYNEIN; OOGENESIS; MIGRATION; ORGANIZATION; CYTOSKELETON; CENTRIOLES; POSTERIOR; MOTORS; PAR-1	The Drosophila dorsal-ventral (DV) axis is polarized when the oocyte nucleus migrates from the posterior to the anterior margin of the oocyte. Prior work suggested that dynein pulls the nucleus to the anterior side along a polarized microtubule cytoskeleton, but this mechanism has not been tested. By imaging live oocytes, we find that the nucleus migrates with a posterior indentation that correlates with its direction of movement. Furthermore, both nuclear movement and the indentation depend on microtubule polymerization from centrosomes behind the nucleus. Thus, the nucleus is not pulled to the anterior but is pushed by the force exerted by growing microtubules. Nuclear migration and DV axis formation therefore depend on centrosome positioning early in oogenesis and are independent of anterior-posterior axis formation.	[Zhao, Tongtong; Raposo, Alexandre; St Johnston, Daniel] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Zhao, Tongtong; Raposo, Alexandre; St Johnston, Daniel] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England; [Graham, Owen S.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England	University of Cambridge; University of Cambridge; University of Cambridge	St Johnston, D (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	d.stjohnston@gurdon.cam.ac.uk	St Johnston, Daniel/C-9568-2009	St Johnston, Daniel/0000-0001-5582-3301; Raposo, Alexandre/0000-0002-2794-0508	Wellcome Trust; FAZIT Stiftung; Boehringer Ingelheim Fonds; Cambridge European Trust; Fundacao para a Ciencia e Tecnologia	Wellcome Trust(Wellcome TrustEuropean Commission); FAZIT Stiftung; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Cambridge European Trust; Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	We would like to thank J. Raff for providing the Dlic-GFP fly stock and centrosomal markers; H. Nash for providing the Mud antibody; S. Young for help with image analysis; and J. Guck, Y.-C. Oei, and P. K. Trong for help with the force calculations. This work was supported by a Wellcome Trust Principal Research Fellowship to D.StJ., Ph.D. scholarships from the FAZIT Stiftung, the Boehringer Ingelheim Fonds and the Cambridge European Trust to T.Z., the Gulbenkian Ph.D. scholarship of the Fundacao para a Ciencia e Tecnologia to A. R., and core support from the Wellcome Trust and Cancer Research UK.	Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Bausch AR, 1999, BIOPHYS J, V76, P573, DOI 10.1016/S0006-3495(99)77225-5; Bolivar J, 2001, DEVELOPMENT, V128, P1889; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; Dogterom M, 2005, CURR OPIN CELL BIOL, V17, P67, DOI 10.1016/j.ceb.2004.12.011; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; Dupin I, 2011, INT J BIOCHEM CELL B, V43, P1698, DOI 10.1016/j.biocel.2011.09.004; Fichelson P, 2010, DEVELOPMENT, V137, P815, DOI 10.1242/dev.045013; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Grieder NC, 2000, DEVELOPMENT, V127, P4253; Hochmuth RM, 2000, J BIOMECH, V33, P15, DOI 10.1016/S0021-9290(99)00175-X; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; KOCH EA, 1983, CELL TISSUE RES, V228, P21; LEE YC, 1982, J BIOL CHEM, V257, P6306; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; MAHOWALD AP, 1970, J CELL BIOL, V45, P306, DOI 10.1083/jcb.45.2.306; Mimori-Kiyosue Y, 2000, CURR BIOL, V10, P865, DOI 10.1016/S0960-9822(00)00600-X; Mogilner A, 2003, CURR BIOL, V13, pR721, DOI 10.1016/j.cub.2003.08.050; Radulescu AE, 2010, TRENDS CELL BIOL, V20, P214, DOI 10.1016/j.tcb.2010.01.003; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Rusan NM, 2009, TRAFFIC, V10, P472, DOI 10.1111/j.1600-0854.2009.00880.x; Shulman JM, 2000, CELL, V101, P377, DOI 10.1016/S0092-8674(00)80848-X; Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060; Swan A, 1999, NAT CELL BIOL, V1, P444, DOI 10.1038/15680; Swan A, 1996, DEVELOPMENT, V122, P3577; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Watanabe N, 2010, P JPN ACAD B-PHYS, V86, P62, DOI 10.2183/pjab.86.62	30	101	101	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					999	1003		10.1126/science.1219147	http://dx.doi.org/10.1126/science.1219147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22499806	Green Accepted			2022-12-24	WOS:000304406800036
J	Tarallo, V; Hirano, Y; Gelfand, BD; Dridi, S; Kerur, N; Kim, Y; Cho, WG; Kaneko, H; Fowler, BJ; Bogdanovich, S; Albuquerque, RJC; Hauswirth, WW; Chiodo, VA; Kugel, JF; Goodrich, JA; Ponicsan, SL; Chaudhuri, G; Murphy, MP; Dunaief, JL; Ambati, BK; Ogura, Y; Yoo, JW; Lee, DK; Provost, P; Hinton, DR; Nunez, G; Baffi, JZ; Kleinman, ME; Ambati, J				Tarallo, Valeria; Hirano, Yoshio; Gelfand, Bradley D.; Dridi, Sami; Kerur, Nagaraj; Kim, Younghee; Cho, Won Gil; Kaneko, Hiroki; Fowler, Benjamin J.; Bogdanovich, Sasha; Albuquerque, Romulo J. C.; Hauswirth, William W.; Chiodo, Vince A.; Kugel, Jennifer F.; Goodrich, James A.; Ponicsan, Steven L.; Chaudhuri, Gautam; Murphy, Michael P.; Dunaief, Joshua L.; Ambati, Balamurali K.; Ogura, Yuichiro; Yoo, Jae Wook; Lee, Dong-ki; Provost, Patrick; Hinton, David R.; Nunez, Gabriel; Baffi, Judit Z.; Kleinman, Mark E.; Ambati, Jayakrishna			DICER1 Loss and Alu RNA Induce Age-Related Macular Degeneration via the NLRP3 Inflammasome and MyD88	CELL			English	Article							RETINAL-PIGMENT EPITHELIUM; ENDOTHELIAL GROWTH-FACTOR; INNATE IMMUNE-RESPONSES; DOUBLE-STRANDED-RNA; CELL-DEATH; ACTIVATION; RECOGNITION; CASPASE-1; PROTEIN; IL-1	Alu RNA accumulation due to DICER1 deficiency in the retinal pigmented epithelium (RPE) is implicated in geographic atrophy (GA), an advanced form of age-related macular degeneration that causes blindness in millions of individuals. The mechanism of Alu RNA-induced cytotoxicity is unknown. Here we show that DICER1 deficit or Alu RNA exposure activates the NLRP3 inflammasome and triggers TLR-independent MyD88 signaling via IL18 in the RPE. Genetic or pharmacological inhibition of inflammasome components (NLRP3, Pycard, Caspase-1), MyD88, or IL18 prevents RPE degeneration induced by DICER1 loss or Alu RNA exposure. These findings, coupled with our observation that human GA RPE contains elevated amounts of NLRP3, PYCARD, and IL18 and evidence of increased Caspase-1 and MyD88 activation, provide a rationale for targeting this pathway in GA. Our findings also reveal a function of the inflammasome outside the immune system and an immunomodulatory action of mobile elements.	[Tarallo, Valeria; Hirano, Yoshio; Gelfand, Bradley D.; Dridi, Sami; Kerur, Nagaraj; Kim, Younghee; Cho, Won Gil; Kaneko, Hiroki; Fowler, Benjamin J.; Bogdanovich, Sasha; Albuquerque, Romulo J. C.; Baffi, Judit Z.; Kleinman, Mark E.; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Fowler, Benjamin J.; Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Cho, Won Gil] Yonsei Univ, Wonju Coll Med, Dept Anat, Wonju 220701, South Korea; [Hauswirth, William W.; Chiodo, Vince A.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Kugel, Jennifer F.; Goodrich, James A.; Ponicsan, Steven L.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Chaudhuri, Gautam] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Murphy, Michael P.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England; [Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Ambati, Balamurali K.] Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Ambati, Balamurali K.] Vet Affairs Salt Lake City Healthcare Syst, Dept Ophthalmol, Salt Lake City, UT 84148 USA; [Ogura, Yuichiro] Nagoya City Univ, Grad Sch Med Sci, Dept Ophthalmol & Visual Sci, Nagoya, Aichi 4678601, Japan; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Global Res Lab RNAi Med, Suwon 440746, South Korea; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Sch Chem Mat Sci BK21, Suwon 440746, South Korea; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Dept Chem, Suwon 440746, South Korea; [Provost, Patrick] Univ Laval, CHUL Res Ctr, CHUQ, Quebec City, PQ G1K 7P4, Canada; [Provost, Patrick] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Hinton, David R.] Univ So Calif, Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, Los Angeles, CA 90033 USA; [Nunez, Gabriel] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; [Nunez, Gabriel] Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	University of Kentucky; University of Kentucky; Yonsei University; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Boulder; Meharry Medical College; University of Pennsylvania; Pennsylvania Medicine; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Nagoya City University; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Laval University; Laval University; Doheny Eye Institute; University of Southern California; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Ambati, J (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.	jamba2@email.uky.edu	Kaneko, Hiroki/AHA-2461-2022; Provost, Patrick/G-2786-2010; Fowler, Benjamin/F-4987-2012; Nuñez, Gabriel/A-7160-2014; Kaneko, Hiroki/O-7695-2015; Murphy, Michael P/C-2120-2009; Gelfand, Brad/L-3926-2019; Dridi, Sami/Q-8207-2019	Kaneko, Hiroki/0000-0003-0731-6465; Provost, Patrick/0000-0002-6099-6562; Kaneko, Hiroki/0000-0003-0731-6465; Murphy, Michael P/0000-0003-1115-9618; Hirano, Yoshio/0000-0002-9173-0839; Tarallo, Valeria/0000-0002-6920-4402; hauswirth, william/0000-0002-3244-4947; Kleinman, Mark/0000-0001-8557-7949	NEI/NIH [R01EY018350, R01EY018836, R01EY020672, R01EY022238, R21EY019778, RC1EY020442]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; Research to Prevent Blindness, RPB; NIH [K08EY021521, K08EY021757, T32HL091812, UL1RR033173, R01AI063331, R01AR052756, P30EY021721, R01EY017182, R01EY017950, P30EY003040, R01EY001545, R01GM068414]; International Retinal Research Foundation; American Health Assistance Foundation; Alcon Japan Research award; VA Merit Award; Department of Defense; MEST, Korea; RPB; University of Kentucky; Fonds de la Recherche en Sante du Quebec (FRSQ); MRC [MC_U105663142] Funding Source: UKRI; Medical Research Council [MC_U105663142] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001998, TL1TR000115, UL1TR000117] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR033173, TL1RR033172] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [K08EY021757, R01EY022238, R01EY018350, RC1EY020442, R01EY001545, R01EY017950, R01EY018836, P30EY003040, R01EY020672, R21EY019778, R01EY017182, P30EY021721, K08EY021521] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068414] Funding Source: NIH RePORTER	NEI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Research to Prevent Blindness, RPB(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Retinal Research Foundation; American Health Assistance Foundation; Alcon Japan Research award; VA Merit Award(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); MEST, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); RPB; University of Kentucky; Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Akira, Z. Chen, M. Chrenek, J. Garcia-Perez, T. Heidmann, and J. V. Moran for providing mice, reagents, or tissues; R. King, L. Xu, M. McConnell, C. Payne, D. Robertson, G. Botzet, G. R. Pattison, and C. Spee for technical assistance; and S. Bondada, M. E. Boulton, R. A. Brekken, R. Kannan, K. Kariko, T. S. Khurana, R. Mohan, M. L. Peterson, V. Rangnekar, A. Sinai, A. M. Rao, G. S. Rao, and K. Ambati for discussions. J. A. was supported by NEI/NIH grants R01EY018350, R01EY018836, R01EY020672, R01EY022238, R21EY019778, and RC1EY020442, Doris Duke Distinguished Clinical Scientist Award, Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, Dr. E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair, and Senior Scientist Investigator Award (Research to Prevent Blindness, RPB); J.Z.B. by NIH K08EY021521, International Retinal Research Foundation, and American Health Assistance Foundation; M. E. K. by NIH K08EY021757; B. J. F., S. B., and M. E. K. by NIH T32HL091812 and UL1RR033173; G.N. by NIH R01AI063331 and R01AR052756; Y.H. by Alcon Japan Research award; W. W. H. by NIH P30EY021721; B. K. A. by NIH R01EY017182 and R01EY017950, VA Merit Award, and Department of Defense; D. R. H. by NIH P30EY003040 and R01EY001545; J. F. K. and J. A. G. by NIH R01GM068414; J.W.Y. and D.-k.L. by Global Research Laboratory grant from MEST, Korea. Departmental unrestricted grants from RPB supported J. A. and W. W. H. University of Kentucky Physician Scientist Awards supported J.Z.B. and M. E. K. P. P. is a Senior Scholar from the Fonds de la Recherche en Sante du Quebec (FRSQ). Several authors are named as inventors on patent applications filed by their universities relating to described technologies. V. T., Y.H., B. D. G., S. D., Y.K., W. G. C., J.Z.B., H. K., N.K., B. J. F., S. B., and M. E. K. performed experiments. W. W. H., V. A. C, S. L. P., J. F. K., J. A. G., M. P. M., J.W.Y., D.-k.L, D. R. H., P. P., and G.N. provided reagents. J. A. conceived and directed the project and wrote the paper with assistance from B. K. A., B. J. F., and B. D. G. All authors had the opportunity to discuss the results and comment on the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allensworth JJ, 2011, J LEUKOCYTE BIOL, V90, P1159, DOI 10.1189/jlb.0511249; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaauwgeers HGT, 1999, AM J PATHOL, V155, P421, DOI 10.1016/S0002-9440(10)65138-3; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Feldmeyer L, 2007, CURR BIOL, V17, P1140, DOI 10.1016/j.cub.2007.05.074; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fink SL, 2008, P NATL ACAD SCI USA, V105, P4312, DOI 10.1073/pnas.0707370105; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Ghayur T, 1997, NATURE, V386, P619, DOI 10.1038/386619a0; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guarda G, 2009, NATURE, V460, P269, DOI 10.1038/nature08100; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kanakaraj P, 1999, J EXP MED, V189, P1129, DOI 10.1084/jem.189.7.1129; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Keller M, 2008, CELL, V132, P818, DOI 10.1016/j.cell.2007.12.040; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kleinman ME, 2012, MOL THER, V20, P101, DOI 10.1038/mt.2011.212; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Kumar MV, 2004, J NEUROIMMUNOL, V153, P7, DOI 10.1016/j.jneuroim.2004.04.018; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Latz E, 2010, BLOOD, V116, P1393, DOI 10.1182/blood-2010-06-287342; Li YB, 1998, BIOCHEM BIOPH RES CO, V253, P295, DOI 10.1006/bbrc.1998.9729; Lin HJ, 2011, INVEST OPHTH VIS SCI, V52, P3521, DOI 10.1167/iovs.10-6163; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Lopez PF, 1996, INVEST OPHTH VIS SCI, V37, P855; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Murphy MP, 2007, ANNU REV PHARMACOL, V47, P629, DOI 10.1146/annurev.pharmtox.47.120505.105110; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Ngo VN, 2011, NATURE, V470, P115, DOI 10.1038/nature09671; Nordgaard CL, 2008, INVEST OPHTH VIS SCI, V49, P2848, DOI 10.1167/iovs.07-1352; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; QURESHI N, 1991, INFECT IMMUN, V59, P441, DOI 10.1128/IAI.59.1.441-444.1991; Rey FE, 2001, CIRC RES, V89, P408, DOI 10.1161/hh1701.096037; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schroder K, 2010, SCIENCE, V327, P296, DOI 10.1126/science.1184003; SINNETT D, 1991, J BIOL CHEM, V266, P8675; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Suzuki N, 2003, J IMMUNOL, V170, P4031, DOI 10.4049/jimmunol.170.8.4031; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Tschopp J, 2003, NAT REV MOL CELL BIO, V4, P95, DOI 10.1038/nrm1019; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; van Bruggen R, 2010, BLOOD, V115, P5398, DOI 10.1182/blood-2009-10-250803; Vandenabeele Peter, 2006, Sci STKE, V2006, ppe44, DOI 10.1126/stke.3582006pe44; Verhoef PA, 2005, J IMMUNOL, V175, P7623, DOI 10.4049/jimmunol.175.11.7623; Vogt SD, 2011, EXP EYE RES, V93, P413, DOI 10.1016/j.exer.2011.06.002; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	82	423	455	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					847	859		10.1016/j.cell.2012.03.036	http://dx.doi.org/10.1016/j.cell.2012.03.036			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22541070	Green Accepted, Bronze			2022-12-24	WOS:000303934700017
J	Hattori, M; Gouaux, E				Hattori, Motoyuki; Gouaux, Eric			Molecular mechanism of ATP binding and ion channel activation in P2X receptors	NATURE			English	Article							PHARMACOLOGICAL CHARACTERIZATION; RECOMBINANT HUMAN; STRUCTURAL MOTIF; PORE; RESIDUES; IDENTIFICATION; SELECTIVITY; ACCESS; SITE; PERMEABILITY	P2X receptors are trimeric ATP-activated ion channels permeable to Na+, K+ and Ca2+. The seven P2X receptor subtypes are implicated in physiological processes that include modulation of synaptic transmission, contraction of smooth muscle, secretion of chemical transmitters and regulation of immune responses. Despite the importance of P2X receptors in cellular physiology, the three-dimensional composition of the ATP-binding site, the structural mechanism of ATP-dependent ion channel gating and the architecture of the open ion channel pore are unknown. Here we report the crystal structure of the zebrafish P2X(4) receptor in complex with ATP and a new structure of the apo receptor. The agonist-bound structure reveals a previously unseen ATP-binding motif and an open ion channel pore. ATP binding induces cleft closure of the nucleotide-binding pocket, flexing of the lower body beta-sheet and a radial expansion of the extracellular vestibule. The structural widening of the extracellular vestibule is directly coupled to the opening of the ion channel pore by way of an iris-like expansion of the transmembrane helices. The structural delineation of the ATP-binding site and the ion channel pore, together with the conformational changes associated with ion channel gating, will stimulate development of new pharmacological agents.	[Hattori, Motoyuki; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97239 USA; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97239 USA	Oregon Health & Science University; Howard Hughes Medical Institute; Oregon Health & Science University	Gouaux, E (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	gouauxe@ohsu.edu	Hattori, Motoyuki/B-6069-2014; Gouaux, Eric/Y-4370-2019	Gouaux, Eric/0000-0002-8549-2360; Hattori, Motoyuki/0000-0002-5327-5337	Japan Society for the Promotion of Science; American Asthma Foundation; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS061800] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Asthma Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Alexander and D. C. Dawson for providing Xenopus oocytes, K. L. Durr and T. Friedrich for providing the pCNA3.1x vector, L. Vaskalis for assistance with figure illustrations, K. J. Swartz and M. P. Kavanaugh for advice related to the oocyte experiments, and Gouaux laboratory members for discussions. We are also grateful to the staff at the Advanced Photon Source beamline 24-ID-C for help with X-ray data collection. This work was supported by a Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad (M. H.), by the American Asthma Foundation (E. G.) and the NIH (E. G.). E. G. is an investigator with the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bianchi BR, 1999, EUR J PHARMACOL, V376, P127, DOI 10.1016/S0014-2999(99)00350-7; Bodnar M, 2011, J BIOL CHEM, V286, P2739, DOI 10.1074/jbc.M110.167437; BRAKE AJ, 1994, NATURE, V371, P519, DOI 10.1038/371519a0; Browne LE, 2011, NAT NEUROSCI, V14, P17, DOI 10.1038/nn.2705; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; BURNSTOCK G, 1972, PHARMACOL REV, V24, P509; CAVARELLI J, 1994, EMBO J, V13, P327, DOI 10.1002/j.1460-2075.1994.tb06265.x; Coddou C, 2011, PHARMACOL REV, V63, P641, DOI 10.1124/pr.110.003129; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Egan TM, 1998, J NEUROSCI, V18, P2350; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; Evans RJ, 1996, J PHYSIOL-LONDON, V497, P413, DOI 10.1113/jphysiol.1996.sp021777; Fujiwara Y, 2009, J GEN PHYSIOL, V133, P93, DOI 10.1085/jgp.200810002; GarciaGuzman M, 1997, MOL PHARMACOL, V51, P109, DOI 10.1124/mol.51.1.109; Gever JR, 2006, PFLUG ARCH EUR J PHY, V452, P513, DOI 10.1007/s00424-006-0070-9; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Jarvis MF, 2009, NEUROPHARMACOLOGY, V56, P208, DOI 10.1016/j.neuropharm.2008.06.067; Jelinkova I, 2006, BIOCHEM BIOPH RES CO, V349, P619, DOI 10.1016/j.bbrc.2006.08.084; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang RT, 2011, P NATL ACAD SCI USA, V108, P9066, DOI 10.1073/pnas.1102170108; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 1999, J NEUROSCI, V19, P7289, DOI 10.1523/JNEUROSCI.19-17-07289.1999; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kracun S, 2010, J BIOL CHEM, V285, P10110, DOI 10.1074/jbc.M109.089185; Kucenas S, 2003, NEUROSCIENCE, V121, P935, DOI 10.1016/S0306-4522(03)00566-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li MF, 2008, NAT NEUROSCI, V11, P883, DOI 10.1038/nn.2151; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Liu DM, 2001, J PHYSIOL-LONDON, V534, P423, DOI 10.1111/j.1469-7793.2001.00423.x; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Migita K, 2001, J BIOL CHEM, V276, P30934, DOI 10.1074/jbc.M103366200; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Roberts JA, 2009, J NEUROCHEM, V109, P1042, DOI 10.1111/j.1471-4159.2009.06035.x; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Silberberg SD, 2007, NEURON, V54, P263, DOI 10.1016/j.neuron.2007.03.020; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Soto F, 1996, P NATL ACAD SCI USA, V93, P3684, DOI 10.1073/pnas.93.8.3684; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; VALERA S, 1994, NATURE, V371, P516, DOI 10.1038/371516a0; VILLARROEL A, 1995, BIOPHYS J, V68, P866, DOI 10.1016/S0006-3495(95)80263-8; Virginio C, 1998, MOL PHARMACOL, V53, P969; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; WEBB TE, 1993, FEBS LETT, V324, P219, DOI 10.1016/0014-5793(93)81397-I; Wildman SS, 1999, EUR J PHARMACOL, V367, P119, DOI 10.1016/S0014-2999(98)00976-5; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658	59	384	392	6	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					207	U91		10.1038/nature11010	http://dx.doi.org/10.1038/nature11010			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22535247	Green Accepted			2022-12-24	WOS:000303799800034
J	Sonkusare, SK; Bonev, AD; Ledoux, J; Liedtke, W; Kotlikoff, MI; Heppner, TJ; Hill-Eubanks, DC; Nelson, MT				Sonkusare, Swapnil K.; Bonev, Adrian D.; Ledoux, Jonathan; Liedtke, Wolfgang; Kotlikoff, Michael I.; Heppner, Thomas J.; Hill-Eubanks, David C.; Nelson, Mark T.			Elementary Ca2+ Signals Through Endothelial TRPV4 Channels Regulate Vascular Function	SCIENCE			English	Article							ACTIVATED POTASSIUM CHANNELS; SHEAR-STRESS; IN-VIVO; CELLS; MICE; RELAXATION; RECEPTORS; DILATION; TONE	Major features of the transcellular signaling mechanism responsible for endothelium-dependent regulation of vascular smooth muscle tone are unresolved. We identified local calcium (Ca2+) signals ("sparklets") in the vascular endothelium of resistance arteries that represent Ca2+ influx through single TRPV4 cation channels. Gating of individual TRPV4 channels within a four-channel cluster was cooperative, with activation of as few as three channels per cell causing maximal dilation through activation of endothelial cell intermediate (IK)- and small (SK)-conductance, Ca2+-sensitive potassium (K+) channels. Endothelial-dependent muscarinic receptor signaling also acted largely through TRPV4 sparklet-mediated stimulation of IK and SK channels to promote vasodilation. These results support the concept that Ca2+ influx through single TRPV4 channels is leveraged by the amplifier effect of cooperative channel gating and the high Ca2+ sensitivity of IK and SK channels to cause vasodilation.	[Sonkusare, Swapnil K.; Bonev, Adrian D.; Ledoux, Jonathan; Heppner, Thomas J.; Hill-Eubanks, David C.; Nelson, Mark T.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [Ledoux, Jonathan] Univ Montreal, Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Ledoux, Jonathan] Univ Montreal, Dept Med, Montreal, PQ H1T 1C8, Canada; [Liedtke, Wolfgang] Duke Univ, Med Ctr, Dept Med & Neurobiol, Durham, NC 27710 USA; [Liedtke, Wolfgang] Duke Univ, Med Ctr, Ctr Translat Neurosci, Durham, NC 27710 USA; [Kotlikoff, Michael I.] Cornell Univ, Dept Biomed Sci, Coll Vet Med, Ithaca, NY 14853 USA; [Nelson, Mark T.] Univ Manchester, Inst Cardiovasc Sci, Manchester M13 9NT, Lancs, England	University of Vermont; Universite de Montreal; Universite de Montreal; Duke University; Duke University; Cornell University; University of Manchester	Nelson, MT (corresponding author), Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA.	mark.nelson@uvm.edu	Ledoux, Jonathan/D-2945-2012; Liedtke, Wolfgang/GNH-1878-2022	Ledoux, Jonathan/0000-0001-8540-7763; Nelson, Mark/0000-0002-6608-8784	COBRE of the National Center for Research Resources; NIH [2-P20-RR-016435-06, HL044455, 1P01HL095488, R37DK053832, R01HL098243]; American Heart Association Founders Affiliate; Pulmonary Hypertension Association [10POST3690006]; FRSQ (Junior 1)/NIA (HSFC); Totman Medical Research Trust;  [NIH GM086736]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016435] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL095488, R01HL044455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK053832] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086736] Funding Source: NIH RePORTER	COBRE of the National Center for Research Resources; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Founders Affiliate(American Heart Association); Pulmonary Hypertension Association; FRSQ (Junior 1)/NIA (HSFC); Totman Medical Research Trust; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank HydraBiosciences for HC-067047, Neurosearch A/S for NS309, and J. E. Brayden, K. Freeman, M. Koide, L. W. Nausch, and G. C. Wellman for comments on the manuscript. This work was supported by a grant from the COBRE Program of the National Center for Research Resources funded by the NIH (2-P20-RR-016435-06), an award from the American Heart Association Founders Affiliate and the Pulmonary Hypertension Association (10POST3690006) to S.K.S, and by grants NIH GM086736 to M.I.K.; FRSQ (Junior 1)/NIA (HSFC) to J.L.; and NIH HL044455, 1P01HL095488, R37DK053832, R01HL098243, and the Totman Medical Research Trust to M.T.N. The authors have no conflicts of interest.	Bogatcheva NV, 2005, MICROVASC RES, V69, P107, DOI 10.1016/j.mvr.2005.01.007; Coleman HA, 2004, CLIN EXP PHARMACOL P, V31, P641, DOI 10.1111/j.1440-1681.2004.04053.x; Dora KA, 2003, J VASC RES, V40, P480, DOI 10.1159/000074549; Earley S, 2009, AM J PHYSIOL-HEART C, V297, pH1096, DOI 10.1152/ajpheart.00241.2009; Edwards G, 2010, PFLUG ARCH EUR J PHY, V459, P863, DOI 10.1007/s00424-010-0817-1; Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Fleming I, 1999, J MOL CELL CARDIOL, V31, P5, DOI 10.1006/jmcc.1998.0839; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Ledoux J, 2008, P NATL ACAD SCI USA, V105, P9627, DOI 10.1073/pnas.0801963105; Mendoza SA, 2010, AM J PHYSIOL-HEART C, V298, pH466, DOI 10.1152/ajpheart.00854.2009; Parker I, 2010, J GEN PHYSIOL, V136, P119, DOI 10.1085/jgp.200910390; Saliez J, 2008, CIRCULATION, V117, P1065, DOI 10.1161/CIRCULATIONAHA.107.731679; Sandow SL, 2006, J ANAT, V209, P689, DOI 10.1111/j.1469-7580.2006.00647.x; Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580; Tallini YN, 2007, CIRC RES, V101, P1300, DOI 10.1161/CIRCRESAHA.107.149484; Wang SQ, 2001, NATURE, V410, P592, DOI 10.1038/35069083; Willette RN, 2008, J PHARMACOL EXP THER, V326, P443, DOI 10.1124/jpet.107.134551; Zhang DX, 2009, HYPERTENSION, V53, P532, DOI 10.1161/HYPERTENSIONAHA.108.127100	20	367	371	5	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 4	2012	336	6081					597	601		10.1126/science.1216283	http://dx.doi.org/10.1126/science.1216283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556255	Green Accepted, Green Published			2022-12-24	WOS:000303498800048
J	Gassmann, R; Rechtsteiner, A; Yuen, KW; Muroyama, A; Egelhofer, T; Gaydos, L; Barron, F; Maddox, P; Essex, A; Monen, J; Ercan, S; Lieb, JD; Oegema, K; Strome, S; Desai, A				Gassmann, Reto; Rechtsteiner, Andreas; Yuen, Karen W.; Muroyama, Andrew; Egelhofer, Thea; Gaydos, Laura; Barron, Francie; Maddox, Paul; Essex, Anthony; Monen, Joost; Ercan, Sevinc; Lieb, Jason D.; Oegema, Karen; Strome, Susan; Desai, Arshad			An inverse relationship to germline transcription defines centromeric chromatin in C. elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; CHROMOSOME SEGREGATION; CENP-A; KINETOCHORE; DYNAMICS; REQUIRES; EMBRYOS; MITOSIS	Centromeres are chromosomal loci that direct segregation of the genome during cell division. The histone H3 variant CENP-A (also known as CenH3) defines centromeres in monocentric organisms, which confine centromere activity to a discrete chromosomal region, and holocentric organisms, which distribute centromere activity along the chromosome length(1-3). Because the highly repetitive DNA found at most centromeres is neither necessary nor sufficient for centromere function, stable inheritance of CENP-A nucleosomal chromatin is postulated to propagate centromere identity epigenetically(4). Here, we show that in the holocentric nematode Caenorhabditis elegans pre-existing CENP-A nucleosomes are not necessary to guide recruitment of new CENP-A nucleosomes. This is indicated by lack of CENP-A transmission by sperm during fertilization and by removal and subsequent reloading of CENP-A during oogenic meiotic prophase. Genome-wide mapping of CENP-A location in embryos and quantification of CENP-A molecules in nuclei revealed that CENP-A is incorporated at low density in domains that cumulatively encompass half the genome. Embryonic CENP-A domains are established in a pattern inverse to regions that are transcribed in the germline and early embryo, and ectopic transcription of genes in a mutant germline altered the pattern of CENP-A incorporation in embryos. Furthermore, regions transcribed in the germline but not embryos fail to incorporate CENP-A throughout embryogenesis. We propose that germline transcription defines genomic regions that exclude CENP-A incorporation in progeny, and that zygotic transcription during early embryogenesis remodels and reinforces this basal pattern. These findings link centromere identity to transcription and shed light on the evolutionary plasticity of centromeres.	[Gassmann, Reto; Yuen, Karen W.; Muroyama, Andrew; Barron, Francie; Maddox, Paul; Essex, Anthony; Monen, Joost; Oegema, Karen; Desai, Arshad] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92037 USA; [Gassmann, Reto; Yuen, Karen W.; Muroyama, Andrew; Barron, Francie; Maddox, Paul; Essex, Anthony; Monen, Joost; Oegema, Karen; Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92037 USA; [Rechtsteiner, Andreas; Egelhofer, Thea; Gaydos, Laura; Strome, Susan] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA; [Ercan, Sevinc; Lieb, Jason D.] Univ N Carolina, Dept Biol, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Ercan, Sevinc; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Santa Cruz; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Desai, A (corresponding author), Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92037 USA.	sstrome@ucsc.edu; abdesai@ucsd.edu	Gassmann, Reto/M-6488-2013	Gassmann, Reto/0000-0002-0360-2977; Muroyama, Andrew/0000-0003-0701-212X; Rechtsteiner, Andreas/0000-0001-6031-1087; Barron, Francie/0000-0001-6568-7358; Lieb, Jason/0000-0001-7601-8061	modENCODE [U01 HG004270]; NIH [GM074215, GM34059, T32 GM008646]; National Science Foundation of Switzerland; Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034059, T32GM008646, R01GM074215] Funding Source: NIH RePORTER	modENCODE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation of Switzerland(Swiss National Science Foundation (SNSF)); Ludwig Institute for Cancer Research; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Ward for the purified sperm sample, M. Gupta for help with analysis, J. Ahringer for advice on fixation and ChIP procedures, and A. Dernburg and other members of the Lieb modENCODE group for helpful discussions. This work was supported by a modENCODE grant (U01 HG004270), and by grants from NIH to A. D. (GM074215 and ARRA supplement) and S. S. (GM34059). R. G. was supported by a fellowship from the National Science Foundation of Switzerland. L. G. was supported by NIH T32 GM008646. A. D. and K.O. receive salary and other support from the Ludwig Institute for Cancer Research.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Andersen EC, 2007, DEVELOPMENT, V134, P2991, DOI 10.1242/dev.009373; Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104; Choo KHA., 1997, CENTROMERE; Claycomb JM, 2009, CELL, V139, P123, DOI 10.1016/j.cell.2009.09.014; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; EDGAR LG, 1994, DEVELOPMENT, V120, P443; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Lomiento M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r173; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Malik HS, 2009, CELL, V138, P1067, DOI 10.1016/j.cell.2009.08.036; Meissner B, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000537; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Oegema K, 2001, J CELL BIOL, V153, P1209, DOI 10.1083/jcb.153.6.1209; Piras FM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000845; Ravi M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002121; Rechtsteiner A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001091; Reinke V, 2004, DEVELOPMENT, V131, P311, DOI 10.1242/dev.00914; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Seydoux G, 1997, DEVELOPMENT, V124, P2191; Shelby RD, 2000, J CELL BIOL, V151, P1113, DOI 10.1083/jcb.151.5.1113; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sullivan KF, 2001, CURR OPIN GENET DEV, V11, P182, DOI 10.1016/S0959-437X(00)00177-5; van Wolfswinkel JC, 2009, CELL, V139, P135, DOI 10.1016/j.cell.2009.09.012; Wang X, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-213; Warburton PE, 2004, CHROMOSOME RES, V12, P617, DOI 10.1023/B:CHRO.0000036585.44138.4b	34	116	117	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					534	U166		10.1038/nature10973	http://dx.doi.org/10.1038/nature10973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22495302	Green Submitted, Green Accepted			2022-12-24	WOS:000303200400055
J	Gupta, V; Poss, KD				Gupta, Vikas; Poss, Kenneth D.			Clonally dominant cardiomyocytes direct heart morphogenesis	NATURE			English	Article							ZEBRAFISH HEART; MOUSE HEART; STEM-CELLS; REGENERATION; PROGENITORS; FIELD; DIFFERENTIATION; POPULATION; MYOCARDIUM; PHASES	As vertebrate embryos develop to adulthood, their organs undergo marked changes in size and tissue architecture. The heart acquires muscle mass and matures structurally to fulfil increasing circulatory needs, a process that is incompletely understood. Here we used multicolour clonal analysis to define the contributions of individual cardiomyocytes as the zebrafish heart undergoes morphogenesis from a primitive embryonic structure into its complex adult form. We find that the single-cardiomyocyte-thick wall of the juvenile ventricle forms by lateral expansion of several dozen cardiomyocytes into muscle patches of variable sizes and shapes. As juvenile zebrafish mature into adults, this structure becomes fully enveloped by a new lineage of cortical muscle. Adult cortical muscle originates from a small number of cardiomyocytes-an average of approximately eight per animal-that display clonal dominance reminiscent of stem cell populations. Cortical cardiomyocytes initially emerge from internal myofibres that in rare events breach the juvenile ventricular wall, and then expand over the surface. Our results illuminate the dynamic proliferative behaviours that generate adult cardiac structure, revealing clonal dominance as a key mechanism that shapes a vertebrate organ.	[Gupta, Vikas; Poss, Kenneth D.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Gupta, Vikas; Poss, Kenneth D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA	Duke University; Duke University; Howard Hughes Medical Institute	Poss, KD (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	kenneth.poss@duke.edu		Gupta, Vikas/0000-0002-3383-9828; Poss, Kenneth/0000-0002-6743-5709	National Heart, Lung, and Blood Institute (NHLBI) [HL081674]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081674] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank K. Kikuchi for generating cmlc2:CreER animals and for advice; J. Burris, A. Eastes, P. Williams and N. Blake for zebrafish care; A. Dickson for artwork; B. Hogan and Poss laboratory members for comments on the manuscript; and S. Johnson and Y. Gao for imaging advice. V. G. was supported by a National Heart, Lung, and Blood Institute (NHLBI) Medical Scientist Training Program supplement. K. D. P. is an Early Career Scientist of the Howard Hughes Medical Institute. This work was supported by grants from NHLBI (HL081674) and American Heart Association to K.D.P.	Auman HJ, 2007, PLOS BIOL, V5, P604, DOI 10.1371/journal.pbio.0050053; Burns CG, 2005, NAT CHEM BIOL, V1, P263, DOI 10.1038/nchembio732; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; de Pater E, 2009, DEVELOPMENT, V136, P1633, DOI 10.1242/dev.030924; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Hami D, 2011, DEVELOPMENT, V138, P2389, DOI 10.1242/dev.061473; Hu N, 2001, ANAT REC, V264, P1, DOI 10.1002/ar.1111; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Keegan BR, 2004, DEVELOPMENT, V131, P3081, DOI 10.1242/dev.01185; Kikuchi K, 2011, DEVELOPMENT, V138, P2895, DOI 10.1242/dev.067041; Kikuchi K, 2011, DEV CELL, V20, P397, DOI 10.1016/j.devcel.2011.01.010; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Lazic S, 2011, DEV BIOL, V354, P123, DOI 10.1016/j.ydbio.2011.03.028; Liu JD, 2010, DEVELOPMENT, V137, P3867, DOI 10.1242/dev.053736; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lopez-Garcia C, 2010, SCIENCE, V330, P822, DOI 10.1126/science.1196236; Meilhac SM, 2004, DEV CELL, V6, P685, DOI 10.1016/S1534-5807(04)00133-9; Meilhac SM, 2003, DEVELOPMENT, V130, P3877, DOI 10.1242/dev.00580; MIKAWA T, 1992, DEV DYNAM, V193, P11, DOI 10.1002/aja.1001930104; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; STAINIER DYR, 1993, DEVELOPMENT, V119, P31; Wang JH, 2011, DEVELOPMENT, V138, P3421, DOI 10.1242/dev.068601; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou Y, 2011, NATURE, V474, P645, DOI 10.1038/nature10094	27	177	179	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 26	2012	484	7395					479	U102		10.1038/nature11045	http://dx.doi.org/10.1038/nature11045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538609	Green Accepted			2022-12-24	WOS:000303200400043
J	Davies, BW; Bogard, RW; Young, TS; Mekalanos, JJ				Davies, Bryan W.; Bogard, Ryan W.; Young, Travis S.; Mekalanos, John J.			Coordinated Regulation of Accessory Genetic Elements Produces Cyclic Di-Nucleotides for V. cholerae Virulence	CELL			English	Article							COMPARATIVE GENOMIC ANALYSIS; VIBRIO-CHOLERAE; DNA-SEQUENCE; PROTEIN; GMP; BACTERIA; TOXT; AMP; ACTIVATION; EVOLUTION	The function of the Vibrio 7th pandemic island-1 (VSP-1) in cholera pathogenesis has remained obscure. Utilizing chromatin immunoprecipitation sequencing and RNA sequencing to map the regulon of the master virulence regulator ToxT, we identify a TCP island-encoded small RNA that reduces the expression of a previously unrecognized VSP-1-encoded transcription factor termed VspR. VspR modulates the expression of several VSP-1 genes including one that encodes a novel class of dinucleotide cyclase (DncV), which preferentially synthesizes a previously undescribed hybrid cyclic AMP-GMP molecule. We show that DncV is required for efficient intestinal colonization and downregulates V. cholerae chemotaxis, a phenotype previously associated with hyperinfectivity. This pathway couples the actions of previously disparate genomic islands, defines VSP-1 as a pathogenicity island in V. cholerae, and implicates its occurrence in 7th pandemic strains as a benefit for host adaptation through the production of a regulatory cyclic di-nucleotide.	[Davies, Bryan W.; Bogard, Ryan W.; Mekalanos, John J.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA; [Young, Travis S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Mekalanos, JJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	jmekalanos@hms.harvard.edu		Davies, Bryan/0000-0002-2046-0341	Jane Coffin Childs Memorial Fund for Medical Research; National Research Council of Canada; National Institutes of Health [AI-018045]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI026289, R01AI018045, R22AI018045, R37AI018045] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund for Medical Research; National Research Council of Canada; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. D. Ewen Cameron for support in use of the V. cholerae transposon library. B. W. D. was supported by the Jane Coffin Childs Memorial Fund for Medical Research and by the National Research Council of Canada H. L. Holmes Award. This work was supported by the National Institutes of Health Grant AI-018045 to J.J.M.	Beyhan S, 2006, J BACTERIOL, V188, P3600, DOI 10.1128/JB.188.10.3600-3613.2006; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bradley ES, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002126; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Butler SM, 2006, MOL MICROBIOL, V60, P417, DOI 10.1111/j.1365-2958.2006.05096.x; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Davies BW, 2011, P NATL ACAD SCI USA, V108, P12467, DOI 10.1073/pnas.1107894108; DHO S, 1992, AM J PHYSIOL, V262, pC67, DOI 10.1152/ajpcell.1992.262.1.C67; DIRITA VJ, 1991, P NATL ACAD SCI USA, V88, P5403, DOI 10.1073/pnas.88.12.5403; Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999; Faruque SM, 2003, TRENDS MICROBIOL, V11, P505, DOI 10.1016/j.tim.2003.09.003; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; Grim CJ, 2010, OMICS, V14, P1, DOI 10.1089/omi.2009.0087; Handstad T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018430; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; Hassan F, 2010, NATURE, V467, P982, DOI 10.1038/nature09469; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kaunitz JD, 2011, ACTA PHYSIOL, V201, P109, DOI 10.1111/j.1748-1716.2010.02156.x; Krasteva PV, 2010, SCIENCE, V327, P866, DOI 10.1126/science.1181185; Lim B, 2007, J BACTERIOL, V189, P717, DOI 10.1128/JB.00834-06; Lowden MJ, 2010, P NATL ACAD SCI USA, V107, P2860, DOI 10.1073/pnas.0915021107; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Merrell DS, 2002, NATURE, V417, P642, DOI 10.1038/nature00778; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Paauw A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008662; POLLITZER R, 1959, CHOLERA; Rahman MH, 2008, DNA CELL BIOL, V27, P347, DOI 10.1089/dna.2008.0737; Richard AL, 2010, MOL MICROBIOL, V78, P1171, DOI 10.1111/j.1365-2958.2010.07397.x; Ritchie JM, 2009, CURR TOP MICROBIOL, V337, P37, DOI 10.1007/978-3-642-01846-6_2; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Srivastava D, 2011, J BACTERIOL, V193, P6331, DOI 10.1128/JB.05167-11; STOCK A, 1987, J BIOL CHEM, V262, P535; Taviani E, 2010, FEMS MICROBIOL LETT, V308, P130, DOI 10.1111/j.1574-6968.2010.02008.x; Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x; Weber GG, 2011, INDIAN J MED RES, V133, P201; Withey JH, 2006, MOL MICROBIOL, V59, P1779, DOI 10.1111/j.1365-2958.2006.05053.x; Withey JH, 2005, J BACTERIOL, V187, P7890, DOI 10.1128/JB.187.23.7890-7900.2005; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Xu Q, 2003, P NATL ACAD SCI USA, V100, P1286, DOI 10.1073/pnas.0337479100	45	273	302	2	50	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					358	370		10.1016/j.cell.2012.01.053	http://dx.doi.org/10.1016/j.cell.2012.01.053			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500802	Bronze, Green Accepted			2022-12-24	WOS:000302805600015
J	Jones, FC; Grabherr, MG; Chan, YF; Russell, P; Mauceli, E; Johnson, J; Swofford, R; Pirun, M; Zody, MC; White, S; Birney, E; Searle, S; Schmutz, J; Grimwood, J; Dickson, MC; Myers, RM; Miller, CT; Summers, BR; Knecht, AK; Brady, SD; Zhang, HL; Pollen, AA; Howes, T; Amemiya, C; Lander, ES; Di Palma, F; Lindblad-Toh, K; Kingsley, DM				Jones, Felicity C.; Grabherr, Manfred G.; Chan, Yingguang Frank; Russell, Pamela; Mauceli, Evan; Johnson, Jeremy; Swofford, Ross; Pirun, Mono; Zody, Michael C.; White, Simon; Birney, Ewan; Searle, Stephen; Schmutz, Jeremy; Grimwood, Jane; Dickson, Mark C.; Myers, Richard M.; Miller, Craig T.; Summers, Brian R.; Knecht, Anne K.; Brady, Shannon D.; Zhang, Haili; Pollen, Alex A.; Howes, Timothy; Amemiya, Chris; Lander, Eric S.; Di Palma, Federica; Lindblad-Toh, Kerstin; Kingsley, David M.		Broad Inst Genome Sequencing Platf; Whole Genome Assembly Team	The genomic basis of adaptive evolution in threespine sticklebacks	NATURE			English	Article							GENETIC ARCHITECTURE; PARALLEL EVOLUTION; REGULATORY CHANGES; SIGNALING PATHWAY; PELVIC REDUCTION; EVO-DEVO; VERTEBRATE; DUPLICATION; ADAPTATION; INVERSIONS	Marine stickleback fish have colonized and adapted to thousands of streams and lakes formed since the last ice age, providing an exceptional opportunity to characterize genomic mechanisms underlying repeated ecological adaptation in nature. Here we develop a high-quality reference genome assembly for threespine sticklebacks. By sequencing the genomes of twenty additional individuals from a global set of marine and freshwater populations, we identify a genome-wide set of loci that are consistently associated with marine-freshwater divergence. Our results indicate that reuse of globally shared standing genetic variation, including chromosomal inversions, has an important role in repeated evolution of distinct marine and freshwater sticklebacks, and in the maintenance of divergent ecotypes during early stages of reproductive isolation. Both coding and regulatory changes occur in the set of loci underlying marine-freshwater evolution, but regulatory changes appear to predominate in this well known example of repeated adaptive evolution in nature.	[Grabherr, Manfred G.; Russell, Pamela; Mauceli, Evan; Johnson, Jeremy; Swofford, Ross; Pirun, Mono; Zody, Michael C.; Lander, Eric S.; Di Palma, Federica; Lindblad-Toh, Kerstin] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Jones, Felicity C.; Chan, Yingguang Frank; Miller, Craig T.; Summers, Brian R.; Knecht, Anne K.; Brady, Shannon D.; Zhang, Haili; Pollen, Alex A.; Howes, Timothy; Kingsley, David M.] Stanford Univ, Sch Med, Dept Dev Biol, Beckman Ctr B300, Stanford, CA 94305 USA; [Grabherr, Manfred G.; Lindblad-Toh, Kerstin] Uppsala Univ, Dept Med Biochem & Microbiol, Sci Life Lab Uppsala, S-75123 Uppsala, Sweden; [White, Simon; Searle, Stephen] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Birney, Ewan] European Bioinformat Inst, Cambridge CB10 1SA, England; [Schmutz, Jeremy; Grimwood, Jane; Dickson, Mark C.; Myers, Richard M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Amemiya, Chris] Benaroya Res Inst Virginia Mason, Dept Mol Genet, Seattle, WA 98101 USA; [Kingsley, David M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Stanford University; Uppsala University; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); HudsonAlpha Institute for Biotechnology; Benaroya Research Institute; Virginia Mason Medical Center; Howard Hughes Medical Institute; Stanford University	Lindblad-Toh, K (corresponding author), Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA.	kersli@broad.mit.edu; kingsley@stanford.edu	Chan, Yingguang Frank/ABG-9852-2020; Grimwood, Jane/ABD-5737-2021; Jones, Felicity C/AAY-3523-2021; Miller, Craig/GWQ-5012-2022; Schmutz, Jeremy/N-3173-2013	Chan, Yingguang Frank/0000-0001-6292-9681; Jones, Felicity C/0000-0002-5027-1031; Schmutz, Jeremy/0000-0001-8062-9172; Birney, Ewan/0000-0001-8314-8497; Russell, Pamela/0000-0003-2997-6392; Grabherr, Manfred/0000-0001-8792-6508; White, Simon/0000-0001-6375-2363; Nicol, Robert/0000-0003-1932-1392; Swofford, Ross/0000-0003-3676-8479; Di-Palma, Federica/0000-0002-4394-0102; Howes, Timothy/0000-0002-0370-0200	National Human Genome Research Institute (NHGRI); NHGRI CEGS [P50-HG002568]; Stanford Affymetrix Bio-X; Jane Coffins Childs Fund; NSF; NDSEG; ESF; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568, R01HG003474, U54HG003067] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI CEGS; Stanford Affymetrix Bio-X; Jane Coffins Childs Fund; NSF(National Science Foundation (NSF)); NDSEG; ESF(European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Stickleback sequencing at Broad Institute was supported by grants from the National Human Genome Research Institute (NHGRI). R.M.M., J.S., J.G. and D.M.K. were supported by NHGRI CEGS Grant P50-HG002568; Y.F.C. by a Stanford Affymetrix Bio-X Graduate Fellowship; C.T.M. by the Jane Coffins Childs Fund; and B.R.S., T.R.H. and A.A.P. by graduate fellowships from NSF and NDSEG. D.M.K. is an investigator of the Howard Hughes Medical Institute. K.L.-T. is a EURYI award recipient funded by ESF. We thank W. Cresko for the BEPA individual used for reference genome sequencing; M. Bell, J. McKinnon, B. Jonsson, S. Mori, C. Peichel, D. Schluter, M. Kalbe, T. Reimchen, D.-P. Hojgaard, M. McLaughlin, B. Geyti and B. Blackman for discussions and assistance with specimens used in population surveys; and G. Bejerano for useful discussions and assistance with computational analysis.	Albert AYK, 2008, EVOLUTION, V62, P76, DOI 10.1111/j.1558-5646.2007.00259.x; Allali-Hassani A, 2007, PLOS BIOL, V5, P1063, DOI 10.1371/journal.pbio.0050097; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Barton NH, 1993, HYBRID ZONES EVOLUTI, P13, DOI DOI 10.1111/J.1558-5646.2009.00849.X; Bell M.A., 1994, EVOLUTIONARY BIOL TH; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Deagle BE, 2011, P R SOC B, V279, P1277, DOI DOI 10.1098/RSPB.2011.1552); Endler J.A., 1986, Monographs in Population Biology, pviii; Feder JL, 2003, GENETICS, V163, P939; Gutman GA, 2005, PHARMACOL REV, V57, P473, DOI 10.1124/pr.57.4.10; HAGEN DW, 1967, J FISH RES BOARD CAN, V24, P1637, DOI 10.1139/f67-138; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Hohenlohe PA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000862; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jones FC, 2006, J EVOLUTION BIOL, V19, P1531, DOI 10.1111/j.1420-9101.2006.01122.x; Joron M, 2011, NATURE, V477, P203, DOI 10.1038/nature10341; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kawahara R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-209; Kimmel CB, 2005, P NATL ACAD SCI USA, V102, P5791, DOI 10.1073/pnas.0408533102; Kingsley David M., 2007, P41; Kingsley DM, 2004, BEHAVIOUR, V141, P1331, DOI 10.1163/1568539042948150; Kirkpatrick M, 2006, GENETICS, V173, P419, DOI 10.1534/genetics.105.047985; Kitano J, 2010, CURR BIOL, V20, P2124, DOI 10.1016/j.cub.2010.10.050; Knecht AK, 2007, EVOL DEV, V9, P141, DOI 10.1111/j.1525-142X.2007.00145.x; Kvitek DJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002056; Lowry DB, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000500; Marshall William S., 2006, P177; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; McPhail J.D., 1994, P399; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Miyake A, 1999, J BIOL CHEM, V274, P25018, DOI 10.1074/jbc.274.35.25018; Miyake A, 2009, J NEUROSCI, V29, P14637, DOI 10.1523/JNEUROSCI.0901-09.2009; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; REIMCHEN TE, 1985, CAN J ZOOL, V63, P2944, DOI 10.1139/z85-441; Shapiro MD, 2004, NATURE, V428, P717, DOI 10.1038/nature02415; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Star B, 2011, NATURE, V477, P207, DOI 10.1038/nature10342; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Vinogradov AE, 1998, CYTOMETRY, V31, P100, DOI 10.1002/(SICI)1097-0320(19980201)31:2<100::AID-CYTO5>3.0.CO;2-Q; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087	50	1161	1181	18	612	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 5	2012	484	7392					55	61		10.1038/nature10944	http://dx.doi.org/10.1038/nature10944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	919QN	22481358	Green Submitted, hybrid, Green Accepted			2022-12-24	WOS:000302343400033
J	Jadhav, SP; Kemere, C; German, PW; Frank, LM				Jadhav, Shantanu P.; Kemere, Caleb; German, P. Walter; Frank, Loren M.			Awake Hippocampal Sharp-Wave Ripples Support Spatial Memory	SCIENCE			English	Article							REACTIVATION; EXPERIENCE; REPLAY; DYNAMICS; PATTERNS; SPACE	The hippocampus is critical for spatial learning and memory. Hippocampal neurons in awake animals exhibit place field activity that encodes current location, as well as sharp-wave ripple (SWR) activity during which representations based on past experiences are often replayed. The relationship between these patterns of activity and the memory functions of the hippocampus is poorly understood. We interrupted awake SWRs in animals learning a spatial alternation task. We observed a specific learning and performance deficit that persisted throughout training. This deficit was associated with awake SWR activity, as SWR interruption left place field activity and post-experience SWR reactivation intact. These results provide a link between awake SWRs and hippocampal memory processes, which suggests that awake replay of memory-related information during SWRs supports learning and memory-guided decision-making.	[Frank, Loren M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Frank, LM (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA.	loren@phy.ucsf.edu	Jadhav, Shantanu/H-6654-2013	Jadhav, Shantanu/0000-0001-5821-0551; Kemere, Caleb/0000-0003-2054-0234; Frank, Loren/0000-0002-1752-5677	Wheeler Center; Helen Hay Whitney Foundation; NIH [RO1 MH080283]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080283] Funding Source: NIH RePORTER	Wheeler Center; Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Supported by a Wheeler Center Fellowship (S.P.J.), a Helen Hay Whitney Foundation grant (C.K.), and NIH grant RO1 MH080283. The authors declare no competing financial interests.	BUZSAKI G, 1986, BRAIN RES, V398, P242, DOI 10.1016/0006-8993(86)91483-6; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Cheng S, 2008, NEURON, V57, P303, DOI 10.1016/j.neuron.2007.11.035; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Diba K, 2007, NAT NEUROSCI, V10, P1241, DOI 10.1038/nn1961; Dragoi G, 2003, NEURON, V39, P843, DOI 10.1016/S0896-6273(03)00465-3; Dupret D, 2010, NAT NEUROSCI, V13, P995, DOI 10.1038/nn.2599; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Eichenbaum HE, 2001, CONDITIONING CONSCIO; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Gupta AS, 2010, NEURON, V65, P695, DOI 10.1016/j.neuron.2010.01.034; Karlsson MP, 2009, NAT NEUROSCI, V12, P913, DOI 10.1038/nn.2344; Kim SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005494; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Neill J, 2006, NEURON, V49, P143, DOI 10.1016/j.neuron.2005.10.037; O'Neill J, 2008, NAT NEUROSCI, V11, P209, DOI 10.1038/nn2037; O'Neill J, 2010, TRENDS NEUROSCI, V33, P220, DOI 10.1016/j.tins.2010.01.006; OLTON DS, 1979, BEHAV BRAIN SCI, V2, P313, DOI 10.1017/S0140525X00062713; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Singer AC, 2009, NEURON, V64, P910, DOI 10.1016/j.neuron.2009.11.016; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	29	477	482	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 15	2012	336	6087					1454	1458		10.1126/science.1217230	http://dx.doi.org/10.1126/science.1217230			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	958BT	22555434	Bronze, Green Accepted			2022-12-24	WOS:000305211700050
J	Jain, M; Nilsson, R; Sharma, S; Madhusudhan, N; Kitami, T; Souza, AL; Kafri, R; Kirschner, MW; Clish, CB; Mootha, VK				Jain, Mohit; Nilsson, Roland; Sharma, Sonia; Madhusudhan, Nikhil; Kitami, Toshimori; Souza, Amanda L.; Kafri, Ran; Kirschner, Marc W.; Clish, Clary B.; Mootha, Vamsi K.			Metabolite Profiling Identifies a Key Role for Glycine in Rapid Cancer Cell Proliferation	SCIENCE			English	Article							SERINE HYDROXYMETHYLTRANSFERASE; EXPRESSION SIGNATURE; DEPENDENCE; PATHWAY; SCREEN	Metabolic reprogramming has been proposed to be a hallmark of cancer, yet a systematic characterization of the metabolic pathways active in transformed cells is currently lacking. Using mass spectrometry, we measured the consumption and release ( CORE) profiles of 219 metabolites from media across the NCI-60 cancer cell lines, and integrated these data with a preexisting atlas of gene expression. This analysis identified glycine consumption and expression of the mitochondrial glycine biosynthetic pathway as strongly correlated with rates of proliferation across cancer cells. Antagonizing glycine uptake and its mitochondrial biosynthesis preferentially impaired rapidly proliferating cells. Moreover, higher expression of this pathway was associated with greater mortality in breast cancer patients. Increased reliance on glycine may represent a metabolic vulnerability for selectively targeting rapid cancer cell proliferation.	[Jain, Mohit; Nilsson, Roland; Madhusudhan, Nikhil; Kitami, Toshimori; Souza, Amanda L.; Clish, Clary B.; Mootha, Vamsi K.] Broad Inst, Cambridge, MA 02142 USA; [Jain, Mohit; Nilsson, Roland; Madhusudhan, Nikhil; Kitami, Toshimori; Kafri, Ran; Kirschner, Marc W.; Mootha, Vamsi K.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Jain, Mohit; Nilsson, Roland; Madhusudhan, Nikhil; Kitami, Toshimori; Mootha, Vamsi K.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Jain, Mohit; Nilsson, Roland; Madhusudhan, Nikhil; Kitami, Toshimori; Mootha, Vamsi K.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Jain, Mohit] Brigham & Womens Hosp, Dept Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Nilsson, Roland] Karolinska Inst, Dept Med, Unit Computat Med, S-17176 Stockholm, Sweden; [Sharma, Sonia] La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Karolinska Institutet; La Jolla Institute for Immunology	Mootha, VK (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	vamsi@hms.harvard.edu	Nilsson, Roland/AAJ-3519-2021; Clish, Clary/AAB-7124-2019; Clish, Clary B/ABB-9374-2021; Kitami, Toshimori/N-7460-2019	Clish, Clary B/0000-0001-8259-9245; Kitami, Toshimori/0000-0001-8418-5230; Nilsson, Roland/0000-0002-6020-7498	NIH [K08HL107451, R01DK081457]; Knut & Alice Wallenberg Foundation; Stockholm County (SLL) [01626-2009]; Leukemia & Lymphoma Society; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL107451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026875] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Knut & Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Stockholm County (SLL); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. R. Golub, O. Shaham, S. B. Vafai, and L. Strittmatter for scientific discussions and feedback; X. Cao for assistance with glucose and lactate measurements; the Broad Institute RNAi Platform for shRNA reagents; D. Gomez-Cabrero for assistance with multidimensional scaling; A. Ploner and P. Dickman for assistance with survival analysis; W. C. Kopp, S. L. Holbeck, K. Gill, and P. Sellers of the Developmental Therapeutics Program, National Cancer Institute, for reagents and assistance with cell culture; and T. Hasaka of the Broad Institute for assistance with imaging studies. Supported by NIH grant K08HL107451 (M.J.), a postdoctoral scholarship from the Knut & Alice Wallenberg Foundation and Stockholm County (SLL) grant 01626-2009 (R.N.), a Special Fellow award from the Leukemia & Lymphoma Society (S. S.), and NIH grant R01DK081457 and a gift from the Nestle Research Center (V. K. M.). The full metabolite CORE profiling data set is available in the supplementary materials as well as through the NCI Molecular Targets data repository (http://dtp.nci.nih.gov/mtargets/download.html). M.J. and R.N. conceived and performed all experiments, collected and analyzed experimental data, and prepared the manuscript. S. S. assisted with cell culture, RNAi, and T lymphocyte experiments. N.M. and T. K. assisted with cell culture and imaging-based experiments. A. L. S. and C. B. C. performed LC-MS/MS profiling experiments and provided experimental feedback. R. K. and M. W. K. performed cell cycle studies. V. K. M. conceived all experiments, reviewed all experimental data, and prepared the manuscript. All authors have discussed the results and reviewed the manuscript. All authors declare no competing financial interests.	Allen J, 2003, NAT BIOTECHNOL, V21, P692, DOI 10.1038/nbt823; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fu TF, 2001, ARCH BIOCHEM BIOPHYS, V393, P42, DOI 10.1006/abbi.2001.2471; GRIFFITH OW, 1979, J BIOL CHEM, V254, P7558; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; KAO FT, 1969, P NATL ACAD SCI USA, V64, P1284, DOI 10.1073/pnas.64.4.1284; Kao KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-143; Katz-Brull R, 1996, ANTICANCER RES, V16, P1375; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; OConnor PM, 1997, CANCER RES, V57, P4285; Patel H, 2003, J BIOL CHEM, V278, P19436, DOI 10.1074/jbc.M301718200; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Possemato R, 2011, NATURE, V476, P346, DOI 10.1038/nature10350; Shaham O, 2010, P NATL ACAD SCI USA, V107, P1571, DOI 10.1073/pnas.0906039107; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Zhang WC, 2012, CELL, V148, P259, DOI 10.1016/j.cell.2011.11.050	29	936	988	10	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					1040	1044		10.1126/science.1218595	http://dx.doi.org/10.1126/science.1218595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628656	Green Accepted			2022-12-24	WOS:000304406800047
J	Wang, YG; Li, G; Goode, J; Paz, JC; Ouyang, KF; Screaton, R; Fischer, WH; Chen, J; Tabas, I; Montminy, M				Wang, Yiguo; Li, Gang; Goode, Jason; Paz, Jose C.; Ouyang, Kunfu; Screaton, Robert; Fischer, Wolfgang H.; Chen, Ju; Tabas, Ira; Montminy, Marc			Inositol-1,4,5-trisphosphate receptor regulates hepatic gluconeogenesis in fasting and diabetes	NATURE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; DEPENDENT PROTEIN-KINASE; MODULATES GLUCONEOGENESIS; COACTIVATOR PGC-1; CREB; CALCIUM; PHOSPHORYLATION; TORC2; HEPATOCYTES; RELEASE	In the fasted state, increases in circulating glucagon promote hepatic glucose production through induction of the gluconeogenic program. Triggering of the cyclic AMP pathway increases gluconeogenic gene expression via the de-phosphorylation of the CREB co-activator CRTC2 (ref. 1). Glucagon promotes CRTC2 dephosphorylation in part through the protein kinase A (PKA)-mediated inhibition of the CRTC2 kinase SIK2. A number of Ser/Thr phosphatases seem to be capable of dephosphorylating CRTC2 (refs 2, 3), but the mechanisms by which hormonal cues regulate these enzymes remain unclear. Here we show in mice that glucagon stimulates CRTC2 dephosphorylation in hepatocytes by mobilizing intracellular calcium stores and activating the calcium/calmodulin-dependent Ser/Thr-phosphatase calcineurin (also known as PP3CA). Glucagon increased cytosolic calcium concentration through the PKA-mediated phosphorylation of inositol-1,4,5-trisphosphate receptors (InsP(3)Rs), which associate with CRTC2. After their activation, InsP(3)Rs enhanced gluconeogenic gene expression by promoting the calcineurin-mediated dephosphorylation of CRTC2. During feeding, increases in insulin signalling reduced CRTC2 activity via the AKT-mediated inactivation of InsP(3)Rs. InsP(3)R activity was increased in diabetes, leading to upregulation of the gluconeogenic program. As hepatic downregulation of InsP(3)Rs and calcineurin improved circulating glucose levels in insulin resistance, these results demonstrate how interactions between cAMP and calcium pathways at the level of the InsP(3)R modulate hepatic glucose production under fasting conditions and in diabetes.	[Wang, Yiguo; Goode, Jason; Paz, Jose C.; Fischer, Wolfgang H.; Montminy, Marc] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Li, Gang; Tabas, Ira] Columbia Univ, Dept Med, New York, NY 10032 USA; [Ouyang, Kunfu; Chen, Ju] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Screaton, Robert] Univ Ottawa, Eastern Ontario Res Inst, Childrens Hosp, Ottawa, ON K1H 8L1, Canada; [Screaton, Robert] Univ Ottawa, Dept Pediat, Ottawa, ON K1H 8L1, Canada; [Screaton, Robert] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8L1, Canada; [Tabas, Ira] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Tabas, Ira] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Salk Institute; Columbia University; University of California System; University of California San Diego; University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; University of Ottawa; Columbia University; Columbia University	Montminy, M (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	montminy@salk.edu	Paz, Jose Carlos/I-5783-2015; Chen, Ju/E-5579-2011; ouyang, kunfu/B-3073-2011	Paz, Jose Carlos/0000-0001-9684-9735; ouyang, kunfu/0000-0003-0292-375X; Screaton, Robert/0000-0002-4917-9473	National Institutes of Health [R01-DK049777, R01-DK083834, R01-DK091618, HL087123]; Kieckhefer Foundation; Clayton Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL087123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091618, R01DK049777, R01DK083834, R37DK083834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008666] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kieckhefer Foundation; Clayton Foundation for Medical Research; Leona M. and Harry B. Helmsley Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01-DK049777, R01-DK083834 and R01-DK091618 (M. M.), HL087123 (I. T.), the Kieckhefer Foundation, The Clayton Foundation for Medical Research, and the Leona M. and Harry B. Helmsley Charitable Trust.	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; BIRD GS, 1993, J BIOL CHEM, V268, P17917; Cruz LN, 2010, HEPATOLOGY, V52, P327, DOI 10.1002/hep.23625; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; FERRIS CD, 1991, P NATL ACAD SCI USA, V88, P2232, DOI 10.1073/pnas.88.6.2232; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jansson D, 2008, P NATL ACAD SCI USA, V105, P10161, DOI 10.1073/pnas.0800796105; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Tovey SC, 2010, J BIOL CHEM, V285, P12979, DOI 10.1074/jbc.M109.096016; VOLPE P, 1990, AM J PHYSIOL, V258, pC1086, DOI 10.1152/ajpcell.1990.258.6.C1086; WAKELAM MJO, 1986, NATURE, V323, P68, DOI 10.1038/323068a0; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yoon YS, 2010, P NATL ACAD SCI USA, V107, P17704, DOI 10.1073/pnas.1012665107	21	134	141	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					128	U166		10.1038/nature10988	http://dx.doi.org/10.1038/nature10988			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22495310	Green Accepted			2022-12-24	WOS:000303451900048
J	Mim, C; Cui, HS; Gawronski-Salerno, JA; Frost, A; Lyman, E; Voth, GA; Unger, VM				Mim, Carsten; Cui, Haosheng; Gawronski-Salerno, Joseph A.; Frost, Adam; Lyman, Edward; Voth, Gregory A.; Unger, Vinzenz M.			Structural Basis of Membrane Bending by the N-BAR Protein Endophilin	CELL			English	Article							CRYSTAL-STRUCTURE; DOMAIN PROTEINS; CURVATURE; DYNAMIN; INVAGINATION; SYNAPTOJANIN; AMPHIPHYSIN; HYDROLYSIS; GENERATION; MICROSCOPY	Functioning as key players in cellular regulation of membrane curvature, BAR domain proteins bend bilayers and recruit interaction partners through poorly understood mechanisms. Using electron cryo-microscopy, we present reconstructions of full-length endophilin and its N-terminal N-BAR domain in their membrane-bound state. Endophilin lattices expose large areas of membrane surface and are held together by promiscuous interactions between endophilin's amphipathic N-terminal helices. Coarse-grained molecular dynamics simulations reveal that endophilin lattices are highly dynamic and that the N-terminal helices are required for formation of a stable and regular scaffold. Furthermore, endophilin accommodates different curvatures through a quantized addition or removal of endophilin dimers, which in some cases causes dimerization of endophilin's SH3 domains, suggesting that the spatial presentation of SH3 domains, rather than affinity, governs the recruitment of downstream interaction partners.	[Mim, Carsten; Gawronski-Salerno, Joseph A.; Unger, Vinzenz M.] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; [Mim, Carsten; Gawronski-Salerno, Joseph A.; Unger, Vinzenz M.] Northwestern Univ, Chem Life Proc Inst, Evanston, IL 60208 USA; [Cui, Haosheng; Voth, Gregory A.] Univ Chicago, James Franck Inst, Dept Chem, Inst Biophys Dynam, Chicago, IL 60637 USA; [Cui, Haosheng; Voth, Gregory A.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Lyman, Edward] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Lyman, Edward] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Frost, Adam] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA	Northwestern University; Northwestern University; University of Chicago; University of Chicago; University of Delaware; University of Delaware; Utah System of Higher Education; University of Utah	Unger, VM (corresponding author), Northwestern Univ, Dept Mol Biosci, 2205 Campus Dr, Evanston, IL 60208 USA.	v-unger@northwestern.edu		Frost, Adam/0000-0003-2231-2577; Mim, Carsten/0000-0001-6402-8270	National Institutes of Health through the National Center for Research Resources' [RR017573]; Deutsche Forschungsgemeinschaft; Cancer Research Institute; PHS from the National Institutes of Health [DA24101, GM094479, GM063796]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR017573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063796, R01GM094479] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA024101] Funding Source: NIH RePORTER	National Institutes of Health through the National Center for Research Resources'(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Research Institute; PHS from the National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Pietro De Camilli and members of his lab for critical discussions and feedback. The majority of data for this work were collected at the National Resource for Automated Molecular Microscopy, which is supported by the National Institutes of Health through the National Center for Research Resources' P41 program (RR017573). We are also indebted to David Morgan for letting us use the cryoEM facility at Indiana University. This work was funded by Deutsche Forschungsgemeinschaft (C.M.) and the Cancer Research Institute (C.M.), as well as PHS grants DA24101 (V.M.U.), GM094479 (V.M.U.), and GM063796 (G.A.V.) from the National Institutes of Health.	Chang-Ileto B, 2011, DEV CELL, V20, P206, DOI 10.1016/j.devcel.2010.12.008; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Dawson JC, 2006, TRENDS CELL BIOL, V16, P493, DOI 10.1016/j.tcb.2006.08.004; Demers JP, 2009, J AM CHEM SOC, V131, P4355, DOI 10.1021/ja808255d; Egelman EH, 2007, CURR OPIN STRUC BIOL, V17, P556, DOI 10.1016/j.sbi.2007.07.006; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Hurley JH, 2010, CELL, V143, P875, DOI 10.1016/j.cell.2010.11.030; Jao CC, 2010, J BIOL CHEM, V285, P20164, DOI 10.1074/jbc.M110.127811; Johannes L, 2010, CELL, V142, P507, DOI 10.1016/j.cell.2010.08.007; Kaneko T, 2005, GENES CELLS, V10, P973, DOI 10.1111/j.1365-2443.2005.00895.x; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; Llobet A, 2011, J NEUROSCI, V31, P8512, DOI 10.1523/JNEUROSCI.6223-09.2011; Lyman E, 2010, BIOPHYS J, V99, P1783, DOI 10.1016/j.bpj.2010.06.074; Mizuno N, 2010, J BIOL CHEM, V285, P23349, DOI 10.1074/jbc.M110.143776; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pykalainen A, 2011, NAT STRUCT MOL BIOL, V18, P902, DOI 10.1038/nsmb.2079; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Ringstad N, 1997, P NATL ACAD SCI USA, V94, P8569, DOI 10.1073/pnas.94.16.8569; Roux A, 2010, P NATL ACAD SCI USA, V107, P4141, DOI 10.1073/pnas.0913734107; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Solomaha E, 2005, J BIOL CHEM, V280, P23147, DOI 10.1074/jbc.M501745200; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Sousa D, 2007, J STRUCT BIOL, V157, P201, DOI 10.1016/j.jsb.2006.08.003; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sundborger A, 2011, J CELL SCI, V124, P133, DOI 10.1242/jcs.072686; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; Trempe JF, 2009, MOL CELL, V36, P1034, DOI 10.1016/j.molcel.2009.11.021; Weissenhorn W, 2005, J MOL BIOL, V351, P653, DOI 10.1016/j.jmb.2005.06.013	36	176	176	1	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					137	145		10.1016/j.cell.2012.01.048	http://dx.doi.org/10.1016/j.cell.2012.01.048			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464326	Green Accepted, Bronze			2022-12-24	WOS:000302235400016
J	Azoulay, L; Yin, H; Filion, KB; Assayag, J; Majdan, A; Pollak, MN; Suissa, S				Azoulay, Laurent; Yin, Hui; Filion, Kristian B.; Assayag, Jonathan; Majdan, Agnieszka; Pollak, Michael N.; Suissa, Samy			The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRACTICE RESEARCH DATABASE; ACTIVATED RECEPTOR-GAMMA; URINARY-BLADDER; VALIDATION; MELLITUS; INFORMATION; AGONIST; EVENTS	Objective To determine if the use of pioglitazone is associated with an increased risk of incident bladder cancer in people with type 2 diabetes. Design Retrospective cohort study using a nested case-control analysis. Setting Over 600 general practices in the United Kingdom contributing to the general practice research database. Participants The cohort consisted of people with type 2 diabetes who were newly treated with oral hypoglycaemic agents between 1 January 1988 and 31 December 2009. All incident cases of bladder cancer occurring during follow-up were identified and matched to up to 20 controls on year of birth, year of cohort entry, sex, and duration of follow-up. Exposure was defined as ever use of pioglitazone, along with measures of duration and cumulative dosage. Main outcome measure Risk of incident bladder cancer associated with use of pioglitazone. Results The cohort included 115 727 new users of oral hypoglycaemic agents, with 470 patients diagnosed as having bladder cancer during follow-up (rate 89.4 per 100 000 person years). The 376 cases of bladder cancer that were diagnosed beyond one year of follow-up were matched to 6699 controls. Overall, ever use of pioglitazone was associated with an increased rate of bladder cancer (rate ratio 1.83, 95% confidence interval 1.10 to 3.05). The rate increased as a function of duration of use, with the highest rate observed in patients exposed for more than 24 months (1.99, 1.14 to 3.45) and in those with a cumulative dosage greater than 28 000 mg (2.54, 1.05 to 6.14). Conclusion The use of pioglitazone is associated with an increased risk of incident bladder cancer among people with type 2 diabetes.	[Azoulay, Laurent; Yin, Hui; Filion, Kristian B.; Assayag, Jonathan] McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Azoulay, Laurent; Pollak, Michael N.] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Filion, Kristian B.] McGill Univ, Div Clin Epidemiol, Montreal, PQ, Canada; [Majdan, Agnieszka] McGill Univ, Jewish Gen Hosp, Div Endocrinol, Montreal, PQ H3T 1E2, Canada; [Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University	Azoulay, L (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst, Ctr Clin Epidemiol, 3755 Cote St Catherine,H-425-1, Montreal, PQ H3T 1E2, Canada.	laurent.azoulay@mcgill.ca	Azoulay, Laurent/Z-4421-2019	Pollak, Michael/0000-0003-3047-0604; Azoulay, Laurent/0000-0001-5162-3556; Filion, Kristian/0000-0001-6055-0088	Canadian Institutes of Health Research; Canadian Foundation for Innovation; Novo Nordisk	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Novo Nordisk(Novo Nordisk)	This study was supported by grants from the Canadian Institutes of Health Research and the Canadian Foundation for Innovation. The funding sources had no role in the design, analysis, and interpretation of the results, and thus the authors were independent from the funding source.; All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: MNP served as a consultant for Novo Nordisk and Sanofi-Aventis and received research funding from Novo Nordisk; no other financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.	Benoit SR, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-36; Caisse nationale de l'assurance maladie Paris France, 2011, RISQ CANC VESS CHEZ; Cancer Research UK, 2012, BLADD CANC C67 AV NU; Chang CH, 2012, HEPATOLOGY, V55, P1462, DOI 10.1002/hep.25509; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Dominick MA, 2006, TOXICOL PATHOL, V34, P903, DOI 10.1080/01926230601072327; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dormandy J, 2009, DRUG SAFETY, V32, P187, DOI 10.2165/00002018-200932030-00002; Edwards KL, 2008, PHARMACOTHERAPY, V28, P506, DOI 10.1592/phco.28.4.506; Essebag V, 2003, AM HEART J, V146, P581, DOI 10.1016/S0002-8703(03)00512-X; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; European Medicines Agency, 2011, QUEST ANSW REV PIOGL; Food and Drug Administration,, 2011, FDA DRUG SAF COMM UP; Guan You-Fei, 1999, Neoplasia (New York), V1, P330, DOI 10.1038/sj.neo.7900050; Health Canada, 2011, HLTH CAN REV DIAB DR; Hillaire-Buys D, 2011, LANCET, V378, P1543, DOI 10.1016/S0140-6736(11)61662-0; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Kahn BB, 2010, NEW ENGL J MED, V363, P2667, DOI 10.1056/NEJMcibr1012075; Khan NF, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-1; Larsson SC, 2006, DIABETOLOGIA, V49, P2819, DOI 10.1007/s00125-006-0468-0; Lawrenson R, 1999, J PUBLIC HEALTH MED, V21, P299, DOI 10.1093/pubmed/21.3.299; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; MacKenzie T, 2011, CANCER-AM CANCER SOC, V117, P1552, DOI 10.1002/cncr.25641; Nakashiro K, 2001, AM J PATHOL, V159, P591, DOI 10.1016/S0002-9440(10)61730-0; Piccinni C, 2011, DIABETES CARE, V34, P1369, DOI 10.2337/dc10-2412; Ray WA, 2003, AM J EPIDEMIOL, V158, P915, DOI 10.1093/aje/kwg231; Rodriguez LAG, 1998, BRIT J CLIN PHARMACO, V45, P419; Sato K, 2011, TOXICOL APPL PHARM, V251, P234, DOI 10.1016/j.taap.2011.01.006; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Suzuki S, 2010, TOXICOL SCI, V113, P349, DOI 10.1093/toxsci/kfp256; Tseng CH, 2012, DIABETES CARE, V35, P278, DOI 10.2337/dc11-1449; van Staa TP, 2012, DIABETOLOGIA, V55, P654, DOI 10.1007/s00125-011-2390-3; Walley T, 1997, LANCET, V350, P1097, DOI 10.1016/S0140-6736(97)04248-7; Yoshimura R, 2003, INT J CANCER, V104, P597, DOI 10.1002/ijc.10980	38	201	205	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2012	344								e3645	10.1136/bmj.e3645	http://dx.doi.org/10.1136/bmj.e3645			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953HG	22653981	Green Published, hybrid			2022-12-24	WOS:000304857000006
J	Wei, B; Dai, MJ; Yin, P				Wei, Bryan; Dai, Mingjie; Yin, Peng			Complex shapes self-assembled from single-stranded DNA tiles	NATURE			English	Article							NANOSCALE SHAPES; FOLDING DNA; ORIGAMI; DESIGN; CRYSTALS; LATTICES; ARRAYS; RNA	Programmed self-assembly of strands of nucleic acid has proved highly effective for creating a wide range of structures with desired shapes(1-25). A particularly successful implementation is DNA origami, in which a long scaffold strand is folded by hundreds of short auxiliary strands into a complex shape(9,14-16,18-21,25). Modular strategies are in principle simpler and more versatile and have been used to assemble DNA(2-5,8,10-13,17,23) or RNA(7,22) tiles into periodic(3,4,7,22) and algorithmic(5) two-dimensional lattices, extended ribbons(10,12) and tubes(4,12,13), three-dimensional crystals(17), polyhedra(11) and simple finite two-dimensional shapes(7,8). But creating finite yet complex shapes from a large number of uniquely addressable tiles remains challenging. Here we solve this problem with the simplest tile form, a 'single-stranded tile' (SST) that consists of a 42-base strand of DNA composed entirely of concatenated sticky ends and that binds to four local neighbours during self-assembly(12). Although ribbons and tubes with controlled circumferences(12) have been created using the SST approach, we extend it to assemble complex two-dimensional shapes and tubes from hundreds (in some cases more than one thousand) distinct tiles. Our main design feature is a self-assembled rectangle that serves as a molecular canvas, with each of its constituent SST strands-folded into a 3 nm-by-7 nm tile and attached to four neighbouring tiles-acting as a pixel. A desired shape, drawn on the canvas, is then produced by one-pot annealing of all those strands that correspond to pixels covered by the target shape; the remaining strands are excluded. We implement the strategy with a master strand collection that corresponds to a 310-pixel canvas, and then use appropriate strand subsets to construct 107 distinct and complex two-dimensional shapes, thereby establishing SST assembly as a simple, modular and robust framework for constructing nanostructures with prescribed shapes from short synthetic DNA strands.	[Wei, Bryan; Yin, Peng] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Wei, Bryan; Dai, Mingjie; Yin, Peng] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA; [Dai, Mingjie] Harvard Univ, Program Biophys, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard University	Yin, P (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	py@hms.harvard.edu	Dai, Mingjie/A-7612-2013	Dai, Mingjie/0000-0002-8665-4966	Office of Naval Research [N000141110914, N000141010827]; NSF [CCF1054898]; NIH [1DP2OD007292]; Wyss Institute for Biologically Inspired Engineering; Direct For Computer & Info Scie & Enginr [1054898] Funding Source: National Science Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007292] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wyss Institute for Biologically Inspired Engineering; Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank S. Chandarasekaran, X. Lim, W. Sun and R. Conturie for technical assistance; A. Marblestone, R. Barish, W. Shih, Y. Ke, E. Winfree, S. Woo, P. Rothemund and D. Woods for discussions; and J. Aliperti for help with preparation of the draft. This work was funded by Office of Naval Research Young Investigator Program Award N000141110914, Office of Naval Research Grant N000141010827, NSF CAREER Award CCF1054898, NIH Director's New Innovator Award 1DP2OD007292 and a Wyss Institute for Biologically Inspired Engineering Faculty Startup Fund (to P.Y.).	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Delebecque CJ, 2011, SCIENCE, V333, P470, DOI 10.1126/science.1206938; Dietz H, 2009, SCIENCE, V325, P725, DOI 10.1126/science.1174251; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; FU TJ, 1993, BIOCHEMISTRY-US, V32, P3211, DOI 10.1021/bi00064a003; Han DR, 2011, SCIENCE, V332, P342, DOI 10.1126/science.1202998; Hansma HG, 1996, BIOPHYS J, V70, P1933, DOI 10.1016/S0006-3495(96)79757-6; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Lin CX, 2006, CHEMPHYSCHEM, V7, P1641, DOI 10.1002/cphc.200600260; Liu WY, 2011, ANGEW CHEM INT EDIT, V50, P264, DOI 10.1002/anie.201005911; O'Neill P, 2006, NANO LETT, V6, P1379, DOI 10.1021/nl0603505; Park SH, 2006, ANGEW CHEM INT EDIT, V45, P735, DOI 10.1002/anie.200503797; Rajendran A, 2011, J AM CHEM SOC, V133, P14488, DOI 10.1021/ja204546h; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Schulman R, 2007, P NATL ACAD SCI USA, V104, P15236, DOI 10.1073/pnas.0701467104; Seelig G, 2006, SCIENCE, V314, P1585, DOI 10.1126/science.1132493; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; SEEMAN NC, 1990, J BIOMOL STRUCT DYN, V8, P573, DOI 10.1080/07391102.1990.10507829; Sharma J, 2009, SCIENCE, V323, P112, DOI 10.1126/science.1165831; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Torring T, 2011, CHEM SOC REV, V40, P5636, DOI 10.1039/c1cs15057j; Wei B, 2007, J COMPUT THEOR NANOS, V4, P133; Winfree E, 1998, NATURE, V394, P539, DOI 10.1038/28998; Woo S, 2011, NAT CHEM, V3, P620, DOI [10.1038/NCHEM.1070, 10.1038/nchem.1070]; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, SCIENCE, V321, P824, DOI 10.1126/science.1157312; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Zhao Z, 2011, NANO LETT, V11, P2997, DOI 10.1021/nl201603a; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274	32	654	693	19	599	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					623	+		10.1038/nature11075	http://dx.doi.org/10.1038/nature11075			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	949WP	22660323	Green Submitted, Green Accepted			2022-12-24	WOS:000304608000044
J	Schirle, NT; MacRae, IJ				Schirle, Nicole T.; MacRae, Ian J.			The Crystal Structure of Human Argonaute2	SCIENCE			English	Article							GUIDE RNA; GW182; RECOGNITION; BINDING; DNA; REQUIRES; DOMAIN; DEADENYLASE; MICRORNAS; CLEAVAGE	Argonaute proteins form the functional core of the RNA-induced silencing complexes that mediate RNA silencing in eukaryotes. The 2.3 angstrom resolution crystal structure of human Argonaute2 (Ago2) reveals a bilobed molecule with a central cleft for binding guide and target RNAs. Nucleotides 2 to 6 of a heterogeneous mixture of guide RNAs are positioned in an A-form conformation for base pairing with target messenger RNAs. Between nucleotides 6 and 7, there is a kink that may function in microRNA target recognition or release of sliced RNA products. Tandem tryptophan-binding pockets in the PIWI domain define a likely interaction surface for recruitment of glycine-tryptophan-182 (GW182) or other tryptophan-rich cofactors. These results will enable structure-based approaches for harnessing the untapped therapeutic potential of RNA silencing in humans.	[Schirle, Nicole T.; MacRae, Ian J.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	MacRae, IJ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	macrae@scripps.edu	MacRae, Ian/CAF-5564-2022		National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative [U54 GM074898]; NIGMS [R01 GM086701]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074898, R01GM086701] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the laboratories of D. Stout, E. O. Saphire, and I. Wilson for sharing synchrotron time and for helpful discussions. Crystallization screens were carried out at the Joint Center for Structural Genomics, supported by the National Institute of General Medical Sciences (NIGMS) Protein Structure Initiative (U54 GM074898). Diffraction data were collected on beamlines 24-ID-E at the Advanced Photon Source and 11-1 at the Stanford Synchrotron Radiation Lightsource. This work was supported by NIGMS grant R01 GM086701 to I.J.M. I.J.M. is a Pew Scholar in the Biomedical Sciences. Coordinates of Ago2 and Ago2 bound to tryptophan have been deposited in the Protein Data Bank (4EI1 and 4EI3).	Baillat D, 2009, MOL CELL BIOL, V29, P4144, DOI 10.1128/MCB.00380-09; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bies-Etheve N, 2009, EMBO REP, V10, P649, DOI 10.1038/embor.2009.31; Boland A, 2011, P NATL ACAD SCI USA, V108, P10466, DOI 10.1073/pnas.1103946108; Boland A, 2010, EMBO REP, V11, P522, DOI 10.1038/embor.2010.81; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chiu YL, 2003, RNA, V9, P1034, DOI 10.1261/rna.5103703; Deleavey GF, 2010, NUCLEIC ACIDS RES, V38, P4547, DOI 10.1093/nar/gkq181; El-Shami M, 2007, GENE DEV, V21, P2539, DOI 10.1101/gad.451207; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Lingel A, 2003, NATURE, V426, P465, DOI 10.1038/nature02123; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011	29	444	470	4	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 25	2012	336	6084					1037	1040		10.1126/science.1221551	http://dx.doi.org/10.1126/science.1221551			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22539551	Green Accepted			2022-12-24	WOS:000304406800046
J	Sosa, BA; Rothballer, A; Kutay, U; Schwartz, TU				Sosa, Brian A.; Rothballer, Andrea; Kutay, Ulrike; Schwartz, Thomas U.			LINC Complexes Form by Binding of Three KASH Peptides to Domain Interfaces of Trimeric SUN Proteins	CELL			English	Article							NUCLEAR-MEMBRANE PROTEIN; DREIFUSS MUSCULAR-DYSTROPHY; ACTIN CYTOSKELETON; CAENORHABDITIS-ELEGANS; LAMIN-A; ENVELOPE; MIGRATION; MICE; LOCALIZATION; ANCHORAGE	Linker of nucleoskeleton and cytoskeleton (LINC) complexes span the nuclear envelope and are composed of KASH and SUN proteins residing in the outer and inner nuclear membrane, respectively. LINC formation relies on direct binding of KASH and SUN in the perinuclear space. Thereby, molecular tethers are formed that can transmit forces for chromosome movements, nuclear migration, and anchorage. We present crystal structures of the human SUN2-KASH1/2 complex, the core of the LINC complex. The SUN2 domain is rigidly attached to a trimeric coiled coil that prepositions it to bind three KASH peptides. The peptides bind in three deep and expansive grooves formed between adjacent SUN domains, effectively acting as molecular glue. In addition, a disulfide between conserved cysteines on SUN and KASH covalently links both proteins. The structure provides the basis of LINC complex formation and suggests a model for how LINC complexes might arrange into higher-order clusters to enhance force-coupling.	[Rothballer, Andrea; Kutay, Ulrike] ETH, Inst Biochem, CH-8093 Zurich, Switzerland; [Sosa, Brian A.; Schwartz, Thomas U.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Rothballer, Andrea] Mol Life Sci Ph D Program, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of Technology (MIT)	Kutay, U (corresponding author), ETH, Inst Biochem, CH-8093 Zurich, Switzerland.	ulrike.kutay@bc.biol.ethz.ch; tus@mit.edu	Schwartz, Thomas/ABA-1770-2021; Schwartz, Thomas/K-9029-2017	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512	NIH [NS075883]; Boehringer Ingelheim PhD fellowship; SNSF [310030-313135]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075883] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Boehringer Ingelheim PhD fellowship; SNSF(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the staff at NE-CAT beamlines 24-ID-C/-E at the Advanced Photon Source (APS), especially K. Rajashankar for technical help with data collection. We thank C. Ashiono for excellent assistance; W. Antonin, A. Keating, and A. Helenius for discussion; and K. Knockenhauer and G. Kabachinski for critical reading of the manuscript. Imaging was performed on instruments of the ETH Light Microscopy Center. This work was supported by NIH Grant NS075883 to T.U.S., a Boehringer Ingelheim PhD fellowship to A.R., and an SNSF grant (310030-313135) to U.K.	Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bianchet MA, 2002, NAT STRUCT BIOL, V9, P628, DOI 10.1038/nsb817; Burke B, 2009, DEV CELL, V17, P587, DOI 10.1016/j.devcel.2009.10.018; Chikashige Y, 2006, CELL, V125, P59, DOI 10.1016/j.cell.2006.01.048; Ciani B, 2010, P NATL ACAD SCI USA, V107, P19850, DOI 10.1073/pnas.1008502107; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Fridkin A, 2004, P NATL ACAD SCI USA, V101, P6987, DOI 10.1073/pnas.0307880101; Fridkin A, 2009, CELL MOL LIFE SCI, V66, P1518, DOI 10.1007/s00018-008-8713-y; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Harding MM, 2006, ACTA CRYSTALLOGR D, V62, P678, DOI 10.1107/S0907444906014594; Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191; Lee KK, 2002, MOL BIOL CELL, V13, P892, DOI 10.1091/mbc.01-06-0294; Lei K, 2009, P NATL ACAD SCI USA, V106, P10207, DOI 10.1073/pnas.0812037106; Liang WC, 2011, ANN NEUROL, V69, P1005, DOI 10.1002/ana.22338; Lombardi ML, 2011, BIOCHEM SOC T, V39, P1729, DOI 10.1042/BST20110686; Lu WS, 2008, BBA-MOL CELL RES, V1783, P2415, DOI 10.1016/j.bbamcr.2008.09.001; Luxton GWG, 2010, SCIENCE, V329, P956, DOI 10.1126/science.1189072; Malone CJ, 1999, DEVELOPMENT, V126, P3171; Mans BJ, 2004, CELL CYCLE, V3, P1612; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mekhail K, 2010, NAT REV MOL CELL BIO, V11, P317, DOI 10.1038/nrm2894; Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Ostlund C, 2009, J CELL SCI, V122, P4099, DOI 10.1242/jcs.057075; Onischenko E, 2011, CURR OPIN CELL BIOL, V23, P293, DOI 10.1016/j.ceb.2011.01.002; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Padmakumar VC, 2004, EXP CELL RES, V295, P330, DOI 10.1016/j.yexcr.2004.01.014; Penkner A, 2007, DEV CELL, V12, P873, DOI 10.1016/j.devcel.2007.05.004; Puckelwartz MJ, 2009, HUM MOL GENET, V18, P607, DOI 10.1093/hmg/ddn386; Razafsky D, 2009, J CELL BIOL, V186, P461, DOI 10.1083/jcb.200906068; Roux KJ, 2009, P NATL ACAD SCI USA, V106, P2194, DOI 10.1073/pnas.0808602106; Schmitt J, 2007, P NATL ACAD SCI USA, V104, P7426, DOI 10.1073/pnas.0609198104; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Starr DA, 2010, ANNU REV CELL DEV BI, V26, P421, DOI 10.1146/annurev-cellbio-100109-104037; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stewart-Hutchinson PJ, 2008, EXP CELL RES, V314, P1892, DOI 10.1016/j.yexcr.2008.02.022; Testa OD, 2009, NUCLEIC ACIDS RES, V37, pD315, DOI 10.1093/nar/gkn675; Turgay Y, 2010, EMBO J, V29, P2262, DOI 10.1038/emboj.2010.119; Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003; Wang Q, 2006, DNA CELL BIOL, V25, P554, DOI 10.1089/dna.2006.25.554; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083; Worman HJ, 2006, TRENDS CELL BIOL, V16, P67, DOI 10.1016/j.tcb.2005.12.006; Yu JH, 2011, HUM MOL GENET, V20, P1061, DOI 10.1093/hmg/ddq549; Zhang JL, 2010, HUM MOL GENET, V19, P329, DOI 10.1093/hmg/ddp499; Zhang QP, 2007, HUM MOL GENET, V16, P2816, DOI 10.1093/hmg/ddm238; Zhang QP, 2001, J CELL SCI, V114, P4485; Zhang XC, 2007, DEVELOPMENT, V134, P901, DOI 10.1242/dev.02783; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhen YY, 2002, J CELL SCI, V115, P3207; Zhou ZC, 2012, J BIOL CHEM, V287, P5317, DOI 10.1074/jbc.M111.304543; Zhu L, 2010, J BIOL CHEM, V285, P37271, DOI 10.1074/jbc.M110.123471	58	260	266	0	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					1035	1047		10.1016/j.cell.2012.03.046	http://dx.doi.org/10.1016/j.cell.2012.03.046			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632968	Bronze, Green Accepted, Green Published			2022-12-24	WOS:000304453900010
J	Thistle, R; Cameron, P; Ghorayshi, A; Dennison, L; Scott, K				Thistle, Robert; Cameron, Peter; Ghorayshi, Azeen; Dennison, Lisa; Scott, Kristin			Contact Chemoreceptors Mediate Male-Male Repulsion and Male-Female Attraction during Drosophila Courtship	CELL			English	Article							FRUITLESS GENE; CUTICULAR HYDROCARBONS; EXPRESSION PATTERNS; SEXUAL ORIENTATION; PHEROMONE RECEPTOR; MELANOGASTER; TASTE; BEHAVIOR; SYSTEM; FLY	The elaborate courtship ritual of Drosophila males is dictated by neural circuitry established by the transcription factor Fruitless and triggered by sexspecific sensory cues. Deciphering the role of different stimuli in driving courtship behavior has been limited by the inability to selectively target appropriate sensory classes. Here, we identify two ion channel genes belonging to the degenerin/epithelial sodium channel/pickpocket (ppk) family, ppk23 and ppk29, which are expressed in fruitless-positive neurons on the legs and are essential for courtship. Gene loss-of-function, cell-inactivation, and cell-activation experiments demonstrate that these genes and neurons are necessary and sufficient to inhibit courtship toward males and promote courtship toward females. Moreover, these cells respond to cuticular hydrocarbons, with different cells selectively responding to male or female pheromones. These studies identify a large population of pheromone-sensing neurons and demonstrate the essential role of contact chemosensation in the early courtship steps of mate selection and courtship initiation.	[Scott, Kristin] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Thistle, Robert; Cameron, Peter; Ghorayshi, Azeen; Dennison, Lisa; Scott, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Thistle, Robert; Cameron, Peter; Ghorayshi, Azeen; Dennison, Lisa; Scott, Kristin] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Scott, K (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, 16 Barker Hall, Berkeley, CA 94720 USA.	kscott@berkeley.edu		Cameron, Peter/0000-0002-1443-557X	NSF; NRSA [F31DC009389]; NIDCD [1R01DC009470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F31DC009389, R01DC009470] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	The Scott lab provided helpful comments and discussion. Dr. Gautam Agarwal provided MATLAB advice, and Dr. Seth Ament performed the ANOVA analysis. Dr. Charles Zuker provided UAS-GCaMP3 flies. R.T. is supported by a predoctoral NSF fellowship; P.C. was supported by a predoctoral NRSA fellowship, F31DC009389. This research was supported by a grant from the NIDCD, 1R01DC009470. K.S. is an Early Career Scientist of the Howard Hughes Medical Institute. R.T. performed most experiments, including Gal4 expression studies, calcium imaging, and behavioral assays and cowrote the paper. P.C. generated Delta ppk23 and Delta ppk29, Gal4, and UAS transgenic animals, made isogenic lines, and carried out expression studies. A.G. assisted R.T. with behavior. L.D. generated ppk28-LexA and contributed to in situ experiments. K.S. supervised the project, cowrote the manuscript, and performed expression studies.	Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Antony C., 1982, J INSECT PHYSL, V28, P87; Ben-Shahar Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009395; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; BUTTERWORTH FM, 1969, SCIENCE, V163, P1356, DOI 10.1126/science.163.3873.1356; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Dahanukar A, 2007, NEURON, V56, P503, DOI 10.1016/j.neuron.2007.10.024; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Ejima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003246; Everaerts C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009607; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Ferveur JF, 2005, BEHAV GENET, V35, P279, DOI 10.1007/s10519-005-3220-5; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; GAILEY DA, 1984, GENETICS, V106, P613; GILL KULBIR S., 1963, AMER ZOOL, V3, P507; Goodwin SF, 2000, GENETICS, V154, P725; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; GREENSPAN RJ, 1995, SCI AM, V272, P72, DOI 10.1038/scientificamerican0495-72; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; HALL JC, 1978, BEHAV GENET, V8, P125, DOI 10.1007/BF01066870; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; JALLON JM, 1984, BEHAV GENET, V14, P441, DOI 10.1007/BF01065444; Krstic D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004457; Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lin HP, 2005, P NATL ACAD SCI USA, V102, P12831, DOI 10.1073/pnas.0506420102; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Mellert DJ, 2010, DEVELOPMENT, V137, P323, DOI 10.1242/dev.045047; Miyamoto T, 2008, NAT NEUROSCI, V11, P874, DOI 10.1038/nn.2161; Moon SJ, 2009, CURR BIOL, V19, P1623, DOI 10.1016/j.cub.2009.07.061; Park SK, 2006, CURR BIOL, V16, P1154, DOI 10.1016/j.cub.2006.04.028; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Ruta V, 2010, NATURE, V468, P686, DOI 10.1038/nature09554; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; Stowers L, 2005, NEURON, V46, P699, DOI 10.1016/j.neuron.2005.04.032; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Thorne N, 2004, CURR BIOL, V14, P1065, DOI 10.1016/j.cub.2004.05.019; Villella A, 1997, GENETICS, V147, P1107; von Philipsborn AC, 2011, NEURON, V69, P509, DOI 10.1016/j.neuron.2011.01.011; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 2008, NEURON, V59, P685, DOI 10.1016/j.neuron.2008.08.014; Wang LM, 2011, NAT NEUROSCI, V14, P757, DOI 10.1038/nn.2800; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Watanabe K, 2011, BEHAV GENET, V41, P746, DOI 10.1007/s10519-011-9461-6; Yew JY, 2009, CURR BIOL, V19, P1245, DOI 10.1016/j.cub.2009.06.037; Zhong LX, 2010, CURR BIOL, V20, P429, DOI 10.1016/j.cub.2009.12.057	59	199	198	1	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAY 25	2012	149	5					1140	1151		10.1016/j.cell.2012.03.045	http://dx.doi.org/10.1016/j.cell.2012.03.045			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632976	Bronze, Green Accepted			2022-12-24	WOS:000304453900018
J	Eames, M; Kortemme, T				Eames, Matt; Kortemme, Tanja			Cost-Benefit Tradeoffs in Engineered lac Operons	SCIENCE			English	Article							ESCHERICHIA-COLI; LACTOSE PERMEASE; GENE-EXPRESSION; MESSENGER-RNA; PROTEIN; INTERDEPENDENCE; CONSEQUENCES; TRANSLATION; TRANSPORT; PRODUCTS	Cells must balance the cost and benefit of protein expression to optimize organismal fitness. The lac operon of the bacterium Escherichia coli has been a model for quantifying the physiological impact of costly protein production and for elucidating the resulting regulatory mechanisms. We report quantitative fitness measurements in 27 redesigned operons that suggested that protein production is not the primary origin of fitness costs. Instead, we discovered that the lac permease activity, which relates linearly to cost, is the major physiological burden to the cell. These findings explain control points in the lac operon that minimize the cost of lac permease activity, not protein expression. Characterizing similar relationships in other systems will be important to map the impact of cost/benefit tradeoffs on cell physiology and regulation.	[Eames, Matt; Kortemme, Tanja] Univ Calif San Francisco, Grad Grp Biophys, San Francisco, CA 94158 USA; [Kortemme, Tanja] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Kortemme, Tanja] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kortemme, T (corresponding author), Univ Calif San Francisco, Grad Grp Biophys, MC 2530, San Francisco, CA 94158 USA.	kortemme@cgl.ucsf.edu	Kortemme, Tanja/AAN-3180-2021	Kortemme, Tanja/0000-0002-8494-680X	Sandler Program for Breakthrough Biomedical Research	Sandler Program for Breakthrough Biomedical Research	We thank C. Gross, A. Sali, B. Simmons, J. Tabor, R. Oberdorf, R. Ritterson, D. Stoebel, D. Dykhuizen, U. Alon, E. Dekel, A. Drummond, K. Geiler, J. Fraser, and A. Stein for discussions and comments, and McKenzie and Craig for the pGRG37 vector. This work was supported by the Sandler Program for Breakthrough Biomedical Research. Data are available in the supplementary materials.	Beckwith J. R., 1987, CELLULAR MOL BIOL, P1444; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Drummond DA, 2009, NAT REV GENET, V10, P715, DOI 10.1038/nrg2662; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P14338, DOI 10.1073/pnas.0504070102; DYKHUIZEN D, 1978, J BACTERIOL, V135, P876, DOI 10.1128/JB.135.3.876-882.1978; DYKHUIZEN D, 1980, ECOLOGY, V61, P1213, DOI 10.2307/1936839; DYKHUIZEN DE, 1987, GENETICS, V115, P25; Geiler-Samerotte KA, 2011, P NATL ACAD SCI USA, V108, P680, DOI 10.1073/pnas.1017570108; Green AL, 2000, J BIOL CHEM, V275, P23240, DOI 10.1074/jbc.M909202199; HUI A, 1984, EMBO J, V3, P623, DOI 10.1002/j.1460-2075.1984.tb01858.x; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; JOBE A, 1972, J MOL BIOL, V69, P397, DOI 10.1016/0022-2836(72)90253-7; Klumpp S, 2009, CELL, V139, P1366, DOI 10.1016/j.cell.2009.12.001; KOCH AL, 1983, J MOL EVOL, V19, P455, DOI 10.1007/BF02102321; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; OSUMI T, 1982, P NATL ACAD SCI-BIOL, V79, P1457, DOI 10.1073/pnas.79.5.1457; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Stoebel DM, 2008, GENETICS, V178, P1653, DOI 10.1534/genetics.107.085399; WILSON DM, 1980, FEBS LETT, V117, pK37, DOI 10.1016/0014-5793(80)80568-0; YARCHUK O, 1992, J MOL BIOL, V226, P581, DOI 10.1016/0022-2836(92)90617-S	22	71	72	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					911	915		10.1126/science.1219083	http://dx.doi.org/10.1126/science.1219083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22605776				2022-12-24	WOS:000304145600064
J	Pinheiro, VB; Taylor, AI; Cozens, C; Abramov, M; Renders, M; Zhang, S; Chaput, JC; Wengel, J; Peak-Chew, SY; McLaughlin, SH; Herdewijn, P; Holliger, P				Pinheiro, Vitor B.; Taylor, Alexander I.; Cozens, Christopher; Abramov, Mikhail; Renders, Marleen; Zhang, Su; Chaput, John C.; Wengel, Jesper; Peak-Chew, Sew-Yeu; McLaughlin, Stephen H.; Herdewijn, Piet; Holliger, Philipp			Synthetic Genetic Polymers Capable of Heredity and Evolution	SCIENCE			English	Article							NUCLEIC-ACID STRUCTURE; IN-VITRO SELECTION; CHEMICAL ETIOLOGY; DNA-POLYMERASES; SYSTEM; RECOGNITION; ANALOGS; TNA	Genetic information storage and processing rely on just two polymers, DNA and RNA, yet whether their role reflects evolutionary history or fundamental functional constraints is currently unknown. With the use of polymerase evolution and design, we show that genetic information can be stored in and recovered from six alternative genetic polymers based on simple nucleic acid architectures not found in nature [xeno-nucleic acids (XNAs)]. We also select XNA aptamers, which bind their targets with high affinity and specificity, demonstrating that beyond heredity, specific XNAs have the capacity for Darwinian evolution and folding into defined structures. Thus, heredity and evolution, two hallmarks of life, are not limited to DNA and RNA but are likely to be emergent properties of polymers capable of information storage.	[Pinheiro, Vitor B.; Taylor, Alexander I.; Cozens, Christopher; Peak-Chew, Sew-Yeu; McLaughlin, Stephen H.; Holliger, Philipp] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Abramov, Mikhail; Renders, Marleen; Herdewijn, Piet] Katholieke Univ Leuven, Rega Inst, B-3000 Louvain, Belgium; [Zhang, Su; Chaput, John C.] Arizona State Univ, Biodesign Inst, Ctr Evolutionary Med & Informat, Tempe, AZ 85287 USA; [Wengel, Jesper] Univ So Denmark, Dept Phys & Chem, Nucle Acid Ctr, DK-5230 Odense M, Denmark	MRC Laboratory Molecular Biology; KU Leuven; Arizona State University; Arizona State University-Tempe; University of Southern Denmark	Holliger, P (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ph1@mrc-lmb.cam.ac.uk	Renders, Marleen/L-2603-2015; Pinheiro, Vitor/O-5514-2017; wengel, jesper/K-1177-2013	Renders, Marleen/0000-0002-4099-9045; Pinheiro, Vitor/0000-0003-2491-0028; McLaughlin, Stephen/0000-0001-9135-6253; Cozens, Christopher/0000-0003-4067-6921; Herdewijn, Piet/0000-0003-3589-8503; Taylor, Alexander/0000-0001-7684-1437; Wengel, Jesper/0000-0001-9835-1009	MRC [U105178804]; European Union [FP6-STREP-029092 NEST]; European Science Foundation; Biotechnology and Biological Sciences Research Council (BBSRC) UK [09-EuroSYNBIO-OP-013]; European Research Council [ERC-2010-AdG_20100317]; Katholieke Universiteit Leuven (GOA/IDO); BBSRC [BB/I004793/1] Funding Source: UKRI; MRC [MC_U105178804] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I004793/1] Funding Source: researchfish; Medical Research Council [MC_U105178804] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); European Science Foundation(European Science Foundation (ESF)European Commission); Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); Katholieke Universiteit Leuven (GOA/IDO); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the MRC (U105178804) (P. Holliger, V.B.P., C.C.) and by grants from the European Union Framework [FP6-STREP-029092 NEST (P. Holliger, V.B.P., M.A., M.R., P. Herdewijn)], the European Science Foundation and the Biotechnology and Biological Sciences Research Council (BBSRC) UK (09-EuroSYNBIO-OP-013) (A.I.T.), the European Research Council (ERC-2010-AdG_20100317) (J.W.), and Katholieke Universiteit Leuven (GOA/IDO programs) (P. Herdewijn). MRC has filed a patent continuation in part (U.S. 2010/018407 A1) and a patent application (WO 2011/135280 A2) on the CST selection system and the polymerases for XNA synthesis and reverse transcription. Polymerases are available for noncommercial purposes from P. Holliger on request subject to a material transfer agreement.	Benner SA, 2004, SCIENCE, V306, P625, DOI 10.1126/science.1101104; Boiziau C, 2001, ANTISENSE NUCLEIC A, V11, P379, DOI 10.1089/108729001753411344; Brudno Y, 2010, NAT CHEM BIOL, V6, P148, DOI [10.1038/NCHEMBIO.280, 10.1038/nchembio.280]; Burmeister PE, 2005, CHEM BIOL, V12, P25, DOI 10.1016/j.chembiol.2004.10.017; Campbell MA, 2011, CHEM SOC REV, V40, P5680, DOI 10.1039/c1cs15048k; Duconge F, 1999, RNA, V5, P1605, DOI 10.1017/S1355838299991318; Eschenmoser A, 1999, SCIENCE, V284, P2118, DOI 10.1126/science.284.5423.2118; Fogg MJ, 2002, NAT STRUCT BIOL, V9, P922, DOI 10.1038/nsb867; Gardner AF, 2002, NUCLEIC ACIDS RES, V30, P605, DOI 10.1093/nar/30.2.605; Hansen J. A., 2003, US Patent, Patent No. [2003/0228616 A1, 20030228616]; Herdewijn P, 2010, CHEM BIODIVERS, V7, P1, DOI 10.1002/cbdv.200900185; Ichida JK, 2005, NUCLEIC ACIDS RES, V33, P5219, DOI 10.1093/nar/gki840; Leconte AM, 2008, J AM CHEM SOC, V130, P2336, DOI 10.1021/ja078223d; Li ZY, 2002, J AM CHEM SOC, V124, P746, DOI 10.1021/ja017319j; Loakes D, 2001, NUCLEIC ACIDS RES, V29, P2437, DOI 10.1093/nar/29.12.2437; Loakes D, 2009, CHEM COMMUN, P4619, DOI 10.1039/b903307f; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; NIELSEN PE, 1995, ANNU REV BIOPH BIOM, V24, P167, DOI 10.1146/annurev.bb.24.060195.001123; Noronha AM, 2000, BIOCHEMISTRY-US, V39, P7050, DOI 10.1021/bi000280v; Potty ASR, 2011, INT J BIOL MACROMOL, V48, P392, DOI 10.1016/j.ijbiomac.2010.12.007; Rosenbaum DM, 2003, J AM CHEM SOC, V125, P13924, DOI 10.1021/ja038058b; Schoning KU, 2000, SCIENCE, V290, P1347, DOI 10.1126/science.290.5495.1347; Schrum JP, 2009, J AM CHEM SOC, V131, P14560, DOI 10.1021/ja906557v; Wilds CJ, 2000, NUCLEIC ACIDS RES, V28, P3625, DOI 10.1093/nar/28.18.3625; Yu HY, 2012, NAT CHEM, V4, P183, DOI [10.1038/NCHEM.1241, 10.1038/nchem.1241]	25	466	480	15	348	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 20	2012	336	6079					341	344		10.1126/science.1217622	http://dx.doi.org/10.1126/science.1217622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	928PO	22517858	Green Accepted			2022-12-24	WOS:000302995400044
J	Filippakopoulos, P; Picaud, S; Mangos, M; Keates, T; Lambert, JP; Barsyte-Lovejoy, D; Felletar, I; Volkmer, R; Muller, S; Pawson, T; Gingras, AC; Arrowsmith, CH; Knapp, S				Filippakopoulos, Panagis; Picaud, Sarah; Mangos, Maria; Keates, Tracy; Lambert, Jean-Philippe; Barsyte-Lovejoy, Dalia; Felletar, Ildiko; Volkmer, Rudolf; Mueller, Susanne; Pawson, Tony; Gingras, Anne-Claude; Arrowsmith, Cheryl H.; Knapp, Stefan			Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; PEPTIDE ARRAYS; TRANSCRIPTION ELONGATION; BET BROMODOMAINS; PHD FINGER; PROTEIN; ACETYLATION; IDENTIFICATION	Bromodomains (BRDs) are protein interaction modules that specifically recognize epsilon-N-lysine acetylation motifs, a key event in the reading process of epigenetic marks. The 61 BRDs in the human genome cluster into eight families based on structure/sequence similarity. Here, we present 29 high-resolution crystal structures, covering all BRD families. Comprehensive crossfamily structural analysis identifies conserved and family-specific structural features that are necessary for specific acetylation-dependent substrate recognition. Screening of more than 30 representative BRDs against systematic histone-peptide arrays identifies new BRD substrates and reveals a strong influence of flanking posttranslational modifications, such as acetylation and phosphorylation, suggesting that BRDs recognize combinations of marks rather than singly acetylated sequences. We further uncovered a structural mechanism for the simultaneous binding and recognition of diverse diacetyl-containing peptides by BRD4. These data provide a foundation for structure-based drug design of specific inhibitors for this emerging target family.	[Filippakopoulos, Panagis; Picaud, Sarah; Keates, Tracy; Felletar, Ildiko; Mueller, Susanne; Knapp, Stefan] Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Oxford OX3 7LD, England; [Knapp, Stefan] Univ Oxford, Dept Oncol, Oxford OX3 7LD, England; [Mangos, Maria; Barsyte-Lovejoy, Dalia; Arrowsmith, Cheryl H.] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Campbell Family Canc Res Inst, Toronto, ON M5G 1L7, Canada; [Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Lambert, Jean-Philippe; Pawson, Tony; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Volkmer, Rudolf] Charite Univ Med Berlin, Inst Med Immunol, D-10115 Berlin, Germany; [Pawson, Tony; Gingras, Anne-Claude] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Knapp, Stefan] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Biol, Washington, DC 20037 USA	University of Oxford; University of Oxford; University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Toronto; George Washington University	Filippakopoulos, P (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Struct Genom Consortium, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7LD, England.	panagis.filippakopoulos@sgc.ox.ac.uk; stefan.knapp@sgc.ox.ac.uk	Knapp, Stefan/AAG-2347-2019; Gingras, Anne-Claude/E-9982-2010; Pawson, Tony J/E-4578-2013; Gingras, Anne-Claude/ABA-8341-2020	Knapp, Stefan/0000-0001-5995-6494; Gingras, Anne-Claude/0000-0002-6090-4437; Gingras, Anne-Claude/0000-0002-6090-4437; Lambert, Jean-Philippe/0000-0002-0833-1221; Volkmer, Rudolf/0000-0003-4710-1143; Muller-Knapp, Susanne/0000-0003-2402-4157; Filippakopoulos, Panagis/0000-0002-1515-1317; Arrowsmith, Cheryl/0000-0002-4971-3250	Canadian Institutes for Health Research; Canada Foundation for Innovation; Genome Canada; GlaxoSmithKline; Pfizer; Eli Lilly; Novartis Research Foundation; Ontario Ministry of Research and Innovation; Wellcome Trust [095751/Z/11/Z]; Ontario Ministry of Health and Innovation; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Genome Canada(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Pfizer(Pfizer); Eli Lilly(Eli Lilly); Novartis Research Foundation; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Wellcome Trust(Wellcome TrustEuropean Commission); Ontario Ministry of Health and Innovation; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	The SGC is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canada Foundation for Innovation, Genome Canada, GlaxoSmithKline, Pfizer, Eli Lilly, the Novartis Research Foundation, the Ontario Ministry of Research and Innovation, and the Wellcome Trust. P.F. is supported by a Wellcome Trust Career Development Fellowship (095751/Z/11/Z). T. P. and A.-C. G. are supported by a Global Leadership Round in Genomics and Life Sciences from the Ontario Ministry of Health and Innovation. J.-P.L. is supported by a fellowship from the Natural Sciences and Engineering Research Council of Canada. A.-C. G. and C. H. A. hold Canada Research Chairs in Functional Proteomics and Structural Proteomics, respectively.	Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Baker LA, 2008, MUTAT RES-FUND MOL M, V647, P3, DOI 10.1016/j.mrfmmm.2008.07.004; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Beyer M, 2009, METHODS MOL BIOL, V570, P309, DOI 10.1007/978-1-60327-394-7_16; Bloch DB, 2000, MOL CELL BIOL, V20, P6138, DOI 10.1128/MCB.20.16.6138-6146.2000; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chung CW, 2011, J MED CHEM, V54, P3827, DOI 10.1021/jm200108t; Ciro M, 2009, CANCER RES, V69, P8491, DOI 10.1158/0008-5472.CAN-09-2131; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Fairbridge NA, 2010, BIRTH DEFECTS RES A, V88, P619, DOI 10.1002/bdra.20695; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Fossey SC, 2000, MAMM GENOME, V11, P919, DOI 10.1007/s003350010174; French CA, 2001, AM J PATHOL, V159, P1987, DOI 10.1016/S0002-9440(10)63049-0; French CA, 2010, J CLIN PATHOL, V63, P492, DOI 10.1136/jcp.2007.052902; French CA, 2010, CANCER GENET CYTOGEN, V203, P16, DOI 10.1016/j.cancergencyto.2010.06.007; Goodwin GH, 2001, GENE, V268, P1, DOI 10.1016/S0378-1119(01)00428-0; Gregory GD, 2007, MOL CELL BIOL, V27, P8466, DOI 10.1128/MCB.00993-07; Harikrishnan KN, 2005, NAT GENET, V37, P254, DOI 10.1038/ng1516; HAYNES SR, 1992, NUCLEIC ACIDS RES, V20, P2603, DOI 10.1093/nar/20.10.2603; Hewings DS, 2011, J MED CHEM, V54, P6761, DOI 10.1021/jm200640v; Huang H, 2003, DEV DYNAM, V227, P608, DOI 10.1002/dvdy.10344; Huang HD, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-57; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; Kalkhoven E, 2004, BIOCHEM PHARMACOL, V68, P1145, DOI 10.1016/j.bcp.2004.03.045; Kanno T, 2004, MOL CELL, V13, P33, DOI 10.1016/S1097-2765(03)00482-9; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Leroy G, 2008, MOL CELL, V30, P51, DOI 10.1016/j.molcel.2008.01.018; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li YY, 2011, J BIOL CHEM, V286, P13925, DOI 10.1074/jbc.M111.223198; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lo WS, 2001, SCIENCE, V293, P1142, DOI 10.1126/science.1062322; Masselink H, 2000, ONCOGENE, V19, P1538, DOI 10.1038/sj.onc.1203421; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Moriniere J, 2009, NATURE, V461, P664, DOI 10.1038/nature08397; Muller P, 2005, NATURE, V436, P871, DOI 10.1038/nature03869; Muller S, 2011, EXPERT REV MOL MED, V13, P1, DOI 10.1017/S1462399411001992; Nady N, 2008, TRENDS BIOCHEM SCI, V33, P305, DOI 10.1016/j.tibs.2008.04.014; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Owen DJ, 2000, EMBO J, V19, P6141, DOI 10.1093/emboj/19.22.6141; Podcheko A, 2007, MOL CELL BIOL, V27, P6484, DOI 10.1128/MCB.02409-06; Racki LR, 2009, NATURE, V462, P1016, DOI 10.1038/nature08621; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Reineke U, 2001, CURR OPIN BIOTECH, V12, P59, DOI 10.1016/S0958-1669(00)00178-6; Reynoird N, 2010, EMBO J, V29, P2943, DOI 10.1038/emboj.2010.176; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2011, CELL, V145, P692, DOI 10.1016/j.cell.2011.03.053; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shen WQ, 2007, BIOCHEMISTRY-US, V46, P2100, DOI 10.1021/bi0611208; Smith BC, 2011, ACS CHEM BIOL, V6, P146, DOI 10.1021/cb100218d; Tsai WW, 2010, NATURE, V468, P927, DOI 10.1038/nature09542; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Umehara T, 2010, J BIOL CHEM, V285, P7610, DOI 10.1074/jbc.M109.062422; Wang PJ, 2002, HUM MOL GENET, V11, P2341, DOI 10.1093/hmg/11.19.2341; Wang ZX, 2010, CELL, V141, P1183, DOI 10.1016/j.cell.2010.05.016; Wassarman DA, 2001, J CELL SCI, V114, P2895; Xue YT, 2000, P NATL ACAD SCI USA, V97, P13015, DOI 10.1073/pnas.240208597; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Yang ZY, 2008, MOL CELL BIOL, V28, P967, DOI 10.1128/MCB.01020-07; Yordy JS, 2005, ONCOGENE, V24, P916, DOI 10.1038/sj.onc.1208245; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zhou YG, 2009, NAT CELL BIOL, V11, P1010, DOI 10.1038/ncb1914; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031; Zong RT, 2000, EMBO J, V19, P4123, DOI 10.1093/emboj/19.15.4123	84	1041	1122	11	195	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					214	231		10.1016/j.cell.2012.02.013	http://dx.doi.org/10.1016/j.cell.2012.02.013			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464331	Green Published, hybrid, Green Accepted			2022-12-24	WOS:000302235400022
J	Barnett, K; Mercer, SW; Norbury, M; Watt, G; Wyke, S; Guthrie, B				Barnett, Karen; Mercer, Stewart W.; Norbury, Michael; Watt, Graham; Wyke, Sally; Guthrie, Bruce			Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study	LANCET			English	Article							QUALITY-OF-CARE; CHRONIC DISEASES; GENERAL-PRACTICE; DETERMINANTS; COMORBIDITY; DEPRESSION; PREVALENCE; GUIDELINES; LAW	Background Long-term disorders are the main challenge facing health-care systems worldwide, but health systems are largely configured for individual diseases rather than multimorbidity. We examined the distribution of multimorbidity, and of comorbidity of physical and mental health disorders, in relation to age and socioeconomic deprivation. Methods In a cross-sectional study we extracted data on 40 morbidities from a database of 1 751 841 people registered with 314 medical practices in Scotland as of March, 2007. We analysed the data according to the number of morbidities, disorder type (physical or mental), sex, age, and socioeconomic status. We defined multimorbidity as the presence of two or more disorders. Findings 42.2% (95% CI 42.1-42.3) of all patients had one or more morbidities, and 23.2% (23.08-23.21) were multimorbid. Although the prevalence of multimorbidity increased substantially with age and was present in most people aged 65 years and older, the absolute number of people with multimorbidity was higher in those younger than 65 years (210 500 vs 194 996). Onset of multimorbidity occurred 10-15 years earlier in people living in the most deprived areas compared with the most affluent, with socioeconomic deprivation particularly associated with multimorbidity that included mental health disorders (prevalence of both physical and mental health disorder 11.0%, 95% CI 10.9-11.2% in most deprived area vs 5.9%, 5.8%-6.0% in least deprived). The presence of a mental health disorder increased as the number of physical morbidities increased (adjusted odds ratio 6.74, 95% CI 6.59-6.90 for five or more disorders vs 1.95, 1.93-1.98 for one disorder), and was much greater in more deprived than in less deprived people (2.28, 2.21-2.32 vs 1.08, 1.05-1.11). Interpretation Our findings challenge the single-disease framework by which most health care, medical research, and medical education is configured. A complementary strategy is needed, supporting generalist clinicians to provide personalised, comprehensive continuity of care, especially in socioeconomically deprived areas.	[Barnett, Karen; Norbury, Michael; Guthrie, Bruce] Univ Dundee, Populat Hlth Sci Div, Qual Safety & Informat Res Grp, Dundee DD2 4BF, Scotland; [Wyke, Sally] Univ Glasgow, Inst Hlth & Wellbeing, Coll Social Sci, Glasgow, Lanark, Scotland	University of Dundee; University of Glasgow	Guthrie, B (corresponding author), Univ Dundee, Populat Hlth Sci Div, Qual Safety & Informat Res Grp, Dundee DD2 4BF, Scotland.	b.guthrie@dundee.ac.uk	Guthrie, Bruce/HHM-9696-2022	Mercer, Stewart William/0000-0002-1703-3664; Guthrie, Bruce/0000-0003-4191-4880	Scottish Government Chief Scientist Office; Chief Scientist Office of the Scottish Government Health Directorates [ARPG/07/1)]; Chief Scientist Office [ARPG/07/01] Funding Source: researchfish	Scottish Government Chief Scientist Office; Chief Scientist Office of the Scottish Government Health Directorates; Chief Scientist Office	Scottish Government Chief Scientist Office.; We thank the Chief Scientist Office of the Scottish Government Health Directorates (Applied Research Programme Grant ARPG/07/1), which funded the work; the Scottish School of Primary Care, which part supported SWM's post and the development of the Applied Research Programme; and the Primary Care Clinical Informatics Unit at the University of Aberdeen, which provided the data contained herein. The views in this publication are not necessarily the views of the University of Aberdeen, its agents, or employees. We thank Katie Wilde and Fiona Chaloner of the University of Aberdeen, who did the initial data extraction and management.	Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Carstairs V., 1991, DEPRIVATION HLTH SCO; Diederichs C, 2011, J GERONTOL A-BIOL, V66, P301, DOI 10.1093/gerona/glq208; Eachus J, 1996, BMJ-BRIT MED J, V312, P287; Elder R, 2007, MEASURING QUALITY PR; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Gijsen R, 2001, J CLIN EPIDEMIOL, V54, P661, DOI 10.1016/S0895-4356(00)00363-2; Gunn JM, 2012, SOC PSYCH PSYCH EPID, V47, P175, DOI 10.1007/s00127-010-0330-z; Guthrie B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a867; Higashi T, 2007, NEW ENGL J MED, V356, P2496, DOI 10.1056/NEJMsa066253; Information Services Division NHS Scotland, 2008, MEAS LONG TERM COND; Kadam UT, 2007, FAM PRACT, V24, P412, DOI 10.1093/fampra/cmm049; Katon WJ, 2010, NEW ENGL J MED, V363, P2611, DOI 10.1056/NEJMoa1003955; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mercer SW, 2007, ANN FAM MED, V5, P503, DOI 10.1370/afm.778; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; NHS- Primary Care Commissioning, QOF IMPL BUS RUL V 1; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schoen C, 2010, 2010 COMMONWEALTH FU; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; The Scottish Government, 2010, LONG TERM MON HLTH I; van den Akker M, 1998, J CLIN EPIDEMIOL, V51, P367, DOI 10.1016/S0895-4356(97)00306-5; Van Spall HGC, 2007, JAMA-J AM MED ASSOC, V297, P1233, DOI 10.1001/jama.297.11.1233; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1; Walker AE, 2007, CHRONIC ILLN, V3, P202, DOI 10.1177/1742395307081504; Watt G, 2002, LANCET, V360, P252, DOI 10.1016/S0140-6736(02)09466-7; WHO, 2011, GLOB STAT REP NONC D; WHO, 2008, PHARMAFORUM 0121; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	30	3382	3461	40	458	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2012	380	9836					37	43		10.1016/S0140-6736(12)60240-2	http://dx.doi.org/10.1016/S0140-6736(12)60240-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970GK	22579043				2022-12-24	WOS:000306115900031
J	Nelson, MR; Wegmann, D; Ehm, MG; Kessner, D; Jean, PS; Verzilli, C; Shen, JD; Tang, ZZ; Bacanu, SA; Fraser, D; Warren, L; Aponte, J; Zawistowski, M; Liu, X; Zhang, H; Zhang, Y; Li, J; Li, Y; Li, L; Woollard, P; Topp, S; Hall, MD; Nangle, K; Wang, J; Abecasis, G; Cardon, LR; Zollner, S; Whittaker, JC; Chissoe, SL; Novembre, J; Mooser, V				Nelson, Matthew R.; Wegmann, Daniel; Ehm, Margaret G.; Kessner, Darren; Jean, Pamela St.; Verzilli, Claudio; Shen, Judong; Tang, Zhengzheng; Bacanu, Silviu-Alin; Fraser, Dana; Warren, Liling; Aponte, Jennifer; Zawistowski, Matthew; Liu, Xiao; Zhang, Hao; Zhang, Yong; Li, Jun; Li, Yun; Li, Li; Woollard, Peter; Topp, Simon; Hall, Matthew D.; Nangle, Keith; Wang, Jun; Abecasis, Goncalo; Cardon, Lon R.; Zoellner, Sebastian; Whittaker, John C.; Chissoe, Stephanie L.; Novembre, John; Mooser, Vincent			An Abundance of Rare Functional Variants in 202 Drug Target Genes Sequenced in 14,002 People	SCIENCE			English	Article							MISSING HERITABILITY; POPULATION-GROWTH; COMPLEX DISEASES; GENOME; ASSOCIATION; TRAITS; SPECTRUM; MUTATION; ALLELES; EUROPE	Rare genetic variants contribute to complex disease risk; however, the abundance of rare variants in human populations remains unknown. We explored this spectrum of variation by sequencing 202 genes encoding drug targets in 14,002 individuals. We find rare variants are abundant (1 every 17 bases) and geographically localized, so that even with large sample sizes, rare variant catalogs will be largely incomplete. We used the observed patterns of variation to estimate population growth parameters, the proportion of variants in a given frequency class that are putatively deleterious, and mutation rates for each gene. We conclude that because of rapid population growth and weak purifying selection, human populations harbor an abundance of rare variants, many of which are deleterious and have relevance to understanding disease risk.	[Nelson, Matthew R.; Ehm, Margaret G.; Jean, Pamela St.; Shen, Judong; Bacanu, Silviu-Alin; Fraser, Dana; Warren, Liling; Aponte, Jennifer; Li, Li; Nangle, Keith; Chissoe, Stephanie L.] GlaxoSmithKline GSK, Dept Quantitat Sci, Res Triangle Pk, NC 27709 USA; [Wegmann, Daniel; Kessner, Darren; Novembre, John] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Verzilli, Claudio; Woollard, Peter; Topp, Simon; Hall, Matthew D.; Whittaker, John C.] GSK, Dept Quantitat Sci, Stevenage SG1 2NY, Herts, England; [Tang, Zhengzheng; Li, Yun] Univ N Carolina, Dept Genet & Biostat, Chapel Hill, NC 27599 USA; [Zawistowski, Matthew; Abecasis, Goncalo; Zoellner, Sebastian] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Liu, Xiao; Zhang, Hao; Zhang, Yong; Wang, Jun] BGI, Shenzhen 518083, Peoples R China; [Li, Yun] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Wang, Jun] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Dept Biol, DK-33939524 Copenhagen, Denmark; [Cardon, Lon R.; Mooser, Vincent] GSK, Dept Quantitat Sci, Upper Merion, PA 19406 USA; [Zoellner, Sebastian] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	GlaxoSmithKline; University of California System; University of California Los Angeles; GlaxoSmithKline; University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; Beijing Genomics Institute (BGI); University of Michigan System; University of Michigan; Novo Nordisk Foundation; University of Copenhagen; GlaxoSmithKline; University of Michigan System; University of Michigan	Nelson, MR (corresponding author), GlaxoSmithKline GSK, Dept Quantitat Sci, Res Triangle Pk, NC 27709 USA.	matthew.r.nelson@gsk.com; jnovembre@ucla.edu	Abecasis, Goncalo R/B-7840-2010; Tang, Zheng-Zheng/F-6642-2014; Liu, Xiao/P-2732-2015; Wegmann, Daniel/K-2199-2012; Wang, Jun/A-7261-2013; Whittaker, John C/B-8609-2012; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Tang, Zheng-Zheng/0000-0003-3802-8087; Liu, Xiao/0000-0002-8073-0534; Wegmann, Daniel/0000-0003-2866-6739; Whittaker, John C/0000-0002-3529-2379; Li, Jun/0000-0001-6727-0812; Woollard, Peter/0000-0002-7654-6902; Fraser, Dana/0000-0002-4542-0784; Bacanu, Silviu-Alin/0000-0002-4364-1583; Hall, Matthew/0000-0002-8307-8633; topp, simon/0000-0002-5200-3284; Abecasis, Goncalo/0000-0003-1509-1825; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	Searle Scholars Program award; NIH; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536, U01HG006513] Funding Source: NIH RePORTER	Searle Scholars Program award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank GSK colleagues who advised on the selection of genes and collections, especially W. Anderson, L. Condreay, P. Agarwal, A. Hughes, J. Rubio, C. Spraggs, and D. Waterworth; the sample preparation team, especially J. Charnecki, M. E. Volk, D. Duran, D. Briley, and K. King for data preparation; A. Slater for subject selection and preparation of genome-wide genotype data; E. Woldu for capillary sequencing; A. Nelsen, S. Buhta-Halburnt, L. Amos, and J. Forte for consent review; M. Lawson for assistance in running the association analyses; J. Brown for discussions about gene feature analyses; S. Ghosh for providing reviews of the manuscript; and G. Tian, H. Jiang, Z. Su, X. Sun, L. Yang, and X. Zhang at BGI for sequencing. We acknowledge the work of collaborating clinicians and researchers who contributed to recruiting and characterizing subjects (13). J.N. and D. W. were supported by a Searle Scholars Program award to J.N. D. K. is supported by a NIH Genome Analysis training grant. All variants described in this study have been submitted to dbSNP; accession nos. are included in database S2. Subject-level sequence data for CoLaus and LOLIPOP studies are available in dbGaP. Additional subject-level sequence data can be made available upon request from the authors under a Data Transfer Agreement for the purpose to understand, assess, or extend the conclusions of this paper.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; [Anonymous], 2012, SEATTLESNPS; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Awadalla P, 2010, AM J HUM GENET, V87, P316, DOI 10.1016/j.ajhg.2010.07.019; Bustamante CD, 2011, NATURE, V475, P163, DOI 10.1038/475163a; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; JOBLING MA, 2003, HUMAN EVOLUTIONARY G; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; LANDER ES, 1994, SCIENCE, V265, P2037, DOI 10.1126/science.8091226; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Livi-Bacci M., 2007, CONCISE HIST WORLD P, p[1, 250]; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; Messer PW, 2009, GENETICS, V182, P1219, DOI 10.1534/genetics.109.105692; MULLER HJ, 1950, AM J HUM GENET, V2, P111; OHTA T, 1973, NATURE, V246, P96, DOI 10.1038/246096a0; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Russ AP, 2005, DRUG DISCOV TODAY, V10, P1607, DOI 10.1016/S1359-6446(05)03666-4; Salmela E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003519; Wakeley J, 2003, MOL BIOL EVOL, V20, P208, DOI 10.1093/molbev/msg024; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	28	473	483	0	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 6	2012	337	6090					100	104		10.1126/science.1217876	http://dx.doi.org/10.1126/science.1217876			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22604722	Green Submitted, Green Accepted			2022-12-24	WOS:000306053100053
J	van den Brand, R; Heutschi, J; Barraud, Q; DiGiovanna, J; Bartholdi, K; Huerlimann, M; Friedli, L; Vollenweider, I; Moraud, EM; Duis, S; Dominici, N; Micera, S; Musienko, P; Courtine, G				van den Brand, Rubia; Heutschi, Janine; Barraud, Quentin; DiGiovanna, Jack; Bartholdi, Kay; Huerlimann, Michele; Friedli, Lucia; Vollenweider, Isabel; Moraud, Eduardo Martin; Duis, Simone; Dominici, Nadia; Micera, Silvestro; Musienko, Pavel; Courtine, Gregoire			Restoring Voluntary Control of Locomotion after Paralyzing Spinal Cord Injury	SCIENCE			English	Article							STIMULATION; RECOVERY; REGENERATION; NEURONS; WALKING; CAT	Half of human spinal cord injuries lead to chronic paralysis. Here, we introduce an electrochemical neuroprosthesis and a robotic postural interface designed to encourage supraspinally mediated movements in rats with paralyzing lesions. Despite the interruption of direct supraspinal pathways, the cortex regained the capacity to transform contextual information into task-specific commands to execute refined locomotion. This recovery relied on the extensive remodeling of cortical projections, including the formation of brainstem and intraspinal relays that restored qualitative control over electrochemically enabled lumbosacral circuitries. Automated treadmill-restricted training, which did not engage cortical neurons, failed to promote translesional plasticity and recovery. By encouraging active participation under functional states, our training paradigm triggered a cortex-dependent recovery that may improve function after similar injuries in humans.	[van den Brand, Rubia; Heutschi, Janine; Barraud, Quentin; Bartholdi, Kay; Huerlimann, Michele; Friedli, Lucia; Vollenweider, Isabel; Duis, Simone; Dominici, Nadia; Musienko, Pavel; Courtine, Gregoire] Univ Zurich, Dept Neurol, CH-8008 Zurich, Switzerland; [DiGiovanna, Jack; Moraud, Eduardo Martin; Micera, Silvestro] Swiss Fed Inst Technol EPFL, Sch Engn, Ctr Neuroprosthet, CH-1015 Lausanne, Switzerland; [DiGiovanna, Jack; Moraud, Eduardo Martin; Micera, Silvestro] Swiss Fed Inst Technol, Automat Control Lab, CH-8092 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich	Courtine, G (corresponding author), Univ Zurich, Dept Neurol, CH-8008 Zurich, Switzerland.	gregoire.courtine@epfl.ch	courtine, gregoire/AAJ-1694-2020; Micera, Silvestro/AAD-6630-2021; Musienko, Pavel/L-6677-2015	courtine, gregoire/0000-0002-5744-4142; Musienko, Pavel/0000-0002-7324-9021; Martin Moraud, Eduardo/0000-0002-6148-7065; Dominici, Nadia/0000-0003-2312-915X; Barraud, Quentin/0000-0003-0894-1959; DiGiovanna, Jack/0000-0002-7757-4120	European Research Council (ERC) [261247]; International Paraplegic Foundation; Neuroscience Center Zurich; European Commission [CP-IP 258654]; Swiss National Science Foundation [310030_130850]	European Research Council (ERC)(European Research Council (ERC)European Commission); International Paraplegic Foundation; Neuroscience Center Zurich; European Commission(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We thank U. Keller for assistance with the robotic interface. Imaging was performed using equipment maintained by the Center for Microscopy and Image Analysis, University of Zurich. Financial support was provided by a Starting Grant from the European Research Council (ERC 261247, Walk Again); an International Paraplegic Foundation Fellowship; the Neuroscience Center Zurich; European Commission's Seventh Framework Program (CP-IP 258654, NeuWALK); and funding from the Swiss National Science Foundation (subsidy 310030_130850).	Alto LT, 2009, NAT NEUROSCI, V12, P1106, DOI 10.1038/nn.2365; BARBEAU H, 1987, BRAIN RES, V412, P84, DOI 10.1016/0006-8993(87)91442-9; Bareyre FM, 2004, NAT NEUROSCI, V7, P269, DOI 10.1038/nn1195; Brosamle C, 1997, J COMP NEUROL, V386, P293, DOI 10.1002/(SICI)1096-9861(19970922)386:2<293::AID-CNE9>3.0.CO;2-X; Cai LL, 2006, J NEUROSCI, V26, P10564, DOI 10.1523/JNEUROSCI.2266-06.2006; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Cowley KC, 2008, J PHYSIOL-LONDON, V586, P1623, DOI 10.1113/jphysiol.2007.148361; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Edgerton VR, 2008, BRAIN RES REV, V57, P241, DOI 10.1016/j.brainresrev.2007.09.002; Fuentes R, 2009, SCIENCE, V323, P1578, DOI 10.1126/science.1164901; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Hagglund M, 2010, NAT NEUROSCI, V13, P246, DOI 10.1038/nn.2482; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Kakulas B A, 1999, J Spinal Cord Med, V22, P119; Liu J, 2005, J NEUROPHYSIOL, V94, P1392, DOI 10.1152/jn.00136.2005; LOVELY RG, 1986, EXP NEUROL, V92, P421, DOI 10.1016/0014-4886(86)90094-4; Musienko P, 2012, EXP NEUROL, V235, P100, DOI 10.1016/j.expneurol.2011.08.025; Musienko P, 2011, J NEUROSCI, V31, P9264, DOI 10.1523/JNEUROSCI.5796-10.2011; Musienko P, 2009, IEEE T BIO-MED ENG, V56, P2707, DOI 10.1109/TBME.2009.2027226; Rosenzweig ES, 2010, NAT NEUROSCI, V13, P1505, DOI 10.1038/nn.2691; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Sun F, 2011, NATURE, V480, P372, DOI 10.1038/nature10594; Wernig A, 2005, ARCH PHYS MED REHAB, V86, P2385, DOI 10.1016/j.apmr.2005.10.009; WERNIG A, 1992, PARAPLEGIA, V30, P229, DOI 10.1038/sc.1992.61; WERNIG A, 1995, EUR J NEUROSCI, V7, P823, DOI 10.1111/j.1460-9568.1995.tb00686.x; Wirz M, 2005, ARCH PHYS MED REHAB, V86, P672, DOI 10.1016/j.apmr.2004.08.004	28	513	532	20	232	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1182	1185		10.1126/science.1217416	http://dx.doi.org/10.1126/science.1217416			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654062	Green Published, Green Submitted			2022-12-24	WOS:000304647900056
J	Moreno, JA; Radford, H; Peretti, D; Steinert, JR; Verity, N; Martin, MG; Halliday, M; Morgan, J; Dinsdale, D; Ortori, CA; Barrett, DA; Tsaytler, P; Bertolotti, A; Willis, AE; Bushell, M; Mallucci, GR				Moreno, Julie A.; Radford, Helois; Peretti, Diego; Steinert, Joern R.; Verity, Nicholas; Martin, Maria Guerra; Halliday, Mark; Morgan, Jason; Dinsdale, David; Ortori, Catherine A.; Barrett, David A.; Tsaytler, Pavel; Bertolotti, Anne; Willis, Anne E.; Bushell, Martin; Mallucci, Giovanna R.			Sustained translational repression by eIF2 alpha-P mediates prion neurodegeneration	NATURE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; TOXICITY IN-VIVO; ALZHEIMERS-DISEASE; GENE-EXPRESSION; ER STRESS; MICE; PRP; PROTEOSTASIS; DYSFUNCTION	The mechanisms leading to neuronal death in neurodegenerative disease are poorly understood. Many of these disorders, including Alzheimer's, Parkinson's and prion diseases, are associated with the accumulation of misfolded disease-specific proteins. The unfolded protein response is a protective cellular mechanism triggered by rising levels of misfolded proteins. One arm of this pathway results in the transient shutdown of protein translation, through phosphorylation of the alpha-subunit of eukaryotic translation initiation factor, eIF2. Activation of the unfolded protein response and/or increased eIF2 alpha-P levels are seen in patients with Alzheimer's, Parkinson's and prion diseases(1-4), but how this links to neurodegeneration is unknown. Here we show that accumulation of prion protein during prion replication causes persistent translational repression of global protein synthesis by eIF2 alpha-P, associated with synaptic failure and neuronal loss in prion-diseased mice. Further, we show that promoting translational recovery in hippocampi of prion-infected mice is neuroprotective. Overexpression of GADD34, a specific eIF2 alpha-P phosphatase, as well as reduction of levels of prion protein by lentivirally mediated RNA interference, reduced eIF2 alpha-P levels. As a result, both approaches restored vital translation rates during prion disease, rescuing synaptic deficits and neuronal loss, thereby significantly increasing survival. In contrast, salubrinal, an inhibitor of eIF2 alpha-P dephosphorylation(5), increased eIF2 alpha-P levels, exacerbating neurotoxicity and significantly reducing survival in prion-diseased mice. Given the prevalence of protein misfolding and activation of the unfolded protein response in several neurodegenerative diseases, our results suggest that manipulation of common pathways such as translational control, rather than disease-specific approaches, may lead to new therapies preventing synaptic failure and neuronal loss across the spectrum of these disorders.	[Moreno, Julie A.; Radford, Helois; Peretti, Diego; Steinert, Joern R.; Verity, Nicholas; Martin, Maria Guerra; Halliday, Mark; Morgan, Jason; Dinsdale, David; Willis, Anne E.; Bushell, Martin; Mallucci, Giovanna R.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Ortori, Catherine A.; Barrett, David A.] Univ Nottingham, Sch Pharm, Ctr Analyt Biosci, Nottingham NG7 2RD, England; [Tsaytler, Pavel; Bertolotti, Anne] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	University of Leicester; University of Nottingham; MRC Laboratory Molecular Biology	Mallucci, GR (corresponding author), Univ Leicester, MRC, Toxicol Unit, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	grm7@le.ac.uk	Steinert, Joern/ABB-4561-2020; Moreno, Julie/L-1832-2018; Martín, María/HDL-9512-2022; Steinert, Joern R/AAI-2742-2020; Barrett, David/C-9922-2011	Moreno, Julie/0000-0002-9618-2712; Steinert, Joern R/0000-0003-1640-0845; Willis, Anne/0000-0002-1470-8531; Barrett, David/0000-0001-6900-9474; Mallucci, Giovanna/0000-0001-8504-1191	Medical Research Council, UK; BBSRC [BB/F02326X/2] Funding Source: UKRI; MRC [MC_UP_A600_1024, MC_U105185860, MC_U132692719, MC_UP_A600_1023, MC_U132681855, MC_U123160654] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F02326X/2] Funding Source: researchfish; Medical Research Council [MC_U123160654, MC_UP_A600_1023, MC_UP_A600_1024, MC_U132692719, MC_U132681855, MC_U105185860] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Read for imaging analysis, J. Edwards, T. Smith, J. McWilliam, P. Glynn, C. Molloy and University of Leicester, Department of Biological Services staff for technical assistance, J. Collinge (MRC Prion Unit) for the original RML prion inoculum, and K. Liddle for reading the manuscript. This work was funded by the Medical Research Council, UK.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chafekar SM, 2007, ANTIOXID REDOX SIGN, V9, P2245, DOI 10.1089/ars.2007.1797; Cunningham C, 2003, EUR J NEUROSCI, V17, P2147, DOI 10.1046/j.1460-9568.2003.02662.x; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haustein MD, 2010, J PHYSIOL-LONDON, V588, P4683, DOI 10.1113/jphysiol.2010.199778; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Hoozemans JJM, 2007, BIOCHEM BIOPH RES CO, V354, P707, DOI 10.1016/j.bbrc.2007.01.043; Hoozemans JJM, 2009, AM J PATHOL, V174, P1241, DOI 10.2353/ajpath.2009.080814; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Jiang M, 2004, GENE THER, V11, P1303, DOI 10.1038/sj.gt.3302305; Johannes G, 1998, RNA, V4, P1500, DOI 10.1017/S1355838298981080; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mallucci GR, 2007, NEURON, V53, P325, DOI 10.1016/j.neuron.2007.01.005; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; MANSON JC, 1994, NEURODEGENERATION, V3, P331; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Saxena S, 2009, NAT NEUROSCI, V12, P627, DOI 10.1038/nn.2297; Sokka AL, 2007, J NEUROSCI, V27, P901, DOI 10.1523/JNEUROSCI.4289-06.2007; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; Steele AD, 2007, J NEUROSCI, V27, P13022, DOI 10.1523/JNEUROSCI.3290-07.2007; Steele AD, 2007, PRION, V1, P243, DOI 10.4161/pri.1.4.5551; Steinert JR, 2011, NEURON, V71, P291, DOI 10.1016/j.neuron.2011.05.037; Tsaytler P, 2011, SCIENCE, V332, P91, DOI 10.1126/science.1201396; Unterberger U, 2006, J NEUROPATH EXP NEUR, V65, P348, DOI 10.1097/01.jnen.0000218445.30535.6f; White MD, 2008, P NATL ACAD SCI USA, V105, P10238, DOI 10.1073/pnas.0802759105; White MD, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00008; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Yoo BC, 2002, NEUROSCI LETT, V334, P196, DOI 10.1016/S0304-3940(02)01071-6; Zhu Y, 2008, J NEUROSCI, V28, P2168, DOI 10.1523/JNEUROSCI.5232-07.2008	34	434	457	1	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					507	U119		10.1038/nature11058	http://dx.doi.org/10.1038/nature11058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622579	Green Accepted			2022-12-24	WOS:000304344500044
J	Zeigerer, A; Gilleron, J; Bogorad, RL; Marsico, G; Nonaka, H; Seifert, S; Epstein-Barash, H; Kuchimanchi, S; Peng, CG; Ruda, VM; Del Conte-Zerial, P; Hengstler, JG; Kalaidzidis, Y; Koteliansky, V; Zerial, M				Zeigerer, Anja; Gilleron, Jerome; Bogorad, Roman L.; Marsico, Giovanni; Nonaka, Hidenori; Seifert, Sarah; Epstein-Barash, Hila; Kuchimanchi, Satya; Peng, Chang Geng; Ruda, Vera M.; Del Conte-Zerial, Perla; Hengstler, Jan G.; Kalaidzidis, Yannis; Koteliansky, Victor; Zerial, Marino			Rab5 is necessary for the biogenesis of the endolysosomal system in vivo	NATURE			English	Article							POLARIZED EPITHELIAL-CELLS; LIPID-LIKE MATERIALS; RECYCLING ENDOSOMES; MEMBRANE-FUSION; PLASMA-MEMBRANE; RNAI THERAPEUTICS; ENDOCYTIC PATHWAY; TRAFFICKING; PROTEINS; TRANSPORT	An outstanding question is how cells control the number and size of membrane organelles. The small GTPase Rab5 has been proposed to be a master regulator of endosome biogenesis. Here, to test this hypothesis, we developed a mathematical model of endosome dependency on Rab5 and validated it by titrating down all three Rab5 isoforms in adult mouse liver using state-of-the-art RNA interference technology. Unexpectedly, the endocytic system was resilient to depletion of Rab5 and collapsed only when Rab5 decreased to a critical level. Loss of Rab5 below this threshold caused a marked reduction in the number of early endosomes, late endosomes and lysosomes, associated with a block of low-density lipoprotein endocytosis. Loss of endosomes caused failure to deliver apical proteins to the bile canaliculi, suggesting a requirement for polarized cargo sorting. Our results demonstrate for the first time, to our knowledge, the role of Rab5 as an endosome organizer in vivo and reveal the resilience mechanisms of the endocytic system.	[Zeigerer, Anja; Gilleron, Jerome; Marsico, Giovanni; Nonaka, Hidenori; Seifert, Sarah; Del Conte-Zerial, Perla; Kalaidzidis, Yannis; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Bogorad, Roman L.; Koteliansky, Victor] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Epstein-Barash, Hila; Kuchimanchi, Satya; Peng, Chang Geng; Koteliansky, Victor] Alnylam Pharmaceut Inc, Cambridge, MA 02142 USA; [Ruda, Vera M.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Ruda, Vera M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Ruda, Vera M.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Hengstler, Jan G.] Leibniz Res Ctr Working Environm & Human Factors, D-44139 Dortmund, Germany; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO); Lomonosov Moscow State University	Zerial, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Kalaidzidis, Yannis/H-3094-2016; Hengstler, Jan G./O-1415-2013; Gilleron, Jerome/GRX-8574-2022; Zeigerer, Anja/AAC-8953-2021; Bogorad, Roman/G-2609-2011	Kalaidzidis, Yannis/0000-0002-6137-1193; Gilleron, Jerome/0000-0002-6389-8685; Zeigerer, Anja/0000-0003-4072-0566; Hengstler, Jan/0000-0002-1427-5246	Virtual Liver initiative; German Federal Ministry of Research and Education (BMBF); Max Planck Society (MPG); DFG; Marie Curie Action, Intra-European Fellowship [fp7-people-ief-2008]; EMBO	Virtual Liver initiative; German Federal Ministry of Research and Education (BMBF)(Federal Ministry of Education & Research (BMBF)); Max Planck Society (MPG)(Max Planck Society); DFG(German Research Foundation (DFG)); Marie Curie Action, Intra-European Fellowship; EMBO(European Molecular Biology Organization (EMBO))	We acknowledge K. Simons, E. Knust, C. Fetzer, T. Galvez, G. O'Sullivan and M. P. McShane for discussions and comments on the manuscript. We thank W. John and A. Muench-Wuttke from the Biomedical Services Facility for mouse care and injections. We acknowledge J. Peychl for the management of the Light Microscopy Facility and K. Manygoats as well as J.-M. Verbavatz for their support. We thank B. Bettencourt and J. Hettinger for siRNA design and serum biochemistry assays, respectively. This work was financially supported by the Virtual Liver initiative (http://www.virtual-liver.de), funded by the German Federal Ministry of Research and Education (BMBF), the Max Planck Society (MPG) and the DFG. A.Z. was supported by a grant from Marie Curie Action, Intra-European Fellowship (fp7-people-ief-2008) and J. G. from an EMBO long-term fellowship.	Akinc A, 2008, NAT BIOTECHNOL, V26, P561, DOI 10.1038/nbt1402; Akinc A, 2010, MOL THER, V18, P1357, DOI 10.1038/mt.2010.85; Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; BUCCI C, 1995, FEBS LETT, V366, P65, DOI 10.1016/0014-5793(95)00477-Q; Chen PI, 2009, J BIOL CHEM, V284, P30328, DOI 10.1074/jbc.M109.034546; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Collinet C, 2010, NATURE, V464, P243, DOI 10.1038/nature08779; Cresawn KO, 2007, EMBO J, V26, P3737, DOI 10.1038/sj.emboj.7601813; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45; Farr GA, 2009, J CELL BIOL, V186, P269, DOI 10.1083/jcb.200901021; FUTTER CE, 1995, J BIOL CHEM, V270, P10999, DOI 10.1074/jbc.270.18.10999; Golachowska MR, 2010, TRENDS CELL BIOL, V20, P618, DOI 10.1016/j.tcb.2010.08.004; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; GRUENBERG J, 1995, CURR OPIN CELL BIOL, V7, P552, DOI 10.1016/0955-0674(95)80013-1; Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077; Heinrich R, 2005, J CELL BIOL, V168, P271, DOI 10.1083/jcb.200409087; Ihrke G, 1998, J CELL BIOL, V141, P115, DOI 10.1083/jcb.141.1.115; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kipp H, 2001, J BIOL CHEM, V276, P7218, DOI 10.1074/jbc.M007794200; KOENIG JH, 1990, CELL TISSUE RES, V262, P233, DOI 10.1007/BF00309878; Lawe DC, 2002, J BIOL CHEM, V277, P8611, DOI 10.1074/jbc.M109239200; Love KT, 2010, P NATL ACAD SCI USA, V107, P1864, DOI 10.1073/pnas.0910603106; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Morrison HA, 2008, MOL BIOL CELL, V19, P4167, DOI 10.1091/mbc.E08-07-0716; Mukherjee S, 1997, PHYSIOL REV, V77, P759, DOI 10.1152/physrev.1997.77.3.759; Nokes RL, 2008, J CELL BIOL, V182, P845, DOI 10.1083/jcb.200802176; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; RENAUD G, 1989, HEPATOLOGY, V9, P380, DOI 10.1002/hep.1840090307; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Rybin V, 1996, NATURE, V383, P266, DOI 10.1038/383266a0; Schroeder B. M. M., 2009, LIVER BIOL PATHOBIOL, P107; Serio G, 2011, P NATL ACAD SCI USA, V108, P17337, DOI 10.1073/pnas.1103516108; Shen HY, 2011, MOL BIOL CELL, V22, P493, DOI 10.1091/mbc.E10-07-0637; Skjeldal F. M., 2012, J CELL SCI; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233; Wakabayashi Y, 2005, P NATL ACAD SCI USA, V102, P15087, DOI 10.1073/pnas.0503702102; Wakabayashi Y, 2004, MOL BIOL CELL, V15, P3485, DOI 10.1091/mbc.E03-10-0737; Wang L, 2004, HEPATOLOGY, V39, P892, DOI 10.1002/hep.20039; Weisz OA, 2009, J CELL SCI, V122, P4253, DOI 10.1242/jcs.032615; Wolfsdorf JI, 2003, REV ENDOCR METAB DIS, V4, P95, DOI 10.1023/A:1021831621210; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	49	248	254	0	51	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 24	2012	485	7399					465	470		10.1038/nature11133	http://dx.doi.org/10.1038/nature11133			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622570				2022-12-24	WOS:000304344500035
J	Gilard, M; Eltchaninoff, H; Iung, B; Donzeau-Gouge, P; Chevreul, K; Fajadet, J; Leprince, P; Leguerrier, A; Lievre, M; Prat, A; Teiger, E; Lefevre, T; Himbert, D; Tchetche, D; Carrie, D; Albat, B; Cribier, A; Rioufol, G; Sudre, A; Blanchard, D; Collet, F; Dos Santos, P; Meneveau, N; Tirouvanziam, A; Caussin, C; Guyon, P; Boschat, J; Le Breton, H; Collart, F; Houel, R; Delpine, S; Souteyrand, G; Favereau, X; Ohlmann, P; Doisy, V; Grollier, G; Gommeaux, A; Claudel, JP; Bourlon, F; Bertrand, B; Van Belle, E; Laskar, M				Gilard, Martine; Eltchaninoff, Helene; Iung, Bernard; Donzeau-Gouge, Patrick; Chevreul, Karine; Fajadet, Jean; Leprince, Pascal; Leguerrier, Alain; Lievre, Michel; Prat, Alain; Teiger, Emmanuel; Lefevre, Thierry; Himbert, Dominique; Tchetche, Didier; Carrie, Didier; Albat, Bernard; Cribier, Alain; Rioufol, Gilles; Sudre, Arnaud; Blanchard, Didier; Collet, Frederic; Dos Santos, Pierre; Meneveau, Nicolas; Tirouvanziam, Ashok; Caussin, Christophe; Guyon, Philippe; Boschat, Jacques; Le Breton, Herve; Collart, Frederic; Houel, Remi; Delpine, Stephane; Souteyrand, Geraud; Favereau, Xavier; Ohlmann, Patrick; Doisy, Vincent; Grollier, Gilles; Gommeaux, Antoine; Claudel, Jean-Philippe; Bourlon, Francois; Bertrand, Bernard; Van Belle, Eric; Laskar, Marc		FRANCE 2 Investigators	Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OUTCOME SOURCE REGISTRY; VALVULAR HEART-DISEASE; EUROPEAN REGISTRY; STENOSIS; REPLACEMENT; SOCIETY; PROSTHESIS; GUIDELINES; MANAGEMENT; COREVALVE	Background Transcatheter aortic-valve implantation (TAVI) is an emerging intervention for the treatment of high-risk patients with severe aortic stenosis and coexisting illnesses. We report the results of a prospective multicenter study of the French national transcatheter aortic-valve implantation registry, FRANCE 2. Methods All TAVIs performed in France, as listed in the FRANCE 2 registry, were prospectively included in the study. The primary end point was death from any cause. Results A total of 3195 patients were enrolled between January 2010 and October 2011 at 34 centers. The mean (+/- SD) age was 82.7 +/- 7.2 years; 49% of the patients were women. All patients were highly symptomatic and were at high surgical risk for aortic-valve replacement. Edwards SAPIEN and Medtronic CoreValve devices were implanted in 66.9% and 33.1% of patients, respectively. Approaches were either transarterial (transfemoral, 74.6%; subclavian, 5.8%; and other, 1.8%) or transapical (17.8%). The procedural success rate was 96.9%. Rates of death at 30 days and 1 year were 9.7% and 24.0%, respectively. At 1 year, the incidence of stroke was 4.1%, and the incidence of periprosthetic aortic regurgitation was 64.5%. In a multivariate model, a higher logistic risk score on the European System for Cardiac Operative Risk Evaluation (EuroSCORE), New York Heart Association functional class III or IV symptoms, the use of a transapical TAVI approach, and a higher amount of periprosthetic regurgitation were significantly associated with reduced survival. Conclusions This prospective registry study reflected real-life TAVI experience in high-risk elderly patients with aortic stenosis, in whom TAVI appeared to be a reasonable option. (Funded by Edwards Lifesciences and Medtronic.)	[Gilard, Martine; Boschat, Jacques] CHU Brest, F-29285 Brest, France; [Eltchaninoff, Helene; Cribier, Alain] Univ Rouen, Hop Charles Nicolle, INSERM, U1096, Rouen, France; [Iung, Bernard; Himbert, Dominique] Hop Bichat Claude Bernard, F-75877 Paris, France; [Chevreul, Karine; Teiger, Emmanuel] CHU Henri Mondor, Paris, France; [Leprince, Pascal] Hop La Pitie Salpetriere, Paris, France; [Donzeau-Gouge, Patrick; Lefevre, Thierry] Inst Jacques Cartier, Massy, France; [Fajadet, Jean; Tchetche, Didier] Clin Pasteur, Toulouse, France; [Carrie, Didier] CHU Toulouse, Toulouse, France; [Leguerrier, Alain; Le Breton, Herve] CHU Rennes, Rennes, France; [Lievre, Michel] Univ Lyon 1, F-69365 Lyon, France; [Doisy, Vincent] Clin Tonkin, Lyon, France; [Claudel, Jean-Philippe] Infirm Protestante, Lyon, France; [Prat, Alain; Sudre, Arnaud; Van Belle, Eric] CHU Lille, F-59037 Lille, France; [Albat, Bernard] CHU Montpellier, Montpellier, France; [Blanchard, Didier] Clin St Gatien, Tours, France; [Rioufol, Gilles] CHU Lyon, Bron, France; [Collet, Frederic] Hop Clairval, Marseille, France; [Houel, Remi] Hop St Joseph, Marseille, France; [Collet, Frederic] Hop Enfants La Timone, Marseille, France; [Caussin, Christophe] Hop Marie Lannelongue, F-92350 Le Plessis Robinson, France; [Meneveau, Nicolas] CHU Besancon, F-25030 Besancon, France; [Guyon, Philippe] Ctr Cardiol Nord, St Denis, France; [Dos Santos, Pierre] CHU Bordeaux, Bordeaux, France; [Tirouvanziam, Ashok] CHU Nantes, F-44035 Nantes 01, France; [Delpine, Stephane] CHU Angers, Angers, France; [Souteyrand, Geraud] CHU Clermont Ferrand, Clermont Ferrand, France; [Favereau, Xavier] Parly 2, Le Chesnay, France; [Ohlmann, Patrick] CHU Strasbourg, F-67000 Strasbourg, France; [Grollier, Gilles] CHU Caen, F-14000 Caen, France; [Gommeaux, Antoine] Polyclin Bois Bernard, Bois Bernard, France; [Bertrand, Bernard] CHU Grenoble, F-38043 Grenoble, France; [Laskar, Marc] CHU Dupuytren, Limoges, France; [Bourlon, Francois] Ctr Cardiothorac, Monte Carlo, Monaco	CHU Brest; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Jacques Cartier Private Hospital; CHU de Toulouse; CHU Rennes; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Montpellier; CHU Lyon; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Hopital Marie Lannelongue; Universite de Franche-Comte; CHU Besancon; CHU Bordeaux; Nantes Universite; CHU de Nantes; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; CHU Clermont Ferrand; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Limoges	Gilard, M (corresponding author), Univ Bretagne Occidentale, Dept Cardiol, CHU Cavale Blanche, EA 4524, Blvd Tanguy Prigent, F-29609 Brest, France.	martine.gilard@chu-brest.fr	banfi, carlo/P-5697-2019; chevreul, karine/AAN-2380-2020; Prunier, Fabrice/A-5210-2011; Sudre, Arnaud/ABF-7614-2020; Iung, Bernard/AAQ-9004-2020; Doğan, Ali/AAN-5331-2020; Chavanon, Olivier/AAC-8171-2019; Carrie, Didier/M-5781-2014; Le Breton, Herve/ABD-8171-2020	banfi, carlo/0000-0003-1134-2068; Iung, Bernard/0000-0002-9127-348X; Chavanon, Olivier/0000-0001-8625-691X; TEIGER, emmanuel/0000-0001-7515-4344; jegaden, olivier/0000-0002-9031-0920; CARRIE, didier/0000-0003-2479-8144; Juthier, Francis/0000-0002-5072-9073; Dos Santos, Pierre/0000-0002-0811-3099; VAN BELLE, ERIC/0000-0001-6509-443X; Piot, Christophe/0000-0001-7497-0294; patrick, nataf/0000-0002-8412-6182; Gilard, Martine/0000-0002-2794-7953	Edwards Lifesciences; Medtronic	Edwards Lifesciences; Medtronic(Medtronic)	Supported by Edwards Lifesciences and Medtronic.	American College of Cardiology/American Heart Association Task Force on Practice Guidelines Society of Cardiovascular Anesthesiologists Society for Cardiovascular Angiography and Interventions, 2007, CIRCULATION, V115, pe409; Bonow RO, 2010, CIRCULATION, V121, pE443, DOI 10.1161/CIR.0b013e3181e3e359; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; Bosmans JM, 2011, INTERACT CARDIOV TH, V12, P762, DOI 10.1510/icvts.2010.253773; Brown JM, 2009, J THORAC CARDIOV SUR, V137, P82, DOI 10.1016/j.jtcvs.2008.08.015; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Eltchaninoff H, 2008, ARCH CARDIOVASC DIS, V101, P126, DOI 10.1016/S1875-2136(08)70270-5; Eltchaninoff H, 2011, EUR HEART J, V32, P191, DOI 10.1093/eurheartj/ehq261; Gotzmann M, 2011, AM HEART J, V162, P238, DOI 10.1016/j.ahj.2011.05.011; Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047; Iung B, 2005, EUR HEART J, V26, P2714, DOI 10.1093/eurheartj/ehi471; Iung B, 2003, EUR HEART J, V24, P1231, DOI 10.1016/S0195-668X(03)00201-X; Kahlert P, 2011, CIRCULATION, V123, P239, DOI 10.1161/CIRCULATIONAHA.110.004713; Kempfert J, 2011, CIRCULATION, V124, pS124, DOI 10.1161/CIRCULATIONAHA.110.013425; Leon MB, 2011, EUR HEART J, V32, P205, DOI 10.1093/eurheartj/ehq406; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Melby SJ, 2007, ANN THORAC SURG, V83, P1651, DOI 10.1016/j.athoracsur.2006.09.068; Moat NE, 2011, J AM COLL CARDIOL, V58, P2130, DOI 10.1016/j.jacc.2011.08.050; O'Brien SM, 2009, ANN THORAC SURG, V88, pS23, DOI 10.1016/j.athoracsur.2009.05.056; Piazza Nicolo, 2008, EuroIntervention, V4, P242, DOI 10.4244/EIJV4I2A43; Rodes-Cabau J, 2008, AM J CARDIOL, V102, P1240, DOI 10.1016/j.amjcard.2008.06.061; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tamburino C, 2011, CIRCULATION, V123, P299, DOI 10.1161/CIRCULATIONAHA.110.946533; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545; Thomas M, 2010, CIRCULATION, V122, P62, DOI 10.1161/CIRCULATIONAHA.109.907402; Vahanian A, 2007, EUR HEART J, V28, P230, DOI 10.1093/eurheartj/ehl428; Walther T, 2009, ANN THORAC SURG, V87, P276, DOI 10.1016/j.athoracsur.2008.08.017; Webb JG, 2009, CIRCULATION, V119, P3009, DOI 10.1161/CIRCULATIONAHA.108.837807; Zahn R, 2011, EUR HEART J, V32, P198, DOI 10.1093/eurheartj/ehq339	30	958	985	1	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 3	2012	366	18					1705	1715		10.1056/NEJMoa1114705	http://dx.doi.org/10.1056/NEJMoa1114705			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	934HH	22551129				2022-12-24	WOS:000303434300010
J	Breitsprecher, D; Jaiswal, R; Bombardier, JP; Gould, CJ; Gelles, J; Goode, BL				Breitsprecher, Dennis; Jaiswal, Richa; Bombardier, Jeffrey P.; Gould, Christopher J.; Gelles, Jeff; Goode, Bruce L.			Rocket Launcher Mechanism of Collaborative Actin Assembly Defined by Single-Molecule Imaging	SCIENCE			English	Article							POLYPOSIS-COLI PROTEIN; FORMIN MDIA1; APC PROTEIN; NUCLEATION; ELONGATION; MOVEMENT; SPIRE	Interacting sets of actin assembly factors work together in cells, but the underlying mechanisms have remained obscure. We used triple-color single-molecule fluorescence microscopy to image the tumor suppressor adenomatous polyposis coli (APC) and the formin mDia1 during filament assembly. Complexes consisting of APC, mDia1, and actin monomers initiated actin filament formation, overcoming inhibition by capping protein and profilin. Upon filament polymerization, the complexes separated, with mDia1 moving processively on growing barbed ends while APC remained at the site of nucleation. Thus, the two assembly factors directly interact to initiate filament assembly and then separate but retain independent associations with either end of the growing filament.	[Bombardier, Jeffrey P.; Gelles, Jeff] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; [Breitsprecher, Dennis; Jaiswal, Richa; Gould, Christopher J.; Goode, Bruce L.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Gelles, J (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA.	gelles@brandeis.edu; goode@brandeis.edu			Deutsche Forschungsgemeinschaft [BR 4116/1-1]; NSF [DMR-MRSEC-0820492]; NIH [GM43369, GM81648, GM083137]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043369, R01GM083137, R01GM063691, R37GM043369, R01GM098143, R01GM081648, T32GM007596] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank B. McCartney, H. Higgs, J. Moseley, S. Reck-Petersen, and B. Smith for helpful comments on the manuscript; K. Okada and A. Deaconescu for purifying CapZ and generating the SNAP-APC-C plasmid; and B. Smith for advice on single-molecule imaging. The project was supported by grants from Deutsche Forschungsgemeinschaft (BR 4116/1-1 to D. B.), NSF (DMR-MRSEC-0820492 to J.G and B.G), and NIH (GM43369 and GM81648 to J.G., GM083137 to B.G.).	Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Chesarone MA, 2009, CURR OPIN CELL BIOL, V21, P28, DOI 10.1016/j.ceb.2008.12.001; Graziano BR, 2011, MOL BIOL CELL, V22, P4016, DOI 10.1091/mbc.E11-05-0404; Kovar DR, 2006, CELL, V124, P423, DOI 10.1016/j.cell.2005.11.038; McCartney BM, 2008, CURR OPIN CELL BIOL, V20, P186, DOI 10.1016/j.ceb.2008.02.001; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Mizuno H, 2011, SCIENCE, V331, P80, DOI 10.1126/science.1197692; Moseley JB, 2007, J BIOL CHEM, V282, P12661, DOI 10.1074/jbc.M610615200; Okada K, 2010, J CELL BIOL, V189, P1087, DOI 10.1083/jcb.201001016; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Schirenbeck A, 2006, P NATL ACAD SCI USA, V103, P7694, DOI 10.1073/pnas.0511243103; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wen Y, 2004, NAT CELL BIOL, V6, P820, DOI 10.1038/ncb1160; Zeth K, 2011, J BIOL CHEM, V286, P30732, DOI 10.1074/jbc.M111.257782; Zigmond SH, 2003, CURR BIOL, V13, P1820, DOI 10.1016/j.cub.2003.09.057	19	102	102	3	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1164	1168		10.1126/science.1218062	http://dx.doi.org/10.1126/science.1218062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654058	Green Accepted			2022-12-24	WOS:000304647900051
J	Lai, YT; Cascio, D; Yeates, TO				Lai, Yen-Ting; Cascio, Duilio; Yeates, Todd O.			Structure of a 16-nm Cage Designed by Using Protein Oligomers	SCIENCE			English	Article							INTERFACES; SYMMETRY		[Cascio, Duilio; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Lai, Yen-Ting] Univ Calif Los Angeles, Biomed Engn Interdept Program, Los Angeles, CA 90095 USA; [Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu	Lai, Yen-Ting/R-2195-2017	Lai, Yen-Ting/0000-0003-3700-6417; Yeates, Todd/0000-0001-5709-9839	NSF [MCB-0843065]; Div Of Molecular and Cellular Bioscience [0843065] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors thank M. Sawaya and N. King for helpful advice. This work was supported by NSF grant MCB-0843065. T.O.Y. holds a patent on self-assembling proteins: US6756039. Structural data are deposited in the Protein Data Bank (codes 3vdx and 4d9j).	Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Harris A, 2001, VIROLOGY, V289, P34, DOI 10.1006/viro.2001.1119; McAllister KA, 2008, J AM CHEM SOC, V130, P11921, DOI 10.1021/ja800697g; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Ringler P, 2003, SCIENCE, V302, P106, DOI 10.1126/science.1088074; Salgado EN, 2010, P NATL ACAD SCI USA, V107, P1827, DOI 10.1073/pnas.0906852107; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]	8	216	222	1	100	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1129	1129		10.1126/science.1219351	http://dx.doi.org/10.1126/science.1219351			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654051				2022-12-24	WOS:000304647900040
J	Liu, TT; Liu, ZX; Song, CJ; Hu, YF; Han, ZF; She, J; Fan, FF; Wang, JW; Jin, CW; Chang, JB; Zhou, JM; Chai, JJ				Liu, Tingting; Liu, Zixu; Song, Chuanjun; Hu, Yunfei; Han, Zhifu; She, Ji; Fan, Fangfang; Wang, Jiawei; Jin, Changwen; Chang, Junbiao; Zhou, Jian-Min; Chai, Jijie			Chitin-Induced Dimerization Activates a Plant Immune Receptor	SCIENCE			English	Article							PATTERN-RECOGNITION RECEPTORS; ARABIDOPSIS-THALIANA; INNATE IMMUNITY; KINASE; LYSM; BINDING; DEFENSE; PERCEPTION; RESISTANCE; PROTEINS	Pattern recognition receptors confer plant resistance to pathogen infection by recognizing the conserved pathogen-associated molecular patterns. The cell surface receptor chitin elicitor receptor kinase 1 of Arabidopsis (AtCERK1) directly binds chitin through its lysine motif (LysM)-containing ectodomain (AtCERK1-ECD) to activate immune responses. The crystal structure that we solved of an AtCERK1-ECD complexed with a chitin pentamer reveals that their interaction is primarily mediated by a LysM and three chitin residues. By acting as a bivalent ligand, a chitin octamer induces AtCERK1-ECD dimerization that is inhibited by shorter chitin oligomers. A mutation attenuating chitin-induced AtCERK1-ECD dimerization or formation of nonproductive AtCERK1 dimer by overexpression of AtCERK1-ECD compromises AtCERK1-mediated signaling in plant cells. Together, our data support the notion that chitin-induced AtCERK1 dimerization is critical for its activation.	[Song, Chuanjun; Fan, Fangfang; Chang, Junbiao] Zhengzhou Univ, Dept Chem, Zhengzhou 450001, Peoples R China; [Liu, Tingting] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Liu, Tingting] Peking Union Med Coll, Beijing 100730, Peoples R China; [Liu, Tingting; Han, Zhifu; Chai, Jijie] Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Liu, Tingting; Han, Zhifu; Wang, Jiawei; Chai, Jijie] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Liu, Tingting; Liu, Zixu; Zhou, Jian-Min] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Liu, Zixu] Nanjing Univ, Sch Life Sci, Nanjing 210093, Peoples R China; [Hu, Yunfei; Jin, Changwen] Peking Univ, Beijing NMR Ctr, Beijing 100871, Peoples R China; [Hu, Yunfei; She, Ji; Jin, Changwen] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Zhou, Jian-Min] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res, Beijing 100101, Peoples R China	Zhengzhou University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Tsinghua University; Tsinghua University; National Institute of Biological Sciences, Beijing; Nanjing University; Peking University; Peking University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Chang, JB (corresponding author), Zhengzhou Univ, Dept Chem, Zhengzhou 450001, Peoples R China.	changjunbiao@zzu.edu.cn; jmzhou@genetics.ac.cn; chaijj@mail.tsinghua.edu.cn	liu, ting/GZM-3326-2022; chang, junbiao/P-1095-2014; She, Ji/AAW-6150-2021; fan, fang/GQY-9173-2022; poinssot, benoit/B-2569-2009; Zhou, Jian-Min/A-3140-2013; Liu, Zixu/AAA-9393-2019; Fan, Fang/GRO-2696-2022	chang, junbiao/0000-0001-6236-1256; poinssot, benoit/0000-0001-5890-4318; Zhou, Jian-Min/0000-0002-9943-2975; LIU, ZIXU/0000-0002-3082-6765; Chai, Jijie/0000-0001-7591-3873	State Key Program of National Natural Science of China [31130063]; Chinese Ministry of Science and Technology [2010CB835300, 2011CB100700]; National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China [30825043]	State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank F. Yu and J. He at Shanghai Synchrotron Radiation Facility (SSRF). J. C. was funded by State Key Program of National Natural Science of China (31130063) and Chinese Ministry of Science and Technology (2010CB835300). J.M.Z. was funded by Chinese Ministry of Science and Technology (2011CB100700; 2010CB835300). J. B. C. was funded by the National Outstanding Young Scholar Science Foundation of National Natural Science Foundation of China (30825043). The coordinates and structural factors for free- and chitin-bound AtCERK1-ECD have been deposited in Protein Data Bank with accession codes 4EBY and 4EBZ, respectively.	Asensio JL, 2000, CHEM BIOL, V7, P529, DOI 10.1016/S1074-5521(00)00136-8; BOLLER T, 1995, ANNU REV PLANT PHYS, V46, P189, DOI 10.1146/annurev.arplant.46.1.189; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; de Jonge R, 2010, SCIENCE, V329, P953, DOI 10.1126/science.1190859; Fliegmann J, 2011, PLANT PHYSIOL BIOCH, V49, P709, DOI 10.1016/j.plaphy.2011.04.004; Gimenez-Ibanez S, 2009, CURR BIOL, V19, P423, DOI 10.1016/j.cub.2009.01.054; Hamel LP, 2010, PLANTA, V232, P787, DOI 10.1007/s00425-010-1215-9; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; Iizasa E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.027540; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li J, 2002, CELL, V110, P213, DOI 10.1016/S0092-8674(02)00812-7; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nam KH, 2002, CELL, V110, P203, DOI 10.1016/S0092-8674(02)00814-0; Ohnuma T, 2008, J BIOL CHEM, V283, P5178, DOI 10.1074/jbc.M707156200; Parker JE, 2003, TRENDS PLANT SCI, V8, P245, DOI 10.1016/S1360-1385(03)00105-5; Petutschnig EK, 2010, J BIOL CHEM, V285, P28902, DOI 10.1074/jbc.M110.116657; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Ramonell KM, 2002, MOL PLANT PATHOL, V3, P301, DOI 10.1046/j.1364-3703.2002.00123.x; Schulze B, 2010, J BIOL CHEM, V285, P9444, DOI 10.1074/jbc.M109.096842; Shibuya N, 2001, PHYSIOL MOL PLANT P, V59, P223, DOI 10.1006/pmpp.2001.0364; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Tanaka S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-288; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Zhang B, 2002, MOL PLANT MICROBE IN, V15, P963, DOI 10.1094/MPMI.2002.15.9.963; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	32	380	422	28	366	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1160	1164		10.1126/science.1218867	http://dx.doi.org/10.1126/science.1218867			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654057				2022-12-24	WOS:000304647900050
J	Nishimura, T; Honda, H; Takeichi, M				Nishimura, Tamako; Honda, Hisao; Takeichi, Masatoshi			Planar Cell Polarity Links Axes of Spatial Dynamics in Neural-Tube Closure	CELL			English	Article							CONVERGENT EXTENSION; PROTEIN DAAM1; RHO-KINASES; MORPHOGENESIS; GASTRULATION; SHAPE; NEURULATION; DROSOPHILA; CADHERIN; SHROOM	Neural-tube closure is a critical step of embryogenesis, and its failure causes serious birth defects. Coordination of two morphogenetic processes-convergent extension and neural-plate apical constriction-ensures the complete closure of the neural tube. We now provide evidence that planar cell polarity (PCP) signaling directly links these two processes. In the bending neural plates, we find that a PCP-regulating cadherin, Celsr1, is concentrated in adherens junctions (AJs) oriented toward the mediolateral axes of the plates. At these AJs, Celsr1 cooperates with Dishevelled, DAAM1, and the PDZ-RhoGEF to upregulate Rho kinase, causing their actomyosin-dependent contraction in a planar-polarized manner. This planar-polarized contraction promotes simultaneous apical constriction and midline convergence of neuroepithelial cells. Together our findings demonstrate that PCP signals confer anisotropic contractility on the AJs, producing cellular forces that promote the polarized bending of the neural plate.	[Nishimura, Tamako; Honda, Hisao; Takeichi, Masatoshi] RIKEN Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Honda, Hisao] Hyogo Univ, Kakogawa, Hyogo 6750195, Japan	RIKEN	Takeichi, M (corresponding author), RIKEN Ctr Dev Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	takeichi@cdb.riken.jp	Takeichi, Masatoshi/G-5903-2012	Takeichi, Masatoshi/0000-0002-9931-3378; , xi cun zhu zi/0000-0001-9015-377X	Japan Society for Promotion of Science; Grants-in-Aid for Scientific Research [20002009] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Nakaya for advice on chicken embryology; E. Fuchs for Celsr1 plasmids; K. Nagata for the PDZ-RhoGEF plasmid; A. Sugimoto for an EM-CCD camera; T. Nagai for computational modeling; and the RIKEN Integrated Cluster of Clusters for computation facilities. We are also grateful to T. Uemura for discussion and H. Saito, M. Nomura-Harata, H. Sylvain, Y. Inoue, S. Kobayashi, H. Abe-Ishigami, and C. Uemura-Yoshii for their technical support. This work was supported by grants from the programs Grants-in-Aid for Specially Promoted Research (to M.T.), for Scientific Research-C (to H.H.), and for Young Scientists-B (to T.N.) from the Japan Society for Promotion of Science.	ALVAREZ IS, 1992, J EXP ZOOL, V261, P340, DOI 10.1002/jez.1402610313; Aspenstrom P, 2006, EXP CELL RES, V312, P2180, DOI 10.1016/j.yexcr.2006.03.013; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Devenport D, 2008, NAT CELL BIOL, V10, P1257, DOI 10.1038/ncb1784; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Formstone CJ, 2005, DEV DYNAM, V232, P408, DOI 10.1002/dvdy.20228; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hacker U, 1998, GENE DEV, V12, P274, DOI 10.1101/gad.12.2.274; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; Honda H, 2008, DEV DYNAM, V237, P1826, DOI 10.1002/dvdy.21609; Hong E, 2006, DEVELOPMENT, V133, P3895, DOI 10.1242/dev.02560; JACOBSON AG, 1976, J EXP ZOOL, V197, P191, DOI 10.1002/jez.1401970205; KELLER R, 1992, DEV DYNAM, V193, P199, DOI 10.1002/aja.1001930302; Kinoshita N, 2008, MOL BIOL CELL, V19, P2289, DOI 10.1091/mbc.E07-12-1286; Kitzing TM, 2007, GENE DEV, V21, P1478, DOI 10.1101/gad.424807; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Li DQ, 2011, DEVELOPMENT, V138, P303, DOI 10.1242/dev.055566; Liu W, 2008, P NATL ACAD SCI USA, V105, P210, DOI 10.1073/pnas.0707277105; Lu J, 2007, J MOL BIOL, V369, P1258, DOI 10.1016/j.jmb.2007.04.002; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; McNeill H, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003376; Nagai T, 2001, PHILOS MAG B, V81, P699, DOI 10.1080/13642810110055328; Nakaya Y, 2008, NAT CELL BIOL, V10, P765, DOI 10.1038/ncb1739; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Ravni A, 2009, J INVEST DERMATOL, V129, P2507, DOI 10.1038/jid.2009.84; SCHOENWOLF GC, 1991, DEVELOPMENT, P157; Simons M, 2008, ANNU REV GENET, V42, P517, DOI 10.1146/annurev.genet.42.110807.091432; Sokol SY, 1996, CURR BIOL, V6, P1456, DOI 10.1016/S0960-9822(96)00750-6; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Watanabe T, 2007, MOL BIOL CELL, V18, P605, DOI 10.1091/mbc.E06-07-0590; Wei L, 2001, DEVELOPMENT, V128, P2953; Winter CG, 2001, CELL, V105, P81, DOI 10.1016/S0092-8674(01)00298-7; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380	45	318	322	3	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1084	1097		10.1016/j.cell.2012.04.021	http://dx.doi.org/10.1016/j.cell.2012.04.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632972	Bronze			2022-12-24	WOS:000304453900014
J	Smith, CC; Wang, Q; Chin, CS; Salerno, S; Damon, LE; Levis, MJ; Perl, AE; Travers, KJ; Wang, S; Hunt, JP; Zarrinkar, PP; Schadt, EE; Kasarskis, A; Kuriyan, J; Shah, NP				Smith, Catherine C.; Wang, Qi; Chin, Chen-Shan; Salerno, Sara; Damon, Lauren E.; Levis, Mark J.; Perl, Alexander E.; Travers, Kevin J.; Wang, Susana; Hunt, Jeremy P.; Zarrinkar, Patrick P.; Schadt, Eric E.; Kasarskis, Andrew; Kuriyan, John; Shah, Neil P.			Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia	NATURE			English	Article							TYROSINE KINASE DOMAIN; MYELODYSPLASTIC SYNDROME; CRYSTAL-STRUCTURE; INSULIN-RECEPTOR; STRUCTURAL BASIS; BCR-ABL; RESISTANCE; INHIBITOR; AUTOINHIBITION; ACTIVATION	Effective targeted cancer therapeutic development depends upon distinguishing disease-associated 'driver' mutations, which have causative roles in malignancy pathogenesis, from 'passenger' mutations, which are dispensable for cancer initiation and maintenance. Translational studies of clinically active targeted therapeutics can definitively discriminate driver from passenger lesions and provide valuable insights into human cancer biology. Activating internal tandem duplication (ITD) mutations in FLT3 (FLT3-ITD) are detected in approximately 20% of acute myeloid leukaemia (AML) patients and are associated with a poor prognosis(1). Abundant scientific(2) and clinical evidence(1,3), including the lack of convincing clinical activity of early FLT3 inhibitors(4,5), suggests that FLT3-ITD probably represents a passenger lesion. Here we report point mutations at three residues within the kinase domain of FLT3-ITD that confer substantial in vitro resistance to AC220 (quizartinib), an active investigational inhibitor of FLT3, KIT, PDGFRA, PDGFRB and RET6,7; evolution of AC220-resistant substitutions at two of these amino acid positions was observed in eight of eight FLT3-ITD-positive AML patients with acquired resistance to AC220. Our findings demonstrate that FLT3-ITD can represent a driver lesion and valid therapeutic target in human AML. AC220-resistant FLT3 kinase domain mutants represent high-value targets for future FLT3 inhibitor development efforts.	[Smith, Catherine C.; Salerno, Sara; Damon, Lauren E.; Shah, Neil P.] Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA; [Wang, Qi; Kuriyan, John] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Chin, Chen-Shan; Travers, Kevin J.; Wang, Susana; Schadt, Eric E.; Kasarskis, Andrew] Pacific Biosci, Menlo Pk, CA 94025 USA; [Levis, Mark J.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD 21231 USA; [Perl, Alexander E.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Hunt, Jeremy P.; Zarrinkar, Patrick P.] Ambit Biosci, San Diego, CA 92121 USA; [Shah, Neil P.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA	University of California System; University of California San Francisco; University of California System; University of California Berkeley; Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania; Pennsylvania Medicine; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Shah, NP (corresponding author), Univ Calif San Francisco, Div Hematol Oncol, San Francisco, CA 94143 USA.	nshah@medicine.ucsf.edu	Wang, Qi/H-9399-2012	Wang, Qi/0000-0002-9703-1676	Leukemia and Lymphoma Society; Doris Duke Charitable Foundation; NCI Leukemia SPORE [P50 CA100632-06]; NCI [R01 CA12886]; NIH; Art and Alison Kern and the Edward S. Ageno family; NATIONAL CANCER INSTITUTE [P50CA100632, R01CA166616, R01CA128864] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NCI Leukemia SPORE; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Art and Alison Kern and the Edward S. Ageno family; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank K. Lin for technical assistance. This work was funded by grants from the Leukemia and Lymphoma Society (to C.C.S. and N.P.S.), the Doris Duke Charitable Foundation (to N.P.S.), NCI Leukemia SPORE P50 CA100632-06 (to M.J.L.), NCI R01 CA12886 (to M.J.L.) and the NIH T-32 Molecular Mechanisms of Cancer (to C.C.S.). C.C.S. would like to acknowledge the EHA/ASH Translational Research Training Institute. N.P.S. would like to thank Art and Alison Kern and the Edward S. Ageno family for their support.	Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Barbie David A, 2006, Clin Adv Hematol Oncol, V4, P768; BARNARD GA, 1990, STAT MED, V9, P601, DOI 10.1002/sim.4780090606; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Choudhary C, 2007, BLOOD, V110, P370, DOI 10.1182/blood-2006-05-024018; Cortes J., 2011, 16 C EUR HEM ASS HAE; Fischer T, 2010, J CLIN ONCOL, V28, P4339, DOI 10.1200/JCO.2010.28.9678; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Heidel F, 2006, BLOOD, V107, P293, DOI 10.1182/blood-2005-06-2469; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Knapper S, 2006, BLOOD, V108, P3262, DOI 10.1182/blood-2006-04-015560; Kralovics R, 2006, BLOOD, V108, P1377, DOI 10.1182/blood-2005-11-009605; Lee BH, 2005, ONCOGENE, V24, P7882, DOI 10.1038/sj.onc.1208933; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Metzelder S, 2009, BLOOD, V113, P6567, DOI 10.1182/blood-2009-03-208298; Mol CD, 2003, J BIOL CHEM, V278, P31461, DOI 10.1074/jbc.C300186200; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Scholl S, 2011, ANN HEMATOL, V90, P473, DOI 10.1007/s00277-010-1027-9; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shih LY, 2004, LEUKEMIA, V18, P466, DOI 10.1038/sj.leu.2403274; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Travers KJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq543; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wodicka LM, 2010, CHEM BIOL, V17, P1241, DOI 10.1016/j.chembiol.2010.09.010; YATES F, 1984, J ROY STAT SOC A STA, V147, P426, DOI 10.2307/2981577; Zarrinkar PP, 2009, BLOOD, V114, P2984, DOI 10.1182/blood-2009-05-222034	33	528	558	4	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2012	485	7397					260	U153		10.1038/nature11016	http://dx.doi.org/10.1038/nature11016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22504184	Green Accepted			2022-12-24	WOS:000303799800046
J	Huber, D; Gutnisky, DA; Peron, S; O'Connor, DH; Wiegert, JS; Tian, L; Oertner, TG; Looger, LL; Svoboda, K				Huber, D.; Gutnisky, D. A.; Peron, S.; O'Connor, D. H.; Wiegert, J. S.; Tian, L.; Oertner, T. G.; Looger, L. L.; Svoboda, K.			Multiple dynamic representations in the motor cortex during sensorimotor learning	NATURE			English	Article							CELLULAR RESOLUTION; OBJECT LOCALIZATION; NEURAL ACTIVITY; BARREL CORTEX; NEURONS; ORGANIZATION; MOUSE; MICROSTIMULATION; CONNECTIONS; PLASTICITY	The mechanisms linking sensation and action during learning are poorly understood. Layer 2/3 neurons in the motor cortex might participate in sensorimotor integration and learning; they receive input from sensory cortex and excite deep layer neurons, which control movement. Here we imaged activity in the same set of layer 2/3 neurons in the motor cortex over weeks, while mice learned to detect objects with their whiskers and report detection with licking. Spatially intermingled neurons represented sensory (touch) and motor behaviours (whisker movements and licking). With learning, the population-level representation of task-related licking strengthened. In trained mice, population-level representations were redundant and stable, despite dynamism of single-neuron representations. The activity of a subpopulation of neurons was consistent with touch driving licking behaviour. Our results suggest that ensembles of motor cortex neurons couple sensory input to multiple, related motor programs during learning.	[Huber, D.; Gutnisky, D. A.; Peron, S.; O'Connor, D. H.; Tian, L.; Looger, L. L.; Svoboda, K.] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Wiegert, J. S.; Oertner, T. G.] Ctr Mol Neurobiol Hamburg, D-20251 Hamburg, Germany	Howard Hughes Medical Institute	Svoboda, K (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus,19700 Helix Dr, Ashburn, VA 20147 USA.	svobodak@janelia.hhmi.org	Huber, Daniel/C-2932-2013; Oertner, Thomas/F-2214-2010; Wiegert, J. Simon/ABE-4199-2020; Gutnisky, Diego/E-3846-2012	Oertner, Thomas/0000-0002-2312-7528; Gutnisky, Diego/0000-0002-8578-0039; Peron, Simon/0000-0001-8265-6940; Wiegert, J. Simon/0000-0003-0893-9349; Huber, Daniel/0000-0002-0744-7679; Tian, Lin/0000-0001-7012-6926				Afshar A, 2011, NEURON, V71, P555, DOI 10.1016/j.neuron.2011.05.047; Anderson CT, 2010, NAT NEUROSCI, V13, P739, DOI 10.1038/nn.2538; Birdwell JA, 2007, J NEUROPHYSIOL, V98, P2439, DOI 10.1152/jn.00707.2006; Brecht M, 2004, J COMP NEUROL, V479, P360, DOI 10.1002/cne.20306; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Carvell GE, 1996, SOMATOSENS MOT RES, V13, P115, DOI 10.3109/08990229609051399; Dombeck DA, 2010, NAT NEUROSCI, V13, P1433, DOI 10.1038/nn.2648; Dombeck DA, 2009, J NEUROSCI, V29, P13751, DOI 10.1523/JNEUROSCI.2985-09.2009; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Ferezou I, 2007, NEURON, V56, P907, DOI 10.1016/j.neuron.2007.10.007; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI DOI 10.1007/978-0-387-84858-7; Ganguly K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000153; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Graf ABA, 2011, NAT NEUROSCI, V14, P239, DOI 10.1038/nn.2733; Graziano M.S.A., 2009, INTELLIGENT MOVEMENT; Graziano MSA, 2007, NEURON, V56, P239, DOI 10.1016/j.neuron.2007.09.013; Greenberg DS, 2009, J NEUROSCI METH, V176, P1, DOI 10.1016/j.jneumeth.2008.08.020; Grinevich V, 2005, J NEUROSCI, V25, P8250, DOI 10.1523/JNEUROSCI.2235-05.2005; Hattox AM, 2002, J COMP NEUROL, V442, P266, DOI 10.1002/cne.10089; Hill DN, 2011, NEURON, V72, P344, DOI 10.1016/j.neuron.2011.09.020; Hooks BM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000572; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; IRIKI A, 1989, SCIENCE, V245, P1385, DOI 10.1126/science.2551038; Kaneko T, 2000, J COMP NEUROL, V423, P52, DOI 10.1002/1096-9861(20000717)423:1<52::AID-CNE5>3.0.CO;2-F; KANEKO T, 1994, J COMP NEUROL, V345, P172, DOI 10.1002/cne.903450203; KELLER A, 1993, CEREB CORTEX, V3, P430, DOI 10.1093/cercor/3.5.430; Kerlin AM, 2010, NEURON, V67, P858, DOI 10.1016/j.neuron.2010.08.002; Kleinfeld D, 2002, NEURON, V34, P1021, DOI 10.1016/S0896-6273(02)00732-8; Knutsen PM, 2009, TRENDS NEUROSCI, V32, P101, DOI 10.1016/j.tins.2008.10.002; Komiyama T, 2010, NATURE, V464, P1182, DOI 10.1038/nature08897; LI CX, 1991, CAN J NEUROL SCI, V18, P28, DOI 10.1017/S0317167100031267; Mao TY, 2011, NEURON, V72, P111, DOI 10.1016/j.neuron.2011.07.029; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006; O'Connor DH, 2010, NEURON, V67, P1048, DOI 10.1016/j.neuron.2010.08.026; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; PAVLIDES C, 1993, J NEUROPHYSIOL, V70, P733, DOI 10.1152/jn.1993.70.2.733; Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709; Pologruto TA, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-13; PORTER LL, 1983, J COMP NEUROL, V214, P279, DOI 10.1002/cne.902140306; Rathenberg J, 2003, J NEUROSCI METH, V126, P91, DOI 10.1016/S0165-0270(03)00069-4; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Rokni U, 2007, NEURON, V54, P653, DOI 10.1016/j.neuron.2007.04.030; Salinas E, 2009, J NEUROSCI, V29, P4369, DOI 10.1523/JNEUROSCI.0164-09.2009; Sato TR, 2010, J NEUROSCI, V30, P4256, DOI 10.1523/JNEUROSCI.3774-09.2010; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Scott SH, 2008, J PHYSIOL-LONDON, V586, P1217, DOI 10.1113/jphysiol.2007.146068; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Tian L, 2009, NAT METHODS, V6, P875, DOI 10.1038/nmeth.1398; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Travers JB, 1997, NEUROSCI BIOBEHAV R, V21, P631, DOI 10.1016/S0149-7634(96)00045-0; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Wolpert DM, 2011, NAT REV NEUROSCI, V12, P739, DOI 10.1038/nrn3112; Zariwala HA, 2012, J NEUROSCI, V32, P3131, DOI 10.1523/JNEUROSCI.4469-11.2012	59	328	330	7	114	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 26	2012	484	7395					473	U95		10.1038/nature11039	http://dx.doi.org/10.1038/nature11039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931FF	22538608	Green Accepted			2022-12-24	WOS:000303200400042
J	Gehrig, SM; van der Poel, C; Sayer, TA; Schertzer, JD; Henstridge, DC; Church, JE; Lamon, S; Russell, AP; Davies, KE; Febbraio, MA; Lynch, GS				Gehrig, Stefan M.; van der Poel, Chris; Sayer, Timothy A.; Schertzer, Jonathan D.; Henstridge, Darren C.; Church, Jarrod E.; Lamon, Severine; Russell, Aaron P.; Davies, Kay E.; Febbraio, Mark A.; Lynch, Gordon S.			Hsp72 preserves muscle function and slows progression of severe muscular dystrophy	NATURE			English	Article							KAPPA-B; MDX; SKELETAL; PROTEIN; MICE; ACTIVATION; STRESS; OVEREXPRESSION; CONTRACTION; MYOPATHIES	Duchenne muscular dystrophy (DMD) is a severe and progressive muscle wasting disorder caused by mutations in the dystrophin gene that result in the absence of the membrane-stabilizing protein dystrophin(1-3). Dystrophin-deficient muscle fibres are fragile and susceptible to an influx of Ca2+, which activates inflammatory and muscle degenerative pathways(4-6). At present there is no cure for DMD, and existing therapies are ineffective. Here we show that increasing the expression of intramuscular heat shock protein 72 (Hsp72) preserves muscle strength and ameliorates the dystrophic pathology in two mouse models of muscular dystrophy. Treatment with BGP-15 (a pharmacological inducer of Hsp72 currently in clinical trials for diabetes) improved muscle architecture, strength and contractile function in severely affected diaphragm muscles in mdx dystrophic mice. In dko mice, a phenocopy of DMD that results in severe spinal curvature (kyphosis), muscle weakness and premature death(7,8), BGP-15 decreased kyphosis, improved the dystrophic pathophysiology in limb and diaphragm muscles and extended lifespan. We found that the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA, the main protein responsible for the removal of intracellular Ca2+) is dysfunctional in severely affected muscles of mdx and dko mice, and that Hsp72 interacts with SERCA to preserve its function under conditions of stress, ultimately contributing to the decreased muscle degeneration seen with Hsp72 upregulation. Treatment with BGP-15 similarly increased SERCA activity in dystrophic skeletal muscles. Our results provide evidence that increasing the expression of Hsp72 in muscle (through the administration of BGP-15) has significant therapeutic potential for DMD and related conditions, either as a self-contained therapy or as an adjuvant with other potential treatments, including gene, cell and pharmacological therapies.	[Gehrig, Stefan M.; van der Poel, Chris; Sayer, Timothy A.; Schertzer, Jonathan D.; Church, Jarrod E.; Lynch, Gordon S.] Univ Melbourne, Basic & Clin Myol Lab, Dept Physiol, Melbourne, Vic 3010, Australia; [Henstridge, Darren C.; Febbraio, Mark A.] Baker IDI Heart & Diabet Inst, Cellular & Mol Metab Lab, Melbourne, Vic 8008, Australia; [Lamon, Severine; Russell, Aaron P.] Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Burwood, Vic 3125, Australia; [Davies, Kay E.] Univ Oxford, MRC Funct Genom Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England	University of Melbourne; Baker Heart and Diabetes Institute; Deakin University; University of Oxford	Lynch, GS (corresponding author), Univ Melbourne, Basic & Clin Myol Lab, Dept Physiol, Melbourne, Vic 3010, Australia.	gsl@unimelb.edu.au	Lynch, Gordon/G-9553-2015; Febbraio, Mark/AAE-9632-2019; Schertzer, Jonathan/P-3395-2017	Lynch, Gordon/0000-0001-9220-9810; Febbraio, Mark/0000-0002-9296-4418; Schertzer, Jonathan/0000-0002-1547-5856; Church, Jarrod/0000-0001-8266-4043; Lamon, Severine/0000-0002-3271-6551; Russell, Aaron/0000-0002-7323-9501	National Health and Medical Research Council (NHMRC) [1009114, 472650, 1004441]; Association Francaise contre les Myopathies (France); Muscular Dystrophy Association (USA); Swiss National Science Foundation; National Heart Foundation (Australia); National Heart Foundation; Fondazione Telethon Funding Source: Custom; Medical Research Council [MC_U137761449] Funding Source: researchfish; MRC [MC_U137761449] Funding Source: UKRI	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Association Francaise contre les Myopathies (France)(Association Francaise contre les Myopathies); Muscular Dystrophy Association (USA)(Muscular Dystrophy Association); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Heart Foundation (Australia)(National Heart Foundation of Australia); National Heart Foundation(National Heart Foundation of Australia); Fondazione Telethon(Fondazione Telethon); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Koopman, J. G. Ryall and G. I. Lancaster for comments; J. Trieu, B. G. Gleeson, T. Naim and A. Chee for technical support; and C. Angelini and the Neuromuscular bank of tissues and DNA samples - Telethon Network of Genetic Biobanks for the provision of human muscle specimens. We thank N-Gene R&D Inc. USA for providing the BGP-15 compound. This study was supported in part by research grants from the National Health and Medical Research Council (NHMRC; project numbers 1009114 to G. S. L. and 472650 and 1004441 to M.A.F.), Association Francaise contre les Myopathies (France, to G. S. L.) and the Muscular Dystrophy Association (USA, to G. S. L.). M. A. F. is a Senior Principal Research Fellow of the NHMRC. A. P. R. was supported by a NHMRC Biomedical career Development Award. S. L. was supported by a postdoctoral fellowship from the Swiss National Science Foundation. S. M. G. was supported by a National Heart Foundation Postgraduate Scholarship (Australia). D. C. H. was supported by a National Heart Foundation Post-Doctoral Fellowship.	Acharyya S, 2007, J CLIN INVEST, V117, P889, DOI 10.1172/JCI30556; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BORNMAN L, 1995, MUSCLE NERVE, V18, P23, DOI 10.1002/mus.880180105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Chung J, 2008, P NATL ACAD SCI USA, V105, P1739, DOI 10.1073/pnas.0705799105; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Finsterer J, 2006, LUNG, V184, P205, DOI 10.1007/s00408-005-2584-x; FONG P, 1990, SCIENCE, V250, P673, DOI 10.1126/science.2173137; Gehrig SM, 2010, AM J PATHOL, V176, P29, DOI 10.2353/ajpath.2010.090760; Gervasio OL, 2008, J CELL SCI, V121, P2246, DOI 10.1242/jcs.032003; Goonasekera SA, 2011, J CLIN INVEST, V121, P1044, DOI 10.1172/JCI43844; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; GREEN MARGARET C., 1952, OHIO JOUR SCI, V52, P31; Gregorevic P, 2002, AM J PATHOL, V161, P2263, DOI 10.1016/S0002-9440(10)64502-6; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; Kolodziejczyk SM, 2001, CURR BIOL, V11, P1278, DOI 10.1016/S0960-9822(01)00397-9; Literati-Nagy B, 2010, BRAIN RES BULL, V83, P340, DOI 10.1016/j.brainresbull.2010.09.005; Literati-Nagy B, 2009, HORM METAB RES, V41, P374, DOI 10.1055/s-0028-1128142; Lou JS, 2010, AM J HOSP PALLIAT ME, V27, P145, DOI 10.1177/1049909109358420; MARBER MS, 1995, J CLIN INVEST, V95, P1446, DOI 10.1172/JCI117815; Monici MC, 2003, NEUROLOGY, V60, P993, DOI 10.1212/01.WNL.0000049913.27181.51; MORIMOTO RI, 1993, SCIENCE, V259, P1409, DOI 10.1126/science.8451637; Morine KJ, 2010, HUM GENE THER, V21, P1735, DOI 10.1089/hum.2010.077; Murphy KT, 2010, FASEB J, V24, P4433, DOI 10.1096/fj.10-159608; Nicolas-Metral V, 2001, J MUSCLE RES CELL M, V22, P69, DOI 10.1023/A:1010384625954; Park HS, 2001, EMBO J, V20, P446, DOI 10.1093/emboj/20.3.446; Plant DR, 2003, AM J PHYSIOL-CELL PH, V285, pC522, DOI 10.1152/ajpcell.00369.2002; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Saegusa T, 2003, J VET MED SCI, V65, P1365, DOI 10.1292/jvms.65.1365; Schertzer JD, 2005, AM J PHYSIOL-ENDOC M, V288, pE526, DOI 10.1152/ajpendo.00399.2004; Schertzer JD, 2007, AM J PATHOL, V171, P1180, DOI 10.2353/ajpath.2007.070292; Schertzer JD, 2006, AM J PHYSIOL-ENDOC M, V291, pE499, DOI 10.1152/ajpendo.00101.2006; Senf SM, 2008, FASEB J, V22, P3836, DOI 10.1096/fj.08-110163; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375; Taleb M, 2008, JARO-J ASSOC RES OTO, V9, P277, DOI 10.1007/s10162-008-0122-2; Tupling AR, 2004, J BIOL CHEM, V279, P52382, DOI 10.1074/jbc.M409336200; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Tutdibi O, 1999, J PHYSIOL-LONDON, V515, P859, DOI 10.1111/j.1469-7793.1999.859ab.x	43	193	201	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 19	2012	484	7394					394	398		10.1038/nature10980	http://dx.doi.org/10.1038/nature10980			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	927YM	22495301				2022-12-24	WOS:000302946500037
J	Barrett, PJ; Song, YL; Van Horn, WD; Hustedt, EJ; Schafer, JM; Hadziselimovic, A; Beel, AJ; Sanders, CR				Barrett, Paul J.; Song, Yuanli; Van Horn, Wade D.; Hustedt, Eric J.; Schafer, Johanna M.; Hadziselimovic, Arina; Beel, Andrew J.; Sanders, Charles R.			The Amyloid Precursor Protein Has a Flexible Transmembrane Domain and Binds Cholesterol	SCIENCE			English	Article							C-TERMINAL DOMAIN; GAMMA-SECRETASE; DIMER; APP; SEQUENCE; MODEL	C99 is the transmembrane carboxyl-terminal domain of the amyloid precursor protein that is cleaved by gamma-secretase to release the amyloid-beta polypeptides, which are associated with Alzheimer's disease. Nuclear magnetic resonance and electron paramagnetic resonance spectroscopy show that the extracellular amino terminus of C99 includes a surface-embedded "N-helix" followed by a short "N-loop" connecting to the transmembrane domain (TMD). The TMD is a flexibly curved alpha helix, making it well suited for processive cleavage by gamma-secretase. Titration of C99 reveals a binding site for cholesterol, providing mechanistic insight into how cholesterol promotes amyloidogenesis. Membrane-buried GXXXG motifs (G, Gly; X, any amino acid), which have an established role in oligomerization, were also shown to play a key role in cholesterol binding. The structure and cholesterol binding properties of C99 may aid in the design of Alzheimer's therapeutics.	[Barrett, Paul J.; Song, Yuanli; Van Horn, Wade D.; Schafer, Johanna M.; Hadziselimovic, Arina; Beel, Andrew J.; Sanders, Charles R.] Vanderbilt Univ, Sch Med, Dept Biochem, Struct Biol Ctr, Nashville, TN 37232 USA; [Barrett, Paul J.; Song, Yuanli; Van Horn, Wade D.; Schafer, Johanna M.; Hadziselimovic, Arina; Beel, Andrew J.; Sanders, Charles R.] Vanderbilt Univ, Sch Med, Inst Biol Chem, Nashville, TN 37232 USA; [Hustedt, Eric J.] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Sanders, CR (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Struct Biol Ctr, 221 Kirkland Hall, Nashville, TN 37232 USA.	chuck.sanders@vanderbilt.edu	Song, Yuanli/B-1798-2014; Van Horn, Wade/GSN-2667-2022	Van Horn, Wade/0000-0002-2493-5578	Alzheimer's Association [IIRG-07-59379]; NIH [PO1 GM080513, T32 GM08320]; American Heart Association [AHA10POST4210008]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM080513, T32GM008320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS077681] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Alzheimer's Association grant IIRG-07-59379, NIH grants PO1 GM080513 (C. R. S. and E.J.H.) and T32 GM08320 (P.J.B.), and by an American Heart Association grant AHA10POST4210008 (W. D. V. H.). We thank S. Howell for technical assistance and F. Sonnichsen, K. Mittendorf, B. Carter, E. Stanley, and C. Deatherage for comments on this manuscript. Coordinates for the structure of C99 have been deposited in the Protein Data Bank (accession code 2LP1).	Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; Botev A, 2011, BIOCHEMISTRY-US, V50, P828, DOI 10.1021/bi1014002; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Fonseca ACRG, 2010, EXP NEUROL, V223, P282, DOI 10.1016/j.expneurol.2009.09.013; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hardy J., 2012, ALZHEIMER RES FORUM; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kim SY, 2005, P NATL ACAD SCI USA, V102, P16524, DOI 10.1073/pnas.0505454102; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Kukar TL, 2011, J BIOL CHEM, V286, P39804, DOI 10.1074/jbc.M111.274696; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; LEMMON MA, 1992, J BIOL CHEM, V267, P7683; Lu JX, 2011, BIOPHYS J, V100, P711, DOI 10.1016/j.bpj.2010.12.3696; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Miyashita N, 2009, J AM CHEM SOC, V131, P17843, DOI 10.1021/ja905457d; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nadezhdin KD, 2011, ACTA NATURAE, V3, P69, DOI 10.32607/20758251-2011-3-1-69-76; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Osenkowski P, 2009, J MOL BIOL, V385, P642, DOI 10.1016/j.jmb.2008.10.078; Renzi F, 2011, J BIOL CHEM, V286, P21440, DOI 10.1074/jbc.M110.193326; Sagi SA, 2011, J BIOL CHEM, V286, P39794, DOI 10.1074/jbc.M111.277228; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Urban S, 2010, BIOCHEM J, V425, P501, DOI 10.1042/BJ20090861; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Yanagisawa K, 2005, SUB CELL BIOCHEM, V38, P179	33	356	363	3	163	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1168	1171		10.1126/science.1219988	http://dx.doi.org/10.1126/science.1219988			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654059	Green Accepted			2022-12-24	WOS:000304647900052
J	O'Connell, LA; Hofmann, HA				O'Connell, Lauren A.; Hofmann, Hans A.			Evolution of a Vertebrate Social Decision-Making Network	SCIENCE			English	Article							RECEPTOR-MESSENGER-RNA; BEHAVIOR NETWORK; ESTROGEN-RECEPTOR; BRAIN; REWARD; NEUROANATOMY; VASOPRESSIN; EXPRESSION; VASOTOCIN; ANDROGEN	Animals evaluate and respond to their social environment with adaptive decisions. Revealing the neural mechanisms of such decisions is a major goal in biology. We analyzed expression profiles for 10 neurochemical genes across 12 brain regions important for decision-making in 88 species representing five vertebrate lineages. We found that behaviorally relevant brain regions are remarkably conserved over 450 million years of evolution. We also find evidence that different brain regions have experienced different selection pressures, because spatial distribution of neuroendocrine ligands are more flexible than their receptors across vertebrates. Our analysis suggests that the diversity of social behavior in vertebrates can be explained, in part, by variations on a theme of conserved neural and gene expression networks.	[O'Connell, Lauren A.; Hofmann, Hans A.] Univ Texas UT Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [O'Connell, Lauren A.; Hofmann, Hans A.] Univ Texas UT Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Hofmann, Hans A.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Hofmann, HA (corresponding author), Univ Texas UT Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	hans@mail.utexas.edu	Hofmann, Hans A/E-4538-2016	Hofmann, Hans A/0000-0002-3335-330X; O'Connell, Lauren/0000-0002-2706-4077	NSF [1011253, 0843712]; Alfred P. Sloan Foundation; Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; Institute for Cellular and Molecular Biology; Division Of Integrative Organismal Systems [0843712] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology; Institute for Cellular and Molecular Biology; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The data reported in this paper are tabulated in the supplementary materials. We thank M. Cummings, S. Phelps, A. Pollen, M. Ryan, and R. Wong for helpful comments on earlier versions of this manuscript; members of the Hofmann laboratory, the Center for Brain, Behavior, and Evolution at UT Austin, and the Sociogenomics Initiative, especially G. Robinson, for discussions; and D. Canatella, E. Martins, and T. Streelman for advice on the evolutionary analysis. The work was supported by NSF Doctoral Dissertation Improvement Grant 1011253 to L.A.O. and NSF grant 0843712, the Alfred P. Sloan Foundation, a Dwight W. and Blanche Faye Reeder Centennial Fellowship in Systematic and Evolutionary Biology, and an Institute for Cellular and Molecular Biology Fellowship to H. A. H. The authors declare no competing financial interests. L.A.O. gathered all data for analysis; L.A.O. and H. A. H. conceived of the project, analyzed data, and wrote the paper.	Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Butler A. B., 1996, COMP VERTEBRATE NEUR, DOI DOI 10.1002/0471733849.CH19; Butler AB, 2011, ANN NY ACAD SCI, V1225, P14, DOI 10.1111/j.1749-6632.2011.06006.x; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Chakraborty M, 2010, HORM BEHAV, V58, P619, DOI 10.1016/j.yhbeh.2010.06.013; CREWS D, 1986, ANN NY ACAD SCI, V474, P187, DOI 10.1111/j.1749-6632.1986.tb28010.x; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Goodson JL, 2010, CURR OPIN NEUROBIOL, V20, P784, DOI 10.1016/j.conb.2010.08.020; Goodson JL, 2005, HORM BEHAV, V48, P11, DOI 10.1016/j.yhbeh.2005.02.003; Harris-Warrick RM, 2000, J COMP PHYSIOL A, V186, P605, DOI 10.1007/s003590000133; INSEL TR, 1994, J NEUROSCI, V14, P5381; KIM YS, 1978, AM ZOOL, V18, P425; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Leung CH, 2011, ENDOCRINOLOGY, V152, P4865, DOI 10.1210/en.2011-1394; Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058; Moore FL, 1998, COMP BIOCHEM PHYS C, V119, P251, DOI 10.1016/S0742-8413(98)00014-0; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; O'Connell LA, 2011, J COMP NEUROL, V519, P3599, DOI 10.1002/cne.22735; O'Connell LA, 2011, FRONT NEUROENDOCRIN, V32, P320, DOI 10.1016/j.yfrne.2010.12.004; Ophir AG, 2008, P NATL ACAD SCI USA, V105, P1249, DOI 10.1073/pnas.0709116105; Parent A., 1984, Handbook of Chemical Neuroanatomy, V2, P409; Pollen AA, 2008, BRAIN BEHAV EVOLUT, V72, P145, DOI 10.1159/000151474; Porges SW, 2011, POLYVAGAL THEORY NEU; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Smeets WJAJ, 2000, J ANAT, V196, P501, DOI 10.1046/j.1469-7580.2000.19640501.x; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Wickens JR, 2007, ANN NY ACAD SCI, V1104, P192, DOI 10.1196/annals.1390.016; Wood RI, 1998, ANN NY ACAD SCI, V855, P362, DOI 10.1111/j.1749-6632.1998.tb10594.x; Yamamoto K, 2011, J COMP NEUROL, V519, P576, DOI 10.1002/cne.22535; YOUNG LJ, 1995, J NEUROENDOCRINOL, V7, P567, DOI 10.1111/j.1365-2826.1995.tb00793.x	30	367	368	6	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1154	1157		10.1126/science.1218889	http://dx.doi.org/10.1126/science.1218889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654056				2022-12-24	WOS:000304647900048
J	Wallace, DJ; Angus, DC; Barnato, AE; Kramer, AA; Kahn, JM				Wallace, David J.; Angus, Derek C.; Barnato, Amber E.; Kramer, Andrew A.; Kahn, Jeremy M.			Nighttime Intensivist Staffing and Mortality among Critically Ill Patients	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LENGTH-OF-STAY; CARE-UNIT; HOSPITAL VOLUME; OUTCOMES; SERVICES; DOCTORS; SEPSIS; HOUSE	BACKGROUND Hospitals are increasingly adopting 24-hour intensivist physician staffing as a strategy to improve intensive care unit (ICU) outcomes. However, the degree to which nighttime intensivists are associated with improvements in the quality of ICU care is unknown. METHODS We conducted a retrospective cohort study involving ICUs that participated in the Acute Physiology and Chronic Health Evaluation (APACHE) clinical information system from 2009 through 2010, linking a survey of ICU staffing practices with patient-level outcomes data from adult ICU admissions. Multivariate models were used to assess the relationship between nighttime intensivist staffing and in-hospital mortality among ICU patients, with adjustment for daytime intensivist staffing, severity of illness, and case mix. We conducted a confirmatory analysis in a second, population-based cohort of hospitals in Pennsylvania from which less detailed data were available. RESULTS The analysis with the use of the APACHE database included 65,752 patients admitted to 49 ICUs in 25 hospitals. In ICUs with low-intensity daytime staffing, nighttime intensivist staffing was associated with a reduction in risk-adjusted in-hospital mortality (adjusted odds ratio for death, 0.62; P = 0.04). Among ICUs with high-intensity daytime staffing, nighttime intensivist staffing conferred no benefit with respect to risk-adjusted in-hospital mortality (odds ratio, 1.08; P = 0.78). In the verification cohort, there was a similar relationship among daytime staffing, nighttime staffing, and in-hospital mortality. The interaction between nighttime staffing and daytime staffing was not significant (P = 0.18), yet the direction of the findings were similar to those in the APACHE cohort. CONCLUSIONS The addition of nighttime intensivist staffing to a low-intensity daytime staffing model was associated with reduced mortality. However, a reduction in mortality was not seen in ICUs with high-intensity daytime staffing. (Funded by the National Heart, Lung, and Blood Institute.)	[Wallace, David J.; Angus, Derek C.; Barnato, Amber E.; Kahn, Jeremy M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Investigat & Syst Modeling Acute Illness, Pittsburgh, PA 15261 USA; [Barnato, Amber E.] Univ Pittsburgh, Sch Med, Dept Internal Med, Div Gen Internal Med,Ctr Res Hlth Care, Pittsburgh, PA 15261 USA; [Angus, Derek C.; Barnato, Amber E.; Kahn, Jeremy M.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA 15261 USA; [Kramer, Andrew A.] Cerner, Kansas City, MO USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kahn, JM (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Clin Res Investigat & Syst Modeling Acute Illness, 602-B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	kahnjm@upmc.edu	Angus, Derek C/E-9671-2012; Kramer, Andrew/AAI-9086-2020	Kramer, Andrew/0000-0002-5681-5781; Kahn, Jeremy/0000-0001-9688-5576	National Heart, Lung, and Blood Institute [K23-HL096651, T32-HL07820]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096651, T32HL007820] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by grants (K23-HL096651 and T32-HL07820) from the National Heart, Lung, and Blood Institute.	Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; Blunt MC, 2000, LANCET, V356, P735, DOI 10.1016/S0140-6736(00)02634-9; Boucher KM, 1998, J CLIN EPIDEMIOL, V51, P1223, DOI 10.1016/S0895-4356(98)00129-2; Burnham EL, 2010, AM J RESP CRIT CARE, V181, P1159, DOI 10.1164/rccm.201004-0651ED; Cartin-Ceba R, 2010, AM J RESP CRIT CARE, V181, P1279, DOI 10.1164/rccm.201004-0676ED; Castellanos-Ortega A, 2010, CRIT CARE MED, V38, P1036, DOI 10.1097/CCM.0b013e3181d455b6; Finks JF, 2011, NEW ENGL J MED, V364, P2128, DOI 10.1056/NEJMsa1010705; Gajic O, 2008, CRIT CARE MED, V36, P36, DOI 10.1097/01.CCM.0000297887.84347.85; Garland A, 2012, AM J RESP CRIT CARE, V185, P738, DOI 10.1164/rccm.201109-1734OC; Haupt MT, 2003, CRIT CARE MED, V31, P2677, DOI 10.1097/01.CCM.0000094227.89800.93; Jones SF, 2010, AM J RESP CRIT CARE, V181, P1280, DOI 10.1164/rccm.201005-0681ED; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Kahn JM, 2010, AM J RESP CRIT CARE, V181, P1160, DOI 10.1164/rccm.201004-0557ED; Kahn JM, 2009, HEALTH SERV RES, V44, P862, DOI 10.1111/j.1475-6773.2009.00959.x; Kim, 2010, ARCH INTERN MED, V170, P867; Kim MM, 2010, ARCH INTERN MED, V170, P369, DOI 10.1001/archinternmed.2009.521; Kumar A, 2006, CRIT CARE MED, V34, P1589, DOI 10.1097/01.CCM.0000217961.75225.E9; Lilly CM, 2011, JAMA-J AM MED ASSOC, V305, P2175, DOI 10.1001/jama.2011.697; Lin CY, 2010, QUAL SAF HEALTH CARE, V19, DOI 10.1136/qshc.2008.030056; Lin CY, 2009, MED CARE, V47, P524, DOI 10.1097/MLR.0b013e31819261bd; Lindell KO, 2010, AM J RESP CRIT CARE, V182, P1338, DOI 10.1164/rccm.201007-1129ED; Lott JP, 2009, AM J RESP CRIT CARE, V179, P676, DOI 10.1164/rccm.200808-1281OC; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Wallace DJ, 2011, AM J RESP CRIT CARE, V183; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zimmerman JE, 2010, J CRIT CARE, V25, P205, DOI 10.1016/j.jcrc.2009.06.010; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	30	216	223	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 31	2012	366	22					2093	2101		10.1056/NEJMsa1201918	http://dx.doi.org/10.1056/NEJMsa1201918			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	949YE	22612639	Green Accepted			2022-12-24	WOS:000304613400009
J	Kato, M; Han, TNW; Xie, SH; Shi, K; Du, XL; Wu, LC; Mirzaei, H; Goldsmith, EJ; Longgood, J; Pei, JM; Grishin, NV; Frantz, DE; Schneider, JW; Chen, S; Li, L; Sawaya, MR; Eisenberg, D; Tycko, R; McKnight, SL				Kato, Masato; Han, Tina W.; Xie, Shanhai; Shi, Kevin; Du, Xinlin; Wu, Leeju C.; Mirzaei, Hamid; Goldsmith, Elizabeth J.; Longgood, Jamie; Pei, Jimin; Grishin, Nick V.; Frantz, Douglas E.; Schneider, Jay W.; Chen, She; Li, Lin; Sawaya, Michael R.; Eisenberg, David; Tycko, Robert; McKnight, Steven L.			Cell-free Formation of RNA Granules: Low Complexity Sequence Domains Form Dynamic Fibers within Hydrogels	CELL			English	Article							MESSENGER-RNA; AMYLOID FIBRILS; STRESS GRANULES; P GRANULES; PROTEIN; DROSOPHILA; LOCALIZATION; AGGREGATION; GERMLINE; REGIONS	Eukaryotic cells contain assemblies of RNAs and proteins termed RNA granules. Many proteins within these bodies contain KH or RRM RNA-binding domains as well as low complexity (LC) sequences of unknown function. We discovered that exposure of cell or tissue lysates to a biotinylated isoxazole (b-isox) chemical precipitated hundreds of RNA-binding proteins with significant overlap to the constituents of RNA granules. The LC sequences within these proteins are both necessary and sufficient for b-isox-mediated aggregation, and these domains can undergo a concentration-dependent phase transition to a hydrogel-like state in the absence of the chemical. X-ray diffraction and EM studies revealed the hydrogels to be composed of uniformly polymerized amyloid-like fibers. Unlike pathogenic fibers, the LC sequence-based polymers described here are dynamic and accommodate heterotypic polymerization. These observations offer a framework for understanding the function of LC sequences as well as an organizing principle for cellular structures that are not membrane bound.	[Kato, Masato; Han, Tina W.; Xie, Shanhai; Shi, Kevin; Du, Xinlin; Wu, Leeju C.; Mirzaei, Hamid; Goldsmith, Elizabeth J.; Longgood, Jamie; Pei, Jimin; Grishin, Nick V.; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Schneider, Jay W.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Pei, Jimin; Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Frantz, Douglas E.] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA; [Chen, She; Li, Lin] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Sawaya, Michael R.; Eisenberg, David] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Tycko, Robert] NIDDK, Chem Phys Lab, NIH, Bethesda, MD 20892 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas at San Antonio (UTSA); National Institute of Biological Sciences, Beijing; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	McKnight, SL (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	steven.mcknight@utsouthwestern.edu		Sawaya, Michael/0000-0003-0874-9043	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075031] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; [Anonymous], 2010, R LANG ENV STAT COMP; ASTBURY WILLIAM THOMAS, 1935, BIOCHEM JOUR, V29, P2351; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brangwynne CP, 2009, SCIENCE, V324, P1729, DOI 10.1126/science.1172046; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; Gallo CM, 2010, SCIENCE, V330, P1685, DOI 10.1126/science.1193697; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Huntley MA, 2002, PROTEINS, V48, P134, DOI 10.1002/prot.10150; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; KELLEY RL, 1993, GENE DEV, V7, P948, DOI 10.1101/gad.7.6.948; Knowles RB, 1996, J NEUROSCI, V16, P7812; LEHMANN R, 1991, DEVELOPMENT, V112, P679; MAHOWALD AP, 1968, J EXP ZOOL, V167, P237, DOI 10.1002/jez.1401670211; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; Meersman F, 2006, BBA-PROTEINS PROTEOM, V1764, P452, DOI 10.1016/j.bbapap.2005.10.021; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Micklem DR, 1995, DEV BIOL, V172, P377, DOI 10.1006/dbio.1995.8048; MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Palacios IM, 2001, ANNU REV CELL DEV BI, V17, P569, DOI 10.1146/annurev.cellbio.17.1.569; Pitt JN, 2000, DEV BIOL, V219, P315, DOI 10.1006/dbio.2000.9607; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sadek H, 2008, P NATL ACAD SCI USA, V105, P6063, DOI 10.1073/pnas.0711507105; Schneider JW, 2008, NAT CHEM BIOL, V4, P408, DOI 10.1038/nchembio.95; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103; STROME S, 1982, P NATL ACAD SCI-BIOL, V79, P1558, DOI 10.1073/pnas.79.5.1558; Sunde M, 1997, ADV PROTEIN CHEM, V50, P123, DOI 10.1016/S0065-3233(08)60320-4; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Voronina E, 2010, DEVELOPMENT, V137, P1441, DOI 10.1242/dev.047654; WANG C, 1991, CELL, V66, P637, DOI 10.1016/0092-8674(91)90110-K; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170; Wille H, 1999, BIOPHYS J, V76, P1048, DOI 10.1016/S0006-3495(99)77270-X; Wootton JC, 1996, METHOD ENZYMOL, V266, P554	51	1246	1261	17	247	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					753	767		10.1016/j.cell.2012.04.017	http://dx.doi.org/10.1016/j.cell.2012.04.017			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579281	Green Accepted, Bronze			2022-12-24	WOS:000303934700010
J	Langelier, MF; Planck, JL; Roy, S; Pascal, JM				Langelier, Marie-France; Planck, Jamie L.; Roy, Swati; Pascal, John M.			Structural Basis for DNA Damage-Dependent Poly(ADP-ribosyl)ation by Human PARP-1	SCIENCE			English	Article							CRYSTAL-STRUCTURES; BINDING DOMAIN; POLYMERASE; INHIBITION; MECHANISM; ACCEPTOR	Poly(ADP-ribose) polymerase-1 (PARP-1) (ADP, adenosine diphosphate) has a modular domain architecture that couples DNA damage detection to poly(ADP-ribosyl)ation activity through a poorly understood mechanism. Here, we report the crystal structure of a DNA double-strand break in complex with human PARP-1 domains essential for activation (Zn1, Zn3, WGR-CAT). PARP-1 engages DNA as a monomer, and the interaction with DNA damage organizes PARP-1 domains into a collapsed conformation that can explain the strong preference for automodification. The Zn1, Zn3, and WGR domains collectively bind to DNA, forming a network of interdomain contacts that links the DNA damage interface to the catalytic domain (CAT). The DNA damage-induced conformation of PARP-1 results in structural distortions that destabilize the CAT. Our results suggest that an increase in CAT protein dynamics underlies the DNA-dependent activation mechanism of PARP-1.	[Langelier, Marie-France; Planck, Jamie L.; Roy, Swati; Pascal, John M.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University	Pascal, JM (corresponding author), Thomas Jefferson Univ, Dept Biochem & Mol Biol, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	john.pascal@kimmelcancercenter.org			NIH [R01087282]; American Cancer Society [RSG0918301]; Kimmel Cancer Center X-ray Crystallography and Molecular Characterization Facility at Thomas Jefferson University [P30CA56036]; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087282] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Kimmel Cancer Center X-ray Crystallography and Molecular Characterization Facility at Thomas Jefferson University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funds from the NIH (R01087282), the American Cancer Society (RSG0918301), and the Kimmel Cancer Center X-ray Crystallography and Molecular Characterization Facility at Thomas Jefferson University (P30CA56036). We thank the National Synchrotron Light Source staff for access and assistance with data collection (beamlines X6A and X29A, Brookhaven National Laboratory); G. Cingolani, Y.-M. Hou, and J. D. Steffen for helpful discussions; and S. Carney for cloning the Zn1-Zn3 interface mutants. The structure of the complex has been deposited under accession number 4DQY in the Protein Data Bank (PDB).	Altmeyer M, 2009, NUCLEIC ACIDS RES, V37, P3723, DOI 10.1093/nar/gkp229; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; D'Silva I, 1999, BBA-PROTEIN STRUCT M, V1430, P119, DOI 10.1016/S0167-4838(98)00278-7; Eustermann S, 2011, J MOL BIOL, V407, P149, DOI 10.1016/j.jmb.2011.01.034; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Langelier MF, 2008, J BIOL CHEM, V283, P4105, DOI 10.1074/jbc.M708558200; Langelier MF, 2011, J BIOL CHEM, V286, P10690, DOI 10.1074/jbc.M110.202507; Langelier MF, 2010, J BIOL CHEM, V285, P18877, DOI 10.1074/jbc.M110.105668; Lilyestrom W, 2010, J MOL BIOL, V395, P983, DOI 10.1016/j.jmb.2009.11.062; Lonskaya I, 2005, J BIOL CHEM, V280, P17076, DOI 10.1074/jbc.M413483200; MARSISCHKY GT, 1995, J BIOL CHEM, V270, P3247, DOI 10.1074/jbc.270.7.3247; MIRANDA EA, 1995, BIOCHEM BIOPH RES CO, V212, P317, DOI 10.1006/bbrc.1995.1972; OGATA N, 1981, J BIOL CHEM, V256, P4135; Pion E, 2003, BIOCHEMISTRY-US, V42, P12409, DOI 10.1021/bi0344432; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Ruf A, 1996, P NATL ACAD SCI USA, V93, P7481, DOI 10.1073/pnas.93.15.7481; Ruf A, 1998, J MOL BIOL, V278, P57, DOI 10.1006/jmbi.1998.1673; Ruf A, 1998, BIOCHEMISTRY-US, V37, P3893, DOI 10.1021/bi972383s; Spagnolo L, 2012, NUCLEIC ACIDS RES, V40, P4168, DOI 10.1093/nar/gkr1231; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; Trucco C, 1996, FEBS LETT, V399, P313, DOI 10.1016/S0014-5793(96)01347-6; Wacker DA, 2007, MOL CELL BIOL, V27, P7475, DOI 10.1128/MCB.01314-07	23	391	412	5	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					728	732		10.1126/science.1216338	http://dx.doi.org/10.1126/science.1216338			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582261	Green Accepted			2022-12-24	WOS:000303872300052
J	Marks, H; Kalkan, T; Menafra, R; Denissov, S; Jones, K; Hofemeister, H; Nichols, J; Kranz, A; Stewart, AF; Smith, A; Stunnenberg, HG				Marks, Hendrik; Kalkan, Tuezer; Menafra, Roberta; Denissov, Sergey; Jones, Kenneth; Hofemeister, Helmut; Nichols, Jennifer; Kranz, Andrea; Stewart, A. Francis; Smith, Austin; Stunnenberg, Hendrik G.			The Transcriptional and Epigenomic Foundations of Ground State Pluripotency	CELL			English	Article							EMBRYONIC STEM-CELLS; RNA-POLYMERASE-II; MOUSE ES CELLS; SELF-RENEWAL; SIGNALING PATHWAYS; RAT BLASTOCYSTS; GENE-REGULATION; GERMLINE; DIFFERENTIATION; HETEROGENEITY	Mouse embryonic stem (ES) cells grown in serum exhibit greater heterogeneity in morphology and expression of pluripotency factors than ES cells cultured in defined medium with inhibitors of two kinases (Mek and GSK3), a condition known as "2i" postulated to establish a naive ground state. We show that the transcriptome and epigenome profiles of serum-and 2i-grown ES cells are distinct. 2i-treated cells exhibit lower expression of lineage-affiliated genes, reduced prevalence at promoters of the repressive histone modification H3K27me3, and fewer bivalent domains, which are thought to mark genes poised for either up-or downregulation. Nonetheless, serum- and 2i-grown ES cells have similar differentiation potential. Precocious transcription of developmental genes in 2i is restrained by RNA polymerase II promoter-proximal pausing. These findings suggest that transcriptional potentiation and a permissive chromatin context characterize the ground state and that exit from it may not require a metastable intermediate or multilineage priming.	[Kalkan, Tuezer; Jones, Kenneth; Nichols, Jennifer; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr, Stem Cell Res & Stem Cell Inst, Cambridge CB2 1QR, England; [Marks, Hendrik; Menafra, Roberta; Denissov, Sergey; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, NCMLS, Fac Sci, Dept Mol Biol, NL-6500 HB Nijmegen, Netherlands; [Nichols, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QR, England; [Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Hofemeister, Helmut; Kranz, Andrea; Stewart, A. Francis] Tech Univ Dresden, BioInnovat Zentrum, D-01307 Dresden, Germany	University of Cambridge; Radboud University Nijmegen; University of Cambridge; University of Cambridge; Technische Universitat Dresden	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr, Stem Cell Res & Stem Cell Inst, Tennis Court Rd, Cambridge CB2 1QR, England.	austin.smith@cscr.cam.ac.uk; h.stunnenberg@ncmls.ru.nl	Stunnenberg, Hendrik G./D-6875-2012; Stewart, A. Francis/E-7789-2010; Kranz, Andrea/D-3617-2012; Marks, Hendrik/E-2801-2012	Stunnenberg, Hendrik G./0000-0002-0066-1576; Marks, Hendrik/0000-0002-4198-3731; Nichols, Jennifer/0000-0002-8650-1388; Smith, Austin/0000-0002-3029-4682	European Union [18883, 223485, 200720, 221952]; Deutsche Forschungsgemeinschaft [SPP1356]; Wellcome Trust; MRC [G0800784] Funding Source: UKRI; Medical Research Council [G0800784B, G1100526, G0800784, MC_PC_12009] Funding Source: researchfish	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Eva Janssen-Megens, Anita Kaan, and Yan Tan for sequencing; Kees-Jan Francoijs, Hinri Kerstens, Simon van Heeringen, and Arjen Brinkman for bioinformatic assistance; and Rachel Walker for help with flow cytometry. We thank Paul Bertone for comments on the manuscript. Tatyana Nesterova and Neil Brockdorff provided the XT67E1 cells and Olga Ujhelly and Andras Dinnyes the HM1 cells. The pThr345-Ezh2 antibody was a gift from Danny Reinberg. The research leading to these results has received funding from the European Union grants HEROIC (18883; FP6/2005-2010), PluriSys (223485; FP7/2009), EuroSyStem (200720; FP7/2008), and ATLAS (221952; FP7/2009), the Deutsche Forschungsgemeinschaft SPP1356 Pluripotency and Reprogramming, and The Wellcome Trust. A. S. is a Medical Research Council Professor.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boettiger AN, 2009, SCIENCE, V325, P471, DOI 10.1126/science.1173976; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Fujita T, 2008, MOL CELL BIOL, V28, P1630, DOI 10.1128/MCB.01767-07; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hishida T, 2011, CELL STEM CELL, V9, P37, DOI 10.1016/j.stem.2011.04.020; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Ma ZY, 2011, NAT STRUCT MOL BIOL, V18, P120, DOI 10.1038/nsmb.2000; Marks H, 2009, GENOME RES, V19, P1361, DOI 10.1101/gr.092643.109; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Nakamura A, 2008, DEVELOPMENT, V135, P3817, DOI 10.1242/dev.022434; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Smith A, 2010, EMBO MOL MED, V2, P113, DOI 10.1002/emmm.201000065; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Wang W, 2011, P NATL ACAD SCI USA, V108, P18283, DOI 10.1073/pnas.1100893108; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Young RA, 2011, CELL, V144, P940, DOI 10.1016/j.cell.2011.01.032	61	596	606	4	87	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					590	604		10.1016/j.cell.2012.03.026	http://dx.doi.org/10.1016/j.cell.2012.03.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541430	Green Published, Green Submitted, hybrid			2022-12-24	WOS:000303443100011
J	Kolling, N; Behrens, TEJ; Mars, RB; Rushworth, MFS				Kolling, Nils; Behrens, Timothy E. J.; Mars, Rogier B.; Rushworth, Matthew F. S.			Neural Mechanisms of Foraging	SCIENCE			English	Article							ANTERIOR CINGULATE; VALUE COMPUTATIONS; DECISION-MAKING; REWARD SIGNALS; CORTEX; INFORMATION; VALUATION; STRIATUM	Behavioral economic studies involving limited numbers of choices have provided key insights into neural decision-making mechanisms. By contrast, animals' foraging choices arise in the context of sequences of encounters with prey or food. On each encounter, the animal chooses whether to engage or, if the environment is sufficiently rich, to search elsewhere. The cost of foraging is also critical. We demonstrate that humans can alternate between two modes of choice, comparative decision-making and foraging, depending on distinct neural mechanisms in ventromedial prefrontal cortex (vmPFC) and anterior cingulate cortex (ACC) using distinct reference frames; in ACC, choice variables are represented in invariant reference to foraging or searching for alternatives. Whereas vmPFC encodes values of specific well-defined options, ACC encodes the average value of the foraging environment and cost of foraging.	[Kolling, Nils; Behrens, Timothy E. J.; Mars, Rogier B.; Rushworth, Matthew F. S.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; [Behrens, Timothy E. J.; Mars, Rogier B.; Rushworth, Matthew F. S.] Univ Oxford, Oxford Ctr Funct Magnet Resonance Imaging Brain F, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Kolling, N (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	nils.kolling@psy.ox.ac.uk	Mars, Rogier/GWZ-9665-2022; Mars, Rogier/G-2312-2018	Mars, Rogier/0000-0001-6302-8631; Kolling, Nils/0000-0002-0283-6966; Rushworth, Matthew/0000-0002-5578-9884; Behrens, Timothy/0000-0003-0048-1177	U.K. Medical Research Council; Wellcome Trust; MRC [G0700399, G0802146, G0600994] Funding Source: UKRI; Medical Research Council [G0600994, G0802146, G0700399] Funding Source: researchfish	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funded by U.K. Medical Research Council and the Wellcome Trust.	Basten U, 2010, P NATL ACAD SCI USA, V107, P21767, DOI 10.1073/pnas.0908104107; Boorman ED, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001093; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Fellows LK, 2006, BRAIN, V129, P944, DOI 10.1093/brain/awl017; Freidin E, 2011, SCIENCE, V334, P1000, DOI 10.1126/science.1209626; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2011, P NATL ACAD SCI USA, V108, P18120, DOI 10.1073/pnas.1109322108; Hayden BY, 2011, NAT NEUROSCI, V14, P933, DOI 10.1038/nn.2856; Hayden BY, 2009, SCIENCE, V324, P948, DOI 10.1126/science.1168488; Kennerley SW, 2011, NAT NEUROSCI, V14, P1581, DOI 10.1038/nn.2961; Lim SL, 2011, J NEUROSCI, V31, P13214, DOI 10.1523/JNEUROSCI.1246-11.2011; Magno E, 2006, J NEUROSCI, V26, P4769, DOI 10.1523/JNEUROSCI.0369-06.2006; Mansouri FA, 2007, SCIENCE, V318, P987, DOI 10.1126/science.1146384; Matsumoto K, 2003, SCIENCE, V301, P229, DOI 10.1126/science.1084204; Noonan MP, 2011, J NEUROSCI, V31, P14399, DOI 10.1523/JNEUROSCI.6456-10.2011; Noonan MP, 2010, P NATL ACAD SCI USA, V107, P20547, DOI 10.1073/pnas.1012246107; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Quilodran R, 2008, NEURON, V57, P314, DOI 10.1016/j.neuron.2007.11.031; Rudebeck PH, 2006, NAT NEUROSCI, V9, P1161, DOI 10.1038/nn1756; Rushworth MFS, 2011, NEURON, V70, P1054, DOI 10.1016/j.neuron.2011.05.014; Seo H, 2007, J NEUROSCI, V27, P8366, DOI 10.1523/JNEUROSCI.2369-07.2007; Stephens D.W., 1986, pi; Vickery TJ, 2011, NEURON, V72, P166, DOI 10.1016/j.neuron.2011.08.011; Wise SP, 2008, TRENDS NEUROSCI, V31, P599, DOI 10.1016/j.tins.2008.08.008; Wunderlich K, 2012, NAT NEUROSCI, V15, P786, DOI 10.1038/nn.3068	30	362	363	2	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					95	98		10.1126/science.1216930	http://dx.doi.org/10.1126/science.1216930			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491854	Green Accepted			2022-12-24	WOS:000302405400059
J	Powell, AE; Wang, Y; Li, YN; Poulin, EJ; Means, AL; Washington, MK; Higginbotham, JN; Juchheim, A; Prasad, N; Levy, SE; Guo, Y; Shyr, Y; Aronow, BJ; Haigis, KM; Franklin, JL; Coffey, RJ				Powell, Anne E.; Wang, Yang; Li, Yina; Poulin, Emily J.; Means, Anna L.; Washington, Mary K.; Higginbotham, James N.; Juchheim, Alwin; Prasad, Nripesh; Levy, Shawn E.; Guo, Yan; Shyr, Yu; Aronow, Bruce J.; Haigis, Kevin M.; Franklin, Jeffrey L.; Coffey, Robert J.			The Pan-ErbB Negative Regulator Lrig1 Is an Intestinal Stem Cell Marker that Functions as a Tumor Suppressor	CELL			English	Article							IMMUNOHISTOCHEMICAL ANALYSIS; OXIDATIVE STRESS; EXPRESSION MARKS; CANCER; RECEPTOR; GENE; PROLIFERATION; GROWTH; CRYPTS; POPULATION	Lineage mapping has identified both proliferative and quiescent intestinal stem cells, but the molecular circuitry controlling stem cell quiescence is incompletely understood. By lineage mapping, we show Lrig1, a pan-ErbB inhibitor, marks predominately noncycling, long-lived stem cells that are located at the crypt base and that, upon injury, proliferate and divide to replenish damaged crypts. Transcriptome profiling of Lrig1(+) colonic stem cells differs markedly from the profiling of highly proliferative, Lgr5(+) colonic stem cells; genes upregulated in the Lrig1(+) population include those involved in cell cycle repression and response to oxidative damage. Loss of Apc in Lrig1(+) cells leads to intestinal adenomas, and genetic ablation of Lrig1 results in heightened ErbB1-3 expression and duodenal adenomas. These results shed light on the relationship between proliferative and quiescent intestinal stem cells and support a model in which intestinal stem cell quiescence is maintained by calibrated ErbB signaling with loss of a negative regulator predisposing to neoplasia.	[Powell, Anne E.; Wang, Yang; Li, Yina; Poulin, Emily J.; Higginbotham, James N.; Franklin, Jeffrey L.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA; [Powell, Anne E.; Wang, Yang; Li, Yina; Poulin, Emily J.; Higginbotham, James N.; Franklin, Jeffrey L.; Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Means, Anna L.] Vanderbilt Univ, Med Ctr, Dept Surg, Nashville, TN 37232 USA; [Washington, Mary K.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Guo, Yan; Shyr, Yu] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN 37232 USA; [Coffey, Robert J.] Vanderbilt Univ, Med Ctr, Epithelial Biol Ctr, Nashville, TN 37232 USA; [Juchheim, Alwin; Haigis, Kevin M.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Mol Pathol Unit, Charlestown, MA 02129 USA; [Juchheim, Alwin; Haigis, Kevin M.] Harvard Univ, Sch Med, Dept Pathol, Charlestown, MA 02129 USA; [Prasad, Nripesh; Levy, Shawn E.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp, Med Ctr, Dept Biomed Informat, Cincinnati, OH 45229 USA; [Aronow, Bruce J.] Cincinnati Childrens Hosp, Med Ctr, Dept Dev Biol, Cincinnati, OH 45229 USA; [Coffey, Robert J.] Dept Vet Affairs Med Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Massachusetts General Hospital; Harvard University; HudsonAlpha Institute for Biotechnology; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Coffey, RJ (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN 37232 USA.	robert.coffey@vanderbilt.edu	Wang, Yang/O-2300-2013; Aronow, Bruce J/F-8438-2012	Wang, Yang/0000-0003-2801-8416; Levy, Shawn/0000-0002-1369-5740; Prasad, Nripesh/0000-0003-4074-2538; Zemper, Anne/0000-0001-8238-1406	National Cancer Institute [CA151566, CA46413]; MMHCC [U01CA084239]; Gastrointestinal Specialized Program of Research Excellence [P50CA095103, T32GM008554, T32CA119925]; Vanderbilt's Clinical and Translational Science Award; Transgenic Mouse/ES Cell, Cell Imaging, and Flow Cytometry Shared Resources; Coffey Memorial Gastrointestinal Cancer Fund; NATIONAL CANCER INSTITUTE [P50CA095103, R01CA046413, U01CA084239, R01CA151566, T32CA119925] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK058404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008554] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MMHCC; Gastrointestinal Specialized Program of Research Excellence; Vanderbilt's Clinical and Translational Science Award; Transgenic Mouse/ES Cell, Cell Imaging, and Flow Cytometry Shared Resources; Coffey Memorial Gastrointestinal Cancer Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	A.E.P., Y.W., Y.L., K.M.H., J.L.F. and R.J.C. designed, executed and analyzed data. E.J.P., J.N.H., and A.J. provided technical assistance. S.E.L. conducted the RNA-Seq. A.L.M., M.K.W., N.P., Y.G., Y.S., and B.J.A. provided expert analysis. A.E.P. and R.J.C. assembled the manuscript. We thank Frank Revetta and Catherine Meador for technical assistance and Robert Whitehead for guidance. This work was supported by the National Cancer Institute CA151566 to R.J.C. and K.M.H., and CA46413, MMHCC U01CA084239, and Gastrointestinal Specialized Program of Research Excellence P50CA095103 to R.J.C., T32GM008554 to E.J.P. and T32CA119925 to A.E.P. The authors acknowledge the support of Vanderbilt's Clinical and Translational Science Award and Transgenic Mouse/ES Cell, Cell Imaging, and Flow Cytometry Shared Resources. We thank the Peter Powell and Mary Catherine Mundell Coffey Memorial Gastrointestinal Cancer Fund for its generous support.	AKASHI T, 1994, VIRCHOWS ARCH, V425, P399; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Cai WB, 1997, INT J RADIAT BIOL, V71, P573, DOI 10.1080/095530097143905; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Escobar M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1260; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Goldoni S, 2007, ONCOGENE, V26, P368, DOI 10.1038/sj.onc.1209803; Gracz AD, 2010, AM J PHYSIOL-GASTR L, V298, pG590, DOI 10.1152/ajpgi.00470.2009; Graham SM, 2007, STEM CELLS, V25, P3111, DOI 10.1634/stemcells.2007-0250; Hedman H, 2007, EUR J CANCER, V43, P676, DOI 10.1016/j.ejca.2006.10.021; HENDRY JH, 1992, RADIAT RES, V132, P115, DOI 10.2307/3578342; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Ledda F, 2008, J NEUROSCI, V28, P39, DOI 10.1523/JNEUROSCI.2196-07.2008; Li YN, 2004, DEV BIOL, V270, P214, DOI 10.1016/j.ydbio.2004.03.009; Ljuslinder I, 2007, ACTA ONCOL, V46, P1118, DOI 10.1080/02841860701426823; Miller JK, 2008, CANCER RES, V68, P8286, DOI 10.1158/0008-5472.CAN-07-6316; Montgomery RK, 2011, P NATL ACAD SCI USA, V108, P179, DOI 10.1073/pnas.1013004108; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Powell AE, 2011, CANCER RES, V71, P1497, DOI 10.1158/0008-5472.CAN-10-3223; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shattuck DL, 2007, MOL CELL BIOL, V27, P1934, DOI 10.1128/MCB.00757-06; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Storz P, 2011, ANTIOXID REDOX SIGN, V14, P593, DOI 10.1089/ars.2010.3405; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; Takeda N, 2011, SCIENCE, V334, P1420, DOI 10.1126/science.1213214; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Thliveris AT, 2011, CANCER PREV RES, V4, P916, DOI 10.1158/1940-6207.CAPR-11-0022; Thomasson M, 2003, BRIT J CANCER, V89, P1285, DOI 10.1038/sj.bjc.6601208; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-75; WHITEHEAD RH, 1987, IN VITRO CELL DEV B, V23, P436; Whitehead RH, 2009, AM J PHYSIOL-GASTR L, V296, pG455, DOI 10.1152/ajpgi.90381.2008; Wong MH, 1998, J CELL BIOL, V141, P765, DOI 10.1083/jcb.141.3.765; Ye F, 2009, J NEURO-ONCOL, V94, P183, DOI 10.1007/s11060-009-9836-1; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	49	483	488	1	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					146	158		10.1016/j.cell.2012.02.042	http://dx.doi.org/10.1016/j.cell.2012.02.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464327	Bronze, Green Accepted			2022-12-24	WOS:000302235400017
J	Tennessen, JA; Bigham, AW; O'Connor, TD; Fu, WQ; Kenny, EE; Gravel, S; McGee, S; Do, R; Liu, XM; Jun, G; Kang, HM; Jordan, D; Leal, SM; Gabriel, S; Rieder, MJ; Abecasis, G; Altshuler, D; Nickerson, DA; Boerwinkle, E; Sunyaev, S; Bustamante, CD; Bamshad, MJ; Akey, JM				Tennessen, Jacob A.; Bigham, Abigail W.; O'Connor, Timothy D.; Fu, Wenqing; Kenny, Eimear E.; Gravel, Simon; McGee, Sean; Do, Ron; Liu, Xiaoming; Jun, Goo; Kang, Hyun Min; Jordan, Daniel; Leal, Suzanne M.; Gabriel, Stacey; Rieder, Mark J.; Abecasis, Goncalo; Altshuler, David; Nickerson, Deborah A.; Boerwinkle, Eric; Sunyaev, Shamil; Bustamante, Carlos D.; Bamshad, Michael J.; Akey, Joshua M.		Broad GO; Seattle GO; NHLBI Exome Sequencing Project	Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human Exomes	SCIENCE			English	Article							POSITIVE SELECTION; DISCOVERY; SPECTRUM	As a first step toward understanding how rare variants contribute to risk for complex diseases, we sequenced 15,585 human protein-coding genes to an average median depth of 111x in 2440 individuals of European (n = 1351) and African (n = 1088) ancestry. We identified over 500,000 single-nucleotide variants (SNVs), the majority of which were rare (86% with a minor allele frequency less than 0.5%), previously unknown (82%), and population-specific (82%). On average, 2.3% of the 13,595 SNVs each person carried were predicted to affect protein function of similar to 313 genes per genome, and similar to 95.7% of SNVs predicted to be functionally important were rare. This excess of rare functional variants is due to the combined effects of explosive, recent accelerated population growth and weak purifying selection. Furthermore, we show that large sample sizes will be required to associate rare variants with complex traits.	[Tennessen, Jacob A.; O'Connor, Timothy D.; Fu, Wenqing; McGee, Sean; Rieder, Mark J.; Nickerson, Deborah A.; Bamshad, Michael J.; Akey, Joshua M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Bigham, Abigail W.; Bamshad, Michael J.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Kenny, Eimear E.; Gravel, Simon] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Do, Ron; Gabriel, Stacey; Altshuler, David; Sunyaev, Shamil] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Do, Ron] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Liu, Xiaoming; Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Jun, Goo; Kang, Hyun Min; Abecasis, Goncalo] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Jordan, Daniel; Sunyaev, Shamil] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Genet, Boston, MA 02115 USA; [Leal, Suzanne M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Baylor College of Medicine; Baylor College of Medicine	Bamshad, MJ (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	mbamshad@u.washington.edu; akeyj@uw.edu	Altshuler, David M/A-4476-2009; Liu, Xiaoming/C-2743-2008; Jordan, Daniel/M-6842-2019; Abecasis, Goncalo R/B-7840-2010; Jun, Goo/M-5235-2016; Jun, Goo/F-1941-2017	Altshuler, David M/0000-0002-7250-4107; Liu, Xiaoming/0000-0001-8285-5528; Jordan, Daniel/0000-0002-5318-8225; Jun, Goo/0000-0003-0891-0204; Jun, Goo/0000-0003-0891-0204; Akey, Joshua/0000-0002-4411-1330; Tennessen, Jacob/0000-0002-5015-4740; Bustamante, Carlos D./0000-0002-4187-7920; O'Connor, Timothy/0000-0002-0276-1896; Abecasis, Goncalo/0000-0003-1509-1825	NHLBI [RC2 HL-103010, RC2 HL-102923, RC2 HL-102924, RC2 HL-102925, RC2 HL-102926]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102924, RC2HL102926, RC2HL102925, RC2HL103010, RC2HL102923] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006513, R01HG003229] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the support of the NHLBI and the contributions of the research institutions, study investigators, field staff, and study participants in creating this resource for biomedical research; and the Population Genetics Project Team. Funding for GO ESP was provided by NHLBI grants RC2 HL-103010 (HeartGO), RC2 HL-102923 (LungGO), and RC2 HL-102924 (Women's Health Initiative Exome Sequencing Project, WHISP). The exome sequencing was performed through NHLBI grants RC2 HL-102925 (BroadGO) and RC2 HL-102926 (SeattleGO). Filtered sets of annotated variants and their allele frequencies are available at http://evs.gs.washington.edu/EVS/ and have been deposited in dbSNP (www.ncbi.nlm.nih.gov/snp; local batch ID, ESP2500). Genotypes and phenotypes from a large subset of individuals are also available via dbGaP (www.ncbi.nlm.nih.gov/gap) using the following accession information: NHLBI GO-ESP: Women's Health Initiative Exome Sequencing Project (WHI) - WHISP, WHISP_Subject_Phenotypes, pht002246.v2. p2, phs000281.v2.p2; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (JHS), ESP_HeartGO_JHS_LDLandEOMI_Subject_Phenotypes, pht002539.v1.p1, phs000402.v1.p1; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (FHS), HeartGO_FHS_LDLandEOMI_PhenotypeDataFile, pht002476.v1.p1, phs000401.v1.p1; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (CHS), HeartGO_CHS_LDL_PhenotypeDataFile, pht002536.v1.p1, phs000400.v1.p1; NHLBI GO-ESP: Heart Cohorts Exome Sequencing Project (ARIC), ESP_ARIC_LDLandEOMI_Sample, pht002466.v1.p1, phs000398.v1.p1; NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Cystic Fibrosis), ESP_LungGO_CF_PA_Culture_Data, pht002227. v1.p1, phs000254.v1.p1; NHLBI GO-ESP: Early-Onset Myocardial Infarction (Broad EOMI), ESP_Broad_EOMI_Subject_Phenotypes, pht001437.v1.p1, phs000279.v1.p1; NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Pulmonary Arterial Hypertension), PAH_Subject_Phenotypes_Baseline_Measures, pht002277.v1.p1, phs000290.v1.p1; NHLBI GO-ESP: Lung Cohorts Exome Sequencing Project (Lung Health Study of Chronic Obstructive Pulmonary Disease), LHS_COPD_Subject_Phenotypes_Baseline_Measures, pht002272.v1.p1, phs000291. v1.p1. C. D. B. is on the scientific advisory board for Personalis, Incorporated; Mubadala Medical Holding Company; 23andme "Roots into the future" project; and Ancestry. com. M.J.R. owns stock in Illumina.	Ajay SS, 2011, GENOME RES, V21, P1498, DOI 10.1101/gr.123638.111; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; Gibson G, 2012, NAT REV GENET, V13, P135, DOI 10.1038/nrg3118; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kryukov GV, 2009, P NATL ACAD SCI USA, V106, P3871, DOI 10.1073/pnas.0812824106; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lohmueller KE, 2008, NATURE, V451, P994, DOI 10.1038/nature06611; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marth GT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r84; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Ramirez-Soriano A, 2009, GENETICS, V181, P701, DOI 10.1534/genetics.108.094060; Sobreira NLM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000991; Tennessen JA, 2010, GENOME RES, V20, P1327, DOI 10.1101/gr.106161.110; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371	28	1154	1174	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2012	337	6090					64	69		10.1126/science.1219240	http://dx.doi.org/10.1126/science.1219240			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22604720	Green Accepted			2022-12-24	WOS:000306053100043
J	Karplus, PA; Diederichs, K				Karplus, P. Andrew; Diederichs, Kay			Linking Crystallographic Model and Data Quality	SCIENCE			English	Article							X-RAY DATA; CYSTEINE DIOXYGENASE	In macromolecular x-ray crystallography, refinement R values measure the agreement between observed and calculated data. Analogously, R-merge values reporting on the agreement between multiple measurements of a given reflection are used to assess data quality. Here, we show that despite their widespread use, R-merge values are poorly suited for determining the high-resolution limit and that current standard protocols discard much useful data. We introduce a statistic that estimates the correlation of an observed data set with the underlying ( not measurable) true signal; this quantity, CC*, provides a single statistically valid guide for deciding which data are useful. CC* also can be used to assess model and data quality on the same scale, and this reveals when data quality is limiting model improvement.	[Diederichs, Kay] Univ Konstanz, Dept Biol, D-78457 Constance, Germany; [Karplus, P. Andrew] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	University of Konstanz; Oregon State University	Diederichs, K (corresponding author), Univ Konstanz, Dept Biol, Box 647, D-78457 Constance, Germany.	kay.diederichs@uni-konstanz.de		Karplus, Paul/0000-0001-8725-6292	Alexander von Humboldt Foundation; Konstanz Research School Chemical Biology; NIH [GM083136, DK056649]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083136] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Konstanz Research School Chemical Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Alexander von Humboldt Foundation, the Konstanz Research School Chemical Biology, and NIH grants GM083136 and DK056649. We thank R. Cooley for providing the EXP data images, V. Lunin for help with deriving Eq. 3, and A. Gittleman for help with mathematical notation. We also thank M. Junk, W. Kabsch, K. Schafer, D. Tronrud, M. Wells and W. Welte for critically reading the manuscript. The program HIRESCUT is available upon request. P. A. K. and K. D. designed and performed the research and wrote the paper. The authors declare no competing financial interests.	ARNDT UW, 1968, J PHYS E SCI INSTRUM, V1, P510, DOI 10.1088/0022-3735/1/5/303; Bobko P., 2001, CORRELATION REGRESSI; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Cruickshank DWJ, 1999, ACTA CRYSTALLOGR D, V55, P583, DOI 10.1107/S0907444998012645; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Diederichs K, 2009, ACTA CRYSTALLOGR D, V65, P535, DOI 10.1107/S0907444909010282; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; GAUCH HG, 1993, AM SCI, V81, P468; LUZZATI V, 1953, ACTA CRYSTALLOGR, V6, P142, DOI 10.1107/S0365110X53000508; Rahman N.A., 1968, COURSE THEORETICAL S; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Simmons CR, 2008, BIOCHEMISTRY-US, V47, P11390, DOI 10.1021/bi801546n; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; Steiner RA, 2003, ACTA CRYSTALLOGR D, V59, P2114, DOI 10.1107/S0907444903018675; Wang JM, 2010, ACTA CRYSTALLOGR D, V66, P988, DOI 10.1107/S0907444910029938; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; WILSON AJC, 1950, ACTA CRYSTALLOGR, V3, P397, DOI 10.1107/S0365110X50001129	20	1302	1311	5	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					1030	1033		10.1126/science.1218231	http://dx.doi.org/10.1126/science.1218231			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628654	Green Accepted, Green Submitted			2022-12-24	WOS:000304406800044
J	Keinan, A; Clark, AG				Keinan, Alon; Clark, Andrew G.			Recent Explosive Human Population Growth Has Resulted in an Excess of Rare Genetic Variants	SCIENCE			English	Article							MISSING HERITABILITY; COALESCENT; SPECTRUM; DISEASE; SAMPLE; COMMON; RISK	Human populations have experienced recent explosive growth, expanding by at least three orders of magnitude over the past 400 generations. This departure from equilibrium skews patterns of genetic variation and distorts basic principles of population genetics. We characterized the empirical signatures of explosive growth on the site frequency spectrum and found that the discrepancy in rare variant abundance across demographic modeling studies is mostly due to differences in sample size. Rapid recent growth increases the load of rare variants and is likely to play a role in the individual genetic burden of complex disease risk. Hence, the extreme recent human population growth needs to be taken into consideration in studying the genetics of complex diseases and traits.	[Keinan, Alon; Clark, Andrew G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University	Keinan, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA.	ak735@cornell.edu		Keinan, Alon/0000-0002-9760-1122; Clark, Andrew/0000-0001-7159-8511	NIH [U01-HG005715, GM065509, HL102419]; Alfred P. Sloan Research Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC2HL102419] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229, U01HG005715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM065509] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alfred P. Sloan Research Fellowship(Alfred P. Sloan Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Blekhman, E. Boerwinkle, C. D. Bustamante, A. Coventry, E. Gazave, S. Gravel, H. Hunter-Zinck, J. M. Kidd, L. Ma, C. F. Sing, and the 1000 Genomes Project for discussion and ongoing collaborations that substantively advanced this project. Supported by NIH grants U01-HG005715, GM065509, and HL102419, and by an Alfred P. Sloan Research Fellowship (A.K.).	Akey J, 2011, GENOME BIOL, V12, P1, DOI 10.1186/1465-6906-12-S1-I1; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Cohen J. E., 1995, MANY PEOPLE CAN EART; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Coventry A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1130; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fawcett KA, 2010, DIABETES, V59, P741, DOI 10.2337/db09-0920; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Glatt CE, 2001, NAT GENET, V27, P435, DOI 10.1038/86948; Gravel S, 2011, P NATL ACAD SCI USA, V108, P11983, DOI 10.1073/pnas.1019276108; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Hartl D., 2007, PRINCIPLES POPULATIO; Haub C, 1995, Popul Today, V23, P4; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Kremer M, 1993, Q J ECON, V108, P681, DOI 10.2307/2118405; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Novembre J., 2011, 12 INT C HUM GEN 12; Pitman J, 1999, ANN PROBAB, V27, P1870, DOI 10.1214/aop/1022677552; Roberts L, 2011, SCIENCE, V333, P540, DOI 10.1126/science.333.6042.540; Sagitov S, 1999, J APPL PROBAB, V36, P1116, DOI 10.1239/jap/1032374759; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Schweinsberg J, 2000, ELECTRON COMMUN PROB, V5, P1, DOI 10.1214/EJP.v5-68; Tennessen JA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-127; Wakeley J, 2003, MOL BIOL EVOL, V20, P208, DOI 10.1093/molbev/msg024; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	30	362	367	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					740	743		10.1126/science.1217283	http://dx.doi.org/10.1126/science.1217283			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582263	Green Accepted			2022-12-24	WOS:000303872300055
J	Grueter, CE; van Rooij, E; Johnson, BA; DeLeon, SM; Sutherland, LB; Qi, XX; Gautron, L; Elmquist, JK; Bassel-Duby, R; Olson, EN				Grueter, Chad E.; van Rooij, Eva; Johnson, Brett A.; DeLeon, Susan M.; Sutherland, Lillian B.; Qi, Xiaoxia; Gautron, Laurent; Elmquist, Joel K.; Bassel-Duby, Rhonda; Olson, Eric N.			A Cardiac MicroRNA Governs Systemic Energy Homeostasis by Regulation of MED13	CELL			English	Article							THYROID-HORMONE ACTION; TRANSCRIPTIONAL ACTIVATION; INSULIN SENSITIVITY; COACTIVATOR COMPLEX; RECEPTOR FUNCTION; MEDIATOR COMPLEX; OBESITY; MICE; METABOLISM; RESISTANCE	Obesity, type 2 diabetes, and heart failure are associated with aberrant cardiac metabolism. We show that the heart regulates systemic energy homeostasis via MED13, a subunit of the Mediator complex, which controls transcription by thyroid hormone and other nuclear hormone receptors. MED13, in turn, is negatively regulated by a heart-specific microRNA, miR-208a. Cardiac-specific overexpression of MED13 or pharmacologic inhibition of miR-208a in mice confers resistance to high-fat diet-induced obesity and improves systemic insulin sensitivity and glucose tolerance. Conversely, genetic deletion of MED13 specifically in cardiomyocytes enhances obesity in response to high-fat diet and exacerbates metabolic syndrome. The metabolic actions of MED13 result from increased energy expenditure and regulation of numerous genes involved in energy balance in the heart. These findings reveal a role of the heart in systemic metabolic control and point to MED13 and miR-208a as potential therapeutic targets for metabolic disorders.	[Grueter, Chad E.; Johnson, Brett A.; DeLeon, Susan M.; Sutherland, Lillian B.; Qi, Xiaoxia; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Gautron, Laurent; Elmquist, Joel K.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [van Rooij, Eva] miRagen Therapeut Inc, Boulder, CO 80301 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	gautron, laurent/AAQ-5983-2021	Grueter, Chad/0000-0001-8950-742X; DeLeon, Susan/0000-0002-9716-9026	National Institute of Health [PL1 DK081182, UL1 RR024923]; UT Southwestern; Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation [I-0025]; Fondation Leducq; American Heart Association-Jon Holden DeHaan Foundation; American Diabetes Association [7-09-CVD-04];  [RL1DK081185]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024923] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093039, R37HL053351, R01HL077439, R01HL061544, R01HL053351, R01HL083371, R01HL111665] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RL1DK081185, PL1DK081182] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UT Southwestern; Donald W. Reynolds Center for Clinical Cardiovascular Research; Robert A. Welch Foundation(The Welch Foundation); Fondation Leducq(Leducq Foundation); American Heart Association-Jon Holden DeHaan Foundation(American Heart Association); American Diabetes Association(American Diabetes Association); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Carrie A. Grueter, Jose Cabrera, John McAnally, Evelyn Tennison, and Jennifer Brown for their assistance. We appreciate the services of the UT Southwestern Mouse Metabolic Phenotyping Core, supported by National Institute of Health Grants PL1 DK081182 and UL1 RR024923, and the UT Southwestern Transgenic Core Facility. We thank James Richardson and the histology group for their assistance. This work was supported, in part, by grants from National Institutes of Health, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the Robert A. Welch Foundation (grant I-0025), the Fondation Leducq-Transatlantic of Excellence in Cardiovascular Research Program, and the American Heart Association-Jon Holden DeHaan Foundation to E.N.O. C. E. G. was supported by a fellowship from the American Diabetes Association (7-09-CVD-04). J.K.E. was supported by RL1DK081185. E.N.O. and E. v. R. are cofounders of miRagen Therapeutics, a company focused on developing miRNA-based therapies for cardiovascular disease.	Akoulitchev S, 2000, NATURE, V407, P102, DOI 10.1038/35024111; Alarcon C, 2009, CELL, V139, P757, DOI 10.1016/j.cell.2009.09.035; Anderson GW, 2009, MOL CELL ENDOCRINOL, V302, P99, DOI 10.1016/j.mce.2009.01.005; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; BALABAN RS, 1986, SCIENCE, V232, P1121, DOI 10.1126/science.3704638; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Belakavadi M, 2010, MOL CELL BIOL, V30, P2437, DOI 10.1128/MCB.01541-09; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Chen W, 2010, P NATL ACAD SCI USA, V107, P10196, DOI 10.1073/pnas.1005626107; Conaway RC, 2011, CURR OPIN GENET DEV, V21, P225, DOI 10.1016/j.gde.2011.01.013; Crunkhorn S, 2008, THYROID, V18, P227, DOI 10.1089/thy.2007.0249; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Fondell JD, 1999, P NATL ACAD SCI USA, V96, P1959, DOI 10.1073/pnas.96.5.1959; FREDERICH RC, 1995, NAT MED, V1, P1311, DOI 10.1038/nm1295-1311; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a; Harmancey R, 2008, HYPERTENSION, V52, P181, DOI 10.1161/HYPERTENSIONAHA.108.110031; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Ito M, 2001, TRENDS ENDOCRIN MET, V12, P127, DOI 10.1016/S1043-2760(00)00355-6; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Malik S, 2004, MOL CELL BIOL, V24, P8244, DOI 10.1128/MCB.24.18.8244-8254.2004; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mitchell CS, 2010, J CLIN INVEST, V120, P1345, DOI 10.1172/JCI38793; Montgomery RL, 2011, CIRCULATION, V124, P1537, DOI 10.1161/CIRCULATIONAHA.111.030932; Park SW, 2005, MOL CELL, V19, P643, DOI 10.1016/j.molcel.2005.08.008; Philibert R, 2002, COMPR PSYCHIAT, V43, P404, DOI 10.1053/comp.2002.33489; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Song YY, 2011, PROTEIN CELL, V2, P358, DOI 10.1007/s13238-011-1046-x; SUBRAMANIAM A, 1991, J BIOL CHEM, V266, P24613; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Tancevski I, 2011, PHARMACOL THERAPEUT, V131, P33, DOI 10.1016/j.pharmthera.2011.04.003; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; Taubert S, 2006, GENE DEV, V20, P1137, DOI 10.1101/gad.1395406; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wang W, 2009, DEV CELL, V16, P764, DOI 10.1016/j.devcel.2009.04.006; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Xu ZP, 2002, MOL CELL BIOL, V22, P6142, DOI 10.1128/MCB.22.17.6142-6147.2002; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942; Zhou ZH, 2003, NAT GENET, V35, P49, DOI 10.1038/ng1225	53	268	281	3	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					671	683		10.1016/j.cell.2012.03.029	http://dx.doi.org/10.1016/j.cell.2012.03.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541436	Green Accepted, Bronze			2022-12-24	WOS:000303443100017
J	Galiano, MR; Jha, S; Ho, TSY; Zhang, CS; Ogawa, Y; Chang, KJ; Stankewich, MC; Mohler, PJ; Rasband, MN				Galiano, Mauricio R.; Jha, Smita; Ho, Tammy Szu-Yu; Zhang, Chuansheng; Ogawa, Yasuhiro; Chang, Kae-Jiun; Stankewich, Michael C.; Mohler, Peter J.; Rasband, Matthew N.			A Distal Axonal Cytoskeleton Forms an Intra-Axonal Boundary that Controls Axon Initial Segment Assembly	CELL			English	Article							BETA-IV-SPECTRIN; ANKYRIN-G; MEMBRANE; NEUROFASCIN; NODES; ESTABLISHMENT; MAINTENANCE; DIFFUSION; CHANNELS; DOMAINS	AnkyrinG (ankG) is highly enriched in neurons at axon initial segments (AISs) where it clusters Na+ and K+ channels and maintains neuronal polarity. How ankG becomes concentrated at the AIS is unknown. Here, we show that as neurons break symmetry, they assemble a distal axonal submembranous cytoskeleton, comprised of ankyrinB (ankB), alpha II-spectrin, and beta II-spectrin, that defines a boundary limiting ankG to the proximal axon. Experimentally moving this boundary altered the length of ankG staining in the proximal axon, whereas disruption of the boundary through silencing of ankB, alpha II-spectrin, or beta II-spectrin expression blocked AIS assembly and permitted ankG to redistribute throughout the distal axon. In support of an essential role for the distal cytoskeleton in ankG clustering, we also found that alpha II and beta II-spectrin-deficient mice had disrupted AIS. Thus, the distal axonal cytoskeleton functions as an intra-axonal boundary restricting ankG to the AIS.	[Galiano, Mauricio R.; Jha, Smita; Zhang, Chuansheng; Ogawa, Yasuhiro; Rasband, Matthew N.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Ho, Tammy Szu-Yu; Chang, Kae-Jiun; Rasband, Matthew N.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Stankewich, Michael C.] Yale Univ, Dept Pathol, New Haven, CT 06520 USA; [Mohler, Peter J.] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Med Ctr, Columbus, OH 43210 USA	Baylor College of Medicine; Baylor College of Medicine; Yale University; University System of Ohio; Ohio State University	Rasband, MN (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	rasband@bcm.edu		Galiano, Mauricio/0000-0002-8245-1715; Rasband, Matthew/0000-0001-8184-2477; Chang, Kae-Jiun/0000-0002-3656-7725	NIH [NS044916, NS069688, HL083422, HL084583]; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Eunice Kennedy Shriver National Institute of Child Health & Human Development, Baylor College of Medicine IDDRC [5P30HD024064-23]; Mission Connect; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084583, R01HL083422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044916, R01NS069688, R37NS044916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; Eunice Kennedy Shriver National Institute of Child Health & Human Development, Baylor College of Medicine IDDRC; Mission Connect; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Ed Cooper and the Rasband lab for discussions and critical reading of the manuscript. This research was supported by NIH grants NS044916 (M.N.R.), NS069688 (M.N.R.), HL083422 (P.J.M.), and HL084583 (P.J.M.), the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation, and Mission Connect. The generation of the SPNB2<SUP>fl/fl</SUP> mice was supported in part by Baylor College of Medicine IDDRC Grant Number 5P30HD024064-23 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health.	Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Boiko T, 2007, J NEUROSCI, V27, P590, DOI 10.1523/JNEUROSCI.4302-06.2007; Brachet A, 2010, J CELL BIOL, V191, P383, DOI 10.1083/jcb.201003042; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Dzhashiashvili Y, 2007, J CELL BIOL, V177, P857, DOI 10.1083/jcb.200612012; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Hedstrom KL, 2007, J CELL BIOL, V178, P875, DOI 10.1083/jcb.200705119; Hedstrom KL, 2008, J CELL BIOL, V183, P635, DOI 10.1083/jcb.200806112; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kaphzan H, 2011, J NEUROSCI, V31, P17637, DOI 10.1523/JNEUROSCI.4162-11.2011; Katsuki T, 2009, NEURON, V64, P188, DOI 10.1016/j.neuron.2009.08.019; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; Komada M, 2002, J CELL BIOL, V156, P337, DOI 10.1083/jcb.200110003; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Mohler PJ, 2004, J BIOL CHEM, V279, P40185, DOI 10.1074/jbc.M406018200; Mohler PJ, 2002, J BIOL CHEM, V277, P10599, DOI 10.1074/jbc.M110958200; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118; Ogawa Y, 2006, J NEUROSCI, V26, P5230, DOI 10.1523/JNEUROSCI.0425-06.2006; Ogawa Y, 2010, J NEUROSCI, V30, P1038, DOI 10.1523/JNEUROSCI.4661-09.2010; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Rasband MN, 2010, NAT REV NEUROSCI, V11, P552, DOI 10.1038/nrn2852; Saitsu H, 2010, AM J HUM GENET, V86, P881, DOI 10.1016/j.ajhg.2010.04.013; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; Sherman DL, 2005, NEURON, V48, P737, DOI 10.1016/j.neuron.2005.10.019; Sobotzik JM, 2009, P NATL ACAD SCI USA, V106, P17564, DOI 10.1073/pnas.0909267106; Song AH, 2009, CELL, V136, P1148, DOI 10.1016/j.cell.2009.01.016; Stankewich MC, 2011, J CELL SCI, V124, P3956, DOI 10.1242/jcs.080374; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; Winckler B, 1999, NATURE, V397, P698, DOI 10.1038/17789; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443; Yang Y, 2007, J CELL BIOL, V176, P509, DOI 10.1083/jcb.200610128; Zhang X, 1998, J CELL BIOL, V142, P1571, DOI 10.1083/jcb.142.6.1571; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; Zonta B, 2011, NEURON, V69, P945, DOI 10.1016/j.neuron.2011.02.021	42	174	174	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1125	1139		10.1016/j.cell.2012.03.039	http://dx.doi.org/10.1016/j.cell.2012.03.039			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632975	Green Accepted, Bronze			2022-12-24	WOS:000304453900017
J	Okuno, H; Akashi, K; Ishii, Y; Yagishita-Kyo, N; Suzuki, K; Nonaka, M; Kawashima, T; Fujii, H; Takemoto-Kimura, S; Abe, M; Natsume, R; Chowdhury, S; Sakimura, K; Worley, PF; Bito, H				Okuno, Hiroyuki; Akashi, Kaori; Ishii, Yuichiro; Yagishita-Kyo, Nan; Suzuki, Kanzo; Nonaka, Mio; Kawashima, Takashi; Fujii, Hajime; Takemoto-Kimura, Sayaka; Abe, Manabu; Natsume, Rie; Chowdhury, Shoaib; Sakimura, Kenji; Worley, Paul F.; Bito, Haruhiko			Inverse Synaptic Tagging of Inactive Synapses via Dynamic Interaction of Arc/Arg3.1 with CaMKII beta	CELL			English	Article							LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; CYTOSKELETAL-ASSOCIATED PROTEIN; IN-VIVO; KINASE-II; TRANSCRIPTION FACTORS; MEMORY CONSOLIDATION; MESSENGER-RNA; ARC; EXPRESSION	The Arc/Arg3.1 gene product is rapidly upregulated by strong synaptic activity and critically contributes to weakening synapses by promoting AMPA-R endocytosis. However, how activity-induced Arc is redistributed and determines the synapses to be weakened remains unclear. Here, we show targeting of Arc to inactive synapses via a high-affinity interaction with CaMKII beta that is not bound to calmodulin. Synaptic Arc accumulates in inactive synapses that previously experienced strong activation and correlates with removal of surface GluA1 from individual synapses. A lack of CaMKII beta either in vitro or in vivo resulted in loss of Arc upregulation in the silenced synapses. The discovery of Arc's role in "inverse'' synaptic tagging that is specific for weaker synapses and prevents undesired enhancement of weak synapses in potentiated neurons reconciles essential roles of Arc both for the late phase of long-term plasticity and for reduction of surface AMPA-Rs in stimulated neurons.	[Okuno, Hiroyuki; Ishii, Yuichiro; Yagishita-Kyo, Nan; Suzuki, Kanzo; Nonaka, Mio; Kawashima, Takashi; Fujii, Hajime; Takemoto-Kimura, Sayaka; Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan; [Ishii, Yuichiro; Yagishita-Kyo, Nan; Suzuki, Kanzo; Nonaka, Mio; Kawashima, Takashi; Bito, Haruhiko] Univ Tokyo, Grad Sch Med, Global Ctr Educ & Res Chem Biol Dis, Bunkyo Ku, Tokyo 1130033, Japan; [Akashi, Kaori; Abe, Manabu; Natsume, Rie; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan; [Takemoto-Kimura, Sayaka] PRESTO JST, Kawaguchi, Saitama 3320012, Japan; [Chowdhury, Shoaib; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Okuno, Hiroyuki; Nonaka, Mio; Fujii, Hajime; Sakimura, Kenji; Bito, Haruhiko] CREST JST, Chiyoda Ku, Tokyo 1020076, Japan	University of Tokyo; University of Tokyo; Niigata University; Japan Science & Technology Agency (JST); Johns Hopkins University; Japan Science & Technology Agency (JST)	Okuno, H (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurochem, Bunkyo Ku, Tokyo 1130033, Japan.	okuno@m.u-tokyo.ac.jp; hbito@m.u-tokyo.ac.jp	Bito, Haruhiko/A-8635-2008	Kawashima, Takashi/0000-0001-7741-3995; OKUNO, HIROYUKI/0000-0001-6237-6503; Bito, Haruhiko/0000-0001-6315-9594	JSPS; MEXT of Japan; MHLW of Japan; NIMH; HFSP; Shimadzu Foundation; Kowa Life Science Foundation; Takeda Science Foundation; Mitsubishi Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053608] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [20670002, 24700321, 10J04788, 11J04506] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MHLW of Japan; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); HFSP(Human Frontier Science Program); Shimadzu Foundation; Kowa Life Science Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Schulman and T. Meyer for several CaMKII constructs, R.Y. Tsien for mCherry cDNA, A. Miyawaki for Venus cDNA, M. Yamamoto for GFP-TeNT cDNA, K. U. Bayer for pmEGFP-CaMKII beta e cDNA, and M. Watanabe for an anti-vGlut1 antibody, and all members of the Bito laboratory for support. BDNF was provided by Dainippon Sumitomo Pharma, Osaka, Japan. We thank T. Bonhoeffer, K. Deisseroth, R. G. M. Morris, V. Naegerl, R. Redondo, M. van Rossum, M. Schnitzer, and R. W. Tsien for valuable comments on an earlier version of this work, and R. Huganir for critical reading of the manuscript. We are indebted to Y. Kondo, K. Saiki, A. Adachi-Morishima, R. Gyobu, and T. Kinbara for assistance. This work was supported in part by Grants-in-Aid (WAKATE, KIBAN, START, CBSN) from JSPS and MEXT of Japan (to H.O., M.N., S. T-K., K. Sakimura, and H. B.), from the MHLW of Japan (to H.O. and H. B.), by a grant from NIMH (to P. F. W.), and by awards from the HFSP (to H.O. and H. B.) and from the Shimadzu Foundation, Kowa Life Science Foundation, Takeda Science Foundation, and the Mitsubishi Foundation (to H. B.). Y. I., N.Y-K., K. Suzuki, and T. K. are JSPS predoctoral fellows.	Beique JC, 2011, P NATL ACAD SCI USA, V108, P816, DOI 10.1073/pnas.1017914108; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Borgesius NZ, 2011, J NEUROSCI, V31, P10141, DOI 10.1523/JNEUROSCI.5105-10.2011; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Donai H, 2003, NEUROSCI RES, V47, P399, DOI 10.1016/j.neures.2003.08.004; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Matsuzaki M., 2004, NAT NEUROSCI, V429, p[450, 761]; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Miller S, 2002, NEURON, V36, P507, DOI 10.1016/S0896-6273(02)00978-9; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; Moga DE, 2004, NEUROSCIENCE, V125, P7, DOI 10.1016/j.neuroscience.2004.02.004; Navakkode S, 2004, J NEUROSCI, V24, P7740, DOI 10.1523/JNEUROSCI.1796-04.2004; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nonaka M, 2006, J NEUROSCI, V26, P763, DOI 10.1523/JNEUROSCI.2489-05.2006; O'Leary H, 2006, MOL BIOL CELL, V17, P4656, DOI 10.1091/mbc.E06-03-0252; Okada D, 2009, SCIENCE, V324, P904, DOI 10.1126/science.1171498; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Ploski JE, 2008, J NEUROSCI, V28, P12383, DOI 10.1523/JNEUROSCI.1662-08.2008; QIAN Z, 1993, NATURE, V361, P453, DOI 10.1038/361453a0; Ramirez-Amaya V, 2005, J NEUROSCI, V25, P1761, DOI 10.1523/JNEUROSCI.4342-04.2005; Redondo RL, 2010, J NEUROSCI, V30, P4981, DOI 10.1523/JNEUROSCI.3140-09.2010; Shen K, 1998, J NEUROCHEM, V70, P96; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Smith-Hicks C, 2010, NAT NEUROSCI, V13, P1082, DOI 10.1038/nn.2611; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; WORLEY PF, 1993, J NEUROSCI, V13, P4776; Yamamoto M, 2003, J NEUROSCI, V23, P6759; Ying SW, 2002, J NEUROSCI, V22, P1532, DOI 10.1523/JNEUROSCI.22-05-01532.2002	43	198	204	3	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					886	898		10.1016/j.cell.2012.02.062	http://dx.doi.org/10.1016/j.cell.2012.02.062			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579289	Bronze, Green Accepted			2022-12-24	WOS:000303934700020
J	Laxminarayan, R; Heymann, DL				Laxminarayan, Ramanan; Heymann, David L.			Challenges of drug resistance in the developing world	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTIBIOTIC USE; IMPACT; ASSOCIATION; INFECTIONS; PREVALENCE; COUNTRIES; CHILDREN; VACCINE; EUROPE		[Heymann, David L.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC USA	University of London; London School of Hygiene & Tropical Medicine	Heymann, DL (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	david.heymann@hpa.org.uk	Laxminarayan, Ramanan/ABD-5050-2021					Apisarnthanarak A, 2008, INFECT CONT HOSP EP, V29, P572, DOI 10.1086/587496; Berkley JA, 2001, LANCET, V357, P1753, DOI 10.1016/S0140-6736(00)04897-2; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Dong HJ, 1999, HEALTH POLICY, V48, P29, DOI 10.1016/S0168-8510(99)00026-3; Dong HJ, 1999, INT J TECHNOL ASSESS, V15, P686, DOI 10.1017/S0266462399015482; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Hamel MJ, 2008, AM J TROP MED HYG, V79, P320, DOI 10.4269/ajtmh.2008.79.320; Health Action International, 2010, BEING SICK NEED MED; Heymann DL, 2006, CELL, V124, P671, DOI 10.1016/j.cell.2006.02.009; IMS Health, 2011, MIDAS MARK SEGM DAT; Irungu P, 2011, ANAL EC INCENTIVES I; Jones N, 1998, AIDS, V12, P2177, DOI 10.1097/00002030-199816000-00013; Kyaw MH, 2006, NEW ENGL J MED, V354, P1455, DOI 10.1056/NEJMoa051642; Larsson DGJ, 2009, REGUL TOXICOL PHARM, V53, P161, DOI 10.1016/j.yrtph.2009.01.008; Laxminarayan R., 2006, EC INFECT DIS, P49; Laxminarayan R, 2011, HEALTH AFFAIR, V30, P1096, DOI 10.1377/hlthaff.2011.0405; Lim V K, 1992, Malays J Pathol, V14, P41; Madhi SA, 2000, CLIN INFECT DIS, V31, P170, DOI 10.1086/313925; Morgan DJ, 2011, LANCET INFECT DIS, V11, P692, DOI 10.1016/S1473-3099(11)70054-8; Nickerson EK, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004308, 10.1371/journal.pone.0006512]; Okeke IN, 2005, LANCET INFECT DIS, V5, P481, DOI 10.1016/S1473-3099(05)70189-4; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Steinfeld H., 2006, Livestock Report 2006, P3; Sweidan M., 2005, P 2 NAT WORKSH RAT U, P1; Trape JF, 1998, CR ACAD SCI III-VIE, V321, P689, DOI 10.1016/S0764-4469(98)80009-7; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; World Health Organization, 2009, COMM BAS SURV ANT US	28	104	105	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 3	2012	344								e1567	10.1136/bmj.e1567	http://dx.doi.org/10.1136/bmj.e1567			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	923GM	22491075	Green Submitted			2022-12-24	WOS:000302607700010
J	Huang, NA; Chelliah, Y; Shan, YL; Taylor, CA; Yoo, SH; Partch, C; Green, CB; Zhang, H; Takahashi, JS				Huang, Nian; Chelliah, Yogarany; Shan, Yongli; Taylor, Clinton A.; Yoo, Seung-Hee; Partch, Carrie; Green, Carla B.; Zhang, Hong; Takahashi, Joseph S.			Crystal Structure of the Heterodimeric CLOCK:BMAL1 Transcriptional Activator Complex	SCIENCE			English	Article							MAMMALIAN CIRCADIAN CLOCK; DEPENDENT TRANSCRIPTION; DROSOPHILA PERIOD; B/HLH/Z DOMAIN; LIGAND-BINDING; MOUSE PERIOD2; FEEDBACK LOOP; PAS-B; PROTEIN; MECHANISM	The circadian clock in mammals is driven by an autoregulatory transcriptional feedback mechanism that takes approximately 24 hours to complete. A key component of this mechanism is a heterodimeric transcriptional activator consisting of two basic helix-loop-helix PER-ARNT-SIM (bHLH-PAS) domain protein subunits, CLOCK and BMAL1. Here, we report the crystal structure of a complex containing the mouse CLOCK: BMAL1 bHLH-PAS domains at 2.3 angstrom resolution. The structure reveals an unusual asymmetric heterodimer with the three domains in each of the two subunits-bHLH, PAS-A, and PAS-B-tightly intertwined and involved in dimerization interactions, resulting in three distinct protein interfaces. Mutations that perturb the observed heterodimer interfaces affect the stability and activity of the CLOCK:BMAL1 complex as well as the periodicity of the circadian oscillator. The structure of the CLOCK:BMAL1 complex is a starting point for understanding at an atomic level the mechanism driving the mammalian circadian clock.	[Huang, Nian; Taylor, Clinton A.; Partch, Carrie; Zhang, Hong] Univ Texas SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; [Chelliah, Yogarany; Shan, Yongli; Yoo, Seung-Hee; Partch, Carrie; Green, Carla B.; Takahashi, Joseph S.] Univ Texas SW Med Ctr, Dept Neurosci, Dallas, TX 75390 USA; [Chelliah, Yogarany; Partch, Carrie; Takahashi, Joseph S.] Univ Texas SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Taylor, Clinton A.] Univ Texas SW Med Ctr, Mol Biophys Grad Program, Div Basic Sci, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, H (corresponding author), Univ Texas SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA.	zhang@chop.swmed.edu; joseph.takahashi@utsouthwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Taylor IV, Clinton/0000-0002-8283-3393; Shan, Yongli/0000-0002-5870-2107	Howard Hughes Medical Institute; American Heart Association [10GRNT4310090]; NIH [R01 GM090247, R01 GM081875]; National Institute of General Medical Sciences; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-05CH11231]; U.S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM090247, R01GM081875] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute (J.S.T.), American Heart Association grant 10GRNT4310090 (H.Z.), NIH grant R01 GM090247 (C. B. G.), and R01 GM081875 (K. Gardner). We thank N. Grishin and K. Gardner for helpful discussions; S. Padrick for help with the fluorescence polarization assay; M. Rosen for use of his fluorometer; D. Tomchick and H. Aronovich for technical assistance; and C. Ralston, L. Steinhour, and C. Brautigam for help with data collection. The Berkeley Center for Structural Biology is supported in part by NIH, the National Institute of General Medical Sciences, and the Howard Hughes Medical Institute. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract DE-AC02-05CH11231. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by UChicago Argonne, LLC, for the U.S. Department of Energy, Office of Biological and Environmental Research under contract DE-AC02-06CH11357. J.S.T. is an investigator, Y.C. is a research specialist 3, and C. P. was an associate in the Howard Hughes Medical Institute. J.S.T. is a cofounder of, a Scientific Advisory Board member of, and a paid consultant for Reset Therapeutics, a biotechnology company aimed at discovering small-molecule therapies that modulate circadian activity for a variety of disease indications. C. B. G. is on the Scientific Advisory Board of, is a paid consultant for, and owns stock in ReSet Therapeutics. Atomic coordinates for the reported crystal structures have been deposited with the Protein Data Bank (PDB) under accession code 4F3L.	Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Cardone L, 2005, SCIENCE, V309, P1390, DOI 10.1126/science.1110689; Chen RM, 2009, MOL CELL, V36, P417, DOI 10.1016/j.molcel.2009.10.012; FERREDAMARE AR, 1993, NATURE, V363, P38, DOI 10.1038/363038a0; FERREDAMARE AR, 1994, EMBO J, V13, P180, DOI 10.1002/j.1460-2075.1994.tb06247.x; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hennig S, 2009, PLOS BIOL, V7, P836, DOI 10.1371/journal.pbio.1000094; Henry JT, 2011, ANNU REV MICROBIOL, V65, P261, DOI 10.1146/annurev-micro-121809-151631; Hong HK, 2007, PLOS GENET, V3, P324, DOI 10.1371/journal.pgen.0030033; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Key J, 2007, BIOCHEMISTRY-US, V46, P3614, DOI 10.1021/bi0620407; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King HA, 2011, J MOL BIOL, V413, P561, DOI 10.1016/j.jmb.2011.08.048; Kiyohara YB, 2006, P NATL ACAD SCI USA, V103, P10074, DOI 10.1073/pnas.0601416103; Kucera N, 2012, P NATL ACAD SCI USA, V109, P3311, DOI 10.1073/pnas.1113280109; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; MA PCM, 1994, CELL, V77, P451, DOI 10.1016/0092-8674(94)90159-7; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Partch CL, 2009, J BIOL CHEM, V284, P15184, DOI 10.1074/jbc.M808479200; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; Reischl S, 2007, J BIOL RHYTHM, V22, P375, DOI 10.1177/0748730407303926; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Verger D, 2007, J MOL BIOL, V367, P102, DOI 10.1016/j.jmb.2006.12.018; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Yildiz O, 2005, MOL CELL, V17, P69, DOI 10.1016/j.molcel.2004.11.022; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Zhao WN, 2007, NAT CELL BIOL, V9, P268, DOI 10.1038/ncb1539	43	178	196	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2012	337	6091					189	194		10.1126/science.1222804	http://dx.doi.org/10.1126/science.1222804			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22653727	Green Accepted			2022-12-24	WOS:000306323500048
J	King, NP; Sheffler, W; Sawaya, MR; Vollmar, BS; Sumida, JP; Andre, I; Gonen, T; Yeates, TO; Baker, D				King, Neil P.; Sheffler, William; Sawaya, Michael R.; Vollmar, Breanna S.; Sumida, John P.; Andre, Ingemar; Gonen, Tamir; Yeates, Todd O.; Baker, David			Computational Design of Self-Assembling Protein Nanomaterials with Atomic Level Accuracy	SCIENCE			English	Article							DNA; PEPTIDE; SYMMETRY; CRYSTAL; BUNDLE	We describe a general computational method for designing proteins that self-assemble to a desired symmetric architecture. Protein building blocks are docked together symmetrically to identify complementary packing arrangements, and low-energy protein-protein interfaces are then designed between the building blocks in order to drive self-assembly. We used trimeric protein building blocks to design a 24-subunit, 13-nm diameter complex with octahedral symmetry and a 12-subunit, 11-nm diameter complex with tetrahedral symmetry. The designed proteins assembled to the desired oligomeric states in solution, and the crystal structures of the complexes revealed that the resulting materials closely match the design models. The method can be used to design a wide variety of self-assembling protein nanomaterials.	[King, Neil P.; Sheffler, William; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Yeates, Todd O.] Univ Calif Los Angeles, US DOE, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Vollmar, Breanna S.; Gonen, Tamir] Howard Hughes Med Inst, Ashburn, VA 20147 USA; [Sumida, John P.] Univ Washington, Dept Med Chem, Seattle, WA 98177 USA; [Andre, Ingemar] Lund Univ, Dept Biochem & Struct Biol, SE-22100 Lund, Sweden; [Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Baker, David] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Lund University; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@uw.edu	Baker, David/K-8941-2012; André, Ingemar/O-4777-2014	Baker, David/0000-0001-7896-6217; André, Ingemar/0000-0002-4753-8233; Yeates, Todd/0000-0001-5709-9839	DOE Biological and Environmental Research (DOE-BER) [DE-FC03-02ER63421]; National Center for Research Resources, NIH [RR-15301]; DOE [DE-AC02-06CH11357]; Washington State Life Sciences Discovery Fund; Center for the Intracellular Delivery of Biologics; Howard Hughes Medical Institute (HHMI); International Aids Vaccine Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	DOE Biological and Environmental Research (DOE-BER); National Center for Research Resources, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); DOE(United States Department of Energy (DOE)); Washington State Life Sciences Discovery Fund; Center for the Intracellular Delivery of Biologics; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); International Aids Vaccine Initiative; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank J. Navarro for assistance with protein crystallization at the UCLA crystallization core facility, which is supported by DOE Biological and Environmental Research (DOE-BER) grant DE-FC03-02ER63421, and D. Cascio and the 24-ID-C beamline staff for their assistance in data collection. This work is based on research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beamlines, which are supported by award RR-15301 from the National Center for Research Resources, NIH. Use of the Advanced Photon Source, operated for the Office of Science, DOE, by Argonne National Laboratory, was supported by the DOE under contract no. DE-AC02-06CH11357. Analytical ultracentrifugation was performed in the Bioanalytical Pharmacy Core at the University of Washington, which is supported by the Washington State Life Sciences Discovery Fund and the Center for the Intracellular Delivery of Biologics. We also thank M. Iadanza for EM analysis of T3-10; Y. Cheng and X. Li (UCSF) for giving us access to their electron cryomicroscope for data collection, for helpful discussions, and for sharing scripts with us; and N. Grigorieff (Brandeis) for helpful discussions. The Gonen laboratory is supported by Howard Hughes Medical Institute (HHMI). Work by N. P. K., W. S., and D. B. was supported by DOE, HHMI, and the International Aids Vaccine Initiative. Coordinates and structure factors were deposited in the Protein Data Bank with the accession codes 3VCD (O3-33, R32 crystal form), 4DDF (O3-33, P4 crystal form), 4DCL (T3-08), and 4EGG (T3-10). N. P. K., W. S., T.O.Y., and D. B. have filed a provisional patent application, U. S. 61/622,889, on the described method for designing self-assembling protein materials.	Andersen ES, 2009, NATURE, V459, P73, DOI 10.1038/nature07971; Ballister ER, 2008, P NATL ACAD SCI USA, V105, P3733, DOI 10.1073/pnas.0712247105; Cooper S, 2010, NATURE, V466, P756, DOI 10.1038/nature09304; DiMaio F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020450; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Fleishman SJ, 2011, J MOL BIOL, V413, P1047, DOI 10.1016/j.jmb.2011.09.001; Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617; Gribbon C, 2008, BIOCHEMISTRY-US, V47, P10365, DOI 10.1021/bi801072s; Grigoryan G, 2011, SCIENCE, V332, P1071, DOI 10.1126/science.1198841; Grueninger D, 2008, SCIENCE, V319, P206, DOI 10.1126/science.1150421; Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; Janin J, 2008, Q REV BIOPHYS, V41, P133, DOI 10.1017/S0033583508004708; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; Karanicolas J, 2011, MOL CELL, V42, P250, DOI 10.1016/j.molcel.2011.03.010; Koder RL, 2009, NATURE, V458, P305, DOI 10.1038/nature07841; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kuhlman B, 2000, P NATL ACAD SCI USA, V97, P10383, DOI 10.1073/pnas.97.19.10383; LOVEJOY B, 1993, SCIENCE, V259, P1288, DOI 10.1126/science.8446897; Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998; Ringler P, 2003, SCIENCE, V302, P106, DOI 10.1126/science.1088074; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Salgado EN, 2007, J AM CHEM SOC, V129, P13374, DOI 10.1021/ja075261o; Salgado EN, 2010, ACCOUNTS CHEM RES, V43, P661, DOI 10.1021/ar900273t; Seeman NC, 2010, ANNU REV BIOCHEM, V79, P65, DOI 10.1146/annurev-biochem-060308-102244; Sinclair JC, 2011, NAT NANOTECHNOL, V6, P558, DOI [10.1038/nnano.2011.122, 10.1038/NNANO.2011.122]; Stranges PB, 2011, P NATL ACAD SCI USA, V108, P20562, DOI 10.1073/pnas.1115124108; Usui K, 2009, PROTEIN SCI, V18, P960, DOI 10.1002/pro.106; Zaccai NR, 2011, NAT CHEM BIOL, V7, P935, DOI [10.1038/nchembio.692, 10.1038/NCHEMBIO.692]; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zheng JP, 2009, NATURE, V461, P74, DOI 10.1038/nature08274; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	32	440	459	7	349	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1171	1174		10.1126/science.1219364	http://dx.doi.org/10.1126/science.1219364			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654060	Green Accepted			2022-12-24	WOS:000304647900053
J	Reijns, MAM; Rabe, B; Rigby, RE; Mill, P; Astell, KR; Lettice, LA; Boyle, S; Leitch, A; Keighren, M; Kilanowski, F; Devenney, PS; Sexton, D; Grimes, G; Holt, IJ; Hill, RE; Taylor, MS; Lawson, KA; Dorin, JR; Jackson, AP				Reijns, Martin A. M.; Rabe, Bjoern; Rigby, Rachel E.; Mill, Pleasantine; Astell, Katy R.; Lettice, Laura A.; Boyle, Shelagh; Leitch, Andrea; Keighren, Margaret; Kilanowski, Fiona; Devenney, Paul S.; Sexton, David; Grimes, Graeme; Holt, Ian J.; Hill, Robert E.; Taylor, Martin S.; Lawson, Kirstie A.; Dorin, Julia R.; Jackson, Andrew P.			Enzymatic Removal of Ribonucleotides from DNA Is Essential for Mammalian Genome Integrity and Development	CELL			English	Article							AICARDI-GOUTIERES-SYNDROME; RNASE-H; SACCHAROMYCES-CEREVISIAE; CATALYTIC SUBUNIT; DAMAGE RESPONSE; HISTONE H2AX; REPLICATION; REPAIR; PHOSPHORYLATION; MUTATIONS	The presence of ribonucleotides in genomic DNA is undesirable given their increased susceptibility to hydrolysis. Ribonuclease (RNase) H enzymes that recognize and process such embedded ribonucleotides are present in all domains of life. However, in unicellular organisms such as budding yeast, they are not required for viability or even efficient cellular proliferation, while in humans, RNase H2 hypomorphic mutations cause the neuroinflammatory disorder Aicardi-Goutie res syndrome. Here, we report that RNase H2 is an essential enzyme in mice, required for embryonic growth from gastrulation onward. RNase H2 null embryos accumulate large numbers of single (or di-) ribonucleotides embedded in their genomic DNA (> 1,000,000 per cell), resulting in genome instability and a p53-dependent DNA-damage response. Our findings establish RNase H2 as a key mammalian genome surveillance enzyme required for ribonucleotide removal and demonstrate that ribonucleotides are the most commonly occurring endogenous nucleotide base lesion in replicating cells.	[Reijns, Martin A. M.; Rabe, Bjoern; Rigby, Rachel E.; Mill, Pleasantine; Astell, Katy R.; Lettice, Laura A.; Boyle, Shelagh; Leitch, Andrea; Keighren, Margaret; Kilanowski, Fiona; Devenney, Paul S.; Sexton, David; Grimes, Graeme; Hill, Robert E.; Taylor, Martin S.; Lawson, Kirstie A.; Dorin, Julia R.; Jackson, Andrew P.] Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Holt, Ian J.] MRC, Mitochondrial Biol Unit, Cambridge CB2 0XY, England	University of Edinburgh	Jackson, AP (corresponding author), Univ Edinburgh, MRC, Inst Genet & Mol Med, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	andrew.jackson@igmm.ed.ac.uk	Reijns, Martin/L-4355-2013; Taylor, Martin S/C-3825-2009; Jackson, Andrew P/D-3442-2009; Mill, Pleasantine/AAE-4718-2019	Reijns, Martin/0000-0002-5048-2752; Taylor, Martin S/0000-0001-7656-330X; Jackson, Andrew P/0000-0002-8739-2646; Mill, Pleasantine/0000-0001-5218-134X; Rigby, Rachel Elizabeth/0000-0001-5201-9422; holt, ian/0000-0001-5468-0193	MRC; Lister Institute for Preventative Medicine; MRC [MC_PC_U127527201, MC_EX_G0601852, MC_U127597124, MC_PC_U127597124, MC_PC_U127580972, MC_U127584494, MC_PC_U127584494, MC_U105663140] Funding Source: UKRI; Medical Research Council [MC_PC_U127597124, MC_U105663140, MC_EX_G0601852, MC_PC_U127527201, MC_PC_U127584494, MC_PC_U127580972, MC_U127584494, MC_U127597124] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lister Institute for Preventative Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank I. Adams, N. Gilbert, N. Hastie, and I. Jackson for commenting on the manuscript; W. Bickmore, M. Ansari, D. Fitzpatrick, and T. Kunkel for helpful discussions; A. Ross, G. Waugh, J. Young, A. Hart, and C. A. Martin for technical assistance; A. Pearce, E. Maher, and E. Freyer for assistance with cytogenetic and FACS analysis; and C. Graham for statistical advice. We also thank Aurelio Reyes and Stuart Wood for providing mouse mitochondrial DNA and the Wellcome Trust Clinical Research Facility, Edinburgh for performing microarrays. This work was supported by funding from the MRC and Lister Institute for Preventative Medicine. A.P.J. is a MRC Senior Clinical Fellow and Lister Institute Prize Fellow.	Alberts B, 2002, MOL BIOL CELL; Arudchandran A, 2000, GENES CELLS, V5, P789, DOI 10.1046/j.1365-2443.2000.00373.x; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Bhoj VG, 2008, CELL, V134, P569, DOI 10.1016/j.cell.2008.08.010; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; Brzostek-Racine S, 2011, J IMMUNOL, V187, P5336, DOI 10.4049/jimmunol.1100040; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; BUSEN W, 1980, J BIOL CHEM, V255, P9434; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Cazzalini O, 2010, MUTAT RES-REV MUTAT, V704, P12, DOI 10.1016/j.mrrev.2010.01.009; Cech T.R., 2011, RNA WORLDS CONTEXT; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Cerritelli SM, 2009, FEBS J, V276, P1494, DOI 10.1111/j.1742-4658.2009.06908.x; Chon HG, 2009, NUCLEIC ACIDS RES, V37, P96, DOI 10.1093/nar/gkn913; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Clayton DA, 2003, IUBMB LIFE, V55, P213, DOI 10.1080/1521654031000134824; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crow YJ, 2009, HUM MOL GENET, V18, pR130, DOI 10.1093/hmg/ddp293; EDER PS, 1993, BIOCHIMIE, V75, P123, DOI 10.1016/0300-9084(93)90033-O; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Esposito G, 2000, CURR BIOL, V10, P1221, DOI 10.1016/S0960-9822(00)00726-0; Figiel M, 2011, J BIOL CHEM, V286, P10540, DOI 10.1074/jbc.M110.181974; Forstemann K, 2005, EMBO REP, V6, P361, DOI 10.1038/sj.embor.7400374; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; GOULIAN M, 1990, J BIOL CHEM, V265, P18461; GROSSMAN LI, 1973, P NATL ACAD SCI USA, V70, P3339, DOI 10.1073/pnas.70.12.3339; HOGREFE HH, 1990, J BIOL CHEM, V265, P5561; Holt IJ, 2009, TRENDS BIOCHEM SCI, V34, P358, DOI 10.1016/j.tibs.2009.03.007; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Kimura SH, 2001, ONCOGENE, V20, P3290, DOI 10.1038/sj.onc.1204270; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Lazzaro F, 2012, MOL CELL, V45, P99, DOI 10.1016/j.molcel.2011.12.019; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; LIPKIN D, 1954, J AM CHEM SOC, V76, P2871, DOI 10.1021/ja01640a004; MACAULEY A, 1993, DEVELOPMENT, V117, P873; MACHIDA Y, 1977, P NATL ACAD SCI USA, V74, P2776, DOI 10.1073/pnas.74.7.2776; Manel N, 2011, CELL, V147, P271, DOI 10.1016/j.cell.2011.09.010; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Miyabe I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002407; Norppa H, 2003, MUTAGENESIS, V18, P221, DOI 10.1093/mutage/18.3.221; Nowotny M, 2007, MOL CELL, V28, P264, DOI 10.1016/j.molcel.2007.08.015; Pohjoismaki JLO, 2010, J MOL BIOL, V397, P1144, DOI 10.1016/j.jmb.2010.02.029; Ramantani G, 2010, ARTHRITIS RHEUM-US, V62, P1469, DOI 10.1002/art.27367; Reijns MAM, 2011, J BIOL CHEM, V286, P10530, DOI 10.1074/jbc.M110.177394; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Rumbaugh JA, 1997, J BIOL CHEM, V272, P22591, DOI 10.1074/jbc.272.36.22591; Rydberg B, 2002, P NATL ACAD SCI USA, V99, P16654, DOI 10.1073/pnas.262591699; SATOH MS, 1992, NATURE, V356, P356, DOI 10.1038/356356a0; Shaban NM, 2010, J BIOL CHEM, V285, P3617, DOI 10.1074/jbc.M109.059048; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; STEIN H, 1969, SCIENCE, V166, P393, DOI 10.1126/science.166.3903.393; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; TANG MS, 1989, J BIOL CHEM, V264, P14455; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; TURCHI JJ, 1994, P NATL ACAD SCI USA, V91, P9803, DOI 10.1073/pnas.91.21.9803; Vengrova S, 2006, EMBO REP, V7, P59, DOI 10.1038/sj.embor.7400576; Vengrova S, 2004, GENE DEV, V18, P794, DOI 10.1101/gad.289404; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Watt DL, 2011, DNA REPAIR, V10, P897, DOI 10.1016/j.dnarep.2011.05.009; Wittschieben J, 2000, CURR BIOL, V10, P1217, DOI 10.1016/S0960-9822(00)00725-9; Yajima H, 2006, MOL CELL BIOL, V26, P7520, DOI 10.1128/MCB.00048-06; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017	77	315	322	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5								10.1016/j.cell.2012.04.011	http://dx.doi.org/10.1016/j.cell.2012.04.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22579044	hybrid, Green Published, Green Submitted			2022-12-24	WOS:000304453900008
J	Wu, LQ; Dickman, JD				Wu, Le-Qing; Dickman, J. David			Neural Correlates of a Magnetic Sense	SCIENCE			English	Article							MAGNETORECEPTION; COMPASS; BIRDS; FIELD; ANIMALS; PIGEONS; ORIENTATION; TRANSDUCER; BRAIN	Many animals rely on Earth's magnetic field for spatial orientation and navigation. However, how the brain receives and interprets magnetic field information is unknown. Support for the existence of magnetic receptors in the vertebrate retina, beak, nose, and inner ear has been proposed, and immediate gene expression markers have identified several brain regions activated by magnetic stimulation, but the central neural mechanisms underlying magnetoreception remain unknown. Here we describe neuronal responses in the pigeon's brainstem that show how single cells encode magnetic field direction, intensity, and polarity; qualities that are necessary to derive an internal model representing directional heading and geosurface location. Our findings demonstrate that there is a neural substrate for a vertebrate magnetic sense.	[Wu, Le-Qing; Dickman, J. David] Baylor Coll Med, Dept Neurosci, Houston, TX 77024 USA	Baylor College of Medicine	Dickman, JD (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77024 USA.	dickman@bcm.edu	Wu, Le-Qing/G-6664-2012		National Institute for Deafness and Other Communication Disorders [DC007618]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007618, R01DC012813] Funding Source: NIH RePORTER	National Institute for Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank D. Angelaki for comments and guidance in the analyses; K. Reed and J. Chen for technical assistance; C. Fetsch and B. Lindseth for help in pilot investigations; and S. Aamodt for critical review. Much of the work was conducted at Washington University in St. Louis and was supported by a National Institute for Deafness and Other Communication Disorders grant (DC007618) to J. D. D. Data are made available as part of the supplementary materials.	Cadiou H, 2010, J R SOC INTERFACE, V7, pS193, DOI 10.1098/rsif.2009.0423.focus; Dickman JD, 1996, J COMP NEUROL, V367, P110; EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V249, P27, DOI 10.1098/rspb.1992.0079; Fleissner G, 2003, J COMP NEUROL, V458, P350, DOI 10.1002/cne.10579; Harada Y, 2001, ACTA OTO-LARYNGOL, V121, P590, DOI 10.1080/000164801316878872; Heyers D, 2010, P NATL ACAD SCI USA, V107, P9394, DOI 10.1073/pnas.0907068107; Johnsen S, 2005, NAT REV NEUROSCI, V6, P703, DOI 10.1038/nrn1745; Liedvogel M, 2007, EUR J NEUROSCI, V25, P1166, DOI 10.1111/j.1460-9568.2007.05350.x; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Lohmann KJ, 2010, NATURE, V464, P1140, DOI 10.1038/4641140a; McArthur KL, 2011, J NEUROPHYSIOL, V105, P1689, DOI 10.1152/jn.00981.2010; Moller A, 2004, NATURWISSENSCHAFTEN, V91, P585, DOI 10.1007/s00114-004-0578-9; Nemec P, 2001, SCIENCE, V294, P366, DOI 10.1126/science.1063351; Putman NF, 2011, CURR BIOL, V21, P463, DOI 10.1016/j.cub.2011.01.057; Ritz T, 2009, BIOPHYS J, V96, P3451, DOI 10.1016/j.bpj.2008.11.072; SEMM P, 1984, J COMP PHYSIOL, V155, P283, DOI 10.1007/BF00610581; Vargas JP, 2006, BRAIN RES BULL, V70, P158, DOI 10.1016/j.brainresbull.2006.03.018; Walker MM, 2008, J THEOR BIOL, V250, P85, DOI 10.1016/j.jtbi.2007.09.030; Walker MM, 2002, CURR OPIN NEUROBIOL, V12, P735, DOI 10.1016/S0959-4388(02)00389-6; WILTSCHK.W, 1972, SCIENCE, V176, P62, DOI 10.1126/science.176.4030.62; Wiltschko R, 2010, CURR BIOL, V20, P1534, DOI 10.1016/j.cub.2010.06.073; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Winklhofer M, 2010, J R SOC INTERFACE, V7, pS273, DOI 10.1098/rsif.2009.0435.focus; Wu LQ, 2011, CURR BIOL, V21, P418, DOI 10.1016/j.cub.2011.01.058	24	119	124	1	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					1054	1057		10.1126/science.1216567	http://dx.doi.org/10.1126/science.1216567			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22539554				2022-12-24	WOS:000304406800050
J	Colombani, J; Andersen, DS; Leopold, P				Colombani, Julien; Andersen, Ditte S.; Leopold, Pierre			Secreted Peptide Dilp8 Coordinates Drosophila Tissue Growth with Developmental Timing	SCIENCE			English	Article							WING IMAGINAL DISCS; PATTERN FORMATION; MELANOGASTER; REGENERATION; DISKS; PUPARIATION; ORGANS	Little is known about how organ growth is monitored and coordinated with the developmental timing in complex organisms. In insects, impairment of larval tissue growth delays growth and morphogenesis, revealing a coupling mechanism. We carried out a genetic screen in Drosophila to identify molecules expressed by growing tissues participating in this coupling and identified dilp8 as a gene whose silencing rescues the developmental delay induced by abnormally growing tissues. dilp8 is highly induced in conditions where growth impairment produces a developmental delay. dilp8 encodes a peptide for which expression and secretion are sufficient to delay metamorphosis without affecting tissue integrity. We propose that Dilp8 peptide is a secreted signal that coordinates the growth status of tissues with developmental timing.	[Andersen, Ditte S.] Univ Nice, CNRS 7277, INSERM 1091, F-06108 Nice, France; France Inst Biol, F-06108 Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Andersen, DS (corresponding author), Univ Nice, CNRS 7277, INSERM 1091, Parc Valrose, F-06108 Nice, France.	andersen@unice.fr; leopold@unice.fr		Colombani, Julien/0000-0002-8250-4899; Andersen, Ditte/0000-0003-1209-6102	CNRS; INSERM; Agence Nationale de la Recherche; Fondation pour la Recherche Medicale; European Research Council [268813]; Danish Research Council [272-08-0064]; Marie Curie Life Long Training [252373]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); European Research Council(European Research Council (ERC)European Commission); Danish Research Council(Det Frie Forskningsrad (DFF)); Marie Curie Life Long Training	We thank P. O'Farrell for initial insightful discussions; G. Jarretou and J. Villalba for technical assistance; V. Pantesco and L. Vallar for microarray data and analysis; the Vienna Drosophila RNAi Center, Drosophila Genetics Resource Center, and Bloomington stock centers; I. Bourget for gamma-ray experiments; S. Leevers, N. Tapon, and laboratory members for comments on the manuscript; and M. Dominguez, A. Garelli, and A. Gontijo for communicating unpublished results. This work was supported by the CNRS, INSERM, Agence Nationale de la Recherche, Fondation pour la Recherche Medicale, European Research Council (grant no. 268813), Danish Research Council (grant no. 272-08-0064 for D.S.A.) and Marie Curie Life Long Training (grant no. 252373 for D.S.A.). The microarray data are presented at www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE36862 (accession no. GSE36862).	Bergantinos C, 2010, DEVELOPMENT, V137, P1169, DOI 10.1242/dev.045559; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; BRYANT PJ, 1984, Q REV BIOL, V59, P387, DOI 10.1086/414040; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Halme A, 2010, CURR BIOL, V20, P458, DOI 10.1016/j.cub.2010.01.038; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Klebes A, 2005, DEVELOPMENT, V132, P3753, DOI 10.1242/dev.01927; KUNKEL JG, 1977, BIOL BULL, V153, P145, DOI 10.2307/1540698; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Martin FA, 2006, DEVELOPMENT, V133, P4421, DOI 10.1242/dev.02618; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Parker NF, 2011, DEV BIOL, V357, P318, DOI 10.1016/j.ydbio.2011.07.002; POODRY CA, 1990, ROUX ARCH DEV BIOL, V199, P219, DOI 10.1007/BF01682081; Riddiford L., 1993, DEV DROSOPHILA MELAN, V2, P899; RUSSELL MA, 1974, DEV BIOL, V40, P24, DOI 10.1016/0012-1606(74)90104-3; SIMPSON P, 1980, J EMBRYOL EXP MORPH, V57, P155; SIMPSON P, 1975, ROUX ARCH DEV BIOL, V178, P247, DOI 10.1007/BF00848432; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556	19	348	353	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 4	2012	336	6081					582	585		10.1126/science.1216689	http://dx.doi.org/10.1126/science.1216689			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	935DJ	22556251				2022-12-24	WOS:000303498800044
J	Ciesla, FJ; Sandford, SA				Ciesla, Fred J.; Sandford, Scott A.			Organic Synthesis via Irradiation and Warming of Ice Grains in the Solar Nebula	SCIENCE			English	Article							PROTOPLANETARY DISKS; CIRCUMSTELLAR DISKS; RESIDENCE TIMES; UV-IRRADIATION; INTERSTELLAR; EVOLUTION; MOLECULES; ANALOGS; PHOTOLYSIS; PARTICLES	Complex organic compounds, including many important to life on Earth, are commonly found in meteoritic and cometary samples, though their origins remain a mystery. We examined whether such molecules could be produced within the solar nebula by tracking the dynamical evolution of ice grains in the nebula and recording the environments to which they were exposed. We found that icy grains originating in the outer disk, where temperatures were less than 30 kelvin, experienced ultraviolet irradiation exposures and thermal warming similar to that which has been shown to produce complex organics in laboratory experiments. These results imply that organic compounds are natural by-products of protoplanetary disk evolution and should be important ingredients in the formation of all planetary systems, including our own.	[Ciesla, Fred J.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60430 USA; [Sandford, Scott A.] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA	University of Chicago; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Ciesla, FJ (corresponding author), Univ Chicago, Dept Geophys Sci, 5734 S Ellis Ave, Chicago, IL 60430 USA.	fciesla@uchicago.edu			NASA; Astrobiology Institute	NASA(National Aeronautics & Space Administration (NASA)); Astrobiology Institute	F.J.C. and S. A. S. acknowledge funding from NASA's Origins of Solar Systems program. S. A. S. also thanks the Astrobiology Institute for funds.	Adams FC, 2006, ASTROPHYS J, V641, P504, DOI 10.1086/500393; Bernstein MP, 1999, SCIENCE, V283, P1135, DOI 10.1126/science.283.5405.1135; Bernstein MP, 2002, NATURE, V416, P401, DOI 10.1038/416401a; BERNSTEIN MP, 1995, ASTROPHYS J, V454, P327, DOI 10.1086/176485; Bethell TJ, 2011, ASTROPHYS J, V739, DOI 10.1088/0004-637X/739/2/78; Caro GMM, 2002, NATURE, V416, P403, DOI 10.1038/416403a; Carr JS, 2008, SCIENCE, V319, P1504, DOI 10.1126/science.1153807; Charnoz S, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/1/33; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Ciesla FJ, 2011, ASTROPHYS J, V740, DOI 10.1088/0004-637X/740/1/9; Ciesla FJ, 2010, ASTROPHYS J, V723, P514, DOI 10.1088/0004-637X/723/1/514; Ciesla FJ, 2006, ICARUS, V181, P178, DOI 10.1016/j.icarus.2005.11.009; HABING HJ, 1968, B ASTRON I NETH, V19, P421; HAGEN W, 1979, ASTROPHYS SPACE SCI, V65, P215, DOI 10.1007/BF00643502; Hartmann L, 1998, ASTROPHYS J, V495, P385, DOI 10.1086/305277; Lodders K, 2003, ASTROPHYS J, V591, P1220, DOI 10.1086/375492; Nakamura-Messenger K, 2006, SCIENCE, V314, P1439, DOI 10.1126/science.1132175; Nuevo M, 2011, ADV SPACE RES, V48, P1126, DOI 10.1016/j.asr.2011.05.020; Nuth JA, 2008, ASTROPHYS J LETT, V673, pL225, DOI 10.1086/528741; Oberg KI, 2009, ASTROPHYS J, V693, P1209, DOI 10.1088/0004-637X/693/2/1209; Peltzer E T, 1984, Adv Space Res, V4, P69, DOI 10.1016/0273-1177(84)90546-5; Sandford SA, 2001, METEORIT PLANET SCI, V36, P1117, DOI 10.1111/j.1945-5100.2001.tb01948.x; Sandford SA, 2006, SCIENCE, V314, P1720, DOI 10.1126/science.1135841; Sano T, 2000, ASTROPHYS J, V543, P486, DOI 10.1086/317075; SCHUTTE WA, 1992, ADV SPACE RES-SERIES, V12, P47, DOI 10.1016/0273-1177(92)90152-N; Throop HB, 2011, ICARUS, V212, P885, DOI 10.1016/j.icarus.2011.01.002; WEIDENSCHILLING SJ, 1984, ICARUS, V60, P553, DOI 10.1016/0019-1035(84)90164-7; Willacy K, 2007, ASTROPHYS J, V660, P441, DOI 10.1086/512796; Woitke P, 2009, ASTRON ASTROPHYS, V501, P383, DOI 10.1051/0004-6361/200911821; Zhu ZH, 2009, ASTROPHYS J, V694, P1045, DOI 10.1088/0004-637X/694/2/1045	30	136	136	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					452	454		10.1126/science.1217291	http://dx.doi.org/10.1126/science.1217291			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22461502	Green Submitted			2022-12-24	WOS:000303233400041
J	Chan, CH; Li, CF; Yang, WL; Gao, Y; Lee, SW; Feng, ZZ; Huang, HY; Tsai, KKC; Flores, LG; Shao, YP; Hazle, JD; Yu, DH; Wei, WY; Sarbassov, D; Hung, MC; Nakayama, KI; Lin, HK				Chan, Chia-Hsin; Li, Chien-Feng; Yang, Wei-Lei; Gao, Yuan; Lee, Szu-Wei; Feng, Zizhen; Huang, Hsuan-Ying; Tsai, Kelvin K. C.; Flores, Leo G.; Shao, Yiping; Hazle, John D.; Yu, Dihua; Wei, Wenyi; Sarbassov, Dos; Hung, Mien-Chie; Nakayama, Keiichi I.; Lin, Hui-Kuan			The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis	CELL			English	Article							UNANCHORED POLYUBIQUITIN CHAINS; GENE-EXPRESSION; BREAST-CANCER; KINASE; GROWTH; METABOLISM; ACTIVATION; PHOSPHORYLATION; TRANSCRIPTION; LOCALIZATION	Akt kinase plays a central role in cell growth, metabolism, and tumorigenesis. The TRAF6 E3 ligase orchestrates IGF-1-mediated Akt ubiquitination and activation. Here, we show that Akt ubiquitination is also induced by activation of ErbB receptors; unexpectedly, and in contrast to IGF-1 induced activation, the Skp2 SCF complex, not TRAF6, is a critical E3 ligase for ErbB-receptor-mediated Akt ubiquitination and membrane recruitment in response to EGF. Skp2 deficiency impairs Akt activation, Glut1 expression, glucose uptake and glycolysis, and breast cancer progression in various tumor models. Moreover, Skp2 overexpression correlates with Akt activation and breast cancer metastasis and serves as a marker for poor prognosis in Her2-positive patients. Finally, Skp2 silencing sensitizes Her2-overexpressing tumors to Herceptin treatment. Our study suggests that distinct E3 ligases are utilized by diverse growth factors for Akt activation and that targeting glycolysis sensitizes Her2-positive tumors to Herceptin treatment.	[Chan, Chia-Hsin; Yang, Wei-Lei; Gao, Yuan; Lee, Szu-Wei; Feng, Zizhen; Yu, Dihua; Sarbassov, Dos; Hung, Mien-Chie; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Flores, Leo G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Diagnost Imaging, Houston, TX 77030 USA; [Shao, Yiping; Hazle, John D.] Univ Texas MD Anderson Canc Ctr, Dept Image Phys, Houston, TX 77030 USA; [Yang, Wei-Lei; Gao, Yuan; Lee, Szu-Wei; Yu, Dihua; Sarbassov, Dos; Hung, Mien-Chie; Lin, Hui-Kuan] Univ Texas Houston, Grad Sch Biomed Sci Houston, Houston, TX 77030 USA; [Li, Chien-Feng] Chi Mei Fdn Med Ctr, Dept Pathol, Tainan 710, Taiwan; [Li, Chien-Feng; Tsai, Kelvin K. C.] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 704, Taiwan; [Huang, Hsuan-Ying] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Dept Pathol, Kaohsiung 833, Kaohsiung Count, Taiwan; [Wei, Wenyi] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 8128582, Japan; [Hung, Mien-Chie] China Med Univ & Hosp, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ & Hosp, Grad Inst Canc Biol, Taichung 404, Taiwan; [Li, Chien-Feng] So Taiwan Univ, Dept Biotechnol, Tainan 710, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Chi Mei Hospital; National Health Research Institutes - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Kyushu University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Southern Taiwan University of Science & Technology	Lin, HK (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	hklin@mdanderson.org	Yang, Wei-Lei/E-2598-2012; Sarbassov, Dos/AAS-4950-2020; Tsai, Kun-Chih/C-1371-2010; Chan, Chia-Hsin/AAT-7782-2020; 高, 雨莉/HGU-8187-2022; Hung, Mien-Chie/ABD-5911-2021; Feng, Zizhen/G-2322-2014	Hung, Mien-Chie/0000-0003-4317-4740; Feng, Zizhen/0000-0002-7763-1869; Yu, Dihua/0000-0001-6231-9381; Tsai, Kelvin/0000-0002-1612-2868; Chan, Chia-Hsin/0000-0001-8506-7500; Sarbassov, Dos/0000-0002-6848-1133	MD Anderson Cancer Center Trust; Prostate SPORE Career Development Award [P50 CA140388 SPORE]; NIH; CPRIT; DOD; MD Anderson Cancer Center Breast SPORE; Susan G. Komen Breast Cancer Foundation; Department of Health in Taiwan; NATIONAL CANCER INSTITUTE [P50CA140388, R01CA149321, R01CA136787] Funding Source: NIH RePORTER	MD Anderson Cancer Center Trust; Prostate SPORE Career Development Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; DOD(United States Department of Defense); MD Anderson Cancer Center Breast SPORE; Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Department of Health in Taiwan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Mrs. J. Delacerda and C.V. Kingsley at small animal imaging facility of MD Anderson Cancer Center for their assistance in CT/PET imaging. We also thank the members from Lin's laboratory for their valuable comments and suggestions. We thank Drs. W. Tansey and M. H. Lee for reagents. This work was supported by the MD Anderson Cancer Center Trust Scholar Award, Prostate SPORE Career Development Award (P50 CA140388 SPORE), NIH grants, CPRIT grant, DOD prostate cancer New Investigator Award (H.K.L.), the MD Anderson Cancer Center Breast SPORE Career Development Award (C.H.C.), the Susan G. Komen Breast Cancer Foundation postdoctoral fellowship (C.H.C.), and a grant from the Department of Health in Taiwan (C.F.L.).	Agus DB, 2002, CANCER CELL, V2, P127, DOI 10.1016/S1535-6108(02)00097-1; Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Birnbaum MJ, 2004, DEV CELL, V7, P781, DOI 10.1016/j.devcel.2004.11.016; Bornstein G, 2003, J BIOL CHEM, V278, P25752, DOI 10.1074/jbc.M301774200; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Chan CH, 2011, J MOL MED, V89, P857, DOI 10.1007/s00109-011-0766-y; Chan CH, 2010, THESCIENTIFICWORLDJO, V10, P1001, DOI 10.1100/tsw.2010.89; Chan CH, 2010, NAT CELL BIOL, V12, P457, DOI 10.1038/ncb2047; DATTA K, 1995, MOL CELL BIOL, V15, P2304; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gao DM, 2009, NAT CELL BIOL, V11, P397, DOI 10.1038/ncb1847; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang HY, 2006, CLIN CANCER RES, V12, P487, DOI 10.1158/1078-0432.CCR-05-1497; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jiang BH, 2001, CELL GROWTH DIFFER, V12, P363; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kunstle G, 2002, MOL CELL BIOL, V22, P1513, DOI 10.1128/MCB.22.5.1513-1525.2002; Lee-Hoeflich ST, 2008, CANCER RES, V68, P5878, DOI 10.1158/0008-5472.CAN-08-0380; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin HK, 2010, NATURE, V464, P374, DOI 10.1038/nature08815; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama KI, 2006, NAT REV CANCER, V6, P369, DOI 10.1038/nrc1881; Noguchi M, 2007, FASEB J, V21, P2273, DOI 10.1096/fj.06-7684com; Oshima RG, 2004, CANCER RES, V64, P169, DOI 10.1158/0008-5472.CAN-03-1944; Osthus R.C., 2000, ONCOGENE, V275, P21797; Plas DR, 2005, ONCOGENE, V24, P7435, DOI 10.1038/sj.onc.1209097; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wang HB, 2010, NAT GENET, V42, P83, DOI 10.1038/ng.498; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yang WL, 2010, ONCOGENE, V29, P4493, DOI 10.1038/onc.2010.190; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhu AZ, 2011, SEMIN ONCOL, V38, P55, DOI 10.1053/j.seminoncol.2010.11.012	45	265	280	6	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5					1098	1111		10.1016/j.cell.2012.02.065	http://dx.doi.org/10.1016/j.cell.2012.02.065			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22632973	Green Accepted, Bronze			2022-12-24	WOS:000304453900015
J	Bell, RD; Winkler, EA; Singh, I; Sagare, AP; Deane, R; Wu, ZH; Holtzman, DM; Betsholtz, C; Armulik, A; Sallstrom, J; Berk, BC; Zlokovic, BV				Bell, Robert D.; Winkler, Ethan A.; Singh, Itender; Sagare, Abhay P.; Deane, Rashid; Wu, Zhenhua; Holtzman, David M.; Betsholtz, Christer; Armulik, Annika; Sallstrom, Jan; Berk, Bradford C.; Zlokovic, Berislav V.			Apolipoprotein E controls cerebrovascular integrity via cyclophilin A	NATURE			English	Article							BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; OXIDATIVE STRESS; APOE; DEMENTIA; PROTEIN; MICE; NEURODEGENERATION; EXPRESSION	Human apolipoprotein E has three isoforms: APOE2, APOE3 and APOE4(1). APOE4 is a major genetic risk factor for Alzheimer's disease(2,3) and is associated with Down's syndrome dementia and poor neurological outcome after traumatic brain injury and haemorrhage(3). Neurovascular dysfunction is present in normal APOE4 carriers(4-6) and individuals with APOE4-associated disorders(3,7-10). In mice, lack of Apoe leads to blood-brain barrier (BBB) breakdown(11,12), whereas APOE4 increases BBB susceptibility to injury(13). How APOE genotype affects brain microcirculation remains elusive. Using different APOE transgenic mice, including mice with ablation and/or inhibition of cyclophilin A (CypA), here we show that expression of APOE4 and lack of murine Apoe, but not APOE2 and APOE3, leads to BBB breakdown by activating a proinflammatory CypA-nuclear factor-kappa B-matrix-metalloproteinase-9 pathway in pericytes. This, in turn, leads to neuronal uptake of multiple blood-derived neurotoxic proteins, and microvascular and cerebral blood flow reductions. We show that the vascular defects in Apoe-deficient and APOE4-expressing mice precede neuronal dysfunction and can initiate neurodegenerative changes. Astrocyte-secreted APOE3, but not APOE4, suppressed the CypA-nuclear factor-kappa B-matrix-metalloproteinase-9 pathway in pericytes through a lipoprotein receptor. Our data suggest that CypA is a key target for treating APOE4-mediated neurovascular injury and the resulting neuronal dysfunction and degeneration.	[Bell, Robert D.; Winkler, Ethan A.; Singh, Itender; Sagare, Abhay P.; Deane, Rashid; Wu, Zhenhua; Sallstrom, Jan; Zlokovic, Berislav V.] Univ Rochester, Med Ctr, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA; [Bell, Robert D.; Berk, Bradford C.] Univ Rochester, Med Ctr, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA; [Holtzman, David M.] Washington Univ, Sch Med, Knight Alzheimers Dis Res Ctr, Hope Ctr Neurol Disorders,Dept Neurol, St Louis, MO 63110 USA; [Betsholtz, Christer; Armulik, Annika] Karolinska Inst, Dept Med Biochem & Biophys, Div Vasc Biol, SE-17177 Stockholm, Sweden; [Armulik, Annika] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Zilkha Neurogenet Inst, Ctr Neurodegenerat & Regenerat, Los Angeles, CA 90089 USA; [Zlokovic, Berislav V.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90089 USA	University of Rochester; University of Rochester; Washington University (WUSTL); Karolinska Institutet; University of Zurich; University Zurich Hospital; University of Southern California; University of Southern California	Zlokovic, BV (corresponding author), Univ Rochester, Med Ctr, Ctr Neurodegenerat & Vasc Brain Disorders, Rochester, NY 14642 USA.	zlokovic@usc.edu	Sagare, Abhay/Y-3273-2019	Sagare, Abhay/0000-0002-8178-3785; Berk, Bradford/0000-0002-2767-4115; Keller, Annika/0000-0003-1466-3633	National Institute of Health [R37NS34467, R37AG23084, RO1AG039452, R37AG13956]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034467, R01NS034467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG039452, RF1AG039452, R37AG013956, R37AG023084] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank the National Institute of Health for grants R37NS34467 (B.V.Z.); R37AG23084 (B.V.Z.); RO1AG039452 (B.V.Z.); and R37AG13956 (D. M. H.) used to support this study.	Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; BEGLEY DJ, 1990, J NEUROCHEM, V55, P1222, DOI 10.1111/j.1471-4159.1990.tb03128.x; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Candelario-Jalil E, 2011, STROKE, V42, P1345, DOI 10.1161/STROKEAHA.110.600825; Deane R, 2008, J CLIN INVEST, V118, P4002, DOI 10.1172/JCI36663; Garcia-Alloza M, 2009, J NEUROCHEM, V109, P1636, DOI 10.1111/j.1471-4159.2009.06096.x; Grammas P, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-26; Hafezi-Moghadam A, 2007, AM J PHYSIOL-CELL PH, V292, pC1256, DOI 10.1152/ajpcell.00563.2005; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Jaeger LB, 2009, J ALZHEIMERS DIS, V17, P553, DOI 10.3233/JAD-2009-1074; Jin ZG, 2004, ARTERIOSCL THROM VAS, V24, P1186, DOI 10.1161/01.ATV.0000130664.51010.28; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; Mahley RW, 2009, J LIPID RES, V50, pS183, DOI 10.1194/jlr.R800069-JLR200; Masliah E, 1997, BRAIN RES, V751, P307, DOI 10.1016/S0006-8993(96)01420-5; Methia N, 2001, MOL MED, V7, P810, DOI 10.1007/BF03401973; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Paul J, 2007, J EXP MED, V204, P1999, DOI 10.1084/jem.20070304; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Sheline YI, 2010, J NEUROSCI, V30, P17035, DOI 10.1523/JNEUROSCI.3987-10.2010; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Thambisetty M, 2010, ARCH NEUROL-CHICAGO, V67, P93, DOI 10.1001/archneurol.2009.913; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Vermeer SE, 2003, NEW ENGL J MED, V348, P1215, DOI 10.1056/NEJMoa022066; Yang Y, 2008, RHEUMATOLOGY, V47, P1299, DOI 10.1093/rheumatology/ken225; Zhong ZH, 2009, J CLIN INVEST, V119, P3437, DOI 10.1172/JCI38476; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016; Zlokovic BV, 2011, NAT REV NEUROSCI, V12, P723, DOI 10.1038/nrn3114	30	808	835	12	189	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					512	516		10.1038/nature11087	http://dx.doi.org/10.1038/nature11087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622580	Green Accepted			2022-12-24	WOS:000304344500045
J	Gontan, C; Achame, EM; Demmers, J; Barakat, TS; Rentmeester, E; van IJcken, W; Grootegoed, JA; Gribnau, J				Gontan, Cristina; Achame, Eskeatnaf Mulugeta; Demmers, Jeroen; Barakat, Tahsin Stefan; Rentmeester, Eveline; van IJcken, Wilfred; Grootegoed, J. Anton; Gribnau, Joost			RNF12 initiates X-chromosome inactivation by targeting REX1 for degradation	NATURE			English	Article							CELLS; GENE; PLURIPOTENCY; REX1/ZFP42; ACTIVATOR; MOTIFS; YY1	Evolution of the mammalian sex chromosomes has resulted in a heterologous X and Y pair, where the Y chromosome has lost most of its genes. Hence, there is a need for X-linked gene dosage compensation between XY males and XX females. In placental mammals, this is achieved by random inactivation of one X chromosome in all female somatic cells(1). Upregulation of Xist transcription on the future inactive X chromosome acts against Tsix antisense transcription, and spreading of Xist RNA in cis triggers epigenetic changes leading to X-chromosome inactivation. Previously, we have shown that the X-encoded E3 ubiquitin ligase RNF12 is upregulated in differentiating mouse embryonic stem cells and activates Xist transcription and X-chromosome inactivation(2). Here we identify the pluripotency factor REX1 as a key target of RNF12 in the mechanism of X-chromosome inactivation. RNF12 causes ubiquitination and proteasomal degradation of REX1, and Rnf12 knockout embryonic stem cells show an increased level of REX1. Using chromatin immunoprecipitation sequencing, REX1 binding sites were detected in Xist and Tsix regulatory regions. Overexpression of REX1 in female embryonic stem cells was found to inhibit Xist transcription and X-chromosome inactivation, whereas male Rex1(+/-) embryonic stem cells showed ectopic X-chromosome inactivation. From this, we propose that RNF12 causes REX1 breakdown through dose-dependent catalysis, thereby representing an important pathway to initiate X-chromosome inactivation. Rex1 and Xist are present only in placental mammals, which points to co-evolution of these two genes and X-chromosome inactivation.	[Gontan, Cristina; Achame, Eskeatnaf Mulugeta; Barakat, Tahsin Stefan; Rentmeester, Eveline; Grootegoed, J. Anton; Gribnau, Joost] Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, NL-3015 GE Rotterdam, Netherlands; [Demmers, Jeroen] Univ Med Ctr, Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [van IJcken, Wilfred] Univ Med Ctr, Erasmus MC, Bi Dept, NL-3015 GE Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Gribnau, J (corresponding author), Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, Dr Molewaterplein 50, NL-3015 GE Rotterdam, Netherlands.	j.gribnau@erasmusmc.nl	van ijcken, willem/N-9805-2018; Barakat, Stefan/X-8234-2019; Demmers, Jeroen AA/F-4046-2016; Mulugeta, Eskeatnaf/H-2640-2016; Mulugeta, Eskeatnaf/AAZ-7471-2020	van ijcken, willem/0000-0002-0421-8301; Barakat, Stefan/0000-0003-1231-1562; Demmers, Jeroen AA/0000-0002-8757-9611; Mulugeta, Eskeatnaf/0000-0003-4045-4835; Mulugeta, Eskeatnaf/0000-0003-4045-4835; Gontan, Cristina/0000-0002-3918-0024	Netherlands Organisation for Scientific Research (NWO-TOP); Netherlands Organisation for Scientific Research (NWO-VICI); European Research Council	Netherlands Organisation for Scientific Research (NWO-TOP)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organisation for Scientific Research (NWO-VICI)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	We thank R. van der Linden and C. Maduro for their help with some of the experiments, A. Inagaki, C. Andrieu-Soler, D. Warmerdam, L. Zhang and A. Mohd-Sarip for experimental advice, and C. Rougeulle and R. Jaenisch for providing the Tsix-stop cells. This work was supported by grants from the Netherlands Organisation for Scientific Research (NWO-TOP and NWO-VICI) and the European Research Council to J.G.	Barakat TS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002001; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Do Kim J, 2007, NUCLEIC ACIDS RES, V35, P3442, DOI 10.1093/nar/gkm235; Do Kim J, 2011, HUM MOL GENET, V20, P1353, DOI 10.1093/hmg/ddr017; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; HOSLER BA, 1989, MOL CELL BIOL, V9, P5623, DOI 10.1128/MCB.9.12.5623; Jonkers I, 2009, CELL, V139, P999, DOI 10.1016/j.cell.2009.10.034; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Monkhorst K, 2008, CELL, V132, P410, DOI 10.1016/j.cell.2007.12.036; Monkhorst K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005616; Navarro P, 2010, NATURE, V468, P457, DOI 10.1038/nature09496; Scotland KB, 2009, DEV DYNAM, V238, P1863, DOI 10.1002/dvdy.22037; Shin J, 2010, NATURE, V467, P977, DOI 10.1038/nature09457; Soler E, 2011, METHODS, V53, P151, DOI 10.1016/j.ymeth.2010.08.002; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014	17	149	152	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					386	U138		10.1038/nature11070	http://dx.doi.org/10.1038/nature11070			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596162				2022-12-24	WOS:000304099100046
J	Granier, S; Manglik, A; Kruse, AC; Kobilka, TS; Thian, FS; Weis, WI; Kobilka, BK				Granier, Sebastien; Manglik, Aashish; Kruse, Andrew C.; Kobilka, Tong Sun; Thian, Foon Sun; Weis, William I.; Kobilka, Brian K.			Structure of the delta-opioid receptor bound to naltrindole	NATURE			English	Article							SELECTIVITY; PEPTIDE; SITE; MUTAGENESIS; LIGANDS	The opioid receptor family comprises three members, the mu-, delta- and kappa-opioid receptors, which respond to classical opioid alkaloids such as morphine and heroin as well as to endogenous peptide ligands like endorphins. They belong to the G-protein-coupled receptor (GPCR) superfamily, and are excellent therapeutic targets for pain control. The delta-opioid receptor (delta-OR) has a role in analgesia, as well as in other neurological functions that remain poorly understood(1). The structures of the mu-OR and kappa-OR have recently been solved(2,3). Here we report the crystal structure of the mouse d delta-OR, bound to the subtype-selective antagonist naltrindole. Together with the structures of the mu-OR and kappa-OR, the delta-OR structure provides insights into conserved elements of opioid ligand recognition while also revealing structural features associated with ligand-subtype selectivity. The binding pocket of opioid receptors can be divided into two distinct regions. Whereas the lower part of this pocket is highly conserved among opioid receptors, the upper part contains divergent residues that confer subtype selectivity. This provides a structural explanation and validation for the 'message-address' model of opioid receptor pharmacology(4,5), in which distinct 'message' (efficacy) and 'address' (selectivity) determinants are contained within a single ligand. Comparison of the address region of the delta-OR with other GPCRs reveals that this structural organization may be a more general phenomenon, extending to other GPCR families as well.	[Granier, Sebastien; Manglik, Aashish; Kruse, Andrew C.; Kobilka, Tong Sun; Thian, Foon Sun; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Granier, Sebastien] CNRS, UMR 5203, F-34094 Montpellier, France; [Granier, Sebastien] INSERM, U661, F-34094 Montpellier, France; [Granier, Sebastien] Univ Montpellier I, Inst Genom Fonctionnelle, F-34094 Montpellier, France; [Granier, Sebastien] Univ Montpellier 2, Inst Genom Fonctionnelle, F-34094 Montpellier, France; [Weis, William I.] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA	Stanford University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Stanford University	Granier, S (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	granier@stanford.edu; kobilka@stanford.edu	Granier, Sebastien/J-1089-2016; Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150; Kobilka, Brian/0000-0001-5958-3990	INSERM; Stanford Medical Scientist Training Program; National Science Foundation; National Institutes of Health [NS028471, DA031418]; Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031418] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Stanford Medical Scientist Training Program; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank R. Sunahara for helpful suggestions on opioid receptor pharmacology and biochemistry. We acknowledge support from INSERM (S. G.), the Stanford Medical Scientist Training Program (A. M.), the National Science Foundation (A. C. K.), National Institutes of Health grants NS028471 (B. K. K.) and DA031418 (B. K. K.), and from the Mathers Foundation (B. K. K. and W.I.W.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bonner G, 2000, EUR J PHARMACOL, V403, P37, DOI 10.1016/S0014-2999(00)00578-1; CHAVKIN C, 1981, P NATL ACAD SCI-BIOL, V78, P6543, DOI 10.1073/pnas.78.10.6543; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cox B. M., 2009, OPIOID RECEPTORS INT; Eguchi M, 2004, MED RES REV, V24, P182, DOI 10.1002/med.10059; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; George SR, 2000, J BIOL CHEM, V275, P26128, DOI 10.1074/jbc.M000345200; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; LIPKOWSKI AW, 1986, J MED CHEM, V29, P1222, DOI 10.1021/jm00157a018; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meng F, 1998, MOL PHARMACOL, V53, P772, DOI 10.1124/mol.53.4.772; Metzger TG, 2001, J MED CHEM, V44, P857, DOI 10.1021/jm000381r; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pepin MC, 1997, J BIOL CHEM, V272, P9260; PORTOGHESE PS, 1980, J MED CHEM, V23, P233, DOI 10.1021/jm00177a002; PORTOGHESE PS, 1988, J MED CHEM, V31, P281, DOI 10.1021/jm00397a001; Pradhan AA, 2011, TRENDS PHARMACOL SCI, V32, P581, DOI 10.1016/j.tips.2011.06.008; Satoh M, 1995, PHARMACOL THERAPEUT, V68, P343, DOI 10.1016/0163-7258(95)02011-X; Schrodinger LLC, 2012, PYMOL MOL GRAPH SYST; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; XUE JC, 1994, J BIOL CHEM, V269, P30195	24	518	531	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					400	U171		10.1038/nature11111	http://dx.doi.org/10.1038/nature11111			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596164	Green Accepted			2022-12-24	WOS:000304099100049
J	Whittle, AJ; Carobbio, S; Martins, L; Slawik, M; Hondares, E; Vazquez, MJ; Morgan, D; Csikasz, RI; Gallego, R; Rodriguez-Cuenca, S; Dale, M; Virtue, S; Villarroya, F; Cannon, B; Rahmouni, K; Lopez, M; Vidal-Puig, A				Whittle, Andrew J.; Carobbio, Stefania; Martins, Luis; Slawik, Marc; Hondares, Elayne; Jesus Vazquez, Maria; Morgan, Donald; Csikasz, Robert I.; Gallego, Rosalia; Rodriguez-Cuenca, Sergio; Dale, Martin; Virtue, Samuel; Villarroya, Francesc; Cannon, Barbara; Rahmouni, Kamal; Lopez, Miguel; Vidal-Puig, Antonio			BMP8B Increases Brown Adipose Tissue Thermogenesis through Both Central and Peripheral Actions	CELL			English	Article							ACTIVATED PROTEIN-KINASE; DIET-INDUCED THERMOGENESIS; BETA-ADRENERGIC-RECEPTORS; ENERGY-BALANCE; DIFFERENTIAL ACTIVATION; PARAVENTRICULAR NUCLEUS; HYPOTHALAMIC AMPK; ADULT HUMANS; FOOD-INTAKE; METABOLISM	Thermogenesis in brown adipose tissue (BAT) is fundamental to energy balance and is also relevant for humans. Bone morphogenetic proteins (BMPs) regulate adipogenesis, and, here, we describe a role for BMP8B in the direct regulation of thermogenesis. BMP8B is induced by nutritional and thermogenic factors in mature BAT, increasing the response to noradrenaline through enhanced p38MAPK/CREB signaling and increased lipase activity. Bmp8b(-/-) mice exhibit impaired thermogenesis and reduced metabolic rate, causing weight gain despite hypophagia. BMP8B is also expressed in the hypothalamus, and Bmp8b(-/-) mice display altered neuropeptide levels and reduced phosphorylation of AMP-activated protein kinase (AMPK), indicating an anorexigenic state. Central BMP8B treatment increased sympathetic activation of BAT, dependent on the status of AMPK in key hypothalamic nuclei. Our results indicate that BMP8B is a thermogenic protein that regulates energy balance in partnership with hypothalamic AMPK. BMP8B may offer a mechanism to specifically increase energy dissipation by BAT.	[Whittle, Andrew J.; Carobbio, Stefania; Slawik, Marc; Rodriguez-Cuenca, Sergio; Dale, Martin; Virtue, Samuel; Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 0QQ, England; [Martins, Luis; Jesus Vazquez, Maria; Lopez, Miguel] Univ Santiago de Compostela, Dept Physiol, Sch Med CIMUS, Inst Invest Sanitaria, Santiago De Compostela 15782, Spain; [Martins, Luis; Hondares, Elayne; Jesus Vazquez, Maria; Villarroya, Francesc; Lopez, Miguel] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Santiago De Compostela 15706, Spain; [Slawik, Marc] Klinikum Univ, Med Klin & Poliklin 4, D-80336 Munich, Germany; [Hondares, Elayne; Villarroya, Francesc] Univ Barcelona, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain; [Hondares, Elayne; Villarroya, Francesc] Univ Barcelona, IBUB, E-08028 Barcelona, Spain; [Morgan, Donald; Rahmouni, Kamal] Univ Iowa, Dept Pharmacol, Iowa City, IA 52242 USA; [Rahmouni, Kamal] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Csikasz, Robert I.; Cannon, Barbara] Stockholm Univ, Wenner Gren Inst, SE-10691 Stockholm, Sweden; [Gallego, Rosalia] Univ Santiago de Compostela, Sch Med, Dept Morphol Sci, Santiago De Compostela 15782, Spain; [Cannon, Barbara] Univ London Royal Vet Coll, London NW1 0TU, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; University of Munich; University of Barcelona; University of Barcelona; University of Iowa; University of Iowa; Stockholm University; Universidade de Santiago de Compostela; University of London; University of London Royal Veterinary College	Whittle, AJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 0QQ, England.	ajw232@cam.ac.uk; ajv22@medschl.cam.ac.uk	Morgan, Donald A/L-6907-2013; carobbio, stefania/E-7095-2018; Martins, Luis/AAB-5436-2020; Virtue, SAm/B-7578-2013; López, Miguel/ABF-4844-2021; Villarroya, Francesc/K-4357-2014; Rahmouni, Kamal/Y-1788-2019; Cannon, Barbara/B-3089-2016	Morgan, Donald A/0000-0003-3167-1643; Martins, Luis/0000-0002-2000-387X; Virtue, SAm/0000-0002-9545-5432; López, Miguel/0000-0002-7823-1648; Vidal-Puig, Antonio/0000-0003-4220-9577; Rosalia, Gallego/0000-0002-6015-4680; Rahmouni, Kamal/0000-0001-5136-6748; Whittle, Andrew/0000-0002-3181-8855; Cannon, Barbara/0000-0001-6594-2363; Villarroya, Francesc/0000-0003-1266-9142	MRC CORD; MRC; Wellcome Trust; European Community [281854]; Sixth Framework Programme (FP6 Hepadip); BBSRC; University of Cambridge School of the Biological Sciences; Marie Curie IEF; Ministerio de Ciencia e Innovacion [SAF2008-01896, RyC-2007-00211]; Generalitat de Catalunya, Spain [2009SGR284]; Xunta de Galicia [10PXIB208164PR]; Fondo Investigationes Sanitarias [PS09/01880]; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BD/65379/2009]; Fritz Thyssen Foundation; National Heart, Lung, and Blood Institute [HL084207]; Swedish Science Research Council; EU; BBSRC [BB/J009865/1] Funding Source: UKRI; MRC [G0802051] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J009865/1] Funding Source: researchfish; Medical Research Council [G0802051, G0600717B] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084207] Funding Source: NIH RePORTER	MRC CORD(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Community(European Commission); Sixth Framework Programme (FP6 Hepadip); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Cambridge School of the Biological Sciences(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Marie Curie IEF(European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Generalitat de Catalunya, Spain(Generalitat de Catalunya); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondo Investigationes Sanitarias(Instituto de Salud Carlos III); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Fritz Thyssen Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swedish Science Research Council; EU(European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Sarah Gray, Constanze Hammerle, and our animal technicians for their work on the project. Johannes Klein donated the brown adipocyte cell line. Thyroid receptor plasmids came from Krishna Chatterjee. A. V.-P. is supported by MRC CORD, MRC programme, and Wellcome Trust project grants, European Community's Seventh Framework Programmes (FP7 MITIN, FP7 BETABAT), and Sixth Framework Programme (FP6 Hepadip). A.J.W. is supported by BBSRC and the University of Cambridge School of the Biological Sciences. S. C. was funded by Marie Curie IEF. F. V. is funded by Ministerio de Ciencia e Innovacion (SAF2008-01896) and Generalitat de Catalunya (2009SGR284), Spain. M. L. was funded by Xunta de Galicia (10PXIB208164PR), Fondo Investigationes Sanitarias (PS09/01880), Ministerio de Ciencia e Innovacion (RyC-2007-00211), and European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement 281854 (the ObERStress project). L. M. is a recipient of a fellowship from Fundacao para a Ciencia e Tecnologia, Portugal (SFRH/BD/65379/2009). M. S. was funded by Fritz Thyssen Foundation fellowship. K. R. is supported by National Heart, Lung, and Blood Institute grant HL084207. B. C. is supported by The Swedish Science Research Council, the EU-project DIABAT, and BBSRC.	AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Alberts P., 2006, CURRENT PROTOCOLS NE, P1; Alonso G, 2000, J BIOL CHEM, V275, P40641, DOI 10.1074/jbc.M007835200; AMIR S, 1990, BRAIN RES, V508, P152, DOI 10.1016/0006-8993(90)91129-5; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bowers RR, 2007, CELL CYCLE, V6, P385, DOI 10.4161/cc.6.4.3804; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193; Collins S, 2001, RECENT PROG HORM RES, V56, P309, DOI 10.1210/rp.56.1.309; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Elia M, 1992, World Rev Nutr Diet, V70, P68; Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502; HALVORSON I, 1990, BRAIN RES, V522, P76, DOI 10.1016/0006-8993(90)91579-6; Klein J, 2002, BIOESSAYS, V24, P382, DOI 10.1002/bies.10058; Lage R, 2010, FASEB J, V24, P2670, DOI 10.1096/fj.09-150672; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lopez M, 2006, DIABETES, V55, P1327, DOI 10.2337/db05-1356; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; LOWELL BB, 1993, NATURE, V366, P740, DOI 10.1038/366740a0; Madden CJ, 2009, AM J PHYSIOL-REG I, V296, pR831, DOI 10.1152/ajpregu.91007.2008; de Morentin PBM, 2012, DIABETES, V61, P807, DOI 10.2337/db11-1079; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morikawa Y, 2009, DEVELOPMENT, V136, P3575, DOI 10.1242/dev.038133; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Rahmouni K, 2005, DIABETES, V54, P2012, DOI 10.2337/diabetes.54.7.2012; Remy G, 2010, CELL SIGNAL, V22, P660, DOI 10.1016/j.cellsig.2009.11.020; Ribeiro MO, 2010, ENDOCRINOLOGY, V151, P432, DOI 10.1210/en.2009-0667; Rim JS, 2002, J BIOL CHEM, V277, P34589, DOI 10.1074/jbc.M108866200; ROTHWELL NJ, 1986, BRIT J NUTR, V56, P123, DOI 10.1079/BJN19860092; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Sellayah D, 2011, CELL METAB, V14, P478, DOI 10.1016/j.cmet.2011.08.010; Shibuya H, 1998, EMBO J, V17, P1019, DOI 10.1093/emboj/17.4.1019; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Silva JE, 1995, THYROID, V5, P481, DOI 10.1089/thy.1995.5.481; Sottile V, 2000, FEBS LETT, V475, P201, DOI 10.1016/S0014-5793(00)01655-0; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Torp-Pedersen C, 2007, EUR HEART J, V28, P2915, DOI 10.1093/eurheartj/ehm217; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Varela L, 2012, J PATHOL, V227, P209, DOI 10.1002/path.3984; WANG EA, 1993, GROWTH FACTORS, V9, P57, DOI 10.3109/08977199308991582; Whittle AJ, 2011, TRENDS MOL MED, V17, P405, DOI 10.1016/j.molmed.2011.04.001; WOODS AJ, 1994, AM J PHYSIOL, V266, pR328, DOI 10.1152/ajpregu.1994.266.2.R328; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Xue B, 2009, MOL CELL BIOL, V29, P4563, DOI 10.1128/MCB.01914-08; Yamaguchi K, 1999, EMBO J, V18, P179, DOI 10.1093/emboj/18.1.179; Ying Y, 2000, MOL ENDOCRINOL, V14, P1053, DOI 10.1210/me.14.7.1053; Zhao GQ, 1996, GENE DEV, V10, P1657, DOI 10.1101/gad.10.13.1657; Zhao GQ, 1996, MECH DEVELOP, V57, P159, DOI 10.1016/0925-4773(96)00543-6; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	57	424	438	0	42	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					871	885		10.1016/j.cell.2012.02.066	http://dx.doi.org/10.1016/j.cell.2012.02.066			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579288	Green Submitted, Green Published, hybrid			2022-12-24	WOS:000303934700019
J	Lindgren, E; Andersson, Y; Suk, JE; Sudre, B; Semenza, JC				Lindgren, Elisabet; Andersson, Yvonne; Suk, Jonathan E.; Sudre, Bertrand; Semenza, Jan C.			Monitoring EU Emerging Infectious Disease Risk Due to Climate Change	SCIENCE			English	Editorial Material							EUROPE; FUTURE		[Suk, Jonathan E.; Sudre, Bertrand; Semenza, Jan C.] European Ctr Dis Prevent & Control, Off Chief Sci, SE-17183 Stockholm, Sweden; [Lindgren, Elisabet] Karolinska Inst, Inst Environm Med, SE-17177 Stockholm, Sweden; [Andersson, Yvonne] Swedish Inst Communicable Dis Control 1, SE-17182 Solna, Sweden	European Centre for Disease Prevention & Control; Karolinska Institutet	Semenza, JC (corresponding author), European Ctr Dis Prevent & Control, Off Chief Sci, SE-17183 Stockholm, Sweden.	jan.semenza@ecdc.europa.eu	Suk, Jonathan/L-2300-2017	Suk, Jonathan/0000-0003-4689-4583				Commission of the european communities, 2009, COM2009147 COMM EUR; Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; King DA, 2006, SCIENCE, V313, P1392, DOI 10.1126/science.1129134; Marsh Inc, 2008, EC SOC IMP EM INF DI; Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Semenza JC, 2012, ENVIRON HEALTH PERSP, V120, P385, DOI 10.1289/ehp.1103805; Semenza JC, 2009, LANCET INFECT DIS, V9, P365, DOI 10.1016/S1473-3099(09)70104-5; Suk JE, 2011, AM J PUBLIC HEALTH, V101, P2068, DOI 10.2105/AJPH.2011.300181; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150	12	142	145	4	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					418	419		10.1126/science.1215735	http://dx.doi.org/10.1126/science.1215735			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539705				2022-12-24	WOS:000303233400028
J	Verret, L; Mann, EO; Hang, GB; Barth, AMI; Cobos, I; Ho, K; Devidze, N; Masliah, E; Kreitzer, AC; Mody, I; Mucke, L; Palop, JJ				Verret, Laure; Mann, Edward O.; Hang, Giao B.; Barth, Albert M. I.; Cobos, Inma; Ho, Kaitlyn; Devidze, Nino; Masliah, Eliezer; Kreitzer, Anatol C.; Mody, Istvan; Mucke, Lennart; Palop, Jorge J.			Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model	CELL			English	Article							INDUCED NEURONAL DYSFUNCTION; DISEASE MOUSE MODELS; TRANSGENIC MICE; HIPPOCAMPAL NETWORK; GAMMA-OSCILLATIONS; FEBRILE SEIZURES; SCN1A GENE; IN-VIVO; EPILEPSY; MUTATIONS	Alzheimer's disease (AD) results in cognitive decline and altered network activity, but the mechanisms are unknown. We studied human amyloid precursor protein (hAPP) transgenic mice, which simulate key aspects of AD. Electroencephalographic recordings in hAPP mice revealed spontaneous epileptiform discharges, indicating network hypersynchrony, primarily during reduced gamma oscillatory activity. Because this oscillatory rhythm is generated by inhibitory parvalbumin (PV) cells, network dysfunction in hAPP mice might arise from impaired PV cells. Supporting this hypothesis, hAPP mice and AD patients had decreased levels of the interneuron-specific and PV cell-predominant voltage-gated sodium channel subunit Nav1.1. Restoring Nav1.1 levels in hAPP mice by Nav1.1-BAC expression increased inhibitory synaptic activity and gamma oscillations and reduced hypersynchrony, memory deficits, and premature mortality. We conclude that reduced Nav1.1 levels and PV cell dysfunction critically contribute to abnormalities in oscillatory rhythms, network synchrony, and memory in hAPP mice and possibly in AD.	[Verret, Laure; Hang, Giao B.; Ho, Kaitlyn; Devidze, Nino; Kreitzer, Anatol C.; Mucke, Lennart; Palop, Jorge J.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Verret, Laure; Hang, Giao B.; Kreitzer, Anatol C.; Mucke, Lennart; Palop, Jorge J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Cobos, Inma] Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Mann, Edward O.; Barth, Albert M. I.; Mody, Istvan] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, San Diego, CA 92093 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California San Diego	Palop, JJ (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	jpalop@gladstone.ucsf.edu	Verret, Laure/D-2219-2011; Palop, Jorge/AAH-9014-2020; Verret, Laure/D-9224-2017; Palop, Jorge J./D-8128-2011	Verret, Laure/0000-0001-5272-6063; Verret, Laure/0000-0001-5272-6063; Palop, Jorge/0000-0001-6086-1070; Cobos, Inma/0000-0002-2043-1890; Mann, Edward/0000-0002-2468-7148	Stephen D. Bechtel, Jr. Foundation; National Institutes of Health [AG022074, AG011385, NS065780, NS002808, NS030549, AG5131, AG18440]; Philippe Foundation; Coelho Endowment; Pew Foundation; McKnight Foundation; Epilepsy Foundation; National Center for Research Resources; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS002808, P30NS065780, R01NS030549, R37NS030549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018440, R01AG011385, P50AG005131, R37AG011385, R37AG018440, P01AG022074] Funding Source: NIH RePORTER	Stephen D. Bechtel, Jr. Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philippe Foundation; Coelho Endowment; Pew Foundation; McKnight Foundation; Epilepsy Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a Stephen D. Bechtel, Jr. Foundation Young Investigator Award to J.J.P.; National Institutes of Health Grants AG022074, AG011385, and NS065780 to L. M. and NS002808, NS030549, AG5131, and AG18440 to E. M.; the Philippe Foundation Award to L. V.; the Coelho Endowment to I. M.; Pew and McKnight Foundations to A. C. K.; Epilepsy Foundation Postdoctoral Fellowship to E.O.M.; and facilities grants from Stephen D. Bechtel, Jr. and the National Center for Research Resources. We thank A. Escayg for the Nav1.1-BAC transgenic mice; J. Noebels and A. Gittis for helpful comments; G. Q. Yu, X. Wang, W. Guo, E. Pham, K. Bummer, I. Lo, and D. H. Kim for excellent technical support; and G. Howard and S. Ordway for editorial review.	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Barth AMI, 2011, J NEUROSCI, V31, P851, DOI 10.1523/JNEUROSCI.5080-10.2011; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Busche MA, 2008, SCIENCE, V321, P1686, DOI 10.1126/science.1162844; Cabrejo L, 2006, BRAIN, V129, P2966, DOI 10.1093/brain/awl237; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; Carter MD, 2007, J NEUROL SCI, V252, P169, DOI 10.1016/j.jns.2006.11.004; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cisse M, 2011, NATURE, V469, P47, DOI 10.1038/nature09635; Fazzari P, 2010, NATURE, V464, P1376, DOI 10.1038/nature08928; Freund TF, 2007, NEURON, V56, P33, DOI 10.1016/j.neuron.2007.09.012; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; HAUSER WA, 1986, NEUROLOGY, V36, P1226, DOI 10.1212/WNL.36.9.1226; Herrmann CS, 2005, CLIN NEUROPHYSIOL, V116, P2719, DOI 10.1016/j.clinph.2005.07.007; HSIAO KK, 1995, NEURON, V15, P1203, DOI 10.1016/0896-6273(95)90107-8; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Ittner LM, 2010, CELL, V142, P387, DOI 10.1016/j.cell.2010.06.036; Jayadev S, 2010, BRAIN, V133, P1143, DOI 10.1093/brain/awq033; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; Lalonde R, 2005, BEHAV BRAIN RES, V157, P91, DOI 10.1016/j.bbr.2004.06.020; Larner AJ, 2006, J NEUROL, V253, P139, DOI 10.1007/s00415-005-0019-5; Liao WP, 2010, EPILEPSIA, V51, P1669, DOI 10.1111/j.1528-1167.2010.02645.x; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Medvedev AV, 2002, BRAIN RES BULL, V58, P115, DOI 10.1016/S0361-9230(02)00768-2; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Mendez MF, 2003, DRUG AGING, V20, P791, DOI 10.2165/00002512-200320110-00001; Minkeviciene R, 2009, J NEUROSCI, V29, P3453, DOI 10.1523/JNEUROSCI.5215-08.2009; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Palop JJ, 2005, J NEUROSCI, V25, P9686, DOI 10.1523/JNEUROSCI.2829-05.2005; Palop JJ, 2003, P NATL ACAD SCI USA, V100, P9572, DOI 10.1073/pnas.1133381100; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Palop JJ, 2009, ARCH NEUROL-CHICAGO, V66, P435, DOI 10.1001/archneurol.2009.15; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sederberg PB, 2007, CEREB CORTEX, V17, P1190, DOI 10.1093/cercor/bhl030; Snider BJ, 2005, ARCH NEUROL-CHICAGO, V62, P1821, DOI 10.1001/archneur.62.12.1821; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Spadoni F, 2002, NEUROREPORT, V13, P1167, DOI 10.1097/00001756-200207020-00019; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Striano P, 2008, LANCET NEUROL, V7, P278, DOI 10.1016/S1474-4422(08)70043-7; Suls A, 2006, HUM MUTAT, V27, P914, DOI 10.1002/humu.20350; Tang B, 2009, NEUROBIOL DIS, V35, P91, DOI 10.1016/j.nbd.2009.04.007; Tsiouris JA, 2002, NEUROLOGY, V59, P779, DOI 10.1212/WNL.59.5.779; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang WZ, 2011, BRAIN RES, V1389, P61, DOI 10.1016/j.brainres.2011.02.083; Wang YL, 2010, J NEUROSCI, V30, P5334, DOI 10.1523/JNEUROSCI.5963-09.2010; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754	55	676	699	6	87	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3					708	721		10.1016/j.cell.2012.02.046	http://dx.doi.org/10.1016/j.cell.2012.02.046			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22541439	Green Accepted, Bronze			2022-12-24	WOS:000303443100020
J	Uyttewaal, M; Burian, A; Alim, K; Landrein, BT; Borowska-Wykret, D; Dedieu, A; Peaucelle, A; Ludynia, M; Traas, J; Boudaoud, A; Kwiatkowska, D; Hamant, O				Uyttewaal, Magalie; Burian, Agata; Alim, Karen; Landrein, Benoi T.; Borowska-Wykret, Dorota; Dedieu, Annick; Peaucelle, Alexis; Ludynia, Michal; Traas, Jan; Boudaoud, Arezki; Kwiatkowska, Dorota; Hamant, Olivier			Mechanical Stress Acts via Katanin to Amplify Differences in Growth Rate between Adjacent Cells in Arabidopsis	CELL			English	Article							SCANNING-ELECTRON-MICROSCOPY; CORTICAL MICROTUBULES; POSITIONAL INFORMATION; EXTERNAL FORCES; SHOOT APEX; SURFACE; TISSUE; PLANTS; MORPHOGENESIS; DYNAMICS	The presence of diffuse morphogen gradients in tissues supports a view in which growth is locally homogenous. Here we challenge this view: we used a high-resolution quantitative approach to reveal significant growth variability among neighboring cells in the shoot apical meristem, the plant stem cell niche. This variability was strongly decreased in a mutant impaired in the microtubule-severing protein katanin. Major shape defects in the mutant could be related to a local decrease in growth heterogeneity. We show that katanin is required for the cell's competence to respond to the mechanical forces generated by growth. This provides the basis for a model in which microtubule dynamics allow the cell to respond efficiently to mechanical forces. This in turn can amplify local growth-rate gradients, yielding more heterogeneous growth and supporting morphogenesis.	[Uyttewaal, Magalie; Landrein, Benoi T.; Dedieu, Annick; Traas, Jan; Boudaoud, Arezki; Hamant, Olivier] UCB Lyon 1, ENS, CNRS, Lab Reprod & Dev Plantes,INRA, F-69364 Lyon 07, France; [Landrein, Benoi T.; Boudaoud, Arezki; Hamant, Olivier] Univ Lyon, ENS Lyon, CNRS, Lab Joliot Curie, F-69364 Lyon 07, France; [Uyttewaal, Magalie; Peaucelle, Alexis] UMR1318 INRA AgroParisTech, Ctr Versailles, Inst Jean Pierre Bourgin, F-78026 Versailles, France; [Burian, Agata; Borowska-Wykret, Dorota; Ludynia, Michal; Kwiatkowska, Dorota] Univ Silesia, Dept Biophys & Morphogenesis Plants, PL-40032 Katowice, Poland; [Alim, Karen] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Peaucelle, Alexis] Univ Paris Diderot, UFR Phys Paris 7, F-75205 Paris, France	INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; University of Silesia in Katowice; Harvard University; UDICE-French Research Universities; Universite Paris Cite	Boudaoud, A (corresponding author), UCB Lyon 1, ENS, CNRS, Lab Reprod & Dev Plantes,INRA, 46 Allee Italie, F-69364 Lyon 07, France.	arezki.boudaoud@ens-lyon.fr; dorota.kwiatkowska@us.edu.pl; olivier.hamant@ens-lyon.fr	Kwiatkowska, Dorota/AAD-4275-2019; Burian, Agata/AAD-7447-2019; Boudaoud, Arezki/Q-7436-2016; Alim, Karen/C-6424-2014; Traas, Jan/AAZ-7004-2020; Landrein, Benoit/AAD-8272-2019	Kwiatkowska, Dorota/0000-0002-0102-6988; Boudaoud, Arezki/0000-0002-2780-4717; Traas, Jan/0000-0001-5107-1472; Landrein, Benoit/0000-0002-2371-9996; Hamant, Olivier/0000-0001-6906-6620; Ludynia, Michal/0000-0003-1992-8880; Alim, Karen/0000-0002-2527-5831; Burian, Agata/0000-0002-8912-483X; BERNE DEDIEU, Annick/0000-0002-9982-8793	INRA, France; Ministry of Science and Higher Education, Poland; National Science Foundation [NSF PHY05-51164]; Agence Nationale de la Recherche [ANR-10-BLAN-1516 "Mechastem"]	INRA, France; Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); National Science Foundation(National Science Foundation (NSF)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This research was supported by a bilateral grant from INRA, France and Ministry of Science and Higher Education, Poland, by the National Science Foundation under grant no. NSF PHY05-51164, and by a grant from Agence Nationale de la Recherche ANR-10-BLAN-1516 "Mechastem". K. A. and A. B. are grateful to Boris Shraiman for hospitality and discussions. We thank Ewa Teper (Laboratory of Scanning Electron Microscopy, Faculty of Earth Sciences, University of Silesia) for the excellent technical assistance at Scanning Electron Microscopy and Platim (UMS 3444 Biosciences Gerland-Lyon Sud) for help with imaging.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Allard JF, 2010, MOL BIOL CELL, V21, P278, DOI 10.1091/mbc.E09-07-0579; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Boehm B, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000420; Burk DH, 2002, PLANT CELL, V14, P2145, DOI 10.1105/tpc.003947; Burk DH, 2001, PLANT CELL, V13, P807, DOI 10.1105/tpc.13.4.807; CLEARY AL, 1993, PLANT CELL PHYSIOL, V34, P1003; Coen E, 2004, P NATL ACAD SCI USA, V101, P4728, DOI 10.1073/pnas.0306308101; Corson F, 2009, P NATL ACAD SCI USA, V106, P8453, DOI 10.1073/pnas.0812493106; Desprez T, 2002, PLANT PHYSIOL, V128, P482, DOI 10.1104/pp.010822; Dixit R, 2004, PLANT CELL, V16, P2546, DOI 10.1105/tpc.104.161030; Dumais J, 2002, PLANT J, V31, P229, DOI 10.1046/j.1365-313X.2001.01350.x; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Farge E, 2003, CURR BIOL, V13, P1365, DOI 10.1016/S0960-9822(03)00576-1; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Gennes P.G.d., 1993, PHYS LIQUID CRYSTALS; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; GREEN PB, 1966, AUST J BIOL SCI, V19, P421, DOI 10.1071/BI9660421; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Heisler MG, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000516; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Jaeger J, 2008, DEVELOPMENT, V135, P3175, DOI 10.1242/dev.018697; Jarvis MC, 2003, PLANT CELL ENVIRON, V26, P977, DOI 10.1046/j.1365-3040.2003.01034.x; Kwiatkowska D, 2003, J EXP BOT, V54, P1585, DOI 10.1093/jxb/erg166; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Mirabet V, 2011, ANNU REV PLANT BIOL, V62, P365, DOI 10.1146/annurev-arplant-042110-103852; Monshausen GB, 2009, TRENDS CELL BIOL, V19, P228, DOI 10.1016/j.tcb.2009.02.005; Nakamura M, 2010, NAT CELL BIOL, V12, P1064, DOI 10.1038/ncb2110; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Oates AC, 2011, DEVELOPMENT, V138, P601, DOI 10.1242/dev.059923; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Peaucelle A, 2011, CURR BIOL, V21, P1720, DOI 10.1016/j.cub.2011.08.057; Raj A, 2010, NATURE, V463, P913, DOI 10.1038/nature08781; Routier-Kierzkowska AL, 2008, FUNCT PLANT BIOL, V35, P1034, DOI 10.1071/FP08047; Ryden P, 2003, PLANT PHYSIOL, V132, P1033, DOI 10.1104/pp.103.021873; SAKAGUCHI S, 1988, BOT MAG TOKYO, V101, P497, DOI 10.1007/BF02488091; Shaw SL, 2003, SCIENCE, V300, P1715, DOI 10.1126/science.1083529; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Stoppin-Mellet V, 2006, PLANT J, V46, P1009, DOI 10.1111/j.1365-313X.2006.02761.x; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Towers M, 2009, DEVELOPMENT, V136, P179, DOI 10.1242/dev.024158; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Wartlick O, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001255; Wasteneys GO, 2009, TRENDS CELL BIOL, V19, P62, DOI 10.1016/j.tcb.2008.11.004; WILLIAMS MH, 1987, MICRON MICROSC ACTA, V18, P27, DOI 10.1016/0739-6260(87)90016-5; WILLIAMS MH, 1988, PROTOPLASMA, V147, P77, DOI 10.1007/BF01403879; WILLIAMSON RE, 1990, AUST J PLANT PHYSIOL, V17, P601, DOI 10.1071/PP9900601; WOLPERT L, 1969, J THEOR BIOL, V25, P1, DOI 10.1016/S0022-5193(69)80016-0; Wymer CL, 1996, PLANT PHYSIOL, V110, P425, DOI 10.1104/pp.110.2.425; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055	52	289	294	2	104	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 13	2012	149	2					439	451		10.1016/j.cell.2012.02.048	http://dx.doi.org/10.1016/j.cell.2012.02.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500806	Bronze			2022-12-24	WOS:000302805600021
J	Shoval, O; Sheftel, H; Shinar, G; Hart, Y; Ramote, O; Mayo, A; Dekel, E; Kavanagh, K; Alon, U				Shoval, O.; Sheftel, H.; Shinar, G.; Hart, Y.; Ramote, O.; Mayo, A.; Dekel, E.; Kavanagh, K.; Alon, U.			Evolutionary Trade-Offs, Pareto Optimality, and the Geometry of Phenotype Space	SCIENCE			English	Article							GROWTH; SHAPE; SIZE	Biological systems that perform multiple tasks face a fundamental trade-off: A given phenotype cannot be optimal at all tasks. Here we ask how trade-offs affect the range of phenotypes found in nature. Using the Pareto front concept from economics and engineering, we find that best-trade-off phenotypes are weighted averages of archetypes-phenotypes specialized for single tasks. For two tasks, phenotypes fall on the line connecting the two archetypes, which could explain linear trait correlations, allometric relationships, as well as bacterial gene-expression patterns. For three tasks, phenotypes fall within a triangle in phenotype space, whose vertices are the archetypes, as evident in morphological studies, including on Darwin's finches. Tasks can be inferred from measured phenotypes based on the behavior of organisms nearest the archetypes.	[Shoval, O.; Sheftel, H.; Shinar, G.; Hart, Y.; Ramote, O.; Mayo, A.; Dekel, E.; Alon, U.] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Kavanagh, K.] Univ Massachusetts Dartmouth, Dept Biol, Dartmouth, MA 02747 USA	Weizmann Institute of Science; University of Massachusetts System; University Massachusetts Dartmouth	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il	mayo, avi/N-3756-2019; Hart, Yuval/HGD-6424-2022; MAYO, AVI E/K-1736-2012	mayo, avi/0000-0002-4479-3423; 	Israel Science Foundation; European Research Council	Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission)	We thank N. Barkai, R. Milo, O. Feinerman, C. Tabin, J. Losos, M. Khammash, T. Dayan, and N. Ulanovski for discussion. U. A. holds the Abisch-Frenkel Professorial Chair; O. S. is an Azrieli Fellow. This work was supported by the Israel Science Foundation and the European Research Council (FP7).	ARNOLD SJ, 1983, AM ZOOL, V23, P347, DOI 10.1093/icb/23.2.347; El Samad H, 2005, P 16 IFAC WORLD C; FARNSWORTH KD, 1995, FUNCT ECOL, V9, P355, DOI 10.2307/2389997; Geva-Zatorsky N, 2010, CELL, V140, P643, DOI 10.1016/j.cell.2010.02.011; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; GRANT PR, 1985, BIOL J LINN SOC, V25, P1, DOI 10.1111/j.1095-8312.1985.tb00384.x; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Kennedy MC, 2010, ECOL RES, V25, P723, DOI 10.1007/s11284-009-0658-6; Klingenberg CP, 2010, NAT REV GENET, V11, P623, DOI 10.1038/nrg2829; McGhee GR., 2007, GEOMETRY EVOLUTION A; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Oster G. F., 1979, CASTE ECOLOGY SOCIAL, DOI DOI 10.1007/BF00046355; Schluter D, 1996, EVOLUTION, V50, P1766, DOI 10.1111/j.1558-5646.1996.tb03563.x; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Steuer R. E., 1986, MULTIPLE CRITERIA OP; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520; Zaslaver A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000545	19	350	349	6	132	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 1	2012	336	6085					1157	1160		10.1126/science.1217405	http://dx.doi.org/10.1126/science.1217405			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22539553				2022-12-24	WOS:000304647900049
J	Zeng, HK; Shen, EH; Hohmann, JG; Oh, SW; Bernard, A; Royall, JJ; Glattfelder, KJ; Sunkin, SM; Morris, JA; Guillozet-Bongaarts, AL; Smith, KA; Ebbert, AJ; Swanson, B; Kuan, L; Page, DT; Overly, CC; Lein, ES; Hawrylycz, MJ; Hof, PR; Hyde, TM; Kleinman, JE; Jones, AR				Zeng, Hongkui; Shen, Elaine H.; Hohmann, John G.; Oh, Seung Wook; Bernard, Amy; Royall, Joshua J.; Glattfelder, Katie J.; Sunkin, Susan M.; Morris, John A.; Guillozet-Bongaarts, Angela L.; Smith, Kimberly A.; Ebbert, Amanda J.; Swanson, Beryl; Kuan, Leonard; Page, Damon T.; Overly, Caroline C.; Lein, Ed S.; Hawrylycz, Michael J.; Hof, Patrick R.; Hyde, Thomas M.; Kleinman, Joel E.; Jones, Allan R.			Large-Scale Cellular-Resolution Gene Profiling in Human Neocortex Reveals Species-Specific Molecular Signatures	CELL			English	Article							HUMAN BRAIN; COPY NUMBER; EVOLUTION; EXPRESSION; TRANSCRIPTOME; NEURONS; INSIGHTS; GENOME; INTERNEURONS; PATTERNS	Although there have been major advances in elucidating the functional biology of the human brain, relatively little is known of its cellular and molecular organization. Here we report a large-scale characterization of the expression of similar to 1,000 genes important for neural functions by in situ hybridization at a cellular resolution in visual and temporal cortices of adult human brains. These data reveal diverse gene expression patterns and remarkable conservation of each individual gene's expression among individuals (95%), cortical areas (84%), and between human and mouse (79%). A small but substantial number of genes (21%) exhibited species-differential expression. Distinct molecular signatures, comprised of genes both common between species and unique to each, were identified for each major cortical cell type. The data suggest that gene expression profile changes may contribute to differential cortical function across species, and in particular, a shift from corticosubcortical to more predominant corticocortical communications in the human brain.	[Zeng, Hongkui; Shen, Elaine H.; Hohmann, John G.; Oh, Seung Wook; Bernard, Amy; Royall, Joshua J.; Glattfelder, Katie J.; Sunkin, Susan M.; Morris, John A.; Guillozet-Bongaarts, Angela L.; Smith, Kimberly A.; Ebbert, Amanda J.; Swanson, Beryl; Kuan, Leonard; Page, Damon T.; Overly, Caroline C.; Lein, Ed S.; Hawrylycz, Michael J.; Jones, Allan R.] Allen Inst Brain Sci, Seattle, WA 98103 USA; [Hof, Patrick R.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [Hof, Patrick R.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Hyde, Thomas M.] Lieber Inst Brain Dev, Baltimore, MD 21205 USA; [Hyde, Thomas M.; Kleinman, Joel E.] NIMH, Sect Neuropathol, Clin Brain Disorders Branch,NIH, Genes Cognit & Psychosis Program,Intramural Res P, Bethesda, MD 20892 USA	Allen Institute for Brain Science; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Zeng, HK (corresponding author), Allen Inst Brain Sci, Seattle, WA 98103 USA.	hongkuiz@alleninstitute.org; allanj@alleninstitute.org		Bernard, Amy/0000-0003-2540-1153; OH, SEUNG WOOK/0000-0001-7632-6822	Allen Institute for Brain Science; Allen Institute	Allen Institute for Brain Science; Allen Institute	We are grateful for the technical support and expertise of the Atlas Production Team, led by Paul Wohnoutka, and the Information Technology Team, led by Chinh Dang, at the Allen Institute, without which the work would have not been accomplished. We thank Drs. Deborah Mash and Margaret Basile of the University of Miami Brain Endowment Bank for providing tissue. This work was funded by the Allen Institute for Brain Science. The authors wish to thank the Allen Institute founders, Paul G. Allen and Jody Allen, for their vision, encouragement, and support.	Abrahams BS, 2007, P NATL ACAD SCI USA, V104, P17849, DOI 10.1073/pnas.0706128104; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Ascoli GA, 2008, NAT REV NEUROSCI, V9, P557, DOI 10.1038/nrn2402; Ayoub AE, 2009, CEREB CORTEX, V19, P1705, DOI 10.1093/cercor/bhp025; Burki F, 2004, NAT GENET, V36, P1061, DOI 10.1038/ng1431; Caceres M, 2003, P NATL ACAD SCI USA, V100, P13030, DOI 10.1073/pnas.2135499100; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Douglas RJ, 2004, ANNU REV NEUROSCI, V27, P419, DOI 10.1146/annurev.neuro.27.070203.144152; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gilbert SL, 2005, NAT REV GENET, V6, P581, DOI 10.1038/nrg1634; Gu JY, 2003, TRENDS GENET, V19, P63, DOI 10.1016/S0168-9525(02)00040-9; Herculano-Houzel S, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.031.2009; Hoerder-Suabedissen A, 2009, CEREB CORTEX, V19, P1738, DOI 10.1093/cercor/bhn195; HOF PR, 1995, J COMP NEUROL, V362, P109, DOI 10.1002/cne.903620107; Hurd YL, 2000, J COMP NEUROL, V425, P583, DOI 10.1002/1096-9861(20001002)425:4<583::AID-CNE8>3.0.CO;2-#; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Khaitovich P, 2006, NAT REV GENET, V7, P693, DOI 10.1038/nrg1940; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lipska BK, 2006, BIOL PSYCHIAT, V60, P650, DOI 10.1016/j.biopsych.2006.06.019; Suarez-Sola ML, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.007.2009; MARINPADILLA M, 1992, J COMP NEUROL, V321, P223, DOI 10.1002/cne.903210205; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; Miller JA, 2010, P NATL ACAD SCI USA, V107, P12698, DOI 10.1073/pnas.0914257107; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Morris JA, 2010, P NATL ACAD SCI USA, V107, P19049, DOI 10.1073/pnas.1003732107; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; Petanjek Z, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.026.2009; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Preuss TM, 2004, NAT REV GENET, V5, P850, DOI 10.1038/nrg1469; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; Somogyi P, 2005, J PHYSIOL-LONDON, V562, P9, DOI 10.1113/jphysiol.2004.078915; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Vallender EJ, 2008, TRENDS NEUROSCI, V31, P637, DOI 10.1016/j.tins.2008.08.010; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Zaitsev AV, 2009, CEREB CORTEX, V19, P1597, DOI 10.1093/cercor/bhn198	46	214	215	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					483	496		10.1016/j.cell.2012.02.052	http://dx.doi.org/10.1016/j.cell.2012.02.052			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500809	Green Accepted, Bronze			2022-12-24	WOS:000302805600024
J	Shapiro, BJ; Friedman, J; Cordero, OX; Preheim, SP; Timberlake, SC; Szabo, G; Polz, MF; Alm, EJ				Shapiro, B. Jesse; Friedman, Jonathan; Cordero, Otto X.; Preheim, Sarah P.; Timberlake, Sonia C.; Szabo, Gitta; Polz, Martin F.; Alm, Eric J.			Population Genomics of Early Events in the Ecological Differentiation of Bacteria	SCIENCE			English	Article							FUNDAMENTAL UNITS; RECOMBINATION; SELECTION	Genetic exchange is common among bacteria, but its effect on population diversity during ecological differentiation remains controversial. A fundamental question is whether advantageous mutations lead to selection of clonal genomes or, as in sexual eukaryotes, sweep through populations on their own. Here, we show that in two recently diverged populations of ocean bacteria, ecological differentiation has occurred akin to a sexual mechanism: A few genome regions have swept through subpopulations in a habitat-specific manner, accompanied by gradual separation of gene pools as evidenced by increased habitat specificity of the most recent recombinations. These findings reconcile previous, seemingly contradictory empirical observations of the genetic structure of bacterial populations and point to a more unified process of differentiation in bacteria and sexual eukaryotes than previously thought.	[Cordero, Otto X.; Preheim, Sarah P.; Szabo, Gitta; Polz, Martin F.; Alm, Eric J.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Shapiro, B. Jesse; Friedman, Jonathan; Alm, Eric J.] MIT, Program Computat & Syst Biol, Cambridge, MA 02139 USA; [Shapiro, B. Jesse; Alm, Eric J.] Broad Inst, Cambridge, MA 02142 USA; [Timberlake, Sonia C.; Alm, Eric J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Polz, MF (corresponding author), MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA.	mpolz@mit.edu; ejalm@mit.edu	Friedman, Jonathan/I-6930-2019; Shapiro, B. Jesse/U-9337-2019; Polz, Martin/ABE-7199-2020; Preheim, Sarah P/B-3432-2010	Friedman, Jonathan/0000-0001-8476-8030; Shapiro, B. Jesse/0000-0001-6819-8699; Preheim, Sarah P/0000-0001-7365-2382; Szabo, Gitta/0000-0002-0397-3022; /0000-0001-9296-3733; Polz, Martin/0000-0002-4975-2946	NSF [DEB-0918333, 0821391]; Gordon and Betty Moore Foundation; Department of Energy Genomes; Moore Foundation; Broad Institute; Natural Sciences and Engineering Research Council of Canada; Harvard MIDAS Center for Communicable Disease Dynamics; Merck-MIT; Netherlands Organisation for Scientific Research; Rosztoczy Foundation; Division Of Ocean Sciences [0911031] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Department of Energy Genomes(United States Department of Energy (DOE)); Moore Foundation(Gordon and Betty Moore Foundation); Broad Institute; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Harvard MIDAS Center for Communicable Disease Dynamics; Merck-MIT(Merck & Company); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Rosztoczy Foundation; Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. DeLong, S. W. Chisholm, J. Wakeley, P. Sabeti, W. Hanage, D. Neafsey, and M. Coleman for valuable suggestions and comments, and X. Didelot and P. Marttinen for help with software. Funding for this work was provided by NSF grant DEB-0918333 (to E.J.A. and M.F.P.), the NSF-supported Woods Hole Center for Oceans and Human Health (COOH), and grants from the Gordon and Betty Moore Foundation and the Department of Energy Genomes to Life program (M.F.P.). Funding for genome sequencing was provided by the Moore Foundation and the Broad Institute's SPARC program. Computational resources were provided by NSF grant 0821391. Support was provided by a Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council of Canada and a postdoctoral fellowship from the Harvard MIDAS Center for Communicable Disease Dynamics (B.J.S.); a Merck-MIT fellowship (J.F.); the Netherlands Organisation for Scientific Research (O.X.C.); and the Rosztoczy Foundation (G.S.). Whole genomes sequences have been deposited at the DNA Data Bank of Japan, European Molecular Biology Laboratory, and GenBank under accessions AHTI00000000, AICZ00000000, and AIDA00000000-AIDS00000000 (table S6).	Bisharat N, 2005, EMERG INFECT DIS, V11, P30, DOI 10.3201/eid1101.040440; Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001; Cohan FM, 2007, CURR BIOL, V17, pR373, DOI 10.1016/j.cub.2007.03.032; Coleman ML, 2010, P NATL ACAD SCI USA, V107, P18634, DOI 10.1073/pnas.1009480107; Denef VJ, 2010, ISME J, V4, P599, DOI 10.1038/ismej.2009.158; Denef VJ, 2010, P NATL ACAD SCI USA, V107, P2383, DOI 10.1073/pnas.0907041107; DYKHUIZEN DE, 1991, J BACTERIOL, V173, P7257, DOI 10.1128/jb.173.22.7257-7268.1991; Eppley JM, 2007, GENETICS, V177, P407, DOI 10.1534/genetics.107.072892; Falush D, 2006, PHILOS T R SOC B, V361, P2045, DOI 10.1098/rstb.2006.1925; Fraser C, 2007, SCIENCE, V315, P476, DOI 10.1126/science.1127573; GUTTMAN DS, 1994, GENETICS, V138, P993; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Koeppel A, 2008, P NATL ACAD SCI USA, V105, P2504, DOI 10.1073/pnas.0712205105; Lawrence JG, 2002, THEOR POPUL BIOL, V61, P449, DOI 10.1006/tpbi.2002.1587; Majewski J, 2001, FEMS MICROBIOL LETT, V199, P161, DOI 10.1016/S0378-1097(01)00183-5; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Neafsey DE, 2010, SCIENCE, V330, P514, DOI 10.1126/science.1193036; Papke RT, 2007, P NATL ACAD SCI USA, V104, P14092, DOI 10.1073/pnas.0706358104; Preheim SP, 2011, APPL ENVIRON MICROB, V77, P7195, DOI 10.1128/AEM.00665-11; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Shapiro BJ, 2009, TRENDS MICROBIOL, V17, P196, DOI 10.1016/j.tim.2009.02.002; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; Visick KL, 2009, MOL MICROBIOL, V74, P782, DOI 10.1111/j.1365-2958.2009.06899.x	25	335	337	4	136	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 6	2012	336	6077					48	51		10.1126/science.1218198	http://dx.doi.org/10.1126/science.1218198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	920LG	22491847	Green Accepted, Green Submitted			2022-12-24	WOS:000302405400046
J	Li, H; Opgenorth, PH; Wernick, DG; Rogers, S; Wu, TY; Higashide, W; Malati, P; Huo, YX; Cho, KM; Liao, JC				Li, Han; Opgenorth, Paul H.; Wernick, David G.; Rogers, Steve; Wu, Tung-Yun; Higashide, Wendy; Malati, Peter; Huo, Yi-Xin; Cho, Kwang Myung; Liao, James C.			Integrated Electromicrobial Conversion of CO2 to Higher Alcohols	SCIENCE			English	Article							ESCHERICHIA-COLI; CARBON-DIOXIDE; FORMIC-ACID; REDUCTION		[Li, Han; Wernick, David G.; Wu, Tung-Yun; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA; [Li, Han; Liao, James C.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Opgenorth, Paul H.; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Rogers, Steve; Higashide, Wendy; Huo, Yi-Xin; Cho, Kwang Myung] Easel Biotechnol, Los Angeles, CA 90024 USA; [Malati, Peter] Univ Calif Los Angeles, Dept Mat Sci & Engn, Los Angeles, CA 90095 USA; [Liao, James C.] Univ Calif Los Angeles, Inst Genom & Prote, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Liao, JC (corresponding author), Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA.	liaoj@seas.ucla.edu		huo, yixin/0000-0003-4644-999X; Liao, James/0000-0002-4580-7276	Advanced Research Projects Agency-Energy (ARPA-E)	Advanced Research Projects Agency-Energy (ARPA-E)(United States Department of Energy (DOE))	This work is supported by the Electrofuel program of Advanced Research Projects Agency-Energy (ARPA-E).	Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2010, APPL MICROBIOL BIOT, V85, P651, DOI 10.1007/s00253-009-2085-6; Blankenship RE, 2011, SCIENCE, V332, P805, DOI 10.1126/science.1200165; IKEDA S, 1987, B CHEM SOC JPN, V60, P2517, DOI 10.1246/bcsj.60.2517; Mehdi H, 2008, TOP CATAL, V48, P49, DOI 10.1007/s11244-008-9047-6; Michan C, 1999, J BACTERIOL, V181, P2759; Pohlmann A, 2000, MOL MICROBIOL, V38, P626, DOI 10.1046/j.1365-2958.2000.02157.x; TOUATI D, 1988, J BACTERIOL, V170, P2511, DOI 10.1128/jb.170.6.2511-2520.1988; UDUPA KS, 1971, ELECTROCHIM ACTA, V16, P1593, DOI 10.1016/0013-4686(71)80028-2	9	447	478	29	670	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1596	1596		10.1126/science.1217643	http://dx.doi.org/10.1126/science.1217643			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461604				2022-12-24	WOS:000302062600036
J	Das, M; Drake, T; Wiley, DJ; Buchwald, P; Vavylonis, D; Verde, F				Das, Maitreyi; Drake, Tyler; Wiley, David J.; Buchwald, Peter; Vavylonis, Dimitrios; Verde, Fulvia			Oscillatory Dynamics of Cdc42 GTPase in the Control of Polarized Growth	SCIENCE			English	Article							YEAST SCHIZOSACCHAROMYCES-POMBE; FISSION YEAST; CELL POLARITY; PROTEIN SCD2; SYMMETRY-BREAKING; EXCHANGE FACTOR; RHO GTPASES; IN-VIVO; KINASE; MORPHOGENESIS	Cells promote polarized growth by activation of Rho-family protein Cdc42 at the cell membrane. We combined experiments and modeling to study bipolar growth initiation in fission yeast. Concentrations of a fluorescent marker for active Cdc42, Cdc42 protein, Cdc42-activator Scd1, and scaffold protein Scd2 exhibited anticorrelated fluctuations and oscillations with a 5-minute average period at polarized cell tips. These dynamics indicate competition for active Cdc42 or its regulators and the presence of positive and delayed negative feedbacks. Cdc42 oscillations and spatial distribution were sensitive to the amounts of Cdc42-activator Gef1 and to the activity of Cdc42-dependent kinase Pak1, a negative regulator. Feedbacks regulating Cdc42 oscillations and spatial self-organization appear to provide a flexible mechanism for fission yeast cells to explore polarization states and to control their morphology.	[Das, Maitreyi; Wiley, David J.; Buchwald, Peter; Verde, Fulvia] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol R 189, Miami, FL 33101 USA; [Drake, Tyler; Vavylonis, Dimitrios] Lehigh Univ, Dept Phys, Bethlehem, PA 18015 USA; [Verde, Fulvia] Marine Biol Lab, Woods Hole, MA 02543 USA	University of Miami; Lehigh University; Marine Biological Laboratory - Woods Hole	Verde, F (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol R 189, POB 016189, Miami, FL 33101 USA.	fverde@med.miami.edu	Buchwald, Peter/G-4275-2010	Buchwald, Peter/0000-0003-2732-8180; Das, Maitreyi/0000-0001-9164-0158	NSF [0745129]; NIH [1R01GM095867, R21GM083928]; University of Miami NSF ADVANCE award [0820128]; Lehigh University; Sigma Xi; Div Of Molecular and Cellular Bioscience [0745129] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R21GM083928, R01GM095867] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Miami NSF ADVANCE award; Lehigh University; Sigma Xi; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Karsenti, C. Luetje, S. Lemmon, G. D'Urso, and T. K. Harris for critically reading the manuscript; M. Ioannidou and K. Zhang for help with data analysis; B. Skibbens and Yi Hu for facilitating experiments; and K. Shiozaki, P. Perez, and S. Martin for various strains. This work was supported by NSF grant 0745129, NIH grant 1R01GM095867, and a University of Miami NSF ADVANCE award 0820128 to F. V., and by NIH grant R21GM083928 and a Lehigh University Class of 68 Faculty Fellowship to D. V. T. D. was supported by a Sigma Xi grant-in-aid and as a Graduate Assistance in Areas of National Need Fellow through the U. S. Department of Education.	Chang E, 1999, MOL CELL BIOL, V19, P8066; CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5; Coll PM, 2003, MOL BIOL CELL, V14, P313, DOI 10.1091/mbc.E02-07-0400; Csikasz-Nagy A, 2008, YEAST, V25, P59, DOI 10.1002/yea.1571; Das M, 2007, MOL BIOL CELL, V18, P2090, DOI 10.1091/mbc.E06-09-0883; Endo M, 2003, J BIOL CHEM, V278, P843, DOI 10.1074/jbc.M209714200; FANTES P, 1979, NATURE, V279, P428, DOI 10.1038/279428a0; Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Howell AS, 2009, CELL, V139, P731, DOI 10.1016/j.cell.2009.10.024; Irazoqui JE, 2003, NAT CELL BIOL, V5, P1062, DOI 10.1038/ncb1068; Karsenti E, 2008, NAT REV MOL CELL BIO, V9, P255, DOI 10.1038/nrm2357; Kelly FD, 2011, MOL BIOL CELL, V22, P3801, DOI 10.1091/mbc.E11-01-0057; Kozubowski L, 2008, CURR BIOL, V18, P1719, DOI 10.1016/j.cub.2008.09.060; MARCUS S, 1995, P NATL ACAD SCI USA, V92, P6180, DOI 10.1073/pnas.92.13.6180; Martin SG, 2007, MOL BIOL CELL, V18, P4155, DOI 10.1091/mbc.E07-02-0094; Mata J, 1997, CELL, V89, P939, DOI 10.1016/S0092-8674(00)80279-2; Meinhardt H, 2001, P NATL ACAD SCI USA, V98, P14202, DOI 10.1073/pnas.251216598; MITCHISON JM, 1985, J CELL SCI, V75, P357; OTTILIE S, 1995, EMBO J, V14, P5908, DOI 10.1002/j.1460-2075.1995.tb00278.x; Ozbudak EM, 2005, DEV CELL, V9, P565, DOI 10.1016/j.devcel.2005.08.014; Perez P, 2010, BIOCHEM J, V426, P243, DOI 10.1042/BJ20091823; Rupes I, 1999, MOL BIOL CELL, V10, P1495, DOI 10.1091/mbc.10.5.1495; Slaughter BD, 2009, DEV CELL, V17, P823, DOI 10.1016/j.devcel.2009.10.022; Tatebe H, 2008, CURR BIOL, V18, P322, DOI 10.1016/j.cub.2008.02.005; Verde F, 1998, P NATL ACAD SCI USA, V95, P7526, DOI 10.1073/pnas.95.13.7526; Wedlich-Soldner R, 2004, J CELL BIOL, V166, P889, DOI 10.1083/jcb.200405061; Wheatley E, 2005, BIOCHEM J, V388, P177, DOI 10.1042/BJ20041838	28	104	104	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 13	2012	337	6091					239	243		10.1126/science.1218377	http://dx.doi.org/10.1126/science.1218377			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	973AN	22604726	Green Accepted			2022-12-24	WOS:000306323500060
J	Bricker, DK; Taylor, EB; Schell, JC; Orsak, T; Boutron, A; Chen, YC; Cox, JE; Cardon, CM; Van Vranken, JG; Dephoure, N; Redin, C; Boudina, S; Gygi, SP; Brivet, M; Thummel, CS; Rutter, J				Bricker, Daniel K.; Taylor, Eric B.; Schell, John C.; Orsak, Thomas; Boutron, Audrey; Chen, Yu-Chan; Cox, James E.; Cardon, Caleb M.; Van Vranken, Jonathan G.; Dephoure, Noah; Redin, Claire; Boudina, Sihem; Gygi, Steven P.; Brivet, Michele; Thummel, Carl S.; Rutter, Jared			A Mitochondrial Pyruvate Carrier Required for Pyruvate Uptake in Yeast, Drosophila, and Humans	SCIENCE			English	Article							RAT-LIVER; IDENTIFICATION; TRANSPORT; MECHANISM; COMPLEX	Pyruvate constitutes a critical branch point in cellular carbon metabolism. We have identified two proteins, Mpc1 and Mpc2, as essential for mitochondrial pyruvate transport in yeast, Drosophila, and humans. Mpc1 and Mpc2 associate to form an similar to 150-kilodalton complex in the inner mitochondrial membrane. Yeast and Drosophila mutants lacking MPC1 display impaired pyruvate metabolism, with an accumulation of upstream metabolites and a depletion of tricarboxylic acid cycle intermediates. Loss of yeast Mpc1 results in defective mitochondrial pyruvate uptake, and silencing of MPC1 or MPC2 in mammalian cells impairs pyruvate oxidation. A point mutation in MPC1 provides resistance to a known inhibitor of the mitochondrial pyruvate carrier. Human genetic studies of three families with children suffering from lactic acidosis and hyperpyruvatemia revealed a causal locus that mapped to MPC1, changing single amino acids that are conserved throughout eukaryotes. These data demonstrate that Mpc1 and Mpc2 form an essential part of the mitochondrial pyruvate carrier.	[Taylor, Eric B.; Schell, John C.; Orsak, Thomas; Chen, Yu-Chan; Cardon, Caleb M.; Van Vranken, Jonathan G.; Rutter, Jared] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Bricker, Daniel K.; Thummel, Carl S.] Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA; [Boutron, Audrey; Brivet, Michele] Hop Bicetre, AP HP, Biochim Lab, Le Kremlin Bicetre, France; [Dephoure, Noah; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Redin, Claire] IGBMC, Strasbourg, France; [Boudina, Sihem] Univ Utah, Sch Med, Dept Med, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Harvard University; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Utah System of Higher Education; University of Utah	Rutter, J (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	rutter@biochem.utah.edu	Dephoure, Noah/N-7818-2014	Dephoure, Noah/0000-0001-5802-2657; Taylor, Eric/0000-0003-4549-6567	NIH [R01GM083746, RC1DK086426, R24DK092784, T32GM007464, K99AR059190];  [P30DK072437]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR059190] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071962, R24DK092784, P30DK072437, RC1DK086426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464, R01GM094232, R01GM087346] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Rutter, Thummel, Winge, Stillman, Shaw, and Metzstein laboratories for helpful discussions. We thank the Shaw and Winge labs for the antibodies against Fzo1, Cyb2, and Mge1 and for the mito-RFP constructs. We thank J. M. Saudubray, L. Burglen, and H. Tevissen for referring patients and C. Thibault and J. L. Mandel (IGBMC, Strasbourg, France) for assistance in single-nucleotide polymorphism array hybridization. This research was supported by NIH grants R01GM083746 (J. R.), RC1DK086426 (C. S. T.), and R24DK092784 (J. R. and C. S. T.) and a pilot grant from P30DK072437 (J. R.). D. K. B. and C. M. C. were supported by the NIH Genetics Predoctoral Training Grant T32GM007464. E. B. T. was supported by NIH Pathway to Independence award K99AR059190. D. K. B., T.O., C. S. T., and J. R. are inventors on a patent application by the University of Utah covering the discovery of the MPC complex.	Boles E, 1998, J BACTERIOL, V180, P2875, DOI 10.1128/JB.180.11.2875-2882.1998; Brivet M, 2003, MOL GENET METAB, V78, P186, DOI 10.1016/S1096-7192(03)00016-7; DESTEENSMA HY, 1990, EUR J BIOCHEM, V191, P769, DOI 10.1111/j.1432-1033.1990.tb19186.x; HALESTRAP AP, 1974, BIOCHEM J, V138, P313, DOI 10.1042/bj1380313; HALESTRAP AP, 1975, BIOCHEM J, V148, P85, DOI 10.1042/bj1480085; HALESTRAP AP, 1978, BIOCHEM J, V172, P377, DOI 10.1042/bj1720377; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hildyard JCW, 2003, BIOCHEM J, V374, P607, DOI 10.1042/BJ20030995; Jiang MR, 2009, MOL BIOL REP, V36, P215, DOI 10.1007/s11033-007-9169-0; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; PAPA S, 1974, EUR J BIOCHEM, V49, P265, DOI 10.1111/j.1432-1033.1974.tb03831.x; ROGNSTAD R, 1983, INT J BIOCHEM, V15, P1417, DOI 10.1016/0020-711X(83)90073-3; Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100; THOMAS AP, 1981, BIOCHEM J, V196, P471, DOI 10.1042/bj1960471; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; ZWIEBEL FM, 1982, BIOCHEMISTRY-US, V21, P346, DOI 10.1021/bi00531a023	19	514	545	7	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 6	2012	337	6090					96	100		10.1126/science.1218099	http://dx.doi.org/10.1126/science.1218099			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	969KC	22628558	Green Accepted			2022-12-24	WOS:000306053100052
J	Dai, L; Vorselen, D; Korolev, KS; Gore, J				Dai, Lei; Vorselen, Daan; Korolev, Kirill S.; Gore, Jeff			Generic Indicators for Loss of Resilience Before a Tipping Point Leading to Population Collapse	SCIENCE			English	Article							EARLY-WARNING SIGNALS; REGIME SHIFTS; THRESHOLDS; ECOSYSTEMS; RECOVERY; CONSEQUENCES; TRANSITIONS; EXTINCTION; MANAGEMENT; DYNAMICS	Theory predicts that the approach of catastrophic thresholds in natural systems (e. g., ecosystems, the climate) may result in an increasingly slow recovery from small perturbations, a phenomenon called critical slowing down. We used replicate laboratory populations of the budding yeast Saccharomyces cerevisiae for direct observation of critical slowing down before population collapse. We mapped the bifurcation diagram experimentally and found that the populations became more vulnerable to disturbance closer to the tipping point. Fluctuations of population density increased in size and duration near the tipping point, in agreement with the theory. Our results suggest that indicators of critical slowing down can provide advance warning of catastrophic thresholds and loss of resilience in a variety of dynamical systems.	[Dai, Lei; Korolev, Kirill S.; Gore, Jeff] MIT, Dept Phys, Cambridge, MA 02139 USA; [Vorselen, Daan] Vrije Univ Amsterdam, Dept Phys & Astron, NL-1081 HV Amsterdam, Netherlands	Massachusetts Institute of Technology (MIT); Vrije Universiteit Amsterdam	Gore, J (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	gore@mit.edu	Korolev, Kirill/J-7957-2012		Pappalardo Fellowship; NIH; NSF; Sloan Research Fellowship; Pew Scholars Program; NATIONAL INSTITUTE ON AGING [DP2AG044279] Funding Source: NIH RePORTER	Pappalardo Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Sloan Research Fellowship(Alfred P. Sloan Foundation); Pew Scholars Program; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Gore lab for valuable suggestions on the manuscript. Supported by a Pappalardo Fellowship (K. S. K.), an NIH R00 Pathways to Independence Award, an NSF CAREER Award, a Sloan Research Fellowship, and the Pew Scholars Program. The data reported in this paper are deposited in the Dryad Repository (http://dx.doi.org/10.5061/dryad.p2481134).	Allee W., 1949, PRINCIPLES ANIMAL EC; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Carpenter SR, 2006, ECOL LETT, V9, P308, DOI 10.1111/j.1461-0248.2005.00877.x; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; Courchamp F, 1999, TRENDS ECOL EVOL, V14, P405, DOI 10.1016/S0169-5347(99)01683-3; Dakos V, 2008, P NATL ACAD SCI USA, V105, P14308, DOI 10.1073/pnas.0802430105; Drake JM, 2010, NATURE, V467, P456, DOI 10.1038/nature09389; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Frank KT, 2011, NATURE, V477, P86, DOI 10.1038/nature10285; Gore J, 2009, NATURE, V459, P253, DOI 10.1038/nature07921; Groffman P, 2006, ECOSYSTEMS, V9, P1, DOI 10.1007/s10021-003-0142-z; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Hastings A, 2010, ECOL LETT, V13, P464, DOI 10.1111/j.1461-0248.2010.01439.x; Hines P. D. H., 2011, 2011 44 HAW INT C SY, P1, DOI DOI 10.1109/HICSS.2011.444; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Hutchings JA, 2004, BIOSCIENCE, V54, P297, DOI 10.1641/0006-3568(2004)054[0297:MFPCCF]2.0.CO;2; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lenton TM, 2011, NAT CLIM CHANGE, V1, P201, DOI [10.1038/NCLIMATE1143, 10.1038/NCLIMATE143]; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M., 2009, CRITICAL TRANSITIONS; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; SCHOLZ JP, 1987, PHYS LETT A, V123, P390, DOI 10.1016/0375-9601(87)90038-7; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; van Nes EH, 2007, AM NAT, V169, P738, DOI 10.1086/516845; Veraart AJ, 2012, NATURE, V481, P357, DOI 10.1038/nature10723; WISSEL C, 1984, OECOLOGIA, V65, P101, DOI 10.1007/BF00384470	29	393	403	16	258	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	2012	336	6085					1175	1177		10.1126/science.1219805	http://dx.doi.org/10.1126/science.1219805			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	950KK	22654061				2022-12-24	WOS:000304647900054
J	Nik-Zainal, S; Van Loo, P; Wedge, DC; Alexandrov, LB; Greenman, CD; Lau, KW; Raine, K; Jones, D; Marshall, J; Ramakrishna, M; Shlien, A; Cooke, SL; Hinton, J; Menzies, A; Stebbings, LA; Leroy, C; Jia, MM; Rance, R; Mudie, LJ; Gamble, SJ; Stephens, PJ; McLaren, S; Tarpey, PS; Papaemmanuil, E; Davies, HR; Varela, I; McBride, DJ; Bignell, GR; Leung, K; Butler, AP; Teague, JW; Martin, S; Jonsson, G; Mariani, O; Boyault, S; Miron, P; Fatima, A; Langerod, A; Aparicio, SAJR; Tutt, A; Sieuwerts, AM; Borg, A; Thomas, G; Salomon, AV; Richardson, AL; Borresen-Dale, AL; Futreal, PA; Stratton, MR; Campbell, PJ				Nik-Zainal, Serena; Van Loo, Peter; Wedge, David C.; Alexandrov, Ludmil B.; Greenman, Christopher D.; Lau, King Wai; Raine, Keiran; Jones, David; Marshall, John; Ramakrishna, Manasa; Shlien, Adam; Cooke, Susanna L.; Hinton, Jonathan; Menzies, Andrew; Stebbings, Lucy A.; Leroy, Catherine; Jia, Mingming; Rance, Richard; Mudie, Laura J.; Gamble, Stephen J.; Stephens, Philip J.; McLaren, Stuart; Tarpey, Patrick S.; Papaemmanuil, Elli; Davies, Helen R.; Varela, Ignacio; McBride, David J.; Bignell, Graham R.; Leung, Kenric; Butler, Adam P.; Teague, Jon W.; Martin, Sancha; Joensson, Goran; Mariani, Odette; Boyault, Sandrine; Miron, Penelope; Fatima, Aquila; Langerod, Anita; Aparicio, Samuel A. J. R.; Tutt, Andrew; Sieuwerts, Anieta M.; Borg, Ake; Thomas, Gilles; Salomon, Anne Vincent; Richardson, Andrea L.; Borresen-Dale, Anne-Lise; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.		Int Canc Genome Consortium	The Life History of 21 Breast Cancers	CELL			English	Article							GENOMIC REARRANGEMENT; EVOLUTION; MUTATIONS; PATTERNS; INSTABILITY; METASTASIS; SIGNATURES	Cancer evolves dynamically as clonal expansions supersede one another driven by shifting selective pressures, mutational processes, and disrupted cancer genes. These processes mark the genome, such that a cancer's life history is encrypted in the somatic mutations present. We developed algorithms to decipher this narrative and applied them to 21 breast cancers. Mutational processes evolve across a cancer's lifespan, with many emerging late but contributing extensive genetic variation. Subclonal diversification is prominent, and most mutations are found in just a fraction of tumor cells. Every tumor has a dominant subclonal lineage, representing more than 50% of tumor cells. Minimal expansion of these subclones occurs until many hundreds to thousands of mutations have accumulated, implying the existence of long-lived, quiescent cell lineages capable of substantial proliferation upon acquisition of enabling genomic changes. Expansion of the dominant subclone to an appreciable mass may therefore represent the final rate-limiting step in a breast cancer's development, triggering diagnosis.	[Nik-Zainal, Serena; Van Loo, Peter; Wedge, David C.; Alexandrov, Ludmil B.; Greenman, Christopher D.; Lau, King Wai; Raine, Keiran; Jones, David; Marshall, John; Ramakrishna, Manasa; Shlien, Adam; Cooke, Susanna L.; Hinton, Jonathan; Menzies, Andrew; Stebbings, Lucy A.; Leroy, Catherine; Jia, Mingming; Rance, Richard; Mudie, Laura J.; Gamble, Stephen J.; Stephens, Philip J.; McLaren, Stuart; Tarpey, Patrick S.; Papaemmanuil, Elli; Davies, Helen R.; Varela, Ignacio; McBride, David J.; Bignell, Graham R.; Leung, Kenric; Butler, Adam P.; Teague, Jon W.; Martin, Sancha; Futreal, P. Andrew; Stratton, Michael R.; Campbell, Peter J.] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Van Loo, Peter] VIB, Ctr Biol Dis, B-3000 Louvain, Belgium; [Van Loo, Peter] Katholieke Univ Leuven, Dept Human Genet, B-3000 Louvain, Belgium; [Greenman, Christopher D.] Univ E Anglia, Dept Comp, Norwich NR4 7TJ, Norfolk, England; [Greenman, Christopher D.] Genome Anal Ctr, Norwich NR4 7UH, Norfolk, England; [Joensson, Goran; Tutt, Andrew] Kings Coll London, Breakthrough Breast Canc Res Unit, London SE1 9RT, England; [Mariani, Odette; Salomon, Anne Vincent] Inst Curie, Dept Tumor Biol, F-75248 Paris 05, France; [Boyault, Sandrine; Thomas, Gilles] Univ Lyon 1, Ctr Leon Berard, INCa Synergie, Lyon 08, France; [Miron, Penelope; Fatima, Aquila; Richardson, Andrea L.] Dana Farber Canc Inst, Boston, MA 02215 USA; [Langerod, Anita; Borresen-Dale, Anne-Lise] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Aparicio, Samuel A. J. R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V6T 2B5, Canada; [Aparicio, Samuel A. J. R.] British Columbia Canc Res Ctr, Vancouver, BC V5Z 1L3, Canada; [Sieuwerts, Anieta M.] Erasmus MC, NL-3000 CA Rotterdam, Netherlands; [Borg, Ake] Lund Univ, Dept Oncol, SE-22184 Lund, Sweden; [Richardson, Andrea L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA; [Borresen-Dale, Anne-Lise] Univ Oslo, Fac Med, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, N-0310 Oslo, Norway; [Campbell, Peter J.] Addenbrookes Hosp, Dept Haematol, Cambridge CB2 0QQ, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; Flanders Institute for Biotechnology (VIB); KU Leuven; University of East Anglia; The Genome Analysis Centre (TGAC); University of London; King's College London; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National du Cancer (INCA) France; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UNICANCER; Centre Leon Berard; Harvard University; Dana-Farber Cancer Institute; University of Oslo; University of British Columbia; British Columbia Cancer Agency; Erasmus University Rotterdam; Erasmus MC; Lund University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	pc8@sanger.ac.uk	Alexandrov, Ludmil/AAS-1454-2021; Jönsson, Göran/D-1212-2014; Van Loo, Peter/A-3287-2012; Alexandrov, Ludmil/B-6582-2014; Wedge, David/AAC-4977-2021; Varela, Ignacio/AAA-7680-2021; Varela, Ignacio/G-1699-2016; Nik-Zainal, Serena/ABD-4437-2020; Gamble, Stephen/D-1417-2011	Alexandrov, Ludmil/0000-0003-3596-4515; Alexandrov, Ludmil/0000-0003-3596-4515; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Gamble, Stephen/0000-0002-0867-3723; Wedge, David/0000-0002-7572-3196; Nik-Zainal, Serena/0000-0001-5054-1727; Van Loo, Peter/0000-0003-0292-1949; Raine, Keiran/0000-0002-5634-1539; Martin, Sancha/0000-0001-6213-5259; Aparicio, Samuel/0000-0002-0487-9599; Tutt, Andrew/0000-0001-8715-2901	Wellcome Trust [098051]; Breakthrough Breast Cancer Research [ICGC 08/09]; National Research Council Canada; EMBO; International Human Frontier Science Program Organization; Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO); Norwegian Research Council; Norwegian Cancer Society; Radium Hospital Foundation; Health Region South-East; European Community [242006]; National Cancer Institute Specialized Program Of Research Excellence [CA089393]; Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre; St Thomas' NHS Foundation Trust; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Breakthrough Breast Cancer Research; National Research Council Canada; EMBO(European Molecular Biology Organization (EMBO)); International Human Frontier Science Program Organization(Human Frontier Science Program); Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); Radium Hospital Foundation; Health Region South-East; European Community(European Commission); National Cancer Institute Specialized Program Of Research Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Wellcome Trust (grant reference 098051) and Breakthrough Breast Cancer Research (ICGC 08/09). S. N.-Z. is a Wellcome Trust Clinical Research Training Fellow. P.J.C. is a Wellcome Trust Senior Clinical Research Fellow (WT088340MA). P.V.L. is a postdoctoral researcher of the Research Foundation-Flanders. A.S. is supported by the HL Holmes Award from the National Research Council Canada and a Fellowship from EMBO. I.V. is supported by a fellowship from the International Human Frontier Science Program Organization. J.W.M.M. is funded in part by a research grant from the Netherlands Genomics Initiative (NGI)/Netherlands Organization for Scientific Research (NWO). A.-L.B.-D. and A.L. are funded by the Norwegian Research Council, Norwegian Cancer Society, Radium Hospital Foundation and Health Region South-East. S. M. is funded by the BASIS project through the European Community's FP7/2010-2014 under grant agreement 242006. We acknowledge the Core Sequencing Facility and IT groups of the Wellcome Trust Sanger Institute, support for samples, sample banking, and processing from the Breakthrough Breast Cancer Unit, members of the ICGC Breast Cancer Working Group, the Pathology Review subgroup of the Breast Cancer Working Group, the OSBREAC Consortium of The Oslo University Hospital and the National Cancer Institute Specialized Program Of Research Excellence (grant reference CA089393). We also acknowledge Dr. Peter Watson, the BCCA Tumour Tissue Repository, and the Centre for Translational Genomics. The authors acknowledge financial support from the Department of Health via the National Institute for Health Research comprehensive Biomedical Research Centre award to Guy's and St Thomas' NHS Foundation Trust.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Burrell RA, 2010, J CELL BIOCHEM, V111, P782, DOI 10.1002/jcb.22781; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dunson D. B., 2010, BAYESIAN NONPARAMETR; Greenman CD, 2012, GENOME RES, V22, P346, DOI 10.1101/gr.118414.110; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hornsby C, 2007, LANCET ONCOL, V8, P1030, DOI 10.1016/S1470-2045(07)70343-1; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Navin N, 2011, NATURE, V472, P90, DOI 10.1038/nature09807; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; O'Hagan RC, 2002, CANCER CELL, V2, P149, DOI 10.1016/S1535-6108(02)00094-6; Papaemmanuil E, 2011, NEW ENGL J MED, V365, P1384, DOI 10.1056/NEJMoa1103283; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515	34	910	931	2	105	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 25	2012	149	5								10.1016/j.cell.2012.04.023	http://dx.doi.org/10.1016/j.cell.2012.04.023			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	947TN	22608083	Green Published, Green Submitted, Green Accepted, hybrid			2022-12-24	WOS:000304453900007
J	Talkowski, ME; Rosenfeld, JA; Blumenthal, I; Pillalamarri, V; Chiang, C; Heilbut, A; Ernst, C; Hanscom, C; Rossin, E; Lindgren, AM; Pereira, S; Ruderfer, D; Kirby, A; Ripke, S; Harris, DJ; Lee, JH; Ha, K; Kim, HG; Solomon, BD; Gropman, AL; Lucente, D; Sims, K; Ohsumi, TK; Borowsky, ML; Loranger, S; Quade, B; Lage, K; Miles, J; Wu, BL; Shen, YP; Neale, B; Shaffer, LG; Daly, MJ; Morton, CC; Gusella, JF				Talkowski, Michael E.; Rosenfeld, Jill A.; Blumenthal, Ian; Pillalamarri, Vamsee; Chiang, Colby; Heilbut, Adrian; Ernst, Carl; Hanscom, Carrie; Rossin, Elizabeth; Lindgren, Amelia M.; Pereira, Shahrin; Ruderfer, Douglas; Kirby, Andrew; Ripke, Stephan; Harris, David J.; Lee, Ji-Hyun; Ha, Kyungsoo; Kim, Hyung-Goo; Solomon, Benjamin D.; Gropman, Andrea L.; Lucente, Diane; Sims, Katherine; Ohsumi, Toshiro K.; Borowsky, Mark L.; Loranger, Stephanie; Quade, Bradley; Lage, Kasper; Miles, Judith; Wu, Bai-Lin; Shen, Yiping; Neale, Benjamin; Shaffer, Lisa G.; Daly, Mark J.; Morton, Cynthia C.; Gusella, James F.			Sequencing Chromosomal Abnormalities Reveals Neurodevelopmental Loci that Confer Risk across Diagnostic Boundaries	CELL			English	Article							AUTISM SPECTRUM DISORDERS; PITT-HOPKINS-SYNDROME; CHROMATIN REMODELING FACTOR; GENOME-WIDE ASSOCIATION; MICRODELETION SYNDROME; DEVELOPMENTAL DELAY; SUSCEPTIBILITY LOCI; BIPOLAR DISORDER; CHD8 INTERACTS; SCHIZOPHRENIA	Balanced chromosomal abnormalities (BCAs) represent a relatively untapped reservoir of single-gene disruptions in neurodevelopmental disorders (NDDs). We sequenced BCAs in patients with autism or related NDDs, revealing disruption of 33 loci in four general categories: (1) genes previously associated with abnormal neurodevelopment (e. g., AUTS2, FOXP1, and CDKL5), (2) single-gene contributors to microdeletion syndromes (MBD5, SATB2, EHMT1, and SNURF-SNRPN), (3) novel risk loci (e. g., CHD8, KIRREL3, and ZNF507), and (4) genes associated with later-onset psychiatric disorders (e. g., TCF4, ZNF804A, PDE10A, GRIN2B, and ANK3). We also discovered among neurodevelopmental cases a profoundly increased burden of copy-number variants from these 33 loci and a significant enrichment of polygenic risk alleles from genome-wide association studies of autism and schizophrenia. Our findings suggest a polygenic risk model of autism and reveal that some neurodevelopmental genes are sensitive to perturbation by multiple mutational mechanisms, leading to variable phenotypic outcomes that manifest at different life stages.	[Talkowski, Michael E.; Blumenthal, Ian; Pillalamarri, Vamsee; Chiang, Colby; Heilbut, Adrian; Ernst, Carl; Hanscom, Carrie; Rossin, Elizabeth; Ruderfer, Douglas; Kirby, Andrew; Ripke, Stephan; Lee, Ji-Hyun; Lucente, Diane; Sims, Katherine; Shen, Yiping; Neale, Benjamin; Daly, Mark J.; Gusella, James F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Rossin, Elizabeth; Kirby, Andrew; Ripke, Stephan; Lage, Kasper; Neale, Benjamin; Daly, Mark J.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Ohsumi, Toshiro K.; Borowsky, Mark L.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Quade, Bradley; Wu, Bai-Lin; Shen, Yiping; Morton, Cynthia C.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Talkowski, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gusella, James F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Talkowski, Michael E.; Rossin, Elizabeth; Ruderfer, Douglas; Kirby, Andrew; Ripke, Stephan; Lage, Kasper; Neale, Benjamin; Daly, Mark J.; Morton, Cynthia C.; Gusella, James F.] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02143 USA; [Rosenfeld, Jill A.; Shaffer, Lisa G.] PerkinElmer Inc, Signature Genom Labs, Spokane, WA 99207 USA; [Lindgren, Amelia M.; Pereira, Shahrin; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Obstet, Boston, MA 02115 USA; [Lindgren, Amelia M.; Pereira, Shahrin; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Gynecol, Boston, MA 02115 USA; [Lindgren, Amelia M.; Pereira, Shahrin; Morton, Cynthia C.] Brigham & Womens Hosp, Dept Reprod Biol, Boston, MA 02115 USA; [Harris, David J.] Childrens Hosp Boston, Div Clin Genet, Boston, MA 02115 USA; [Wu, Bai-Lin; Shen, Yiping] Childrens Hosp Boston, Dept Lab Med, Boston, MA 02115 USA; [Ha, Kyungsoo] Georgia Hlth Sci Univ, Canc Res Ctr, Augusta, GA 30912 USA; [Kim, Hyung-Goo] Georgia Hlth Sci Univ, Inst Mol Med & Genet, Dept Obstet & Gynecol, Augusta, GA 30912 USA; [Solomon, Benjamin D.] NHGRI, Med Genet Branch, Bethesda, MD 20892 USA; [Gropman, Andrea L.] Childrens Natl Med Ctr, Dept Neurol, Washington, DC 20010 USA; [Gropman, Andrea L.] George Washington Univ Hlth Sci, Dept Neurol, Washington, DC 20052 USA; [Loranger, Stephanie; Daly, Mark J.; Gusella, James F.] Autism Consortium Boston, Boston, MA 02115 USA; [Lage, Kasper] Massachusetts Gen Hosp, MassGen Hosp Children, Pediat Surg Res Labs, Boston, MA 02114 USA; [Lage, Kasper] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Lage, Kasper] Univ Copenhagen, Ctr Prot Res, DK-1165 Copenhagen, Denmark; [Miles, Judith] Univ Missouri Hosp & Clin, Thompson Ctr Autism & Neurodev Disorders, Dept Pediat, Columbia, MO 65201 USA; [Miles, Judith] Univ Missouri Hosp & Clin, Thompson Ctr Autism & Neurodev Disorders, Dept Med Genet, Columbia, MO 65201 USA; [Miles, Judith] Univ Missouri Hosp & Clin, Thompson Ctr Autism & Neurodev Disorders, Dept Pathol, Columbia, MO 65201 USA; [Wu, Bai-Lin] Fudan Univ, Childrens Hosp, Shanghai 200032, Peoples R China; [Wu, Bai-Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Shen, Yiping] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200025, Peoples R China	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University System of Georgia; Augusta University; University System of Georgia; Augusta University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Children's National Health System; George Washington University; Harvard University; Massachusetts General Hospital; Technical University of Denmark; University of Copenhagen; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Fudan University; Fudan University; Shanghai Jiao Tong University	Gusella, JF (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	gusella@helix.mgh.harvard.edu	Heilbut, Adrian M/J-9427-2012; Daly, Mark J/B-2453-2017; Ripke, Stephan/AAK-5486-2021; Ruderfer, Douglas M/M-5795-2016	Heilbut, Adrian M/0000-0002-8169-7967; Daly, Mark J/0000-0002-0949-8752; Ruderfer, Douglas M/0000-0002-2365-386X; Chiang, Colby/0000-0002-4113-6065; Talkowski, Michael/0000-0003-2889-0992; ripke, stephan/0000-0003-3622-835X	National Institutes of Health [GM061354, HD065286]; Simons Foundation Autism Research Initiative; Autism Speaks; Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health and Human Services; National Institute of Mental Health National Research Service [MH087123]; Massachusetts General Hospital Executive Committee; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD065286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753, P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH087123, R00MH095867] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; Autism Speaks; Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health and Human Services; National Institute of Mental Health National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Massachusetts General Hospital Executive Committee; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to all participating subjects and families and to the many healthcare professionals who have contributed to this study, including Mary-Alice Abbott, Darius J. Adams, Kwame Anyane-Yeboa, Stephen G. Bamforth, Tina Bartell, David P. Bick, Joann N. Bodurtha, Carol Clericuzio, Stephanie Cohen, Kristin Dalton, Maria Descartes, Joanne Milisa Drautz, Dawn L. Earl, Luis F. Escobar, Shannon Gerner, Edwin Guzman, Kenneth Handelman, Tim Heshka, Robert J. Hopkin, Micheil Innes, Debby Lambert, Emmanuelle Lemyre, Cynthia Lim, Livija Medne, Graciela Moya, Katie Rutledge, Wendy Smith, Mark Stephan, Darci Sternen, Katie Stoll, Paulien van Galen, Nancy J. Van Vranken, Erica Wahl, Susan E. Wiley, Amy L. White, Anne Woods, and Elaine H. Zackai. The invaluable control data for this study were provided by Pamela Sklar, Shaun Purcell, the International Schizophrenia Consortium, the Wellcome Trust Case Control Consortium, Evan Eichler, Bradley Coe, and Greg Cooper. We thank Tammy Gillis, Mary Anne Anderson, Jayla Ruliera, and Thon de Boer for technical assistance. We also thank Dennis Gurgul, Nilay Roy, and Brent Richter of Partners Research Computing at Massachusetts General Hospital, and contributing staff from Signature Genomic Laboratories and Children's Hospital Boston. This work was funded by grants GM061354 and HD065286 from the National Institutes of Health, the Simons Foundation Autism Research Initiative, and Autism Speaks. This research was also supported by the Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health and Human Services. M. T. was supported by a National Institute of Mental Health National Research Service Award (MH087123) and an Massachusetts General Hospital Executive Committee on Research Fund for Medical Discovery Award. L. G. S. and J. A. R. are employees of Signature Genomic Laboratories, PerkinElmer.	Amiel J, 2007, AM J HUM GENET, V80, P988, DOI 10.1086/515582; Bakkaloglu B, 2008, AM J HUM GENET, V82, P165, DOI 10.1016/j.ajhg.2007.09.017; Batsukh T, 2010, HUM MOL GENET, V19, P2858, DOI 10.1093/hmg/ddq189; Blake DJ, 2010, SCHIZOPHRENIA BULL, V36, P443, DOI 10.1093/schbul/sbq035; Chiang C, 2012, NAT GENET, V44, P390, DOI 10.1038/ng.2202; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Cooper GM, 2011, NAT GENET, V43, P838, DOI 10.1038/ng.909; Endele S, 2010, NAT GENET, V42, P1021, DOI 10.1038/ng.677; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Higgins AW, 2008, AM J HUM GENET, V82, P712, DOI 10.1016/j.ajhg.2008.01.011; Kehler J, 2011, CURR PHARM DESIGN, V17, P137, DOI 10.2174/138161211795049624; Kirov G, 2012, MOL PSYCHIATR, V17, P142, DOI 10.1038/mp.2011.154; Kleefstra T, 2006, AM J HUM GENET, V79, P370, DOI 10.1086/505693; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Lakics V, 2010, NEUROPHARMACOLOGY, V59, P367, DOI 10.1016/j.neuropharm.2010.05.004; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Meerabux JMA, 2009, J HUM GENET, V54, P386, DOI 10.1038/jhg.2009.47; Morikawa Y, 2007, NEUROSCIENCE, V150, P880, DOI 10.1016/j.neuroscience.2007.10.013; MURRAY RM, 1987, BRIT MED J, V295, P681, DOI 10.1136/bmj.295.6600.681; Nishiyama M, 2009, NAT CELL BIOL, V11, P172, DOI 10.1038/ncb1831; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Owen MJ, 2011, BRIT J PSYCHIAT, V198, P173, DOI 10.1192/bjp.bp.110.084384; Ravel C, 2006, HUM REPROD, V21, P1484, DOI 10.1093/humrep/del024; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rodriguez-Paredes M, 2009, NUCLEIC ACIDS RES, V37, P2449, DOI 10.1093/nar/gkp101; Rosenfeld JA, 2010, GENET MED, V12, P694, DOI 10.1097/GIM.0b013e3181f0c5f3; Rosenfeld JA, 2009, GENET MED, V11, P797, DOI 10.1097/GIM.0b013e3181bd38a9; Rosenfeld JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006568; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Serizawa S, 2006, CELL, V127, P1057, DOI 10.1016/j.cell.2006.10.031; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Sultana R, 2002, GENOMICS, V80, P129, DOI 10.1006/geno.2002.6810; Talkowski ME, 2011, AM J HUM GENET, V89, P551, DOI 10.1016/j.ajhg.2011.09.011; Talkowski ME, 2011, AM J HUM GENET, V88, P469, DOI 10.1016/j.ajhg.2011.03.013; Tamura S, 2005, NEUROSCIENCE, V133, P615, DOI 10.1016/j.neuroscience.2005.03.030; Thompson BA, 2008, MOL CELL BIOL, V28, P3894, DOI 10.1128/MCB.00322-08; Walters JTR, 2010, ARCH GEN PSYCHIAT, V67, P692, DOI 10.1001/archgenpsychiatry.2010.81; Wang K, 2009, NATURE, V459, P528, DOI 10.1038/nature07999; Weinberger DR, 1986, NEUROLOGY SCHIZOPHRE, P387; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Weiss LA, 2009, NATURE, V461, P802, DOI 10.1038/nature08490; Williams HJ, 2011, HUM MOL GENET, V20, P387, DOI 10.1093/hmg/ddq471; Zahir F, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050823	45	392	412	0	61	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3								10.1016/j.cell.2012.03.028	http://dx.doi.org/10.1016/j.cell.2012.03.028			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22521361	Green Accepted, Bronze			2022-12-24	WOS:000303443100006
J	Duncan, JS; Whittle, MC; Nakamura, K; Abell, AN; Midland, AA; Zawistowski, JS; Johnson, NL; Granger, DA; Jordan, NV; Darr, DB; Usary, J; Kuan, PF; Smalley, DM; Major, B; He, XP; Hoadley, KA; Zhou, B; Sharpless, NE; Perou, CM; Kim, WY; Gomez, SM; Chen, X; Jin, J; Frye, SV; Earp, HS; Graves, LM; Johnson, GL				Duncan, James S.; Whittle, Martin C.; Nakamura, Kazuhiro; Abell, Amy N.; Midland, Alicia A.; Zawistowski, Jon S.; Johnson, Nancy L.; Granger, Deborah A.; Jordan, Nicole Vincent; Darr, David B.; Usary, Jerry; Kuan, Pei-Fen; Smalley, David M.; Major, Ben; He, Xiaping; Hoadley, Katherine A.; Zhou, Bing; Sharpless, Norman E.; Perou, Charles M.; Kim, William Y.; Gomez, Shawn M.; Chen, Xin; Jin, Jian; Frye, Stephen V.; Earp, H. Shelton; Graves, Lee M.; Johnson, Gary L.			Dynamic Reprogramming of the Kinome in Response to Targeted MEK Inhibition in Triple-Negative Breast Cancer	CELL			English	Article							RESISTANCE; MYC; PHOSPHORYLATION; EXPRESSION; RECEPTOR; KINASES; TRIAL; HER2	Kinase inhibitors have limited success in cancer treatment because tumors circumvent their action. Using a quantitative proteomics approach, we assessed kinome activity in response to MEK inhibition in triple-negative breast cancer (TNBC) cells and genetically engineered mice (GEMMs). MEK inhibition caused acute ERK activity loss, resulting in rapid c-Myc degradation that induced expression and activation of several receptor tyrosine kinases (RTKs). RNAi knockdown of ERK or c-Myc mimicked RTK induction by MEK inhibitors, and prevention of proteasomal c-Myc degradation blocked kinome reprogramming. MEK inhibitor-induced RTK stimulation overcame MEK2 inhibition, but not MEK1 inhibition, reactivating ERK and producing drug resistance. The C3Tag GEMM for TNBC similarly induced RTKs in response to MEK inhibition. The inhibitor-induced RTK profile suggested a kinase inhibitor combination therapy that produced GEMM tumor apoptosis and regression where single agents were ineffective. This approach defines mechanisms of drug resistance, allowing rational design of combination therapies for cancer.	[Duncan, James S.; Whittle, Martin C.; Nakamura, Kazuhiro; Abell, Amy N.; Zawistowski, Jon S.; Johnson, Nancy L.; Granger, Deborah A.; Jordan, Nicole Vincent; Smalley, David M.; Earp, H. Shelton; Graves, Lee M.; Johnson, Gary L.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Midland, Alicia A.; Gomez, Shawn M.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Darr, David B.; Usary, Jerry; He, Xiaping; Hoadley, Katherine A.; Zhou, Bing; Sharpless, Norman E.; Perou, Charles M.; Kim, William Y.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet, Chapel Hill, NC 27599 USA; [Kuan, Pei-Fen] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Biostat, Chapel Hill, NC 27599 USA; [Major, Ben] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Zhou, Bing; Sharpless, Norman E.; Kim, William Y.; Earp, H. Shelton] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Med, Chapel Hill, NC 27599 USA; [Chen, Xin; Jin, Jian; Frye, Stephen V.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Eshelman Sch Pharm, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Johnson, GL (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Pharmacol, Chapel Hill, NC 27599 USA.	glj@med.unc.edu	Perou, Charles M/H-9934-2014; Graves, Lee/AAG-5470-2021; Kuan, Pei Fen/GRX-4622-2022; zhou, bing/C-2150-2011	Perou, Charles M/0000-0001-9827-2247; Major, Michael/0000-0002-6753-8513; Sharpless, Norman/0000-0001-7078-9455; Hoadley, Katherine/0000-0002-1216-477X; Gomez, Shawn/0000-0002-8251-4552; Chen, Xin/0000-0002-5208-2154	NIH [GM30324, U54CA156735, DK37871, GM007040, CA71341]; NCI Breast SPORE [CA58223]; Breast Cancer Research Fund; University Cancer Research Fund; CIHR; High-throughput Sequencing and Proteomics Cores; NATIONAL CANCER INSTITUTE [F31CA165595, U54CA156735, T32CA071341, P30CA016086, P50CA058223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037871] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007040, R37GM030324, R01GM030324, R01GM101141] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Breast SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Fund; University Cancer Research Fund; CIHR(Canadian Institutes of Health Research (CIHR)); High-throughput Sequencing and Proteomics Cores; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM30324, U54CA156735, and DK37871, NCI Breast SPORE CA58223, Breast Cancer Research Fund, and the University Cancer Research Fund. N.V.J. and M. W. are supported by NIH training grants GM007040 and CA71341. J.D. was supported by CIHR postdoctoral fellowship. The authors also acknowledge support by the High-throughput Sequencing and Proteomics Cores. Kinome illustration reproduced courtesy of Cell Signaling Technology, Inc. (http://www.cellsignal.com).	Amin DN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000389; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; Bianchi G, 2009, ANTI-CANCER DRUG, V20, P616, DOI 10.1097/CAD.0b013e32832b2ea0; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Finn RS, 2009, J CLIN ONCOL, V27, P3908, DOI 10.1200/JCO.2008.18.1925; Garrett JT, 2011, P NATL ACAD SCI USA, V108, P5021, DOI 10.1073/pnas.1016140108; Gilmartin AG, 2011, CLIN CANCER RES, V17, P989, DOI 10.1158/1078-0432.CCR-10-2200; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Marampon F, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-31; Marchetti S, 2005, MOL CELL BIOL, V25, P854, DOI 10.1128/MCB.25.2.854-864.2005; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Oster SK, 2000, MOL CELL BIOL, V20, P6768, DOI 10.1128/MCB.20.18.6768-6778.2000; Ritt DA, 2010, MOL CELL BIOL, V30, P806, DOI 10.1128/MCB.00569-09; Rodrik-Outmezguine VS, 2011, CANCER DISCOV, V1, P248, DOI 10.1158/2159-8290.CD-11-0085; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1	23	518	532	2	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 13	2012	149	2					307	321		10.1016/j.cell.2012.02.053	http://dx.doi.org/10.1016/j.cell.2012.02.053			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	926BF	22500798	Green Published, Green Accepted, Bronze			2022-12-24	WOS:000302805600011
J	Prince, M; Acosta, D; Ferri, CP; Guerra, M; Huang, YQ; Rodriguez, JJL; Salas, A; Sosa, AL; Williams, JD; Dewey, ME; Acosta, I; Jotheeswaran, AT; Liu, ZR				Prince, Martin; Acosta, Daisy; Ferri, Cleusa P.; Guerra, Mariella; Huang, Yueqin; Rodriguez, Juan J. Llibre; Salas, Aquiles; Sosa, Ana Luisa; Williams, Joseph D.; Dewey, Michael E.; Acosta, Isaac; Jotheeswaran, Amuthavalli T.; Liu, Zhaorui			Dementia incidence and mortality in middle-income countries, and associations with indicators of cognitive reserve: a 10/66 Dementia Research Group population-based cohort study	LANCET			English	Article							NEUROPSYCHOLOGICAL TEST-PERFORMANCE; DWELLING BRAZILIAN POPULATION; EDGE-PALM TEST; ALZHEIMERS-DISEASE; CONSTRUCT-VALIDITY; VERBAL FLUENCY; COMMUNITY; VALIDATION; DIAGNOSIS; HEALTH	Background Results of the few cohort studies from countries with low incomes or middle incomes suggest a lower incidence of dementia than in high-income countries. We assessed incidence of dementia according to criteria from the 10/66 Dementia Research Group and Diagnostic and Statistical Manual of Mental Disorders (DSM) IV, the effect of dementia at baseline on mortality, and the independent effects of age, sex, socioeconomic position, and indicators of cognitive reserve. Methods We did a population-based cohort study of all people aged 65 years and older living in urban sites in Cuba, the Dominican Republic, and Venezuela, and rural and urban sites in Peru, Mexico, and China, with ascertainment of incident 10/66 and DSM-IV dementia 3-5 years after cohort inception. We used questionnaires to obtain information about age in years, sex, educational level, literacy, occupational attainment, and number of household assets. We obtained information about mortality from all sites. For participants who had died, we interviewed a friend or relative to ascertain the likelihood that they had dementia before death. Findings 12 887 participants were interviewed at baseline. 11 718 were free of dementia, of whom 8137 (69%) were reinterviewed, contributing 34 718 person-years of follow-up. Incidence for 10/66 dementia varied between 18.2 and 30.4 per 1000 person-years, and were 1.4-2.7 times higher than were those for DSM-IV dementia (9.9-15.7 per 1000 person-years). Mortality hazards were 1.56-5.69 times higher in individuals with dementia at baseline than in those who were dementia-free. Informant reports suggested a high incidence of dementia before death; overall incidence might be 4-19% higher if these data were included. 10/66 dementia incidence was independently associated with increased age (HR 1.67; 95% CI 1.56-1.79), female sex (0.72; 0.61-0.84), and low education (0.89; 0.81-0.97), but not with occupational attainment (1.04; 0.95-1.13). Interpretation Our results provide supportive evidence for the cognitive reserve hypothesis, showing that in middle-income countries as in high-income countries, education, literacy, verbal fluency, and motor sequencing confer substantial protection against the onset of dementia.	[Prince, Martin; Ferri, Cleusa P.; Dewey, Michael E.] Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Ctr Global Mental Hlth, London SE5 8AF, England; [Acosta, Daisy] UNPHU, Dept Internal Med, Geriatr Sect, Santo Domingo, Dominican Rep; [Guerra, Mariella] Inst Memoria & Desordenes Relacionados, Lima, Peru; [Huang, Yueqin; Liu, Zhaorui] Peking Univ, Inst Mental Hlth, Beijing 100871, Peoples R China; [Rodriguez, Juan J. Llibre] Med Univ Havana, Fac Med Finley Albarran, Havana, Cuba; [Salas, Aquiles] Hop Univ Caracas, Dept Med, Caracas, Venezuela; [Salas, Aquiles] Cent Univ Venezuela, Fac Med, Caracas, Venezuela; [Sosa, Ana Luisa; Acosta, Isaac] Univ Nacl Autonoma Mexico, Natl Inst Neurol & Neurosurg Mexico, Mexico City 04510, DF, Mexico; [Williams, Joseph D.] Voluntary Hlth Serv, Madras, Tamil Nadu, India; [Jotheeswaran, Amuthavalli T.] Publ Hlth Fdn India, New Delhi, India	University of London; King's College London; Universidad Nacional Pedro Henriquez Urena; Peking University; University of Central Venezuela; Universidad Nacional Autonoma de Mexico; Public Health Foundation of India	Prince, M (corresponding author), Kings Coll London, Inst Psychiat, Hlth Serv & Populat Res Dept, Ctr Global Mental Hlth, London SE5 8AF, England.	martin.prince@kcl.ac.uk	Dewey, Michael E/E-2049-2010; Castillo, Gilberto Isaac Acosta/CAA-2728-2022; Rodriguez, Juan J Llibre/D-2380-2010; Ortiz, Ana Luisa Sosa/AAU-9376-2021; Ferri, Cleusa Pinheiro/B-2922-2010; Castillo, Gilberto Isaac Acosta/AAY-5476-2020; Prince, Martin J/A-9170-2010	Dewey, Michael E/0000-0002-7522-3677; Castillo, Gilberto Isaac Acosta/0000-0002-8664-9542; Rodriguez, Juan J Llibre/0000-0002-8215-3160; Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Ferri, Cleusa Pinheiro/0000-0002-1815-7685; Castillo, Gilberto Isaac Acosta/0000-0002-8664-9542; Prince, Martin J/0000-0003-1379-7146; Amuthavalli Thiyagarajan, Jotheeswaran/0000-0001-7895-788X; Liu, Zhaorui/0000-0002-6536-7503; Guerra, Mariella/0000-0001-8923-349X	Wellcome Trust Health Consequences of Population Change Programme; WHO; US Alzheimer's Association; FONACIT/CDCH/UCV; Wellcome Trust Health Consequences of Population Change Programme [GR066133, GR08002]; WHO (India); WHO (Dominican Republic); WHO (China); US Alzheimer's Association [IIRG-04-1286-Peru]; FONACIT/CDCH/UCV (Venezuela)	Wellcome Trust Health Consequences of Population Change Programme(Wellcome Trust); WHO(World Health Organization); US Alzheimer's Association(Alzheimer's Association); FONACIT/CDCH/UCV; Wellcome Trust Health Consequences of Population Change Programme(Wellcome Trust); WHO (India)(World Health Organization); WHO (Dominican Republic); WHO (China); US Alzheimer's Association(Alzheimer's Association); FONACIT/CDCH/UCV (Venezuela)	Wellcome Trust Health Consequences of Population Change Programme, WHO, US Alzheimer's Association, FONACIT/CDCH/UCV; The 10/66 Dementia Research Group's research has been funded by the Wellcome Trust Health Consequences of Population Change Programme (GR066133-Prevalence phase in Cuba and Brazil; GR08002-Incidence phase in Peru, Mexico, Argentina, Cuba, Dominican Republic, Venezuela, and China), WHO (India, Dominican Republic, and China), the US Alzheimer's Association (IIRG-04-1286-Peru, Mexico and Argentina), and FONACIT/CDCH/UCV (Venezuela). The Rockefeller Foundation supported our dissemination meeting at their Bellagio Centre. ADI has provided support for networking and infrastructure.	American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Auriacombe S, 2006, DEMENT GERIATR COGN, V21, P260, DOI 10.1159/000091407; Brayne C, 2006, PLOS MED, V3, P1922, DOI 10.1371/journal.pmed.0030397; Chan RCK, 2006, NEUROSCI LETT, V398, P189, DOI 10.1016/j.neulet.2006.01.014; Chandra V, 2001, NEUROLOGY, V57, P985, DOI 10.1212/WNL.57.6.985; Clark LJ, 2009, AM J ALZHEIMERS DIS, V24, P461, DOI 10.1177/1533317509345154; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; DAVIS PB, 1991, ARCH NEUROL-CHICAGO, V48, P613, DOI 10.1001/archneur.1991.00530180069019; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P751, DOI 10.1002/gps.397.abs; Dewey ME, 2001, INT J GERIATR PSYCH, V16, P912, DOI 10.1002/gps.446; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Ganguli M, 1996, Int Psychogeriatr, V8, P507, DOI 10.1017/S1041610296002852; HALL KS, 1993, INT J METHOD PSYCH, V3, P1; Hendrie HC, 2001, JAMA-J AM MED ASSOC, V285, P739, DOI 10.1001/jama.285.6.739; Hermsdorfer J, 2007, NEUROIMAGE, V36, pT109, DOI 10.1016/j.neuroimage.2007.03.037; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Jones RA, 2011, JUNGIAN AND DIALOGICAL SELF PERSPECTIVES, P1; Jotheeswaran AT, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-366; Jotheeswaran AT, 2010, ALZ DIS ASSOC DIS, V24, P296, DOI 10.1097/WAD.0b013e3181d5e540; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; LI G, 1991, ACTA PSYCHIAT SCAND, V83, P99, DOI 10.1111/j.1600-0447.1991.tb07373.x; Manly JJ, 2002, J INT NEUROPSYCH SOC, V8, P341, DOI 10.1017/S1355617702813157; Mejia-Arango S, 2011, J AGING HEALTH, V23, P1050, DOI 10.1177/0898264311421199; Nitrini R, 2005, COGN BEHAV NEUROL, V18, P211, DOI 10.1097/01.wnn.0000195292.48422.d5; Nitrini R, 2005, INT J GERIATR PSYCH, V20, P247, DOI 10.1002/gps.1274; Nitrini R, 2004, ALZ DIS ASSOC DIS, V18, P241; Perkins AJ, 2002, INT J GERIATR PSYCH, V17, P566, DOI 10.1002/gps.643; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince MJ, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-219; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Saxton J, 2004, NEUROLOGY, V63, P2341, DOI 10.1212/01.WNL.0000147470.58328.50; Siedlecki KL, 2009, J INT NEUROPSYCH SOC, V15, P558, DOI 10.1017/S1355617709090857; Tierney MC, 2005, NEUROLOGY, V64, P1853, DOI 10.1212/01.WNL.0000163773.21794.0B; Umetsu A, 2002, NEUROIMAGE, V17, P385, DOI 10.1006/nimg.2002.1218; Valenzuela MJ, 2006, PSYCHOL MED, V36, P441, DOI 10.1017/S0033291705006264	37	168	188	0	51	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 7	2012	380	9836					50	58		10.1016/S0140-6736(12)60399-7	http://dx.doi.org/10.1016/S0140-6736(12)60399-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	970GK	22626851	Green Published			2022-12-24	WOS:000306115900033
J	Song, YH; Smith, RW; To, BJ; Millar, AJ; Imaizumi, T				Song, Young Hun; Smith, Robert W.; To, Benjamin J.; Millar, Andrew J.; Imaizumi, Takato			FKF1 Conveys Timing Information for CONSTANS Stabilization in Photoperiodic Flowering	SCIENCE			English	Article							LOCUS-T; ARABIDOPSIS; PROTEIN; COMPLEX; TIME	Plants use day-length information to coordinate flowering time with the appropriate season to maximize reproduction. In Arabidopsis, the long day-specific expression of CONSTANS (CO) protein is crucial for flowering induction. Although light signaling regulates CO protein stability, the mechanism by which CO is stabilized in the long-day afternoon has remained elusive. Here, we demonstrate that FLAVIN-BINDING, KELCH REPEAT, F-BOX 1 (FKF1) protein stabilizes CO protein in the afternoon in long days. FKF1 interacts with CO through its LOV domain, and blue light enhances this interaction. In addition, FKF1 simultaneously removes CYCLING DOF FACTOR 1 (CDF1), which represses CO and FLOWERING LOCUS T (FT) transcription. Together with CO transcriptional regulation, FKF1 protein controls robust FT mRNA induction through multiple feedforward mechanisms that accurately control flowering timing.	[Song, Young Hun; To, Benjamin J.; Imaizumi, Takato] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Smith, Robert W.; Millar, Andrew J.] Univ Edinburgh, Sch Biol Sci & SynthSys, Edinburgh EH9 3JD, Midlothian, Scotland	University of Washington; University of Washington Seattle; University of Edinburgh	Imaizumi, T (corresponding author), Univ Washington, Dept Biol, Seattle, WA 98195 USA.	takato@u.washington.edu	Millar, Andrew J/G-2423-2012	Millar, Andrew J/0000-0003-1756-3654	SSAC [PJ008109]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F59011/1, BB/F005237/1]; NIH [GM079712]; BBSRC [BB/G019621]; UK Engineering and Physical Sciences Research Council; BBSRC [BB/F005237/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005237/1] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079712] Funding Source: NIH RePORTER	SSAC; UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Harmer, K. Torii, D. Nusinow, S. Ito, and H. Kinmonth-Schultz for critical reading of the manuscript and G. Coupland for providing cdf quadruple mutant. Supported by the Next Generation Biogreen 21 program (SSAC grant PJ008109) (Y.H.S.), UK Biotechnology and Biological Sciences Research Council (BBSRC) grants BB/F59011/1 and BB/F005237/1 (R. W. S.), and NIH grant GM079712 (T. I.). SynthSys is partly supported by BBSRC grant BB/G019621 and by the UK Engineering and Physical Sciences Research Council.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Amasino R, 2010, PLANT J, V61, P1001, DOI 10.1111/j.1365-313X.2010.04148.x; de Montaigu A, 2010, TRENDS GENET, V26, P296, DOI 10.1016/j.tig.2010.04.003; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fukamatsu Y, 2005, PLANT CELL PHYSIOL, V46, P1340, DOI 10.1093/pcp/pci144; Han LQ, 2004, PLANT J, V40, P291, DOI 10.1111/j.1365-313X.2004.02207.x; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Mockler T, 2003, P NATL ACAD SCI USA, V100, P2140, DOI 10.1073/pnas.0437826100; Salazar JD, 2009, CELL, V139, P1170, DOI 10.1016/j.cell.2009.11.029; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Thomas B., 1997, PHOTOPERIODISM PLANT; Tiwari SB, 2010, NEW PHYTOL, V187, P57, DOI 10.1111/j.1469-8137.2010.03251.x; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Zuo ZC, 2011, CURR BIOL, V21, P841, DOI 10.1016/j.cub.2011.03.048	18	308	347	7	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 25	2012	336	6084					1045	1049		10.1126/science.1219644	http://dx.doi.org/10.1126/science.1219644			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	947DK	22628657	Green Submitted, Green Accepted			2022-12-24	WOS:000304406800048
J	Funfschilling, U; Supplie, LM; Mahad, D; Boretius, S; Saab, AS; Edgar, J; Brinkmann, BG; Kassmann, CM; Tzvetanova, ID; Mobius, W; Diaz, F; Meijer, D; Suter, U; Hamprecht, B; Sereda, MW; Moraes, CT; Frahm, J; Goebbels, S; Nave, KA				Fuenfschilling, Ursula; Supplie, Lotti M.; Mahad, Don; Boretius, Susann; Saab, Aiman S.; Edgar, Julia; Brinkmann, Bastian G.; Kassmann, Celia M.; Tzvetanova, Iva D.; Moebius, Wiebke; Diaz, Francisca; Meijer, Dies; Suter, Ueli; Hamprecht, Bernd; Sereda, Michael W.; Moraes, Carlos T.; Frahm, Jens; Goebbels, Sandra; Nave, Klaus-Armin			Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity	NATURE			English	Article							CYTOCHROME-C-OXIDASE; MICE LACKING; RAT OLIGODENDROCYTES; CELL-DEVELOPMENT; OPTIC-NERVE; MOUSE MODEL; LACTATE; GLUCOSE; BRAIN; DEFICIENCY	Oligodendrocytes, the myelin-forming glial cells of the central nervous system, maintain long-term axonal integrity(1-3). However, the underlying support mechanisms are not understood(4). Here we identify a metabolic component of axon-glia interactions by generating conditional Cox10 (protoheme IX farnesyltransferase) mutant mice, in which oligodendrocytes and Schwann cells fail to assemble stable mitochondrial cytochrome c oxidase (COX, also known as mitochondrial complex IV). In the peripheral nervous system, Cox10 conditional mutants exhibit severe neuropathy with dysmyelination, abnormal Remak bundles, muscle atrophy and paralysis. Notably, perturbing mitochondrial respiration did not cause glial cell death. In the adult central nervous system, we found no signs of demyelination, axonal degeneration or secondary inflammation. Unlike cultured oligodendrocytes, which are sensitive to COX inhibitors(5), post-myelination oligodendrocytes survive well in the absence of COX activity. More importantly, by in vivo magnetic resonance spectroscopy, brain lactate concentrations in mutants were increased compared with controls, but were detectable only in mice exposed to volatile anaesthetics. This indicates that aerobic glycolysis products derived from oligodendrocytes are rapidly metabolized within white matter tracts. Because myelinated axons can use lactate when energy-deprived(6), our findings suggest a model in which axon-glia metabolic coupling serves a physiological function.	[Fuenfschilling, Ursula; Supplie, Lotti M.; Saab, Aiman S.; Edgar, Julia; Brinkmann, Bastian G.; Kassmann, Celia M.; Tzvetanova, Iva D.; Moebius, Wiebke; Hamprecht, Bernd; Sereda, Michael W.; Goebbels, Sandra; Nave, Klaus-Armin] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Mahad, Don] Newcastle Univ, Sch Med, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Boretius, Susann; Frahm, Jens] Max Planck Inst Biophys Chem, Biomed NMR Forsch GmbH, D-37070 Gottingen, Germany; [Diaz, Francisca; Moraes, Carlos T.] Univ Miami, Miller Sch Med, Dept Neurol & Cell Biol & Anat, Miami, FL 33136 USA; [Meijer, Dies] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Suter, Ueli] ETH Honggerberg, Dept Biol, Inst Cell Biol, CH-8093 Zurich, Switzerland; [Sereda, Michael W.] Univ Gottingen UMG, Dept Clin Neurophysiol, D-37075 Gottingen, Germany	Max Planck Society; Newcastle University - UK; Max Planck Society; University of Miami; Erasmus University Rotterdam; Erasmus MC; Swiss Federal Institutes of Technology Domain; ETH Zurich	Nave, KA (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.	nave@em.mpg.de	Boretius, Susann/ABF-4993-2021; Edgar, Julia M/G-3275-2012; Edgar, Julia M/U-8456-2019; Meijer, Dies/C-7786-2012; Suter, Ueli/A-1624-2010; Moraes, Carlos/AAT-3818-2021	Boretius, Susann/0000-0003-2792-7423; Edgar, Julia M/0000-0002-3869-0962; Meijer, Dies/0000-0002-8461-6341; /0000-0002-2902-7165; Saab, Aiman S./0000-0003-3886-8369	BMBF (Leukonet); DFG (CMPB); EU; Oliver's Army; Swiss National Science Foundation; National Center 'Neural Plasticity and Repair'; Swiss National Science Foundation [PAOOA-117479/1]; European Leukodystrophy Association	BMBF (Leukonet)(Federal Ministry of Education & Research (BMBF)); DFG (CMPB)(German Research Foundation (DFG)); EU(European Commission); Oliver's Army; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center 'Neural Plasticity and Repair'; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); European Leukodystrophy Association	We thank C. Stiles for the OLIG2 antibodies, A. Fahrenholz, U. Bode, T. Ruhwedel, and R. Tammer for technical support, and members of the Nave laboratory for discussions. We acknowledge grant support from the BMBF (Leukonet), DFG (CMPB), EU-FP7 programs (NGIDD, Leukotreat) and Oliver's Army. U. S. is supported by the Swiss National Science Foundation and the National Center 'Neural Plasticity and Repair'. U. F. was supported by fellowships from the EU-FP7 (Marie- Curie), the Swiss National Science Foundation (PAOOA-117479/1) and the European Leukodystrophy Association. K.-A.N. holds an ERC Advanced Grant.	Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; BEATTIE DS, 1967, J BIOL CHEM, V242, P4584; Brown AM, 2001, J NEUROSCI RES, V66, P839, DOI 10.1002/jnr.10081; Diaz F, 2008, GUT, V57, P232, DOI 10.1136/gut.2006.119180; Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307; Diaz F, 2006, MOL CELL BIOL, V26, P4872, DOI 10.1128/MCB.01767-05; Dubois-Dalcq M, 2005, NEURON, V48, P9, DOI 10.1016/j.neuron.2005.09.004; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Gandhi GK, 2009, J NEUROCHEM, V111, P522, DOI 10.1111/j.1471-4159.2009.06333.x; Garlid KD, 2003, BBA-BIOENERGETICS, V1606, P23, DOI 10.1016/S0005-2728(03)00108-7; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Goebbels S, 2010, J NEUROSCI, V30, P8953, DOI 10.1523/JNEUROSCI.0219-10.2010; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Kassmann CM, 2007, NAT GENET, V39, P969, DOI 10.1038/ng2070; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; LEVEILLE PJ, 1980, BRAIN RES, V196, P287, DOI 10.1016/0006-8993(80)90397-2; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; Michaelis T, 2009, PROG NUCL MAG RES SP, V55, P1, DOI 10.1016/j.pnmrs.2008.11.001; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Moreland C., 1990, NEUROCHEM INT, V50, P703; Nave KA, 2010, NAT REV NEUROSCI, V11, P275, DOI 10.1038/nrn2797; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; Rinholm JE, 2011, J NEUROSCI, V31, P538, DOI 10.1523/JNEUROSCI.3516-10.2011; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Tekkok SB, 2005, J NEUROSCI RES, V81, P644, DOI 10.1002/jnr.20573; Vannucci SJ, 2003, AM J PHYSIOL-ENDOC M, V285, pE1127, DOI 10.1152/ajpendo.00187.2003; Viader A, 2011, J NEUROSCI, V31, P10128, DOI 10.1523/JNEUROSCI.0884-11.2011; Ziabreva I, 2010, GLIA, V58, P1827, DOI 10.1002/glia.21052	32	860	879	2	108	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 24	2012	485	7399					517	U130		10.1038/nature11007	http://dx.doi.org/10.1038/nature11007			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	946IH	22622581	Green Accepted			2022-12-24	WOS:000304344500046
J	Neale, BM; Kou, Y; Liu, L; Ma'ayan, A; Samocha, KE; Sabo, A; Lin, CF; Stevens, C; Wang, LS; Makarov, V; Polak, P; Yoon, S; Maguire, J; Crawford, EL; Campbell, NG; Geller, ET; Valladares, O; Schafer, C; Liu, H; Zhao, T; Cai, GQ; Lihm, J; Dannenfelser, R; Jabado, O; Peralta, Z; Nagaswamy, U; Muzny, D; Reid, JG; Newsham, I; Wu, YQ; Lewis, L; Han, Y; Voight, BF; Lim, E; Rossin, E; Kirby, A; Flannick, J; Fromer, M; Shakir, K; Fennell, T; Garimella, K; Banks, E; Poplin, R; Gabriel, S; DePristo, M; Wimbish, JR; Boone, BE; Levy, SE; Betancur, C; Sunyaev, S; Boerwinkle, E; Buxbaum, JD; Cook, EH; Devlin, B; Gibbs, RA; Roeder, K; Schellenberg, GD; Sutcliffe, JS; Daly, MJ				Neale, Benjamin M.; Kou, Yan; Liu, Li; Ma'ayan, Avi; Samocha, Kaitlin E.; Sabo, Aniko; Lin, Chiao-Feng; Stevens, Christine; Wang, Li-San; Makarov, Vladimir; Polak, Paz; Yoon, Seungtai; Maguire, Jared; Crawford, Emily L.; Campbell, Nicholas G.; Geller, Evan T.; Valladares, Otto; Schafer, Chad; Liu, Han; Zhao, Tuo; Cai, Guiqing; Lihm, Jayon; Dannenfelser, Ruth; Jabado, Omar; Peralta, Zuleyma; Nagaswamy, Uma; Muzny, Donna; Reid, Jeffrey G.; Newsham, Irene; Wu, Yuanqing; Lewis, Lora; Han, Yi; Voight, Benjamin F.; Lim, Elaine; Rossin, Elizabeth; Kirby, Andrew; Flannick, Jason; Fromer, Menachem; Shakir, Khalid; Fennell, Tim; Garimella, Kiran; Banks, Eric; Poplin, Ryan; Gabriel, Stacey; DePristo, Mark; Wimbish, Jack R.; Boone, Braden E.; Levy, Shawn E.; Betancur, Catalina; Sunyaev, Shamil; Boerwinkle, Eric; Buxbaum, Joseph D.; Cook, Edwin H., Jr.; Devlin, Bernie; Gibbs, Richard A.; Roeder, Kathryn; Schellenberg, Gerard D.; Sutcliffe, James S.; Daly, Mark J.			Patterns and rates of exonic de novo mutations in autism spectrum disorders	NATURE			English	Article							DNA-SEQUENCING DATA; ASSOCIATION; FRAMEWORK; DISEASE	Autism spectrum disorders (ASD) are believed to have genetic and environmental origins, yet in only a modest fraction of individuals can specific causes be identified(1,2). To identify further genetic risk factors, here we assess the role of de novo mutations in ASD by sequencing the exomes of ASD cases and their parents (n = 175 trios). Fewer than half of the cases (46.3%) carry a missense or nonsense de novo variant, and the overall rate of mutation is only modestly higher than the expected rate. In contrast, the proteins encoded by genes that harboured de novo missense or nonsense mutations showed a higher degree of connectivityamong themselves and to previous ASD genes(3) as indexed by protein-protein interaction screens. The small increase in the rate of de novo events, when taken together with the protein interaction results, are consistent with an important but limited role for de novo point mutations in ASD, similar to that documented for de novo copy number variants. Genetic models incorporating these data indicate that most of the observed de novo events are unconnected to ASD; those that do confer risk are distributed across many genes and are incompletely penetrant (that is, not necessarily sufficient for disease). Our results support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold. Despite the challenge posed by such models, results from de novo events and a large parallel case-control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors.	[Neale, Benjamin M.; Samocha, Kaitlin E.; Lim, Elaine; Rossin, Elizabeth; Kirby, Andrew; Fromer, Menachem; Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Neale, Benjamin M.; Samocha, Kaitlin E.; Lim, Elaine; Rossin, Elizabeth; Kirby, Andrew; Fromer, Menachem; Daly, Mark J.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Neale, Benjamin M.; Samocha, Kaitlin E.; Stevens, Christine; Polak, Paz; Maguire, Jared; Voight, Benjamin F.; Lim, Elaine; Rossin, Elizabeth; Kirby, Andrew; Flannick, Jason; Fromer, Menachem; Shakir, Khalid; Fennell, Tim; Garimella, Kiran; Banks, Eric; Poplin, Ryan; Gabriel, Stacey; DePristo, Mark; Sunyaev, Shamil; Daly, Mark J.] Broad Inst Harvard & MIT, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Kou, Yan; Ma'ayan, Avi; Dannenfelser, Ruth] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Kou, Yan; Makarov, Vladimir; Yoon, Seungtai; Cai, Guiqing; Lihm, Jayon; Buxbaum, Joseph D.] Mt Sinai Sch Med, Seaver Autism Ctr Res & Treatment, New York, NY 10029 USA; [Liu, Li; Schafer, Chad; Roeder, Kathryn] Carnegie Mellon Univ, Dept Stat, Pittsburgh, PA 15232 USA; [Sabo, Aniko; Nagaswamy, Uma; Muzny, Donna; Reid, Jeffrey G.; Newsham, Irene; Wu, Yuanqing; Lewis, Lora; Han, Yi; Boerwinkle, Eric; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Makarov, Vladimir; Yoon, Seungtai; Cai, Guiqing; Lihm, Jayon; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; [Polak, Paz; Sunyaev, Shamil] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Polak, Paz; Sunyaev, Shamil] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Crawford, Emily L.; Campbell, Nicholas G.; Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Brain Inst, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Crawford, Emily L.; Campbell, Nicholas G.; Sutcliffe, James S.] Vanderbilt Univ, Vanderbilt Brain Inst, Dept Psychiat, Nashville, TN 37232 USA; [Liu, Han; Zhao, Tuo] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA; [Liu, Han; Zhao, Tuo] Johns Hopkins Univ, Dept Comp Sci, Baltimore, MD 21205 USA; [Jabado, Omar; Peralta, Zuleyma; Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; [Voight, Benjamin F.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Wimbish, Jack R.; Boone, Braden E.; Levy, Shawn E.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Betancur, Catalina] INSERM, U952, F-75005 Paris, France; [Betancur, Catalina] CNRS, UMR 7224, F-75005 Paris, France; [Betancur, Catalina] Univ Paris 06, F-75005 Paris, France; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Human Genet Ctr, Houston, TX 77030 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Friedman Brain Inst, New York, NY 10029 USA; [Cook, Edwin H., Jr.] Univ Illinois, Dept Psychiat, Chicago, IL 60608 USA; [Devlin, Bernie] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15213 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Carnegie Mellon University; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Vanderbilt University; Vanderbilt University; Johns Hopkins University; Johns Hopkins University; Icahn School of Medicine at Mount Sinai; University of Pennsylvania; Pennsylvania Medicine; HudsonAlpha Institute for Biotechnology; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; University of Texas System; University of Texas Health Science Center Houston; Icahn School of Medicine at Mount Sinai; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Daly, MJ (corresponding author), Massachusetts Gen Hosp, Dept Med, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	joseph.buxbaum@mssm.edu; kathryn.roeder@gmail.com; mjdaly@atgu.mgh.harvard.edu	Polak, Paz/AAH-9380-2020; Buxbaum, Joseph D/G-6001-2010; Fromer, Menachem/G-2116-2012; Betancur, Catalina/K-3791-2017; Daly, Mark J/B-2453-2017; Liu, Li/G-1897-2015; Ma'ayan, Avi/AAG-3131-2019; Sutcliffe, James S/C-1348-2012	Fromer, Menachem/0000-0003-3749-4342; Betancur, Catalina/0000-0002-3327-4804; Daly, Mark J/0000-0002-0949-8752; Ma'ayan, Avi/0000-0002-6904-1017; Sutcliffe, James S/0000-0001-5200-6007; Valladares, Otto/0000-0001-8055-2187; Buxbaum, Joseph/0000-0001-8898-8313; Samocha, Kaitlin/0000-0002-1704-3352; Geller, Evan/0000-0002-8035-8736; Dannenfelser, Ruth/0000-0002-8766-6424; Stevens, Christine/0000-0002-2621-2234; Garimella, Kiran/0000-0002-6212-5736	NIH [R01MH089208, R01 MH089025, R01 MH089004, R01MH089175, R01 MH089482, P50 HD055751, RO1 MH057881, R01 MH061009]; Seaver Foundation; NIH NCRR [UL1 RR024975]; Vanderbilt Kennedy Center for Research on Human Development [P30 HD015052];  [R01MH084676];  [U54 HG003273];  [U54 HG003067]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD015052] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055751] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978, UL1RR024975, KL2RR024977] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558, T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057881, R01MH089175, R01MH089025, R01MH089482, R01MH061009, R01MH089208, R01MH089004, R01MH084676] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation; NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Vanderbilt Kennedy Center for Research on Human Development; ; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was directly supported by NIH grants R01MH089208 (M.J.D.), R01 MH089025 (J.D.B.), R01 MH089004 (G. D. S.), R01MH089175 (R. A. G.) and R01 MH089482 (J.S.S.), and supported in part by NIH grants P50 HD055751 (E. H. C.), RO1 MH057881 (B. D.) and R01 MH061009 (J.S.S.). Y.K., G. C. and S.Y. are Seaver Fellows, supported by the Seaver Foundation. We thank T. Lehner, A. Felsenfeld and P. Bender for their support and contribution to the project. We thank S. Sanders and M. State for discussions on the interpretation of de novo events. We thank D. Reich for comments on the abstract and message of the manuscript. We thank E. Lander and D. Altshuler for comments on the manuscript. We acknowledge the assistance of M. Potter, A. McGrew and G. Crockett without whom these studies would not be possible, and Center for Human Genetics Research resources: Computational Genomics Core, Genetic Studies Ascertainment Core and DNA Resources core, supported in part by NIH NCRR grant UL1 RR024975, and the Vanderbilt Kennedy Center for Research on Human Development (P30 HD015052). This work was supported in part by R01MH084676 (S. S.). We acknowledge the clinicians and organizations that contributed to samples used in this study and the particular support of the Mount Sinai School of Medicine, University of Illinois-Chicago, Vanderbilt University, the Autism Genetics Resource Exchange and the institutions of the Boston Autism Consortium. We acknowledge A. Estes and G. Dawson for patient collection/characterization. We acknowledge partial support from U54 HG003273 (R. A. G.) and U54 HG003067 (E. Lander). J.D.B., B. D., M.J.D., R. A. G., A. S., G. D. S. and J.S.S. are lead investigators in the Autism Sequencing Consortium (ASC). The ASC is comprised of groups sharing massively parallel sequencing data in autism. Finally, we are grateful to the many families, without whose participation this project would not have been possible.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Betancur C, 2011, BRAIN RES, V1380, P42, DOI 10.1016/j.brainres.2010.11.078; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Hallmayer J, 2011, ARCH GEN PSYCHIAT, V68, P1095, DOI 10.1001/archgenpsychiatry.2011.76; Kryukov GV, 2007, AM J HUM GENET, V80, P727, DOI 10.1086/513473; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lichtenstein P, 2010, AM J PSYCHIAT, V167, P1357, DOI 10.1176/appi.ajp.2010.10020223; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; O'Roak BJ, 2011, NAT GENET, V43, P585, DOI 10.1038/ng.835; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanders SJ, 2011, NEURON, V70, P863, DOI 10.1016/j.neuron.2011.05.002; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029	18	1224	1263	2	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 10	2012	485	7397					242	U129		10.1038/nature11011	http://dx.doi.org/10.1038/nature11011			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22495311	Green Accepted, Green Submitted			2022-12-24	WOS:000303799800042
J	Oka, T; Hikoso, S; Yamaguchi, O; Taneike, M; Takeda, T; Tamai, T; Oyabu, J; Murakawa, T; Nakayama, H; Nishida, K; Akira, S; Yamamoto, A; Komuro, I; Otsu, K				Oka, Takafumi; Hikoso, Shungo; Yamaguchi, Osamu; Taneike, Manabu; Takeda, Toshihiro; Tamai, Takahito; Oyabu, Jota; Murakawa, Tomokazu; Nakayama, Hiroyuki; Nishida, Kazuhiko; Akira, Shizuo; Yamamoto, Akitsugu; Komuro, Issei; Otsu, Kinya			Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure	NATURE			English	Article							PATTERN; DAMPS	Heart failure is a leading cause of morbidity and mortality in industrialized countries. Although infection with microorganisms is not involved in the development of heart failure in most cases, inflammation has been implicated in the pathogenesis of heart failure(1). However, the mechanisms responsible for initiating and integrating inflammatory responses within the heart remain poorly defined. Mitochondria are evolutionary endosymbionts derived from bacteria and contain DNA similar to bacterial DNA(2-4). Mitochondria damaged by external haemodynamic stress are degraded by the autophagy/lysosome systemin cardiomyocytes(5). Here we show that mitochondrial DNA that escapes from autophagy cell-autonomously leads to Toll-like receptor (TLR) 9-mediated inflammatory responses in cardiomyocytes and is capable of inducing myocarditis and dilated cardiomyopathy. Cardiac-specific deletion of lysosomal deoxyribonuclease (DNase) II showed no cardiac phenotypes under baseline conditions, but increased mortality and caused severe myocarditis and dilated cardiomyopathy 10 days after treatment with pressure overload. Early in the pathogenesis, DNase II-deficient hearts showed infiltration of inflammatory cells and increased messenger RNA expression of inflammatory cytokines, with accumulation of mitochondrial DNA deposits in autolysosomes in the myocardium. Administration of inhibitory oligodeoxynucleotides against TLR9, which is known to be activated by bacterial DNA(6), or ablation of Tlr9 attenuated the development of cardiomyopathy in DNase II-deficient mice. Furthermore, Tlr9 ablation improved pressure overload-induced cardiac dysfunction and inflammation even in mice with wild-type Dnase2a alleles. These data provide new perspectives on the mechanism of genesis of chronic inflammation in failing hearts.	[Oka, Takafumi; Hikoso, Shungo; Yamaguchi, Osamu; Taneike, Manabu; Takeda, Toshihiro; Tamai, Takahito; Oyabu, Jota; Murakawa, Tomokazu; Nishida, Kazuhiko; Komuro, Issei; Otsu, Kinya] Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, Suita, Osaka 5650871, Japan; [Taneike, Manabu; Nishida, Kazuhiko; Otsu, Kinya] Kings Coll London, Div Cardiovasc, London SE5 9NU, England; [Nakayama, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Pharmacogen, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Host Def Lab, Suita, Osaka 5650871, Japan; [Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Yamamoto, Akitsugu] Nagahama Inst Biosci & Technol, Fac Biosci, Nagahama, Shiga 5260829, Japan	Osaka University; University of London; King's College London; Osaka University; Osaka University; Osaka University	Otsu, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kinya.otsu@kcl.ac.uk	Akira, Shizuo/C-3134-2009; Hikoso, Shungo/R-4281-2018	Yamaguchi, Osamu/0000-0002-7461-369X; Hikoso, Shungo/0000-0003-2284-1970	Ministry of Education, Culture, Sports, Science and Technology in Japan; Mitsubishi Pharma Research Foundation; British Heart Foundation [CH/11/3/29051, RG/11/12/29052]	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsubishi Pharma Research Foundation; British Heart Foundation(British Heart Foundation)	We thank S. Nagata and K. Kawane, Kyoto University, for discussions and a gift of Dnase2a<SUP>flox/flox</SUP> mice, and Y. Uchiyama, Juntendo University, for anti-LC3 antibody. We also thank K. Takada for technical assistance. This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology in Japan and research grants from Mitsubishi Pharma Research Foundation and the British Heart Foundation (CH/11/3/29051, RG/11/12/29052).	Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Bugger H, 2010, CARDIOVASC RES, V85, P376, DOI 10.1093/cvr/cvp344; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; KOIZUMI T, 1995, EXP ANIM TOKYO, V44, P169, DOI 10.1538/expanim.44.169; Lentz SI, 2010, J HISTOCHEM CYTOCHEM, V58, P207, DOI 10.1369/jhc.2009.954701; Lu ZH, 2005, ARCH HISTOL CYTOL, V68, P71, DOI 10.1679/aohc.68.71; Mann DL, 2002, CIRC RES, V91, P988, DOI 10.1161/01.RES.0000043825.01705.1B; MEERSON FZ, 1964, EXP CELL RES, V36, P568, DOI 10.1016/0014-4827(64)90313-1; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MOSGOLLER W, 1993, J HISTOCHEM CYTOCHEM, V41, P1487, DOI 10.1177/41.10.7504007; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; POLLACK Y, 1984, NUCLEIC ACIDS RES, V12, P4811, DOI 10.1093/nar/12.12.4811; Stunz LL, 2002, EUR J IMMUNOL, V32, P1212, DOI 10.1002/1521-4141(200205)32:5<1212::AID-IMMU1212>3.0.CO;2-D; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Yamaguchi O, 2003, P NATL ACAD SCI USA, V100, P15883, DOI 10.1073/pnas.2136717100; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	26	759	794	7	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 10	2012	485	7397					251	U142		10.1038/nature10992	http://dx.doi.org/10.1038/nature10992			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	939HJ	22535248	Green Accepted			2022-12-24	WOS:000303799800044
J	Barbez, E; Kubes, M; Rolcik, J; Beziat, C; Pencik, A; Wang, BJ; Rosquete, MR; Zhu, JS; Dobrev, PI; Lee, Y; Zazimalova, E; Petrasek, J; Geisler, M; Friml, J; Kleine-Vehn, J				Barbez, Elke; Kubes, Martin; Rolcik, Jakub; Beziat, Chloe; Pencik, Ales; Wang, Bangjun; Rosquete, Michel Ruiz; Zhu, Jinsheng; Dobrev, Petre I.; Lee, Yuree; Zazimalova, Eva; Petrasek, Jan; Geisler, Markus; Friml, Jiri; Kleine-Vehn, Juergen			A novel putative auxin carrier family regulates intracellular auxin homeostasis in plants	NATURE			English	Article							SOLID-PHASE EXTRACTION; TOBACCO CELLS; ABSCISIC-ACID; ARABIDOPSIS; EFFLUX; TRANSPORT; PROTEINS; BIOSYNTHESIS; LOCALIZATION; PURIFICATION	The phytohormone auxin acts as a prominent signal, providing, by its local accumulation or depletion in selected cells, a spatial and temporal reference for changes in the developmental program(1-7). The distribution of auxin depends on both auxin metabolism (biosynthesis, conjugation and degradation)(8-10) and cellular auxin transport(11-15). We identified in silico a novel putative auxin transport facilitator family, called PIN-LIKES (PILS). Here we illustrate that PILS proteins are required for auxin-dependent regulation of plant growth by determining the cellular sensitivity to auxin. PILS proteins regulate intracellular auxin accumulation at the endoplasmic reticulum and thus auxin availability for nuclear auxin signalling. PILS activity affects the level of endogenous auxin indole-3-acetic acid (IAA), presumably via intracellular accumulation and metabolism. Our findings reveal that the transport machinery to compartmentalize auxin within the cell is of an unexpected molecular complexity and demonstrate this compartmentalization to be functionally important for a number of developmental processes.	[Barbez, Elke; Beziat, Chloe; Rosquete, Michel Ruiz; Friml, Jiri; Kleine-Vehn, Juergen] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Barbez, Elke; Beziat, Chloe; Rosquete, Michel Ruiz; Friml, Jiri; Kleine-Vehn, Juergen] Univ Ghent, Dept Plant Biotechnol & Bioinformat, B-9052 Ghent, Belgium; [Barbez, Elke; Beziat, Chloe; Rosquete, Michel Ruiz; Kleine-Vehn, Juergen] Univ Nat Resources & Life Siences BOKU, Dept Appl Genet & Cell Biol, A-1190 Vienna, Austria; [Kubes, Martin; Dobrev, Petre I.; Zazimalova, Eva; Petrasek, Jan] Acad Sci Czech Republ, Inst Expt Bot, CR-16502 Prague 6, Czech Republic; [Rolcik, Jakub] Palacky Univ, Fac Sci, Lab Growth Regulators, Olomouc 78371, Czech Republic; [Rolcik, Jakub] Inst Expt Bot AS CR, Olomouc 78371, Czech Republic; [Pencik, Ales] Palacky Univ, Fac Sci, Dept Growth Regulators, Ctr Reg Hana Biotechnol & Agr Res, Olomouc 78371, Czech Republic; [Wang, Bangjun; Zhu, Jinsheng; Geisler, Markus] Univ Fribourg, Dept Biol Plant Biol, CH-1700 Fribourg, Switzerland; [Lee, Yuree] Univ Lausanne, Dept Plant Mol Biol, CH-1015 Lausanne, Switzerland	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; University of Fribourg; University of Lausanne	Kleine-Vehn, J (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium.	juergen.kleine-vehn@boku.ac.at	Barbez, Elke/AAP-2131-2021; Petrasek, Jan/C-8240-2009; Eva, Zazimalova/G-7432-2014; Kubes, Martin/F-9761-2014; Friml, Jiri/D-9511-2012; Geisler, Markus M/B-3921-2012; Zhu, Jinsheng/AEN-5830-2022; Pencik, Ales/D-4488-2018; Kleine-Vehn, Jürgen/C-8984-2014; Dobrev, Petre I./H-2391-2014; Petrasek, Jan/AAW-1081-2021	Petrasek, Jan/0000-0002-6719-2735; Eva, Zazimalova/0000-0002-8325-7092; Friml, Jiri/0000-0002-8302-7596; Geisler, Markus M/0000-0002-6641-5810; Zhu, Jinsheng/0000-0002-8131-1876; Pencik, Ales/0000-0002-1314-2249; Kleine-Vehn, Jürgen/0000-0002-4354-3756; Petrasek, Jan/0000-0002-6719-2735; Barbez, Elke/0000-0002-5531-7916; Kubes, Martin/0000-0003-2182-4490; Lee, Yuree/0000-0002-4663-6974	Vienna Science and Technology Fund (WWTF); Agency for Innovation by Science and Technology (IWT); Research Foundation-Flanders; Swiss National Funds; Ministry of Education, Youth and Sports of the Czech Republic [LC06034]; Grant Agency of the Czech Republic [P305/11/2476, P305/11/0797]	Vienna Science and Technology Fund (WWTF); Agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation-Flanders(FWO); Swiss National Funds(Swiss National Science Foundation (SNSF)); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	We are grateful to C. Braeckman for plant transformation; W. Ardiles for sequencing support; L. Charrier for technical assistance; A. Maizel, N. Geldner and P. Pimpl for providing material; J.K.-V. group members for critical reading of the manuscript and the BOKU-VIBT Imaging Center for access and expertise. This work was supported by the Vienna Science and Technology Fund (WWTF) (to J.K.-V.), the Agency for Innovation by Science and Technology (IWT) (predoctoral fellowship to E. B.), the Odysseus program of the Research Foundation-Flanders (to J.F.), the Swiss National Funds (to M. G.), the Ministry of Education, Youth and Sports of the Czech Republic (LC06034) (to E.Z.), Grant Agency of the Czech Republic project P305/11/2476 (to J.P.) and P305/11/0797 (to E.Z).	Bailly A, 2008, J BIOL CHEM, V283, P21817, DOI 10.1074/jbc.M709655200; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Delbarre A, 1996, PLANTA, V198, P532, DOI 10.1007/BF00262639; Dobrev PI, 2002, J CHROMATOGR A, V950, P21, DOI 10.1016/S0021-9673(02)00024-9; Dobrev PI, 2005, J CHROMATOGR A, V1075, P159, DOI 10.1016/j.chroma.2005.02.091; Dubrovsky JG, 2008, P NATL ACAD SCI USA, V105, P8790, DOI 10.1073/pnas.0712307105; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Ikeda Y, 2009, NAT CELL BIOL, V11, P731, DOI 10.1038/ncb1879; Karimi M, 2005, TRENDS PLANT SCI, V10, P103, DOI 10.1016/j.tplants.2005.01.008; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Langhans M, 2008, TRAFFIC, V9, P770, DOI 10.1111/j.1600-0854.2008.00719.x; Lee SH, 2006, PLANT CELL, V18, P1604, DOI 10.1105/tpc.105.035972; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Leyser O, 2006, CURR BIOL, V16, pR424, DOI 10.1016/j.cub.2006.05.014; Luschnig C, 1998, GENE DEV, V12, P2175, DOI 10.1101/gad.12.14.2175; Marin E, 2010, PLANT CELL, V22, P1104, DOI 10.1105/tpc.109.072553; Mravec J, 2009, NATURE, V459, P1136, DOI 10.1038/nature08066; NAGATA T, 1992, INT REV CYTOL, V132, P1, DOI 10.1016/S0074-7696(08)62452-3; Pencik A, 2009, TALANTA, V80, P651, DOI 10.1016/j.talanta.2009.07.043; Petrasek J, 2006, SCIENCE, V312, P914, DOI 10.1126/science.1123542; Prasad K, 2011, CURR BIOL, V21, P1123, DOI 10.1016/j.cub.2011.05.009; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Sorefan K, 2009, NATURE, V459, P583, DOI 10.1038/nature07875; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Zazimalova E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001552; Zhao YD, 2010, ANNU REV PLANT BIOL, V61, P49, DOI 10.1146/annurev-arplant-042809-112308	35	240	264	15	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 3	2012	485	7396					119	U155		10.1038/nature11001	http://dx.doi.org/10.1038/nature11001			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	934NV	22504182	Green Submitted			2022-12-24	WOS:000303451900046
J	Djuranovic, S; Nahvi, A; Green, R				Djuranovic, Sergej; Nahvi, Ali; Green, Rachel			miRNA-Mediated Gene Silencing by Translational Repression Followed by mRNA Deadenylation and Decay	SCIENCE			English	Article							POLY(A) TAIL; MAMMALIAN-CELLS; GW182 PROTEINS; LET-7 MICRORNA; INITIATION; CAP; CCR4-NOT; TARGETS; DEGRADATION; INHIBITION	microRNAs (miRNAs) regulate gene expression through translational repression and/or messenger RNA (mRNA) deadenylation and decay. Because translation, deadenylation, and decay are closely linked processes, it is important to establish their ordering and thus to define the molecular mechanism of silencing. We have investigated the kinetics of these events in miRNA-mediated gene silencing by using a Drosophila S2 cell-based controllable expression system and show that mRNAs with both natural and engineered 3' untranslated regions with miRNA target sites are first subject to translational inhibition, followed by effects on deadenylation and decay. We next used a natural translational elongation stall to show that miRNA-mediated silencing inhibits translation at an early step, potentially translation initiation.	[Green, Rachel] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst HHMI, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst HHMI, Baltimore, MD 21205 USA.	ragreen@jhmi.edu		Djuranovic, Sergej/0000-0002-9417-0822	HHMI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Wehner, J. Doudna, M. Jinek, N. Guydosh, and J. Coller for helpful comments. Funding is from HHMI.	Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Beilharz TH, 2007, RNA, V13, P982, DOI 10.1261/rna.569407; Beilharz TH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006783; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; GALLIE DR, 1991, GENE DEV, V5, P2108, DOI 10.1101/gad.5.11.2108; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; JOHANSEN H, 1989, GENE DEV, V3, P882, DOI 10.1101/gad.3.6.882; Kuroha K, 2010, EMBO REP, V11, P956, DOI 10.1038/embor.2010.169; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Marzluff WF, 2008, NAT REV GENET, V9, P843, DOI 10.1038/nrg2438; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Muckenthaler M, 1997, RNA, V3, P983; Nahvi A, 2009, RNA, V15, P814, DOI 10.1261/rna.1565109; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009	30	608	640	8	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 13	2012	336	6078					237	240		10.1126/science.1215691	http://dx.doi.org/10.1126/science.1215691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	924PN	22499947	Green Accepted			2022-12-24	WOS:000302703900052
J	Boucrot, E; Pick, A; Camdere, G; Liska, N; Evergren, E; McMahon, HT; Kozlov, MM				Boucrot, Emmanuel; Pick, Adi; Camdere, Gamze; Liska, Nicole; Evergren, Emma; McMahon, Harvey T.; Kozlov, Michael M.			Membrane Fission Is Promoted by Insertion of Amphipathic Helices and Is Restricted by Crescent BAR Domains	CELL			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; INFLUENZA-VIRUS; COATED PITS; EPSIN 1; CURVATURE; MECHANISMS; PROTEINS; SCISSION; VESICLE; DEFORMATION	Shallow hydrophobic insertions and crescent-shaped BAR scaffolds promote membrane curvature. Here, we investigate membrane fission by shallow hydrophobic insertions quantitatively and mechanistically. We provide evidence that membrane insertion of the ENTH domain of epsin leads to liposome vesiculation, and that epsin is required for clathrin-coated vesicle budding in cells. We also show that BAR-domain scaffolds from endophilin, amphiphysin, GRAF, and beta 2-centaurin limit membrane fission driven by hydrophobic insertions. A quantitative assay for vesiculation reveals an antagonistic relationship between amphipathic helices and scaffolds of N-BAR domains in fission. The extent of vesiculation by these proteins and vesicle size depend on the number and length of amphipathic helices per BAR domain, in accord with theoretical considerations. This fission mechanism gives a new framework for understanding membrane scission in the absence of mechanoenzymes such as dynamin and suggests how Arf and Sar proteins work in vesicle scission.	[Boucrot, Emmanuel; Camdere, Gamze; Liska, Nicole; Evergren, Emma; McMahon, Harvey T.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Pick, Adi; Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel	MRC Laboratory Molecular Biology; Tel Aviv University; Sackler Faculty of Medicine	McMahon, HT (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB2 0QH, England.	hmm@mrc-lmb.cam.ac.uk; michk@post.tau.ac.il	Evergren, Emma/X-3677-2019	Evergren, Emma/0000-0002-0775-2921; Boucrot, Emmanuel/0000-0001-7312-6462	Israel Science Foundation (ISF); Marie Curie Network "Virus Entry"; Medical Research Council UK [U105178795]; Cambridge Overseas Trust; Trinity College Cambridge; Austrian Academy; MRC [MC_U105178795] Funding Source: UKRI; Medical Research Council [MC_U105178795] Funding Source: researchfish	Israel Science Foundation (ISF)(Israel Science Foundation); Marie Curie Network "Virus Entry"; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Overseas Trust; Trinity College Cambridge; Austrian Academy; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Sew Yeu Peak-Chew for Mass Spectrometry, Tom Kirchhausen and David Drubin for the kind gift of sigma 2-EGFP BSC1 cells and SK-MEL-2 genome-edited cells, respectively, Rohit Mittal for helpful comments, and Felix Campeio for a supplemental computation. This work was supported by the Israel Science Foundation (ISF) and Marie Curie Network "Virus Entry" (M.M.K.), the Medical Research Council UK (grant number U105178795) (H.T.M., E.E., E.B.), Cambridge Overseas Trust and Trinity College Cambridge (G.C.), and Austrian Academy Science Fellowship (N.L.). E.B. designed, performed, and quantified live and fixed-cell imaging and ligand uptake, A.P. did theoretical modeling, G.C. and N.L. purified proteins and performed vesiculation assay and electron microscopy, E.E. performed and quantified electron microscopy of clathrin-coated pits, H.T.M. designed and performed vesiculation assay and supervised the project, M.M.K. suggested the mechanism and supervised the theoretical modeling. H.T.M., M.M.K., and E.B. wrote the paper with input from all the other authors.	Antonny B, 2006, CURR OPIN CELL BIOL, V18, P386, DOI 10.1016/j.ceb.2006.06.003; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Beck R, 2011, J CELL BIOL, V194, P765, DOI 10.1083/jcb.201011027; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Chen C, 2008, P NATL ACAD SCI USA, V105, P11790, DOI 10.1073/pnas.0803711105; Chen H, 1998, NATURE, V394, P793, DOI 10.1038/29555; Chen H, 2009, P NATL ACAD SCI USA, V106, P13838, DOI 10.1073/pnas.0907008106; Chernomordik LV, 2003, ANNU REV BIOCHEM, V72, P175, DOI 10.1146/annurev.biochem.72.121801.161504; Coon Brian G, 2011, Commun Integr Biol, V4, P95, DOI 10.4161/cib.4.1.14129; Corda D, 2006, TRENDS CELL BIOL, V16, P167, DOI 10.1016/j.tcb.2006.01.007; Doyon JB, 2011, NAT CELL BIOL, V13, P331, DOI 10.1038/ncb2175; Farsad K, 2003, CURR OPIN CELL BIOL, V15, P372, DOI 10.1016/S0955-0674(03)00073-5; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; GOORMAGHTIGH E, 1986, ANAL BIOCHEM, V159, P122, DOI 10.1016/0003-2697(86)90316-7; Henne WM, 2010, SCIENCE, V328, P1281, DOI 10.1126/science.1188462; Hughes AC, 2004, MOL BRAIN RES, V128, P182, DOI 10.1016/j.molbrainres.2004.06.016; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; HUSE DA, 1991, PHYS REV LETT, V66, P437, DOI 10.1103/PhysRevLett.66.437; Jakobsson J, 2008, P NATL ACAD SCI USA, V105, P6445, DOI 10.1073/pnas.0710267105; Kazazic M, 2009, TRAFFIC, V10, P235, DOI 10.1111/j.1600-0854.2008.00858.x; Kozlovsky Y, 2003, BIOPHYS J, V85, P85, DOI 10.1016/S0006-3495(03)74457-9; Kweon DH, 2006, MOL CELLS, V21, P428; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Lundmark R, 2008, CURR BIOL, V18, P1802, DOI 10.1016/j.cub.2008.10.044; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rossman JS, 2010, CELL, V142, P902, DOI 10.1016/j.cell.2010.08.029; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Schwarz US, 1999, PHYS REV E, V59, P5528, DOI 10.1103/PhysRevE.59.5528; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Wang J, 2011, P NATL ACAD SCI USA, V108, P12277, DOI 10.1073/pnas.1013101108; Williger BT, 1999, FEBS LETT, V454, P85, DOI 10.1016/S0014-5793(99)00771-1	40	266	267	0	100	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	MAR 30	2012	149	1					124	136		10.1016/j.cell.2012.01.047	http://dx.doi.org/10.1016/j.cell.2012.01.047			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464325	Green Published, hybrid, Green Submitted			2022-12-24	WOS:000302235400015
J	Winzer, T; Gazda, V; He, Z; Kaminski, F; Kern, M; Larson, TR; Li, Y; Meade, F; Teodor, R; Vaistij, FE; Walker, C; Bowser, TA; Graham, IA				Winzer, Thilo; Gazda, Valeria; He, Zhesi; Kaminski, Filip; Kern, Marcelo; Larson, Tony R.; Li, Yi; Meade, Fergus; Teodor, Roxana; Vaistij, Fabian E.; Walker, Carol; Bowser, Tim A.; Graham, Ian A.			A Papaver somniferum 10-Gene Cluster for Synthesis of the Anticancer Alkaloid Noscapine	SCIENCE			English	Article							METABOLIC GENE CLUSTERS; MORPHINE BIOSYNTHESIS; OPIUM POPPY; MOLECULAR-CLONING; COPTIS-JAPONICA; ENZYME; CELLS; IDENTIFICATION; APOPTOSIS; PLANTS	Noscapine is an antitumor alkaloid from opium poppy that binds tubulin, arrests metaphase, and induces apoptosis in dividing human cells. Elucidation of the biosynthetic pathway will enable improvement in the commercial production of noscapine and related bioactive molecules. Transcriptomic analysis revealed the exclusive expression of 10 genes encoding five distinct enzyme classes in a high noscapine-producing poppy variety, HN1. Analysis of an F-2 mapping population indicated that these genes are tightly linked in HN1, and bacterial artificial chromosome sequencing confirmed that they exist as a complex gene cluster for plant alkaloids. Virus-induced gene silencing resulted in accumulation of pathway intermediates, allowing gene function to be linked to noscapine synthesis and a novel biosynthetic pathway to be proposed.	[Winzer, Thilo; Gazda, Valeria; He, Zhesi; Kaminski, Filip; Kern, Marcelo; Larson, Tony R.; Li, Yi; Meade, Fergus; Teodor, Roxana; Vaistij, Fabian E.; Graham, Ian A.] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England; [Walker, Carol; Bowser, Tim A.] GlaxoSmithKline, Boronia, Vic 3155, Australia	University of York - UK; GlaxoSmithKline	Graham, IA (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5DD, N Yorkshire, England.	ian.graham@york.ac.uk	Larson, Tony/AAI-4782-2020; Teodor, Roxana/I-3952-2012; TEODOR, Roxana/R-6929-2018	Larson, Tony/0000-0003-1337-3482; TEODOR, Roxana/0000-0003-2652-1894; Bowser, Tim/0000-0002-2126-8538; Meade, Fergus/0000-0001-9242-3622; Vaistij, Fabian E./0000-0002-1469-0589	GlaxoSmithKline Australia; Garfield Weston Foundation for the Centre for Novel Agricultural Products; Biotechnology and Biological Sciences Research Council [1098027] Funding Source: researchfish	GlaxoSmithKline Australia(GlaxoSmithKline); Garfield Weston Foundation for the Centre for Novel Agricultural Products; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the laboratory and field staff at GlaxoSmithKline Australia for valuable technical assistance and J. Mitchell for administrative support. Supported by GlaxoSmithKline Australia and by the Garfield Weston Foundation for the Centre for Novel Agricultural Products. The identities of three of the P450s and the methyltransferase genes associated with noscapine production have been disclosed in PCT patent applications WO2011/161431 and WO2012/010872, respectively. The sequences of four BAC clones and genomic sequences of the 10 genes are available through the National Centre for Biotechnology Information under GenBank accession nos. JQ659009 to JQ659012 and JQ658999 to JQ659008. HN1, HM1, and HT1 are available from GSK Australia for experimental purposes, subject to a material transfer agreement.	Apuya NR, 2008, PLANT BIOTECHNOL J, V6, P160, DOI 10.1111/j.1467-7652.2007.00302.x; BATTERSBY AR, 1968, J CHEM SOC C, P2163, DOI 10.1039/j39680002163; Chavez MLD, 2011, ARCH BIOCHEM BIOPHYS, V507, P186, DOI 10.1016/j.abb.2010.11.016; Chu HY, 2011, PLANT J, V66, P66, DOI 10.1111/j.1365-313X.2011.04503.x; Field B, 2008, SCIENCE, V320, P543, DOI 10.1126/science.1154990; Field B, 2011, P NATL ACAD SCI USA, V108, P16116, DOI 10.1073/pnas.1109273108; Frey M, 1997, SCIENCE, V277, P696, DOI 10.1126/science.277.5326.696; Gesell A, 2009, J BIOL CHEM, V284, P24432, DOI 10.1074/jbc.M109.033373; Grothe T, 2001, J BIOL CHEM, V276, P30717, DOI 10.1074/jbc.M102688200; Hagel JM, 2010, NAT CHEM BIOL, V6, P273, DOI [10.1038/NCHEMBIO.317, 10.1038/nchembio.317]; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hileman LC, 2005, PLANT J, V44, P334, DOI 10.1111/j.1365-313X.2005.02520.x; Ikezawa N, 2009, PLANT CELL REP, V28, P123, DOI 10.1007/s00299-008-0624-8; KARLSSON MO, 1990, EUR J CLIN PHARMACOL, V39, P275, DOI 10.1007/BF00315110; Kato N, 2007, PLANT CELL PHYSIOL, V48, P8, DOI 10.1093/pcp/pcl041; Ke Y, 2000, CANCER IMMUNOL IMMUN, V49, P217, DOI 10.1007/s002620000109; Kingston DGI, 2009, J NAT PROD, V72, P507, DOI 10.1021/np800568j; KONZETT H., 1954, EXPERIENTIA, V10, P472, DOI 10.1007/BF02170409; Landen JW, 2002, CANCER RES, V62, P4109; Lenz R, 1995, J BIOL CHEM, V270, P31091, DOI 10.1074/jbc.270.52.31091; Liscombe DK, 2007, J BIOL CHEM, V282, P14741, DOI 10.1074/jbc.M611908200; Mahmoudian M, 2009, RECENT PAT ANTI-CANC, V4, P92, DOI 10.2174/157489209787002524; Robiquet P. -J., 1817, ANN CHIM PHYS, V5, P275; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; TAKESHITA N, 1995, PLANT CELL PHYSIOL, V36, P29; Takos AM, 2011, PLANT J, V68, P273, DOI 10.1111/j.1365-313X.2011.04685.x; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601; Zhou J, 2002, J BIOL CHEM, V277, P39777, DOI 10.1074/jbc.M203927200; Ziegler J, 2008, ANNU REV PLANT BIOL, V59, P735, DOI 10.1146/annurev.arplant.59.032607.092730; Ziegler J, 2006, PLANT J, V48, P177, DOI 10.1111/j.1365-313X.2006.02860.x	31	216	265	5	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 29	2012	336	6089					1704	1708		10.1126/science.1220757	http://dx.doi.org/10.1126/science.1220757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965VD	22653730				2022-12-24	WOS:000305794500050
J	Charrier, C; Joshi, K; Coutinho-Budd, J; Kim, JE; Lambert, N; de Marchena, J; Jin, WL; Vanderhaeghen, P; Ghosh, A; Sassa, T; Polleux, F				Charrier, Cecile; Joshi, Kaumudi; Coutinho-Budd, Jaeda; Kim, Ji-Eun; Lambert, Nelle; de Marchena, Jacqueline; Jin, Wei-Lin; Vanderhaeghen, Pierre; Ghosh, Anirvan; Sassa, Takayuki; Polleux, Franck			Inhibition of SRGAP2 Function by Its Human-Specific Paralogs Induces Neoteny during Spine Maturation	CELL			English	Article							DENDRITIC SPINES; BAR-DOMAIN; SEGMENTAL DUPLICATIONS; MEMBRANE INVAGINATION; NEURONAL MIGRATION; ACTIN CYTOSKELETON; PYRAMIDAL CELLS; EVOLUTION; GENOME; NECK	Structural genomic variations represent a major driving force of evolution, and a burst of large segmental gene duplications occurred in the human lineage during its separation from nonhuman primates. SRGAP2, a gene recently implicated in neocortical development, has undergone two human-specific duplications. Here, we find that both duplications (SRGAP2B and SRGAP2C) are partial and encode a truncated F-BAR domain. SRGAP2C is expressed in the developing and adult human brain and dimerizes with ancestral SRGAP2 to inhibit its function. In the mouse neocortex, SRGAP2 promotes spine maturation and limits spine density. Expression of SRGAP2C phenocopies SRGAP2 deficiency. It underlies sustained radial migration and leads to the emergence of human-specific features, including neoteny during spine maturation and increased density of longer spines. These results suggest that inhibition of SRGAP2 function by its human-specific paralogs has contributed to the evolution of the human neocortex and plays an important role during human brain development.	[Charrier, Cecile; Joshi, Kaumudi; Sassa, Takayuki; Polleux, Franck] Scripps Res Inst, Dorris Neurosci Ctr, Dept Cell Biol, La Jolla, CA 92037 USA; [Coutinho-Budd, Jaeda; de Marchena, Jacqueline] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Kim, Ji-Eun; Ghosh, Anirvan] Univ Calif San Diego, Neurobiol Sect, La Jolla, CA 92093 USA; [Lambert, Nelle; Vanderhaeghen, Pierre] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Lambert, Nelle] Hop Erasme ULB, Dept Med Genet, B-1070 Brussels, Belgium; [Jin, Wei-Lin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China	Scripps Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Shanghai Jiao Tong University	Polleux, F (corresponding author), Scripps Res Inst, Dorris Neurosci Ctr, Dept Cell Biol, La Jolla, CA 92037 USA.	polleux@scripps.edu	SASSA, Takayuki/B-2519-2012; Kim, Jean Jieun/G-5774-2018; Jin, Wei-Lin/A-8355-2013; Polleux, Franck/H-9948-2014; Joshi, Kaumudi/P-1862-2018	SASSA, Takayuki/0000-0003-3145-9829; Kim, Jean Jieun/0000-0003-4709-262X; Jin, Wei-Lin/0000-0001-8011-2405; , Nelle/0000-0003-1137-9725; Polleux, Franck/0000-0003-4313-0481; Vanderhaeghen, Pierre/0000-0001-7899-5720; Charrier, Cecile/0000-0002-9053-1715	FNRS; Belgian Queen Elizabeth Foundation; Welbio and Excellence Programs of the Walloon Region; Fonds Erasme; Belgian Kids' Fund; NIH [RO1NS067557, F31NS061610, F31NS068038]; ADI-Novartis; NSFC [31171033]; "973'' Project [2011CB933101]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067557, F31NS061610, F31NS068038] Funding Source: NIH RePORTER	FNRS(Fonds de la Recherche Scientifique - FNRS); Belgian Queen Elizabeth Foundation; Welbio and Excellence Programs of the Walloon Region(WELBIO); Fonds Erasme; Belgian Kids' Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ADI-Novartis; NSFC(National Natural Science Foundation of China (NSFC)); "973'' Project(National Basic Research Program of China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank Marie Rougie and Virginie Courchet for excellent technical support and management of the mouse colonies and members of the Polleux laboratory for useful discussions. We thank Maxime Camo for help with the initial characterization of the SRGAP2 KO, Daniel Choquet for providing HOMER1c expression plasmid, and Evan Eichler's lab for reagents and useful discussions. N.L. is a clinical scientist of the FNRS and P. V. is a Research Director of the FNRS. This work was partially supported by grants of the FNRS, Belgian Queen Elizabeth Foundation, Welbio and Excellence Programs of the Walloon Region (to P. V.), Fonds Erasme and the Belgian Kids' Fund (to N.L.), NIH RO1NS067557 (F. P.) and ADI-Novartis funds (F. P.), NIH F31NS061610 (J.d.M.), NIH F31NS068038 (J.C.-B.), by NSFC (No. 31171033), and "973'' Project (No. 2011CB933101) (W.-L.J.). C. C., K.J., T. S. and F. P. conceived the experiments, and C. C., K.J., J.C.-B., J.d.M., T. S., N.L., and P. V. performed the experiments. W.-L. J. provided the anti-SRGAP2 antibodies. J.-E.K. and A. G. provided RNA from cultured human ES cells. C. C., K. J., and F. P. prepared the manuscript. A. G. is currently an employee of F. Hoffmann La Roche.	Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Bacon C, 2009, J COMP NEUROL, V513, P224, DOI 10.1002/cne.21955; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Benavides-Piccione R, 2002, J NEUROCYTOL, V31, P337, DOI 10.1023/A:1024134312173; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Bourne J, 2007, CURR OPIN NEUROBIOL, V17, P381, DOI 10.1016/j.conb.2007.04.009; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Calarco JA, 2007, GENE DEV, V21, P2963, DOI 10.1101/gad.1606907; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Dennis MY, 2012, CELL, V149, DOI 10.1016/j.cell.2012.03.033; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; DOLLE P, 1993, CELL, V75, P431, DOI 10.1016/0092-8674(93)90378-4; Elias GM, 2008, P NATL ACAD SCI USA, V105, P20953, DOI 10.1073/pnas.0811025106; Elston GN, 2001, J NEUROSCI, V21; Enard W, 2002, NATURE, V418, P869, DOI 10.1038/nature01025; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hayashi MK, 2009, CELL, V137, P159, DOI 10.1016/j.cell.2009.01.050; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Hurles M, 2004, PLOS BIOL, V2, P900, DOI 10.1371/journal.pbio.0020206; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Kim JE, 2011, P NATL ACAD SCI USA, V108, P3005, DOI 10.1073/pnas.1007753108; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Lambert N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017753; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McLean CY, 2011, NATURE, V471, P216, DOI 10.1038/nature09774; MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8; Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015; Perez-Otano I, 2006, NAT NEUROSCI, V9, P611, DOI 10.1038/nn1680; Petanjek Z, 2011, P NATL ACAD SCI USA, V108, P13281, DOI 10.1073/pnas.1105108108; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Romand S, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00005; Saitsu H, 2012, AM J MED GENET A, V158A, P199, DOI 10.1002/ajmg.a.34363; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Sikela JM, 2006, PLOS GENET, V2, P646, DOI 10.1371/journal.pgen.0020080; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Varki A, 2008, NAT REV GENET, V9, P749, DOI 10.1038/nrg2428; Yi JJ, 2010, CELL, V142, P144, DOI 10.1016/j.cell.2010.06.010; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Yuste R, 2011, NEURON, V71, P772, DOI 10.1016/j.neuron.2011.07.024	53	246	263	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					923	935		10.1016/j.cell.2012.03.034	http://dx.doi.org/10.1016/j.cell.2012.03.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22559944	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-24	WOS:000303934700023
J	Sawarkar, R; Sievers, C; Paro, R				Sawarkar, Ritwick; Sievers, Cem; Paro, Renato			Hsp90 Globally Targets Paused RNA Polymerase to Regulate Gene Expression in Response to Environmental Stimuli	CELL			English	Article							ELONGATION-FACTOR NELF; TRANSCRIPTION ELONGATION; P-TEFB; POL-II; PROMOTER; ACTIVATION; CELLS; PROLIFERATION; RECRUITMENT; COMPLEXES	The molecular chaperone Heat shock protein 90 (Hsp90) promotes the maturation of several important proteins and plays a key role in development, cancer progression, and evolutionary diversification. By mapping chromatin-binding sites of Hsp90 at high resolution across the Drosophila genome, we uncover an unexpected mechanism by which Hsp90 orchestrates cellular physiology. It localizes near promoters of many coding and noncoding genes including microRNAs. Using computational and biochemical analyses, we find that Hsp90 maintains and optimizes RNA polymerase II pausing via stabilization of the negative elongation factor complex (NELF). Inhibition of Hsp90 leads to upregulation of target genes, and Hsp90 is required for maximal activation of paused genes in Drosophila and mammalian cells in response to environmental stimuli. Our findings add a molecular dimension to the chaperone's functionality with wide ramifications into its roles in health, disease, and evolution.	[Sawarkar, Ritwick; Sievers, Cem; Paro, Renato] ETH, Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland; [Paro, Renato] Univ Basel, Fac Sci, CH-4056 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Basel	Paro, R (corresponding author), ETH, Dept Biosyst Sci & Engn, Mattenstr 26, CH-4058 Basel, Switzerland.	renato.paro@bsse.ethz.ch	Sawarkar, Ritwick/AGF-7365-2022		EU-NoE "EpiGeneSys''; ETH Zurich	EU-NoE "EpiGeneSys''; ETH Zurich(ETH Zurich)	We thank I. Nissen and C. Beisel for assistance with deep sequencing, M. Seimiya for lacZ staining of imaginal discs, S. Nechaev for help in permanganate footprinting, and Didier Picard and the Paro lab members for useful discussions. We thank the Bloomington stock centre, D. Ruden for fly stocks and J. Kreher and A. Brehm for Ecdysone-sensitive cell line. This work was supported by a grant from the EU-NoE "EpiGeneSys'' and the ETH Zurich.	Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; BENTLEY DL, 1986, NATURE, V321, P702, DOI 10.1038/321702a0; Boulon S, 2010, MOL CELL, V39, P912, DOI 10.1016/j.molcel.2010.08.023; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cornwell WD, 2001, J CELL BIOCHEM, V82, P22, DOI 10.1002/jcb.1144; Echeverria PC, 2010, BBA-MOL CELL RES, V1803, P641, DOI 10.1016/j.bbamcr.2009.11.012; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Enderle D, 2011, GENOME RES, V21, P216, DOI 10.1101/gr.114348.110; Figeac N, 2010, DEVELOPMENT, V137, P1965, DOI 10.1242/dev.049080; Floer M, 2008, P NATL ACAD SCI USA, V105, P2975, DOI 10.1073/pnas.0800053105; Freeman BC, 2002, SCIENCE, V296, P2232, DOI 10.1126/science.1073051; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Gilchrist DA, 2010, CELL, V143, P540, DOI 10.1016/j.cell.2010.10.004; Gilmour DS, 2009, METHODS, V48, P368, DOI 10.1016/j.ymeth.2009.02.020; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Guertin MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001114; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Lis JT, 2000, GENE DEV, V14, P792; Luo SX, 2011, AM J PHYSIOL-CELL PH, V301, pC227, DOI 10.1152/ajpcell.00493.2010; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335, DOI 10.1074/jbc.270.21.12335; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nairz K, 2006, DEV BIOL, V291, P314, DOI 10.1016/j.ydbio.2005.11.047; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Nechaev S, 2011, BBA-GENE REGUL MECH, V1809, P34, DOI 10.1016/j.bbagrm.2010.11.001; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; O'Keeffe B, 2000, J BIOL CHEM, V275, P279, DOI 10.1074/jbc.275.1.279; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Renault AD, 2010, DEVELOPMENT, V137, P1815, DOI 10.1242/dev.046110; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Specchia V, 2010, NATURE, V463, P662, DOI 10.1038/nature08739; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Tariq M, 2009, P NATL ACAD SCI USA, V106, P1157, DOI 10.1073/pnas.0809669106; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Vozzolo L, 2010, J BIOL CHEM, V285, P39314, DOI 10.1074/jbc.M110.155275; Workman P, 2007, ANN NY ACAD SCI, V1113, P202, DOI 10.1196/annals.1391.012; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Zhang ZQ, 2007, J BIOL CHEM, V282, P16981, DOI 10.1074/jbc.M610688200; Zou JY, 1998, CELL, V94, P471, DOI 10.1016/S0092-8674(00)81588-3	47	108	108	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAY 11	2012	149	4					807	818		10.1016/j.cell.2012.02.061	http://dx.doi.org/10.1016/j.cell.2012.02.061			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	941AR	22579285	Bronze, Green Submitted			2022-12-24	WOS:000303934700014
J	Dixon, JR; Selvaraj, S; Yue, F; Kim, A; Li, Y; Shen, Y; Hu, M; Liu, JS; Ren, B				Dixon, Jesse R.; Selvaraj, Siddarth; Yue, Feng; Kim, Audrey; Li, Yan; Shen, Yin; Hu, Ming; Liu, Jun S.; Ren, Bing			Topological domains in mammalian genomes identified by analysis of chromatin interactions	NATURE			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR LAMINA INTERACTIONS; GENE-EXPRESSION; ORGANIZATION; ARCHITECTURE; DROSOPHILA; PLURIPOTENT; PRINCIPLES; BOUNDARY; LOCUS	The spatial organization of the genome is intimately linked to its biological function, yet our understanding of higher order genomic structure is coarse, fragmented and incomplete. In the nucleus of eukaryotic cells, interphase chromosomes occupy distinct chromosome territories, and numerous models have been proposed for how chromosomes fold within chromosome territories(1). These models, however, provide only few mechanistic details about the relationship between higher order chromatin structure and genome function. Recent advances in genomic technologies have led to rapid advances in the study of three-dimensional genome organization. In particular, Hi-C has been introduced as a method for identifying higher order chromatin interactions genome wide(2). Here we investigate the three-dimensional organization of the human and mouse genomes in embryonic stem cells and terminally differentiated cell types at unprecedented resolution. We identify large, megabase-sized local chromatin interaction domains, which we term 'topological domains', as a pervasive structural feature of the genome organization. These domains correlate with regions of the genome that constrain the spread of heterochromatin. The domains are stable across different cell types and highly conserved across species, indicating that topological domains are an inherent property of mammalian genomes. Finally, we find that the boundaries of topological domains are enriched for the insulator binding protein CTCF, housekeeping genes, transfer RNAs and short interspersed element (SINE) retrotransposons, indicating that these factors may have a role in establishing the topological domain structure of the genome.	[Dixon, Jesse R.; Selvaraj, Siddarth; Yue, Feng; Kim, Audrey; Li, Yan; Shen, Yin; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Dixon, Jesse R.] Univ Calif San Diego, Med Scientist Training Program, La Jolla, CA 92093 USA; [Dixon, Jesse R.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Selvaraj, Siddarth] Univ Calif San Diego, Bioinformat & Syst Biol Grad Program, La Jolla, CA 92093 USA; [Hu, Ming; Liu, Jun S.] Harvard Univ, Dept Stat, Cambridge, MA 02138 USA; [Ren, Bing] Univ Calif San Diego, Sch Med, UCSD Moores Canc Ctr, Inst Genom Med,Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Harvard University; University of California System; University of California San Diego	Ren, B (corresponding author), Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Dixon, Jesse/AAT-2914-2020	Dixon, Jesse/0000-0002-6273-2181; Hu, Ming/0000-0002-6062-8794	Ludwig Institute for Cancer Research; California Institute for Regenerative Medicine (CIRM) [RN2-00905-1]; NIH [B.R. R01GH003991]; Rett Syndrome Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003991] Funding Source: NIH RePORTER	Ludwig Institute for Cancer Research; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rett Syndrome Research Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are grateful for the comments from and discussions with Z. Qin, A. Desai and members of the Ren laboratory during the course of the study. We also thank W. Bickmore and R. Eskeland for sharing the FISH data generated in mouse ES cells. This work was supported by funding from the Ludwig Institute for Cancer Research, California Institute for Regenerative Medicine (CIRM, RN2-00905-1) (to B.R.) and NIH (B.R. R01GH003991). J.R.D. is funded by a pre-doctoral training grant from CIRM. Y.S. is supported by a postdoctoral fellowship from the Rett Syndrome Research Foundation.	Amouyal M, 2010, BIOCHEM CELL BIOL, V88, P875, DOI 10.1139/O10-110; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Capelson M, 2004, BIOL CELL, V96, P617, DOI 10.1016/j.biolcel.2004.06.004; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Donze D, 2001, EMBO J, V20, P520, DOI 10.1093/emboj/20.3.520; Ebersole T, 2011, CELL CYCLE, V10, P2779, DOI 10.4161/cc.10.16.17092; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Handoko L, 2011, NAT GENET, V43, P630, DOI 10.1038/ng.857; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Jhunjhunwala S, 2008, CELL, V133, P265, DOI 10.1016/j.cell.2008.03.024; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim YJ, 2011, P NATL ACAD SCI USA, V108, P7391, DOI 10.1073/pnas.1018279108; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lunyak VV, 2007, SCIENCE, V317, P248, DOI 10.1126/science.1140871; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schmidt D, 2012, CELL, V148, P335, DOI 10.1016/j.cell.2011.11.058; Scott KC, 1999, GENETICS, V153, P787; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Xie W, 2012, CELL, V148, P816, DOI 10.1016/j.cell.2011.12.035; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947	29	3746	3838	19	480	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAY 17	2012	485	7398					376	380		10.1038/nature11082	http://dx.doi.org/10.1038/nature11082			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22495300	Green Accepted, Green Submitted			2022-12-24	WOS:000304099100044
J	Patrick, SW; Schumacher, RE; Benneyworth, BD; Krans, EE; McAllister, JM; Davis, MM				Patrick, Stephen W.; Schumacher, Robert E.; Benneyworth, Brian D.; Krans, Elizabeth E.; McAllister, Jennifer M.; Davis, Matthew M.			Neonatal Abstinence Syndrome and Associated Health Care Expenditures United States, 2000-2009	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							METHADONE-MAINTENANCE; WITHDRAWAL SYMPTOMS; PREGNANCY; TERM; EXPOSURE; PREVALENCE; MANAGEMENT; CHILDREN; INFANTS; HEROIN	Context Neonatal abstinence syndrome (NAS) is a postnatal drug withdrawal syndrome primarily caused by maternal opiate use. No national estimates are available for the incidence of maternal opiate use at the time of delivery or NAS. Objectives To determine the national incidence of NAS and antepartum maternal opiate use and to characterize trends in national health care expenditures associated with NAS between 2000 and 2009. Design, Setting, and Patients Aretrospective, serial, cross-sectional analysis of a nationally representative sample of newborns with NAS. The Kids' Inpatient Database (KID) was used to identify newborns with NAS by International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code. The Nationwide Inpatient Sample (NIS) was used to identify mothers using diagnosis related groups for vaginal and cesarean deliveries. Clinical conditions were identified using ICD-9-CM diagnosis codes. NAS and maternal opiate use were described as an annual frequency per 1000 hospital births. Missing hospital charges (<5% of cases) were estimated using multiple imputation. Trends in health care utilization outcomes over time were evaluated using variance-weighted regression. All hospital charges were adjusted for inflation to 2009 US dollars. Main Outcome Measures Incidence of NAS and maternal opiate use, and related hospital charges. Results The separate years (2000, 2003, 2006, and 2009) of national discharge data included 2920 to 9674 unweighted discharges with NAS and 987 to 4563 unweighted discharges for mothers diagnosed with antepartum opiate use, within data sets including 784 191 to 1.1 million discharges for children (KID) and 816 554 to 879 910 discharges for all ages of delivering mothers (NIS). Between 2000 and 2009, the incidence of NAS among newborns increased from 1.20 (95% CI, 1.04-1.37) to 3.39 (95% CI, 3.12-3.67) per 1000 hospital births per year (P for trend<.001). Antepartum maternal opiate use also increased from 1.19 (95% CI, 1.01-1.35) to 5.63 (95% CI, 4.40-6.71) per 1000 hospital births per year (P for trend<.001). In 2009, newborns with NAS were more likely than all other hospital births to have low birthweight (19.1%; SE, 0.5%; vs 7.0%; SE, 0.2%), have respiratory complications (30.9%; SE, 0.7%; vs 8.9%; SE, 0.1%), and be covered by Medicaid (78.1%; SE, 0.8%; vs 45.5%; SE, 0.7%; all P<.001). Mean hospital charges for discharges with NAS increased from $39 400 (95% CI, $33 400-$45 400) in 2000 to $53 400 (95% CI, $49 000-$57 700) in 2009 (P for trend<.001). By 2009, 77.6% of charges for NAS were attributed to state Medicaid programs. Conclusion Between 2000 and 2009, a substantial increase in the incidence of NAS and maternal opiate use in the United States was observed, as well as hospital charges related to NAS. JAMA. 2012;307(18):1934-1940 Published online April 30, 2012. doi:10.1001/jama.2012.3951 www.jama.com	[Patrick, Stephen W.; Schumacher, Robert E.; Benneyworth, Brian D.; McAllister, Jennifer M.; Davis, Matthew M.] Univ Michigan Hlth Syst, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Patrick, Stephen W.; Davis, Matthew M.] Univ Michigan Hlth Syst, Robert Wood Johnson Fdn Clin Scholars Program, Ann Arbor, MI 48109 USA; [Krans, Elizabeth E.] Univ Pittsburgh, Dept Obstet & Gynecol, Pittsburgh, PA USA; [Davis, Matthew M.] Univ Michigan, Gerald R Ford Sch Publ Policy, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Robert Wood Johnson Foundation (RWJF); University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan	Patrick, SW (corresponding author), Univ Michigan Hlth Syst, Dept Pediat & Communicable Dis, 6312 Med Sci Bldg 1,1150 Med Ctr Dr,SPC 5604, Ann Arbor, MI 48109 USA.	stepatri@med.umich.edu	Patrick, Stephen/ABD-8528-2021; Benneyworth, Brian/A-4667-2009	McAllister, Jennifer/0000-0003-3225-5561; Benneyworth, Brian/0000-0002-4692-5303	Robert Wood Johnson Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA038720] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the Robert Wood Johnson Foundation Clinical Scholars Program (Drs Patrick and Davis).	Agthe AG, 2009, PEDIATRICS, V123, pE849, DOI 10.1542/peds.2008-0978; Almario CV, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.052; Arlettaz R, 2005, ACTA OBSTET GYN SCAN, V84, P145, DOI 10.1111/j.0001-6349.2005.00510.x; Backes CH, 2012, J PERINATOL, V32, P425, DOI 10.1038/jp.2011.114; Bauer CR, 2005, ARCH PEDIAT ADOL MED, V159, P824, DOI 10.1001/archpedi.159.9.824; Benneyworth BD, 2011, PEDIATRICS, V127, pE1533, DOI 10.1542/peds.2010-2026; Berlin CM, 1998, PEDIATRICS, V101, P1079; Brown HL, 1998, AM J OBSTET GYNECOL, V179, P459, DOI 10.1016/S0002-9378(98)70379-5; Burns L, 2007, DRUG ALCOHOL REV, V26, P487, DOI 10.1080/09595230701494416; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P869; Coyle MG, 2002, J PEDIATR-US, V140, P561, DOI 10.1067/mpd.2002.123099; DOBERCZAK TM, 1991, J PEDIATR-US, V118, P933, DOI 10.1016/S0022-3476(05)82214-0; Dryden C, 2009, BJOG-INT J OBSTET GY, V116, P665, DOI 10.1111/j.1471-0528.2008.02073.x; HCUP databases, 2011, OV NAT INP SAMPL NIS; Healthcare Cost and Utilization Project (HCUP), 2011, INTR KID 2009 HCUP; Healthcare Cost and Utilization Project (HCUP), 2003, OV KIDS INP DAT KID; Healthcare Cost and Utilization Project (HCUP), 2009, OV KIDS INP DAT KID; Healthcare Cost and Utilization Project (HCUP), 2011, INTR NIS 2009 HCUP N; Healthcare Cost and Utilization Project (HCUP), 2006, OV KIDS INP DAT KID; Healthcare Cost and Utilization Project (HCUP), 2000, OV KIDS INP DAT KID; Hulse GK, 1997, ADDICTION, V92, P1571; Jansson LM, 2004, J HUM LACT, V20, P62, DOI 10.1177/0890334403261027; Jones HE, 2008, AM J ADDICTION, V17, P372, DOI 10.1080/10550490802266276; Jones HE, 2010, NEW ENGL J MED, V363, P2320, DOI 10.1056/NEJMoa1005359; Kaltenbach K, 1998, OBSTET GYN CLIN N AM, V25, P139, DOI 10.1016/S0889-8545(05)70362-4; KANDALL SR, 1976, PEDIATRICS, V58, P681; Kellogg A, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.050; Levison-Castiel R, 2006, ARCH PEDIAT ADOL MED, V160, P173, DOI 10.1001/archpedi.160.2.173; Macy ML, 2010, MED CARE, V48, P827, DOI 10.1097/MLR.0b013e3181f2595e; MADDEN JD, 1977, AM J OBSTET GYNECOL, V127, P199, DOI 10.1016/S0002-9378(16)33250-1; Minozzi S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006318.pub2; Myrvik MP, 2012, PEDIATR BLOOD CANCER, V58, P239, DOI 10.1002/pbc.23117; O'Donnell M, 2009, PEDIATRICS, V123, pE614, DOI 10.1542/peds.2008-2888; Odetola FO, 2010, PEDIATR CRIT CARE ME, V11, P457, DOI 10.1097/PCC.0b013e3181c514fa; Osborn DA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002053.pub3; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P1487; PIEROG S, 1977, J PEDIATR-US, V90, P630, DOI 10.1016/S0022-3476(77)80387-9; REMENTERIA JL, 1977, J PEDIATR-US, V90, P123, DOI 10.1016/S0022-3476(77)80785-3; Royston P, 2009, STATA J, V9, P466, DOI 10.1177/1536867X0900900308; Saiki T, 2010, EUR J PEDIATR, V169, P95, DOI 10.1007/s00431-009-0994-0; Sarkar S, 2006, J PERINATOL, V26, P15, DOI 10.1038/sj.jp.7211427; Substance Abuse and Mental Health Services Administration, 2011, NSDUH SER H; US Bureau of Labor Statistics, 2010, 2010 CONS PRIC IND; *US GEN ACC OFF, 1990, DRUG EXP INF GEN RIS; Wachman EM, 2010, BREASTFEED MED, V5, P159, DOI 10.1089/bfm.2009.0079; Weisberg S., 2005, WILEY SERIES PROBABI; Zickafoose JS, 2012, ARCH PEDIAT ADOL MED, V166, P350, DOI 10.1001/archpediatrics.2011.1501	47	660	664	0	53	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 9	2012	307	18					1934	1940		10.1001/jama.2012.3951	http://dx.doi.org/10.1001/jama.2012.3951			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	938OD	22546608	Bronze			2022-12-24	WOS:000303741900027
J	Hawkey, PM; Livermore, DM				Hawkey, Peter M.; Livermore, David M.			Carbapenem antibiotics for serious infections	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PENICILLIN ALLERGY; BETA-LACTAMASE; MEROPENEM; IMIPENEM; RESISTANCE; DORIPENEM; SAFETY; EPIDEMIOLOGY; PNEUMONIA; MECHANISM		[Hawkey, Peter M.] Heart England NHS Fdn Trust, W Midlands Publ Hlth Lab, Birmingham B9 5SS, W Midlands, England; [Hawkey, Peter M.] Univ Birmingham, Sch Med, Sch Immun & Infect, Edgbaston B15 2TT, England; [Livermore, David M.] Univ E Anglia, Norwich Med Sch, Norwich NR4 7TJ, Norfolk, England; [Livermore, David M.] Hlth Protect Agency Colindale, Antibiot Resistance Monitoring & Reference Lab, London NW9 5EQ, England	Heart of England NHS Foundation Trust; University of Birmingham; University of East Anglia; Health Protection Agency	Hawkey, PM (corresponding author), Heart England NHS Fdn Trust, W Midlands Publ Hlth Lab, Birmingham B9 5SS, W Midlands, England.	Peter.Hawkey@heartofengland.nhs.uk	Staves, Peter/C-8219-2014					Berthoin K, 2010, J ANTIMICROB CHEMOTH, V65, P1073, DOI 10.1093/jac/dkq044; Carmeli Y, 2011, DIAGN MICR INFEC DIS, V70, P367, DOI 10.1016/j.diagmicrobio.2011.03.009; Chastre J, 2008, CRIT CARE MED, V36, P1089, DOI 10.1097/CCM.0b013e3181691b99; Coelho JM, 2006, J CLIN MICROBIOL, V44, P3623, DOI 10.1128/JCM.00699-06; Cunha BA, 2008, J CHEMOTHERAPY, V20, P233, DOI 10.1179/joc.2008.20.2.233; Dellinger EP, 2007, ANN SURG, V245, P674, DOI 10.1097/01.sla.0000250414.09255.84; Edwards SJ, 2005, CURR MED RES OPIN, V21, P785, DOI 10.1185/030079905X46223; Edwards SJ, 2012, EUR J HEALTH ECON, V13, P181, DOI 10.1007/s10198-011-0296-0; Frumin J, 2009, ANN PHARMACOTHER, V43, P304, DOI 10.1345/aph.1L486; Giakoupi P, 2009, EUROSURVEILLANCE, V14, P69; Goldstein EJC, 2009, ANTIMICROB AGENTS CH, V53, P5122, DOI 10.1128/AAC.00064-09; Gu J, 2009, AM J GERIATR PHARMAC, V7, P26, DOI 10.1016/j.amjopharm.2009.02.005; Hawkey PM, 2009, J ANTIMICROB CHEMOTH, V64, P3, DOI 10.1093/jac/dkp256; Hawser S, 2011, EUR J CLIN MICROBIOL, V30, P173, DOI 10.1007/s10096-010-1066-0; Health Protection Agency, 2011, CARB PROD ENT UK, V5; Hoo GWS, 2005, CHEST, V128, P2778, DOI 10.1378/chest.128.4.2778; Hsueah PR, 2010, INT J ANTIMICROB AG, V36, P408, DOI 10.1016/j.ijantimicag.2010.07.002; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Lascols C, 2011, J ANTIMICROB CHEMOTH, V66, P1992, DOI 10.1093/jac/dkr240; Livermore DM, 2009, DIAGN MICR INFEC DIS, V63, P455, DOI 10.1016/j.diagmicrobio.2009.02.012; Martin-Canal G, 2010, INT J ANTIMICROB AG, V35, P301, DOI 10.1016/j.ijantimicag.2009.11.012; Masterton RG, 2009, INT J ANTIMICROB AG, V33, DOI 10.1016/j.ijantimicag.2008.07.023; Metzger R, 2010, ANN SURG, V251, P722, DOI 10.1097/SLA.0b013e3181c1ce3d; Miller AD, 2011, PHARMACOTHERAPY, V31, P408, DOI 10.1592/phco.31.4.408; Patel G, 2011, EXPERT REV ANTI-INFE, V9, P555, DOI [10.1586/eri.11.28, 10.1586/ERI.11.28]; Perrott J, 2010, ANN PHARMACOTHER, V44, P557, DOI 10.1345/aph.1M339; Prescott WA, 2007, PHARMACOTHERAPY, V27, P137, DOI 10.1592/phco.27.1.137; Schwaber MJ, 2007, J ANTIMICROB CHEMOTH, V60, P913, DOI 10.1093/jac/dkm318; Slama TG, 2008, CRIT CARE, V12, DOI 10.1186/cc6994; US Food and Drug Administration, 2010, TYG TIG LAB CHANG MO; Zhanel GG, 2007, DRUGS, V67, P1027, DOI 10.2165/00003495-200767070-00006	31	63	66	3	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 31	2012	344								e3236	10.1136/bmj.e3236	http://dx.doi.org/10.1136/bmj.e3236			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	953HG	22654063				2022-12-24	WOS:000304857000001
J	Canto, C; Auwerx, J				Canto, Carles; Auwerx, Johan			FGF21 Takes a Fat Bite	SCIENCE			English	Editorial Material							ACTIVATED-RECEPTOR-GAMMA; FIBROBLAST GROWTH FACTOR-21; PPAR-ALPHA; FIBROBLAST-GROWTH-FACTOR-21; METABOLISM; EXPRESSION; MICE; PGC-1-ALPHA; PROMOTES; OBESITY		[Canto, Carles] Nestle Inst Hlth Sci, CH-1015 Lausanne, Switzerland; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, SV IBI, CH-1015 Lausanne, Switzerland	Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Canto, C (corresponding author), Nestle Inst Hlth Sci, Ecole Polytech Fed Lausanne EPFL Campus,Batiment, CH-1015 Lausanne, Switzerland.	carlos.cantoalvarez@rd.nestle.com; admin.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021	Auwerx, Johan/0000-0002-5065-5393; Canto, Carles/0000-0002-5167-7922	European Research Council [231138] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Chau MDL, 2010, P NATL ACAD SCI USA, V107, P12553, DOI 10.1073/pnas.1006962107; Chen WW, 2008, EXP CLIN ENDOCR DIAB, V116, P65, DOI 10.1055/s-2007-985148; Cock TA, 2004, EMBO REP, V5, P1007, DOI 10.1038/sj.embor.7400254; Dutchak PA, 2012, CELL, V148, P556, DOI 10.1016/j.cell.2011.11.062; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Galman C, 2008, CELL METAB, V8, P169, DOI 10.1016/j.cmet.2008.06.014; Hale C, 2012, ENDOCRINOLOGY, V153, P69, DOI 10.1210/en.2010-1262; Hondares E, 2010, CELL METAB, V11, P206, DOI 10.1016/j.cmet.2010.02.001; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Muise ES, 2008, MOL PHARMACOL, V74, P403, DOI 10.1124/mol.108.044826; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Oishi K, 2011, BIOCHEM BIOPH RES CO, V412, P396, DOI 10.1016/j.bbrc.2011.07.125; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Vila-Bedmar R, 2010, ENDOCRINOLOGY, V151, P980, DOI 10.1210/en.2009-0810; Wang H, 2008, MOL CELL BIOL, V28, P188, DOI 10.1128/MCB.00992-07; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109	20	39	42	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 11	2012	336	6082					675	676		10.1126/science.1222646	http://dx.doi.org/10.1126/science.1222646			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22582248	Green Accepted			2022-12-24	WOS:000303872300033
J	Muller, P; Rogers, KW; Jordan, BM; Lee, JS; Robson, D; Ramanathan, S; Schier, AF				Mueller, Patrick; Rogers, Katherine W.; Jordan, Ben M.; Lee, Joon S.; Robson, Drew; Ramanathan, Sharad; Schier, Alexander F.			Differential Diffusivity of Nodal and Lefty Underlies a Reaction-Diffusion Patterning System	SCIENCE			English	Article							LEFT-RIGHT ASYMMETRY; MORPHOGEN GRADIENT; MECHANISM; GENERATION; STABILITY; MOLECULES; DYNAMICS; XENOPUS; STRIPE; RANGE	Biological systems involving short-range activators and long-range inhibitors can generate complex patterns. Reaction-diffusion models postulate that differences in signaling range are caused by differential diffusivity of inhibitor and activator. Other models suggest that differential clearance underlies different signaling ranges. To test these models, we measured the biophysical properties of the Nodal/Lefty activator/inhibitor system during zebrafish embryogenesis. Analysis of Nodal and Lefty gradients revealed that Nodals have a shorter range than Lefty proteins. Pulse-labeling analysis indicated that Nodals and Leftys have similar clearance kinetics, whereas fluorescence recovery assays revealed that Leftys have a higher effective diffusion coefficient than Nodals. These results indicate that differential diffusivity is the major determinant of the differences in Nodal/Lefty range and provide biophysical support for reaction-diffusion models of activator/inhibitor-mediated patterning.	[Mueller, Patrick; Rogers, Katherine W.; Lee, Joon S.; Robson, Drew; Ramanathan, Sharad; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Jordan, Ben M.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Ramanathan, Sharad; Schier, Alexander F.] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Ramanathan, Sharad; Schier, Alexander F.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University	Muller, P (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	pmueller@fas.harvard.edu; schier@fas.harvard.edu	Müller, Patrick/C-8096-2014	Müller, Patrick/0000-0002-0702-6209; Schier, Alexander Franz/0000-0001-7645-5325; Robson, Drew/0000-0002-0150-1515; Rogers, Katherine/0000-0001-5700-2662	European Molecular Biology Organization; Human Frontier Science Program (HFSP) [RGP0066/2004-C]; NSF; NIH [5RO1GM56211]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056211] Funding Source: NIH RePORTER	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program (HFSP)(Human Frontier Science Program); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank X. Zhang for help with the cloning of Cyclops constructs, H. Othmer and A. Lander for helpful discussions, J. Dubrulle for discussions and primers for quantitative reverse transcription polymerase chain reaction, and S. Mango for comments on the manuscript. Supported by European Molecular Biology Organization and Human Frontier Science Program (HFSP) Long-Term Fellowships (P.M.), the NSF Graduate Research Fellowship Program (K.W.R.), NIH grant 5RO1GM56211, and HFSP grant RGP0066/2004-C.	Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121; Chen Y, 2002, CURR BIOL, V12, P2124, DOI 10.1016/S0960-9822(02)01362-3; Duboc V, 2008, DEV BIOL, V320, P49, DOI 10.1016/j.ydbio.2008.04.012; Economou AD, 2012, NAT GENET, V44, P348, DOI 10.1038/ng.1090; GIERER A, 1972, KYBERNETIK, V12, P30, DOI 10.1007/BF00289234; Grande C, 2009, NATURE, V457, P1007, DOI 10.1038/nature07603; GRANERO MI, 1977, J MATH BIOL, V4, P21, DOI 10.1007/BF00276349; Gregor T, 2007, CELL, V130, P141, DOI 10.1016/j.cell.2007.05.026; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Klein DE, 2004, NATURE, V430, P1040, DOI 10.1038/nature02840; KONDO S, 1995, NATURE, V376, P765, DOI 10.1038/376765a0; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Le Good JA, 2005, CURR BIOL, V15, P31, DOI 10.1016/j.cub.2004.12.062; LENGYEL I, 1991, SCIENCE, V251, P650, DOI 10.1126/science.251.4994.650; Marjoram L, 2011, DEVELOPMENT, V138, P475, DOI 10.1242/dev.056010; Meinhardt H, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001362; Muller P, 2011, DEV CELL, V21, P145, DOI 10.1016/j.devcel.2011.06.001; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Rogers KW, 2011, ANNU REV CELL DEV BI, V27, P377, DOI 10.1146/annurev-cellbio-092910-154148; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Yamaguchi M, 2007, P NATL ACAD SCI USA, V104, P4790, DOI 10.1073/pnas.0607790104; Yu SR, 2009, NATURE, V461, P533, DOI 10.1038/nature08391; Zhang LJ, 2007, BIOTECHNIQUES, V42, P446, DOI 10.2144/000112453; Zhou SH, 2012, CURR BIOL, V22, P668, DOI 10.1016/j.cub.2012.02.065	30	252	259	0	74	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 11	2012	336	6082					721	724		10.1126/science.1221920	http://dx.doi.org/10.1126/science.1221920			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	940EH	22499809	Green Accepted			2022-12-24	WOS:000303872300050
J	Lickwar, CR; Mueller, F; Hanlon, SE; McNally, JG; Lieb, JD				Lickwar, Colin R.; Mueller, Florian; Hanlon, Sean E.; McNally, James G.; Lieb, Jason D.			Genome-wide protein-DNA binding dynamics suggest a molecular clutch for transcription factor function	NATURE			English	Article							GLUCOCORTICOID-RECEPTOR; EUKARYOTIC GENOME; BUDDING YEAST; LIVING CELLS; CHROMATIN; PROMOTER; EQUILIBRIUM; MECHANISM; EXCHANGE; SITES	Dynamic access to genetic information is central to organismal development and environmental response. Consequently, genomic processes must be regulated by mechanisms that alter genome function relatively rapidly(1-4). Conventional chromatin immunoprecipitation (ChIP) experiments measure transcription factor occupancy(5), but give no indication of kinetics and are poor predictors of transcription factor function at a given locus. To measure transcription-factor-binding dynamics across the genome, we performed competition ChIP (refs 6, 7) with a sequence-specific Saccharomyces cerevisiae transcription factor, Rap1 (ref. 8). Rap1-binding dynamics and Rap1 occupancy were only weakly correlated (R-2 = 0.14), but binding dynamics were more strongly linked to function than occupancy. Long Rap1 residence was coupled to transcriptional activation, whereas fast binding turnover, which we refer to as 'treadmilling', was linked to low transcriptional output. Thus, DNA-binding events that seem identical by conventional ChIP may have different underlying modes of interaction that lead to opposing functional outcomes. We propose that transcription factor binding turnover is a major point of regulation in determining the functional consequences of transcription factor binding, and is mediated mainly by control of competition between transcription factors and nucleosomes. Our model predicts a clutch-like mechanism that rapidly engages a treadmilling transcription factor into a stable binding state, or vice versa, to modulate transcription factor function.	[Lickwar, Colin R.; Hanlon, Sean E.; Lieb, Jason D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Dept Biol,Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; [Mueller, Florian; McNally, James G.] NCI, LRBGE, NIH, Bethesda, MD 20892 USA; [Mueller, Florian] Ctr Natl Rech Sci, Inst Pasteur, Grp Imagerie & Modelisat, Unite Rech Associee 2582, F-75015 Paris, France	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lieb, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Curriculum Genet & Mol Biol, Dept Biol,Carolina Ctr Genome Sci, CB 3280,408 Fordham Hall, Chapel Hill, NC 27599 USA.	jlieb@bio.unc.edu	Mueller, Florian/C-9075-2012	Mueller, Florian/0000-0002-9622-4396; Hanlon, Sean/0000-0001-6899-6906; Lieb, Jason/0000-0001-7601-8061	US National Institutes of Health (NIH) [R01-GM072518]; NIH, National Cancer Institute, Center for Cancer Research; Region Ile-de-France in the framework of C'Nano IdF, the nanoscience competence center of Paris Region; NATIONAL CANCER INSTITUTE [ZIABC010561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072518] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Region Ile-de-France in the framework of C'Nano IdF, the nanoscience competence center of Paris Region(Region Ile-de-France); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Kaplan and O. Rando for help with their turnover model, T. Palpant and S. Adar for help with time course experiments, and A. Leonardo Iniguez and H. Rosenbaum of Roche Nimblegen for pre-release custom HD4 12-plex microarrays. This work was supported by the US National Institutes of Health (NIH) Grant R01-GM072518 (to J.D.L.), and the intramural program of the NIH, National Cancer Institute, Center for Cancer Research (to J.G.M. and F.M.). F.M. was also supported in part by the Region Ile-de-France in the framework of C'Nano IdF, the nanoscience competence center of Paris Region.	Anderson JD, 2001, J MOL BIOL, V307, P977, DOI 10.1006/jmbi.2001.4528; Bosisio D, 2006, EMBO J, V25, P798, DOI 10.1038/sj.emboj.7600977; Buck MJ, 2006, NAT GENET, V38, P1446, DOI 10.1038/ng1917; Cesaroni M, 2008, BIOINFORMATICS, V24, P2918, DOI 10.1093/bioinformatics/btn542; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dion MF, 2007, SCIENCE, V315, P1405, DOI 10.1126/science.1134053; ERLMANN T, 1990, J BIOL CHEM, V265, P17222; Frith MC, 2004, NUCLEIC ACIDS RES, V32, P1372, DOI 10.1093/nar/gkh299; Ganapathi M, 2011, NUCLEIC ACIDS RES, V39, P2032, DOI 10.1093/nar/gkq1161; Gelbart ME, 2001, MOL CELL BIOL, V21, P2098, DOI 10.1128/MCB.21.6.2098-2106.2001; Gorski SA, 2008, MOL CELL, V30, P486, DOI 10.1016/j.molcel.2008.04.021; HOFFMAN CS, 1997, CURRENT PROTOCOLS MO, V2; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; John S, 2011, NAT GENET, V43, P264, DOI 10.1038/ng.759; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Karpova TS, 2008, SCIENCE, V319, P466, DOI 10.1126/science.1150559; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Layer JH, 2010, J BIOL CHEM, V285, P15489, DOI 10.1074/jbc.M110.104810; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu X, 2001, Pac Symp Biocomput, P127; MacArthur S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r80; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Mueller F, 2008, BIOPHYS J, V94, P3323, DOI 10.1529/biophysj.107.123182; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Pelechano V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015442; Pina B, 2003, MOL GENET GENOMICS, V268, P791, DOI 10.1007/s00438-002-0801-3; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Rossetti L, 2001, J MOL BIOL, V306, P903, DOI 10.1006/jmbi.2001.4458; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; SIKORSKI RS, 1989, GENETICS, V122, P19; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; van Werven FJ, 2009, NAT STRUCT MOL BIOL, V16, P1043, DOI 10.1038/nsmb.1674; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025; Zanton SJ, 2004, P NATL ACAD SCI USA, V101, P16843, DOI 10.1073/pnas.0404988101	38	170	172	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					251	U141		10.1038/nature10985	http://dx.doi.org/10.1038/nature10985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22498630	Green Accepted, Green Submitted			2022-12-24	WOS:000303149900037
J	Novoa, EM; Pavon-Eternod, M; Pan, T; de Pouplana, LR				Novoa, Eva Maria; Pavon-Eternod, Mariana; Pan, Tao; de Pouplana, Lluis Ribas			A Role for tRNA Modifications in Genome Structure and Codon Usage	CELL			English	Article							ESCHERICHIA-COLI; TRANSLATION EFFICIENCY; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; PHYLOGENETIC ANALYSIS; ADENOSINE-DEAMINASE; PROTEIN EXPRESSION; BACILLUS-SUBTILIS; SELECTION	Transfer RNA (tRNA) gene content is a differentiating feature of genomes that contributes to the efficiency of the translational apparatus, but the principles shaping tRNA gene copy number and codon composition are poorly understood. Here, we report that the emergence of two specific tRNA modifications shaped the structure and composition of all extant genomes. Through the analysis of more than 500 genomes, we identify two kingdom-specific tRNA modifications as major contributors that separated archaeal, bacterial, and eukaryal genomes in terms of their tRNA gene composition. We show that, contrary to prior observations, genomic codon usage and tRNA gene frequencies correlate in all kingdoms if these two modifications are taken into account and that presence or absence of these modifications explains patterns of gene expression observed in previous studies. Finally, we experimentally demonstrate that human gene expression levels correlate well with genomic codon composition if these identified modifications are considered.	[Novoa, Eva Maria; de Pouplana, Lluis Ribas] Inst Res Biomed, Barcelona 08028, Catalonia, Spain; [Pavon-Eternod, Mariana; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [de Pouplana, Lluis Ribas] Catalan Inst Res & Adv Studies, Barcelona 08010, Catalonia, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Chicago; ICREA	de Pouplana, LR (corresponding author), Inst Res Biomed, C Baldiri Reixac 15-21, Barcelona 08028, Catalonia, Spain.	lluis.ribas@irbbarcelona.org	Novoa, Eva Maria/B-1004-2015; de Pouplana, Lluis Ribas/AAA-4738-2019; Novoa, Eva Maria/B-1004-2015	Novoa, Eva Maria/0000-0002-9367-6311; de Pouplana, Lluis Ribas/0000-0002-2087-0359; Novoa, Eva Maria/0000-0001-5567-1299	Spanish Ministry of Education and Science [BIO2009-09776]; European Union [MEPHITIS-223024]; La Caixa/IRB; NIH [1F31CA139968]; NATIONAL CANCER INSTITUTE [F31CA139968] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	Spanish Ministry of Education and Science(Spanish Government); European Union(European Commission); La Caixa/IRB; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ICREA(ICREA)	We thank Dr. M. Santos and Dr. V. de Crecy-Lagard for their critical analysis of the manuscript. We also thank E. Planet and D. Rossell for their help with the statistical analysis of the data. This work has been supported by grant BIO2009-09776 from the Spanish Ministry of Education and Science, and by grant MEPHITIS-223024 from the European Union. E.M.N. is supported by a La Caixa/IRB International Ph.D. Programme Fellowship. M.P.-E. was supported by a Ruth Kirshstein Pre-doctoral Fellowship from the NIH (1F31CA139968).	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; AKASHI H, 1994, GENETICS, V136, P927; Akashi H, 2003, GENETICS, V164, P1291; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3026; Brochier C, 2002, NATURE, V417, P244, DOI 10.1038/417244a; Cannarrozzi G, 2010, CELL, V141, P355, DOI 10.1016/j.cell.2010.02.036; Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dong HJ, 1996, J MOL BIOL, V260, P649, DOI 10.1006/jmbi.1996.0428; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Drummond DA, 2008, CELL, V134, P341, DOI 10.1016/j.cell.2008.05.042; Duret L, 2000, TRENDS GENET, V16, P287, DOI 10.1016/S0168-9525(00)02041-2; Duret L, 2002, CURR OPIN GENET DEV, V12, P640, DOI 10.1016/S0959-437X(02)00353-2; Duret L, 1999, P NATL ACAD SCI USA, V96, P4482, DOI 10.1073/pnas.96.8.4482; Elf J, 2003, SCIENCE, V300, P1718, DOI 10.1126/science.1083811; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fitz-Gibbon ST, 1999, NUCLEIC ACIDS RES, V27, P4218, DOI 10.1093/nar/27.21.4218; Gerber AP, 2001, TRENDS BIOCHEM SCI, V26, P376, DOI 10.1016/S0968-0004(01)01827-8; Gerber AP, 1999, SCIENCE, V286, P1146, DOI 10.1126/science.286.5442.1146; Geslain R, 2010, J MOL BIOL, V396, P821, DOI 10.1016/j.jmb.2009.12.018; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GONOS ES, 1990, FEBS LETT, V276, P138, DOI 10.1016/0014-5793(90)80527-P; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; Hershberg R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000556; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; IKEMURA T, 1981, J MOL BIOL, V146, P1, DOI 10.1016/0022-2836(81)90363-6; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Iwasaki W, 2007, BIOINFORMATICS, V23, pI230, DOI 10.1093/bioinformatics/btm165; Jolliffe Ian, 2011, PRINCIPAL COMPONENT; Kanaya S, 2001, J MOL EVOL, V53, P290, DOI 10.1007/s002390010219; Kanaya S, 1999, GENE, V238, P143, DOI 10.1016/S0378-1119(99)00225-5; Knight R. D., 2001, GENOME BIOL, V2, DOI DOI 10.1186/GB-2001-2-4-RESEARCH0010; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Ledoux S, 2009, NAT STRUCT MOL BIOL, V16, P359, DOI 10.1038/nsmb.1581; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Maas S, 2000, BIOESSAYS, V22, P790, DOI 10.1002/1521-1878(200009)22:9<790::AID-BIES4>3.0.CO;2-0; Man O, 2007, NAT GENET, V39, P415, DOI 10.1038/ng1967; Marck C, 2002, RNA, V8, P1189, DOI 10.1017/S1355838202022021; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; McInerney JO, 1998, BIOINFORMATICS, V14, P372, DOI 10.1093/bioinformatics/14.4.372; Mian IS, 1998, J COMPUT BIOL, V5, P57, DOI 10.1089/cmb.1998.5.57; Moriyama EN, 1998, NUCLEIC ACIDS RES, V26, P3188, DOI 10.1093/nar/26.13.3188; Nasvall SJ, 2004, RNA, V10, P1662, DOI 10.1261/rna.7106404; Navon S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r12; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pavon-Eternod M, 2010, RNA, V16, P267, DOI 10.1261/rna.1928110; Ran WQ, 2010, MOL BIOL EVOL, V27, P2129, DOI 10.1093/molbev/msq102; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; Sharp PM, 2005, NUCLEIC ACIDS RES, V33, P1141, DOI 10.1093/nar/gki242; SHARP PM, 1988, NUCLEIC ACIDS RES, V16, P8207, DOI 10.1093/nar/16.17.8207; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Stetter K.O., 1996, CIBA F SYMP, V202, P11; Stetter KO, 1996, CIBA F SYMP, V202, P1; Supek F, 2010, GENETICS, V185, P1129, DOI 10.1534/genetics.110.115477; Supek F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001004; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Tekaia F, 1999, GENOME RES, V9, P550; Tuller T, 2010, CELL, V141, P344, DOI 10.1016/j.cell.2010.03.031; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Tuller T, 2007, PLOS COMPUT BIOL, V3, P2510, DOI 10.1371/journal.pcbi.0030248; Withers M, 2006, RNA, V12, P933, DOI 10.1261/rna.2272306; Wolf J, 2002, EMBO J, V21, P3841, DOI 10.1093/emboj/cdf362; Yang S, 2005, P NATL ACAD SCI USA, V102, P373, DOI 10.1073/pnas.0408810102; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; YOKOYAMA S, 1985, P NATL ACAD SCI USA, V82, P4905, DOI 10.1073/pnas.82.15.4905; Zhang G, 2009, NAT STRUCT MOL BIOL, V16, P274, DOI 10.1038/nsmb.1554	71	172	184	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 30	2012	149	1					202	213		10.1016/j.cell.2012.01.050	http://dx.doi.org/10.1016/j.cell.2012.01.050			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	918FT	22464330	Bronze			2022-12-24	WOS:000302235400021
J	Garnett, MJ; Edelman, EJ; Heidorn, SJ; Greenman, CD; Dastur, A; Lau, KW; Greninger, P; Thompson, IR; Luo, X; Soares, J; Liu, QS; Iorio, F; Surdez, D; Chen, L; Milano, RJ; Bignell, GR; Tam, AT; Davies, H; Stevenson, JA; Barthorpe, S; Lutz, SR; Kogera, F; Lawrence, K; McLaren-Douglas, A; Mitropoulos, X; Mironenko, T; Thi, H; Richardson, L; Zhou, WJ; Jewitt, F; Zhang, TH; O'Brien, P; Boisvert, JL; Price, S; Hur, W; Yang, WJ; Deng, XM; Butler, A; Choi, HG; Chang, J; Baselga, J; Stamenkovic, I; Engelman, JA; Sharma, SV; Delattre, O; Saez-Rodriguez, J; Gray, NS; Settleman, J; Futreal, PA; Haber, DA; Stratton, MR; Ramaswamy, S; McDermott, U; Benes, CH				Garnett, Mathew J.; Edelman, Elena J.; Heidorn, Sonja J.; Greenman, Chris D.; Dastur, Anahita; Lau, King Wai; Greninger, Patricia; Thompson, I. Richard; Luo, Xi; Soares, Jorge; Liu, Qingsong; Iorio, Francesco; Surdez, Didier; Chen, Li; Milano, Randy J.; Bignell, Graham R.; Tam, Ah T.; Davies, Helen; Stevenson, Jesse A.; Barthorpe, Syd; Lutz, Stephen R.; Kogera, Fiona; Lawrence, Karl; McLaren-Douglas, Anne; Mitropoulos, Xeni; Mironenko, Tatiana; Thi, Helen; Richardson, Laura; Zhou, Wenjun; Jewitt, Frances; Zhang, Tinghu; O'Brien, Patrick; Boisvert, Jessica L.; Price, Stacey; Hur, Wooyoung; Yang, Wanjuan; Deng, Xianming; Butler, Adam; Choi, Hwan Geun; Chang, JaeWon; Baselga, Jose; Stamenkovic, Ivan; Engelman, Jeffrey A.; Sharma, Sreenath V.; Delattre, Olivier; Saez-Rodriguez, Julio; Gray, Nathanael S.; Settleman, Jeffrey; Futreal, P. Andrew; Haber, Daniel A.; Stratton, Michael R.; Ramaswamy, Sridhar; McDermott, Ultan; Benes, Cyril H.			Systematic identification of genomic markers of drug sensitivity in cancer cells	NATURE			English	Article							MESENCHYMAL PROGENITOR CELLS; KINASE INHIBITOR; IN-VIVO; POLY(ADP-RIBOSE) POLYMERASE; EWINGS-SARCOMA; LUNG-CANCER; P53 PATHWAY; GROWTH; EXPRESSION; MELANOMA	Clinical responses to anticancer therapies are often restricted to a subset of patients. In some cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here, to uncover new biomarkers of sensitivity and resistance to cancer therapeutics, we screened a panel of several hundred cancer cell lines-which represent much of the tissue-type and genetic diversity of human cancers-with 130 drugs under clinical and preclinical investigation. In aggregate, we found that mutated cancer genes were associated with cellular response to most currently available cancer drugs. Classic oncogene addiction paradigms were modified by additional tissue-specific or expression biomarkers, and some frequently mutated genes were associated with sensitivity to a broad range of therapeutic agents. Unexpected relationships were revealed, including the marked sensitivity of Ewing's sarcoma cells harbouring the EWS (also known as EWSR1)-FLI1 gene translocation to poly(ADP-ribose) polymerase (PARP) inhibitors. By linking drug activity to the functional complexity of cancer genomes, systematic pharmacogenomic profiling in cancer cell lines provides a powerful biomarker discovery platform to guide rational cancer therapeutic strategies.	[Garnett, Mathew J.; Heidorn, Sonja J.; Greenman, Chris D.; Lau, King Wai; Thompson, I. Richard; Soares, Jorge; Iorio, Francesco; Bignell, Graham R.; Davies, Helen; Barthorpe, Syd; Kogera, Fiona; Lawrence, Karl; McLaren-Douglas, Anne; Mironenko, Tatiana; Richardson, Laura; Jewitt, Frances; O'Brien, Patrick; Price, Stacey; Yang, Wanjuan; Butler, Adam; Futreal, P. Andrew; Stratton, Michael R.; McDermott, Ultan] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England; [Edelman, Elena J.; Dastur, Anahita; Greninger, Patricia; Luo, Xi; Chen, Li; Milano, Randy J.; Stevenson, Jesse A.; Lutz, Stephen R.; Mitropoulos, Xeni; Thi, Helen; Boisvert, Jessica L.; Baselga, Jose; Engelman, Jeffrey A.; Sharma, Sreenath V.; Settleman, Jeffrey; Haber, Daniel A.; Ramaswamy, Sridhar; Benes, Cyril H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Charlestown, MA 02129 USA; [Liu, Qingsong; Zhou, Wenjun; Zhang, Tinghu; Hur, Wooyoung; Deng, Xianming; Choi, Hwan Geun; Chang, JaeWon; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Liu, Qingsong; Zhou, Wenjun; Zhang, Tinghu; Hur, Wooyoung; Deng, Xianming; Choi, Hwan Geun; Chang, JaeWon; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Iorio, Francesco; Saez-Rodriguez, Julio] EMBL EBI, Cambridge CB10 1SD, England; [Surdez, Didier; Delattre, Olivier] Inst Curie, Lab Genet & Biol Canc, F-75248 Paris 05, France; [Stamenkovic, Ivan] CHU Vaudois, Inst Pathol, Div Expt Pathol, CH-1005 Lausanne, Switzerland; [Haber, Daniel A.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Wellcome Trust Sanger Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Howard Hughes Medical Institute	McDermott, U (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England.	um1@sanger.ac.uk; cbenes@partners.org	Iorio, Francesco/H-3284-2019; Surdez, Didier/ABG-4565-2020; 刘, 青松/AEM-1932-2022; Thompson, I Richard/J-9900-2016; Saez-Rodriguez, Julio/H-7114-2019; Chang, Jae Won/AAN-4139-2020; Lawrence, Karl P/I-8271-2019; Iorio, Francesco/H-3282-2019; Liu, Qingsong/AFS-0714-2022	Iorio, Francesco/0000-0001-7063-8913; 刘, 青松/0000-0002-7829-2547; Thompson, I Richard/0000-0002-9554-550X; Saez-Rodriguez, Julio/0000-0002-8552-8976; Lawrence, Karl P/0000-0003-0124-961X; Liu, Qingsong/0000-0002-7829-2547; Gill, Sonja/0000-0002-7273-9053; Chen, Li/0000-0001-9303-4047; delattre, olivier/0000-0002-8730-2276; Deng, Xianming/0000-0002-9354-5864; McDermott, Ultan/0000-0001-9032-4700	Wellcome Trust [086357]; National Institutes of Health [P41GM079575-02, 1U54HG006097-01]; Howard Hughes Medical Institute; Cancer Research UK Clinician Scientist Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM079575] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Cancer Research UK Clinician Scientist Fellowship(Cancer Research UK); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Lo Grasso of the Scripps Research Institute for providing the inhibitor JNK9L. This work was supported by a grant from the Wellcome Trust (086357; M. R. S., P. A. F., J.S., D. A. H.) and by grants from the National Institutes of Health (P41GM079575-02 to N.S.G. and 1U54HG006097-01 to N.S.G. and D. A. H.). S. R. is supported by a Physician-Scientist Early Career Award from the Howard Hughes Medical Institute. U. M. is supported by a Cancer Research UK Clinician Scientist Fellowship.	Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Boisvert-Adamo K, 2009, MOL CANCER RES, V7, P549, DOI 10.1158/1541-7786.MCR-08-0358; Boland CR, 1998, CANCER RES, V58, P5248; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Byron SA, 2008, CANCER RES, V68, P6902, DOI 10.1158/0008-5472.CAN-08-0770; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Deng L, 2010, CANCER BIOL THER, V9, P875, DOI 10.4161/cbt.9.11.11634; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Kelland LR, 1999, J NATL CANCER I, V91, P1940, DOI 10.1093/jnci/91.22.1940; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Konecny GE, 2011, CLIN CANCER RES, V17, P1591, DOI 10.1158/1078-0432.CCR-10-2307; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; McCabe N, 2005, CANCER BIOL THER, V4, P934, DOI 10.4161/cbt.4.9.2141; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; McDermott U, 2009, J CLIN ONCOL, V27, P5650, DOI 10.1200/JCO.2009.22.9054; O'Farrell AM, 2003, BLOOD, V101, P3597, DOI 10.1182/blood-2002-07-2307; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Riggi N, 2006, CANCER RES, V66, P7016, DOI 10.1158/0008-5472.CAN-05-3979; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shoemaker R H, 1988, Prog Clin Biol Res, V276, P265; Suwaki N, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002004; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Weber DM, 2007, NEW ENGL J MED, V357, P2133, DOI 10.1056/NEJMoa070596; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	37	1609	1636	10	371	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 29	2012	483	7391					570	U87		10.1038/nature11005	http://dx.doi.org/10.1038/nature11005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915EF	22460902	Green Accepted, Green Submitted			2022-12-24	WOS:000302006100033
J	Rydin, Y; Bleahu, A; Davies, M; Davila, JD; Friel, S; De Grandis, G; Groce, N; Hallal, PC; Hamilton, I; Howden-Chapman, P; Lai, KM; Lim, CJ; Martins, J; Osrin, D; Ridley, I; Scott, I; Taylor, M; Wilkinson, P; Wilson, J				Rydin, Yvonne; Bleahu, Ana; Davies, Michael; Davila, Julio D.; Friel, Sharon; De Grandis, Giovanni; Groce, Nora; Hallal, Pedro C.; Hamilton, Ian; Howden-Chapman, Philippa; Lai, Ka-Man; Lim, C. J.; Martins, Juliana; Osrin, David; Ridley, Ian; Scott, Ian; Taylor, Myfanwy; Wilkinson, Paul; Wilson, James			Shaping cities for health: complexity and the planning of urban environments in the 21st century	LANCET			English	Review							EPIDEMIOLOGIC TRANSITION THEORY; PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; PUBLIC-HEALTH; DEVELOPING-COUNTRIES; INFECTIOUS-DISEASES; ANTHROPOGENIC HEAT; SLUDGE MANAGEMENT; CHANGING RELATION; WINTER MORTALITY		[Rydin, Yvonne] UCL, Bartlett Sch Planning, London WC1H 0QB, England; [Friel, Sharon] Australian Natl Univ, Canberra, ACT, Australia; [Hallal, Pedro C.] Univ Fed Pelotas, Pelotas, Brazil; [Howden-Chapman, Philippa] Univ Otago, Wellington, New Zealand; [Ridley, Ian] RMIT Univ, Melbourne, Vic, Australia; [Wilkinson, Paul] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; University College London; Australian National University; Universidade Federal de Pelotas; University of Otago; Royal Melbourne Institute of Technology (RMIT); University of London; London School of Hygiene & Tropical Medicine	Rydin, Y (corresponding author), UCL, Bartlett Sch Planning, Wates House,22 Gordon St, London WC1H 0QB, England.	y.rydin@ucl.ac.uk	Hamilton, Ian/O-6756-2019; Hallal, Pedro C/A-3249-2011; Bleahu, Ana/AAQ-8701-2020; Hamilton, Ian/O-6234-2014; Davies, Michael/GWV-2527-2022; Davila, Julio D/C-3257-2008; Lai, Ka Man/C-3259-2015	Hamilton, Ian/0000-0003-2582-2361; Hallal, Pedro C/0000-0003-1470-6461; Hamilton, Ian/0000-0003-2582-2361; Davila, Julio D/0000-0001-8319-2893; Lai, Ka Man/0000-0002-0037-792X; Martins, Juliana/0000-0002-2228-8274; Friel, Sharon/0000-0002-8345-5435; Osrin, David/0000-0001-9691-9684; Taylor, Myfanwy/0000-0003-2881-9192; Rydin, Yvonne/0000-0001-8283-9827; Wilkinson, Paul/0000-0001-7456-259X; Davies, Michael/0000-0003-2173-7063; RIDLEY, Ian Alexander/0000-0001-9240-5088; Wilson, James/0000-0002-0911-8510; Groce, Nora/0000-0002-7885-7042	UCL Alumni; Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [EP/G029881/1, EP/I02929X/1] Funding Source: researchfish; EPSRC [EP/I02929X/1, EP/G029881/1] Funding Source: UKRI	UCL Alumni; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank the very insightful and constructive comments made by Anne Johnson, Hugh Montgomery, David Satterthwaite, and four anonymous reviewers. We are also grateful for financial support from UCL Alumni and the Engineering and Physical Sciences Research Council Crucible Programme.	Allen A., 2006, GOVERNANCE WATER SAN; Allen A, 2008, MOVING LADDER GOVERN; Allen PM., 1997, CITIES REGIONS SELF; Amorim TC, 2010, J PHYS ACT HEALTH, V7, pS204, DOI 10.1123/jpah.7.s2.s204; Angel S, 2011, PROG PLANN, V75, P53, DOI 10.1016/j.progress.2011.04.001; [Anonymous], 2008, BBC NEWS; [Anonymous], 2008, PHARM ENV SOURCES FA, DOI DOI 10.1007/978-3-540-74664-5; [Anonymous], 2011, CIT CLIM CHANG; [Anonymous], INDICATOR S AFRICA, V13, P84; [Anonymous], 2002, NUTR TRANSITION DIET; [Anonymous], 2010, WORLD URB PROSP 2009; Armstrong BG, 2011, J EPIDEMIOL COMMUN H, V65, P340, DOI 10.1136/jech.2009.093161; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Ashton J., 1986, Health Promotion, V1, P319, DOI 10.1093/heapro/1.3.319; Asomani-Boateng R, 1999, 3 WORLD PLAN REV, V4, P21; Backman G, 2008, LANCET, V372, P2047, DOI 10.1016/S0140-6736(08)61781-X; Baker M, 2008, J EPIDEMIOL COMMUN H, V62, P715, DOI 10.1136/jech.2007.063610; Baker MG, 2012, LANCET, V379, P1112, DOI 10.1016/S0140-6736(11)61780-7; Barnes DF, 2005, URBAN HOUSEHOLD ENER; Barnes DF, 1990, POPULATION GROWTH RE; Barrett R, 1998, ANNU REV ANTHROPOL, V27, P247, DOI 10.1146/annurev.anthro.27.1.247; Barton H, 2006, J R SOC PROMO HEALTH, V126, P252, DOI 10.1177/1466424006070466; Barton H, 2009, LAND USE POLICY, V26, pS115, DOI 10.1016/j.landusepol.2009.09.008; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Baum FE, 2011, HEALTH PROMOT INT, V26, pII253, DOI 10.1093/heapro/dar078; Bauman A, 2005, J EPIDEMIOL COMMUN H, V59, P535, DOI 10.1136/jech.2004.032342; Bedimo-Rung AL, 2005, AM J PREV MED, V28, P159, DOI 10.1016/j.amepre.2004.10.024; Beitz Roma, 2004, J Br Menopause Soc, V10, P70, DOI 10.1258/136218004774202382; Bethany M, 2005, URBAN AGR REPORT REG; Bloom DE, 2007, INT J EPIDEMIOL, V36, P498, DOI 10.1093/ije/dym079; Bogota City Government, 2011, MOB; Bohnenstengel SI, 2011, Q J ROY METEOR SOC, V137, P1625, DOI 10.1002/qj.855; Boyce T, 2009, HLTH IMPACTS SPATIAL; Brand Peter, 2011, CITY, V15, P647, DOI DOI 10.1080/13604813.2011.609007; Braubach M., 2011, ENV BURD ENDISEASE A; Brook R., 2000, PERIURBAN INTERFACE; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Burns J, 2008, ENVIRON IMPACT ASSES, V28, P184, DOI 10.1016/j.eiar.2007.06.001; Burra S, 2003, ENVIRON URBAN, V15, P11, DOI 10.1177/095624780301500202; Burstrom B, 2005, AM J PUBLIC HEALTH, V95, P208, DOI 10.2105/AJPH.2003.034900; Butler EN, 2011, J PHYS ACT HEALTH, V8, pS91, DOI 10.1123/jpah.8.s1.s91; Button J, 1993, TRANSPORT ENV SUSTAI; Byrne J, 2009, J ENVIRON PLANN MAN, V52, P365, DOI 10.1080/09640560802703256; Caldwell J, 2002, ASIA PAC POPUL J, V17, P49; CALDWELL JC, 1993, SOC SCI MED, V36, P125, DOI 10.1016/0277-9536(93)90204-H; Caldwell JC, 2001, B WORLD HEALTH ORGAN, V79, P159; Campbell HW, 2000, WATER SCI TECHNOL, V41, P1; Campbell M, 2009, SURVEY ALLOTMENT WAI; Capon AG, 2010, PLAN THEORY PRACT, V11, P109; Echeverry JC, 2005, ECONOMIA, V5, P151, DOI 10.1353/eco.2005.0014; Carver A, 2008, HEALTH PLACE, V14, P217, DOI 10.1016/j.healthplace.2007.06.004; Cervero R, 2009, INT J SUSTAIN TRANSP, V3, P203, DOI 10.1080/15568310802178314; CIEH, 2008, GOOD LEADS GOOD HLTH; City of Toronto, TOR FACTS TOR RAC DI; Cofie OO, 2005, RENEW AGR FOOD SYST, V20, P73, DOI 10.1079/RAF200491; Cohen ML, 1998, BRIT MED BULL, V54, P523; COHRE, 2008, WATERAID SDC UN HABI; Corcoran E., 2010, SICK WATER CENTRAL R; Costello A, 2009, LANCET, V373, P1693, DOI 10.1016/S0140-6736(09)60929-6; Costongs C, 1997, EVALUATION, DOI 10. 1177/135638909700300306; Cotton A, 2000, SERVICES URBAN POOR; CSDH, 2008, CLOS GAP GEN HLTH EQ; Cutler D, 2006, J ECON PERSPECT, V20, P97, DOI 10.1257/jep.20.3.97; Davila JD, 2004, FORTALEZAS COLOMBIA, P417; Davila JD, 2009, ENVIRON URBAN, V21, P37, DOI 10.1177/0956247809103003; De Carbonnel E, CATASTROPHIC FALL GL; de Leeuw E, 2005, SOC SCI MED, V61, P1331, DOI 10.1016/j.socscimed.2005.01.028; De Leeuw E, 2009, HEALTH PROMOT INT, V24, P19, DOI 10.1093/heapro/dap052; De Sousa CA, 2003, LANDSCAPE URBAN PLAN, V62, P181, DOI 10.1016/S0169-2046(02)00149-4; Deaton A, 2003, J ECON LIT, V41, P113, DOI 10.1257/002205103321544710; Dennis Kingsley., 2009, CAR; Despommier D, 2008, VERTICAL FARM ESSAY; Diamond J, 2011, NATURE, V469, P478, DOI 10.1038/469478a; Drechsel P., 2010, WASTEWATER IRRIGATIO; Dryzek J.S., 1990, DISCURSIVE DEMOCRACY; Duhl L, 2005, BUILT ENV, V31, P356; Duhl L. J., 1986, HEALTH PROMOT INT, V1, P55; Enriquez LJ, 2000, 14 FOOD 1 I FOOD DEV; Feinleib M, 2008, ANN EPIDEMIOL, V18, P865, DOI 10.1016/j.annepidem.2008.08.004; Florindo AA, 2009, J PHYS ACT HEALTH, V6, P625, DOI 10.1123/jpah.6.5.625; Forester J., 1999, DELIBERATIVE PRACTIT; Foster S, 2008, PREV MED, V47, P241, DOI 10.1016/j.ypmed.2008.03.017; Frenk J., 1989, Health Policy and Planning, V4, P29, DOI 10.1093/heapol/4.1.29; Frumkin H, 2002, PUBLIC HEALTH REP, V117, P201, DOI 10.1093/phr/117.3.201; Gage TB, 2005, YEARB PHYS ANTHROPOL, V48, P96, DOI 10.1002/ajpa.20353; Galea S, 2005, ANNU REV PUBL HEALTH, V26, P341, DOI 10.1146/annurev.publhealth.26.021304.144708; Gerrits L, 2009, MANAGING COMPLEX GOV, P309; Gilbert A., 2002, CAPITAL CITY POLITIC, P29; Gilbert A, 2008, TRANSPORT REV, V28, P439, DOI 10.1080/01441640701785733; Giles-Corti B, 2006, J SCI MED SPORT, V9, P357, DOI 10.1016/j.jsams.2006.06.021; Glazier R, 2007, NEIGHBORHOOD ENV RES; Glouberman S, 2006, J URBAN HEALTH, V83, P325, DOI 10.1007/s11524-006-9034-9; Gomez LF, 2010, J PHYS ACT HEALTH, V7, pS196, DOI 10.1123/jpah.7.s2.s196; Goumans D, 1997, SOC SCI MED, V63, P179; Greater London Authority, 2011, MAN RISKS INCR RES M; Greater London Authority GL, 2009, LOND PLAN SPAT DEV S; Grimm NB, 2008, SCIENCE, V319, P756, DOI 10.1126/science.1150195; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; Hallal PC, 2005, AM J PREV MED, V28, P156, DOI 10.1016/j.amepre.2004.10.012; Hallal Pedro Curi, 2006, Cad. Saúde Pública, V22, P1277, DOI 10.1590/S0102-311X2006000600017; Hamilton IG, 2013, PROC INST CIV ENG-U, V166, P164, DOI 10.1680/udap.10.00046; Hamilton IG, 2009, BUILD ENVIRON, V44, P807, DOI 10.1016/j.buildenv.2008.05.024; Hancock T, 1988, HLTH CITIES PROJECT; Hancock Trevor, 1993, Journal of Public Health Policy, V14, P5, DOI 10.2307/3342823; Hanna AK, 2000, B SCI TECHNOL SOC, V20, P207, DOI DOI 10.1177/027046760002000308; Hanson M, 2011, AM J CLIN NUTR, V94, p1754S, DOI 10.3945/ajcn.110.001206; Hardoy J., 1989, SQUATTER CITIZEN; Harpham T, 2001, HEALTH PROMOT INT, V16, P111, DOI 10.1093/heapro/16.2.111; Harpham T, 1996, URBAN HLTH RES DEV C; Harpham T, 2009, HEALTH PLACE, V15, P107, DOI 10.1016/j.healthplace.2008.03.004; Healy JD, 2003, J EPIDEMIOL COMMUN H, V57, P784, DOI 10.1136/jech.57.10.784; Heuveline P, 2002, SOC SCI MED, V55, P313, DOI 10.1016/S0277-9536(01)00172-1; HM Government, 2013, APPR DOC F VENT 2010; Housing Stock CLG, 2010, ENGL DWELL STOCK EST; Howden-Chapman P, 2011, TACKLING COLD HOUSIN; Howden-Chapman P, 2009, ENERG POLICY, V37, P3387, DOI 10.1016/j.enpol.2008.12.023; Howden-Chapman P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1411; Huber Machteld, 2011, BMJ, V343, pd4163, DOI 10.1136/bmj.d4163; Hughes BB, 2011, B WORLD HEALTH ORGAN, V89, P478, DOI 10.2471/BLT.10.083766; Ichinose T, 1999, ATMOS ENVIRON, V33, P3897, DOI 10.1016/S1352-2310(99)00132-6; Ingallinella AM, 2002, WATER SCI TECHNOL, V46, P285, DOI 10.2166/wst.2002.0355; Innes JE, 2018, PLANNING WITH COMPLEXITY: AN INTRODUCTION TO COLLABORATIVE RATIONALITY FOR PUBLIC POLICY, 2ND EDITION; International Energy Agency, 2008, WORLD EN OUTL; Jackson L., 2019, CLIMATE CHANGE FLOOD; Jaine R, 2011, PEDIATR INFECT DIS J, V30, P1; Joshi D, 2011, ENVIRON URBAN, V23, P91, DOI 10.1177/0956247811398602; Kauffman S., 1995, HOME UNIVERSE SEARCH; Kenzer M, 1999, ENVIRON URBAN, V11, P201, DOI 10.1177/095624789901100103; Kickbusch Ilona, 2007, Promot Educ, VSuppl 2, P40; Kien CL, 2003, ARCH PEDIAT ADOL MED, V157, P811, DOI 10.1001/archpedi.157.8.811; Knowlton K, 2008, ADV GLOB CHANGE RES, V30, P143, DOI 10.1007/978-1-4020-6877-5_9; Kornov L, 2009, ENVIRON IMPACT ASSES, V29, P60, DOI 10.1016/j.eiar.2008.04.003; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Kunitz SJ, 2007, INT J EPIDEMIOL, V36, P491, DOI 10.1093/ije/dym076; Lathrop Pack C, 2009, WAR GARDEN VICTORIOU; LEACH G, 1992, ENERG POLICY, V20, P116, DOI 10.1016/0301-4215(92)90105-B; Lim C. J., 2010, SMARTCITIES ECOWARRI; Lopez R, 2004, AM J PUBLIC HEALTH, V94, P1574, DOI 10.2105/AJPH.94.9.1574; MACKENBACH JP, 1994, J EPIDEMIOL COMMUN H, V48, P329, DOI 10.1136/jech.48.4.329-a; Majone G., 1989, EVIDENCE ARGUMENT PE; Maller C., 2002, HLTH PARKS HLTH PEOP; Marmot M, 2000, MARMOT REV STRATEGIC; Martinez J, 2008, HABITAT INT, V32, P86, DOI 10.1016/j.habitatint.2007.08.018; Mavrogianni A, 2011, BUILD SERV ENG RES T, V32, P35, DOI 10.1177/0143624410394530; Mayntz R, 1993, MODERN GOVERNANCE NE, P14; McFarlane C, 2008, ENVIRON PLANN A, V40, P88, DOI 10.1068/a39221; McGranahan G., 2001, CITIZENS RISK URBAN; McGranahan G, 2007, URBAN ENV WEALTH HLT; McKeown T., 1976, ROLE MED DREAM MIRAG; McKeown Thomas, 1976, MODERN RISE POPULATI; McMichael AJ, 2008, INT J EPIDEMIOL, V37, P1121, DOI 10.1093/ije/dyn086; Minkler M, 1998, COMMUNITY ORG COMMUN; Mogk J, 2010, URBAN AGR GOOD FOOD; Monteiro CA, 2002, NUTR TRANSITION DIET; Montes F, 2010, 5 M NETW CICL RECR M; Montgomery MR, 2009, URBAN POVERTY HLTH D; Morgan K, 2009, INT PLAN STUD, V14, P341, DOI 10.1080/13563471003642852; Murch S, 2009, VEGETABLE GARDENERS; Nickson A, 1997, INT REV ADM SCI, V63, P165, DOI 10.1177/002085239706300202; NONAKA I, 1994, ORGAN SCI, V5, P14, DOI 10.1287/orsc.5.1.14; Northridge ME, 2003, J URBAN HEALTH, V80, P556, DOI 10.1093/jurban/jtg064; Nugent R., 2000, IMPACT URBAN AGR HOU; O'Neill MS, 2009, J OCCUP ENVIRON MED, V51, P13, DOI 10.1097/JOM.0b013e318173e122; Obosu-Mensah K., 2002, AFR STUD Q, V6, P19; Oikonomou E, BUILDING EN IN PRESS; Oke T.R., 1987, BOUNDARY LAYER CLIMA, DOI DOI 10.4324/9780203407219; OKE TR, 1973, ATMOS ENVIRON, V7, P769, DOI 10.1016/0004-6981(73)90140-6; OKE TR, 1995, NATO ADV SCI INST SE, V277, P81; OLSHANSKY SJ, 1986, MILBANK Q, V64, P355, DOI 10.2307/3350025; Olshansky SJ, 1997, POPUL BULL, V52, P2; OMRAN AR, 1983, J TROP PEDIATRICS, V29, P305, DOI 10.1093/tropej/29.6.305; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Pachauri S, 2008, ENERG POLICY, V36, P4022, DOI 10.1016/j.enpol.2008.06.016; Panter JR, 2010, J PHYS ACT HEALTH, V7, P551, DOI 10.1123/jpah.7.4.551; Parra DC, 2010, PREV MED; Petersen A, 1996, HEALTH PLACE, V2, P157, DOI 10.1016/1353-8292(96)00008-1; Pinderhughes RR, 2000, URBAN AGR HAVANA CUB; Population Reference Bureau, 2010, 2010 WORLD POP DAT; PRESTON SH, 1975, POP STUD-J DEMOG, V29, P231, DOI 10.2307/2173509; Prigogine I., 1977, SELF ORG NONEQUILIBR; Ramaraj R, 2008, AM J CARDIOL, V102, P102, DOI 10.1016/j.amjcard.2008.02.104; Reynolds L Raymond, 2004, Endocr Pract, V10, P153; Ritsatakis A, 2009, B WORLD HEALTH ORGAN, V12, P188; Ritsatakis A, 2009, HEALTH PROMOT INT, V24, P81, DOI 10.1093/heapro/dap058; ROGERS RG, 1987, SOC BIOL, V34, P234; Room G, 2011, COMPLEXITY I PUBLIC, P239; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Ross NA, 2007, AM J PUBLIC HEALTH, V97, P500, DOI 10.2105/AJPH.2004.060954; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI 10.1249/MSS.0b013e31817c67a4; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Sanderson I, 2006, POLICY POLIT, V34, P115, DOI 10.1332/030557306775212188; Sarmiento O, 2010, J PHYS ACT HEALTH, V7, pS163, DOI 10.1123/jpah.7.s2.s163; Sarmiento OL, 2010, J PHYS ACT HEALTH, V7, pS181, DOI 10.1123/jpah.7.s2.s181; Satterthwaite D., 2007, IIED HUMAN SETTLEMEN; Satterthwaite DE, 2000, ENV HLTH URBAN POVER; Schaub-Jones D, 2006, SANITATION PARTNERSH; Schubeler P, 1996, 9 WORLD BANK SDC COL; Schwandt TA, 1997, EVALUATION, V3, P69; Sclar ED, 2005, LANCET, V365, P901, DOI 10.1016/S0140-6736(05)71049-7; Scott P, 2011, THESIS U LOUGHBOROUG; Sen A., 2009, J HUMAN DEV 9, P331, DOI DOI 10.2307/J.CTVJNRV7N; Sharp D, 2008, J URBAN HEALTH, V85, P1, DOI 10.1007/s11524-007-9242-y; Smallman-Raynor M, 1999, HEALTH PLACE, V5, P209, DOI 10.1016/S1353-8292(99)00010-6; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Sommers P., 1994, PROMOTING URBAN AGR; SPAHG, 2011, STEPS HLTH PLANN PRO; Stephens C, 1996, ENVIRON URBAN, V8, P9, DOI 10.1177/095624789600800211; Sterman J., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Stern DI, 2001, J ENVIRON ECON MANAG, V41, P162, DOI 10.1006/jeem.2000.1132; Sverdlik A, 2011, ENVIRON URBAN, V23, P123, DOI 10.1177/0956247811398604; Szreter S, 2002, AM J PUBLIC HEALTH, V92, P722, DOI 10.2105/AJPH.92.5.722; Szreter S., 2005, HLTH WEALTH STUDIES; Szreter S., 1988, SOC HIST MED, V1, P1, DOI [10.1145/1073943.1073950, DOI 10.1145/1073943.1073950]; Taha H, 1997, ENERG BUILDINGS, V25, P99, DOI 10.1016/S0378-7788(96)00999-1; Takano T, 2001, J EPIDEMIOL COMMUN H, V55, P263, DOI 10.1136/jech.55.4.263; Takano T., 2003, HLTH CITIES URBAN PO; The Energy and Climate Change Committee, 2010, 5 EN CLIM CHANG COMM; The World Bank, DAT URB POP; Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2; Thompson WS, 1929, AM J SOCIOL, V34, P959, DOI 10.1086/214874; Troesken Werner., 2004, WATER RACE DIS; Tsouros A, 1990, HLTH CITIES PROJECT; Tzoulas K, 2007, LANDSCAPE URBAN PLAN, V81, P167, DOI 10.1016/j.landurbplan.2007.02.001; UN, UN HAB 2011 CIT CLIM; UN Department of Economic and Social Affairs, ONL DAT URB RUR POP; UN Habitat, 2021, URBAN REGENERATION T; UN-Habitat, 2003, RENT HOUS ESS OPT UR; UN-Habitat, 2003, WAT SAN WORLDS CIT; UNDP, 2006, HUMAN DEV REPORT 200; United Nations Environment Programme, 2011, GREEN EC PATHW SUST; van Ginkel HJA, 2007, MANAGING URBAN FUTUR; van Kamp I, 2003, LANDSCAPE URBAN PLAN, V65, P7; van Naerssen T, 2002, VANNAERSSEN BARTEN H; van Naerssen T, HLTH CITIES POLITICA; Wahdan M. H., 1996, Eastern Mediterranean Health Journal, V2, P8; Waliczek Tina M., 1999, Journal of Environmental Horticulture, V17, P180; Wallerstein N., 2006, WHAT IS EVIDENCE EFF; Wang XD, 1999, ENVIRON SCI TECHNOL, V33, P3056, DOI 10.1021/es981360d; Water Utility Partnership (WUP), 2003, BETT WAT SAN URB POO; Wells JCK, 2010, AM J HUM BIOL, V22, P1, DOI 10.1002/ajhb.20994; Wenger E., 2007, COMMUNITIES PRACTICE; Werna E, 1996, URBAN HLTH RES DEV C; Whitzman C, 2005, URBAN PLAN INT, V19, p[58, 121]; WHO, 2006, WHO GUID SAF US WAST; WHO, CONST WORLD HLTH ORG; WHO, 2011, HLTH GREEN EC HLTH C; WHO, 2004, WAT SAN HYG; WHO, 2010, 2010 URB HEART; WHO, 2009, MEG URB HLTH; WHO. Regional Office for Europe, 2008, CIT LEAD HLTH SUMM E, P20; WHO Regional Office for Europe, PHAS 5 2009 2013 WHO; WHO Regional Office for Europe, HLTH CIT WORLD OV HL; WHO Regional Office for Europe, HLTH CIT PROJ PHAS 3; WHO UNICEF, 2010, PROGR SAN DRINK WAT; WHO/World Bank, WORLD REP DIS; Wilkinson P, 2004, BMJ-BRIT MED J, V329, P647, DOI 10.1136/bmj.38167.589907.55; Wilkinson P, 2001, COLD COMFORT SOCIAL; Wilkinson P, 2007, LANCET, V370, P1175, DOI 10.1016/S0140-6736(07)61255-0; Wilkinson P, 2007, LANCET, V370, P965, DOI 10.1016/S0140-6736(07)61252-5; Wilkinson P, 2009, LANCET, V374, P1917, DOI 10.1016/S0140-6736(09)61713-X; Williams P, 2009 JOINT REV WINT; WolleswinkelVandenBosch JH, 1997, INT J EPIDEMIOL, V26, P772, DOI 10.1093/ije/26.4.772; Wood DM, 2004, CLIN SCI, V106, P527, DOI 10.1042/CS20030333; Woodcock J, 2007, LANCET, V370, P1078, DOI 10.1016/S0140-6736(07)61254-9; World Health Organisation, 2010, HIDD CIT UNM OV HLTH; World Health Organization, 2006, WHO HOUS EN DAT; World Health Organization, TYP HLTH SETT; WRC. RPA, 2008, ENV EC SOC I 1 UNPUB; Wright L, 2004, RECLAIMING PUBLIC SP; WSP, PARTN COMM SUST SAN; WSP, 2006, MUMB SLUM SAN PROGR; WSP, 2004, CAS MARK SAN WAT SAN; Ye Y, 2009, AM J TROP MED HYG, V81, P770, DOI 10.4269/ajtmh.2009.09-0070; Yokohari M., 2005, LANDSC ECOL ENG, V1, P53, DOI DOI 10.1007/s11355-005-0012-2; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479	275	418	435	39	368	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	2012	379	9831					2079	2108		10.1016/S0140-6736(12)60435-8	http://dx.doi.org/10.1016/S0140-6736(12)60435-8			30	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	951ZI	22651973	Green Accepted			2022-12-24	WOS:000304759100033
J	Peron, S; Laffleur, B; Denis-Lagache, N; Cook-Moreau, J; Tinguely, A; Delpy, L; Denizot, Y; Pinaud, E; Cogne, M				Peron, Sophie; Laffleur, Brice; Denis-Lagache, Nicolas; Cook-Moreau, Jeanne; Tinguely, Aurelien; Delpy, Laurent; Denizot, Yves; Pinaud, Eric; Cogne, Michel			AID-Driven Deletion Causes Immunoglobulin Heavy Chain Locus Suicide Recombination in B Cells	SCIENCE			English	Article							CLASS-SWITCH RECOMBINATION; IGH LOCUS; HISTONE MODIFICATIONS; REGION; ELEMENTS; IDENTIFICATION; ACTIVATION; END; MU	Remodeling of immunoglobulin genes by activation-induced deaminase (AID) is required for affinity maturation and class-switch recombination in mature B lymphocytes. In the immunoglobulin heavy chain locus, these processes are predominantly controlled by the 3' cis-regulatory region. We now show that this region is transcribed and undergoes AID-mediated mutation and recombination around phylogenetically conserved switchlike DNA repeats. Such recombination, which we term locus suicide recombination, deletes the whole constant region gene cluster and thus stops expression of the immunoglobulin of the B cell surface, which is critical for B cell survival. The frequency of this event is approaching that of class switching and makes it a potential regulator of B cell homeostasis.	[Peron, Sophie; Laffleur, Brice; Denis-Lagache, Nicolas; Cook-Moreau, Jeanne; Tinguely, Aurelien; Delpy, Laurent; Denizot, Yves; Pinaud, Eric; Cogne, Michel] Univ Limoges, CNRS, F-87025 Limoges, France	Centre National de la Recherche Scientifique (CNRS); Universite de Limoges	Cogne, M (corresponding author), Univ Limoges, CNRS, 2 Rue Marcland, F-87025 Limoges, France.	cogne@unilim.fr	Denizot, Yves/H-9769-2016; PERON, SOPHIE/O-8364-2016; PINAUD, Eric/O-8443-2016; Delpy, Laurent/O-8408-2016; cogné, michel/D-7370-2015; Moreau, Jeanne/O-8522-2016	PERON, SOPHIE/0000-0002-0056-3271; PINAUD, Eric/0000-0001-7405-9273; Delpy, Laurent/0000-0002-9480-8515; cogné, michel/0000-0002-8519-4427; Moreau, Jeanne/0000-0003-3590-1602	Association pour la Recherche sur le Cancer; Ligue Nationale contre le Cancer; Canceropole Grand Sud-Ouest; Institut National du Cancer; Region Limousin	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Canceropole Grand Sud-Ouest; Institut National du Cancer(Institut National du Cancer (INCA) France); Region Limousin	We thank T. Honjo for providing AID<SUP>-/-</SUP> mice and F. Lechouane for sorted B cells DNA samples. We are indebted to the cell sorting facility of Limoges University for excellent technical assistance in cell sorting. This work was supported by grants from Association pour la Recherche sur le Cancer, Ligue Nationale contre le Cancer, Canceropole Grand Sud-Ouest, Institut National du Cancer, and Region Limousin. The data presented in this paper are tabulated here and in the supplementary materials.	Bebin AG, 2010, J IMMUNOL, V184, P3710, DOI 10.4049/jimmunol.0901978; Chauveau C, 1998, EUR J IMMUNOL, V28, P3048, DOI 10.1002/(SICI)1521-4141(199810)28:10<3048::AID-IMMU3048>3.0.CO;2-V; Chauveau C, 1996, NAT GENET, V14, P15, DOI 10.1038/ng0996-15; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Duan H, 2008, ONCOGENE, V27, P6720, DOI 10.1038/onc.2008.286; Duchez S, 2010, P NATL ACAD SCI USA, V107, P3064, DOI 10.1073/pnas.0912393107; Dunnick WA, 2009, J EXP MED, V206, P2613, DOI 10.1084/jem.20091280; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Giambra V, 2008, MOL CELL BIOL, V28, P6123, DOI 10.1128/MCB.00233-08; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Gostissa M, 2009, NATURE, V462, P803, DOI 10.1038/nature08633; Ju ZL, 2007, J BIOL CHEM, V282, P35169, DOI 10.1074/jbc.M705719200; Khamlichi AA, 2004, BLOOD, V103, P3828, DOI 10.1182/blood-2003-10-3470; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim W, 2004, J BIOL CHEM, V279, P8333, DOI 10.1074/jbc.M312026200; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Pinaud E, 1997, EUR J IMMUNOL, V27, P2981, DOI 10.1002/eji.1830271134; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Pinaud E, 2011, ADV IMMUNOL, V110, P27, DOI 10.1016/B978-0-12-387663-8.00002-8; Sepulveda MA, 2005, MOL IMMUNOL, V42, P605, DOI 10.1016/j.molimm.2004.09.006; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964	26	57	60	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 18	2012	336	6083					931	934		10.1126/science.1218692	http://dx.doi.org/10.1126/science.1218692			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943SN	22539552				2022-12-24	WOS:000304145600069
J	Hochberg, LR; Bacher, D; Jarosiewicz, B; Masse, NY; Simeral, JD; Vogel, J; Haddadin, S; Liu, J; Cash, SS; van der Smagt, P; Donoghue, JP				Hochberg, Leigh R.; Bacher, Daniel; Jarosiewicz, Beata; Masse, Nicolas Y.; Simeral, John D.; Vogel, Joern; Haddadin, Sami; Liu, Jie; Cash, Sydney S.; van der Smagt, Patrick; Donoghue, John P.			Reach and grasp by people with tetraplegia using a neurally controlled robotic arm	NATURE			English	Article							LOCAL-FIELD POTENTIALS; PRIMARY MOTOR; CORTICAL CONTROL; SPIKING ACTIVITY; PROSTHETIC ARM; BRAIN; RESTORATION; MOVEMENTS; SIGNALS; HUMANS	Paralysis following spinal cord injury, brainstem stroke, amyotrophic lateral sclerosis and other disorders can disconnect the brain from the body, eliminating the ability to perform volitional movements. A neural interface system(1-5) could restore mobility and independence for people with paralysis by translating neuronal activity directly into control signals for assistive devices. We have previously shown that people with long-standing tetraplegia can use a neural interface system to move and click a computer cursor and to control physical devices(6-8). Able-bodied monkeys have used a neural interface system to control a robotic arm(9), but it is unknown whether people with profound upper extremity paralysis or limb loss could use cortical neuronal ensemble signals to direct useful arm actions. Here we demonstrate the ability of two people with long-standing tetraplegia to use neural interface system-based control of a robotic arm to perform three-dimensional reach and grasp movements. Participants controlled the arm and hand over a broad space without explicit training, using signals decoded from a small, local population of motor cortex (MI) neurons recorded from a 96-channel microelectrode array. One of the study participants, implanted with the sensor 5 years earlier, also used a robotic arm to drink coffee from a bottle. Although robotic reach and grasp actions were not as fast or accurate as those of an able-bodied person, our results demonstrate the feasibility for people with tetraplegia, years after injury to the central nervous system, to recreate useful multidimensional control of complex devices directly from a small sample of neural signals.	[Hochberg, Leigh R.; Jarosiewicz, Beata; Simeral, John D.; Liu, Jie; Donoghue, John P.] Rehabil Res & Dev Serv, Dept Vet Affairs, Providence, RI 02908 USA; [Hochberg, Leigh R.; Bacher, Daniel; Simeral, John D.; Liu, Jie; Donoghue, John P.] Brown Univ, Sch Engn, Providence, RI 02912 USA; [Hochberg, Leigh R.; Bacher, Daniel; Jarosiewicz, Beata; Masse, Nicolas Y.; Simeral, John D.; Liu, Jie; Donoghue, John P.] Brown Univ, Inst Brain Sci, Providence, RI 02912 USA; [Hochberg, Leigh R.; Simeral, John D.; Cash, Sydney S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Hochberg, Leigh R.; Cash, Sydney S.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Jarosiewicz, Beata; Masse, Nicolas Y.; Donoghue, John P.] Brown Univ, Dept Neurosci, Providence, RI 02912 USA; [Vogel, Joern; Haddadin, Sami; van der Smagt, Patrick] German Aerosp Ctr, Inst Robot & Mechatron DLR Oberpfaffenhofen, D-82230 Oberpfaffenhofen, Germany	Brown University; Brown University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Brown University; Helmholtz Association; German Aerospace Centre (DLR)	Donoghue, JP (corresponding author), Rehabil Res & Dev Serv, Dept Vet Affairs, Providence, RI 02908 USA.	leigh@brown.edu; john_donoghue@brown.edu	Simeral, John/CCI-2624-2022; Hochberg, Leigh/R-6872-2019; Jarosiewicz, Beata/AAT-8548-2021	Hochberg, Leigh/0000-0003-0261-2273; van der Smagt, Patrick/0000-0003-4418-4916; Masse, Nicolas/0000-0002-9094-1298; Vogel, Jorn/0000-0002-1987-0028	Rehabilitation Research and Development Service, Office of Research and Development, Department of Veterans Affairs [B6453R, A6779I, B6310N]; National Institutes of Health: NINDS/NICHD [RC1HD063931]; NIDCD [R01DC009899]; NICHD-NCMRR [N01HD53403, N01HD10018]; NIBIB [R01EB007401]; NINDS-Javits [NS25074]; Defense Advanced Research Projects Agency (DARPA); Department of Veterans Affairs; Doris Duke Charitable Foundation; MGH-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; Katie Samson Foundation; Craig H. Neilsen Foundation; European Commission [248587]; Cyberkinetics Neurotechnology Systems (CKI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [RC1HD063931, R03HD053403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB007401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS025074, R01NS025074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009899] Funding Source: NIH RePORTER	Rehabilitation Research and Development Service, Office of Research and Development, Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health: NINDS/NICHD; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NICHD-NCMRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NINDS-Javits; Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Department of Veterans Affairs(US Department of Veterans Affairs); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); MGH-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; Katie Samson Foundation; Craig H. Neilsen Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Cyberkinetics Neurotechnology Systems (CKI); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank participants S3 and T2 for their dedication to this research. We thank M. Black for initial guidance in the BrainGate-DLR research. We thank E. Gallivan, E. Berhanu, D. Rosler, L. Barefoot, K. Centrella and B. King for their contributions to this research. We thank G. Friehs and E. Eskandar for their surgical contributions. We thank K. Knoper for assistance with illustrations. We thank D. Van Der Merwe and DEKA Research and Development for their technical support. The contents do not represent the views of the Department of Veterans Affairs or the United States Government. The research was supported by the Rehabilitation Research and Development Service, Office of Research and Development, Department of Veterans Affairs (Merit Review Awards B6453R and A6779I; Career Development Transition Award B6310N). Support was also provided by the National Institutes of Health: NINDS/NICHD (RC1HD063931), NIDCD (R01DC009899), NICHD-NCMRR (N01HD53403 and N01HD10018), NIBIB (R01EB007401), NINDS-Javits (NS25074); a Memorandum of Agreement between the Defense Advanced Research Projects Agency (DARPA) and the Department of Veterans Affairs; the Doris Duke Charitable Foundation; the MGH-Deane Institute for Integrated Research on Atrial Fibrillation and Stroke; Katie Samson Foundation; Craig H. Neilsen Foundation; the European Commission's Seventh Framework Programme through the project The Hand Embodied (grant 248587). The pilot clinical trial into which participant S3 was recruited was sponsored in part by Cyberkinetics Neurotechnology Systems (CKI).	Albu-Schaffer A, 2007, IND ROBOT, V34, P376, DOI 10.1108/01439910710774386; Albu-Schaffer A, 2008, IEEE ROBOT AUTOM MAG, V15, P20, DOI 10.1109/MRA.2008.927979; Bansal AK, 2011, J NEUROPHYSIOL, V105, P1603, DOI 10.1152/jn.00532.2010; Burrow M., 1997, P INT C REH ROB, P83; Chadwick EK, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/034003; Chestek CA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/4/045005; Donoghue JP, 2008, NEURON, V60, P511, DOI 10.1016/j.neuron.2008.10.037; Fraser GW, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055004; Gilja V, 2011, IEEE T BIO-MED ENG, V58, P1891, DOI 10.1109/TBME.2011.2107553; Green AM, 2011, TRENDS NEUROSCI, V34, P61, DOI 10.1016/j.tins.2010.11.003; Haddadin S, 2009, INT J ROBOT RES, V28, P1507, DOI 10.1177/0278364909343970; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Jarosiewicz B, 2008, P NATL ACAD SCI USA, V105, P19486, DOI 10.1073/pnas.0808113105; Kim SP, 2007, 2007 3RD INTERNATIONAL IEEE/EMBS CONFERENCE ON NEURAL ENGINEERING, VOLS 1 AND 2, P486, DOI 10.1109/CNE.2007.369715; Kim SP, 2011, IEEE T NEUR SYS REH, V19, P193, DOI 10.1109/TNSRE.2011.2107750; Kim SP, 2008, J NEURAL ENG, V5, P455, DOI 10.1088/1741-2560/5/4/010; Kruger Jurgen, 2010, Front Neuroeng, V3, P6, DOI 10.3389/fneng.2010.00006; Kuiken TA, 2007, LANCET, V369, P371, DOI 10.1016/S0140-6736(07)60193-7; Liu H, 2008, 2008 IEEE/RSJ INTERNATIONAL CONFERENCE ON ROBOTS AND INTELLIGENT SYSTEMS, VOLS 1-3, CONFERENCE PROCEEDINGS, P3692, DOI 10.1109/IROS.2008.4650624; Malik WQ, 2011, IEEE T NEUR SYS REH, V19, P25, DOI 10.1109/TNSRE.2010.2092443; Mehring C, 2003, NAT NEUROSCI, V6, P1253, DOI 10.1038/nn1158; Moritz CT, 2008, NATURE, V456, P639, DOI 10.1038/nature07418; Mulliken GH, 2008, J NEUROSCI, V28, P12913, DOI 10.1523/JNEUROSCI.1463-08.2008; Musallam S, 2004, SCIENCE, V305, P258, DOI 10.1126/science.1097938; Nicolelis MAL, 2009, NAT REV NEUROSCI, V10, P530, DOI 10.1038/nrn2653; Pohlmeyer EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005924; Quiroga RQ, 2009, J NEUROSCI METH, V177, P194, DOI 10.1016/j.jneumeth.2008.09.033; Resnik L, 2010, J REHABIL RES DEV, V47, pIX, DOI 10.1682/JRRD.2010.03.0034; Santhanam G, 2006, NATURE, V442, P195, DOI 10.1038/nature04968; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Shin HC, 2010, IEEE T BIO-MED ENG, V57, P754, DOI 10.1109/TBME.2009.2020791; Simeral JD, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025027; Stark E, 2007, J NEUROSCI, V27, P8387, DOI 10.1523/JNEUROSCI.1321-07.2007; Suner S, 2005, IEEE T NEUR SYS REH, V13, P524, DOI 10.1109/TNSRE.2005.857687; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Vargas-Irwin CE, 2010, J NEUROSCI, V30, P9659, DOI 10.1523/JNEUROSCI.5443-09.2010; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Wu W, 2006, NEURAL COMPUT, V18, P80, DOI 10.1162/089976606774841585	38	1466	1508	60	925	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 17	2012	485	7398					372	U121		10.1038/nature11076	http://dx.doi.org/10.1038/nature11076			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	943CW	22596161	Green Published, Green Accepted, Green Submitted			2022-12-24	WOS:000304099100043
J	Jenal, M; Elkon, R; Loayza-Puch, F; van Haaften, G; Kuhn, U; Menzies, FM; Vrielink, JAFO; Bos, AJ; Drost, J; Rooijers, K; Rubinsztein, DC; Agami, R				Jenal, Mathias; Elkon, Ran; Loayza-Puch, Fabricio; van Haaften, Gijs; Kuehn, Uwe; Menzies, Fiona M.; Vrielink, Joachim A. F. Oude; Bos, Arnold J.; Drost, Jarno; Rooijers, Koos; Rubinsztein, David C.; Agami, Reuven			The Poly(A)-Binding Protein Nuclear 1 Suppresses Alternative Cleavage and Polyadenylation Sites	CELL			English	Article							OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; MESSENGER-RNA POLYADENYLATION; 3' UNTRANSLATED REGIONS; B-CELL DIFFERENTIATION; POLY(A) TAIL LENGTH; BINDING PROTEINS; CANCER; MICRORNAS; GENES; TRANSCRIPTION	Alternative cleavage and polyadenylation (APA) is emerging as an important layer of gene regulation. Factors controlling APA are largely unknown. We developed a reporter-based RNAi screen for APA and identified PABPN1 as a regulator of this process. Genome-wide analysis of APA in human cells showed that loss of PABPN1 resulted in extensive 30 untranslated region shortening. Messenger RNA transcription, stability analyses, and in vitro cleavage assays indicated enhanced usage of proximal cleavage sites (CSs) as the underlying mechanism. Using Cyclin D1 as a test case, we demonstrated that enhanced usage of proximal CSs compromises microRNA-mediated repression. Triplet-repeat expansion in PABPN1 (trePABPN1) causes autosomal-dominant oculopharyngeal muscular dystrophy (OPMD). The expression of trePABPN1 in both a mouse model of OPMD and human cells elicited broad induction of proximal CS usage, linked to binding to endogenous PABPN1 and its sequestration in nuclear aggregates. Our results elucidate a novel function for PABPN1 as a suppressor of APA.	[Jenal, Mathias; Elkon, Ran; Loayza-Puch, Fabricio; van Haaften, Gijs; Vrielink, Joachim A. F. Oude; Bos, Arnold J.; Drost, Jarno; Rooijers, Koos; Agami, Reuven] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Kuehn, Uwe] Univ Halle Wittenberg, Inst Biochem & Biotechnol, D-06120 Halle, Germany; [Menzies, Fiona M.; Rubinsztein, David C.] Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England; [Agami, Reuven] Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands	Netherlands Cancer Institute; Martin Luther University Halle Wittenberg; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Agami, R (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	r.agami@nki.nl	Rubinsztein, David C/C-3472-2011; agami, reuven/GOG-8289-2022; Drost, Jarno/J-9758-2012; Drost, Jarno/M-6964-2017; van Haaften, Gijs/G-7832-2012	Drost, Jarno/0000-0002-2941-6179; Drost, Jarno/0000-0002-2941-6179; van Haaften, Gijs/0000-0003-3033-0329; Loayza-Puch, Fabricio/0000-0002-2999-8594; Rooijers, Koos/0000-0002-0412-468X; Agami, Reuven/0000-0002-2848-2473	ERC (European Research Council); KWF (Dutch cancer foundation); Horizon; VICI-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); CBG (Centre for Biomedical Genetics); SNF (The Swiss National Science Foundation); VENI-NWO; Wellcome Trust	ERC (European Research Council)(European Research Council (ERC)); KWF (Dutch cancer foundation)(KWF Kankerbestrijding); Horizon; VICI-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek); CBG (Centre for Biomedical Genetics); SNF (The Swiss National Science Foundation)(Swiss National Science Foundation (SNSF)); VENI-NWO(Netherlands Organization for Scientific Research (NWO)); Wellcome Trust(Wellcome TrustEuropean Commission)	We thank all members of the Agami group including Bob Rosier for technical help and discussions. We thank Roderick Beijersbergen, Pasi Halonen, and Ben Morris from the NKI Robotics and screening center. Further we are grateful to Arno Velds and Ron Kerkhoven at the NKI Central genomics facility for deep sequencing our samples. This work was supported by funds from the ERC (European Research Council), KWF (Dutch cancer foundation), Horizon and VICI-NWO (Nederlandse Organisatie voor Wetenschappelijk Onderzoek), and CBG (Centre for Biomedical Genetics) to R. A., the SNF (The Swiss National Science Foundation) to M.J., the VENI-NWO to G. v. H., and the Wellcome Trust Principal Research Fellowship to D.C.R.	Andreassi C, 2009, TRENDS CELL BIOL, V19, P465, DOI 10.1016/j.tcb.2009.06.001; Bear DG, 2003, EXP CELL RES, V286, P332, DOI 10.1016/S0014-4827(03)00123-X; Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001; Beck AH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008768; Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006; Blumen SC, 1997, NEUROMUSCULAR DISORD, V7, pS38, DOI 10.1016/S0960-8966(97)00080-1; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Calado A, 2000, RNA, V6, P245, DOI 10.1017/S1355838200991908; Davies JE, 2011, HUM MOL GENET, V20, P1154, DOI 10.1093/hmg/ddq559; Davies JE, 2005, NAT MED, V11, P672, DOI 10.1038/nm1242; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Gomez-Benito M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025449; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kedde M, 2010, NAT CELL BIOL, V12, P1014, DOI 10.1038/ncb2105; Kuhn U, 2009, J BIOL CHEM, V284, P22803, DOI 10.1074/jbc.M109.018226; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lee JY, 2007, NUCLEIC ACIDS RES, V35, pD165, DOI 10.1093/nar/gkl870; Lemay JF, 2010, RNA BIOL, V7, P291, DOI 10.4161/rna.7.3.11649; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Lutz CS, 2008, ACS CHEM BIOL, V3, P609, DOI 10.1021/cb800138w; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Nunes NM, 2010, EMBO J, V29, P1523, DOI 10.1038/emboj.2010.42; Ozsolak F, 2010, CELL, V143, P1018, DOI 10.1016/j.cell.2010.11.020; Ruegg S, 2005, SWISS MED WKLY, V135, P574; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Shepard PJ, 2011, RNA, V17, P761, DOI 10.1261/rna.2581711; Shi YS, 2009, MOL CELL, V33, P365, DOI 10.1016/j.molcel.2008.12.028; Takagaki Y, 1998, MOL CELL, V2, P761, DOI 10.1016/S1097-2765(00)80291-9; Takagaki Y, 1996, CELL, V87, P941, DOI 10.1016/S0092-8674(00)82000-0; Tavanez JP, 2005, RNA, V11, P752, DOI 10.1261/rna.7217105; Thome FS, 1997, ADV PERIT D, V13, P141; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; WAHLE E, 1995, J BIOL CHEM, V270, P2800, DOI 10.1074/jbc.270.6.2800; Wahle E., 1994, RNA PROCESSING PRACT, VII, P1; Zhang XK, 2010, CELL CYCLE, V9, P4437, DOI 10.4161/cc.9.22.13887	44	232	238	1	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	APR 27	2012	149	3								10.1016/j.cell.2012.03.022	http://dx.doi.org/10.1016/j.cell.2012.03.022			16	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	934KN	22502866	Bronze			2022-12-24	WOS:000303443100007
J	Pelkmans, L				Pelkmans, Lucas			Using Cell-to-Cell Variability-A New Era in Molecular Biology	SCIENCE			English	Editorial Material							HETEROGENEITY; CONSEQUENCES; INFORMATION; INFECTION; ORIGINS; GROWTH; IMAGES		Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland	University of Zurich	Pelkmans, L (corresponding author), Univ Zurich, Inst Mol Life Sci, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	lucas.pelkmans@imls.uzh.ch		Pelkmans, Lucas/0000-0002-6754-9730				Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Boland MV, 1999, TRENDS CELL BIOL, V9, P201, DOI 10.1016/S0962-8924(99)01550-0; BROOKS RF, 1988, J CELL SCI, V90, P601; Carpenter Anne E., 2009, V486, P193, DOI 10.1007/978-1-60327-545-3_14; Danuser G, 2011, CELL, V147, P973, DOI 10.1016/j.cell.2011.11.001; das Neves RP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000560; EAGLE H, 1967, NATURE, V213, P1102, DOI 10.1038/2131102a0; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Li DL, 2011, P NATL ACAD SCI USA, V108, P21063, DOI 10.1073/pnas.1109773109; Loewer A, 2011, CURR OPIN GENET DEV, V21, P753, DOI 10.1016/j.gde.2011.09.010; Pearl J., 2000, CAUSALITY MODELS REA, DOI DOI 10.1017/CBO9780511803161; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Snijder B, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.9; Snijder B, 2011, NAT REV MOL CELL BIO, V12, P119, DOI 10.1038/nrm3044; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Tsou L, 2011, CELL METAB, V13, P476, DOI 10.1016/j.cmet.2011.03.006; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Welch CM, 2011, NAT REV MOL CELL BIO, V12, P749, DOI 10.1038/nrm3212; Yuan TL, 2011, CURR BIOL, V21, P173, DOI 10.1016/j.cub.2010.12.047	23	118	118	5	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 27	2012	336	6080					425	426		10.1126/science.1222161	http://dx.doi.org/10.1126/science.1222161			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	931QC	22539709				2022-12-24	WOS:000303233400033
J	Lamming, DW; Ye, L; Katajisto, P; Goncalves, MD; Saitoh, M; Stevens, DM; Davis, JG; Salmon, AB; Richardson, A; Ahima, RS; Guertin, DA; Sabatini, DM; Baur, JA				Lamming, Dudley W.; Ye, Lan; Katajisto, Pekka; Goncalves, Marcus D.; Saitoh, Maki; Stevens, Deanna M.; Davis, James G.; Salmon, Adam B.; Richardson, Arlan; Ahima, Rexford S.; Guertin, David A.; Sabatini, David M.; Baur, Joseph A.			Rapamycin-Induced Insulin Resistance Is Mediated by mTORC2 Loss and Uncoupled from Longevity	SCIENCE			English	Article							LIFE-SPAN EXTENSION; CALORIE RESTRICTION; GLUCOSE-METABOLISM; COMPLEX 2; KINASE; TOR; SENSITIVITY; DROSOPHILA; ABLATION; RECEPTOR	Rapamycin, an inhibitor of mechanistic target of rapamycin complex 1 (mTORC1), extends the life spans of yeast, flies, and mice. Calorie restriction, which increases life span and insulin sensitivity, is proposed to function by inhibition of mTORC1, yet paradoxically, chronic administration of rapamycin substantially impairs glucose tolerance and insulin action. We demonstrate that rapamycin disrupted a second mTOR complex, mTORC2, in vivo and that mTORC2 was required for the insulin-mediated suppression of hepatic gluconeogenesis. Further, decreased mTORC1 signaling was sufficient to extend life span independently from changes in glucose homeostasis, as female mice heterozygous for both mTOR and mLST8 exhibited decreased mTORC1 activity and extended life span but had normal glucose tolerance and insulin sensitivity. Thus, mTORC2 disruption is an important mediator of the effects of rapamycin in vivo.	[Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] Seven Cambridge Ctr, Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Lamming, Dudley W.; Katajisto, Pekka; Saitoh, Maki; Stevens, Deanna M.; Guertin, David A.; Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Ye, Lan; Davis, James G.; Baur, Joseph A.] Univ Penn, Perelman Sch Med, Dept Physiol, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Goncalves, Marcus D.; Ahima, Rexford S.] Univ Penn, Perelman Sch Med, Dept Med, Inst Diabet Obes & Metab, Philadelphia, PA 19104 USA; [Salmon, Adam B.; Richardson, Arlan] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78245 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Health San Antonio	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu; baur@mail.med.upenn.edu	Ahima, Rexford/W-1394-2019; Lamming, Dudley/O-7191-2015; Goncalves, Marcus/L-6073-2019	Lamming, Dudley/0000-0002-0079-4467; Goncalves, Marcus/0000-0002-0784-9248; Katajisto, Pekka/0000-0002-3033-4189; /0000-0002-1446-7256; Baur, Joseph/0000-0001-8262-6549	American Federation for Aging Research (AFAR); Bingham Trust from Penn's Institute on Aging; NIH [CA129105]; AFAR; Starr Foundation; Koch Institute; Ellison Medical Foundation; Damon Runyon Fellowship; Ruth L. Kirschstein National Research Service [1F32AG032833-01A1]; American Heart Association [7600031]; Academy of Finland; Foundations' post-doc pool; NATIONAL CANCER INSTITUTE [R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK019525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG032833] Funding Source: NIH RePORTER	American Federation for Aging Research (AFAR); Bingham Trust from Penn's Institute on Aging; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AFAR; Starr Foundation; Koch Institute; Ellison Medical Foundation(Lawrence Ellison Foundation); Damon Runyon Fellowship; Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Academy of Finland(Academy of Finland); Foundations' post-doc pool; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank all the members of the Baur and Sabatini laboratories, especially D. Frederick, A. Hutchins, P. Hsu, H. Keys, N. Kalaany, M. Laplante, M. Pacold, and Y. Sancak for help with protocols, reagents, and advice. We also thank D. Cohen and D. Harrison for valuable advice and consultation, C. Patterson for critical reading of the manuscript, and G. Bell of the Whitehead Institute Bioinformatics and Research Computing group for help with statistical analysis and R. The mtor-, Raptor-, and mlst8-deficient mice were generated in collaboration with Bristol-Meyers Squibb. Rictor conditional knockout mice were the kind gift of M. Magnuson. This project was supported by a research grant from the American Federation for Aging Research (AFAR) and a Bingham Trust Pilot Award from Penn's Institute on Aging to J.A.B.; a grant from NIH (CA129105) and awards from AFAR, the Starr Foundation, the Koch Institute Frontier Research Program, and the Ellison Medical Foundation to D.M.S.; and a Damon Runyon Fellowship to D.A.G. D.W.L. was supported by a Ruth L. Kirschstein National Research Service Award (1F32AG032833-01A1), L.Y. is supported by a postdoctoral fellowship from the American Heart Association (7600031), and P.K. is supported by the Academy of Finland and the Foundations' post-doc pool. Core services were provided by Penn's Diabetes and Endocrinology Research Center (P30DK19525). D.M.S. is an investigator of the Howard Hughes Medical Institute.	Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106; Dominici FP, 2002, J ENDOCRINOL, V173, P81, DOI 10.1677/joe.0.1730081; Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922; Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Johnston O, 2008, J AM SOC NEPHROL, V19, P1411, DOI 10.1681/ASN.2007111202; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; OLSHANSKY SJ, 1985, AM J PUBLIC HEALTH, V75, P754, DOI 10.2105/AJPH.75.7.754; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Taguchi A, 2007, SCIENCE, V317, P369, DOI 10.1126/science.1142179; Teutonico A, 2005, J AM SOC NEPHROL, V16, P3128, DOI 10.1681/ASN.2005050487; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Weindruch R., 1988, RETARDATION AGING DI; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181	30	812	850	3	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 30	2012	335	6076					1638	1643		10.1126/science.1215135	http://dx.doi.org/10.1126/science.1215135			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	915YD	22461615	Green Accepted, Green Submitted			2022-12-24	WOS:000302062600049
J	Powell, K				Powell, Kendall			MOLECULAR ONCOLOGY The positive in the negative	NATURE			English	Editorial Material																		Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Shah S.P, 2012, NATURE          0404, DOI [10.1038/nature10933, DOI 10.1038/NATURE10933]; Stead LA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2242	6	7	7	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAY 31	2012	485	7400					S52	S53		10.1038/nj7395-553a	http://dx.doi.org/10.1038/nj7395-553a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	949WP	22548214	Bronze			2022-12-24	WOS:000304608000002
J	Hughes, V				Hughes, Virginia			Genomics: A complex code	NATURE			English	Editorial Material																			0	8	8	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 12	2012	484	7393					S3	S3		10.1038/nature11105	http://dx.doi.org/10.1038/nature11105			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	930OV	22509504	Bronze			2022-12-24	WOS:000303149900045
